Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Elsevier_Pathway_Collection__Natural Killer Cell Precursor -> Natural Killer Cell Surface Expression Markers,-0.6276856248154914,-2.365312775955935,0.0,0.0,0.0,45/73,18.36%,LAG3;CXCR1;FPR1;CD69;IL7R;FASLG;NCR1;KIR3DL2;KLRC1;FPR2;IL18RAP;FCRL6;CD38;PDGFRA;NCAM1;CD1D;STX11;CCR7;NCR3;SEMA4D;CD96;CD48;PTPRC;FCGR3A;CD300A;TLR8;CD2;CD40LG;NTRK1;LILRB1;CD274;SYK;CD226;KLRK1;CXCR3;LTA;LILRB4;ITGB2;TNFSF8;CD6;KIR2DS4;LILRB2;CD33;SLAMF1;CD19
prerank,Elsevier_Pathway_Collection__Proteins Involved in Acne Vulgaris,-0.6875874303294796,-2.345333288178165,0.0,0.0028032479998092216,0.004,28/40,15.75%,TAC1;CYP26A1;CSF3;IL10;PTGS2;IFNG;CD4;TNF;PTH1R;FASLG;SRD5A1;CD80;IL18;NGFR;FGFR2;FOXO1;SHBG;IL1RN;CXCL8;TLR4;TLR2;AKT1;CAMP;MAL;PSTPIP1;IGF1;CD83;TNFRSF1B
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,-0.6679886965751473,-2.331872225976973,0.0,0.0037376639997456287,0.008,29/43,18.49%,CSF3;IL10;CXCL10;PTGS2;TNF;IL1B;CCL5;FPR1;CD80;CCR5;CCL4;CCL3;IL18;CXCL2;CCL2;IL6;CCR1;IL12B;IL1RN;CCR2;CXCL8;CCL22;CSF2;CD86;TNFRSF1B;IL10RA;CXCL1;PTAFR;LIF
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.7176981628745212,-2.3276865502750805,0.0,0.0028032479998092216,0.008,24/34,18.36%,IGLL5;IGLL1;CD79A;CD38;ITK;PIK3CD;NFAM1;CTLA4;PRKCB;PTPRC;MS4A1;RFTN1;BLK;MNDA;BTK;LCK;NCKAP1L;SYK;LAT2;PLCG2;BMX;VAV3;BCL2;CD19
prerank,KEGG_2021_Human__Staphylococcus aureus infection,-0.6380564809909768,-2.3249837981466084,0.0,0.002242598399847377,0.008,47/68,24.54%,KRT39;IL10;KRT23;FCAR;KRT15;KRT36;KRT19;KRT14;FPR1;FPR2;FCGR3B;DEFB1;KRT16;FCGR3A;C4A;FCGR2B;HLA-DQA2;MBL2;PLG;C1QC;C1R;HLA-DOB;CAMP;FPR3;CFI;C1QB;ITGB2;HLA-DQA1;PTAFR;C3AR1;SELPLG;C1S;C1QA;C5;HLA-DOA;HLA-DRB5;KRT13;SELP;HLA-DRA;MASP1;ITGAM;HLA-DPA1;C3;HLA-DPB1;CFD;C4B;HLA-DRB1
prerank,WikiPathway_2021_Human__Allograft Rejection WP2328,-0.6188632434865076,-2.324671985149739,0.0,0.0018688319998728144,0.008,50/80,24.54%,CXCL13;FOXP3;IL10;CXCL11;IFNG;TNF;IL1B;FASLG;LRRK2;CD80;CXCL9;C9;PDGFRA;C7;C6;CTLA4;CXCL12;PRF1;CD40LG;ABCB1;IL12B;C4A;HLA-DQA2;CXCL8;C1QC;HLA-DOB;C1QB;CD86;CASP7;HLA-DQA1;C8A;GZMB;C8B;C1QA;C5;PECR;AGTR1;HLA-DOA;PRKCZ;HLA-DRB5;GNLY;CD55;HLA-DRA;CD40;STAT1;HLA-DPA1;C3;HLA-DPB1;C4B;HLA-DRB1
prerank,Elsevier_Pathway_Collection__CD8+ Naive T-cell -> CD4+ Naive T-cell Surface Expression Markers,-0.6996880674352257,-2.310645678965115,0.0,0.0032037119997819674,0.012,21/35,14.96%,CCR9;CD4;CD27;CD69;IL7R;CD80;KLRC1;BTLA;CCR5;CD38;CXCR6;ICOS;CCR7;CTLA4;PTPRC;PRF1;CD40LG;TLR2;CCR4;CXCR3;CXCR4
prerank,Elsevier_Pathway_Collection__Natural Killer Cell Inhibitory Receptor Signaling,-0.602015905828682,-2.3056714362094684,0.0,0.0028032479998092216,0.012,23/50,18.93%,KIR2DL1;KLRD1;KIR3DL2;KLRC1;TIGIT;SIGLEC7;MAP2K1;SIGLEC9;KLRB1;FYN;LCP2;CD300A;LILRB1;LCK;DOK2;LAT;SYK;PLCG2;VAV1;VAV3;ZAP70;INPP5D;KIR3DL1
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.5719039974628038,-2.2948352983646267,0.0,0.0024917759998304193,0.012,41/89,17.38%,GSTA2;CYP2C19;UGT2A1;GGT6;UGT1A5;GLYATL3;SLC28A3;BCHE;GLYATL2;CYP2C8;SLC22A7;GLYAT;GSTA1;PCK1;ADH1A;UGT1A9;SLC22A1;UGT2B7;GLYATL1;XDH;SLCO1B3;SLC28A2;CYP2C9;ALB;UGT2B28;UGT2B10;ABCB1;SLCO2B1;PON3;SULT1C4;CYP3A4;UGT2A3;ACSM5;PON1;SULT2A1;SLCO1B1;VAV1;UGT2B15;TPMT;VAV3;UGT1A7
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5682913567711875,-2.2711881624083,0.0,0.002803247999809222,0.016,37/71,18.36%,FOXP3;IL10;RIPK3;IL1B;PNP;CCL5;CD80;IL27;VTCN1;IL15;CD1D;PLA2G2D;LGALS3;VSIG4;PTPRC;CD3E;IL6;CR1;CD40LG;IL12B;LILRB1;CD274;PDCD1LG2;SPN;NCKAP1L;SFTPD;VCAM1;TNFRSF13C;CD86;TNFRSF1B;LILRB4;TNFSF8;CD6;LILRB2;CLC;TNFRSF21;AIF1
prerank,Elsevier_Pathway_Collection__Proteins Involved in HIV Type 1 Infection,-0.5989217578285618,-2.2679730111921623,0.0,0.0030580887270646056,0.016,42/79,17.22%,TAC1;CLEC4M;CR2;IL10;IFNG;CD4;TNF;IL1B;CD8A;CCL5;IL7R;FASLG;FPR2;CCR5;CCL4;CCL3;CD38;CXCR6;TNFSF10;IL15;CTLA4;CXCL12;CCL2;IL6;CD40LG;ABCB1;CCR2;LCK;TLR4;CCL22;CD207;TLR2;SFTPD;IL16;CAMP;PTN;CSF2;CXCR4;PLAUR;LILRB2;THBS1;GATA1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.6478426947081521,-2.2600542488392596,0.0,0.003270455999777425,0.02,26/41,18.26%,FOXP3;IFNL1;IL10;LAX1;PTPN22;CD80;TIGIT;VTCN1;PLA2G2D;LGALS3;VSIG4;CR1;LILRB1;CD274;FCGR2B;PDCD1LG2;SPN;NCKAP1L;RIPOR2;SFTPD;HAVCR2;TNFAIP8L2;CD86;LILRB4;LILRB2;TNFRSF21
prerank,Elsevier_Pathway_Collection__Th1-Cell Activation in Crohn's Disease,-0.6892811176642739,-2.241073440727208,0.0,0.004312689230475726,0.028,23/34,20.09%,IFNG;CD4;IL18R1;CD80;IL27;CCR5;IL18;TNFSF15;ICOS;CD3E;CD3G;RUNX3;TBX21;IL12B;LCK;CD247;LAT;CXCR3;FCER1G;IL12RB1;ZAP70;CD3D;IL12RB2
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.575907722135423,-2.2349788827855614,0.0,0.005206031999645698,0.032,47/90,16.17%,CXCL13;IL20RA;IL20RB;IL10;CXCL10;CXCL14;CCR9;CXCL11;TNF;IL2RB;CCL5;CXCR1;CXCR2;IL18R1;CXCL3;CCL4L2;CXCL9;IL18RAP;CCR5;XCR1;CCL4;CCL3;IL18;TNFSF10;XCL1;CCL23;CCR7;ACKR4;CXCL12;CXCL2;CCL2;IL6;CCR1;CCL3L3;XCL2;CCR2;CXCL8;CCL22;CCR4;PF4V1;CXCR3;CXCR4;LTA;TNFRSF1B;IL10RA;CXCL1;CSF1R
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.5667508586514682,-2.2236510940835976,0.0,0.005232729599643881,0.032,64/112,19.63%,CLEC1B;TREML1;TREML2;IGLL5;CD160;CD8B;CD8A;SLAMF7;CD1B;CD200R1;SH2D1A;KIR2DL3;NCR1;KLRD1;KIR3DL2;KLRC1;CRTAM;SIGLEC7;KIR2DL4;SIGLEC8;SLAMF6;SIGLEC6;CD1D;LILRA2;LILRA1;SIGLEC10;CD1E;SIGLEC11;LILRA5;NCR3;KLRF1;CD96;SIGLEC9;ICAM3;SIGLEC1;KLRB1;CD3E;CD300A;LILRB5;CD40LG;LILRB1;SH2D1B;FCGR2B;CD1C;ULBP3;LILRA6;CD247;CD226;KLRK1;CD300C;VCAM1;OSCAR;CD300E;LILRB4;ITGB2;LILRA4;LILRB2;ITGA4;CD33;CD19;JAML;KIR3DL1;SELL;CD3D
prerank,Elsevier_Pathway_Collection__Natural Killer Cell Activation through ITAM-Containing Receptors,-0.6004111810254532,-2.2223063367252998,0.0,0.004905683999666138,0.032,25/55,16.88%,IFNG;TNF;FOS;FASLG;NCR1;KLRD1;FCGR3B;MAP2K1;NCR3;PRF1;PRKCQ;FCGR3A;FYN;LCP2;LCK;CD247;LAT;SYK;LAT2;PLCG2;CSF2;FCER1G;KIR2DS4;VAV3;ZAP70
prerank,Elsevier_Pathway_Collection__B-Cell Chronic Lymphocytic Leukemia,-0.5476600537525241,-2.211151269804081,0.0,0.004617114352626953,0.032,37/90,17.09%,CXCL13;IRF4;CXCL10;DLEU7;CXCL11;TNFRSF17;FOS;CD79A;CXCL9;CCL4;CCL3;CD38;CCR7;TNFRSF13B;CXCL12;FOXO1;MS4A1;CD40LG;TCL1A;BTK;CD180;LCK;TLR4;CCL22;TLR2;AKT1;TNFSF13;SYK;VCAM1;PLCG2;MYD88;CXCR3;CXCR4;TNFSF13B;ZAP70;BCL2;ITGA4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.6681052226184439,-2.204106657581476,0.0,0.004672079999682036,0.036,23/36,18.26%,FOXP3;IL10;CD80;VTCN1;PLA2G2D;VSIG4;TNFRSF13B;CTLA4;CR1;CD300A;BLK;LILRB1;CD274;MNDA;FCGR2B;PDCD1LG2;SPN;SFTPD;CD86;LILRB4;LST1;LILRB2;TNFRSF21
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.6665825075309075,-2.195623660794643,0.0,0.00442618105233035,0.036,24/35,24.54%,IFNG;TNF;KIR2DL1;IL1B;KIR2DL3;FASLG;KLRD1;CD80;KIR3DL2;KLRC1;PRF1;IL6;HLA-DQA2;HLA-DOB;CD86;HLA-DQA1;GZMB;KIR3DL1;HLA-DOA;HLA-DRB5;HLA-DRA;HLA-DPA1;HLA-DPB1;HLA-DRB1
prerank,Elsevier_Pathway_Collection__Th1-Cell Function in Systemic Lupus Erythematosus,-0.6087524101740609,-2.194497438435296,0.0,0.004485196799694754,0.04,29/51,22.05%,IL10;IFNG;CD4;CD80;CAMK4;ICOS;MAP2K1;CD3E;CD3G;IKZF1;FYN;TBX21;IL12B;LCK;CD247;LAT;AKT1;SYK;CREM;FCER1G;IL12RB1;CD86;ZAP70;ETS1;CD3D;IL12RB2;NFATC2;JAK2;STAT1
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.7665542263424228,-2.177630921947308,0.0,0.005072543999654782,0.044,13/18,16.10%,CYP2C19;CYP2A7;CYP2A13;CYP2B6;CYP2C8;CYP4A11;CYP4F2;CYP1A2;CYP2C18;CYP2C9;CYP4F12;EPHX2;CYP2J2
prerank,Elsevier_Pathway_Collection__Crohn's Disease,-0.5895415055159513,-2.1770786516340443,0.0,0.004841973817852293,0.044,18/52,12.75%,IRF4;ITLN1;MUC1;IL10;TNFSF11;IFNG;CD4;TNF;IL1B;LRRK2;TLR3;TNFSF10;CASP1;NLRP3;IL6;TICAM2;TLR4;TLR2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hashimoto's Thyroiditis,-0.7565802476074381,-2.1715557790395477,0.0,0.005362735303982859,0.052,13/22,11.59%,CXCL10;PTGS2;CD1A;IFNG;CD4;TNF;CD8A;FASLG;CTLA4;TG;CD40LG;IL12B;CD1C
prerank,Elsevier_Pathway_Collection__T-Cell Cytotoxic Response against Melanocytes in Vitiligo,-0.5541576276135449,-2.1707535692696855,0.0,0.0051392879996502395,0.052,37/86,16.88%,IFNG;CD4;IL1B;IL2RB;IL18R1;CD80;IL27;IL18RAP;IL1RAP;IL18;ICOS;MAP2K1;CTLA4;MAF;PTPRC;PRKCQ;CD3E;CD3G;IL6;FYN;LCP2;CD40LG;TBX21;IL12B;CARD11;CXCL8;GATA3;LCK;CD247;LAT;AKT1;MYD88;FCER1G;IL12RB1;CD86;VAV3;ZAP70
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.5932015870777566,-2.167938826612141,0.0,0.005157976319648968,0.056,30/55,24.54%,FOXP3;IL10;IFNG;TNF;IL1B;IL18R1;IL18RAP;IL18;MAF;IL6;TBX21;IL12B;HLA-DQA2;GATA3;TLR4;TLR2;HLA-DOB;IL21R;IL12RB1;HLA-DQA1;NOD2;IL12RB2;HLA-DOA;HLA-DRB5;JUN;HLA-DRA;STAT1;HLA-DPA1;HLA-DPB1;HLA-DRB1
prerank,KEGG_2021_Human__Retinol metabolism,-0.6030819949972626,-2.1676471746947388,0.0,0.004959592615047085,0.056,27/62,13.70%,CYP26A1;UGT2A1;AWAT2;UGT1A5;CYP2A7;CYP2B6;LRAT;ADH4;CYP2C8;RDH16;ADH1A;UGT1A9;UGT2B7;CYP3A7;CYP1A2;CYP3A7-CYP3A51P;CYP2C18;CYP2C9;ADH1C;UGT2B28;UGT2B10;BCO1;CYP26B1;ADH7;HSD17B6;CYP3A4;UGT2A3
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5015271822928087,-2.167211251112221,0.0,0.00477590399967497,0.056,91/192,22.53%,CXCL13;IRF4;EREG;IL10;IFNG;CD4;TNF;IL1B;CFP;CD8B;CD8A;IL2RB;CCL5;INHBA;CD79A;FASLG;NCR1;KLRD1;CD80;TLR3;CRTAM;CXCL9;IL18RAP;CCR5;CCL4;IL18;IL15;GPR65;CD1D;ITK;PRKCB;CD96;FYB1;NLRP3;PTPRC;PRF1;CD3E;CD3G;CCL2;IL6;TRAT1;CCR1;LCP2;CD2;CD40LG;GCNT1;IL12B;CCR2;FCGR2B;HDAC9;MBL2;LCK;CD247;CCL22;IRF8;SRGN;TLR2;HLA-DOB;HCLS1;AKT1;IL16;FGR;CXCR3;GZMA;STAB1;IL12RB1;SPI1;CD86;ITGB2;SIT1;ACVR2A;ZAP70;LY75;HLA-DQA1;ETS1;LY86;LIF;GZMB;MAP4K1;ST8SIA4;CD7;CD3D;HLA-DOA;PF4;HLA-DRA;JAK2;CD40;STAT1;F2;ELF4;IGSF6
prerank,Reactome_2022__Aspirin ADME R-HSA-9749641,-0.6291807913313792,-2.1539763193307304,0.0,0.006207191999577562,0.076,20/41,14.15%,CYP2C19;UGT2A1;UGT1A5;GLYATL3;BCHE;GLYATL2;CYP2C8;SLC22A7;GLYAT;UGT1A9;UGT2B7;GLYATL1;CYP2C9;ALB;UGT2B28;UGT2B10;SLCO2B1;CYP3A4;UGT2A3;ACSM5
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.4964310205954538,-2.152708386999479,0.0,0.005993150896143854,0.076,92/194,21.29%,EREG;PROK2;CSF3;MARCO;IL10;CXCL10;ITGB8;KCNMB2;CXCL11;HAS2;KCNA3;IL1B;IL2RB;RGS1;CCL5;INHBA;FPR1;CD69;IL7R;IL18R1;TLR3;ADGRE1;CSF3R;TNFAIP6;FFAR2;CXCL9;IL18RAP;IL18;CXCR6;TNFSF10;TNFSF15;IL15;CCR7;GPR183;SLC28A2;SEMA4D;CD48;LAMP3;TPBG;NLRP3;NMUR1;GCH1;CCL2;PTGER2;IL6;OSM;AXL;LCP2;CLEC5A;CYBB;IL12B;MEFV;PTGER4;CXCL8;LCK;CCL22;TNFRSF9;SLC31A1;PIK3R5;GPR132;TLR2;SELE;RASGRP1;CD82;SLC31A2;MSR1;HBEGF;STAB1;KLF6;LTA;TNFRSF1B;IL10RA;ITGB3;ACVR2A;F3;PLAUR;EBI3;GP1BA;LPAR1;PTAFR;SLAMF1;C3AR1;LIF;SELL;NOD2;MXD1;SLC4A4;CMKLR1;NMI;RNF144B;PTGIR;CD55
prerank,TRRUST_Transcription_Factors_2019__NR1I2 human,-0.7016781417318185,-2.145940563426179,0.0,0.006354028799567569,0.084,15/26,19.88%,THRSP;IL10;CYP2B6;CYP2C8;CYP2C9;CCL2;CYP4F12;ABCB1;CYP3A4;KLF6;HP;THBS1;BCL2;PTAFR;NOD2
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5824346160378299,-2.1434335639170623,0.0,0.006329914838278888,0.088,42/68,24.67%,EREG;IFNL1;IL10;IFNG;GBP5;SIGLEC16;CCL5;PCK1;FPR2;IL15;CD1D;CCR7;RSAD2;NLRP3;PTPRC;TLR8;IL12B;LILRB1;SASH3;SH2D1B;FCGR2B;SKAP1;SPHK2;CD226;IL12RB1;CD177;ITGB2;LGALS9;SLC15A4;ADAM8;NOD2;MYB;XBP1;NMI;RIOK3;CYBA;HLA-DRA;ITGAM;F2RL1;CD81;HLA-DRB1;PLSCR1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6291685933622216,-2.136948749531347,0.0,0.006657713999546902,0.092,21/38,19.22%,GNMT;GLYAT;CYP4F2;CYP1A2;CYP2C9;DAO;PLA2G4A;PON3;CYP4F3;HAO1;TBXAS1;ST6GAL1;PON1;DDO;GNE;CYP2J2;CARNMT1;PTGIS;GSTO2;AGXT;CYB5A
prerank,Elsevier_Pathway_Collection__CD4+T-Cell Response in Celiac Disease,-0.5424352030269917,-2.136715745352061,0.0,0.006455965090469724,0.092,36/86,16.88%,IFNG;CD4;IL1B;IL2RB;IL18R1;CD80;IL27;IL18RAP;IL1RAP;IL18;ICOS;MAP2K1;CTLA4;MAF;PTPRC;PRKCQ;CD3E;CD3G;IL6;FYN;LCP2;CD40LG;TBX21;IL12B;CARD11;GATA3;LCK;CD247;LAT;AKT1;MYD88;FCER1G;IL12RB1;CD86;VAV3;ZAP70
prerank,Elsevier_Pathway_Collection__Natural Killer Cell in Diabetes Mellitus Type 1,-0.5932706981521726,-2.1266184604742775,0.0,0.0070905684701056786,0.108,26/49,21.42%,IFNG;IL2RB;FOS;CD69;FASLG;NCR1;MAP2K1;PRF1;PRKCQ;FCGR3A;FYN;LCP2;CD274;PDCD1LG2;ULBP3;LAT;SYK;KLRK1;FCER1G;GZMA;VAV1;ZAP70;INPP5D;GZMB;NFATC2;JUN
prerank,Elsevier_Pathway_Collection__Goblet-Cell Related Mucus Secretion in Asthma,-0.605245275811408,-2.126552196618959,0.0,0.00688798079953123,0.108,11/44,9.58%,ERN2;IL13RA2;MUC5AC;PTGS2;AGR2;TNF;IL1B;ANO1;MAP2K1;TGFA;PTGER2
prerank,Elsevier_Pathway_Collection__B-Cell Activation in Crohn's Disease,-0.6878541831883956,-2.117053864196378,0.0,0.0074753279994912575,0.124,19/27,21.48%,IL10;CD4;CD80;MAF;CD3E;CD3G;IL6;FYN;GATA3;LCK;CD247;LAT;PLCG2;FCER1G;CD86;ZAP70;CD3D;NFATC2;JAK2
prerank,Elsevier_Pathway_Collection__CCR1 Expression Targets,-0.6870383755142692,-2.1096803041955483,0.0,0.0075763459454303295,0.128,13/26,9.92%,IL10;CXCL10;PTGS2;CXCL11;TNF;MMP1;CCL5;CXCL9;CCL4;CCL3;CCL23;CCL2;CCR1
prerank,Elsevier_Pathway_Collection__Treg-Cell Differentiation,-0.5769679574582061,-2.107862662876975,0.0,0.007672047157372607,0.136,23/55,16.88%,IRF4;FOXP3;IL10;CD4;IL2RB;CD80;ICOS;MAP2K1;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;FYN;CD40LG;CARD11;LCK;CD247;LAT;AKT1;FCER1G;CD86;ZAP70
prerank,Elsevier_Pathway_Collection__Proteins Involved in Inflammatory Bowel Diseases,-0.5756913204968057,-2.104699831985168,0.0,0.008194109537903877,0.148,28/58,14.91%,TAC1;FOXP3;MUC1;IL10;CXCL10;PTGS2;IFNG;CD4;TNF;IL1B;HGF;LGALS2;IL18;TNFSF15;IL15;CTLA4;PTPRC;VNN1;CCL2;IL6;ABCB1;IL12B;NR1I2;CXCL8;TLR4;TLR2;S100A12;REEP6
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.7448206559742613,-2.1038569519914585,0.0,0.00798925679945628,0.148,12/16,18.36%,CR2;IL10;CD79A;GAPT;PTPRC;MS4A1;CD40LG;CD180;RASGRP1;CTPS1;BCL2;CD19
prerank,Elsevier_Pathway_Collection__Natural Killer Cell Activation through ITSM-Containing Receptors,-0.653710389348671,-2.0939564261074057,0.0,0.00875160351159952,0.16,17/33,15.00%,IFNG;TNF;SLAMF7;FOS;SH2D1A;CD244;FASLG;SLAMF6;MAP2K1;CD48;PRF1;PRKCQ;FYN;SH2D1B;LAT;CSF2;VAV1
prerank,Elsevier_Pathway_Collection__Proteins Involved in B-Cell Chronic Lymphocytic Leukemia,-0.5982063399507488,-2.0832494134283106,0.0,0.009344159999364072,0.172,21/51,17.44%,CXCL13;IRF4;DLEU7;IFNG;TNF;CD38;CCR7;CXCL12;IL6;CD40LG;BCL2A1;TCL1A;CD5;AKT1;TNFSF13;SYK;CXCR4;TNFSF13B;ZAP70;BCL2;LPAR1
prerank,Elsevier_Pathway_Collection__Lymphocyte Mediated Myocardial Injury in Myocarditis,-0.5453412520510972,-2.0832035779696363,0.0,0.009126853952867234,0.172,30/68,16.88%,IRF4;FOXP3;IFNG;CD4;IL1B;CD80;IL27;IL1RAP;IL18;ICOS;PTPRC;PRKCQ;CD3E;CD3G;IL6;FYN;CD40LG;TBX21;IL12B;CARD11;LCK;CD247;LAT;IL21R;AKT1;MYD88;FCER1G;IL12RB1;CD86;ZAP70
prerank,Elsevier_Pathway_Collection__Proteins Involved in Atopic Dermatitis,-0.621768322036675,-2.0830929876473734,0.0,0.008919425453938434,0.172,24/39,15.60%,TAC1;IL10;IFNG;CD4;TNF;IL1B;CD8A;CCL5;S100A8;IL18;FCER1A;PRF1;HRH4;CTSE;CCL22;TLR2;SELE;TSLP;IL16;CAMP;CCR4;MYD88;CSF2;LTA
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,-0.6972219156689808,-2.0817191620104607,0.0,0.009094982399381031,0.172,4/20,1.97%,IFNL2;IL20RA;IL20RB;IFNL1
prerank,Elsevier_Pathway_Collection__CD8+ T-Cell Action Impairment in HIV Type 1 Infection,-0.6731253110373336,-2.080127086343482,0.0,0.009019145738516627,0.176,18/27,21.42%,IFNG;CD8A;FOS;FASLG;MAP2K1;PRF1;CD3E;CD3G;LCK;CD247;LAT;FCER1G;GZMA;LTA;ZAP70;GZMB;CD3D;JUN
prerank,Elsevier_Pathway_Collection__Immune System Activation in Hyperthyroidism,-0.6175552143537281,-2.0754028799551647,0.0,0.009662259063172212,0.188,21/41,16.88%,TSHR;CD4;IL2RB;CD79A;CD80;CTLA4;MAF;PRKCQ;CD3E;CD3G;FYN;CD40LG;GATA3;LCK;CD247;LAT;AKT1;SYK;FCER1G;CD86;ZAP70
prerank,Elsevier_Pathway_Collection__Th17-Cell and Th1 Immune Responsein Psoriatic Arthritis,-0.5431336272230992,-2.0740087725736904,0.0,0.009694565999340224,0.192,27/59,16.88%,IRF4;IFNG;CD4;IL1B;CD80;IL1RAP;IL18;ICOS;PTPRC;PRKCQ;CD3E;CD3G;IL6;FYN;CD40LG;IL12B;CARD11;LCK;CD247;LAT;IL21R;AKT1;MYD88;FCER1G;IL12RB1;CD86;ZAP70
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.6116822183285804,-2.0708222930615814,0.0136986301369863,0.009725554285052401,0.192,24/40,25.15%,EREG;GBP5;SIGLEC16;ACOD1;CCL5;OASL;FPR2;CD1D;SCIMP;TLR8;SH2D1B;CD180;DDX60;SLC15A4;LY86;ADAM8;USP15;NMI;RIOK3;CYBA;DHX58;PLSCR1;LY96;SASH1
prerank,Elsevier_Pathway_Collection__T-Cell Receptor -> NF-kB Signaling,-0.6142847006759447,-2.068104208768877,0.0,0.009643173119343722,0.196,21/39,16.88%,CD4;CD80;ICOS;ITK;CTLA4;PRKCB;PRKCQ;CD3E;CD3G;FYN;LCP2;CARD11;LCK;CD247;LAT;AKT1;IL16;FCER1G;VAV1;CD86;ZAP70
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,-0.4588543937024087,-2.0658909414314275,0.0,0.009564022587584405,0.196,110/239,17.50%,CXCL13;IFNL2;IL20RA;IL13RA2;CSF3;IL20RB;AMHR2;IFNL1;IL10;CXCL10;EDAR;CXCL14;TNFSF11;BMP5;CCR9;CXCL11;IL5RA;IFNG;CD4;TNFRSF17;GHR;TNF;IL1B;TNFRSF11B;BMP10;IL2RB;CCL5;CXCR1;INHBE;CD27;INHBA;CXCR2;IL7R;IL18R1;FASLG;CXCL3;CSF3R;IL27;CCL4L2;CXCL9;GDF2;IL18RAP;CCR5;XCR1;CCL4;CCL3;INHBC;IL1RAP;LIFR;IL18;CXCR6;TNFSF10;TNFSF15;XCL1;IL15;GDF6;NGFR;CCL23;CCR7;TNFRSF13B;ACKR4;CTF1;CXCL12;CXCL2;IL1RL2;CCL2;ACVR1C;IL6;OSM;CCR1;CCL3L3;NGF;XCL2;IL33;CD40LG;BMP7;IL12B;IL1RN;TNFRSF11A;CCR2;CXCL8;CCL22;TNFRSF9;IL21R;TSLP;TNFSF13;IL16;CCR4;PF4V1;IL17RE;IL17RC;CXCR3;CSF2;CXCR4;TNFRSF13C;IL12RB1;LTA;TNFRSF1B;BMPR2;IL10RA;TNFSF8;CXCL1;CSF1R;ACVR2A;TNFSF13B;BMPR1B;GDF10;EBI3;TNFRSF10C;CSF2RB
prerank,Elsevier_Pathway_Collection__Myoblast -> Neutrophil Surface Expression Markers,-0.5528355977898602,-2.062859271930246,0.0,0.00959573353780849,0.2,35/57,25.96%,CEACAM6;TNFSF11;CXCR2;FCGR3B;TNFSF10;NGFR;CCR7;SIGLEC9;ICAM3;KLRB1;FCGR3A;LPAR2;CR1;TLR8;CLEC5A;CD274;FCGR2B;TLR2;CXCR4;CSF1R;TNFSF13B;LPAR1;SELPLG;ITGA3;DMD;CMKLR1;CD55;ITGAM;CD40;THBD;TLR1;CD24;CD14;S1PR3;CLEC4A
prerank,Elsevier_Pathway_Collection__non-Suppressive Treg-Cell in Diabetes Mellitus Type 1,-0.5763426214452534,-2.0588989304095606,0.0,0.00994359667856856,0.204,18/46,16.88%,FOXP3;IFNG;CD4;IL2RB;MAP2K1;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;FYN;CARD11;LCK;CD247;LAT;FCER1G;CD86;ZAP70
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.629666483967229,-2.054712381296468,0.0,0.010174751999307546,0.212,14/29,15.16%,RIPK3;CD1A;CD1B;KLRD1;KLRC1;XCL1;CD1D;CD1E;PTPRC;IL12B;LILRB1;CD1C;AZGP1;IL12RB1
prerank,WikiPathway_2021_Human__Kynurenine Pathway and links to Cellular Senescence WP5044,-0.6956075545786617,-2.0491713974879517,0.0,0.011111055708334733,0.244,11/22,14.24%,AADAT;KLF5;IFNG;TNF;TDO2;FOXO1;IDO2;HAAO;TLR4;KYNU;KMO
prerank,Elsevier_Pathway_Collection__Th2-Cell Function in Ulcerative Colitis,-0.5788241076067909,-2.0452492328980743,0.0,0.011212991999236886,0.248,23/52,16.88%,IL10;IFNG;CD4;IL2RB;CD80;ICOS;MAP2K1;MAF;PTPRC;PRKCQ;CD3E;CD3G;FYN;CD40LG;CARD11;GATA3;LCK;CD247;LAT;AKT1;FCER1G;CD86;ZAP70
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),-0.7439158092791521,-2.040122818771064,0.0,0.011704789893940259,0.268,9/17,13.20%,CIDEA;MFSD2A;TNF;IL1B;ALK;HCAR2;GPLD1;AKT1;SORL1
prerank,Elsevier_Pathway_Collection__Macrophage Related Iron Uptake and Release,-0.7117623050518791,-2.034999945594118,0.0,0.012566284137075822,0.3,9/19,16.81%,ITLN1;TNF;IL1B;TF;CD163;CP;IL6;CSF2;HP
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.7956753589373303,-2.0332468461025384,0.0,0.012543346982197197,0.308,7/15,11.18%,CXCL13;CCL5;CCL4;CCL3;XCL1;XCL2;CCR2
prerank,KEGG_2021_Human__Allograft rejection,-0.6193360080351015,-2.031283592000463,0.0,0.0126146159991415,0.312,20/33,24.54%,IL10;IFNG;TNF;FASLG;CD80;PRF1;CD40LG;IL12B;HLA-DQA2;HLA-DOB;CD86;HLA-DQA1;GZMB;HLA-DOA;HLA-DRB5;HLA-DRA;CD40;HLA-DPA1;HLA-DPB1;HLA-DRB1
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,-0.5759616762644781,-2.027111699189428,0.0,0.012775458097491206,0.328,28/51,16.09%,CXCL13;CXCL10;CCR9;CXCL11;CCL5;CXCR1;CXCR2;CXCL3;CXCL9;CCR5;XCR1;CCL4;CCL3;CXCR6;XCL1;CCR7;ACKR4;CXCL12;CXCL2;CCL2;CCR1;XCL2;CCR2;CXCL8;CCL22;CXCR3;CXCR4;CXCL1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.6068781195909373,-2.027005038853539,0.0,0.01256940232172522,0.328,15/25,14.15%,SLAMF7;CD244;NCR1;PBX1;PIK3CD;NCR3;PTPRC;AXL;CD2;IL12B;ULBP3;IL21R;RASGRP1;NFIL3;KLRK1
prerank,Elsevier_Pathway_Collection__Hashimoto's Thyroiditis,-0.5978113854561752,-2.024782325960592,0.0,0.012814847999127871,0.328,21/46,16.88%,CXCL10;CXCL11;IFNG;CD4;TNF;CD8A;CD79A;IL18R1;FASLG;PTPN22;CXCL9;IL18;CAT;CTLA4;TG;CD247;LAT;SYK;CXCR3;LTA;ZAP70
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.7202415098753276,2.021187008176205,0.0,0.37199095160678713,0.248,11/38,6.05%,TBX4;SIX1;HOXD3;HOXD9;HOXA3;OSR2;HOXD4;HOXB9;SFRP4;RFLNA;HOXC9
prerank,Elsevier_Pathway_Collection__Acute Phase in Atopic Dermatitis,-0.6135009343272674,-2.0177741857131926,0.0,0.013140224999105726,0.34,20/36,16.88%,IL10;CD4;IL2RB;CD80;ICOS;FCER1A;MAF;PTPRC;CD3E;CD3G;FYN;IL33;CD40LG;GATA3;LCK;CD247;TSLP;FCER1G;CD86;ZAP70
prerank,TRRUST_Transcription_Factors_2019__FOXO1 mouse,-0.5674564505659434,-2.016206724259048,0.0,0.013110575260646207,0.34,20/42,15.46%,GCK;FOXP3;PDX1;PCK1;IL7R;PDK4;PPARGC1A;OSTN;CCR7;CCL2;EGR1;IKZF1;G6PC;CCR2;PIK3R1;AKT1;RUNX2;BCL2L11;KLF2;IGFBP1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.49335200293033754,-2.0144805506516423,0.0,0.01316677090819483,0.348,52/109,21.10%,CXCL13;NLRP7;IL10;CXCL10;CXCL11;TNF;IL1B;ACOD1;BPI;CCL5;STAP1;PTPN22;CD80;CXCL3;TNIP3;CXCL9;CCR5;CCL3;IL18;CASP1;CXCL2;NLRP3;CCL2;IL6;AXL;LILRB1;CD274;PDCD1LG2;CXCL8;CD180;TICAM2;TLR4;HCK;CARD16;PF4V1;MYD88;LDOC1;PRKCE;NUGGC;CD86;TNFRSF1B;CXCL1;CD6;LILRB2;SHPK;WNT5A;NOD2;GSTP1;PPBP;PF4;XBP1;CX3CR1
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.49061175967058607,-2.0128378999042966,0.0,0.013221289073727075,0.356,42/104,16.88%,SHC4;IFNG;TNF;KIR2DL1;RAET1L;SH2D1A;CD244;KIR2DL3;FASLG;NCR1;KLRD1;KIR3DL2;KLRC1;FCGR3B;TNFSF10;MAP2K1;PIK3CD;NCR3;PRKCB;CD48;PRF1;FCGR3A;FYN;LCP2;RAC2;SH2D1B;ULBP3;LCK;CD247;LAT;PIK3R1;KLRC4-KLRK1;SYK;KLRK1;PLCG2;CSF2;FCER1G;VAV1;ITGB2;KIR2DS4;VAV3;ZAP70
prerank,Elsevier_Pathway_Collection__T-Cells Differentiation Block in Psoriasis,-0.6175978890060991,-2.0107625518824124,0.015151515151515152,0.01368644611671561,0.364,16/37,15.16%,FOXP3;IL10;PTGS2;IFNG;TNF;IL1B;IL27;IL1RAP;IL18;IL6;RUNX3;TBX21;IL12B;GATA3;MYD88;IL12RB1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.6184463328328705,-2.0095051477169013,0.0,0.013894359651228318,0.376,19/33,18.26%,FOXP3;IL10;CD80;CRTAM;VTCN1;PLA2G2D;VSIG4;CR1;LILRB1;CD274;PDCD1LG2;SPN;SFTPD;CD86;LILRB4;LGALS9;PRNP;LILRB2;TNFRSF21
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,0.7119267102651596,2.0093784762269427,0.005780346820809248,0.2405996521860412,0.308,18/32,16.39%,H3C13;H2AC19;H2BC13;PLK1;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;CDK1;CCNB1;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,Elsevier_Pathway_Collection__Proteins Involved in Multiple Sclerosis,-0.5769190138343835,-2.0084550634996874,0.0,0.01377596159906246,0.376,25/47,15.60%,PLP1;IL10;CXCL10;PTGS2;IFNG;TNF;IL1B;CCL5;CXCR2;FASLG;CD80;CCR5;CCL3;IL18;TNFSF10;CTLA4;MS4A1;CCL2;IL6;CD40LG;CCR2;RTN4;CXCR3;CSF2;LTA
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,-0.570778450910669,-2.0037158893638782,0.0,0.014529510759574558,0.404,27/42,24.54%,IL10;CCR9;TNFRSF17;CD80;IL15;ICOS;TNFRSF13B;CXCL12;IL6;CD40LG;HLA-DQA2;HLA-DOB;TNFSF13;CXCR4;TNFRSF13C;PIGR;CD86;TNFSF13B;HLA-DQA1;ITGA4;HLA-DOA;HLA-DRB5;HLA-DRA;CD40;HLA-DPA1;HLA-DPB1;HLA-DRB1
prerank,Elsevier_Pathway_Collection__Th1-Cell Differentiation,-0.5312495284353519,-1.9995280649370977,0.0,0.014717051998998414,0.404,28/62,16.88%,IFNG;CD4;IL18R1;CD80;IL27;IL18RAP;IL18;ICOS;MAP2K1;PTPRC;PRKCQ;CD3E;CD3G;FYN;CD40LG;TBX21;IL12B;CARD11;LCK;CD247;LAT;AKT1;MYD88;FCER1G;IL12RB1;LTA;CD86;ZAP70
prerank,Elsevier_Pathway_Collection__Th2-Cell Response in Asthma,-0.560697181175988,-1.9963850879438112,0.0,0.015152691890860659,0.424,22/52,16.88%,IL10;CD4;IL2RB;CD80;ICOS;MAP2K1;MAF;PTPRC;PRKCQ;CD3E;CD3G;FYN;CD40LG;CARD11;GATA3;LCK;CD247;LAT;AKT1;FCER1G;CD86;ZAP70
prerank,Elsevier_Pathway_Collection__Th2-Cell Differentiation,-0.560697181175988,-1.9963850879438112,0.0,0.015152691890860659,0.424,22/52,16.88%,IL10;CD4;IL2RB;CD80;ICOS;MAP2K1;MAF;PTPRC;PRKCQ;CD3E;CD3G;FYN;CD40LG;CARD11;GATA3;LCK;CD247;LAT;AKT1;FCER1G;CD86;ZAP70
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.47168385470927404,-1.9932024887786082,0.0,0.015772942078926554,0.432,98/199,27.66%,IRF4;CXCL10;PTGS2;GBP6;CXCL11;ZBP1;EIF4E3;PNP;SLAMF7;IL2RB;CCL5;FPR1;CD69;OASL;TNFAIP6;BANK1;GPR18;CXCL9;CD38;TNFSF10;CASP1;XCL1;IL15;IFI30;RSAD2;GBP4;GCH1;CCL2;IL6;APOL6;LCP2;PLA2G4A;CD274;FGL2;IRF8;C1R;ISOC1;MX2;DDX60;KLRK1;USP18;SAMD9L;VCAM1;MYD88;SECTM1;GZMA;EPSTI1;SERPING1;MARCHF1;CD86;IL10RA;CASP7;IFIT2;MT2A;IFIT3;HLA-DQA1;CSF2RB;BTG1;AUTS2;C1S;LAP3;ST8SIA4;UBE2L6;OAS3;OAS2;SSPN;CMKLR1;NMI;IFIT1;SELP;JAK2;BATF2;TNFAIP2;CD40;STAT1;DHX58;IFIH1;CASP4;IRF2;DDX58;TRIM21;TRIM14;IRF9;CMTR1;HLA-DRB1;PLSCR1;LGALS3BP;PSMB9;PDE4B;IFI44;CFB;ARID5B;SP110;CMPK2;TRAFD1;IRF1;HERC6;PSMA2
prerank,KEGG_2021_Human__African trypanosomiasis,-0.6173101372247707,-1.9930327197952065,0.0,0.015565403367361733,0.432,20/34,15.81%,IL10;IFNG;TNF;IL1B;FASLG;HBA1;IL18;APOA1;PRKCB;HBB;APOL1;IL6;IDO2;IL12B;HBA2;SELE;PLCB2;VCAM1;MYD88;KNG1
prerank,Elsevier_Pathway_Collection__Immune Sustem Activation in Hashimoto's Thyroiditis,-0.6473168577080572,-1.9895436846162713,0.0,0.015945748362551155,0.448,18/30,16.88%,IFNG;CD4;CD79A;FASLG;PTPN22;CD80;CTLA4;TG;CD3E;CD3G;LCK;CD247;LAT;SYK;FCER1G;LTA;CD86;ZAP70
prerank,Reactome_2022__Keratinization R-HSA-6805567,-0.5512936954991264,-1.9866572007612258,0.0,0.0163163409219665,0.46,28/59,13.02%,KRT39;PKP3;LCE2D;KRT80;EVPL;KRT4;TCHH;KRT23;KRT83;KRT15;SPRR3;KRT36;RCAN1;KRT6C;KRT19;KRT14;KRT5;PRSS8;LIPJ;PI3;LIPN;KRT16;DSG2;TGM1;KAZN;ST14;KRT6A;KRTAP5-1
prerank,Elsevier_Pathway_Collection__CD8+ T-Cell Activation,-0.5517859576142917,-1.9838595259369085,0.0,0.016606583087477415,0.48,30/58,22.05%,IFNG;CD8A;IL2RB;FOS;FASLG;CD80;MAP2K1;PRF1;PRKCQ;CD3E;CD3G;TBX21;IL12B;CARD11;LCK;CD247;LAT;AKT1;FCER1G;GZMA;IL12RB1;LTA;CD86;ZAP70;GZMB;CD3D;IL12RB2;JUN;JAK2;STAT1
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.7441663803885513,1.9836672538898936,0.00625,0.2593698378175764,0.424,15/27,16.39%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,Elsevier_Pathway_Collection__T-Cell Receptor -> CREBBP Signaling,-0.6696945581601925,-1.9822201481996897,0.0,0.01681948799885533,0.488,13/22,19.63%,CD4;CAMK4;CTLA4;PTPRC;CD3E;CD3G;FYN;LCK;CD247;LAT;FCER1G;ZAP70;CD3D
prerank,Elsevier_Pathway_Collection__Th1-Cells Activation and Proliferation in Atherosclerosis,-0.5240184784192585,-1.9815894589980634,0.0,0.01668105599886475,0.488,29/68,16.88%,IFNG;CD4;IL2RB;IL18R1;CD80;IL27;IL18RAP;IL18;ICOS;MAP2K1;PTPRC;PRKCQ;CD3E;CD3G;FYN;CD40LG;TBX21;IL12B;CARD11;LCK;CD247;LAT;AKT1;MYD88;FCER1G;IL12RB1;LTA;CD86;ZAP70
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.6654802586485578,-1.979745143226692,0.0,0.01681948799885533,0.488,11/21,12.95%,CYP2C19;CYP2A7;CYP2A13;CYP2D7;CYP2B6;CYP2C8;CYP1A2;CYP2C18;CYP2C9;NR1I2;CYP3A4
prerank,Elsevier_Pathway_Collection__Th2-Cells Function in Systemic Scleroderma,-0.5574331405786983,-1.9790136963540077,0.0,0.0166843917097079,0.492,23/55,16.88%,IL10;CD4;IL2RB;CD80;ICOS;MAP2K1;MAF;PTPRC;PRKCQ;CD3E;CD3G;CCL2;FYN;CD40LG;CARD11;GATA3;LCK;CD247;LAT;AKT1;FCER1G;CD86;ZAP70
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.6364142369408409,-1.9787850725824794,0.0,0.0165525119988735,0.496,11/25,15.71%,IRF4;CD4;IL1B;PNP;CD80;PTPRC;CCR2;CARD11;CLEC7A;PLCG2;CD86
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.5814711567784533,-1.9768959694602761,0.0,0.01675352922238923,0.504,22/46,17.07%,IRF4;FOXP3;CD4;IL1B;PNP;CD80;XCL1;VSIG4;PTPRC;CR1;TBX21;CCR2;CARD11;CLEC7A;SFTPD;HAVCR2;GBP1;PLCG2;CD86;LILRB4;PRNP;EZR
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.6111083108917797,-1.974979819084373,0.0,0.01714544706860059,0.512,13/26,14.86%,IL10;IGLL5;MZB1;IGLL1;BANK1;IKZF3;ZFP36L1;FCRL3;IL6;SAMSN1;FCGR2B;THEMIS2;SH3KBP1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.5969304970499374,-1.9732896122976982,0.0,0.017270585378134976,0.52,2/36,0.18%,KLK3;KLK2
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,0.6748846009633778,1.9713294067927418,0.0,0.23804008141810462,0.484,22/48,17.33%,HMGA2;H2AC19;H1-5;H2BC13;H1-2;H2AC20;H2BC17;H2BC21;CCNE1;H2BC9;H2BC15;CCNA2;CCNE2;H2BC11;H2BC12;H1-4;H2BC4;H4C15;H2AC6;H2BC5;H2AX;HMGA1
prerank,Reactome_2022__Initial Triggering Of Complement R-HSA-166663,-0.6870412532316414,-1.9678988584393113,0.0,0.018348532362387635,0.56,16/21,24.41%,FCN3;FCN2;IGLL5;COLEC10;C4A;MBL2;C1QC;C1R;GZMM;C1QB;FCN1;C1S;C1QA;MASP1;C3;C4B
prerank,Elsevier_Pathway_Collection__Antigen-Presenting Cell Role in Asthma,-0.5471266926553384,-1.9673118644625502,0.0,0.018142369077416988,0.56,24/56,15.00%,CD4;TNF;IL1B;IL18;CASP1;ITK;MAP2K1;IFI30;CCR7;NLRP3;PTPRC;FYN;IL33;TICAM2;LCK;TLR4;CCL22;CLEC7A;TLR2;SYK;PLCG2;MYD88;CSF2;VAV1
prerank,Elsevier_Pathway_Collection__GLP1R -> ARRB1 Signaling,0.8219362695200105,1.9666845859814883,0.0,0.2040831092301456,0.508,4/15,3.38%,MAFA;GLP1R;GCG;NEUROD1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.7533595562689709,1.9654093669986872,0.0,0.17291322521171756,0.508,11/29,6.05%,COL2A1;SIX1;HOXD3;HOXD9;HOXA3;OSR2;HOXD4;HOXB9;OSR1;IRX5;HOXC9
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.5964268449414473,-1.9643940153790669,0.0,0.018563731198736624,0.56,15/31,23.72%,IGLL5;CD79A;DAPP1;FYN;BLK;BTK;PIK3R1;SYK;PLCG2;SH3KBP1;VAV1;CD19;PIK3AP1;CD22;ITPR3
prerank,Reactome_2022__Xenobiotics R-HSA-211981,-0.6601704852340949,-1.9632875541466357,0.0,0.01872939322949458,0.564,10/21,9.03%,CYP2C19;CYP2A7;CYP2A13;CYP2B6;CYP2C8;CYP1A2;CYP3A43;CYP3A7-CYP3A51P;CYP2C18;CYP2C9
prerank,Elsevier_Pathway_Collection__Proteins Involved in Psoriasis,-0.5698116256630634,-1.9623734768466257,0.016666666666666666,0.018769573563940007,0.572,21/49,14.87%,CSF3;IL10;CXCL10;PTGS2;TNFSF11;CXCL11;IFNG;TNF;IL1B;CCL5;IL27;CXCL9;IL18;TGFA;IL6;IL12B;CXCL8;SELE;CAMP;HBEGF;CSF2
prerank,KEGG_2021_Human__Starch and sucrose metabolism,-0.6349939062026874,-1.9576901348811262,0.0,0.0195925935470537,0.604,15/30,19.60%,GCK;GBA3;ENPP3;MGAM2;HK3;AGL;GYS2;UGP2;GBE1;ENPP1;PYGL;TREH;PGM2;PGM1;PGM2L1
prerank,WikiPathway_2021_Human__Constitutive Androstane Receptor Pathway WP2875,-0.6011204302698968,-1.9563370887304177,0.0,0.0195034488497365,0.608,13/32,16.59%,GSTA2;CYP2C19;CYP2B6;CYP4A11;UGT1A9;PPARGC1A;FOXO1;CYP2C9;ABCB1;EHHADH;CYP3A4;SULT2A1;NR1I3
prerank,Elsevier_Pathway_Collection__Genes with Mutations Associated with Vitiligo,-0.6070685942003707,-1.953321939428464,0.0,0.019593228124982348,0.608,12/26,13.16%,IL10;PTGS2;CD4;TNF;FASLG;PTPN22;PDGFRA;CAT;CTLA4;MITF;MBL2;TSLP
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.6559496729575276,-1.9469752660845479,0.0,0.020732354998589036,0.636,11/22,12.95%,CYP2C19;CYP2A7;CYP2A13;CYP2D7;CYP2B6;CYP2C8;CYP1A2;CYP2C18;CYP2C9;NR1I2;CYP3A4
prerank,WikiPathway_2021_Human__Oxidation by Cytochrome P450 WP43,-0.5270500555887923,-1.9461562753345918,0.0,0.020576418307878,0.64,23/56,13.29%,CYP26A1;CYP2C19;CYP2A7;CYP2A13;CYP2B6;CYP39A1;CYP2C8;CYP4A22;CYP4A11;CYP4F2;CYP3A7;CYP1A2;CYP3A43;CYP2C18;CYP8B1;CYP2C9;CYB5R2;CYP4F12;CYP4X1;CYP26B1;CYP4F3;CYP3A4;CYP4V2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.5012976504994594,-1.9452645973928286,0.0,0.02070970971287629,0.652,52/80,26.43%,FOXP3;IFNL1;RIPK3;LGALS9B;IL1B;INHBA;CD244;IL18R1;PTPN22;TLR3;CRTAM;IL27;IL18;SLAMF6;XCL1;CCR7;AXL;CR1;TLR8;CD2;IL12B;LILRB1;CCR2;CD274;PDCD1LG2;SLC7A5;TLR4;CLEC7A;RASGRP1;HAVCR2;CD226;IL12RB1;LILRB4;LGALS9;PRNP;EBI3;LGALS9C;NR1H4;IL12RB2;BTN3A2;LAPTM5;SIRPA;HLA-DPA1;F2RL1;HLA-DPB1;HLA-DRB1;BTN3A1;CD14;PDE4B;PDE4D;FZD5;TXK
prerank,Elsevier_Pathway_Collection__Proteins Involved in Glomerulonephritis,-0.48539463325938015,-1.944938646439199,0.0,0.02050052072587754,0.652,57/114,22.14%,CR2;CXCL10;PTGS2;IFNG;CD4;TNF;IL1B;HGF;CCL5;COL4A3;CD80;TLR3;IL27;CXCL9;CCR5;CCL3;ESR1;IL18;TNFRSF13B;CTLA4;CXCL2;PRF1;ALB;CCL2;IL6;CCR1;AXL;CD40LG;TBX21;BMP7;KL;ALOX5;CCR2;FCGR2B;CXCL8;TLR4;TLR2;SELE;CR1L;SYK;VCAM1;CXCR3;CSF2;FCER1G;CD86;TNFRSF1B;F3;EBI3;LIF;C1QA;C5;AGTR1;CX3CR1;CD55;SELP;MST1;F2
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,-0.6930143515715901,-1.9445403783671822,0.0,0.020295515518618763,0.652,14/18,24.54%,CD4;CD3E;CD274;HLA-DQA2;PDCD1LG2;LCK;CD247;HLA-DQA1;HLA-DQB2;CD3D;HLA-DRB5;HLA-DRA;HLA-DPA1;HLA-DRB1
prerank,Elsevier_Pathway_Collection__Peripheral Tolerance to Autoantigens Recession in Diabetes Mellitus Type 1,-0.6142970826265702,-1.9445348770618667,0.0,0.020094569820414618,0.652,17/38,17.09%,FOXP3;CD4;IL2RB;FOS;MAP2K1;PTPRC;PRKCQ;CD3E;CD3G;FYN;CARD11;LCK;CD247;LAT;FCER1G;ZAP70;HLA-DQA1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Graves Disease,-0.6857368134165078,-1.9423067267717682,0.0,0.02055715199860096,0.664,15/18,24.18%,TSHR;CXCL10;IFNG;TNF;IL1B;CTLA4;TG;IL6;CD1C;IGF1;TAB2;CD40;IFIH1;IGF1R;HLA-DPB1
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,0.7241355198060375,1.9411271275617752,0.0058823529411764705,0.20379058685666715,0.608,17/24,16.39%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;UHRF1;H2BC11;DNMT3A;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,Elsevier_Pathway_Collection__Proteins Involved in Systemic Lupus Erythematosus,-0.5339753742734056,-1.940039449729824,0.0,0.02062972799859602,0.668,36/61,19.49%,IL10;PTGS2;CD1A;IFNG;CD4;TNF;CD8A;FASLG;ESR1;IL18;TNFSF10;CD1D;ICOS;TNFRSF13B;CTLA4;FCGR3A;CCL2;IL6;CR1;NGF;CD40LG;C4A;IL1RN;FCGR2B;MBL2;TLR4;TNFRSF9;TNFRSF13C;CD86;CORO1A;F3;TNFSF13B;BCL2;SIGIRR;APOH;C1QA
prerank,Elsevier_Pathway_Collection__Th17-Cell Differentiation,-0.523392181533359,-1.9398859122700185,0.0,0.020539182460140647,0.668,25/57,16.88%,IRF4;CD4;IL1B;CD80;IL1RAP;IL18;ICOS;PTPRC;PRKCQ;CD3E;CD3G;IL6;FYN;CD40LG;CARD11;LCK;CD247;LAT;IL21R;AKT1;MYD88;FCER1G;IL12RB1;CD86;ZAP70
prerank,WikiPathway_2021_Human__Tryptophan metabolism WP465,-0.5940272852450384,-1.9395285740327008,0.0,0.020396966398611858,0.668,19/39,18.14%,CYP2A13;AADAT;AOC1;TDO2;CYP1A2;CYP2C18;CAT;CYP4F12;HAAO;CYP3A4;KYNU;INMT;ALDH2;DDC;ECHS1;CYP2J2;ALDH1A2;GCDH;ACAT1
prerank,Elsevier_Pathway_Collection__Th17-Cell Function in Systemic Lupus Erythematosus,-0.5594454440526079,-1.9387886444541111,0.0,0.02031032513069323,0.668,23/45,21.48%,IRF4;CD4;IL1B;IL1RAP;IL18;PRKCQ;CD3E;CD3G;IL6;FYN;CARD11;LCK;CD247;LAT;IL21R;SYK;MYD88;FCER1G;IL12RB1;ZAP70;CD3D;IL12RB2;JAK2
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.6162353578682318,-1.9349416382545686,0.0,0.020958863549975486,0.676,18/29,24.54%,CD4;ITK;FYB1;CD3E;LCP2;HLA-DQA2;LCK;CD247;PLCG2;ZAP70;HLA-DQA1;CD101;HLA-DQB2;CD3D;HLA-DRB5;HLA-DRA;HLA-DPA1;HLA-DRB1
prerank,Elsevier_Pathway_Collection__Enamel Formation Disruption,0.7224586438375289,1.934654881033612,0.0,0.2026326857949815,0.632,7/27,6.21%,ODAM;KLK4;DLX6;DLX1;AMBN;DLX3;BMP4
prerank,Elsevier_Pathway_Collection__Proteins Involved in Celiac Disease,-0.6765005859436779,-1.9346375711238288,0.0,0.020816711998583294,0.676,11/19,13.92%,FOXP3;IFNG;CD4;TNF;FASLG;IL15;CTLA4;IL6;TLR4;TLR2;CD226
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.5294227967817398,-1.9315771248869542,0.0,0.021242961906811166,0.684,22/57,13.59%,CYP26A1;CYP2C19;CYP2A7;CYP2A13;CYP2B6;CYP39A1;CYP2C8;CYP4A22;CYP4A11;CYP4F2;CYP1A2;CYP3A43;CYP3A7-CYP3A51P;CYP2C18;CYP8B1;CYP2C9;CYP4F12;CYP26B1;CYP4F3;CYP3A4;CYP4V2;TBXAS1
prerank,Elsevier_Pathway_Collection__Acute Cytotoxic CD8+T-Cell Response against Melanocytes,-0.5475405939446059,-1.9299367418582025,0.0,0.02140662108945224,0.688,23/49,19.63%,IFNG;CD8A;IL2RB;FOS;FASLG;ICOS;MAP2K1;CTLA4;PRF1;PRKCQ;CD3E;CD3G;FYN;CARD11;LCK;CD247;LAT;AKT1;FCER1G;LTA;ZAP70;GZMB;CD3D
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.6519290110590137,-1.9299033605648386,0.0,0.021213768647204923,0.688,6/19,11.82%,MFSD2A;APOA4;APOA1;GPLD1;APOA5;ABHD5
prerank,KEGG_2021_Human__Tryptophan metabolism,-0.5647950178115715,-1.9274280189682915,0.0,0.021474881998538503,0.704,29/41,30.35%,AADAT;AOC1;ALDH1B1;TDO2;CYP1A2;ALDH8A1;CAT;IDO2;EHHADH;HAAO;KYNU;INMT;KMO;ALDH2;DDC;ECHS1;GCDH;ACAT1;DHTKD1;AANAT;ALDH9A1;MAOB;ALDH7A1;CYP1B1;HADH;IL4I1;MAOA;CYP1A1;AFMID
prerank,WikiPathway_2021_Human__Selective expression of chemokine receptors during T-cell polarization WP4494,-0.6420459236451674,-1.92467248978526,0.011904761904761904,0.021880218901165784,0.72,16/27,15.16%,IFNG;CD4;IL18R1;CCR5;CCL4;CCL3;CCR7;CCR1;CD40LG;IL12B;CCR2;CCR4;CXCR3;CSF2;CXCR4;IL12RB1
prerank,Elsevier_Pathway_Collection__T-Cell Receptor -> STAT Signaling,-0.6795130197166853,-1.9195353947695717,0.0,0.022770242524766133,0.732,14/19,22.05%,CD4;CTLA4;CD3E;CD3G;FYN;LCK;CD247;IL16;FCER1G;CD86;ZAP70;CD3D;JAK2;STAT1
prerank,Elsevier_Pathway_Collection__PTPN22 Role in Rheumatoid Arthritis,-0.6119197904841225,-1.918887736153393,0.0,0.022816001111490708,0.736,16/35,16.88%,IFNG;CD4;FOS;PTPN22;MAP2K1;PTPRC;PRKCQ;CD3E;CD3G;FYN;CARD11;LCK;CD247;LAT;FCER1G;ZAP70
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.5548958522559897,-1.9172470253454215,0.0,0.02310263006739324,0.744,27/44,24.86%,CCR9;CD5L;CXCR2;NCR1;KIR3DL2;CXCL9;KIR2DL4;CCR5;FCMR;ITK;PRF1;IL1RL2;TRAT1;CLEC5A;MNDA;SPN;CD300C;LILRB2;NCF1;NCF2;GNLY;CX3CR1;TYROBP;FOSL1;DCDC2;LGALS3BP;LY96
prerank,Elsevier_Pathway_Collection__T-Cell Receptor Signaling,-0.5654814912211261,-1.914988496712111,0.0,0.02309116148995393,0.748,22/50,16.88%,IFNG;CD4;CD80;ICOS;MAP2K1;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;FYN;LCP2;CD40LG;CARD11;LCK;CD247;LAT;AKT1;FCER1G;CD86;VAV3;ZAP70
prerank,Elsevier_Pathway_Collection__Atopic Dermatitis Onset,-0.5654814912211261,-1.914988496712111,0.0,0.02309116148995393,0.748,22/50,16.88%,IFNG;CD4;CD80;ICOS;MAP2K1;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;FYN;LCP2;CD40LG;CARD11;LCK;CD247;LAT;AKT1;FCER1G;CD86;VAV3;ZAP70
prerank,Elsevier_Pathway_Collection__Atopic Dermatitis,-0.5020853474706379,-1.9112916538580078,0.0,0.02369804611603426,0.764,41/71,23.15%,PKP3;PADI1;IL10;IFNG;CD4;IL2RB;CDH1;CD80;IL27;ICOS;FCER1A;DSG2;MAF;PTPRC;CD3E;CD3G;FYN;TLR8;IL33;CD40LG;TBX21;IL12B;GATA3;LCK;CD247;TSLP;CAMP;FCER1G;IL12RB1;LTA;CD86;ZAP70;DSC1;DSC2;CD3D;IL12RB2;JAK2;PKP2;STAT1;DSC3;MS4A2
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,0.7399206625046327,1.9106131623630087,0.011764705882352941,0.2529235114390694,0.764,15/22,16.39%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,Elsevier_Pathway_Collection__Gluten Impact on Neuronal System (Hypothesis),-0.5483849967786768,-1.9102028166451506,0.0,0.023734166398384746,0.764,20/46,16.88%,IL10;CD4;TNF;IL2RB;FOS;TLR3;MAP2K1;MAF;CD3E;CD3G;REL;GATA3;CD247;TLR4;TLR2;LAT;MYD88;FCER1G;IL10RA;ZAP70
prerank,Elsevier_Pathway_Collection__Treg-Cell Function in Diabetes Mellitus Type 1,-0.5277606940808197,-1.9079887565110718,0.0,0.02409403239505447,0.764,23/56,16.88%,IRF4;FOXP3;IL10;CD4;IL2RB;CD80;ICOS;MAP2K1;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;FYN;CD40LG;CARD11;LCK;CD247;LAT;AKT1;FCER1G;CD86;ZAP70
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.7009526891495518,-1.9079846168942216,0.0,0.023896540326242548,0.764,9/18,15.67%,ADH4;ALDH1B1;ADH1A;SULT1A2;ADH1C;ADH7;SULT1C4;SULT2A1;ALDH2
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,0.7081962102496113,1.9068329701347266,0.005494505494505495,0.23923454777647504,0.768,15/27,16.39%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,Elsevier_Pathway_Collection__CD8+ T-Cell Response to Self-Determinants in Diabetes,-0.6490387459977262,-1.9067989633105709,0.0,0.024112490925188263,0.768,14/23,21.42%,IFNG;CD8A;FASLG;MAP2K1;PRF1;CD3E;CD3G;LCK;CD247;LAT;FCER1G;ZAP70;CD3D;JUN
prerank,Elsevier_Pathway_Collection__Natural Killer Cell Activation,-0.5226701156998474,-1.9052565648329924,0.0,0.024460599482206274,0.772,31/64,22.05%,IFNG;IL2RB;FOS;CD244;FASLG;TNFSF10;MAP2K1;NCR3;CD48;PRF1;PRKCQ;FCGR3A;FYN;LCP2;CD2;ULBP3;CD247;LAT;SYK;KLRK1;FCER1G;GZMA;VAV1;ITGB2;ZAP70;INPP5D;GZMB;NFATC2;JUN;JAK2;STAT1
prerank,Elsevier_Pathway_Collection__Myeloblast -> Neutrophil Surface Expression Markers,-0.5205227255181567,-1.9038294053215674,0.0,0.024444322558336413,0.772,42/64,25.14%,CR2;ENPP3;CXCR1;CD200R1;FPR1;CXCR2;CD69;CD244;ADGRE1;CD38;NCAM1;LGALS3;FCER1A;PTPRC;CR1;CD300A;CD40LG;ABCB1;NTRK1;CCR2;CD274;CYSLTR2;FCGR2B;FLT3;TLR4;HAVCR2;FCER1G;CXCR4;ITGB2;ITGA4;CD33;CD19;SELPLG;CD7;ITGAM;ANPEP;CD22;LAMP1;CD164;IL1RL1;CD14;TPT1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.6653524780725514,1.9030619308327397,0.005263157894736842,0.22741398459364054,0.784,4/46,0.82%,REG1A;REG3A;GHRHR;REG1B
prerank,Elsevier_Pathway_Collection__Hemapoietic Stem Cell -> Lymphoid Multipotent Progenitor Surface Expression Markers,-0.5494885706695467,-1.9025106356149772,0.0,0.024739775998316303,0.784,23/45,19.48%,MUC1;CCR9;CD4;IL2RB;PROM1;CD27;IL7R;CSF3R;CD38;PTPRC;HRH4;CD2;CD274;SPN;FLT3;CXCR4;CSF1R;NOTCH2;INPP5D;SLAMF1;CD19;SELL;CD7
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.4626836162340656,-1.90235416677823,0.0,0.024544974612502792,0.784,63/168,14.49%,CXCL13;IRF4;FOXP3;IFNL1;TREML1;RIPK3;CD1A;TREML2;KIR2DL1;LAG3;CD160;CD8B;CD8A;SLAMF7;CD1B;CD200R1;SH2D1A;KIR2DL3;TKFC;NCR1;PTPN22;KLRD1;KIR3DL2;KLRC1;CRTAM;SIGLEC7;KIR2DL4;FCGR3B;SLAMF6;IL15;CD1D;LILRA1;FCER1A;NCR3;KLRF1;CD96;SIGLEC9;RSAD2;ICAM3;KLRB1;CD3E;FCGR3A;CD3G;CD300A;CD40LG;SLA2;LILRB1;SH2D1B;FCGR2B;CD1C;SPN;ULBP3;CD247;HERC5;SFTPD;SYK;CD226;FGR;KLRK1;CD300C;VCAM1;OSCAR;CD300E
prerank,Elsevier_Pathway_Collection__IL1B Expression Targets -> Nociception,-0.5546861018226888,-1.90065710265146,0.0,0.024703622998318766,0.792,17/45,11.86%,TAC1;CSF3;PTGS2;TNF;IL1B;TNFRSF11B;FOS;IL1RAP;IL15;MAP2K1;CCL2;EGR1;IL6;NGF;CD40LG;IL1RN;CXCL8
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.5833580121979702,-1.8959000210473702,0.0,0.025729035905225725,0.8,17/42,19.14%,KLK3;KLK2;CD5L;F9;KLKB1;PRSS3;C1R;PRSS12;C1RL;NLRC4;HP;PERP;F11;LGMN;GGT2;APOH;IFI16
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.7973957679078336,1.8958959360774952,0.006369426751592357,0.2317833528742596,0.808,9/15,11.72%,HOXD8;SIX2;MESP2;TDGF1;MESP1;TBX3;CDX1;RIPPLY1;CDX2
prerank,Elsevier_Pathway_Collection__Th2-Cell Function in Systemic Lupus Erythematosus,-0.5474952925565673,-1.8950095106109126,0.0,0.025660500921330567,0.8,22/50,16.88%,IL10;CD4;CD80;ICOS;MAP2K1;MAF;PTPRC;PRKCQ;CD3E;CD3G;FYN;CD40LG;CARD11;GATA3;LCK;CD247;LAT;AKT1;SYK;FCER1G;CD86;ZAP70
prerank,WikiPathway_2021_Human__Complement Activation WP545,-0.6283527454244531,-1.8930687369315466,0.0,0.0258925960287722,0.812,18/22,24.41%,CFP;C9;C7;C6;C4A;C1QC;C1R;C1QB;C8A;C8B;C1S;C1QA;C5;CD55;MASP1;C3;CFD;C4B
prerank,WikiPathway_2021_Human__Cells and molecules involved in local acute inflammatory response  WP4493,-0.6905525874915066,-1.890553500171102,0.0,0.02603622763459171,0.816,13/16,23.77%,TNF;C7;C6;IL6;CXCL8;VCAM1;KNG1;ITGB2;ITGA4;SELPLG;C5;SELP;C3
prerank,Elsevier_Pathway_Collection__T-Cell Receptor -> ATF/CREB Signaling,-0.5944373879020428,-1.8903314753272404,0.0,0.025882620629817474,0.816,17/32,23.65%,CD4;CD8B;CD8A;CD80;CTLA4;PTPRC;FYN;LCP2;LCK;IL16;VAV1;CD86;ZAP70;MAP2K3;MAP2K6;CD22;MAP2K4
prerank,TRRUST_Transcription_Factors_2019__IRF1 mouse,-0.6266378867075506,-1.8902393421951573,0.0,0.025689466744520332,0.816,10/22,15.46%,FOXP3;CXCL10;CXCL11;IFNG;TNF;CCL5;IL27;IL12B;MYD88;PIGR
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.49022702771832427,-1.8850046283217734,0.0,0.026745062398179833,0.816,28/65,24.72%,IFNG;CD4;TNF;KIR2DL1;CD8B;CD8A;KIR2DL3;KLRD1;KIR3DL2;KLRC1;KIR2DL4;IFI30;HSPA1B;HLA-DQA2;HLA-DOB;KIR2DS4;CTSB;HLA-DQA1;HSPA1A;LGMN;KIR3DL1;HLA-DOA;HLA-DRB5;HLA-DRA;HLA-DPA1;HLA-DPB1;HLA-DRB1;CTSS
prerank,Elsevier_Pathway_Collection__Natural Killer Cell Activation through Integrins and non-ITAM-Containing Receptors,-0.5690664263366794,-1.8827465452427858,0.0,0.027166771056974664,0.82,22/44,21.97%,KIR2DL4;MAP2K1;KLRF1;CD48;ICAM3;PRF1;FYN;LCP2;CD2;LAT;SYK;CD226;VCAM1;PLCG2;VAV1;ITGB2;CSF1R;ITGA4;NECTIN3;CLEC2B;NFATC2;RAP1A
prerank,Elsevier_Pathway_Collection__Macrophage Dysfunction,-0.5860926916559707,-1.8823194368066696,0.0,0.027132166771876118,0.824,11/37,10.76%,IFNG;CD4;TNF;IL1B;CD8A;LRRK2;IL18;CASP1;NLRP3;IL33;CYBB
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,-0.673849732224399,-1.8819173027901341,0.0,0.026976183650338017,0.824,14/17,24.54%,CD4;PTPN22;PTPRC;CD3E;HLA-DQA2;LCK;CD247;HLA-DQA1;HLA-DQB2;CD3D;HLA-DRB5;HLA-DRA;HLA-DPA1;HLA-DRB1
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,0.6889442286752363,1.8810465258378988,0.011834319526627219,0.26304511892025456,0.864,23/32,24.95%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;EZH2;H2BC11;DNMT3A;H2BC12;H2BC4;H4C15;PRIM1;H2AC6;H2BC5;H2AX;H2AJ;POLA1;POLA2;DNMT1;DNMT3B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.5535754781376565,-1.879629086996568,0.0,0.027306458933393424,0.84,19/41,15.35%,CD1A;CD160;CD1B;STAP1;KLRD1;CRTAM;SLAMF6;XCL1;CD1D;CD1E;NCR3;IL12B;CD1C;AZGP1;RASGRP1;CD226;KLRK1;IL12RB1;SPI1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.6883196130621013,-1.8788264698471702,0.0,0.027431783998133098,0.848,8/15,14.94%,CCL5;CXCR2;DNASE1L3;IL15;LILRA2;CXCL8;SYK;FCER1G
prerank,Elsevier_Pathway_Collection__CD4+ T-Cell Function Decline in HIV,-0.5492172862495412,-1.8787995703991456,0.0,0.027237232338571872,0.848,21/51,16.88%,IL10;CD4;IL1B;IL2RB;CD80;MAP2K1;MAF;PRKCQ;CD3E;CD3G;IL6;FYN;CARD11;GATA3;LCK;CD247;LAT;AKT1;FCER1G;CD86;ZAP70
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,0.6883070645556001,1.877555470748765,0.0,0.2586385318838802,0.876,15/32,16.39%,H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;NEIL3;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,WikiPathway_2021_Human__Tamoxifen metabolism WP691,-0.6678002078652661,-1.875950025501158,0.0,0.02795351526570322,0.86,10/19,16.78%,CYP2C19;FMO1;CYP2C8;UGT2B7;CYP1A2;CYP2C9;CYP3A4;SULT2A1;UGT2B15;FMO3
prerank,KEGG_2021_Human__Drug metabolism,-0.4809539427392625,-1.875762434066907,0.0,0.027914861200897426,0.86,37/101,17.38%,GSTA2;CYP2C19;UGT2A1;UPP2;UGT1A5;CYP2A7;NAT2;CYP2D7;CYP2B6;ADH4;FMO1;CYP2C8;GSTA1;ADH1A;UGT1A9;UGT2B7;CYP1A2;XDH;GSTT2B;NAT1;CYP2C9;DPYS;GSTM5;CDA;ADH1C;UGT2B28;UGT2B10;ADH7;DPYD;CYP3A4;UGT2A3;UGT2B15;TPMT;FMO3;ALDH3B2;HPGDS;UGT1A7
prerank,WikiPathway_2021_Human__Development and heterogeneity of the ILC family WP3893,-0.608459903779329,-1.8726057139238828,0.0,0.028655423998049823,0.872,15/26,13.64%,IFNG;TNF;IL1B;EOMES;ID2;IL18;BCL11B;IL15;IL6;IL33;TBX21;IL12B;GATA3;TSLP;NFIL3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Psoriatic Arthritis,-0.5292694868442346,-1.8705324980701086,0.0,0.02892178626010066,0.876,16/48,11.09%,CYP2C19;IL10;TNFSF11;IFNG;CD4;TNF;IL1B;TNFRSF11B;APOA1;IL15;IL6;RUNX3;CD40LG;ABCB1;IL12B;TNFRSF11A
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.615736242534182,-1.867313792093319,0.0,0.029875711559610607,0.88,18/23,24.99%,IL10;TNF;FFAR2;APOA1;SCIMP;LILRB1;CCR2;BTK;SLC7A5;SPHK2;TNFRSF1B;CLC;WNT5A;NOD2;INAVA;LAPTM5;F2RL1;TRIM6
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.7067986093556301,1.8671017949428643,0.006134969325153374,0.2737034341180214,0.9,3/35,0.82%,REG1A;REG3A;REG1B
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.518212024797547,-1.8665466171643246,0.0,0.03001573028367153,0.88,36/53,25.66%,IRF4;CR2;CFP;C9;C7;C6;CR1;C4A;FCGR2B;C1QC;C1R;CPN2;CR1L;CFI;C1QB;SERPING1;CLU;ZNF683;C8A;VTN;CD19;C3AR1;C8B;C1S;C1QA;C5;CD55;HLA-DRA;F2;CD81;C3;C4B;HLA-DRB1;CPB2;PHB2;PROS1
prerank,Elsevier_Pathway_Collection__Leukocyte Migration toward the Endothelial Cell in Ulcerative Colitis,-0.5879920235513428,-1.8658424564210938,0.0,0.03019173859253986,0.88,18/31,21.99%,CXCL10;IL5RA;IL1B;CXCR1;CXCR2;CXCL3;IL1RAP;CXCL8;VCAM1;MYD88;CXCR3;ITGB2;CXCL1;ITGA4;SELPLG;SELP;JAK2;ITGAM
prerank,WikiPathway_2021_Human__SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,-0.5035842756560657,-1.8654535204876945,0.0,0.029989109474469127,0.88,23/65,16.09%,CXCL13;IL10;CXCL10;ACE2;CXCL11;TNF;LAG3;CD160;CCL5;CXCR2;CXCL3;CXCL9;CCL4;CCL3;CXCL12;CXCL2;CCL2;IL6;CXCL8;HAVCR2;CSF2;IFIT2;CXCL1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.44155170893313556,-1.8644886874101565,0.0,0.03012557183794977,0.88,58/146,21.48%,CXCL13;NLRP7;IL10;CXCL10;CXCL11;NOCT;IL1B;ACOD1;STAP1;S100A14;PTPN22;CD80;CXCL3;TNIP3;CXCL9;S100A8;CCR5;CASP1;CXCL2;NLRP3;GCH1;CCL2;IL6;AXL;TNFRSF11A;LILRB1;CD274;PDCD1LG2;CXCL8;CD180;TICAM2;TRIB1;TLR4;CARD16;SELE;PF4V1;MYD88;LDOC1;NUGGC;CD86;TNFRSF1B;CXCL1;CD6;LGALS9;LILRB2;GGT2;SHPK;WNT5A;NOD2;PALM3;GSTP1;PPBP;PF4;TAB2;XBP1;CX3CR1;SELP;JAK2
prerank,TRRUST_Transcription_Factors_2019__SPI1 human,-0.4972207713879986,-1.8626962053812988,0.0,0.030557259653549527,0.88,30/61,23.52%,JCHAIN;TNF;IL1B;BPI;CCL5;CXCR1;CSF3R;IL18;CD163;FCER1A;P2RY10;MS4A1;CCL2;CYBB;IL12B;TNFRSF11A;MNDA;BTK;TLR4;HCK;MSR1;ITGB2;IFIT3;GATA1;NCF2;PTGIR;ITGAM;CD40;CSF2RA;CD22
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,0.728159556023482,1.855987806152468,0.005813953488372093,0.3003229701045621,0.948,4/21,2.10%,NPHS1;KIRREL2;ACTN2;PIK3R2
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.415813528581259,-1.855056489419983,0.0,0.03264308526093634,0.888,81/199,24.10%,FOSB;NR4A2;EGR3;CXCL10;PTGS2;CXCL11;EGR2;TNF;RCAN1;IL1B;NR4A3;CCL5;FOS;INHBA;NR4A1;CD69;IL7R;SIK1;ID2;CD80;CXCL3;TNFAIP6;CCL4;IL18;DUSP2;GPR183;CXCL2;PLEK;GCH1;CCL2;EGR1;IL6;KLF4;CCN1;BCL2A1;IL12B;PTGER4;REL;TRIB1;TNFRSF9;TLR2;DNAJB4;PER1;KYNU;SERPINB2;NFIL3;HBEGF;CD83;CSF2;KLF2;KLF6;IFIT2;CXCL1;F3;PLAUR;PPP1R15A;BTG1;GADD45A;DUSP1;LIF;IRS2;SERPINB8;MXD1;MAP2K3;FUT4;TIPARP;JUN;PFKFB3;TNFAIP2;GEM;ETS2;PLPP3;IFIH1;LDLR;KDM6B;KLF9;PDLIM5;FOSL1;F2RL1;DDX58;MARCKS
prerank,TRRUST_Transcription_Factors_2019__WT1 mouse,0.7340609218631114,1.8536794026438161,0.005649717514124294,0.28988393638435006,0.956,8/16,7.48%,IGF2;PAX2;NPHS1;INHA;WNT4;SNAI2;NR5A1;AMH
prerank,TRRUST_Transcription_Factors_2019__PGR human,-0.6303718345261858,-1.8519729758169476,0.0,0.03323589458597339,0.892,7/24,8.81%,KLK3;FOXP3;IL10;PTGS2;PLD1;ESR1;RLN2
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.6210004971801696,1.8517544152380325,0.0,0.2821215779770129,0.96,26/49,23.00%,H3C13;LEF1;H2AC19;AXIN2;TERT;H2BC13;H2AC20;TCF7;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;PYGO2;BCL9L;SMARCA4;BCL9;HDAC1;H2AJ;KMT2D
prerank,WikiPathway_2021_Human__Pregnane X receptor pathway WP2876,-0.5920228363605887,-1.8503212079652995,0.012658227848101266,0.03342054108863461,0.9,14/33,14.97%,GSTA2;CYP2C19;CYP2B6;UGT1A9;CYP3A7;PPARGC1A;FOXO1;CYP2C9;CYP4F12;ABCB1;NR1I2;CYP3A4;SULT2A1;SLCO1B1
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,0.6775160297996552,1.8492555474230286,0.005952380952380952,0.27589478593337763,0.96,17/32,16.39%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;EZH2;H2BC11;DNMT3A;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,Elsevier_Pathway_Collection__Complement Activation in Glomerulonephritis,-0.6262228407848507,-1.8487998416497944,0.0,0.033675146939643685,0.904,15/20,26.60%,CFP;C9;C7;C6;C1R;CFI;C8A;C3AR1;C1S;C1QA;C5;C3;CFD;C4B;CFB
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,0.73724703608472,1.8486957339233971,0.006134969325153374,0.264147703251058,0.96,14/23,16.39%,H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,MSigDB_Hallmark_2020__E2F Targets,0.5315133168592325,1.846604041493273,0.0,0.25969486267699693,0.968,98/199,29.85%,CDKN2A;DEPDC1;MELK;HMMR;KIF2C;PLK1;KIF4A;BUB1B;CENPE;TOP2A;CDC20;UBE2T;BIRC5;MXD3;CCNB2;MKI67;SPC24;CDKN3;CCNE1;KIF18B;CENPM;CDKN2C;E2F8;AURKB;EZH2;DLGAP5;UBE2S;TRIP13;HELLS;PTTG1;CDK1;MCM2;TCF19;CDCA8;SPC25;CDCA3;MCM6;DIAPH3;AURKA;RACGAP1;HMGB3;MYBL2;DDX39A;NME1;DSCC1;CKS1B;STMN1;POLD1;CHEK1;H2AX;MCM3;MCM5;HMGA1;CDC25A;RRM2;MSH2;LBR;ASF1B;ATAD2;BARD1;MCM4;PSMC3IP;NAA38;SUV39H1;JPT1;RAD51AP1;MCM7;DONSON;PRKDC;POLA2;GINS4;DNMT1;KPNA2;DUT;NCAPD2;PLK4;CBX5;HMGB2;TK1;MYC;GINS1;SMC4;LMNB1;TIPIN;NAP1L1;CHEK2;ILF3;MAD2L1;NOP56;CDKN1A;SPAG5;SNRPB;MMS22L;PRDX4;TIMELESS;KIF22;PCNA;TACC3
prerank,Elsevier_Pathway_Collection__Th17-Cell Activation in Crohn's Disease,-0.5642076534290211,-1.8422987017052277,0.012658227848101266,0.03547186892066284,0.916,19/34,21.48%,FOXP3;IL10;CD4;CD80;TNFSF15;CD3E;CD3G;IL6;IL12B;LCK;CD247;LAT;IL21R;FCER1G;IL12RB1;ZAP70;CD3D;IL12RB2;JAK2
prerank,Elsevier_Pathway_Collection__Lipoxins and Resolvins in Inflammation Resolution,-0.6560488037666559,-1.8420300038764532,0.0,0.03528164361543326,0.916,14/21,22.14%,ITLN1;PTGS2;TNF;HPGD;CCL5;FPR2;CCR5;ALOX5;GPR132;SELE;SELL;CMKLR1;CX3CR1;F2
prerank,WikiPathway_2021_Human__T-cell receptor (TCR) signaling pathway WP69,-0.47111120424795605,-1.8405256297315378,0.0,0.03576802511148982,0.92,31/86,16.88%,IRF4;CD4;IL1B;CD8A;FOS;CCR5;ICOS;ITK;MAP2K1;FYB1;PRKCQ;CD3E;CD3G;IL6;FYN;LCP2;CARD11;REL;SKAP1;GATA3;LCK;CD247;TNFRSF9;LAT;PIK3R1;AKT1;PSTPIP1;CD83;VAV1;VAV3;ZAP70
prerank,TRRUST_Transcription_Factors_2019__GLI1 human,-0.6813721488095213,-1.8398947958225744,0.0,0.03571937388436153,0.924,8/16,17.08%,MUC5AC;EGR2;SFRP1;PDGFRA;BHLHE41;AKT1;SOX9;BCL2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.4488060130352388,-1.838413326502135,0.0,0.03574141199756758,0.924,45/103,21.10%,CXCL13;NLRP7;IL10;CXCL10;CXCL11;IL1B;ACOD1;STAP1;CD80;CXCL3;TNIP3;CXCL9;CCR5;CASP1;CXCL2;NLRP3;CCL2;IL6;AXL;LILRB1;CD274;FCGR2B;PDCD1LG2;CXCL8;CD180;TICAM2;TLR4;TLR2;CARD16;PF4V1;MYD88;LDOC1;NUGGC;CD86;TNFRSF1B;CXCL1;LILRB2;SHPK;WNT5A;NOD2;GSTP1;PPBP;PF4;XBP1;CX3CR1
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",0.6641410079579336,1.8383020601988158,0.0,0.27240037990889004,0.976,15/34,16.39%,H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;NEIL3;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,KEGG_2021_Human__Primary immunodeficiency,-0.5493579899284393,-1.8361236621739037,0.0,0.036215874780143986,0.924,17/33,19.63%,CD4;CD8B;CD8A;IGLL1;CD79A;IL7R;ICOS;TNFRSF13B;PTPRC;CD3E;CD40LG;BTK;LCK;TNFRSF13C;ZAP70;CD19;CD3D
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,0.626561408217747,1.8348459973291285,0.0,0.27153707277240546,0.976,20/52,17.32%,H3C13;H2AC19;E2F1;H2BC13;H2AC20;H2BC17;AGO2;H2BC21;H2BC9;H2BC15;NOTCH3;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;KAT2A;H2BC5;H2AX;ELF3
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5819016698232029,-1.834669957103501,0.0,0.03658065599751047,0.932,17/30,24.54%,IL10;IFNG;IL1B;PCK1;PTPRC;IL12B;LILRB1;CCR2;DDX60;IL12RB1;LGALS9;MYB;XBP1;HLA-DRA;DHX58;CD81;HLA-DRB1
prerank,WikiPathway_2021_Human__MECP2 and Associated Rett Syndrome WP3584,0.5943961301442189,1.832646750512626,0.0,0.26662195499339675,0.984,15/64,9.94%,IGF2;DLX5;DLX6;POU3F2;E2F1;GRIN1;MYT1;GAD1;POU4F1;GPRIN1;FGF2;BDNF;CAMK2A;EZH2;CDON
prerank,KEGG_2021_Human__Alcoholism,0.5394640339065802,1.830270016790863,0.0,0.262373067518622,0.988,59/145,16.57%,GNG4;H3C13;H2AC19;CALML6;GRIN1;H2AC18;H2BC7;H2AC16;H2AC13;SHC3;H2BC13;H2BC18;H4C12;H3C1;H2BC6;H2AW;H2BC8;H3C2;H2AC11;H4C8;H4C14;H3C10;H4C5;H2AC8;H2AC20;HDAC4;H2BC17;H2BU1;SLC6A3;BDNF;H2BC21;H2BC9;H2BC15;GRIN2A;GNG3;H3C8;GRIN3B;H2BC11;H2BC12;HDAC11;H4C9;H2BC4;H3C6;H4C15;H2AC6;CREB3L1;SLC29A2;GNB5;H4C4;SHC1;H4-16;GNG8;H2BC5;HRAS;HDAC5;ADORA2A;CREB3L4;H2AX;PPP1R1B
prerank,Elsevier_Pathway_Collection__Apoptosis of Thyroid Cell in Hashimoto's Thyroiditis,-0.65427520534671,-1.8299770207692674,0.0,0.037663270672283415,0.936,6/19,5.29%,IFNG;CD4;TNF;IL1B;CD8A;FASLG
prerank,WikiPathway_2021_Human__TYROBP causal network in microglia WP3945,-0.48080075139885264,-1.82712221292274,0.0,0.03880105463150569,0.94,34/61,24.11%,CD4;LGALS9B;RGS1;GAPT;IL18;MAF;PLEK;RUNX3;SLC7A7;CD84;SAMSN1;BIN2;RPS6KA1;NCKAP1L;C1QC;DPYD;HCLS1;ADAP2;RBM47;TNFRSF1B;IL10RA;ITGB2;LGALS9C;NCF2;CD37;APBB1IP;TMEM106A;ITGAM;TYROBP;ELF4;IGSF6;SH2B3;C3;NRROS
prerank,Elsevier_Pathway_Collection__CD8+ T-Cell Response in Celiac Disease,-0.5032995163012122,-1.82630625506115,0.0,0.03873579054281834,0.94,25/62,17.36%,IFNG;IL2RB;FOS;CD244;FASLG;IL15;MAP2K1;NCR3;CD48;PRF1;PRKCQ;FCGR3A;FYN;LCP2;REL;CD247;LAT;SYK;KLRK1;FCER1G;GZMA;VAV1;ITGB2;ZAP70;INPP5D
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.6134882490014677,1.8261438859290509,0.00510204081632653,0.26606409982602597,0.988,19/49,16.39%,H3C13;LEF1;H2AC19;E2F1;GFI1;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;IL6R;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,Elsevier_Pathway_Collection__B-Cells Function in Systemic Scleroderma,-0.48602733613482724,-1.8259667547624707,0.0,0.0386037646238788,0.94,25/65,22.03%,IL10;IL5RA;IL2RB;FOS;CD79A;MAP2K1;PRKCB;IL6;CD40LG;BTK;CARD11;LAT;AKT1;SYK;PLCG2;VAV1;IL10RA;LILRB3;CD19;NFATC2;MAP2K3;JUN;JAK2;PIK3AP1;CD40
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.5606813208299428,-1.8249347376865632,0.0,0.038674750847667354,0.94,17/29,20.58%,IRF4;TIGIT;XCL1;LILRA5;IL6;CD40LG;IL12B;CD274;TLR4;CLEC7A;TSLP;SYK;PLCG2;LGALS9;NOD2;INAVA;PRKCZ
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,0.6995653397026312,1.8236796864809068,0.0,0.2649313743009942,0.988,15/27,16.39%,H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;NEIL3;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.4747857365121845,-1.8236590292482664,0.0,0.03897849599734727,0.94,32/70,16.88%,TNFSF11;IL1B;PNP;CCL5;CD80;IL15;CD1D;CCR7;SIRPB1;SIRPG;RHOH;PTPRC;PRKCQ;CD3E;CCL2;IL6;DOCK8;CD40LG;IL12B;CCR2;CD274;PDCD1LG2;GATA3;LCK;NCKAP1L;VCAM1;TNFRSF13C;CD86;CD6;LGALS9;LILRB2;ZAP70
prerank,TRRUST_Transcription_Factors_2019__REL human,-0.6332727515406095,-1.822793339449876,0.0,0.039013250269534255,0.94,10/21,12.85%,KLK3;IL10;IL1B;CCL5;CCL2;IL6;CD40LG;BCL2A1;IL12B;SELE
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5654242518804944,-1.8220553414914196,0.0,0.03901461627969775,0.94,14/26,18.32%,PTGS2;IFNG;TNF;IL1B;HBB;KLF4;DDAH1;TLR4;CLEC7A;AKT1;KLF2;CLU;AGXT2;ASS1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.5942519754024039,-1.8204168824838745,0.0,0.039507764207837574,0.944,13/27,18.63%,CXCL10;TNF;CCL5;S100A14;FPR2;LGALS3;CCR7;CXCL12;CCR1;CCR2;LGALS9;AIF1;LGMN
prerank,Elsevier_Pathway_Collection__T-Cell Receptor -> AP-1 Signaling,-0.5902738789410281,-1.818122860294109,0.0,0.04002777376471773,0.948,14/31,16.88%,CD4;MAP2K1;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;FYN;CARD11;LCK;CD247;LAT;FCER1G;ZAP70
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.49316135670212347,-1.8167773282323145,0.0,0.0403797341937837,0.952,19/51,14.94%,IFNG;TNF;IL1B;IL2RB;STAP1;FPR2;APOA1;IL15;SIRPB1;SIRPG;PTPRC;CCL2;C4A;FCGR2B;NCKAP1L;CLEC7A;SFTPD;DOCK2;FCER1G
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,-0.6137704854324737,-1.8156862453871772,0.011904761904761904,0.04069542785929939,0.952,8/27,8.49%,PCYT1B;MFSD2A;BCHE;SLC44A4;PEMT;SLC44A3;PHOSPHO1;SLC44A5
prerank,Elsevier_Pathway_Collection__Neutrophil Chemotaxis,-0.48129126452250404,-1.8138709504955552,0.0,0.041071587837204826,0.956,27/56,21.40%,CXCR1;FPR1;CXCR2;CCR5;MAP2K1;PRKCB;CXCL12;CXCL2;HRH4;CYBB;RAC2;CCR2;CXCL8;GNA14;VCAM1;CXCR3;CXCR4;VAV1;ITGA4;NCF1;NCF2;IQGAP1;C5;PPBP;PRKCZ;PF4;CYBA
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.5849233660218451,-1.8135780679436282,0.0,0.0409019367244891,0.956,18/29,19.88%,FOXP3;IFNG;LY9;IL18;SLAMF6;IL15;PRKCQ;IL6;OSM;RFTN1;IL12B;SLC7A5;NCKAP1L;TLR4;MYD88;PRNP;NR1H4;NOD2
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.5910674555753032,-1.8129698258271967,0.0,0.041050953759918095,0.956,17/25,21.86%,CYP26A1;BCO2;CYP2C8;ADH1A;UGT1A9;CYP3A7;CYP2C18;ALDH8A1;ADH1C;CYP26B1;ADH7;CYP3A4;ALDH1A2;UGT1A7;SCPEP1;ADH6;CYP2S1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.6793712882073532,1.8117893899530273,0.005917159763313609,0.2964226717915158,0.996,11/32,9.23%,SIX1;HOXD3;HOXD9;HOXA3;OSR2;HOXD4;HOXB9;OSR1;HOXC9;COL1A1;HOXA4
prerank,Elsevier_Pathway_Collection__ECL-cell: CHGA and Histamine Synthesis,-0.6595387104888545,-1.8111167939603985,0.0,0.04154476530054341,0.956,7/17,11.86%,PCSK2;GNAO1;ADCYAP1R1;SSTR2;VIPR1;SLC18A2;CXCL8
prerank,WikiPathway_2021_Human__Cardiac Progenitor Differentiation WP2406,0.6485113253293413,1.8110383626722402,0.0,0.2897316427889623,0.996,11/38,6.72%,SOX1;IGF2;DKK1;TNNI3;NODAL;THY1;SOX2;MESP2;MESP1;BMP4;FGF2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Rheumatoid Arthritis,-0.4645174239464259,-1.8086387699677047,0.0,0.042001738187085656,0.956,46/83,17.09%,IL10;CXCL10;PTGS2;TNFSF11;IFNG;CD4;TNF;IL1B;TNFRSF11B;MMP1;CD8A;CCL5;FASLG;PTPN22;TLR3;IL27;CCR5;IL18;PADI4;TNFSF10;IL15;CTLA4;CXCL12;FCGR3A;ALB;CCL2;IL6;CCR1;IL33;CD40LG;IL1RN;CCR2;PTGER4;CXCL8;TLR4;TNFRSF9;TLR2;AKT1;HAVCR2;CXCR3;CSF2;CXCR4;TNFRSF1B;TNFSF13B;CTSB;HLA-DQA1
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6339695845901997,-1.8071155092180933,0.011904761904761904,0.042111014397134085,0.956,9/23,11.68%,CXCL13;CXCL10;CCL5;XCL1;CXCL12;XCL2;DOCK8;CCR2;SPN
prerank,Elsevier_Pathway_Collection__Proteins Involved in Chronic Bronchitis,-0.627144325024672,-1.8068664324876595,0.0,0.04194030709106836,0.956,8/22,11.86%,TAC1;MUC5AC;MUC5B;TNF;CCL3;CTLA4;CXCL2;CXCL8
prerank,TRRUST_Transcription_Factors_2019__IRF8 mouse,-0.6174589602235904,-1.8056832383274142,0.0,0.0421411347663628,0.956,10/21,15.35%,IFNG;TNF;IL1B;CD8A;CCL5;FANCC;IL27;IL12B;C1QB;SPI1
prerank,Elsevier_Pathway_Collection__Effector T-cell Inactivation in Cancer Immune Escape,-0.5099862777031048,-1.8042793859331443,0.0,0.042370404193837745,0.956,21/57,17.08%,FOXP3;IFNG;TNF;LAG3;FASLG;CD80;BTLA;ESR1;VTCN1;CTLA4;PRKCQ;FYN;CD274;PDCD1LG2;LCK;PIK3R1;AKT1;PLCG2;CD86;ZAP70;BCL2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.4685994339711532,-1.8004699954992613,0.0,0.043663634605724075,0.96,43/76,23.97%,NLRP7;NLRP2;IFNG;TNF;GBP5;AIM2;NLRP12;CCL3;APOA1;CASP1;LILRA2;PYHIN1;CCR7;LILRA5;NLRP3;EGR1;IL6;TLR8;MEFV;MNDA;TLR4;CLEC7A;CARD16;IGF1;ORM2;MYD88;LILRB4;LGALS9;NLRC4;CD33;IFI16;WNT5A;NOD2;GSTP1;INAVA;CX3CR1;TMEM106A;JAK2;TYROBP;APP;SIRPA;F2RL1;ORM1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.5149068048643173,-1.799982528327415,0.0,0.04367005802946042,0.96,34/53,26.43%,IFNL1;IL1B;CD244;IL18R1;PTPN22;TLR3;CRTAM;IL27;IL18;SLAMF6;TLR8;CD2;IL12B;LILRB1;CCR2;SLC7A5;TLR4;CLEC7A;RASGRP1;CD226;IL12RB1;LGALS9;EBI3;IL12RB2;BTN3A2;HLA-DPA1;F2RL1;HLA-DPB1;BTN3A1;CD14;PDE4B;PDE4D;FZD5;TXK
prerank,Elsevier_Pathway_Collection__Kinetochore Assembly,0.6459733071158346,1.7998413225450534,0.005813953488372093,0.31431529030261557,0.996,18/40,14.95%,CENPF;CENPA;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;SPC24;TTK;CENPI;CENPM;AURKB;NDC80;CDCA8;SPC25;CENPL;ZWINT
prerank,Elsevier_Pathway_Collection__Natural Killer T-Cell Roles in Diabetes Mellitus Type 1,-0.49399405681177994,-1.7996506564218195,0.0,0.043555842577680914,0.96,23/59,16.88%,IL10;IFNG;CD4;IL2RB;CD69;CD80;CD1D;ICOS;MAP2K1;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;CD40LG;CARD11;LCK;CD247;LAT;AKT1;FCER1G;CD86;ZAP70
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.6839626167169528,-1.7995268906040989,0.0,0.043352904895445285,0.96,10/18,14.96%,CCL5;CXCR1;CXCR2;CCR5;CCR7;GPR183;CCR1;ALOX5;CCR2;CXCR4
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.5222204771294636,1.7989995612397995,0.0,0.30758884841354345,0.996,72/198,20.83%,E2F1;SQLE;CENPF;NEK2;CENPA;HMMR;KIF2C;PLK1;KIF4A;CENPE;TOP2A;CDC20;TROAP;BIRC5;UCK2;PBK;CCNB2;UBE2C;MKI67;E2F2;KIF15;BUB1;CDKN3;TTK;CDKN2C;EXO1;AURKB;CDC6;CDC7;EZH2;NDC80;CCNA2;UBE2S;CDC45;CCNF;KIF23;PTTG1;CDK1;MCM2;H2BC12;MCM6;AURKA;RACGAP1;HMGB3;POLQ;SLC7A1;MYBL2;DDX39A;CKS1B;ODC1;STMN1;CHEK1;H2AX;MCM3;MCM5;SMAD3;KIF11;PRC1;HMGA1;EGF;CDC25A;LBR;BARD1;CHAF1A;STIL;BCL3;TRAIP;SUV39H1;RAD54L;DTYMK;TPX2;JPT1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.4678025242452794,-1.7972000868779614,0.0,0.044344997614003324,0.96,43/88,22.36%,EREG;IFNG;TNF;GBP5;ZBP1;SIGLEC16;IL1B;CCL5;NLRP12;TLR3;FPR2;S100A8;CCL3;IL18;IL15;CD1D;LILRA5;NFKBIZ;OSM;TLR8;IL33;IL12B;CCR2;PTGER4;SH2D1B;TLR4;TLR2;TSLP;IL16;S100A12;GPSM3;SLC15A4;ETS1;ADAM8;WNT5A;MAPK13;PDE2A;AGTR1;NMI;RIOK3;CYBA;SNCA;APP
prerank,TRRUST_Transcription_Factors_2019__RUNX1 human,-0.5391145591560608,-1.7970096299062994,0.0,0.044140031996996,0.96,14/37,17.21%,KLK3;BPI;CCL3;NCAM1;LGALS3;PIK3CD;PRKCQ;KLF4;CSF2;SPI1;ITGB2;CD6;CSF1R;GP1BA
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.5796937783519287,-1.7963224637060962,0.024390243902439025,0.04408476328121029,0.96,9/32,8.49%,PCYT1B;MFSD2A;SLC44A4;LCAT;PEMT;APOA1;SLC44A3;PHOSPHO1;SLC44A5
prerank,Elsevier_Pathway_Collection__Treg-Cell Activation in Diabetes Mellitus,-0.5161868364018373,-1.7963076454901217,0.0,0.043883306384448026,0.96,21/54,16.88%,IRF4;FOXP3;IL10;CD4;IL2RB;MAP2K1;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;FYN;CARD11;LCK;CD247;LAT;AKT1;CCR4;FCER1G;CD86;ZAP70
prerank,WikiPathway_2021_Human__G1 to S cell cycle control WP45,0.5779734739081254,1.7952818893130602,0.0,0.31077455074030325,0.996,26/63,23.50%,E2F1;MYT1;CDKN2A;E2F2;CCNE1;CDKN2C;CCNE2;CDC45;CDK1;MCM2;CCNB1;MCM6;CDKN2B;PRIM1;CREB3L1;ORC1;CDKN1C;CREB3L4;MCM3;MCM5;CDC25A;MCM4;CDK6;MCM7;POLA2;CDKN2D
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.605371972784689,-1.7949370786283376,0.0,0.04415115599699524,0.96,10/24,12.06%,CEACAM6;IL10;TNF;IL1B;APOA1;KLF4;BMP7;IL1RN;SKAP1;LCK
prerank,WikiPathway_2021_Human__Cytokines and Inflammatory Response WP530,-0.6438912092402299,-1.7939552716854228,0.0,0.04427098395553631,0.968,12/20,16.09%,CSF3;IL10;IFNG;CD4;TNF;IL1B;IL15;CXCL2;IL6;IL12B;CSF2;CXCL1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.7582902615461252,1.7933638718182192,0.0,0.3074587431545672,0.996,9/17,9.94%,PVALEF;TNNC1;TNNI3;MYH3;TNNT1;MYH8;TNNI2;TNNT3;CCDC78
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.5492118624482378,-1.7931875867744307,0.012987012987012988,0.04438957657429861,0.968,14/27,18.32%,PTGS2;IFNG;TNF;IL1B;HBB;KLF4;DDAH1;TLR4;CLEC7A;AKT1;KLF2;CLU;AGXT2;ASS1
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.6233205172407761,1.7899257239899409,0.0,0.3096578752582133,1.0,21/43,18.03%,H2AC19;H2BC13;HJURP;CENPA;H2AC20;H2BC17;H2BC21;CENPI;H2BC9;CENPM;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;CENPU;CENPL;H2BC5;H2AX;CENPK
prerank,Elsevier_Pathway_Collection__Th17-Cell Differentiation in Asthma,-0.4835640568201269,-1.7895166927872068,0.0,0.045513247012287164,0.968,25/59,16.88%,IRF4;CD4;IL1B;CD80;IL1RAP;IL18;ICOS;PTPRC;PRKCQ;CD3E;CD3G;IL6;FYN;CD40LG;CARD11;LCK;CD247;LAT;IL21R;AKT1;MYD88;FCER1G;IL12RB1;CD86;ZAP70
prerank,Elsevier_Pathway_Collection__Toll-like Receptors (TLR) in Antiviral Innate Immune Response,-0.6353736235621801,-1.7883455637456165,0.01282051282051282,0.045881732568306036,0.968,10/20,14.75%,TNF;IL1B;TLR3;IL6;TLR8;CXCL8;TICAM2;TLR4;TLR2;MYD88
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.47716083020889893,-1.786153614402963,0.0,0.04630339589532593,0.968,40/70,24.09%,EREG;IFNG;TNF;SIGLEC16;IL1B;POU2AF1;TLR3;LILRA2;SCIMP;LILRA5;IL6;TLR8;IL33;TLR4;CLEC7A;TLR2;SPHK2;TSLP;IL16;SYK;POU2F2;PLCG2;MYD88;LGALS9;LILRB2;AIF1;TWIST1;WNT5A;MAPK13;NOD2;INAVA;XBP1;TMEM106A;CYBA;TYROBP;APP;IFIH1;F2RL1;DDX58;TLR1
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.5676352415533318,-1.7860569981495547,0.0,0.04609785599686276,0.968,5/23,12.84%,FOXP3;MUC1;IL1B;PPARGC1A;SPHK2
prerank,TRRUST_Transcription_Factors_2019__PITX2 mouse,0.7395240338903993,1.7854379279895767,0.006493506493506494,0.31602167081457333,1.0,5/17,6.21%,TBX4;LEF1;GAD1;NR5A1;BMP4
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.6240605540136887,-1.7847449427595354,0.0,0.04645784876065735,0.972,12/20,16.11%,TNF;IL1B;BPI;CCL5;PTPN22;CCL3;IL18;CCL2;TLR4;HCK;PRKCE;CD6
prerank,Elsevier_Pathway_Collection__Toll-like Receptors in beta-Cell,-0.4881651650736645,-1.7838727109686832,0.015151515151515152,0.046618014236827356,0.972,16/45,15.75%,CXCL10;IFNG;TNF;IL1B;CCL5;TLR3;CXCL9;MAP2K1;CCL2;IL12B;TLR4;TLR2;AKT1;MYD88;IL12RB1;TNFRSF1B
prerank,Elsevier_Pathway_Collection__AHR Signaling in Treg and Dendritic Cells Function,-0.5960744228179355,-1.7821961043787162,0.0136986301369863,0.047139195220672475,0.98,6/21,10.06%,FOXP3;IL10;IFNG;IL2RB;IKZF3;IDO2
prerank,WikiPathway_2021_Human__Cancer immunotherapy by PD-1 blockade WP4585,-0.5959548588713525,-1.7815187479142702,0.011363636363636364,0.0473221568284626,0.98,13/23,21.42%,IFNG;CD8B;CD8A;CD3E;CD3G;CD274;PDCD1LG2;LCK;ZAP70;BATF;CD3D;NFATC2;JUN
prerank,KEGG_2021_Human__Hematopoietic cell lineage,-0.4441494644083845,-1.7813579732739733,0.0,0.047144279169205335,0.98,53/89,24.83%,CR2;CSF3;IL5RA;CD1A;CD4;TNF;IL1B;CD8B;CD8A;CD1B;IL7R;CSF3R;CD38;GP5;CD1D;CD1E;MS4A1;CD3E;CD3G;IL6;CR1;CD2;HLA-DQA2;CD1C;CD5;FLT3;HLA-DOB;CR1L;CSF2;CSF1R;ITGB3;HLA-DQA1;ITGA4;GP1BA;CD33;CD19;ITGA3;CD37;CD7;CD3D;HLA-DOA;HLA-DRB5;CD55;HLA-DRA;ITGAM;ANPEP;HLA-DPA1;CSF2RA;CD22;CD24;HLA-DPB1;HLA-DRB1;CD14
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.42020522225313484,-1.7813051242056417,0.0,0.04691317976151316,0.98,60/128,22.37%,EREG;IFNG;TNF;GBP5;ZBP1;SIGLEC16;IL1B;ACOD1;P2RY12;CCL5;NLRP12;OASL;TLR3;FPR2;S100A8;CCL3;IL18;IL15;CD1D;SCIMP;LILRA5;NFKBIZ;OSM;TLR8;IL33;IL12B;CCR2;PTGER4;SH2D1B;PLG;CD180;TLR4;TLR2;TSLP;IL16;DDX60;S100A12;PTN;GPSM3;THBS1;SLC15A4;STX3;ETS1;LY86;AIF1;APOH;ADAM8;WNT5A;MAPK13;SERPINF2;USP15;PDE2A;AGTR1;NMI;RIOK3;CYBA;F2;SNCA;APP;DHX58
prerank,TRRUST_Transcription_Factors_2019__AR human,-0.4519878738131027,-1.7804385451837803,0.0,0.04698517135289993,0.984,12/86,6.21%,KLK3;CRISP3;KLK2;SERPINB5;MUC1;WNT7B;PTGS2;KLF5;TH;GNMT;CDH1;IGFBP3
prerank,WikiPathway_2021_Human__Fatty Acid Omega Oxidation WP206,-0.6773537852299845,-1.7793503755032403,0.0,0.04719254399678825,0.984,8/15,15.67%,ADH4;CYP4A11;ADH1A;CYP1A2;ADH1C;ADH7;CYP3A4;ALDH2
prerank,Elsevier_Pathway_Collection__G2/M Phase Transition,0.6675452439966381,1.7784611227489804,0.0,0.33435578142638595,1.0,12/29,11.47%,CENPF;KIF20A;NEK2;CDC25C;CENPA;FOXM1;PLK1;CCNB2;DLGAP5;CDK1;CCNB1;AURKA
prerank,Reactome_2022__Biosynthesis Of Specialized Proresolving Mediators (SPMs) R-HSA-9018678,-0.6337704807768864,-1.7775682597885132,0.011494252873563218,0.047560420170676264,0.984,10/18,14.14%,PTGS2;CYP2C8;HPGD;CYP1A2;CYP2C9;ALOX5AP;ALOX5;PTGR1;CYP3A4;EPHX2
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,0.5646534450270941,1.776788648843766,0.0,0.33205242394853307,1.0,38/90,24.63%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;BIRC5;SPC24;BUB1;CENPI;CENPM;AURKB;KIF18A;NDC80;CDCA8;SPC25;KNTC1;CENPU;ERCC6L;CENPL;SGO2;ZWINT;CENPK;SPDL1;SGO1;NUP37;DSN1;B9D2;PPP2R5A;AHCTF1;RPS27;CENPP;NUP133;DYNLL1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.696590491268253,1.775690602493603,0.006024096385542169,0.3261881062858163,1.0,2/21,0.59%,MT3;DLX5
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.43902287324456535,-1.7754227509370017,0.0,0.0483290736890186,0.984,30/96,14.04%,CYP26A1;CYP2C19;CYP2A7;CYP2A13;CYP2B6;AOC1;FMO1;CYP39A1;CYP2C8;CYP4A22;CYP4A11;ALDH1B1;ADH1A;CYP4F2;CYP1A2;CYP3A43;CYP3A7-CYP3A51P;CYP2C18;CYP8B1;CYP2C9;ADH1C;CYP4F12;CMBL;CYP26B1;ADH7;CYP4F3;CYP3A4;CYP4V2;TBXAS1;CES3
prerank,TRRUST_Transcription_Factors_2019__PPARG mouse,-0.5355694964725443,-1.774822993538351,0.0,0.048366087499100735,0.984,16/44,11.21%,CIDEA;GCK;MUC1;PDX1;PTGS2;CIDEC;KLF5;IFNG;HGF;GYS2;CAT;MAF;PLIN1;EGR1;SCNN1G;TMEM159
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.5268209347018309,1.774147659947586,0.0,0.32324972364984045,1.0,58/125,29.99%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;KIF4A;BUB1B;CENPE;NUF2;CDC20;BIRC5;SPC24;BUB1;TTK;CENPI;CENPM;AURKB;DLGAP5;KIF18A;NDC80;CDCA8;SPC25;CCNB1;KNTC1;AURKA;CENPU;TBCE;ERCC6L;CENPL;SGO2;PMF1;ZWINT;STMN1;KIF11;CENPK;SPDL1;STIL;WDR62;SGO1;NUP37;DSN1;B9D2;GPSM2;AHCTF1;RPS27;CENPP;NUP133;DYNLL1;RANGAP1;MECP2;ITGB3BP;INCENP;MAD2L1;CENPS;CENPH;TACC3;NUP160
prerank,WikiPathway_2021_Human__T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,-0.49339844621485196,-1.7738422210962623,0.0,0.048536236796696816,0.984,21/60,15.21%,IL10;IFNG;CD4;TNF;CD8A;FOS;ICOS;ITK;MAP2K1;CTLA4;PTPRC;PRKCQ;FYN;LCP2;CD40LG;CARD11;LCK;LAT;AKT1;CSF2;CHP1
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.40510019475763853,-1.7732343948965046,0.0,0.04857191794930101,0.984,72/202,18.88%,CYP26A1;GSTA2;CYP2C19;UGT2A1;GGT6;UGT1A5;CYP2A7;GLYATL3;CHAC1;CYP2A13;CYP2B6;GLYATL2;GSTZ1;AOC1;FMO1;CYP39A1;CYP2C8;CYP4A22;GLYAT;GSTA1;CYP4A11;ALDH1B1;ADH1A;SULT1A2;CYP4F2;UGT1A9;UGT2B7;GLYATL1;CYP1A2;CYP3A43;GSTT2B;DPEP3;CYP3A7-CYP3A51P;CYP2C18;CYP8B1;CYP2C9;UGP2;GSTM5;ADH1C;UGT2B28;CYP4F12;CMBL;UGT2B10;DPEP2;AKR7A3;MAT1A;CYP26B1;ADH7;CYP4F3;SULT1C4;CYP3A4;CYP4V2;SLC35D1;TBXAS1;UGT2A3;CES3;ACSM5;SULT2A1;PODXL2;ALDH2;UGT2B15;CYP2J2;TPMT;PRNP;FMO3;HPGDS;UGT1A7;PTGIS;ESD;GSTO2;FMO4;NR1H4
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.48473793071257254,-1.7698452927062787,0.014925373134328358,0.049823766336231826,0.984,21/48,17.67%,IL10;IFNG;TLR3;TIGIT;CCR7;SCIMP;LILRA5;TLR8;CD40LG;IL12B;MEFV;LILRB1;TLR4;CLEC7A;TLR2;IL16;SYK;PLCG2;LGALS9;THBS1;SLAMF1
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,-0.5324643284573236,-1.768986376631719,0.0,0.05001099717969504,0.984,14/33,17.19%,CIDEC;LPA;CETP;LCAT;APOA4;APOF;APOA1;LIPG;ALB;APOA5;ANGPTL3;PCSK5;LIPC;PLTP
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.675170195181692,-1.7680229479809098,0.0,0.050013088146129016,0.984,7/15,13.87%,ENPP3;IFNL1;LGALS3;CR1;CD300A;LILRB1;HAVCR2
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.46603757571307475,-1.7675445235037466,0.0,0.049989082936132814,0.984,36/78,23.73%,CR2;FOS;CD79A;LILRA2;LILRA1;MAP2K1;PIK3CD;LILRA5;PRKCB;DAPP1;LILRB5;RAC2;LILRB1;FCGR2B;BTK;CARD11;LILRA6;PIK3R1;AKT1;SYK;PLCG2;VAV1;LILRB4;LILRA4;LILRB2;VAV3;INPP5D;LILRB3;CD19;PPP3CA;NFATC2;JUN;PIK3AP1;AKT3;CD22;CD81
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.6401098805216613,1.7675331601305004,0.0,0.33974035993078583,1.0,13/34,15.52%,ODAM;AQP6;OSR2;OSR1;AXIN2;ACP4;BMP4;SSUH2;MSX1;FOXC1;COL1A2;TUFT1;WNT6
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,0.5785714448440914,1.767419828493888,0.0,0.3319534381310958,1.0,22/66,16.39%,ODAM;H3C13;CALCA;H2AC19;TSPAN5;H2BC13;SAA2;H2AC20;H2BC17;H2BC21;PRKN;H2BC9;H2BC15;H2BC11;H2BC12;MFGE8;H2BC4;H4C15;H2AC6;IAPP;H2BC5;H2AX
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.6191714674883559,-1.7665615088485365,0.025974025974025976,0.05017294799658542,0.992,5/20,5.08%,RAB25;WNT7B;WNT7A;GRHL2;POF1B
prerank,Elsevier_Pathway_Collection__Mast-Cells De Novo Synthesized Mediators via IgE Independent Signaling,-0.4665872721549892,-1.7661146594464758,0.0,0.05022593651271085,0.992,32/82,16.62%,IL10;PTGS2;IFNG;TNF;NTRK3;NTF3;P2RY12;CXCR1;CCL4;NTRK2;IL18;MAP2K1;CCL2;PTGER2;IL6;CCR1;NGF;NTRK1;CNR2;PTGER4;P2RY1;CXCL8;RASGRP4;GNA14;LPAR5;AKT1;CSF2;VAV1;PRKCE;ADORA3;DDC;PLAUR
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,-0.4778263361464293,-1.7658362206711198,0.0,0.05022700315254505,0.992,33/69,20.81%,GSTA2;UGT2A1;UGT1A5;CYP2A7;CYP2A13;CYP2D7;CYP2B6;ADH4;GSTA1;ADH1A;UGT1A9;UGT2B7;CYP1A2;GSTT2B;CYP2C9;GSTM5;ADH1C;UGT2B28;UGT2B10;AKR7A3;ADH7;CYP3A4;UGT2A3;SULT2A1;UGT2B15;ALDH3B2;HPGDS;UGT1A7;GSTO2;DHDH;GSTP1;GSTM1;ADH6
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.6638109297211394,-1.764735031142789,0.010526315789473684,0.0505864661883381,0.996,8/17,15.75%,WNT7A;TNF;IL1B;ROBO2;IL6;TLR2;SORL1;SLIT1
prerank,WikiPathway_2021_Human__Gastric Cancer Network 1 WP2361,0.6631575649715487,1.7641074357827449,0.006024096385542169,0.33453183655857205,1.0,13/26,20.73%,S100P;ESM1;E2F7;CENPF;TOP2A;UBE2C;KIF15;AURKA;MYBL2;SMOC2;ECT2;MCM4;TPX2
prerank,WikiPathway_2021_Human__miRNA regulation of prostate cancer signaling pathways WP3981,-0.5625514359450692,-1.7637181034350367,0.0,0.050560400287468145,0.996,1/33,0.01%,KLK3
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.6967467458211065,1.761057517137082,0.006329113924050633,0.33841890711571165,1.0,6/20,5.22%,PAX2;SIX1;OSR2;EPHB2;OSR1;GSC
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,0.5421497501024877,1.7608466476429714,0.0,0.3315807585736062,1.0,46/107,28.21%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;BIRC5;UBE2C;SPC24;BUB1;CENPI;CENPM;AURKB;KIF18A;NDC80;UBE2S;CDCA8;SPC25;KNTC1;CENPU;ERCC6L;CENPL;SGO2;ZWINT;CENPK;SPDL1;SGO1;NUP37;DSN1;ANAPC11;B9D2;PPP2R5A;AHCTF1;RPS27;CENPP;NUP133;DYNLL1;RANGAP1;ANAPC7;ITGB3BP;INCENP;MAD2L1
prerank,Elsevier_Pathway_Collection__Natural Killer Cell Activation through C-Type Lectin-like Receptors,-0.5485091397667733,-1.7606873586576193,0.0,0.05149858316391602,0.996,14/34,15.00%,IFNG;TNF;FOS;FASLG;MAP2K1;PRF1;PRKCQ;LCP2;LCK;AKT1;KLRK1;PLCG2;CSF2;VAV1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.6127284990160793,-1.7604989814232295,0.0125,0.0513171165370481,0.996,11/19,22.12%,ENPP3;IFNG;DNASE1L3;LILRA2;SYK;DOCK2;PLCG2;FCER1G;SLAMF1;NMI;TYROBP
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,0.5638619422726237,1.7603809302698454,0.015873015873015872,0.32603243648472535,1.0,21/72,15.60%,GNG4;GLP1R;CACNA1E;SYT5;GCG;ADRA2C;KCNC2;KCNG2;CACNA2D2;KCNB1;ACSL4;GNG3;ABCC8;CD36;CACNA1C;SNAP25;GNB5;ADCY6;GNG8;KCNJ11;PRKCA
prerank,Elsevier_Pathway_Collection__T-Cell Receptor -> NFATC Signaling,-0.5910829012932263,-1.7603209788675183,0.0,0.05113727741356015,0.996,13/24,20.91%,CD4;CTLA4;PTPRC;CD3E;CD3G;FYN;LCK;CD247;LAT;FCER1G;ZAP70;CD3D;NFATC2
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,-0.5210846532817144,-1.759876383496799,0.013333333333333334,0.05115927599651829,0.996,15/33,23.89%,GSTA2;GGT6;CHAC1;GSTZ1;GSTA1;GSTT2B;GSTM5;PRNP;HPGDS;ESD;GSTO2;GSTP1;GSTM1;AKR1A1;GGT5
prerank,Elsevier_Pathway_Collection__Proteins Involved in Helicobacter Infections,-0.47728600356889733,-1.758263955049879,0.0,0.05165451647648459,0.996,17/55,13.38%,CXCL13;CYP2C19;PTGS2;IFNG;CD4;TNF;IL1B;IL18;CASP1;MS4A1;TBX21;IL1RN;MBL2;CXCL8;TLR4;TLR2;CAMP
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.5095689043754787,-1.7578452912599798,0.0,0.051525186686758886,0.996,23/45,20.58%,IRF4;FOXP3;TIGIT;XCL1;LILRA5;IL6;CD40LG;IL12B;LILRB1;CD274;FCGR2B;PDCD1LG2;TLR4;CLEC7A;TSLP;SYK;PLCG2;LILRB4;LGALS9;TNFRSF21;NOD2;INAVA;PRKCZ
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.4916339751595324,-1.7565403237148236,0.0,0.051866262551536264,0.996,22/56,12.33%,TFF2;CXCL13;CXCL10;CXCL11;GPR75;CCL5;CXCL3;CXCL9;CCL4;CCL3;XCL1;CCL23;CXCL12;CXCL2;CCL2;CCR1;XCL2;DOCK8;CCR2;CXCL8;CCL22;RIPOR2
prerank,KEGG_2021_Human__Propanoate metabolism,-0.5217091994588339,-1.7556825350560743,0.0,0.0518600879964706,0.996,16/34,19.70%,ALDH6A1;BCKDHB;MMUT;ACACB;ACADS;EHHADH;ACOX1;DBT;ABAT;ECHDC1;ECHS1;MLYCD;SUCLG2;ACAT1;PCCA;ACOX3
prerank,Elsevier_Pathway_Collection__T-Cell Positive Selection and Neglect Induced Death,-0.5766592810050664,-1.7551936866642215,0.013888888888888888,0.051878449882932234,0.996,16/30,20.90%,NR4A1;BCL11B;CD3E;CD3G;EGR1;LCP2;TRAC;CD247;LAT;AKT1;FCER1G;ZAP70;TRBC2;BCL2;CD3D;MYB
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.4925237319172596,-1.7534377179751695,0.0,0.0525060538399049,0.996,34/53,25.66%,CXCL13;CR2;CFP;C9;C7;CCR7;C6;CR1;C4A;FCGR2B;C1QC;C1R;CPN2;CR1L;CFI;C1QB;SERPING1;CLU;C8A;VTN;CD19;C3AR1;C8B;C1S;C1QA;C5;CD55;F2;CD81;C3;C4B;CPB2;PHB2;PROS1
prerank,Elsevier_Pathway_Collection__T-Cell Central Tolerance,-0.5622675977325382,-1.7502058824197653,0.0,0.05392915199632979,0.996,18/39,17.08%,NR4A1;FASLG;CD80;TNFSF10;CD3E;CD3G;CD274;HDAC9;TRAC;LCK;CD247;LAT;AKT1;FCER1G;BCL2L11;ZAP70;TRBC2;BCL2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.43954974775661926,-1.7496366520170172,0.0,0.05379336247909765,0.996,27/61,17.19%,HHLA2;IL1B;PNP;CCL5;CD80;IL18;IL15;CD1D;PTPRC;CD3E;IL6;CD40LG;IL12B;CCR2;CD274;PDCD1LG2;NCKAP1L;TMIGD2;SYK;IGF1;VCAM1;TNFRSF13C;IL12RB1;CD86;CD6;LILRB2;EBI3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.6544936873466565,-1.7492071590581673,0.0,0.05382717403925518,0.996,11/18,16.36%,IRF4;NLRP3;PRKCQ;CD40LG;SLC7A5;GATA3;SYK;HAVCR2;FCER1G;CD86;LGALS9
prerank,Elsevier_Pathway_Collection__TLR2 Signaling in Treg-Cell in Type 1 Diabetes (Animal Model),-0.46773728746194604,-1.7472440794636839,0.0,0.05450759999629042,0.996,21/56,16.88%,FOXP3;CD4;IL2RB;TLR3;MAP2K1;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;FYN;CARD11;LCK;CD247;TLR4;TLR2;LAT;MYD88;FCER1G;CD86;ZAP70
prerank,WikiPathway_2021_Human__Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,-0.5398624360520758,-1.747183314796434,0.0,0.05429951019204927,0.996,16/39,21.55%,NLRP7;NLRP2;AIM2;IL1B;NLRP12;IL18;CASP1;NLRP3;MEFV;PRDM1;CASP7;NLRC4;ACAP1;NAIP;NOD2;DUOX2
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,0.5519312037669251,1.7469718811382584,0.0,0.36739114327020544,1.0,42/103,24.63%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;BIRC5;CCNB2;SPC24;BUB1;CENPI;CENPM;AURKB;KIF18A;NDC80;CDCA5;CDK1;CDCA8;SPC25;CCNB1;KNTC1;CENPU;ERCC6L;CENPL;SGO2;ZWINT;CENPK;SPDL1;SGO1;NUP37;DSN1;B9D2;PPP2R5A;AHCTF1;RPS27;CENPP;NUP133;DYNLL1
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5895275633393671,1.7446729817708668,0.01639344262295082,0.36865080251955074,1.0,4/47,0.82%,REG1A;MUC7;REG3A;REG1B
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.6204147674811585,-1.7421932225101906,0.0,0.056730137487664596,1.0,10/18,16.28%,FGF10;MZB1;PTPN22;IL27;LGALS3;IKZF3;IL12B;TNFRSF1B;TNFSF8;LST1
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.5703733406312058,1.7411571613149597,0.010810810810810811,0.3744083239987273,1.0,31/60,25.23%,H3C13;H2AC19;H2BC13;CDKN2A;CDC25C;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;EZH2;H2BC11;DNMT3A;H2BC12;H2BC4;H4C15;PRIM1;H2AC6;LMNA;H2BC5;H2AX;CDC25A;CDK5R1;FADD;H2AJ;POLA1;POLA2;DNMT1;CAPN2;DNMT3B;CDK5
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.5055663872090191,-1.7410314017606843,0.0,0.05686926743916767,1.0,17/47,12.49%,CEACAM6;CXCL13;IL10;TNFSF11;MEGF10;TNF;IL1B;CCL5;ANK3;SIRPG;FUT3;CD3E;FUT7;BMP7;SKAP1;LCK;CITED2
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,0.551507356098551,1.7409956391564276,0.0,0.3673941714521255,1.0,38/94,24.63%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;BIRC5;SPC24;BUB1;CENPI;CENPM;AURKB;KIF18A;NDC80;CDCA8;SPC25;KNTC1;CENPU;ERCC6L;CENPL;SGO2;ZWINT;CENPK;SPDL1;SGO1;NUP37;DSN1;B9D2;PPP2R5A;AHCTF1;RPS27;CENPP;NUP133;DYNLL1
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,0.6423251815237105,1.7399600404033269,0.010471204188481676,0.3631177729446069,1.0,18/35,22.69%,CDC25C;CDC6;CDC7;CDC45;MCM6;SERPINA2;RFC4;MCM10;CHEK1;MCM3;MCM5;CDC25A;MCM4;POLR1A;CLSPN;ATRIP;RAD9B;MCM7
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.4984972443944429,1.7393810460375156,0.0,0.3585406581595909,1.0,132/258,36.11%,DYNC1I1;H2BC13;CENPF;CDKN2A;CDC25C;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;GTSE1;CDC20;H2BC17;BIRC5;CCNB2;UBE2C;SPC24;BUB1;H2BC21;PSMD4;CCNE1;CENPI;H2BC9;CENPM;EXO1;H2BC15;AURKB;CDC6;CDC7;KIF18A;NDC80;ZNF385A;CCNA2;UBE2S;CCNE2;CDC45;H2BC11;CDK1;CDCA8;SPC25;CCNB1;KNTC1;H2BC12;MCM6;H2BC4;H4C15;CENPU;SERPINA2;ERCC6L;RFC4;PSMB4;CENPL;SGO2;ZWINT;H2BC5;MCM10;PKMYT1;CHEK1;H2AX;MCM3;MCM5;CDC25A;CENPK;BARD1;SPDL1;MCM4;DNA2;RMI1;PCBP4;SGO1;NUP37;POLR1A;CLSPN;DSN1;ATRIP;RAD9B;ANAPC11;B9D2;MCM7;PPP2R5A;AHCTF1;RPS27;CENPP;BLM;NUP133;DYNLL1;RHNO1;RANGAP1;ANAPC7;PSMB3;ITGB3BP;NSD2;PSMD14;CHEK2;INCENP;UBA52;MAD2L1;CDKN1A;MDC1;PSMB5;CENPH;PSMD2;NUP160;ABRAXAS1;PSMA1;PIAS4;BABAM2;PSMD10;PSMC4;PSMC3;TP53BP1;BRIP1;RMI2;UIMC1;MCM8;DYNC1H1;TOPBP1;CENPT;REXO2;CENPQ;PSMC5;PPP2R1A;SEM1;PSMB6;CDC23;YWHAH;KIF2A;PSMD8;MDM4;NDE1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.5283121516899539,-1.7359057928723736,0.0,0.058915321407755156,1.0,18/32,26.11%,CD160;FFAR2;KIR2DL4;XCL1;SCIMP;SLC7A5;CLEC7A;SPHK2;CD226;PLCG2;WNT5A;NOD2;INAVA;CD55;LAPTM5;F2RL1;TRIM6;FZD5
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6448512036858797,-1.734164531221782,0.011764705882352941,0.059161434774216384,1.0,10/16,23.73%,PTPN22;IL18;XCL1;IL12B;CCR2;SYK;LGALS9;EBI3;CD55;CD81
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.5571141668560101,-1.7331205812224841,0.0,0.05931205559596345,1.0,13/29,17.44%,ADRA1A;HTR2A;AVPR1A;P2RY12;NTRK2;ITK;NMUR1;LPAR2;RASGRP4;SELE;PLCB2;CD86;LPAR1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.6822192341896319,-1.732305802035082,0.010869565217391304,0.059438162983506744,1.0,9/16,14.96%,CCL5;CXCR1;CXCR2;CCR5;CCR7;GPR183;CCR1;CCR2;CXCR4
prerank,Elsevier_Pathway_Collection__P-cell Activation,-0.6159574368767354,-1.7317789869054274,0.0196078431372549,0.05944739146702862,1.0,3/15,6.54%,TCN1;GNAO1;SSTR2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.4636592904540715,-1.731208724581598,0.0,0.05945654399595361,1.0,28/64,16.09%,CXCL13;CXCL10;CXCL11;CCL5;CXCR1;CXCR2;CXCL3;CXCL9;S100A8;CCL4;CCL3;XCL1;LGALS3;CCL23;PIK3CD;CXCL2;CCL2;XCL2;CXCL8;NCKAP1L;CCL22;SYK;PF4V1;S100A12;CD300H;FCER1G;ITGB2;CXCL1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.5917226249287284,1.7305184963741296,0.00546448087431694,0.38623266587966526,1.0,14/49,11.72%,HOXD3;HOXD9;HOXA3;HOXD4;HOXB9;SIX2;HOXC6;TDGF1;HES5;HOXC9;CDX1;HOXA4;HES2;CDX2
prerank,Elsevier_Pathway_Collection__T-Cell Maturation (Hypothesis),-0.4848686878623757,-1.7297246257521914,0.0,0.060086012454927167,1.0,24/62,17.08%,FOXP3;CD4;TNF;CD8A;IL2RB;IL7R;MAP2K1;CD3E;CD3G;IKZF1;IL6;CD40LG;CXCL8;GATA3;TRAC;LCK;CD247;LAT;AKT1;FCER1G;CXCR4;ZAP70;TRBC2;BCL2
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Rheumatoid Arthritis,-0.6166833077139163,-1.7295088782906005,0.036585365853658534,0.06000094902448799,1.0,11/20,15.75%,TNFSF11;IFNG;TNF;IL1B;INHBA;IL15;CXCL12;IL6;CXCL8;TLR2;TNFRSF1B
prerank,Elsevier_Pathway_Collection__Humoral Immunity in Vitiligo,-0.4694150549705766,-1.7263771508982038,0.0,0.06128401521534144,1.0,26/68,22.03%,IL10;IL5RA;IL2RB;FOS;CD79A;MAP2K1;CCR7;PRKCB;IL6;CD40LG;BTK;CARD11;LAT;AKT1;SYK;PLCG2;VAV1;IL10RA;LILRB3;CD19;NFATC2;MAP2K3;JUN;JAK2;PIK3AP1;CD40
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Prostate Cancer,-0.5601701324930044,-1.724786465915897,0.03571428571428571,0.061784947817657504,1.0,7/27,13.06%,KLK3;PTGS2;CDH1;EGR1;NKX3-1;TRPM8;AKT1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.4356972737254818,-1.7224552717248514,0.0,0.06253051586671216,1.0,31/68,19.01%,FGF10;IL1B;PNP;CCL5;CD80;BST1;IL18;CD38;IL15;CD1D;GPR183;FCRL3;PTPRC;CD3E;IL6;CD40LG;IL12B;CD274;SASH3;PDCD1LG2;NCKAP1L;VCAM1;TNFRSF13C;CD86;CD6;LILRB2;TNFSF13B;VAV3;BCL2;AIF1;IRS2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.512884971704528,1.722045184762571,0.0,0.40824348852121006,1.0,33/139,14.38%,TBX4;HOXA13;COL2A1;EN1;IGF2;DLX5;HOXD3;PITX1;DLX6;INHA;NOTUM;EXTL1;RFLNA;BCAN;CHI3L1;MATN3;PHEX;HES5;TBX3;SHOX;COL10A1;IHH;COL1A1;COMP;PTHLH;NCAN;GDF11;BPNT2;HHIP;BGLAP;SH3PXD2B;COL1A2;TEAD4
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.5234786430969277,-1.7210137467951447,0.012195121951219513,0.0630224188872772,1.0,2/36,0.18%,KLK3;KLK2
prerank,TRRUST_Transcription_Factors_2019__FOXA1 human,-0.5791035880093968,-1.7199800335416866,0.012987012987012988,0.06351038668367773,1.0,6/20,6.58%,TFF1;NKX2-1;RET;SFTPB;AGR2;ESR1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.5501760066773275,-1.7194431443240399,0.0,0.06357007017894059,1.0,14/28,16.36%,CD160;NCR1;KLRD1;KLRC1;CRTAM;CLEC12B;KIR2DL4;SLAMF6;NCR3;LILRB1;RASGRP1;CD226;KLRK1;LGALS9
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.48597755441136686,-1.7192289876483058,0.0,0.06342904799568326,1.0,32/50,25.66%,CR2;IL1B;CFP;C9;C7;C6;CR1;C4A;C1QC;C1R;CPN2;CR1L;CFI;C1QB;SERPING1;CLU;C8A;VTN;CD19;C3AR1;C8B;C1S;C1QA;C5;CD55;F2;CD81;C3;C4B;CPB2;PHB2;PROS1
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.5905892399726014,1.718404092264086,0.016304347826086956,0.4141448701799654,1.0,17/48,17.34%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;KAT2A;H2BC5;H2AX;POLR2L
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.4895504332944783,-1.7181512679971152,0.0,0.06364370162412716,1.0,27/41,23.73%,IL10;MZB1;BST1;CD38;IKZF3;TNFRSF13B;CTLA4;GPR183;FCRL3;PTPRC;CD300A;BLK;SASH3;MNDA;FCGR2B;NCKAP1L;TNFRSF13C;TNFSF13B;VAV3;BCL2;TNFRSF21;IRS2;NFATC2;CD40;TYROBP;CD22;CD81
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3774680881334074,-1.716816618169662,0.0,0.06407739325548166,1.0,81/190,22.48%,LRFN5;LRRC19;ENPP3;IL10;PTGS2;ACE2;IFNG;TNF;ZBP1;IL1B;ACOD1;CCL5;CD200R1;GPR31;NLRP12;TLR3;TNFAIP6;FFAR2;FPR2;S100A8;BST1;CCL3;IL18;APOA1;CASP1;DNASE1L3;XCL1;IL15;LILRA5;NFKBIZ;NLRP3;IL1RL2;IL6;OSM;KLF4;IL33;IL12B;ALOX5;MEFV;CCR2;PTGES;PTGER4;GATA3;TLR4;HCK;TLR2;SELE;TSLP;IL16;S100A12;USP18;MYD88;TNFAIP8L2;GPSM3;AOAH;TNFRSF1B;NLRC3;MGLL;PTGIS;ETS1;GGT2;NR1H4;MACIR;SHPK;WNT5A;MAPK13;AHSG;AKNA;NOD2;PDE2A;AGTR1;NLRP6;LPCAT3;TEK;NMI;JAK2;TMSB4X;PIK3AP1;SNCA;APP;CASP4
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,0.5597519449031126,1.7163397609694444,0.010256410256410256,0.4144953389046436,1.0,22/68,17.32%,H3C13;H2AC19;E2F1;H2BC13;H2AC20;H2BC17;AGO2;H2BC21;H2BC9;H2BC15;NOTCH3;H2BC11;H2BC12;ATP2A1;H2BC4;H4C15;H2AC6;KAT2A;H2BC5;H2AX;ST3GAL3;ELF3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4498171488121252,-1.7161873738583595,0.0,0.06411193072504855,1.0,44/74,24.86%,IFNG;TLR3;CCL3;LILRA2;LILRA5;PTPRC;IL6;CD2;IL33;IL12B;CCR2;SPN;TLR4;CLEC7A;TLR2;SPHK2;RASGRP1;SYK;HAVCR2;ORM2;PLCG2;CLU;CD86;LGALS9;THBS1;TWIST1;ADAM8;WNT5A;OAS3;NOD2;OAS2;PF4;TMEM106A;CYBA;JAK2;TYROBP;APP;IFIH1;DDX58;OAS1;ORM1;TLR1;CD14;LY96
prerank,Elsevier_Pathway_Collection__Th0-Cell Aberrant Activation in Systemic Lupus Erythematosus,-0.46711247787706234,-1.7157898026142253,0.0,0.06412429799563595,1.0,34/76,23.34%,IFNG;CD4;TNF;FOS;LY9;CD80;CAMK4;SLAMF6;ICOS;MAP2K1;CTLA4;PTPRC;CD3E;CD3G;FYN;CD40LG;LCK;CD247;LAT;AKT1;RASGRP1;SYK;CREM;FCER1G;VAV1;CD86;ZAP70;CD3D;NFATC2;JUN;CD40;ELF1;MAP3K5;PIK3CG
prerank,Elsevier_Pathway_Collection__Alveolar Macrophage Negative Regulation Declined in COPD,-0.5115569988884342,-1.715706345962606,0.0,0.06394023258708816,1.0,16/42,15.92%,IL10;TNF;IL1B;FOS;CD200R1;SFTPA1;IL18;MAP2K1;IL6;CXCL8;DOK2;TLR4;TLR2;SFTPD;MYD88;IL10RA
prerank,Elsevier_Pathway_Collection__Epithelial Cell in the Innate Immune Response in Ulcerative Colitis,-0.5697461628495406,-1.7156522214050176,0.011235955056179775,0.06369240222822348,1.0,13/22,21.42%,TNF;ECM1;FOS;CDH1;CASP1;NLRP3;IL33;TLR4;TLR2;MYD88;MAP2K3;MAP2K6;JUN
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.5984986804412763,1.71383617730411,0.0,0.4164787292399711,1.0,10/38,11.25%,NEK2;BUB1B;ANLN;CDC20;NPM2;UBE2C;UBE2S;CDCA5;KNTC1;RGCC
prerank,Elsevier_Pathway_Collection__Thymic Follicular Hyperplasia,-0.5274413771722203,-1.7137519602709488,0.0125,0.06468034767127379,1.0,14/27,16.76%,CXCL13;TNF;CD79A;CCR7;CXCL12;IL6;TLR4;CCL22;IRF8;AKT1;SYK;CXCR4;TNFRSF13C;TNFSF13B
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.632577478010597,1.7133680103527795,0.011560693641618497,0.4109682748799271,1.0,9/28,6.44%,CACNA1E;CACNA1I;CACNB4;CACNG4;KCNH2;SCN1A;SCN4A;CHRNB2;CACNA1G
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.6643374462562969,1.7131424902714922,0.012269938650306749,0.39172808619509836,1.0,9/21,14.95%,CENPF;PLK1;BUB1B;CDC20;BUB1;TTK;TRIP13;KNTC1;ZWINT
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.6643374462562969,1.7131424902714922,0.012269938650306749,0.39172808619509836,1.0,9/21,14.95%,CENPF;PLK1;BUB1B;CDC20;BUB1;TTK;TRIP13;KNTC1;ZWINT
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.6643374462562969,1.7131424902714922,0.012269938650306749,0.39172808619509836,1.0,9/21,14.95%,CENPF;PLK1;BUB1B;CDC20;BUB1;TTK;TRIP13;KNTC1;ZWINT
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.612786150905471,-1.7128622512830383,0.011494252873563218,0.06505691704172632,1.0,13/19,24.55%,TNF;GCNT1;SPN;SELE;VCAM1;PODXL2;ITGA4;SLC39A8;SELPLG;SELL;CX3CR1;SELP;ADD2
prerank,Elsevier_Pathway_Collection__Cell Cycle Overiew,0.5295211328156004,1.7126236305086793,0.0,0.38732040276339114,1.0,47/105,28.74%,SFN;CDKN2A;NEK2;CDC25C;CENPA;PLK1;BUB1B;CENPE;CDC20;BIRC5;CCNB2;BUB1;TTK;CCNE1;CDKN2C;AURKB;CDC6;CDC7;CCNA2;CCNE2;CDC45;PTTG1;CDK1;CCNB1;CDT1;CDCA3;CDKN2B;AURKA;CDKN1C;CHEK1;SMAD3;CDC25A;CDK6;CLSPN;TGFB2;GMNN;PRKDC;MED12;CDKN2D;NPM1;CCNB3;MYC;CHEK2;INCENP;MAD2L1;CDKN1A;ZBTB17
prerank,KEGG_2021_Human__Asthma,-0.5914058738832559,-1.7125254014172353,0.011111111111111112,0.06504394592660784,1.0,19/23,29.03%,IL10;TNF;FCER1A;CD40LG;HLA-DQA2;HLA-DOB;FCER1G;HLA-DQA1;HLA-DOA;HLA-DRB5;HLA-DRA;CD40;MS4A2;HLA-DPA1;HLA-DPB1;HLA-DRB1;HLA-DMB;HLA-DQB1;EPX
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.42150866729366365,-1.711908247087217,0.0,0.06528785990395371,1.0,56/123,23.59%,FOSB;TNFSF11;IFNG;TNF;IL1B;TNFRSF11B;FOS;CAMK4;FCGR3B;LILRA2;LILRA1;MAP2K1;PIK3CD;SIRPB1;LILRA5;MITF;CALCR;SIRPG;FCGR3A;FYN;LCP2;LILRB5;TNFRSF11A;LILRB1;FCGR2B;BTK;LILRA6;LCK;PIK3R1;AKT1;SYK;OSCAR;PLCG2;SPI1;LILRB4;CSF1R;ITGB3;LILRA4;LILRB2;NCF1;LILRB3;MAPK10;NCF2;PPP3CA;MAPK13;TAB2;NFATC2;MAP2K6;CYBA;JUN;STAT1;TYROBP;AKT3;SIRPA;GAB2;FOSL1
prerank,KEGG_2021_Human__Malaria,-0.4942494759756192,-1.711555925066324,0.0,0.06523147436818418,1.0,26/47,16.90%,CSF3;IL10;IFNG;TNF;IL1B;HGF;HBA1;IL18;HBB;KLRB1;CCL2;IL6;CR1;CD40LG;HBA2;CXCL8;TLR4;TLR2;SELE;CR1L;KLRC4-KLRK1;KLRK1;VCAM1;MYD88;ITGB2;THBS1
prerank,Elsevier_Pathway_Collection__Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma,-0.4703628931333316,-1.7111888878684236,0.0,0.06523922617737826,1.0,22/58,17.08%,IRF4;CCL5;CD79A;CCR5;ICOS;CCR7;PRKCB;CXCL12;CCL2;CD40LG;CCR2;BTK;CARD11;LCK;TLR2;AKT1;SYK;PLCG2;MYD88;CXCR4;CD86;BCL2
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,0.5574737625609155,1.7102185532495096,0.0,0.3890547567263645,1.0,22/62,22.73%,H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;NEIL3;H2BC4;H4C15;H2AC6;RFC4;H2BC5;POLD1;H2AX;MUTYH;FEN1;POLR1A;PARP1;H2AJ
prerank,WikiPathway_2021_Human__Eicosanoid metabolism via cyclooxygenases (COX) WP4719,-0.5397831818528858,-1.708637932381012,0.0,0.06630474891624227,1.0,21/30,24.18%,PTGS2;HPGD;CYP4A22;CYP4A11;CYP4F2;CYP4F12;ACAA1;PLA2G4A;PTGES;EHHADH;PTGR1;ACOX1;TBXAS1;PTGDR;TBXA2R;PTGIS;ACOX2;ACOX3;PTGIR;AKR1B1;PTGS1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.48513279378893037,-1.70833929083546,0.0,0.06611871410076338,1.0,20/52,12.32%,TFF2;CXCL13;CXCL10;CXCL11;GPR75;CCL5;CXCL3;CXCL9;CCL4;CCL3;XCL1;CCL23;CXCL12;CXCL2;CCL2;CCR1;XCL2;CCR2;CXCL8;CCL22
prerank,WikiPathway_2021_Human__Kallmann's Syndrome WP5074,-0.6244374555657757,-1.7065123874944763,0.012195121951219513,0.06702597464712386,1.0,4/19,3.38%,ASCL1;PROK2;SOX10;SEMA3E
prerank,Elsevier_Pathway_Collection__Spindle Assembly,0.7375397869679612,1.7064564154401916,0.006211180124223602,0.3976679155010084,1.0,8/16,10.26%,NEK2;KIF2C;PLK1;BUB1B;CDC20;AURKB;PTTG1;CDK1
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,0.5380946331470844,1.706149991650107,0.015306122448979591,0.39262749092327603,1.0,24/81,16.39%,H3C13;H2AC19;E2F1;H2BC13;CDKN2A;MAPK11;H2AC20;H2BC17;E2F2;H2BC21;H2BC9;CDKN2C;H2BC15;CBX6;EZH2;H2BC11;H2BC12;CDKN2B;H2BC4;H4C15;H2AC6;MAPKAPK2;H2BC5;H2AX
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.530057620132926,-1.704873368721304,0.015384615384615385,0.0675289891297326,1.0,15/30,14.95%,AADAT;GSTZ1;HOGA1;TDO2;SARDH;CBS;IDO2;DAO;TAT;HAAO;OTC;KYNU;ACADSB;KMO;DDO
prerank,Reactome_2022__Recycling Of Bile Acids And Salts R-HSA-159418,-0.6509997075786689,-1.7047944777055826,0.0,0.06736131996567586,1.0,11/16,25.74%,SLC10A1;SLCO1B3;ALB;STARD5;SLCO1B1;SLC27A5;NR1H4;ABCC3;SLC51A;NCOA1;SLC51B
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.5750100822783883,1.7034999004145963,0.0,0.39729788719951425,1.0,19/56,16.39%,HMGA2;H3C13;H1-5;H2BC13;H2BC18;H3C1;H1-2;H2BC17;H2BU1;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H1-4;CHAF1B;H4-16;H2BC5;H2AX
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.5911621477221343,1.7032002703090314,0.0,0.3929328942535413,1.0,16/48,11.79%,PVALEF;KCNE5;SMPX;TNNC1;KCNH2;TNNI3;MYH3;TNNT1;MYH8;KLHL41;TNNI2;ATP1A2;TNNT3;CCDC78;SCN4B;ARHGEF11
prerank,Elsevier_Pathway_Collection__T-Cell Cytotoxic Response in Ulcerative Colitis,-0.4978736291844248,-1.701198609306773,0.0,0.06898066559530544,1.0,19/45,16.88%,CD8A;FOS;FASLG;TNFSF15;ICOS;MAP2K1;CTLA4;PRKCQ;CD3E;CD3G;FYN;CARD11;LCK;CD247;LAT;AKT1;FCER1G;LTA;ZAP70
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,0.553367229490522,1.7010885131726121,0.0,0.39577840531079506,1.0,40/73,33.12%,H2BC13;H2BC17;H2BC21;H2BC9;EXO1;H2BC15;CCNA2;H2BC11;H2BC12;H2BC4;H4C15;SERPINA2;RFC4;H2BC5;CHEK1;H2AX;BARD1;DNA2;RMI1;POLR1A;CLSPN;ATRIP;RAD9B;BLM;RHNO1;TIPIN;NSD2;UBA52;SIRT6;TIMELESS;MDC1;ABRAXAS1;PIAS4;BABAM2;UBE2I;TP53BP1;BRIP1;RMI2;UIMC1;TOPBP1
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,0.5925846768284005,1.7008305844551648,0.01098901098901099,0.39061057425197315,1.0,22/42,23.96%,H3C13;H2AC19;H2BC13;MSH4;MSH5;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;PSMC3IP;POLR1A;RAD51;H2AJ;BLM
prerank,Elsevier_Pathway_Collection__B-Cell Receptor -> NF-kB Signaling,-0.6061064977849524,-1.7004396483423787,0.0,0.06928470517609656,1.0,15/19,33.21%,CD79A;CD40LG;BTK;CARD11;SYK;PLCG2;LILRB3;CD19;CD40;CD22;NFKBIA;TRAF6;CD79B;BCL10;PTPN6
prerank,Elsevier_Pathway_Collection__APC/C-CDC20 Complex,0.6256075617179866,1.7000858735180717,0.005208333333333333,0.38766986819492055,1.0,10/33,10.65%,NEK2;BUB1B;CENPE;CDC20;BUB1;AURKB;CCNA2;PTTG1;CDK1;CCNB1
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,0.5968932329825778,1.699365782676397,0.004975124378109453,0.3851544584133183,1.0,19/47,16.39%,H2AC19;SMC1B;SYCE1;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;LMNA;SERPINA2;HSPA2;H2BC5;H2AX
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.5777945798763873,-1.6976369691973836,0.01282051282051282,0.07036976964226972,1.0,6/21,9.55%,CIDEA;TNF;ASXL3;IL1B;ALK;HCAR2
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.4992257723489786,1.697579071634129,0.004524886877828055,0.38569006275912393,1.0,55/154,24.63%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;KIF4A;BUB1B;CENPE;NUF2;CDC20;BIRC5;SPC24;ARHGEF10;BUB1;KIFC1;TTK;CENPI;CENPM;AURKB;DLGAP5;KIF18A;NDC80;KIF23;CDCA8;SPC25;CCNB1;KNTC1;AURKA;CENPU;TBCE;ERCC6L;CENPL;SGO2;PMF1;ZWINT;STMN1;KIFC2;KIF11;PRC1;CENPK;SPDL1;STIL;WDR62;SGO1;NUP37;TPX2;DSN1;B9D2;GPSM2;AHCTF1;RPS27;CENPP;NUP133;DYNLL1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.6576740620431328,1.6973305137588914,0.023121387283236993,0.3809968487532308,1.0,11/24,22.14%,HMGA2;H3C13;H3C1;CDKN2A;HELLS;BEND3;H4-16;HMGA1;SUV39H1;CENPV;HDAC1
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.6546230463760363,1.6970064324308267,0.018072289156626505,0.3768529673120914,1.0,9/22,14.95%,CENPF;PLK1;BUB1B;CDC20;BUB1;TTK;TRIP13;KNTC1;ZWINT
prerank,KEGG_2021_Human__Rheumatoid arthritis,-0.4230248019914013,-1.696231592898876,0.0,0.07076917661056835,1.0,37/83,21.46%,TNFSF11;IFNG;TNF;IL1B;MMP1;CCL5;FOS;CD80;CXCL3;CCL3;IL18;IL15;CTLA4;CXCL12;CXCL2;CCL2;IL6;CCL3L3;TNFRSF11A;HLA-DQA2;CXCL8;TLR4;TLR2;HLA-DOB;TNFSF13;CSF2;CD86;ITGB2;CXCL1;TNFSF13B;HLA-DQA1;HLA-DOA;TEK;ATP6V1B2;HLA-DRB5;JUN;HLA-DRA
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.5648053424268036,-1.6945202187628943,0.023255813953488372,0.07132936151339377,1.0,11/23,18.63%,CXCL10;CCL5;S100A14;FPR2;CXCL12;CCR1;CCR2;GREM1;DUSP1;AIF1;LGMN
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.49146229951836273,-1.6940247457573236,0.013513513513513514,0.07129424185696617,1.0,12/47,10.39%,CXCL10;RIPK3;ZBP1;AIM2;IL1B;CCL5;CCL4L2;CCL4;IL18;CASP1;IL6;IL33
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.5728725987147576,-1.6934597198817791,0.0,0.07146251060383219,1.0,14/23,23.73%,STAP1;PTPN22;GCSAM;NFAM1;PRKCB;FCRL3;CD300A;BLK;FCGR2B;CD19;LPXN;ELF1;CD22;CD81
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.6048269896727085,1.6914534215290606,0.017142857142857144,0.393067056849076,1.0,15/38,17.34%,H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;POLR2L
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.5876507550806802,-1.690890001386436,0.015384615384615385,0.07235820649327053,1.0,7/20,12.95%,LRAT;ADH4;ADH1A;CYP1A2;ADH1C;ADH7;CYP3A4
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.6245783543247865,-1.6889877818011203,0.012048192771084338,0.07348946554895541,1.0,9/18,18.53%,CIDEA;FZD3;MTRNR2L10;MTRNR2L6;MTRNR2L8;MTRNR2L1;MTRNR2L3;PTGIS;DLC1
prerank,Reactome_2022__RA Biosynthesis Pathway R-HSA-5365859,-0.5635813932279126,-1.685218421601065,0.0136986301369863,0.07535612902712961,1.0,8/20,16.33%,CYP26A1;RDH16;ADH1A;ALDH8A1;ADH1C;CYP26B1;ADH7;ALDH1A2
prerank,Elsevier_Pathway_Collection__Dendritic Cells Function in Atherosclerosis,-0.517944119303803,-1.6850001126185365,0.0,0.07520713919488169,1.0,21/42,22.03%,FOXP3;IFNG;CD4;TNF;FOS;CD80;IL27;IL6;IL12B;CXCL8;TICAM2;TLR4;CCL22;CAMP;MYD88;CD86;MAPK10;MAP2K3;MAP2K6;JUN;CD40
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.5707827058996787,-1.6848254010686676,0.02197802197802198,0.07499935395930864,1.0,13/20,19.88%,LY9;IL18;SLAMF6;IL15;PRKCQ;IL6;OSM;RFTN1;IL12B;SLC7A5;MYD88;NR1H4;NOD2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Chronic Obstructive Pulmonary Disease,-0.3799395556903661,-1.6843269730157302,0.0,0.07509126025020874,1.0,61/156,17.45%,FOXP3;MUC1;MUC5AC;CSF3;IL10;CXCL10;TRPV4;PTGS2;FGF10;MUC5B;IFNG;TNF;IL1B;MMP1;CXCR1;INHBA;CXCR2;COL4A3;TLR3;IL27;S100A8;CCR5;CYP1A2;CCL4;CCL3;IL18;LGALS3;CAT;PIK3CD;CTLA4;TRPC3;CCL2;EGR1;IL6;NGF;NTRK1;CCR2;HEY2;CXCL8;TLR4;FGL2;HCK;TLR2;SFTPD;AKT1;TSLP;CAMP;MSR1;CXCR3;CSF2;MAFB;GZMA;PIGR;CXCL1;PLAUR;TNFSF13B;HP;FUT8;CTSB;HMOX1;PTAFR
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.5910354706227333,-1.6831339764161894,0.010869565217391304,0.07544005924574923,1.0,8/17,17.19%,CETP;LCAT;APOA4;APOA1;LIPG;ALB;LIPC;PLTP
prerank,KEGG_2021_Human__Cell cycle,0.5170837815448018,1.6815643039356416,0.004739336492890996,0.425093513138912,1.0,52/123,28.74%,SFN;E2F1;SMC1B;CDKN2A;CDC25C;PLK1;BUB1B;CDC20;WEE2;CCNB2;E2F2;BUB1;TTK;CCNE1;CDKN2C;CDC6;CDC7;CCNA2;CCNE2;CDC45;PTTG1;CDK1;MCM2;CCNB1;MCM6;CDKN2B;ORC1;CDKN1C;PKMYT1;CHEK1;MCM3;MCM5;SMAD3;CDC25A;MCM4;E2F5;CDK6;TGFB2;HDAC1;ANAPC11;MCM7;PRKDC;CDKN2D;CCNB3;MYC;ANAPC7;CHEK2;RBL1;MAD2L1;CDKN1A;MAD2L2;ZBTB17
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.3831561021071586,-1.680832706171177,0.0,0.07645760213564166,1.0,62/177,21.46%,HHLA2;CD4;THEMIS;IGLL5;LAX1;IGLL1;CD79A;PTPN22;CD38;PRAM1;VTCN1;ITK;PIK3CD;NFAM1;NFKBIZ;CTLA4;PRKCB;FYB1;PTPRC;MS4A1;PRKCQ;CD3E;CD3G;TRAT1;FYN;RFTN1;LCP2;BLK;FYB2;SLA2;MNDA;NFKBID;HLA-DQA2;BTK;CARD11;SKAP1;GATA3;LCK;CD247;NCKAP1L;LAT;PIK3R1;SYK;THEMIS2;LAT2;BTN3A3;PLCG2;BMX;VAV3;ZAP70;BCL2;HLA-DQA1;INPP5D;TNFRSF21;CD19;HLA-DQB2;CD3D;TAB2;HLA-DRB5;NFATC2;BTN3A2;HLA-DRA
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,0.5150266634751235,1.6795479466229692,0.0,0.427268699244155,1.0,44/115,24.63%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;BIRC5;SRC;SPC24;BUB1;CENPI;CENPM;AURKB;KIF18A;NDC80;CDCA8;SPC25;RNASE1;KNTC1;DIAPH3;CENPU;ERCC6L;CENPL;SGO2;ZWINT;DVL2;RHOC;CENPK;SPDL1;SGO1;NUP37;SRGAP2;DSN1;B9D2;PPP2R5A;AHCTF1;RPS27;CENPP;NUP133;DYNLL1
prerank,WikiPathway_2021_Human__Overview of interferons-mediated signaling pathway WP4558,-0.5646442790271811,-1.6789658966755419,0.025974025974025976,0.07717292563685317,1.0,4/19,6.28%,IFNL2;IFNL1;IFNG;IFNL4
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,0.5330359939805601,1.6780069327974962,0.005050505050505051,0.4278804535698706,1.0,32/81,23.96%,H2AC19;TERT;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;CCNA2;H2BC11;H2BC12;H2BC4;H4C15;PRIM1;H2AC6;RFC4;DSCC1;RTEL1;PIF1;H2BC5;POLD1;H2AX;POLR2L;DNA2;NHP2;FEN1;POLR1A;H2AJ;POLA1;POLA2;POLR2K;BLM
prerank,WikiPathway_2021_Human__Nuclear Receptors in Lipid Metabolism and Toxicity WP299,-0.4977440503129827,-1.6757118837843734,0.012048192771084338,0.07907903798063218,1.0,12/32,13.90%,CYP26A1;CYP2B6;CYP4A11;ABCD2;CYP1A2;CYP8B1;CYP2C9;ABCB1;NR1I2;CYP3A4;ABCG5;RARB
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.46174600558191314,-1.6744045165675743,0.0,0.07964349892140904,1.0,19/48,16.73%,ERBB4;IFNL1;IFNG;GHR;TNF;CCL5;IL18;IL15;CTF1;IL6;OSM;IL12B;FLT3;HCLS1;TSLP;IGF1;CSF2;CSF1R;PTK6
prerank,Elsevier_Pathway_Collection__Proteins Involved in Periodontitis,-0.45431724514623245,-1.6738161013861612,0.0,0.07963949699458003,1.0,21/56,13.38%,IL10;PTGS2;TNFSF11;IFNG;TNF;IL1B;TNFRSF11B;MMP1;HGF;CCL5;SFRP1;CCR5;IL18;NLRP3;IL6;IL1RN;CXCL8;PLG;TLR4;TLR2;CAMP
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,0.5238714222301007,1.673269957312767,0.005025125628140704,0.4402024187386363,1.0,59/106,35.14%,H2AC19;TERT;H2BC13;HJURP;CENPA;H2AC20;H2BC17;H2BC21;CENPI;H2BC9;CENPM;H2BC15;CCNA2;H2BC11;H2BC12;H2BC4;H4C15;PRIM1;H2AC6;CENPU;RFC4;DSCC1;CENPL;RTEL1;PIF1;H2BC5;POLD1;H2AX;POLR2L;CENPK;DNA2;NHP2;FEN1;POLR1A;H2AJ;POLA1;POLA2;POLR2K;CENPP;BLM;NPM1;CENPW;CHTF18;POLR2G;ITGB3BP;DKC1;CENPH;PCNA;POLR2H;RBBP7;H2AZ1;POLR2I;POLR2J;CENPT;RUVBL2;CENPQ;NOP10;RUVBL1;CENPX
prerank,TRRUST_Transcription_Factors_2019__AHR human,-0.5984412792815738,-1.6721237076272712,0.012987012987012988,0.08023691160699613,1.0,6/20,9.64%,MFSD2A;CYP2B6;IL1B;FOS;CYP1A2;IL6
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.566517697063254,-1.6707343122408533,0.0,0.08092686984276828,1.0,10/21,14.15%,CD160;KLRD1;CRTAM;KIR2DL4;SLAMF6;NCR3;SH2D1B;RASGRP1;CD226;KLRK1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Cryptorchidism,0.724798199018581,1.6704024187885467,0.023391812865497075,0.4460349059737635,1.0,5/15,7.48%,HOXA13;E2F1;HOXA10;PTGDS;AMH
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.5395427411160565,-1.6699706840930733,0.012345679012345678,0.08111116205633556,1.0,15/27,22.09%,CLEC4M;CCL5;APOA4;SEMA4D;CD40LG;SELE;SYK;VCAM1;CD177;ITGB2;EZR;ITGA4;FERMT3;SELP;CD209
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.6107380664825284,-1.6699516945799735,0.010869565217391304,0.08089098509038528,1.0,6/18,12.28%,RIPK3;FASLG;TLR3;PPIF;TICAM2;TLR4
prerank,Elsevier_Pathway_Collection__Transcription Factors in beta-Cell Neogenesis (Rodent Model),0.6858499732847526,1.6696635120349925,0.00625,0.4434456355450174,1.0,4/15,3.38%,MAFA;MNX1;MYT1;NEUROD1
prerank,WikiPathway_2021_Human__Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,-0.5750519643869418,-1.6688148897991286,0.011111111111111112,0.08128462459515068,1.0,12/20,12.09%,CD4;CD8B;CD8A;IGLL1;CD3E;CD3G;IL6;FYN;CD2;CXCL8;LCK;CD247
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.5574442791250501,1.668508241162213,0.0051813471502590676,0.44235281469245197,1.0,15/51,15.43%,KIF2C;CENPE;NUF2;KIF14;KIFC1;KIF18A;NDC80;RRS1;CDCA5;CDCA8;CCNB1;CEP55;CDT1;ANKRD53;PSRC1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.5505199777293179,-1.6684588707471466,0.011494252873563218,0.08116070399447652,1.0,12/22,17.07%,FOXP3;XCL1;VSIG4;PTPRC;CR1;TBX21;SFTPD;HAVCR2;GBP1;LILRB4;PRNP;EZR
prerank,WikiPathway_2021_Human__Cell cycle WP179,0.5122421590966437,1.668362973582587,0.0047169811320754715,0.43762417276184457,1.0,50/119,28.74%,SFN;E2F1;SMC1B;CDKN2A;CDC25C;PLK1;CDC20;WEE2;CCNB2;E2F2;BUB1;TTK;CCNE1;CDKN2C;CDC6;CDC7;CCNA2;CCNE2;CDC45;PTTG1;CDK1;MCM2;CCNB1;MCM6;CDKN2B;ORC1;CDKN1C;PKMYT1;CHEK1;MCM3;MCM5;SMAD3;CDC25A;MCM4;E2F5;CDK6;TGFB2;HDAC1;ANAPC11;MCM7;PRKDC;CDKN2D;CCNB3;MYC;ANAPC7;CHEK2;RBL1;CDKN1A;MAD2L2;ZBTB17
prerank,Elsevier_Pathway_Collection__Macrophage Function in Diabetes Mellitus Type 1,-0.5538202255133057,-1.6677753420990589,0.04,0.08132269960124515,1.0,14/28,15.99%,TNF;IL1B;CASP1;NLRP3;LCP2;CYBB;IL12B;HCK;LAT;AKT1;SYK;FGR;VAV1;ITGB2
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,0.5697258654139709,1.6663590207694734,0.010752688172043012,0.44078070092016786,1.0,16/48,15.12%,H3C13;H2AC19;H2BC13;H2BC18;H2AC11;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5
prerank,TRRUST_Transcription_Factors_2019__HIF1A human,-0.44009786478207996,-1.6662797469236243,0.0,0.08199500399441974,1.0,24/80,18.74%,KLK3;GCK;MUC1;ACE2;NR4A1;CDH1;CCR7;CXCL12;ABCB1;ALOX5AP;PTGES;TLR2;WASF3;EDNRB;HBEGF;PPP1R3C;CXCR4;ITGB2;RECK;ASS1;TWIST1;AR;CA9;SDHB
prerank,Reactome_2022__Regulation Of Gene Expression In Beta Cells R-HSA-210745,0.701407572109594,1.665880405753928,0.0064516129032258064,0.4374022045651672,1.0,3/16,3.38%,MAFA;RFX6;NEUROD1
prerank,Elsevier_Pathway_Collection__Mast-Cells Activation in Atopic Dermatitis,-0.4680479855806533,-1.6658641426189131,0.0,0.08203983708532578,1.0,24/52,24.65%,TNF;MAP2K1;FCER1A;PRKCB;EGR1;IL33;BTK;CARD11;CXCL8;LAT;SYK;LAT2;PLCG2;MYD88;FCER1G;VAV1;NFATC2;MAP2K3;MAP2K6;JUN;MAP3K5;MS4A2;MAP2K4;IL1RL1
prerank,Elsevier_Pathway_Collection__T-lymphoid precursor cell -> CD8+ Naive T-cell Surface Expression Markers,-0.46189494859010716,-1.6655407643214912,0.0,0.08202792804810878,1.0,29/56,20.09%,CCR9;CD8B;CD8A;CD27;CD69;IL7R;CD80;BTLA;CCR5;CD38;TNFSF10;ICOS;CCR7;CTLA4;PTPRC;CD3E;CD3G;CD2;LCK;FLT3;TLR2;CCR4;CXCR4;PTCRA;LILRB3;SELPLG;SELL;CD7;IL12RB2
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.629610887666871,1.6654018043812029,0.011904761904761904,0.43430395289051454,1.0,13/27,15.96%,EPHB2;NETO1;SHISA8;GRIK2;ACP4;SYNGR1;CAMK2A;MCTP1;PPFIA3;SHISA6;DLG4;SYP;DBN1
prerank,WikiPathway_2021_Human__Microglia Pathogen Phagocytosis Pathway WP3937,-0.4949626596205729,-1.6653488006300574,0.0,0.08186609208807398,1.0,23/40,23.34%,SIGLEC7;PIK3CD;CYBB;RAC2;NCKAP1L;C1QC;HCK;LAT;PIK3R1;SYK;PLCG2;C1QB;FCER1G;VAV1;ITGB2;VAV3;NCF1;NCF2;C1QA;CYBA;ITGAM;TYROBP;PIK3CG
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,0.5607027319208943,1.6629956116876183,0.02197802197802198,0.4377461262187401,1.0,16/49,17.34%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;POLR2L
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.5906052441385741,-1.661469672366105,0.0,0.08361154367430972,1.0,14/22,20.93%,LAX1;FPR1;FPR2;LILRA2;NCR3;CR1;BLK;GPLD1;SLA2;FPR3;FCER1G;CD19;C3AR1;CMKLR1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.624532558844755,-1.6613172224672745,0.011494252873563218,0.08342689562222926,1.0,7/15,12.06%,CEACAM6;IL10;TNF;IL1B;BMP7;SKAP1;LCK
prerank,Elsevier_Pathway_Collection__Proteins Involved in Diabetes Mellitus Type 1,-0.4363562584935351,-1.6606736557163546,0.0,0.08348480963670245,1.0,39/79,17.12%,FOXP3;PDX1;IL10;CXCL10;PTGS2;IFNG;CD4;TNF;IL1B;CD8A;FASLG;PTPN22;CD80;CCR5;CCL4;IL18;TNFSF10;IL15;ICOS;CTLA4;CXCL12;PRF1;ALB;CCL2;IL6;FYN;CD40LG;IL12B;CD274;MBL2;TLR4;TLR2;IGF1;KLRK1;CSF2;HP;HLA-DQA1;ITGA4;HMOX1
prerank,Elsevier_Pathway_Collection__IFNLR1-> STAT/NFKB Signaling,-0.621689845153701,-1.6601487969164521,0.05063291139240506,0.0835608446675805,1.0,3/16,1.99%,IFNL2;IFNL1;IL10
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.44408398967666046,-1.6599509424900212,0.0,0.08339662799432435,1.0,42/71,24.86%,IFNG;TLR3;CCL3;LILRA2;LILRA5;PTPRC;IL6;CD2;IL33;IL12B;CCR2;SPN;TLR4;CLEC7A;TLR2;SPHK2;RASGRP1;SYK;HAVCR2;ORM2;PLCG2;CLU;LGALS9;THBS1;TWIST1;WNT5A;OAS3;NOD2;OAS2;PF4;TMEM106A;CYBA;JAK2;TYROBP;APP;IFIH1;DDX58;OAS1;ORM1;TLR1;CD14;LY96
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.6083850114987626,1.6597006837872619,0.01764705882352941,0.4460910156777796,1.0,19/35,23.64%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;EHMT2;HDAC1;H2AJ;GATAD2B
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.6442263740488701,-1.6587439530021229,0.0,0.08367465505004314,1.0,8/15,16.36%,KLRD1;KLRC1;CLEC12B;KIR2DL4;PTPRC;LILRB1;FCGR2B;LGALS9
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.594497626320348,-1.6586563329882162,0.013513513513513514,0.08340120846491228,1.0,11/15,18.36%,CD4;CCL5;CRTAM;IKZF3;FCRL3;LCK;CLEC7A;LAT;THEMIS2;SIT1;CD19
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,0.5802428332009637,1.6585100667834645,0.005405405405405406,0.4447835929918935,1.0,13/48,11.47%,E2F1;E2F7;CDC25C;ARID3A;CCNE1;E2F8;ZNF385A;CCNA2;CCNE2;CDK1;CCNB1;RGCC;AURKA
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,0.544973578033891,1.6583052338221942,0.0,0.4405145914914721,1.0,37/71,33.12%,H2BC13;CDC25C;H2BC17;H2BC21;H2BC9;EXO1;H2BC15;H2BC11;CDK1;CCNB1;H2BC12;H2BC4;H4C15;SERPINA2;RFC4;H2BC5;CHEK1;H2AX;BARD1;DNA2;RMI1;POLR1A;ATRIP;RAD9B;BLM;RHNO1;NSD2;CHEK2;MDC1;ABRAXAS1;PIAS4;BABAM2;TP53BP1;BRIP1;RMI2;UIMC1;TOPBP1
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.408916692772939,-1.657852498847793,0.0,0.08356783613763517,1.0,36/99,19.63%,PAK5;IL10;IFNG;CD4;TNF;PAK6;CD8B;CD8A;FOS;ICOS;ITK;MAP2K1;PIK3CD;CTLA4;PTPRC;PRKCQ;CD3E;CD3G;FYN;LCP2;CD40LG;CARD11;LCK;CD247;LAT;PIK3R1;AKT1;RASGRP1;CSF2;VAV1;VAV3;ZAP70;MAPK10;PPP3CA;MAPK13;CD3D
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.5808265463379308,-1.6573604631393173,0.011764705882352941,0.08356955563067621,1.0,8/18,11.20%,FFAR2;DNASE1L3;KLKB1;PLA2G2D;NLRP3;IL6;OSM;PTGES
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.4833204817489804,-1.6571273535201347,0.0410958904109589,0.0834986879943174,1.0,16/34,17.07%,CD160;SH2D1A;PTPN22;LGALS3;TRAT1;CD300A;TESPA1;UBASH3A;SLA2;CARD11;LCK;CD226;GBP1;LILRB4;PRNP;EZR
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.5128016769713183,1.656972062373905,0.01507537688442211,0.44043576991975875,1.0,29/99,18.91%,GNG4;GLP1R;CACNA1E;SYT5;GCG;ADRA2C;KCNC2;PRKAA2;KCNG2;CACNA2D2;KCNB1;ACSL4;GNG3;ABCC8;TKT;CD36;CACNA1C;SNAP25;GNB5;ACLY;ADCY6;GNG8;ACACA;KCNJ11;PRKCA;GNG10;ADCY4;STXBP1;RAPGEF3
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.604720303288978,-1.6560424103504774,0.011363636363636364,0.08375381604591293,1.0,12/18,24.55%,TNF;GCNT1;SPN;SELE;VCAM1;PODXL2;ITGA4;SELPLG;SELL;CX3CR1;SELP;ADD2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.5359579177013266,-1.6560351712595036,0.024390243902439025,0.08348451117116723,1.0,6/25,4.60%,ERBB4;IFNL1;IL10;GHR;TNF;CCL5
prerank,TRRUST_Transcription_Factors_2019__NFKB1 human,-0.3700204394338419,-1.6557790785948656,0.0,0.08330678030202276,1.0,98/282,17.46%,KLK3;TFF1;IRF4;FOXP3;MUC6;CR2;MUC5AC;CCK;IL10;CXCL10;PTGS2;NLRP2;MUC5B;IFNG;EPCAM;TNF;TFPI2;BHMT;IL1B;MMP1;CCL5;CXCR2;SFTPA1;CD69;FASLG;PTPN13;CDH1;CD80;TLR3;TNIP3;CCR5;CYP3A7;CCL4;BST1;CCL3;IL18;CD38;PDK4;TNFSF10;FBP1;NCAM1;TF;CCR7;NFKBIZ;CXCL12;CXCL2;PLIN1;CD3G;CCL2;EGR1;IL6;CD40LG;ABCB1;TBX21;BCL2A1;ALOX5AP;IL12B;ALOX5;IL1RN;CCR2;PTGES;PGLYRP2;PTGER4;CXCL8;GATA3;CCL22;TNFRSF9;TLR2;SELE;AKT1;TSLP;SLC25A27;POU2F2;CFI;VCAM1;SLC9A2;HBEGF;CD83;CSF2;CXCR4;BCL2L11;TNFRSF13C;ADORA3;BGN;PIGR;CD86;CFTR;CXCL1;F3;PLAUR;TNFSF13B;CTSB;BCL2;HMOX1;NCOR1;EBI3;PTAFR;REPS2
prerank,Elsevier_Pathway_Collection__CXC Chemokine Receptor Signaling,-0.44471522352467363,-1.6547997713199976,0.0,0.08390040658853927,1.0,23/74,17.18%,CXCL13;CXCL10;CXCL11;CXCR1;CXCR2;CXCL3;CXCL9;CXCR6;ITK;MAP2K1;PRKCB;CXCL12;CXCL2;EGR1;CXCL8;AKT1;CXCR3;TIAM1;CXCR4;VAV1;CXCL1;VAV3;NCF1
prerank,Reactome_2022__Kinesins R-HSA-983189,0.5843591826767296,1.6540156737863836,0.04419889502762431,0.4467341683173756,1.0,17/40,16.69%,KIF1A;KIF26B;KIF20A;KIF2C;KIF4A;CENPE;KIF5A;KIF15;KIFC1;KIF18B;KIF18A;KIF23;KIF21B;RACGAP1;KIF25;KIFC2;KIF11
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.5535483682600428,-1.6526530987958414,0.02247191011235955,0.08511517971395262,1.0,10/21,16.28%,LAX1;PTPN22;BANK1;TIGIT;VTCN1;LGALS3;SAMSN1;FCGR2B;TNFAIP8L2;LST1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.6119053753445606,-1.6511961636690724,0.022988505747126436,0.08553911039417854,1.0,7/15,16.36%,KLRD1;KLRC1;CLEC12B;KIR2DL4;LILRB1;SERPINB9;LGALS9
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.6034938077250865,1.6510876054747923,0.005847953216374269,0.4536375495811129,1.0,2/31,0.68%,DLK1;DNER
prerank,Elsevier_Pathway_Collection__CCR5 Signaling in Macrophages,-0.506620748882588,-1.6510288915609939,0.0125,0.08533938531064783,1.0,16/34,23.65%,CD4;FOS;FASLG;CCR5;CCL4;MAP2K1;CCL2;PLCG2;CXCR4;MAPK10;MAP2K3;MAP2K6;JUN;JAK2;STAT1;MAP2K4
prerank,TRRUST_Transcription_Factors_2019__CEBPB mouse,-0.5099286914406922,-1.650461671011721,0.0,0.08556538689638495,1.0,20/37,17.08%,GSTA2;CR2;CSF3;PTGS2;IL5RA;IL1B;HGF;FOS;PCK1;SLC10A1;ID2;PPARGC1A;ALB;IL6;RUNX2;MAFB;CXCR4;CLU;CSF1R;BCL2
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.5836855380956998,1.6489767920058724,0.011695906432748537,0.4568329245884279,1.0,11/42,6.05%,SIX1;HOXD3;HOXD9;HOXA3;OSR2;HOXD4;HOXB9;NEUROD1;SIX2;MESP1;HOXC9
prerank,Elsevier_Pathway_Collection__Neutrophil Recruitment in Sinovium in Gout,-0.5090927289780277,-1.6483499241300692,0.0,0.08667149161674298,1.0,20/36,23.65%,CSF3;TNF;IL1B;CXCR2;CCL3;IL1RAP;CXCL2;CCL2;IL6;CXCL8;SELE;VCAM1;MYD88;TNFRSF1B;CXCL1;C5;JAK2;STAT1;MAP3K5;MAP2K4
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.40092831439503906,-1.6482403074308276,0.0,0.08650524548627579,1.0,27/97,12.55%,CASR;ATP2C2;MT1G;HTR2A;MT1HL1;MT1F;MT1H;TRPV4;ATP13A4;MT1M;CCL5;PTH1R;MT1E;SLC39A5;MT1X;CCL3;CCL23;CXCL12;SLC39A12;MT1A;CCR1;CCR2;SLC39A14;LCK;CHRNA7;MT1B;SLC8A1
prerank,Elsevier_Pathway_Collection__Treg Cells Promote Immunosuppression in Cancer Immune Escape,-0.4741269433433374,-1.6480218666299007,0.0,0.08637507899412164,1.0,11/43,13.06%,IRF4;FOXP3;IL10;IL2RB;FOS;TNFSF10;MAP2K1;CTLA4;PRF1;LAT;AKT1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.6095658961730934,1.64668689197706,0.017341040462427744,0.4603233725768548,1.0,15/27,26.52%,MAPT;SKA1;STMND1;STMN3;STMN2;SKA3;STMN1;MAP1B;ARL2;MAP1A;GAS2L1;PRUNE1;GBA2;CAMSAP2;CAMSAP1
prerank,TRRUST_Transcription_Factors_2019__MYC mouse,0.5600264270922587,1.6457016542923115,0.011235955056179775,0.4595013290200304,1.0,13/44,14.49%,DKK1;WNT4;TERT;CDCA7;CDKN2A;PDGFRB;EZH2;CCNB1;CDKN2B;NDRG1;SLC1A2;CAD;ODC1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.6878572078710717,1.6454482887802517,0.02040816326530612,0.45553249750471814,1.0,3/19,7.91%,TRIM71;TERT;AGO2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.6197674440712615,-1.6439008241505775,0.0,0.08912756724627077,1.0,9/16,18.63%,CXCL10;CCL5;S100A14;FPR2;CXCL12;CCR1;CCR2;AIF1;LGMN
prerank,Elsevier_Pathway_Collection__PAPA Syndrome,-0.5515285946286472,-1.6437754967577622,0.0,0.08886818503743024,1.0,13/26,17.02%,TNF;IL1B;IL18;CASP1;NLRP3;IL6;IL33;MEFV;TICAM2;TLR4;PSTPIP1;MYD88;CTSB
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.6138783314720095,-1.6421856128044288,0.010869565217391304,0.08935678453881037,1.0,5/16,12.28%,RIPK3;FASLG;TLR3;TICAM2;TLR4
prerank,Elsevier_Pathway_Collection__Peripheral T-Cell Tolerance,-0.4559102315777836,-1.6420473566920133,0.0,0.08913290399393396,1.0,22/58,18.26%,TNF;CD160;FASLG;CD80;BTLA;TNFSF10;TNFSF15;ICOS;CTLA4;PRKCQ;FYN;CD40LG;CD274;PDCD1LG2;LCK;PIK3R1;AKT1;PLCG2;CD86;ZAP70;BCL2;TNFRSF21
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.7132989007021404,1.641793144880069,0.033112582781456956,0.46441696407921973,1.0,5/15,8.61%,PAX2;SIX1;BMP4;FGF2;NPNT
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.4459825314190382,-1.6415307669274724,0.0,0.0891174102585504,1.0,32/54,23.97%,NLRP2;IFNG;TNF;GBP5;AIM2;NLRP12;CCL3;CASP1;LILRA2;PYHIN1;LILRA5;NLRP3;EGR1;IL6;TLR8;MNDA;TLR4;CLEC7A;ORM2;MYD88;LGALS9;NLRC4;IFI16;WNT5A;NOD2;INAVA;TMEM106A;JAK2;TYROBP;APP;F2RL1;ORM1
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,0.6668516300412097,1.6405848874651177,0.012269938650306749,0.4643444438049897,1.0,1/21,0.07%,SH3GL3
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.4080634595833254,-1.640276390275071,0.0,0.0896351446319366,1.0,51/97,30.23%,CXCL10;CXCL11;OASL;CASP1;IL15;IFI30;SAMD9;LAMP3;RSAD2;GBP4;DDX60;USP18;SAMD9L;EPSTI1;IFIT2;IFIT3;TRIM5;C1S;LAP3;SELL;TENT5A;UBE2L6;GMPR;TMEM140;NMI;BATF2;DHX58;ELF1;IFIH1;IRF2;OAS1;TRIM21;TRIM14;IRF9;CMTR1;PLSCR1;LGALS3BP;PSMB9;LPAR6;IFI44;SP110;CMPK2;TRAFD1;IRF1;HERC6;PNPT1;CASP8;TAP1;STAT2;IL7;TRIM26
prerank,Elsevier_Pathway_Collection__Microglia Activation in Parkinson's Disease,-0.5957052273840636,-1.6400044856729457,0.0125,0.08954962876454779,1.0,7/16,14.75%,NR4A2;PTGS2;TNF;IL1B;IL6;TLR4;MYD88
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.47814654110888966,1.6398501141140311,0.0,0.46275660590950896,1.0,49/155,16.43%,H3C13;H2AC19;PIK3R2;H2AC18;H2BC7;MAPK12;H2AC16;H2AC13;H2BC13;H2BC18;VWF;H4C12;H3C1;H2BC6;H2AW;H2BC8;H3C2;H2AC11;H4C8;MAPK11;H4C14;H3C10;H4C5;H2AC8;H2AC20;HDAC4;H2BC17;SRC;H2BU1;H2BC21;H2BC9;H2BC15;H3C8;H2BC11;H2BC12;HDAC11;H4C9;H2BC4;H3C6;H4C15;H2AC6;H4C4;H4-16;H2BC5;AQP9;PRKCA;HDAC5;H2AX;GSDMD
prerank,Elsevier_Pathway_Collection__Proteins Involved in Vitiligo,-0.47883874024815615,-1.639750770276497,0.015151515151515152,0.08941335540854901,1.0,18/38,16.76%,IFNL2;PNOC;IL20RB;IL10;IFNG;CD4;TNF;CD8A;FASLG;ESR1;CAT;CTLA4;IL6;IL1RN;KLRK1;CSF2;DDC;TNFSF13B
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.6372531513762275,1.639623159392182,0.0223463687150838,0.4588457196654361,1.0,7/24,9.67%,PVALEF;TNNC1;MYBPH;TNNT1;CHRNA3;ATP1A2;TNNT3
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.5968437765309177,-1.6393604628383291,0.022988505747126436,0.08948240271731442,1.0,7/16,19.61%,GLYAT;CBS;DAO;MTHFD1;SHMT1;CDO1;CTH
prerank,WikiPathway_2021_Human__The influence of laminopathies on Wnt signaling WP4844,0.5903949425789796,1.6392274273378398,0.02631578947368421,0.45616112695899963,1.0,7/33,7.91%,HMGA2;LEF1;SPP1;HES5;SLC2A4;TCF7;AGO2
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.6374264169272291,1.6388680959191804,0.011111111111111112,0.4528600044970197,1.0,9/27,14.67%,SIX1;POPDC3;SIX4;MYMX;MSC;MYF6;IGSF8;DISP1;MYLPF
prerank,KEGG_2021_Human__Viral myocarditis,-0.4616496570857521,-1.6386558355018175,0.0,0.08968694661207807,1.0,28/55,29.70%,LAMA1;CD80;PRF1;FYN;CD40LG;RAC2;HLA-DQA2;HLA-DOB;SGCA;CD86;ITGB2;HLA-DQA1;SGCD;DMD;HLA-DOA;HLA-DRB5;CD55;HLA-DRA;CD40;HLA-DPA1;SGCB;HLA-DPB1;HLA-DRB1;HLA-DMB;HLA-DQB1;LAMA2;CASP3;CASP8
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,0.5989168835315772,1.6385587334830052,0.030120481927710843,0.44972238230684264,1.0,4/32,3.38%,MAFA;RFX6;ONECUT3;NEUROD1
prerank,TRRUST_Transcription_Factors_2019__CTNNB1 mouse,0.5728314557858161,1.6373206089800894,0.005405405405405406,0.4506485302060699,1.0,18/45,14.81%,INHA;EPHB2;VEGFD;LEF1;GLUL;E2F1;AXIN2;WNT4;TBX3;BMP4;BIRC5;IHH;CDX1;CCNE1;CDX2;LHB;BGLAP;FOXJ1
prerank,TRRUST_Transcription_Factors_2019__ATF2 human,-0.5279781325939704,-1.6372086910902268,0.012987012987012988,0.09021207762528045,1.0,7/28,8.05%,ITGB8;PTGS2;IFNG;TNF;PCK1;FASLG;DUSP10
prerank,KEGG_2021_Human__Ascorbate and aldarate metabolism,-0.5308867623357745,-1.6335893931571541,0.011904761904761904,0.09262539324670833,1.0,12/27,17.38%,UGT2A1;UGT1A5;ALDH1B1;UGT1A9;UGT2B7;UGT2B28;UGT2B10;KL;UGT2A3;ALDH2;UGT2B15;UGT1A7
prerank,Reactome_2022__DNA Replication R-HSA-69306,0.4814554329694429,1.6333780618871894,0.0,0.46143779291931475,1.0,59/141,31.98%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;UBE2C;H2BC21;PSMD4;CCNE1;H2BC9;H2BC15;CDC6;CDC7;CCNA2;UBE2S;CCNE2;CDC45;H2BC11;CDT1;H2BC12;MCM6;H2BC4;H4C15;PRIM1;H2AC6;RFC4;PSMB4;H2BC5;MCM10;POLD1;H2AX;MCM3;MCM5;MCM4;DNA2;FEN1;POLR1A;ANAPC11;GMNN;MCM7;H2AJ;POLA1;POLA2;GINS4;ANAPC7;GINS1;PSMB3;GINS2;PSMD14;UBA52;PSMB5;PSMD2;PCNA;PSMA1;PSMD10;PSMC4;PSMC3;H2AZ1;CUL1
prerank,"WikiPathway_2021_Human__Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",-0.5154498771444108,-1.6327713970688569,0.013888888888888888,0.09270080172342088,1.0,13/25,16.09%,ASCL1;PLP1;SOX10;TNF;IL1B;MAG;SOX6;CXCL2;OMG;SOX9;IGF1;SOX5;CXCL1
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,0.7048223939277172,1.6326904154470219,0.018292682926829267,0.45962807903223935,1.0,1/15,0.07%,SH3GL3
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.5972977637422037,1.6322106131666536,0.00558659217877095,0.45734187216751443,1.0,10/29,14.67%,SIX1;POPDC3;SIX4;SGCZ;GATA5;MSC;MYF6;IGSF8;PGM5;MYLPF
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,0.694156240629503,1.6318441819208684,0.0196078431372549,0.4544028104065239,1.0,9/16,17.48%,CENPF;CDC25C;FOXM1;PLK1;CCNB2;CCNB1;MYBL2;PKMYT1;CDC25A
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,0.5287553001636989,1.6310394857355979,0.015306122448979591,0.45361542857327936,1.0,23/66,24.46%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;AGO2;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;POLR2L;NUP37;H2AJ;NUP62;POLR2K;TPR;NUP133
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.5811803498476361,1.6290654390469674,0.016304347826086956,0.4569997262025,1.0,10/40,9.93%,S100P;SCG2;PTP4A3;CDH13;FERMT1;S100A2;ANLN;FAP;LOXL2;NANOS1
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5772581737699479,1.626648878813705,0.005555555555555556,0.45855929150807173,1.0,10/31,10.41%,TNNC1;ACTN2;TNNI3;MYH3;MYH4;TNNT1;MYH8;TNNI2;TNNT3;MYBPC1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5772581737699479,1.626648878813705,0.005555555555555556,0.45855929150807173,1.0,10/31,10.41%,TNNC1;ACTN2;TNNI3;MYH3;MYH4;TNNT1;MYH8;TNNI2;TNNT3;MYBPC1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.6245715818937145,1.626528245134602,0.0111731843575419,0.45090356615978017,1.0,3/26,2.76%,SFN;E2F1;TP73
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.6245715818937145,1.626528245134602,0.0111731843575419,0.45090356615978017,1.0,3/26,2.76%,SFN;E2F1;TP73
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.44606623041246113,-1.6262390027435585,0.018518518518518517,0.09690509402933316,1.0,32/70,24.99%,IL10;NOCT;IL1B;ACOD1;S100A14;GPR31;PTPN22;S100A8;CXCL2;GCH1;IL6;TNFRSF11A;FCGR2B;CXCL8;TRIB1;TLR4;SELE;CD6;LGALS9;GGT2;PALM3;INAVA;TAB2;SELP;JAK2;SNCA;GGT5;CD24;C4B;CD14;LY96;TRIM6
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.5070125011570266,-1.626166635350107,0.012195121951219513,0.09664929670984033,1.0,20/33,24.54%,TSHR;IL10;FASLG;CD80;CTLA4;TG;PRF1;CD40LG;HLA-DQA2;HLA-DOB;CD86;HLA-DQA1;GZMB;HLA-DOA;HLA-DRB5;HLA-DRA;CD40;HLA-DPA1;HLA-DPB1;HLA-DRB1
prerank,Elsevier_Pathway_Collection__Basophil Activation,-0.414550122876807,-1.626007516620416,0.0,0.09652850999343063,1.0,35/75,23.65%,TNF;IL18R1;CD80;IL18RAP;IL18;MAP2K1;FCER1A;IL6;LCP2;HRH4;IL33;BTK;TLR2;LAT;AKT1;TSLP;SYK;LAT2;PLCG2;MYD88;FCER1G;VAV1;HSPA1A;IQGAP1;C5;MAP2K6;JAK2;CD40;STAT1;F2;MAP3K5;MS4A2;IGHD;GAB2;MAP2K4
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.4832249236696243,-1.6259025326638858,0.0,0.0962587117323214,1.0,23/47,16.50%,TNFSF11;CD4;LAX1;CCL5;PTPN22;CRTAM;IL27;TIGIT;VTCN1;LGALS3;SIRPB1;SIRPG;PRKCQ;CCL2;CD2;TBX21;CCR2;LCK;LAT;TNFAIP8L2;TNFRSF1B;TNFSF8;SIT1
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,0.4717238059008319,1.6250868323005556,0.0,0.4522947023086592,1.0,96/183,38.01%,DYNC1I1;CENPF;NEK2;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;BIRC5;CCNB2;SPC24;BUB1;NCAPH;NCAPG;CENPI;CENPM;AURKB;KIF18A;NDC80;CDCA5;CDK1;CDCA8;SPC25;TUBA4A;CCNB1;KNTC1;CENPU;ERCC6L;CENPL;SGO2;CEP131;ZWINT;PRKCA;CENPK;SPDL1;CETN2;CEP250;SGO1;HAUS4;NUP37;HAUS5;MZT2B;DSN1;B9D2;PPP2R5A;AHCTF1;RPS27;CENPP;NCAPD2;NUP133;PLK4;DYNLL1;RANGAP1;SMC4;CEP70;SFI1;TUBGCP6;ITGB3BP;INCENP;SSNA1;MAD2L1;CENPH;NUP160;SMC3;NEK7;MZT2A;CSNK1D;TUBA1A;ALMS1;CEP290;CEP152;DCTN2;DYNC1H1;HDAC8;DCTN3;CEP41;CENPT;CENPQ;CSNK2B;SMC1A;TUBG1;CEP72;PPP2R1A;TUBGCP2;KIF2A;NDE1;HAUS1;STAG2;TUBB4B;PMEPA1;EML4;XPO1;SDCCAG8
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.6014958418058589,-1.6249235170750127,0.05813953488372093,0.09672034962655368,1.0,9/16,18.42%,AADAT;GSTZ1;TDO2;IDO2;TAT;HAAO;KYNU;KMO;QDPR
prerank,Elsevier_Pathway_Collection__LH and FSH Signaling Impairment in Primary Ovarian Insufficiency,0.6794967859886172,1.6243504391296897,0.01935483870967742,0.44820928114089953,1.0,7/18,15.42%,INHA;CYP17A1;CGA;NR5A1;LHB;PDPK1;HSD17B1
prerank,Elsevier_Pathway_Collection__LH and FSH Signaling and Steroidogenesis,0.6794967859886172,1.6243504391296897,0.01935483870967742,0.44820928114089953,1.0,7/18,15.42%,INHA;CYP17A1;CGA;NR5A1;LHB;PDPK1;HSD17B1
prerank,Reactome_2022__Biosynthesis Of DHA-derived SPMs R-HSA-9018677,-0.605202967593709,-1.6230764957634793,0.04878048780487805,0.0977415674269764,1.0,8/16,14.14%,PTGS2;CYP2C8;HPGD;CYP1A2;CYP2C9;ALOX5;CYP3A4;EPHX2
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6440864644428587,1.6230303431862507,0.01775147928994083,0.44964572575266054,1.0,5/19,14.21%,HMGA2;NODAL;WNT9B;LOXL2;KAT2A
prerank,WikiPathway_2021_Human__Interactions between immune cells and microRNAs in tumor microenvironment WP4559,-0.5379350569032533,-1.6228042796921407,0.012048192771084338,0.09773441702864269,1.0,10/27,15.71%,CXCL10;IL2RB;CCL5;CD80;CTLA4;CCL2;TLR8;CD274;TLR4;CD86
prerank,WikiPathway_2021_Human__Retinoblastoma gene in cancer WP2446,0.5165745740606045,1.6225744815028915,0.019230769230769232,0.44727244478139333,1.0,45/86,30.96%,E2F1;KIF4A;TOP2A;ANLN;CCNB2;E2F2;TTK;CCNE1;CDC7;CCNA2;CCNE2;CDC45;CDK1;CCNB1;CDT1;MCM6;TYMS;PRIM1;RFC4;ORC1;RABIF;STMN1;CHEK1;MCM3;CDC25A;RRM2;BARD1;MCM4;SUV39H1;CDK6;HDAC1;MCM7;PRKDC;POLA1;DNMT1;PLK4;HMGB2;MYC;FANCG;CDKN1A;MSH6;SMC2;PCNA;SMC3;RBBP7
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.4472591407754103,-1.622246184829356,0.0,0.0978423979288251,1.0,30/73,19.48%,IRF4;FOXP3;TREML2;CD4;CD8B;CD8A;PTPN22;CRTAM;ITK;CCR7;PIK3CD;RHOH;PTPRC;CD3E;CD3G;CD2;SLA2;CD1C;GATA3;LCK;LCP1;CLEC7A;LAT;RASGRP1;CTPS1;NLRC3;ZAP70;JAML;PPP3CA;CD7
prerank,MSigDB_Oncogenic_Signatures__KRAS.KIDNEY UP.V1 UP,-0.3872451977009697,-1.622214915322418,0.0,0.09755630904599227,1.0,36/124,9.66%,NOL4;GABRA5;PMP2;NRXN1;TCEAL2;PLP1;GABRB1;ESRRG;TRIM9;HPCAL4;PLGLA;ARPP21;NAP1L2;SCG3;SATB1;NEBL;SYT1;PCDH9;FZD3;NME5;SFRP1;SV2B;GLDC;TSPAN7;CRTAM;CPEB3;GPM6A;CP;PNMA2;ANK3;MAP7;XK;GCGR;LIMCH1;VIPR2;DLGAP2
prerank,Elsevier_Pathway_Collection__Lipids Enhance Apoptotic Cell Engulfment and Reduce Inflammation,-0.5338775710010348,-1.6209975506100887,0.04,0.0980074344423096,1.0,12/25,16.90%,TIMD4;TNF;STAB2;IL1B;NR4A1;IL18;CCL2;IL6;CXCL8;CSF2;ALDH1A2;THBS1
prerank,Elsevier_Pathway_Collection__CHRM1/2/3/5 -> Ion Channels,0.6255682705992537,1.6209304162395557,0.041176470588235294,0.4497734632768608,1.0,10/23,15.54%,CACNA1E;KCNC1;KCNH2;KCNJ5;CAMK2A;CHRM5;CACNA1C;PDPK1;KCNJ4;KCNJ11
prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.49742520115450456,1.6208563314075741,0.010101010101010102,0.4463383735823343,1.0,39/101,15.12%,H3C13;H2AC19;H2AC18;H2BC7;H2AC16;H2AC13;H2BC13;H2BC18;H4C12;H3C1;H2BC6;H2AW;H2BC8;H3C2;H2AC11;H4C8;H4C14;H3C10;H4C5;H2AC8;H2AC20;H2BC17;H2BU1;H2BC21;H2BC9;H2BC15;GRIN2A;H3C8;H2BC11;H2BC12;H4C9;H2BC4;H3C6;H4C15;C8G;H2AC6;H4C4;H4-16;H2BC5
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.613657981539943,-1.6196419628514755,0.024096385542168676,0.09865807888024222,1.0,7/16,12.24%,LRFN5;WNT7A;IL1RAPL2;SLITRK3;GPC6;PTPRD;GPC4
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.613657981539943,-1.6196419628514755,0.024096385542168676,0.09865807888024222,1.0,7/16,12.24%,LRFN5;WNT7A;IL1RAPL2;SLITRK3;GPC6;PTPRD;GPC4
prerank,MSigDB_Oncogenic_Signatures__RB P107 DN.V1 UP,0.4811576979555856,1.6188581107968225,0.0,0.4501767471956705,1.0,60/128,29.80%,LYPD1;E2F1;SNCG;KIF4A;GTSE1;BEX2;TMEM119;NCAPH;CCNE1;COL1A1;E2F8;PAQR4;CCNE2;CDC45;CCNF;MCM2;TCF19;MFGE8;MCM6;PRIM1;SPIRE2;LOXL1;CHAF1B;NSMCE2;GSTM2;TMEM45B;COL1A2;COL5A1;CDKN1C;STMN1;POLD1;CD248;MCM5;PRC1;RRM2;ASF1B;CENPK;NRM;DNA2;FEN1;CDH11;ANAPC11;GMNN;MCM7;WDHD1;RBPMS2;GINS4;FBN1;RHEBL1;NCAPD2;IPO9;TSSC4;ACTG2;INCENP;MAD2L1;TCFL5;PRDX4;TRPM1;CENPH;PCNA
prerank,Elsevier_Pathway_Collection__Toll-like Receptor Independent Sterile Inflammation,-0.44483051283932884,-1.6184661526487785,0.0,0.09932896091809554,1.0,25/65,17.07%,TNF;AIM2;IL1B;FOS;IL1RAP;IL18;CASP1;MAP2K1;CXCL2;NLRP3;CCL2;IL6;CLEC4E;IL33;S100B;BTK;AKT1;SYK;S100A12;PLCG2;MYD88;PRKCE;BGN;CXCL1;EZR
prerank,Reactome_2022__Complement Cascade R-HSA-166658,-0.44636347168298957,-1.6175434996639921,0.0,0.09975362046583364,1.0,31/55,25.66%,CR2;FCN3;FCN2;IGLL5;COLEC10;CR1;C4A;MBL2;C1QC;C1R;GZMM;CFI;C1QB;SERPING1;CLU;C8A;VTN;CD19;C3AR1;C8B;FCN1;C1S;C1QA;C5;CD55;MASP1;CD81;C3;C4B;CPB2;PROS1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.5288158055479696,-1.61751179429022,0.0,0.09949919337253882,1.0,13/22,23.34%,CR2;IL10;CD79A;PTPRC;MS4A1;CD40LG;FLT3;RASGRP1;CTPS1;BCL2;CD40;ELF4;PIK3CG
prerank,Elsevier_Pathway_Collection__Proteins Involved in Spontaneous Abortion,-0.4275267183980668,-1.6171435430370578,0.0,0.0995353845662919,1.0,40/80,19.04%,MUC1;NLRP7;PDX1;IL10;PTGS2;TNF;IL1B;CD200R1;CD69;KIR2DL3;FASLG;NCR1;CDH1;TLR3;CCR5;IL18;NCAM1;CAT;SEMA4D;PTPRC;IL6;IL33;TBX21;GATA3;TLR4;FGL2;CD82;PGR;IGF1;VCAM1;CXCR3;LTA;CD86;HMOX1;GP1BA;UCP2;LIF;AR;CDH3;APOH
prerank,TRRUST_Transcription_Factors_2019__CEBPB human,-0.46171590536103496,-1.616085774515563,0.0,0.10006794431318977,1.0,19/51,12.82%,IRF4;CR2;IL10;PTGS2;PLAC1;TNF;IL1B;MMP1;FASLG;SLC10A1;PTPN13;CSF3R;TNFAIP6;HBB;ALB;IL6;ABCB1;CXCL8;SFTPD
prerank,Elsevier_Pathway_Collection__Vitamin A (Retinol) Metabolism and Visual Cycle,-0.5281590015994808,-1.6148733794499979,0.0,0.10074122583929779,1.0,10/25,12.95%,CYP26A1;CYP2C19;CYP2C8;RDH16;CYP4A11;CYP3A7;CYP1A2;ALDH8A1;CYP26B1;CYP3A4
prerank,Elsevier_Pathway_Collection__Inherited Channelopathies,0.6150805796047917,1.6146221143159978,0.018518518518518517,0.46111118257277517,1.0,10/22,16.72%,CACNA1E;CACNB4;GABRD;HCN2;SCN1A;CHRNB2;SCN2A;CHRNA4;KCNJ11;CACNA1H
prerank,Elsevier_Pathway_Collection__Conventional Dendritic Cell Role in Diabetes Mellitus Type 1,-0.5536775038619429,-1.6129975511297774,0.0,0.10174516035671198,1.0,11/21,17.02%,TNF;IL1B;IL18;CASP1;NLRP3;IL33;IL12B;TLR4;TLR2;MYD88;CTSB
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.6133955269283267,1.6129698192134343,0.030303030303030304,0.4632547867302043,1.0,10/25,11.72%,DKK1;SOX2;TDGF1;GSC;FGF13;NR5A1;ZSCAN10;TSC22D1;NR6A1;CDX2
prerank,Elsevier_Pathway_Collection__Apoptotic Keratinocytes Clearance Recession in Systemic Lupus Erythematosus,-0.48024349481335593,-1.6122275972728308,0.012987012987012988,0.10207634501288311,1.0,16/44,17.20%,IL10;AIM2;IL1B;SFTPA1;IL18;CASP1;CAT;NLRP3;IL33;RAC2;TLR4;TLR2;MYD88;VAV1;HSPA1A;TLR10
prerank,Elsevier_Pathway_Collection__Fatty Acids in Hypertension and Atherosclerosis Development,-0.6011734278379147,-1.611795460689187,0.03614457831325301,0.10215225762016655,1.0,6/15,13.03%,TNF;IL1B;PRKCQ;CCL2;IL6;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.51306371658095,-1.611724809202909,0.02631578947368421,0.10191188362123327,1.0,14/33,21.21%,EREG;GBP5;ZBP1;CCL5;FPR2;CD1D;TLR8;SH2D1B;SPI1;SLC15A4;ADAM8;WNT5A;NMI;RIOK3
prerank,KEGG_2021_Human__Maturity onset diabetes of the young,0.636549501245841,1.6112851839938567,0.01282051282051282,0.46642887466057625,1.0,4/20,3.38%,MAFA;RFX6;MNX1;NEUROD1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.5630831949595851,-1.6106487939101801,0.027777777777777776,0.10255478075706546,1.0,12/22,11.52%,IL10;INHBA;SFRP1;ID2;BANK1;TNFRSF13B;CTLA4;CD300A;BLK;SAMSN1;MNDA;FCGR2B
prerank,Elsevier_Pathway_Collection__Monocytes Function in Gout,-0.5102629331541683,-1.6090710809940543,0.012658227848101266,0.10333541646355564,1.0,14/34,17.02%,PTGS2;TNF;IL1B;CASP1;NLRP3;IL6;PLA2G4A;CXCL8;TICAM2;TLR4;TLR2;SYK;MYD88;CTSB
prerank,TRRUST_Transcription_Factors_2019__CTCF human,0.6048732893371936,1.6067456433489307,0.01675977653631285,0.48111804815722736,1.0,8/28,11.07%,IGF2;SLC6A4;CELSR3;TERT;MEG3;ASAP2;IRAK2;PTPRG
prerank,TRRUST_Transcription_Factors_2019__RFX5 human,-0.5854206751279595,-1.6063335973306736,0.045454545454545456,0.1050669878811177,1.0,13/16,27.54%,IFNG;HLA-DQA2;HLA-DOB;HLA-DQA1;HLA-DQB2;HLA-DOA;HLA-DRB5;HLA-DRA;HLA-DPA1;HLA-DPB1;HLA-DRB1;HLA-DMB;HLA-DQB1
prerank,KEGG_2021_Human__Legionellosis,-0.43118654592906225,-1.6060003257715203,0.0,0.10491487500121645,1.0,21/56,17.11%,TNF;IL1B;CXCL3;IL18;CASP1;CXCL2;IL6;CR1;IL12B;HSPA1B;CXCL8;TLR4;TLR2;CR1L;MYD88;ITGB2;CASP7;CXCL1;SEC22B;NLRC4;HSPA1A
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.5702300643961418,1.605776510498923,0.027932960893854747,0.48103807156780304,1.0,13/39,18.91%,GNG4;GLP1R;GCG;KCNC2;KCNG2;KCNB1;GNG3;GNB5;ADCY6;GNG8;PRKCA;GNG10;RAPGEF3
prerank,WikiPathway_2021_Human__Platelet-mediated interactions with vascular and circulating cells WP4462,-0.608703477260772,-1.605585488453243,0.037037037037037035,0.10490376959286067,1.0,12/17,22.03%,IL1B;CCL5;CCL2;CD40LG;TLR4;TLR2;SELE;VCAM1;SELPLG;PF4;SELP;CD40
prerank,Elsevier_Pathway_Collection__Basophil Activation in Asthma,-0.4328365077362121,-1.6049946830812547,0.0,0.10503249984880758,1.0,26/60,23.45%,CD4;TNF;CD80;MAP2K1;IFI30;FCER1A;IL6;LCP2;HRH4;IL33;TLR2;LAT;AKT1;TSLP;SYK;LAT2;MYD88;FCER1G;VAV1;IQGAP1;MAP2K6;JAK2;CD40;MS4A2;IGHD;GAB2
prerank,Reactome_2022__Reproduction R-HSA-1474165,0.5129964410297145,1.6040804123760242,0.018867924528301886,0.4849053495464906,1.0,26/87,16.39%,KCNU1;H3C13;H2AC19;SMC1B;SYCE1;H2BC13;MSH4;MSH5;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;ZP3;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;LMNA;SERPINA2;HSPA2;H2BC5;CATSPER1;ACR;H2AX
prerank,Elsevier_Pathway_Collection__CD4+ T-Cell Death in HIV,-0.5162243288092148,-1.6033181631168762,0.025974025974025976,0.1059503843463806,1.0,12/28,22.05%,CD4;FASLG;CCR5;MAP2K1;PRKCQ;CARD11;LCK;LAT;CXCR4;ZAP70;JAK2;STAT1
prerank,Elsevier_Pathway_Collection__FAS Mediated Apoptosis in Systemic Scleroderma,-0.6055017542187253,-1.603168469480374,0.0,0.1057975140423866,1.0,6/15,17.08%,IFNG;TNF;IL1B;FASLG;CXCL8;BCL2
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,0.4776509479237728,1.6030801181518253,0.0,0.4848501650023176,1.0,34/148,16.39%,HMGA2;H3C13;H2AC19;E2F1;H1-5;H2BC13;CDKN2A;MAPK11;H1-2;H2AC20;H2BC17;UBE2C;E2F2;H2BC21;CCNE1;H2BC9;CDKN2C;H2BC15;CBX6;EZH2;CCNA2;UBE2S;CCNE2;H2BC11;H2BC12;CDKN2B;H1-4;H2BC4;H4C15;H2AC6;MAPKAPK2;H2BC5;DAND5;H2AX
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.5683501190601226,-1.6022590951156044,0.0,0.10598581478730756,1.0,11/20,22.42%,GSTA2;GSTZ1;GSTA1;GSTT2B;GSTM5;HPGDS;ESD;GSTO2;GSTP1;GSTM1;AKR1A1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.5683501190601226,-1.6022590951156044,0.0,0.10598581478730756,1.0,11/20,22.42%,GSTA2;GSTZ1;GSTA1;GSTT2B;GSTM5;HPGDS;ESD;GSTO2;GSTP1;GSTM1;AKR1A1
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,0.4824020978513104,1.6011233685245512,0.004672897196261682,0.4887073786246965,1.0,69/139,35.94%,H2BC13;CDC25C;GTSE1;H2BC17;CCNB2;H2BC21;PSMD4;H2BC9;EXO1;H2BC15;CDC6;CDC7;CDC45;H2BC11;CDK1;CCNB1;H2BC12;MCM6;H2BC4;H4C15;SERPINA2;RFC4;PSMB4;H2BC5;MCM10;PKMYT1;CHEK1;H2AX;MCM3;MCM5;CDC25A;BARD1;MCM4;DNA2;RMI1;POLR1A;CLSPN;ATRIP;RAD9B;MCM7;BLM;RHNO1;PSMB3;NSD2;PSMD14;CHEK2;UBA52;MDC1;PSMB5;PSMD2;ABRAXAS1;PSMA1;PIAS4;BABAM2;PSMD10;PSMC4;PSMC3;TP53BP1;BRIP1;RMI2;UIMC1;MCM8;TOPBP1;REXO2;PSMC5;SEM1;PSMB6;YWHAH;PSMD8
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.5305019715867217,1.6006631236132853,0.010582010582010581,0.486930658763391,1.0,32/63,31.85%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;KAT2A;H2BC5;H2AX;POLR2L;POLR1A;EHMT2;HDAC1;H2AJ;POLR2K;GATAD2B;TAF1A;POLR1H;POLR1G;CHD3;CHD4;POLR2H;RBBP7;CBX3;H2AZ1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.3901155476381112,-1.6005152197874426,0.0,0.10705956432058279,1.0,63/113,27.28%,CIDEA;IL10;IFNG;BPI;PTPN22;TLR3;CCL3;LILRA2;LILRA5;PTPRC;IL6;CD2;IL33;IL12B;LILRB1;CCR2;SPN;CHRNA7;TLR4;CLEC7A;TLR2;SPHK2;RASGRP1;SYK;IGF1;HAVCR2;ORM2;PLCG2;CLU;LGALS9;LILRA4;NLRC3;THBS1;CD33;SLAMF1;TWIST1;NR1H4;WNT5A;OAS3;NOD2;OAS2;GSTP1;PF4;CX3CR1;TMEM106A;CYBA;JAK2;TYROBP;APP;IFIH1;SIRPA;DDX58;OAS1;ORM1;TLR1;CD14;LY96;CLEC4A;FZD5;IFNGR1;DICER1;HMGB1;ZFP36
prerank,TRRUST_Transcription_Factors_2019__RELA human,-0.36076052440152706,-1.6003697363502858,0.0,0.10685950822161039,1.0,95/281,17.46%,KLK3;TFF1;IRF4;FOXP3;MUC6;CR2;MUC5AC;CCK;IL10;CXCL10;PTGS2;NLRP2;MUC5B;IFNG;EPCAM;TNF;BHMT;IL1B;MMP1;CCL5;CXCR2;SFTPA1;CD69;FASLG;PTPN13;CDH1;CD80;TLR3;TNIP3;CCR5;CYP3A7;CCL4;CCL3;IL18;CD38;PDK4;TNFSF10;FBP1;NCAM1;TF;CCR7;NFKBIZ;CXCL12;CXCL2;PLIN1;CCL2;EGR1;IL6;CD40LG;ABCB1;TBX21;BCL2A1;ALOX5AP;IL12B;ALOX5;IL1RN;CCR2;PTGES;PTGER4;CXCL8;GATA3;CCL22;TNFRSF9;TLR2;SELE;CYP3A4;AKT1;TSLP;PGR;SLC25A27;POU2F2;CFI;VCAM1;SLC9A2;HBEGF;CD83;CSF2;CXCR4;BCL2L11;TNFRSF13C;ADORA3;BGN;PIGR;CD86;CFTR;CXCL1;F3;PLAUR;CTSB;BCL2;HMOX1;NCOR1;EBI3;PTAFR;REPS2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.511162336080348,-1.5995456453199468,0.02564102564102564,0.10708712060140771,1.0,5/28,6.68%,RET;TNF;INHBA;SFRP1;TNFSF10
prerank,"Elsevier_Pathway_Collection__Hypothyroidism, Secondary (Central)",0.6122135810054542,1.5992585275786395,0.016304347826086956,0.48846434867299354,1.0,5/20,8.23%,GHRHR;LHX3;CGA;LHX4;TRH
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.6045017768511592,1.5989850359861288,0.01875,0.48592071811945425,1.0,6/24,7.80%,PAX2;SLC2A5;PRKAA2;CYP7A1;KCNB1;SLC26A6
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.42268014330243897,-1.5987336289926548,0.0,0.10743504935854205,1.0,34/81,22.48%,LRRC19;PTGS2;ACE2;ZBP1;TKFC;PTPN22;BST1;CASP1;XCL1;IL1RL2;ALOX5;CCR2;PTGES;FCGR2B;HERC5;HCK;SELE;FGR;USP18;MYD88;MGLL;GGT2;SHPK;WNT5A;AHSG;AKNA;NOD2;AGTR1;NLRP6;JAK2;TMSB4X;PIK3AP1;DHX58;CASP4
prerank,MSigDB_Oncogenic_Signatures__LEF1 UP.V1 DN,-0.37000491995534296,-1.5975446433256133,0.0,0.10788716626292788,1.0,45/168,16.17%,ERN2;TFF1;RAB25;TMPRSS3;IL20RA;AP1M2;SLC6A20;PLAC8;NLRP2;SLC44A4;AGR2;FAM83E;PRSS8;S100A14;PTPN13;MLLT3;TLR3;BDH2;IL18;TNFSF15;CAT;ANK3;SAMD9;ZNF711;KLRF1;CXCL2;XK;LIMCH1;GALC;SULT1C2;IL33;RAB26;RAC2;CYP26B1;GALNT12;SORL1;USP18;BTN3A3;SH3BGRL;CPOX;PLSCR4;RBM47;CFTR;CYP2J2;RAB27B
prerank,TRRUST_Transcription_Factors_2019__GLI2 human,-0.5743795623611399,-1.5973349576368643,0.03260869565217391,0.10776259561530761,1.0,5/16,9.77%,FOXE1;MUC5AC;CDH1;PDGFRA;BHLHE41
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,0.49104996605404244,1.5967457951992219,0.014285714285714285,0.4906480681024753,1.0,75/88,47.14%,RPL8;MRPL13;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPSA;RPL26L1;RPL39;UBA52;TRMT112;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;N6AMT1;RPS7;RPS11;RPL36A;GSPT2;RPL7A;FAU;RPS3;RPL18A;APEH;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;RPS15A;RPL4;RPL19;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13;ETF1
prerank,Elsevier_Pathway_Collection__Neutrophil Degranulation via FPR1 Signaling,-0.4239348485538834,-1.5967274587939986,0.0,0.10784969186362789,1.0,21/62,21.40%,SYT1;BPI;CXCR1;FPR1;PLD1;PADI4;CYBB;RAC2;CXCL8;HCK;CAMP;SYK;FGR;LAT2;VAV1;NCF1;NCF2;IQGAP1;PRKCZ;MAP2K6;CYBA
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5323907210914394,-1.5958338067679387,0.012987012987012988,0.10814675259317615,1.0,16/24,23.52%,CD160;SH2D1A;PTPN22;LGALS3;FCRL3;CD300A;UBASH3A;SLA2;FCGR2B;GBP1;LILRB4;PRNP;EZR;LPXN;LAPTM5;CD22
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,0.4854595386493074,1.5951964398959264,0.0,0.49287853098725987,1.0,36/116,23.30%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;UBE2C;H2BC21;PSMD4;H2BC9;H2BC15;CDC6;CDC7;UBE2S;CDC45;H2BC11;CDT1;H2BC12;MCM6;H2BC4;H4C15;PRIM1;H2AC6;PSMB4;H2BC5;MCM10;H2AX;MCM3;MCM5;MCM4;POLR1A;ANAPC11;GMNN;MCM7;H2AJ;POLA1;POLA2
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,0.498031242600871,1.5951759283960572,0.014563106796116505,0.48932970563493994,1.0,75/87,46.98%,EEF1A2;RPL8;MRPL13;EEF1D;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPSA;RPL26L1;RPL39;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;EEF1B2;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;EEF2;RPS15A;RPL4;RPL19;EEF1A1;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,Elsevier_Pathway_Collection__Lipoxin A4/FPR2-Related Neutrophil Depression,-0.4556014961747115,-1.5950022957153127,0.0,0.10854715917977846,1.0,16/36,23.34%,EGR2;FOS;PLD1;FPR2;MAP2K1;PRKCB;LCP2;CXCL8;LAT;VAV1;ITGB2;IQGAP1;PRKCZ;JUN;ITGAM;PIK3CG
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.5597683968723068,-1.5948824089744822,0.0,0.10837730533662425,1.0,9/18,14.15%,CD160;KLRD1;CRTAM;SLAMF6;NCR3;IL12B;RASGRP1;CD226;KLRK1
prerank,Elsevier_Pathway_Collection__NFKB Non-Canonical Signaling Activation in Cancer,-0.5141680758094986,-1.594416596306452,0.03225806451612903,0.10843201837559927,1.0,11/29,16.76%,TNFSF11;TNFRSF17;TNF;TNFRSF13B;CD40LG;TNFRSF11A;REL;TNFSF13;TNFRSF13C;TNFSF8;TNFSF13B
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.4406155462876531,-1.5940215872435872,0.0,0.10850131250189964,1.0,29/57,25.08%,ADH4;HAO2;ABCD2;BDH2;PPARGC1A;SCP2;ACADL;ACAA1;ACADS;EHHADH;ADH7;ACOX1;HAO1;CYP4V2;ABCD4;CROT;ECHDC1;ACAD11;ACADM;ECHS1;PHYH;ACAT1;PECR;ADIPOR2;SLC27A2;ECHDC2;ILVBL;ACAA2;PEX13
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.5967288221111196,1.5940056151719926,0.010869565217391304,0.4901671435590136,1.0,7/32,10.35%,HMGA2;COL7A1;LAMA3;NODAL;COL8A1;COL11A1;COL4A2
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.5092049957332258,-1.593863605489969,0.05128205128205128,0.1083032639926293,1.0,8/27,14.38%,AP1M2;CD4;CD8B;FYN;LCK;CD247;HCK;DOCK2
prerank,TRRUST_Transcription_Factors_2019__FOXA2 human,-0.586911115907905,-1.592457202682699,0.05747126436781609,0.10926010409810508,1.0,7/15,11.16%,TFF1;NKX2-1;AGR2;CDH1;APOA1;SLCO1B3;MMP7
prerank,Elsevier_Pathway_Collection__Myeloid Progenitor Cell -> GEMM - CFU Surface Expression Markers,-0.5854813666216065,-1.5909493158323387,0.010101010101010102,0.11004961489777361,1.0,11/17,21.10%,CSF3;CSF3R;PTPRC;CCR2;FLT3;CSF2;CXCR4;CSF1R;CD33;CD7;CX3CR1
prerank,TRRUST_Transcription_Factors_2019__RUNX2 mouse,0.5507527492509202,1.5908298783153874,0.005555555555555556,0.49781796674941003,1.0,12/45,9.04%,COL2A1;DKK1;CSN2;LEF1;SPP1;OSR1;AXIN2;TCF7;COL10A1;IHH;COL1A1;ASRGL1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.6032371094247099,1.5908277470940344,0.029940119760479042,0.49423654252819127,1.0,12/27,20.17%,VIL1;STMND1;STMN3;KIF2C;STMN2;KIF14;KIF18B;KIF18A;MICAL2;STMN1;TWF2;KIF24
prerank,WikiPathway_2021_Human__Prader-Willi and Angelman Syndrome WP3998,0.5483539990019046,1.589816053511856,0.010416666666666666,0.4945578260942659,1.0,18/51,12.67%,DLX5;GABRD;CGA;E2F1;GABRR3;SLC45A2;KISS1;ATP10A;OCA2;MKRN3;CDKN2A;BDNF;MSX1;CDKN2C;CDC6;PCSK1;CDKN2B;LHB
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.5153368926942413,1.5892630602454088,0.016216216216216217,0.4932286818819122,1.0,28/64,28.99%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;POLR2L;POLR1A;HDAC1;H2AJ;POLR2K;SAP30L;DNMT1;DNMT3B;TAF1A;POLR1H;SIN3B;SAP130;POLR1G
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.5100447848971701,1.58925553976843,0.020942408376963352,0.4897552404602086,1.0,29/67,28.99%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;POLR2L;SUV39H1;POLR1A;HDAC1;H2AJ;POLR2K;SAP30L;DNMT1;DNMT3B;TAF1A;POLR1H;SIN3B;SAP130;POLR1G
prerank,TRRUST_Transcription_Factors_2019__EP300 human,-0.42736437726279525,-1.5892291371487068,0.015384615384615385,0.11132058329951057,1.0,15/54,14.74%,KLK3;PTGS2;IFNG;IGFBP3;KRT16;IL6;ABCB1;CYBB;IL12B;CXCL8;TRIM22;TBXAS1;IGF1;VCAM1;SLC9A2
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,0.4933934610829046,1.5890281982454657,0.014492753623188406,0.4869986115665682,1.0,72/84,46.98%,RPL8;MRPL13;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPSA;RPL26L1;RPL39;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;EEF2;RPS15A;RPL4;RPL19;EEF1A1;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.5826823004462051,-1.588717487939115,0.01282051282051282,0.11152817565733128,1.0,7/20,13.30%,CIDEA;TNF;IL1B;ALK;HCAR2;APOA5;ANGPTL3
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,0.5946000810535492,1.5885105114939126,0.03428571428571429,0.48539415646397865,1.0,15/31,23.30%,CDC6;CDC7;CDC45;CDT1;MCM6;PRIM1;MCM10;MCM3;MCM5;MCM4;POLR1A;GMNN;MCM7;POLA1;POLA2
prerank,Elsevier_Pathway_Collection__Familial Mediterranean Fever,-0.5399247614698927,-1.588403194581134,0.0,0.11142727819607204,1.0,12/25,17.02%,TNF;IL1B;IL18;CASP1;NLRP3;IL6;IL33;MEFV;TICAM2;TLR4;MYD88;CTSB
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.5559481014008676,1.5876897422391247,0.031914893617021274,0.4849651096398513,1.0,26/37,35.26%,HJURP;CENPF;CENPA;CENPE;CENPI;CENPM;DLGAP5;HELLS;CENPU;CENPL;H4-16;CENPK;POGZ;CENPV;CENPP;NPM1;CENPW;ITGB3BP;CENPS;CENPH;RBBP7;CENPT;CENPQ;RUVBL1;CENPX;NASP
prerank,Elsevier_Pathway_Collection__Potassium Flux Regulation,0.5518473449730814,1.5874045950985871,0.021505376344086023,0.4826719341289775,1.0,15/44,15.54%,KCNJ6;KCNC2;KCNH2;KCNJ9;OPRL1;HTR4;KCNJ5;CHRNA3;SRC;CHRNB4;KCNJ14;ABCC8;PDPK1;GRM1;KCNJ11
prerank,Elsevier_Pathway_Collection__Dendritic Cell Dysfunction in Crohn's disease,-0.472356907613206,-1.5873378807065806,0.03076923076923077,0.11185251524238775,1.0,12/42,12.28%,IRF4;IL10;TNFSF11;CCR9;TNF;IL1B;TNFSF10;TNFSF15;IL6;IL12B;TICAM2;TLR4
prerank,Elsevier_Pathway_Collection__Cholesteatoma,-0.4160500169660362,-1.5871183560871598,0.0,0.111736737156032,1.0,21/69,14.96%,NR4A2;EREG;ERBB4;KRT4;CXCR2;TLR3;LGALS3;MAP2K1;KRT16;FGFR2;TGFA;IL6;KLF4;CXCL8;TLR4;TLR2;AKT1;RARB;MYD88;CSF2;CXCR4
prerank,KEGG_2021_Human__Cardiac muscle contraction,0.5050703038670719,1.5863793742653851,0.010582010582010581,0.4831030214058313,1.0,29/70,25.30%,CACNB4;CACNG1;TNNC1;CACNG4;CACNA1S;CACNG5;TNNI3;COX4I2;CACNA2D2;ATP1A2;ATP1A4;ATP1B3;ATP2A1;CACNA1C;CACNA2D3;CACNG8;TPM2;FXYD2;SLC8A3;COX6C;COX7B;UQCRB;COX6B1;CACNA1D;CASQ2;COX8A;UQCRQ;CYC1;CACNB1
prerank,Reactome_2022__M Phase R-HSA-68886,0.4377971841342319,1.5860112827473836,0.0,0.4812684819604051,1.0,175/360,38.98%,DYNC1I1;H3C13;H2AC19;H2BC13;CENPF;KIF20A;NEK2;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;H2AC20;H2BC17;BIRC5;CCNB2;UBE2C;SPC24;BUB1;NCAPH;TUBA4B;H2BC21;NCAPG;PSMD4;CENPI;H2BC9;CENPM;H2BC15;AURKB;KIF18A;NDC80;TUBB8;UBE2S;KIF23;CDCA5;PTTG1;H2BC11;CDK1;TUBB8B;CDCA8;SPC25;TUBA4A;CCNB1;KNTC1;H2BC12;H2BC4;H4C15;TUBA3E;H2AC6;CENPU;LMNA;ERCC6L;PSMB4;CENPL;SGO2;CEP131;ZWINT;H2BC5;TUBA8;PRKCA;H2AX;TUBB2B;LBR;CENPK;SPDL1;CETN2;CEP250;SGO1;TUBA3D;HAUS4;NUP37;HAUS5;MZT2B;LPIN1;DSN1;ANAPC11;B9D2;H2AJ;PPP2R5A;AHCTF1;RPS27;NUP62;CENPP;TPR;NCAPD2;NUP133;NCAPH2;PLK4;DYNLL1;EMD;RANGAP1;ANAPC7;PSMB3;SMC4;LMNB1;CEP70;SFI1;TUBGCP6;ITGB3BP;PSMD14;INCENP;UBA52;SSNA1;MAD2L1;ENSA;TUBB2A;PSMB5;NUP155;CENPH;VPS4A;PSMD2;NUP160;PSMA1;SMC3;UBE2I;PSMD10;NEK7;MZT2A;CHMP2A;CSNK1D;PSMC4;NCAPG2;PSMC3;H2AZ1;TUBA1A;ALMS1;CEP290;TUBA1B;CEP152;DCTN2;NUP188;DYNC1H1;HDAC8;DCTN3;CEP41;CENPT;CENPQ;CSNK2B;BANF1;PSMC5;SMC1A;TUBG1;ESPL1;CEP72;PPP2R1A;MAU2;SEM1;PSMB6;CDC23;TUBGCP2;KIF2A;PSMD8;NDE1;HAUS1;NUP205;TUBB6;STAG2;MAPK3;PSME2;TUBB4B;PMEPA1;EML4;XPO1;SDCCAG8;PSMD13;NUP210;PSMB7;PSMA7;LEMD2;HSP90AA1;RAN;ANAPC1
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.5051119294712729,1.5857793132658589,0.01507537688442211,0.4788630518590666,1.0,22/78,17.34%,HOXD3;H3C13;HOXA3;H2AC19;HOXD4;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;HOXA4;EZH2;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;PCGF2;POLR2L
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),0.6573486322427149,1.585375400046413,0.011627906976744186,0.47667170808035464,1.0,3/15,2.64%,C1QTNF3;SPP1;RASL10B
prerank,Elsevier_Pathway_Collection__Proteins Involved in Myocarditis,-0.3620320082265096,-1.5845943197617904,0.0,0.11305949445862686,1.0,70/182,17.12%,CR2;CSF3;IL10;CXCL10;PTGS2;TNFSF11;CD1A;IFNG;CD4;TNF;LAG3;IL1B;BPI;HGF;CCL5;SOCS2;PROM1;CD69;FASLG;CD80;TLR3;NR3C2;S100A8;CCR5;CCL3;IL18;NCAM1;SEMA4A;CD1D;ICOS;PZP;CTLA4;CXCL2;NLRP3;PRF1;CCL2;IL6;CCR1;CR1;CD2;IL33;CD40LG;TBX21;CYBB;ALOX5;IL1RN;CCR2;CD274;PTGER4;PDCD1LG2;TLR4;TNFRSF9;TLR2;IL21R;HAVCR2;MSR1;MYD88;CXCR3;CSF2;GZMA;IL12RB1;SMAD9;CLU;CD86;ITGB2;LGALS9;F3;NR1I3;THBS1;HMOX1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.4646601891538388,-1.5839189912504754,0.0,0.11347721748064928,1.0,15/40,13.51%,ADRA1A;HTR2A;AVPR1A;NTRK3;NTF3;P2RY12;NTRK2;ESR1;PDGFRA;ITK;NMUR1;LPAR2;RASGRP4;SELE;PLCB2
prerank,Elsevier_Pathway_Collection__Glycolysis,-0.5693853207993609,-1.5836641926892834,0.022988505747126436,0.11335814720878014,1.0,4/17,6.88%,GCK;HK3;ENO3;ALDOB
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.4633873046838416,1.582880136938239,0.009302325581395349,0.48325600141298514,1.0,27/136,10.18%,OLIG3;EN1;ISL2;LHX3;POU3F2;IRX6;SPINK5;VAX2;IRX3;FOXN4;BRSK2;WNT4;NEUROD1;WNT9B;EN2;LHX9;WNT8B;LHX4;IRX5;VSX1;EMX1;TENM2;ACSL4;VXN;MYO7A;MANF;IL1RAPL1
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,0.5780327846294856,1.5828099583867339,0.041916167664670656,0.4803910188664182,1.0,4/30,0.68%,GNG4;GLP1R;GHRHR;GCG
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.6202286553543677,1.5822745942371572,0.02531645569620253,0.4791694922598191,1.0,8/22,10.75%,PAX2;SIX1;SIX4;MDK;BMP4;FGF2;LBX2;SOX8
prerank,Elsevier_Pathway_Collection__Proteins Involved in Otitis Media,-0.49404251594531157,-1.5820100771000498,0.0273972602739726,0.11437828342666316,1.0,12/29,11.86%,MUC5AC;IL10;PTGS2;TNF;IL1B;CCL5;CCL3;ALB;IL6;SPN;MBL2;CXCL8
prerank,Elsevier_Pathway_Collection__IL17 Signaling in Psoriasis,-0.48407373426765,-1.5819635523987126,0.0125,0.11414250829992423,1.0,18/36,23.65%,CSF3;MMP1;FOS;MAP2K1;CXCL2;CCL2;CXCL8;IL17RC;HBEGF;CSF2;SPI1;CXCL1;MAPK10;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,WikiPathway_2021_Human__Canonical and non-canonical Notch signaling WP3845,0.6018042333533916,1.5818363608471395,0.031446540880503145,0.4775870962753408,1.0,9/26,20.43%,DLK1;DNER;LEF1;NOTCH3;JAG2;MFAP2;NOTCH4;DLL4;HEY1
prerank,TRRUST_Transcription_Factors_2019__STAT5A mouse,-0.5202644133346391,-1.5804558676093496,0.047058823529411764,0.11521277584893655,1.0,10/22,14.87%,CSF3;SFTPB;IL10;DPF3;SOCS2;PCK1;PDK4;PRF1;CLNK;CSF2
prerank,TRRUST_Transcription_Factors_2019__HNF4A human,-0.467407280093791,-1.5800026888517678,0.016666666666666666,0.11524781827787095,1.0,17/42,17.38%,GCK;CYP2B6;CYP2C8;FABP2;UGT2B7;APOA1;CYP2C9;AKR1C4;SHBG;MMP7;NR1I2;ABCG8;CYP3A4;ABCG5;MTTP;LIPC;UGT1A7
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.4340204572051881,-1.579649371543173,0.031746031746031744,0.11526841648070489,1.0,23/46,19.69%,IFNG;TNF;CHIA;IL1B;TLR3;FFAR2;IL18;EGR1;IL6;IL33;TLR4;CLEC7A;TLR2;TSLP;SYK;CSF1R;LGALS9;HMOX1;AIF1;TWIST1;WNT5A;C5;OAS3
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,0.4588867721327359,1.5789219995233343,0.0,0.4845460119568254,1.0,114/223,38.98%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;BIRC5;CCNB2;UBE2C;SPC24;BUB1;TUBA4B;PSMD4;CENPI;CENPM;AURKB;KIF18A;NDC80;TUBB8;UBE2S;CDCA5;PTTG1;CDK1;TUBB8B;CDCA8;SPC25;TUBA4A;CCNB1;KNTC1;TUBA3E;CENPU;LMNA;ERCC6L;PSMB4;CENPL;SGO2;ZWINT;TUBA8;TUBB2B;LBR;CENPK;SPDL1;SGO1;TUBA3D;NUP37;DSN1;ANAPC11;B9D2;PPP2R5A;AHCTF1;RPS27;NUP62;CENPP;NUP133;DYNLL1;EMD;RANGAP1;ANAPC7;PSMB3;LMNB1;ITGB3BP;PSMD14;INCENP;UBA52;MAD2L1;TUBB2A;PSMB5;NUP155;CENPH;VPS4A;PSMD2;NUP160;PSMA1;SMC3;UBE2I;PSMD10;CHMP2A;PSMC4;PSMC3;TUBA1A;TUBA1B;NUP188;DYNC1H1;HDAC8;CENPT;CENPQ;BANF1;PSMC5;SMC1A;ESPL1;PPP2R1A;SEM1;PSMB6;CDC23;KIF2A;PSMD8;NDE1;NUP205;TUBB6;STAG2;PSME2;TUBB4B;PMEPA1;XPO1;PSMD13;PSMB7;PSMA7;LEMD2;RAN;ANAPC1
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.5762857611929169,1.5787454746976888,0.026881720430107527,0.4820962479745218,1.0,5/25,7.62%,FGF20;FGF13;FGF17;SRC;FGF23
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.6060778767279499,1.5777385560976713,0.01744186046511628,0.48267744290473374,1.0,5/24,7.17%,CEMIP;STOX1;CHI3L1;PLK1;SPHK1
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.5395099313413887,1.5776172385994844,0.021505376344086023,0.4801193167062865,1.0,24/55,21.01%,COL2A1;COL7A1;COL15A1;COL9A1;ITGA6;COL10A1;COL4A1;COL4A5;COL8A1;COL1A1;LOXL2;COL11A1;COL4A2;LOXL1;TLL2;COL1A2;COL5A1;LOX;LAMA4;PLEC;MMP9;MMP3;COL11A2;COL27A1
prerank,WikiPathway_2021_Human__Complement and Coagulation Cascades WP558,-0.45498424006121096,-1.5766741391849861,0.017543859649122806,0.11766526756559621,1.0,35/58,25.66%,CR2;C9;F9;KLKB1;C7;C6;CR1;SERPINA5;PLG;C1QC;C1R;CFI;C1QB;SERPING1;CLU;KNG1;F13B;LMAN1;F3;PLAUR;F7;C3AR1;C1S;SERPINF2;C1QA;CD55;MASP1;SERPIND1;F2;THBD;C3;CFD;C4B;CPB2;PROS1
prerank,TRRUST_Transcription_Factors_2019__NR5A1 mouse,0.6319968642350602,1.5765987845686023,0.04790419161676647,0.4806627067268128,1.0,7/18,13.28%,INHA;CYP17A1;WNT4;NR5A1;AMH;LHB;POU5F1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.5403029990733486,1.5757710013977126,0.016129032258064516,0.4809433472952888,1.0,10/48,6.72%,COL2A1;HMGA2;HOXD3;OSR2;OSR1;CHI3L1;GDF5;HES5;BMP4;FGF2
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.39177152327320575,-1.5752971333439156,0.0,0.1184035180476381,1.0,52/102,24.09%,EREG;IL10;IFNG;TNF;SIGLEC16;IL1B;BPI;CD200R1;POU2AF1;NLRP12;PTPN22;TLR3;LILRA2;SCIMP;LILRA5;IL6;TLR8;IL33;NCKAP1L;TLR4;CLEC7A;TLR2;SPHK2;TSLP;IL16;SYK;POU2F2;PLCG2;MYD88;LILRB4;LGALS9;LILRB2;NLRC3;AFAP1L2;SLAMF1;AIF1;TWIST1;WNT5A;MAPK13;NOD2;INAVA;XBP1;TMEM106A;CYBA;TYROBP;APP;IFIH1;SIRPA;F2RL1;DDX58;ORM1;TLR1
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,0.6677013461755803,1.5752830437555767,0.04678362573099415,0.47973669250469014,1.0,10/15,28.26%,HMGA2;H1-5;H1-2;H1-4;HMGA1;UBN1;H1-0;LMNB1;EP400;CDKN1A
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,0.5367338201569646,1.5746127593766117,0.02185792349726776,0.47919799389509504,1.0,19/52,16.80%,H3C13;H2AC19;H2BC13;CDC25C;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;RNASE1;H2BC12;H2BC4;H4C15;H2AC6;PDPK1;H2BC5;H2AX;RHOC
prerank,WikiPathway_2021_Human__Acute viral myocarditis WP4298,-0.39733262325804203,-1.5744156020667852,0.0,0.11903893526462594,1.0,27/84,19.88%,IL10;IFNG;CD4;TNF;CD80;TLR3;CCR5;CASP1;IL6;FYN;CD40LG;RAC2;IL12B;TLR4;PIK3R1;AKT1;SGCA;CASP6;CXCR4;PTCRA;ITGB2;CASP7;BCL2;AIF1;SGCD;NOD2;DMD
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.48934513891051445,1.5733247453899453,0.010256410256410256,0.4809480581617329,1.0,82/96,47.77%,RPL8;MRPL13;RPL30;RPLP1;RPS27;RPS21;RPLP2;EIF3E;RPS5;EIF3K;RPL28;RPS14;RPSA;RPL26L1;RPL39;EIF3D;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;EIF3H;RPL10A;RPS8;RPS12;EIF3B;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;EIF3G;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;EIF3M;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;EIF3C;RPL6;EIF3F;RPS15A;RPL4;EIF3L;RPL19;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13;EIF3A;RPL3
prerank,Reactome_2022__Meiosis R-HSA-1500620,0.5151671011534772,1.5729220188186426,0.014778325123152709,0.4797010190445098,1.0,22/71,16.39%,H3C13;H2AC19;SMC1B;SYCE1;H2BC13;MSH4;MSH5;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;LMNA;SERPINA2;HSPA2;H2BC5;H2AX
prerank,WikiPathway_2021_Human__Photodynamic therapy-induced NF-kB survival signaling WP3617,-0.5044029957772536,-1.5726337874788257,0.014285714285714285,0.12034901488349717,1.0,13/33,14.87%,PTGS2;TNF;IL1B;MMP1;CXCL2;IL6;CD40LG;BCL2A1;CXCL8;REL;SELE;VCAM1;CSF2
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.5105654539899264,1.5725296895054865,0.015306122448979591,0.478138161150631,1.0,19/69,12.73%,H3C13;H2AC19;H2BC13;CDKN2A;H2AC20;H2BC17;UBE2C;H2BC21;H2BC9;CDKN2C;H2BC15;CCNA2;UBE2S;H2BC11;H2BC12;CDKN2B;H2BC4;H4C15;H2AC6
prerank,Elsevier_Pathway_Collection__B-Cell Receptor -> NFATC Signaling,-0.5457780497852619,-1.5724356536629585,0.0449438202247191,0.12020158383101553,1.0,10/18,23.52%,CD79A;CD40LG;BTK;SYK;PLCG2;LILRB3;CD19;NFATC2;CD40;CD22
prerank,KEGG_2021_Human__Viral carcinogenesis,0.4553214986214804,1.5717891668618604,0.004219409282700422,0.47807436656705143,1.0,46/184,16.35%,PIK3R2;H2BC7;H2BC13;H2BC18;H4C12;H2BC6;H2BC8;CDKN2A;H4C8;H4C14;ATP6V0D2;H4C5;CDC20;HDAC4;H2BC17;SRC;H2BU1;H2BC21;CCNE1;H2BC9;CCR3;H2BC15;CCNA2;CCNE2;IKBKG;H2BC11;CDK1;H2BC12;CDKN2B;HDAC11;H4C9;H2BC4;H4C15;NFKB2;CREB3L1;SCRIB;KAT2A;MAPKAPK2;SCIN;H4C4;H4-16;H2BC5;HRAS;HDAC5;CREB3L4;CHEK1
prerank,MSigDB_Oncogenic_Signatures__MEK UP.V1 DN,-0.3690866762936384,-1.5706947978646926,0.0,0.12120710399175112,1.0,66/165,27.57%,ASCL1;TCN1;EGR3;PRKAR2B;TFPI2;AGL;ID2;OASL;S100A8;NPY1R;MSMB;AK4P3;ARMCX3;CALCR;GALC;AMIGO2;CYP26B1;RASGRP1;DDX60;PGR;USP18;WIPF1;MAFB;ARMCX1;PLBD1;PTER;BCL2;SEC24D;CBR4;ZNF43;ASS1;AUTS2;DLC1;KIF5C;UBE2L6;MPDZ;OAS3;LIN7C;OAS2;MYB;IFIT1;SMAD7;JAK2;GDAP1;INPP4B;IFIH1;HSPA4L;JMJD1C;HSPB8;IGF1R;ANXA9;BAZ2B;DDX58;OAS1;TRIM14;IRF9;MYLK;ATF3;ELOVL6;IFI44;TM4SF1;SP110;CALB2;SP100;HERC6;MOCOS
prerank,WikiPathway_2021_Human__DNA Replication WP466,0.5535710747443803,1.5705183844289226,0.010869565217391304,0.4794418346232398,1.0,18/42,23.30%,CDC6;CDC7;CDC45;MCM2;CDT1;MCM6;PRIM1;RFC4;ORC1;MCM10;POLD1;MCM3;MCM5;MCM4;GMNN;MCM7;POLA1;POLA2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5595727478842035,-1.5701789848616732,0.011235955056179775,0.12140867087173739,1.0,9/18,22.96%,LAX1;PTPN22;TIGIT;VTCN1;AKT1;TNFAIP8L2;ASS1;ADTRP;LAPTM5
prerank,Elsevier_Pathway_Collection__Celiac Disease,-0.4519471165114263,-1.569908098694348,0.0,0.1214414569892414,1.0,19/48,16.88%,IFNG;CD4;TLR3;IL15;MAP2K1;CTLA4;CD3E;CD3G;REL;CD247;TLR4;TLR2;LAT;MYD88;CXCR3;FCER1G;CD86;HP;ZAP70
prerank,TRRUST_Transcription_Factors_2019__REL mouse,-0.5566826046593738,-1.5697168172857143,0.021052631578947368,0.12127882888726861,1.0,7/21,11.02%,FOXP3;IFNG;TNF;IL1B;CCL5;CCL2;IL12B
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6678577345886711,1.5692440870880546,0.01282051282051282,0.4808945935663758,1.0,6/17,10.87%,LYPD1;LY6H;CHRNB2;CHRM4;CHRNA3;CHRM5
prerank,Elsevier_Pathway_Collection__Proteins Involved in Systemic Scleroderma,-0.4553389622506062,-1.5692090733541793,0.016129032258064516,0.12127003878082872,1.0,18/44,13.92%,IL10;CXCL10;IFNG;TNF;IL1B;MMP1;HGF;PTPN22;PDGFRA;CXCL12;CCL2;IL6;CD40LG;TBX21;CCR2;CXCL8;CCL22;CD226
prerank,Elsevier_Pathway_Collection__IL6/IL12 Signaling Activates Immune System in Multiple Sclerosis,-0.5669133583504888,-1.5685148493391936,0.03296703296703297,0.12155271896202463,1.0,6/18,11.02%,CXCL10;CXCL11;IFNG;CXCL9;IL6;IL12B
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.4936682211351804,-1.568036505305478,0.04285714285714286,0.12155713919172728,1.0,15/34,14.86%,TNFSF11;FGF10;IGLL5;IGLL1;SIRPB1;SIRPG;PRKCQ;CCL2;IL6;IL12B;CCR2;LCK;NCKAP1L;CLEC7A;SH3KBP1
prerank,Elsevier_Pathway_Collection__Single Strand Nucleotide Excision DNA Repair Suppression in Cancer,0.6494754499846181,1.5678684372605987,0.03821656050955414,0.4833802404110344,1.0,1/19,0.15%,HMGA2
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.6801996482643083,1.5674578056726143,0.024844720496894408,0.4820223820307915,1.0,4/15,12.23%,UCN2;PRKAA2;KCNB1;CD68
prerank,Elsevier_Pathway_Collection__NF-kB non-Canonical Signaling,-0.5046564653130708,-1.5670615539014454,0.031746031746031744,0.12204485626755618,1.0,11/28,16.76%,TNFSF11;TNFRSF17;TNF;TNFRSF13B;CXCL12;CD40LG;TNFRSF11A;REL;TNFSF13;TNFRSF13C;TNFSF13B
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,0.45733225453339277,1.566437359702669,0.0,0.4825564257149261,1.0,114/224,38.98%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;BIRC5;CCNB2;UBE2C;SPC24;BUB1;TUBA4B;PSMD4;CENPI;CENPM;AURKB;KIF18A;NDC80;TUBB8;UBE2S;CDCA5;PTTG1;CDK1;TUBB8B;CDCA8;SPC25;TUBA4A;CCNB1;KNTC1;TUBA3E;CENPU;LMNA;ERCC6L;PSMB4;CENPL;SGO2;ZWINT;TUBA8;TUBB2B;LBR;CENPK;SPDL1;SGO1;TUBA3D;NUP37;DSN1;ANAPC11;B9D2;PPP2R5A;AHCTF1;RPS27;NUP62;CENPP;NUP133;DYNLL1;EMD;RANGAP1;ANAPC7;PSMB3;LMNB1;ITGB3BP;PSMD14;INCENP;UBA52;MAD2L1;TUBB2A;PSMB5;NUP155;CENPH;VPS4A;PSMD2;NUP160;PSMA1;SMC3;UBE2I;PSMD10;CHMP2A;PSMC4;PSMC3;TUBA1A;TUBA1B;NUP188;DYNC1H1;HDAC8;CENPT;CENPQ;BANF1;PSMC5;SMC1A;ESPL1;PPP2R1A;SEM1;PSMB6;CDC23;KIF2A;PSMD8;NDE1;NUP205;TUBB6;STAG2;PSME2;TUBB4B;PMEPA1;XPO1;PSMD13;PSMB7;PSMA7;LEMD2;RAN;ANAPC1
prerank,Elsevier_Pathway_Collection__Dendritic Cells Function in Psoriasis,-0.466821851485162,-1.5658667284889491,0.05063291139240506,0.12266792844374015,1.0,14/39,14.75%,TNF;IL1B;IL27;S100A8;TNFSF10;TNFSF15;IL6;TLR8;IL12B;TLR4;AKT1;CAMP;VCAM1;MYD88
prerank,WikiPathway_2021_Human__Tryptophan catabolism leading to NAD+ production WP4210,-0.55810277974865,-1.5658205362020698,0.047619047619047616,0.12240849599166935,1.0,7/16,14.28%,NMRK2;AADAT;TDO2;HAAO;KYNU;KMO;NMRK1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.5606984381815849,1.565777843024206,0.023121387283236993,0.4820524946280614,1.0,6/38,3.62%,TLCD3B;ST8SIA3;B4GALNT1;CERS1;ALOX12B;SPTSSB
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.49633932035277073,-1.565243302217231,0.03125,0.12246561188408599,1.0,13/26,12.30%,MT1G;MT1HL1;MT1F;MT1H;MT1M;MT1E;SLC39A5;MT1X;SLC39A12;MT1A;SLC39A14;LCK;MT1B
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.6562226406086974,1.5652127624478849,0.01910828025477707,0.48125848519908676,1.0,5/18,3.45%,MAFA;PTPRN2;PTPRN;NEUROD1;GAL
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,0.5845534476085049,1.5645077609857212,0.034482758620689655,0.48153273504683286,1.0,17/31,26.45%,CDC45;MCM6;PRIM1;RFC4;POLD1;MCM3;MCM5;MCM4;DNA2;FEN1;POLR1A;MCM7;POLA1;POLA2;GINS4;GINS1;GINS2
prerank,Elsevier_Pathway_Collection__Macrophage M1 Lineage,-0.4538870098623816,-1.5624626981837033,0.016129032258064516,0.12445053681104257,1.0,16/51,15.75%,CXCL10;IFNG;CD4;TNF;IL1B;CCL5;CXCL9;IL15;MAP2K1;IL6;IL12B;TICAM2;MYD88;CSF2;CD86;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.4336469647409139,-1.5605532747415305,0.028169014084507043,0.1258937994658847,1.0,20/61,22.37%,EREG;GBP5;ACOD1;CCL5;TKFC;PTPN22;FPR2;CD1D;TLR8;SH2D1B;FCGR2B;FGR;USP18;NLRC3;SLC15A4;ADAM8;IFI16;NMI;RIOK3;DHX58
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.638880964368205,1.5603185468329859,0.023809523809523808,0.4947918439930487,1.0,2/19,6.66%,SH3GL3;SRC
prerank,WikiPathway_2021_Human__Metapathway biotransformation Phase I and II WP702,-0.36438844101547335,-1.5601708313371403,0.0,0.12592843199142978,1.0,49/165,14.14%,CYP26A1;GSTA2;CYP2C19;UGT2A1;AKR1D1;CHST4;UGT1A5;CYP2A7;NAT2;NDST3;CYP2A13;CYP2B6;GLYATL2;GSTZ1;HS6ST3;FMO1;CYP39A1;CYP2C8;HS3ST3A1;GLYAT;GSTA1;SULT1A2;CYP4F2;UGT1A9;UGT2B7;CYP3A7;GLYATL1;CYP1A2;CYP3A43;GSTT2B;HS3ST6;CYP2C18;CYP8B1;CYP2C9;AKR1C4;GSTM5;SULT1C2;UGT2B28;CYP4F12;AKR7A3;CYP4X1;CYP26B1;CYP4F3;SULT1C4;CYP3A4;CYP4V2;INMT;UGT2A3;EPHX2
prerank,Reactome_2022__Glucuronidation R-HSA-156588,-0.5432253355554315,-1.5597000342625598,0.012987012987012988,0.1260986473134521,1.0,11/22,17.38%,UGT2A1;UGT1A5;UGT1A9;UGT2B7;UGP2;UGT2B28;UGT2B10;SLC35D1;UGT2A3;UGT2B15;UGT1A7
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.42262367017419644,-1.5596130061580054,0.0,0.12587531477404212,1.0,19/56,16.73%,ERBB4;IFNL1;IFNG;GHR;TNF;CCL5;IL18;IL15;CTF1;IL6;OSM;IL12B;FLT3;HCLS1;TSLP;IGF1;CSF2;CSF1R;PTK6
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.429134266682229,-1.5591775438382578,0.0,0.12590974148540698,1.0,36/66,27.54%,IRF4;IFNG;OASL;NCAM1;IFI30;CAMK2B;HLA-DQA2;TRIM34;IRF8;TRIM22;HCK;GBP1;VCAM1;MT2A;HLA-DQA1;TRIM5;PTAFR;HLA-DQB2;OAS3;OAS2;HLA-DRB5;HLA-DRA;JAK2;STAT1;TRIM31;IRF2;HLA-DPA1;OAS1;TRIM21;HLA-DPB1;IRF9;HLA-DRB1;IFNGR1;SP100;IRF1;HLA-DQB1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.5389074593422585,1.5590239239848152,0.015873015873015872,0.49682819860660454,1.0,12/42,15.88%,NKD1;DKK1;DKK4;LEF1;AXIN2;TCF7;HDAC11;JAG2;KAT2A;DVL2;WNT6;HDAC5
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.5669449128751296,-1.5589903111428547,0.0625,0.12568793676067694,1.0,6/17,11.37%,SLC45A3;NR4A3;APOA4;APOA1;PPARGC1A;APOA5
prerank,Elsevier_Pathway_Collection__T-Cell Independent B-Cell Activation,-0.4382086868783453,-1.5587909659730275,0.01639344262295082,0.12562853386195383,1.0,26/54,23.77%,CR2;TNFRSF17;FOS;CD79A;MAP2K1;TNFRSF13B;PRKCB;FCGR2B;BTK;CARD11;TICAM2;TLR4;AKT1;TNFSF13;SYK;PLCG2;VAV1;TNFRSF13C;TNFSF13B;INPP5D;CD19;NFATC2;JUN;PIK3AP1;CD81;C3
prerank,Reactome_2022__FRS-mediated FGFR3 Signaling R-HSA-5654706,0.661182073336268,1.5587315685075547,0.05063291139240506,0.49512028436794114,1.0,6/15,20.14%,FGF20;FGF13;FGF17;FGF23;HRAS;FGF18
prerank,Elsevier_Pathway_Collection__CD46/CD55/CD59 Inhibit Complement Mediated Lysis of Cancer Cells,-0.596591610450578,-1.558357623679891,0.01098901098901099,0.12570354188618194,1.0,10/15,24.41%,C9;C7;C6;C1R;C8A;C1S;C5;CD55;C3;C4B
prerank,MSigDB_Oncogenic_Signatures__ATM DN.V1 DN,-0.36354018161071455,-1.557824712188099,0.0,0.125885237146564,1.0,27/119,10.76%,CEACAM6;HHLA2;GRM8;SRD5A2;FCN2;PRSS21;CHIA;PLSCR2;KCNE1;CD69;MAG;KIR3DL2;CXCL3;CYP1A2;NTRK2;ANGPT4;GPR65;EPHA1;LILRA2;PPARGC1A;RASSF9;ZFP36L1;WNT2;TFEC;STK17B;CLEC4E;CYBB
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.5857063672085635,1.5572135811711971,0.05952380952380952,0.49766875223468576,1.0,9/28,14.21%,TBX4;DKK1;RSPO2;LRP4;ZNRF3;KREMEN2;COMP;KREMEN1;KAT2A
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.6086660552898984,1.5566311452187083,0.025157232704402517,0.4971954300651835,1.0,3/20,1.28%,PAX2;SIX1;EPHB2
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.6481381985091843,1.5564914661720177,0.04790419161676647,0.494812428900812,1.0,9/18,22.72%,BANF2;H1-5;H1-2;NAA10;H1-4;CHAF1B;CHAF1A;H1-0;AIFM1
prerank,Elsevier_Pathway_Collection__Mucin Hyperproduction in Goblet and Mucous Cells,-0.4372477436187815,-1.5562619181173045,0.015625,0.12716066879134594,1.0,13/52,15.75%,IL13RA2;MUC5AC;MUC5B;TNF;IL1B;IL1RAP;MAP2K1;TGFA;TICAM2;TLR4;TLR2;MYD88;TNFRSF1B
prerank,Elsevier_Pathway_Collection__Majeed Syndrome,-0.5022703389165811,-1.5560696122086273,0.02666666666666667,0.12705838083695858,1.0,14/29,21.42%,TNF;IL1B;FOS;CASP1;NLRP3;CCL2;IL6;TICAM2;TLR4;TLR2;MYD88;MGLL;MAP2K3;JUN
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.5641391312330657,-1.5559010958643553,0.03333333333333333,0.12693000658851805,1.0,7/20,9.64%,IL1B;IL18R1;IL18;XCL1;RSAD2;NLRP3;IL6
prerank,TRRUST_Transcription_Factors_2019__CREB1 mouse,-0.4919103835115737,-1.5557160798062684,0.024390243902439025,0.1267889851828606,1.0,13/28,18.51%,IL10;PTGS2;NOCT;FOS;ESR1;PPARGC1A;NFKBIZ;MITF;PRKCE;CLDN11;CFTR;BCL2;TWIST1
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,0.46528657699416104,1.5554651695631967,0.0045662100456621,0.4958119551650908,1.0,76/165,36.11%,DYNC1I1;CENPF;CENPA;SKA1;KIF2C;PLK1;BUB1B;CENPE;NUF2;CDC20;BIRC5;UBE2C;SPC24;BUB1;PSMD4;CENPI;CENPM;AURKB;KIF18A;NDC80;UBE2S;CDCA5;PTTG1;CDCA8;SPC25;KNTC1;CENPU;ERCC6L;PSMB4;CENPL;SGO2;ZWINT;CENPK;SPDL1;SGO1;NUP37;DSN1;ANAPC11;B9D2;PPP2R5A;AHCTF1;RPS27;CENPP;NUP133;DYNLL1;RANGAP1;ANAPC7;PSMB3;ITGB3BP;PSMD14;INCENP;UBA52;MAD2L1;PSMB5;CENPH;PSMD2;NUP160;PSMA1;SMC3;PSMD10;PSMC4;PSMC3;DYNC1H1;HDAC8;CENPT;CENPQ;PSMC5;SMC1A;ESPL1;PPP2R1A;SEM1;PSMB6;CDC23;KIF2A;PSMD8;NDE1
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",-0.48862033925206455,-1.5545850598522089,0.017241379310344827,0.1274552239158542,1.0,26/39,27.35%,BHMT;GNMT;PHGDH;GLDC;PIPOX;SARDH;CBS;DAO;DMGDH;GCSH;GATM;SHMT1;AGXT2;PSAT1;AGXT;GCAT;CTH;AOC3;PGAM1;CBSL;ALAS1;MAOB;ALDH7A1;GRHPR;SHMT2;GLYCTK
prerank,MSigDB_Oncogenic_Signatures__STK33 NOMO DN,-0.34451668453017137,-1.5538528655721067,0.0,0.12785449230188697,1.0,73/235,17.44%,CEACAM6;HHLA2;BSPRY;TEX15;CR2;PROK2;RET;PCYT1B;ART3;PRSS21;PRG4;KLF5;SLAIN1;CHRDL1;SOCS2;IGLL1;HK3;IL18R1;APOBEC3C;LRRK2;FPR2;BTLA;IL18RAP;BDH2;FCGR3B;PRAM1;FBN2;SYDE2;STX11;GPM6A;USP44;PNMA2;CCR7;DSG2;ANXA3;LAMP3;GCH1;PTGER2;CDA;KAZN;CR1;CLEC5A;BTBD11;ALOX5;ST14;GJB2;JDP2;DDAH1;SLC39A14;LCK;RORB;FLT3;SLC16A4;CYP4F3;SLC8A1;SLC16A14;GALNT12;RASGRP1;BTN3A3;GZMA;SEMA3C;TSPAN2;SLC26A8;FAHD2A;SLC9B2;MAP3K15;BMX;BCL2;TET1;MATN2;TPD52L1;ACAP1;UCA1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Cystic Fibrosis,-0.41694647469543444,-1.552886697079969,0.015873015873015872,0.12858090590674223,1.0,22/57,17.12%,MUC1;MUC5AC;PTGS2;MUC5B;IFNG;TNF;IL1B;HGF;CXCR2;SFTPA1;S100A8;MBL2;CXCL8;TLR4;TLR2;SFTPD;CAMP;GUCA2A;KNG1;CFTR;PRNP;HMOX1
prerank,Elsevier_Pathway_Collection__OPRK -> Pain Perception,0.6383006583181843,1.5528302936438871,0.0440251572327044,0.503269742422349,1.0,5/18,7.35%,SLC6A4;KCNJ6;RASGRF1;SRC;SLC6A3
prerank,Elsevier_Pathway_Collection__TLR2 Induced Synovial Fibroblast Activation in Rheumatoid Arthritis,-0.48449613619565046,-1.5523042325143228,0.039473684210526314,0.12879184838467755,1.0,13/33,14.75%,CXCL10;TNF;IL1B;MMP1;CCL5;FOS;CXCL2;IL6;CXCL8;TICAM2;TLR4;TLR2;MYD88
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.3770219430746874,-1.5523020971705324,0.0,0.1284909328510685,1.0,9/100,6.96%,KLK3;KLK2;PCSK2;TMPRSS4;CD5L;ADAMTS13;F9;CASP1;KLKB1
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.6022199464124881,1.5519096900239198,0.03529411764705882,0.5038577996947999,1.0,15/26,16.39%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.562734276212406,-1.5515969019124212,0.011363636363636364,0.12872723915207848,1.0,7/17,16.80%,CETP;LCAT;APOA4;APOA1;LIPG;CLU;LIPC
prerank,WikiPathway_2021_Human__Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.49825677443427935,1.550942209771687,0.009950248756218905,0.5049031553968867,1.0,12/68,6.48%,CTNNA2;CACNB4;CACNG1;LEF1;ACTN2;CACNG4;CACNA1S;CACNG5;ITGA2;CACNA2D2;ITGA6;TCF7
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,0.6011976591910418,1.5505210834066756,0.046511627906976744,0.5040555795538731,1.0,16/26,29.80%,E2F1;TOP2A;CCNE1;CDC6;CCNA2;CCNE2;CDK1;MYBL2;CDC25A;E2F5;HDAC1;LIN37;LIN9;MYC;RBL1;PCNA
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",0.6675093225722184,1.5501542805572175,0.045454545454545456,0.502593279392972,1.0,6/16,15.40%,GPR119;GCG;PCSK1;LEP;CDX2;DPP4
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,0.4820277208085669,1.549048713579623,0.009852216748768473,0.5042856289456283,1.0,40/99,31.85%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;UBE2C;H2BC21;PSMD4;H2BC9;H2BC15;CDC6;UBE2S;H2BC11;CDT1;H2BC12;MCM6;H2BC4;H4C15;H2AC6;PSMB4;H2BC5;H2AX;MCM3;MCM5;MCM4;ANAPC11;GMNN;MCM7;H2AJ;ANAPC7;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;H2AZ1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.558636083164543,1.548510114243863,0.023809523809523808,0.5032007211858355,1.0,5/34,5.89%,TBX4;OSR2;OSR1;MYH3;TBX3
prerank,TRRUST_Transcription_Factors_2019__SPI1 mouse,-0.48620192874314533,-1.5478352475711417,0.039473684210526314,0.13192215470730095,1.0,16/32,18.36%,IGHM;TNF;IL1B;CCL5;IL7R;PTPRO;PTPRC;FLT3;TLR4;IRF8;FCER1G;BCL2L11;CSF1R;ITGB3;NCF1;AIF1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.5989763851152252,1.5472700816755853,0.031446540880503145,0.5047455497434359,1.0,4/24,4.98%,MT3;MRAP2;COX4I2;ACSM1
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,-0.49281820738916193,-1.5468554872134523,0.0,0.1324485899492227,1.0,10/29,17.95%,NMRK2;PTGS2;PARP6;BST1;CD38;CYP8B1;PARP8;NMRK1;NUDT12;PTGIS
prerank,Elsevier_Pathway_Collection__NFKB Canonical Signaling Activation in Cancer,-0.41967662745142204,-1.545712336018633,0.02,0.1332191699909336,1.0,22/70,16.76%,TNFSF11;TNFRSF17;TNF;CD79A;TLR3;IL1RAP;TNFRSF13B;NFKBIZ;PRKCB;TLR8;CD40LG;TNFRSF11A;CARD11;REL;TLR4;TLR2;TNFSF13;SYK;PLCG2;MYD88;TNFSF8;TNFSF13B
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.6570345003268314,1.5451927540697978,0.026845637583892617,0.5105310872776297,1.0,8/15,25.47%,PAX2;GCM1;METRN;CDK6;NDUFS2;TGFB2;METTL3;RELN
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.5049112950602561,-1.5450554543745052,0.060240963855421686,0.13336468544127014,1.0,15/32,20.35%,SLC27A6;HACD1;ABCD2;ACSL1;CYP4F2;ELOVL2;ELOVL7;CYP4F12;ACAA1;ACOX1;ABCD4;HACD4;SLC27A5;ACOX2;ACOT2
prerank,Reactome_2022__Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,-0.571952344295132,-1.544697415626774,0.02666666666666667,0.13341910295866194,1.0,2/15,4.43%,CHAC1;ATF5
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.6570859191703186,1.5444153163195322,0.03289473684210526,0.5106991391913728,1.0,5/16,8.61%,PAX2;SIX1;BMP4;FGF2;NPNT
prerank,"Reactome_2022__Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",0.6356381453876823,1.5437771347403562,0.0440251572327044,0.5102610974663627,1.0,6/18,15.40%,GPR119;GCG;PCSK1;LEP;CDX2;DPP4
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.4961375582485605,1.5432718754241779,0.014423076923076924,0.5097038161365993,1.0,21/76,15.92%,IGF2;THBS4;SCG2;APLN;VEGFD;CDH13;CCL26;MDK;EGFL7;BMP4;JCAD;FGF2;PRKD1;PPP1R16B;PDGFB;PGF;CCL24;CCL11;PDPK1;PRKCA;HTR2B
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.5416641093002028,1.5427745273953117,0.011111111111111112,0.509046730665166,1.0,13/55,11.47%,SFN;E2F1;E2F7;CDC25C;ARID3A;GTSE1;PRAP1;E2F8;ZNF385A;CDK1;CCNB1;RGCC;AURKA
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.3921395475363538,-1.5415656123780832,0.0,0.13614118906659683,1.0,43/96,21.35%,TNFSF11;CCR9;RCAN1;P2RY12;CXCR1;CXCR2;LRRK2;FPR2;CCR5;XCR1;CCL3;CXCR6;DEFB1;CCR7;ACKR4;MCTP2;PTPRC;NMUR1;CCR1;CCR2;BTK;CXCL8;SLC8A1;LAT;SELE;CCR4;EDNRB;VCAM1;LAT2;PLCG2;CXCR3;CXCR4;PRNP;TPCN2;RCAN2;KSR2;CHRM3;EIF2AK3;PPP3CA;AGTR1;ANK2;CX3CR1;SELP
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.49220852527408554,1.5405121745259005,0.010256410256410256,0.5140668182331762,1.0,22/75,18.22%,H3C13;H1-5;H2BC13;H2BC18;H3C1;H2AW;H1-2;H2BC17;H2BU1;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H1-4;CHAF1B;H4-16;H2BC5;H2AX;HMGA1;VPS72;CHAF1A
prerank,TRRUST_Transcription_Factors_2019__IRF1 human,-0.4230613615556946,-1.5400916383998844,0.0,0.13715340901818882,1.0,17/48,17.08%,FOXP3;IL10;CXCL10;IFNG;CCL5;SOCS2;FASLG;IL27;TNFSF10;CYBB;IL12B;TRIM22;VCAM1;PIGR;CASP7;IFIT3;BCL2
prerank,WikiPathway_2021_Human__DNA IR-damage and cellular response via ATR WP4016,0.4994030856439691,1.5400000886406866,0.024752475247524754,0.5135682979611583,1.0,42/79,35.44%,E2F1;CDC25C;FOXM1;PLK1;EXO1;CDC45;IKBKG;CDK1;MCM2;FANCI;POLN;CHEK1;MSH2;BCL6;BARD1;RMI1;FEN1;CLSPN;ATRIP;PARP1;RAD51;TRIM28;PRKDC;FANCD2;CHEK2;CLK2;EEF1E1;MDC1;RECQL5;POLB;PCNA;ABRAXAS1;TP53BP1;RAD1;BRIP1;UIMC1;RFWD3;SMARCAL1;TOPBP1;BRCA2;SMC1A;SEM1
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.5436392979478407,-1.539944102801058,0.0273972602739726,0.13690370437512223,1.0,9/17,8.78%,MT1G;MT1HL1;MT1F;MT1H;AOC1;MT1M;MT1E;MT1X;MT1A
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.5086736964023557,-1.5398558840235494,0.02531645569620253,0.13662953949755083,1.0,16/27,18.88%,FOXP3;LGALS9B;INHBA;XCL1;AXL;CR1;LILRB1;CD274;PDCD1LG2;TLR4;HAVCR2;LILRB4;LGALS9;PRNP;LGALS9C;NR1H4
prerank,Elsevier_Pathway_Collection__NF-kB Canonical Signaling,-0.44533879971929835,-1.5393834497736973,0.0,0.13675252656928086,1.0,17/50,14.75%,TNFSF11;TNFRSF17;TNF;TLR3;IL1RAP;TNFRSF13B;PRKCB;CD40LG;TNFRSF11A;CARD11;REL;TLR4;TLR2;TNFSF13;SYK;PLCG2;MYD88
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.4396811578163039,1.5387711597834226,0.004310344827586207,0.515933242711933,1.0,143/186,47.36%,BOP1;EXOSC4;UTP14A;RPL8;DCAF13;UTP25;MRPL13;NHP2;RPP21;HEATR1;RPL30;RPLP1;BYSL;RPS27;RPS21;LAS1L;RPLP2;WDR46;NOP58;RPS5;PDCD11;RRP9;DNAJC5;EXOSC5;RPL28;RPS14;RPSA;RPL26L1;NOP2;RPL39;UBA52;TRMT112;NOC4L;NOP56;RPLP0;PELP1;FBL;RPS15;DKC1;RPS2;RPL31;RPS19;RPL36;RPL37A;PES1;RPL37;RPP25;RPL7;CSNK1D;RPS4X;RPS20;RPL27;RRP7A;RBM28;RPL38;RPL35;RPP40;SNU13;UTP15;RPL10A;NOP10;ISG20L2;DDX49;RPS8;RPS12;RPL22L1;RPL35A;NOL9;RPS3A;RPS7;TSR3;EXOSC2;RPS11;RPL36A;WDR12;TBL3;DHX37;BUD23;WDR75;RPL7A;FAU;FTSJ3;RPS3;RPL18A;RPL32;UTP4;RPS24;RRP36;IMP4;RPL3L;UTP18;DDX56;PWP2;PNO1;RPL29;RPL23;RIOK2;RPL5;EXOSC1;CSNK1E;RPL14;EXOSC7;EXOSC10;RPS16;EXOSC9;RPL13A;RPL41;RPL9;NAT10;NOL6;RPP38;RPS28;EBNA1BP2;RPS23;RPL27A;RPL23A;RPL18;RPL12;GNL3;RPS9;NOL12;TSR1;RPL6;EMG1;RIOK1;RPS15A;RPL4;MTREX;RPL19;UTP20;DIMT1;RPL39L;RPS6;RPL26;RPS27A;NOB1;RPS4Y1;RPL34;TEX10;RPS13;MPHOSPH10;UTP6;BMS1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.647810306840976,1.5385257142679971,0.02857142857142857,0.5144133977715023,1.0,3/16,5.17%,HMGA2;TERT;FOXM1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.5311249925312801,1.538459872910982,0.02631578947368421,0.5120513500103938,1.0,18/46,18.22%,H3C13;H2BC13;H2BC18;H3C1;H2BC17;H2BU1;H2BC21;H2BC9;H2BC15;H2BC11;IPO4;H2BC12;CHAF1B;H4-16;H2BC5;H2AX;ASF1B;CHAF1A
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.5603590366968254,1.5376187951660671,0.0449438202247191,0.5131256837508118,1.0,16/38,23.30%,CDC6;CDC7;CDC45;MCM2;CDT1;MCM6;PRIM1;ORC1;MCM10;MCM3;MCM5;MCM4;GMNN;MCM7;POLA1;POLA2
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.5536779479920437,1.5371273076999161,0.03867403314917127,0.5123386263514904,1.0,4/36,2.57%,IGF2BP1;E2F1;RBM24;AXIN2
prerank,WikiPathway_2021_Human__Nephrogenesis WP5052,0.672657236006416,1.5367220076521604,0.024691358024691357,0.5113735181775927,1.0,6/15,3.64%,PAX2;FGF20;OSR1;WNT4;SIX2;WNT9B
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,0.49255184236471006,1.536634429464493,0.009852216748768473,0.5092747275737517,1.0,19/83,12.73%,DYNC1I1;H3C13;H2AC19;H2BC13;H2BC18;H2AC11;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;EZH2;H2BC11;PCSK1;RNASE1;H2BC12;H2BC4;H4C15;H2AC6
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.5239917414945506,-1.536520470915076,0.025,0.1389646485723608,1.0,8/23,17.08%,EREG;FOS;KCNH8;TGFA;BTC;AKT1;HBEGF;BCL2
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.45723249506277086,-1.5358040993990911,0.0273972602739726,0.13938689827622816,1.0,22/34,26.31%,IL10;MZB1;CD244;PTPN22;FFAR2;XCL1;SCIMP;PTPRC;IL6;SASH3;SLC7A5;SPHK2;CD86;WNT5A;NOD2;INAVA;XBP1;LAPTM5;F2RL1;TRIM6;PHB2;DNAJB9
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.5356343127707673,-1.5356940146292561,0.06578947368421052,0.13916033396337996,1.0,3/20,4.06%,AP1M2;CD4;CD8B
prerank,Elsevier_Pathway_Collection__Dectin-1 (CLEC7A) Signaling,-0.5089188152596507,-1.535430131811014,0.0,0.1390866614803763,1.0,10/26,14.55%,IL10;IL1B;CASP1;NLRP3;IL12B;REL;CCL22;CLEC7A;SYK;PLCG2
prerank,Elsevier_Pathway_Collection__OPRD/OPRM -> Ion Channels,0.640790249464255,1.5353526036285243,0.04819277108433735,0.5118472367044999,1.0,4/16,5.95%,CACNA1E;KCNJ6;KCNJ9;KCNJ5
prerank,Reactome_2022__Aflatoxin Activation And Detoxification R-HSA-5423646,-0.5173963082338668,-1.5347014514483255,0.013157894736842105,0.13941739263916045,1.0,7/19,12.95%,GGT6;CYP2A13;CYP1A2;DPEP3;DPEP2;AKR7A3;CYP3A4
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.6439561328788158,1.5345190275772411,0.03428571428571429,0.5122970487265903,1.0,5/16,9.48%,PAEP;NODAL;WEE2;TIMP1;ZP3
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.6106538113030215,1.5342362568769272,0.06097560975609756,0.5108704451188428,1.0,3/18,5.89%,TBX4;MYH3;TBX3
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.4685802489476327,1.5339106732043357,0.018433179723502304,0.509737900180767,1.0,35/114,17.88%,CHRND;LMOD1;SMPX;TNNC1;ACTN2;CACNA1S;TNNI3;MYH3;MYH4;TNNT1;SCN4A;MYH8;CHRNB2;KLHL41;TNNI2;GJC1;MYH13;GALR2;SLC6A8;OXTR;TNNT3;MYBPC1;CLCN1;ARHGEF11;BDKRB2;MYOM3;TMOD4;TPM2;MYLPF;ROCK2;CACNA1H;MYLK2;TRIM72;MYOM1;NEB
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.48957226869597675,-1.5337957343226134,0.013333333333333334,0.1398348294376744,1.0,13/31,17.58%,TNFSF11;IFNG;TNF;TLR3;CAMK4;CCL3;CCR1;IL12B;TLR4;UBASH3B;MAFB;LILRB4;LILRB3
prerank,WikiPathway_2021_Human__Glucuronidation WP698,-0.5240401796235327,-1.533395111109423,0.013333333333333334,0.1399235582326298,1.0,13/23,19.23%,UGT2A1;UGT1A5;UGT1A9;UGT2B7;UGP2;UGT2B28;UGT2B10;PGM3;UGT2A3;UGT2B15;UGT1A7;PGM2;PGM1
prerank,KEGG_2021_Human__GnRH secretion,0.5117148912109197,1.533349136158325,0.015789473684210527,0.5092069152750811,1.0,20/63,16.72%,CACNA1I;KCNJ6;HCN2;CGA;CACNA1S;SPP1;PIK3R2;KISS1;KCNJ9;KCNJ5;CACNA1G;KISS1R;KCNN3;HCN3;CACNA1C;LHB;KCNJ11;PRKCA;HRAS;CACNA1H
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,0.4941958420528618,1.5325133601531473,0.015228426395939087,0.5096280935713018,1.0,20/77,15.12%,H3C13;H2AC19;H2BC13;H2BC18;H2AC11;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;TARBP1;VPS28;H2BC11;PCSK1;H2BC12;H2BC4;H4C15;H2AC6;MVB12B;H2BC5
prerank,WikiPathway_2021_Human__Vitamin A and carotenoid metabolism WP716,-0.44478942804123206,-1.5323425544801343,0.015384615384615385,0.14057630237969465,1.0,13/38,16.33%,CYP26A1;AWAT2;LRAT;ADH4;BCO2;ADH1A;BCO1;CYP26B1;ABCG8;ABCG5;RARB;CRABP2;ALDH1A2
prerank,Elsevier_Pathway_Collection__TNFR -> AP-1/ATF/TP53 Signaling,-0.4801025611851659,-1.532308603765569,0.015384615384615385,0.14026251599045428,1.0,18/39,23.65%,TNF;FOS;FASLG;TNFSF10;MAP2K1;TNFRSF13B;CD40LG;TNFSF13;LTA;TNFRSF1B;TNFSF13B;MAPK10;MAP2K3;MAP2K6;JUN;CD40;MAP3K5;MAP2K4
prerank,Elsevier_Pathway_Collection__Chromosome Condensation,0.6249662524838694,1.5320183440527655,0.046242774566473986,0.5090376835814501,1.0,12/15,31.70%,PLK1;NCAPH;NCAPG;AURKB;CDK1;AURKA;PARP1;NCAPD2;NCAPH2;SMC4;SMC2;NCAPG2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.6081903781191831,1.5312420754051872,0.02824858757062147,0.5097144592780681,1.0,12/22,26.35%,STOX1;CDC25C;DTL;CDC7;CDK1;CCNB1;CDC25A;DYRK3;ATAD5;DBF4B;NPM1;MECP2
prerank,Elsevier_Pathway_Collection__T-Cell Genetic Rearrangements in Acute Lymphoblastic Leukemia,0.6643409435924157,1.5311039783615847,0.039735099337748346,0.5077447898835761,1.0,4/16,3.88%,TLX1;TAL2;TLX3;HOXA10
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5430110377025396,1.5310248076767698,0.040697674418604654,0.5055853244584645,1.0,6/31,5.96%,PAX2;PTPRN2;PTPRN;PRKAA2;CYP7A1;KCNB1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.5146645669773927,1.53082840473951,0.010416666666666666,0.5037809380630373,1.0,14/64,11.47%,SFN;E2F1;E2F7;CDC25C;ARID3A;GTSE1;PRAP1;E2F8;ZNF385A;CDK1;CCNB1;FBXO31;RGCC;AURKA
prerank,WikiPathway_2021_Human__Vitamin B12 metabolism WP1533,-0.44206938697846604,-1.5308245365256086,0.0,0.14138608954048917,1.0,15/47,11.90%,TCN1;IFNG;TNF;IL1B;CCL5;HBA1;APOA1;HBB;ALB;CCL2;CBS;IL6;SAA4;MAT1A;PLG
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,-0.5161867447709756,-1.530593840080154,0.041666666666666664,0.14142074687037545,1.0,12/27,20.35%,HACD1;ELOVL2;SCD5;ELOVL7;SCP2;ACAA1;ACOX1;HSD17B12;HACD4;ACOX3;FADS2;ACOT2
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.4767744482527289,1.5304753662413744,0.01015228426395939,0.5026441422479421,1.0,42/92,37.24%,H3C13;H2AC19;H2BC13;H2BC18;H2AC11;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;KAT2A;H2BC5;USP22;VPS72;ING5;JADE2;BRD8;TAF10;JADE3;HCFC1;MRGBP;WDR5;YEATS2;EP400;SAP130;BRPF3;GDNF;RBBP7;ATXN7L3;OGT;RUVBL2;NCOA2;RUVBL1;HAT1;SGF29;DMAP1;TAF9
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.41482432186424906,-1.5301320008672754,0.0,0.1414925442741843,1.0,28/67,16.09%,CXCL13;CXCL10;CXCL11;CCL5;CXCR1;CXCR2;CXCL3;CXCL9;S100A8;CCL4;CCL3;XCL1;LGALS3;CCL23;PIK3CD;CXCL2;CCL2;XCL2;CXCL8;NCKAP1L;CCL22;SYK;PF4V1;S100A12;CD300H;FCER1G;ITGB2;CXCL1
prerank,Elsevier_Pathway_Collection__Sister Chromatid Cohesion,0.6478864573210118,1.5300119748636887,0.052941176470588235,0.5018180688915718,1.0,7/18,11.47%,KIF2C;PLK1;CDC20;BUB1;AURKB;PTTG1;AURKA
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.4823150550577436,1.529730170508067,0.01485148514851485,0.5004334367787582,1.0,19/68,17.65%,SEPTIN3;SEPTIN5;KIF20A;CENPA;NOX5;PLK1;KIF4A;ANLN;AURKB;KIF23;CEP55;RACGAP1;SPIRE2;STMN1;ROPN1B;ECT2;ROCK2;RHOC;JTB
prerank,Elsevier_Pathway_Collection__Male Sex Determination,0.5733797449723864,1.5296307408809278,0.029585798816568046,0.4985605519662213,1.0,10/26,7.48%,SIX1;CYP17A1;SIX4;STRA8;NODAL;WNT4;LHX9;NR5A1;PTGDS;AMH
prerank,Elsevier_Pathway_Collection__Desmosome Assembly,-0.5353234755153906,-1.5294164793258367,0.021739130434782608,0.14165085025584653,1.0,4/17,8.14%,PKP3;EVPL;CDH1;DSG2
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.5076513868688787,1.52918040112151,0.025380710659898477,0.49799819196925543,1.0,29/58,33.51%,HMGA2;PLK1;TICRR;DTL;EME1;CDK1;FBXO31;CHEK1;CLSPN;RAD9B;TAOK2;DONSON;PRKDC;FANCD2;BLM;TIPIN;BRSK1;CHEK2;CDKN1A;STK33;SDE2;MDC1;MRNIP;ABRAXAS1;BABAM2;UIMC1;RFWD3;TOPBP1;MUS81
prerank,KEGG_2021_Human__Leishmaniasis,-0.41634926565085717,-1.5288994577346344,0.0,0.14198172650689359,1.0,37/72,24.54%,IL10;PTGS2;IFNG;TNF;IL1B;FOS;FCGR3B;PRKCB;FCGR3A;CR1;CYBB;IL12B;HLA-DQA2;TLR4;TLR2;HLA-DOB;CR1L;MYD88;ITGB2;HLA-DQA1;ITGA4;NCF1;NCF2;MAPK13;HLA-DOA;TAB2;HLA-DRB5;CYBA;JUN;HLA-DRA;JAK2;ITGAM;STAT1;HLA-DPA1;C3;HLA-DPB1;HLA-DRB1
prerank,TRRUST_Transcription_Factors_2019__BCL3 mouse,-0.5948360397862096,-1.5284455491406688,0.06315789473684211,0.1421259085013407,1.0,3/15,3.50%,CXCL10;IFNG;TNF
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.472641131380512,1.5279242470424794,0.019704433497536946,0.5002332033554656,1.0,74/90,47.14%,RPL8;MRPL13;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPSA;RPL26L1;PABPC1;RPL39;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;GSPT2;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;UPF1;RPS15A;RPL4;RPL19;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13;ETF1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6037065266463728,1.5271647787045033,0.029239766081871343,0.5005022513399302,1.0,4/23,4.06%,GLP1R;GHRHR;GAL;CAP2
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.46687946446066186,-1.526277570493436,0.0,0.14377273697483076,1.0,15/37,18.85%,AWAT2;GGT6;HPGD;HMGCLL1;BDH2;SCD5;ALOX5AP;ALOX5;HMGCS2;GCDH;HMGCL;ACAT1;CBR4;GGT2;SLC27A5
prerank,Elsevier_Pathway_Collection__Proteins Involved in Dental Caries,-0.5220624610576594,-1.5262202831710854,0.05952380952380952,0.1435189206218116,1.0,12/24,15.60%,MUC1;TRAV4;MUC5B;CD4;TNF;IL1B;CCR5;CCL3;CCL23;CCR2;CCR4;LTA
prerank,Elsevier_Pathway_Collection__TNFR/NF-kB Classical Pathway in Multiple Myeloma Plasma Cells,-0.47108238524029705,-1.526044892432297,0.06666666666666667,0.14340116354385116,1.0,9/29,17.08%,TNFRSF17;TNF;TNFRSF13B;IL6;CXCL8;TNFSF13;VCAM1;TNFSF13B;BCL2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.46278823113340745,1.5260369136278389,0.00966183574879227,0.5021524272351311,1.0,49/102,33.12%,HMGA2;SOX1;H3C13;H1-5;AXIN2;SOX2;H3C1;TOP2A;NUF2;ACTL6B;EZH2;NDC80;FAM50A;CDCA8;CDT1;HDAC11;H4-16;HDAC5;MSH2;MTHFR;CETN2;DOT1L;SUV39H1;HDAC10;SMARCA4;PARP1;CENPV;HDAC1;L3MBTL1;NUP133;HMGB2;CENPW;MYC;LDB1;COPS5;CUL4B;UBA52;MSH6;H3-3A;NUP155;CENPH;EZH1;TCF7L1;COPS7B;PHF19;RFWD3;DDB2;HDAC8;COPS6
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.5202901458833517,1.526032093488183,0.015873015873015872,0.49990062262869556,1.0,22/45,32.53%,H2BC13;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;NHEJ1;H2BC4;H4C15;H2BC5;H2AX;BARD1;PRKDC;NSD2;MDC1;ABRAXAS1;PIAS4;BABAM2;POLM;TP53BP1;UIMC1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5737513628505496,-1.5258755606837742,0.08045977011494253,0.14322271440073314,1.0,10/18,18.49%,CXCL13;RET;P2RY12;CCL5;CD3E;SKAP1;NCKAP1L;SYK;SFRP2;LIF
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.6565453146194726,1.5252064677492403,0.046052631578947366,0.500258965269039,1.0,2/15,1.97%,TRIM71;RBM24
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.45991164562483433,1.5246296566110868,0.014563106796116505,0.49987089912959337,1.0,83/106,47.28%,RPL8;MRPL13;RPL30;RPLP1;RPS27;RPS21;RPLP2;EIF3E;RPS5;EIF3K;RPL28;RPS14;RPSA;RPL26L1;PABPC1;RPL39;EIF3D;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;EIF3H;RPL10A;RPS8;RPS12;EIF3B;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;EIF3G;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;EIF3M;RPS28;RPS23;RPL27A;RPL23A;RPL18;EIF2S3;RPL12;RPS9;EIF3C;RPL6;EIF3F;RPS15A;RPL4;EIF3L;RPL19;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13;EIF3A
prerank,WikiPathway_2021_Human__Neural Crest Differentiation WP2064,0.4779171962049214,1.5238643059105357,0.009852216748768473,0.5003621085284928,1.0,12/79,7.78%,OLIG3;COL2A1;ZIC5;DLX5;MPZ;AXIN2;SNAI2;HES5;BMP4;HDAC4;FGF2;MSX1
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,0.47181331019148137,1.523496215945451,0.02403846153846154,0.4995259814124039,1.0,70/88,46.98%,RPL8;MRPL13;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPSA;RPL26L1;RPL39;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;RPS15A;RPL4;RPL19;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,KEGG_2021_Human__Mineral absorption,-0.3977650556502498,-1.5230482509491687,0.0,0.1454513166959835,1.0,18/58,12.60%,SLC6A19;SLC5A1;MT1G;TRPV6;MT1HL1;MT1F;MT1H;SLC26A9;SLC34A2;MT1M;ATP1A3;MT1E;MT1X;TF;MT1A;MT1B;SLC8A1;SLC31A1
prerank,KEGG_2021_Human__Ribosome,0.45014325647821146,1.5228438613545405,0.013452914798206279,0.49972999800193935,1.0,97/129,46.98%,MRPS21;MRPL24;RPL8;MRPS12;MRPL13;MRPL9;MRPS14;RPL30;RPLP1;RPS27;RPS21;RPLP2;MRPL23;RPS5;MRPL28;RPL28;MRPL12;RPS14;RPL10;RPSA;RPL26L1;RPL39;UBA52;RPLP0;MRPL15;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;MRPL36;RPL13;RPL27;RPL38;RPL35;MRPL27;MRPL21;MRPL17;RPL10A;MRPS15;RPS8;RPS12;RPL22L1;RPL35A;MRPL22;MRPL4;MRPL33;RPS3A;MRPL1;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPS18;RPL14;RPS16;MRPS5;RPL13A;RPL41;RPL9;MRPS18C;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;MRPL2;MRPS11;RPS9;RPL6;RPS15A;RPL4;RPS26;RPL19;RPS6;RPL26;MRPL20;RPS27A;RPS4Y1;MRPS16;RPL34;RPS13
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.46508402676159766,1.5225562321755222,0.00966183574879227,0.49853136144987154,1.0,75/93,47.14%,RPL8;FTSJ1;RPL30;RPLP1;RPS27;RPS21;RPS5;RPL28;RPS14;RPL10;RPSA;RPL26L1;RPL39;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL13;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;DRG1;RPS11;RPL36A;GSPT2;RPL7A;RPS3;RPL18A;RPL32;RPS24;RPL29;RPL23;RPL5;RPS18;RPL14;RPS16;RPL13A;RPL41;RPL9;EIF3M;DRG2;TMA7;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;RPS15A;RPL4;RPS26;RPL19;RPS6;RPL26;RPS27A;RPL34;RPS13;ETF1
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.5810594268957326,1.521396218735111,0.025157232704402517,0.5005036612943174,1.0,9/24,17.48%,CDC25C;FOXM1;PLK1;CCNB2;CCNA2;CDK1;CCNB1;PKMYT1;CDC25A
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.4990507756051675,-1.5213874588037788,0.02631578947368421,0.1467317507378401,1.0,13/28,25.24%,NKX2-1;OVOL2;BMP5;SFRP1;GATA3;IL17RD;SPRY2;LDLRAD4;SFRP2;SMAD7;PTEN;SPRED1;FUZ
prerank,Elsevier_Pathway_Collection__Familial Cold Autoinflammatory Syndrome 2,-0.4825101598780031,-1.5208257515246584,0.011764705882352941,0.14705802522209593,1.0,12/28,17.02%,TNF;IL1B;NLRP12;CASP1;NLRP3;IL6;TICAM2;TLR4;TLR2;AKT1;MYD88;CTSB
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",-0.4569891503821195,-1.5206378463325867,0.018867924528301886,0.14694601744454489,1.0,21/48,19.33%,HMGCLL1;ALDH1B1;ALDH6A1;BCKDHB;MMUT;ACAA1;ACADS;EHHADH;HMGCS2;ACADSB;DBT;IVD;ABAT;ACADM;ALDH2;ECHS1;AGXT2;MCCC1;HMGCL;ACAT1;PCCA
prerank,TRRUST_Transcription_Factors_2019__POU5F1 human,0.6166425615849838,1.520469006189484,0.06097560975609756,0.5014542626568795,1.0,8/20,6.21%,DKK1;DLX5;SPP1;THY1;SOX2;TDGF1;ITGA6;BMP4
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,0.4706327555233389,1.5204130039270507,0.018518518518518517,0.4994987643451465,1.0,52/111,33.74%,H2BC13;H2BC17;H2BC21;EME1;H2BC9;EXO1;H2BC15;CCNA2;H2BC11;H2BC12;H2BC4;H4C15;SERPINA2;XRCC2;RFC4;RTEL1;H2BC5;POLD1;CHEK1;H2AX;BARD1;DNA2;RMI1;FEN1;POLR1A;CLSPN;ATRIP;PARP1;RAD9B;RAD51AP1;RAD51;BLM;RHNO1;TIPIN;NSD2;UBA52;SIRT6;TIMELESS;MDC1;PCNA;ABRAXAS1;XRCC1;PIAS4;BABAM2;UBE2I;TP53BP1;BRIP1;RMI2;UIMC1;TOPBP1;MUS81;BRCA2
prerank,TRRUST_Transcription_Factors_2019__HMGA1 human,-0.5610170169098136,-1.5200886777780582,0.060240963855421686,0.14707667475456937,1.0,7/16,18.51%,PTGS2;IL1B;CDH1;KL;POU1F1;CXCL1;TWIST1
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,0.47405817710719345,1.5196129370389584,0.023474178403755867,0.5002844014285711,1.0,61/106,40.59%,H2BC13;H2BC17;H2BC21;EME1;H2BC9;EXO1;H2BC15;CCNA2;H2BC11;H2BC12;H2BC4;H4C15;SERPINA2;XRCC2;RFC4;RTEL1;H2BC5;POLD1;CHEK1;H2AX;BARD1;DNA2;RMI1;POLR1A;CLSPN;ATRIP;RAD9B;RAD51AP1;RAD51;BLM;RHNO1;TIPIN;NSD2;UBA52;SIRT6;TIMELESS;MDC1;PCNA;ABRAXAS1;PIAS4;BABAM2;UBE2I;TP53BP1;BRIP1;RMI2;UIMC1;TOPBP1;MUS81;BRCA2;SEM1;ABL1;EME2;POLH;XRCC3;BABAM1;SPIDR;CDK2;SLC19A1;HERC2;RAD52;POLK
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5446494881165833,1.5196041515806795,0.0335195530726257,0.4982047716963793,1.0,3/34,2.76%,SFN;E2F1;TP73
prerank,Elsevier_Pathway_Collection__Cryopyrin (NLPR3) Associated Periodic Syndromes,-0.5196555527710043,-1.5195690912972277,0.013513513513513514,0.1472792666796319,1.0,11/26,17.02%,TNF;IL1B;IL18;CASP1;NLRP3;IL6;IL33;TICAM2;TLR4;MYD88;CTSB
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5060254322289346,-1.5193893759355583,0.037037037037037035,0.14708310688031268,1.0,9/25,15.16%,CD1A;CD1B;XCL1;CD1D;CD1E;IL12B;CD1C;AZGP1;IL12RB1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.5695813247276602,-1.5191667277366974,0.05263157894736842,0.1469720067196114,1.0,7/16,20.62%,CASR;CD4;CAMK2B;IL16;BCL2;PLN;ANK2
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.46554102961924076,-1.5189941745546853,0.014084507042253521,0.1468613823625962,1.0,12/28,13.06%,MT1G;MT1HL1;MT1F;MT1H;MT1M;FOS;MT1E;MT1X;MT1A;HAAO;MT1B;AKT1
prerank,Elsevier_Pathway_Collection__TRPM7/8 in Pancreatic Adenocarcinoma,-0.5250214337438537,-1.51880496525923,0.0,0.14667935260540219,1.0,7/21,11.86%,TNF;IL1B;FOS;MAP2K1;IL6;TRPM8;CXCL8
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.5031553515416726,1.51853733713173,0.02197802197802198,0.500020318359293,1.0,14/51,15.39%,CPLX2;RAB3C;SAA1;SEPTIN5;RAB3B;LGI3;CAMK2A;CHRNB4;MCTP1;DISP1;SYN1;RAB3D;CPLX1;RHBDF2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.47953199867466334,-1.5180554376113777,0.031746031746031744,0.14725121049744133,1.0,14/28,12.30%,MT1G;MT1HL1;MT1F;MT1H;MT1M;MT1E;SLC39A5;MT1X;SLC39A12;MT1A;TMC8;SLC39A14;LCK;MT1B
prerank,Reactome_2022__SHC-mediated cascade:FGFR4 R-HSA-5654719,0.6547482570053358,1.5179770314764345,0.045454545454545456,0.5000417942625989,1.0,7/15,20.14%,FGF20;FGF13;FGF17;FGF23;SHC1;HRAS;FGF18
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,0.5372856292385436,1.5177990978725173,0.03468208092485549,0.4986951045579783,1.0,13/43,18.69%,GNG4;RGSL1;ADRA2C;GNAZ;RGS20;GNG3;RGS16;GNB5;ADCY6;GNG8;PRKCA;GNG10;ADCY4
prerank,Elsevier_Pathway_Collection__Dendritic Spine Morphogenesis and Stabilization,0.5357661434375189,1.5162875412663412,0.03296703296703297,0.5018192638359079,1.0,12/40,18.53%,DOCK3;PAK3;PTPRT;BDNF;GRIP2;DCX;DLG4;ABL2;HRAS;ARHGEF2;GRIP1;SHARPIN
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5528307257283479,1.5152597857707806,0.01744186046511628,0.5033465526904628,1.0,17/32,33.12%,HMGA2;PLK1;TICRR;DTL;CDK1;CHEK1;CLSPN;TAOK2;DONSON;BLM;BRSK1;CDKN1A;MRNIP;ABRAXAS1;BABAM2;UIMC1;TOPBP1
prerank,Elsevier_Pathway_Collection__Complement System Defects in Systemic Lupus Erythematosis,-0.5212879602307522,-1.515168019005906,0.024096385542168676,0.14971730061959806,1.0,17/23,24.41%,CR2;C9;C7;C6;CR1;FCGR2B;MBL2;C1R;C8A;C3AR1;C1S;C1QA;C5;MASP1;ITGAM;C3;C4B
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.48083894535634086,-1.5150846795566266,0.016129032258064516,0.14949465660129094,1.0,14/30,22.39%,GNMT;GLDC;HOGA1;BCKDHB;DAO;GCSH;HAO1;DBT;DDO;AGXT2;AGXT;PXMP2;PRODH2;DHTKD1
prerank,Elsevier_Pathway_Collection__Glutamate Overdose and Aura Effect Caused by Mutations in PRRT2 Gene,0.5847655041366147,1.5150456090940292,0.05357142857142857,0.5021166854811645,1.0,12/24,20.62%,CACNB4;SCN1A;SLC7A6;CACNA2D2;ATP1A2;CAMK2A;SLC1A2;SNAP25;PRRT2;SLC1A3;SNAPIN;STX1A
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.38150732169301016,-1.5148335364824557,0.0,0.14941549402372967,1.0,20/100,18.10%,KLK3;KLK2;KRT19;HPGD;LIFR;MAF;MAP7;HSD17B14;NKX3-1;ADAMTS1;MAK;AZGP1;AKT1;PGM3;HERC3;LMAN1;BMPR1B;ABHD2;SEC24D;GUCY1A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.6377985421115552,1.5148224891429143,0.028089887640449437,0.5007837379657551,1.0,5/16,6.72%,SFN;SFRP4;MESP1;BMP4;FGF2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Cholesteatoma,-0.47246449778114497,-1.5146165913678435,0.028985507246376812,0.14924184171500174,1.0,15/34,13.38%,TCN1;EREG;ERBB4;TNFSF11;TNF;FOS;DEFB1;FGFR2;TGFA;IL6;TNFRSF11A;CXCL8;TLR4;TLR2;CAMP
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.49688459148136843,1.5134798118317176,0.04419889502762431,0.5033822510275331,1.0,12/60,13.96%,MAFA;SCG2;RAB3C;PTPRN;NEUROD1;GAL;RAB3B;PORCN;NECAB3;LTBP2;RAB3D;FAM3B
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,0.49636628003138683,1.5125533674144764,0.009900990099009901,0.5047515687223141,1.0,26/55,32.53%,H2BC13;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;EYA4;H2BC12;H2BC4;H4C15;H2BC5;H2AX;BARD1;APBB1;EYA1;KPNA2;NSD2;CHEK2;UBA52;MDC1;ABRAXAS1;PIAS4;BABAM2;UBE2I;TP53BP1;UIMC1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",0.607910746794091,1.512491551381163,0.055900621118012424,0.5029486625367897,1.0,6/17,18.30%,CENPA;TTK;AURKB;CDK1;MTBP;SPDL1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.48814323930845044,-1.5115134617418136,0.0273972602739726,0.15209690307825646,1.0,7/25,5.25%,ERBB4;IFNL1;IL10;GHR;TNF;CCL5;IL7R
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.4366674702622185,1.5112396959946248,0.00881057268722467,0.5054786613707956,1.0,135/176,47.36%,BOP1;EXOSC4;UTP14A;RPL8;DCAF13;UTP25;MRPL13;RPP21;HEATR1;RPL30;RPLP1;BYSL;RPS27;RPS21;LAS1L;RPLP2;WDR46;NOP58;RPS5;PDCD11;RRP9;DNAJC5;EXOSC5;RPL28;RPS14;RPSA;RPL26L1;RPL39;UBA52;NOC4L;NOP56;RPLP0;PELP1;FBL;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;PES1;RPL37;RPP25;RPL7;CSNK1D;RPS4X;RPS20;RPL27;RRP7A;RBM28;RPL38;RPL35;RPP40;SNU13;UTP15;RPL10A;ISG20L2;DDX49;RPS8;RPS12;RPL22L1;RPL35A;NOL9;RPS3A;RPS7;EXOSC2;RPS11;RPL36A;WDR12;TBL3;DHX37;BUD23;WDR75;RPL7A;FAU;FTSJ3;RPS3;RPL18A;RPL32;UTP4;RPS24;RRP36;IMP4;RPL3L;UTP18;DDX56;PWP2;PNO1;RPL29;RPL23;RIOK2;RPL5;EXOSC1;CSNK1E;RPL14;EXOSC7;EXOSC10;RPS16;EXOSC9;RPL13A;RPL41;RPL9;NOL6;RPP38;RPS28;EBNA1BP2;RPS23;RPL27A;RPL23A;RPL18;RPL12;GNL3;RPS9;NOL12;TSR1;RPL6;EMG1;RIOK1;RPS15A;RPL4;MTREX;RPL19;UTP20;RPL39L;RPS6;RPL26;RPS27A;NOB1;RPS4Y1;RPL34;TEX10;RPS13;MPHOSPH10;UTP6;BMS1
prerank,Elsevier_Pathway_Collection__S/G2 Phase Transition,0.5833942639543485,1.5111418218766073,0.022598870056497175,0.5037429493471339,1.0,10/26,17.48%,CDC6;CDC7;CCNA2;CDC45;CCNF;CCNB1;CDT1;CKS1B;CDKN1C;CDC25A
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.4637633221344632,1.5106424756195105,0.01507537688442211,0.5036240458369198,1.0,55/101,37.70%,KIF2C;PLK1;CENPE;KIF14;NCAPH;KIFC1;NCAPG;KIF18B;DLGAP5;KIF18A;NDC80;RRS1;KIF23;CDCA5;CDK1;CDCA8;CCNB1;CEP55;ANKRD53;KIF25;SGO2;H4-16;ZWINT;PSRC1;PRC1;CENPK;SPDL1;SGO1;AKAP8L;DSN1;POGZ;NUP62;NCAPD2;NCAPH2;SMC4;SPAG5;SMC2;VPS4A;KIF22;CHMP2A;NCAPG2;WRAP73;DCTN2;PHF13;DIS3L2;CSNK2B;PINX1;SMC1A;TUBG1;ESPL1;CDC23;EML3;TEX14;BOD1;EML4
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.5320747832249331,1.5101033589000443,0.03260869565217391,0.5034923400928206,1.0,21/43,33.12%,HMGA2;PLK1;TICRR;DTL;CDC6;CDK1;ORC1;CHEK1;CLSPN;TAOK2;DONSON;BLM;INTS3;BRSK1;NABP2;CDKN1A;MRNIP;ABRAXAS1;BABAM2;UIMC1;TOPBP1
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,0.42999003199525015,1.5097243828697011,0.0041841004184100415,0.5028682809938109,1.0,87/252,26.37%,DYNC1I1;H3C13;H2AC19;H2BC13;CENPF;TAX1BP3;CDC25C;CENPA;SKA1;KIF2C;PLK1;MAPK11;BUB1B;CENPE;NUF2;CDC20;H2AC20;KIF14;H2BC17;BIRC5;SRC;KIF5A;SPC24;BUB1;RHPN1;H2BC21;CENPI;H2BC9;CENPM;H2BC15;AURKB;KIF18A;NDC80;IQGAP3;H2BC11;CDCA8;SPC25;RNASE1;KNTC1;H2BC12;DIAPH3;H2BC4;H4C15;H2AC6;CENPU;NOX1;ERCC6L;CENPL;SGO2;ZWINT;PDPK1;H2BC5;DVL2;PRKCA;H2AX;ROCK2;RHOC;PRC1;NCKIPSD;VPS72;CENPK;SPDL1;LIMK2;SGO1;NUP37;SRGAP2;WASF2;DSN1;B9D2;LLGL1;H2AJ;PPP2R5A;AHCTF1;RPS27;NF2;ARPC1A;CENPP;PDZD2;LIN7B;CYFIP2;NUP133;DYNLL1;PKN3;RANGAP1;PTK2;CTNNB1;FMNL2
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.4936587360508198,1.5096767705036291,0.055,0.499065312282142,1.0,27/55,40.48%,TRIM71;H3C13;H3C1;AGO2;H4-16;POLR2L;NUP37;NUP62;POLR2K;TPR;NUP133;POLR2G;H3-3A;NUP155;NUP160;POLR2H;FMR1;NUP188;POLR2I;POLR2J;AGO1;NUP205;POLR2A;NUP210;POLR2B;RAE1;NUP214
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.4936587360508198,1.5096767705036291,0.055,0.499065312282142,1.0,27/55,40.48%,TRIM71;H3C13;H3C1;AGO2;H4-16;POLR2L;NUP37;NUP62;POLR2K;TPR;NUP133;POLR2G;H3-3A;NUP155;NUP160;POLR2H;FMR1;NUP188;POLR2I;POLR2J;AGO1;NUP205;POLR2A;NUP210;POLR2B;RAE1;NUP214
prerank,Elsevier_Pathway_Collection__Ependymoma,0.5099620521410028,1.5094882347648646,0.0582010582010582,0.49782974301243255,1.0,7/42,5.28%,IGF2;EPHB2;TP73;TERT;CDKN2A;HES5;EFNA3
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,0.5970133801164081,1.5083916346449868,0.059602649006622516,0.49998972376462897,1.0,7/19,15.74%,MAPK12;SHC3;MAPK11;SRC;MAPKAPK2;SHC1;HRAS
prerank,Elsevier_Pathway_Collection__Glutamate Overdose and Aura Effect Overiew,0.5709501747270108,1.5082638067567424,0.06321839080459771,0.4964697370320338,1.0,12/25,20.62%,CACNB4;SCN1A;SLC7A6;CACNA2D2;ATP1A2;CAMK2A;SLC1A2;SNAP25;PRRT2;SLC1A3;SNAPIN;STX1A
prerank,Elsevier_Pathway_Collection__Glutamate Overdose and Aura Effect Caused by Mutations in SLC1A3 Gene,0.5709501747270108,1.5082638067567424,0.06321839080459771,0.4964697370320338,1.0,12/25,20.62%,CACNB4;SCN1A;SLC7A6;CACNA2D2;ATP1A2;CAMK2A;SLC1A2;SNAP25;PRRT2;SLC1A3;SNAPIN;STX1A
prerank,WikiPathway_2021_Human__Cholesterol Biosynthesis Pathway WP197,0.6375833859312745,1.5076216604646075,0.023391812865497075,0.49653006678420275,1.0,10/15,23.86%,SQLE;FDPS;MVD;HMGCR;IDI1;PMVK;NSDHL;FDFT1;HMGCS1;CYP51A1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.6019086763063076,1.5064492910909808,0.04878048780487805,0.4985685316844616,1.0,10/18,26.45%,TERT;RFC4;MCM3;MCM4;MCMDC2;MCM7;POLA1;GINS4;GINS1;GINS2
prerank,WikiPathway_2021_Human__Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6214668249085796,1.50580640167493,0.050314465408805034,0.4989774083106189,1.0,2/18,4.00%,COL2A1;NQO1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5408065629620856,1.50544432183922,0.05917159763313609,0.4985002897944803,1.0,13/29,26.56%,LEF1;AXIN2;TERT;TCF7;PYGO2;BCL9L;SMARCA4;BCL9;HDAC1;KMT2D;MYC;CTNNB1;TLE1
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,-0.49060725644593667,-1.5049211739031947,0.014285714285714285,0.1583392501786977,1.0,14/28,16.76%,EDAR;TNFSF11;TNFRSF17;TNFRSF11B;CD27;FASLG;TNFSF15;TNFRSF13B;TNFRSF9;TNFSF13;LTA;TNFRSF1B;TNFSF8;TNFSF13B
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5203819479586934,-1.504823935011633,0.03409090909090909,0.15810083151865204,1.0,10/18,17.07%,CD160;SH2D1A;PTPN22;LGALS3;UBASH3A;SLA2;GBP1;LILRB4;PRNP;EZR
prerank,Elsevier_Pathway_Collection__Proteins Involved in Antiphospholipid Syndrome,-0.5307820329845144,-1.5047555405629442,0.011363636363636364,0.1578634125175583,1.0,12/18,27.48%,TNF;ADAMTS13;TLR4;F3;TNFSF13B;APOH;JUN;F2;F2RL1;ANXA5;ABCA1;EDN1
prerank,Elsevier_Pathway_Collection__Neurogenic Transcription Factors Role in Hirschsprung Disease,-0.5400934966010874,-1.5046404300087592,0.06521739130434782,0.15766217411479314,1.0,9/17,15.85%,ASCL1;SOX10;RET;L1CAM;ZEB2;SOX9;EDNRB;SMAD9;BMPR2
prerank,WikiPathway_2021_Human__Cytosolic DNA-sensing pathway WP4655,-0.4209061524399488,-1.503901179152162,0.014925373134328358,0.1582225739516537,1.0,12/57,10.39%,CXCL10;RIPK3;ZBP1;AIM2;IL1B;CCL5;CCL4L2;CCL4;IL18;CASP1;IL6;IL33
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.4907601607754097,-1.5029974740234544,0.02631578947368421,0.15889744078918605,1.0,12/30,21.22%,TCN1;SLC52A1;FOLR3;AFM;APOA1;SLC2A14;SLC2A2;GC;SLC35F3;SLC2A10;SLC19A2;TTPA
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.5905591364328449,1.5025238927380422,0.07017543859649122,0.5069919021105207,1.0,6/24,9.94%,CTNNA2;MAPK12;MESP1;MAPK11;MYF6;CDON
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.3483566816732263,-1.5021989558648177,0.0,0.15925479177294552,1.0,74/176,23.97%,CIDEA;FOXP3;NLRP7;IFNL1;IL10;IFNG;LGALS9B;TNF;ACOD1;BPI;CD200R1;INHBA;ABCD2;NLRP12;PTPN22;TIGIT;APOA1;XCL1;VSIG4;CCR7;LILRA5;PTPRC;IL6;KLF4;AXL;CR1;TLR8;TBX21;CD84;IL12B;MEFV;LILRB1;CD274;PTGER4;FCGR2B;HDAC9;PDCD1LG2;NCKAP1L;HERC5;TLR4;SRGN;SFTPD;HAVCR2;GBP1;LILRB4;LGALS9;PRNP;NLRC3;THBS1;EZR;ITCH;CD33;SLAMF1;SIGIRR;LGALS9C;TNFRSF21;NR1H4;MACIR;ANXA4;UBE2L6;SLC2A10;SSC5D;CMKLR1;TMSB4X;TYROBP;F2;DHX58;IFIH1;RNF125;LAPTM5;SIRPA;F2RL1;DDX58;ORM1
prerank,Elsevier_Pathway_Collection__B-Cell Activation in Systemic Lupus Erythematosus,-0.40482426682997313,-1.5013655899956,0.03225806451612903,0.15984329466132086,1.0,27/62,22.05%,FCAR;TNFRSF17;FOS;CD79A;BANK1;MAP2K1;TNFRSF13B;PRKCB;BLK;CD40LG;FCGR2B;BTK;CARD11;AKT1;SYK;PLCG2;VAV1;TNFRSF13C;TNFSF13B;INPP5D;NFATC2;MAP2K3;JUN;JAK2;PIK3AP1;CD40;STAT1
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.5595720375062911,1.5013348663714179,0.04371584699453552,0.5091421024874364,1.0,7/32,13.94%,DKK1;DKK4;KREMEN2;PORCN;RNF43;KREMEN1;AMER1
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,0.4407776112382326,1.5013082621654883,0.0,0.5072509152416663,1.0,36/179,15.15%,DKK1;DKK4;LGR6;H3C13;RSPO2;LEF1;H2AC19;LGR5;AXIN2;WNT4;TERT;SOX2;H2BC13;WNT8B;ZNRF3;KREMEN2;H2AC20;TCF7;H2BC17;RSPO4;H2BC21;PSMD4;PIP5K1B;H2BC9;H2BC15;H2BC11;RNF43;H2BC12;H2BC4;H4C15;KREMEN1;H2AC6;PSMB4;AMER1;H2BC5;DVL2
prerank,Elsevier_Pathway_Collection__POMC Secretion in adenohypophysis,-0.5232754673916067,-1.5008344915260905,0.07894736842105263,0.15998826990215528,1.0,5/18,8.78%,PCSK2;NR4A2;NR4A1;MAP2K1;CAMK2B
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.6304502331840834,1.5007867192215834,0.07692307692307693,0.5071907885200015,1.0,10/16,23.96%,RECQL4;MCM2;MCM6;HMGA1;MCM4;TWNK;MCMDC2;RAD51;MCM7;BLM
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,-0.4098757939709214,-1.5006235241706458,0.017241379310344827,0.15995889103043612,1.0,27/61,25.62%,GCK;ADH4;PCK1;HK3;ENO3;ALDH1B1;ADH1A;ALDOB;FBP1;ADH1C;ALDOC;ADH7;ALDH2;ALDH3B2;PGM2;PCK2;PGM1;ENO2;ADH6;ENO4;PGAM1;AKR1A1;GALM;ALDH9A1;LDHB;HK2;ALDH7A1
prerank,Elsevier_Pathway_Collection__Splenic Marginal Zone Lymphoma,-0.43277303940777073,-1.5000915650485003,0.01818181818181818,0.16012614966332925,1.0,15/45,17.08%,TNFRSF17;TNF;CD79A;TNFRSF13B;PRKCB;TLR8;CD40LG;CARD11;TNFSF13;SYK;PLCG2;MYD88;TNFRSF13C;TNFSF13B;BCL2
prerank,WikiPathway_2021_Human__Striated Muscle Contraction Pathway WP383,0.5336602917219704,1.4999212254089098,0.011363636363636364,0.5082816314368663,1.0,12/33,17.88%,TNNC1;ACTN2;TNNI3;MYH3;TNNT1;MYH8;TNNI2;TNNT3;MYBPC1;TPM2;MYOM1;NEB
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.38587142717874134,-1.4998008632540976,0.021739130434782608,0.1601658239890997,1.0,39/84,18.59%,PDX1;NDNF;TNFSF11;CCR9;RCAN1;P2RY12;CXCR1;FPR1;CXCR2;LRRK2;FPR2;CCR5;XCR1;CCL3;CXCR6;CCR7;ACKR4;MCTP2;NMUR1;CCR1;CCR2;BTK;DDAH1;CXCL8;LAT;SELE;CCR4;EDNRB;LAT2;PLCG2;CXCR3;CXCR4;GUCY1B1;TPCN2;RCAN2;KSR2;GUCY1A1;CHRM3;EIF2AK3
prerank,KEGG_2021_Human__Tyrosine metabolism,-0.4586372621246461,-1.4995816483242317,0.046875,0.16004416301169527,1.0,16/32,24.35%,GSTZ1;ADH4;DBH;TH;ADH1A;ADH1C;TAT;ADH7;DDC;ALDH3B2;TYRP1;AOC3;ADH6;FAHD1;COMT;MAOB
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.504686044539162,1.4988077298666793,0.03278688524590164,0.5100081587513237,1.0,10/61,9.80%,TRIM71;E2F1;CDKN2A;CAMK2A;CDKN3;CCNE1;CDKN2C;CDC7;CCNA2;CCNE2
prerank,Elsevier_Pathway_Collection__Adipokines Production by Adipocyte Impaired in Obesity,-0.41459089183584746,-1.4981360606640761,0.0,0.16106038405461262,1.0,12/42,14.75%,ITLN1;SERPINA12;TNF;IL1B;FOS;FOXO1;CCL2;IL6;TLR4;PIK3R1;AKT1;MYD88
prerank,MSigDB_Oncogenic_Signatures__BCAT.100 UP.V1 UP,0.5126340402989347,1.4977265929652608,0.03296703296703297,0.5122092419465325,1.0,15/45,14.61%,DKK1;FGF20;EEF1A2;GAD1;TBX3;SERPINI1;DBNDD1;BMP4;ERVMER34-1;IHH;BIK;CDX2;EFEMP1;CRYM;QPCT
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.39924087904723454,-1.4972581048716072,0.016129032258064516,0.16177435287242584,1.0,38/69,28.98%,GLYATL2;HAO2;ABCD2;BDH2;SCP2;MMUT;ACADL;ACAA1;ACADS;EHHADH;ACOX1;HAO1;ABCD4;CROT;ECHDC1;ACAD11;ACADM;ECHS1;PHYH;ABHD2;ACAT1;ACBD5;PCCA;PECR;AIG1;ADTRP;SLC27A2;ECHDC2;ILVBL;ACAA2;PEX13;CPT2;LPIN3;NUDT7;ECI2;HADH;MMAA;ABCD3
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.47127942738610723,1.4970541760780864,0.04081632653061224,0.5124893380295548,1.0,19/76,16.69%,KIF1A;KIF26B;KIF20A;KIF2C;KIF4A;CENPE;KIF5A;KIF15;KIFC1;KIF18B;KIF18A;KIF23;KIF21B;RACGAP1;KIF25;TMED3;KIFC2;NBAS;KIF11
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.45965752073797783,-1.4969933996709526,0.018867924528301886,0.16166159587471224,1.0,12/32,13.84%,HTR2A;CD160;LTK;PIK3C2G;ZFP36L1;PIK3CD;GATA3;PIK3R5;PIK3R1;AKT1;TPTE2;IGF1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.5065504870892739,1.4966617028508316,0.053475935828877004,0.5120414954165724,1.0,16/47,19.77%,HMGA2;LEF1;E2F1;HJURP;MDFI;PRKN;FOXC1;CDT1;HABP4;NME1;TFAP4;PPARG;EGF;DOT1L;BCL3;MMP9
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.45543311446217105,1.4949197902695244,0.009569377990430622,0.5164941042551043,1.0,29/117,15.92%,REG3A;ODAM;PAX2;THBS4;SCG2;OSR2;VEGFD;OSR1;PTPRN;NODAL;CDH13;CCL26;MDK;EGFL7;BMP4;FGF2;ZNF703;MMP12;PRKD1;PPP1R16B;LAMC1;PDGFB;NME1;PGF;CCL24;CCL11;PRKCA;HRAS;HTR2B
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.5474205574402389,1.4946980917753687,0.044444444444444446,0.5151752363435077,1.0,5/27,7.62%,FGF20;FGF13;FGF17;SRC;FGF23
prerank,Elsevier_Pathway_Collection__DNA Replication in DNA Machinery,0.6243747506204775,1.4943459173119347,0.0547945205479452,0.5144076099811788,1.0,9/15,23.11%,CDC6;CDC7;CDC45;CDT1;DNA2;FEN1;GMNN;WDHD1;POLA1
prerank,Elsevier_Pathway_Collection__Immune System Role in Otitis Media,-0.43391564054650794,-1.4935165050266226,0.027777777777777776,0.164940600233174,1.0,13/37,17.02%,TNF;IL1B;S100A8;IL18;CASP1;NLRP3;IL6;IL33;TLR4;TLR2;AKT1;MYD88;CTSB
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.4758055644373135,1.4933719460253818,0.03,0.5158413381479304,1.0,17/71,13.52%,CTNNA2;CACNB4;CACNG1;LEF1;ACTN2;CACNG4;CACNA1S;CACNG5;ITGA2;CACNA2D2;ITGA6;TCF7;ATP2A1;CACNA1C;CACNA2D3;LMNA;CACNG8
prerank,WikiPathway_2021_Human__Complement system WP2806,-0.3925373677087163,-1.4930806273177624,0.0,0.16503837715949982,1.0,43/95,22.03%,CLEC4M;CR2;FCN2;CFP;FPR1;SFTPA1;C9;APOA1;KLKB1;C7;DCN;VSIG4;C6;FCGR3A;ALB;CR1;C4A;MBL2;PLG;C1R;TLR2;SELE;CFI;SERPING1;ITGB2;ITGB3;PRNP;PLAUR;THBS1;F11;C8A;VTN;CD19;C3AR1;SELPLG;FCN1;C1S;SELL;C5;CD55;SELP;MASP1;CD40
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.4698059665310461,-1.4930366726889315,0.06896551724137931,0.16474910252834155,1.0,13/29,26.43%,IGLL5;ITK;LCP2;BTK;SYK;PLCG2;VAV1;VAV3;PPP3CA;NFATC2;ITPR3;CALM1;TXK
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.4570685386762539,1.4926033641017378,0.020100502512562814,0.5170020427328662,1.0,24/105,13.94%,NKD1;DKK1;DKK4;LGR6;RSPO2;PTK7;NOTUM;SFRP4;TERT;APCDD1;TAX1BP3;NKD2;GPC3;MDFI;RSPO4;PRKN;ZNF703;DAAM2;RNF43;FOXL1;KREMEN1;SOX30;SOSTDC1;AMER1
prerank,Reactome_2022__rRNA Processing R-HSA-72312,0.424513018882777,1.4923647063130343,0.008695652173913044,0.5158251278994,1.0,146/196,47.36%,BOP1;EXOSC4;UTP14A;RPL8;DCAF13;UTP25;MRPL13;NHP2;RPP21;HEATR1;RPL30;RPLP1;BYSL;RPS27;RPS21;LAS1L;RPLP2;WDR46;NOP58;RPS5;PDCD11;RRP9;DNAJC5;EXOSC5;RPL28;RPS14;RPSA;RPL26L1;NOP2;RPL39;UBA52;TRMT112;NOC4L;NOP56;RPLP0;PELP1;FBL;RPS15;DKC1;RPS2;RPL31;RPS19;RPL36;RPL37A;PES1;RPL37;RPP25;RPL7;CSNK1D;RPS4X;RPS20;RPL27;RRP7A;RBM28;RPL38;RPL35;RPP40;SNU13;UTP15;RPL10A;NOP10;ISG20L2;DDX49;RPS8;RPS12;RPL22L1;RPL35A;NOL9;RPS3A;RPS7;TSR3;EXOSC2;RPS11;RPL36A;WDR12;TBL3;DHX37;BUD23;WDR75;RPL7A;FAU;FTSJ3;RPS3;RPL18A;RPL32;UTP4;RPS24;RRP36;IMP4;RPL3L;UTP18;DDX56;PWP2;PNO1;RPL29;RPL23;RIOK2;RPL5;EXOSC1;CSNK1E;RPL14;EXOSC7;EXOSC10;RPS16;HSD17B10;EXOSC9;RPL13A;RPL41;RPL9;NAT10;NOL6;RPP38;RPS28;EBNA1BP2;RPS23;RPL27A;RPL23A;RPL18;RPL12;GNL3;RPS9;NOL12;TSR1;RPL6;EMG1;RIOK1;RPS15A;RPL4;MTREX;RPL19;UTP20;DIMT1;RPL39L;RPS6;RPL26;MRM1;MRM3;RPS27A;NOB1;RPS4Y1;RPL34;TEX10;RPS13;MPHOSPH10;UTP6;BMS1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.5797712244663908,-1.492310239445588,0.045454545454545456,0.16506250570536568,1.0,6/15,23.77%,MFSD2A;SIK1;GPLD1;LDLR;FBXW7;C3
prerank,Elsevier_Pathway_Collection__G1/S Phase Transition,0.533523358938963,1.4917276696455994,0.04597701149425287,0.5163445378983684,1.0,14/33,19.98%,FOXM1;CCNE1;CCNA2;CCNE2;HELLS;CCNB1;MYBL2;CKS1B;CDKN1C;CDC25A;ATAD2;CHAF1A;CDK6;RAD54L
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.5733957434607435,1.4910899270746765,0.06626506024096386,0.5166499777618132,1.0,6/23,6.21%,PAX2;SIX1;OSR2;SIX4;OSR1;BMP4
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.5493949180787985,1.4905825884735708,0.03636363636363636,0.5168669692249175,1.0,4/30,1.93%,HMGA2;ANKRD33;LEF1;E2F1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.377185127789581,-1.4905609457631674,0.0196078431372549,0.1664393105341273,1.0,17/83,11.18%,KLK3;CXCL10;SEMA3E;TNF;CD160;CCN6;FASLG;COL4A3;ISM1;GDF2;ANGPT4;DCN;KLF4;SEMA6A;ADAMTS1;ALOX5;CCR2
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.3643153499484066,-1.4905291452769258,0.0,0.16614896108546673,1.0,34/114,21.08%,TCN1;NMRK2;ENPP3;PTGS2;SLC52A1;SLC19A3;PARP6;BST1;CD38;CYP8B1;MMUT;PRSS3;VNN1;PARP8;ACACB;MTHFD1;SHMT1;PANK1;SLC25A16;ABCD4;NMRK1;NUDT12;MCCC1;ENPP1;MMACHC;PTGIS;GSTO2;CYB5A;PCCA;LMBRD1;MTHFD2L;DHFR;MMADHC;SLC19A2
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5183442486651213,-1.4902758448788453,0.03409090909090909,0.16620948100277294,1.0,9/21,13.92%,STAP1;NFAM1;PRKCB;PTPRC;TRAT1;TESPA1;CARD11;LCK;CD226
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.42629893287346643,1.4900844786801695,0.004629629629629629,0.5167632205097916,1.0,24/166,6.32%,OLIG3;EN1;LHX3;SIX1;DNER;POU3F2;IRX6;SIX4;VAX2;IRX3;BRSK2;MAPT;NRCAM;WNT4;NEUROD1;WNT9B;EN2;LHX9;WNT8B;LHX4;HES5;IRX5;FGF13;EMX1
prerank,Elsevier_Pathway_Collection__HMGB1 and IL1B in Neuroinflammation,-0.4923260186258267,-1.4900198612775608,0.037037037037037035,0.16611214553086373,1.0,9/23,14.75%,TNF;IL1B;IL1RAP;CASP1;CCL2;IL6;TICAM2;TLR4;MYD88
prerank,Elsevier_Pathway_Collection__Proteins Involved in Osteoporosis,-0.38484352930950816,-1.4898174807242233,0.0,0.16598149379231117,1.0,25/86,11.09%,TAC1;CASR;TSHR;CSF3;IL10;PTGS2;TNFSF11;TNF;IL1B;TNFRSF11B;PTH1R;SRD5A1;GDF2;IGFBP3;ESR1;OXT;CAT;CALCR;IL6;SHBG;IL33;ABCB1;KL;IL1RN;TNFRSF11A
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.535955176587711,1.489244454597265,0.061855670103092786,0.5177244098108338,1.0,22/32,35.26%,HJURP;CENPA;CENPI;CENPM;HELLS;CENPU;CENPL;H4-16;CENPK;CENPV;CENPP;NPM1;CENPW;ITGB3BP;CENPS;CENPH;RBBP7;CENPT;CENPQ;RUVBL1;CENPX;NASP
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.3730076429823745,-1.4892162783066567,0.02040816326530612,0.1664568662286716,1.0,34/98,22.05%,IRF4;FOXP3;IFNG;CD4;IL1B;IL2RB;FOS;IL1RAP;PRKCQ;CD3E;CD3G;IL6;TBX21;HLA-DQA2;GATA3;LCK;CD247;LAT;HLA-DOB;IL21R;IL12RB1;ZAP70;HLA-DQA1;MAPK10;PPP3CA;MAPK13;CD3D;HLA-DOA;HLA-DRB5;NFATC2;JUN;HLA-DRA;JAK2;STAT1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.3923112587287819,-1.488909866991589,0.015625,0.16641557287490194,1.0,22/71,17.42%,PCYT1B;MFSD2A;SLC44A4;PLAAT1;CETP;LCAT;APOA4;PEMT;APOA1;SLC44A3;PHOSPHO1;PLA2G2D;SLC44A5;GPLD1;PLAAT2;PLA2G4A;APOA5;PLAAT3;PON1;PLBD1;LIPC;PLA2G12A
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,0.5687551381196772,1.488794002544402,0.0658682634730539,0.5177036588957498,1.0,17/28,29.80%,E2F1;CCNE1;CDC6;CDC45;CDK1;CDT1;TYMS;CDC25A;RRM2;E2F5;HDAC1;LIN37;POLA1;TK1;LIN9;RBL1;PCNA
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.5639811133676571,1.4886585007398183,0.07272727272727272,0.5164199697434522,1.0,8/26,15.00%,GNG4;ADRA2C;CACNA2D2;GNG3;CACNA1C;GNB5;ADCY6;GNG8
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.5902733921515357,1.487533452175695,0.0918918918918919,0.5189454094557434,1.0,11/22,29.61%,BUB1B;PLK5;WEE2;BUB1;AURKB;ZWINT;CHEK1;PRCC;INTS3;NABP2;VPS4A
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.513866423737084,-1.487097712838615,0.10666666666666667,0.1681613750323803,1.0,6/17,16.76%,TNFSF11;CD40LG;TNFRSF11A;TNFRSF13C;LTA;TNFSF13B
prerank,Elsevier_Pathway_Collection__Proteins Involved in Atherosclerosis,-0.3456493650737332,-1.4863885580681035,0.0,0.16860728625492682,1.0,71/186,17.19%,FOXP3;CSF3;MARCO;IL10;CXCL10;PTGS2;LPA;CXCL11;IFNG;CD4;TNF;IL1B;CETP;HGF;CCL5;FOS;LCAT;INHBA;CXCR2;APOA4;PTPN22;CXCL9;S100A8;CCR5;CCL4;CCL3;IL18;CXCR6;TNFSF10;APOA1;IL15;LIPG;DCN;CCL23;CXCL12;ALB;CCL2;IL6;TBX21;BMP7;ALOX5;CNR2;CCR2;BTC;APOA5;CXCL8;PLG;TLR4;TLR2;SELE;S100A12;VCAM1;PON1;PTN;MSR1;MYD88;HBEGF;CXCR3;CSF2;CXCR4;LTA;TNFRSF1B;ITGB2;CXCL1;F3;PLAUR;LIPC;THBS1;ITGA4;HSPA1A;PLTP
prerank,Elsevier_Pathway_Collection__Hyperglycemia and Hyperlipidemia Trigger beta-Cell Apoptosis,-0.4932192059384741,-1.4857717291266939,0.06097560975609756,0.16900693198849803,1.0,9/26,20.96%,GCK;PDX1;ST18;SLC2A2;CREM;BCL2;UCP2;EIF2AK3;XBP1
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,-0.3940845603746052,-1.4850931409396693,0.0,0.16941609693896525,1.0,34/99,18.50%,GSTA2;UGT2A1;GGT6;UGT1A5;GLYATL3;CHAC1;GLYATL2;GSTZ1;GLYAT;GSTA1;SULT1A2;UGT1A9;UGT2B7;GLYATL1;CYP1A2;GSTT2B;UGP2;GSTM5;UGT2B28;UGT2B10;MAT1A;SULT1C4;SLC35D1;UGT2A3;ACSM5;SULT2A1;PODXL2;UGT2B15;TPMT;PRNP;HPGDS;UGT1A7;ESD;GSTO2
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.3196815167642189,-1.4848658307996125,0.0,0.16926964305567382,1.0,76/248,17.34%,CRISP3;IFNL2;CR2;IFNL1;FCN3;CXCL10;FCN2;TREML1;JCHAIN;STYK1;IGLL5;WFDC2;SIGLEC16;CFP;BPI;IGLL1;APOA4;TKFC;KLRD1;TLR3;APOBEC3A;COLEC10;IFNL4;SIGLEC14;DEFB1;PI3;KRT16;PIK3CD;SIRPB1;CLEC4D;VNN1;GCH1;APOL1;FYN;CLEC4E;TRIM10;CR1;BLK;TLR8;CLEC5A;CYBB;MEFV;S100B;PGLYRP2;TRIM61;BTK;MBL2;REL;TRIM34;PGLYRP1;LCK;SLA;TLR4;MFAP4;CLEC7A;TRIM22;HCK;TLR2;SFTPD;CAMP;KYNU;SYK;FGR;S100A12;CD300E;PLCG2;MYD88;FCER1G;CORO1A;KIR2DS4;RNASE7;PTK6;ZAP70;BPIFB1;NCF1;TRIM5
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.6180431292769019,1.4847299232584519,0.075,0.5276635030475112,1.0,2/18,7.91%,TRIM71;AGO2
prerank,Reactome_2022__FRS-mediated FGFR4 Signaling R-HSA-5654712,0.6112412344177454,1.4845282484746667,0.043209876543209874,0.5263703208822877,1.0,6/17,20.14%,FGF20;FGF13;FGF17;FGF23;HRAS;FGF18
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,0.4924601777463966,1.4838688417462491,0.01015228426395939,0.5268704290921303,1.0,25/54,32.53%,H2BC13;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;EYA4;H2BC12;H2BC4;H4C15;H2BC5;H2AX;BARD1;APBB1;EYA1;NSD2;CHEK2;UBA52;MDC1;ABRAXAS1;PIAS4;BABAM2;UBE2I;TP53BP1;UIMC1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5242820113452394,1.4836489498878156,0.020833333333333332,0.5256725922606593,1.0,21/39,32.24%,E2F1;CDC6;CDC45;CDT1;CHEK1;H2AX;DNA2;DOT1L;CLSPN;ATRIP;RAD9B;DONSON;RHNO1;TIPIN;CHEK2;TIPRL;TIMELESS;INTS7;TP53BP1;RAD1;BRIP1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5474931587758491,1.4831139979581691,0.06521739130434782,0.5256960003703114,1.0,5/32,5.48%,MT3;NKD1;SLC6A4;FGF13;MSTN
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.5667374362372832,-1.4830831963275204,0.023529411764705882,0.1708267262368949,1.0,7/15,18.93%,GLYATL2;CYP4A22;CYP4A11;CROT;ACADM;ABHD2;CYP4Z1
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.3411229122371481,-1.4824476709163754,0.0,0.17119678335842775,1.0,53/176,21.42%,TCN1;NMRK2;RIMBP2;ENPP3;PTGS2;SLC52A1;LRAT;BCO2;SLC19A3;PARP6;APOA4;GPC5;BST1;CD38;APOA1;CYP8B1;MMUT;PRSS3;VNN1;GCH1;PARP8;AKR1C4;ACACB;GPC6;BCO1;MTHFD1;GPC4;SHMT1;AKT1;TTR;PANK1;SLC25A16;ABCD4;NMRK1;NUDT12;MCCC1;ENPP1;MMACHC;PTGIS;PDSS2;RBP1;SDC3;GSTO2;CYB5A;PCCA;LMBRD1;MTHFD2L;DHFR;MMADHC;SLC19A2;TTPA;APOB;IDH1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5838717466201209,1.4821889824075078,0.03225806451612903,0.5271056800896122,1.0,4/22,8.07%,MT3;PAX2;PAGE4;PRKN
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.36807143792310393,-1.4814825526844164,0.0,0.17200597550106408,1.0,37/90,18.42%,GLS2;UROC1;AADAT;GSTZ1;HMGCLL1;GLDC;HOGA1;TDO2;ALDH6A1;BCKDHB;PIPOX;SARDH;CBS;IDO2;FTCD;DAO;MAT1A;DDAH1;GCSH;HAAO;SHMT1;OTC;KYNU;ACADSB;KMO;DBT;IVD;ABAT;DDO;ECHS1;MCCC1;AASS;GCDH;CARNMT1;HMGCL;ACAT1;QDPR
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.5479796028444017,-1.4814169561320423,0.022222222222222223,0.17178963330595573,1.0,6/17,11.12%,FOXP3;IL10;TNF;APOA1;XCL1;LILRB1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.4940513106950964,-1.4811956953982082,0.03225806451612903,0.1717935701800892,1.0,12/24,27.68%,PTPN22;TLR3;RSAD2;TICAM2;TLR2;RTN4;SLC15A4;CYBA;F2RL1;TLR1;HMGB1;PJA2
prerank,Elsevier_Pathway_Collection__Vascular Smooth Muscle Cell Vasodilation in Brain,0.5747717804051005,1.480111465609005,0.03550295857988166,0.5326505146876526,1.0,8/28,17.27%,HTR1D;CALCA;RASGRF1;RAMP1;BDKRB2;ACE;HTR1B;MME
prerank,Elsevier_Pathway_Collection__Genes with Mutation in Cancer-Associated Dysregulated DNA Repair,0.5392250897459798,1.4799276849327723,0.056179775280898875,0.531472804696796,1.0,19/34,34.84%,HMGA2;XRCC2;MSH2;BARD1;MUTYH;FEN1;RAD51;PRKDC;DNMT1;MECP2;MSH6;POLB;OGG1;MLH3;TP53BP1;PMS1;LIG1;BRCA2;SMC1A
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.42517009601720035,1.479161446320959,0.0,0.5325431798452851,1.0,141/210,47.15%,EEF1A2;AGO2;MRPL55;MRPS21;MRPL24;MRPS24;RPL8;MRPS12;MRPL13;VARS1;EEF1D;FTSJ1;MRPL9;MRPS14;EPRS1;RPL30;RPLP1;HARS2;RPS27;RPS21;QARS1;RPLP2;DARS2;EIF4EBP2;MRPL23;RPS5;MRPL28;IGF2BP3;MRPL52;RPL28;FARSB;LARS1;RPS14;IARS2;RPL10;COPS5;RPSA;RPL26L1;RPL39;UBA52;TRMT112;RPLP0;EEF1E1;RPS15;MRPS28;RPS2;AIMP1;RPL31;HARS1;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;MRPL36;RPL13;RPL27;MRPL41;RPL38;RPL35;MRPL27;MRPS34;TUFM;RPL10A;MRPS15;GARS1;RPS8;RPS12;RPL22L1;RPL35A;MRPL51;RPS3A;IGHMBP2;N6AMT1;RPS7;DRG1;RPS11;RPL36A;GSPT2;RPL7A;MRRF;RPS3;RPL18A;APEH;RPL32;RPS24;RPL3L;MARS1;RPL29;RPL23;RPL5;RPS18;RPL14;RPS16;MRPS5;MRPL43;PTCD3;EEF2K;RPL13A;RPL41;RPL9;EEF1B2;RPS6KB2;MRPS18C;NOA1;IARS1;DRG2;TMA7;RPS28;FARSA;PABPC4;RPS23;PPA1;RPL27A;RPL23A;RPL18;RPL12;MRPL2;MRPS11;RPS9;RPL6;EEF2;RPS15A;RPL4;RPS26;RPL19;EEF1A1;RPS6;RPL26;FARS2;RPS27A;RARS1;MRPL47;RPS4Y1;MRPS16;RPL34;RPS13;ETF1;TNIP1
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.4447981333640935,1.4784299236564042,0.01932367149758454,0.5331504096847683,1.0,83/107,47.28%,RPL8;MRPL13;RPL30;RPLP1;RPS27;RPS21;RPLP2;EIF3E;RPS5;EIF3K;RPL28;RPS14;RPSA;RPL26L1;RPL39;EIF3D;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;EIF3H;RPL10A;RPS8;RPS12;EIF3B;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;EIF5B;RPS24;EIF3G;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;EIF3M;RPS28;RPS23;RPL27A;RPL23A;RPL18;EIF2S3;RPL12;RPS9;EIF3C;RPL6;EIF3F;RPS15A;RPL4;EIF3L;RPL19;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13;EIF3A
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,-0.48631563005250966,-1.477499226003438,0.013157894736842105,0.17592571236302718,1.0,10/27,17.03%,AMHR2;CHRDL1;BMP10;NOG;GDF2;GREM2;SMAD9;BMPR2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.49567451133349155,1.4774060144543728,0.030927835051546393,0.5348600212225214,1.0,13/60,14.87%,ODAM;H3C13;CALCA;TSPAN5;MAPT;SAA1;H3C1;SERF1A;PRKN;MFGE8;CD36;H4-16;IAPP
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.5475850769360623,1.4771778345047835,0.06043956043956044,0.5338301155368198,1.0,4/31,4.61%,HMGA2;TERT;ARG2;CDKN2A
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.6041118642511241,1.4766720702553977,0.06707317073170732,0.532021772593094,1.0,2/19,3.63%,AVIL;VIL1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.6041118642511241,1.4766720702553977,0.06707317073170732,0.532021772593094,1.0,2/19,3.63%,AVIL;VIL1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.5310153063270858,1.4765209775276786,0.06896551724137931,0.5307360477192192,1.0,16/36,34.06%,KIF1A;MAPT;KIF4A;AP3B2;BLOC1S1;TMEM108;SNAPIN;BLOC1S3;KIF1B;DTNBP1;AP3D1;NEFL;AP3M2;DYNC1H1;AP3B1;KIF3B
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.3261463010717217,-1.4763204029440087,0.0,0.17705817093531853,1.0,143/434,19.53%,IRF4;MUC1;IFNL2;IL20RA;IL13RA2;NLRP7;EREG;CSF3;IL20RB;CRHBP;IFNL1;IL10;CXCL10;PTPN20;PTGS2;GBP6;TNFSF11;IL5RA;HAS2;CD4;GHR;TNF;GBP5;AIM2;IL1B;MMP1;ACOD1;IL2RB;HGF;CCL5;SOCS2;FOS;FPR1;SFRP1;IL18R1;FASLG;NLRP12;PTPN13;CD80;CSF3R;MT1X;CCR5;CCL4;CCL3;IL1RAP;LIFR;IL18;CASP1;XCL1;CCL23;GBP7;PYHIN1;CCR7;ZFP36L1;PIK3CD;ASAH2;CTF1;CXCL12;CXCL2;FOXO1;GBP4;IL1RL2;CCL2;EGR1;GREM2;IL6;OSM;FYN;CCR1;NKX3-1;AXL;XCL2;DOCK8;TCL1A;SLA2;IL12B;ALOX5;IL1RN;CCR2;MNDA;CXCL8;GATA3;LCK;PDE1B;FLT3;SLA;TLR4;CCL22;RIPOR2;SHMT1;IRF8;GBP3;HCK;TLR2;HCLS1;PIK3R1;AKT1;IL16;SOX9;SYK;GBP1;VCAM1;CSF2;CXCR4;VAV1;BCL2L11;BAG4;IL12RB1;CD86;TNFRSF1B;IL10RA;PTPN7;ITGB2;CXCL1;CSF1R;LGALS9;F3;MT2A;BCL2;HMOX1;EBI3;STX3;INPP5D;PTAFR;CSF2RB;AKAP6;SLC12A2;PTGIS;SIGIRR;YBX3;TNFRSF21;DUSP1;AIF1;LIF;TWIST1;SELPLG;BATF;PID1;IFI16;SHPK;WNT5A;MAPK13;MYLK3
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.554339484279962,-1.4763012213147009,0.037037037037037035,0.1767246073654047,1.0,9/16,22.70%,NR4A3;PDK4;PPARGC1A;ACADL;SOX9;PRKAG2;MLYCD;FABP3;LONP2
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.45431013167936624,1.4761079081571054,0.014925373134328358,0.5304667470730369,1.0,31/101,26.78%,H3C13;H2AC19;H2BC13;PLK1;H2AC20;H2BC17;CCNB2;H2BC21;H2BC9;H2BC15;H2BC11;CDK1;CCNB1;H2BC12;H2BC4;H4C15;H2AC6;LMNA;H2BC5;PRKCA;H2AX;NUP37;LPIN1;H2AJ;NUP62;TPR;NUP133;NCAPH2;EMD;SMC4;LMNB1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.5627569761496352,1.47605264138353,0.06790123456790123,0.5288638195422197,1.0,9/26,9.29%,MAPT;STMND1;STMN3;KIF2C;FGF13;STMN2;KIF14;KIF18B;KIF18A
prerank,Elsevier_Pathway_Collection__Steroidogenesis Impairement in Polycystic Ovary Syndrome,0.5091808636880257,1.4742240705052374,0.06486486486486487,0.5336420654395837,1.0,5/38,7.48%,IGF2;CYP17A1;RASGRF1;NR5A1;AMH
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Polycystic Ovary Syndrome,0.6102879426339254,1.4740424542512607,0.06060606060606061,0.5324587481897631,1.0,4/17,7.48%,IGF2;CYP17A1;NR5A1;AMH
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.3872565437784218,-1.4739684216706146,0.015873015873015872,0.1791139391878102,1.0,32/59,22.36%,NLRP2;IFNG;TNF;GBP5;AIM2;NLRP12;CCL3;CASP1;LILRA2;PYHIN1;LILRA5;NLRP3;EGR1;IL6;TLR8;MNDA;TLR4;CLEC7A;IL16;ORM2;MYD88;LGALS9;NLRC4;IFI16;WNT5A;NOD2;INAVA;TMEM106A;JAK2;TMED10;TYROBP;APP
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.47345543028820725,1.473914954677274,0.041884816753926704,0.5312154642788702,1.0,32/66,40.48%,TRIM71;H3C13;H3C1;AGO2;POU5F1;H4-16;PPARG;POLR2L;NUP37;NUP62;POLR2K;TPR;NUP133;POLR2G;H3-3A;NUP155;NUP160;POLR2H;FMR1;NUP188;TGFB1;POLR2I;POLR2J;AGO1;DHX9;NUP205;POLR2A;NUP210;LIMD1;POLR2B;RAE1;NUP214
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,-0.5239507479920609,-1.473771693497168,0.09195402298850575,0.17895152929014685,1.0,4/16,4.44%,CASR;GRM8;TAS2R60;TAS2R19
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.6013456261320476,1.4731954738689066,0.06358381502890173,0.5318388210833828,1.0,6/19,10.65%,STOX1;CDC25C;DTL;CDC7;CDK1;CCNB1
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.614258732740474,1.4724728338862727,0.03680981595092025,0.5331091957358495,1.0,4/15,7.32%,HMGA2;MESP1;BMP4;MEOX1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.5341366587065394,-1.4723495283578611,0.031578947368421054,0.18036216917921463,1.0,4/16,11.19%,GGT6;ALOX5AP;ALOX5;PLA2G4A
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.45929382745441194,1.4721494755896478,0.014285714285714285,0.5325585604369089,1.0,49/106,33.12%,TICRR;NT5M;EXO1;RECQL4;CDC6;CDC7;CDC45;CDK1;MCM2;MCM6;FAM111B;RFC4;ORC1;PIF1;MCM10;POLD1;CHEK1;MCM3;MCM5;BARD1;ING5;MCM4;PCLAF;DNA2;RMI1;FEN1;CLSPN;TOP1MT;ATRIP;RAD9B;RBMS1;MCM7;DONSON;WDHD1;POLA1;POLA2;BLM;DUT;RHNO1;TIPIN;NAP1L1;TIMELESS;RECQL5;POLB;RAD1;BRIP1;RMI2;MCM8;TOPBP1
prerank,Elsevier_Pathway_Collection__Dexamethasone Induced Neurotoxicity,0.6163797339451889,1.471724751856137,0.057692307692307696,0.5324576366136365,1.0,2/16,2.84%,DKK1;MAPT
prerank,Elsevier_Pathway_Collection__DREAM Complex and FOXM1/MYBL2 Promote Cell Cycle Progression in Cancer,0.563625380007419,1.4715997533955267,0.061452513966480445,0.5311456733637836,1.0,10/28,13.29%,NEK2;FOXM1;PLK1;BIRC5;CCNE1;CCNA2;CDK1;CCNB1;AURKA;MYBL2
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.4522967975102915,1.4711815097516872,0.028708133971291867,0.5308948666846179,1.0,75/96,46.98%,RPL8;MRPL13;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPSA;RPL26L1;RPL39;DDIT3;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;GDNF;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;GCN1;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;EIF2S3;RPL12;RPS9;RPL6;RPS15A;RPL4;RPL19;EIF2AK4;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.45455384314801295,-1.4703924456323758,0.04225352112676056,0.18243841036596234,1.0,11/30,21.37%,LRAT;ADH4;ADH1A;CYP1A2;ADH1C;ADH7;CYP3A4;IGF1;PECR;ADH6;NAAA
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.46809465794234767,1.46983516889879,0.024752475247524754,0.5336387520793663,1.0,27/82,28.26%,TRIM71;E2F1;GFI1;CDKN2A;CAMK2A;CDKN3;CCNE1;CDKN2C;CDC6;CDC7;CCNE2;CDC45;CDT1;TYMS;ORC1;CDC25A;RRM2;CDK6;CDK16;POLA1;CDKN2D;ZNF324;CDK5;MYC;BCAT1;CUL4B;CDKN1A
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,0.48717716980215964,1.469551507307083,0.03825136612021858,0.5328200670854362,1.0,32/68,31.85%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;KAT2A;H2BC5;H2AX;POLR2L;POLR1A;EHMT2;HDAC1;H2AJ;POLR2K;GATAD2B;TAF1A;POLR1H;POLR1G;CHD3;CHD4;POLR2H;RBBP7;CBX3;H2AZ1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.37750965700256156,-1.4693065400534429,0.015873015873015872,0.1832643634557358,1.0,16/74,11.18%,KLK3;CXCL10;SEMA3E;CD160;CCN6;FASLG;COL4A3;ISM1;GDF2;ANGPT4;DCN;KLF4;SEMA6A;ADAMTS1;ALOX5;CCR2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.41771680783618137,-1.4690840535434582,0.03076923076923077,0.18323538367983738,1.0,24/51,24.49%,ABCD2;BDH2;SCP2;ACADL;ACAA1;ACADS;EHHADH;ACOX1;ETFDH;ABCD4;CROT;IVD;ECHDC1;ACAD11;ACADM;ECHS1;GCDH;ACAT1;ACOX2;ACOX3;SLC27A2;ECHDC2;CRAT;ACAA2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.5919989077570602,1.4689947973540325,0.04294478527607362,0.5331808123151295,1.0,4/21,3.45%,MAFA;PTPRN;NEUROD1;GAL
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.5622792042264321,1.468932250275639,0.04597701149425287,0.531657851177602,1.0,8/32,9.94%,IGF2;CTNNA2;MAPK12;TCF23;MAPK11;MYF6;ZBED6;CDON
prerank,KEGG_2021_Human__Cell adhesion molecules,-0.3471564906116532,-1.4688805605812087,0.0,0.1832280372082596,1.0,60/141,22.24%,NRXN1;NCAM2;CLDN4;L1CAM;CLDN10;ITGB8;CD4;CLDN8;CD8B;CD8A;MAG;CDH1;CD80;LRRC4;TIGIT;NEGR1;VTCN1;NCAM1;ICOS;CTLA4;IGSF11;PTPRC;ICAM3;SIGLEC1;CD2;CD40LG;CD274;HLA-DQA2;PDCD1LG2;SPN;SELE;NLGN4X;HLA-DOB;CDH4;CD226;CLDN1;VCAM1;CLDN11;NLGN4Y;CD86;LRRC4C;ITGB2;CD6;ITGA9;HLA-DQA1;ITGA4;SDC3;SELPLG;NECTIN3;CDH3;SELL;HLA-DOA;HLA-DRB5;SELP;HLA-DRA;NTNG2;CLDN34;ITGAM;CD40;CLDN3
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.38041123844856517,-1.4683363827759166,0.025,0.18337108467717564,1.0,22/119,12.58%,CPNE6;PITPNM3;AWAT2;PCYT1B;MFSD2A;BCHE;SLC44A4;GPD1;PLAAT1;PEMT;LIPH;DGAT2;SLC44A3;PHOSPHO1;PLA2G2D;SLC44A5;AGPAT2;ETNK2;PLAAT2;PLA2G4A;PLAAT3;PLD4
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.46221935814383786,-1.4681210311914492,0.08,0.1833099074445036,1.0,8/28,21.32%,ART3;PARP6;ART5;PARP8;PARP15;SIRT5;ART4;TIPARP
prerank,MSigDB_Oncogenic_Signatures__KRAS.50 UP.V1 UP,0.507903177160759,1.4676112771956424,0.049723756906077346,0.5344187502434289,1.0,9/44,6.68%,CHGB;DYNC1I1;NRCAM;PEG3;TERT;MMP11;ITGA2;FAM155B;NTM
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,0.4519348709095173,1.467421018224583,0.023809523809523808,0.5331841323255466,1.0,71/88,46.98%,RPL8;MRPL13;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPSA;RPL26L1;RPL39;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;GNL3;RPS9;RPL6;RPS15A;RPL4;RPL19;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,-0.4539087608920585,-1.4671762052365775,0.04,0.18398722368213502,1.0,10/33,18.12%,NMRK2;ENPP3;PNP;BST1;CD38;ASPDH;NMRK1;NUDT12;ENPP1;SIRT5
prerank,Elsevier_Pathway_Collection__Ca2+ Flux Regulation,0.4527425186256258,1.4671668978833843,0.034482758620689655,0.532553232160525,1.0,32/93,16.39%,HTR1D;CACNA1E;ADRA2C;CALCA;GRIN1;P2RX5;RAMP1;OPRL1;CHRNB2;HRH3;SRC;ADRA1D;PTGER1;PTGER3;BDNF;CAMK2A;GRIN2A;GRIN3B;PRKD1;CHRM5;CACNA1C;BDKRB2;CHRNA4;PTGFR;BDKRB1;HTR1B;SHC1;PDPK1;P2RX2;GRM1;HTR2B;TACR1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.6147782870316546,1.4666428168160517,0.06358381502890173,0.5328227147971331,1.0,5/15,11.34%,ST8SIA3;B4GALNT1;A4GALT;ST6GALNAC4;ST8SIA5
prerank,Elsevier_Pathway_Collection__Toll-like Receptors in Pyelonephritis,-0.539546882033706,-1.4665743243505311,0.047619047619047616,0.1843095513474566,1.0,7/18,14.75%,TNF;IL1B;IL6;CXCL8;TLR4;TLR2;MYD88
prerank,Elsevier_Pathway_Collection__Vitiligo,-0.3852755284837566,-1.4661632572446601,0.0,0.18453472479352492,1.0,25/75,19.52%,IFNG;TNF;IL1B;IL2RB;CXCR1;CXCR2;FASLG;PTPN22;IL1RAP;MAP2K1;MITF;MAF;PRF1;IL6;TBX21;RAC2;CXCL8;GATA3;C1R;MYD88;VAV1;BCL2;GZMB;C1S;TYRP1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.5321191428473528,-1.4651464364852111,0.04878048780487805,0.18537607740673887,1.0,4/15,11.92%,SPINT2;TACSTD2;SPOCK3;GATA3
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,0.43591204327165517,1.4642731361062802,0.023474178403755867,0.5397222347380274,1.0,87/114,47.28%,RPL8;MRPL13;EIF2B4;RPL30;RPLP1;RPS27;RPS21;RPLP2;EIF3E;RPS5;EIF3K;RPL28;RPS14;RPSA;RPL26L1;PABPC1;RPL39;EIF3D;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;EIF3H;RPL10A;RPS8;RPS12;EIF3B;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;EIF5B;RPS24;EIF3G;RPL3L;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;EIF3M;RPS28;EIF2B5;RPS23;RPL27A;RPL23A;RPL18;EIF2S3;RPL12;RPS9;EIF3C;RPL6;EIF3F;RPS15A;RPL4;EIF3L;RPL19;EIF2B1;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13;EIF3A
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,0.4812950105801264,1.4642510543187564,0.0374331550802139,0.5380893867235792,1.0,32/69,31.85%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;KAT2A;H2BC5;H2AX;POLR2L;POLR1A;EHMT2;HDAC1;H2AJ;POLR2K;GATAD2B;TAF1A;POLR1H;POLR1G;CHD3;CHD4;POLR2H;RBBP7;CBX3;H2AZ1
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.41088128988753997,-1.4636744308130363,0.015625,0.18677701635092503,1.0,20/55,14.94%,IFNG;TNF;IL1B;IL2RB;SYT7;FPR2;APOA1;IL15;SIRPB1;SIRPG;PTPRC;FCGR2B;CLEC7A;HCK;TLR2;SFTPD;SYK;FGR;DOCK2;FCER1G
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,-0.45745622625092414,-1.4635677995153968,0.05714285714285714,0.18659351336348262,1.0,14/33,11.30%,PKP3;LCE2D;EVPL;TCHH;SPRR3;RCAN1;PRSS8;LIPJ;PI3;LIPN;DSG2;TGM1;KAZN;ST14
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.37256190463628364,-1.4633409960670487,0.0,0.1864530160174994,1.0,34/84,22.05%,IFNG;CD4;IL2RB;FOS;MAF;PRKCQ;CD3E;CD3G;RUNX3;TBX21;IL12B;HLA-DQA2;GATA3;LCK;CD247;LAT;HLA-DOB;IL12RB1;NOTCH2;ZAP70;HLA-DQA1;MAPK10;PPP3CA;MAPK13;CD3D;IL12RB2;HLA-DOA;HLA-DRB5;NFATC2;MAML2;JUN;HLA-DRA;JAK2;STAT1
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer-Associated Dysregulated DNA Repair,0.5542249447367941,1.463280970711416,0.06896551724137931,0.540146994785168,1.0,14/25,33.74%,HMGA2;XRCC2;MSH2;MUTYH;FEN1;RAD51;DNMT1;MSH6;POLB;OGG1;TP53BP1;PMS1;LIG1;BRCA2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.5302515572819338,1.4628968743501918,0.06077348066298342,0.5400267725218255,1.0,12/36,19.42%,PRKAA2;MAPT;SKA1;STMND1;STMN3;STMN2;SKA3;CDK2AP2;STMN1;MAP6;MAP6D1;GAS2L1
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,0.5358243751135038,1.4622465345480058,0.028735632183908046,0.5409173064634633,1.0,10/29,13.63%,ACTN2;TNNI3;MYH3;TNNT1;MYH8;TNNI2;TNNT3;MYBPC1;TMOD4;TPM2
prerank,Elsevier_Pathway_Collection__TNFR -> NF-kB Signaling,-0.47824269573904327,-1.4622372884358061,0.0684931506849315,0.18709436744489422,1.0,13/29,22.85%,TNF;FASLG;TNFSF10;TNFRSF13B;CD40LG;TNFSF13;LTA;TNFRSF1B;TNFSF13B;MAP2K3;MAP2K6;CD40;MAP3K5
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.4086069428320059,-1.4618437947682474,0.0,0.1872274585135738,1.0,22/53,19.59%,SERPINB5;NLRP7;SERPINA12;ECM1;SPOCK3;CST7;SERPINA11;FETUB;SERPINA9;SERPINA5;SERPINA4;AKT1;SERPINB2;SERPINA10;SERPING1;SERPINB9;KNG1;SPOCK1;VTN;SERPINB8;SERPINF2;AHSG
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.4211664956958534,-1.46092949790125,0.02631578947368421,0.18771768782212148,1.0,8/38,9.64%,ERBB4;IFNL1;IL10;GHR;TNF;CCL5;PTPRC;IL6
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,0.4431483797561329,1.4609262549575532,0.03153153153153153,0.5438372473886678,1.0,76/141,40.59%,H2BC13;H2BC17;H2BC21;EME1;H2BC9;EXO1;H2BC15;CCNA2;H2BC11;EYA4;H2BC12;NHEJ1;H2BC4;H4C15;SERPINA2;XRCC2;RFC4;RTEL1;H2BC5;POLD1;CHEK1;H2AX;BARD1;DNA2;RMI1;FEN1;POLR1A;CLSPN;ATRIP;PARP1;RAD9B;APBB1;EYA1;RAD51AP1;RAD51;PRKDC;KPNA2;BLM;RHNO1;TIPIN;NSD2;CHEK2;UBA52;SIRT6;TIMELESS;MDC1;PCNA;ABRAXAS1;XRCC1;PIAS4;BABAM2;UBE2I;POLM;TP53BP1;BRIP1;RMI2;UIMC1;TOPBP1;MUS81;BRCA2;PAXIP1;SEM1;POLL;ABL1;EME2;POLH;BAZ1B;XRCC3;BABAM1;SPIDR;XRCC6;CDK2;SLC19A1;HERC2;RAD52;POLK
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.44428285042365645,1.4608907531010966,0.019230769230769232,0.542301462270854,1.0,83/106,46.98%,SSR2;SSR4;RPL8;MRPL13;RPL30;RPLP1;SEC61G;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;SEC11C;RPSA;RPL26L1;RPL39;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPN2;RPS7;SRPRB;RPS11;RPL36A;SEC61B;RPL7A;FAU;RPS3;RPL18A;SPCS1;RPL32;RPS24;RPL3L;DDOST;RPL29;SRP14;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;SEC61A1;RPS15A;RPL4;RPL19;SRP19;RPL39L;SPCS2;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,Elsevier_Pathway_Collection__AGER -> CREB/SP1 Signaling,0.6049143010741211,1.4606482375222758,0.07453416149068323,0.5416283475640674,1.0,2/17,2.12%,S100P;S100A1
prerank,Elsevier_Pathway_Collection__Vascular Motility,0.4704492256701047,1.4605294643803446,0.041025641025641026,0.5403398277157501,1.0,19/76,16.14%,HTR1D;ADRA2C;CALCA;RASGRF1;RAMP1;HTR4;SRC;ADRA1D;PTGER1;PTGER3;CAMK2A;PRKD1;CACNA1C;BDKRB2;PTGFR;BDKRB1;HTR1B;PDPK1;ADORA2A
prerank,MSigDB_Oncogenic_Signatures__CYCLIN D1 KE .V1 DN,-0.3340099222358156,-1.460306296777077,0.0,0.1881535857849478,1.0,47/162,17.64%,KLK3;GRIN2B;AMHR2;PVALB;KRT5;PCK1;CD27;PTH1R;IL7R;MAG;SPIB;CXCL3;CAMK4;OXT;EPHA1;ALK;CXCL12;NPAS1;CYP2C9;MS4A1;PRKCQ;NKX3-1;DAO;CD53;PEPD;NCKAP1L;DNAJB4;PIK3R1;MYO1F;KCNJ8;POU2F2;VCAM1;PLCG2;DNAH3;C1QB;CSF2;GRIA1;GPSM3;LILRB4;CFTR;PTCRA;F3;PIP4K2A;IFIT3;GATA1;UCP2;AKAP6
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.4245367983520429,1.460246242215959,0.0228310502283105,0.539812951528226,1.0,119/162,47.30%,LHX3;ROBO1;LHX9;LHX4;MSI1;PSMD4;COL4A5;PSMB4;ELOC;RPL8;CASC3;MRPL13;ELOB;RBM8A;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;PSMB3;RPS14;RPSA;HOXA2;RPL26L1;PABPC1;PSMD14;RPL39;UPF3B;UBA52;RPLP0;RPS15;PSMB5;ROBO3;RPS2;PSMD2;RPL31;RPS19;PSMA1;RPL36;RPL37A;PSMD10;RPL37;RPL7;RPS4X;RPS20;PSMC4;PSMC3;RPL27;RPL38;RPL35;RPL10A;PSMC5;RPS8;RPS12;RPL22L1;RPL35A;SEM1;MAGOHB;PSMB6;RPS3A;PSMD8;RPS7;RPS11;RPL36A;GSPT2;RPL7A;PSME2;FAU;RPS3;RPL18A;RPL32;RPS24;PSMD13;RPL3L;PSMB7;PSMA7;RPL29;RPL23;RPL5;RPL14;PSME3;RPS16;RPL13A;RPL41;RPL9;RPS28;SLIT3;RPS23;RPL27A;RPL23A;RPL18;PSMB2;RBX1;PSMA6;RPL12;UBC;PSMD9;RNPS1;RPS9;RPL6;RPS15A;RPL4;RPL19;PSMC2;RPL39L;RPS6;RPL26;EIF4A3;RPS27A;MAGOH;RPS4Y1;PSME1;RPL34;RPS13;PSMB1;ETF1;PSMD3
prerank,Elsevier_Pathway_Collection__Nicotine anti-Inflammatory Effect in Ulcerative Colitis,-0.4662931561366506,-1.4601123402071492,0.0,0.18806388263393006,1.0,10/28,14.75%,IL10;TNF;IL1B;IL6;TICAM2;CHRNA7;TLR4;TLR2;AKT1;MYD88
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.5057392035327463,1.459678750595043,0.05612244897959184,0.5403329556305079,1.0,12/43,10.35%,COL2A1;COL22A1;COL7A1;COL15A1;COL9A1;COL10A1;COL4A1;COL4A5;COL8A1;COL1A1;COL11A1;COL4A2
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.48378415117798906,-1.4596192268036547,0.03896103896103896,0.18815233216629956,1.0,9/22,19.01%,IL1B;APOA4;ABCD2;APOA1;APOA5;ABHD5;ANGPTL3;TWIST1;IRS2
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.5795895158430495,1.4594003133413627,0.05813953488372093,0.5396220273881965,1.0,6/25,9.94%,CTNNA2;MAPK12;MAPK11;MYF6;NTN3;CDON
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.566544472076473,-1.4586365947965119,0.03296703296703297,0.1889190784228971,1.0,7/15,12.74%,DSCAM;TNN;IGSF9;CNTN6;VSTM2L;EMB;CNTN4
prerank,Elsevier_Pathway_Collection__Dendritic Cell Activation in Systemic Lupus Erythematosis,-0.4182539712527321,-1.458327135146602,0.03076923076923077,0.18895350458193608,1.0,15/50,14.75%,IL10;TNF;IL1B;TLR3;IL18;CASP1;NLRP3;IL6;TLR8;IL33;TICAM2;TLR4;TLR2;CAMP;MYD88
prerank,Elsevier_Pathway_Collection__AHR Signaling in Th17 Cells Function,-0.5162260601441748,-1.4582894208593127,0.09876543209876543,0.18863414648066879,1.0,4/18,9.64%,IRF4;IL10;IKZF3;IL6
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.4639798268584075,1.4582718021094063,0.037037037037037035,0.5422244505839207,1.0,18/64,15.60%,GLP1R;RFX6;CACNA1E;GCG;ADRA2C;KCNC2;RASL10B;KCNG2;NEUROD1;CACNA2D2;KCNB1;SSTR5;ABCC8;CACNA1C;SNAP25;DPP4;KCNJ11;PRKCA
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,0.5258435850463377,1.458254858976718,0.056179775280898875,0.5406227129885017,1.0,7/32,5.96%,KCNH6;KCNC1;KCNF1;KCNC2;KCNH2;KCNG2;KCNB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.5993546906445426,1.4570785124326837,0.04790419161676647,0.5433198033723566,1.0,7/18,15.45%,IGF2;APLN;MDK;FGF2;FLT1;PDPK1;PPARG
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.47912914269134443,1.4570264635660297,0.046153846153846156,0.54190944475535,1.0,15/73,11.57%,SFN;E2F1;E2F7;CDC25C;ARID3A;FOXM1;GTSE1;PRAP1;E2F8;ZNF385A;CDK1;CCNB1;RGCC;AURKA;NDRG1
prerank,Elsevier_Pathway_Collection__Neutrophil Recruitment and Priming,-0.40104500274014465,-1.4568046863498236,0.03508771929824561,0.18989409598707652,1.0,28/64,25.20%,CSF3;TNF;IL2RB;FOS;CXCR2;CSF3R;MAP2K1;PRKCB;CXCL8;TLR4;TLR2;MYD88;CXCR3;CSF2;ITGB2;SELL;PF4;MAP2K3;MAP2K6;JUN;JAK2;ITGAM;STAT1;MAP3K5;CSF2RA;MAP2K4;CD14;GNAI2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.378711742960116,-1.4566765816070972,0.02127659574468085,0.1897089016063128,1.0,26/95,13.29%,CYP26A1;CYP2C19;UGT2A1;AKR1D1;SRD5A2;CYP2B6;CYP39A1;CYP2C8;RDH16;SRD5A1;UGT2B7;CYP3A7;CYP1A2;CYP3A43;SCP2;CYP8B1;HSD3B1;CYP2C9;AKR1C4;HSD17B14;UGT2B28;ACAA1;NR1I2;CYP26B1;CYP3A4;CYP4V2
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.5002269287982307,-1.4562765938975382,0.05434782608695652,0.1899381541420551,1.0,15/20,24.86%,S100A14;TNIP3;SCIMP;TICAM2;TLR4;PRKCE;ITGB2;LGALS9;NR1H4;NMI;ITGAM;PIK3AP1;OAS1;CD14;LY96
prerank,Elsevier_Pathway_Collection__Clozapine Induced Granulocytopenia,-0.4485857791937481,-1.4558468493418462,0.01694915254237288,0.1901149370920339,1.0,17/41,22.05%,CSF3;IL10;PTGS2;IFNG;FOS;CYP1A2;TNFSF10;MAP2K1;AKT1;RASGRP1;CSF2;MAP2K3;MAP2K6;JUN;JAK2;RAP1A;STAT1
prerank,WikiPathway_2021_Human__Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.621402985753983,1.4558276085850674,0.05357142857142857,0.5447606973760579,1.0,5/15,10.17%,BUB1B;CENPE;CDC20;BUB1;PTTG1
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,0.5004902387205517,1.455768150225125,0.046875,0.5433135985768196,1.0,24/51,35.44%,EXO1;NEIL3;SERPINA2;XRCC2;RFC4;MSH2;BARD1;DNA2;RMI1;MUTYH;POLR1A;ATRIP;RAD9B;RAD51AP1;RAD51;BLM;RHNO1;MSH6;OGG1;BRIP1;RMI2;TOPBP1;BRCA2;SEM1
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,0.6186067904278643,1.4555512485432316,0.08024691358024691,0.5424150685294201,1.0,4/16,7.62%,FGF20;FGF13;FGF17;FGF23
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.5101511278828247,-1.455481922686637,0.034482758620689655,0.19019831557529115,1.0,12/23,16.36%,IRF4;FOXP3;NLRP3;PRKCQ;CD40LG;SLC7A5;GATA3;SYK;HAVCR2;FCER1G;CD86;LGALS9
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.4457083052551355,1.455478503125603,0.02912621359223301,0.541146076881455,1.0,74/94,46.98%,SIL1;SSR2;RPL8;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPL10;RPSA;RPL39;UBA52;RPLP0;SRP9;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL13;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;RPS3;RPL18A;RPL32;RPS24;RPL29;SRP14;RPL23;RPL5;RPS18;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;SEC61A1;RPS15A;RPL4;RPS26;RPL19;SRP19;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.5786389039464599,1.4554164966740524,0.07142857142857142,0.539702332369589,1.0,5/23,13.21%,MAFA;SLC2A5;NEUROD1;LPL;APOA2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.4699481441244839,1.4551454372488746,0.014925373134328358,0.5391354663697955,1.0,19/72,18.85%,E2F7;KIF20A;PLK1;PLK5;KIF14;RAB11FIP4;SSTR5;E2F8;AURKB;KLHL21;CDC6;KIF23;KLHL13;AURKA;RACGAP1;ANKRD53;ECT2;PRC1;CETN2
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,-0.3871742287598978,-1.4551315651529526,0.0,0.1900550708127537,1.0,38/85,24.54%,IRF4;GBP6;IFNG;GBP5;OASL;BCL11B;NCAM1;GBP7;IFI30;CAMK2B;GBP4;TRIM10;HLA-DQA2;IRF8;TRIM22;GBP1;VCAM1;MT2A;HLA-DQA1;TRIM5;PTAFR;HLA-DQB2;OAS3;OAS2;HLA-DRB5;SMAD7;HLA-DRA;JAK2;STAT1;TRIM31;IRF2;HLA-DPA1;OAS1;TRIM21;TRIM29;TRIM14;IRF9;HLA-DRB1
prerank,TRRUST_Transcription_Factors_2019__EGR1 human,-0.3695977788847247,-1.4550992743697064,0.021739130434782608,0.18974805783324034,1.0,11/84,6.68%,KLK3;PCSK2;PTGS2;CYP2B6;IFNG;TNF;TH;TFPI2;IL2RB;FASLG;TNFSF10
prerank,TRRUST_Transcription_Factors_2019__MYC human,0.4344569498140899,1.4547967273805689,0.03902439024390244,0.5386323475621645,1.0,21/97,17.27%,IGF2BP1;DKK1;TLX1;AXIN2;PRODH;TP73;TERT;CDCA7;CDC25C;FOXM1;UBE2C;CCNE1;CCNA2;CCNB1;NDRG1;CAD;TFAP4;ODC1;CHEK1;ST3GAL3;MME
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.5907880297507532,1.4546338312842668,0.05521472392638037,0.5377407245124233,1.0,8/20,21.80%,FGF20;FGF13;FGF17;FGF23;SHC1;HRAS;FGF18;PLCG1
prerank,WikiPathway_2021_Human__Androgen receptor signaling pathway WP138,-0.37271628737210927,-1.4542139868201136,0.04081632653061224,0.19038512466711624,1.0,1/87,0.01%,KLK3
prerank,WikiPathway_2021_Human__Farnesoid X receptor pathway WP2879,-0.5143009943196164,-1.4536377626903616,0.08695652173913043,0.1907027106439558,1.0,10/19,19.01%,IP6K3;SLC10A1;PPARGC1A;CYP8B1;SLCO2B1;CYP3A4;SULT2A1;SLC27A5;NR1H4;IRS2
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.3840803160648843,-1.453619695190731,0.0,0.19036555906901168,1.0,29/70,16.09%,CXCL13;CXCL10;CXCL11;CCL5;CXCR1;CXCR2;CXCL3;CXCL9;S100A8;CCL4;CCL3;XCL1;LGALS3;CCL23;PIK3CD;CXCL2;CCL2;XCL2;CXCL8;NCKAP1L;CCL22;SYK;PF4V1;S100A12;CD300H;FCER1G;CD177;ITGB2;CXCL1
prerank,MSigDB_Oncogenic_Signatures__RPS14 DN.V1 UP,-0.32034682630979805,-1.4534106482721008,0.0,0.1902436997106891,1.0,85/178,23.17%,CEACAM6;PMP2;SPINT1;EGR3;IL1B;NR4A3;PROM1;CD69;PTPN22;CRTAM;MS4A6A;BST1;IL1RAP;CDCP1;CASP1;PTPRO;FBN2;DCN;ANXA3;GPR183;MAF;ICAM3;NKG7;VNN1;SPTLC3;CCL2;EVI2B;TFEC;CR1;CD300A;TRIM36;SEMA3D;CLEC5A;BCL2A1;SASH3;PTGER4;MNDA;ARL4C;LECT2;CLEC7A;TNFRSF9;TRIM22;HCK;SH2D2A;MX2;SORL1;MYO1F;KYNU;PF4V1;ATP8B4;KMO;CROT;SLC31A2;RBM47;ITGB2;SCN3A;LST1;LY75;STX3;TNFRSF10C;LY86;AIF1;KCTD12;C3AR1;ARHGAP25;NCF2;PID1;IFI16;CLEC2B;KBTBD11;ANXA6;ST3GAL6;RCBTB2;HLA-DRB6;LPXN;NYNRIN;ADAMTS6;ITGAM;TNFAIP2;EVI2A;TYROBP;IGSF6;ANPEP;SIRPA;PILRA
prerank,Elsevier_Pathway_Collection__Telogen Maintenance in Androgenic Alopecia,0.5619521325428868,1.4531921148128286,0.07272727272727272,0.5413279502127986,1.0,7/22,9.33%,DKK1;LEF1;SFRP4;ITGA6;BMP4;CD34;CD200
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.5287422089878777,-1.4529229108626183,0.06944444444444445,0.19054963808503556,1.0,9/16,20.29%,TAS2R60;TAS2R19;RTP5;AZGP1;PIGR;RTP3;TAS2R31;TAS2R14;PKD1L3
prerank,MSigDB_Oncogenic_Signatures__E2F3 UP.V1 UP,0.4209550367662545,1.4523921248939957,0.019417475728155338,0.542279743633447,1.0,68/167,24.72%,ZIC2;CDC20B;MNX1;LEF1;TSPAN5;EEF1A2;LRP4;E2F7;NAT8L;GAD1;FAM43B;SHISA8;RASD1;CHRDL2;DHRS13;SLC4A3;KISS1R;EPHX4;DTL;MANEAL;CCNE1;CDKN2C;FBXL16;RECQL4;ZNF703;CCNE2;NPTX1;FUT5;EML6;GPR137C;JPH1;SYN1;TLCD1;CSPG5;SAC3D1;HSPA2;ATRNL1;APOLD1;CDKN1C;INHBB;TMEM201;CHML;RTN4RL1;SLC6A2;MEX3B;PLXND1;MAP6D1;ATAD2;CDK5R1;EGLN1;FEN1;RAB9B;HEY1;SIX5;SYNM;REEP1;TMEM106C;RHOBTB2;CABLES2;SLC27A3;MFHAS1;CHST1;ZNF367;SAMD1;LIN7B;MICB;SHANK3;PDIA2
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.46114862914816906,-1.451541365764923,0.05952380952380952,0.19178888398694757,1.0,9/26,22.30%,GCK;HK3;ENO3;ALDOB;ALDOC;PGM1;ENO2;ENO4;PGAM1
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,0.449412833368695,1.4514669239981088,0.004784688995215311,0.5436140271214172,1.0,23/107,15.12%,DYNC1I1;H3C13;H2AC19;H2BC13;H2BC18;H2AC11;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;EZH2;TARBP1;VPS28;H2BC11;PCSK1;RNASE1;H2BC12;H2BC4;H4C15;H2AC6;MVB12B;H2BC5
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.44751116720578465,1.4513511118005744,0.0196078431372549,0.5425000321824712,1.0,24/80,19.89%,CCNO;CDKN2A;CDC25C;PLK1;CCNB2;CDKN3;CCNE1;CDKN2C;CDC6;CCNA2;CCNE2;CCNF;CCNB1;RGCC;CDKN2B;PDGFB;TFAP4;CDKN1C;PSRC1;PKMYT1;PKD1;CDC25A;CDK5R1;CCNP
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.5703174220543391,1.4510596065273886,0.06451612903225806,0.5420255870852891,1.0,9/21,18.02%,CACNG4;CACNG5;MAPK8IP2;SHISA8;SHISA6;CACNG8;CNIH3;CNIH2;NLGN2
prerank,Elsevier_Pathway_Collection__Retinal Ganglion and Suprachiasmatic Nucleus in Melatonin Synthesis Regulation,-0.5372023550196257,-1.450782949397513,0.1,0.19227341163248424,1.0,4/15,13.06%,NKX2-1;GLS2;VIPR1;PER1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.4594924064256055,1.4506654936638697,0.045,0.542244327427033,1.0,10/66,6.21%,PAX2;SIX1;REN;OSR2;OSR1;WNT4;LRP4;SIX2;CENPF;BMP4
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.5056425305620604,1.450277432416841,0.046511627906976744,0.5418028589235729,1.0,20/45,30.96%,H3C13;PRDM16;EZH2;SMYD3;H4C15;NFKB2;SMYD2;DOT1L;SUV39H1;EHMT2;NSD1;SETDB1;KMT2D;KMT2B;KMT5C;NSD2;WDR5;ASH1L;SUV39H2;RBBP7
prerank,WikiPathway_2021_Human__Modulators of TCR signaling and T cell activation WP5072,-0.38320428512359445,-1.4498380717600672,0.01639344262295082,0.1928877504561869,1.0,19/61,15.00%,CD8A;SH2D1A;ITK;ZFP36L1;RHOH;PRKCQ;CD3E;CD3G;LCP2;UBASH3A;CARD11;REL;LCK;CD5;CD247;LAT;PIK3R1;AKT1;VAV1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.4592304007993086,-1.4493186217306004,0.06153846153846154,0.19337865391116374,1.0,11/26,13.06%,MT1G;MT1HL1;MT1F;MT1H;MT1M;FOS;MT1E;MT1X;MT1A;MT1B;AKT1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.46395183371205767,-1.4491956966527275,0.0547945205479452,0.19315185408757427,1.0,11/29,23.99%,ACOD1;LILRA2;TRIB1;CARD16;NLRC3;ITCH;SIGIRR;IFI16;NMI;DHX58;TRIM21
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,-0.39537947698726345,-1.4490060128950928,0.07246376811594203,0.19308691698506392,1.0,23/56,14.39%,CYP2C19;FA2H;PTGS2;CYP2C8;HPGD;CYP4A22;CYP4A11;CYP4F2;CYP1A2;DPEP3;CYP8B1;CYP2C9;ALOX5AP;DPEP2;ALOX5;PLA2G4A;PTGES;PON3;CYP4F3;PTGR1;TBXAS1;EPHX2;PON1
prerank,TRRUST_Transcription_Factors_2019__PPARA human,-0.41997936302575534,-1.4486910823681125,0.0273972602739726,0.19319301985781975,1.0,19/37,21.28%,PTGS2;CETP;APOA4;ACSL1;UGT1A9;PDK4;CYP2C9;IL6;ACADL;APOA5;ACOX1;SULT2A1;APOBR;IGFBP1;HMOX1;MLYCD;SLC25A20;PLIN2;APOB
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.5612680557855224,-1.448004607387905,0.046511627906976744,0.19356953987949188,1.0,1/18,0.01%,ERN2
prerank,WikiPathway_2021_Human__White fat cell differentiation WP4149,-0.4461445587278899,-1.4479417141849513,0.06666666666666667,0.19329396118684514,1.0,8/31,15.07%,IRF4;KLF5;EGR2;FOXO1;WNT10B;KLF4;GATA3;KLF2
prerank,WikiPathway_2021_Human__Type II interferon signaling (IFNG) WP619,0.5142162503311252,1.447866635026076,0.05,0.5490426398992299,1.0,1/34,0.00%,REG1A
prerank,WikiPathway_2021_Human__ATM Signaling Network in Development and Disease  WP3878,0.519515432367244,1.4475869644722132,0.04891304347826087,0.5485157711016933,1.0,19/44,31.89%,RASGRF1;HDAC4;BUB1;AURKB;HSPB1;IKBKG;CDK1;CHEK1;LBR;CDK5R1;TRIM28;TSC2;PRKDC;CDK5;CHEK2;MDC1;G6PD;RNF20;TP53BP1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.616443133086699,1.4474402531807617,0.03680981595092025,0.547475123456521,1.0,7/17,23.26%,KCNE5;KCNH2;ATP1A2;EPO;NEDD4L;MMP9;CBARP
prerank,Elsevier_Pathway_Collection__Dendritic Cell Function in Ulcerative Colitis,-0.43065024670084434,-1.4472736700766946,0.013513513513513514,0.1936989402221117,1.0,13/44,14.75%,IL10;TNF;IL1B;IL18;CASP1;NLRP3;IL6;IL12B;TICAM2;TLR4;TLR2;AKT1;MYD88
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5081791376243503,1.4462621453839912,0.05113636363636364,0.5501643013596395,1.0,5/37,7.17%,CEMIP;STOX1;CHI3L1;PLK1;SPHK1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.5997204486152904,1.4457767665438488,0.09523809523809523,0.5503561918254606,1.0,6/17,15.31%,KIF2C;MKI67;BUB1;AURKB;CDC6;IHO1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.3653679359719567,-1.4454292888863538,0.0,0.1955689458656939,1.0,55/115,24.54%,IRF4;GBP6;IFNG;GBP5;ACOD1;CCL5;OASL;CCL4;CCL3;CASP1;XCL1;NCAM1;CCL23;GBP7;IFI30;CAMK2B;GBP4;CCL2;XCL2;HLA-DQA2;TRIM34;TLR4;CCL22;IRF8;TRIM22;GBP3;HCK;TLR2;GBP1;VCAM1;IL12RB1;LGALS9;MT2A;HLA-DQA1;TRIM5;PTAFR;AIF1;WNT5A;HLA-DQB2;OAS3;OAS2;HLA-DRB5;HLA-DRA;JAK2;STAT1;TRIM31;IRF2;CCL14;SIRPA;HLA-DPA1;OAS1;TRIM21;HLA-DPB1;IRF9;HLA-DRB1
prerank,KEGG_2021_Human__Pentose and glucuronate interconversions,-0.47913954811813464,-1.4453784677817472,0.05,0.19530124253022543,1.0,18/30,23.74%,UGT2A1;UGT1A5;UGT1A9;UGT2B7;UGP2;UGT2B28;UGT2B10;KL;UGT2A3;UGT2B15;UGT1A7;XYLB;DHDH;CRPPA;AKR1A1;DCXR;AKR1B1;SORD
prerank,WikiPathway_2021_Human__miRNA regulation of DNA damage response WP1530,0.4783281260670746,1.444839209690101,0.015463917525773196,0.5523548883268076,1.0,24/70,28.26%,CDC20B;SFN;E2F1;TP53AIP1;CDC25C;CCNB2;CCNE1;CCNE2;CDK1;CCNB1;CHEK1;CDC25A;BBC3;CDK6;ATRIP;RAD51;MCM7;PRKDC;FANCD2;CDK5;CCNB3;MYC;CHEK2;CDKN1A
prerank,Elsevier_Pathway_Collection__Mucin Production in Goblet Airway Epithelial Cells,-0.4214984448036893,-1.4445525869017128,0.05555555555555555,0.19579991436965336,1.0,10/44,14.75%,IL13RA2;MUC5AC;MUC5B;MAP2K1;TGFA;IL6;TICAM2;TLR4;TLR2;MYD88
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.45741642169034835,1.4445268643651747,0.03626943005181347,0.5518839479521624,1.0,10/72,5.85%,ISL2;PAX2;CTNNA2;PAK3;MAPK8IP2;BRSK2;NRCAM;LRP4;POU4F1;ADGRB1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.5160796665164835,1.4443579927003627,0.053763440860215055,0.5508676963166331,1.0,26/39,36.35%,HJURP;CENPA;CENPI;CENPM;IPO4;CENPU;CENPL;H4-16;ASF1B;CENPK;UBN1;CENPP;NPM1;CENPW;ITGB3BP;H3-3A;CENPS;CENPH;RBBP7;CENPT;CENPQ;RUVBL1;CENPX;NASP;HAT1;CABIN1
prerank,TRRUST_Transcription_Factors_2019__NANOG human,0.5731762168362382,1.4438585319967652,0.07514450867052024,0.5511513189549792,1.0,4/21,2.98%,SOX1;DKK1;CGA;NODAL
prerank,Elsevier_Pathway_Collection__Thyroid Dysfunction,-0.45517584398479605,-1.4424167523563058,0.07936507936507936,0.1980333463086465,1.0,6/34,8.23%,NKX2-1;TSHR;GNAO1;FOS;MAP2K1;TG
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.52425800920153,1.4423949372025593,0.06878306878306878,0.5537824396684301,1.0,20/30,35.26%,HJURP;CENPA;CENPI;CENPM;CENPU;CENPL;H4-16;CENPK;CENPP;NPM1;CENPW;ITGB3BP;CENPS;CENPH;RBBP7;CENPT;CENPQ;RUVBL1;CENPX;NASP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.52425800920153,1.4423949372025593,0.06878306878306878,0.5537824396684301,1.0,20/30,35.26%,HJURP;CENPA;CENPI;CENPM;CENPU;CENPL;H4-16;CENPK;CENPP;NPM1;CENPW;ITGB3BP;CENPS;CENPH;RBBP7;CENPT;CENPQ;RUVBL1;CENPX;NASP
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.5330690750139537,1.4417134505650246,0.05649717514124294,0.5545689132372069,1.0,10/31,18.00%,SIX1;POPDC3;SIX4;MSC;MYF6;KLHL41;IGSF8;MYLPF;MYLK2;ZBTB18
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.33984261030465956,-1.4416409552649623,0.0,0.19857495636811118,1.0,79/211,17.20%,TAC1;CXCL13;PROK2;CRHBP;CXCL10;CXCL11;IFNG;TMIGD3;TNF;IL1B;CCL5;FOS;FPR1;CXCR2;CXCL3;TNFAIP6;FPR2;CXCL9;S100A8;CCR5;XCR1;CCL4;CCL3;IL18;XCL1;PLA2G2D;CCL23;CCR7;KRT16;PIK3CD;NFAM1;NCR3;CXCL2;CD96;NLRP3;VNN1;SIGLEC1;CCL2;PTGER2;IL6;CCR1;APOL3;HRH4;XCL2;CD40LG;FUT7;CYBB;IL1RN;MEFV;CCR2;PTGER4;FCGR2B;HDAC9;CXCL8;REL;TLR4;CCL22;TLR2;LAT;SELE;PF4V1;FPR3;PTGDR;ADGRE5;CXCR4;ADORA3;ITGB2;CXCL1;CSF1R;LGALS9;NLRC4;HP;THBS1;MGLL;TBXA2R;LY75;ITCH;AFAP1L2;TLR10
prerank,Elsevier_Pathway_Collection__Somatostatin Receptors Signaling,-0.5151617071734413,-1.4415268792273401,0.1038961038961039,0.1983433919865015,1.0,4/18,6.54%,GNAO1;PTGS2;TNF;SSTR2
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,0.589209997767161,1.4397383815285634,0.06779661016949153,0.5604322394773201,1.0,6/19,10.48%,LGR6;RSPO2;LGR5;ZNRF3;RSPO4;RNF43
prerank,TRRUST_Transcription_Factors_2019__HNF1A human,-0.46343899829036056,-1.4395168466165045,0.06521739130434782,0.20017559660609513,1.0,11/23,17.38%,SLC22A10;UGT1A9;UGT2B7;CYP1A2;SLCO1B3;ALB;AKR1C4;IGFBP1;MTTP;CSRP1;UGT1A7
prerank,Elsevier_Pathway_Collection__Microglia and Motor Neuron Interaction Dysregulation,-0.46558637285417664,-1.4387759603298476,0.05263157894736842,0.20056278747316944,1.0,12/26,21.42%,TNF;IL1B;FOS;CD200R1;IL6;DOK2;AKT1;INPP5D;CX3CR1;MAP2K3;MAP2K6;JUN
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4763633101292332,1.4381911814503543,0.06315789473684211,0.5648733980637055,1.0,6/51,6.66%,MT3;PAX2;SFN;CSN2;DPEP1;SRC
prerank,WikiPathway_2021_Human__Purine metabolism and related disorders WP4224,-0.5005109492957184,-1.438050632333637,0.033707865168539325,0.20120435468104367,1.0,3/20,6.47%,AMPD1;PNP;XDH
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.4901687124982843,1.4374434138314973,0.03225806451612903,0.566075236687859,1.0,6/50,10.68%,MT3;IGF2;ASPSCR1;PPP1R16A;HSPB1;PPP1R16B
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.3719757413087103,-1.4358226589313137,0.0,0.20324775340122905,1.0,34/81,22.36%,IFNG;TNF;ZBP1;IL1B;NLRP12;TLR3;S100A8;CCL3;IL18;IL15;LILRA5;NFKBIZ;IL6;OSM;IL33;IL12B;CCR2;PTGER4;TLR4;TLR2;TSLP;IL16;S100A12;GPSM3;ETS1;ADAM8;WNT5A;MAPK13;PDE2A;AGTR1;NMI;SNX4;SNCA;APP
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.46241702382664196,-1.4355452914238818,0.058823529411764705,0.20326488468546727,1.0,6/26,5.08%,EREG;DSCAM;IFNG;CCL5;PTH1R;CD244
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,-0.46199795987539666,-1.4352596796692212,0.038461538461538464,0.20324281833171784,1.0,12/38,16.56%,CYP26A1;RDH16;ADH1A;PDK4;ALDH8A1;ADH1C;CYP26B1;ADH7;RARB;CRABP2;ALDH1A2;PDK3
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.37487046259370843,-1.4350741150377602,0.019230769230769232,0.20305478281544917,1.0,45/85,24.41%,CR2;C9;F9;KLKB1;C7;VSIG4;C6;CR1;C4A;F2RL2;SERPINA5;MBL2;PLG;C1QC;C1R;CR1L;SERPINB2;CFI;C1QB;SERPING1;CLU;KNG1;ITGB2;F13B;F3;PLAUR;F11;C8A;F7;VTN;C3AR1;C8B;C1S;SERPINF2;C1QA;C5;CD55;MASP1;SERPIND1;ITGAM;F2;THBD;C3;CFD;C4B
prerank,TRRUST_Transcription_Factors_2019__HDAC9 human,-0.5300821436703451,-1.4345211534682802,0.09,0.2034719278609351,1.0,6/16,15.46%,DIRAS3;ESR1;IL18;MYEF2;CITED2;IGFBP1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.52755811246492,1.4339840184860477,0.056179775280898875,0.5770762655894105,1.0,13/31,25.23%,E2F1;GFI1;E2F7;CCNE1;CDC6;CDC45;CDT1;TYMS;ORC1;RRM2;CDK16;POLA1;CDK5
prerank,Elsevier_Pathway_Collection__Dopamine Synthesis and Release in Migraine,-0.4882353421084692,-1.433345809060613,0.05194805194805195,0.20436989663773783,1.0,6/18,15.79%,DBH;TH;TDO2;SLC18A2;ALDH2;DDC
prerank,Elsevier_Pathway_Collection__Dopamine Synthesis and Release,-0.4882353421084692,-1.433345809060613,0.05194805194805195,0.20436989663773783,1.0,6/18,15.79%,DBH;TH;TDO2;SLC18A2;ALDH2;DDC
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.46098847041034613,1.4328110874096822,0.06770833333333333,0.5798881025526712,1.0,25/63,18.77%,SLC6A4;GLUL;PTPRN2;GAD1;UNC13A;SLC29A4;HRH3;SLC6A3;SYN3;ATP1A2;PPFIA3;PPFIA4;SYN1;SLC1A2;SNAP25;CPLX1;SLC29A2;UNC13B;PPFIA2;SLC6A2;SLC1A3;SYN2;NRXN2;SNAPIN;STXBP1
prerank,GO_Biological_Process_2021__cellular glucuronidation (GO:0052695),-0.5277616888213847,-1.4324773251674598,0.06451612903225806,0.20510269534936332,1.0,8/16,17.38%,UGT2A1;UGT1A5;UGT1A9;UGT2B7;UGT2B28;UGT2A3;UGT2B15;UGT1A7
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.453798083848432,1.4317114235321418,0.03980099502487562,0.5824507814350434,1.0,23/80,11.39%,SLC6A4;SLC6A7;HCN2;SLC34A3;ASIC1;SCN1A;SCN4A;SLC6A11;SLC12A1;FGF13;SLC6A9;SLC5A4;SLC6A3;SLC5A2;ATP1A2;ATP1A4;SLC5A6;ATP1B3;SLC6A8;ASIC3;HCN3;SCN4B;SCN2A
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5758098248095522,1.431707716401962,0.062111801242236024,0.5808687103410239,1.0,10/19,27.03%,ACTN2;OSR1;TCAF2;EPO;NEDD4L;NEDD4;MMP9;PCSK9;CASQ2;HECW1
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,-0.33838688322554106,-1.4299599420437419,0.03125,0.20776957627601544,1.0,29/129,15.16%,IFNL2;IL20RA;IL13RA2;CSF3;IL20RB;IFNL1;IL10;IL5RA;IFNG;GHR;IL2RB;SOCS2;IL7R;CSF3R;LIFR;PDGFRA;IL15;PIK3CD;CTF1;IL6;OSM;IL12B;IL21R;PIK3R1;AKT1;TSLP;CISH;CSF2;IL12RB1
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,0.45652591448539637,1.4296452192174318,0.046153846153846156,0.5872087748697296,1.0,18/85,16.39%,H3C13;H2AC19;TP73;H2BC13;H2AC20;H2BC17;H2BC21;PSMD4;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;PSMB4;H2BC5;H2AX
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.5685107079560076,1.4293980631935068,0.07647058823529412,0.586484836721301,1.0,5/23,12.37%,PRSS56;PAX2;HES5;CACNA1C;EFEMP1
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.519121401119799,1.4287503017513488,0.07407407407407407,0.5872353616598629,1.0,20/40,32.63%,H3C13;H2AC19;H2AC11;H2AC20;ACTL6B;DNMT3A;H4C15;H2AC6;H2AX;SMARCA4;H2AJ;PRMT7;SMARCD3;WDR5;SMARCC1;RPS2;RBBP7;H2AZ1;CDK4;PRMT3
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.43415851324463267,1.4287472116182038,0.02857142857142857,0.5856482390607821,1.0,86/110,47.14%,RPL8;SMG5;CASC3;MRPL13;RBM8A;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPSA;RPL26L1;PABPC1;RPL39;UPF3B;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;SMG7;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;SMG9;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;PPP2R1A;RPL35A;MAGOHB;RPS3A;RPS7;RPS11;RPL36A;GSPT2;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;SMG8;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RNPS1;RPS9;RPL6;UPF1;RPS15A;RPL4;RPL19;RPL39L;RPS6;RPL26;EIF4A3;RPS27A;MAGOH;RPS4Y1;RPL34;RPS13;ETF1
prerank,Elsevier_Pathway_Collection__Age-Related Cataract,-0.49261139569856716,-1.4285954510487087,0.0625,0.20915129990300735,1.0,6/19,12.62%,CASR;MIP;CAT;CRYAA;SLC8A1;GJA3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.4268436275463674,-1.4285147174141277,0.06349206349206349,0.20888781222674777,1.0,17/42,19.88%,NLRP7;TNF;GBP5;ABCD2;IL6;ALOX5;MEFV;TLR4;CLEC7A;PLD4;PER1;MYD88;LILRB4;CD6;NLRC3;MACIR;NOD2
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,0.5644403046885147,1.4285112930617094,0.09523809523809523,0.5850723434072673,1.0,5/20,10.65%,PLK1;UBE2C;UBE2S;CDK1;CCNB1
prerank,TRRUST_Transcription_Factors_2019__GATA4 mouse,0.5963336377613304,1.4281183109445466,0.08053691275167785,0.5850316411158335,1.0,5/16,8.78%,SPDEF;LHX9;BMP4;AMH;ADORA1
prerank,Elsevier_Pathway_Collection__NF-kB Signaling Activation in Huntington Disease,-0.5391397074608725,-1.427861069713952,0.07228915662650602,0.20941514868677893,1.0,6/15,14.89%,TNF;IL1B;CCL2;IL6;CXCL8;CASP6
prerank,Elsevier_Pathway_Collection__Neutrophil Activation via LTB4/Polyisoprenyl Phosphate Signaling,-0.4509448963901983,-1.427826655104509,0.054945054945054944,0.2091136458176725,1.0,11/23,23.34%,FOS;MAP2K1;LCP2;RAC2;LAT;AKT1;VAV1;IQGAP1;PRKCZ;JUN;PIK3CG
prerank,Elsevier_Pathway_Collection__NOD-like Receptors,-0.44606389068701036,-1.4277474371055883,0.02702702702702703,0.20888997680770155,1.0,12/32,20.87%,AIM2;IL1B;TLR3;IL18;CASP1;NLRP3;IL33;NLRC4;BCL2;NAIP;NOD2;TAB2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.48545380314205805,1.4264691180353248,0.05319148936170213,0.5900050794294628,1.0,23/52,25.93%,CCNO;STOX1;CDC25C;CCNB2;CDKN3;CCNE1;CDKN2C;CDC6;CCNA2;CCNE2;CCNF;CCNB1;CDKN2B;CDKN1C;PKMYT1;CDC25A;CAMK2N1;CDK5R1;CCNP;CDKN2D;BLM;HSP90AB1;CCNB3
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.44772688855670095,1.4259933496198895,0.02030456852791878,0.5903620319899991,1.0,74/90,46.98%,RPL8;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPL10;ZFAND2B;RPSA;RPL39;UBA52;RPLP0;SRP9;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL13;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL35A;RPS3A;RPS7;RPS11;RPL36A;SEC61B;RPL7A;RPS3;RPL18A;RPL32;RPS24;RPL29;SRP14;RPL23;RPL5;RPS18;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;SEC61A1;RPS15A;RPL4;RPS26;RPL19;SRP19;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.4142933314007021,-1.425909683531823,0.038461538461538464,0.210948005893336,1.0,24/54,17.95%,CYP2C19;CYP2A7;CYP2A13;CYP2D7;PTGS2;CYP2B6;CYP2C8;CYP4A22;CYP4A11;CYP4F2;CYP1A2;CYP2C18;CYP2C9;CYP4F12;ALOX5;PLA2G4A;PTGES;CYP4F3;TBXAS1;EPHX2;CYP2J2;MGLL;HPGDS;PTGIS
prerank,WikiPathway_2021_Human__Fragile X Syndrome  WP4549,0.428741045327791,1.4258656765199849,0.028708133971291867,0.5893246743057886,1.0,16/116,9.88%,SH3GL3;KCNC1;GABRD;HOXB8;GRIN1;PTPN5;GAD1;PDK1;CDKN2A;SRC;BDNF;AGO2;CAMK2A;GRIN2A;GRIP2;CLTCL1
prerank,TRRUST_Transcription_Factors_2019__ETS1 mouse,-0.4041414001956782,-1.4255186697835063,0.03125,0.21117163771941685,1.0,20/54,17.12%,SERPINB5;FOXP3;IGHM;IL10;PTGS2;CD4;FOS;SH2D1A;IL7R;CSF3R;CCL2;EGR1;IKZF1;RUNX3;TBX21;TLR4;RUNX2;PRDM1;CSF1R;HMOX1
prerank,Reactome_2022__DNA Repair R-HSA-73894,0.3971750526490959,1.425408357823826,0.004219409282700422,0.5896724612785024,1.0,147/295,41.14%,H2AC19;H2BC13;H2AC20;UBE2T;H2BC17;H2BC21;DTL;EME1;H2BC9;EXO1;H2BC15;CCNA2;H2BC11;EYA4;H2BC12;NEIL3;NHEJ1;H2BC4;H4C15;H2AC6;SERPINA2;XRCC2;FANCI;RFC4;RTEL1;POLN;H2BC5;POLD1;CHEK1;ACTR5;H2AX;FANCE;POLR2L;MSH2;BARD1;PCLAF;DNA2;PIAS3;CETN2;RMI1;UVSSA;MUTYH;FEN1;POLR1A;CLSPN;ALKBH2;ATRIP;ISG15;PARP1;RAD9B;APBB1;EYA1;FAAP20;PIAS1;RAD51AP1;RAD51;H2AJ;PRKDC;FANCD2;POLR2K;NPLOC4;KPNA2;INO80E;BLM;RHNO1;TRIM25;NFRKB;TFPT;POLR2G;RAD18;FANCB;FANCG;TIPIN;COPS5;CHD1L;NSD2;UFD1;CHEK2;CUL4B;UBA52;MSH6;SPRTN;MAD2L2;SIRT6;TIMELESS;MDC1;PCNA;ABRAXAS1;XRCC1;PIAS4;BABAM2;UBE2I;POLR2H;POLM;OGG1;H2AZ1;TP53BP1;BRIP1;RMI2;UIMC1;DDB2;COPS6;TOPBP1;MUS81;POLR2I;BRCA2;POLR2J;PNKP;PAXIP1;FAN1;RUVBL1;CENPX;DCLRE1B;SEM1;POLL;XAB2;ABL1;TERF1;EME2;FAAP24;POLH;VCP;DDB1;ACTR8;BAZ1B;POLR2A;XRCC3;ACD;ERCC2;BABAM1;INO80D;SPIDR;XRCC6;FANCM;COPS8;CDK2;USP7;SLC19A1;GPS1;ELL;POLR2B;HERC2;RAD52;POLK;USP1;XPC;TERF2
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.4121299822930354,1.4247939909261373,0.013100436681222707,0.5904619716364322,1.0,139/191,47.90%,GLUL;BOP1;RRS1;EXOSC4;UTP14A;NVL;RPL8;RBIS;RRP12;DCAF13;TSC1;HEATR1;RPL30;RPLP1;BYSL;RPS27;LAS1L;RRP1;RPLP2;WDR46;NPM1;NOP16;NOP58;PDCD11;RRP9;EXOSC5;RPL28;URB2;RPS14;RPL10;RPL26L1;RPL39;CUL4B;UBA52;NOC4L;NOP56;RPLP0;PELP1;FBL;RPS15;DKC1;RPS2;RPL31;RPS19;RPL36;RPL37A;PES1;RPL37;RPL7;MRPL36;RPL13;ZNF622;RPL27;RRP7A;RPL38;WDR55;RPL35;SNU13;UTP15;RPL10A;POP5;DDX49;RPL35A;MRPL22;NOL9;DDX31;RPS7;EXOSC2;RPL36A;WDR12;TBL3;DHX37;POP4;WDR75;RPL7A;RPL18A;RPL32;XPO1;UTP4;RPS24;PIH1D1;RRP36;IMP4;UTP18;PWP2;RPL29;RPL23;RAN;RIOK2;RPL5;EXOSC1;RPL14;NOL8;EXOSC7;EXOSC10;RPS16;MRTO4;EXOSC9;RPL13A;RPL41;RPL9;NOL6;RPS28;EBNA1BP2;RPL27A;RPL23A;SURF6;RPL18;EIF6;DDX54;RPL12;RPS9;NOC2L;RPL6;DDX10;EMG1;RIOK1;RPL4;NOM1;LTO1;DHX29;DDX27;MTREX;RPL19;UTP20;RPS6;RPL26;NOB1;WDR74;NOP53;RPL34;TEX10;MPHOSPH10;UTP6;LSG1;BMS1;MALSU1;RPL3;UTP11
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,-0.44081130872144936,-1.424276392235394,0.0,0.21217769783905233,1.0,12/37,12.53%,ASCL1;FOSB;EGR3;EGR2;FOS;ID4;ID2;TF;KCNH8;EGR1;TRIB1;EGR4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.5223600195510296,-1.4240786117919035,0.09195402298850575,0.21199801369985793,1.0,8/17,18.26%,FOXP3;IL12B;LILRB1;CD274;FCGR2B;PDCD1LG2;LILRB4;TNFRSF21
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.5595299396052119,1.423503620598276,0.1144578313253012,0.5940912722108104,1.0,4/20,6.59%,MT3;KCNC2;DPEP1;MTR
prerank,TRRUST_Transcription_Factors_2019__POU5F1 mouse,0.6065490385481023,1.423186577462695,0.08641975308641975,0.5938474321007966,1.0,5/17,13.28%,PAX2;SOX2;MESP1;CDX2;POU5F1
prerank,Elsevier_Pathway_Collection__DNA Damage Checkpoint Impairment in Cancer,0.5326747606019224,1.4231364739134027,0.08791208791208792,0.5924912375519789,1.0,19/32,34.58%,TP53AIP1;CDKN2A;CDC25C;CDK1;MAPKAPK2;CHEK1;SMAD3;CDC25A;BBC3;CDK6;TGFB2;PRKDC;AATF;CHEK2;CDKN1A;CDK4;TGFB1;BRCA2;BAX
prerank,Elsevier_Pathway_Collection__T-Cell Cytotoxic Activation,-0.4115685272140581,-1.4219121289394274,0.03333333333333333,0.21444609231817305,1.0,20/42,21.42%,IFNG;TNF;IL1B;FOS;IL18;DEFB1;PRF1;IL6;S100B;TLR4;TLR2;AKT1;S100A12;MYD88;BGN;HSPA1A;GZMB;MAP2K3;MAP2K6;JUN
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.4569333633083673,-1.4218593578674679,0.039473684210526314,0.2141491421142394,1.0,6/26,9.64%,CXCL13;PROK2;BMPER;SFRP1;TSPAN12;IL6
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.4363958163453697,1.420961705052351,0.05,0.5987290613138017,1.0,20/85,11.65%,KCNH6;GNG4;KCNC1;KCNF1;KCNJ6;HCN2;KCNC2;KCNH2;KCNG2;KCNJ9;KCNK17;KCNJ5;KCNB1;KCNJ14;KCNN3;GNG3;ABCC8;HCN3;KCNH3;KCNS2
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.3324307798790114,-1.4208862722859439,0.0,0.21493465289907795,1.0,50/181,15.00%,CXCL13;SHC4;CXCL10;CXCL14;CCR9;CXCL11;CCL5;CXCR1;CXCR2;CXCL3;CCL4L2;CXCL9;CCR5;XCR1;CCL4;CCL3;CXCR6;XCL1;ITK;CCL23;MAP2K1;CCR7;PIK3CD;PRKCB;CXCL12;CXCL2;CCL2;CCR1;CCL3L3;XCL2;RAC2;CCR2;CXCL8;ADCY5;CCL22;PIK3R5;HCK;PIK3R1;AKT1;PLCB2;GNG2;CCR4;PF4V1;FGR;DOCK2;PLCG2;CXCR3;TIAM1;CXCR4;VAV1
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,0.5533105544331293,1.4206005995545887,0.06790123456790123,0.5984124578636298,1.0,13/25,23.86%,SQLE;FDPS;MVD;SREBF2;HMGCR;TM7SF2;IDI1;LBR;PMVK;NSDHL;FDFT1;HMGCS1;CYP51A1
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.4263671752999174,1.4202355060240412,0.018779342723004695,0.5979371168376613,1.0,74/145,38.68%,E2F1;CDKN2A;TOP2A;SRC;E2F2;PSMD4;CCNE1;CDKN2C;CDC6;CDC7;CCNA2;CCNE2;CDC45;CDK1;CCNB1;CDT1;MCM6;CDKN2B;TYMS;PRIM1;MYBL2;PSMB4;CKS1B;CDKN1C;MCM10;MCM3;MCM5;CDC25A;RRM2;MCM4;E2F5;CDK6;POLR1A;PPP2R3B;HDAC1;GMNN;LIN37;MCM7;POLA1;POLA2;CDKN2D;TK1;LIN9;MYC;PSMB3;PSMD14;UBA52;RBL1;CDKN1A;PSMB5;PSMD2;PCNA;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;CDK4;MCM8;SKP2;SKP1;PSMC5;PPP2R1A;E2F3;SEM1;PSMB6;PSMD8;ABL1;E2F4;PSME2;DBF4;PSMD13;PSMB7;PSMA7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.43129643963070213,1.419955143794712,0.0330188679245283,0.5972242917867089,1.0,88/113,47.14%,RPL8;DHX34;SMG5;CASC3;RBM8A;RPL30;RPLP1;RPS27;RPS21;RPLP2;EIF3E;RPS5;RPL28;RPS14;RPL10;RPSA;PABPC1;RPL39;UPF3B;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;SMG7;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL13;SMG9;RPL27;RPL38;CTIF;RPL35;RPL10A;RPS8;RPS12;PPP2R1A;RPL35A;MAGOHB;RPS3A;RPS7;RPS11;RPL36A;GSPT2;RPL7A;RPS3;RPL18A;RPL32;RPS24;RPL29;RPL23;SMG8;RPL5;RPS18;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RNPS1;RPS9;RPL6;SKIV2L;UPF1;RPS15A;RPL4;RPS26;RPL19;RPS6;RPL26;EIF4A3;RPS27A;MAGOH;RPS4Y1;RPL34;RPS13;ETF1
prerank,Elsevier_Pathway_Collection__Thrombophilia Hereditary,-0.4804718058581964,-1.4196965945173727,0.075,0.21534985307625323,1.0,16/23,29.33%,F9;KLKB1;PLG;FGL2;PROZ;SERPINA10;KNG1;F3;F11;F7;F2;THBD;PROS1;VKORC1;F8;PROC
prerank,Elsevier_Pathway_Collection__Hereditary Thrombophilia and Pregnancy Complications,-0.4804718058581964,-1.4196965945173727,0.075,0.21534985307625323,1.0,16/23,29.33%,F9;KLKB1;PLG;FGL2;PROZ;SERPINA10;KNG1;F3;F11;F7;F2;THBD;PROS1;VKORC1;F8;PROC
prerank,Elsevier_Pathway_Collection__Coagulation Cascade,-0.4804718058581964,-1.4196965945173727,0.075,0.21534985307625323,1.0,16/23,29.33%,F9;KLKB1;PLG;FGL2;PROZ;SERPINA10;KNG1;F3;F11;F7;F2;THBD;PROS1;VKORC1;F8;PROC
prerank,Elsevier_Pathway_Collection__Diabetes Induced Periodontitis,-0.4352305805913386,-1.4188159639099631,0.05405405405405406,0.21604326097353224,1.0,13/30,22.85%,TNF;IL1B;FOS;IL6;CXCL8;AKT1;CAMP;MAP2K3;MAP2K6;JUN;JAK2;STAT1;MAP3K5
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.5029601839202567,-1.4179315070896277,0.05263157894736842,0.2168472244684637,1.0,10/20,21.38%,CD8A;IL18;SLA2;IL12B;TLR4;BTN3A3;EBI3;MYO1G;CD55;BTN3A2
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,0.4200476117815878,1.4167884653942788,0.041474654377880185,0.6080476426895643,1.0,96/135,46.98%,RPL8;POLR2L;MRPL13;NUP37;PARP1;RPL30;RPLP1;RPS27;RPS21;NUP62;RPLP2;POLR2K;TPR;NUP133;RPS5;RPL28;POLR2G;RPS14;RPSA;RPL26L1;RPL39;UBA52;RPLP0;RPS15;NUP155;RPS2;RPL31;NUP160;RPS19;RPL36;RPL37A;POLR2H;RPL37;RPL7;RPS4X;RPS20;RPL27;NUP188;RPL38;RPL35;POLR2I;POLR2J;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;NUP205;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;POLR2A;RPL3L;NUP210;RPL29;RPL23;HSP90AA1;RPL5;RPL14;RPS16;POLR2B;NUP214;RPL13A;RPL41;RPL9;GTF2F1;RPS28;NUP107;RPS23;RPL27A;RPL23A;RPL18;RPL12;GNL3;POLR2F;RPS9;RPL6;RPS15A;AAAS;RPL4;RPL19;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;NUP93;RPL34;RPS13
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.3591992576175206,-1.4163906609520982,0.0,0.21852186836703774,1.0,34/102,17.94%,EDAR;PTGS2;TNFSF11;TNF;IL1B;CXCL3;CCL4L2;CCL4;PRKCB;CXCL12;CXCL2;PRKCQ;CD40LG;BCL2A1;TNFRSF11A;BTK;CARD11;CXCL8;TICAM2;LCK;TLR4;LAT;CSNK2A3;SYK;VCAM1;PLCG2;MYD88;TNFRSF13C;LTA;CXCL1;TNFSF13B;ZAP70;BCL2;GADD45A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.4397885861375561,-1.4163611286421454,0.05063291139240506,0.2181658225938481,1.0,13/31,16.36%,IFNG;TLR3;CCR7;SCIMP;CD40LG;IL12B;TLR4;CLEC7A;TLR2;IL16;SYK;PLCG2;LGALS9
prerank,Elsevier_Pathway_Collection__Tertiary Hypothyroidism,-0.447654229163672,-1.4161102452835144,0.07407407407407407,0.21769089550518478,1.0,7/24,11.23%,NKX2-1;PCSK2;TSHR;SSTR2;TG;PRKCB;SLC16A2
prerank,Elsevier_Pathway_Collection__Central Hypothyroidism,-0.447654229163672,-1.4161102452835144,0.07407407407407407,0.21769089550518478,1.0,7/24,11.23%,NKX2-1;PCSK2;TSHR;SSTR2;TG;PRKCB;SLC16A2
prerank,WikiPathway_2021_Human__LTF danger signal response pathway WP4478,-0.5213286224463405,-1.4159933007930554,0.10588235294117647,0.21751525328303367,1.0,7/16,14.75%,TNF;IL1B;IL6;CXCL8;TLR4;TLR2;MYD88
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.586991630332678,1.4159846402112475,0.07878787878787878,0.6094872900120141,1.0,4/18,5.23%,HMGA2;MESP2;ITGA2;MESP1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.42007309160451034,1.4157721128692367,0.015228426395939087,0.6086002307609892,1.0,29/118,11.78%,KCNH6;KCNC1;KCNF1;KCNJ6;HCN2;LRRC26;KCNE5;KCNC2;ATP4A;KCNH2;KCNG2;KCNJ9;SLC12A5;LRRC52;KCNK17;SLC12A1;KCNJ5;KCNB1;ATP1A2;ATP1A4;SLC9C2;ATP1B3;KCNJ14;KCNN3;ABCC8;HCN3;KCNH3;KCNS2;SLC9A3
prerank,WikiPathway_2021_Human__MAPK Signaling Pathway WP382,0.39986141269938014,1.4156813035911349,0.013157894736842105,0.6074274833777811,1.0,48/228,17.35%,CACNA1E;CACNA1I;CACNB4;CACNG1;DUSP9;FGF20;RASGRF1;CACNG4;CACNA1S;CACNG5;MAPK8IP2;MAPK12;MAPT;PTPN5;CACNA2D2;MAPK11;FGF13;FGF17;CACNA1G;FGF2;FGF23;BDNF;PDGFRB;MAP3K8;HSPB1;FGF14;IKBKG;RASGRF2;CACNA1C;PLA2G4C;NFKB2;CACNA2D3;PDGFB;HSPA2;CACNG8;PLA2G4F;PDGFA;MAPKAPK2;RELB;PRKCA;HRAS;STMN1;ELK4;PTPRR;MRAS;CACNA1H;FGF12;EGF
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.4917287582126487,-1.4153439060017823,0.06666666666666667,0.21778722417122473,1.0,9/20,8.78%,MT1G;MT1HL1;MT1F;MT1H;AOC1;MT1M;MT1E;MT1X;MT1A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.4463981397182248,-1.4152759001882083,0.05194805194805195,0.2174911350299745,1.0,13/31,12.06%,TNFSF11;HAS2;TNF;NR4A3;SIRPB1;SIRPG;PRKCQ;CCL2;IL6;FUT7;CCR2;SKAP1;LCK
prerank,Elsevier_Pathway_Collection__CD16/CD14 Proinflammatory Monocyte Activation,-0.3867610395079015,-1.4152106017297144,0.046153846153846156,0.21715889720376405,1.0,22/66,16.88%,CXCL13;IL10;CD4;TNF;FOS;FCGR3B;MAP2K1;CXCL12;FCGR3A;IL12B;SPN;TICAM2;TLR4;LAT;SELE;SYK;VCAM1;MYD88;CSF2;CXCR4;CSF1R;ZAP70
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.32655929224699004,-1.4152021645050856,0.0,0.21679995687780743,1.0,76/198,21.10%,CXCL13;NLRP7;WNT7B;RET;CRHBP;IL10;CXCL10;CXCL11;IL1B;ACOD1;STAP1;SFRP1;LTK;ATP1A3;CD80;CXCL3;FFAR2;TNIP3;CXCL9;CCR5;SSTR2;ESR1;PDK4;CASP1;OR51E2;WNT2;CXCL2;NLRP3;WNT10B;CCL2;IL6;WNT11;NKX3-1;AXL;GPLD1;LILRB1;CD274;PDCD1LG2;CXCL8;CD180;TICAM2;ADCY5;RORB;TLR4;BRINP2;CARD16;SPHK2;SOX9;PF4V1;MYD88;LDOC1;NUGGC;CD86;TNFRSF1B;CFTR;CXCL1;PDK3;PTK6;LILRB2;EPHA3;AR;FZD7;MAP4K1;NR1H4;ADCY1;PID1;SHPK;WNT5A;NOD2;WNT5B;GSTP1;PPBP;PF4;ADTRP;XBP1;CX3CR1
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.600754363178379,1.4151239495585846,0.09259259259259259,0.6080768106133824,1.0,7/17,21.80%,FGF20;FGF13;FGF17;FGF23;HRAS;FGF18;PLCG1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5169381415625258,1.4150007579328656,0.07734806629834254,0.606963923438014,1.0,6/34,6.21%,DKK1;NOTUM;LRP4;MDK;KREMEN2;BMP4
prerank,TRRUST_Transcription_Factors_2019__RB1 mouse,0.5990786458409343,1.4149147373296822,0.07784431137724551,0.605778174178593,1.0,4/17,6.65%,IGF2;E2F1;TDGF1;BIRC5
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.550106167049131,1.4149028643767623,0.05263157894736842,0.6042850578315647,1.0,5/21,12.32%,ALOX12B;CERKL;SPHK1;ST6GALNAC4;CERK
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.39580659438312765,1.4147834038531797,0.022222222222222223,0.6032337335555029,1.0,73/237,16.39%,GRPR;HTR1D;GLP1R;GHRHR;CHRND;PTH2R;RXFP4;GCG;GABRD;ADRA2C;NTS;APLN;CALCA;UCN2;CGA;GABRR3;GRIN1;GABRQ;UTS2R;F2RL3;GPR35;P2RX5;KISS1;GAL;LPAR4;TAC4;OPRL1;CHRNB2;GRIK2;HTR4;AVPR2;CHRM4;CHRNA3;HRH3;ADRA1D;PTGER1;PTGER3;KISS1R;GRIK4;TRH;CRHR2;SSTR5;CHRNB4;GALR2;GRIN2A;ADORA1;GALR3;OXTR;GRIN3B;GABRE;CHRNA5;CHRM5;LEP;BDKRB2;NPW;CHRNA4;LHB;GALR1;PTGFR;MC1R;UCN;GPR156;BDKRB1;NMB;MLNR;HTR1B;IAPP;LEPR;P2RX2;GRM1;HTR2B;ADORA2A;TACR1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.4367894269018128,-1.4142738001343005,0.014705882352941176,0.217580153331727,1.0,15/33,17.61%,HHLA2;FOXP3;RIPK3;CRTAM;IL18;IL12B;CD274;PDCD1LG2;TMIGD2;IGF1;IL12RB1;LILRB4;LGALS9;PRNP;CLC
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.5322319167228448,1.4129950669872016,0.07975460122699386,0.6087101039483763,1.0,7/28,13.63%,MT3;NOX4;NOX5;DUOX1;ALOX12;NOX1;SH3PXD2B
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.47078745963454954,-1.4124155035928483,0.05263157894736842,0.21958622058472632,1.0,1/28,0.01%,ERN2
prerank,Elsevier_Pathway_Collection__Eosinophil Activation,-0.35318674254550564,-1.412378680105321,0.021739130434782608,0.21926194387981474,1.0,24/81,15.00%,FCAR;AOC1;TNF;CD244;SIGLEC8;MAP2K1;CD48;EGOT;IL6;FYN;LCP2;IL33;FCGR2B;CXCL8;GNA14;LAT;AKT1;SYK;VCAM1;LAT2;CSF2;TIAM1;FCER1G;VAV1
prerank,Elsevier_Pathway_Collection__Alveolar Macrophages Dysfunction in COPD,-0.34994470135226824,-1.4123401018596886,0.0,0.2189755563988905,1.0,22/69,17.11%,TNF;IL1B;FOS;IL18;CASP1;DEFB1;NLRP3;CCL2;IL6;S100B;CXCL8;TICAM2;TLR4;TLR2;AKT1;S100A12;MYD88;BGN;TNFRSF1B;CXCL1;CTSB;HSPA1A
prerank,Elsevier_Pathway_Collection__MHC1 Causes Antigen Presentation Failure in Cancer Immune Escape,-0.4612655875044757,-1.4122824925484254,0.04054054054054054,0.2187176808244592,1.0,6/25,16.74%,IFNG;CD8A;KIR2DL4;LILRB1;KLRK1;LILRB2
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.44165805548828485,-1.412180186099851,0.09090909090909091,0.21853405683619126,1.0,12/30,17.96%,CTNNA3;CD200R1;CD1D;DSG2;ITGAD;CD2;VCAM1;ITGB2;ITGB3;LILRB2;ITGA4;DSC2
prerank,Elsevier_Pathway_Collection__VEGFR -> NFATC Signaling,0.5604280875652183,1.4121794356308073,0.10493827160493827,0.6103399094973094,1.0,3/21,6.66%,VEGFD;RASGRF1;SRC
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.45549584650668357,1.4119557521859438,0.06310679611650485,0.6096949277725365,1.0,26/79,22.72%,COL2A1;CEMIP;CEACAM16;USH1G;LOXHD1;SNAI2;CHRNB2;ROR1;BIRC5;TMC1;COL1A1;PCDH15;COL11A1;WHRN;MYO7A;CRYM;P2RX2;NDUFB9;TSPEAR;TPRN;COL11A2;PDZD7;CACNA1D;EYA1;USH1C;TIMM10
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.5515272818124117,1.4117626600028104,0.07514450867052024,0.6088554786923467,1.0,7/21,8.72%,ATP4A;KCNH2;SLC12A5;SLC12A1;ATP1A2;ATP1A4;ATP1B3
prerank,MSigDB_Oncogenic_Signatures__KRAS.AMP.LUNG UP.V1 UP,0.4333932513689819,1.4116271146947055,0.0297029702970297,0.6079516497377071,1.0,15/106,5.36%,DYNC1I1;KCNC1;NPHS1;DOCK3;DLX5;SPINK1;DUSP9;CSN2;PNMA3;SPP1;PAGE4;OPN1SW;SLC2A4;EFNA3;FAM155B
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,0.50604490629856,1.4109784515904067,0.09045226130653267,0.6088485412666054,1.0,19/40,35.44%,EXO1;SERPINA2;XRCC2;RFC4;CHEK1;BARD1;DNA2;RMI1;POLR1A;ATRIP;RAD9B;RAD51;BLM;RHNO1;BRIP1;RMI2;TOPBP1;BRCA2;SEM1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.370135726262726,-1.4109296082275178,0.043478260869565216,0.2197801397497485,1.0,25/83,13.58%,CYP26A1;AWAT2;LRAT;ADH4;BCO2;CYP2C8;APOA4;GPC5;ADH1A;UGT1A9;CYP3A7;CYP1A2;APOA1;CYP2C18;ALDH8A1;AKR1C4;GPC6;ADH1C;BCO1;CYP26B1;GPC4;ADH7;CYP3A4;CYP4V2;TTR
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.5820821065652373,1.410620300458339,0.10429447852760736,0.6087512476409235,1.0,6/17,19.97%,E2F1;E2F2;CCNE1;CCNE2;CDKN1C;CDK6
prerank,Elsevier_Pathway_Collection__Neutrophil Activation via FCGR3B,-0.38643978311536287,-1.4105224870391397,0.046875,0.22002524349562952,1.0,18/50,21.40%,PLD1;FCGR3B;MAP2K1;PRKCB;LCP2;CYBB;RAC2;FCGR2B;HCK;LAT;SYK;VAV1;NCF1;INPP5D;NCF2;IQGAP1;PRKCZ;CYBA
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.5074775747882166,-1.4102621363881738,0.08333333333333333,0.21997735362672302,1.0,6/16,14.58%,SLC5A1;SLC45A3;SLC2A9;SLC2A12;SLC5A3;SLC2A2
prerank,Elsevier_Pathway_Collection__Cortisol in Resolving Inflammation,-0.39294857224111673,-1.4099975105333118,0.030303030303030304,0.21990227073625385,1.0,17/45,18.34%,IL10;PTGS2;TNF;FOS;NR3C2;TNFSF10;IL6;NR1I2;CXCL8;TICAM2;TLR4;TLR2;CYP3A4;CSF2;NR1I3;HSPA1A;DUSP1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.5808402325269272,1.4095317381157366,0.09941520467836257,0.6113352864585951,1.0,12/18,33.35%,RFC4;MCM3;MCM4;MCMDC2;MCM7;POLA1;GINS4;LIG3;GINS1;GINS2;PCNA;LIG1
prerank,WikiPathway_2021_Human__Regulation of Microtubule Cytoskeleton WP2038,0.4803802459883247,1.4093954180477613,0.06976744186046512,0.6103748559638684,1.0,11/45,16.33%,EPHB2;MAPT;RHO;KIF2C;SRC;AURKB;CDK1;MAPKAPK2;PRKCA;STMN1;MAP1B
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4641188474762939,1.409252790183846,0.05319148936170213,0.6094361286528569,1.0,4/56,2.76%,SFN;UBL4B;E2F1;TP73
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.5176092194627182,1.4088226244767863,0.07734806629834254,0.6093974759041154,1.0,13/38,15.58%,LMOD1;ACTN2;SIX4;MYH3;CASQ1;TNNT1;KLHL41;PDGFRB;TNNT3;PGM5;OBSCN;TMOD4;ANKRD1
prerank,Elsevier_Pathway_Collection__T-Cell Dependent B-Cell Activation,-0.39185454680411735,-1.4084978912642,0.03125,0.22140198325765947,1.0,20/59,22.03%,IL2RB;FOS;CD79A;IL7R;MAP2K1;CCR7;PRKCB;CD40LG;BTK;CARD11;LAT;AKT1;SYK;PLCG2;VAV1;NFATC2;MAP2K3;JUN;PIK3AP1;CD40
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.4569044538520507,-1.4084546699828846,0.0625,0.22107040709030323,1.0,13/27,18.99%,CYP26A1;HAO2;HOGA1;CYP4F2;CYP4F12;ACAA1;CYP26B1;CYP4F3;ACOX1;HAO1;AGXT2;AGXT;ACBD5
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.5716913862383027,1.407686266554502,0.0755813953488372,0.6128897470430729,1.0,6/19,4.55%,SIX1;HOXD3;WNT4;SOX2;DKK3;MDK
prerank,TRRUST_Transcription_Factors_2019__PPARGC1A mouse,-0.5088395994521462,-1.407599266118003,0.13253012048192772,0.22199183998489208,1.0,4/16,11.23%,CIDEA;APOA4;G6PC;NR1I2
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.5797958420771735,1.4069985772099958,0.09032258064516129,0.6141036505521998,1.0,11/17,20.62%,SYN3;PPFIA3;PPFIA4;SYN1;SNAP25;CPLX1;UNC13B;PPFIA2;SYN2;STXBP1;STX1A
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.38476864617343576,-1.4067129849757678,0.05555555555555555,0.22286500899291017,1.0,22/63,14.96%,EGR3;EPHB1;CCR9;HGF;CXCR1;CXCR2;NR4A1;CCR5;XCR1;CXCR6;PDGFRA;CCR7;ACKR4;CXCL12;PRKCQ;CCR1;CCR2;BIN2;CCR4;HBEGF;CXCR3;CXCR4
prerank,Elsevier_Pathway_Collection__Methylases in Histone Methylation Cancer,0.6117792920781974,1.4064442412847626,0.07792207792207792,0.6146994720913904,1.0,10/17,27.33%,PRDM12;PRDM16;EZH2;SMYD3;DOT1L;SUV39H1;NSD1;KMT2D;DNMT1;NSD2
prerank,Elsevier_Pathway_Collection__Leptin in Insulin Synthesis and Secretion,0.5830263348593759,1.4048669305305757,0.06666666666666667,0.619583418047714,1.0,6/17,15.00%,GLP1R;NEUROD1;LEP;IAPP;PDPK1;LEPR
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.4748984955768441,-1.4039092894708056,0.09195402298850575,0.22662903668135068,1.0,5/22,11.19%,AWAT2;MOGAT2;DGAT2;MOGAT1;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.5463997513658655,-1.40357294753948,0.125,0.22668841876718113,1.0,10/17,13.58%,CD27;INHBA;SFRP1;ID2;IKZF3;ZFP36L1;FCRL3;BTK;NCKAP1L;SYK
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.4183423901215283,-1.4032456404678035,0.05970149253731343,0.22682873284629923,1.0,8/29,15.49%,ATP10B;MFSD2A;PLSCR2;TMEM30B;ATP11C;ABCB1;ATP8B4;PLSCR4
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.46815835153713065,1.4030613410463675,0.04891304347826087,0.6248022804639782,1.0,15/56,16.39%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.4806134187989774,1.4027126270353378,0.06111111111111111,0.6246434768724128,1.0,39/49,47.28%,RPS27;RPS21;EIF3E;RPS5;EIF3K;RPS14;RPSA;EIF3D;RPS15;RPS2;RPS19;RPS4X;RPS20;EIF3H;RPS8;RPS12;EIF3B;RPS3A;RPS7;RPS11;FAU;RPS3;RPS24;EIF3G;RPS16;EIF3M;RPS28;RPS23;EIF2S3;RPS9;EIF3C;EIF3F;RPS15A;EIF3L;RPS6;RPS27A;RPS4Y1;RPS13;EIF3A
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5715889270404636,1.4026264136634936,0.08982035928143713,0.6234475016973771,1.0,5/17,10.06%,SOX1;MDK;HES5;TMEM98;DAAM2
prerank,WikiPathway_2021_Human__Cytoplasmic Ribosomal Proteins WP477,0.43320748607849996,1.4025553314958301,0.03398058252427184,0.6222159152243569,1.0,72/88,46.98%,RPL8;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPL10;RPSA;RPL39;UBA52;RPLP0;RPS15;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL13;RPL27;RPL38;RPL35;RPL10A;RPS6KA3;RPS8;RPS12;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPS18;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS6KB2;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;RPS15A;RPL4;RPS26;RPL19;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,Elsevier_Pathway_Collection__Sarcomere in Cardiomyocyte in Dilated Cardiomyopathy,0.5525989440412431,1.4024572314224788,0.0949367088607595,0.6211390330403843,1.0,3/19,2.50%,TNNC1;ACTN2;TNNI3
prerank,Elsevier_Pathway_Collection__Androgens Promote Scalp Dermal Papilla Regression,0.5149330087574487,1.4024507613331336,0.05357142857142857,0.6196551839800157,1.0,5/29,6.48%,DKK1;LEF1;AXIN2;CDKN2A;TCF7
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.44953098702323585,1.4021887353244011,0.019230769230769232,0.6190748497382679,1.0,44/102,31.01%,HMGA2;FBXO43;KIF20A;NEK2;CDC25C;PLK1;PLK5;RAB11FIP4;MKI67;BUB1;AURKB;KLHL21;CDKN2B;KLHL13;AURKA;USP51;RACGAP1;E4F1;IHO1;PKMYT1;CHEK1;ECT2;KIF11;TTL;PRC1;OBSL1;CETN2;CEP250;MARK4;DBF4B;AHCTF1;L3MBTL1;CUL7;PLK4;MYO19;CTNNB1;TIPIN;SPAG5;BBS4;CUL9;PIN1;TXLNG;CEP85;DAPK3
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.45381023419176875,1.4019096124934038,0.06829268292682927,0.6185055093174512,1.0,26/77,22.72%,COL2A1;CEMIP;CEACAM16;USH1G;LOXHD1;SNAI2;CHRNB2;ROR1;BIRC5;COL1A1;PCDH15;COL11A1;WHRN;MYO7A;PIEZO2;CRYM;P2RX2;NDUFB9;TSPEAR;TPRN;COL11A2;PDZD7;CACNA1D;EYA1;USH1C;TIMM10
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.38938078424781125,-1.40176689364964,0.018518518518518517,0.22845346299568828,1.0,29/61,27.40%,HAO2;GLYAT;PIPOX;DAO;ACAA1;EHHADH;ACOX1;HAO1;EPHX2;CROT;DDO;PHYH;MLYCD;HMGCL;AGXT;ACOX2;ACOX3;PECR;ACOT2;IDH1;SLC27A2;LONP2;PEX7;CRAT;PEX13;PAOX;PEX14;NUDT7;ECI2
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,0.5523653255474799,1.4012307817281242,0.07738095238095238,0.6200422078990036,1.0,8/22,21.80%,FGF20;FGF13;FGF17;FGF23;SHC1;HRAS;FGF18;PLCG1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.5400832353141072,1.4005819867997569,0.06666666666666667,0.6211714933529604,1.0,9/23,24.51%,EPHB2;GPR35;SLC6A9;EPO;GSTM2;GNB5;MMP9;CBARP;CASQ2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.504938536905326,1.4005481443526,0.06626506024096386,0.6198763191529534,1.0,13/34,21.32%,PLK1;TOP2A;KIFC1;KIF18B;KIF18A;NDC80;CDCA8;KIF25;SGO2;ZWINT;CENPK;SGO1;DSN1
prerank,WikiPathway_2021_Human__Wnt/beta-catenin signaling pathway in leukemia WP3658,0.5357065824051386,1.4004372374505796,0.05202312138728324,0.6188310810937024,1.0,3/25,2.57%,DKK1;LEF1;AXIN2
prerank,Elsevier_Pathway_Collection__MC1R in anti-Inflammatory Signaling,-0.4134111518526953,-1.4002889012318718,0.03389830508474576,0.23015384859972124,1.0,13/43,15.71%,PCSK2;IL10;TNF;IL1B;CXCR1;MAP2K1;CXCL8;TICAM2;TLR4;SELE;VCAM1;CREM;CD86
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.4829066763514598,1.4000130797788446,0.06951871657754011,0.6191040324928667,1.0,18/42,25.32%,SQLE;FDPS;MVD;ACACA;SREBF2;PKMYT1;DAND5;HMGCR;TM7SF2;SCD;IDI1;PMVK;FDFT1;GPAM;HMGCS1;CYP51A1;LIN9;SMARCD3
prerank,WikiPathway_2021_Human__GABA receptor Signaling WP4159,-0.45294733912539,-1.3989143433640252,0.1,0.23170526667223104,1.0,5/25,0.91%,GABRA5;GABRA3;GABRB1;GABRA4;GABRG1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.4992081505179517,-1.398554859806503,0.09375,0.23180980185003863,1.0,10/20,19.12%,NLRP7;CHAC1;LRRK2;CCBE1;GAS1;CLN3;PRNP;NLRC4;MAGEA3;ADAM8
prerank,Elsevier_Pathway_Collection__Osteoclast Activation in Postmenopause,-0.4211045511990617,-1.397958382412757,0.07017543859649122,0.23234320901768044,1.0,14/41,21.42%,TNFSF11;TNF;TNFRSF11B;FOS;MAP2K1;MITF;CALCR;TNFRSF11A;AKT1;TNFRSF1B;CSF1R;TAB2;MAP2K6;JUN
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.5774349030993389,1.3977468728268592,0.11242603550295859,0.6267349616857862,1.0,11/19,29.80%,E2F1;TOP2A;CDC6;CDC25A;E2F5;HDAC1;LIN37;LIN9;MYC;RBL1;PCNA
prerank,MSigDB_Hallmark_2020__Myogenesis,0.40619162427746663,1.3977059203587783,0.022727272727272728,0.6254308145955743,1.0,48/183,17.12%,CACNG1;SPDEF;COL15A1;MYH1;TNNC1;ACTN2;PTP4A3;KCNH2;MYBPH;MYH3;MAPK12;MYH4;CASQ1;CDH13;TNNT1;CKB;NQO1;MYH8;MYF6;FGF2;SPHK1;TNNI2;COL1A1;SLC6A8;FDPS;TNNT3;COL4A2;ATP2A1;PDLIM7;CD36;PPFIA4;BDKRB2;STC2;DAPK2;APOD;GJA5;TPM2;TEAD4;MYLPF;KIFC3;GPX3;ATP6AP1;HDAC5;MRAS;MEF2D;CACNA1H;ABLIM1;SCD
prerank,Elsevier_Pathway_Collection__IL36 Receptor Antagonist (IL1F5) Deficiency (DITRA),-0.442378219422208,-1.3974074212201988,0.05333333333333334,0.2327320767739701,1.0,9/26,14.75%,TNF;IL1B;IL1RAP;IL1RL2;IL6;IL33;CARD11;CXCL8;MYD88
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.562827750573418,1.3973442116519967,0.07142857142857142,0.6254689472793019,1.0,7/19,21.47%,TOMM40L;TOMM20L;DNLZ;TIMM17B;ROMO1;TIMM17A;TOMM20
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.5088308370724222,1.3967517900856319,0.07734806629834254,0.6262536929273983,1.0,7/35,10.35%,HMGA2;COL7A1;LAMA3;NODAL;COL8A1;COL11A1;COL4A2
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,0.4181875097365235,1.3965505995025855,0.055,0.6255126308622548,1.0,21/110,16.69%,KIF1A;DYNC1I1;KIF26B;KIF20A;KIF2C;KIF4A;CENPE;KIF5A;KIF15;KIFC1;KIF18B;KIF18A;KIF23;KIF21B;PAFAH1B3;RACGAP1;KIF25;TMED3;KIFC2;NBAS;KIF11
prerank,Elsevier_Pathway_Collection__NFKB Signaling Activation by Blocking of Tumor Suppressors,-0.37869552377403853,-1.396352858366171,0.03508771929824561,0.23366342230524245,1.0,16/53,16.76%,TNFSF11;TNFRSF17;TNF;IL1RAP;TNFRSF13B;NFKBIZ;CD40LG;TNFRSF11A;CARD11;REL;TLR4;TLR2;TNFSF13;MYD88;TNFSF8;TNFSF13B
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Psoriasis,-0.4874279855494592,-1.3962809254115143,0.0641025641025641,0.23339931838411573,1.0,8/24,13.38%,FOXP3;IL10;MMP1;S100A8;KLF4;GATA3;AKT1;CAMP
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.4028128415221893,1.3958986630327455,0.037383177570093455,0.6263095834123856,1.0,32/181,13.94%,NKD1;DKK1;DKK4;TPBGL;NOTUM;AXIN2;SFRP4;LRP4;SOX2;APCDD1;DKK3;SNAI2;DKKL1;MDK;TAX1BP3;ZNRF3;KREMEN2;TMEM88;NKD2;MDFI;IGFBP2;PRKN;PSMD4;TLE6;RNF43;KREMEN1;SOX30;SOSTDC1;APC2;SHISA6;PSMB4;AMER1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3677806718028163,-1.3957665525906524,0.0,0.23360696168299228,1.0,23/73,13.93%,CSF3;TNF;NTRK3;NTF3;HGF;WNT16;CCL5;NTRK2;IL18;PDGFRA;DCN;PIK3CD;SEMA4D;OSM;NKX3-1;NTRK1;FLT3;PIK3R5;HCLS1;PIK3R1;SOX9;IGF1;FGR
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.4819378924661147,1.3957195360202548,0.06779661016949153,0.6256276698538139,1.0,11/50,16.03%,CPLX2;RAB3C;SEPTIN5;RAB3B;LGI3;STXBP6;IL1RAPL1;RAB3D;CPLX1;ATP6AP1;SYTL4
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3451853825678019,-1.395426333698064,0.023809523809523808,0.2337252375030809,1.0,41/115,23.90%,IFNL2;AGBL4;IFNL1;FCN3;RIPK3;ZBP1;ACOD1;APOBEC3C;OASL;TLR3;APOBEC3A;IFNL4;RSAD2;PTPRC;PRF1;IL6;TLR8;LILRB1;CD207;TLR2;MX2;MYD88;IFIT2;NT5C3A;IFIT3;BCL2;TRIM5;PMAIP1;ABCC9;IFI16;OAS3;OAS2;IFIT1;APOBEC3G;CD40;STAT1;IFIH1;IRF2;F2RL1;DDX58;OAS1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.45562730999381545,1.3953486329486997,0.06486486486486487,0.6254421549213492,1.0,8/55,6.21%,PAX2;SIX1;REN;WNT4;LRP4;SIX2;CENPF;BMP4
prerank,MSigDB_Oncogenic_Signatures__HINATA NFKB IMMU INF,-0.49982624237662404,-1.394963195725145,0.10891089108910891,0.2340114230741215,1.0,6/16,14.85%,IL1B;CXCL3;CXCL2;CCL2;IL6;CD83
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.4600752510584743,1.394926797068892,0.06936416184971098,0.6256067156049712,1.0,18/48,18.02%,NETO1;ACTN2;CACNG4;CACNG5;GRIN1;MAPK8IP2;SHISA8;LYNX1;CAMK2A;GRIN2A;NPTX1;SHISA6;CACNG8;DLG4;CNIH3;NPTX2;CNIH2;NLGN2
prerank,Elsevier_Pathway_Collection__Inflammatory Reaction in Acne Vulgaris,-0.38632618509472744,-1.3947654714446232,0.029411764705882353,0.2339606698137305,1.0,19/49,23.65%,TNF;IL1B;FOS;IL1RAP;CASP1;MAP2K1;NLRP3;IL12B;CXCL8;TLR2;MYD88;TNFRSF1B;CTSB;MAPK10;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.48948169539535624,1.3943198170883468,0.06629834254143646,0.6266652736768418,1.0,5/36,3.15%,CTNNA2;EPHB2;PAK3;MAPK8IP2;LRP4
prerank,Elsevier_Pathway_Collection__DRD1/5 Expression Targets,-0.4989640819367144,-1.3936687054724712,0.1232876712328767,0.23507552124384418,1.0,3/17,7.46%,TAC1;FOS;MAP2K1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.5031432001431265,1.393542359397488,0.08875739644970414,0.6284694224457684,1.0,9/34,13.13%,KCNE5;TNNC1;KCNH2;SGCZ;TNNI3;TNNI2;ATP1A2;SCN4B;ACE
prerank,Reactome_2022__Influenza Infection R-HSA-168255,0.40643163583280556,1.3930214171646265,0.03255813953488372,0.6292327398251554,1.0,106/155,46.98%,KPNA7;RPL8;POLR2L;MRPL13;NUP37;ISG15;PARP1;RPL30;RPLP1;RPS27;RPS21;NUP62;RPLP2;POLR2K;KPNA2;TPR;NUP133;RPS5;CPSF4;RPL28;POLR2G;RPS14;SLC25A6;RPSA;RPL26L1;RPL39;CLTA;UBA52;RPLP0;RPS15;NUP155;RPS2;RPL31;NUP160;RPS19;RPL36;RPL37A;POLR2H;RPL37;RPL7;RPS4X;RPS20;RPL27;NUP188;TGFB1;RPL38;RPL35;POLR2I;POLR2J;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;PABPN1;RPS7;RPS11;RPL36A;NUP205;RPL7A;FAU;RPS3;RPL18A;RPL32;XPO1;RPS24;POLR2A;RPL3L;NUP210;RPL29;RPL23;HSP90AA1;RAN;RPL5;RPL14;RPS16;POLR2B;NUP214;RPL13A;RPL41;RPL9;GTF2F1;RPS28;NUP107;RPS23;RPL27A;RPL23A;RPL18;RPL12;GNL3;POLR2F;RPS9;RPL6;RPS15A;AAAS;RPL4;RPL19;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;NUP93;RPL34;RPS13
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.40664540976714375,1.393016918517967,0.04205607476635514,0.6278143488211703,1.0,22/158,8.32%,NKD1;DKK1;DKK4;TPBGL;NOTUM;AXIN2;SFRP4;LRP4;SOX2;DKK3;SNAI2;DKKL1;MDK;ZNRF3;MESP1;KREMEN2;TMEM88;NKD2;IGFBP2;PRKN;PSMD4;TLE6
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.4584437938505397,-1.3927757516372135,0.0963855421686747,0.235922409493378,1.0,5/26,0.91%,GABRA5;GABRA3;GRIN2B;GABRA4;GABRG1
prerank,Elsevier_Pathway_Collection__Oxygen Shortage in Myocardial Ischemia,0.5682000737884091,1.3924117040600295,0.07692307692307693,0.6289365522832374,1.0,4/16,11.68%,TNNC1;TNNI3;ATP2A1;CACNA1C
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.4046247342347969,1.3922631106048768,0.013452914798206279,0.6279636832675302,1.0,125/173,47.36%,BOP1;EXOSC4;UTP14A;NVL;RPL8;RRP12;DCAF13;NHP2;RRP15;HEATR1;RPL30;RPLP1;BYSL;PRKDC;RPS27;LAS1L;RRP1;RPLP2;WDR46;NOP58;PDCD11;RRP9;EXOSC5;RPL28;RPS14;RPL10;NOP2;RPL39;UBA52;NOC4L;NOP56;RPLP0;PELP1;FBL;RPS15;DKC1;RPS2;RPL31;RPS19;RPL36;RPL37A;PES1;RPL37;RPL7;RPL13;RPL27;RRP7A;RPL38;WDR55;RPL35;SNU13;UTP15;RPL10A;POP5;DDX49;RPL35A;NOL9;MRPL1;RPS7;TSR3;EXOSC2;RPL36A;WDR12;TBL3;DHX37;POP4;WDR75;RPL7A;RPL18A;RPL32;UTP4;RPS24;PIH1D1;RRP36;IMP4;UTP18;PWP2;RPL29;RPL23;RIOK2;RPL5;EXOSC1;RPL14;NOL8;EXOSC7;SART1;EXOSC10;RPS16;MRTO4;EXOSC9;RPL13A;RPL41;RPL9;NAT10;NOL6;RPS28;EBNA1BP2;RPL27A;RPL23A;RPL18;EIF6;DDX54;RPL12;RPS9;RPL6;DDX10;EMG1;RIOK1;RPL4;NSA2;DDX27;MTREX;RPL19;UTP20;RPS6;RPL26;NOB1;WDR74;NOP53;RPL34;SRFBP1;TEX10;MPHOSPH10;UTP6;BMS1
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.4253291934977367,-1.3916861317110658,0.016666666666666666,0.2372331133025361,1.0,16/38,16.80%,SIGLEC16;KLRD1;SIGLEC14;SIRPB1;FYN;LCP2;CLEC5A;BTK;LCK;PIK3R1;SYK;KLRK1;CD300E;PLCG2;KIR2DS4;VAV3
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,-0.4750190522513598,-1.3912811883514384,0.09523809523809523,0.23733580557632433,1.0,9/20,12.81%,CYP4A22;CYP4A11;CYP4F2;DPEP3;ALOX5AP;DPEP2;ALOX5;CYP4F3;PTGR1
prerank,"Elsevier_Pathway_Collection__Overt Hypothyroidism, Primary",-0.42256411347453493,-1.3905399388211244,0.07462686567164178,0.23797338184295938,1.0,5/31,8.23%,NKX2-1;TSHR;GNAO1;MAP2K1;TG
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.4995712258459778,1.3903667296783964,0.09714285714285714,0.6339925982688933,1.0,9/33,11.68%,CACNB4;CACNA1S;COL9A1;CACNA1G;COL4A1;COL4A5;NCAN;COL4A2;CACNA1C
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.41987787740547355,1.390343161229883,0.05263157894736842,0.6326230435017022,1.0,83/127,47.37%,PSMD4;RECQL4;CDC6;CDC7;CDC45;MCM2;CDT1;MCM6;PRIM1;RFC4;PSMB4;ORC1;MCM10;POLD1;MCM3;MCM5;HMGA1;MCM4;DNA2;TWNK;MCMDC2;GMNN;RAD51;MCM7;WDHD1;POLA1;POLA2;GINS4;BLM;PSMD1;GINS1;PSMB3;GINS2;PSMD14;UBA52;PSMB5;RECQL5;POLB;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;MCM8;TOPBP1;PNKP;PSMC5;SIRT7;PSMB6;PSMD8;PSME2;DBF4;BAZ1A;PSMD13;PSMB7;POLG;PSMA7;PSME3;CDK2;RPA2;RECQL;LRWD1;RFC3;POLD3;PSMB2;PSMA6;UBC;POLG2;PSMD9;POLD4;SSBP1;ORC6;WRN;PSMC2;PRIMPOL;CDC34;RPS27A;RPA1;PSME1;PSMB1;RFC1;PSMD3;PRIM2
prerank,WikiPathway_2021_Human__Wnt Signaling Pathway WP363,0.48134372328261665,1.3899740662868811,0.06593406593406594,0.6326901336956381,1.0,18/50,26.12%,SOX1;LEF1;AXIN2;ROR1;PIP5K1B;DVL2;PPARG;PRKCA;CDK6;TSC1;BCL9;TSC2;GJA1;TCF3;DVL1;ROR2;MYC;CTNNB1
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,0.4249987035885856,1.3897190529272914,0.06310679611650485,0.6322372485055054,1.0,75/115,47.37%,UBE2C;PSMD4;CCNE1;CDC6;CCNA2;UBE2S;CCNE2;CDC45;CDT1;MCM6;PRIM1;RFC4;PSMB4;POLD1;MCM3;MCM5;MCM4;DNA2;FEN1;POLR1A;ANAPC11;GMNN;MCM7;POLA1;POLA2;GINS4;ANAPC7;GINS1;PSMB3;GINS2;PSMD14;UBA52;PSMB5;PSMD2;PCNA;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;MCM8;SKP2;SKP1;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;CDK2;SLC19A1;ANAPC2;RFC3;POLD3;PSMB2;RBX1;PSMA6;ANAPC4;UBC;PSMD9;POLD4;ORC6;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;PSMB1;PSMD3;PRIM2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hypogonadotropic Hypogonadism,0.5319803697089475,1.388987771110789,0.09826589595375723,0.6335198831333713,1.0,8/20,15.68%,SOX2;KISS1;NR5A1;KISS1R;PCSK1;LEP;LEPR;HS6ST1
prerank,Elsevier_Pathway_Collection__IGF1R -> MEF/MYOD/MYOG Signaling,0.5126622210236057,1.3884576281822687,0.06918238993710692,0.6343411644361993,1.0,5/29,16.55%,IGF2;MAPK12;SRC;PDPK1;MEF2D
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.4934070537366714,1.388323443114531,0.10555555555555556,0.6334022830391212,1.0,6/36,4.02%,LRRC26;EPHB2;ACTN2;CASQ1;GAL;LRRC52
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.40678061748285504,1.3881123597403413,0.02843601895734597,0.632836577975246,1.0,37/162,12.85%,COL2A1;HTR1D;GP2;NPHS1;CACNG1;ADRA2C;AMBN;SMPX;CDH16;TLX1;CAPN9;ATP4A;TNNI3;PRODH;ALOX12B;RIBC2;PLAG1;SLC30A3;MSH5;TENM2;MAGIX;SLC6A3;AKR1B10;IGFBP2;PRKN;YPEL1;KLHDC8A;NR6A1;GPR19;ITGB1BP2;MAST3;GPR3;IDUA;COQ8A;NUDT11;PKP1;PTGFR
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.5263703930145495,-1.3876526821044222,0.08974358974358974,0.24140345353357098,1.0,10/17,25.63%,PLG;ENPP4;F3;THBS1;APOH;SERPINF2;HPSE;F2;THBD;HRG
prerank,Elsevier_Pathway_Collection__Low-Density Lipoproteins and Chemokines in Atherosclerosis,-0.4742184377455951,-1.387272734899201,0.05063291139240506,0.2415253986481493,1.0,14/22,22.41%,CCL5;CCR5;CCL2;CCR2;TLR4;VCAM1;MYD88;ITGB2;ACAT1;SELPLG;CX3CR1;SELP;ITGAM;LDLR
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer Immune Escape,-0.40636450548914765,-1.3870525282192,0.05405405405405406,0.2414723066751551,1.0,16/46,15.71%,CSF3;IL10;TNF;LAG3;FASLG;CD80;TDO2;VTCN1;CTLA4;IL6;CD274;PDCD1LG2;CD247;KLRK1;CSF2;CD86
prerank,KEGG_2021_Human__Vitamin digestion and absorption,-0.467579055669778,-1.386467341007407,0.03125,0.24194253654340991,1.0,5/22,6.74%,AWAT2;LRAT;SLC19A3;APOA4;APOA1
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,0.5219995745754072,1.3863068347726468,0.09142857142857143,0.6385851060188094,1.0,5/26,9.66%,NEK2;BUB1B;CDC20;UBE2C;UBE2S
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.4227241793456915,1.3861424853000874,0.03015075376884422,0.6378725823197717,1.0,23/94,15.60%,GLP1R;RFX6;CACNA1E;GCG;ADRA2C;KCNC2;BRSK2;KCNG2;NEUROD1;CACNA2D2;KCNB1;PRKN;ACSL4;TRH;SSTR5;ABCC8;NR1D1;CACNA1C;SNAP25;INHBB;DPP4;KCNJ11;PRKCA
prerank,TRRUST_Transcription_Factors_2019__SP3 human,-0.3595129995884609,-1.3861269255023216,0.0,0.24196731337483698,1.0,17/105,6.95%,KLK3;TFF2;TFF1;NKX2-1;FOXP3;MUC6;PADI1;SLC19A3;CETP;BPI;HGF;LCAT;ID4;LAMA1;IGFBP3;CYP3A7;FBP1
prerank,WikiPathway_2021_Human__DNA IR-double strand breaks and cellular response via ATM WP3959,0.48060896047061114,1.385916894276957,0.08040201005025126,0.6373846561981205,1.0,27/54,34.84%,E2F1;TP73;CDKN2A;CDC25C;EXO1;CHEK1;PARP1;RAD51;TRIM28;PRKDC;FANCD2;BLM;HSF1;CDK5;CHEK2;NABP2;MDC1;YAP1;PCNA;SMC3;TP53BP1;CASP9;RASSF1;BRCA2;BAX;STK3;SMC1A
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,0.4034531031801983,1.3858305725829112,0.023148148148148147,0.6363504288678115,1.0,36/191,17.35%,DLK1;DNER;H3C13;H2AC19;E2F1;H2BC13;HES5;H2AC20;HDAC4;H2BC17;AGO2;H2BC21;PSMD4;H2BC9;H2BC15;CNTN1;DLGAP5;NOTCH3;H2BC11;H2BC12;ATP2A1;HDAC11;H2BC4;H4C15;JAG2;H2AC6;PSMB4;KAT2A;H2BC5;HDAC5;PLXND1;H2AX;SMAD3;ST3GAL3;ELF3;EGF
prerank,MSigDB_Oncogenic_Signatures__RELA DN.V1 UP,-0.33556948524676866,-1.385743703028004,0.0,0.24208762803933842,1.0,46/131,18.63%,NOL4;SLC27A6;MEP1B;FOSB;EGR3;GLS2;PTGS2;KCNJ16;ADAMTS13;IL1B;CST5;GLYAT;FOS;F9;CD38;DEFB1;XCL1;ZFP36L1;SIRPB1;DNMT3L;GPR183;P2RY10;CTF1;DAPP1;CCL2;EGR1;SAMSN1;DLGAP1;LAMC2;MAK;CYP26B1;TNFRSF9;USP9Y;ETFDH;GRAP;KMO;PODXL2;KLF6;GPR85;TPMT;F3;PPP1R15A;SNAPC1;RNF39;APBA2;LGMN
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,0.48906921474582454,1.3856689583165749,0.1065989847715736,0.635609638895118,1.0,20/43,35.44%,EXO1;SERPINA2;XRCC2;RFC4;CHEK1;BARD1;DNA2;RMI1;POLR1A;ATRIP;RAD9B;RAD51AP1;RAD51;BLM;RHNO1;BRIP1;RMI2;TOPBP1;BRCA2;SEM1
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,0.5330840050493953,1.3844367544648615,0.10714285714285714,0.6391949719525962,1.0,24/29,42.18%,TUBA4B;TUBA4A;CCT3;TUBA3E;TUBA8;PFDN2;TUBB2B;TUBA3D;VBP1;TUBB2A;PFDN6;TUBA1A;TUBA1B;CCT8;CCT6A;CCT4;TUBB6;TUBB4B;PFDN4;CCT2;CCT7;TUBA1C;CCT5;TUBB4A
prerank,TRRUST_Transcription_Factors_2019__DDIT3 human,-0.4849952574213242,-1.384356183649251,0.08571428571428572,0.24370900025585993,1.0,4/18,11.86%,ATF5;TF;IL6;CXCL8
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.4512773223355233,-1.3842214571003009,0.05813953488372093,0.24350563228018218,1.0,5/23,11.95%,GCK;HK3;ENO3;ALDOB;ALDOC
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.5273534489925915,1.3840317324065181,0.10982658959537572,0.6395256877498731,1.0,5/25,8.72%,WNK4;ACTN2;SLC6A9;TRPC6;ATP1B3
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.4735190357546928,1.3839186997317943,0.060109289617486336,0.6385336278595841,1.0,13/47,17.65%,KIF20A;CENPA;PLK1;KIF4A;ANLN;KIF23;CEP55;RACGAP1;STMN1;ECT2;ROCK2;RHOC;JTB
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.32966308038636294,-1.3838154458315035,0.0,0.24375279598341112,1.0,40/123,16.75%,CXCL13;FCN2;GBP6;JCHAIN;STAB2;IGLL5;WFDC2;CFP;BPI;IGLL1;S100A14;TLR3;FPR2;S100A8;DEFB1;TF;PI3;GBP7;ANXA3;GBP4;IL6;IL12B;PGLYRP2;SPN;MBL2;PGLYRP1;TLR4;KRT6A;TLR2;SFTPD;CAMP;SYK;FGR;S100A12;MYD88;FCER1G;STAB1;RNASE7;GSDMA;NLRC4
prerank,KEGG_2021_Human__DNA replication,0.48624141567001966,1.3836957033417767,0.08602150537634409,0.6379678344971536,1.0,13/35,23.30%,MCM2;MCM6;PRIM1;RFC4;POLD1;MCM3;MCM5;MCM4;DNA2;FEN1;MCM7;POLA1;POLA2
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,0.5046346960768499,1.3833172517650087,0.10059171597633136,0.6382689995146241,1.0,21/29,44.26%,ELOC;POLR2L;ELOB;POLR2K;NELFE;POLR2G;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;POLR2A;ELL;POLR2B;GTF2F1;POLR2F;CDK9;SUPT16H
prerank,Elsevier_Pathway_Collection__CD38/CD3 -> JUN/FOS/NF-kB Signaling in T-cell Proliferation,-0.46038434955231494,-1.383301740415981,0.05128205128205128,0.24403375268601146,1.0,13/29,16.88%,CD4;FOS;CD38;MAP2K1;CD3E;CD3G;FYN;LCK;CD247;LAT;AKT1;FCER1G;ZAP70
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.429311616182372,1.3826780357829616,0.06132075471698113,0.6393789026871451,1.0,21/78,13.95%,CACNB4;KCNE5;NETO1;ACTN2;CACNG4;CACNG5;GRIN1;MAPK8IP2;SHISA8;FGF13;CAMK2A;GRIN2A;HPCA;FGF14;KCNS2;EPO;JPH1;SHISA6;CACNG8;DLG4;CNIH3
prerank,TRRUST_Transcription_Factors_2019__GATA3 human,-0.4179136252146467,-1.3824739519320124,0.028169014084507043,0.24474511382949746,1.0,13/35,11.92%,SLCO4C1;MUC1;CHST4;IL10;IFNG;CD8B;MMP1;CD8A;CDH1;ESR1;CD40LG;FUT7;GATA3
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,0.49629836080262874,1.382093088603322,0.10416666666666667,0.6401621204860404,1.0,19/41,35.44%,EXO1;SERPINA2;XRCC2;RFC4;BARD1;DNA2;RMI1;POLR1A;ATRIP;RAD9B;RAD51AP1;RAD51;BLM;RHNO1;BRIP1;RMI2;TOPBP1;BRCA2;SEM1
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.5287363122517905,-1.3820895720504531,0.09090909090909091,0.2449806224349405,1.0,7/17,20.54%,TCN1;MMUT;PRSS3;ABCD4;MMACHC;LMBRD1;MMADHC
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.41170118390627053,1.3815835761584159,0.04932735426008968,0.6407029426867666,1.0,29/136,16.28%,CACNB4;CACNG1;PPP2R2C;TNNC1;CACNG4;CACNA1S;CACNG5;CALML6;TNNI3;MAPK12;CACNA2D2;MAPK11;ADRA1D;ATP1A2;ATP1A4;ATP2B4;CAMK2A;ATP1B3;ATP2A1;SCN4B;CACNA1C;CACNA2D3;CREB3L1;CACNG8;TPM2;ADCY6;FXYD2;PRKCA;CREB3L4
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.5309447266930533,1.3811294960231668,0.10119047619047619,0.6411221801259559,1.0,10/25,11.68%,CACNA1I;HCN2;KCNH2;SCN1A;SCN4A;CACNA1G;ATP1A2;SCN4B;SCN2A;CACNA1C
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,0.3968487678861316,1.3810276966181647,0.037037037037037035,0.6400674194004093,1.0,48/171,17.88%,LMOD1;KCNE5;ACTN2;CACNG4;KCNH2;TNNI3;MYH3;SCN1A;TNNT1;SCN4A;KCNK17;CACNA2D2;MYH8;FGF13;CACNA1G;FXYD7;TNNI2;ATP1A2;ATP1A4;ATP2B4;CAMK2A;ATP1B3;KCNJ14;MMP12;TNNT3;NANOS1;FGF14;MYBPC1;KCNIP3;ATP2A1;SCN4B;SCN2A;CACNA1C;CACNG8;TMOD4;TPM2;FXYD2;KCNJ4;CORIN;KCNJ11;PRKCA;KCNE4;CACNA1H;FGF12;KCNK13;SLC8A3;TRIM72;NEB
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.5764292006406494,1.3808102747088675,0.09210526315789473,0.6394623873333107,1.0,7/17,9.29%,STMND1;STMN3;KIF2C;STMN2;KIF14;KIF18B;KIF18A
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.5996986950252097,1.3807529324031524,0.10828025477707007,0.6383491764234442,1.0,5/16,10.17%,PLK1;CENPE;UBE2C;CDC6;PTTG1
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,-0.47292006557595867,-1.3806951478591978,0.06944444444444445,0.24657403802002897,1.0,8/21,16.53%,ALDH6A1;BCKDHB;PPM1K;ACADSB;DBT;IVD;ECHS1;MCCC1
prerank,WikiPathway_2021_Human__The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.466200931559566,1.3803593875419022,0.05970149253731343,0.6384596278312528,1.0,8/53,7.91%,HMGA2;LEF1;E2F1;SPP1;HES5;MSTN;TCF7;AGO2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.3937189425888335,1.3801685518244737,0.03587443946188341,0.6377440530241708,1.0,84/183,39.56%,E2F1;TM4SF5;CENPF;NEK2;HMMR;PLK1;BUB1B;CENPE;ANLN;PLK5;CDC20;NPM2;KIF14;UBE2C;PSMD4;CDC6;UBE2S;CDK1;TUBA4A;CCNB1;KNTC1;RGCC;AURKA;PSMB4;TFAP4;CEP131;PKD1;CETN2;CEP250;HAUS4;HAUS5;TPX2;ANAPC11;PLK4;DYNLL1;PSMD1;ANAPC7;PSMB3;CEP70;SFI1;PSMD14;UBA52;SSNA1;MAD2L1;PSMB5;PSMD2;PSMA1;PSMD10;CSNK1D;PSMC4;PSMC3;TUBA1A;ALMS1;CUL1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;SKP1;PSMC5;TUBG1;CEP72;PPP2R1A;PSMB6;CDC23;PSMD8;NDE1;HAUS1;PSME2;TUBB4B;DDB1;SDCCAG8;PSMD13;PSMB7;PSMA7;ERCC2;HSP90AA1;ANAPC1;RIOK2;CSNK1E;PSME3;CDK2
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.42359815863351746,-1.3800332708082659,0.05063291139240506,0.2472095548499446,1.0,9/33,15.21%,MFSD2A;SLC45A3;APOA4;HSD17B13;APOA1;GPLD1;APOA5;AKT1;CHP1
prerank,Elsevier_Pathway_Collection__Thyroid Stimulating Hormone (TSH) Resistance in Congenital Hypothyroidism,-0.4290331714109869,-1.3799746245400024,0.058823529411764705,0.24692585745108503,1.0,5/31,8.23%,NKX2-1;TSHR;GNAO1;MAP2K1;TG
prerank,Reactome_2022__Translation R-HSA-72766,0.3874445426486569,1.3780478057664771,0.017241379310344827,0.6446734994529993,1.0,174/277,47.28%,EEF1A2;MRPL55;MRPS21;SSR2;MRPL24;MRPS24;SSR4;RPL8;MRPL13;VARS1;EEF1D;MRPL9;MRPS14;EPRS1;DTD1;EIF2B4;RPL30;RPLP1;SEC61G;PARS2;RPS27;RPS21;MRPS23;QARS1;RPLP2;DARS2;EIF3E;GADD45GIP1;MRPL23;RPS5;EIF3K;MRPL52;RPL28;MRPL12;FARSB;LARS1;RPS14;IARS2;SEC11C;RPSA;RPL26L1;PABPC1;RPL39;EIF3D;UBA52;TRMT112;RPLP0;MRPL15;EEF1E1;RPS15;RPS2;AIMP1;RPL31;HARS1;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;MRPL36;RPL27;MRPL41;RPL38;RPL35;EIF3H;AURKAIP1;MRPL21;MRPS34;TUFM;MRPL17;RPL10A;MRPS15;GARS1;RPS8;RPS12;EIF3B;RPL22L1;RPL35A;MRPL51;MRPL4;MRPL33;OXA1L;CHCHD1;RPS3A;MRPL1;RPN2;VARS2;N6AMT1;RPS7;SRPRB;RPS11;RPL36A;CARS2;GSPT2;SEC61B;RPL7A;FAU;MRRF;AARS2;RPS3;RPL18A;APEH;SPCS1;RPL32;EIF5B;RPS24;TARS2;EIF3G;RPL3L;DDOST;MARS1;RPL29;SRP14;RPL23;RPL5;RPL14;RPS16;MRPS5;MRPL43;PTCD3;MRPS27;RPL13A;RPL41;RPL9;EIF3M;EEF1B2;MRPS18C;IARS1;MRPL58;RPS28;MRPL50;FARSA;EIF2B5;RPS23;PPA1;RPL27A;RPL23A;RPL18;EIF2S3;RPL12;MRPS11;MRPS26;DLGAP3;RPS9;EIF3C;RPL6;MRPL49;EIF3F;SEC61A1;EEF2;RPS15A;RPL4;EIF3L;RPL19;SRP19;EIF2B1;EEF1A1;RPL39L;SPCS2;RPS6;RPL26;MRPL20;FARS2;RPS27A;RARS1;MRPL47;RPS4Y1;MRPS16;RPL34;RPS13;ETF1;EIF3A
prerank,WikiPathway_2021_Human__Oxidative Damage WP3941,-0.39998841275344665,-1.3778301127355235,0.0641025641025641,0.24951903035859122,1.0,15/40,19.67%,CR2;TNF;C1QC;C1R;C1QB;BAG4;TNFRSF1B;BCL2;MAPK10;GADD45A;C3AR1;C1S;MAPK13;C1QA;C5
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.483652607786599,1.3774593493211231,0.04891304347826087,0.6457310820799044,1.0,38/46,46.98%,SNRPE;RPS27;RPS21;RPS5;SNRPD2;RPS14;RPSA;SNRPB;GEMIN8;RPS15;RPS2;RPS19;GEMIN7;RPS4X;RPS20;SNRPD3;RPS8;RPS12;RPS3A;RPS7;RPS11;FAU;RPS3;RPS24;DDX20;GEMIN4;RPS16;SNRPG;RPS28;RPS23;RPS9;GEMIN5;RPS15A;GEMIN6;RPS6;RPS27A;RPS4Y1;RPS13
prerank,KEGG_2021_Human__Yersinia infection,-0.3168682136958946,-1.37738679219814,0.022727272727272728,0.24983093149519256,1.0,41/133,21.42%,IL10;CD4;TNF;IL1B;CD8B;CD8A;FOS;IL18;CASP1;MAP2K1;PIK3CD;FYB1;NLRP3;CCL2;IL6;LCP2;RAC2;MEFV;RPS6KA1;CXCL8;LCK;TLR4;LAT;PIK3R1;AKT1;WIPF1;MYD88;RPS6KA6;VAV1;ACTR3C;NLRC4;VAV3;ZAP70;ITGA4;MAPK10;MAPK13;TAB2;NFATC2;MAP2K3;MAP2K6;JUN
prerank,Elsevier_Pathway_Collection__Mast-Cell Activation via IgE Signaling,-0.34857637921247664,-1.377142415706916,0.022727272727272728,0.24978347702409656,1.0,21/83,15.00%,TAC1;HAS2;TNF;CCL5;MAP2K1;FCER1A;PRKCB;CCL2;IL6;LCP2;FCGR2B;BTK;CARD11;CXCL8;LAT;AKT1;SYK;LAT2;PLCG2;FCER1G;VAV1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.40512773289854753,-1.3771015692940858,0.07352941176470588,0.24947203096174528,1.0,15/43,12.75%,NRXN1;LRFN5;WNT7A;EPHB1;MUSK;IL1RAPL2;SLITRK3;IL1RAP;LHFPL4;ROBO2;GPC6;EPHB3;PTPRD;GPC4;TLR2
prerank,TRRUST_Transcription_Factors_2019__PAX6 mouse,0.509148377401157,1.3764247925544721,0.11176470588235295,0.6483660063718566,1.0,7/32,3.39%,MAFA;PAX2;GCG;ALDH3A1;HOXD4;SOX2;DKK3
prerank,Elsevier_Pathway_Collection__Genes with Mutations Associated with Systemic Scleroderma,-0.528463389992814,-1.3760153367540169,0.0898876404494382,0.25070140230160287,1.0,6/15,11.86%,IL10;TNF;PTPN22;CCL2;IL6;CXCL8
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.5428419200099849,-1.375669989466988,0.10714285714285714,0.2507632756192977,1.0,7/15,19.29%,STAP1;CCL3;IL33;TLR4;TTBK1;THBS1;WNT5A
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.5837010310527985,1.375094064721613,0.09090909090909091,0.6524073670450843,1.0,3/16,8.98%,RASGRF1;STMN3;ARHGAP44
prerank,MSigDB_Oncogenic_Signatures__RPS14 DN.V1 DN,0.40568502094794945,1.3746199342890428,0.02830188679245283,0.6528145136388066,1.0,55/167,21.08%,TSPO2;GAL;KIF20A;DEPDC1;KIF2C;PLK1;CENPE;STMN2;CDC20;S100A3;PBK;SPHK1;CCNB2;KIF5A;MKI67;KIF15;NCAPH;EXO1;E2F8;SLC6A8;CDC6;DLGAP5;RRS1;TRIP13;KIF23;AGAP1;IPO4;GPATCH4;FOXRED2;CDCA3;RASIP1;ARHGAP11A;MYBL2;CAD;ERCC6L;SLC29A2;SRM;ORC1;RGS5;MCM10;POLD1;TMSB15A;MCM5;ECT2;TUBB2B;PRC1;MSH2;AGFG2;ATAD2;SLC25A21;DYRK3;TGM2;ZNHIT2;TLN2;SH3TC2
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,0.5562554919917084,1.374349025690382,0.09941520467836257,0.6523612762367731,1.0,5/18,11.47%,CDC25C;ZNF385A;CDK1;CCNB1;AURKA
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.4477550792880505,1.3743066225072937,0.07853403141361257,0.6511330197820696,1.0,39/71,40.49%,CCNB2;TUBA4B;TUBB8;CDK1;TUBB8B;TUBA4A;CCNB1;TUBA3E;LMNA;TUBA8;TUBB2B;LBR;TUBA3D;NUP37;AHCTF1;NUP62;NUP133;EMD;RANGAP1;LMNB1;TUBB2A;NUP155;VPS4A;NUP160;UBE2I;CHMP2A;TUBA1A;TUBA1B;NUP188;BANF1;PPP2R1A;NUP205;TUBB6;TUBB4B;LEMD2;RAN;TMPO;CC2D1B;TUBA1C
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.41810468155334124,1.3741941237483197,0.05025125628140704,0.6503084965953593,1.0,44/105,32.95%,H3C13;H2AC19;H2BC13;H2AC20;H2BC17;H2BC21;H2BC9;H2BC15;UHRF1;EZH2;H2BC11;DNMT3A;H2BC12;H2BC4;H4C15;H2AC6;KAT2A;H2BC5;H2AX;POLR2L;JARID2;SUV39H1;POLR1A;EHMT2;HDAC1;H2AJ;POLR2K;SAP30L;DNMT1;GATAD2B;DNMT3B;TAF1A;POLR1H;SIN3B;SAP130;POLR1G;CHD3;CHD4;POLR2H;RBBP7;CBX3;H2AZ1;PHF19;TET3
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.36453918549875813,-1.3731569439722608,0.038461538461538464,0.25407350630646064,1.0,21/81,14.87%,FOSB;MUC5AC;CSF3;CXCL10;PTGS2;MUC5B;IFNG;TNF;IL1B;MMP1;FOS;CXCL3;S100A8;CXCL2;CCL2;IL6;CXCL8;MAPK15;IL17RE;IL17RC;CSF2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.49063850565477735,-1.3724187814746633,0.11363636363636363,0.25469752370472065,1.0,12/22,23.69%,CAMK4;CCR7;AXL;BLK;LILRB1;FLT3;IRF8;CSF2;LGALS9;BATF;BATF2;F2RL1
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.49012011180953946,1.371930787102275,0.11976047904191617,0.6579759871553654,1.0,7/30,18.45%,GNG4;F2RL3;SRC;GNG3;GNB5;GNG8;GNG10
prerank,Elsevier_Pathway_Collection__HTR1 -> Membrane Transport,0.5550644277853574,1.3713348697799281,0.07142857142857142,0.6589081923615925,1.0,3/20,1.59%,HTR1D;SLC6A4;RASGRF1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.497454713896164,1.3709555541469238,0.1130952380952381,0.6589868739154261,1.0,2/37,1.97%,TRIM71;RBM24
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.5656989237983799,1.3708075699575994,0.11377245508982035,0.658346748173472,1.0,2/18,1.00%,MT3;MRAP2
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5636093528424603,1.3704220978536878,0.1111111111111111,0.6584262786371387,1.0,11/21,29.01%,FGF13;STMN2;SPEF1;APC2;ARHGEF2;TRIM54;TPX2;CAMSAP2;CAMSAP1;MID1IP1;KATNB1
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,0.5630551182265203,1.3702996929710582,0.09714285714285714,0.6575753730546074,1.0,8/21,20.07%,CERS1;NODAL;TDGF1;FOXH1;DAND5;TDGF1P3;SMAD3;ACVR2B
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,0.3947255034422858,1.3702359339218488,0.02252252252252252,0.6564424410499181,1.0,84/181,39.56%,E2F1;CENPF;NEK2;CDC25C;HMMR;FOXM1;PLK1;GTSE1;CCNB2;PSMD4;FBXL18;CCNA2;CDK1;TUBA4A;CCNB1;AURKA;MYBL2;PSMB4;CEP131;PRKCA;PKMYT1;CDC25A;CETN2;CEP250;HAUS4;HAUS5;TPX2;MZT2B;PPP2R3B;LIN37;PLK4;DYNLL1;LIN9;HSP90AB1;PSMB3;CEP70;SFI1;TUBGCP6;PSMD14;UBA52;SSNA1;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;MZT2A;CSNK1D;PSMC4;PSMC3;TUBA1A;ALMS1;CUL1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;SKP1;FKBPL;PSMC5;TUBG1;CEP72;PPP2R1A;E2F3;SEM1;PPME1;PSMB6;TUBGCP2;PSMD8;NDE1;HAUS1;PSME2;TUBB4B;XPO1;SDCCAG8;PSMD13;PSMB7;PSMA7;HSP90AA1;CSNK1E;PSME3;CDK2
prerank,Elsevier_Pathway_Collection__GCG and PPY Regulate Metabolism and Satiety,0.5813659293592123,1.3700279602121943,0.13125,0.6558913451766413,1.0,2/15,0.68%,GLP1R;GCG
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5112414783983482,1.3699314623669412,0.09195402298850575,0.6548661809765814,1.0,7/26,13.53%,PLK1;CENPE;UBE2C;CDC6;DLGAP5;CCNB1;NSMCE2
prerank,WikiPathway_2021_Human__Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,-0.4939806328033112,-1.369669700854296,0.13043478260869565,0.25831317239870977,1.0,7/15,13.06%,CLDN4;ERBB4;TNF;SFRP1;CDH1;ZEB2;AKT1
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5601196017601775,1.3691876768331237,0.14465408805031446,0.6562363406714481,1.0,7/17,14.81%,SIX1;OSR1;BMP4;GPC3;NPNT;FOXC1;FOXJ1
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,0.5051143628831414,1.368975173241583,0.08994708994708994,0.6557669870373026,1.0,17/35,35.44%,EXO1;SERPINA2;RFC4;BARD1;DNA2;RMI1;POLR1A;ATRIP;RAD9B;RAD51;BLM;RHNO1;BRIP1;RMI2;TOPBP1;BRCA2;SEM1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.474481902054414,1.3689663937505843,0.0872093023255814,0.6544446202010341,1.0,12/43,9.13%,AGRP;RXFP4;NTS;UTS2R;GAL;NXPH4;OPRL1;KISS1R;SSTR5;GALR2;SORCS3;GALR3
prerank,Elsevier_Pathway_Collection__WNT Canonical Signaling,0.52108250975222,1.368873856688107,0.0782122905027933,0.6534873268066916,1.0,3/26,3.32%,DKK1;LEF1;APCDD1
prerank,Elsevier_Pathway_Collection__AHR Signaling in Tr1 Cells Function,-0.45745913260892856,-1.368000881389973,0.08,0.26050786306660817,1.0,13/28,23.49%,IL10;IFNG;IL27;ICOS;MAF;TBX21;IL21R;AKT1;PRDM1;GZMB;JAK2;STAT1;GADD45G
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3784833531013844,-1.3677190719556063,0.05172413793103448,0.26064726364541924,1.0,21/51,25.23%,LRRC19;TNF;IL1B;TCIM;CD27;NLRP12;TLR3;NR3C2;IL12B;TLR4;TLR2;CD86;LGALS9;NOD2;NMI;APP;TRIM44;LAPTM5;CD14;SASH1;PHB2
prerank,Elsevier_Pathway_Collection__NO Effect on Vasodilation and Vasoconstriction,0.6041074314320333,1.3675935333359044,0.1038961038961039,0.6572203703787747,1.0,2/16,1.59%,HTR1D;RASGRF1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.46595511207526275,-1.3675328078715072,0.08974358974358974,0.2605842097119954,1.0,9/20,19.05%,IFNL1;IL15;PIK3CD;RSAD2;HCAR2;NCKAP1L;LGALS9;LILRB2;AQP3
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.4462877708778013,-1.367302260961608,0.060240963855421686,0.2605465614695246,1.0,7/25,19.62%,AMPD1;PNP;ADK;MTHFD1;SHMT1;AMPD3;GMPR
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.3932465251835196,1.3670595720125687,0.048672566371681415,0.6580659955436033,1.0,109/200,43.63%,CDC20;CCNA2;CDC45;MCM2;MCM6;TYMS;CCT3;CAD;RFC4;NME1;SRM;ODC1;MCM5;MCM4;NHP2;ILF2;MRPL9;EPRS1;IMPDH2;TRIM28;MCM7;KPNA2;DUT;NPM1;NOP16;PGK1;MRPL23;RPS5;RRP9;CYC1;TXNL4A;PSMD1;HSP90AB1;SNRPD2;MYC;PSMB3;COPS5;NAP1L1;PABPC1;PSMD14;EIF3D;LSM2;MAD2L1;NOP56;RPLP0;FBL;VBP1;SNRPD1;PRPF31;SMARCC1;PRDX4;CSTF2;RPS2;RACK1;PCNA;PPIA;PSMA1;LSM7;HSPE1;CBX3;PSMC4;H2AZ1;CUL1;CDK4;PPM1G;RRM1;G3BP1;NDUFAB1;TUFM;RUVBL2;PRPS2;SNRPA;SNRPD3;EIF3B;HNRNPU;UBA2;SSB;PSMD8;CCT4;HSPD1;RPS3;HNRNPA1;XPOT;XPO1;PSMA7;CCT2;CCT7;RAN;RPL14;XRCC6;EXOSC7;CDK2;EEF1B2;USP1;PCBP1;IARS1;HNRNPR;SNRPG;PABPC4;CCT5;U2AF1;RPL18;PSMB2;SNRPA1;APEX1;PSMA6;PA2G4;RNPS1;GNL3
prerank,MSigDB_Oncogenic_Signatures__PRC2 EZH2 UP.V1 UP,0.38897741038597045,1.3668379844731557,0.02727272727272727,0.6577028195863723,1.0,57/166,20.04%,PITX1;LMOD1;APLP1;CGA;PAGE4;HOXA10;HJURP;CENPF;CACNA2D2;DEPDC1;HMMR;OLFML2B;KIF4A;MSH5;PTGDS;MXD3;TOX;KIF15;BUB1;NCAPH;TTK;AURKB;GALR3;EZH2;DLGAP5;WDR76;NR6A1;OXTR;CDH17;CDC45;HELLS;MCM2;HBD;KNTC1;CDT1;SYN1;PRIM1;MYBL2;RFC4;DSCC1;SYP;INHBB;MCM10;THBS2;PSRC1;ECT2;GNB1L;CDC25A;ZNF219;LBR;CASC3;DOC2B;DNA2;ZNF446;NUP37;RAD54L;HAUS5
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.5752881099091683,1.3668260229425746,0.10465116279069768,0.6563900347206617,1.0,10/17,29.06%,TICRR;CDC6;CDC45;CDT1;ORC1;DNA2;CLSPN;RAD9B;TIPIN;TIMELESS
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.4325709449227468,1.366539160491155,0.05612244897959184,0.6561853108191844,1.0,28/88,21.40%,COL2A1;COL22A1;COL7A1;COL15A1;LAMA3;COL9A1;ITGA6;COL10A1;COL4A1;COL4A5;COL8A1;COL1A1;LOXL2;COL11A1;COL4A2;CRTAP;LOXL1;TLL2;COL1A2;COL5A1;LOX;PLEC;P3H4;SCX;P4HA2;COL11A2;COL27A1;TGFB2
prerank,TRRUST_Transcription_Factors_2019__ESR2 human,-0.49700320421986505,-1.3662391174615698,0.10714285714285714,0.2616924330360825,1.0,5/16,9.00%,TFF1;FOS;OXT;TGFA;PTPRC
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3885922750769128,1.3660922513912566,0.013636363636363636,0.656789341461742,1.0,82/206,36.11%,TRIM71;CCNO;E2F1;BRSK2;CDKN2A;NEK2;CDC25C;MELK;FOXM1;PLK1;CCNB2;UBE2C;CAMK2A;CDKN3;CCNE1;CDKN2C;CDC7;CCNA2;UBE2S;CCNE2;CCNF;CDK1;TUBA4A;CCNB1;CDKN2B;AURKA;CEP131;PKMYT1;CDC25A;NES;CETN2;CEP250;HAUS4;CCNP;FBXL6;CDK6;HAUS5;FBXL8;USH1C;CDKN2D;FBXL15;PLK4;DYNLL1;ZNF324;CCNB3;MYC;ANAPC7;BCAT1;CEP70;SFI1;BRSK1;CHEK2;CUL4B;SSNA1;CDKN1A;ENSA;FBXL22;TACC3;CHMP2A;CSNK1D;TUBA1A;ALMS1;CUL1;CDK4;CEP290;CEP152;DCTN2;DYNC1H1;SKP2;DCTN3;CEP41;SKP1;CTDP1;TUBG1;CEP72;PPP2R1A;NASP;E2F3;PPME1;CDC23;CDK3;NDE1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.4021003209675091,-1.365929074386761,0.0375,0.26167838204497146,1.0,17/34,24.09%,IFNG;TNF;FPR2;TLR4;SYK;PLCG2;CLU;ITGB2;AIF1;C1QA;NMI;TMEM106A;JAK2;ITGAM;SNCA;APP;TLR1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.4771333080246763,1.3650969182898303,0.09473684210526316,0.6592189282916818,1.0,24/39,42.18%,MAPT;STMN2;ANKRD53;PSRC1;STMN1;ARL2;CDK5R1;PRUNE1;GBA2;CAMSAP2;CAMSAP1;CLIP3;TBCD;CAMSAP3;MET;ABL1;DRG1;RPS3;NAV3;NUMA1;CDH5;OCLN;MAP2;TUBB4A
prerank,MSigDB_Oncogenic_Signatures__YAP1 DN,0.5067392197666403,1.3650478910851793,0.08670520231213873,0.6581357031485785,1.0,4/35,6.54%,CACNB4;GUCY2C;ITGA2;RHBDL1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.3763962404286454,-1.3646475257542836,0.06349206349206349,0.26332121808357195,1.0,15/50,15.85%,RAB25;TACSTD2;PFN2;FGF10;MARVELD3;IFNG;BMPER;DUSP10;MCC;SOX9;RTN4;PTN;PLCG2;PRKCE;BMPR2
prerank,Elsevier_Pathway_Collection__Graves Ophthalmopathy,-0.42029106384585,-1.3642792129857335,0.03225806451612903,0.26356380001783036,1.0,11/41,13.84%,TSHR;HAS2;IFNG;IL1B;CCL5;MAP2K1;IL6;CD40LG;AKT1;IL16;IGF1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.4828948961930844,1.3636577285926421,0.1092896174863388,0.6621587078734507,1.0,22/38,35.26%,HJURP;CENPA;CENPI;CENPM;CENPU;CENPL;H4-16;VPS72;CENPK;CENPP;NPM1;CENPW;ITGB3BP;SRCAP;CENPS;CENPH;RBBP7;CENPT;CENPQ;RUVBL1;CENPX;NASP
prerank,WikiPathway_2021_Human__Fibrin Complement Receptor 3 Signaling Pathway WP4136,-0.3987322001513136,-1.363424811834454,0.09210526315789473,0.26449812898199926,1.0,15/40,16.63%,CXCL10;TNF;TLR3;CXCL3;CCL2;IL6;IL12B;PLG;TICAM2;TLR4;AKT1;SYK;MYD88;ITGB2;RASSF5
prerank,TRRUST_Transcription_Factors_2019__SOX2 human,0.5584262999708541,1.3633036106603904,0.1069182389937107,0.6622068986789842,1.0,7/17,8.58%,LHX3;DKK1;RHO;ITGA6;BMP4;MKI67;PGA5
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.4530718516465967,-1.3631490228983132,0.047058823529411764,0.26412086198795964,1.0,5/22,11.95%,GCK;HK3;ENO3;ALDOB;ALDOC
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.4530718516465967,-1.3631490228983132,0.047058823529411764,0.26412086198795964,1.0,5/22,11.95%,GCK;HK3;ENO3;ALDOB;ALDOC
prerank,KEGG_2021_Human__Influenza A,-0.32834128982885546,-1.3631409667786034,0.0,0.26373787774205104,1.0,32/148,14.75%,TMPRSS4;CXCL10;IFNG;TNF;IL1B;CCL5;FASLG;TLR3;IL18;TNFSF10;CASP1;NXF3;MAP2K1;PIK3CD;PRKCB;RSAD2;NLRP3;PRSS3;CCL2;IL6;IL33;IL12B;HLA-DQA2;CXCL8;PLG;TLR4;HLA-DOB;MX2;PIK3R1;AKT1;BCL2L2-PABPN1;MYD88
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.4296719281471473,1.3621714105252316,0.06770833333333333,0.6654952941302332,1.0,22/76,11.78%,SLC6A4;SLC6A7;HCN2;ATP4A;ASIC1;SCN1A;SCN4A;SLC6A11;SLC12A1;SLC6A9;SLC6A3;SLC5A2;ATP1A2;ATP1A4;SLC9C2;ATP1B3;SLC6A8;ASIC3;HCN3;SCN4B;SCN2A;SLC9A3
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,0.551470257229148,1.3621101598156693,0.1411764705882353,0.6643943895772227,1.0,18/20,42.18%,TUBA4B;TUBA4A;TUBA3E;TBCE;TUBA8;TUBB2B;ARL2;TUBA3D;TUBB2A;TBCD;TUBA1A;TUBA1B;TBCA;TUBB6;TUBB4B;TUBA1C;TBCB;TUBB4A
prerank,Elsevier_Pathway_Collection__Osteoclast Activation in Gout,-0.3807193124904371,-1.3620971023000417,0.018867924528301886,0.26470788878671875,1.0,21/58,22.12%,TNFSF11;IL1B;TNFRSF11B;FOS;IL1RAP;MAP2K1;MITF;PTGER2;IL6;TNFRSF11A;PTGER4;AKT1;SYK;MYD88;CSF1R;TAB2;MAP2K6;JUN;JAK2;STAT1;TYROBP
prerank,Elsevier_Pathway_Collection__B-Cell Receptor -> AP-1 Signaling,-0.44375535395398863,-1.3620647085862936,0.12790697674418605,0.2643500130041659,1.0,13/21,23.52%,FOS;CD79A;MAP2K1;CD40LG;BTK;RASGRP1;SYK;PLCG2;LILRB3;CD19;JUN;CD40;CD22
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,0.575766479193104,1.3616734276750997,0.09259259259259259,0.6647742605357775,1.0,8/15,29.80%,PRIM1;POLD1;DNA2;FEN1;POLR1A;POLA1;POLA2;PCNA
prerank,Reactome_2022__Protein Folding R-HSA-391251,0.4290261823125937,1.360844039259654,0.07,0.6665368985323116,1.0,21/87,19.44%,GNG4;FBXW10;SPHK1;TUBA4B;CCNE1;RGS9BP;GNG3;CCNE2;TUBA4A;CCT3;TUBA3E;TBCE;GNB5;KIFC3;GNG8;TUBA8;PFDN2;TUBB2B;ARL2;GNG10;TUBA3D
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.42576298810748825,-1.3604077696067804,0.09859154929577464,0.2663829824951453,1.0,3/29,3.34%,ERN2;CHAC1;RNF186
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.4331212656606213,-1.3601885100938693,0.0975609756097561,0.266304431487031,1.0,11/25,24.32%,GGT6;UGT1A9;SULT1C4;SULT2A1;UGT2B15;GSTP1;GSTM1;ABCC3;SLC38A3;GGT5;SULT1A1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.4879898478021799,-1.360093714988766,0.10256410256410256,0.26613541819365255,1.0,4/21,6.66%,CEACAM6;SIK1;CEACAM5;PDK4
prerank,Elsevier_Pathway_Collection__APC/C-FZR1 Complex,0.5343343549144556,1.3600736634165074,0.10365853658536585,0.6679778686268555,1.0,9/23,26.24%,CDC20;AURKB;CDK1;CCNB1;AURKA;CDC25A;ANAPC11;GMNN;ANAPC7
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,0.4619841306362862,1.3599957640681715,0.0962566844919786,0.6669285848156106,1.0,31/49,44.05%,TERT;CCNA2;PRIM1;RFC4;DSCC1;RTEL1;PIF1;POLD1;DNA2;NHP2;FEN1;POLR1A;POLA1;POLA2;BLM;CHTF18;DKC1;PCNA;RUVBL2;NOP10;RUVBL1;TERF1;ACD;CDK2;SLC19A1;TERF2;RFC3;POLD3;SHQ1;WRAP53;POLD4
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.43392174797376193,1.3597714615989378,0.06862745098039216,0.6665442438924742,1.0,22/75,17.57%,COL2A1;ZIC2;PAX2;CRYBA2;USH1G;CABP1;CHRNB2;ARR3;FSCN2;COL1A1;PCDH15;COL11A1;WHRN;MYO7A;EYA4;EFEMP1;RGS16;KIFC3;ROM1;BBS2;ABLIM1;CRYBB2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.41624902403726416,-1.3593458362381632,0.05063291139240506,0.26694659733866083,1.0,10/35,15.16%,CD1A;IL1B;CD1B;XCL1;CD1D;CD1E;IL12B;CD1C;AZGP1;IL12RB1
prerank,KEGG_2021_Human__Chagas disease,-0.3482053636306407,-1.3582533811944661,0.022727272727272728,0.26841305114888825,1.0,36/98,19.63%,IL10;GNAO1;IFNG;TNF;PPP2R2B;IL1B;CCL5;FOS;FASLG;CCL3;PIK3CD;CD3E;CD3G;CCL2;IL6;CCL3L3;IL12B;CXCL8;CD247;GNA14;TLR4;C1QC;TLR2;PIK3R1;AKT1;PLCB2;PPP2R2A;MYD88;C1QB;KNG1;MAPK10;PPP2CB;ADCY1;MAPK13;C1QA;CD3D
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.43042152795030997,1.3581939623172647,0.06598984771573604,0.6717088704541212,1.0,43/74,40.47%,PLK1;UBE2C;ARHGEF10;KIFC1;KIF18B;KIF18A;NDC80;UBE2S;CDCA8;KIF25;SGO2;ZWINT;KIFC2;KIF11;CENPK;SGO1;TPX2;DSN1;NUP62;KLHDC8B;SMC4;CHEK2;SPAG5;ABRAXAS1;SMC3;CHMP2A;NCAPG2;WRAP73;CCDC61;KIF3B;CTDP1;TOGARAM2;SMC1A;TUBG1;ESPL1;KIF2A;NDE1;STAG2;FLNA;RAN;NSL1;CEP192;KLHL22
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.38455268698089445,1.3581182415159245,0.03982300884955752,0.6706312880454823,1.0,171/270,49.09%,ELAVL2;NCBP2L;CELF4;SCNM1;SRSF12;PUF60;DDX39A;PRPF3;CPSF1;SNRPE;USP49;SF3B4;POLR2L;GPKOW;CASC3;PQBP1;RNF113A;PRCC;NOVA2;SNRNP70;RBM8A;POLR2K;RBMX2;PRMT7;METTL3;TXNL4A;DDX41;CPSF4;SF3B5;SNRPD2;POLR2G;SF3A2;PRPF6;PPIL3;PABPC1;UPF3B;NOVA1;LSM2;SNRPB;GEMIN8;LSM4;SNRPD1;PRPF31;CSTF2;LSM7;SRRM2;RALY;POLR2H;GEMIN7;WDR83;SUGP1;ESS2;FUS;NONO;ZMAT2;IK;PPIH;RBMX;POLR2I;RBM10;SNU13;POLR2J;SNRPC;RNPC3;DDX39B;CCAR1;RBM22;SNRPA;SNRPD3;BUD13;HNRNPU;MAGOHB;SLU7;HSPA8;PABPN1;XAB2;DHX9;SPEN;RBM4B;DCPS;RBM15B;USP39;RBM41;HNRNPA1;POLR2A;ZRSR2;DDX20;PRPF8;SNRNP35;HNRNPH2;CD2BP2;PTBP1;RBM4;GEMIN4;SART1;SYMPK;RBM6;PHF5A;POLR2B;ZMAT5;CPSF3;CLP1;SF3A3;PCBP1;GTF2F1;HNRNPR;UBL5;ALYREF;SNRPG;CPSF7;CRNKL1;CTNNBL1;DDX1;PSPC1;U2AF1;U2AF2;SNRPA1;DDX17;SNRNP200;FIP1L1;TGS1;PPWD1;RBM15;RNPS1;POLR2F;SYF2;SRRT;RBM5;PCF11;GEMIN5;HNRNPM;U2SURP;MTREX;PPIL1;DHX35;DDX5;RBM19;GEMIN6;SFPQ;EIF4A3;MAGOH;PRPF38A;SF3B3;SART3;PRPF19;WDR77;CWC27;SNRNP25;PRPF40B;HNRNPUL1;MFAP1;CWF19L1;SNRNP40;SRPK1;CDC5L;DDX42;HNRNPF;PRMT5;DBR1;CSTF2T;DHX16;SF1;DHX8;SF3A1;ISY1;TFIP11;SF3B6;SNUPN;NCBP2;SF3B1;RBM14
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.5057566885021414,1.358060751037013,0.09659090909090909,0.6694834968938956,1.0,9/25,8.27%,SYT5;FGF20;SYT3;CHRNB2;KCNB1;HRH3;SYT15;PRKN;SYT2
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,0.6022690778693504,1.357972818708124,0.1411042944785276,0.6684618944170289,1.0,9/16,28.17%,E2F1;CCNA2;CDK1;MYBL2;E2F5;HDAC1;LIN37;LIN9;RBL1
prerank,WikiPathway_2021_Human__NRF2-ARE regulation WP4357,0.5237242600465772,1.3579604044503837,0.12048192771084337,0.6671947801754761,1.0,4/23,6.66%,SLC7A11;EPHB2;NQO1;SRC
prerank,TRRUST_Transcription_Factors_2019__STAT6 human,-0.42042904356877475,-1.3576030955442557,0.05454545454545454,0.26898046986163565,1.0,10/33,14.02%,IRF4;FOSB;PTGS2;FOS;SIDT1;CXCL8;TLR4;SELE;ADRA2B;CISH
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.4300165729194661,1.3571629826037739,0.06103286384976526,0.6690694427892049,1.0,18/81,13.63%,CACNB4;CACNG1;TNNC1;CACNG4;CACNA1S;CACNG5;TNNI3;PRKAA2;ITGA2;CACNA2D2;ITGA6;ATP2A1;CACNA1C;CACNA2D3;LMNA;ACE;CACNG8;TPM2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.3409041885516553,-1.356978372641744,0.0,0.26956262271849674,1.0,46/120,19.51%,CPNE6;SYT9;MT1G;MT1HL1;CRHBP;MT1F;MT1H;CPNE4;SYT10;AOC1;SYT8;MT1M;SYT1;FOS;MT1E;LRRK2;CDH1;SYT7;MT1X;FBP1;TF;ANK3;MT1A;SYT4;PPIF;ALOX5AP;GPLD1;DLG2;MT1B;SLC25A24;AKT1;ADGRV1;PLCG2;SLC13A5;PRNP;MT2A;NCF1;SLC12A2;ZNF658;LGMN;SYT13;CLIC4;ADCY1;WNT5A;IQGAP1;RYR1
prerank,MSigDB_Oncogenic_Signatures__WNT UP.V1 UP,0.40102928358091194,1.3568188027894021,0.04186046511627907,0.6691295738268298,1.0,35/154,15.55%,IGF2;HOXD3;HOXD10;SFN;ST8SIA3;REG1B;RETNLB;SYT3;LCN2;VAX2;UTS2R;IRX3;TSPO2;KCNJ9;HES5;KRT86;CHRNB2;DPYSL4;KIFC1;A4GALT;INSRR;CCR3;AURKB;CLDN6;GDF15;TFF3;PLAC9;C8G;MFAP2;MC1R;FOXK1;SEMA5B;PMF1;INHBB;FABP5
prerank,Elsevier_Pathway_Collection__Proteins Involved in Diffuse Large-B-Cell Lymphoma,-0.3767573554895862,-1.35672943947911,0.0625,0.269586518591872,1.0,17/54,17.08%,IRF4;IL10;SPIB;ALK;CAT;PRKCB;MS4A1;TCL1A;CARD11;REL;AKT1;TNFSF13;ING1;PRDM1;RIPK4;TNFSF13B;BCL2
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.37701559049061156,1.3564383097264083,0.017316017316017316,0.6693235652935373,1.0,49/272,15.60%,GNG4;DKK1;DKK4;LGR6;H3C13;RSPO2;LEF1;H2AC19;LGR5;AXIN2;WNT4;TERT;SOX2;H2BC13;WNT9B;WNT8B;ZNRF3;KREMEN2;H2AC20;TCF7;H2BC17;RSPO4;AGO2;H2BC21;CAMK2A;PSMD4;PIP5K1B;H2BC9;H2BC15;PORCN;GNG3;H2BC11;RNF43;RNASE1;H2BC12;H2BC4;H4C15;KREMEN1;H2AC6;PSMB4;AMER1;SCRIB;GNB5;GNG8;H2BC5;DVL2;WNT2B;WNT6;PRKCA
prerank,WikiPathway_2021_Human__Inflammatory Response Pathway WP453,-0.44636098144168584,-1.3563705271921886,0.10144927536231885,0.2697002448796044,1.0,12/28,17.97%,IL5RA;IFNG;IL2RB;CD80;CD40LG;LAMC2;LCK;CD86;TNFRSF1B;ZAP70;THBS1;VTN
prerank,Elsevier_Pathway_Collection__Complement Activation in Macular Degeneration,-0.44061685850064525,-1.3556057402875652,0.08695652173913043,0.270499150514342,1.0,18/29,24.41%,CFP;C9;C7;C6;CR1;MBL2;C1R;CFI;CLU;C8A;VTN;C1S;C5;CD55;MASP1;C3;CFD;C4B
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4356489014610663,1.3554892939016592,0.06735751295336788,0.6720328708034974,1.0,14/82,13.84%,CDC20B;PLK1;BUB1B;CDC20;UBE2C;PSMD4;AURKB;UBE2S;PTTG1;CDK1;CCNB1;FBXO31;AURKA;PSMB4
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.33188878581739756,-1.3554665401327648,0.037037037037037035,0.27035860142346096,1.0,55/135,19.75%,SHC4;RET;ANGPTL1;ERBB4;STYK1;EPHB1;CD4;MUSK;NTRK3;CD8B;CD8A;NTF3;STAP1;LTK;NTRK2;LIFR;PDGFRA;EPHA1;ALK;PDZD3;CNKSR1;EPHA7;FGFR2;CD3E;FYN;EPHB3;AXL;LCP2;BLK;NGF;NTRK1;EFS;PTPRD;LCK;RASGRP4;FLT3;SLA;HCK;SYK;CLNK;EPHB6;FGR;PTN;BMPR2;CSF1R;ACVR2A;PTK6;ZAP70;LIF;EPHA3;DDR2;FRK;GP6;CD7;YES1
prerank,MSigDB_Oncogenic_Signatures__CTIP DN.V1 DN,0.41303839133828685,1.3550651045153967,0.07281553398058252,0.6723339574903547,1.0,20/102,11.34%,CDH22;KCNC1;PI15;CDH16;MYH1;RASGRF1;PLA2G2A;SYNDIG1;MAPK11;REEP2;BCAM;FAM169A;TRPC6;OLFML2A;KCTD17;GPR19;ADAM15;FOXRED2;RPL13P5;ABLIM2
prerank,Elsevier_Pathway_Collection__Mast-Cell Activation without Degranulation,-0.38430041691336825,-1.3548741289507256,0.03076923076923077,0.27097521521523044,1.0,18/45,22.85%,TNF;FOS;IL1RAP;CXCL12;CCL2;IL6;IL33;CXCL8;AKT1;MYD88;CXCR4;TNFSF8;MAP2K3;MAP2K6;JAK2;STAT1;F2;MAP3K5
prerank,WikiPathway_2021_Human__Mesodermal commitment pathway WP2857,0.4042965715380828,1.3547301680996235,0.06046511627906977,0.6722605973203505,1.0,18/133,11.39%,TRIM71;HMGA2;ZIC5;ZIC2;DKK1;LEF1;AXIN2;NODAL;SOX2;PLCH1;TBX3;BMP4;AMH;TOX;FOXH1;ARL4A;FOXC1;TEAD2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.38386159814987847,1.3545431179832423,0.044444444444444446,0.6715688354839057,1.0,157/247,49.09%,ELAVL2;NCBP2L;SRSF12;PUF60;DDX39A;PRPF3;CPSF1;SNRPE;USP49;SF3B4;POLR2L;GPKOW;CASC3;PQBP1;RNF113A;PRCC;NOVA2;SNRNP70;RBM8A;POLR2K;RBMX2;METTL3;TXNL4A;DDX41;CPSF4;SF3B5;SNRPD2;POLR2G;SF3A2;PRPF6;PPIL3;PABPC1;UPF3B;NOVA1;LSM2;SNRPB;LSM4;SNRPD1;PRPF31;CSTF2;LSM7;SRRM2;RALY;POLR2H;GEMIN7;WDR83;SUGP1;ESS2;FUS;NONO;ZMAT2;IK;PPIH;RBMX;POLR2I;RBM10;SNU13;POLR2J;SNRPC;RNPC3;DDX39B;CCAR1;RBM22;SNRPA;SNRPD3;BUD13;HNRNPU;MAGOHB;SLU7;HSPA8;PABPN1;XAB2;DHX9;SPEN;RBM4B;RBM15B;USP39;RBM41;HNRNPA1;POLR2A;ZRSR2;PRPF8;SNRNP35;HNRNPH2;CD2BP2;PTBP1;RBM4;SART1;SYMPK;RBM6;PHF5A;POLR2B;ZMAT5;CPSF3;CLP1;SF3A3;PCBP1;GTF2F1;HNRNPR;UBL5;ALYREF;SNRPG;CPSF7;CRNKL1;CTNNBL1;PSPC1;U2AF1;U2AF2;SNRPA1;SNRNP200;FIP1L1;PPWD1;RBM15;RNPS1;POLR2F;SYF2;SRRT;RBM5;PCF11;GEMIN5;HNRNPM;U2SURP;MTREX;PPIL1;DHX35;DDX5;RBM19;GEMIN6;SFPQ;EIF4A3;MAGOH;PRPF38A;SF3B3;SART3;PRPF19;CWC27;SNRNP25;PRPF40B;HNRNPUL1;MFAP1;CWF19L1;SNRNP40;CDC5L;DDX42;HNRNPF;DBR1;CSTF2T;DHX16;SF1;DHX8;SF3A1;ISY1;TFIP11;SF3B6;NCBP2;SF3B1;RBM14
prerank,WikiPathway_2021_Human__Genes controlling nephrogenesis WP4823,0.48225117053722694,1.3543681069880416,0.07954545454545454,0.6709262426179672,1.0,8/36,12.84%,PAX2;NPHS1;SIX1;WNT4;PDGFRB;FOXC1;CD36;PDGFB
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,0.43101717542274565,1.3538022778487198,0.08205128205128205,0.6720621063348273,1.0,19/81,19.44%,GNG4;FBXW10;SPHK1;TUBA4B;CCNE1;RGS9BP;GNG3;CCNE2;TUBA4A;CCT3;TUBA3E;GNB5;KIFC3;GNG8;TUBA8;PFDN2;TUBB2B;GNG10;TUBA3D
prerank,Elsevier_Pathway_Collection__G-Proteins Signaling in Insulin Secretion in beta-Cell,0.5387825082950519,1.3531506252715293,0.10714285714285714,0.6735044197429476,1.0,3/19,1.59%,GLP1R;GPR119;RASGRF1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.2970387416587538,-1.3530306949402995,0.0,0.27321511302488427,1.0,118/312,22.41%,HHLA2;IRF4;EREG;IFNL1;IL10;PTGS2;IFNG;CD4;TNF;GBP5;CHIA;ZBP1;SIGLEC16;IL1B;PNP;CD244;POU2AF1;IL18R1;PTPN22;LY9;CD80;TLR3;CRTAM;IL27;FFAR2;TIGIT;CCBE1;GDF2;IL18;SLAMF6;XCL1;IL15;ITK;LILRA2;CCR7;PIK3CD;NFAM1;SCIMP;LILRA5;NLRP3;PTPRC;PRKCQ;EGR1;AGPAT2;IL6;OSM;RFTN1;CLEC9A;TLR8;CD2;IL33;CD40LG;IL12B;LILRB1;CCR2;CD274;PTGER4;HSPA1B;CARD11;SLC7A5;GATA3;TLR4;CLEC7A;TLR2;SPHK2;TSLP;SORL1;TMIGD2;IL16;RASGRP1;SYK;HAVCR2;CD226;FGR;POU2F2;ORM2;PLCG2;MYD88;CSF2;FCER1G;PLA2R1;IL12RB1;CD86;CD6;CSF1R;LGALS9;F3;LILRB2;HSPA1A;HMOX1;AFAP1L2;EBI3;AIF1;TWIST1;EIF2AK3;BATF;FCN1;NR1H4;IFI16;WNT5A;MAPK13;SERPINF2;C5;NOD2;IL12RB2;INAVA;PRKCZ;XBP1;TMEM106A;BTN3A2;CYBA;TMED10;HPSE;CD40;TYROBP;APP;DHX58;IFIH1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.3794073493944901,1.352638142802165,0.016597510373443983,0.6744130667898891,1.0,138/290,41.64%,HMGA2;TP73;H2AW;TICRR;UBE2T;EME1;EXO1;RECQL4;TRIP13;CDCA5;CDK1;NEIL3;CHRNA4;RAD51AP2;POLQ;XRCC2;FANCI;MC1R;RFC4;POLN;H4-16;POLD1;CHEK1;ACTR5;H2AX;FANCE;MSH2;BARD1;DNA2;CETN2;DOT1L;TRAIP;RAD54L;MUTYH;FEN1;ALKBH2;ATRIP;PARP1;RAD9B;UBE2A;NUDT1;APBB1;EYA1;FAAP20;RAD51AP1;RAD51;TRIM28;WDHD1;PRKDC;FANCD2;POLA1;APEX2;CDKN2D;KPNA2;BLM;KMT5C;NPM1;RHNO1;LIG3;INTS3;RAD18;FANCB;FANCG;CHD1L;NSD2;CHEK2;CUL4B;NABP2;UBA52;MSH6;SPRTN;MAD2L2;CENPS;TIMELESS;MDC1;NSMCE1;RECQL5;POLB;PCNA;PARK7;ABRAXAS1;XRCC1;PIAS4;BABAM2;OGG1;MLH3;HROB;TP53BP1;BAP1;RAD1;BRIP1;PMS1;RMI2;UIMC1;RFWD3;SMARCAL1;DDB2;TOPBP1;LIG1;MUS81;BRCA2;MMS19;PNKP;SMC1A;FAN1;CENPX;DCLRE1B;CIB1;POLL;IGHMBP2;ABL1;UBE2V1;EME2;FAAP24;POLH;VCP;DDB1;ACTR8;GTF2H2C;BAZ1B;XRCC3;ERCC2;BABAM1;CSNK1E;ATR;FANCM;HUWE1;HPF1;RPA2;HERC2;RAD52;RECQL;POLK;USP1;XPC;RAD21;RFC3;POLD3
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.5019903975606093,-1.352634937818127,0.1411764705882353,0.27342012835186963,1.0,6/15,20.43%,CCL2;CXCL8;IGFBP1;HERPUD1;EIF2AK3;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.4944405572752235,-1.3525439026520794,0.07766990291262135,0.27317894814325816,1.0,2/15,3.20%,SMPD3;IFNG
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,0.5353069503635276,1.3517885895424115,0.11904761904761904,0.6763986935932558,1.0,20/23,42.18%,TUBA4B;TUBA4A;CCT3;TUBA3E;TUBA8;TUBB2B;TUBA3D;TUBB2A;TUBA1A;TUBA1B;CCT8;CCT6A;CCT4;TUBB6;TUBB4B;CCT2;CCT7;TUBA1C;CCT5;TUBB4A
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.3715960718488399,-1.3516658804923833,0.04411764705882353,0.27418435198134006,1.0,23/48,22.03%,IGLL5;IGLL1;CD27;BST1;CD38;GPR183;FCRL3;PTPRC;IL6;SASH3;BTK;NCKAP1L;SYK;SH3KBP1;TNFRSF13C;TNFSF13B;VAV3;BCL2;IRS2;NOD2;NFATC2;XBP1;CD40
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.45233710783344994,1.351143979158868,0.10152284263959391,0.6775678640198435,1.0,43/56,47.77%,BOP1;RRS1;NVL;NHP2;RRP15;LAS1L;NPM1;NOP16;RPL10;RPL26L1;NOP2;RPLP0;TRAF7;PES1;NLE1;RPL7;ZNF622;SNU13;RPL10A;RPL35A;MRPL1;BRIX1;PPAN;WDR12;RPL7A;RPL3L;RPL5;RPL14;MRTO4;EBNA1BP2;RPL23A;SURF6;EIF6;NOC2L;RPL6;NSA2;LTO1;RPL26;MRPL20;WDR74;NOP53;MALSU1;RPL3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.4436126060753668,1.3506125888734481,0.07368421052631578,0.6783387575189539,1.0,23/61,31.92%,E2F1;FBXO43;E2F7;NEK2;BMP4;E2F8;AURKB;CDC7;EZH2;KIF25;CHEK1;PCGF2;RRM2;EHMT2;RAD51;UXT;CBX5;VPS4A;RBBP7;DAB2IP;CHMP2A;CBX3;TOM1L2
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.4780563263856546,1.3503773536417976,0.1,0.677849013967028,1.0,2/31,7.91%,TRIM71;AGO2
prerank,WikiPathway_2021_Human__Cell Differentiation - Index expanded WP2023,0.5702780286352046,1.3500627128207177,0.12101910828025478,0.6778057210601789,1.0,6/15,16.55%,TLX1;TLX3;SOX2;EZH2;HDAC5;MEF2D
prerank,Elsevier_Pathway_Collection__Mevalonate Kinase Deficiency,-0.43875313883503625,-1.3499936494884177,0.08333333333333333,0.2762613021598731,1.0,10/28,14.75%,TNF;IL1B;IL18;CASP1;IL6;IL33;TICAM2;TLR4;AKT1;MYD88
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.32728306230336074,-1.3499235247185777,0.034482758620689655,0.27595253979129164,1.0,40/136,14.95%,HHLA2;CIDEA;FOXP3;EREG;LRRC19;IL10;ACE2;RIPK3;IFNG;TNF;ZBP1;NLRP12;CRTAM;VTCN1;IL15;ITK;CCR7;PIK3CD;NFAM1;PTPRC;AGPAT2;IL6;CLEC9A;IL33;IL12B;ALOX5;CCR2;PTGER4;FCGR2B;HDAC9;GATA3;IRF8;SRGN;PLD4;SFTPD;PER1;TMIGD2;FGR;BTN3A3;PLA2R1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.41804327097831434,1.3499121951656727,0.06467661691542288,0.6772144638317327,1.0,45/71,40.37%,COX4I2;COA6;NDUFA1;NDUFS6;NDUFV1;NDUFB9;COX6C;COX7B;NDUFA3;UQCRB;NDUFS2;NDUFA9;COX6B1;NDUFB11;NDUFA2;NDUFS7;COX8A;UQCRQ;CYC1;NDUFA13;UQCRHL;NDUFA11;UQCC3;NDUFA6;UQCR11;NDUFS8;COX4I1;NDUFV2;SDHAF2;COX5B;NDUFA8;NDUFB7;UQCRH;NDUFAB1;NDUFB2;NDUFB10;UQCRC1;COX7C;UQCR10;NDUFB3;NDUFS4;SDHA;NDUFB8;SDHC;COX6A1
prerank,Elsevier_Pathway_Collection__beta-Catenin/Androgen Receptor Signaling in Prostate Cancer,0.5304597330290032,1.3498351251098413,0.09941520467836257,0.6761695601200477,1.0,3/23,2.57%,CTNNA2;LEF1;AXIN2
prerank,Elsevier_Pathway_Collection__TLR4 Signaling in Leukocytes,-0.37503295521543073,-1.3496707375717063,0.03225806451612903,0.2759024346019128,1.0,13/54,15.71%,IRF4;IL10;TNF;IL1B;CCL5;TNFSF10;IL6;IL12B;CXCL8;TICAM2;TLR4;MYD88;CD86
prerank,Elsevier_Pathway_Collection__Androgen Receptor and Cell Cycle in Prostate Cancer,0.5858796600888615,1.349618187744114,0.11627906976744186,0.6759281981481056,1.0,4/16,10.65%,E2F1;CCNE1;CDK1;CCNB1
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,0.5260268733966778,1.3493742846267311,0.1242603550295858,0.6756034080975188,1.0,8/20,23.30%,PRIM1;RFC4;POLD1;DNA2;FEN1;POLR1A;POLA1;POLA2
prerank,MSigDB_Oncogenic_Signatures__P53 DN.V2 UP,-0.3220890692493393,-1.3488099727918959,0.05128205128205128,0.27684989858661063,1.0,46/123,16.09%,MT1G;FCRL2;CYP2A13;TNR;CD5L;CYP2C8;NTRK3;LGSN;RFPL2;KRT14;BPI;BARX2;CD69;POU2AF1;PCDHA6;ATP12A;ANXA10;CCL4;CEACAM5;GP5;CTLA4;SLC4A10;CXCL12;CXCL2;DPYS;IKZF1;SARDH;APOL3;ALOX5AP;TUBB1;IL1RN;SLC15A2;SLA;NCKAP1L;SLC16A4;TNFRSF9;HAO1;ANGPTL3;PF4V1;CDH4;FPR3;CD83;KCNK3;PRKCE;RIPK4;CXCL1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Endometriosis,-0.3069859943651139,-1.3487584639779744,0.0,0.27646129772330547,1.0,63/238,13.84%,CXCL13;CYP2C19;FOXP3;CLDN4;L1CAM;NAT2;IL10;PTGS2;WNT7A;CCR9;TNF;KIR2DL1;HPGD;IL1B;TNFRSF11B;MMP1;NTF3;HGF;FOS;CXCR1;SFRP1;CXCR2;FASLG;KLRD1;CDH1;KLRC1;TDO2;IGFBP3;XDH;ESR1;IL18;CXCR6;IL15;LGALS3;CD163;DCN;DUSP2;PRKCB;CXCL12;FGFR2;FCGR3A;CCL2;PTGER2;IL6;RUNX3;CCR1;TLR8;NGF;CCN1;IL1RN;MMP7;CCR2;PTGES;PTGER4;HSD17B2;CXCL8;GATA3;TLR4;AKT1;IL16;CD82;PGR;IGF1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.5559267828850989,1.3487455318879338,0.11042944785276074,0.6768534766976202,1.0,4/20,6.14%,MT3;SLC39A4;SLC30A3;SLC30A2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.3057705646800463,-1.3487432388189806,0.0,0.27609787095116695,1.0,68/195,19.17%,CIDEA;GABRA3;EREG;CXCL10;PTGS2;WNT7A;NAP1L2;SCG3;SATB1;IL1B;GALNT3;INHBA;IL7R;ID2;TSPAN7;ANXA10;IGFBP3;ANO1;MAP7;IL1RL2;IKZF1;RABGAP1L;KLF4;TLR8;NGF;IL33;ABCB1;CA2;BTC;HDAC9;PDCD1LG2;TRIB1;LCP1;IRF8;SOX9;ST6GAL1;DOCK2;CROT;LAT2;HBEGF;CSF2;MAFB;FCER1G;CXCR4;SPRY2;PIGR;TNFRSF1B;PRDM1;IL10RA;ITGB2;EPB41L3;ALDH1A2;PLAUR;TMEM158;DUSP6;PPP1R15A;ETS1;GUCY1A1;CBR4;VWA5A;TSPAN1;C3AR1;LIF;KIF5C;MAP4K1;NR1H4;ADAM8;CD37
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5373734272176169,1.3485858538107578,0.10897435897435898,0.6761855956759807,1.0,3/23,7.30%,KIF1A;DYNC1I1;KIF5A
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5054557746300896,1.3485276155975143,0.08,0.675204123863928,1.0,4/32,4.06%,GLP1R;GHRHR;GAL;CAP2
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.4349993547693521,-1.3483482187212734,0.08450704225352113,0.27638423422119035,1.0,16/29,24.71%,PTGS2;HPGD;GSTA1;AKR1C4;PLA2G4A;PTGES;PTGR1;ACOX1;TBXAS1;HPGDS;PTGIS;GSTP1;GSTM1;CYP2S1;PTGS1;PNPLA8
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.408561448502626,1.3482980110974767,0.05581395348837209,0.6748187595194683,1.0,49/129,31.70%,H3C13;H2BC13;H2BC18;DMC1;H3C1;H2BC17;H2BU1;H2BC21;PSMD4;H2BC9;H2BC15;CDC6;H2BC11;MCM2;CDT1;H2BC12;MCM6;CHAF1B;PSMB4;ORC1;H4-16;H2BC5;H2AX;MCM3;MCM5;CHAF1A;MCM4;CETN2;PARP1;CENPV;GMNN;RAD51;MCM7;NPM1;HMGB2;PSMD1;PSMB3;NAP1L1;CHD1L;PSMD14;CUL4B;UBA52;H3-3A;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3
prerank,Elsevier_Pathway_Collection__TNF and IL1B Induce Metalloproteinase Synthesis in Osteoarthritis,-0.4078256805369102,-1.348187228246737,0.06944444444444445,0.27620590491700847,1.0,14/37,23.65%,TNF;IL1B;MMP1;FOS;IL1RAP;MAP2K1;MYD88;TNFRSF1B;MAPK10;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.37502680195459326,1.3480973497098991,0.016597510373443983,0.6744027114152523,1.0,62/337,15.96%,COL2A1;ODAM;COL22A1;AVIL;BFSP2;COL7A1;H3C13;COL15A1;CALCA;LMOD1;TSPAN5;LAMA3;KASH5;MAPT;COL9A1;SAA1;XIRP1;H3C1;ITGA6;STMND1;STMN3;KIF2C;FGF13;STMN2;KLHL41;KIF14;COL10A1;COL4A1;CLIP2;SERF1A;PRKN;RHOBTB1;COL4A5;COL8A1;TLE6;KIF18B;COL1A1;KIF18A;LOXL2;COL11A1;MYO7A;FAT1;LTBP2;COL4A2;BFSP1;MFGE8;CD36;PGM5;CRTAP;LOXL1;TLL2;TMOD4;TPM2;MYO1H;COL1A2;COL5A1;H4-16;IAPP;SHROOM4;STMN1;ARHGEF2;DBN1
prerank,Elsevier_Pathway_Collection__Exocytosis: Vesicle Priming,0.5497876597800115,1.347612741296247,0.15862068965517243,0.6751814107671579,1.0,9/18,20.62%,CACNB4;CACNA2D2;SNAP25;CPLX1;SYP;UNC13B;SNAPIN;STXBP1;STX1A
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.5048694656660646,1.3470720305681998,0.09302325581395349,0.6760404262440299,1.0,13/30,32.30%,H3C13;H3C1;EZH2;DNMT3A;H4-16;JARID2;DNMT1;DNMT3B;H3-3A;TRIM27;RBBP7;MORC2;PHF19
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,0.5344644903633168,1.3466678720504341,0.096045197740113,0.6764999862631557,1.0,4/20,5.42%,TNNI3;ITGA2;ITGA6;FGF13
prerank,Elsevier_Pathway_Collection__Sarcomere Disorganization and Intracellular Calcium Overload,0.5113746801877794,1.346637792799644,0.12345679012345678,0.6753630801588849,1.0,3/23,2.50%,TNNC1;ACTN2;TNNI3
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,0.4255292272020879,1.3464590341865696,0.10638297872340426,0.674898960845136,1.0,23/83,15.52%,GNG4;GLP1R;GHRHR;PTH2R;GCG;CALCA;UCN2;WNT4;RAMP1;WNT9B;WNT8B;IHH;CRHR2;PTHLH;GNG3;ADM2;RAMP2;UCN;GNB5;IAPP;GNG8;WNT2B;WNT6
prerank,KEGG_2021_Human__Pyruvate metabolism,-0.3835867381463706,-1.3462207909024062,0.04477611940298507,0.27871952121180066,1.0,20/46,28.12%,ADH4;PCK1;ALDH1B1;ADH1A;ACACB;ADH1C;ADH7;ALDH2;ACAT1;PCK2;ADH6;ACOT12;AKR1A1;ALDH9A1;LDHB;ALDH7A1;GRHPR;ME1;ME2;LDHD
prerank,Elsevier_Pathway_Collection__G2/M Damage Checkpoint,0.5753846146407042,1.3461219391858132,0.12790697674418605,0.675091159267124,1.0,5/17,16.35%,SFN;CDC25C;CDK1;CCNB1;CHEK1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.4681805854754765,1.345674010315082,0.11170212765957446,0.675694965625377,1.0,12/39,9.01%,KCNJ6;HCN2;ATP4A;KCNH2;KCNJ9;SLC12A5;SLC12A1;KCNJ5;ATP1A2;ATP1A4;ATP1B3;KCNJ14
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.38778097718825266,1.3453215137131649,0.017937219730941704,0.6759292956346438,1.0,45/201,14.90%,COL2A1;COL22A1;COL7A1;COL15A1;APLP1;LAMA3;SPP1;SPINK5;MATN1;COL9A1;HRNR;BCAN;ICAM5;MMP11;VWF;MATN3;ITGA2;ITGA6;TGM3;COL10A1;FGF2;MMP21;COL4A1;ELN;COL4A5;COL8A1;NPNT;COL1A1;COMP;COL11A1;MMP12;NCAN;ADAM15;COL4A2;MMP17;LAMC1;MMP10;LOXL1;PDGFB;MFAP2;PDGFA;COL1A2;COL5A1;SMOC2;MADCAM1
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,0.4281687394206974,1.3448841939419345,0.06435643564356436,0.6765419534243113,1.0,42/84,40.08%,NEK2;PLK1;BUB1B;CDC20;UBE2C;PSMD4;AURKB;CCNA2;UBE2S;PTTG1;CDK1;CCNB1;AURKA;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;MAD2L1;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP2;SKP1;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;CDK2;ANAPC2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.5071393585199554,1.3444327670263638,0.12352941176470589,0.6769189412075753,1.0,16/22,36.52%,MAPT;MAP1B;ARL2;MAP1A;PRUNE1;GPX1;GBA2;CAMSAP2;CAMSAP1;PARK7;APOE;AEBP1;MAP1S;CAMSAP3;HSPA8;ABL1
prerank,Elsevier_Pathway_Collection__Insulin Resistance in Hepatocytes,-0.39359021212618833,-1.3444003469513042,0.078125,0.2810983847774556,1.0,21/47,26.43%,TNF;PCK1;ACSL1;PRKCQ;ACACB;IL6;G6PC;AKT1;ACOX1;VAV1;PRKCE;UCP2;PCK2;IRS2;ADIPOR2;APOB;JAK2;MAP2K4;FABP1;GAB1;CPT2
prerank,TRRUST_Transcription_Factors_2019__SIRT1 mouse,0.5312779410110163,1.344195339059906,0.08045977011494253,0.6764193095113362,1.0,9/22,21.81%,DKK1;CRP;TIMP1;NOX1;SHC1;PPARG;SMAD3;MMP9;PARP1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.4922936567403633,-1.3441662856012302,0.05063291139240506,0.2809857931172408,1.0,9/15,19.11%,GLDC;FFAR2;PDK4;OR51E2;FOXO1;SOX9;PDK3;NR1H4;PID1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.39276637069270204,1.3440942211248492,0.02912621359223301,0.6755695574579206,1.0,25/114,16.96%,GLP1R;RFX6;CACNA1E;GCG;ADRA2C;KCNC2;KCNG2;NEUROD1;SAA1;CACNA2D2;KCNB1;SSTR5;ABCC8;CACNA1C;DISP1;SNAP25;UNC13B;RHBDF2;DPP4;KCNJ11;ANKRD1;PRKCA;SYTL4;ADAM9;HMGCR
prerank,Elsevier_Pathway_Collection__IL23A and IL17A Provoke Cancer-Associated Inflammation,-0.4552968699327584,-1.343811921135819,0.11627906976744186,0.28112004764044257,1.0,6/25,15.16%,PTGS2;TNF;IL1B;IL6;REL;IL12RB1
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.4436608098266397,1.3437585045158609,0.08542713567839195,0.6757078623619712,1.0,16/66,14.49%,COL2A1;COL22A1;COL7A1;COL15A1;COL9A1;COL10A1;COL4A1;COL4A5;COL8A1;COL1A1;COL11A1;COL4A2;CRTAP;TLL2;COL1A2;COL5A1
prerank,Elsevier_Pathway_Collection__SCF/BTRC Complex,0.4809490647071191,1.343747332635307,0.11299435028248588,0.6744930792091889,1.0,14/34,29.49%,FOXM1;CDC20;CCNB2;AURKB;CDK1;CCNB1;AURKA;CHEK1;CDC25A;CLSPN;CTNNB1;DDIT3;RB1CC1;ULK1
prerank,Elsevier_Pathway_Collection__Microangiopathy in Diabetic Neuropathy,-0.44315999244362464,-1.3434664320397918,0.0821917808219178,0.2811903921395035,1.0,7/23,14.37%,FOS;MAP2K1;PRKCB;CCL2;IL6;AKT1;VCAM1
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.41637413769597764,1.3433149388482224,0.08955223880597014,0.6748078624595952,1.0,27/81,25.06%,DLK1;TSPAN5;MESP1;EGFL7;SRC;PRAG1;NOTCH3;BEND6;JAG2;SREBF2;ELF3;EGF;TSPEAR;AAK1;HIF1AN;NOTCH4;DLL4;HEY1;CD46;ENHO;TGFB2;LLGL1;DLK2;LFNG;YJEFN3;METTL3;POGLUT1
prerank,TRRUST_Transcription_Factors_2019__YBX1 human,0.5301341363111791,1.3428329075578715,0.13793103448275862,0.6754584035322879,1.0,7/28,11.43%,SLC6A4;E2F1;TOP2A;CDC20;CDKN3;CCNB1;TYMS
prerank,TRRUST_Transcription_Factors_2019__FOS mouse,-0.38526826625368926,-1.3427856269223333,0.028985507246376812,0.2817680563768636,1.0,12/45,15.35%,TFF2;CSF3;PPP1R3B;CCL5;FOS;IL27;EGR1;IL6;NGF;TSLP;GRIA1;SPI1
prerank,Elsevier_Pathway_Collection__IGF1R -> ELK/SRF/HIF1A/MYC/SREBF Signaling,0.5244002945637841,1.3418120349000136,0.11392405063291139,0.6782800258370993,1.0,5/20,16.31%,IGF2;SRC;MAPKAPK2;SHC1;ELK4
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.49358289124793586,1.341807660857207,0.11538461538461539,0.6770507594166746,1.0,5/28,7.62%,FGF20;FGF13;FGF17;SRC;FGF23
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.4462456158293971,1.3417719378259672,0.07291666666666667,0.6759562684768735,1.0,8/65,10.38%,TRIM71;TRIM17;RNF157;UBE2T;SH3RF3;PRKN;UHRF1;RAG1
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.40461263533295133,1.3417239406945447,0.0825242718446602,0.6749091065916044,1.0,24/116,16.69%,KIF1A;DOCK3;H3C13;KIF26B;GATA5;KIF20A;KIF2C;KIF4A;CENPE;KIF5A;KIF15;KIFC1;KIF18B;KIF18A;KIF23;KIF21B;HBD;RNASE1;RACGAP1;KIF25;MAFG;PRKCA;KIFC2;KIF11
prerank,TRRUST_Transcription_Factors_2019__USF2 human,-0.3836428726757592,-1.3412321060285681,0.04477611940298507,0.2837219564552672,1.0,16/46,17.12%,PDX1;PTGS2;CXCR2;CEACAM5;FBP1;FCER1A;CD2;ASCL2;APOA5;CXCR4;PIGR;CFTR;LIPC;THBS1;CTSB;HMOX1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.3805409587481474,1.3411908050568093,0.030434782608695653,0.6758008731923064,1.0,138/199,47.36%,AGO2;BOP1;EXOSC4;UTP14A;NVL;RPL8;RRP12;SMAD3;DCAF13;RPP21;ADAR;HEATR1;INTS8;RPL30;RPLP1;BYSL;RPS27;LAS1L;RRP1;RPLP2;POP1;WDR46;NOP58;METTL3;PDCD11;RRP9;EXOSC5;INTS3;RPL28;RPS14;RPL10;RPL39;UBA52;NOC4L;NOP56;RPLP0;PELP1;FBL;RPS15;DKC1;INTS7;RPS2;RPL31;INTS1;RPS19;RPL36;RPL37A;PES1;RPL37;RPL7;INTS11;RPL13;RPL27;RRP7A;TUT1;RPL38;WDR55;RPL35;SNU13;UTP15;RPL10A;POP5;DDX49;INTS9;RPL35A;AGO1;NOL9;SSB;TUT7;RPS7;EXOSC2;RPL36A;WDR12;TBL3;DHX37;INTS5;POP4;DROSHA;WDR75;RPL7A;RPL18A;RPL32;UTP4;RPS24;PIH1D1;RRP36;IMP4;UTP18;PWP2;RPL29;RPL23;RPL5;EXOSC1;RPL14;NOL8;EXOSC7;EXOSC10;RPS16;MRTO4;EXOSC9;SMAD2;RPL13A;RPL41;RPL9;NOL6;ADAT1;RPS28;EBNA1BP2;RPL27A;RPL23A;RPL18;DDX54;RPL12;RPS9;SRRT;RPL6;INTS4;DDX10;EMG1;RPL4;DDX27;MTREX;RPL19;UTP20;TUT4;POP7;RPS6;RPL26;DGCR8;FARS2;NOB1;WDR74;NOP53;RPL34;TEX10;MPHOSPH10;UTP6;BMS1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.46240098887508246,1.3408408493769384,0.08021390374331551,0.6759797084169655,1.0,20/46,27.00%,HMGA2;LEF1;WNT4;SNAI2;DLG5;TBX3;FAM83D;LOXL2;FOXF2;ROCK2;OLFM1;NOTCH4;TGFBR3;HEY1;TGFB2;TRIM28;CUL7;SNAI1;CTNNB1;HEYL
prerank,WikiPathway_2021_Human__Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,-0.4232272129325459,-1.3406896077002914,0.1095890410958904,0.28412836073665765,1.0,19/29,32.69%,ACE2;TLR3;TLR4;TLR2;MYD88;OAS3;OAS2;STAT1;IFIH1;DDX58;OAS1;IRF9;TMPRSS2;STAT2;IFNAR1;TRAF6;IRAK4;TLR7;JAK1
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,0.398786309791111,1.340415224041582,0.056338028169014086,0.6762934228330991,1.0,103/148,46.98%,ATP6V0D2;CASTOR2;LAMTOR2;RPL8;ATP6V0B;CASTOR1;LAMTOR4;MRPL13;TCIRG1;RPL30;WDR24;ATP6V0D1;RPLP1;RPS27;RPS21;RPLP2;ATP6V0E1;RPS5;ATP6V1C1;RPL28;SH3BP4;RPS14;RPSA;RPL26L1;RPL39;ATP6V1H;DDIT3;UBA52;RPLP0;RHEB;RPS15;RPS2;KPTN;RPL31;ATP6V1F;RPS19;RPL36;RPL37A;GDNF;RPL37;RPL7;ATP6V1E1;RPS4X;RPS20;MLST8;RPL27;RPL38;GCN1;RPL35;ATP6V1E2;LAMTOR5;RPL10A;RRAGD;NPRL3;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;RPTOR;NPRL2;RPS11;RPL36A;RRAGA;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPL14;ATP6V1C2;RPS16;MTOR;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;RPL18;RRAGB;EIF2S3;RPL12;RPS9;RPL6;RPS15A;RPL4;RPL19;EIF2AK4;RPL39L;RPS6;RPL26;RPS27A;RPS4Y1;RPL34;RPS13
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.4561849005943066,1.3402268033986937,0.08648648648648649,0.6759419018989351,1.0,44/60,46.53%,GLUL;BOP1;RRS1;NVL;RBIS;BYSL;NPM1;NOP16;URB2;RPL26L1;CUL4B;RPS15;RPS19;PES1;RPL7;MRPL36;ZNF622;RPL38;RPL35A;DDX31;RPS7;WDR12;DHX37;XPO1;RPS24;RRP36;RIOK2;RPL5;RPL14;RPS16;MRTO4;RPS28;EBNA1BP2;SURF6;SHQ1;TGS1;NOC2L;EMG1;RIOK1;NOM1;LTO1;RPS6;RPL26;WDR74
prerank,Reactome_2022__SHC-mediated cascade:FGFR1 R-HSA-5654688,0.5740752308230553,1.339929977057466,0.10778443113772455,0.6759231006359218,1.0,6/15,15.74%,FGF20;FGF13;FGF17;FGF23;SHC1;HRAS
prerank,Elsevier_Pathway_Collection__Glutamate Overdose and Aura Effect in Migraine Type 1,0.5600598100061157,1.339692712907391,0.10738255033557047,0.6757695720120465,1.0,9/19,20.62%,CACNB4;SLC7A6;CACNA2D2;CAMK2A;SLC1A2;SNAP25;SLC1A3;SNAPIN;STX1A
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.4204971223758827,-1.3394934556355287,0.06097560975609756,0.28549698995240114,1.0,15/34,17.31%,FOXP3;IFNL1;IFNG;CRTAM;CAMK4;CTLA4;RHOH;CR1;CD2;TBX21;CCR2;GATA3;PRDM1;ZAP70;ZNF683
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.33308800178071735,-1.339073502002584,0.0,0.2857420471704269,1.0,44/124,24.67%,IFNL2;AGBL4;IFNL1;FCN3;CXCL10;RIPK3;ZBP1;ACOD1;APOBEC3C;OASL;TLR3;APOBEC3A;IFNL4;RSAD2;PTPRC;PRF1;IL6;TLR8;LILRB1;CD207;TLR2;MX2;MYD88;IFIT2;NT5C3A;IFIT3;BCL2;TRIM5;PMAIP1;ABCC9;IFI16;OAS3;OAS2;IFIT1;APOBEC3G;CD40;STAT1;IFIH1;IRF2;F2RL1;DDX58;OAS1;AKAP1;PLSCR1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.46839775281784374,-1.3388293467259351,0.0975609756097561,0.28572656438504895,1.0,13/21,22.36%,IFNG;TNF;FPR2;CLU;ITGB2;AIF1;C1QA;CX3CR1;JAK2;ITGAM;TYROBP;SNCA;APP
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4020154057570317,1.3385906697016672,0.056338028169014086,0.6786746232612993,1.0,28/139,9.53%,HTR1D;GLP1R;GHRHR;GPR119;PTH2R;GCG;CALCA;GNAZ;UCN2;LGR5;RAMP1;GPHA2;ADGRB2;ADGRG3;OPRL1;AVPR2;ADGRB1;ADRA1D;PTGER1;ADGRL1;PTGER3;PSAPL1;CRHR2;CCR3;GNAL;GALR2;GALR3;PTHLH
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.4988978371635936,1.338182608301763,0.12209302325581395,0.6790356567512973,1.0,12/30,20.99%,RBM24;MSTN;TBX3;MYF6;BMP4;KLHL41;SOX8;SOSTDC1;BOC;HIF1AN;SRA1;ANKRD2
prerank,Elsevier_Pathway_Collection__Antiphospholipid Antibodies in Endothelial Cell,-0.46222446522074245,-1.3381608336658892,0.14666666666666667,0.28597055715700853,1.0,13/23,23.65%,FOS;IL6;CXCL8;TLR4;SELE;VCAM1;MYD88;F3;APOH;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,Elsevier_Pathway_Collection__Antiphospholipid Antibodies and Endothelial Cell Interaction,-0.46222446522074245,-1.3381608336658892,0.14666666666666667,0.28597055715700853,1.0,13/23,23.65%,FOS;IL6;CXCL8;TLR4;SELE;VCAM1;MYD88;F3;APOH;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.36994963318694907,-1.3380670479711672,0.08620689655172414,0.28574310590502894,1.0,26/55,19.59%,SERPINB5;SERPINA12;SPINK2;ANXA8;ANXA8L1;SPOCK3;SERPINA11;FETUB;SERPINA9;CR1;SERPINA5;SERPINA4;AKT1;SORL1;SERPINB2;SERPINA10;SERPING1;SERPINB9;KNG1;SPOCK1;RECK;VTN;IFI16;SERPINB8;SERPINF2;AHSG
prerank,Elsevier_Pathway_Collection__G0/G1 Cell Cycle Phase Transition Activation in Cancer,0.4501190001548636,1.3380315928936204,0.11864406779661017,0.6784507973382831,1.0,13/49,14.95%,RASGRF1;E2F1;CDKN2A;SRC;E2F2;CCNE1;CDKN2C;CCNA2;CCNE2;CDKN2B;CDKN1C;SHC1;PDPK1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5643724513760968,1.3380308884454415,0.13664596273291926,0.6772475209812164,1.0,4/16,18.57%,CELF3;CELF4;SF3B4;RBM3
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.402739283356021,1.337862969388065,0.07425742574257425,0.6768622455670659,1.0,34/110,17.27%,KCNE5;CACNG4;KCNH2;TNNI3;SCN1A;SCN4A;KCNK17;CACNA2D2;FGF13;FXYD7;ATP1A2;ATP1A4;ATP2B4;CAMK2A;ATP1B3;KCNJ14;MMP12;NANOS1;FGF14;KCNIP3;ATP2A1;SCN4B;SCN2A;CACNA1C;CACNG8;FXYD2;KCNJ4;CORIN;KCNJ11;PRKCA;KCNE4;FGF12;KCNK13;SLC8A3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.48817915791666494,1.33764082378864,0.09550561797752809,0.6764298448645263,1.0,14/32,29.26%,FGF13;STMN2;SPEF1;APC2;STMN1;ARHGEF2;TRIM54;TPX2;CAMSAP2;CAMSAP1;CLIP3;MID1IP1;KATNB1;TBCD
prerank,WikiPathway_2021_Human__DNA damage response WP707,0.4503799317801094,1.3375521560579149,0.05235602094240838,0.6756480198038625,1.0,29/67,34.84%,SFN;E2F1;TP53AIP1;CDC25C;CCNB2;CCNE1;CCNE2;CDK1;CCNB1;CHEK1;CDC25A;BBC3;CDK6;ATRIP;RAD51;PRKDC;FANCD2;CDK5;CCNB3;MYC;CHEK2;CDKN1A;PIDD1;RAD1;CASP9;CDK4;DDB2;BAX;SMC1A
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.38082313223260944,1.3375049863985664,0.030434782608695653,0.6746696328606008,1.0,57/214,15.74%,GNG4;CACNA1E;CHRND;CACNB4;SLC6A4;KCNJ6;GLUL;RASGRF1;ACTN2;CACNG4;GABRR3;GABRQ;PRKAA2;MAPT;GAD1;KCNJ9;SLC6A11;CACNA2D2;CHRFAM7A;CHRNB2;KCNJ5;GPRIN1;CHRNA3;SRC;SLC6A3;SYN3;GRIK4;CAMK2A;CHRNB4;GNAL;GRIN2A;GRIP2;GNG3;GRIN3B;CHRNA5;RNASE1;MPP3;PPFIA3;RASGRF2;PPFIA4;CHRNA4;SYN1;SLC1A2;CACNA2D3;SNAP25;CPLX1;PPM1F;CACNG8;UNC13B;PPFIA2;GNB5;ADCY6;PDPK1;GNG8;KCNJ4;PRKCA;HRAS
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.5166569984624311,-1.3372916345617152,0.075,0.28651856860619895,1.0,8/15,8.78%,MT1G;MT1HL1;MT1F;MT1H;MT1M;MT1E;MT1X;MT1A
prerank,KEGG_2021_Human__Oxidative phosphorylation,0.40103538186212395,1.337121244187991,0.05314009661835749,0.6749247441907757,1.0,54/112,34.33%,ATP4A;COX4I2;ATP6V0D2;NDUFA4L2;NDUFA1;ATP6V0A1;ATP6AP1;NDUFS6;NDUFV1;NDUFB9;COX6C;ATP5MF;ATP6V0B;COX7B;NDUFA3;UQCRB;TCIRG1;NDUFS2;NDUFA9;ATP5F1D;COX6B1;ATP6V0D1;NDUFB11;NDUFA2;NDUFS7;COX8A;ATP6V0E1;UQCRQ;CYC1;ATP6V1C1;COX7A1;NDUFA13;ATP6V1H;UQCRHL;NDUFA11;ATP5F1E;NDUFA6;ATP5MC1;UQCR11;ATP6V1F;NDUFS8;COX4I1;NDUFV2;ATP5ME;COX5B;ATP6V1E1;NDUFA8;NDUFB7;UQCRH;NDUFAB1;ATP6V1E2;NDUFB2;NDUFB10;UQCRC1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.4981279691274298,-1.3369605255431127,0.10989010989010989,0.286658498390533,1.0,9/16,27.23%,AIM2;ACOD1;PYHIN1;MNDA;IFI16;STAT1;OAS1;TRIM6;IRF1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Prostate Cancer,-0.31507009212515086,-1.336408985954524,0.0,0.28719627140106735,1.0,29/130,15.53%,KLK3;KLK2;SERPINB5;MUC1;PCA3;PTGS2;HGF;SRD5A1;CDH1;IGFBP3;TNFSF10;MSMB;CXCL12;FGFR2;CCL2;EGR1;IL6;WNT11;NKX3-1;MMP7;IGFBP5;AKT1;CD82;IGF1;MSR1;CXCR4;PRKCE;KLF6;CLU
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.4618954261982074,1.3362508011584908,0.078125,0.6769064025953836,1.0,20/49,27.00%,HMGA2;LEF1;WNT4;SNAI2;DLG5;FAM83D;LOXL2;FOXC1;FOXF2;HTR2B;ROCK2;NOTCH4;TGFBR3;TGFB2;TRIM28;CUL7;SNAI1;CTNNB1;RANBP3L;HEYL
prerank,Reactome_2022__G2/M Transition R-HSA-69275,0.38625785336506147,1.3361423065550564,0.031818181818181815,0.6760631521319888,1.0,95/179,43.56%,CENPF;NEK2;CDC25C;HMMR;FOXM1;PLK1;GTSE1;CCNB2;PSMD4;FBXL18;CCNA2;CDK1;TUBA4A;CCNB1;AURKA;MYBL2;PSMB4;CEP131;PRKCA;PKMYT1;CDC25A;CETN2;CEP250;HAUS4;HAUS5;TPX2;MZT2B;PPP2R3B;LIN37;PLK4;DYNLL1;LIN9;HSP90AB1;PSMB3;CEP70;SFI1;TUBGCP6;PSMD14;UBA52;SSNA1;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;MZT2A;CSNK1D;PSMC4;PSMC3;TUBA1A;ALMS1;CUL1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;SKP1;FKBPL;PSMC5;TUBG1;CEP72;PPP2R1A;SEM1;PPME1;PSMB6;TUBGCP2;PSMD8;NDE1;HAUS1;PSME2;TUBB4B;XPO1;SDCCAG8;PSMD13;PSMB7;PSMA7;HSP90AA1;CSNK1E;PSME3;CDK2;CEP192;FBXW11;CKAP5;TUBB4A;CDC25B;PSMB2;RBX1;PSMA6;RBBP4;UBC;FBXL7;PHLDA1;PSMD9
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.3978437702211332,-1.3360027975304711,0.05970149253731343,0.28745963146861464,1.0,17/43,20.37%,CIDEA;IL10;BPI;PTPN22;LILRB1;CD274;CHRNA7;TLR4;IGF1;HAVCR2;LGALS9;LILRA4;NLRC3;CD33;SLAMF1;NR1H4;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.48420901545937134,-1.3358212685220041,0.08888888888888889,0.28737185398044257,1.0,8/16,19.88%,TNF;GBP5;IL6;TLR4;CLEC7A;MYD88;CD6;NOD2
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.4278787857537376,1.3355618332009391,0.10270270270270271,0.6770881884513084,1.0,11/66,7.73%,DKK1;SIX1;HOXD3;ADRA2C;NRCAM;DISP3;SOX2;NEUROD1;HES5;BRINP1;BDNF
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.49178546907637405,1.3352585467843687,0.1111111111111111,0.6770678379446631,1.0,6/33,3.38%,HOXD3;DLX1;ADRA2C;FGF20;NRCAM;NEUROD1
prerank,MSigDB_Oncogenic_Signatures__ATF2 UP.V1 UP,0.39535882676130235,1.335186996080298,0.04205607476635514,0.6761689670010611,1.0,32/152,14.52%,COL2A1;IGF2;PITX1;FGF20;LYPD1;FABP4;KISS1;PTPRT;MELK;ZFR2;FOXM1;REEP2;STEAP1B;CLDN15;PTGER1;BAALC;SLC5A2;NCAPG;DTL;GALR2;FRMD1;RNF43;PAFAH1B3;ADM2;PODXL;APOD;IL32;ALOX12;CA14;PLAU;SAG;UPP1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.48018301898318544,1.3351647821961588,0.12,0.6750644161729314,1.0,7/31,11.32%,KCNE5;TNNC1;KCNH2;TNNI3;TNNI2;ATP1A2;SCN4B
prerank,Elsevier_Pathway_Collection__Werner Syndrome (Adult Progeria),0.5296436890317566,1.335039481921867,0.12921348314606743,0.6743627695162828,1.0,13/21,39.42%,TERT;BRINP1;NHEJ1;PRKDC;LIG3;RPS19BP1;POLB;PCNA;XRCC1;TP53BP1;PNKP;XRCC6;ATR
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.4790393395195943,1.3348558962514774,0.125,0.6738538260757989,1.0,5/31,6.21%,HMGA2;OSR2;OSR1;HES5;BMP4
prerank,WikiPathway_2021_Human__Phytochemical activity on NRF2 transcriptional activation WP3,0.5835245786896179,1.3341151637800353,0.14838709677419354,0.6756139132405615,1.0,3/15,4.00%,SLC7A11;EPHB2;NQO1
prerank,MSigDB_Oncogenic_Signatures__PTEN DN.V1 UP,-0.32642126692235185,-1.3340965495701838,0.0,0.2899281599802686,1.0,46/136,17.14%,GABRA5;CYP26A1;CLEC1B;LRRC19;KCNH7;GNAO1;TCHH;BCL2L14;PRKAR2B;CYP39A1;BMP10;TUSC3;NR4A3;CD27;P2RX6;CDKL2;KIR2DL4;DEFB1;MSMB;CD1E;RSAD2;CYB5R2;EFNB3;NAP1L3;IL33;BMP7;ALOX5AP;LHX2;MEFV;CNR2;MX2;RGS2;MAL;PGR;RARB;VCAM1;MAN1A1;SLC9A2;FCER1G;TSPAN2;ITGB2;SIT1;SPOCK1;BMPR1B;GDF10;CPVL
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.5173362166557736,1.3340112299337221,0.12716763005780346,0.6748260930206204,1.0,6/24,15.31%,STRA8;DMC1;MDK;TRIP13;NANOS1;IHO1
prerank,Elsevier_Pathway_Collection__ROS in Triggering Vascular Inflammation,-0.4080895372599605,-1.3338132580690216,0.09876543209876543,0.28990709369772155,1.0,16/32,16.58%,PTGS2;IFNG;TNF;CCL5;FASLG;CXCL2;CCL2;IL6;IL12B;CXCL8;SELE;RASGRP1;VCAM1;CSF2;VAV1;F3
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,0.44118229040503926,1.333808224554768,0.08695652173913043,0.6745437499713426,1.0,27/51,38.43%,NDUFA1;NDUFS6;NDUFV1;NDUFB9;NDUFA3;NDUFS2;NDUFA9;NDUFAF2;NDUFB11;NDUFA2;NDUFS7;NDUFAF6;NDUFA13;NDUFA11;NDUFA6;NDUFS8;NDUFV2;NDUFA8;NDUFB7;TMEM186;NDUFAB1;NDUFB2;NDUFB10;NDUFAF3;ACAD9;NDUFB3;NDUFS4
prerank,KEGG_2021_Human__Steroid biosynthesis,0.5383334923916387,1.3337217894140438,0.11320754716981132,0.6737191762506086,1.0,8/19,23.86%,CEL;SQLE;HSD17B7;TM7SF2;LBR;NSDHL;FDFT1;CYP51A1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.49157258880258525,1.3335165641329958,0.13559322033898305,0.6732687874900614,1.0,2/26,7.91%,TRIM71;AGO2
prerank,MSigDB_Oncogenic_Signatures__RB P130 DN.V1 UP,0.4098565217807759,1.3331503137303389,0.03980099502487562,0.6735201562111816,1.0,28/114,16.44%,HMGA2;SIM2;RASGRF1;CACNG4;TAL2;TWIST2;KIF20A;SDF2L1;STMN3;RASD1;NKD2;BIRC5;CCNB2;UBE2C;PIWIL1;AURKB;CDC7;CDK1;ATP2A1;AURKA;RACGAP1;RGS16;SEMA5B;ORC1;WNT2B;SEMA6B;GLIS2;MRAS
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.39803457243229345,-1.3331412133269014,0.06896551724137931,0.2906615346524179,1.0,13/37,12.32%,CXCL13;CXCL10;CXCL11;CCL5;CCL4;CCL3;XCL1;CCL23;PIK3CD;GPR183;CCL2;XCL2;CCL22
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,-0.38910091356001797,-1.333117408672443,0.06666666666666667,0.2903142748973694,1.0,12/40,17.38%,UGT2A1;UGT1A5;UGT1A9;UGT2B7;CP;UGT2B28;UGT2B10;UGT2A3;CPOX;UGT2B15;HMOX1;UGT1A7
prerank,Elsevier_Pathway_Collection__Oxidation of Fatty Acid in non-Alcoholic Fatty Liver Disease,-0.43503432113746154,-1.3326598151048512,0.11594202898550725,0.29058662093470655,1.0,10/27,22.85%,TNF;ACSL1;PDK4;IL6;ACADL;ACADM;ACOT2;MAP2K3;MAP2K6;MAP3K5
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.4605026933200336,-1.33190853669798,0.15853658536585366,0.2913601757157083,1.0,5/16,11.73%,TNN;SFRP1;FGFR2;CCN1;GREM1
prerank,MSigDB_Oncogenic_Signatures__ESC J1 UP LATE.V1 UP,0.38772554081584454,1.3308882974485579,0.08071748878923767,0.6811542062913714,1.0,32/169,15.61%,DLK1;COL2A1;HMGA2;B4GALNT2;IGF2;CA4;SPINK1;S100A1;PEG3;GLIPR1;TNNT1;VIL1;TAX1BP3;SLCO2A1;GPC3;COL4A1;EFNA1;PGA5;LOXL2;MYO7A;COL4A2;TFF3;PODXL;RAMP2;APOA2;CLDN7;HTRA1;TUFT1;GPX3;DPP4;ANKRD1;TMED3
prerank,Elsevier_Pathway_Collection__IL1B Induced Arthralgia,-0.4566035902424759,-1.3307602266826837,0.075,0.29281024292917834,1.0,9/21,22.85%,PTGS2;IL1B;IL1RAP;MAP2K1;PTGES;MYD88;MAP2K3;MAP2K6;MAP3K5
prerank,MSigDB_Oncogenic_Signatures__E2F1 UP.V1 UP,0.3871735415714508,1.3302972910229007,0.05555555555555555,0.6820420497846754,1.0,49/169,25.16%,RHBDL3;DLX1;TOP2A;DMBT1;UBE2T;UCK2;BUB1;NCAPH;KIFC1;E2F8;AURKB;KLHL21;EZH2;DLGAP5;GPR19;TYMS;HMGB3;ARHGAP39;SPEF1;SLC7A1;CHAF1B;CAD;TPM2;CMA1;ADCY6;MCM10;PIM1;CHEK1;TYRO3;PRC1;CNIH2;MCM4;DNA2;NBL1;STIL;CDK5R1;FEN1;UBN1;PTPRU;PARP1;WDHD1;ELANE;POLA2;INO80E;KANK3;PPM1M;PLK4;RDH13;TK1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.42506863392225636,-1.3302165309643128,0.14084507042253522,0.29334758121080506,1.0,8/27,20.58%,IL1B;PRKCB;PRKCQ;PIP4K2A;ENPP1;PID1;AHSG;PRKCZ
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5375295689582524,1.3301473073549137,0.12883435582822086,0.6814868145492148,1.0,3/23,7.30%,KIF1A;DYNC1I1;KIF5A
prerank,MSigDB_Oncogenic_Signatures__KRAS.PROSTATE UP.V1 DN,-0.32050173546253014,-1.3299626557210953,0.023809523809523808,0.2933912426466996,1.0,37/116,14.25%,DIRAS3;SOX10;IGLV2-14;CWH43;KRT4;PLGLA;ARPP21;SPRR3;FBXO40;SLC19A3;KCNA2;NTF3;PTH1R;FOLH1B;COLEC10;S100A8;IGFBP3;OXT;KLKB1;PI3;KRT16;NCR3;SLC30A4;CD96;CD48;TGM1;ABCB1;CTSE;HBA2;GPRASP1;ABCG4;RASGRP1;SERPINB2;EPHB6;PF4V1;EPHX2;CFI
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.342832929757729,-1.3296366870893772,0.06521739130434782,0.29346550498824703,1.0,26/78,21.10%,LRFN5;ENPP3;IL10;ACOD1;GPR31;NLRP12;TNFAIP6;FPR2;APOA1;NLRP3;KLF4;ALOX5;MEFV;PTGER4;GATA3;TNFAIP8L2;AOAH;NLRC3;ITCH;PTGIS;NR1H4;IFI16;MACIR;LPCAT3;TEK;NMI
prerank,Reactome_2022__G1/S Transition R-HSA-69206,0.40522158041029577,1.3288661080833464,0.08490566037735849,0.6854098077637372,1.0,64/127,39.56%,E2F1;PSMD4;CCNE1;CDC6;CDC7;CCNA2;CCNE2;CDC45;CDK1;CCNB1;CDT1;MCM6;TYMS;PRIM1;PSMB4;CKS1B;MCM10;MCM3;MCM5;CDC25A;RRM2;MCM4;E2F5;POLR1A;PPP2R3B;HDAC1;GMNN;LIN37;MCM7;POLA1;POLA2;TK1;LIN9;MYC;PSMB3;PSMD14;UBA52;RBL1;CDKN1A;PSMB5;PSMD2;PCNA;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;CDK4;MCM8;SKP2;SKP1;PSMC5;PPP2R1A;SEM1;PSMB6;PSMD8;E2F4;PSME2;DBF4;PSMD13;PSMB7;PSMA7;PSME3;CDK2
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.5333323941192885,1.328502760404696,0.13529411764705881,0.6856849443896642,1.0,11/20,31.01%,FBXO43;NEK2;CDC25C;MKI67;PKMYT1;OBSL1;L3MBTL1;CUL7;CUL9;PIN1;DAPK3
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.4116878500419603,1.3284746361285964,0.08040201005025126,0.684608014751427,1.0,44/70,40.37%,COX4I2;NDUFA1;NDUFS6;NDUFV1;NDUFB9;COX6C;COX7B;NDUFA3;UQCRB;NDUFS2;NDUFA9;COX6B1;NDUFB11;NDUFA2;NDUFS7;COX8A;UQCRQ;CYC1;NDUFA13;UQCRHL;NDUFA11;UQCC3;NDUFA6;UQCR11;NDUFS8;COX4I1;NDUFV2;SDHAF2;COX5B;NDUFA8;NDUFB7;UQCRH;NDUFAB1;NDUFB2;NDUFB10;UQCRC1;COX7C;UQCR10;NDUFB3;NDUFS4;SDHA;NDUFB8;SDHC;COX6A1
prerank,Elsevier_Pathway_Collection__Cell Cycle Dysregulation in Mantle Cell Lymphoma,0.5053819841163251,1.3284122527856719,0.13068181818181818,0.683761496593955,1.0,8/25,19.97%,CDKN2A;CCNE1;CDKN2C;CCNA2;CCNE2;PIM1;CHEK1;CDK6
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.5293115524525074,1.3282520432817029,0.09615384615384616,0.68319645048659,1.0,4/18,7.78%,OSR2;OSR1;TBX3;MSX1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.4838755448488974,-1.3280543541959735,0.09411764705882353,0.29551065781846597,1.0,3/16,6.66%,CEACAM6;CEACAM5;PDK4
prerank,Elsevier_Pathway_Collection__G1/S Damage Checkpoint,0.5367517772671269,1.3270676125118135,0.1488095238095238,0.6866486768440605,1.0,15/22,39.56%,TP53AIP1;CDKN2A;CHEK1;SMAD3;CDC25A;BBC3;CDK6;PRKDC;CHEK2;CDKN1A;CDK4;TGFB1;TGFBR2;ATR;CDK2
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.4168356772386734,1.3269670093159052,0.07253886010362694,0.6858839850369521,1.0,11/75,6.59%,ISL2;PAX2;CTNNA2;EPHB2;PAK3;BRSK2;MAPT;NRCAM;POU4F1;ADGRB1;MTR
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.5639599493862726,1.326755817125335,0.10240963855421686,0.6854625796664349,1.0,4/17,11.46%,ALOX15B;PLA2G2A;LPL;CD36
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.3828985600996233,1.3261031774316883,0.055299539170506916,0.6870256888279579,1.0,110/180,49.08%,ELAVL2;COLEC12;PUF60;PRPF3;CPSF1;SNRPE;SF3B4;POLR2L;GPKOW;CASC3;PQBP1;PRCC;SNRNP70;RBM8A;POLR2K;TXNL4A;CPSF4;SF3B5;SNRPD2;POLR2G;SF3A2;PRPF6;PPIL3;UPF3B;LSM2;SNRPB;LSM4;PRPF31;CSTF2;LSM7;SRRM2;POLR2H;SUGP1;FUS;PPIH;RBMX;POLR2I;SNU13;POLR2J;SNRPC;CCAR1;RBM22;SNRPA;SNRPD3;RBM42;HNRNPU;MAGOHB;SLU7;HSPA8;PABPN1;XAB2;DHX9;USP39;HNRNPA1;POLR2A;PRPF8;HNRNPH2;CD2BP2;PTBP1;SART1;SYMPK;PHF5A;POLR2B;CPSF3;SF3A3;PCBP1;GTF2F1;HNRNPR;ALYREF;SNRPG;CPSF7;CRNKL1;CTNNBL1;U2AF1;U2AF2;SNRPA1;SNRNP200;CPSF6;FIP1L1;PPWD1;RNPS1;POLR2F;SYF2;SRRT;RBM5;PCF11;HNRNPM;U2SURP;MTREX;PPIL1;DDX5;EIF4A3;MAGOH;PRPF38A;SF3B3;PRPF19;CWC27;HNRNPUL1;SNRNP40;CDC5L;DDX42;HNRNPF;CSTF2T;DHX16;SF1;SF3A1;TFIP11;SF3B6;NCBP2;SF3B1
prerank,Elsevier_Pathway_Collection__Toll-like Receptors Act through MYD88-TIRAP Signaling,-0.3929589012874013,-1.3260715235777332,0.08108108108108109,0.2983084784059278,1.0,16/38,24.09%,LPA;TNF;IL1B;TNFSF10;IL6;IL12B;CXCL8;TLR2;AKT1;MYD88;HSPA1A;TAB2;MAP2K3;MAP2K6;MAP2K4;TLR1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.41951286870561,-1.3260597315054679,0.14084507042253522,0.2979397526236524,1.0,8/28,20.58%,IL1B;PRKCB;PRKCQ;PIP4K2A;ENPP1;PID1;AHSG;PRKCZ
prerank,Reactome_2022__Amine Ligand-Binding Receptors R-HSA-375280,0.5095080220081586,1.32573247469533,0.1464968152866242,0.687374959821951,1.0,9/25,15.39%,HTR1D;ADRA2C;HTR4;CHRM4;HRH3;ADRA1D;CHRM5;HTR1B;DHX34
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,0.4754762831088616,1.3255352003344651,0.13043478260869565,0.6871370251485579,1.0,11/32,15.54%,GNG4;KCNJ6;KCNJ9;KCNJ5;KCNJ14;GNG3;ABCC8;GNB5;GNG8;KCNJ4;KCNJ11
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.4964050685927441,1.3253496877147413,0.09239130434782608,0.6868769473243265,1.0,4/31,6.66%,AVIL;VIL1;MSTN;SRC
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,0.38292646830556887,1.3247190708272514,0.045662100456621,0.688072173956006,1.0,115/188,49.08%,ELAVL2;COLEC12;PUF60;PRPF3;CPSF1;SNRPE;SF3B4;POLR2L;GPKOW;CASC3;PQBP1;PRCC;SNRNP70;RBM8A;POLR2K;TXNL4A;CPSF4;SF3B5;SNRPD2;POLR2G;SF3A2;PRPF6;PPIL3;UPF3B;LSM2;SNRPB;LSM4;PRPF31;CSTF2;LSM7;SRRM2;POLR2H;SUGP1;FUS;PPIH;RBMX;POLR2I;SNU13;POLR2J;SNRPC;RNPC3;CCAR1;RBM22;SNRPA;SNRPD3;RBM42;HNRNPU;MAGOHB;SLU7;HSPA8;PABPN1;XAB2;DHX9;USP39;HNRNPA1;POLR2A;ZRSR2;PRPF8;SNRNP35;HNRNPH2;CD2BP2;PTBP1;SART1;SYMPK;PHF5A;POLR2B;ZMAT5;CPSF3;SF3A3;PCBP1;GTF2F1;HNRNPR;ALYREF;SNRPG;CPSF7;CRNKL1;CTNNBL1;U2AF1;U2AF2;SNRPA1;SNRNP200;CPSF6;FIP1L1;PPWD1;RNPS1;POLR2F;SYF2;SRRT;RBM5;PCF11;HNRNPM;U2SURP;MTREX;PPIL1;DDX5;EIF4A3;MAGOH;PRPF38A;SF3B3;PRPF19;CWC27;SNRNP25;HNRNPUL1;SNRNP40;CDC5L;DDX42;HNRNPF;CSTF2T;DHX16;SF1;SF3A1;TFIP11;SF3B6;NCBP2;SF3B1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.4457746095516441,-1.3235879180688475,0.10843373493975904,0.3017730844045306,1.0,4/27,5.49%,TACSTD2;PFN2;STAP1;TBC1D30
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.515361817079221,1.3231564957030735,0.15950920245398773,0.6933678561352701,1.0,6/21,16.56%,HS3ST4;HS3ST5;HS6ST2;EXTL3;HS6ST1;B3GAT3
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.3633635841295796,-1.3230890679531262,0.08333333333333333,0.3023312502651388,1.0,23/63,17.09%,CR2;IL10;CD4;CD79A;PTPN22;PBX1;PIK3CD;NFAM1;RHOH;PTPRC;MS4A1;IKZF1;AXL;HDAC9;GATA3;LCK;FLT3;NFIL3;VCAM1;PLCG2;KLF6;ZAP70;ITGA4
prerank,TRRUST_Transcription_Factors_2019__RARA human,-0.4597580773456357,-1.3226125850655328,0.125,0.30272031389244153,1.0,11/21,24.35%,MUC5AC;SFTPB;ANXA8;HSD17B2;HCK;RARB;NR1I3;ETS1;ABCC3;THBD;MAOB
prerank,WikiPathway_2021_Human__Monoamine GPCRs WP58,0.5142731050788923,1.3218335911583297,0.15853658536585366,0.6976870580195904,1.0,8/22,15.92%,HTR1D;ADRA2C;HTR4;CHRM4;ADRA1D;CHRM5;HTR1B;HTR2B
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.4739417480365486,-1.3216408684773726,0.11688311688311688,0.303891861862629,1.0,7/17,17.64%,PRKAR2B;TCIM;LRRK2;CALCR;ADGRV1;AKAP7;AKAP6
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.48174123389961804,1.321586975007658,0.13978494623655913,0.6975079605222912,1.0,5/28,7.62%,FGF20;FGF13;FGF17;SRC;FGF23
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.4222589521331497,1.321558730928484,0.115,0.6964933335657905,1.0,57/88,48.29%,PRKAA2;MAPK11;EXO1;AURKB;CCNA2;AURKA;SERPINA2;RFC4;CHEK1;BARD1;DNA2;RMI1;CDK5R1;POLR1A;TPX2;ATRIP;RAD9B;BLM;PDZD2;TAF10;PRKAB2;RHNO1;CDK5;CHEK2;UBA52;NUAK1;TAF6;HIPK2;BRIP1;RMI2;TOPBP1;TP53RK;CSNK2B;SSRP1;MDM4;TAF9;TAF1;CDK2;RFC3;TAF12;UBC;NOC2L;TAF5;SUPT16H;TAF9B;WRN;STK11;TAF2;CSNK2A2;RPS27A;TOP3A;PRKAB1;MDM2;MAPKAPK5;RAD9A;MRE11;RAD50
prerank,TRRUST_Transcription_Factors_2019__FOXA2 mouse,-0.40187844991296207,-1.3212346931746475,0.1323529411764706,0.30412581890613166,1.0,5/30,1.85%,ASCL1;WNT7B;PDX1;LMX1A;ST18
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,0.4753700767598476,1.3210833547027871,0.12352941176470589,0.697304872237559,1.0,22/31,44.54%,ELOC;POLR2L;ELOB;POLR2K;NELFE;POLR2G;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;POLR2A;ELL;POLR2B;GTF2F1;POLR2F;CDK9;SUPT16H;CCNT2
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.3769154577831367,1.3209178744494319,0.03153153153153153,0.6967531455885911,1.0,151/239,50.18%,ELAVL2;COLEC12;SARNP;PUF60;DDX39A;PRPF3;CPSF1;SNRPE;SF3B4;POLR2L;GPKOW;CASC3;PQBP1;NUP37;PRCC;SNRNP70;THOC5;RBM8A;CHTOP;NUP62;POLR2K;NXF1;TPR;NUP133;METTL3;TXNL4A;CPSF4;SF3B5;SNRPD2;POLR2G;SF3A2;PRPF6;PPIL3;UPF3B;LSM2;SNRPB;LSM4;PRPF31;CSTF2;NUP155;NUP160;THOC1;LSM7;SRRM2;POLR2H;SUGP1;POLDIP3;FUS;THOC6;PPIH;NUP188;NXT1;RBMX;POLR2I;SNU13;POLR2J;SNRPC;RNPC3;THOC2;DDX39B;CCAR1;RBM22;SNRPA;SNRPD3;RBM42;HNRNPU;MAGOHB;SLU7;HSPA8;PABPN1;XAB2;ZC3H11A;DHX9;NUP205;USP39;HNRNPA1;POLR2A;NUP210;ZRSR2;PRPF8;SNRNP35;HNRNPH2;CD2BP2;PTBP1;SART1;SYMPK;PHF5A;POLR2B;ZMAT5;CPSF3;NUP214;SF3A3;PCBP1;GTF2F1;HNRNPR;GLE1;ALYREF;SNRPG;CPSF7;CRNKL1;NUP107;CTNNBL1;SLBP;U2AF1;U2AF2;SNRPA1;SNRNP200;CPSF6;FIP1L1;PPWD1;RNPS1;POLR2F;SYF2;SRRT;RBM5;PCF11;HNRNPM;AAAS;U2SURP;MTREX;PPIL1;DDX5;EIF4A3;MAGOH;PRPF38A;SF3B3;PRPF19;CWC27;SNRNP25;NUP93;HNRNPUL1;SNRNP40;CDC5L;DDX42;HNRNPF;CSTF2T;DHX16;SF1;SF3A1;TFIP11;SF3B6;NCBP2;NUP88;SF3B1;SEC13;THOC3;SEH1L;POM121C;HNRNPC;NUP42;LSM8
prerank,Elsevier_Pathway_Collection__ADRA2C/ADRB2 -> Vasoconstriction,0.5071157710238796,1.3202934457598257,0.13095238095238096,0.6981445043202219,1.0,3/24,6.66%,ADRA2C;RASGRF1;SRC
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.48999092991103255,1.3201520063525662,0.10215053763440861,0.6975819139281539,1.0,15/32,32.24%,E2F1;CHEK1;H2AX;DOT1L;CLSPN;ATRIP;DONSON;RHNO1;CHEK2;TIPRL;STK33;INTS7;TP53BP1;RAD1;BRIP1
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,-0.37541936589588754,-1.3200187358737703,0.08196721311475409,0.3057550768289885,1.0,25/45,26.60%,CR2;IGLL5;CR1;C4A;C1QC;C1R;CFI;C1QB;SERPING1;CLU;C8A;VTN;CD19;C3AR1;C8B;C1S;C1QA;C5;CD55;CD81;C3;C4B;CPB2;PROS1;CFB
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.529422780112676,1.31941756161805,0.11299435028248588,0.6991760175723171,1.0,13/24,30.06%,EZH2;SMYD3;SMYD2;CTCFL;FBLL1;SUV39H1;EHMT2;NSD1;PRMT7;NTMT1;TRMT112;FBL;SUV39H2
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,0.5065208186888968,1.3191906395870685,0.12195121951219512,0.6990246899232818,1.0,4/26,7.62%,FGF20;FGF13;FGF17;FGF23
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,0.5163036886713662,1.3191024436150502,0.13609467455621302,0.6981935576142866,1.0,20/25,42.18%,TUBA4A;CCT3;PFDN2;TUBB2B;TUBA3D;VBP1;TUBB2A;PFDN6;TUBA1A;CCT8;CCT6A;CCT4;TUBB6;TUBB4B;PFDN4;CCT2;CCT7;TUBA1C;CCT5;TUBB4A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.41199392836306525,1.319003990502527,0.09569377990430622,0.6974661949813579,1.0,32/84,25.22%,IGF2;E2F7;NPM2;KIF14;SSTR5;PDGFRB;E2F8;AURKB;CDC6;CDC7;NDC80;KIF23;CCNB1;RGCC;AURKA;RACGAP1;PDGFB;ECT2;EGF;FEN1;ZNF16;ANKRD31;DBF4B;CENPV;DDX11;GPSM2;NUP62;TPR;CEP295;PLK4;OOEP;RHNO1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.5719253552703323,1.3187423517812509,0.13414634146341464,0.6973968746555951,1.0,4/16,18.32%,KIF1A;KIF5A;TMEM108;MAP1A
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.44147495840179873,1.3180743402037252,0.08247422680412371,0.6991516506158124,1.0,17/72,16.51%,LMOD1;FRMD3;ACTN2;SIX4;MYH3;CASQ1;TNNT1;KLHL41;SRC;TNNT3;FHDC1;PGM5;OBSCN;TMOD4;FRMD5;ANKRD1;ROCK2
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.400629036227708,1.3179283098889187,0.0673076923076923,0.6985659295876222,1.0,80/103,46.98%,RPL8;RPL30;RPLP1;SEC61G;RPS27;RPS21;RPLP2;RPS5;RPL28;RPS14;RPL10;ZFAND2B;RPSA;RPL39;UBA52;RPLP0;SRP9;RPS15;GET3;RPS2;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL13;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL35A;RPS3A;RPS7;SRPRB;RPS11;RPL36A;RPL7A;RPS3;RPL18A;SPCS1;RPL32;RPS24;RPL29;SRP14;RPL23;RPL5;RPS18;RPL14;RPS16;RPL13A;RPL41;RPL9;RPS28;RPS23;RPL27A;RPL23A;ZFAND2A;RPL18;RPL12;RPS9;RPL6;SEC61A1;RPS15A;RPL4;RPS26;RPL19;SRP19;SPCS2;RPS6;RPL26;SGTA;RPS27A;RPS4Y1;RPL34;RPS13
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.4945314579527448,1.3176529670403572,0.10795454545454546,0.6986847499500688,1.0,5/26,14.21%,ALOX15B;DUSP9;CDK1;RACGAP1;KAT2A
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.3445284616646832,-1.317551932594897,0.03278688524590164,0.309599800714065,1.0,19/62,19.59%,SERPINB5;SERPINA12;SPOCK3;SERPINA11;FETUB;SERPINA9;SERPINA5;SERPINA4;AKT1;SERPINB2;SERPINA10;SERPING1;SERPINB9;KNG1;SPOCK1;VTN;SERPINB8;SERPINF2;AHSG
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,0.5581859147329414,1.3171353964348522,0.1375,0.699454557912961,1.0,5/17,18.45%,GNG4;GNG3;GNB5;GNG8;GNG10
prerank,Elsevier_Pathway_Collection__Vascular Endothelial Cell Activation by Cytokines,-0.3571065105471545,-1.3170104717508246,0.11864406779661017,0.3100974879141187,1.0,28/66,23.65%,TNF;IL1B;IL1RAP;CCL2;EGR1;IL6;CD40LG;CCR2;PTGES;FCGR2B;GNA14;SELE;AKT1;SYK;VCAM1;MYD88;TNFRSF1B;MAPK10;PTGIS;MAP2K3;MAP2K6;SELP;JAK2;CD40;STAT1;MAP3K5;THBD;MAP2K4
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,-0.366150203176809,-1.3160679335913528,0.1044776119402985,0.31108496873354574,1.0,20/55,15.90%,UGT2A1;AKR1D1;SRD5A2;UGT1A5;SRD5A1;UGT1A9;UGT2B7;CYP3A7;CYP1A2;CYP3A7-CYP3A51P;HSD3B1;AKR1C4;UGT2B28;UGT2B10;HSD17B2;HSD17B6;CYP3A4;UGT2A3;HSD17B12;UGT2B15
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.42750534662363693,1.315897123564542,0.11518324607329843,0.7033455907610563,1.0,22/67,20.62%,CPLX2;SLC6A4;SLC6A7;SLC6A11;UNC13A;ATP6V0D2;SLC6A9;SLC6A3;CLTCL1;DNM3;SLC1A2;SNAP25;CPLX1;ATP6V0A1;UNC13B;SLC6A2;SLC1A3;ATP6V0B;STXBP1;CLTB;TCIRG1;STX1A
prerank,Elsevier_Pathway_Collection__Endothelial Cell Dysfunction in Pyelonephritis,-0.375185780453557,-1.3156000689953582,0.04054054054054054,0.31145858530316406,1.0,16/37,23.65%,TNF;IL1B;IL1RAP;CXCL2;IL6;CXCL8;SELE;VCAM1;MYD88;TNFRSF1B;CXCL1;F3;JAK2;STAT1;MAP3K5;MAP2K4
prerank,MSigDB_Oncogenic_Signatures__KRAS.600 UP.V1 UP,0.37122226760706994,1.3152911335569557,0.049107142857142856,0.7046269419426662,1.0,53/233,12.33%,CHGB;IGF2;DYNC1I1;KCNC1;CTNNA2;SPINK1;CSN2;SMPX;ESM1;CGA;CEL;SLCO4A1;SPP1;ATP4A;KCNH2;GFI1;CEND1;NRCAM;PEG3;BEX1;TERT;EN2;MMP11;CLUL1;ITGA2;MKRN3;ITPKA;REEP2;FAM155B;TRIB2;TBX3;MYF6;CHRNA3;NTM;KIF5A;OR2B6;ATP1A2;PIWIL1;NMNAT2;GALR2;GRIN2A;ALPI;GPR19;DNM3;MMP17;RNASE1;KRT8P12;SCN2A;PLA2G4C;MMP10;SLCO5A1;APOD;MTMR8
prerank,Elsevier_Pathway_Collection__VEGFR -> ATF/CREB/ELK-SRF Signaling,0.46630806740740705,1.3149777366027962,0.12790697674418605,0.704757312224416,1.0,7/37,16.31%,VEGFD;RASGRF1;SRC;FLT1;MAPKAPK2;SHC1;ELK4
prerank,KEGG_2021_Human__MAPK signaling pathway,0.37121145017470747,1.3149414280689888,0.022026431718061675,0.7037367667305776,1.0,54/276,16.72%,IGF2;CACNA1E;CACNA1I;CACNB4;CACNG1;DUSP9;FGF20;VEGFD;RASGRF1;CACNG4;CACNA1S;CACNG5;MAPK8IP2;MAPK12;MAPT;PTPN5;CACNA2D2;EFNA3;MAPK11;FGF17;CACNA1G;FGF2;EFNA4;IRAK1;FGF23;BDNF;EFNA1;PDGFRB;MAP3K8;HSPB1;IKBKG;FLT3LG;RASGRF2;CACNA1C;PLA2G4C;NFKB2;CACNA2D3;PDGFB;FLT1;HSPA2;CACNG8;PLA2G4F;PDGFA;PGF;MAPKAPK2;RELB;PRKCA;HRAS;STMN1;ANGPT2;ELK4;PTPRR;MRAS;CACNA1H
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.509285806050362,1.314437493945841,0.13636363636363635,0.7045473943595607,1.0,12/27,33.35%,TP73;MSH4;MSH5;EXO1;POLD1;MSH2;MUTYH;MSH6;PCNA;MLH3;PMS1;LIG1
prerank,WikiPathway_2021_Human__ATM Signaling Pathway WP2516,0.46727444427379056,1.3143730777617224,0.14136125654450263,0.7036738323802205,1.0,22/39,37.99%,TP73;CDC25C;CCNE1;IKBKG;CDK1;CCNB1;AP3B2;CHEK1;CDC25A;RAD51;FANCD2;CHEK2;CDKN1A;MDC1;PIDD1;TP53BP1;CASP2;SMC1A;MDM4;ABL1;MAPK9;BID
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.3128683100255875,-1.3143712736131614,0.05128205128205128,0.31322528591416693,1.0,45/122,21.99%,CEACAM6;L1CAM;JCHAIN;FCAMR;EPCAM;IGLL5;SLC7A8;MMP1;IGLL1;CD244;MAG;TSPAN7;CEACAM5;ANGPT4;SIRPG;CD48;FYN;CD2;SLC7A7;CD84;SLC7A5;LCK;DOK2;CEACAM21;SELE;PIK3R1;PF4V1;FCER1G;CD177;ITGB2;ITGB3;ITGA4;INPP5D;SDC3;JAML;SELPLG;ITGA3;SELL;GP6;YES1;PF4;TEK;APOB;SELENOP;ITGAM
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,0.547553774604139,1.314172255962951,0.14285714285714285,0.703441604921417,1.0,4/17,7.62%,FGF20;FGF13;FGF17;FGF23
prerank,Elsevier_Pathway_Collection__Macrophage M2-Related Phagocytosis,-0.405865884829809,-1.31392578689984,0.09195402298850575,0.31367780705516235,1.0,14/31,24.83%,ITK;MAP2K1;PTPRC;FYN;LCK;TLR2;SYK;MSR1;VAV1;THBS1;IQGAP1;PIK3AP1;MARCKS;CD14
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.46679185846623295,1.3137955467821136,0.11052631578947368,0.7039465343581407,1.0,11/44,17.63%,IGF2;FGF20;PIK3R2;FGF13;FGF17;FGF23;FLT3LG;SHC1;PDPK1;HRAS;THEM4
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.4550315207946132,1.3131192532720675,0.12849162011173185,0.7054923234985148,1.0,6/45,5.96%,MAFA;PAX2;PRKAA2;NEUROD1;CYP7A1;KCNB1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.415949975063294,-1.3129978282057,0.10294117647058823,0.31473034781772274,1.0,14/37,18.34%,IL1B;PTPN22;XDH;GDF6;DUSP10;HAND2;PER1;RASGRP1;SPI1;LGALS9;EZR;NCF1;GADD45A;DUSP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.36038790116460345,-1.3129955545889904,0.0,0.3143090220508985,1.0,20/57,17.15%,TNF;IL1B;CD244;TLR3;FFAR2;GDF2;LILRA2;IL6;TLR8;CD2;HSPA1B;TLR4;CLEC7A;TLR2;SYK;MYD88;LGALS9;F3;HSPA1A;AFAP1L2
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.41349793925971895,-1.3129458972759995,0.1,0.31391880408558775,1.0,14/32,27.05%,MARVELD3;PTPN22;DUSP10;DACT1;PER1;ITCH;NCOR1;GSTP1;SIRPA;KLHL31;F2RL1;PINK1;CYLD;AMBP
prerank,MSigDB_Oncogenic_Signatures__STK33 SKM UP,-0.29883853006264205,-1.3119895174988832,0.0,0.3151314840907029,1.0,91/239,24.37%,TCTEX1D1;ITGB8;FCAMR;TNF;TFPI2;IL1B;TNFRSF11B;RGS1;PKIB;FOS;NAPSB;CCL4;PTPRO;IL15;GPR65;OR52K3P;RND3;ASB2;VSIG4;NFKBIZ;GPR183;TMEM71;ARRDC3;EGR1;MYEF2;TFEC;ADAM28;BCL2A1;MFAP3L;CD53;CYBB;TRIB1;FGL2;ERRFI1;GBP3;GPR132;RGS2;DNAJB4;SUCNR1;FGR;KMO;CLDN1;HBEGF;MAFB;ADORA3;KLF6;CREB5;CD86;IL10RA;FGD4;PLCXD2;ZNF682;SYNJ2BP;NLRC4;PRKY;ZNF254;HMOX1;TLR10;SLC12A6;CD101;TNFRSF21;DUSP1;GK3P;RTN1;TTLL7;NCF2;PID1;IFI16;MPEG1;MNS1;MIR22HG;KIAA0895;MXD1;EVI5;BBS12;RCBTB2;TMTC3;LPXN;CDC37L1;CPEB2;TNFAIP2;TYROBP;MFSD9;MILR1;THBD;SH2B3;AFF4;TLR1;IRF9;TP53INP2;KLHL28
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.4112719545417716,1.3117855960403606,0.08947368421052632,0.709783079662524,1.0,20/73,28.24%,DLK1;DNER;HES5;HDAC4;CNTN1;HDAC11;JAG2;KAT2A;HDAC5;DLL4;HDAC10;HEY1;HDAC1;MYC;MAML1;TLE1;NCOR2;HEYL;UBA52;NCSTN
prerank,Elsevier_Pathway_Collection__Nociception Expression Targets Signaling,-0.3121774956946448,-1.3113665131289438,0.025,0.31591483658650005,1.0,34/128,13.38%,TAC1;GRIN2B;ADRA1A;IL10;GNAO1;CXCL10;PTGS2;CXCL11;TNF;IL1B;MMP1;CCL5;FOS;NR4A1;CXCL9;CAMK4;CCL4;P2RY13;CCL3;NPY1R;CCL23;MAP2K1;CCL2;PTGER2;IL6;CCR1;HRH4;IL1RN;CNR2;CXCL8;CHRNA7;AKT1;IL16;RASGRP1
prerank,WikiPathway_2021_Human__Chemokine signaling pathway WP3929,-0.31236462126807996,-1.3107837941729026,0.0,0.316584122311344,1.0,39/157,15.00%,CXCL13;SHC4;CXCL10;CXCL14;CCR9;CXCL11;CCL5;CXCR2;CXCL3;CXCL9;XCR1;CCL4;CCL3;CXCR6;XCL1;ITK;MAP2K1;CCR7;PIK3CD;PRKCB;CXCL12;CCR1;RAC2;CCR2;ADCY5;CCL22;PIK3R5;HCK;PIK3R1;AKT1;PLCB2;GNG2;CCR4;FGR;DOCK2;CXCR3;TIAM1;CXCR4;VAV1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.46392864696127134,1.3102793063372415,0.11764705882352941,0.7146507535801468,1.0,6/29,19.14%,CERS1;MAPT;SRC;CDKN1C;PIF1;PHPT1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.36247863283739923,-1.3101800291831072,0.11864406779661017,0.31716961810607425,1.0,26/66,17.09%,CR2;IL10;LAX1;CD79A;BANK1;PIK3CD;NFAM1;GPR183;PRKCB;PTPRC;MS4A1;CD40LG;BTK;HDAC9;FLT3;RASGRP1;FCRL1;VCAM1;LAT2;PLCG2;KLF6;CD86;CTPS1;ZAP70;BCL2;ITGA4
prerank,TRRUST_Transcription_Factors_2019__NFE2L2 human,-0.4902968150584119,-1.3100866509513887,0.125,0.3169047665760422,1.0,9/16,18.74%,GSTA1;UGT2B7;CAT;KRT16;HBB;CXCL8;CFTR;HMOX1;SDHB
prerank,Elsevier_Pathway_Collection__TNFR -> CREB/ELK-SRF Signaling,-0.38843776176591754,-1.3100754867069708,0.10606060606060606,0.3165439538458312,1.0,15/40,23.65%,TNF;FASLG;TNFSF10;MAP2K1;TNFRSF13B;CD40LG;TNFSF13;LTA;TNFRSF1B;TNFSF13B;MAP2K3;MAP2K6;CD40;MAP3K5;MAP2K4
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.43069396382503766,-1.3099957774992481,0.11235955056179775,0.31634003918376913,1.0,8/24,16.80%,CETP;APOA4;IL18;APOA1;APOA5;ANGPTL3;GCKR;LIPC
prerank,TRRUST_Transcription_Factors_2019__RBPJ mouse,-0.4901747678823054,-1.309870023002043,0.136986301369863,0.31620340797848046,1.0,3/16,4.66%,ASCL1;CR2;FOS
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.43560808101260257,-1.309603898620142,0.09859154929577464,0.31620044941573294,1.0,6/23,13.67%,TACSTD2;PFN2;P2RY12;STAP1;EPS8L1;CARMIL2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.30499841338956063,-1.309568021060432,0.0,0.3158350734560781,1.0,32/150,14.55%,HHLA2;CD4;THEMIS;PTPN22;PRAM1;VTCN1;ITK;PIK3CD;NFKBIZ;CTLA4;FYB1;PTPRC;PRKCQ;CD3E;CD3G;TRAT1;FYN;RFTN1;LCP2;FYB2;NFKBID;HLA-DQA2;CARD11;SKAP1;GATA3;LCK;CD247;LAT;PIK3R1;THEMIS2;BTN3A3;PLCG2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.5256182805738369,1.309352123845117,0.13924050632911392,0.7172476984566301,1.0,4/19,14.49%,NKD1;EFEMP1;MFAP2;COL5A1
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.2965335845263749,-1.309243493086203,0.0625,0.31604682192315514,1.0,67/196,22.46%,CYP2A7;CYP2B6;TNF;CYP2C8;IL1B;MMP1;CCL5;FOS;APOA4;FASLG;CXCL3;CCL3;IL18;TNFSF10;APOA1;CASP1;PIK3CD;CXCL2;CAMK2B;NLRP3;CYP2C9;CCL2;IL6;CCL3L3;CD40LG;CYBB;IL12B;HSPA1B;CXCL8;TICAM2;TLR4;TLR2;SELE;PIK3R1;AKT1;PLCB2;POU2F2;VCAM1;MYD88;CASP6;VAV1;CASP7;CXCL1;CYP2J2;VAV3;BCL2;HSPA1A;NCF1;MAPK10;EIF2AK3;NCF2;PPP3CA;MAPK13;TAB2;NFATC2;XBP1;MAP2K3;MAP2K6;APOB;SELP;CYBA;JUN;JAK2;RAP1A;CD40;LDLR;AKT3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Migraine,0.4764300363216234,1.3085377080415723,0.13218390804597702,0.7192312082477975,1.0,8/35,7.73%,HTR1D;SLC6A4;CALCA;CRP;SCN1A;RAMP1;ATP1A2;BDNF
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.3432331185768863,-1.3084752869808562,0.03225806451612903,0.31693669425211474,1.0,30/76,20.68%,IL10;TNF;IL1B;BPI;CD244;PTPN22;TLR3;FFAR2;GDF2;LILRA2;PTPRC;IL6;KLF4;TLR8;CD2;HSPA1B;TLR4;CLEC7A;TLR2;SYK;MYD88;LGALS9;F3;HSPA1A;AFAP1L2;CD33;FCN1;ANXA4;NOD2;SSC5D
prerank,WikiPathway_2021_Human__Estrogen signaling pathway WP712,-0.44270862301340014,-1.3084359170704667,0.10843373493975904,0.3166159948483604,1.0,6/22,21.42%,FOS;ESR1;MAP2K1;AKT1;BCL2;JUN
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3532277435195994,1.3081733990819024,0.020491803278688523,0.7195482760423517,1.0,96/393,18.67%,SH3GL3;TRIM71;IGF2BP1;AVIL;ZIC5;ZIC2;DLX5;DNER;DLX6;POU3F2;MNX1;APLP1;EPHB2;ZIC4;MPZ;SPINK5;VAX2;NRCAM;P2RX5;NEUROD1;BCAN;ROBO1;LY6H;ADGRB2;POU4F1;SDK1;WNT8B;MDK;HES5;STMN3;MESP1;IGF2BP2;FGF13;DPYSL4;POU3F1;ADGRB1;TBX3;SERPINI1;FGF17;MSI1;CHRNA3;EMX1;HDAC4;MTR;PRDM12;FGF2;NTN5;ACTL6B;UNC119B;BDNF;SERF1A;PRKN;VXN;ADORA1;B3GNT5;NCAN;PCDHB14;DCX;NPTX1;PRX;GDF11;DNM3;SOX8;PAFAH1B3;IGSF8;SCN2A;NHEJ1;CSPG5;APC2;ZIC1;DLG4;CBLN1;SCIN;VLDLR;PCDHB2;SREBF2;SEMA6B;GLIS2;PLXND1;ADORA2A;PCDHB11;ECT2;VCAN;TYRO3;CRIM1;PKD1;HMGCR;FGF12;SDK2;NLGN2;NRXN2;NES;OBSL1;COX7B;NBL1;STIL
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.4899487982396334,1.3078265485891685,0.1286549707602339,0.7198208594041344,1.0,8/27,16.29%,PRSS56;PLVAP;THY1;MDK;ZP3;IL6R;MADCAM1;TNFRSF18
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.475143277752276,-1.3077631084778636,0.10256410256410256,0.3174292085453262,1.0,9/18,23.62%,TLR3;CCL3;LILRB1;TLR4;MAFB;LILRB4;LILRB3;GPR55;FBXW7
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.5382043263363271,1.3076630473663378,0.1393939393939394,0.7193709588503301,1.0,5/18,18.45%,GNG4;GNG3;GNB5;GNG8;GNG10
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.34216006551503925,-1.307654973640024,0.06382978723404255,0.31713809612520577,1.0,34/87,22.46%,IFNG;CD4;FOS;ALK;MAP2K1;PIK3CD;PRKCQ;CD3E;CD3G;CD274;TICAM2;LCK;CD247;TLR4;TLR2;LAT;PIK3R1;AKT1;RASGRP1;CSNK2A3;MYD88;ZAP70;BATF;PPP3CA;MAPK13;CD3D;NFATC2;MAP2K3;MAP2K6;JUN;JAK2;BATF2;STAT1;AKT3
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.3772942246358841,1.307639382817817,0.044444444444444446,0.7183699442912372,1.0,43/200,14.90%,COL2A1;COL22A1;COL7A1;COL15A1;APLP1;LAMA3;SPP1;SPINK5;MATN1;COL9A1;BCAN;ICAM5;MMP11;VWF;MATN3;ITGA2;ITGA6;COL10A1;FGF2;MMP21;COL4A1;ELN;COL4A5;COL8A1;NPNT;COL1A1;COMP;COL11A1;MMP12;NCAN;ADAM15;COL4A2;MMP17;LAMC1;MMP10;LOXL1;PDGFB;MFAP2;PDGFA;COL1A2;COL5A1;SMOC2;MADCAM1
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,0.5224608860238811,1.3074080564155552,0.1402439024390244,0.7182158279078162,1.0,7/21,23.30%,E2F1;CDK1;CCNB1;PRIM1;PPP2R3B;POLA1;POLA2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.2849411163064549,-1.3072785077526785,0.0,0.31735409162238115,1.0,137/469,22.38%,TCN1;CEACAM6;CRISP3;SLCO4C1;ACP3;CLEC12A;PLAC8;FCAR;AOC1;ADGRE3;FOLR3;CFP;PNP;BPI;GPR84;CEACAM3;CXCR1;HK3;FPR1;CXCR2;AGL;PLD1;TNFAIP6;FPR2;FRMPD3;S100A8;FCGR3B;BST1;SIGLEC14;DNASE1L3;LGALS3;LILRA2;CMTM6;CAT;NFAM1;SIRPB1;ANXA3;HBB;CLEC4D;SIGLEC9;PRSS3;PTPRC;A1BG;VNN1;AGPAT2;CDA;CR1;CD300A;ACAA1;CLEC5A;CD53;CYBB;ALOX5;BIN2;HSPA1B;MNDA;PGLYRP1;ALDOC;ARHGAP9;TICAM2;CLEC4C;NHLRC3;NCKAP1L;FGL2;TLR2;CAMP;ENPP4;SYK;TTR;ATP8B4;FGR;COTL1;ORM2;S100A12;DOCK2;OSCAR;OSTF1;FCER1G;ADGRE5;QSOX1;PIGR;UNC13D;TNFRSF1B;CD177;ITGB2;CXCL1;P2RX1;PLAUR;LILRB2;HP;TMC6;CTSB;HSPA1A;SLC15A4;DSC1;METTL7A;CD33;PTAFR;LILRB3;PYGL;CTSZ;PGM2;DERA;CTSC;C3AR1;AMPD3;FCN1;FRK;ATP11B;ADAM8;PGM1;ADA2;SELL;IQGAP1;MCEMP1;AHSG;RAB27A;TMEM30A;IRAG2;RAB14;GSTP1;PPBP;RAB44;HVCN1;STOM;CD55;CYBA;IDH1;NIT2;HPSE;RAP1A;ITGAM;SLC27A2;TYROBP;DOK3;PGAM1;MGAM
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.5347897265166393,1.307017149601853,0.17197452229299362,0.718737191525592,1.0,6/16,11.59%,HOXD8;MESP2;TDGF1;MESP1;TBX3;RIPPLY1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.4031595930417045,1.3069908390230756,0.11931818181818182,0.7176933996549457,1.0,9/64,8.07%,MT3;SIX1;FGF20;SIX4;POU4F1;MDK;KIF14;BDNF;PRKN
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.45165512435062655,1.3069208862560449,0.12716763005780346,0.716765941483422,1.0,11/36,17.41%,WNK4;NETO1;OSR1;FGF13;FXYD7;FGF14;SCN4B;FXYD2;NEDD4L;FGF12;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.38173645938192174,-1.3066629614178373,0.12345679012345678,0.3179799325901242,1.0,11/40,13.06%,MUC21;SPINT2;IL10;EPCAM;CDH1;APOA1;WNT1;KLF4;IL1RN;PLG;AKT1
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.34380789310530085,-1.3066546677689814,0.021739130434782608,0.31756481518465407,1.0,24/87,13.06%,CXCL10;CXCL11;TNF;IL1B;CCL5;FOS;CD80;TLR3;CCL4L2;CXCL9;CCL4;CCL3;MAP2K1;PIK3CD;IL6;CCL3L3;TLR8;IL12B;CXCL8;TICAM2;TLR4;TLR2;PIK3R1;AKT1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3649595792090491,1.3065521976073153,0.02666666666666667,0.717249504264038,1.0,30/243,9.22%,NKD1;DKK1;DKK4;LGR6;TPBGL;LGR5;PTK7;NOTUM;AXIN2;SFRP4;PRDM15;LRP4;SOX2;DKK3;SNAI2;DKKL1;MDK;ZNRF3;KREMEN2;TMEM88;NKD2;GPC3;IGFBP2;TMEM198;PRKN;PSMD4;TLE6;JRK;COL1A1;ZNF703
prerank,KEGG_2021_Human__Peroxisome,-0.338743482230591,-1.3065501538264308,0.034482758620689655,0.3173700695064323,1.0,39/82,27.80%,HAO2;HMGCLL1;ABCD2;ACSL1;XDH;CAT;SCP2;PIPOX;DAO;ACAA1;PEX3;EHHADH;ACOX1;HAO1;ABCD4;EPHX2;CROT;DDO;PEX11G;NUDT12;PHYH;MLYCD;HMGCL;AGXT;ACOX2;ACOX3;PECR;PXMP2;IDH1;SLC27A2;MPV17L;PEX7;CRAT;PEX13;PAOX;PEX14;NUDT7;ECI2;NOS2
prerank,KEGG_2021_Human__RNA polymerase,0.4876471224288187,1.3063660776262132,0.13855421686746988,0.7167656706454937,1.0,22/31,43.67%,POLR2L;POLR1A;POLR2K;POLR2G;POLR1H;POLR3K;POLR2H;POLR3H;POLR3A;POLR3C;POLR2I;POLR3G;POLR2J;POLR2J2;POLR3GL;POLR2J3;POLR2A;POLR3E;POLR2B;POLR3F;POLR1C;POLR2F
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,0.4358607097587254,1.3062799909597829,0.10989010989010989,0.7159083274438458,1.0,49/73,47.30%,NEK2;PLK1;BUB1B;CDC20;UBE2C;PSMD4;CCNA2;UBE2S;PTTG1;CDK1;CCNB1;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;MAD2L1;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;ANAPC2;PSMB2;PSMA6;ANAPC4;UBC;PSMD9;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;BUB3;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.4333838953938404,1.306080524613936,0.14754098360655737,0.7156313806011103,1.0,37/55,46.67%,TOMM40L;TOMM20L;DNLZ;TIMM17B;BCAP31;SAMM50;ROMO1;TIMM17A;TOMM20;AIFM1;TIMM10;TOMM5;SLC25A6;NDUFA13;FIS1;HSPA4;TSPO;TOMM40;TIMM13;TIMM9;PAM16;AIP;HSPD1;GRPEL2;CHCHD4;HSP90AA1;TIMM10B;TOMM7;TIMM50;TIMM8B;TOMM34;MFF;PITRM1;TIMM22;TIMM8A;IMMP2L;TOMM22
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4577763843040314,1.305987128252941,0.12643678160919541,0.7149280378456553,1.0,28/39,45.45%,NDUFA1;NDUFS6;NDUFV1;NDUFB9;NDUFA3;NDUFS2;NDUFA9;NDUFB11;NDUFA2;NDUFS7;NDUFA13;NDUFA11;NDUFA6;NDUFS8;NDUFV2;NDUFA8;NDUFB7;NDUFAB1;NDUFB2;NDUFB10;NDUFB3;NDUFS4;NDUFB8;NDUFA4;NDUFA10;NDUFB1;NDUFS5;NDUFS3
prerank,Elsevier_Pathway_Collection__Diffuse Large-B-Cell Lymphoma,-0.33684078652737726,-1.3058800566904412,0.05128205128205128,0.3180737463533531,1.0,23/87,15.92%,IRF4;IL10;TNFSF11;CD79A;SPIB;ALK;NFKBIZ;MS4A1;IL6;TNFRSF11A;CD274;BTK;PDCD1LG2;CARD11;LCK;TLR2;AKT1;SYK;PLCG2;MYD88;ING1;PRDM1;IL10RA
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.4417737738785118,-1.305773447317183,0.12987012987012986,0.31789342662075815,1.0,7/25,14.55%,HTR2A;FASLG;XCL1;CCR7;PTPRC;LCK;PLCG2
prerank,MSigDB_Oncogenic_Signatures__KRAS.300 UP.V1 UP,0.39234266551333646,1.3054608627860613,0.10900473933649289,0.7160772494039654,1.0,30/121,12.86%,CHGB;DYNC1I1;CTNNA2;SMPX;CGA;CEL;SPP1;KCNH2;NRCAM;PEG3;BEX1;TERT;MMP11;CLUL1;ITGA2;MKRN3;FAM155B;TRIB2;NTM;KIF5A;OR2B6;ATP1A2;GRIN2A;GPR19;DNM3;RNASE1;SCN2A;SLCO5A1;APOD;SNAP25
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.4530960735669868,1.3053058813693055,0.11864406779661017,0.7155670739083685,1.0,25/47,37.24%,E2F1;CDKN2A;SRC;E2F2;CCNE1;CDKN2C;CCNE2;CDKN2B;CKS1B;CDKN1C;E2F5;CDK6;PPP2R3B;CDKN2D;UBA52;RBL1;CDKN1A;CUL1;CDK4;SKP2;SKP1;PPP2R1A;E2F3;ABL1;E2F4
prerank,Elsevier_Pathway_Collection__Proteins Involved in Multiple Myeloma,-0.3653271058054802,-1.3050948012480512,0.07407407407407407,0.31871837583285473,1.0,22/55,17.09%,IL10;PTGS2;TNFSF11;IFNG;TNF;IL1B;TNFRSF11B;HGF;CCL3;TNFSF10;CXCL12;IL6;IL1RN;TNFRSF11A;AKT1;IGF1;VCAM1;PTN;CXCR4;TNFSF13B;BCL2;ITGA4
prerank,TRRUST_Transcription_Factors_2019__SMAD3 human,0.4707974132917447,1.3050550407883088,0.14673913043478262,0.7153030157929762,1.0,7/31,13.33%,COL7A1;CYP17A1;TERT;CYP7A1;PTHLH;EPO;BGLAP
prerank,WikiPathway_2021_Human__B Cell Receptor Signaling Pathway WP23,-0.3309843355404063,-1.305051625401707,0.06521739130434782,0.3183704382040139,1.0,35/97,23.73%,IRF4;CR2;CD79A;MAP2K1;PRKCB;FOXO1;PTPRC;DAPP1;FYN;BLK;RAC2;BTK;CARD11;RPS6KA1;REL;LCK;HCLS1;PIK3R1;AKT1;SYK;LAT2;PLCG2;VAV1;INPP5D;ETS1;CD19;MAP4K1;NFATC2;MAP2K6;JUN;PIK3AP1;PIK3CG;GAB2;CD22;CD81
prerank,Elsevier_Pathway_Collection__Genes with Mutations Associated with Age-Related Macular Degeneration,-0.4432163809393259,-1.304752913448269,0.10810810810810811,0.3185971237088875,1.0,11/23,26.82%,CETP;TLR3;TLR4;CFI;SERPING1;LIPC;GSTM1;CX3CR1;C3;CFB;ERCC6
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.4616445564972827,1.304404178334962,0.1348314606741573,0.7167010452619016,1.0,18/36,40.08%,E2F1;UBE2C;E2F2;CCNE1;UBE2S;CCNE2;CDKN1C;CDK6;ANAPC11;ANAPC7;CDKN1A;CDK4;SKP2;E2F3;CDC23;ANAPC1;CDK2;ANAPC2
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.3572024940148986,-1.3035960442362833,0.06666666666666667,0.3202520451011027,1.0,14/53,11.36%,TNF;IL1B;CCL5;SOCS2;SFRP1;LRRK2;GLDC;TLR3;CCL3;ESR1;IL18;CCL2;NKX3-1;IGFBP5
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.4805564835882395,1.3035703010438249,0.12138728323699421,0.7190062157823419,1.0,14/28,37.06%,PRDM7;DYDC2;BEND3;KMT2D;KMT2B;WDR5;ZNF335;TET3;OGT;PAXIP1;CXXC1;SETD4;SETD1B;SETD1A
prerank,Elsevier_Pathway_Collection__TP53 Signaling in Pancreatic Neoplasms,0.5271543346551731,1.3028214633124613,0.13609467455621302,0.7209021147076529,1.0,10/21,34.58%,E2F1;CDKN2A;CCNE1;CDC25A;CDK6;CHEK2;CDKN1A;CASP9;CDK4;BAX
prerank,TRRUST_Transcription_Factors_2019__SOX9 human,0.5294436970649469,1.3026991150557745,0.16463414634146342,0.7202880437828298,1.0,4/20,7.48%,COL2A1;POU3F2;NR5A1;AMH
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.3606334357843602,-1.302101887710881,0.08695652173913043,0.3225546083501412,1.0,13/59,12.53%,ASCL1;FOSB;EGR3;EGR2;FOS;ID4;ID2;TF;KCNH8;EGR1;RPS6KA1;TRIB1;EGR4
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.3971762271207848,-1.3020802883438642,0.16666666666666666,0.3221818139858155,1.0,10/39,11.30%,EREG;OVOL2;OVOL1;EVPL;SPRR3;WNT16;KRT16;TGM1;USH2A;ST14
prerank,Elsevier_Pathway_Collection__Hodgkin Lymphoma,-0.32290293853462315,-1.3018296026243332,0.025,0.32227959672033496,1.0,31/105,17.08%,IRF4;IL10;TNFSF11;TNFRSF17;TNF;CCL5;POU2AF1;FASLG;ID2;CD80;TNFRSF13B;SCIMP;NGF;CD40LG;NTRK1;TNFRSF11A;CXCL8;GATA3;CCL22;IL21R;AKT1;TNFSF13;RASGRP1;SYK;POU2F2;CSF2;SPI1;ITGB2;TNFSF8;TNFSF13B;BCL2
prerank,WikiPathway_2021_Human__G13 Signaling Pathway WP524,0.4695163933672597,1.3016604350946546,0.15873015873015872,0.7230991815850096,1.0,3/37,2.58%,PIK3R2;PAK3;MYBPH
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.4477247523777174,1.3014450340754837,0.12432432432432433,0.7227732787640255,1.0,17/45,30.76%,TOP2A;BIRC5;AURKB;CDCA8;AURKA;PIAS3;NUP37;NUP62;TPR;NUP133;RANGAP1;INCENP;NUP155;PCNA;NUP160;PIAS4;UBE2I
prerank,WikiPathway_2021_Human__IL-3 signaling pathway WP286,-0.3641828681649072,-1.3010826244821876,0.09230769230769231,0.32312754678882,1.0,17/48,17.50%,ENPP3;IL5RA;FOS;CD69;MAP2K1;PIK3CD;FYN;CXCL8;HCK;PIK3R1;AKT1;SYK;VAV1;CD86;BCL2;INPP5D;CSF2RB
prerank,Elsevier_Pathway_Collection__Neutrophil Activation via Adherence on Endothelial Cells,-0.35348764757109596,-1.3007986312136055,0.14583333333333334,0.3232526877312141,1.0,24/57,21.99%,FPR1;CXCR2;MAP2K1;PRKCB;CR1;CYBB;BTK;CXCL8;SELE;SYK;VCAM1;VAV1;ITGB2;ITGB3;ITGA9;NCF1;SELPLG;NCF2;SELL;IQGAP1;PRKCZ;SELP;CYBA;ITGAM
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4583286192146919,1.3006605922250039,0.09836065573770492,0.7249882316906426,1.0,15/40,21.40%,LEF1;AXIN2;MDK;COL1A1;ZNF703;EZH2;LOXL2;FOXC1;RGCC;PDPN;SMAD3;CRB2;OLFM1;BCL9L;TGFB2
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.5755579026027025,1.300133890221204,0.12101910828025478,0.7259047705899728,1.0,5/15,10.13%,CGA;WNT4;CYP7A1;NR5A1;AKR1C3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.4474603401279126,1.2999144590886504,0.12234042553191489,0.725738572394487,1.0,15/39,25.52%,FOXN4;MESP1;TBX3;IHH;MMP21;SOX18;DNAAF1;MICAL2;BBS5;DAND5;MEGF8;STIL;TBX6;CCDC40;SOX17
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.3535589729370938,-1.2998851188461151,0.05555555555555555,0.32438509331810333,1.0,18/49,27.64%,MIP;GBP5;GNMT;TDO2;ACACB;KCNJ12;MAT1A;SHMT1;ALDH1A2;CBR4;RYR1;CTH;ALDH9A1;ACOT13;UPB1;SHMT2;TRPV1;AQP4
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5486633386989124,1.2994813044473557,0.18354430379746836,0.7265202915942768,1.0,7/16,22.40%,KCNE5;KCNH2;SCN4B;GJA5;KCNE4;NOS1AP;SCN5A
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,0.4168942155755061,1.299461377915801,0.11794871794871795,0.7255226812587973,1.0,57/86,47.30%,UBE2C;PSMD4;CCNE1;CDC6;CCNA2;UBE2S;CCNE2;CDT1;MCM6;PSMB4;MCM3;MCM5;MCM4;ANAPC11;GMNN;MCM7;ANAPC7;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;MCM8;SKP2;SKP1;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;CDK2;ANAPC2;PSMB2;RBX1;PSMA6;ANAPC4;UBC;PSMD9;ORC6;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5114003162655302,1.2990751409396837,0.18292682926829268,0.7259944609361483,1.0,8/20,22.40%,KCNE5;KCNH2;SCN4B;GJA5;KCNE4;NOS1AP;CACNA1D;SCN5A
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,0.4034016427657369,1.298826424553553,0.09313725490196079,0.7258656130148659,1.0,31/95,27.84%,H3C13;H2AC19;H2BC13;H2AC20;TDRD9;H2BC17;AGO2;H2BC21;PIWIL1;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;H2BC5;H2AX;MOV10L1;POLR2L;TDRKH;NUP37;H2AJ;NUP62;POLR2K;TPR;NUP133;POLR2G;TSNAX;XPO5;TDRD12
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.5081056062760613,1.2984948854443834,0.15517241379310345,0.7260597054584084,1.0,12/22,33.82%,ATP6V0D2;ATP6V0A1;ATP6AP1;ATP6V0B;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1C1;ATP6V1H;ATP6V1F;ATP6V1E1;ATP6V1E2
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.31136923477029155,-1.2980477972155098,0.024390243902439025,0.3270455999777426,1.0,29/152,12.84%,GSTA2;A4GNT;FA2H;HACD1;PCYT1B;MFSD2A;GSTZ1;SLC44A4;GSTA1;LCAT;INHBA;SULT1A2;PEMT;ELOVL2;GSTT2B;APOA1;SLC44A3;SGPP2;PHOSPHO1;ELOVL7;SLC44A5;SPTLC3;GCH1;GSTM5;GCNT1;PLA2G4A;DEGS2;OTC;SPHK2
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.3672636755685822,1.2979447003551265,0.034334763948497854,0.7272193768449665,1.0,190/305,45.04%,HOXD3;INHA;E2F1;EEF1A2;TERT;GAL3ST2;TICRR;AGO2;NT5M;EXO1;MRPL55;RECQL4;CDC6;CDC7;CDC45;MRPS21;CDK1;MCM2;MRPL24;MCM6;TYMS;FAM111B;RFC4;ORC1;PIF1;RPL8;MCM10;POLD1;CHEK1;MCM3;MCM5;POLR2L;MRPS12;BARD1;ING5;MCM4;PCLAF;DNA2;RMI1;MRPL13;BCL3;SCX;EEF1D;FEN1;MRPL9;CLSPN;TOP1MT;MRPS14;ATRIP;RPL30;RAD9B;RBMS1;RPLP1;MCM7;HARS2;DONSON;RPS27;POLA1;RPS21;POLA2;RPLP2;POLR2K;BLM;DUT;EIF4EBP2;MRPL23;RPS5;RHNO1;MRPL28;IGF2BP3;MRPL52;RPL28;POLR2G;FARSB;RPS14;RPL10;TIPIN;COPS5;NAP1L1;RPSA;RPL39;RPLP0;ST3GAL2;RPS15;TIMELESS;RECQL5;RPS2;RPL31;HARS1;RPS19;RPL36;RPL37A;POLR2H;APOE;RPL37;RPL7;RPS4X;RPS20;POLR3A;MRPL36;RPL13;RAD1;BRIP1;RMI2;RPL27;MRPL41;MCM8;ALAS2;TOPBP1;RPL38;RPL35;POLR2I;MRPL27;MMS19;POLR2J;TUFM;RPL10A;MRPS15;RPS8;RPS12;RPL35A;MRPL51;RPS3A;POLL;IGHMBP2;RPS7;XAB2;PTMA;DRG1;RPS11;RPL36A;GSPT2;RPL7A;MRRF;RPS3;RPL18A;DBF4;RPL32;RPS24;POLR2A;RPL3L;RPL29;BAZ2A;RPL23;RPL5;RPS18;RPL14;ATR;CDK2;RPS16;MRPS5;MRPL43;POLR2B;RPA2;EEF2K;RPL13A;RPL41;RPL9;EEF1B2;RPS6KB2;MRPS18C;GRWD1;RPS28;ST3GAL4;RFC3;POLD3;PABPC4;PAX8;RPS23;RPL27A;RPL23A;RPL18;RPL12;NFKBIB;MRPS11;RNPS1;TAF1B;POLR2F;RPS9;EXT1;RPL6;MED20;UPF1;EEF2;RPS15A;RPL4;ORC6;RPS26;WRN;RPL19
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.4629747319815174,1.2973515837956227,0.10734463276836158,0.7284792547325966,1.0,2/38,0.23%,MT3;IGF2
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.30541319831968855,-1.2973344610436413,0.0,0.3279046405513076,1.0,62/167,20.35%,CYP2C19;FA2H;HACD1;THRSP;ACOT11;PTGS2;HAO2;MUSK;CYP2C8;HPGD;CYP4A22;CYP4A11;ACSL1;CYP4F2;CYP1A2;ELOVL2;DPEP3;SCD5;ELOVL7;ACSM3;CYP8B1;MMUT;CYP2C9;ACADL;ACAA1;ALOX5AP;DPEP2;ALOX5;ACADS;PLA2G4A;PTGES;EHHADH;ACBD4;PON3;CYP4F3;PTGR1;ACOX1;TBXAS1;EPHX2;CROT;PON1;ACAD11;ACADM;HSD17B12;ECHS1;CYP2J2;PRKAG2;PHYH;MLYCD;HPGDS;PTGIS;CBR4;HACD4;ACBD5;SLC25A20;PCCA;ACOX2;ACOX3;PECR;FADS2;PCTP;ACOT2
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.4818977356883572,1.2967599723826582,0.14450867052023122,0.7296213776910894,1.0,17/31,36.22%,DYDC2;EZH2;SMYD3;SMYD2;DOT1L;SUV39H1;EHMT2;SETDB1;KMT2D;KMT2B;WDR5;TRMT112;SUV39H2;PAXIP1;CXXC1;SETD1B;N6AMT1
prerank,KEGG_2021_Human__Nitrogen metabolism,0.5650380498810063,1.2965851266303001,0.12578616352201258,0.7292966891106653,1.0,5/15,13.38%,CA4;GLUL;CA5B;CA1;CA14
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,0.4541287681463328,1.296155017397363,0.12921348314606743,0.7299074908819652,1.0,15/45,22.46%,GNG4;AQP6;AQP8;AVPR2;GNG3;GNB5;ADCY6;GNG8;AQP9;PRKCA;GNG10;ADCY4;ADCY2;AQP10;MINDY4
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.45291056736278645,-1.29613276378471,0.1411764705882353,0.32973652687270005,1.0,14/21,26.43%,PDGFRA;PLEK;PRKCQ;BLK;PLA2G4A;TLR4;SYK;FCER1G;C1QTNF1;SELP;F2;THBD;HRG;TXK
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.3158304096305405,-1.2959618225754828,0.045454545454545456,0.3296877417706662,1.0,39/112,19.83%,BBOX1;AKR1D1;CYP39A1;GNMT;ABCD2;ACSL1;NR3C2;APOA1;ALDH8A1;CAT;SCP2;PIPOX;CYP8B1;HSD3B1;NR1I2;DIO1;LCK;ISOC1;ABCG8;HSD17B6;HAO1;ABCG4;TTR;EPHX2;CROT;ABCA8;PEX11G;NUDT12;PHYH;MLYCD;GC;ABCA9;RBP1;AR;AGXT;SLC27A5;NR1H4;PECR;FADS2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.2798330674653024,-1.2958465322733779,0.0,0.32949605826329004,1.0,134/465,22.38%,TCN1;CEACAM6;CRISP3;SLCO4C1;ACP3;CLEC12A;PLAC8;FCAR;AOC1;ADGRE3;FOLR3;CFP;PNP;BPI;GPR84;CEACAM3;CXCR1;HK3;FPR1;CXCR2;AGL;PLD1;TNFAIP6;FPR2;FRMPD3;S100A8;FCGR3B;BST1;SIGLEC14;LGALS3;CMTM6;CAT;NFAM1;SIRPB1;ANXA3;HBB;CLEC4D;SIGLEC9;PRSS3;PTPRC;A1BG;VNN1;AGPAT2;CDA;CR1;CD300A;ACAA1;CLEC5A;CD53;CYBB;ALOX5;BIN2;HSPA1B;MNDA;PGLYRP1;ALDOC;ARHGAP9;TICAM2;CLEC4C;NHLRC3;NCKAP1L;FGL2;TLR2;CAMP;ENPP4;TTR;ATP8B4;FGR;COTL1;ORM2;S100A12;DOCK2;OSCAR;OSTF1;FCER1G;ADGRE5;QSOX1;PIGR;UNC13D;TNFRSF1B;CD177;ITGB2;CXCL1;P2RX1;PLAUR;LILRB2;HP;TMC6;CTSB;HSPA1A;SLC15A4;DSC1;METTL7A;CD33;PTAFR;LILRB3;PYGL;CTSZ;PGM2;DERA;CTSC;C3AR1;AMPD3;FCN1;FRK;ATP11B;ADAM8;PGM1;ADA2;SELL;IQGAP1;MCEMP1;AHSG;RAB27A;TMEM30A;IRAG2;RAB14;GSTP1;PPBP;RAB44;HVCN1;STOM;CD55;CYBA;IDH1;NIT2;HPSE;RAP1A;ITGAM;SLC27A2;TYROBP;DOK3;PGAM1;MGAM
prerank,KEGG_2021_Human__cAMP signaling pathway,0.37177336445112424,1.2957845217789112,0.08755760368663594,0.7302689963803187,1.0,41/189,16.57%,HTR1D;GLP1R;GPR119;GCG;HCN2;CGA;CACNA1S;PIK3R2;CALML6;GRIN1;TNNI3;HTR4;PTGER3;PDE4C;AMH;ATP1A2;BDNF;ATP1A4;ATP2B4;CAMK2A;SSTR5;ATP1B3;GRIN2A;ADORA1;HCAR1;OXTR;GRIN3B;ATP2A1;CACNA1C;LHB;CREB3L1;ARAP3;HHIP;PDE10A;HTR1B;ADCY6;FXYD2;ADORA2A;CREB3L4;ROCK2;PPP1R1B
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.4541806995914782,1.295661150446939,0.13812154696132597,0.7296256581220203,1.0,19/38,40.08%,E2F1;UBE2C;E2F2;CCNE1;UBE2S;CCNE2;CDKN1C;CDK6;ANAPC11;ANAPC7;CDKN1A;CDK4;SKP2;E2F3;CDC23;DAXX;ANAPC1;CDK2;ANAPC2
prerank,Reactome_2022__Lewis Blood Group Biosynthesis R-HSA-9037629,0.5300104537602484,1.295658465814925,0.13815789473684212,0.7285422434005592,1.0,2/17,0.41%,B4GALNT2;B3GALT1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.5246656346723956,1.2956570855711647,0.13836477987421383,0.7274518231263085,1.0,7/21,10.90%,APLN;CSN2;WNT4;TDGF1;TBX3;OXTR;ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.38621081974748284,-1.2956356666573345,0.07352941176470588,0.32946912988331006,1.0,16/41,20.37%,CIDEA;IL10;BPI;PTPN22;LILRB1;CHRNA7;TLR4;IGF1;HAVCR2;LGALS9;LILRA4;NLRC3;CD33;SLAMF1;NR1H4;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.47752417693750127,1.2955431308722576,0.12280701754385964,0.7268873524991869,1.0,19/28,40.02%,PRDM7;PARP1;RAD51AP1;KMT5C;OOEP;FANCB;MAD2L2;TIMELESS;MRNIP;SHLD3;FUS;TP53BP1;MMS19;PAXIP1;SHLD1;TFRC;ERCC2;ARID2;SHLD2
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,-0.4452357311656941,-1.2948046622452292,0.14772727272727273,0.3305050790614765,1.0,7/19,9.87%,SEMA3E;PLXNA4;SEMA4A;SEMA6D;SEMA4D;PTPRC;SEMA6A
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.3765452150156371,1.2947288360686562,0.07860262008733625,0.7289954308911629,1.0,81/198,36.56%,CENPF;NEK2;KIF2C;PLK1;KIF4A;CENPE;TOP2A;ANLN;BIRC5;CCNB2;KIF15;BUB1;CLIP2;TTK;DLGAP5;NDC80;KIF23;CDK1;TUBA4A;KNTC1;AURKA;ARHGEF11;RACGAP1;SAC3D1;ARAP3;PALLD;CEP131;PIF1;PLEKHG2;ARHGEF2;ECT2;KIF11;PRC1;CEP250;TSC1;TPX2;ARHGAP4;WASF2;MARK4;MID1;TAOK2;LLGL1;GSN;UXT;SMC4;BCR;LMNB1;FLNB;TUBGCP6;CDC42EP4;MID1IP1;KIF1B;INCENP;SASS6;KATNB1;CDC42BPA;KIFAP3;TBCD;KIF22;KPTN;SMC3;RASAL2;CSNK1D;CYTH2;SPTAN1;ALMS1;SHROOM1;DYNC1H1;MYH9;BRCA2;KIF3B;ACTN4;SMC1A;ESPL1;CEP72;MAP3K11;MAP1S;TUBGCP2;MYO9B;ABL1;ARL8A
prerank,TRRUST_Transcription_Factors_2019__STAT1 human,-0.34470223230419644,-1.2945886696667923,0.09836065573770492,0.3305125564196921,1.0,26/77,18.88%,FOXP3;MUC1;IL10;CXCL10;PTGS2;IFNG;IL1B;TLR3;IL27;CCL3;CCL2;IL6;CCR1;CD40LG;TBX21;IRF8;PRKCE;CD86;CFTR;TNFSF13B;IFIT3;CTSB;HMOX1;FCGRT;ACAT1;NR1H4
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.3970151039735466,1.2945665478082764,0.058823529411764705,0.7285478447506273,1.0,32/82,33.10%,IGF2;H3C13;H3C1;HDAC4;TFAP2C;EZH2;DNMT3A;KAT2A;H4-16;HDAC5;CTCFL;POLR2L;JARID2;POLR1A;POLR2K;DNMT1;PRMT7;DNMT3B;GPX1;TAF1A;MECP2;POLR1H;H3-3A;POLR1G;TRIM27;ZNF335;POLR2H;GLMN;RBBP7;MORC2;PHF19;KDM1B
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.413521042646682,-1.2945101033838684,0.1111111111111111,0.33020696172372027,1.0,12/25,21.10%,NLRP7;IL10;NLRP12;APOA1;NLRP3;MEFV;CARD16;IGF1;LILRB4;CD33;GSTP1;CX3CR1
prerank,Reactome_2022__Heme Degradation R-HSA-189483,-0.4838096191622976,-1.293975524303411,0.17708333333333334,0.33064825330069125,1.0,6/16,17.12%,GSTA1;SLCO1B3;ALB;SLCO2B1;SLCO1B1;HMOX1
prerank,Elsevier_Pathway_Collection__TLR -> AP-1 Signaling,-0.4468728636061693,-1.2932647435247877,0.08139534883720931,0.3315426248280694,1.0,12/23,24.86%,FOS;TLR4;TLR2;MYD88;MAPK10;MAP2K3;MAP2K6;JUN;MAP2K4;TLR1;CD14;LY96
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,0.46752193477059334,1.2928972459530874,0.1488095238095238,0.7342078372616729,1.0,11/39,18.69%,GNG4;GNAZ;SRC;GNG3;GNB5;SHC1;ADCY6;GNG8;PRKCA;GNG10;ADCY4
prerank,Elsevier_Pathway_Collection__Insulin Secretion,0.5325655859099844,1.2925313497840192,0.14935064935064934,0.7346350129465821,1.0,9/18,16.03%,GLP1R;GCG;NEUROD1;ONECUT2;PCSK1;ABCC8;DPP4;KCNJ11;SYTL4
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.47190692921378674,1.292313060319748,0.12,0.7344251551302106,1.0,18/37,34.84%,KIF1A;KIF4A;KIF5A;HSPB1;AP3B2;BLOC1S1;MAP1A;SNAPIN;BLOC1S3;KIF1B;DTNBP1;AP3D1;NEFL;AP3M2;MAPK8IP3;AP3B1;KIF3B;KIF1C
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.5293700740059759,1.2922587227781899,0.16666666666666666,0.7335354010912617,1.0,10/18,31.84%,CACNB4;GPR35;HPCA;GNB5;NOS1AP;CBARP;CACNB1;CACNB3;DRD4;FMR1
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.3580221041067649,-1.291948792834951,0.08620689655172414,0.3336821980657865,1.0,17/69,17.19%,CIDEC;LPA;CETP;LCAT;APOA4;APOF;APOA1;LIPG;ALB;APOA5;LSR;ANGPTL3;CES3;PCSK5;APOBR;LIPC;PLTP
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.39458344576005894,1.2918386606145276,0.10606060606060606,0.7341949362356296,1.0,24/103,11.78%,KCNH6;KCNC1;KCNF1;KCNJ6;HCN2;LRRC26;KCNC2;KCNH2;KCNG2;LRRC52;KCNK17;KCNJ5;KCNB1;ATP1A2;ATP1A4;SLC9C2;ATP1B3;KCNJ14;KCNN3;ABCC8;HCN3;KCNH3;KCNS2;SLC9A3
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,0.50028367838654,1.2915313570983915,0.1724137931034483,0.7343411064931958,1.0,11/24,33.74%,EXO1;XRCC2;BARD1;DNA2;RMI1;RAD51AP1;RAD51;BLM;BRIP1;RMI2;BRCA2
prerank,Elsevier_Pathway_Collection__Synovial Fibroblast Activation in Psoriatic Arthritis,-0.3638215829041228,-1.2910645304906332,0.09375,0.33486779452266474,1.0,19/47,23.65%,TNFSF11;TNF;IL1B;MMP1;FOS;IL1RAP;IL15;CXCL12;IL6;CXCL8;IL17RC;MYD88;TNFRSF1B;WNT5A;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,Reactome_2022__Inflammasomes R-HSA-622312,-0.4582505053467531,-1.2910222980477275,0.13793103448275862,0.33449500470863536,1.0,8/21,17.12%,AIM2;CASP1;NLRP3;MEFV;PSTPIP1;NLRC4;BCL2;HMOX1
prerank,Elsevier_Pathway_Collection__Angiotensin-Aldosterone System Activation Scheme,0.5427187597497843,1.2907666434895768,0.15432098765432098,0.7361957521367894,1.0,3/17,3.20%,REN;CYP17A1;CYP21A2
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.4169182029755832,1.2905526312093,0.12690355329949238,0.7359043623285672,1.0,11/61,14.95%,PYDC1;SFN;CAMK2N2;MAPT;THY1;TRIB2;DBNDD1;HSPB1;PPM1F;CDKN1C;PDPK1
prerank,Elsevier_Pathway_Collection__Prolactinoma Overiew,0.4388496148744191,1.2903734996569913,0.14583333333333334,0.7355483002696885,1.0,18/54,24.71%,HMGA2;RASGRF1;E2F1;FGF2;CCNB2;TRH;CDKN2C;PTTG1;SHC1;HRAS;SMAD3;EGF;PREB;CDK6;PLCG1;NRG1;ERBB3;MAP2K2
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,0.5090694466272268,1.2896855233856723,0.14285714285714285,0.7371261797407529,1.0,4/21,9.66%,BUB1B;CDC20;UBE2C;UBE2S
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.4374515010779234,-1.289270123214479,0.16279069767441862,0.33739243306519956,1.0,3/23,9.50%,ERN2;DNASE1L3;ACVR1C
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.5062235898937791,1.2892450426796545,0.13291139240506328,0.7376791015582135,1.0,4/18,16.03%,PRSS56;MDK;IL6R;CAMK1D
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,0.5546139346075375,1.2890310419258146,0.18902439024390244,0.7374625259046534,1.0,4/16,7.62%,FGF20;FGF13;FGF17;FGF23
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.358122114885092,1.2886223482906032,0.055793991416309016,0.7379882729865509,1.0,48/235,11.78%,KCNH6;KCNC1;KCNF1;SLC6A4;SLC6A7;HCN2;LRRC26;KCNC2;ATP4A;KCNH2;TRPM3;ASIC1;SCN1A;RHBG;KCNG2;SCN4A;SLC6A11;LRRC52;SLC39A4;KCNK17;SLC12A1;NOX5;SLC30A3;TRPM5;KCNB1;SLC6A9;SLC30A2;CACNA1G;TRPC6;SLC6A3;ATP1A2;ATP1A4;ATP2B4;SLC9C2;ATP1B3;KCNJ14;SLC6A8;KCNN3;ASIC3;ABCC8;HCN3;ATP2A1;KCNH3;SCN4B;SCN2A;KCNS2;CACNA1C;SLC9A3
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.44967474372327304,-1.2885319602678211,0.12987012987012986,0.3382726963694313,1.0,12/25,12.30%,MT1G;MT1HL1;MT1F;MT1H;MT1M;MT1E;MT1X;SLC30A4;MT1A;ZACN;HAAO;MT1B
prerank,Elsevier_Pathway_Collection__Thyrotropin Releasing Hormone (TRH) Hypothalamic Release in non-Autoimmune Hypothyroidism,0.5183916651532582,1.28852926665952,0.15568862275449102,0.7373665511994743,1.0,6/18,15.00%,DIO2;AGRP;TRH;PCSK1;LEP;LEPR
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4326379467294554,-1.2881822764948205,0.11392405063291139,0.33851684765535384,1.0,12/26,26.77%,EREG;TGFA;BTC;ERRFI1;HBEGF;NCF1;ZFYVE28;APP;GPRC5A;FBXW7;CBLC;SNX6
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.2928269656133767,-1.2881461250647703,0.0,0.3381483848201488,1.0,62/197,20.30%,IRF4;MUC1;GPR83;IL10;CXCL10;TNFSF11;EOMES;PNP;IL2RB;IKZF2;ECM1;SOCS2;PTH1R;SCN9A;IL18R1;ENO3;CDCP1;TNFSF10;GPR65;ICOS;CST7;NFKBIZ;CTLA4;RHOH;CD48;GBP4;RABGAP1L;PTGER2;ABCB1;CA2;F2RL2;FGL2;IRF8;TNFRSF9;FAM126B;NFIL3;CCR4;CISH;CD83;CSF2;TIAM1;PLAGL1;KLF6;CD86;TNFRSF1B;BMPR2;IL10RA;PRNP;GUCY1B1;BCL2;GATA1;ENPP1;SLC39A8;CTSZ;TNFRSF21;LIF;BATF;ANXA4;SELL;P4HA1;MXD1;TTC39B
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.4058244402194649,1.288136900053853,0.12121212121212122,0.7380457976551386,1.0,43/85,39.37%,H2AC19;H2AC11;H2AC20;PSMD4;H2AC6;FOXK1;UCHL1;PSMB4;ACTR5;BARD1;ASXL2;ASXL1;INO80E;NEDD8;NFRKB;HCFC1;TFPT;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;ADRM1;PSMC4;PSMC3;TGFB1;KDM1B;OGT;PSMC5;RUVBL1;SEM1;PSMB6;PSMD8;PSME2;TGFBR2;ACTR8;PSMD13;PSMB7;PSMA7;INO80D;PSME3
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5087424037969379,1.2880809838513116,0.15286624203821655,0.7371813282492515,1.0,8/19,21.35%,GUCY2C;NPR2;GUCY2D;ADCY6;ADCY4;AMPD2;ADCY10;ADCY2
prerank,WikiPathway_2021_Human__Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5158308288361902,1.287781424164077,0.14965986394557823,0.7373307558166005,1.0,9/22,31.44%,LEF1;E2F1;SUV39H1;HDAC1;CBX5;CHD3;CHD4;RBBP7;CBX3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.5325169796866552,1.287740535561932,0.15625,0.736400200880561,1.0,4/19,10.36%,SFN;SFRP4;BMP4;FOXC1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,0.49998368677562777,1.2877377911528665,0.1569767441860465,0.7353382290045308,1.0,5/24,10.65%,CDC20;UBE2C;UBE2S;CDK1;CCNB1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,0.4302469385185652,1.2875013380671452,0.10869565217391304,0.735261505132116,1.0,48/72,47.30%,NEK2;BUB1B;CDC20;UBE2C;PSMD4;CCNA2;UBE2S;PTTG1;CDK1;CCNB1;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;MAD2L1;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;ANAPC2;PSMB2;PSMA6;ANAPC4;UBC;PSMD9;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;BUB3;PSMB1;PSMD3
prerank,WikiPathway_2021_Human__PPAR-alpha pathway WP2878,-0.4194909929952857,-1.2873366179902859,0.15,0.3392632648190163,1.0,10/25,17.19%,CYP4A11;UGT1A9;APOA1;SCP2;CYP8B1;ACAA1;APOA5;EHHADH;ACADM;PLTP
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.31606533321940444,-1.2870664162759398,0.0425531914893617,0.3392456346602664,1.0,41/101,23.89%,CSF3;TNF;NTRK3;NTF3;HGF;WNT16;CCL5;PTPN13;NTRK2;IL18;PDGFRA;DCN;PIK3CD;SEMA4D;OSM;NKX3-1;NTRK1;FLT3;PIK3R5;ENTPD5;HCLS1;PIK3R1;SOX9;IGF1;FGR;DIPK2A;NLRC3;PIP4K2A;NCF1;TWIST1;IRS2;FBXL2;TEK;SELP;JAK2;PIK3AP1;PDGFC;PIK3CG;IGF1R;F2RL1;PTEN
prerank,Elsevier_Pathway_Collection__Histone Methylation,0.4690116720971549,1.2869669866082025,0.125,0.7363539613023554,1.0,16/28,30.96%,UHRF1;DNMT3A;ZBTB33;SUV39H1;EHMT2;KDM5B;SETDB1;HDAC1;DNMT1;CBX5;DNMT3B;MECP2;KDM3A;ZHX1;PCNA;RBBP7
prerank,Elsevier_Pathway_Collection__ActivinR/BMPR -> SMAD1/5/9 Signaling,0.5002647700612209,1.2868597334232015,0.16279069767441862,0.7356379498116244,1.0,8/25,10.39%,INHA;NODAL;TDGF1;GDF5;MSTN;BMP4;AMH;GDF11
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.333207019964497,-1.2867916303974791,0.06818181818181818,0.3393541947369048,1.0,22/68,17.45%,MUC5AC;PLCZ1;HTR2A;CD160;LTK;PIK3C2G;PDGFRA;ZFP36L1;PIK3CD;NGF;NTRK1;GATA3;PIK3R5;PIK3R1;AKT1;TPTE2;PLCB2;IGF1;PLCL2;CSF1R;EZR;PTAFR
prerank,Elsevier_Pathway_Collection__Proteins Involved in Ulcerative Colitis,-0.30427461854359256,-1.2867722528418077,0.02631578947368421,0.3389585290555835,1.0,35/130,13.16%,ERN2;TAC1;IRF4;IL10;PTGS2;IFNG;TNF;IL1B;HGF;CXCR2;FASLG;CDH1;CCL3;PTPRO;IL15;CTLA4;CXCL12;TGFA;KLRB1;ALB;IL6;IL33;CD40LG;TBX21;IL1RN;MEFV;CA2;NR1I2;MBL2;CXCL8;PLG;CD5;TLR4;AKT1;TSLP
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,0.4261424282491766,1.28659518207753,0.11290322580645161,0.7358179466686652,1.0,40/56,47.28%,RPS27;RPS21;EIF3E;RPS5;EIF3K;RPS14;RPSA;PABPC1;EIF3D;RPS15;RPS2;RPS19;RPS4X;RPS20;EIF3H;RPS8;RPS12;EIF3B;RPS3A;RPS7;RPS11;FAU;RPS3;RPS24;EIF3G;RPS16;EIF3M;RPS28;RPS23;EIF2S3;RPS9;EIF3C;EIF3F;RPS15A;EIF3L;RPS6;RPS27A;RPS4Y1;RPS13;EIF3A
prerank,WikiPathway_2021_Human__LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.3991846094795587,1.286335977634757,0.10552763819095477,0.735765631731142,1.0,19/87,15.52%,NKD1;DKK1;DKK4;LEF1;NOTUM;AXIN2;SFRP4;WNT4;ROR1;NKD2;TCF7;PORCN;EZH2;KREMEN1;APC2;PLAU;DVL2;WNT2B;WNT6
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.5240493255228865,1.2861114149322936,0.13095238095238096,0.7355312568686407,1.0,5/19,14.29%,MAPK11;IRAK1;IKBKG;IRAK2;MAPKAPK2
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,0.3879720090066716,1.2859714760843943,0.09134615384615384,0.73504676376047,1.0,30/121,16.45%,GNG4;GLP1R;GHRHR;PTH2R;GCG;CALCA;GNAZ;RAMP1;GPHA2;HTR4;AVPR2;SRC;PDE4C;CRHR2;PTHLH;GNG3;ADM2;GPR150;RAMP2;LHB;MC1R;PDE10A;GNB5;SHC1;ADCY6;IAPP;GNG8;PRKCA;ADORA2A;GRK3
prerank,KEGG_2021_Human__Amoebiasis,-0.30965111053288347,-1.2854731355815723,0.043478260869565216,0.34095465011145926,1.0,29/94,16.09%,IL10;CD1A;IFNG;TNF;IL1B;CD1B;LAMA1;COL4A3;CXCL3;C9;CD1D;CD1E;PIK3CD;PRKCB;CXCL2;IL6;IL12B;LAMC2;CD1C;CXCL8;GNA14;TLR4;TLR2;PIK3R1;PLCB2;CSF2;SERPINB9;ITGB2;CXCL1
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.45675919342558247,1.285259992817768,0.11578947368421053,0.7368764856573071,1.0,10/43,17.63%,IGF2;FGF20;PIK3R2;FGF13;FGF17;FGF23;FLT3LG;PDPK1;HRAS;THEM4
prerank,WikiPathway_2021_Human__Toll-like Receptor Signaling Pathway WP75,-0.3292208127201654,-1.2851326324444083,0.061224489795918366,0.3411514415110291,1.0,39/88,24.86%,CXCL10;CXCL11;TNF;IL1B;CCL5;FOS;CD80;TLR3;CXCL9;CCL4;CCL3;MAP2K1;PIK3CD;IL6;TLR8;IL12B;CXCL8;TICAM2;TLR4;PIK3R5;TLR2;PIK3R1;AKT1;MYD88;CD86;MAPK10;MAPK13;TAB2;MAP2K3;MAP2K6;JUN;CD40;STAT1;AKT3;PIK3CG;MAP2K4;TLR1;CD14;LY96
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.44021285033926727,-1.2845624419536579,0.14634146341463414,0.34175219209614466,1.0,10/23,23.72%,HTR2A;XCL1;CCR7;PTPRC;LCK;PLCG2;RYR1;ANXA6;IBTK;ITPR3
prerank,MSigDB_Oncogenic_Signatures__STK33 UP,-0.285847383665865,-1.2845555931636388,0.0,0.3413415843941609,1.0,76/254,20.47%,EGR3;ITGB8;FCAMR;EGR2;TNF;TFPI2;IL1B;MMP1;RGS1;PKIB;FOS;TDO2;CXCL3;CCL4;PTPRO;TNFSF15;GPR65;ACSM3;RND3;ASB2;VSIG4;ZFP36L1;TMEM71;CXCL2;MEIS3P1;ARRDC3;EGR1;TFEC;ADAM28;BCL2A1;CSRNP1;ZEB2;TRAC;TRIB1;FGL2;GBP3;RGS2;KYNU;HAVCR2;KMO;SAMD9L;CLDN1;HBEGF;LRRC25;MAFB;ADORA3;KLF6;CREB5;IL10RA;CXCL1;PLCXD2;NLRC4;OTUD1;PPP1R15A;HMOX1;TLR10;SLC12A6;ABHD2;CD101;MTMR9;VWA5A;DUSP1;NCEH1;RTN1;TTLL7;NCF2;PID1;IFI16;MPEG1;WNT5A;MIR22HG;CLEC2B;KIAA0895;BBS12;SOCS6;PPBP
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.42648921107609594,-1.284551264057941,0.13157894736842105,0.34091808366910614,1.0,12/22,27.85%,LRAT;CYP4F2;CYP4F12;CYP3A4;ALDH1A2;GC;RBP1;LGMN;TTPA;VDR;VKORC1L1;VKORC1
prerank,Reactome_2022__SHC-mediated cascade:FGFR2 R-HSA-5654699,0.5439594940031774,1.2844960020662282,0.17575757575757575,0.7390981245069367,1.0,7/16,20.14%,FGF20;FGF13;FGF17;FGF23;SHC1;HRAS;FGF18
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,0.46950121031884906,1.2844667275110895,0.13186813186813187,0.7381356526216731,1.0,15/37,33.12%,EXO1;SERPINA2;RFC4;BARD1;DNA2;RMI1;POLR1A;ATRIP;RAD9B;RAD51;BLM;RHNO1;BRIP1;RMI2;TOPBP1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.4265332091212537,-1.2842679623859141,0.11688311688311688,0.3409958403336705,1.0,8/24,14.52%,APOA4;APOA1;APOA5;TSKU;ABCG8;ABCG5;ABCG4;ABCA8
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.4910842927140353,-1.2842269937164839,0.14130434782608695,0.34070565169958517,1.0,7/15,19.01%,SLC45A3;GPLD1;PPM1K;AKT1;PRKCE;PMAIP1;IRS2
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,-0.3877931840202864,-1.2841550783037365,0.125,0.34041618046632577,1.0,14/37,23.45%,SOCS2;FYN;SLA2;LCK;FLT3;HCK;PIK3R1;AKT1;SYK;BCL2L11;SOCS6;AKT3;SH2B3;GAB2
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.4550135703871858,1.2838085866309124,0.15591397849462366,0.7396841712078126,1.0,13/38,25.22%,DMC1;EXO1;RECQL4;RAG1;HMGB3;XRCC2;RTEL1;MSH2;RAD54L;HDAC10;RAD51;BLM;RHNO1
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.4248217058879712,1.2835646402763725,0.11413043478260869,0.7396024373502665,1.0,10/53,11.68%,CACNB4;CACNA1S;COL9A1;CACNA1G;SRC;COL4A1;COL4A5;NCAN;COL4A2;CACNA1C
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,-0.4381054678490307,-1.2835483668263477,0.13580246913580246,0.34111721277678486,1.0,7/24,17.26%,CSF3;IFNL1;CD4;CSF3R;IL16;CSF1R;STX3
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.46948777596210556,1.2833220177584548,0.1393939393939394,0.7395014355264624,1.0,7/29,8.72%,KCNE5;ATP4A;KCNH2;ATP1A2;ATP1A4;ATP2B4;ATP1B3
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.4719506024668003,1.2830400035512637,0.1696969696969697,0.7396392743500472,1.0,15/27,34.51%,PLK1;NCAPH;NCAPG;CDCA5;CDK1;CCNB1;H4-16;AKAP8L;NCAPD2;NCAPH2;SMC4;SMC2;NCAPG2;PHF13;CSNK2B
prerank,TRRUST_Transcription_Factors_2019__BCL6 mouse,-0.4761346121228424,-1.2829280813400679,0.175,0.3417197333626872,1.0,8/15,18.69%,IFNG;SOCS2;TBX21;GATA3;PRDM1;CSF1R;GADD45A;BATF
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.5247972798050864,1.282917580284516,0.15822784810126583,0.7390766669270633,1.0,5/18,18.45%,GNG4;GNG3;GNB5;GNG8;GNG10
prerank,Reactome_2022__S Phase R-HSA-69242,0.38445503562743444,1.282908082457473,0.09009009009009009,0.7380496216044353,1.0,83/157,43.21%,E2F1;UBE2C;PSMD4;CCNE1;CDC6;CCNA2;UBE2S;CCNE2;CDC45;CDCA5;CDT1;MCM6;PRIM1;RFC4;PSMB4;CKS1B;POLD1;MCM3;MCM5;CDC25A;MCM4;DNA2;E2F5;FEN1;POLR1A;ANAPC11;GMNN;LIN37;MCM7;POLA1;POLA2;GINS4;LIN9;MYC;ANAPC7;GINS1;PSMB3;GINS2;PSMD14;UBA52;CDKN1A;PSMB5;PSMD2;PCNA;PSMA1;SMC3;PSMD10;PSMC4;PSMC3;CUL1;CDK4;MCM8;SKP2;SKP1;PSMC5;SMC1A;SEM1;PSMB6;CDC23;PSMD8;E2F4;STAG2;PSME2;PMEPA1;GSK3B;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;CDK2;SLC19A1;ANAPC2;RAD21;RFC3;POLD3;CDC25B;PSMB2;RBX1;PSMA6;RBBP4;ANAPC4;UBC
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.48131115837765365,1.2827850291275293,0.14130434782608695,0.7375393472465521,1.0,3/31,2.57%,E2F1;RBM24;AXIN2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.40629378195412985,-1.2826339565126623,0.2191780821917808,0.341830546735357,1.0,11/27,21.07%,AGL;GYS2;UGP2;PPP1R3C;GBE1;PRKAG2;PYGL;PGM2;PGM1;PGM2L1;NHLRC1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.5081359991135038,1.2825769818756925,0.12101910828025478,0.737258037877094,1.0,18/25,43.71%,POLR2L;POLR2K;NELFE;MDFIC;POLR2G;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;DHX9;SUPT5H;NELFB;POLR2A;POLR2B;GTF2F1;POLR2F;CDK9
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.4454067293044515,1.2825618219715083,0.1366120218579235,0.7362669363663094,1.0,17/51,16.56%,HS3ST4;HS3ST5;HPSE2;BCAN;B3GAT1;GPC3;NCAN;HS6ST2;IDUA;NDST1;CSPG5;CSPG4;HS3ST2;HS6ST1;GPC2;VCAN;B3GAT3
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.4057733868680591,-1.2825407677054257,0.08333333333333333,0.3415824924343178,1.0,12/30,16.17%,INHBA;SFRP1;MLLT3;TNFRSF13B;MLF1;PLEK;PTPRC;FLT3;PLD4;MIXL1;ARMC6;CSF1R
prerank,TRRUST_Transcription_Factors_2019__JUN mouse,-0.3065932972637121,-1.282397055667943,0.05263157894736842,0.34139014830109066,1.0,36/110,17.12%,TFF2;SERPINB5;SFTPB;PTGS2;TNFSF11;IFNG;TNF;PPP1R3B;IL1B;CCL5;FOS;IL27;ESR1;GNRHR;CAT;CXCL2;MAF;TGM1;CCL2;IL6;NGF;CTSE;IL12B;MMP7;JDP2;SLC39A14;SLC8A1;MMP19;MSR1;CSF2;SPI1;PRDM1;CXCL1;CSF1R;PLAUR;HMOX1
prerank,Elsevier_Pathway_Collection__GALR1/2/3 -> POMC/NPY Production,0.5100706355437292,1.2823624466530525,0.1696969696969697,0.7359930496144511,1.0,6/20,14.95%,RASGRF1;GAL;GALR2;GALR3;GALR1;PDPK1
prerank,WikiPathway_2021_Human__Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5038288317627253,1.2821968450794061,0.16666666666666666,0.7356861945664578,1.0,4/19,12.32%,B3GALT1;B4GALNT1;SPHK1;CERK
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.3985452885156059,1.2821792985187557,0.14084507042253522,0.734706317186656,1.0,55/102,46.91%,EEF1A2;MRPL55;MRPS21;DAP3;MRPL24;MRPS24;MRPS12;MRPL13;EEF1D;MRPL9;MRPS14;MRPS23;GADD45GIP1;MRPL23;MRPL28;MRPL52;MRPL12;MRPL15;MRPS28;RACK1;MRPL36;MRPL41;AURKAIP1;MRPL27;MRPL21;MRPS34;TUFM;MRPL17;MRPS15;MRPL51;MRPL22;MRPL4;MRPL33;OXA1L;CHCHD1;MRPL1;MRPS5;MRPL43;PTCD3;MRPS27;EEF2K;EEF1B2;MRPS18C;MRPL58;MRPL50;MRPL2;MRPS11;MRPS26;MRPL49;EEF2;ZNF598;EEF1A1;MRPL20;MRPL47;MRPS16
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.4689591334787451,1.2821469761920226,0.1286549707602339,0.7337868804928352,1.0,11/39,16.04%,S100P;SCG2;PTP4A3;CDH13;S100A2;FAP;LOXL2;LGALS8;SOX18;DPP4;PLXND1
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,0.36715115473266047,1.2817752298324039,0.044642857142857144,0.7341900150436903,1.0,100/220,39.59%,H3C13;H2AC19;H2BC13;H2BC18;H2AC11;H2AC20;H2BC17;ACTL6B;H2BC21;PRDM16;H2BC9;H2BC15;EZH2;SMYD3;H2BC11;DNMT3A;H2BC12;H2BC4;H4C15;H2AC6;NFKB2;SMYD2;KAT2A;H2BC5;USP22;H2AX;VPS72;ING5;DOT1L;SUV39H1;HDAC10;JADE2;EHMT2;KDM5B;SMARCA4;NSD1;SETDB1;HDAC1;H2AJ;KMT2D;KMT2B;BRD8;SAP30L;GATAD2B;KMT5C;PRMT7;TAF10;JADE3;SMARCD3;HCFC1;NCOR2;NSD2;MRGBP;WDR5;ASH1L;YEATS2;EP400;JMJD6;SAP130;PHF21A;CHD3;SMARCC1;CHD4;KDM3A;KDM3B;RPS2;SUV39H2;BRPF3;GDNF;RBBP7;H2AZ1;CDK4;PRMT3;HDAC8;KDM1B;ATXN7L3;OGT;RUVBL2;TBL1X;NCOA2;MTA3;RUVBL1;KDM5C;SETD1B;HAT1;SGF29;ARID4B;PADI2;SETD1A;DMAP1;TAF9;EED;TAF5L;SAP30;KDM5D;ENY2;RIOX2;RBBP5;ARID2;KDM2B
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.42364058121296366,1.281700886631286,0.12154696132596685,0.7334704075317672,1.0,18/50,29.34%,OPN1SW;RHO;DTL;CPT1B;POLD1;RRH;USF1;PCLAF;UVSSA;UBE2A;ELANE;CDKN2D;TP53I13;BRSK1;MSH6;UBE4B;SPRTN;TRPM1
prerank,Elsevier_Pathway_Collection__Diffuse Large-B-Cell Lymphoma ABC Subtype,-0.3576529270751469,-1.2816369386245166,0.06349206349206349,0.342415883284672,1.0,16/48,17.08%,IRF4;IL10;CD79A;SPIB;NFKBIZ;IL6;BTK;CARD11;TLR2;AKT1;SYK;PLCG2;MYD88;PRDM1;IL10RA;BCL2
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.4560493254600455,-1.2815336711222465,0.10869565217391304,0.34219550644729974,1.0,10/19,26.11%,FOXP3;XCL1;CCR2;TNFRSF1B;LILRB4;CLC;SMAD7;CD55;HFE;FZD5
prerank,WikiPathway_2021_Human__Ovarian infertility WP34,0.4833268880470551,1.2811421979442543,0.15568862275449102,0.7345908272964324,1.0,5/27,9.48%,INHA;DMC1;MSH5;NR5A1;ZP3
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.3477759050482313,-1.280923940570828,0.12244897959183673,0.34293639055683245,1.0,15/68,14.58%,GCK;RET;GLS2;NTRK3;HK3;PDGFRA;MAP2K1;PIK3CD;FGFR2;NTRK1;SLC7A5;FLT3;PIK3R1;AKT1;SLC2A2
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.46303489747445287,-1.2807627657320007,0.14814814814814814,0.34276389357080483,1.0,11/19,25.15%,LILRA2;SCIMP;CD180;TRIB1;CARD16;TRIM5;LY86;SIGIRR;CD55;LY96;SASH1
prerank,MSigDB_Hallmark_2020__Apical Junction,0.3645493418696077,1.2804960279473463,0.039647577092511016,0.736080931263249,1.0,51/194,23.94%,ALOX15B;CDH8;PPP2R2C;WNK4;ACTN2;LAMA3;KCNH2;COL9A1;CLDN19;THY1;ICAM5;VWF;ITGA2;MDK;MAPK11;SLC30A3;CD34;CLDN15;SRC;AMH;NECTIN1;CNTN1;CLDN6;IKBKG;ADAM15;MVD;CLDN7;SHC1;MADCAM1;HRAS;VCAN;PKD1;ADAM9;CLDN5;NLGN2;NRXN2;CERCAM;MMP9;TSC1;THBS3;PECAM1;CDH11;PLCG1;MAP4K2;TAOK2;CDH15;INPPL1;TSPAN4;NF2;STX4;FBN1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5717243987995055,1.2804738224537064,0.1794871794871795,0.7351373631054409,1.0,7/15,16.56%,UST;BCAN;NCAN;CSPG5;CSPG4;VCAN;B3GAT3
prerank,WikiPathway_2021_Human__Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,-0.4353799905480592,-1.2802684717293151,0.1111111111111111,0.3431736885920295,1.0,8/17,19.77%,ACSL1;SCP2;ACADL;ACADS;EHHADH;ACADM;SLC25A20;PECR
prerank,Elsevier_Pathway_Collection__TNFRSF1A -> AP-1/ATF/TP53 Signaling,-0.41802900615278255,-1.28020708388268,0.14285714285714285,0.34286457913764157,1.0,10/28,23.65%,TNF;FOS;MAP2K1;LTA;MAPK10;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,WikiPathway_2021_Human__mBDNF and proBDNF regulation of GABA neurotransmission WP4829,-0.3883455556180959,-1.2801224123148036,0.08620689655172414,0.34257670927753814,1.0,8/34,8.02%,GABRA5;GABRA3;GABRB1;GABRA4;GABRG1;NTRK2;NGFR;GABRG3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4676114522169964,1.2800849682379163,0.15263157894736842,0.73565019054625,1.0,11/29,35.45%,HMGA2;USP51;PRKDC;KMT5C;HSF1;MAD2L2;MRNIP;SHLD3;PNKP;SHLD1;SIRT7
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.48068891303094197,-1.2799835362941876,0.15,0.34239866870662466,1.0,11/17,24.18%,HPGD;GSTA1;AKR1C4;PTGES;PTGR1;ACOX1;HPGDS;GSTP1;GSTM1;CYP2S1;PTGS1
prerank,MSigDB_Oncogenic_Signatures__STK33 DN,-0.2965127133111097,-1.279717875705069,0.045454545454545456,0.34241861655020783,1.0,63/236,17.44%,CEACAM6;HHLA2;SLCO4C1;BSPRY;TEX15;CR2;KCNN2;PROK2;RET;PCYT1B;ART3;KLF5;PRKAR2B;BPI;CCL5;HK3;GPM6B;LRRK2;CYP4F2;BTLA;BDH2;TNFSF10;PRAM1;FBN2;SYDE2;STX11;GPM6A;PNMA2;DSG2;ANXA3;LAMP3;CDA;KAZN;RXFP1;ALOX5;CCDC26;GJB2;DDAH1;LCK;RORB;FLT3;CYP4F3;SLC8A1;SLC38A5;GALNT12;RASGRP1;OGDHL;SERPINB2;ARHGEF26;BTN3A3;GZMA;TSPAN2;SLC26A8;FAHD2A;SLC9B2;MAP3K15;BMX;NLRC3;BCL2;MATN2;TPD52L1;ACAP1;UCA1
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.4324970778721541,-1.2796809632234054,0.16,0.3421051199767176,1.0,9/25,19.02%,JCHAIN;ZG16B;TF;SLC28A2;ALB;AZGP1;PIGR;PRR4;CDH3
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.42116965339938395,1.2794505755118697,0.11052631578947368,0.7371183029395351,1.0,51/77,47.30%,PLK1;BUB1B;CDC20;UBE2C;PSMD4;CCNA2;UBE2S;CDK1;CCNB1;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;MAD2L1;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;CDK2;ANAPC2;PSMB2;PSMA6;ANAPC4;UBC;PSMD9;BTRC;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;BUB3;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.4509968805435901,-1.2790014677241288,0.1643835616438356,0.3429544571112053,1.0,11/24,23.80%,IL10;TLR3;TLR8;TLR4;HAVCR2;LILRA4;NLRC3;PTPRS;STAT1;IFIH1;DDX58
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.48646784609501925,1.2789503645484899,0.1534090909090909,0.7379263913132006,1.0,16/26,37.65%,BOP1;NHP2;RRP15;LAS1L;NOP2;PES1;RPL7;RPL35;SNU13;URB1;RPL10A;MRPL1;NIFK;WDR12;RPL7A;FTSJ3
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,-0.432559778662522,-1.278857024469542,0.15555555555555556,0.34279039645124726,1.0,4/22,11.62%,AMPD1;UPP2;CDA;ADK
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.30383900315974044,-1.2785748014113556,0.02857142857142857,0.3429928157251458,1.0,38/139,16.53%,CYP26A1;UGT2A1;FA2H;ACOT11;BCO2;CYP2C8;GLYAT;CYP4A11;ADH1A;HOGA1;UGT1A9;CYP3A7;CYP1A2;CYP2C18;ALDH8A1;SCP2;CYP2C9;VNN1;ADH1C;CYP4F12;ACAA1;CYP26B1;MTHFS;GATM;ADH7;PTGR1;CYP3A4;ANGPTL3;KYNU;IGF1;ACADSB;CROT;ABAT;AOAH;CYP2J2;AGXT2;ALDH1A2;MCCC1
prerank,MSigDB_Oncogenic_Signatures__RAF UP.V1 DN,-0.29915937239115414,-1.278418101817333,0.0,0.34284264728101527,1.0,58/176,22.23%,ASCL1;TCN1;TFF1;TMPRSS3;EGR3;GHR;AGR2;FOS;S100A14;CA12;ID2;TBC1D30;ELOVL2;CBFA2T3;NPY1R;MSMB;AK4P3;RND3;CALCR;GALC;SIDT1;IGFBP5;GPC4;MYO10;RASGRP1;KYNU;SOX9;WASF3;PGR;AK4;PPM1E;ABAT;PPP1R3C;MAFB;SH3BGRL;PDK3;IGFBP4;VAV3;MEGF9;EPB41L2;BCL2;SLC39A8;PMAIP1;AUTS2;DLC1;MPDZ;LIN7C;SPIN1;IL24;MYB;SLC19A2;SMAD7;JAK2;GDAP1;SLC24A3;TSPAN3;SYTL2;INPP4B
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3999762282558965,1.2783661661925083,0.10101010101010101,0.739183153011657,1.0,27/95,16.95%,GLP1R;GHRHR;GPR119;ADRA2C;CALCA;UCN2;LGR5;RAMP1;GPHA2;ADGRB2;ADGRG3;ADGRB1;ADRA1D;PTGER1;ADGRL1;PTGER3;GNAL;PTHLH;GPR3;RAMP2;PTGFR;MC1R;ADCY6;IAPP;ADORA2A;ADGRG2;GPR4
prerank,KEGG_2021_Human__Pertussis,-0.3439270114794881,-1.2783173115140798,0.046875,0.3426590263120237,1.0,35/72,25.98%,IL10;TNF;IL1B;FOS;SFTPA1;CASP1;NLRP3;IL6;IL12B;C4A;CXCL8;TICAM2;TLR4;C1QC;IRF8;C1R;MYD88;C1QB;SERPING1;ITGB2;CASP7;MAPK10;C1S;MAPK13;C1QA;C5;JUN;ITGAM;C3;C4B;CD14;LY96;GNAI2;CFL2;CALM1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),0.4438905190372261,1.2782295058240312,0.1736842105263158,0.7386447241678399,1.0,31/52,40.02%,H1-5;H1-2;PARPBP;H1-4;POLQ;RTEL1;H4-16;POLR2L;MSH2;UBQLN4;RADX;H1-0;POLR2K;BLM;POLR2G;FANCB;MSH6;MAD2L2;POLR2H;SHLD3;TP53BP1;RMI2;POLR2I;POLR2J;SHLD1;TERF1;POLR2A;DAXX;ACD;POLR2B;SHLD2
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,0.4321530781003547,1.2781105711337697,0.14213197969543148,0.738169322717918,1.0,46/66,48.60%,EME1;EXO1;SERPINA2;XRCC2;RFC4;RTEL1;POLD1;CHEK1;BARD1;DNA2;RMI1;POLR1A;ATRIP;RAD9B;RAD51AP1;RAD51;BLM;RHNO1;UBA52;PCNA;BRIP1;RMI2;TOPBP1;MUS81;BRCA2;SEM1;EME2;POLH;XRCC3;SPIDR;SLC19A1;POLK;RFC3;POLD3;SLX4;UBC;POLD4;WRN;RPS27A;TOP3A;RAD51C;RAD9A;POLE2;MRE11;RAD50;PALB2
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.40055788755690197,1.2779392592699546,0.11940298507462686,0.7378323158283748,1.0,31/76,32.95%,CERS1;OPN1SW;H2AW;TIMP1;AURKB;MC1R;POLD1;CHEK1;ACTR5;BMF;MME;NEDD4;CDC25A;MMP9;MMP3;PARP1;TMEM161A;NPM1;METTL3;COPS9;RHNO1;MYC;HYAL2;HYAL3;CUL4B;CDKN1A;SDE2;PCNA;FMR1;CASP9;DDB2
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.5046953449540604,1.2771507907059596,0.17647058823529413,0.7400546318831488,1.0,15/18,44.26%,H2AW;HMGA1;SMARCA4;SMARCD3;MYC;SMARCC1;NFE2;RPL23;ARID2;ARID1A;GRWD1;SMARCB1;SMARCC2;SMARCE1;SUPT16H
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.45047805229676324,1.2768264505073463,0.12299465240641712,0.7402533203821972,1.0,11/45,17.63%,IGF2;FGF20;PIK3R2;FGF13;FGF17;FGF23;FLT3LG;SHC1;PDPK1;HRAS;THEM4
prerank,Elsevier_Pathway_Collection__Circadian Clock Genes in Suprachiasmatic Nuclei Neurons,-0.37119733267394384,-1.2767227954225,0.14285714285714285,0.3451507543283176,1.0,13/39,23.65%,KCNJ3;VIPR1;NGFR;MAP2K1;NGF;RORB;PER1;PER3;MAP2K3;MAP2K6;MAP3K5;CRY1;MAP2K4
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.42508087286345503,1.2766747773627811,0.12222222222222222,0.7398818827282911,1.0,29/48,46.22%,HMGA2;NEIL3;POLQ;RFC4;POLD1;DNA2;MUTYH;FEN1;PARP1;APEX2;LIG3;POLB;PCNA;XRCC1;OGG1;LIG1;PNKP;POLL;POLG;HUWE1;RPA2;RFC3;POLD3;APEX1;POLD4;WRN;XPA;RPA1;NEIL1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.3083127180538502,-1.276529945402332,0.05714285714285714,0.3450794914422192,1.0,32/102,19.51%,CPNE6;CASR;SYT9;TRPV6;CRHBP;CPNE4;SYT10;KCNMB2;SYT8;SYT1;SYT7;KCNMA1;TRPC3;SYT4;PPIF;ALOX5AP;GPLD1;TTN;SLC25A24;ADGRV1;PLCG2;THBS1;KCNMB4;LGMN;SYT13;AQP3;CLIC4;ADCY1;WNT5A;PPP3CA;IQGAP1;RYR1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.4145798817905541,-1.276263342183999,0.15942028985507245,0.3450892627842069,1.0,6/23,13.84%,BMP10;MLIP;NR4A3;HAND2;RGS2;IGF1
prerank,TRRUST_Transcription_Factors_2019__PTTG1 human,0.5598397386015,1.2758922819056917,0.15976331360946747,0.7420733894729274,1.0,5/15,26.07%,FGF2;CDK1;CCNB1;LGALS1;MYC
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,0.49378125790959304,1.2757954793385078,0.18125,0.7414375889426498,1.0,2/21,0.41%,B4GALNT2;B3GALT1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.46060205776145413,1.2751099333481255,0.15,0.7430537072208061,1.0,7/34,9.24%,E2F1;TM4SF5;PLK5;KIF14;FAM83D;ATP2B4;EZH2
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.5131293331495795,1.2750385964004203,0.14689265536723164,0.7423106334117391,1.0,9/21,33.08%,MAPT;BUB1;CDT1;PIF1;SMG5;CENPV;MYC;RMI2;HDAC8
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.2781486403182518,-1.2748014726592396,0.0,0.347501794665426,1.0,135/472,22.38%,TCN1;CEACAM6;CRISP3;SLCO4C1;ACP3;CLEC12A;PLAC8;FCAR;AOC1;ADGRE3;FOLR3;CFP;PNP;BPI;GPR84;CEACAM3;CXCR1;HK3;FPR1;CXCR2;AGL;PLD1;TNFAIP6;FPR2;FRMPD3;S100A8;FCGR3B;BST1;SIGLEC14;LGALS3;CMTM6;CAT;NFAM1;SIRPB1;ANXA3;HBB;CLEC4D;SIGLEC9;PRSS3;PTPRC;A1BG;VNN1;AGPAT2;IL6;CDA;CR1;CD300A;ACAA1;CLEC5A;CD53;CYBB;ALOX5;BIN2;HSPA1B;MNDA;PGLYRP1;ALDOC;ARHGAP9;TICAM2;CLEC4C;NHLRC3;NCKAP1L;FGL2;TLR2;CAMP;ENPP4;TTR;ATP8B4;FGR;COTL1;ORM2;S100A12;DOCK2;OSCAR;OSTF1;FCER1G;ADGRE5;QSOX1;PIGR;UNC13D;TNFRSF1B;CD177;ITGB2;CXCL1;P2RX1;PLAUR;LILRB2;HP;TMC6;CTSB;HSPA1A;SLC15A4;DSC1;METTL7A;CD33;PTAFR;LILRB3;PYGL;CTSZ;PGM2;DERA;CTSC;C3AR1;AMPD3;FCN1;FRK;ATP11B;ADAM8;PGM1;ADA2;SELL;IQGAP1;MCEMP1;AHSG;RAB27A;TMEM30A;IRAG2;RAB14;GSTP1;PPBP;RAB44;HVCN1;STOM;CD55;CYBA;IDH1;NIT2;HPSE;RAP1A;ITGAM;SLC27A2;TYROBP;DOK3;PGAM1;MGAM
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.45872606977672753,-1.2747235027621089,0.1797752808988764,0.34728007594758853,1.0,10/21,23.77%,IL1B;IL18;CASP1;NLRP3;MEFV;ENTPD5;PSTPIP1;C3AR1;APP;C3
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.4095665980166079,1.2746403819268177,0.14594594594594595,0.7426541989248181,1.0,34/62,41.63%,TIMM17B;COA6;SLC25A12;SAMM50;IDH3G;TIMM17A;TOMM20;CS;TIMM10;TOMM5;CHCHD5;SLC25A6;CHCHD7;MTX1;GFER;ATP5MC1;TOMM40;TIMM13;TIMM9;PAM16;BCS1L;COX19;COA4;HSPD1;GRPEL2;CHCHD4;TIMM10B;CHCHD2;TOMM7;NDUFB8;COX17;TIMM50;MTX2;TIMM8B
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.3600981192365473,1.2745265816054574,0.037815126050420166,0.7420677691235532,1.0,166/271,47.38%,AXIN2;TERT;DMC1;DNASE1L2;TOP2A;TICRR;UBE2T;EXO1;RECQL4;UHRF1;CDC6;CDC7;CDC45;HELLS;CDK1;MCM2;RAG1;TREX2;CDT1;MCM6;TYMS;NEIL3;CHRNA4;HMGB3;PRIM1;POLQ;XRCC2;RFC4;ORC1;RTEL1;MCM10;POLD1;CHEK1;MCM3;MCM5;MSH2;BARD1;MCM4;GLRX2;DNA2;DOT1L;ZNF445;RAD54L;MUTYH;FEN1;TOP1MT;ATRIP;PARP1;RAD9B;UBE2A;NUDT1;RAD51AP1;GMNN;RAD51;TRIM28;MCM7;WDHD1;PRKDC;POLA1;POLA2;DNMT1;KPNA2;BLM;KMT5C;NPM1;HMGB2;LIG3;INTS3;RAD18;FANCG;CHD1L;NABP2;UBA52;MSH6;CENPS;TIMELESS;DNASE1;RECQL5;POLB;PCNA;PARK7;XRCC1;OGG1;LONP1;RAD1;RMI2;MCM8;SMARCAL1;DDB2;TOPBP1;LIG1;MUS81;MMS19;PNKP;DCTPP1;SMC1A;FAN1;DCLRE1B;DNASE1L1;SIRT7;POLL;IGHMBP2;TERF1;POLH;VCP;DBF4;DDB1;XRCC3;POLG;ACD;RAN;CSNK1E;XRCC6;ATR;CDK2;USP7;RPA2;RAD52;RECQL;POLK;XPC;TERF2;LRWD1;RAD21;RFC3;POLD3;SMARCB1;FBXO6;SLX4;TSN;APEX1;UBE2V2;UBC;ERCC3;SUPV3L1;SETMAR;POLD4;UPF1;TRRAP;ORC6;LTO1;WRN;INO80;PRIMPOL;CDC34;NBN;FANCA;PWWP3A;XPA;RIF1;CTC1;RNASEH1;ERCC1;RPS27A;RPA1;NEIL1;DNASE2;TOP3A;NOP53;STN1;RAD51C;RFC1;MEN1;HINFP;PRIM2;REXO4
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.48463449812037834,1.274216412280845,0.15789473684210525,0.7423920787475153,1.0,5/22,18.45%,GNG4;GNG3;GNB5;GNG8;GNG10
prerank,WikiPathway_2021_Human__ID signaling pathway WP53,0.5375882889317662,1.2737502563531344,0.16666666666666666,0.7432229945547772,1.0,4/15,16.31%,PAX2;CCNE1;PAX5;ELK4
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.2912547908469557,-1.2737233939600827,0.0,0.34870390807686735,1.0,54/203,17.38%,GSTA2;CYP2C19;UGT2A1;UGT1A5;CYP2A7;NAT2;CYP2A13;PTGS2;CYP2B6;TNFSF11;KLF5;FGF10;CYP2C8;GSTA1;FOS;SULT1A2;CACNA1F;UGT1A9;UGT2B7;CYP3A7;CYP1A2;CYP3A43;ESR1;GSTT2B;CYP3A7-CYP3A51P;CYP2C18;MAP2K1;PIK3CD;PRKCB;NAT1;CYP2C9;GSTM5;WNT1;KLF4;UGT2B28;UGT2B10;RPS6KA1;ADCY5;CHRNA7;CYP3A4;PIK3R1;AKT1;PGR;UGT2A3;EPHX2;SULT2A1;RPS6KA6;CREB5;UGT2B15;NOTCH2;NR1I3;BCL2;HPGDS;UGT1A7
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.3807469036144419,-1.2736590741170277,0.1375,0.3484276311724596,1.0,11/38,15.18%,GRIN2B;TRPV6;HTR2A;TRPV4;XCL1;CCR7;PTPRC;LCK;SLC8A1;PLCG2;TRPV3
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.3920842721545756,1.2733787756146169,0.08080808080808081,0.74372152907551,1.0,17/105,11.41%,HMGA2;CCNO;THY1;CDC25C;TRIB2;SRC;CCNB2;CDKN3;CCNE1;CDKN2C;CDC6;EZH2;CCNA2;CCNE2;CCNF;CCNB1;CDKN2B
prerank,Elsevier_Pathway_Collection__Adipokines Production by Adipocyte,-0.34613881410488895,-1.2733229892627296,0.06451612903225806,0.3485874053956313,1.0,12/44,14.75%,ITLN1;SERPINA12;TNF;IL1B;FOS;FOXO1;CCL2;IL6;TLR4;PIK3R1;AKT1;MYD88
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.4875573734081723,1.2733079601641857,0.16363636363636364,0.7430114718475902,1.0,10/29,18.32%,CPLX2;SEPTIN5;CHRNA3;CAMK2A;CHRNB4;MCTP1;SYN1;CPLX1;SNCAIP;SNAPIN
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.37336654571989714,1.2732505787094182,0.09090909090909091,0.7422059691481401,1.0,33/159,15.88%,TRIM71;IGF2BP1;HMGA2;HOXD10;MIR483;E2F1;PIK3R2;CDKN2A;CDC25C;EFNA3;HDAC4;EFNA4;E2F2;EFNA1;CCNE1;PDGFRB;EZH2;CCNE2;KIF23;CDCA5;NOTCH3;DNMT3A;PDGFB;SLC7A1;APC2;PDGFA;PLAU;SHC1;PIM1;PRKCA;HRAS;STMN1;HDAC5
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3384661982688379,-1.272604793062632,0.037037037037037035,0.34957639913611366,1.0,21/73,17.81%,NR4A3;PLPP4;FCGR3A;CD3G;FYN;BLK;FCGR2B;CD247;NCKAP1L;HCK;PIK3R1;MYO10;SYK;FGR;PLCG2;WIPF1;FCER1G;VAV1;PRKCE;VAV3;MYO1G
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.3780869341789514,-1.272557269417826,0.06666666666666667,0.34921319957575714,1.0,17/39,21.48%,PTGS2;IFNG;TNF;IL1B;HBB;KLF4;DDAH1;TLR4;CLEC7A;AKT1;KLF2;CLU;AGXT2;PTGIS;ASS1;CX3CR1;JAK2
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.5007589323133687,1.2724715469238874,0.14457831325301204,0.744190280752348,1.0,8/25,15.58%,ACTN2;SIX4;MYH3;CASQ1;TNNT1;TNNT3;OBSCN;ANKRD1
prerank,Elsevier_Pathway_Collection__TP53 Signaling in Hepatocellular Carcinoma,0.5455766591016125,1.272358964652802,0.18072289156626506,0.7436304535688351,1.0,3/18,8.28%,E2F1;CDKN2A;CCNE1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.3707592930639456,1.2722999403457982,0.0871559633027523,0.7428550917252992,1.0,107/157,47.15%,EEF1A2;AGO2;MRPL55;MRPS21;PCSK1;MRPL24;CARNS1;RPL8;MRPS12;MRPL13;MRPL9;MRPS14;RPL30;RPLP1;RHD;HARS2;RPS27;RPS21;RPLP2;EIF4EBP2;MRPL23;RPS5;MRPL28;IGF2BP3;MRPL52;RPL28;FARSB;RPS14;RPL10;COPS5;RPSA;RPL39;RPLP0;RPS15;RPS2;RPL31;HARS1;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;MRPL36;RPL13;RPL27;MRPL41;RPL38;RPL35;MRPL27;RPL10A;MRPS15;RPS8;RPS12;RPL35A;MRPL51;RPS3A;RHCE;IGHMBP2;RPS7;RPS11;RPL36A;GSPT2;RPL7A;MRRF;RPS3;RPL18A;RPL32;RPS24;RPL3L;RPL29;RPL23;RPL5;RPS18;RPL14;RPS16;MRPS5;MRPL43;RPL13A;RPL41;RPL9;RPS6KB2;MRPS18C;RPS28;PABPC4;RPS23;RPL27A;RPL23A;RPL18;RPL12;MRPS11;RPS9;RPL6;RPS15A;RPL4;RPS26;RPL19;EEF1A1;RPS6;RPL26;RPS27A;RPS4Y1;MRPS16;RPL34;RPS13;TNIP1
prerank,Elsevier_Pathway_Collection__Single-Strand Base Excision,0.5276205938719869,1.2722684802420399,0.20666666666666667,0.7409329858075933,1.0,9/15,34.02%,MUTYH;FEN1;LIG3;POLB;PCNA;XRCC1;OGG1;LIG1;PNKP
prerank,Elsevier_Pathway_Collection__Single Strand Base Excision DNA Repair Impairment in Cancer,0.5276205938719869,1.2722684802420399,0.20666666666666667,0.7409329858075933,1.0,9/15,34.02%,MUTYH;FEN1;LIG3;POLB;PCNA;XRCC1;OGG1;LIG1;PNKP
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.45380124335646393,-1.2722474445927383,0.18518518518518517,0.34937814237622267,1.0,5/18,11.90%,RIPK3;SAMSN1;SASH3;FCGR2B;SKAP1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.362190395993822,-1.2720846299747335,0.08928571428571429,0.3492627014459095,1.0,7/51,6.88%,GCK;NR4A3;PCK1;HK3;ENO3;HOGA1;ALDOB
prerank,Reactome_2022__G-protein Activation R-HSA-202040,0.4961918994178947,1.2719142769881828,0.21686746987951808,0.7412590534478629,1.0,5/20,18.45%,GNG4;GNG3;GNB5;GNG8;GNG10
prerank,WikiPathway_2021_Human__Synaptic Vesicle Pathway WP2267,0.43717670540888964,1.271680582326168,0.11801242236024845,0.7411708537564596,1.0,15/45,18.77%,CPLX2;SLC6A4;UNC13A;SYN3;ATP1A2;CLTCL1;DNM3;SYN1;SNAP25;CPLX1;SYP;UNC13B;SLC1A3;SYN2;STXBP1
prerank,KEGG_2021_Human__Wnt signaling pathway,0.3685983761576964,1.271562810497763,0.06451612903225806,0.740569142189659,1.0,23/154,10.48%,NKD1;DKK1;DKK4;LGR6;RSPO2;LEF1;LGR5;NOTUM;AXIN2;SFRP4;WNT4;WNT9B;WNT8B;ZNRF3;ROR1;NKD2;TCF7;RSPO4;CAMK2A;TLE6;PORCN;DAAM2;RNF43
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer Metastases,0.3824774134595394,1.2714175349354147,0.1111111111111111,0.7401660241089816,1.0,34/101,26.20%,HMGA2;SIX1;HOXD10;LEF1;SPP1;SOX2;MMP11;SNAI2;HMMR;SRC;FGF2;PDGFRB;NOTCH3;PKP1;CLDN7;POU5F1;PLAU;PDPK1;VCAN;RHOC;DLL4;MMP9;SPARC;MMP3;TGFB2;FOXQ1;GLI1;DNMT1;SNAI1;ROR2;PTK2;MYC;CTNNB1;BSG
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.44240331732309585,-1.2711823269269222,0.10112359550561797,0.3504259756151062,1.0,6/20,11.92%,LGI1;TNF;SYT1;CD80;ANK3;GATA3
prerank,Elsevier_Pathway_Collection__Toll-like Receptors (TLR) in Periodontitis,-0.4295464228531991,-1.2709321901860333,0.1527777777777778,0.35051573566297795,1.0,9/26,14.75%,TNF;IL1B;IL6;CXCL8;TICAM2;TLR4;TLR2;AKT1;MYD88
prerank,WikiPathway_2021_Human__Calcium Regulation in the Cardiac Cell WP536,0.3854461811631562,1.2704764532128878,0.09090909090909091,0.7429434357170209,1.0,30/139,15.93%,GNG4;CACNA1E;GJB6;SFN;GNAZ;CACNA1S;RGS20;CASQ1;CHRM4;KCNJ5;KCNB1;ADRA1D;ATP1A4;CAMK2A;GJC1;ATP1B3;GNG3;PRKD1;CHRM5;CACNA1C;GJA5;RGS16;RGS5;GNB5;ADCY6;FXYD2;GNG8;RGS14;PRKCA;GJB3
prerank,Elsevier_Pathway_Collection__Oxytocin Signaling in Brain Nerve Cell (Hypothesis),-0.4679530556753164,-1.2703456462557563,0.19148936170212766,0.3509639924690057,1.0,5/17,9.64%,FOSB;TNF;FOS;OXT;IL6
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.4391212695968214,1.270292020198988,0.14136125654450263,0.7427118261524652,1.0,12/51,15.74%,THBS4;PIK3R2;COL9A1;SRC;COL4A1;COL4A5;PDGFRB;COL4A2;PDGFB;PDGFA;THBS2;HRAS
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.41266495229645017,1.2700261698219606,0.15625,0.7426131487922177,1.0,38/54,46.21%,UBE2T;EME1;NEIL3;RAD51AP2;FANCI;POLN;FANCE;ATRIP;FAAP20;RAD51AP1;RAD51;FANCD2;FANCB;FANCG;UBA52;MSH6;CENPS;HROB;RFWD3;MCM8;MUS81;FAN1;CENPX;DCLRE1B;FAAP24;VCP;XRCC3;ATR;FANCM;RPA2;USP1;SLX4;UBC;FANCA;XPA;ERCC1;RPS27A;RPA1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.4705456087928693,1.2699268097383054,0.18235294117647058,0.742036310480314,1.0,8/28,11.68%,HCN2;KCNH2;SCN1A;CACNA1G;SLC4A3;ATP1A2;SCN4B;CACNA1C
prerank,Elsevier_Pathway_Collection__Plasmacytoid Dendritic Cell in Diabetes Mellitus Type 1,-0.40662605246789385,-1.2698428555138244,0.08955223880597014,0.3514642675642464,1.0,12/34,17.02%,TNF;IL1B;TLR3;IL18;CASP1;NLRP3;IL33;CD274;TLR4;TLR2;MYD88;CTSB
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,0.42185401239644643,1.2697766404837714,0.14285714285714285,0.7416748767614074,1.0,46/70,47.30%,NEK2;BUB1B;CDC20;UBE2C;PSMD4;CCNA2;UBE2S;CDK1;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;MAD2L1;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;ANAPC2;PSMB2;PSMA6;ANAPC4;UBC;PSMD9;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;BUB3;PSMB1;PSMD3
prerank,MSigDB_Oncogenic_Signatures__IL2 UP.V1 UP,-0.304231132574867,-1.2696640693607308,0.0,0.35140668661438246,1.0,54/160,19.29%,FOXP3;EVPL;EGR3;IL10;TNFSF11;EGR2;AIM2;KCNA3;PAK6;SOCS2;FOS;PTH1R;CD69;TLR3;CXCL3;IL18RAP;CDCP1;STX11;AK4P3;DUSP2;CXCL12;SIGLEC9;TPBG;USH2A;EGR1;OSM;LRRC6;AMIGO2;F2RL2;BTC;SLC7A5;TRIB1;TNFRSF9;CCR4;CISH;KLRK1;RGS3;SPRY2;KLF6;TNFRSF1B;LILRB4;PTPN7;KCNK5;ITGA9;TMEM158;RAB11FIP1;DUSP6;SLAMF1;ESRP2;TNFRSF21;KCTD12;LIF;CDH3;PPP4R4
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.4702237391721435,1.2696404553115765,0.1797752808988764,0.7412326083807262,1.0,5/29,11.46%,ALOX15B;PLA2G2A;CRP;LPL;CD36
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4880259711934676,1.2695399151574185,0.1728395061728395,0.7406962130788471,1.0,3/23,4.17%,C1QTNF3;TRIM40;ADGRG3
prerank,WikiPathway_2021_Human__Zinc homeostasis WP3529,-0.39571845679347145,-1.2693388107534416,0.12857142857142856,0.3516802036124297,1.0,13/34,12.30%,MT1G;MT1F;MT1H;SLC39A2;MT1M;MT1E;SLC39A5;MT1X;SLC30A4;SLC39A12;MT1A;SLC39A14;MT1B
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.3235977342461204,-1.2692144643700773,0.05357142857142857,0.3514241608062721,1.0,16/82,12.55%,CASR;ATP2C2;TRPV6;HTR2A;TRPV4;ATP13A4;CCL5;S100A14;PTH1R;CCL3;CCL23;CXCL12;CCR1;CCR2;CHRNA7;SLC8A1
prerank,Elsevier_Pathway_Collection__WNT Signaling Activation by Blocking of Tumor Suppressors,0.4678491610597605,1.2690967716048103,0.13372093023255813,0.7415027793356438,1.0,6/35,6.38%,CTNNA2;DKK1;LEF1;AXIN2;SFRP4;GPC3
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.39264357996181276,1.268704722138728,0.12903225806451613,0.7420582647053992,1.0,48/95,44.08%,MRPL55;MRPS21;DAP3;MRPL24;MRPS24;MRPS12;MRPL13;MRPL9;MRPS14;MRPS23;GADD45GIP1;MRPL23;MRPL28;MRPL52;MRPL12;TRMT112;MRPL15;MRPS28;MRPL36;MRPL41;AURKAIP1;MRPL27;MRPL21;MRPS34;MRPL17;MRPS15;MRPL51;MRPL22;MRPL4;MRPL33;OXA1L;CHCHD1;MRPL1;N6AMT1;GSPT2;MRRF;APEH;MRPS5;MRPL43;PTCD3;MRPS27;MRPS18C;MRPL58;MRPL50;MRPL2;MRPS11;MRPS26;MRPL49
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.551981838274872,1.2681338628732401,0.16666666666666666,0.7432496286627474,1.0,4/15,8.72%,KCNE5;KCNH2;ATP1A2;ATP1B3
prerank,Elsevier_Pathway_Collection__SIRT6 Signaling in Aging,0.5134794107888576,1.267964440536274,0.15428571428571428,0.7429662005278852,1.0,10/20,32.13%,CDKN2A;CDK1;NFKB2;LMNA;SHC1;RELB;PARP1;SIRT6;POLB;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.44680246957750774,-1.2678235436473033,0.18292682926829268,0.35378376523387334,1.0,6/18,17.64%,BMP10;NR4A3;TRPC3;HAND2;IGF1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.46350304795649994,1.26737440601748,0.14285714285714285,0.7443200235263797,1.0,5/25,5.11%,CALCA;F2RL3;GPR35;LPAR4;OPRL1
prerank,Elsevier_Pathway_Collection__Toll-like Receptors in Sterile Inflammation,-0.35202383760933803,-1.2670236776538084,0.13559322033898305,0.35478566273350176,1.0,23/56,24.83%,TNF;IL1B;CCL5;TLR3;TNFSF10;SIGLEC10;IL6;IL12B;CXCL8;TICAM2;TLR4;TLR2;AKT1;MYD88;BGN;HSPA1A;TAB2;MAP2K3;IFIH1;MAP2K4;DDX58;CD24;CD14
prerank,KEGG_2021_Human__Bile secretion,-0.33875201322990206,-1.2667585982455245,0.07407407407407407,0.35492216097232016,1.0,29/83,19.10%,UGT2A1;SLC5A1;KCNN2;UGT1A5;SLC22A7;ATP1A3;SLC10A1;UGT1A9;SLC22A1;UGT2B7;SLCO1B3;UGT2B28;UGT2B10;ABCB1;CA2;ADCY5;ABCG8;CYP3A4;ABCG5;UGT2A3;SULT2A1;SLCO1B1;UGT2B15;CFTR;UGT1A7;NCEH1;SLC27A5;NR1H4;ADCY1
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.28136454809399986,-1.2666619716010992,0.0,0.3546832563138898,1.0,99/421,17.80%,GSTA2;IRF4;MUC1;IFNL2;IL20RA;IL13RA2;CSF3;IL20RB;IFNL1;IL10;CXCL10;PTPN20;PTGS2;IL5RA;IFNG;CD4;TNF;IL1B;MMP1;IL2RB;CCL5;SOCS2;FOS;FPR1;IL7R;IL18R1;FASLG;PTPN13;CD80;CSF3R;IL27;IL18RAP;CCR5;CCL4;CCL3;IL1RAP;LIFR;IL18;CASP1;IL15;MAP2K1;KCNH8;CTF1;CXCL2;FOXO1;IL1RL2;CCL2;IL6;FYN;CCR1;IL33;IL12B;ALOX5;IL1RN;S100B;CCR2;PELI2;RPS6KA1;CXCL8;GATA3;LCK;CCL22;HCK;IL21R;PIK3R1;AKT1;TSLP;IL16;SERPINB2;SYK;HAVCR2;CISH;IL17RE;S100A12;USP18;VCAM1;IL17RC;MYD88;CSF2;VAV1;IL12RB1;CD86;TNFRSF1B;IL10RA;PTPN7;ITGB2;CXCL1;CSF1R;LGALS9;DUSP6;BCL2;HMOX1;EBI3;STX3;INPP5D;PTAFR;CSF2RB;MAPK10;PPP2CB
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.3852291915089707,1.2665238884264365,0.08333333333333333,0.7468588877706747,1.0,90/133,49.08%,CELF3;BOP1;RRS1;NOL3;CELF4;PUF60;SNRPE;MCTS1;KHDC4;PRKDC;RPS27;PRMT7;EIF2D;RPS5;TXNL4A;HSP90AB1;SNRPD2;SF3A2;RPS14;RPL10;RPSA;PRPF6;NOP2;RPLP0;SNRPB;GEMIN8;LSM4;LUC7L;SNRPD1;RPS15;TRAF7;RPS19;GEMIN7;NLE1;RRP7A;RPL38;LUC7L3;SNRPC;DDX39B;SNRPD3;BRIX1;XAB2;PPAN;DHX9;USP39;RAMAC;RPL3L;PWP2;ZRSR2;DDX20;HSP90AA1;GEMIN4;RPL5;SART1;CLP1;SNRPG;RPS28;CPSF7;CRNKL1;RPL23A;DDX1;EIF6;SNRNP200;CPSF6;SHQ1;EIF2S3;TGS1;MRPS11;RPL6;RBM5;GEMIN5;DHX29;GEMIN6;MRPL20;NOP53;SART3;PRPF19;WDR77;LUC7L2;EIF3A;RPL3;SRPK1;PRMT5;SF1;ISY1;PTGES3;CDC73;SNUPN;MRPS7;SF3B1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.48017025882920666,1.2660083524926642,0.1875,0.7479162456324492,1.0,13/27,35.44%,EXO1;XRCC2;RTEL1;BARD1;DNA2;RMI1;RAD51AP1;RAD51;BLM;BRIP1;RMI2;BRCA2;SEM1
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,-0.33284114004588117,-1.2659901234216246,0.10344827586206896,0.35550311327944006,1.0,26/85,18.50%,GRIN2B;NRXN1;SLITRK6;SYT9;SYT10;LRRTM4;NTRK3;SYT1;IL1RAPL2;LRFN2;SLITRK3;SYT7;IL1RAP;GRIA3;DLGAP2;DLGAP1;PTPRD;NLGN4X;LRRTM3;GRIA1;NLGN4Y;SLITRK4;EPB41L3;EPB41L2;PTPRS;APBA2
prerank,MSigDB_Oncogenic_Signatures__KRAS.AMP.LUNG UP.V1 DN,0.38321567394735556,1.264849025649559,0.08780487804878048,0.7514540536659368,1.0,27/110,16.71%,CPLX2;HTR1D;CACNG1;ADRA2C;GNAZ;IGF2-AS;SNTG1;CEND1;PRODH;PLCH2;KREMEN2;CD34;MXD3;SLC5A2;RHOBTB1;RAG1;CA1;PPFIA3;ABCD1;APC2;ACE;ZNF862;RELB;SDS;ST20;CGREF1;GCNT3
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.510337654081881,1.2648292955596085,0.2088607594936709,0.7505652582505099,1.0,4/18,7.73%,DKK1;HDAC4;TMEM119;BDNF
prerank,MSigDB_Oncogenic_Signatures__PTEN DN.V1 DN,-0.31289519848071196,-1.264768147512962,0.030303030303030304,0.3571482381396283,1.0,46/142,15.60%,GABRB1;HPCAL4;CLDN10;NDST3;FCN3;KRT23;TNR;B3GALT5;MSX2;CXCL11;FOLR3;UGT8;ADCYAP1R1;KRT14;WNT16;MTUS2;SV2B;KLRD1;TSPAN7;NR3C2;IL18RAP;SLC14A1;KCNJ10;CXCR6;PIK3C2G;GPM6A;HMGN5;GALNT14;SEMA4D;TGFA;RLN2;CAND2;XK;PRSS3;RFTN1;LILRA6;PON3;HAAO;LCP1;SERPINB2;FGR;SERPINA10;SGCE;SH3BGRL;CCDC68;DGKB
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.44682961204584043,1.2646798593382191,0.18435754189944134,0.7502117596233728,1.0,15/40,31.44%,E2F1;CDC7;EZH2;CDKN2B;CHEK1;PCGF2;RRM2;EHMT2;RAD51;UXT;CBX5;RHNO1;RBBP7;DAB2IP;CBX3
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,-0.3860721485848092,-1.264535829536585,0.12987012987012986,0.3571239592178007,1.0,14/32,20.58%,CLEC1B;FYN;LCP2;RAC2;LCK;PIK3R5;PIK3R1;SYK;PLCG2;FCER1G;VAV1;VAV3;GP6;PRKCZ
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.34300900276782814,-1.2642779458900666,0.13793103448275862,0.35727657743362906,1.0,17/55,17.34%,CASR;CD4;CCL5;CCL4;CCL3;LILRA2;PLPP4;LILRA5;CAMK2B;FCRL3;CCR1;CD84;LILRB1;IL16;LILRB2;BCL2;CD33
prerank,Elsevier_Pathway_Collection__Sebocyte Proliferation in Acne Vulgaris,-0.3763794353302481,-1.2641808036241933,0.0945945945945946,0.3570690293525954,1.0,9/40,13.84%,FGF10;FOS;MAP2K1;CAT;MITF;FGFR2;ALOX5;PIK3R1;IGF1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.5349599311168507,1.2639523469415221,0.1794871794871795,0.7523237109587937,1.0,5/15,10.36%,SIX1;OSR1;BMP4;NPNT;FOXC1
prerank,Elsevier_Pathway_Collection__CFTR Related Ion-Channel Dysfunction in Cystic Fibrosis Airway Epithelium (Class III Mutations),-0.38036151412556407,-1.2639518125017861,0.11842105263157894,0.35714947768198746,1.0,11/28,21.43%,TNF;DEFB1;CXCL8;TLR4;TLR2;MYD88;PRKCE;CFTR;EZR;AQP3;ADRB2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.40468206413233054,1.26367848745317,0.13917525773195877,0.7524468013029981,1.0,16/73,16.51%,GNG4;MRAP2;RGS20;PPEF1;RHO;RNF157;CAMK2A;RGS16;SAG;RGS5;SYP;GUCY2D;KLK14;TULP3;RGS14;ROCK2
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,-0.4464899649968148,-1.2635213568457315,0.14606741573033707,0.3575952378615773,1.0,6/15,17.93%,EREG;ERBB4;NRG4;BTC;HBEGF;NRG3
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Amyotrophic Lateral Sclerosis,-0.45296682539969557,-1.263382687698198,0.16666666666666666,0.3573945624314911,1.0,5/19,10.76%,TNF;IL1B;CASP1;IL6;CYBB
prerank,Elsevier_Pathway_Collection__Keratinocyte Activation in Psoriatic Arthritis,-0.37972193266332566,-1.26319306534542,0.14492753623188406,0.3573376085610468,1.0,10/40,14.71%,IFNG;TNF;MMP1;FOS;MAP2K1;CCL2;IL6;CXCL8;AKT1;IL17RC
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.46711822596983393,1.2625255941021343,0.15204678362573099,0.7559064917324319,1.0,6/28,7.01%,WNK4;SLC12A5;SLC30A3;SLC30A2;SLC4A3;SLC4A1
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.5316688887182783,1.2624213131422592,0.18674698795180722,0.7553696540975534,1.0,9/18,27.70%,ST8SIA3;B4GALNT1;ST6GALNAC4;NEU3;ABCA2;NEU1;HEXB;ST6GALNAC5;HEXA
prerank,Elsevier_Pathway_Collection__Cetuximab Resistance in Colorectal Cancer,-0.3454836520632426,-1.2616134675639465,0.08,0.35996696183165056,1.0,17/64,17.93%,SLC5A1;EREG;ERBB4;PTGS2;HGF;IGFBP3;NRG4;TGFA;AXL;BTC;AKT1;IGF1;HBEGF;PRKCE;PLAUR;IGFBP4;NRG3
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,-0.33845508936093377,-1.2614376904172098,0.0625,0.3599006626684382,1.0,14/51,18.88%,ESRRG;NR4A2;NR4A3;NR4A1;NR3C2;ESR1;NR1I2;RORB;PGR;RARB;NR1I3;NCOR1;NRBF2;NR1H4
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,0.45871128491941876,1.2614002764287273,0.14942528735632185,0.7584027095740828,1.0,23/33,47.37%,PRIM1;RFC4;DSCC1;POLD1;DNA2;FEN1;POLR1A;POLA1;POLA2;BLM;CHTF18;PCNA;TERF1;ACD;SLC19A1;TERF2;RFC3;POLD3;POLD4;WRN;CTC1;STN1;PRIM2
prerank,Elsevier_Pathway_Collection__Prostate Cancer,-0.302641953549374,-1.2613707215070833,0.05405405405405406,0.35955548997553,1.0,23/113,15.99%,KLK3;PTGS2;HGF;SRD5A1;IGFBP3;MSMB;CXCL12;FGFR2;EGR1;IL6;RUNX3;NKX3-1;MMP7;IGFBP5;AKT1;IGF1;HBEGF;CASP6;CXCR4;BCL2L11;PRKCE;CLU;CASP7
prerank,Elsevier_Pathway_Collection__Neutrophil Degranulation via FPR1/IL8,-0.3444921543361153,-1.261153626518785,0.06976744186046512,0.359522227286515,1.0,26/64,21.99%,FPR1;CXCR2;MAP2K1;PRKCB;CXCL12;CR1;CYBB;BTK;CXCL8;SELE;SYK;VCAM1;CXCR4;VAV1;ITGB2;ITGB3;ITGA9;NCF1;SELPLG;NCF2;SELL;IQGAP1;PRKCZ;SELP;CYBA;ITGAM
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.3435225275355275,-1.260825855917317,0.125,0.3597026838739034,1.0,11/55,4.63%,OVOL2;OVOL1;EVPL;EDAR;KRT83;KRT15;SPRR3;GRHL2;GJB5;KRT14;KRT5
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.2972119587152705,-1.2608064269751829,0.03125,0.3593201346191447,1.0,51/155,24.22%,CASR;NLRP7;RIPK3;TNF;GBP5;AIM2;IL1B;CCL5;NLRP12;CXCL3;IL18;CASP1;GBP7;CXCL2;NLRP3;GBP4;CCL2;IL6;CYBB;MEFV;CXCL8;TLR4;GBP3;CARD16;CAMP;PLCB2;PSTPIP1;GBP1;MYD88;CXCL1;NLRC4;CTSB;BCL2;MAPK10;IFI16;MAPK13;OAS3;NAIP;NOD2;OAS2;NLRP6;TAB2;CYBA;JUN;STAT1;CASP4;ATG5;ITPR3;OAS1;GABARAPL1;IRF9
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,0.4098740689771308,1.260783977212863,0.13157894736842105,0.7599747768139282,1.0,27/88,21.01%,COL2A1;COL22A1;COL7A1;COL15A1;COL9A1;ITGA6;COL10A1;COL4A1;COL4A5;COL8A1;COL1A1;LOXL2;COL11A1;COL4A2;CRTAP;LOXL1;TLL2;COL1A2;COL5A1;LOX;LAMA4;PLEC;MMP9;P4HA2;MMP3;COL11A2;COL27A1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5119728744415667,1.2607566627746214,0.17613636363636365,0.7591196507461826,1.0,16/22,45.06%,RRS1;RPS21;KRI1;PES1;RPP40;URB1;NOL9;ERI3;EXOSC2;WDR12;FTSJ3;EXOSC7;EXOSC10;EXOSC9;NOP9;UTP20
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.45137786877826414,1.2606750051198272,0.15104166666666666,0.7585193787440194,1.0,32/47,46.64%,BOP1;RRS1;MTERF3;RPS27;NPM1;RPS5;RPS14;RPL10;RPSA;NOP2;RPLP0;RPS15;TRAF7;RPS19;NLE1;RRP7A;MRPL22;MPV17L2;BRIX1;PPAN;DHX37;RPL3L;PWP2;RPL5;RPS28;RPL23A;EIF6;MRPS11;RPL6;DHX29;MRPL20;NOP53
prerank,Elsevier_Pathway_Collection__Alternative Lengthening of Telomeres in Cancer,0.5361990550729154,1.2606543875316911,0.13253012048192772,0.7576152416748709,1.0,3/16,3.80%,E2F1;TERT;DMC1
prerank,KEGG_2021_Human__Salivary secretion,0.40144835158106423,1.2602253039643996,0.12690355329949238,0.7583977240671862,1.0,8/73,8.72%,MUC7;CALML6;DMBT1;ADRA1D;ATP1A2;ATP1A4;ATP2B4;ATP1B3
prerank,Elsevier_Pathway_Collection__Complement Component GPCRs Signaling,0.5524464389153599,1.2599160723435334,0.18125,0.7587322713648054,1.0,2/15,10.11%,RASGRF1;C5AR2
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.3940097130319955,1.2588325086203962,0.14285714285714285,0.7620995195537147,1.0,44/88,44.08%,MRPL55;MRPS21;DAP3;MRPL24;MRPS24;MRPS12;MRPL13;MRPL9;MRPS14;MRPS23;GADD45GIP1;MRPL23;MRPL28;MRPL52;MRPL12;MRPL15;MRPS28;MRPL36;MRPL41;AURKAIP1;MRPL27;MRPL21;MRPS34;TUFM;MRPL17;MRPS15;MRPL51;MRPL22;MRPL4;MRPL33;OXA1L;CHCHD1;MRPL1;MRPS5;MRPL43;PTCD3;MRPS27;MRPS18C;MRPL58;MRPL50;MRPL2;MRPS11;MRPS26;MRPL49
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.48119776195119884,1.258815574668532,0.15384615384615385,0.7611866223367199,1.0,6/23,12.55%,GJB6;MSC;BMP4;CACNA1G;MSX1;GJA5
prerank,MSigDB_Oncogenic_Signatures__VEGF A UP.V1 DN,0.3640760972886243,1.2586869597508834,0.09777777777777778,0.7607510498426848,1.0,39/185,18.32%,DKK1;FABP4;ITGA2;AQP8;CENPA;RAB3B;HMMR;BUB1B;CENPE;BIRC5;CCNB2;BUB1;TSPAN8;CDKN3;TTK;CCNE1;EXO1;DLGAP5;NDC80;RRS1;CDC45;KIF23;CCNB1;STEAP1;ACE;FLT1;RFC4;RGS5;ATP8B3;INHBB;ROM1;RRP12;ANGPT2;MAP1B;KIF11;ADAM9;GPR4;RRM2;MCM4
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.47098763985509845,1.2584894016050812,0.16279069767441862,0.7606899378789211,1.0,7/25,16.48%,KIF14;SSTR5;AURKB;CDC6;KIF23;RACGAP1;ECT2
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.4818774986222645,1.2580857266401353,0.16149068322981366,0.7614887531447397,1.0,5/22,7.62%,DKK1;LRP4;MDK;KREMEN2;FGF23
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,0.4861704451961883,1.2580291377992372,0.1656441717791411,0.7607302798431365,1.0,19/27,42.18%,TUBA4B;TUBB8;TUBB8B;TUBA4A;TUBA3E;TUBA8;TUBB2B;TUBA3D;TUBB2A;VPS4A;CHMP2A;TUBA1A;TUBA1B;TUBB6;TUBB4B;LEMD2;CC2D1B;TUBA1C;TUBB4A
prerank,TRRUST_Transcription_Factors_2019__SREBF1 mouse,-0.412929867937748,-1.25792049469187,0.11764705882352941,0.36416387610424866,1.0,8/31,8.37%,CIDEA;GCK;KCNJ3;THRSP;CD5L;ABCD2;PPARGC1A;CYP8B1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.5028594148660963,1.2578786821869894,0.17857142857142858,0.7604419121519974,1.0,4/21,18.57%,CELF3;CELF4;SF3B4;RBM3
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.447582696512501,-1.25755347204815,0.19318181818181818,0.36455772491880295,1.0,10/19,17.31%,CRTAM;IKZF3;ZFP36L1;FCRL3;CD2;TBX21;CCR2;NCKAP1L;PRDM1;ZNF683
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.3947466750609728,1.2573144018022853,0.14423076923076922,0.7617011681968999,1.0,44/88,44.08%,MRPL55;MRPS21;DAP3;MRPL24;MRPS24;MRPS12;MRPL13;MRPL9;MRPS14;MRPS23;GADD45GIP1;MRPL23;MRPL28;MRPL52;MRPL12;MRPL15;MRPS28;MRPL36;MRPL41;AURKAIP1;MRPL27;MRPL21;MRPS34;MRPL17;MRPS15;MRPL51;MRPL22;MRPL4;MRPL33;OXA1L;CHCHD1;MRPL1;MRRF;MRPS5;MRPL43;PTCD3;MRPS27;MRPS18C;MRPL58;MRPL50;MRPL2;MRPS11;MRPS26;MRPL49
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,0.46246934455039057,1.2572932628179787,0.1744186046511628,0.7607882238057718,1.0,10/33,24.73%,E2F1;CDC7;EZH2;CHEK1;PCGF2;RRM2;EHMT2;RAD51;UXT;CBX5
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.4599886515560026,1.2570459112799455,0.17222222222222222,0.760792911220269,1.0,9/34,19.08%,ACTN2;TRIM40;MAPT;TAX1BP3;CDT1;NEDD4L;ROCK2;MAP1A;OTUD7B
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.49225577704292867,1.256944317687885,0.1711229946524064,0.7602534602383141,1.0,7/26,17.33%,HMGA2;CDKN2A;TBX3;CDKN2B;NSMCE2;HRAS;HMGA1
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,0.48915600947970905,1.2566401139401693,0.20348837209302326,0.7606370465035364,1.0,12/25,35.44%,EXO1;XRCC2;BARD1;DNA2;RMI1;RAD51AP1;RAD51;BLM;BRIP1;RMI2;BRCA2;SEM1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.42948057030802234,1.2565481289595515,0.1348314606741573,0.7600644309903974,1.0,9/42,14.04%,B4GALNT2;B3GALT1;ST8SIA3;ST6GALNAC4;FUT5;ST8SIA5;IDUA;NEU3;GLA
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.43035695251593387,1.2565263206334998,0.17435897435897435,0.7591550300530663,1.0,12/44,21.40%,TSPAN5;ROBO1;GATA5;MESP1;SRC;JAG2;ELF3;AAK1;NOTCH4;DLL4;ENHO;TGFB2
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,0.5376099728080485,1.256490052313011,0.17763157894736842,0.7583302246250362,1.0,5/16,18.45%,GNG4;GNG3;GNB5;GNG8;GNG10
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.4662913396956076,-1.256361228542937,0.1506849315068493,0.3659027153826756,1.0,8/20,18.14%,ALDH6A1;BCKDHB;ACADSB;DBT;IVD;ECHS1;MCCC1;ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.4662913396956076,-1.256361228542937,0.1506849315068493,0.3659027153826756,1.0,8/20,18.14%,ALDH6A1;BCKDHB;ACADSB;DBT;IVD;ECHS1;MCCC1;ACAT1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.4418644350801783,1.2562514693718942,0.15934065934065933,0.7583077137474249,1.0,29/38,48.83%,SRSF12;PRPF3;SNRPE;PRMT7;SNRPD2;PRPF6;LSM2;SNRPB;GEMIN8;LSM4;SNRPD1;PRPF31;GEMIN7;SNRPC;SNRPD3;DDX20;PRPF8;CD2BP2;GEMIN4;SART1;SNRPG;TGS1;GEMIN5;GEMIN6;SART3;PRPF19;WDR77;PRMT5;SNUPN
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.46677955686547956,-1.2561484145447537,0.12,0.36584958184666133,1.0,8/17,21.98%,IL10;BPI;PTPN22;KLF4;CD33;ANXA4;SSC5D;TMSB4X
prerank,Elsevier_Pathway_Collection__Proteins Involved in Congenital Hypothyroidism,-0.45225110317784434,-1.2558406000573725,0.13953488372093023,0.36614978570704,1.0,3/18,1.09%,NKX2-1;FOXE1;TSHR
prerank,KEGG_2021_Human__Homologous recombination,0.4481464357162559,1.2556584636405113,0.17777777777777778,0.7594386866864472,1.0,32/40,48.60%,EME1;XRCC2;POLD1;BARD1;RAD54L;RAD51;BLM;SYCP3;ABRAXAS1;BABAM2;BRIP1;UIMC1;TOPBP1;MUS81;BRCA2;SEM1;XRCC3;BABAM1;RPA2;RAD52;POLD3;RAD54B;POLD4;SSBP1;BRCC3;NBN;RPA1;TOP3A;RAD51C;MRE11;RAD50;PALB2
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,-0.4550178883093094,-1.2553967927787049,0.20224719101123595,0.36662891574621564,1.0,7/16,17.93%,EREG;ERBB4;NRG4;BTC;PIK3R1;HBEGF;NRG3
prerank,MSigDB_Oncogenic_Signatures__GCNP SHH UP EARLY.V1 UP,0.36957755960676236,1.2552102592318943,0.09545454545454546,0.7603122451548134,1.0,28/152,20.40%,REG1A;KIF1A;ICAM5;KIF4A;TOP2A;ANLN;UBE2T;KIFC1;E2F8;AURKB;LOXL2;MCM6;TYMS;AURKA;FOXK1;SHC1;ADCY6;NVL;KCNJ4;MCM10;CHEK1;MCM5;PRC1;LBR;COX7B;TRAIP;FEN1;MRPL9
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.49050127307171426,1.2549911949710406,0.17791411042944785,0.7602873169945038,1.0,7/24,17.41%,WNK4;ACTN2;HRH3;PACSIN3;HTR1B;STC1;NEDD4
prerank,TRRUST_Transcription_Factors_2019__HDAC2 human,-0.3994386431019688,-1.254941428682927,0.15942028985507245,0.3670300615430213,1.0,10/26,13.84%,MUC5AC;CDH1;TNFSF10;CD1D;CCL2;KLF4;BMP7;ALOX5;CXCL8;IGF1
prerank,Elsevier_Pathway_Collection__Leptin Role in Endometriosis,-0.45485021195332165,-1.2548994338074522,0.20212765957446807,0.3666814786599765,1.0,4/17,7.46%,TNF;IL1B;FOS;MAP2K1
prerank,Elsevier_Pathway_Collection__CFL1 in Cancer Cell Motility,0.52991061606725,1.2548979816666623,0.20512820512820512,0.7596728574294581,1.0,6/18,21.80%,RASGRF1;SRC;ABL2;RHOC;LIMK2;PLCG1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5309776741597461,1.254743082810053,0.2012987012987013,0.7593694151350069,1.0,2/15,4.96%,TRIM71;HES5
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,0.4918445602572101,1.2543700484087779,0.17197452229299362,0.7598179729207746,1.0,11/24,32.53%,H2AC19;H2AC11;H2AC20;H2AC6;BARD1;STAMBPL1;PSMD14;UBA52;ABRAXAS1;BABAM2;UIMC1
prerank,WikiPathway_2021_Human__Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5355681391947269,1.2543316821608732,0.2138728323699422,0.7589834745988511,1.0,3/17,3.39%,LEF1;SFRP4;DKK3
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,0.44350927334773393,1.2537755118416918,0.16477272727272727,0.7603134848261386,1.0,25/36,46.20%,ACTR5;CETN2;PARP1;INO80E;NFRKB;TFPT;COPS5;CUL4B;UBA52;DDB2;COPS6;RUVBL1;DDB1;ACTR8;INO80D;COPS8;GPS1;XPC;RBX1;UBC;COPS7A;MCRS1;INO80;COPS4;RPS27A
prerank,Elsevier_Pathway_Collection__Il17 Signaling Related Neutrophilia in Asthma,-0.4083592348673128,-1.2535963443438012,0.1780821917808219,0.3689419579589277,1.0,10/26,21.48%,CCL4;MAP2K1;IL12B;CXCL8;AKT1;IL17RC;IL12RB1;CXCL1;IL12RB2;JAK2
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,0.4225725610352459,1.253290401594029,0.15025906735751296,0.7613835631212336,1.0,32/49,49.08%,SNRPE;SF3B4;POLR2L;POLR2K;TXNL4A;SF3B5;SNRPD2;POLR2G;PRPF6;SNRPB;POLR2H;POLR2I;POLR2J;RNPC3;SNRPD3;POLR2A;ZRSR2;PRPF8;SNRNP35;POLR2B;ZMAT5;GTF2F1;SNRPG;SNRNP200;POLR2F;SF3B3;SNRNP25;SNRNP40;DDX42;SF3B6;NCBP2;SF3B1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.4910837148150284,1.253219356885006,0.21428571428571427,0.7606783773593636,1.0,4/23,3.29%,MT3;CSN2;GRIN1;SOX2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.3820507303433055,-1.2531648273523508,0.15492957746478872,0.369415725022695,1.0,8/34,9.42%,TACSTD2;PFN2;MARVELD3;BMP10;GDF2;DCN;DUSP10;MCC
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,0.4314122456737775,1.253151109370422,0.17553191489361702,0.7600176140746971,1.0,29/57,39.37%,PLK1;GTSE1;CCNB2;PSMD4;CDK1;CCNB1;PSMB4;HSP90AB1;PSMB3;PSMD14;UBA52;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;FKBPL;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;HSP90AA1;PSME3
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,0.5248688223353432,1.2529895079424793,0.2275449101796407,0.7596397019188045,1.0,4/17,7.62%,FGF20;FGF13;FGF17;FGF23
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.3995556104786221,1.2529693394540038,0.1407766990291262,0.7587435840015578,1.0,19/74,17.57%,COL2A1;ZIC2;PAX2;CRYBA2;CABP1;CHRNB2;ARR3;FSCN2;COL1A1;COL11A1;MYO7A;EYA4;EFEMP1;RGS16;KIFC3;ROM1;BBS2;ABLIM1;CRYBB2
prerank,TRRUST_Transcription_Factors_2019__CREBBP mouse,-0.40678286746818343,-1.2529678108816154,0.07936507936507936,0.36930161362674385,1.0,9/34,9.64%,FOXP3;FOSB;TNF;HGF;FOS;SPIB;ESR1;KRT16;IL6
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.39201098746547436,1.2527439252459633,0.1111111111111111,0.7586784506864257,1.0,21/85,18.80%,CACNB4;CACNG1;TNNC1;CACNG4;CACNA1S;CACNG5;TNNI3;ITGA2;CACNA2D2;ITGA6;ATP2A1;CACNA1C;CACNA2D3;LMNA;CACNG8;TPM2;ADCY6;SLC8A3;ADCY4;ITGA7;ITGA11
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.4364102204079785,1.2523969656958445,0.1793478260869565,0.7591440703496765,1.0,16/39,33.04%,ACTN2;STRIT1;PRR5L;ATP2A1;CEP131;B3GAT3;NEDD4;EHD2;PLA2G4E;TPR;ABCA12;CAPN10;SPAG5;STX18;CEP290;DYNC1H1
prerank,Elsevier_Pathway_Collection__Proteins Involved in T-Cell Acute Lymphoblastic Leukemia,0.44844187374195627,1.2520985542469563,0.15591397849462366,0.7593668842766665,1.0,4/37,4.61%,TLX1;TAL2;TLX3;CDKN2A
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,0.40843312313875413,1.2514702323983518,0.15625,0.7607874224492077,1.0,45/71,47.30%,PLK1;CDC20;UBE2C;PSMD4;AURKB;UBE2S;PTTG1;AURKA;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;SKP2;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;ANAPC2;PSMB2;PSMA6;ANAPC4;UBC;PSMD9;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;PSMB1;PSMD3
prerank,Elsevier_Pathway_Collection__Melatonin Effects on Circadian Cycle,-0.41590878467137576,-1.2514043906599357,0.19047619047619047,0.3719209283746885,1.0,7/21,22.79%,FOS;MAP2K1;SLC7A5;DDC;BCL2;JUN;AANAT
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,0.37837907958067046,1.2512867177401814,0.10945273631840796,0.7607200793383047,1.0,47/90,40.37%,NDUFA1;NDUFS6;NDUFV1;NDUFB9;COX6C;COX20;COX7B;NDUFA3;UQCRB;NDUFS2;NDUFA9;NDUFAF2;COX6B1;NDUFB11;NDUFA2;NDUFS7;COX8A;UQCRQ;NDUFAF6;TRAP1;NDUFA13;NDUFA11;NDUFA6;UQCR11;NDUFS8;COX4I1;NDUFV2;COX5B;NDUFA8;NDUFB7;ETFB;TMEM186;UQCRH;NDUFAB1;COX19;NDUFB2;NDUFB10;UQCRC1;NDUFAF3;ACAD9;COX7C;UQCR10;NDUFB3;NDUFS4;SDHA;NDUFB8;COX6A1
prerank,Elsevier_Pathway_Collection__Synovial Fibroblast Activation by Citokines in Rheumatoid Arthritis,-0.35608699994124654,-1.251229830879832,0.0967741935483871,0.3718742340904692,1.0,21/48,23.65%,TNFSF11;TNF;IL1B;MMP1;FOS;IL1RAP;IL18;IL15;CXCL12;OSM;CXCL8;IL16;MYD88;TNFRSF1B;LIF;WNT5A;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.40874432960072493,1.2505168106668283,0.13297872340425532,0.7629843931227275,1.0,40/57,47.28%,RPS27;RPS21;EIF3E;RPS5;EIF3K;RPS14;RPSA;PABPC1;EIF3D;RPS15;RPS2;RPS19;RPS4X;RPS20;EIF3H;RPS8;RPS12;EIF3B;RPS3A;RPS7;RPS11;FAU;RPS3;RPS24;EIF3G;RPS16;EIF3M;RPS28;RPS23;EIF2S3;RPS9;EIF3C;EIF3F;RPS15A;EIF3L;RPS6;RPS27A;RPS4Y1;RPS13;EIF3A
prerank,TRRUST_Transcription_Factors_2019__HSF1 human,-0.41414670928781955,-1.2503804615420082,0.175,0.37308624683175207,1.0,11/29,21.42%,TNF;IL1B;NAT1;SESN3;ABCB1;HSPA1B;HSD17B6;HSP90B2P;HSPA1A;FUT4;JUN
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2986949348464338,-1.2503632414262031,0.03225806451612903,0.372695472463877,1.0,46/159,16.36%,ALKAL1;MARCO;ADRA1A;HTR2A;ERBB4;TNFSF11;FGF10;CD4;TNF;NTRK3;BMPER;CCL5;PTPN22;FPR2;CCL4;NTRK2;CCL3;PDGFRA;XCL1;CCL23;MAP2K1;CCR7;SCIMP;GPR183;CALCR;FGFR2;PTPRC;NDRG4;CCL2;HAND2;CCR1;XCL2;FERMT2;NTRK1;TNFRSF11A;P2RY1;CHRNA7;CCL22;GAREM1;RASGRP1;MTURN;SPRY2;GCNT2;CSF1R;NOTCH2;LGALS9
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.4678172088361695,-1.2500957074819437,0.23255813953488372,0.37283832616467133,1.0,6/17,18.36%,CCR7;PLEK;CSF1R;LIMA1;CARMIL1;AIF1
prerank,WikiPathway_2021_Human__miR-509-3p alteration of YAP1/ECM axis WP3967,0.5138025050398303,1.2498922001693815,0.2011173184357542,0.7646229905930779,1.0,11/17,31.42%,SNAI2;COL1A1;TEAD2;TEAD4;COL5A1;THBS2;SPARC;TEAD3;COL3A1;YAP1;TEAD1
prerank,WikiPathway_2021_Human__Oxidative phosphorylation WP623,0.42085523563786115,1.2486676452766974,0.15555555555555556,0.7686001287231276,1.0,35/52,46.27%,NDUFA4L2;ATP6AP1;NDUFS6;NDUFV1;NDUFB9;ATP5MF;NDUFA3;NDUFS2;NDUFA9;ATP5F1D;NDUFA2;NDUFS7;NDUFA11;ATP5F1E;NDUFA6;ATP5MC1;NDUFS8;NDUFV2;ATP5ME;NDUFA8;NDUFB7;NDUFAB1;NDUFB2;NDUFB10;NDUFS4;ATP5MG;NDUFB8;ATP6AP2;ATP5PO;NDUFA4;NDUFA10;NDUFB1;NDUFS5;NDUFS3;ATP5MC2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.46902232238507235,1.2486289947307858,0.18994413407821228,0.7678123171203972,1.0,6/32,3.21%,CEMIP;GRIN1;F2RL3;P2RX5;THY1;CASQ1
prerank,WikiPathway_2021_Human__Fatty acid transporters WP5061,0.5379521905545207,1.2485221791023564,0.17088607594936708,0.7672912291232237,1.0,7/15,17.93%,FABP4;ACSBG2;ACSL6;ACSL4;CD36;FABP5;ACSL5
prerank,MSigDB_Oncogenic_Signatures__P53 DN.V1 DN,-0.2901991049597659,-1.248325426606634,0.034482758620689655,0.3757619324490034,1.0,53/176,17.14%,IRF4;SOX10;L1CAM;CHL1;AJAP1;BCHE;CDH19;TFPI2;IL2RB;NR4A3;ECM1;NR4A1;LAMA1;CA12;PTPN13;GLDC;CDH1;TSPAN7;COLEC10;UGT2B7;GRAMD1B;ELOVL2;CASP1;CD1D;ITK;MITF;ST8SIA1;RUNX3;FAM50B;NCALD;BCL2A1;ACADS;S100B;CA2;MMP7;PLA2G4A;CD247;SLC16A4;TRIM22;LAT;MYOM2;MAL;KCNJ8;DOCK2;BASP1;FRMD4B;CXCL1;RASSF2;EPB41L3;MGLL;ITGA4;HMOX1;CPVL
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.33618342711214805,-1.247499443060202,0.0847457627118644,0.37682487220911776,1.0,16/58,20.23%,ATP10B;MFSD2A;APOA4;TMEM30B;APOA1;SCP2;ATP11C;ABCB1;APOA5;PRELID2;ATP8B4;MTTP;PLTP;ATP11B;TMEM30A;PCTP
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,-0.40976483369780814,-1.2474789784032332,0.1875,0.3764316451604018,1.0,4/23,12.57%,TUSC3;NIPAL1;LRRC8B;AZGP1
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,0.4556508672222798,1.247063886033274,0.16666666666666666,0.7721403299644046,1.0,11/28,13.52%,CACNG4;SCN1A;SCN4A;CACNA2D2;FGF13;CAMK2A;FGF14;SCN4B;SCN2A;CACNA1C;CACNG8
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.41012815433082284,1.2470213507262204,0.14136125654450263,0.7704088171055138,1.0,29/58,38.43%,NDUFA1;NDUFS6;NDUFV1;NDUFB9;NDUFA3;NDUFS2;NDUFA9;NDUFAF2;NDUFB11;NDUFA2;NDUFS7;NDUFAF6;NDUFA13;NDUFA11;NDUFA6;NDUFS8;NDUFV2;NDUFA8;NDUFB7;BCS1L;NDUFAB1;NDUFB2;NDUFB10;NDUFAF8;NDUFAF3;OXA1L;ACAD9;NDUFB3;NDUFS4
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.41012815433082284,1.2470213507262204,0.14136125654450263,0.7704088171055138,1.0,29/58,38.43%,NDUFA1;NDUFS6;NDUFV1;NDUFB9;NDUFA3;NDUFS2;NDUFA9;NDUFAF2;NDUFB11;NDUFA2;NDUFS7;NDUFAF6;NDUFA13;NDUFA11;NDUFA6;NDUFS8;NDUFV2;NDUFA8;NDUFB7;BCS1L;NDUFAB1;NDUFB2;NDUFB10;NDUFAF8;NDUFAF3;OXA1L;ACAD9;NDUFB3;NDUFS4
prerank,Elsevier_Pathway_Collection__Dopamine Mediated Glutamate Release and Glutamate Uptake Circle,0.5133226508045521,1.2469207880666189,0.22085889570552147,0.769811819982817,1.0,8/18,24.10%,GLUL;SLC7A6;SLC1A2;SNAP25;SLC1A3;SNAPIN;STX1A;DRD1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.45102237975586307,-1.2467498899262783,0.1625,0.37745355500133904,1.0,13/22,30.50%,PNP;NUDT10;XDH;MLYCD;ACAT1;AMPD3;NUDT3;PDE2A;PDE4D;NUDT7;NUDT4;NT5E;NUDT18
prerank,Elsevier_Pathway_Collection__PARK2/PINK1/UCHL1 in Young Onset Parkinson's Disease,0.4935498892904835,1.2467290931860655,0.18404907975460122,0.7696089397885088,1.0,6/18,18.04%,SEPTIN5;PRKN;PSMD4;CCNE1;UCHL1;SNCAIP
prerank,Reactome_2022__FRS-mediated FGFR2 Signaling R-HSA-5654700,0.5184552227828729,1.2467020033056406,0.18404907975460122,0.768784915789586,1.0,4/18,7.62%,FGF20;FGF13;FGF17;FGF23
prerank,MSigDB_Oncogenic_Signatures__SNF5 DN.V1 UP,0.3697157679376459,1.246664044851634,0.13302752293577982,0.7680045739130527,1.0,25/149,12.98%,DLK1;MT3;LIX1;SCG2;C1QTNF3;COL15A1;LGR5;MYH1;GABRQ;SOX2;KIF20A;UBE2C;BUB1;MSX1;ELN;DTL;AURKB;FDPS;NCAN;FNDC1;PRRX2;CD68;APOD;EGFL6;SOSTDC1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.413276935638226,-1.2465080978929597,0.12359550561797752,0.3774830422420265,1.0,10/21,19.59%,ECM1;CCL3;CCR1;HEY2;GREM1;SRGN;SOX9;ENPP1;ASPN;AHSG
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.3536246342670636,-1.246503907432038,0.125,0.37705890399231634,1.0,25/39,29.33%,PDGFRA;KLKB1;PLG;SERPINB2;SERPING1;KNG1;F3;PLAUR;F11;GP1BA;F7;VTN;APOH;SERPINF2;C1QTNF1;ADTRP;F2;THBD;CPB2;HRG;EDN1;FGG;FGB;F8;PROC
prerank,MSigDB_Oncogenic_Signatures__SRC UP.V1 UP,0.37038885533866656,1.2464671826794609,0.10344827586206896,0.7678795541883581,1.0,24/130,13.16%,CPLX2;GP2;POU3F2;SULT4A1;MAPK8IP2;TM4SF5;NAT8L;COX4I2;ICAM5;ASPSCR1;OPRL1;TMEM88;SRC;FGF23;ATOX1;FAM182B;RNASE1;FUT5;TONSL;KCNH3;SYN1;PACSIN3;APC2;CEACAM19
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4179838628697456,-1.2462822146404113,0.17647058823529413,0.3770006748834337,1.0,4/22,3.95%,IL10;IFNG;TNF;IL1B
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.47481768108848776,-1.2462226986828857,0.17391304347826086,0.3762756156160495,1.0,6/16,17.12%,GSTA1;SLCO1B3;ALB;SLCO2B1;SLCO1B1;HMOX1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.47481768108848776,-1.2462226986828857,0.17391304347826086,0.3762756156160495,1.0,6/16,17.12%,GSTA1;SLCO1B3;ALB;SLCO2B1;SLCO1B1;HMOX1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.43340656217715945,1.246077961211084,0.13559322033898305,0.7684365598563206,1.0,9/43,8.18%,SIX1;GCM1;SIX4;MAPT;NEUROD1;MESP1;PRDM12;NTN5;VXN
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,0.5437966648510687,1.2460515407339237,0.19205298013245034,0.7675889095176904,1.0,6/15,29.80%,EXO1;POLD1;MSH2;POLR1A;MSH6;PCNA
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.40854903060951714,1.2460251119540908,0.16666666666666666,0.7667640527462495,1.0,23/61,24.96%,USH1G;BSN;CABP1;LRRC52;CACNA2D2;FSCN2;TMC1;ATP2B4;PCDH15;WHRN;MYO7A;SYN1;SNAP25;SYP;TWF2;CIB2;TPRN;STX1A;CACNA1D;USH1C;EPB41L1;DNAJC5;TMIE
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.5277958039236853,1.2459757807688419,0.16875,0.7650872447214734,1.0,8/15,33.47%,AP3B2;BLOC1S1;SNAPIN;BLOC1S3;DTNBP1;AP3D1;AP3M2;AP3B1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.5277958039236853,1.2459757807688419,0.16875,0.7650872447214734,1.0,8/15,33.47%,AP3B2;BLOC1S1;SNAPIN;BLOC1S3;DTNBP1;AP3D1;AP3M2;AP3B1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.49679144933976865,1.2458822858345846,0.17482517482517482,0.7644915227326016,1.0,7/18,17.27%,CACNG5;NPTX1;TYMP;ROCK2;NPTX2;TMEM108;SLC8A3
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,0.3995973646444679,1.2457654377852807,0.13020833333333334,0.7639880282969386,1.0,38/66,44.23%,COLEC12;SARNP;DDX39A;CPSF1;SNRPE;CASC3;THOC5;RBM8A;CHTOP;CPSF4;ZNF473;LSM10;UPF3B;LSM11;SNRPB;CSTF2;THOC1;POLDIP3;THOC6;THOC2;DDX39B;SNRPD3;MAGOHB;SLU7;PABPN1;ZC3H11A;SYMPK;CPSF3;ALYREF;SNRPG;CPSF7;SLBP;U2AF1;U2AF2;CPSF6;FIP1L1;RNPS1;PCF11
prerank,MSigDB_Oncogenic_Signatures__JAK2 DN.V1 UP,-0.30624049746924514,-1.245753861677072,0.02857142857142857,0.3768267691555627,1.0,34/130,12.55%,CIDEA;L1TD1;ESRRG;CHST4;NDST3;INA;KRT23;GPR15;ADCYAP1R1;NACA2;PLSCR2;MATN4;CD8B;TSPYL5;NELL2;CXCR2;LAMA1;CDKL2;C9;PTPRO;OR51E2;PIPOX;TGM1;SIDT1;WNT1;LRRC6;XCL2;LILRB5;CCR2;DLGAP1;SPN;PDZRN4;EGR4;SLC8A1
prerank,Elsevier_Pathway_Collection__Osteoblast Function Decline in Gout,-0.4123175151293328,-1.2456454762547207,0.19480519480519481,0.37656233969280833,1.0,9/24,22.68%,TNFSF11;TNFRSF11B;PTH1R;RUNX2;SMAD9;BMPR2;MAP2K3;MAP2K6;SMAD1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5129009684667376,1.245587080350379,0.20224719101123595,0.7637495383231138,1.0,1/17,0.41%,CTNNA2
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.4680958010220745,1.2454126819921412,0.1907514450867052,0.7635363240381805,1.0,8/26,15.01%,GNG4;KCNJ6;KCNJ9;KCNJ5;GNG3;GNB5;GNG8;KCNJ4
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.37127555675221746,1.2454066082205593,0.11961722488038277,0.7626369595575557,1.0,69/145,39.56%,STOX1;CENPF;NEK2;CDC25C;HMMR;PLK1;KIF14;PSMD4;DTL;CDC7;CDK1;TUBA4A;CCNB1;AURKA;PSMB4;CEP131;CDC25A;CETN2;CEP250;HAUS4;HAUS5;TPX2;DBF4B;PLK4;DYNLL1;PSMD1;MECP2;PSMB3;CEP70;SFI1;PSMD14;SSNA1;PSMB5;PSMD2;PSMA1;PSMD10;CSNK1D;PSMC4;PSMC3;TUBA1A;ALMS1;CUL1;CDK4;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;SKP1;PINX1;PSMC5;TUBG1;CEP72;PPP2R1A;PSMB6;PSMD8;NDE1;HAUS1;PSME2;TUBB4B;SDCCAG8;PSMD13;PSMB7;PSMA7;HSP90AA1;CSNK1E;PSME3;CDK2
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.495061914799943,1.2450543294586767,0.21637426900584794,0.7631196485462413,1.0,8/20,33.17%,MAPT;UBAP2L;BICD1;PRRC2C;ATXN2;ATXN2L;DYNC1H1;G3BP1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.48141233271361933,1.2449519937136606,0.2,0.7626085231770361,1.0,7/21,24.40%,TDGF1;MMP21;DNAH11;FOXJ1;STIL;DNAH5;CFAP53
prerank,WikiPathway_2021_Human__Physiological and pathological hypertrophy of the heart WP1528,-0.4068712120810276,-1.2448860620493782,0.18571428571428572,0.3777814687242897,1.0,9/25,21.42%,FOS;LIFR;PRKCB;CTF1;MYEF2;PRKCE;PPP3CA;MAP2K3;JUN
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.3629362439232635,-1.244582680431284,0.07575757575757576,0.378022836736815,1.0,13/44,17.96%,MEGF10;P2RY12;CEACAM5;PDGFRA;HBB;PLEK;XG;UBASH3B;ITGB3;CSRP1;GP1BA;GATA1;DSC2
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.4432642365114891,1.2443547411694882,0.19879518072289157,0.764015998540041,1.0,11/41,11.61%,BANF2;H1-5;PLK1;TOP2A;H1-2;NCAPH;NCAPG;CDCA5;CDK1;CCNB1;H1-4
prerank,WikiPathway_2021_Human__Major receptors targeted by epinephrine and norepinephrine WP4589,0.5415443418019062,1.2440245051667513,0.2,0.7644011808027089,1.0,6/15,21.35%,ADRA2C;ADRA1D;ADCY6;ADCY4;ADCY10;ADCY2
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.3862165580010548,1.243902221885247,0.10945273631840796,0.7640047969335289,1.0,25/99,16.14%,GNG4;GLP1R;GHRHR;PTH2R;GCG;CALCA;GNAZ;RAMP1;GPHA2;HTR4;AVPR2;CRHR2;PTHLH;GNG3;ADM2;GPR150;RAMP2;LHB;MC1R;GNB5;ADCY6;IAPP;GNG8;PRKCA;ADORA2A
prerank,Elsevier_Pathway_Collection__Replication Stress Triggers Genomic Instability,0.46301892193985983,1.2436916257186676,0.17277486910994763,0.7639277768533483,1.0,16/29,39.56%,CDC6;TONSL;CDT1;CHAF1A;FHIT;ATRIP;BLM;MMS22L;PCNA;RBBP7;RAD1;TOPBP1;NASP;CDAN1;ATR;CDK2
prerank,Elsevier_Pathway_Collection__Eosinophil Survival by Cytokine Signaling,-0.3282075329002784,-1.2433522101933057,0.13725490196078433,0.3800117951099953,1.0,20/68,17.50%,IL5RA;TNF;IL2RB;IL27;IL15;MAP2K1;CCL2;IL6;IL33;CXCL8;IRF8;AKT1;SYK;PLCG2;MYD88;CSF2;ITGB2;BCL2;GATA1;CSF2RB
prerank,WikiPathway_2021_Human__FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5256953298718934,1.2433023668661274,0.17647058823529413,0.7645930226590854,1.0,5/18,12.73%,SLC34A3;SPP1;PHEX;FGF23;NFKB2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.4701622962226366,1.2432916537965228,0.22093023255813954,0.7637050555272052,1.0,10/29,17.06%,KCNE5;KCNH2;SCN1A;CACNA1G;GJC1;SCN4B;CACNA1C;KCNE4;NEDD4L;FGF12
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.45786748455485693,-1.2431918523132384,0.14473684210526316,0.3799320904213068,1.0,6/18,13.00%,CSF3;NTRK3;NTF3;STAP1;HCK;HCLS1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.39345131835150127,-1.2430844127610845,0.19718309859154928,0.37985256285414876,1.0,12/30,22.05%,IFNG;GHR;SOCS2;IFNL4;IL15;CCL2;CCR2;PTK6;SOCS6;NMI;JAK2;STAT1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.43408844368243815,-1.2423158637817024,0.17204301075268819,0.380818596200498,1.0,5/20,11.04%,NTF3;NTRK2;NGFR;NGF;NTRK1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.5214336764420666,1.2422341803173778,0.19393939393939394,0.7669071965756573,1.0,5/16,20.70%,CDH13;MVB12B;RHBDF2;EGF;WDR54
prerank,Elsevier_Pathway_Collection__Genes with Mutations in Cancer-Associated Resisting to Cell Death,-0.3928936820939411,-1.2418338003181693,0.13432835820895522,0.3813846874064169,1.0,8/31,17.49%,CASP1;MITF;AKT1;CASP6;BCL2L11;CASP7;BCL2;TNFRSF10C
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.42651865001562994,1.2416099928420206,0.15816326530612246,0.768448149506454,1.0,33/47,48.53%,TERT;H3C1;RECQL4;RTEL1;H4-16;POLD1;DNA2;DOT1L;PARP1;PRKDC;BLM;H3-3A;PCNA;DCLRE1B;TERF1;ACD;XRCC6;ATR;RPA2;TERF2;POLD3;APEX1;POLD4;LTO1;WRN;NBN;RIF1;CTC1;RPA1;STN1;MRE11;RAD50;PTGES3
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.41785989905225507,1.2414617254745899,0.17964071856287425,0.7682161586652072,1.0,7/40,7.63%,PAX2;PTK7;STRA8;WNT9B;WNT8B;TESC;BRINP1
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Medulloblastoma,0.48619521989974657,1.2412367524465324,0.18471337579617833,0.7681590047666097,1.0,4/23,6.65%,IGF2;LEF1;MSI1;BIRC5
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,0.41377361080008196,1.2410482682593265,0.1774193548387097,0.7680898414074256,1.0,45/69,47.30%,BUB1B;CDC20;UBE2C;PSMD4;CCNA2;UBE2S;CDK1;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;MAD2L1;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;ANAPC2;PSMB2;PSMA6;ANAPC4;UBC;PSMD9;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;BUB3;PSMB1;PSMD3
prerank,TRRUST_Transcription_Factors_2019__NFKBIA human,-0.44618433894443715,-1.2406368163829986,0.1595744680851064,0.3833092397878669,1.0,5/18,11.86%,IL1B;MMP1;CCL5;TNFSF10;CXCL8
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.41542621995816403,1.2402222133265208,0.17647058823529413,0.7704186704817727,1.0,11/41,15.29%,TEX19;SIX4;WNT4;IRX5;NR5A1;TFAP2C;BIK;AKR1C3;SOX8;LHB;WNT2B
prerank,Elsevier_Pathway_Collection__Podocyte Dysfunction in Glomerulonephritis,0.42736771107058547,1.2401902621042098,0.17647058823529413,0.7696200179825867,1.0,3/48,4.57%,PAX2;NPHS1;NOX4
prerank,MSigDB_Oncogenic_Signatures__KRAS.600.LUNG.BREAST UP.V1 UP,0.3462893888541727,1.2401868133483684,0.08370044052863436,0.768734505628167,1.0,47/226,12.86%,DYNC1I1;KCNC1;CTNNA2;NPHS1;CACNG1;SPINK1;SMPX;ESM1;SLCO4A1;PLVAP;KCNC2;ATP4A;KCNH2;GFI1;BRSK2;NRCAM;TERT;ITGA2;MKRN3;ITPKA;FAM155B;RMST;ANO2;TBX3;MYF6;SHOX;PLAC4;CCL20;NTM;SPHK1;KIF5A;OR2B6;PRRX1;SSTR5;PIWIL1;GRIN2A;KCNJ14;FRMD1;LPL;RNASE1;FUT5;TONSL;MMP10;SLCO5A1;MTMR8;LHB;SNAP25
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.47141086559167916,-1.2400034297279279,0.1827956989247312,0.3841814172481904,1.0,7/17,20.54%,TCN1;MMUT;PRSS3;ABCD4;MMACHC;LMBRD1;MMADHC
prerank,KEGG_2021_Human__Circadian entrainment,0.38627640110128103,1.239944565258553,0.1326530612244898,0.7687697495171493,1.0,23/86,19.62%,GNG4;CACNA1I;KCNJ6;CALML6;GRIN1;KCNJ9;RASD1;KCNJ5;CACNA1G;CAMK2A;GRIN2A;GNG3;CACNA1C;GNB5;ADCY6;GNG8;PRKCA;CACNA1H;GRIN2C;GNG10;ADCY4;ADCY10;NOS1AP
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.2832111580082853,-1.2399106226210392,0.0,0.3839675381838134,1.0,48/199,20.75%,CPNE6;PITPNM3;AWAT2;PCYT1B;MFSD2A;BCHE;SLC44A4;GPD1;PLAAT1;PTPN13;PEMT;LIPH;DGAT2;PIK3C2G;SLC44A3;PHOSPHO1;PLA2G2D;SLC44A5;AGPAT2;ETNK2;PLAAT2;PLA2G4A;PLEKHA2;PLAAT3;PLD4;PIK3R5;PIK3R1;TPTE2;PNPLA7;PLA2R1;TNFAIP8L2;TNFAIP8L1;PI4K2B;PLBD1;BMX;PIP4K2A;MGLL;PIK3R4;INPP5D;PLA2G12A;MTMR9;DDHD1;MTMR2;RAB14;PCTP;MBOAT2;GPD1L;LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.5066633823881167,1.239896531196578,0.17333333333333334,0.7680402586392426,1.0,9/16,30.53%,FAM83D;EZH2;ZNF16;DYRK3;ATAD5;GLI1;NPM1;DDRGK1;STXBP4
prerank,Elsevier_Pathway_Collection__Centriole Duplication and Separation,0.4464483162984675,1.2398139681724174,0.15384615384615385,0.7675054338519175,1.0,20/33,41.63%,NEK2;TTK;CCNE2;CETN2;CEP250;TPX2;NPM1;PLK4;CROCC;CEP350;SASS6;BBS4;CEP152;CEP170;TUBG1;ESPL1;CDK2;NUMA1;CEP192;NIN
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.4532889388442032,1.2397928234344653,0.13218390804597702,0.7666908165680049,1.0,11/31,24.40%,TDGF1;MMP21;DNAAF1;DNAH11;FOXJ1;DAND5;MEGF8;STIL;DNAH5;CCDC40;CFAP53
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.45412176564807805,-1.2393993214302736,0.23157894736842105,0.3845029016956865,1.0,9/18,15.75%,PTGS2;TNF;IL1B;CD200R1;IL18;IL6;IL33;IGF1;TNFRSF1B
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,0.4002634557860464,1.2388564634250858,0.14835164835164835,0.7696598219399325,1.0,36/72,39.25%,NEK2;HMMR;PLK1;CDK1;TUBA4A;AURKA;CEP131;PRKCA;CETN2;CEP250;HAUS4;HAUS5;TPX2;PLK4;DYNLL1;CEP70;SFI1;SSNA1;CSNK1D;TUBA1A;ALMS1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;TUBG1;CEP72;PPP2R1A;NDE1;HAUS1;TUBB4B;SDCCAG8;HSP90AA1;CSNK1E
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.29065331450011445,-1.2387783176171623,0.0,0.3851236237709234,1.0,40/194,13.05%,ASCL1;TFF1;PKP3;KLK11;TMPRSS3;OVOL2;RET;EGR3;CXCL14;PLAC1;AGR2;PRKAR2B;TH;TFPI2;KRT19;FOS;CA12;ID2;CDH1;HR;NPY1R;DUSP2;CALCR;CXCL12;TPBG;KLF4;PPIF;MEST;SCNN1A;CA2;PTGES;ST14;SERPINA5;LAMC2;CYP26B1;SLC7A5;PLAAT3;LSR;HMGCS2;FAM102A
prerank,TRRUST_Transcription_Factors_2019__NFKB1 mouse,-0.28993944530237636,-1.2386920679002553,0.07407407407407407,0.3849835083438436,1.0,55/179,18.51%,CXCL13;IRF4;FOXP3;IL10;CXCL10;PTGS2;KLF5;IFNG;EGR2;TNF;IL1B;CCL5;FOS;PCK1;CDH1;CD80;ATP12A;CD38;PDK4;TNFSF15;FBP1;IL15;PPARGC1A;NFKBIZ;CXCL2;CCL2;IL6;IL12B;ALOX5;PLA2G4A;PTGES;BTK;REL;TLR4;CCL22;TLR2;SELE;PER1;AKT1;SOX9;VCAM1;CSF2;CD86;BMPR2;CXCL1;KCND2;PLAUR;TNFSF13B;BCL2;HMOX1;EBI3;PMAIP1;DUSP1;LIF;TWIST1
prerank,Elsevier_Pathway_Collection__Follicular Lymphoma,-0.302081403390796,-1.2383004549154664,0.0196078431372549,0.3853432899539731,1.0,29/94,22.05%,CXCL13;IL2RB;FOS;CD79A;FASLG;IL15;ICOS;EPHA7;SCIMP;CXCL12;MS4A1;CD40LG;IL12B;LCK;IL21R;AKT1;CXCR4;TNFRSF13C;IL12RB1;PRDM1;TNFSF13B;BCL2;AR;IL12RB2;GSTP1;JUN;JAK2;CD40;STAT1
prerank,Elsevier_Pathway_Collection__Osteoclast Activation in Rheumatoid Arthritis,-0.34556906687430605,-1.2382332762568162,0.1,0.3850492164661027,1.0,19/57,22.12%,TNFSF11;IL1B;TNFRSF11B;FOS;IL1RAP;MAP2K1;MITF;IL6;TNFRSF11A;AKT1;SYK;MYD88;CSF1R;TAB2;MAP2K6;JUN;JAK2;STAT1;TYROBP
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,-0.3980977042668499,-1.2380320107744403,0.22388059701492538,0.384989649010023,1.0,12/32,17.93%,EREG;ERBB4;ESR1;NRG4;ADAP1;CXCL12;S100B;BTC;PGR;HBEGF;NCOR1;NRG3
prerank,Elsevier_Pathway_Collection__ActivinR -> SMAD2/3 Signaling,0.4944995253189396,1.2379114210865123,0.18787878787878787,0.7725056957620511,1.0,8/22,16.65%,INHA;NODAL;TDGF1;GDF5;MSTN;GDF11;INHBB;SMAD3
prerank,Elsevier_Pathway_Collection__Estrogen Effects on Pregnancy Gingivitis,-0.39610838416225436,-1.2378760986023745,0.11428571428571428,0.38481955765802117,1.0,10/34,13.64%,FOS;CDH1;ESR1;MAP2K1;CCL2;IL6;CXCL8;PIK3R1;AKT1;PGR
prerank,Elsevier_Pathway_Collection__Leukotriene Effect on Vascular Endothelial Cell Response,-0.3720594524228207,-1.2373242621993013,0.1111111111111111,0.3854604166397035,1.0,14/34,22.85%,TNF;NR4A1;CDH1;EGR1;ADAMTS1;CYSLTR2;CXCL8;SELE;VCAM1;TNFRSF1B;IQGAP1;MAP2K3;MAP2K6;MAP3K5
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.36485672410181885,1.237080335776033,0.10666666666666667,0.7744727024671029,1.0,94/161,46.21%,EME1;RECQL4;TRIP13;CDCA5;TONSL;NHEJ1;RAD51AP2;POLQ;XRCC2;NSMCE2;POLN;H4-16;ACTR5;H2AX;BARD1;DNA2;RMI1;FEN1;PARP1;PAXX;APBB1;EYA1;RAD51AP1;RAD51;PRKDC;POLA1;KPNA2;BLM;HMGB2;LIG3;IFFO1;NSD2;PSMD14;CHEK2;NABP2;MAD2L2;MMS22L;MDC1;NSMCE1;RECQL5;POLB;SWSAP1;AP5Z1;ABRAXAS1;XRCC1;PIAS4;BABAM2;POLM;TP53BP1;BAP1;BRIP1;UIMC1;RFWD3;MCM8;SMARCAL1;BRCA2;PAXIP1;FAN1;DCLRE1B;SEM1;CIB1;POLL;EME2;SFR1;VCP;ACTR8;BAZ1B;XRCC3;BABAM1;SPIDR;XRCC6;HPF1;RPA2;HERC2;RAD52;RECQL;ZFYVE26;RAD21;SLX4;DDX1;UBE2V2;UBXN1;RAD54B;SETMAR;SWI5;BRCC3;KDM2A;WRN;INO80;NBN;SFPQ;RIF1;ERCC1;RPA1
prerank,WikiPathway_2021_Human__T-Cell Receptor and Co-stimulatory Signaling WP2583,-0.40481114293135434,-1.237079052708963,0.14666666666666667,0.38549873915976,1.0,11/28,20.91%,CD8B;CD8A;ITK;CTLA4;FYN;LCK;AKT1;RASGRP1;ZAP70;PPP3CA;NFATC2
prerank,WikiPathway_2021_Human__ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.3825555471243971,1.2370583331584026,0.15228426395939088,0.7736617347412327,1.0,17/80,15.52%,NKD1;DKK1;DKK4;LEF1;NOTUM;SFRP4;WNT4;ROR1;NKD2;TCF7;PORCN;EZH2;KREMEN1;PLAU;DVL2;WNT2B;WNT6
prerank,WikiPathway_2021_Human__Mitochondrial complex III assembly WP4921,0.5094602959333221,1.2369518345275292,0.24342105263157895,0.7730961475509305,1.0,10/15,37.08%,UQCRB;UQCRQ;CYC1;UQCC3;UQCR11;UQCC2;BCS1L;UQCRH;UQCRC1;UQCR10
prerank,KEGG_2021_Human__Collecting duct acid secretion,0.48848574426328695,1.236908473951625,0.17159763313609466,0.7723883544932446,1.0,12/23,33.82%,ATP4A;ATP6V0D2;SLC4A1;ATP6V0A1;SLC12A7;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1C1;ATP6V1F;ATP6V1E1;ATP6V1E2
prerank,WikiPathway_2021_Human__Alpha 6 Beta 4 signaling pathway WP244,0.43961350426135565,1.2367249799754538,0.20108695652173914,0.7722476882167856,1.0,8/33,15.74%,LAMA3;PIK3R2;ITGA6;SRC;LAMC1;SHC1;PRKCA;HRAS
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.4466966673523188,1.236674159222593,0.19672131147540983,0.771538556329759,1.0,4/37,4.96%,COL2A1;HOXD3;CHI3L1;HES5
prerank,WikiPathway_2021_Human__Folate Metabolism WP176,-0.3416060176385274,-1.2361796796314464,0.140625,0.3868604786097373,1.0,18/64,12.39%,IFNG;FOLR3;TNF;IL1B;HBA1;APOA1;CAT;HBB;ALB;CCL2;CBS;IL6;SAA4;MAT1A;PLG;MTHFD1;MTHFS;SHMT1
prerank,MSigDB_Oncogenic_Signatures__CTIP DN.V1 UP,0.38596067623909686,1.2361594227073796,0.15463917525773196,0.77268644151135,1.0,18/101,7.50%,GRPR;ODAM;RGSL1;FSTL4;S100A1;PPEF1;OPN1SW;TERT;BCAN;ALPK3;OLFML2B;EGFL7;MYF6;FGF17;RALYL;CCL20;CD34;SALL2
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.49604656468624314,1.2360696029875666,0.19480519480519481,0.772176864928597,1.0,12/22,24.21%,SYN3;PPFIA3;PPFIA4;SYN1;SNAP25;CPLX1;UNC13B;PPFIA2;SYN2;STXBP1;STX1A;LIN7B
prerank,WikiPathway_2021_Human__FOXA2 pathway WP5066,-0.4395469942792826,-1.235928887418715,0.17073170731707318,0.3869583952924424,1.0,9/20,21.31%,GSTA2;GSTA1;FOXO1;SLCO1B1;MTTP;SLC27A5;IRS2;APOB;ABCC3
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.46061221958504706,1.2358346535215277,0.19760479041916168,0.7720569163754714,1.0,9/30,26.76%,GLUL;GOLGA7B;PORCN;ZDHHC11B;ZDHHC11;HHAT;ZDHHC1;ZDHHC9;CLIP3
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,-0.42967222843520136,-1.2357500987032446,0.1951219512195122,0.3868971356072571,1.0,10/21,21.34%,GSTA2;SLC28A3;GSTA1;XDH;SLC28A2;VAV1;TPMT;VAV3;GSTM1;NUDT15
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.44002957323110026,1.2356687287848371,0.16201117318435754,0.7717986769421477,1.0,7/34,18.45%,GNG4;RGS9BP;GNG3;CCT3;GNB5;GNG8;GNG10
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,0.4062543877716179,1.2356651115761201,0.14130434782608695,0.7709162199388214,1.0,45/59,47.90%,UTP14A;DCAF13;UTP25;NHP2;HEATR1;WDR46;NOP58;PDCD11;RRP9;RPS14;NOP2;TRMT112;NOC4L;NOP56;FBL;DKC1;RPS2;RRP7A;SNU13;UTP15;NOP10;DDX49;RPS7;TSR3;TBL3;DHX37;BUD23;WDR75;UTP4;RRP36;IMP4;UTP18;PWP2;PNO1;NAT10;NOL6;RPS9;EMG1;UTP20;DIMT1;RPS6;MPHOSPH10;UTP6;BMS1;UTP11
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,0.4765983092444937,1.235632763288344,0.18292682926829268,0.7701622042164815,1.0,6/23,18.45%,GNG4;SRC;GNG3;GNB5;GNG8;GNG10
prerank,WikiPathway_2021_Human__Glycerolipids and Glycerophospholipids WP4722,-0.433114801067516,-1.2351434929266767,0.17647058823529413,0.38777653267949175,1.0,3/22,6.39%,PLD1;PEMT;DGAT2
prerank,Elsevier_Pathway_Collection__EPCAM in Cancer Cell Motility and Proliferation,0.43604202036718825,1.2349493762794774,0.19230769230769232,0.7719625982212144,1.0,9/35,15.15%,DKK1;LEF1;SOX2;TSPAN8;CCNE1;KREMEN1;CLDN7;POU5F1;DVL2
prerank,MSigDB_Oncogenic_Signatures__CAHOY NEURONAL,0.38715840418626973,1.2348989849080232,0.1326530612244898,0.7712406422463959,1.0,16/76,10.10%,DYNC1I1;RPRML;SYT5;SLC6A7;GABRD;SCG2;NTS;CBLN4;MYH3;RASGEF1A;ICAM5;ITPKA;CKMT1A;HPCA;SH2D5;CELF4
prerank,TRRUST_Transcription_Factors_2019__HDAC1 human,-0.3408192428042901,-1.2340025794967258,0.12962962962962962,0.38976433397129784,1.0,21/70,13.90%,TFF1;SERPINB5;GRIN2B;PTGS2;EPCAM;FOS;SFRP1;CDH1;IGFBP3;ESR1;DEFB1;CD1D;EGR1;RUNX3;KLF4;ABCB1;BCL2A1;CXCL8;CYP3A4;CD82;RARB
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.286592061639933,-1.233608534478073,0.05263157894736842,0.3899805489125899,1.0,73/199,24.95%,TFF1;TMPRSS3;MUC1;OVOL2;RET;EGR3;KRT15;KRT19;FOS;OLFML3;CA12;TBC1D30;ELOVL2;CBFA2T3;FCMR;HR;NPY1R;BCL11B;MSMB;RETREG1;CALCR;CXCL12;TPBG;KAZN;KLF4;PPIF;SCNN1A;THSD4;KCNK15;PTGES;CYP26B1;SLC7A5;TSKU;PLAAT3;FAM102A;RASGRP1;PGR;CISH;ABAT;TIAM1;KCNK5;IGFBP4;BCL2;TPD52L1;ABHD2;ESRP2;PMAIP1;RAB17;DLC1;AR;FRK;AQP3;ADCY1;MYB;KRT13;XBP1;SLC19A2;TIPARP;JAK2;SLC24A3;SLC27A2;ELF1;PAPSS2;GAB2;HSPB8;IGF1R;ANXA9;MAST4;AKAP1;B4GALT1;SLC7A2;SIAH2;TOB1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.4871741511294818,1.233294076288115,0.2261904761904762,0.7757740525676994,1.0,15/21,43.83%,H4-16;POLR2L;POLR2K;POLR2G;POLR2H;POLR2I;POLR2J;TERF1;POLR2A;DAXX;ACD;POLR2B;TERF2;POLR2F;ATRX
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.4871741511294818,1.233294076288115,0.2261904761904762,0.7757740525676994,1.0,15/21,43.83%,H4-16;POLR2L;POLR2K;POLR2G;POLR2H;POLR2I;POLR2J;TERF1;POLR2A;DAXX;ACD;POLR2B;TERF2;POLR2F;ATRX
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.38818297685457814,1.232890660875454,0.155,0.7764679322007192,1.0,41/60,48.29%,NHEJ1;POLQ;NSMCE2;H4-16;H2AX;BARD1;PAXX;PRKDC;POLA1;HMGB2;LIG3;IFFO1;NSD2;PSMD14;MDC1;POLB;ABRAXAS1;PIAS4;BABAM2;POLM;TP53BP1;UIMC1;SMARCAL1;PAXIP1;DCLRE1B;POLL;BABAM1;XRCC6;HERC2;ZBTB7A;UBE2V2;SETMAR;BRCC3;KDM2A;NBN;RIF1;ERCC1;PRPF19;RNF8;MRE11;RAD50
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.35163816032101575,1.2325529249669205,0.11403508771929824,0.7767993270366513,1.0,38/228,12.18%,ALOX15B;PAX2;CTNNA2;HOXD3;DLX1;ADRA2C;LEF1;PLA2G2A;RBM24;AXIN2;MAPK12;NRCAM;TCF15;WNT4;NEUROD1;GATA5;MDK;GDF5;MAPK11;MYF6;BMP4;CD34;TMEM119;BRINP1;NPNT;COL1A1;ZNF703;EZH2;LOXL2;ZNF385A;CDON;LPL;FOXC1;PRKD1;RGCC;CD36;IL6R;BEND6
prerank,WikiPathway_2021_Human__Pre-implantation embryo WP3527,-0.3628747649981253,-1.2325380625106288,0.19402985074626866,0.39140768706131024,1.0,10/40,9.78%,NKX2-1;IRF4;FOSB;BARX2;CDH1;NR3C2;PBX1;DNMT3L;EGR1;KLF4
prerank,Elsevier_Pathway_Collection__ADRA1 -> Ion Channels,-0.45431053670908084,-1.2318882665437947,0.1958762886597938,0.3922722960253642,1.0,3/16,4.99%,ADRA1A;KCNE1;SCN9A
prerank,MSigDB_Oncogenic_Signatures__ESC V6.5 UP EARLY.V1 UP,0.36619958764639,1.2315828678517418,0.12735849056603774,0.7797238160266133,1.0,22/147,12.83%,B4GALNT2;KCNC1;CA4;SYT3;LEF1;PTK7;CELSR3;CCDC114;TERT;LPAR4;SLC29A4;POU3F1;MDFI;SLC16A3;FAM189B;PKDREJ;MAST3;IGSF8;HDAC11;F13A1;SPEF1;KLF13
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.45949228082258303,1.2314852568387649,0.18072289156626506,0.7791662169807763,1.0,15/28,38.12%,PRDM7;BEND3;SUV39H1;ANTKMT;EEF2KMT;KMT2D;KMT5C;SUV39H2;ZNF335;TET3;OGT;SETD4;SETD1B;SETD1A;CSKMT
prerank,Elsevier_Pathway_Collection__Subepithelial Fibroblasts in Middle Ear Cholesteatoma,-0.35018954745564557,-1.231360571922254,0.13636363636363635,0.39292243415744127,1.0,16/45,23.65%,EREG;TNF;IL1B;FOS;IL1RAP;MAP2K1;TGFA;MYD88;CSF2;TNFRSF1B;MAPK10;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,Reactome_2022__Termination Of O-glycan Biosynthesis R-HSA-977068,0.5095030391729174,1.231257638232522,0.1977401129943503,0.7791650065529091,1.0,2/20,0.53%,MUC7;MUC13
prerank,Elsevier_Pathway_Collection__Potassium Cycling in the Inner Ear (Age-Related),0.47932417341882905,1.231166642512338,0.20786516853932585,0.7786522752174022,1.0,5/21,9.05%,GJB6;ATP1A2;TMC1;CLCNKA;PCDH15
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,-0.45919412192698034,-1.2311026489479604,0.23170731707317074,0.3930978894277928,1.0,6/17,17.95%,PTGS2;PARP6;CYP8B1;PARP8;NUDT12;PTGIS
prerank,KEGG_2021_Human__Galactose metabolism,-0.41070358422204073,-1.2310011869629294,0.1518987341772152,0.3928547510392098,1.0,11/26,24.89%,GCK;MGAM2;HK3;UGP2;PGM2;PGM1;MGAM;GALM;AKR1B1;B4GALT1;HK2
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,-0.4303034838094807,-1.2309942313030355,0.18309859154929578,0.3924426109106569,1.0,9/21,22.46%,CD80;CTLA4;FYN;LCK;AKT1;CD86;PPP2CB;YES1;AKT3
prerank,KEGG_2021_Human__Hippo signaling pathway,0.34873988500339215,1.2309105381332963,0.11363636363636363,0.7787101593929382,1.0,29/159,15.52%,NKD1;CTNNA2;PPP2R2C;LEF1;AXIN2;TP73;WNT4;SOX2;WNT9B;SNAI2;WNT8B;GDF5;DLG5;BMP4;NKD2;TCF7;BIRC5;CRB1;AMH;FRMD1;TEAD2;GDF7;APC2;DLG4;SCRIB;TEAD4;DVL2;WNT2B;WNT6
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.3544074984934476,1.2306407796985335,0.12727272727272726,0.7788653075607651,1.0,64/178,35.82%,KIF1A;DYNC1I1;KIF26B;KIF20A;KIF2C;KIF4A;CENPE;KIF5A;AKR1B10;KIF15;KIFC1;KIF18B;KIF18A;KIF23;KIF21B;PAFAH1B3;RAB41;RACGAP1;KIF25;TMED3;KIFC2;NBAS;KIF11;COG8;NAA38;PLA2G6;RAB9B;VPS45;COPE;STX10;NAPSA;KDELR3;TMED9;DYNLL1;COG2;BICD1;MAN2A2;KIF9;RABEPK;ARFGAP1;VPS54;KIF1B;KIFAP3;COPA;STX6;KIF22;RAB43;RAB3GAP2;VAMP4;CYTH3;STX18;CYTH2;COG4;DCTN4;DCTN2;DYNC1H1;RHOBTB3;DCTN3;KIF3B;KIF1C;YKT6;RAB6B;GOLGA8B;KIF2A
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.46899600142151837,-1.2305974094803604,0.20253164556962025,0.39284179197326474,1.0,6/15,19.12%,IFNG;TNF;IL1B;GPLD1;TNFRSF1B;ADAM8
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.4471733517915911,-1.2304452481076151,0.18556701030927836,0.39266013038707015,1.0,4/18,7.22%,MOGAT2;PCK1;DGAT2;MOGAT1
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.39837434696681134,1.2302324292271682,0.17989417989417988,0.7797244459782992,1.0,9/51,8.89%,SLC6A4;SOX2;GAD1;GPRIN1;IRAK1;AGO2;CAMK2A;GRIN2A;AURKB
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.36314269214224487,1.2301557830214056,0.09821428571428571,0.7791473348574961,1.0,34/157,11.65%,KCNC1;KCNF1;KCNJ6;SLC34A3;SLC22A4;GRIN1;TRPM3;ASIC1;SCN1A;RHBG;KCNG2;SCN4A;SLC7A6;KCNK17;PANX2;FGF13;SLC29A4;TRPM5;KCNJ5;SLC6A9;SLC5A4;TRPC6;SLC6A3;SLC5A2;ATP1A2;ATP1A4;SLC5A6;PIEZO2;ABCC8;SLC22A16;KCNH3;SCN4B;SCN2A;KCNS2
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,0.3901333288825339,1.2296282949643598,0.1722488038277512,0.7803497445230354,1.0,17/67,25.29%,PIK3R2;ANLN;ARHGEF10;IQGAP3;DIAPH3;ARHGEF11;RACGAP1;ARHGAP39;MCAM;ARHGEF2;ECT2;ROCK2;ARHGEF28;STARD13;ARHGAP26;MCF2L;PKN3
prerank,TRRUST_Transcription_Factors_2019__ERG human,-0.4063253223859111,-1.2292395886808969,0.15476190476190477,0.39462127763084004,1.0,10/26,17.12%,TDRD1;CRISP3;KCNN2;HPGD;WNT11;ADAMTS1;CXCL8;CXCR4;EPB41L3;HMOX1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.36397481768394124,-1.2286760584661265,0.16071428571428573,0.3953483953279328,1.0,7/44,15.16%,GSTA2;IL10;IFNG;IL12B;LCP1;SERPINB2;IL12RB1
prerank,Elsevier_Pathway_Collection__Androgen Induced Sebocyte Hyperfunction,-0.44801697630858506,-1.2286718948447488,0.18604651162790697,0.39492374613853654,1.0,9/16,23.89%,FGF10;SRD5A1;FOXO1;AKT1;IGF1;AR;FADS2;IGF1R;PTEN
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.5319734404464875,1.227889096663289,0.22929936305732485,0.7864203621734688,1.0,4/16,8.79%,GLUL;PRODH;GAD1;ARHGAP11B
prerank,Reactome_2022__Synthesis Of Prostaglandins (PG) And Thromboxanes (TX) R-HSA-2162123,-0.4449174874613624,-1.2277527000298738,0.22093023255813954,0.39627459653955466,1.0,7/15,17.95%,PTGS2;HPGD;CYP8B1;PTGES;TBXAS1;HPGDS;PTGIS
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.35060289638514525,-1.2277440516165037,0.12698412698412698,0.395885919561482,1.0,15/53,21.15%,CIDEA;ACOT11;IL1B;IL18R1;IL15;WNT10B;ARRDC3;TLR4;ABHD6;PLCL2;CCDC3;PCTP;GSTP1;NPR3;MAP2K6
prerank,WikiPathway_2021_Human__Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.534849478792535,1.2273025760952916,0.24025974025974026,0.7880224027378594,1.0,3/17,6.66%,LEF1;TCF7;SRC
prerank,MSigDB_Oncogenic_Signatures__PRC2 EDD UP.V1 UP,0.3605316558077461,1.2272168093383415,0.091324200913242,0.787504279627408,1.0,85/174,36.90%,LMOD1;APLP1;PLK1;KIF4A;BUB1B;RECQL4;CDC45;HELLS;KIF23;PFKFB4;MCM2;CDCA8;MVD;SYN1;PACSIN3;CHAF1B;MYBL2;CAD;ORC1;CSPG4;INHBB;MCM10;TNFRSF10D;HS6ST1;POLD1;ANKZF1;GSDMD;MRAS;MCM5;SCD;ASF1B;BBC3;PCDH12;ZNF446;FBXL6;RAD54L;TCIRG1;CLSPN;EHMT2;MAP3K6;DBF4B;LIPE;TMEM59L;OSGEPL1;TSC2;DLK2;POLA2;GLI1;MFHAS1;ABCB8;SURF2;PRMT7;AMDHD2;ATP13A2;TRPM4;RANGAP1;LRRC20;ABCB9;INCENP;MCOLN1;FKBP5;TNK2;RAPGEF1;TACC3;CUL9;FASN;DUSP7;MAPK7;QTRT1;DNAJB2;PEAK1;TUT1;NUP188;RASSF1;TCAP;VAC14;WIZ;ARHGAP19;TRMT2A;DCLRE1B;TUBGCP2;DDX31;EXOSC2;TBL3;SLC35C2
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.483143050009158,1.2270973687707487,0.18787878787878787,0.7870723592222195,1.0,2/22,0.41%,B4GALNT2;B3GALT1
prerank,Elsevier_Pathway_Collection__FPR1 -> Cytoskeleton Signaling,-0.4216859747963,-1.2269896644197367,0.18421052631578946,0.3970647723584163,1.0,10/22,25.20%,FPR1;FPR2;SYK;FPR3;LAT2;VAV1;IQGAP1;PIK3CG;ANXA5;GNAI2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.4895231992210037,1.2268213379083126,0.20496894409937888,0.7872398073685211,1.0,3/20,7.73%,CACNG1;CASQ1;ATP1A2
prerank,TRRUST_Transcription_Factors_2019__ESR1 human,-0.3311315640436403,-1.226816266914971,0.08,0.3969698980350158,1.0,12/71,8.69%,TFF1;CYP2C19;RET;CRHBP;PLAC1;KRT19;FOS;CDH1;ESR1;OXT;CXCL12;TGFA
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.41258081948966807,1.2265817179712812,0.1518324607329843,0.7873798835109131,1.0,14/50,16.51%,C1QTNF3;GFI1;WNT4;SNAI2;DKKL1;ERFE;CD34;ATP2B4;AKR1C3;SOGA1;GLA;PGP;C1QTNF12;ROCK2
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.35633997377093046,-1.22646503370696,0.18333333333333332,0.3972645664345022,1.0,20/39,19.67%,IFNG;TNF;CHIA;TLR3;FFAR2;IL18;EGR1;IL6;IL33;TLR4;TLR2;TSLP;LILRB4;CSF1R;LGALS9;HMOX1;SIGIRR;AIF1;WNT5A;C5
prerank,KEGG_2021_Human__Nicotine addiction,-0.3909836317891239,-1.2262315641788097,0.14864864864864866,0.39725943319388185,1.0,9/30,8.02%,GABRA5;GABRA3;GRIN2B;GABRB1;GABRA4;GABRG1;CHRNA6;GRIA3;GABRG3
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.348516599929574,-1.2257991457772872,0.12307692307692308,0.39777431639083943,1.0,17/58,13.81%,CEACAM6;L1CAM;DSCAM;CDH1;IGSF9;CNTN6;CEACAM5;DSG2;IGSF11;VSTM2L;ROBO2;PCDHA7;CD84;AMIGO2;EMB;CNTN4;CDH4
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.31696518225828635,-1.2255907742841339,0.04838709677419355,0.39784029973011303,1.0,15/71,13.06%,CSF3;PFN2;IFNG;TNF;NTRK3;NTF3;CALCR;IL6;OSM;NGF;TCL1A;SH2D3A;FNIP2;HCLS1;AKT1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.47084467725167356,1.225473896099827,0.1797752808988764,0.7908746263570812,1.0,5/28,9.99%,MT3;THY1;LRP4;FGF13;LINGO1
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.4985066553587377,1.2252027617433647,0.21818181818181817,0.790169473016971,1.0,13/16,44.26%,H2AW;HMGA1;SMARCA4;SMARCD3;SMARCC1;NFE2;ARID2;ARID1A;GRWD1;SMARCB1;SMARCC2;SMARCE1;SUPT16H
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.4985066553587377,1.2252027617433647,0.21818181818181817,0.790169473016971,1.0,13/16,44.26%,H2AW;HMGA1;SMARCA4;SMARCD3;SMARCC1;NFE2;ARID2;ARID1A;GRWD1;SMARCB1;SMARCC2;SMARCE1;SUPT16H
prerank,Elsevier_Pathway_Collection__B-Cell Mediated IgE Production in Asthma,-0.38884974156410446,-1.225042252514342,0.18181818181818182,0.3984608279218185,1.0,9/28,16.76%,TNFRSF17;CD79A;TNFRSF13B;CD40LG;AKT1;TNFSF13;SYK;TNFRSF13C;TNFSF13B
prerank,Elsevier_Pathway_Collection__HRH2/4 -> IL6/10 Production,-0.41574743305016737,-1.2250316213128918,0.23809523809523808,0.3980671739920377,1.0,6/23,13.38%,IL10;CD4;MAP2K1;HRH4;IL16;RASGRP1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.41092062303864263,1.2250176392261962,0.17297297297297298,0.7900023522064862,1.0,13/52,13.92%,ESM1;VEGFD;E2F7;CDH13;ROBO1;TDGF1;BMP4;FGF2;E2F8;LOXL2;NAXE;RAMP2;PGF
prerank,TRRUST_Transcription_Factors_2019__USF1 mouse,0.5320097273882021,1.2250073261129617,0.2229299363057325,0.7891377164918087,1.0,5/15,8.70%,SPP1;PRND;GATA5;BDNF;COL1A1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.3606209685286853,1.2246457642187218,0.10849056603773585,0.7897037083117551,1.0,46/146,23.94%,APLN;POPDC3;OSR1;SGCZ;TNNI3;ALPK3;MESP2;TDGF1;GATA5;POU4F1;MESP1;SCUBE1;BMP4;GPC3;MMP21;FOXC1;PDLIM7;SOX18;CACNA1C;FOXL1;RAMP2;MICAL2;PDGFB;SH3PXD2B;KAT2A;DVL2;HTR2B;DAND5;MEF2D;TBX19;PKD1;FGF12;MEGF8;ACVRL1;PDLIM4;TGFBR3;PDLIM3;FOXC2;TGFB2;BORCS8;CRELD1;LDB3;TSC2;EPHB4;MYBPC3;FBN1
prerank,Elsevier_Pathway_Collection__AXL Receptor Inhibits Macrophages and Dendritic Cells Function,-0.36600064966743795,-1.223555115033115,0.14925373134328357,0.4006978165332396,1.0,16/39,25.66%,TNF;FOS;TLR3;IL6;AXL;IL12B;TICAM2;TLR4;MYD88;MAP2K3;JUN;STAT1;MAP3K5;MAP2K4;CD14;PROS1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.43526554731831746,1.223551458016636,0.17857142857142858,0.7932756397966764,1.0,5/41,12.96%,HMGA2;MAPT;WDR76;USP51;SMYD2
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.3141393232699592,-1.2231145857506103,0.09375,0.4010160712346384,1.0,29/99,18.69%,IRF4;MUC1;IL13RA2;IL10;PTGS2;TNF;IL1B;MMP1;FOS;FASLG;IL18;FOXO1;CCL2;IL6;IL12B;ALOX5;CXCL8;GATA3;CCL22;PIK3R1;AKT1;VCAM1;TNFRSF1B;ITGB2;BCL2;HMOX1;LIF;TWIST1;BATF
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,0.4054327035200573,1.223090886102967,0.1595744680851064,0.7943057970130356,1.0,44/69,47.30%,UBE2C;PSMD4;CCNE1;CDC6;CCNA2;UBE2S;CCNE2;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;CDK2;ANAPC2;PSMB2;PSMA6;ANAPC4;UBC;PSMD9;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;PSMB1;PSMD3
prerank,Reactome_2022__Fertilization R-HSA-1187000,0.525565955454081,1.223025940760126,0.21604938271604937,0.7936921650183029,1.0,10/16,31.83%,KCNU1;ZP3;CATSPER1;ACR;CATSPER2;IZUMO1;ADAM21;OVGP1;CATSPERB;CD9
prerank,"WikiPathway_2021_Human__GPCRs, Class B Secretin-like WP334",0.4750422393986229,1.2228696732372646,0.2077922077922078,0.7934421526450912,1.0,5/22,8.34%,GLP1R;GHRHR;PTH2R;ADGRL1;CRHR2
prerank,WikiPathway_2021_Human__Lung fibrosis WP3624,-0.33479749285953636,-1.2225093903804458,0.12307692307692308,0.4016721794980875,1.0,20/60,11.86%,CSF3;MUC5B;TNF;IL1B;HGF;CCL5;SFTPA1;CCL4;CCL3;CXCL2;FAM13A;TGFA;CCL2;IL6;BMP7;IL12B;CCR2;CYSLTR2;GREM1;CXCL8
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.42129557027192754,-1.2223807130928364,0.14893617021276595,0.4014666431726778,1.0,4/18,6.58%,CRHBP;SFRP1;SSTR2;ESR1
prerank,Reactome_2022__Dectin-2 Family R-HSA-5621480,0.48444552279019215,1.2223668575512376,0.23076923076923078,0.7946819723981043,1.0,2/22,0.53%,MUC7;MUC13
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.3922116247861654,-1.2223539538848518,0.14285714285714285,0.4010837455287291,1.0,10/27,22.19%,PCK1;ENO3;ALDOB;FBP1;ALDOC;SLC37A2;PCK2;ENO2;SLC25A10;PCNX4
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.42921169292353634,1.2223505918410238,0.1676300578034682,0.7938835460114287,1.0,5/37,7.32%,HMGA2;PAX2;OSR1;ELL3;MEOX1
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5331496128421932,1.2218279870707451,0.19463087248322147,0.7951885201804308,1.0,13/15,43.05%,CCT3;NHP2;DKC1;RUVBL2;NOP10;RUVBL1;CCT8;CCT6A;CCT4;CCT2;CCT7;CCT5;SHQ1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.5293224832291437,1.2217962348007563,0.24260355029585798,0.7944368606872791,1.0,13/16,42.78%,GPR137C;GPR137B;LARS1;CLEC16A;TELO2;LAMTOR5;RRAGD;PIP4P1;RRAGA;PIH1D1;GPR137;KLHL22;RRAGB
prerank,Elsevier_Pathway_Collection__IDO1 in Cancer Immune Escape,-0.3371294785638551,-1.2216616013708614,0.14035087719298245,0.4019567538480403,1.0,16/61,15.71%,IL10;IFNG;TNF;IL1B;CD200R1;CD80;TDO2;CTLA4;IL6;CD40LG;CD247;DOK2;TLR4;AKT1;MYD88;CD86
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.32718978651378894,-1.2215915423783004,0.08928571428571429,0.40168059946633405,1.0,24/67,18.83%,ERBB4;GHR;IFNL4;PDGFRA;IL15;EPHA1;ITK;FGFR2;FYN;BLK;NTRK1;BTK;LCK;FLT3;HCK;TTBK1;SYK;FGR;CSF1R;BMX;PTK6;ZAP70;EPHA3;DDR2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4692333593286069,1.2212458435920401,0.18857142857142858,0.7956586890290411,1.0,4/26,10.18%,CTNNA2;BRSK2;FRMD7;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.476887202946254,1.221128389293532,0.2,0.7952414980378232,1.0,3/22,4.55%,REG3A;SNAI2;MDK
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.3051284084982534,-1.22093859311798,0.0625,0.40264566370283983,1.0,47/123,22.80%,LRRC19;PTGS2;ACE2;ZBP1;P2RY12;TKFC;PTPN22;BST1;CASP1;PDGFRA;XCL1;IL1RL2;CNGA1;ALOX5;CCR2;PTGES;FCGR2B;HERC5;HCK;SELE;FGR;USP18;MYD88;CXCR4;PDE6G;MGLL;GP1BA;TRIM5;PDE6A;GGT2;SHPK;WNT5A;AHSG;AKNA;NOD2;AGTR1;NLRP6;GUCA1B;CD55;JAK2;TMSB4X;PIK3AP1;F2;DHX58;CASP4;PDE6B;ADGRA2
prerank,KEGG_2021_Human__Calcium signaling pathway,0.34838897491698423,1.2206331490351467,0.0730593607305936,0.796312166763214,1.0,50/211,17.69%,GRPR;CACNA1E;CACNA1I;FGF20;VEGFD;TNNC1;CACNA1S;CALML6;GRIN1;P2RX5;CASQ1;ITPKA;HTR4;FGF17;CACNA1G;ADRA1D;PTGER1;FGF2;PTGER3;SPHK1;FGF23;ATP2B4;CAMK2A;PDE1C;PDGFRB;GNAL;GRIN2A;OXTR;ATP2A1;CHRM5;CACNA1C;BDKRB2;PDGFB;PTGFR;FLT1;PDGFA;BDKRB1;P2RX2;GRM1;PRKCA;HTR2B;CAMK1D;ADORA2A;PLCD3;TACR1;CACNA1H;MYLK2;SLC8A3;EGF;PLCD4
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,-0.4398638928753358,-1.2204503865643912,0.16049382716049382,0.4030775544988839,1.0,11/19,22.80%,SLITRK6;NTRK3;IL1RAPL2;SLITRK3;IL1RAP;PTPRD;SLITRK4;PTPRS;PPFIBP2;SLITRK5;PPFIBP1
prerank,Elsevier_Pathway_Collection__Alcoholic Dilated Cardiomyopathy (Mouse Model),0.4617383831605399,1.2203823457604426,0.21951219512195122,0.7964696386511582,1.0,3/26,2.50%,TNNC1;ACTN2;TNNI3
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,0.418213662894704,1.2203375950814535,0.1781609195402299,0.7957207194002576,1.0,5/42,1.91%,REG3A;BPIFB4;BPIFA2;PLA2G2A;LCN2
prerank,WikiPathway_2021_Human__Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.3945260261496413,1.2200995619524908,0.21243523316062177,0.7958257027238395,1.0,22/68,27.41%,PRKAA2;SQLE;FDPS;LPL;MVD;ACLY;ACACA;SREBF2;PPARG;HMGCR;SCD;IDI1;PPARGC1B;FDFT1;GPAM;LPIN1;HMGCS1;CYP51A1;PRKAB2;INSIG2;ATF6;SEC31B
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,0.37011811913512704,1.2200978289381412,0.15196078431372548,0.7949510747528683,1.0,16/113,9.80%,NPHS1;CDH8;KIRREL2;ACTN2;PIK3R2;CLDN19;CDH13;SDK1;ITGA6;CLDN15;SRC;PARVB;CDH24;NECTIN1;CLDN6;CDH17
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.41967793499685263,1.2199073874121338,0.22105263157894736,0.7948760659583161,1.0,41/62,47.30%,PSMD4;CDC6;MCM2;CDT1;MCM6;PSMB4;ORC1;MCM3;MCM5;MCM4;GMNN;MCM7;PSMD1;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;MCM8;PSMC5;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;ORC6;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Parkinson's Disease,-0.2998994003377855,-1.2198062048299843,0.1111111111111111,0.40404501559395334,1.0,11/88,5.52%,TAC1;NR4A2;PNOC;HTR2A;IL10;PTGS2;TNF;TH;IL1B;HGF;LRRK2
prerank,WikiPathway_2021_Human__Nephrotic syndrome WP4758,0.4283368928337377,1.2192318343278405,0.18994413407821228,0.796650427693891,1.0,7/42,12.81%,PAX2;NPHS1;ANLN;TRPC6;COL4A5;PODXL;LMNA
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,-0.3060889132477407,-1.2192310532800166,0.06521739130434782,0.4049162173842077,1.0,23/98,14.94%,CLEC4M;CLEC1B;EGR3;IL10;PTGS2;EGR2;TNF;IL1B;CASP1;PIK3CD;CLEC4D;NLRP3;IL6;CLEC4E;RRAS2;IL12B;CCL22;CLEC7A;PIK3R1;AKT1;SYK;PLCG2;FCER1G
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.3500484299904737,1.2192213774399767,0.11504424778761062,0.795822831946495,1.0,41/198,14.49%,DKK1;SCG2;COL7A1;APLP1;LAMA3;SPP1;SFRP4;THY1;GLIPR1;MATN3;CAP2;ITGA2;SNAI2;CTHRC1;FAP;NTM;FGF2;EDIL3;IGFBP2;BDNF;COL4A1;MSX1;PRRX1;ELN;PDGFRB;COL1A1;TIMP1;SLC6A8;LOXL2;COMP;COL11A1;PTHLH;OXTR;COL4A2;LAMC1;IL32;LOXL1;TPM2;COL1A2;HTRA1;COL5A1
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.3677943031343266,-1.218869803927864,0.10126582278481013,0.4052090571476591,1.0,22/37,29.34%,F9;KLKB1;GP5;SERPINA5;ZNF160;PF4V1;SERPING1;KNG1;CD177;F13B;F3;GP1BA;F7;PF4;SERPIND1;THBD;PROS1;FGG;FGB;F8;PROC;F2R
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5187489959256355,1.2188439173896473,0.23214285714285715,0.7966246795791805,1.0,3/16,3.38%,MAFA;KCNC2;NEUROD1
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.3708893888630562,-1.2187609510750215,0.13095238095238096,0.40504876706677356,1.0,10/35,14.55%,IL10;PRKAR2B;IGLL5;FYN;CD247;ADCY5;HCK;SYK;FGR;PLCG2
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.5255285046180895,1.2181442946531742,0.2413793103448276,0.7985336332138566,1.0,6/16,15.53%,AQP6;AQP8;UPK3A;SLC26A6;PDPN;AQP9
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,0.4381284477978782,1.2179085111739862,0.15517241379310345,0.7984513653452779,1.0,12/36,28.73%,FGF20;FGF13;FGF17;SRC;FGF23;SHC1;HRAS;FGF18;PLCG1;UBA52;FGFR4;KLB
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.3342198630078322,1.217669416506182,0.08786610878661087,0.7984664647520102,1.0,78/337,15.74%,KCNH6;GNG4;CACNA1E;KCNC1;CHRND;KCNF1;CACNB4;SLC6A4;KCNJ6;HCN2;GLUL;RASGRF1;ACTN2;CACNG4;GABRR3;KCNC2;KCNH2;GABRQ;PRKAA2;MAPT;GAD1;KCNG2;KCNJ9;SLC6A11;KCNK17;CACNA2D2;CHRFAM7A;PANX2;NRXN3;CHRNB2;KCNJ5;KCNB1;GPRIN1;CHRNA3;SRC;SLC6A3;SYN3;GRIK4;CAMK2A;SYT2;CHRNB4;GNAL;GRIN2A;KCNJ14;KCNN3;GRIP2;GNG3;GRIN3B;IL1RAPL1;CHRNA5;RNASE1;ABCC8;HCN3;MPP3;PPFIA3;RASGRF2;KCNH3;PPFIA4;KCNS2;CHRNA4;SYN1;SLC1A2;CACNA2D3;SNAP25;CPLX1;PPM1F;CACNG8;UNC13B;PPFIA2;GNB5;ADCY6;PDPK1;GNG8;KCNJ4;GRM1;KCNJ11;PRKCA;HRAS
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.4688366733911688,1.2165746293531334,0.18888888888888888,0.8020361793621934,1.0,7/22,8.27%,SYT5;FGF20;SYT3;CHRNB2;SYT15;PRKN;SYT2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.4345635043790432,1.216519096409343,0.21264367816091953,0.8013647757304483,1.0,11/29,24.84%,DLK1;EGFL7;NOTCH3;BEND6;EGF;HIF1AN;DLL4;HEY1;DLK2;LFNG;METTL3
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.5120651001956853,1.2162457091722982,0.21739130434782608,0.8015331254149087,1.0,2/17,5.57%,HMGA2;TOP2A
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.4193177399459961,1.216233103158944,0.21105527638190955,0.8007074250527453,1.0,22/43,38.68%,KIF4A;ARHGEF10;KIFC1;AURKB;KIF23;RACGAP1;KIFC2;KIF11;PRC1;TPX2;CHEK2;ABRAXAS1;SMC3;MAP10;WRAP73;CCDC61;KIF3B;TOGARAM2;SMC1A;KIF2A;STAG2;FLNA
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.4587326782696912,1.2160298392312177,0.21243523316062177,0.8006493501498964,1.0,14/32,32.40%,HMGA2;PARPBP;POLQ;UBQLN4;RADX;UBR5;OTUB2;HSF1;FANCB;MAD2L2;OGG1;SHLD3;TP53BP1;RMI2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.47419074111894777,1.2158690181454659,0.23809523809523808,0.8003945829897442,1.0,2/20,4.06%,DKK1;INPP5J
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,0.47421927047349277,1.2157708378094405,0.2085889570552147,0.7999326363915278,1.0,7/23,19.19%,GJB6;SRC;CLTCL1;GJB7;GJA5;GJB3;CLTB
prerank,MSigDB_Oncogenic_Signatures__LTE2 UP.V1 DN,-0.28117612459844465,-1.2152074974560567,0.08571428571428572,0.4118690469583572,1.0,75/179,27.57%,ASCL1;EGR3;DSCAM;PRKAR2B;TFPI2;CA12;OASL;ELOVL2;CBFA2T3;NPY1R;DUSP2;SAMD9;ANXA3;CALCR;LAMP3;XK;KAZN;BHLHE41;KLF4;AMIGO2;PTGES;HERC5;MYO10;DDX60;NFIL3;USP18;PPM1E;WIPF1;BCL2L11;IFIT3;PTER;EPB41L2;BCL2;MATN2;IGSF1;PMAIP1;GADD45A;PSAT1;ZNF43;DLC1;UBE2L6;OAS3;AGTR1;OAS2;IL24;NMI;IFIT1;JAK2;SLC24A3;SYTL2;GEM;ELF4;IFIH1;JMJD1C;NCBP1;IGF1R;DDX58;OAS1;TRIM14;TFAP2A;IRF9;PLSCR1;LGALS3BP;ID1;ATF3;GCA;PSMB9;IFI44;TM4SF1;SP110;CALB2;SP100;PEG10;HERC6;MOCOS
prerank,MSigDB_Oncogenic_Signatures__ESC V6.5 UP LATE.V1 DN,0.3546080084534284,1.2149527350816771,0.16279069767441862,0.8022285813188158,1.0,48/155,26.21%,NPHS1;SFN;SULT4A1;TEX19;SPP1;NOTUM;TCF15;MSC;CBR3;FGF17;FAM169A;E2F8;TIMP1;KIF18A;PRX;GPATCH4;RASIP1;KLK10;PTCD1;INHBB;RRP12;GJB3;ZNF423;MRAS;TTYH2;CBX7;GPX2;BNIPL;TMEM79;LOX;CLTB;BCL3;ZBTB45;ETV4;PRCC;DYRK3;MGP;POLA1;CRMP1;GLI1;AP4M1;WDR46;ZMYM3;RRP9;ABCA2;ADA;MYC;S100A6
prerank,Elsevier_Pathway_Collection__non-Hereditary Genetic Rearrangements in Neuroblastoma,0.460154028022032,1.2144624883084307,0.20670391061452514,0.803501639943033,1.0,8/29,16.80%,HOXD10;E2F1;TERT;CDKN2A;E2F2;NME1;ODC1;RHOC
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.4162831084828311,1.2139952387402455,0.21025641025641026,0.804520512362619,1.0,12/44,14.85%,PRSS56;CDH13;CCL26;MDK;FGF2;PDGFRB;HSPB1;PRKD1;IL6R;PDGFB;PPM1F;SMOC2
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.35683403350992826,1.2137191685241129,0.11981566820276497,0.8047652453895235,1.0,31/158,16.38%,MT3;AVIL;KIF1A;CTNNA2;PTK7;PAK3;GFI1;BRSK2;KNDC1;MDK;ITGA6;STMN2;ACP4;SERPINI1;ROR1;PLK5;FRMD7;TOX;BDNF;ARHGAP44;PRAG1;IL1RAPL1;PRKD1;CBFA2T2;PPFIA2;ABL2;ADCY6;RTN4RL1;DBN1;CAMK1D;GPC2
prerank,WikiPathway_2021_Human__p38 MAPK Signaling Pathway WP400,0.44649315042446414,1.213191879205392,0.1783783783783784,0.8061236696198537,1.0,9/34,21.40%,RASGRF1;MAP3K9;HSPB1;MAPKAPK2;SHC1;HRAS;MEF2D;TRAF2;TGFB2
prerank,WikiPathway_2021_Human__Histone Modifications WP2369,0.42946159874481893,1.213142420721149,0.19540229885057472,0.8054300290793872,1.0,18/38,38.03%,EZH2;SMYD3;SMYD2;DOT1L;SUV39H1;EHMT2;NSD1;SETDB1;KMT2D;KMT2B;KMT5C;ASH1L;SUV39H2;EZH1;SETD4;SETD1B;SETD1A;EED
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.4269628139654,1.2126225374300352,0.19662921348314608,0.8068768431624115,1.0,13/37,31.44%,E2F1;CDC7;EZH2;CHEK1;PCGF2;RRM2;EHMT2;RAD51;UXT;CBX5;RBBP7;DAB2IP;CBX3
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.4174278619131086,1.2124256908846587,0.19576719576719576,0.8068127459868458,1.0,9/49,18.00%,AVIL;VIL1;CATIP;DIAPH3;MICAL2;SPIRE2;SCIN;PSTPIP2;TWF2
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.4971149960518527,1.2118653798761243,0.20125786163522014,0.8081447493316666,1.0,6/19,11.00%,RASGRF1;ACTN2;GPRIN1;CAMK2A;MPP3;RASGRF2
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.4433060806123238,-1.211391768523253,0.24742268041237114,0.4192908347162346,1.0,3/17,5.74%,RIPK3;ZBP1;TLR3
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.405888980237168,1.2109892356919914,0.17708333333333334,0.810754590946011,1.0,41/51,49.22%,RECQL4;MCM2;MCM6;RTEL1;PIF1;HMGA1;MCM4;TWNK;CETN2;MCMDC2;PARP1;DDX11;RAD51;MCM7;BLM;CHD1L;CUL4B;UBA52;RECQL5;DDB2;DHX9;DDB1;ERCC2;RECQL;XPC;DDX1;RBX1;UBC;ERCC3;SUPV3L1;SSBP1;WRN;NBN;XPA;RPS27A;RPA1;GTF2H2;MRE11;RAD50;GTF2H5;ASCC3
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.4155574109591459,1.2109604847114281,0.20967741935483872,0.8100047161048114,1.0,11/35,17.74%,TEX19;SIX4;WNT4;NR5A1;TFAP2C;BIK;AKR1C3;SOX8;LHB;WNT2B;MSH2
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.4635510274170424,1.210412918583387,0.27647058823529413,0.8113729481536391,1.0,18/24,47.77%,BOP1;RRS1;RPL10;NOP2;DHX30;RPLP0;TRAF7;NLE1;BRIX1;PPAN;RPL3L;RPL5;DDX28;RPL23A;RPL6;MRPL20;NOP53;RPL3
prerank,Elsevier_Pathway_Collection__High Fat Diet Activates cAMP Related Exocytosis in Synapse and Endocrine Cell,0.46212556197036014,1.2101181666583833,0.21637426900584794,0.8117579471708412,1.0,9/29,20.62%,GCG;RASGRF1;UNC13A;SRC;SYN1;HRAS;STXBP1;RAPGEF3;STX1A
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.44274667137928453,1.210008847349609,0.2,0.8113382594393324,1.0,13/35,30.64%,DISP3;HES5;IHH;GPC2;DHH;STIL;B9D1;GLI1;DISP2;IFT27;SMO;HIPK2;ULK3
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.4237067517836991,1.2098123982521238,0.19886363636363635,0.8113209707325226,1.0,12/38,18.69%,GNG4;KCNJ6;KCNJ9;KCNJ5;GNAL;GNG3;GNB5;ADCY6;GNG8;KCNJ4;GNG10;ADCY4
prerank,Elsevier_Pathway_Collection__HTR1 -> IL6 Production,0.45368091443335357,1.209795562110992,0.1881720430107527,0.8105307431799261,1.0,2/26,1.59%,HTR1D;RASGRF1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.3744491135765455,1.2096963779539176,0.14427860696517414,0.8100445066839895,1.0,43/90,41.54%,NDUFA1;NDUFS6;SAMM50;NDUFV1;NDUFB9;COX20;NDUFA3;NDUFS2;NDUFA9;NDUFAF2;AIFM1;NDUFB11;NDUFA2;NDUFS7;NDUFAF6;NDUFA13;SLC25A33;NDUFA11;UQCC3;NDUFA6;NDUFS8;NDUFV2;SDHAF2;UQCC2;NDUFA8;NDUFB7;COA3;BCS1L;NDUFAB1;COX19;NDUFB2;NDUFB10;NDUFAF8;NDUFAF3;OXA1L;ACAD9;CHCHD4;NDUFB3;NDUFS4;FASTKD3;NDUFB8;COX17;SDHAF1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.3560449133680632,-1.2096565430626998,0.13513513513513514,0.4226723859775041,1.0,6/39,9.64%,GSTA2;CHAC1;GSTZ1;GSTA1;GSTT2B;GSTM5
prerank,KEGG_2021_Human__Prostate cancer,-0.3075416863232333,-1.2095344249020563,0.11428571428571428,0.42254135455997,1.0,10/96,9.97%,KLK3;SRD5A2;SPINT1;PDGFRA;MAP2K1;PIK3CD;FGFR2;TGFA;FOXO1;NKX3-1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.4829443536939267,1.2091296311431605,0.2275449101796407,0.8112584107756438,1.0,8/25,21.49%,COL22A1;COL15A1;PPP1R16B;SOX18;STC1;RAPGEF3;PECAM1;GSTM3
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.39185246100160676,1.2089157189250477,0.18518518518518517,0.8112594530684193,1.0,10/59,15.60%,GNG4;LEF1;AXIN2;TCF7;AGO2;CAMK2A;GNG3;GNB5;GNG8;PRKCA
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.3801222081853179,-1.2088117224406578,0.20634920634920634,0.42358568055511403,1.0,3/35,3.20%,GSTA2;IL10;IFNG
prerank,WikiPathway_2021_Human__Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.41212030227447893,1.208731868526317,0.16304347826086957,0.8110717021081851,1.0,17/46,21.21%,SQLE;ACSL4;FDPS;HSD17B7;MVD;ELOVL3;SREBF2;HMGCR;TM7SF2;SCD;IDI1;LBR;PMVK;NSDHL;CH25H;FDFT1;HMGCS1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.30638412193418463,-1.2086212986908729,0.08108108108108109,0.4235240519711766,1.0,24/116,15.53%,CXCL13;CLTRN;IFNG;TNF;GBP5;MMP1;TPPP2;ESR1;LGALS3;GTF2H4;PLEK;TCL1A;FERMT2;SKAP1;TLR4;LCP1;CLEC7A;FNIP2;TTBK1;SYK;MYD88;CSF2;BCL2L11;CLU
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,0.357584473328603,1.2083227181693768,0.14351851851851852,0.8118744498317442,1.0,56/154,35.24%,TP73;PRKAA2;POU4F1;CDKN2A;MAPK11;EXO1;AURKB;ZNF385A;CCNA2;CDK1;AURKA;SMYD2;SERPINA2;RFC4;PDPK1;CHEK1;BARD1;ING5;DNA2;RMI1;CDK5R1;POLR1A;TPX2;EHMT2;ATRIP;RAD9B;HDAC1;GATAD2B;L3MBTL1;BLM;PDZD2;TAF10;PRKAB2;RHNO1;CDK5;PIP4K2B;CHEK2;UBA52;CHD3;CHD4;NUAK1;PPP1R13L;TAF6;BRPF3;HIPK2;RBBP7;TP63;BRIP1;MLST8;RMI2;TOPBP1;TP53RK;CSNK2B;SGK1;PPP2R1A;SSRP1
prerank,MSigDB_Oncogenic_Signatures__KRAS.KIDNEY UP.V1 DN,0.3642433685942058,1.208268732506979,0.19248826291079812,0.8112263377835268,1.0,20/105,11.78%,ECEL1;KCNF1;AGRP;HHIPL2;RASGRF1;CAPN9;CACNA1S;GPR35;EPS8L3;MSC;EGFL7;BMP4;CCL20;SRC;MDFI;ABCA3;KLHDC8A;KIF21B;PHLDA3;SLC9A3
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.4871259860256661,1.2082311702661972,0.21022727272727273,0.8104746479563092,1.0,11/19,39.54%,CCNB2;CDK1;CCNB1;LMNA;LBR;EMD;LMNB1;BANF1;PPP2R1A;LEMD2;TMPO
prerank,KEGG_2021_Human__Histidine metabolism,-0.44365489975789707,-1.2080889765082692,0.2235294117647059,0.42421514059964155,1.0,16/22,29.32%,CNDP1;UROC1;AOC1;ALDH1B1;FTCD;ALDH2;ALDH3B2;CARNMT1;ALDH9A1;MAOB;AMDHD1;ALDH7A1;ASPA;CNDP2;ALDH3B1;MAOA
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.3631141599588994,-1.207979447223391,0.16216216216216217,0.42401311481521814,1.0,8/35,10.36%,SOX10;ERBB4;SEMA3E;SEMA4A;SEMA6D;SEMA4D;SEMA6A;SEMA3D
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,0.411571260622747,1.2079359354966694,0.21311475409836064,0.8106175082907037,1.0,44/65,47.30%,PSMD4;CDC6;CCNA2;CDT1;MCM6;PSMB4;MCM3;MCM5;MCM4;MCM7;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;MCM8;SKP2;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;CDK2;PSMB2;RBX1;PSMA6;UBC;PSMD9;ORC6;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,Elsevier_Pathway_Collection__IL1 Receptor Antagonist (IL1RN) Deficiency (DIRA),-0.3629877979237244,-1.207577448689068,0.15942028985507245,0.42440534307392036,1.0,11/39,15.75%,TNF;IL1B;IL1RAP;MAP2K1;IL1RN;TICAM2;TLR4;TLR2;AKT1;MYD88;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.35990455506426033,1.207352477421911,0.1320754716981132,0.8121829528819805,1.0,98/154,48.29%,TP73;PRKAA2;POU4F1;MAPK11;BOP1;EXO1;AURKB;ZNF385A;RRS1;CDK1;AURKA;SMYD2;RFC4;PDPK1;CHEK1;BARD1;ING5;DNA2;RMI1;CDK5R1;TPX2;EHMT2;ATRIP;RAD9B;HDAC1;L3MBTL1;BLM;TAF10;PRKAB2;RHNO1;CDK5;PIP4K2B;NOP2;CHEK2;RPS15;CHD3;CHD4;NUAK1;PPP1R13L;TAF6;PIN1;HIPK2;RPL37;RBBP7;TP63;RPS20;RAD1;BRIP1;MLST8;RMI2;TOPBP1;TP53RK;CSNK2B;SGK1;SSRP1;MDM4;PIP4P1;TAF9;DAXX;TAF1;RPL23;RPL5;BRPF1;ATR;CDK2;USP7;RPA2;MTOR;TP53BP2;CDK5RAP3;RFC3;TAF12;RBBP4;NOC2L;TAF5;SUPT16H;TAF9B;MAPKAP1;WRN;STK11;TAF2;NBN;BANP;CSNK2A2;RPA1;KAT6A;TOP3A;NOP53;PRKAB1;PHF20;MEAF6;MDM2;MAPKAPK5;RAD9A;MRE11;MTA2;PRMT5;RAD50
prerank,TRRUST_Transcription_Factors_2019__SOX2 mouse,0.49488626565463056,1.2070242905332436,0.23636363636363636,0.8127890818701704,1.0,5/18,6.65%,LEF1;SOX2;NEUROD1;ZSCAN10;BIRC5
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.423261793940703,-1.2069210904210503,0.16666666666666666,0.42529110629470784,1.0,5/20,12.90%,GRIK3;IL1B;LRRK2;TMEM25;NLGN4X
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.39793594671592036,1.206346226897931,0.19597989949748743,0.8145615490988801,1.0,32/72,34.31%,TICRR;NHEJ1;H2AX;ECT2;MSH2;FIGNL1;AEN;EEF1D;RAD9B;EYA1;RAD51AP1;RAD51;FANCD2;COP1;BLM;RHNO1;INTS3;MYC;BRSK1;NABP2;CDKN1A;CLK2;BRAT1;MRNIP;INTS7;ABRAXAS1;BABAM2;RAD1;UIMC1;RFWD3;TOPBP1;PAXIP1
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5024184316779868,1.2063052077714986,0.24025974025974026,0.813842705355034,1.0,4/17,24.84%,RBM24;ROCK2;DXO;METTL3
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.4472640531275158,-1.206195514371777,0.21686746987951808,0.4263202797471521,1.0,10/17,25.63%,S100A8;CLEC4D;CLEC4E;CLEC7A;S100A12;PLCG2;RNASE7;CX3CR1;CARD9;HRG
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,0.3817013368195494,1.2053872611398622,0.21621621621621623,0.8167215420236253,1.0,20/76,19.75%,GNG4;ARHGEF39;FGD1;ADRA1D;ARHGEF37;ARHGEF10;GNG3;RASGRF2;ARHGEF11;OBSCN;GNB5;GNG8;PLEKHG2;ARHGEF2;ARHGEF15;ECT2;ROCK2;RHOC;GNG10;ARHGEF19
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.3912253228079189,-1.2053033474186305,0.20833333333333334,0.42784645144914324,1.0,7/24,10.36%,DSCAM;SEMA3E;SEMA4A;SEMA6D;SEMA4D;SEMA6A;SEMA3D
prerank,KEGG_2021_Human__ECM-receptor interaction,0.3813531081007443,1.2049079891617076,0.19117647058823528,0.817848421291206,1.0,18/83,11.46%,COL2A1;THBS4;LAMA3;SPP1;COL9A1;VWF;ITGA2;FRAS1;ITGA6;HMMR;COL4A1;COL4A5;NPNT;COL1A1;COMP;COL4A2;LAMC1;CD36
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.4185351545884677,-1.2046618300372283,0.1686746987951807,0.42882447116833394,1.0,9/24,18.43%,IL1B;IL18;CASP1;NLRP3;MEFV;ENTPD5;PSTPIP1;HMOX1;C3AR1
prerank,Elsevier_Pathway_Collection__Medulloblastoma,0.37180103257834096,1.2046347324371118,0.15865384615384615,0.818129609077025,1.0,16/96,10.04%,IGF2;LEF1;AXIN2;SOX2;NEUROD1;CDKN2A;HES5;BMP4;MSI1;TCF7;BIRC5;SRC;CCNE1;CCNA2;CCNE2;NOTCH3
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.4843449439815199,1.2043784350328162,0.2235294117647059,0.818334924639027,1.0,2/15,3.20%,HMGA2;TERT
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.441287369410964,1.2042207482051408,0.1893491124260355,0.818181702180551,1.0,6/31,8.21%,ROBO1;GATA5;SNAI2;BMP4;ELN;EFNA1
prerank,MSigDB_Oncogenic_Signatures__PTEN DN.V2 UP,-0.3031728756497323,-1.2041976060425834,0.07142857142857142,0.42935449891292854,1.0,20/121,8.18%,ERN2;NOL4;SERPINB5;KCNJ3;CHAC1;PTGS2;KRT15;CHRDL1;SATB1;IL1B;IL7R;SPIB;SLITRK3;SH3BGR;GYS2;LIPG;GPM6A;SLCO1B3;ANXA3;GPR183
prerank,TRRUST_Transcription_Factors_2019__TP53 human,0.35342908568614073,1.2038980274845705,0.12556053811659193,0.8186762954351207,1.0,43/159,21.05%,DKK1;SFN;E2F1;TP73;E2F7;TERT;FOXM1;PLK1;ADGRB1;BIRC5;FGF2;CCNB2;MKI67;PDGFRB;RECQL4;UHRF1;EZH2;CCNA2;PTTG1;GDF15;CDK1;CCNB1;TYMS;BDKRB2;FLT1;BGLAP;NME1;PAX5;FRMD5;ANKRD1;HRAS;POLD1;CHEK1;VCAN;SMAD3;PRC1;PIAS3;BBC3;CTSD;BCL3;TP53I3;BTG3;ALKBH2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.33753405533367964,-1.203828382900377,0.125,0.42976192967973037,1.0,14/43,28.81%,EREG;TGFA;BTC;ERRFI1;HBEGF;SH3KBP1;SPRY2;ZFYVE28;SH3GL2;GPRC5A;CBLC;SNX6;RAB7A;EGFR
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.4270102075206477,1.2037133977245191,0.15517241379310345,0.8185373306920546,1.0,9/44,9.36%,KCNJ6;KCNE5;WNK4;ACTN2;KCNH2;KCNJ9;KCNJ5;ATP1B3;KCNN3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hirschsprung Disease,-0.43329622899505177,-1.20349934994263,0.21505376344086022,0.4299142051006386,1.0,8/20,14.22%,SOX10;RET;L1CAM;NCAM1;HAND2;ZEB2;SOX9;EDNRB
prerank,MSigDB_Oncogenic_Signatures__KRAS.LUNG UP.V1 DN,-0.30081607197794014,-1.2033711554609066,0.08333333333333333,0.4297543741005157,1.0,48/108,18.06%,BBOX1;GABRB1;KLK11;CDH12;KRT4;CXCL14;KRT15;SPRR3;SLC3A1;SLC39A2;RHCG;SCRG1;GLYAT;WNT16;PROM1;RDH16;COL19A1;APOBEC3A;CACNA1F;GAS1;FCGR3B;TNFSF10;DEFB1;TF;NGFR;CYP2C18;KRT16;TGM1;EPHB3;MORC1;CCR2;HEY2;SPTBN2;CYP26B1;HAAO;TRGV7;UPK3B;S100A12;CRABP2;MAFB;ADORA3;IL10RA;VAV3;ALDH3B2;METTL7A;INPP5D;AKAP6;SH3BP1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.2905981598815851,-1.2031597302490848,0.09090909090909091,0.42964678397075984,1.0,43/150,21.10%,TNFSF11;RIPK3;TNF;AIM2;IL1B;IL18R1;S100A8;IL18RAP;IL1RAP;IL18;ALK;PRKCB;NLRP3;PRKCQ;IL6;CD40LG;NTRK1;TNFRSF11A;HSPA1B;BTK;CARD11;TRIM34;TLR4;CLEC7A;TRIM22;TLR2;CARD16;S100A12;MYD88;CLU;RIPK4;LGALS9;NLRC4;HSPA1A;TRIM5;AR;ADAM8;WNT5A;NOD2;CARD14;PRKCZ;TAB2;CX3CR1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.3958037405488806,1.2031063402340334,0.17647058823529413,0.8202442606967401,1.0,8/48,7.78%,GJB6;SGCZ;GATA5;MSC;MESP1;BMP4;CACNA1G;MSX1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.40061868211110646,1.2030089998693672,0.2192513368983957,0.8198329240899402,1.0,5/52,3.62%,TLCD3B;CERS1;PLPP2;ALOX12B;SPTSSB
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.36845067764658523,1.202887511724956,0.18009478672985782,0.8194580700337176,1.0,48/104,44.08%,MRPL55;MRPS21;DAP3;MRPL24;MRPS24;MRPS12;MRPL13;MRPL9;MRPS14;MRPS23;GADD45GIP1;MRPL23;MRPL28;MRPL52;MRPL12;IARS2;MRPL15;MRPS28;HARS1;MRPL36;MRPL41;AURKAIP1;MRPL27;MRPL21;MRPS34;TUFM;MRPL17;MRPS15;MRPL51;MRPL22;MRPL4;MRPL33;OXA1L;CHCHD1;MRPL1;MRRF;MRPS5;MRPL43;PTCD3;MRPS27;MRPS18C;NOA1;MRPL58;MRPL50;MRPL2;MRPS11;MRPS26;MRPL49
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.26301492578594865,-1.2027129618481531,0.06451612903225806,0.430081049754903,1.0,59/222,17.07%,ALKAL1;MARCO;ADRA1A;HTR2A;ERBB4;FGF10;EPHB1;CD4;TNF;IL1B;NTRK3;BMPER;CCL5;NEK10;PTPN22;FPR2;CCL4;NTRK2;CCL3;PDGFRA;XCL1;CCL23;MAP2K1;CCR7;EPHA7;SCIMP;DUSP10;GPR183;CALCR;FGFR2;PTPRC;NDRG4;CCL2;HAND2;SEMA6A;CCR1;XCL2;CCN1;FERMT2;NTRK1;P2RY1;CHRNA7;TLR4;CCL22;GAREM1;RASGRP1;SYK;GBP1;MTURN;RPS6KA6;SPRY2;GCNT2;CSF1R;NOTCH2;LGALS9;DUSP26;SYNJ2BP;DUSP6;EZR
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.4091391440692963,1.2026327067924674,0.21052631578947367,0.8195750936932538,1.0,9/46,15.74%,REG3A;EPHB2;CLDN19;VIL1;FGF2;DUOX1;PLAU;CD109;HRAS
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.5103797217859722,1.2024262355577209,0.23870967741935484,0.8195070156647039,1.0,4/16,18.42%,CELF4;SCNM1;PUF60;PQBP1
prerank,Elsevier_Pathway_Collection__Persisted DNA Repair Triggers Genomic Instability,0.4289968156131673,1.2021754336092443,0.22905027932960895,0.819627296106835,1.0,18/32,41.14%,EXO1;NHEJ1;XRCC2;BARD1;FEN1;PARP1;RAD51;PRKDC;MDC1;POLB;ABRAXAS1;UIMC1;BRCA2;XRCC3;XRCC6;ATR;RAD52;TERF2
prerank,Elsevier_Pathway_Collection__AHR Signaling in M1 Macrophages Function,-0.4161677047839337,-1.2017526256878548,0.23529411764705882,0.43140087185565085,1.0,7/22,14.75%,IFNG;TNF;MAF;IL6;IL12B;TLR4;MYD88
prerank,Elsevier_Pathway_Collection__Mast-Cell Activation in Asthma,-0.3168684543131297,-1.2016931180113262,0.08,0.43110791598296816,1.0,17/73,15.00%,TAC1;HAS2;CCL5;MAP2K1;FCER1A;PRKCB;CCL2;LCP2;BTK;CXCL8;LAT;AKT1;SYK;LAT2;PLCG2;FCER1G;VAV1
prerank,Elsevier_Pathway_Collection__Adiponectin Synthesis Declines in Insulin Resistance,-0.34389136202222576,-1.2015230536401642,0.12280701754385964,0.431051079216566,1.0,13/42,21.48%,TNF;FOS;MAP2K1;FOXO1;IL6;PKIA;PIK3R1;AKT1;IGF1;EIF2AK3;IRS2;JUN;JAK2
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.4579034767791761,1.2015144597264538,0.22784810126582278,0.8214927302525861,1.0,9/30,21.35%,GNG4;GCG;GNG3;ADCY6;GNG8;PRKCA;GNG10;ADCY4;ADCY2
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.4266945227887073,1.2013280323359092,0.18562874251497005,0.821295293138538,1.0,23/35,48.37%,RFC4;POLD1;MUTYH;FEN1;PARP1;LIG3;POLB;PCNA;XRCC1;OGG1;LIG1;PNKP;POLL;POLG;RPA2;RFC3;POLD3;APEX1;POLD4;RPA1;NEIL1;RFC1;NTHL1
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.3582698888923163,-1.2013147705232257,0.14084507042253522,0.43102305120505724,1.0,10/40,9.38%,MARCO;SCARA5;JCHAIN;STAB2;IGLL5;HBA1;APOA1;CD163;APOL1;ALB
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5022192274267397,1.2012849627322744,0.2,0.820599096242183,1.0,14/18,43.05%,CCT3;NHP2;DKC1;RUVBL2;NOP10;RUVBL1;CCT8;CCT6A;CCT4;CCT2;CCT7;EXOSC10;CCT5;SHQ1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.49841414025881214,1.2011718165327994,0.26174496644295303,0.8201978750544059,1.0,8/15,43.60%,SRSF12;BARD1;PCBP4;RBMX;PTBP1;U2AF2;SFSWAP;RNPS1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.3616282232269085,-1.2010925775346524,0.1506849315068493,0.4310753370994971,1.0,12/37,18.72%,TACSTD2;AJAP1;SEMA3E;PTPRO;WNT1;PLG;GBP1;EFNA5;GCNT2;THBS1;SPOCK1;FZD7
prerank,Elsevier_Pathway_Collection__CUL4/CRL (SCF4) Complex,0.479578222318866,1.2007631540681671,0.22941176470588234,0.8210728538376526,1.0,12/23,33.35%,DTL;CDT1;KAT2A;MSH2;DET1;HDAC1;COP1;WDR5;CDKN1A;PCNA;DDB2;LIG1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.43427278730354707,1.200646039305855,0.20710059171597633,0.8206402095222279,1.0,22/30,48.53%,TERT;RTEL1;PIF1;NHP2;HSP90AB1;DKC1;TELO2;PPIA;NOP10;PINX1;TERF1;ACD;HSP90AA1;CDK2;TERF2;SHQ1;WRAP53;RPA1;RFC1;MRE11;RAD50;PTGES3
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.3367425753748098,1.200616383659469,0.125,0.8198946825182727,1.0,179/292,49.09%,ELAVL2;NCBP2L;SARNP;SRSF12;PUF60;DDX39A;PRPF3;CPSF1;SNRPE;USP49;SF3B4;POLR2L;GPKOW;CASC3;PQBP1;RNF113A;PRCC;AKAP8L;NOVA2;SNRNP70;THOC5;RBM8A;CHTOP;POLR2K;RBMX2;METTL3;TXNL4A;DDX41;CPSF4;SF3B5;SNRPD2;POLR2G;SF3A2;PRPF6;PPIL3;PABPC1;UPF3B;NOVA1;LSM2;SNRPB;LSM4;SNRPD1;PRPF31;CSTF2;THOC1;LSM7;SRRM2;RALY;POLR2H;GEMIN7;WDR83;SUGP1;POLDIP3;ESS2;RPRD2;TCERG1;FUS;NONO;ZMAT2;THOC6;IK;PPIH;RBMX;POLR2I;RBM10;AURKAIP1;SNU13;POLR2J;SNRPC;RNPC3;THOC2;DDX39B;CCAR1;RBM22;SNRPA;SNRPD3;BUD13;HNRNPU;MAGOHB;SLU7;HSPA8;PABPN1;XAB2;ZC3H11A;DHX9;SPEN;SUPT5H;RBM4B;RBM15B;USP39;RBM41;HNRNPA1;RNMT;RAMAC;POLR2A;ZRSR2;PRPF8;ERCC2;SNRNP35;HNRNPH2;CD2BP2;PTBP1;TBRG4;RBM4;SART1;SYMPK;RBM6;PHF5A;POLR2B;ZMAT5;CPSF3;CLP1;SF3A3;PCBP1;GTF2F1;HNRNPR;UBL5;ALYREF;SNRPG;CPSF7;CRNKL1;CTNNBL1;PSPC1;U2AF1;U2AF2;SNRPA1;SNRNP200;CPSF6;FIP1L1;PPWD1;RBM15;RNPS1;POLR2F;SYF2;ERCC3;SRRT;RBM5;PCF11;GEMIN5;HNRNPM;U2SURP;MTREX;PPIL1;DHX35;DDX5;RBM19;GEMIN6;SFPQ;EIF4A3;RPRD1B;MAGOH;PRPF38A;SF3B3;SART3;PRPF19;CWC27;SNRNP25;PRPF40B;HNRNPUL1;GTF2H2;MFAP1;CWF19L1;SNRNP40;CDC5L;DDX42;HNRNPF;DBR1;CSTF2T;DHX16;SF1;DHX8;SF3A1;ISY1;TFIP11;SF3B6;NCBP2;GTF2H5;SF3B1;RBM14
prerank,WikiPathway_2021_Human__Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.3726104409440399,1.200453378543142,0.1736842105263158,0.8196578538027094,1.0,9/88,8.23%,MAFA;DIO2;AGRP;SLCO1C1;WNT4;SRC;ACTL6B;PRDM16;TRH
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.4478422609099626,-1.200152844655831,0.18518518518518517,0.43253057186841865,1.0,8/19,14.55%,TNF;ID2;PDGFRA;FGFR2;TCF21;CXCL8;RARB;PCSK5
prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.35493626376740356,1.2000318254075157,0.18018018018018017,0.8204945980456257,1.0,28/142,16.94%,CACNB4;CACNG1;KCNJ6;CACNG4;CACNA1S;CACNG5;CALML6;PRKAA2;KCNJ9;CACNA2D2;KCNJ5;SRC;CAMK2A;KCNJ14;OXTR;NPR2;CACNA1C;PLA2G4C;CACNA2D3;CACNG8;PLA2G4F;ADCY6;KCNJ4;PRKCA;HRAS;CAMK1D;ROCK2;MYLK2
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,0.4758730677250681,1.199948803078304,0.23636363636363636,0.8199729496585554,1.0,15/22,43.90%,TERT;CCNA2;RTEL1;PIF1;NHP2;DKC1;RUVBL2;NOP10;RUVBL1;TERF1;ACD;CDK2;TERF2;SHQ1;WRAP53
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.4114395361443711,1.1999043933782652,0.1925133689839572,0.8193259760656343,1.0,37/58,39.72%,PLK1;IPO4;SLC29A2;SRM;RRP12;MCM5;TCOF1;MCM4;PUS1;MAP3K6;BYSL;LAS1L;NPM1;NOP16;PLK4;RRP9;EXOSC5;MYC;RABEPK;NOP2;TFB2M;NOC4L;NOP56;PES1;HSPE1;PPRC1;CBX3;CDK4;PRMT3;DCTPP1;PPAN;HSPD1;MYBBP1A;IMP4;TBRG4;SLC19A1;MRTO4
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.38949530887236583,-1.1997576988579264,0.19718309859154928,0.43288442122768245,1.0,2/25,1.16%,PCSK2;CLTRN
prerank,MSigDB_Oncogenic_Signatures__CYCLIN D1 KE .V1 UP,0.3398657483393977,1.1996801103478827,0.12727272727272726,0.8194063770658647,1.0,39/175,22.70%,GP2;CA4;REN;LCN2;THY1;EVX1;RHO;CDKN2A;S100A2;NTN3;TROAP;CCL20;PDE4C;SLC6A3;KIFC1;CHRNB4;HSF4;CHRNA5;NPR2;DGKD;APOA2;ZIC1;PPM1F;NEK3;POLD1;CGREF1;PCGF2;PKD1;ABLIM1;HSPG2;HGFAC;CDK6;CHKA;PTPRH;PIGC;GOT1;BCL9;NRG1;TSC2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.40697621784702676,1.1992651947876707,0.21164021164021163,0.8201768736715477,1.0,5/54,6.66%,MT3;PAX2;SFN;DPEP1;SRC
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.46372640885381333,1.199236775355681,0.22598870056497175,0.8194476751885669,1.0,11/24,29.01%,FGF13;STMN2;SPEF1;APC2;ARHGEF2;TRIM54;TPX2;CAMSAP2;CAMSAP1;MID1IP1;KATNB1
prerank,Elsevier_Pathway_Collection__Glutamate Overdose and Aura Effect in Familial Hemiplegic Migraine Type 3,0.4919788744112653,1.1992361057599992,0.2532467532467532,0.8186115738420867,1.0,8/18,20.62%,SCN1A;SLC7A6;CAMK2A;SLC1A2;SNAP25;SLC1A3;SNAPIN;STX1A
prerank,WikiPathway_2021_Human__IL-18 signaling pathway WP4754,-0.2690941617770899,-1.1986955126371108,0.058823529411764705,0.4347806214749977,1.0,52/257,15.07%,GRIN2B;CLDN4;IL10;SYT10;DES;PTGS2;TNFSF11;IFNG;TNF;IL1B;TNFRSF11B;MMP1;ACOD1;CETP;CCL5;FOS;NR4A1;IL18R1;FASLG;PLD1;CXCL3;TNIP3;IL18RAP;CCL4;CCL3;IL18;TF;NFKBIZ;SEMA6D;PRKCB;CXCL2;CCL2;HCAR2;ACACB;IL6;UGT2B10;TBX21;IL12B;ACADS;GRM7;CXCL8;REL;TICAM2;LCK;PIK3R1;PTMS;CLDN1;IL17RC;MYD88;RUNX2;CD83;KLF2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.45777128667379047,1.1985995393027546,0.23837209302325582,0.8203446143126698,1.0,13/31,27.09%,KIF1A;EFNA1;ARHGAP44;PPFIA2;DBN1;TANC2;CDK5R1;LRP8;SRCIN1;SHANK3;CDK5;RELN;NGEF
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.3932302650046265,1.1985976017116904,0.1693121693121693,0.8195093056692253,1.0,39/56,47.28%,RPS27;RPS21;EIF3E;RPS5;EIF3K;RPS14;RPSA;EIF3D;RPS15;RPS2;RPS19;RPS4X;RPS20;EIF3H;RPS8;RPS12;EIF3B;RPS3A;RPS7;RPS11;FAU;RPS3;RPS24;EIF3G;RPS16;EIF3M;RPS28;RPS23;EIF2S3;RPS9;EIF3C;EIF3F;RPS15A;EIF3L;RPS6;RPS27A;RPS4Y1;RPS13;EIF3A
prerank,KEGG_2021_Human__Focal adhesion,0.3411585738283362,1.1985515910238678,0.17167381974248927,0.8188500017944045,1.0,41/193,18.80%,COL2A1;THBS4;VEGFD;RASGRF1;LAMA3;SPP1;PIK3R2;PAK3;COL9A1;SHC3;VWF;ITGA2;ITGA6;SRC;COL4A1;PARVB;COL4A5;PIP5K1B;PDGFRB;COL1A1;COMP;COL4A2;LAMC1;PDGFB;FLT1;PDGFA;PGF;COL1A2;SHC1;MYLPF;PDPK1;THBS2;PRKCA;HRAS;ROCK2;LAMB4;MYLK2;EGF;LAMA4;ITGA7;ITGA11
prerank,MSigDB_Oncogenic_Signatures__RAPA EARLY UP.V1 UP,0.3530750519733889,1.1985441993051948,0.19138755980861244,0.8180666767062049,1.0,20/149,10.56%,GRPR;DLX5;PTH2R;TGM4;HOXD10;ST8SIA3;MATN1;SNCG;SHC3;ITPKA;GREB1;AVPR2;ANK1;OLFML2A;PIP5K1B;PAQR4;VGF;FAM50A;CDON;ABCC8
prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.2920904376157131,-1.1984556400269224,0.11428571428571428,0.4347603567932225,1.0,22/116,13.64%,TFF1;KRT39;SHC4;KCNJ3;GNAO1;KRT23;KRT15;KRT36;KRT19;KRT14;FOS;ESR1;MAP2K1;KRT16;PIK3CD;TGFA;HSPA1B;ADCY5;PIK3R1;AKT1;PLCB2;PGR
prerank,Elsevier_Pathway_Collection__Bradykinin Effects in Inflammation,-0.35760753283766683,-1.1982332191019376,0.2318840579710145,0.4348770162552462,1.0,14/37,21.15%,IL1B;MMP1;IL1RAP;KLKB1;PRKCQ;PTGES;PLG;AKT1;KNG1;PLAUR;F11;AGTR1;MAP2K3;MAP2K6
prerank,Elsevier_Pathway_Collection__Proteins Involved in non-Alcoholic Fatty Liver Disease,-0.2807396970336572,-1.1981229376339548,0.03571428571428571,0.4346686720679791,1.0,60/177,20.66%,IL10;PTGS2;ACE2;GHR;TNF;CYP4A22;IL1B;TNFRSF11B;HGF;LCAT;CYP4A11;FASLG;SRD5A1;ACSL1;DGAT2;IL18;APOA1;CASP1;LGALS3;PPARGC1A;NLRP3;FOXO1;PAQR3;CCL2;IL6;TLR8;IL1RN;CCR2;PLA2G4A;NR1I2;APOA5;CXCL8;TLR4;TLR2;CYP3A4;AKT1;ABCG5;IGF1;SLC2A2;MSR1;MYD88;TNFRSF13C;SLC13A5;PRKCE;KLF6;GCKR;CXCL1;MTTP;HMOX1;TLR10;UCP2;SMARCA2;SLC27A5;NR1H4;IRS2;AHSG;AGTR1;NLRP6;GSTP1;ADIPOR2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.3724261042389231,-1.1978469158024647,0.2054794520547945,0.43486487397649615,1.0,10/37,7.80%,UNC13C;PCLO;CPLX4;OTOF;SYT10;SYT8;SYT1;SYT7;STX11;STX19
prerank,TRRUST_Transcription_Factors_2019__NR2F2 mouse,0.5022476272342216,1.197760429779201,0.2621951219512195,0.8201097824045452,1.0,5/15,13.33%,CYP7A1;SLC2A4;POU5F1;FLT1;BGLAP
prerank,Elsevier_Pathway_Collection__Nitric Oxide Effects on beta-Cell,-0.3856736651180965,-1.1975021121869518,0.23170731707317074,0.4351004806194759,1.0,12/25,27.80%,PDX1;IFNG;IL1B;PPP1R15A;BCL2;HSPA1A;XBP1;STAT1;MAP3K5;EDEM1;IFNGR1;NOS2
prerank,KEGG_2021_Human__Cushing syndrome,0.3462180733706695,1.196853327266091,0.1598173515981735,0.8225866168988293,1.0,31/146,16.72%,CACNA1I;CYP17A1;LEF1;CACNA1S;E2F1;AXIN2;WNT4;CYP21A2;WNT9B;WNT8B;CDKN2A;RASD1;NR5A1;CACNA1G;TCF7;E2F2;CAMK2A;CCNE1;CRHR2;CDKN2C;CCNE2;CDKN2B;CACNA1C;CREB3L1;APC2;ADCY6;DVL2;WNT2B;WNT6;CREB3L4;CACNA1H
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.5033541487422568,1.1967785242393536,0.24691358024691357,0.8220067162873043,1.0,6/15,23.52%,WNT4;BMP4;RGCC;CREB3L1;SCX;SUCO
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.2878824103447548,-1.1966812813469991,0.08571428571428572,0.43646031724689194,1.0,51/132,21.29%,TAC1;CXCL13;PROK2;PLCZ1;ADRA1A;TRPV4;CCR9;SLC35G1;CXCR1;FPR1;CXCR2;FPR2;CCR5;XCR1;ESR1;CXCR6;PDGFRA;CCR7;ACKR4;TRPC3;CALCR;LPAR2;PTGER2;CCR1;CCR2;PTGER4;P2RY1;ADCY5;SLC8A1;CCR4;FPR3;CLN3;PTGDR;SCGN;CXCR3;CXCR4;KNG1;TBXA2R;CAV2;LPAR1;C3AR1;WNT5A;RYR1;PLN;C1QTNF1;LPAR3;AGTR1;CMKLR1;CX3CR1;PTGIR;CD55
prerank,"WikiPathway_2021_Human__Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",-0.32122262729010886,-1.196559019943247,0.10714285714285714,0.4363136345290106,1.0,25/67,22.05%,IFNG;TNF;PRKCB;CAMK2B;RSAD2;PRKCQ;CCL2;IL6;TLR8;CD40LG;CXCL8;TLR4;TLR2;CAMP;PLCB2;PLCG2;PRKCE;ETS1;MAPK13;NOD2;OAS2;PRKCZ;JUN;CD40;STAT1
prerank,WikiPathway_2021_Human__Drug Induction of Bile Acid Pathway WP2289,-0.44385016224474727,-1.1964400957565553,0.22916666666666666,0.4361785861462506,1.0,12/17,25.74%,SLC10A1;ABCB1;NR1I2;CYP3A4;SULT2A1;SLCO1B1;NR1I3;NR1H4;ABCC3;SLC51A;VDR;SLC51B
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.435784888801258,1.1964201928692504,0.22459893048128343,0.8227667400217695,1.0,14/32,37.09%,TOMM40L;TOMM20L;DNLZ;TIMM17B;ROMO1;TIMM17A;TOMM20;AIFM1;TOMM40;PEX6;PAM16;HSPD1;GRPEL2;CHCHD4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.41540971597668624,-1.1962366578246282,0.17647058823529413,0.43616273626122554,1.0,8/19,23.17%,NLRP7;ABCD2;MEFV;LILRB4;NLRC3;MACIR;F2;SIRPA
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.3460025365050315,-1.1959753301112224,0.18333333333333332,0.4362657240308543,1.0,7/46,15.16%,GSTA2;IL10;IFNG;IL12B;LCP1;SERPINB2;IL12RB1
prerank,TRRUST_Transcription_Factors_2019__TFAP2A human,-0.32428291438022333,-1.1959193586164476,0.12,0.43597288448645843,1.0,21/66,17.96%,ADRA1A;L1CAM;PTGS2;DBH;TH;HGF;GALNT3;ECM1;KRT5;CDH1;OAT;IGFBP5;ADRA2B;CD82;CRABP2;SPRY2;CFTR;PLAUR;BCL2;HMOX1;ETS1
prerank,Elsevier_Pathway_Collection__Alveolar Epithelial Cell Dysfunction in COPD,-0.32530122502598985,-1.1959102168396154,0.12,0.4355564223510224,1.0,16/67,14.87%,GSTA2;TNF;IL1B;MMP1;FOS;MAP2K1;CAT;EGR1;IL6;S100B;CXCL8;TLR4;AKT1;S100A12;MYD88;CSF2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.4187754231466067,1.1958992671391298,0.20725388601036268,0.8239964241133755,1.0,25/37,50.08%,TOMM20L;NUP37;TOMM20;NUP62;TPR;NUP133;NUP155;NUP160;NUP188;SSB;NUP205;XPOT;NUP210;RAN;RAE1;NUP214;NOL6;NUP107;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.38916502799887737,1.1958515321976333,0.21761658031088082,0.8233303276286478,1.0,11/60,16.38%,CALY;CDH13;GPC3;SRC;SPHK1;MCTP1;PRKD1;PACSIN3;ABL2;ABCA7;NEDD4L
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.3938543521092679,1.1958004121024595,0.17435897435897435,0.8227036157074789,1.0,9/64,5.89%,ALOX15B;SIX1;HOXD3;WNT4;SOX2;DKK3;TDGF1;MDK;TBX3
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.35116761969719507,1.1957122924167158,0.1590909090909091,0.8221887072039289,1.0,113/171,47.14%,EXOSC4;RPL8;DHX34;SMG5;NBAS;CASC3;RBM8A;RPL30;RPLP1;RPS27;RPS21;RPLP2;EIF3E;DXO;RPS5;EXOSC5;RPL28;POLR2G;RPS14;RPL10;RPSA;PABPC1;RPL39;UPF3B;UBA52;SAMD4B;RPLP0;RPS15;RPS2;RPL31;RPS19;SMG7;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL13;SMG9;RPL27;CNOT3;TUT1;RPL38;CTIF;DIS3L2;RPL35;RPL10A;CNOT10;RPS8;RPS12;PPP2R1A;RPL35A;AGO1;MAGOHB;RPS3A;TUT7;RPS7;RPS11;RPL36A;GSPT2;DCPS;RPL7A;CNOT6;RPS3;RPL18A;CNOT6L;RPL32;RPS24;CNOT9;RPL29;RPL23;SMG8;RPL5;RPS18;RPL14;EXOSC7;EXOSC10;RPS16;MRTO4;EXOSC9;RPL13A;RPL41;RPL9;RPS28;CNOT1;RPS23;RPL27A;RPL23A;RPL18;PELO;RPL12;RNPS1;RPS9;RPL6;UPF1;RPS15A;RPL4;RPS26;DDX5;RPL19;DCP1B;TUT4;RPS6;RPL26;EIF4A3;RPS27A;MAGOH;MTPAP;RPS4Y1;RPL34;RPS13;ETF1
prerank,WikiPathway_2021_Human__IL1 and megakaryocytes in obesity WP2865,-0.40379724052856925,-1.1955298333113247,0.22093023255813954,0.43589660346329234,1.0,9/24,14.80%,IFNG;IL1B;IL18;FCER1A;NLRP3;CCL2;TLR2;MYD88;HBEGF
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,0.45730341449638906,1.1954800557955987,0.23728813559322035,0.822226955000514,1.0,18/25,47.37%,PRIM1;RFC4;DSCC1;POLD1;POLA1;POLA2;CHTF18;PCNA;TERF1;ACD;SLC19A1;TERF2;RFC3;POLD3;POLD4;CTC1;STN1;PRIM2
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3689854025816079,1.1954608593690226,0.19576719576719576,0.8214584729231705,1.0,34/82,39.37%,KIF2C;KIF4A;CENPE;KIF5A;KIF15;KIF18A;KIF23;RAB41;ATP9A;RACGAP1;LMAN2;TMED3;NBAS;KIF11;COPE;KDELR3;TMED9;KLC2;ARFGAP1;KIFAP3;COPA;KIF22;STX18;COG4;KIF3B;KIF1C;RAB6B;KIF2A;GOLPH3L;COG7;USE1;HTT;TMEM115;ERGIC3
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,0.4586261468938131,1.195429242891786,0.21714285714285714,0.8207363105809085,1.0,6/28,15.74%,PIK3R2;SRC;PDGFRB;PDGFB;PDGFA;HRAS
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.3736516899376399,1.1953118360281711,0.18226600985221675,0.8202873865910393,1.0,26/86,31.99%,TRIM71;IGF2BP1;RBM24;IGF2BP2;AGO2;NANOS1;TYMS;EIF4EBP3;ROCK2;MRPL13;TSC1;EPRS1;TPR;EIF3E;EIF4EBP2;METTL3;LARP1;IGF2BP3;ILF3;SAMD4B;GAPDH;RACK1;DAPK3;PUS7;FMR1;EIF4ENIF1
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,0.4184478920718576,1.1952458382448996,0.24022346368715083,0.8196984572094271,1.0,13/45,17.27%,TNNI3;FXYD7;ATP1A2;ATP1A4;ATP2B4;CAMK2A;ATP1B3;NANOS1;ATP2A1;FXYD2;KCNJ11;PRKCA;SLC8A3
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.43656750554095636,-1.1947843750765887,0.2247191011235955,0.43706439718834555,1.0,7/19,12.33%,CXCL10;CCL5;CD200R1;CXCL12;DOCK8;SPN;RIPOR2
prerank,MSigDB_Oncogenic_Signatures__KRAS.LUNG.BREAST UP.V1 UP,0.3587880743206481,1.1944391272924977,0.1650485436893204,0.8220599700595118,1.0,20/116,7.51%,KCNC1;CTNNA2;SPINK1;SMPX;ESM1;SLCO4A1;KCNC2;GFI1;TERT;ITGA2;MKRN3;ITPKA;FAM155B;RMST;TBX3;SHOX;CCL20;NTM;KIF5A;OR2B6
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,0.42535518745398443,1.1943415604950478,0.2154696132596685,0.8217173965261576,1.0,26/36,46.20%,UBE2T;EME1;SERPINA2;FANCI;POLN;FANCE;POLR1A;ATRIP;FAAP20;FANCD2;FANCB;FANCG;UBA52;MUS81;FAN1;CENPX;DCLRE1B;EME2;FAAP24;FANCM;USP1;SLX4;UBC;FANCA;ERCC1;RPS27A
prerank,Elsevier_Pathway_Collection__Proteins Involved in Pulmonary Emphysema,-0.37097928831258103,-1.194294793170529,0.19402985074626866,0.43783018609068486,1.0,9/35,14.15%,IFNG;TNF;IL18;TGFA;IL6;ITGB6;KL;TLR4;KLRK1
prerank,Elsevier_Pathway_Collection__DNA Repair and Chromatin Remodeling Block in Pancreatic Neoplasms,0.4291398101899539,1.194118026807447,0.23728813559322035,0.8217866869184425,1.0,25/33,51.01%,ACTL6B;KAT2A;MSH2;BARD1;SMARCA4;PARP1;RAD51;SMARCD3;MSH6;SMARCC1;BRIP1;BRCA2;ARID2;ARID1A;SMARCB1;SMARCC2;ATRX;NBN;MRE11;ACTL6A;RAD50;PALB2;SMARCD2;SMARCD1;KAT2B
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.4801626910897403,1.1936446023980467,0.25142857142857145,0.8230162455216832,1.0,10/19,27.00%,SNAI2;TBX3;BMP4;ACVRL1;OLFM1;TGFBR3;HEY1;TGFB2;SNAI1;HEYL
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.43985857844670656,1.193502971017042,0.26011560693641617,0.8227181983795602,1.0,5/33,8.39%,TRIM71;MAPT;TDRD9;AGO2;PIWIL1
prerank,WikiPathway_2021_Human__Eicosanoid Synthesis WP167,0.4588872524589942,1.1932226408713618,0.24277456647398843,0.8229844171665966,1.0,4/25,6.79%,ALOX15B;PLA2G2A;DPEP1;PTGDS
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.43457708362071984,-1.1931063085030853,0.23655913978494625,0.4398484494464949,1.0,3/16,4.89%,FAM3D;CRHBP;SFRP1
prerank,Elsevier_Pathway_Collection__Vascular Endothelial Cell Vasodilation in Brain,0.45465586381947387,1.1930210530715593,0.2185792349726776,0.8229668443510741,1.0,8/29,17.27%,CALCA;RAMP1;CAMK2A;PRKD1;BDKRB2;ACE;PDPK1;MME
prerank,TRRUST_Transcription_Factors_2019__RFX1 human,-0.4537895136079182,-1.1924485976123442,0.2708333333333333,0.4408570942545661,1.0,2/15,3.00%,MSLN;IL5RA
prerank,Elsevier_Pathway_Collection__Glioma Stem Cell Program Activation,0.3790915441399215,1.1924098041299949,0.19270833333333334,0.8247801284940668,1.0,16/69,14.95%,DKK1;LEF1;AXIN2;PEG3;SOX2;FOXM1;BMP4;MSI1;TCF7;PDGFRB;EZH2;IL6R;PDGFB;POU5F1;PDGFA;PDPK1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.40678611500933376,1.1921475714800929,0.2261904761904762,0.8250775518956378,1.0,22/39,40.76%,PPP1R16A;CDCA2;PPP1R16B;GBA;TSC1;PPP2R5A;MFHAS1;PPP6R2;TIPRL;ENSA;PIN1;PPIA;PPP1R2;TGFB1;PPP6R1;HTT;PTBP1;CALM3;SYMPK;CDH5;PPP1R7;CAMTA1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,0.4776734649647561,1.1921042609974708,0.25609756097560976,0.8243978494141909,1.0,6/23,18.45%,GNG4;GNG3;GNB5;PDPK1;GNG8;GNG10
prerank,TRRUST_Transcription_Factors_2019__POU2F1 mouse,0.47435450905618903,1.1920321132277012,0.25882352941176473,0.8238724633182412,1.0,5/18,11.72%,CSN2;ALDH3A1;MYH4;LPL;CDX2
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,-0.3354049125572786,-1.1919512761983948,0.22,0.4414259753213096,1.0,27/64,24.54%,CD4;CD80;BTLA;ICOS;CTLA4;CD3E;FYN;CD274;HLA-DQA2;PDCD1LG2;LCK;CD247;PIK3R1;AKT1;VAV1;CD86;HLA-DQA1;PPP2CB;HLA-DQB2;CD3D;YES1;HLA-DRB5;HLA-DRA;AKT3;HLA-DPA1;PRR5;HLA-DRB1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.32701701673438305,-1.1916181831436836,0.1875,0.4417750652819345,1.0,15/68,9.30%,GABRA5;GABRA3;SLC5A1;GABRB1;GABRA4;GABRG1;SLC26A9;GLRB;GLRA3;FXYD1;ANO1;GABRG3;SLC4A10;NMUR1;APOL1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3717268164802344,-1.1915916479368678,0.20833333333333334,0.4413617360259067,1.0,11/32,17.18%,EREG;AGR2;TGFA;BTC;AKT1;HBEGF;PDE6G;PLAUR;PTK6;AFAP1L2;NCF1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.41642184543949623,1.1914974819327449,0.21893491124260356,0.8252259902754429,1.0,8/41,6.87%,CACNA1I;KCNE5;KCNH2;SCN1A;SCN4A;KCNB1;CACNA1G;SLC4A3
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.3592859836303662,-1.1914585642828814,0.20588235294117646,0.44117304399392754,1.0,10/37,22.30%,GCK;HK3;ENO3;ALDOB;ALDOC;DERA;PGM1;ENO2;ENO4;PGAM1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.3279520116859125,-1.191343880170695,0.14285714285714285,0.4410126768513423,1.0,21/46,24.15%,GRIN2B;IFNG;TNF;FOS;CCL3;EPHA7;EGR1;FYN;FCGR2B;TLR4;CLU;ITGB2;PRNP;WNT5A;C1QA;ITGAM;TYROBP;SNCA;MAP3K5;PICALM;TFAP2A
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4949029801429148,1.19077915752232,0.23636363636363636,0.8272926241134911,1.0,6/19,20.37%,APLN;FGF2;CREB3L1;SMOC2;DSTYK;SPRY3
prerank,Elsevier_Pathway_Collection__TNF Receptor Associated Periodic Syndrome,-0.3685765747692478,-1.1905454201456929,0.18181818181818182,0.4424329462647104,1.0,11/37,18.59%,TNF;IL1B;LRRK2;FOXO1;IL6;TICAM2;TLR4;AKT1;MYD88;BCL2;EIF2AK3
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,0.40309861014286946,1.1902244663528212,0.2,0.8286841239392144,1.0,43/64,47.37%,CDKN2A;PSMD4;CCNE1;ZNF385A;CCNA2;CCNE2;PSMB4;CHEK1;CDC25A;PCBP4;PSMB3;PSMD14;CHEK2;UBA52;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;MDM4;PSME2;PSMD13;PSMB7;PSMA7;PSME3;CDK2;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PHF20;PSMB1;PSMD3;MDM2
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.3797512053213011,1.1901863781621598,0.17277486910994763,0.8280482288324447,1.0,12/86,14.25%,HMGA2;DKK1;LEF1;E2F1;XIRP1;MDFI;AURKB;AURKA;PDGFB;ARHGAP28;HABP4;TFAP4
prerank,MSigDB_Oncogenic_Signatures__KRAS.600.LUNG.BREAST UP.V1 DN,0.3409253440422278,1.1900253931838591,0.1297071129707113,0.827870207391128,1.0,50/226,14.61%,SH3GL3;COL2A1;HTR1D;PAX2;CACNA1I;DLX6;HCN2;AMBN;CDH16;IGF2-AS;VAX2;TNNI3;SYNDIG1;ALOX12B;CYP21A2;NEUROD1;FRAS1;EMID1;NOX5;SLC30A3;KCNB1;SLC6A9;CA5B;PRDM12;FSCN2;MXD3;SLC6A3;OLFML2A;AKR1B10;IGFBP2;YPEL1;EPHX3;DAAM2;RAG1;MAST3;CHRM5;PPFIA3;RPL13P5;CD36;STAG3L1;CACNA2D3;CREB3L1;PTGFR;APC2;FLT1;FBXO24;KIF25;BDKRB1;PPFIA2;HTR1B
prerank,WikiPathway_2021_Human__Endochondral Ossification WP474,0.38671412643196773,1.1898157154232454,0.22105263157894736,0.8269649934716498,1.0,17/60,21.40%,COL2A1;IGF2;SPP1;HDAC4;COL10A1;FGF2;IHH;PTHLH;PLAU;SCIN;CDKN1C;THRA;MMP9;FGF18;HMGCS1;MGP;TGFB2
prerank,WikiPathway_2021_Human__Endochondral Ossification with Skeletal Dysplasias WP4808,0.38671412643196773,1.1898157154232454,0.22105263157894736,0.8269649934716498,1.0,17/60,21.40%,COL2A1;IGF2;SPP1;HDAC4;COL10A1;FGF2;IHH;PTHLH;PLAU;SCIN;CDKN1C;THRA;MMP9;FGF18;HMGCS1;MGP;TGFB2
prerank,MSigDB_Oncogenic_Signatures__NFE2L2.V2,0.3241356173982434,1.1897785823410016,0.10416666666666667,0.8263063321817806,1.0,86/375,17.92%,GRPR;CPLX2;ACTL8;SLC7A11;VSIG1;RHBDL3;SFN;B4GALNT1;MRAP2;ZIM2;CALCA;SMPX;TM4SF20;LEF1;ALDH3A1;TEX19;LCN2;SNTG1;SPP1;AXIN2;TP73;NRCAM;HIGD1B;PEG3;TERT;BCAN;VIL1;NQO1;HJURP;FERMT1;PANX2;SCUBE1;SLC2A4;CHRDL2;CBR3;FXYD7;JAKMIP3;RIMKLA;AKR1B10;RDM1;IL3RA;SLC1A4;CDC45;AKR1B15;AKR1C3;TKT;MPP3;LEP;CDKN2B;NEIL3;STC2;TRIM16L;PIR;CRTAP;MPPED2;ANKS6;SPACA1;FLT1;CPLX1;ARHGAP28;HPDL;UCHL1;PALLD;ORC1;GLA;PPFIA2;MAFG;AKR1C1;SQSTM1;CYP4F24P;MCM10;UNKL;SDS;SLC5A11;PLXND1;KCNE4;MCM3;GCNT3;MTBP;GPX2;ABCB6;NEDD4;CKAP4;EPHX1;RRM2;ACVRL1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.4883008695036043,1.1897036314491387,0.26704545454545453,0.8249289598074513,1.0,3/19,4.18%,H3C13;CRLF2;H3C1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.4883008695036043,1.1897036314491387,0.26704545454545453,0.8249289598074513,1.0,3/19,4.18%,H3C13;CRLF2;H3C1
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.3658438766970676,1.1893359184016654,0.20095693779904306,0.8256393556537825,1.0,21/117,13.75%,CHGB;IGF2;PAPPA2;SCG2;SPARCL1;AMBN;KLK13;NOTUM;TNNI3;MATN3;BMP4;GPC3;FGF23;IGFBP2;TIMP1;VGF;MFGE8;LAMC1;STC2;VWA1;MELTF
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.27735445682286075,-1.1892626604632932,0.04,0.4447039155279441,1.0,50/192,15.76%,EREG;CSF3;RET;ERBB4;FGF10;SFRP5;TNF;NTRK3;TSPYL5;P2RY12;HGF;CD80;BANK1;NTRK2;XDH;CCL3;ESR1;IL18;PDGFRA;NRG4;ICOS;CCR7;PIK3CD;CALCR;FGFR2;TGFA;FAM110C;OSM;TRAT1;FYN;AXL;FERMT2;RAC2;KL;NTRK1;BTC;GATA3;LCK;FLT3;PIK3R5;HCLS1;PIK3R1;AKT1;TPTE2;RTN4;HBEGF;VAV1;SPRY2;CD86;GCNT2
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.35956645230975914,1.188723574914435,0.17727272727272728,0.8274064433611776,1.0,17/113,7.47%,TRIM71;ACTL8;PAX2;SIX1;SPINK5;OSR1;WNT4;DLX3;VIL1;SNAI2;UPK1A;HES5;DMBT1;CD34;IHH;MEOX1;UPK3A
prerank,Elsevier_Pathway_Collection__UrokinaseR -> ELK/SRF Signaling,0.45353070636866005,1.1887093151580457,0.23391812865497075,0.8266532705539694,1.0,7/23,16.31%,RASGRF1;PDGFRB;PLAU;MAPKAPK2;SHC1;PDPK1;ELK4
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.2821329976476939,-1.1882943994767026,0.16666666666666666,0.4465523906177207,1.0,41/143,21.32%,GABRB1;CRHBP;AOC1;TNF;KCNE1;IL1B;P2RY12;NR4A3;CCL5;SFRP1;ATP1A3;LRRK2;CDH1;CCL3;SSTR2;ESR1;IL18;ZFP36L1;P2RX3;CCL2;EGR1;NKX3-1;IGFBP5;P2RY1;ADCY5;GNG2;CASP6;CFTR;CASP7;EZR;AKAP6;AR;NR1H4;ADCY1;PDE2A;ARL6IP5;IMPACT;GABRB2;ADTRP;RIOK3;TIPARP
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.4596301467195806,1.1882725576235962,0.2235294117647059,0.8275107378617846,1.0,2/23,0.41%,B4GALNT2;B3GALT1
prerank,KEGG_2021_Human__Insulin secretion,0.3788419932935437,1.1882473598504288,0.17346938775510204,0.8267756866014199,1.0,19/78,16.28%,KCNU1;GLP1R;GPR119;GCG;CACNA1S;ATP1A2;ATP1A4;CAMK2A;ATP1B3;KCNN3;ABCC8;CACNA1C;CREB3L1;SNAP25;ADCY6;FXYD2;KCNJ11;PRKCA;CREB3L4
prerank,WikiPathway_2021_Human__Vitamin D Receptor Pathway WP2877,-0.2773694589656696,-1.1881457009730447,0.02857142857142857,0.4465042365217477,1.0,47/156,15.84%,IRF4;ATP2C2;TRPV6;PNOC;CYP2B6;TNFSF11;SLC34A2;SATB1;TNFRSF11B;ID4;SFRP1;BTLA;S100A8;IGFBP3;KRT16;DUSP10;CTLA4;CST6;FOXO1;CYP2C9;PRKCQ;CBS;KLF4;SULT1C2;ABCB1;KL;ALOX5;IGFBP5;PTGER4;HLA-DQA2;HSD17B2;IRF8;SLC8A1;MX2;CYP3A4;KRTAP5-1;RASGRP1;CAMP;ORM2;EFNA5;SULT2A1;LRRC25;ADGRE5;ZNF257;IGFBP1;KNG1;PRDM1
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.40223024175326966,1.1879661498471517,0.23404255319148937,0.8271194384314684,1.0,35/52,47.30%,PSMD4;FBXL18;AURKA;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;RBX1;PSMA6;UBC;FBXL7;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.5150680702158448,1.1878328419272468,0.25,0.8267739480728913,1.0,6/15,12.68%,SFRP4;ZNRF3;GPC3;LBX2;DAAM2;SPEF1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.46767008077647637,1.1875208191675808,0.27218934911242604,0.8271136896033746,1.0,18/23,46.20%,CETN2;PARP1;COPS5;CUL4B;UBA52;COPS7B;DDB2;COPS6;DDB1;COPS8;GPS1;XPC;RBX1;UBC;COPS7A;COPS4;XPA;RPS27A
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.4066754169378968,1.1873158305603526,0.20212765957446807,0.8271425159253682,1.0,8/36,13.89%,FOXN4;MESP1;TBX3;IHH;SOX18;DNAAF1;MICAL2;BBS5
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.4104482006243505,1.1871177031109124,0.21311475409836064,0.8270946321338908,1.0,11/35,17.74%,TEX19;SIX4;WNT4;NR5A1;TFAP2C;BIK;AKR1C3;SOX8;LHB;WNT2B;MSH2
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.38959462341220047,-1.1869961897096144,0.19444444444444445,0.44860310996946984,1.0,7/32,10.41%,UGT2A1;AKR1D1;CYP39A1;SCP2;CYP8B1;AKR1C4;ACAA1
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,0.4405317463724899,1.1869709504133505,0.2802197802197802,0.8268903541955444,1.0,18/33,39.28%,EME1;EXO1;XRCC2;RTEL1;BARD1;DNA2;RMI1;RAD51AP1;RAD51;BLM;BRIP1;RMI2;MUS81;BRCA2;SEM1;EME2;XRCC3;SPIDR
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.35546172734540715,-1.1869249950545433,0.15151515151515152,0.4483474288535308,1.0,13/39,16.88%,RIPK3;CD4;CD8A;PTPN22;ZFP36L1;PIK3CD;RHOH;PTPRC;GATA3;LCK;FCER1G;SPI1;ZAP70
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.43788115456410354,1.1864648708374113,0.24858757062146894,0.8282365199151134,1.0,19/33,30.72%,SQLE;FDPS;HSD17B7;MVD;ACLY;HMGCR;TM7SF2;IDI1;LBR;PMVK;NSDHL;FDFT1;HMGCS1;CYP51A1;NPC1L1;INSIG2;ARV1;G6PD;GGPS1
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,-0.3833062908304893,-1.186391118617946,0.2564102564102564,0.4492080022506168,1.0,8/24,21.07%,AGL;GYS2;UGP2;PPP1R3C;GBE1;PYGL;PGM1;NHLRC1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3995035461712312,1.1863110693601917,0.21311475409836064,0.8279883284176476,1.0,11/55,11.86%,SLCO1C1;SLC16A11;SLC16A9;SLC6A11;SLCO2A1;SLC26A6;SLC5A6;SLC6A8;SLC16A3;CD36;SLC10A6
prerank,WikiPathway_2021_Human__Type II diabetes mellitus WP1584,0.47665602788459654,1.1862016252674192,0.2375,0.827624426557495,1.0,2/20,5.24%,MAFA;SLC2A4
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.38140365073842153,-1.1856206080309275,0.19480519480519481,0.45053824034916,1.0,11/33,14.42%,WNT7A;TNF;IL1B;MAG;NGFR;EFNB3;IL6;OMG;SORL1;RTN4;PTN
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.32994690352568395,1.185582007199489,0.09829059829059829,0.8291185169005619,1.0,193/349,44.57%,HOXD3;TSPAN5;E2F1;EEF1A2;NOX4;TESC;AGO2;MRPL55;MRPS21;SARNP;MRPL24;DDX39A;CPSF1;RPL8;SMG5;ANGPT2;RNASEL;POLR2L;MRPS12;CASC3;RBM3;MRPL13;BCL3;NUP37;SCX;ADAR;DUOXA2;MRPL9;MRPS14;THOC5;RBM8A;RPL30;CHTOP;RBMS1;RPLP1;HARS2;RPS27;RPS21;NUP62;RPLP2;POLR2K;NXF1;TPR;EIF4EBP2;NUP133;MRPL23;RPS5;BICD1;MRPL28;CPSF4;TSPAN17;ADAD2;IGF2BP3;MRPL52;RPL28;POLR2G;FARSB;RPS14;RPL10;LMF1;COPS5;RPSA;RPL39;UPF3B;NOVA1;RPLP0;RPS15;DKC1;DNAJB11;NUP155;RPS2;RPL31;NUP160;THOC1;HARS1;RPS19;SMG7;RPL36;RPL37A;POLR2H;POLDIP3;RPL37;RPL7;RPS4X;RPS20;POLR3A;MRPL36;RPL13;NXF5;RPL27;MRPL41;THOC6;NUP188;NXT1;RPL38;RPL35;POLR2I;MRPL27;MMS19;POLR2J;RPL10A;THOC2;DDX39B;MRPS15;RPS8;RPS12;HNRNPU;RPL35A;MRPL51;MAGOHB;SLU7;NOL9;RPS3A;PABPN1;IGHMBP2;RPS7;XAB2;PTMA;ZC3H11A;HSPD1;DRG1;RPS11;RPL36A;NUP205;MCM3AP;GSPT2;RBM15B;DROSHA;RPL7A;MRRF;RPS3;RPL18A;RPL32;RPS24;POLR2A;RPL3L;NUP210;DDX20;RPL29;BAZ2A;RPL23;RBM4;RPL5;RPS18;RPL14;SYMPK;RBM6;RPS16;MRPS5;MRPL43;POLR2B;CPSF3;RAE1;NUP214;RPL13A;CLP1;RPL41;RPL9;RPS6KB2;MRPS18C;TSPAN14;GLE1;ALYREF;RPS28;PABPC4;NUP107;PAX8;RPS23;RPL27A;RPL23A;SLBP;U2AF1;RPL18;U2AF2;DDX17;DDX54;FIP1L1;RPL12;NFKBIB;STUB1;MRPS11;TSPAN33;RNPS1;TAF1B;POLR2F;RPS9;RPL6;MED20;UPF1;RBM5;RPS15A;AAAS;RPL4
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.39857022401753617,1.185186664884668,0.20967741935483872,0.8300364947797226,1.0,26/53,43.67%,H1-5;H1-2;H1-4;KAT2A;CHEK1;HMGA1;POLR2L;ATAD2;POLR1A;H1-0;POLR2K;CDCA4;TAF1A;POLR1H;POLR1G;POLR2H;PADI2;SERTAD1;MYBBP1A;BAZ1B;TAF1D;ARID1A;MACROH2A1;POLR1C;TAF1B;POLR2F
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.40737263337535656,1.185132150058805,0.23118279569892472,0.829430024524296,1.0,13/40,25.52%,FOXN4;MESP1;TBX3;IHH;SOX18;DNAAF1;MICAL2;BBS5;MEGF8;STIL;TBX6;CCDC40;SOX17
prerank,KEGG_2021_Human__Spliceosome,0.3484996951099412,1.18500876979064,0.14814814814814814,0.8291091263508148,1.0,84/134,50.28%,NCBP2L;RNU4-2;RNU4-1;PUF60;HSPA2;PRPF3;SNRPE;SF3B4;PQBP1;SNRNP70;RBM8A;TXNL4A;SF3B5;SNRPD2;SF3A2;PRPF6;LSM2;SNRPB;LSM4;SNRPD1;PRPF31;THOC1;LSM7;TCERG1;FUS;ZMAT2;PPIH;RBMX;SNU13;SNRPC;THOC2;DDX39B;RBM22;SNRPA;SNRPD3;HNRNPU;MAGOHB;SLU7;HSPA8;XAB2;USP39;HNRNPA1;PRPF8;CCDC12;SART1;PHF5A;HSPA1L;SF3A3;PCBP1;ALYREF;SNRPG;CRNKL1;CTNNBL1;U2AF1;U2AF2;SNRPA1;SNRNP200;SYF2;RP9;HNRNPM;U2SURP;PPIL1;DDX5;EIF4A3;MAGOH;PRPF38A;SF3B3;PRPF19;PRPF40B;SNRNP40;CDC5L;DDX42;DHX16;DHX8;SF3A1;ISY1;SF3B6;NCBP2;SF3B1;THOC3;ACIN1;HNRNPC;LSM8;U2AF1L5
prerank,Elsevier_Pathway_Collection__GABA(B)R -> Postsynaptic Inhibition,0.4670135630833243,1.184983229084253,0.23699421965317918,0.828408919637737,1.0,7/25,12.86%,KCNJ6;GAD1;KCNJ5;SRC;KCNJ14;SYN1;SNAP25
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.399526181027961,1.184971277621123,0.22916666666666666,0.8276572586084536,1.0,27/56,42.41%,PYDC1;COLEC12;CPSF1;NUP37;RPP21;TSEN2;NUP62;TPR;NUP133;CPSF4;TSEN54;TSEN15;CSTF2;NUP155;NUP160;RPP25;NUP188;RPP40;POP5;NUP205;XPOT;NUP210;RAN;NUP214;RPP38;NUP107;DDX1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.48652888309939357,1.1849671486720266,0.27388535031847133,0.8268773738814343,1.0,4/21,9.66%,PLK1;CDC20;UBE2C;UBE2S
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.28317180591893454,-1.1849641909640023,0.1111111111111111,0.4516497889020688,1.0,40/154,17.69%,CIDEA;AADAT;GSTZ1;HAO2;FMO1;HPGD;CYP4A22;GPD1;FABP2;RDH16;CYP4A11;ENO3;TDO2;ACSL1;CD1D;ACSM3;BCKDHB;VNN1;ADH1C;ACADL;ACAA1;ACADS;CA2;EHHADH;ADH7;HMGCS2;ACOX1;INMT;ETFDH;REEP6;CPOX;ACADM;SDHD;ECHS1;GCDH;MGLL;BMPR1B;MLYCD;HMGCL;SUCLG2
prerank,Elsevier_Pathway_Collection__T-Cell Cytotoxic Mediated Cell Death,-0.3404128639050155,-1.1847077016112364,0.14864864864864866,0.45182380446283404,1.0,11/47,15.99%,IFNG;CD8A;FASLG;TNFSF10;CASP1;PRF1;CD2;CASP6;GZMA;LTA;CASP7
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,0.37684338924059513,1.184554373426982,0.2019704433497537,0.8276241958373561,1.0,43/94,39.37%,LEF1;CDKN2A;HDAC4;TCF7;SRC;PSMD4;TEAD2;PSMB4;KAT2A;TEAD4;SMAD3;ZFHX3;MYC;CTNNB1;PSMB3;MAML1;TEAD3;PSMD14;UBA52;CDKN1A;SMURF1;PSMB5;PSMD2;YAP1;PSMA1;MAMLD1;PSMD10;TCF7L1;TEAD1;PSMC4;PSMC3;TGFB1;SMURF2;CXXC1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.4622629679706182,1.1844425989547605,0.2681564245810056,0.8272111474708767,1.0,2/23,5.48%,AVIL;MSTN
prerank,KEGG_2021_Human__Thermogenesis,0.33481658487929605,1.184396172207979,0.15246636771300448,0.8265457325320382,1.0,96/211,37.31%,GCG;PRKAA2;MAPK12;COX4I2;ACSL6;MAPK11;ACTL6B;PRDM16;NDUFA4L2;ACSL4;CPT1B;COA6;NDUFA1;CREB3L1;ADCY6;PPARG;HRAS;NDUFS6;CREB3L4;NDUFV1;NDUFB9;COX6C;ACSL5;ATP5MF;COX20;COX7B;NDUFA3;ADCY4;UQCRB;ADCY10;TSC1;NDUFS2;NDUFA9;NDUFAF2;ATP5F1D;ADCY2;COX6B1;SMARCA4;CPT1C;LIPE;TSC2;NDUFB11;NDUFA2;NDUFS7;ZNF516;COX8A;PRKAB2;UQCRQ;SLC25A29;CYC1;SMARCD3;ACSL3;NDUFAF6;COX7A1;NDUFA13;UQCRHL;SIRT6;KLB;RHEB;SMARCC1;NDUFA11;ATP5F1E;KDM3A;KDM3B;NDUFA6;ATP5MC1;UQCR11;NDUFS8;COX4I1;NDUFV2;ATP5ME;COX5B;NDUFA8;MLST8;NDUFB7;COA3;ADCY8;UQCRH;NDUFAB1;ADCY9;COX19;NDUFB2;NDUFB10;UQCRC1;RPS6KA3;CREB3L3;NDUFAF8;NDUFAF3;COA4;NPPA;RPTOR;COA7;COX7C;AKT1S1;UQCR10;NDUFB3
prerank,WikiPathway_2021_Human__Eicosanoid metabolism via lipooxygenases (LOX) WP4721,-0.3642127641568194,-1.1842365384662499,0.21176470588235294,0.4524674493419879,1.0,12/29,13.11%,HPGD;CYP4A22;CYP4A11;FPR2;CYP4F2;CYP4F12;ACAA1;ALOX5;CYSLTR2;EHHADH;PTGR1;ACOX1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.4181768827706004,1.1838467455470845,0.20430107526881722,0.8278228321216038,1.0,27/38,50.08%,NUP37;TSC1;NUP62;TPR;NPM1;NUP133;NUP155;NUP160;NUP188;SSB;NUP205;XPOT;NUP210;RAN;RAE1;NUP214;NOL6;PHAX;NUP107;AAAS;NUP93;NCBP2;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3515480482741975,1.1838209996486864,0.17307692307692307,0.8270826341459162,1.0,53/130,36.53%,BRSK2;NEK2;CDC25C;MELK;FOXM1;PLK1;CCNB2;CCNA2;CDK1;TUBA4A;CCNB1;CDKN2B;AURKA;CEP131;PKMYT1;CDC25A;NES;CETN2;CEP250;HAUS4;FBXL6;HAUS5;FBXL8;USH1C;FBXL15;PLK4;DYNLL1;CEP70;SFI1;BRSK1;CHEK2;SSNA1;CDKN1A;ENSA;FBXL22;CSNK1D;TUBA1A;ALMS1;CUL1;CEP290;CEP152;DCTN2;DYNC1H1;SKP2;DCTN3;CEP41;SKP1;TUBG1;CEP72;PPP2R1A;PPME1;NDE1;HAUS1
prerank,Elsevier_Pathway_Collection__Arterial Hypertension,-0.3582649390051142,-1.1835929584324874,0.18333333333333332,0.4535517172656848,1.0,9/43,13.06%,PTGS2;FOS;ESR1;MAP2K1;CCL2;IL6;CXCL8;PIK3R1;AKT1
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,-0.28451789355188745,-1.1830268398639177,0.08888888888888889,0.4544131226147437,1.0,43/143,12.32%,TAC1;CXCL13;PROK2;PNOC;CXCL10;CCR9;CXCL11;AVPR1A;CCL5;CXCR1;CD200R1;FPR1;CXCR2;CXCL3;FPR2;CXCL9;CCR5;XCR1;CCL4;CCL3;SSTR2;CXCR6;NPY1R;XCL1;OXT;CCL23;CCR7;ACKR4;CXCL12;CXCL2;RLN2;XK;NLRP3;NMUR1;CCL2;NPY5R;CCR1;RXFP1;XCL2;CCR2;F2RL2;CXCL8;CCL22
prerank,Elsevier_Pathway_Collection__Proteins Involved in Stem Cell Exhaustion in Aging,0.4130010691384642,1.1829847148308652,0.23809523809523808,0.8295861451506358,1.0,6/36,9.24%,TP73;CDKN2A;FOXM1;FGF2;CCNE1;EZH2
prerank,WikiPathway_2021_Human__Hematopoietic Stem Cell Differentiation WP2849,-0.33698725233187515,-1.1827624756337827,0.17333333333333334,0.45455065993366683,1.0,19/51,17.99%,FOSB;MUC1;CSF3;IL1B;FOS;CBFA2T3;HMGN5;RHOH;IKZF1;IL6;NCKAP1L;CSF2;CXCR4;VAV1;TNXB;SPI1;ITGB3;GATA1;TRAF3IP3
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3386593083728147,1.1826478603760213,0.16299559471365638,0.8300837022132999,1.0,60/161,33.38%,CALY;MAPK8IP2;MAPT;HIGD1B;CASQ1;CENPF;CENPA;CENPE;ANLN;CHRNA3;SRC;PSMD4;STXBP6;DLGAP5;PTGES3L;DNAAF1;TBCE;DRC1;SAMM50;SMAD3;ARL2;TRAF2;STXBP1;CLTB;RAB5IF;PSMG3;OTUD6B;POGZ;NRG1;USH1C;AIFM1;AHCTF1;CCDC40;TPR;CASQ2;HSF1;CENPW;HSP90AB1;HIGD2A;NSG2;COX7A1;MID1IP1;CLTA;HIP1;VBP1;HSPA4;PILRB;TBCD;PFDN6;VAMP4;PDE4DIP;LONP1;CHMP2A;ADRM1;SGIP1;COG4;TGFB1;RPL38;TBCA;ANGPT1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.3424851190808211,-1.1816631554225567,0.18666666666666668,0.45657695270763055,1.0,10/53,13.20%,ASCL1;WNT7A;IFNG;TNF;IL1B;IL6;BHLHE41;ASCL2;HEY2;SORL1
prerank,Elsevier_Pathway_Collection__HIF1A as Master Regulator of Angiogenesis in Cancer,0.4069390337704531,1.18161409058171,0.24083769633507854,0.8335088009847645,1.0,17/44,23.15%,CDKN2A;FGF2;PDGFB;FLT1;PGF;ELOC;ANGPT2;HIF1AN;ELOB;EGLN1;TSC1;P4HA2;ARNT2;FH;TSC2;HIF3A;ARNTL
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.4492079274626127,1.1815035047996154,0.25308641975308643,0.8331713397811126,1.0,6/27,11.68%,CACNA1E;CACNA1I;CACNA1S;CACNA1G;ATP2A1;CACNA1C
prerank,Elsevier_Pathway_Collection__Negative Acute Phase Proteins Synthesis,-0.34822212533549485,-1.1810953108315336,0.17142857142857143,0.4573173120630868,1.0,10/46,15.75%,GHR;TNF;IL1B;IL1RAP;TF;ALB;IL6;TTR;MYD88;TNFRSF1B
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.35281916039115624,1.1808012897566846,0.16585365853658537,0.8350683316518773,1.0,57/131,38.01%,BRSK2;NEK2;CDC25C;MELK;FOXM1;PLK1;CCNB2;CCNA2;CDK1;TUBA4A;CCNB1;CDKN2B;AURKA;CEP131;PKMYT1;CDC25A;NES;CETN2;CEP250;HAUS4;FBXL6;HAUS5;FBXL8;AKAP8L;USH1C;FBXL15;PLK4;DYNLL1;CEP70;SFI1;BRSK1;CHEK2;SSNA1;CDKN1A;ENSA;FBXL22;CSNK1D;TUBA1A;ALMS1;CUL1;CEP290;CEP152;DCTN2;DYNC1H1;SKP2;DCTN3;CEP41;SKP1;TUBG1;CEP72;PPP2R1A;PPME1;NDE1;HAUS1;TUBB4B;AKAP8;SDCCAG8
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.4743005082491948,1.1806825944596104,0.2578947368421053,0.8347691768765496,1.0,3/20,6.66%,ACTN2;THY1;SRC
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.260265869684333,-1.1805562538146601,0.038461538461538464,0.4580177437805938,1.0,35/195,13.30%,KLK3;CXCL13;PROK2;CXCL10;ITGB8;SEMA3E;IL1B;CD160;BMPER;CCN6;ECM1;SFRP1;FASLG;COL4A3;ISM1;GDF2;TSPAN12;ANGPT4;EPHA1;DCN;PIK3CD;ANXA3;PRKCB;RLN2;IL6;KLF4;SEMA6A;ADAMTS1;ALOX5;CCR2;CXCL8;CHRNA7;TNMD;TMIGD2;ANGPTL3
prerank,Elsevier_Pathway_Collection__IL4R -> ELK/SRF/HMGY Signaling,0.4626086220814666,1.1800495252246292,0.25925925925925924,0.8365306365010932,1.0,7/21,17.33%,CDK1;MAPKAPK2;SHC1;PDPK1;PKMYT1;ELK4;HMGA1
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.4786305586221964,1.1799761679967056,0.24675324675324675,0.8359994492563031,1.0,7/18,12.35%,NQO1;CHRFAM7A;CHRNB2;CHRNA3;CHRNB4;CHRNA5;CHRNA4
prerank,Elsevier_Pathway_Collection__Potassium Cycling in the Inner Ear (Congenital Deafness),0.45084220125399693,1.179828707424158,0.2346368715083799,0.8357360492168997,1.0,7/23,16.41%,GJB6;TMC1;CLCNKA;PCDH15;P2RX2;GJB3;SLC12A7
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.26815777537571955,-1.1798250053864798,0.13043478260869565,0.4592274832988153,1.0,44/176,19.56%,GCK;EREG;MFSD2A;PTGS2;IFNG;TNF;SLC45A3;IL1B;HGF;CCL5;PTH1R;CD244;APOA4;PLD1;CPEB3;APOA1;PPARGC1A;HBB;EGR1;IL6;KLF4;GPLD1;APOA5;DDAH1;CXCL8;ZEB2;DUOXA1;TLR4;CLEC7A;AKT1;IGF1;KLF2;CHP1;CLU;AGXT2;THBS1;STARD4;PIWIL2;ASS1;SLC25A37;IRS2;CDH3;TYRP1;SAMD4A
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.4242181321498202,-1.1792659901152485,0.21348314606741572,0.46005633465362183,1.0,4/19,13.56%,GNPNAT1;UGP2;SLC35D1;PGM3
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.4349513598501878,-1.1791644446551548,0.25842696629213485,0.45986968311239806,1.0,7/18,20.54%,TCN1;MMUT;PRSS3;ABCD4;MMACHC;LMBRD1;MMADHC
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,-0.3461339989133567,-1.1791464859879917,0.1774193548387097,0.4594862927499791,1.0,11/41,13.58%,RIMBP2;LRAT;BCO2;APOA4;GPC5;APOA1;AKR1C4;GPC6;BCO1;GPC4;TTR
prerank,Elsevier_Pathway_Collection__Scavenger Receptors in Platelet Activation,-0.40607880476099734,-1.1789783333855923,0.21052631578947367,0.45942089609361164,1.0,10/22,23.65%,FYN;LCP2;LAT;SYK;PLCG2;VAV1;GP1BA;YES1;MAP2K6;MAP2K4
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.44983142227457656,1.1787538635688897,0.26666666666666666,0.8392076865265988,1.0,4/27,8.27%,SYT5;CEL;SNCG;SYT2
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4411029298482779,1.177998236544127,0.21965317919075145,0.8411238240427422,1.0,3/27,2.83%,RFX6;GCG;BRSK2
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,0.39467266432596954,1.1776834520762043,0.2393617021276596,0.841602440030746,1.0,41/65,47.30%,CDC20;UBE2C;PSMD4;UBE2S;PTTG1;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;ANAPC2;PSMB2;PSMA6;ANAPC4;UBC;PSMD9;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.42863889827207485,1.1776551302528853,0.2392638036809816,0.8409490419358224,1.0,27/35,50.25%,TERT;RTEL1;PIF1;NHP2;RAD51;HSP90AB1;DKC1;TELO2;NOP10;PINX1;DCLRE1B;TERF1;ACD;HSP90AA1;CDK2;TERF2;SHQ1;WRAP53;CTC1;RPA1;STN1;RFC1;MRE11;RAD50;PTGES3;ZBTB48;GAR1
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.2608637916409117,-1.177456919599742,0.0,0.4626014930211487,1.0,125/451,22.38%,TCN1;CEACAM6;CRISP3;SLCO4C1;ACP3;CLEC12A;PLAC8;FCAR;AOC1;ADGRE3;FOLR3;RCAN1;CFP;BPI;GPR84;GLYAT;CXCR1;FPR1;CXCR2;AGL;TNFAIP6;FPR2;FRMPD3;S100A8;BST1;SIGLEC14;LGALS3;CMTM6;NFAM1;SIRPB1;CLEC4D;SIGLEC9;PRSS3;PTPRC;A1BG;VNN1;AGPAT2;CDA;CR1;CD300A;ACAA1;CLEC5A;CD53;CYBB;ALOX5;BIN2;HSPA1B;MNDA;LILRA6;PGLYRP1;ALDOC;ARHGAP9;CLEC4C;NHLRC3;NCKAP1L;FGL2;CEACAM21;TLR2;ENPP4;TTR;ATP8B4;FGR;COTL1;ORM2;S100A12;DOCK2;OSCAR;OSTF1;FCER1G;ADGRE5;QSOX1;PIGR;UNC13D;TNFRSF1B;CD177;ITGB2;CXCL1;P2RX1;PLAUR;LILRB2;TMC6;CTSB;HSPA1A;SLC15A4;METTL7A;CD33;PTAFR;PYGL;CTSZ;PGM2;DERA;CTSC;C3AR1;DLC1;AMPD3;FCN1;FRK;ATP11B;ADAM8;PGM1;ADA2;SELL;IQGAP1;MCEMP1;AHSG;RAB27A;TMEM30A;IRAG2;RAB14;GSTP1;PPBP;RAB44;HVCN1;STOM;CD55;CYBA;IDH1;NIT2;HPSE;RAP1A;ITGAM;SLC27A2;TYROBP;DOK3;MGAM
prerank,Elsevier_Pathway_Collection__Proteins Involved in Polycystic Ovary Syndrome,0.3721985321750143,1.1770925362074391,0.17676767676767677,0.842456572113329,1.0,21/92,17.35%,DKK1;INHA;FBN3;APLN;CALCA;CYP17A1;FABP4;CRP;CYP21A2;NEK2;SLC2A4;AMH;LEP;CD36;ACE;IAPP;LEPR;H6PD;PPARG;HMGCR;EGF
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.4400917614645673,-1.1770333498634662,0.22727272727272727,0.4630736413472581,1.0,3/15,0.82%,TFF2;TFF1;MUC6
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.48353255386098387,1.1769231756399166,0.2710843373493976,0.8422500116349055,1.0,6/20,12.11%,TRIM71;DISP3;MDK;TOX;SHCBP1;RASSF10
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.26596593568256377,-1.1767732159860183,0.06451612903225806,0.46324491265329826,1.0,63/197,17.12%,CYP26A1;SPINT2;FMO1;GNMT;LCAT;NDRG2;TKFC;ABCD2;ID2;TDO2;PEMT;CYP4F2;SLC22A1;CYP1A2;XDH;ESR1;PDK4;FBP1;CYP2C18;SLC46A3;CAT;FETUB;VNN1;GCH1;CDA;G6PC;ADH1C;TAT;CA2;PTGES;HSD17B2;MBL2;PLG;MTHFD1;DHRS1;ADH7;IRF8;ENTPD5;PTGR1;ATOH8;ENPEP;ACOX1;ANGPTL3;SLC35D1;KYNU;ABHD6;ETFDH;IGF1;LEAP2;CROT;MAN1A1;CASP6;IGFBP1;ALDH2;GCKR;GCNT2;DDC;CYP2J2;IGFBP4;MT2A;FMO3;F11;HMOX1
prerank,Elsevier_Pathway_Collection__CNR1/2 -> IL1B/2/4/6/10 Production,-0.3346538734458428,-1.1766550742553146,0.14705882352941177,0.46307804470317854,1.0,14/37,25.20%,IL10;IL1B;FOS;MAP2K1;IL6;CNR2;RASGRP1;MAPK10;MAP2K3;MAP2K6;JUN;RAP1A;MAP2K4;GNAI2
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.39062195556722284,1.1766318581406365,0.23809523809523808,0.8425997087484047,1.0,9/53,9.59%,SLC6A7;SLC16A11;SLC16A9;SLC6A11;SLC7A6;SLC13A3;SLC6A9;SLC16A3;SLC1A4
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3538086761339506,1.1765996713968794,0.18617021276595744,0.8419607547100163,1.0,11/88,8.07%,MT3;SIX1;FGF20;SIX4;POU4F1;MDK;KCNB1;KIF14;FAIM2;BDNF;PRKN
prerank,TRRUST_Transcription_Factors_2019__ETS2 mouse,-0.3986508282834813,-1.176529493337262,0.1744186046511628,0.4629550463684931,1.0,8/23,17.12%,CD4;SH2D1A;CSF3R;EGR1;STAB1;CSF1R;DUSP6;HMOX1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.38288719891063727,-1.176447900421011,0.225,0.4627017765427101,1.0,11/27,17.22%,RET;TNF;IL1B;INHBA;HSPA1B;AKT1;CSF2;EYA2;BCL2;HSPA1A;GATA1
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.44126396918283806,1.1763567409402025,0.2247191011235955,0.8422358737130692,1.0,8/27,15.74%,RASGRF1;ACTN2;GPRIN1;CAMK2A;MPP3;RASGRF2;PDPK1;HRAS
prerank,Elsevier_Pathway_Collection__Apoptosis of Myocyte,-0.4330058668780289,-1.176249697578767,0.2235294117647059,0.46266630359641975,1.0,5/19,15.99%,TNF;FASLG;TNFSF10;CASP6;CASP7
prerank,WikiPathway_2021_Human__Globo Sphingolipid Metabolism WP1424,-0.41891761272621475,-1.1760184216103087,0.24705882352941178,0.4627774389152622,1.0,6/20,14.33%,B3GALT5;ST6GAL2;ST6GALNAC1;ST8SIA1;GCNT1;ST6GAL1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.34609726716676614,-1.1756495976567727,0.2413793103448276,0.4632028435738921,1.0,9/44,14.61%,CIDEA;ACOT11;IL18R1;IL15;WNT10B;ARRDC3;TLR4;ABHD6;PLCL2
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.4659216516146492,1.1756072078646411,0.27485380116959063,0.8443473700018875,1.0,8/23,21.80%,FGF20;FGF13;FGF17;FGF23;SHC1;HRAS;FGF18;PLCG1
prerank,MSigDB_Oncogenic_Signatures__KRAS.BREAST UP.V1 UP,0.35689882959388824,1.1754789409892672,0.1890547263681592,0.8441174629926489,1.0,25/109,14.29%,IGF2;CTNNA2;SPINK1;SMPX;ESM1;KCNC2;GFI1;COL9A1;TERT;OCA2;MKRN3;FAM155B;RMST;ANO2;KIF5A;PRRX1;NDUFA4L2;SPON2;KCNJ14;IL1RAPL1;MMP10;SNAP25;SPACA1;SYP;CMA1
prerank,Reactome_2022__TRP Channels R-HSA-3295583,-0.390726530093881,-1.175282594261684,0.21518987341772153,0.4635624233423648,1.0,6/23,11.35%,MCOLN3;TRPV6;TRPV4;MCOLN2;TRPC3;TRPM8
prerank,TRRUST_Transcription_Factors_2019__CREM human,-0.4087448016204232,-1.1747506577516014,0.20454545454545456,0.46425683283326935,1.0,5/22,6.36%,IL5RA;TH;FOS;FASLG;CCL4
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.4154302699208787,1.1746868437347042,0.22151898734177214,0.8463132691088118,1.0,10/30,22.70%,PAX2;GRHL3;SCRIB;DVL2;MTHFD1L;MTHFR;STIL;DEAF1;TGFB2;TSC2
prerank,WikiPathway_2021_Human__Regulation of toll-like receptor signaling pathway WP1449,-0.281825654827733,-1.1745684025032936,0.1,0.46422003135124207,1.0,31/124,14.75%,CXCL10;CXCL11;TNF;IL1B;CCL5;FOS;CD80;TLR3;CXCL9;CCL4;CCL3;MAP2K1;PIK3CD;IL6;TLR8;IL12B;BTK;PELI2;MBL2;CXCL8;CD180;TICAM2;TLR4;PIK3R5;TLR2;SFTPD;PIK3R1;AKT1;SYK;CISH;MYD88
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.4257411090122938,1.174293183285873,0.20994475138121546,0.8470492142493945,1.0,5/41,6.61%,MUC13;PIK3R2;STMN2;DLG5;KIF14
prerank,WikiPathway_2021_Human__Resistin as a regulator of inflammation WP4481,-0.3607719961593818,-1.1740816622384853,0.19480519480519481,0.46502589555216717,1.0,8/33,14.55%,TNF;PIK3CD;IL6;IL12B;CXCL8;AKT1;PLCB2;PLCG2
prerank,WikiPathway_2021_Human__Neural Crest Cell Migration in Cancer WP4565,-0.3528383062791402,-1.1739175686694765,0.21875,0.46488050371427153,1.0,13/42,14.92%,PAK5;EPHB1;PAK6;FOS;NTRK2;NGFR;PIK3CD;EPHB3;F2RL2;PIK3R5;AKT1;EPHB6;TIAM1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.33834415503925513,-1.1736276522318145,0.234375,0.4650804066145023,1.0,14/46,19.08%,ASCL1;FREM2;MAB21L2;CHRDL1;SLC39A5;PBX1;ASCL2;GATA3;MAFB;CPAMD8;BMPR1B;MEIS1;SMOC1;MYO7B
prerank,Elsevier_Pathway_Collection__Histone Phosphorylation,0.491995536187048,1.17362681945606,0.25316455696202533,0.8489877120651299,1.0,10/16,39.56%,AURKB;CDK1;AURKA;KAT2A;HDAC1;CBX5;RPS6KA3;RPS6KA4;ATR;CDK2
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.36208679476924965,1.1735758264906944,0.19806763285024154,0.8483405429448845,1.0,51/104,42.41%,PYDC1;COLEC12;LAGE3;CPSF1;CTU1;NUP37;RPP21;FTSJ1;PUS1;EPRS1;TSEN2;NUP62;TPR;DUS2;NUP133;CPSF4;WDR4;TRMT61A;TRMU;TSEN54;TRMT112;TSEN15;THADA;CSTF2;NUP155;NUP160;METTL1;ADAT3;RPP25;QTRT1;TRMT12;TYW5;PUS7;CTU2;NUP188;RPP40;TP53RK;POP5;NUP205;XPOT;NUP210;RAN;TRMT6;HSD17B10;NUP214;TRMT5;RPP38;ADAT1;NUP107;GTPBP3;DDX1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.313786436123692,-1.1734711925572472,0.14035087719298245,0.4649136990115874,1.0,23/74,15.16%,GBP6;GBP5;ACOD1;CCL5;CCL4;CCL3;CASP1;XCL1;CCL23;GBP7;GBP4;GCH1;CCL2;XCL2;MEFV;TLR4;CCL22;IRF8;GBP3;TLR2;KYNU;GBP1;IL12RB1
prerank,Elsevier_Pathway_Collection__Intraflagellar Transport: BBSome Interaction,0.4376874630053796,1.1733780978708228,0.2275449101796407,0.8482361446709134,1.0,12/30,32.29%,MAPT;IHH;BBS5;LEPR;BBS2;DHH;ASAP1;BBS4;SMO;ARRB1;TUBA1A;CEP290
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.45214516769199337,1.1733393149043014,0.2647058823529412,0.8476261108948498,1.0,7/19,34.47%,PLK1;AKAP8L;EMD;TOR1AIP1;VPS4A;CHMP2A;NSFL1C
prerank,Elsevier_Pathway_Collection__Thyroid Hormones Common Genomic Effects in Hyperthyroidism,0.427936152228917,1.1733324033498338,0.2111111111111111,0.8468572973777894,1.0,7/30,17.13%,DIO2;SLCO1C1;CYP7A1;PTTG1;DIO3;PPARG;THRA
prerank,Elsevier_Pathway_Collection__Antiviral Signaling through Pattern Recognition Receptors,-0.38842484268016997,-1.1731172248200539,0.2235294117647059,0.46529074333877557,1.0,7/23,14.75%,TNF;TLR3;TLR8;TICAM2;TLR4;TLR2;MYD88
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.4086630688165669,1.1729888325476552,0.21428571428571427,0.8474384115565401,1.0,9/47,10.52%,EPHA6;EPHB2;EFNA3;SRC;EPHA10;EFNA4;EFNA1;CLTCL1;RNASE1
prerank,MSigDB_Oncogenic_Signatures__BCAT GDS748 UP,0.40634450771806624,1.172448643340328,0.20108695652173914,0.8488101735421886,1.0,7/41,10.72%,DYNC1I1;FGF20;LEF1;GAD1;ASRGL1;NPTX1;PHLDA2
prerank,Elsevier_Pathway_Collection__beta-Cell Mass Regulation,0.4122246032835137,1.172441465233356,0.25,0.848039219480156,1.0,3/40,1.43%,IGF2;GLP1R;LEF1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.3779254859046852,1.172411188982415,0.18848167539267016,0.8473621141369075,1.0,12/71,13.27%,TLCD3B;ST8SIA3;CERS1;PLPP2;ALOX12B;SPTSSB;SPHK1;A4GALT;PRKD1;ST8SIA5;ELOVL3;GBA
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.3058024111348246,-1.172410620411521,0.1568627450980392,0.4664894940890579,1.0,21/70,17.10%,CYP39A1;CETP;LCAT;APOA4;DGAT2;GRAMD1B;IL18;APOA1;LIPG;ACSM3;APOA5;HDAC9;TSKU;ABCG8;ABCG5;ABCG4;ANGPTL3;EPHX2;MTTP;LIPC;LIMA1
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.3487819988698491,-1.1721669674140547,0.2054794520547945,0.46657968576134984,1.0,20/37,24.54%,IFNG;TNF;IL1B;FASLG;CD80;PRF1;IL12B;HLA-DQA2;HLA-DOB;LTA;CD86;HLA-DQA1;GZMB;HLA-DOA;HLA-DRB5;ICA1;HLA-DRA;HLA-DPA1;HLA-DPB1;HLA-DRB1
prerank,TRRUST_Transcription_Factors_2019__SRF mouse,-0.44169241901560985,-1.1718808269294905,0.2619047619047619,0.46679310138067204,1.0,4/16,13.14%,BARX2;FOS;EGR1;MYH11
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.27305495691140363,-1.1717098341301535,0.10344827586206896,0.46680779120341254,1.0,48/191,15.05%,NRXN1;LGI1;RET;L1CAM;DOK6;GFRA3;TNR;EPHB1;DSCAM;DAB1;SEMA3E;PLXNA4;LAMA1;IGSF9;CNTN6;RNF165;PTPRO;FEZ1;NCAM1;EPHA1;SEMA4A;EPHA7;PIK3CD;SEMA6D;SEMA4D;CXCL12;RHOH;VSTM2L;ROBO2;PRKCQ;EFNB3;FYN;EPHB3;SEMA6A;SEMA3D;RAC2;UNC5C;LAMC2;SPTBN2;EMB;DOK2;CNTN4;PIK3R1;EPHB6;EFNA5;SH3KBP1;CXCR4;SEMA3C
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4175419642105084,-1.171667411041006,0.21839080459770116,0.46652793789375135,1.0,3/20,7.48%,FOXP3;IL1B;PPARGC1A
prerank,TRRUST_Transcription_Factors_2019__SMAD4 mouse,-0.34351090436717496,-1.1712252968707109,0.24050632911392406,0.46708852311324994,1.0,9/34,11.16%,NKX2-1;MUC5AC;IL10;HGF;ID2;CDH1;SSTR2;SCNN1A;MMP7
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.42392709015032437,1.171124256269972,0.24293785310734464,0.8516939894851754,1.0,2/36,0.35%,MT3;PAX2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hypothyroidism,-0.32208495055935316,-1.1710075649288556,0.27450980392156865,0.46713495696344215,1.0,18/53,15.02%,NKX2-1;TSHR;IFNG;CD4;TNF;IL1B;APOA4;FASLG;IYD;APOA1;TG;GCGR;NTRK1;SLC16A2;TTR;IGF1;RUNX2;POU1F1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.2794299315186732,-1.1709045141253558,0.037037037037037035,0.46690364732822437,1.0,40/133,14.96%,TAC1;CXCL13;PROK2;PLCZ1;ADRA1A;TRPV4;CCR9;CXCR1;FPR1;CXCR2;GPR174;FPR2;GPR18;CCR5;XCR1;ESR1;CXCR6;PDGFRA;GPR65;CCR7;P2RX3;ACKR4;P2RY10;TRPC3;CALCR;LPAR2;PTGER2;CCR1;CCR2;F2RL2;PTGER4;P2RY1;JPH3;ADCY5;SLC8A1;CCR4;FPR3;PTGDR;CXCR3;CXCR4
prerank,MSigDB_Oncogenic_Signatures__IL15 UP.V1 UP,-0.2745148958977125,-1.1708417166327918,0.06666666666666667,0.46661943346776796,1.0,48/162,19.28%,L1TD1;FOXP3;SPINT1;EGR3;IL10;TNFSF11;EGR2;AIM2;ANKRD36BP2;PAK6;SLAMF7;ECM1;SOCS2;FOS;PTH1R;CD69;TLR3;IL18RAP;C9;CCL4;AK4P3;DUSP2;CXCL12;MAF;EGR1;OSM;HSD17B14;HABP2;OR7C1;SLC7A5;TRIB1;TNFRSF9;CISH;RGS3;APOBR;SPRY2;LILRB4;PTPN7;TMEM158;RAB11FIP1;DUSP6;SPOCK1;SLAMF1;TNFRSF21;KCTD12;LIF;CDH3;TPST2
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.3926464793048381,-1.170556336123661,0.25882352941176473,0.4669060024016843,1.0,8/21,17.21%,F9;KLKB1;GP5;SERPINA5;ZNF160;SERPING1;KNG1;GP1BA
prerank,Elsevier_Pathway_Collection__Genes with Susceptibility for Crohn's Disease and Ulcerative Colitis,-0.41982018147290545,-1.1702803308936698,0.27906976744186046,0.46709086519898085,1.0,4/19,6.91%,ITLN1;IL7R;IL27;TNFSF15
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.41932401431646943,1.1702584377001701,0.23255813953488372,0.8543766118613677,1.0,6/37,11.18%,SYT5;CEL;SNCG;SYT2;DNM3;DNAJC6
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.43552432033776534,1.1699708697016014,0.2085889570552147,0.8547441108584736,1.0,11/32,21.67%,CDH22;CDH8;CDH13;CDH24;PCDHB14;CDH17;PCDHB2;PCDHB11;PCDHB3;CDH11;DCHS1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.30575053047232237,-1.169807903406227,0.1774193548387097,0.46772219473097704,1.0,22/72,21.08%,TCN1;SLC52A1;SLC19A3;MMUT;PRSS3;VNN1;MTHFD1;MTHFS;SHMT1;ABCD4;MCCC1;ENPP1;MMACHC;GSTO2;CYB5A;PCCA;LMBRD1;MTHFD2L;DHFR;MMADHC;VNN3;SLC19A2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.41020826217431255,1.1696085398335812,0.225,0.8553648990499227,1.0,10/31,22.70%,PAX2;GRHL3;SCRIB;DVL2;MTHFD1L;MTHFR;STIL;DEAF1;TGFB2;TSC2
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.32484228118981867,-1.169502021731543,0.1791044776119403,0.46811850200416066,1.0,28/57,29.80%,AADAT;PCK1;HOGA1;TAT;MTHFD1;HAAO;MTHFS;SHMT1;L2HGDH;PHYH;ASS1;MDH1B;MTHFD2L;DHFR;IDH1;NIT2;ALDH5A1;GPT2;DGLUCY;ADHFE1;SHMT2;ME1;FOLR2;ME2;SLC25A32;MTHFD2;GOT2;DHFR2
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.3850619474812916,-1.169436921904235,0.2535211267605634,0.4678344834227065,1.0,10/27,24.99%,AIM2;PTPN22;IL12B;LILRB1;IL12RB1;APOBEC3G;STAT1;TRIM44;DDX58;TRIM6
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.36645698005777205,1.1687614516331593,0.17766497461928935,0.8580080849708097,1.0,33/97,30.14%,NKD1;TRIM40;EEF1A2;ADGRB1;GPC3;FAM83D;PRKN;DTL;OAZ3;VPS28;C4BPB;APC2;CTSA;TMEM9;ODC1;NEDD4L;HMGCR;NEDD4;BARD1;CYP51A1;ATP13A2;HECW1;NDUFA13;CHEK2;MAD2L1;HGS;MAD2L2;SMURF1;GFAP;AZIN1;C4BPA;SNF8;PIN1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.4244551398879522,1.1685829432903416,0.2833333333333333,0.8579053798447808,1.0,2/33,5.48%,AVIL;MSTN
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.40684384186012174,-1.1685806062304847,0.24675324675324675,0.4693862412395785,1.0,7/23,13.84%,WNT7A;TNF;IL1B;IL6;LILRB1;SORL1;IGF1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.4681053296684942,1.1684894322163426,0.28901734104046245,0.8574926142641212,1.0,7/18,15.90%,C1QTNF3;WNT4;DKKL1;ERFE;SOGA1;PGP;C1QTNF12
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.37887511493023346,-1.168372130706487,0.1744186046511628,0.46937711688298983,1.0,16/28,27.40%,HAO2;ACAA1;EHHADH;ACBD4;ACOX1;CROT;PHYH;MLYCD;ACBD5;ACOX2;ACOX3;PECR;SLC27A2;CRAT;NUDT7;ECI2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.40749104038234063,1.1681860042942096,0.24242424242424243,0.8579187802891141,1.0,27/45,40.24%,PARPBP;USP51;POLQ;RTEL1;CHEK1;FIGNL1;UBQLN4;RADX;PARP1;RAD51AP1;RAD51;OOEP;FANCB;MAD2L2;SIRT6;TIMELESS;MRNIP;SHLD3;FUS;TP53BP1;RMI2;MMS19;SHLD1;SPIDR;ARID2;SHLD2;RPA2
prerank,WikiPathway_2021_Human__Mitochondrial complex I assembly model OXPHOS system WP4324,0.3922519751581037,1.1677370477458133,0.22994652406417113,0.8589350703691273,1.0,24/50,38.43%,NDUFA1;NDUFS6;TMEM70;NDUFV1;NDUFB9;NDUFA3;NDUFS2;NDUFAF2;NDUFB11;NDUFA2;NDUFAF6;NDUFA13;NDUFA6;NDUFV2;NDUFA8;NDUFB7;TMEM186;NDUFAB1;NDUFB2;NDUFB10;NDUFAF3;ACAD9;NDUFB3;NDUFS4
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.4961421340199802,1.167349293755516,0.2565789473684211,0.8595611641622752,1.0,3/16,21.68%,LEF1;TFAP4;SMARCA4
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.3967828396567789,-1.167184617936154,0.26881720430107525,0.4716921379395698,1.0,3/20,5.74%,RIPK3;ZBP1;TLR3
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.3461758381164416,-1.1671553872630192,0.20253164556962025,0.4713264825641497,1.0,13/41,19.50%,TRPV4;TNF;RND3;RHOH;PLEK;RAC2;NCKAP1L;LCP1;FHOD3;EPB41L3;EZR;FMNL1;RND2
prerank,Elsevier_Pathway_Collection__Thyroid Hormones in Adipose Tissue Metabolism,0.43287752394579465,1.1670670883664607,0.25136612021857924,0.8600031615349302,1.0,9/29,17.13%,CYP7A1;TRH;LPL;LEP;IL6R;LEPR;ACACA;PPARG;THRA
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,0.3697564198287616,1.1670314307049896,0.2048780487804878,0.8593886871275693,1.0,38/81,44.08%,MRPL55;MRPS21;MRPL24;MRPS24;MRPL13;MRPL9;MRPS14;MRPS23;GADD45GIP1;MRPL23;MRPL52;MRPL12;MRPL15;MRPL36;MRPL41;AURKAIP1;MRPL21;MRPS34;MRPL17;MRPS15;MRPL51;MRPL4;MRPL33;OXA1L;CHCHD1;MRPL1;MRRF;MRPS5;MRPL43;PTCD3;MRPS27;MRPS18C;MRPL58;MRPL50;MRPS11;MRPS26;DLGAP3;MRPL49
prerank,Elsevier_Pathway_Collection__CD19 -> JUN/ELK Signaling,-0.3818454347553455,-1.1666440062206882,0.19767441860465115,0.4721028954702267,1.0,8/22,15.00%,CR2;FOS;MAP2K1;BTK;RASGRP1;SYK;PLCG2;VAV1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.4963041576777031,1.1666431132085782,0.29714285714285715,0.8601731932030805,1.0,13/17,45.00%,TERT;TYMS;POLD1;POLA1;CDKN2D;PPIA;HROB;POLL;POLH;RFC3;POLD3;POLD4;WRN
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.3681649503524329,1.166631083510112,0.21052631578947367,0.8594150062704169,1.0,44/83,40.79%,CENPF;NEK2;HMMR;PLK1;GTSE1;KIF14;CDK1;TUBA4A;AURKA;CEP131;CETN2;CEP250;HAUS4;HAUS5;DYRK3;TPX2;ATAD5;NPM1;PLK4;DYNLL1;CEP70;SFI1;SSNA1;CSNK1D;TUBA1A;ALMS1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;TUBG1;CEP72;PPP2R1A;NDE1;HAUS1;TUBB4B;SDCCAG8;HSP90AA1;CSNK1E;CDK2;CEP192;MACROH2A1
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.3678775549307236,1.1666038572688529,0.24644549763033174,0.8587022107081034,1.0,51/95,41.44%,RECQL4;CDC7;CDC45;MCM2;TONSL;MCM6;RAD51AP2;POLQ;XRCC2;NSMCE2;POLN;MCM3;MCM5;MCM4;RMI1;MCMDC2;RAD54L;FEN1;PARP1;RAD51AP1;RAD51;MCM7;GINS4;BLM;LIG3;GINS2;FANCB;PSMD14;NABP2;MMS22L;NSMCE1;RECQL5;SWSAP1;AP5Z1;XRCC1;RFWD3;MCM8;MUS81;BRCA2;FAN1;SEM1;POLL;SFR1;XRCC3;SPIDR;FANCM;RPA2;RAD52;RECQL;ZFYVE26;RAD21
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,0.37286291715717473,1.1664437527090756,0.19791666666666666,0.8585213214973688,1.0,39/80,40.40%,NEK2;PLK1;CDK1;TUBA4A;CEP131;PRKCA;CETN2;CEP250;HAUS4;HAUS5;MZT2B;PLK4;DYNLL1;CEP70;SFI1;TUBGCP6;SSNA1;MZT2A;CSNK1D;TUBA1A;ALMS1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;TUBG1;CEP72;PPP2R1A;TUBGCP2;NDE1;HAUS1;TUBB4B;SDCCAG8;HSP90AA1;CSNK1E;NUMA1;CEP192
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,0.4310863220135208,1.1663830110746294,0.2823529411764706,0.8579486736932813,1.0,6/32,17.53%,FGF20;FGF13;FGF17;FGF23;HRAS;TRIM24
prerank,Elsevier_Pathway_Collection__Dexamethasone Induced Diabetes,0.47197952484541517,1.1663658765839384,0.2727272727272727,0.8572360544011607,1.0,2/19,5.24%,DKK1;SLC2A4
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.3429269779471529,1.1660589845589024,0.1891891891891892,0.8575955355757955,1.0,39/156,15.74%,GNG4;CHRND;KCNJ6;RASGRF1;ACTN2;CACNG4;GABRR3;GABRQ;PRKAA2;MAPT;KCNJ9;CHRFAM7A;CHRNB2;KCNJ5;GPRIN1;CHRNA3;SRC;GRIK4;CAMK2A;CHRNB4;GNAL;GRIN2A;GRIP2;GNG3;GRIN3B;CHRNA5;RNASE1;MPP3;RASGRF2;CHRNA4;PPM1F;CACNG8;GNB5;ADCY6;PDPK1;GNG8;KCNJ4;PRKCA;HRAS
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.30998409270410576,-1.1657589888291253,0.18181818181818182,0.4737277952219972,1.0,6/55,6.79%,RIPK3;IL1B;FASLG;IL18;TNFSF10;CASP1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.38804564984225703,-1.165704496037739,0.22826086956521738,0.47335070834784204,1.0,6/25,10.11%,FOXP3;IFNG;LAG3;DUSP10;CTLA4;CR1
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,-0.4304081138942488,-1.1655190305427154,0.23655913978494625,0.47336952502041585,1.0,6/15,17.93%,EREG;ERBB4;NRG4;BTC;HBEGF;NRG3
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.4474376522332343,1.1654190868183203,0.2556818181818182,0.8592212397131586,1.0,9/24,17.92%,SNAI2;MDK;GDF5;CHADL;LOXL2;PTHLH;EFEMP1;SCIN;ACVRL1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.3370768614626533,-1.1653816033970807,0.21739130434782608,0.47323564120723005,1.0,7/44,9.55%,CIDEA;TNF;IL1B;CBFA2T3;FBP1;ALK;HCAR2
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.329022488458064,-1.1653731068264594,0.16666666666666666,0.4728022240878979,1.0,4/47,4.83%,PKP3;CNDP1;WNT7A;INHBA
prerank,Elsevier_Pathway_Collection__NTSR1 Expression Targets,0.4210516338977258,1.165246342501347,0.2541436464088398,0.8592188420733138,1.0,6/26,16.31%,NTS;RASGRF1;MAPKAPK2;SHC1;PDPK1;ELK4
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.35802878275254346,-1.1651165884431418,0.23880597014925373,0.4729318453061459,1.0,12/35,19.04%,AWAT2;CETP;DGAT2;APOA5;DGKE;PLAAT3;ABHD6;APOBR;DGKB;MGLL;ABHD2;APOH
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.36636531579467746,-1.1651132606109982,0.24561403508771928,0.4724942747543607,1.0,13/43,11.85%,GABRA5;GABRA3;SLC5A1;GABRB1;GABRA4;GABRG1;GLRB;GLRA3;ANO1;GABRG3;APOL1;ANO5;GABRP
prerank,KEGG_2021_Human__Type II diabetes mellitus,0.4082555920279489,1.164843343116596,0.26666666666666666,0.8600719808614953,1.0,7/42,11.68%,MAFA;CACNA1E;PIK3R2;SLC2A4;CACNA1G;ABCC8;CACNA1C
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.4837592275345943,1.1648100780445083,0.2893081761006289,0.858641323586932,1.0,5/18,4.81%,SFN;FLG2;ALOX12B;HRNR;FLG
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.4837592275345943,1.1648100780445083,0.2893081761006289,0.858641323586932,1.0,5/18,4.81%,SFN;FLG2;ALOX12B;HRNR;FLG
prerank,Elsevier_Pathway_Collection__TERT/WNT Activation in Cancer,0.45089861800164094,1.16472449578416,0.26993865030674846,0.8582315516884673,1.0,14/23,39.50%,LEF1;TERT;DVL2;SMARCA4;SNAI1;DVL1;MYC;CTNNB1;LRP5;GNL3L;AXIN1;GSK3B;VIM;DVL3
prerank,KEGG_2021_Human__Protein digestion and absorption,0.3603266295592446,1.1643334848161542,0.1902439024390244,0.8589798168407717,1.0,27/88,17.75%,COL2A1;COL22A1;COL7A1;COL15A1;COL9A1;CPA1;MEP1A;COL10A1;ATP1A2;COL4A1;ELN;ATP1A4;COL4A5;COL8A1;PGA5;COL1A1;ATP1B3;COL11A1;COL4A2;SLC9A3;COL1A2;COL5A1;FXYD2;DPP4;MME;SLC8A3;XPNPEP2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3870950650453764,1.164247214365525,0.22043010752688172,0.8585331851228684,1.0,11/57,13.53%,STOX1;CDC25C;UBE2C;DTL;CDC7;DLGAP5;CDCA5;CDK1;CCNB1;RGCC;NSMCE2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.3950060329208753,1.1642033166931103,0.23157894736842105,0.8579289942158987,1.0,15/51,18.34%,IGF2;FBXO43;NEK2;CDC25C;BMP4;MKI67;PDGFRB;CCNB1;RGCC;AURKA;PDGFB;PKMYT1;CHEK1;EGF;OBSL1
prerank,MSigDB_Hallmark_2020__DNA Repair,0.3493841119361079,1.1638580910854295,0.20754716981132076,0.8584303954055907,1.0,85/147,44.56%,CCNO;BCAM;GUK1;VPS28;NPR2;TYMS;PRIM1;BCAP31;SAC3D1;RFC4;NME1;ADCY6;ZWINT;POLD1;VPS37D;CETN2;FEN1;IMPDH2;RAD51;POLA1;POLA2;POLR2K;NELFE;DUT;TAF10;USP11;ZNF707;ADA;POLR2G;MPC2;UPF3B;NME3;POLB;TAF6;PCNA;AK1;APRT;POLR2H;ADRM1;POLR3C;GTF3C5;SDCBP;DCTN4;DDB2;LIG1;POLR2I;EDF1;POLR2J;SSRP1;POLR3GL;POLL;SMAD5;DAD1;SUPT5H;NELFB;TAF9;POLH;DDB1;RNMT;ITPA;POLR2A;ERCC2;GPX4;ELL;RAE1;RPA2;RAD52;CLP1;SF3A3;GTF2F1;UMPS;XPC;COX17;ALYREF;RFC3;POLD3;RRM2B;TAF12;RBX1;POLR1C;POLR2F;ERCC3;POLD4;SEC61A1;AAAS
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.497881416730695,1.163786048725003,0.2781456953642384,0.8579606821512638,1.0,3/15,8.32%,OSR1;WNT4;TLE6
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.3742226575500993,1.1637848763075256,0.225130890052356,0.8571976178345381,1.0,37/85,39.37%,IGF2BP1;AGO2;PSMD4;HSPB1;CDK1;RAG1;RNASE1;MMP10;PSMB4;PRKCA;CDC42EP5;ETV4;ZNF367;MYC;PSMB3;PSMD14;UBA52;MAPK4;PSMB5;PSMD2;PSMA1;PKN1;PSMD10;PSMC4;PSMC3;PSMC5;AGO1;SEM1;PSMB6;PSMD8;PSME2;XPO1;MMP2;PSMD13;PSMB7;PSMA7;PSME3
prerank,MSigDB_Oncogenic_Signatures__RELA DN.V1 DN,0.36020878224002395,1.1637058150484314,0.25,0.8566958391521209,1.0,21/106,12.37%,DLK1;ECEL1;CALY;HOXD3;CAPN9;TNNI3;RAMP1;SLC12A5;GDF5;NRXN3;ADRA1D;CLDN6;CDON;CLCN1;GPR3;DNMT3A;MUC4;TXNRD2;IDUA;EGFL6;HAS1
prerank,KEGG_2021_Human__Fatty acid degradation,-0.35085822684958995,-1.1636997554980637,0.1774193548387097,0.47515709173941195,1.0,19/43,20.81%,ADH4;ALDH1B1;ADH1A;ACSL1;ADH1C;ACADL;ACAA1;ACADS;EHHADH;ADH7;ACOX1;ACADSB;ACADM;ALDH2;ECHS1;GCDH;ACAT1;ACOX3;ADH6
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.4833783277875703,1.1636703904033876,0.26380368098159507,0.8561115052248842,1.0,5/17,22.51%,SNAI2;SOX8;HTR2B;TCOF1;NRG1
prerank,Elsevier_Pathway_Collection__beta-Cell Granules Exocytois,0.4593166764848606,1.1636381403088636,0.27710843373493976,0.8554479286562291,1.0,11/22,20.62%,CACNA1E;UNC13A;ARFGEF3;ONECUT2;ABCC8;CACNA1C;SNAP25;KCNJ11;SYTL4;RAPGEF3;STX1A
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.43092007104244606,1.1633172940811543,0.2716049382716049,0.855942681687127,1.0,21/29,48.53%,TERT;RTEL1;PIF1;NHP2;HSP90AB1;DKC1;TELO2;NOP10;PINX1;TERF1;ACD;HSP90AA1;CDK2;TERF2;SHQ1;WRAP53;RPA1;RFC1;MRE11;RAD50;PTGES3
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.38617612892817776,1.1632017951953704,0.23529411764705882,0.8556380719255624,1.0,31/68,38.19%,PRKAA2;FAM83D;LAMTOR2;LEP;GBA;LAMTOR4;TSC1;DYRK3;WDR24;TSC2;ARNTL;SMCR8;LARS1;SH3BP4;TBCK;RHEB;TELO2;GAS6;DGKQ;TREM2;MLST8;LAMTOR5;RRAGD;NPRL3;DDIT4;RPTOR;NPRL2;AKT1S1;RRAGA;GNA12;PIH1D1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.35366132698705366,-1.1628995309446588,0.24675324675324675,0.4766569542853176,1.0,15/30,25.74%,GNMT;SULT1A2;SULT1C2;DAO;SULT1C4;HAO1;SULT2A1;DDO;ENPP1;AGXT;TPST2;MTARC2;MTARC1;SULT1A1;GRHPR
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.38259161248434115,1.1628812162855238,0.21164021164021163,0.8561379205094537,1.0,19/55,25.48%,SQLE;FDPS;MVD;ACACA;SREBF2;PKMYT1;DAND5;HMGCR;TM7SF2;SCD;IDI1;PMVK;FDFT1;GPAM;HMGCS1;CYP51A1;LIN9;SMARCD3;INSIG2
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.3109800026954117,-1.1628485110830007,0.1896551724137931,0.4763008884381731,1.0,24/81,14.14%,CYP2D7;PTGS2;GLYATL2;CYP2C8;HPGD;CYP4A22;GSTA1;CYP4A11;ACSL1;CYP4F2;CYP1A2;ELOVL2;ASAH2;SCP2;CYP2C9;ACADL;CYP4F12;ACAA1;ALOX5;PLA2G4A;CYP4F3;CYP3A4;ACOX1;EPHX2
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.40860410853899526,-1.1624753299639161,0.23255813953488372,0.47671951805710855,1.0,7/16,11.20%,PROK2;KCNA2;SCN9A;RETREG1;CCL2;CCR2;PTGES
prerank,Elsevier_Pathway_Collection__Glutamine in Cancer Metabolism,0.44773722895728474,1.1624410307532862,0.2254335260115607,0.8571138540902241,1.0,2/26,2.76%,SLC7A11;TP73
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.45314770885684014,1.1621732720460793,0.2634730538922156,0.8574823410143525,1.0,13/25,29.01%,FGF13;STMN2;SPEF1;APC2;ARHGEF2;MAP1B;TRIM54;MAP1A;TPX2;CAMSAP2;CAMSAP1;MID1IP1;KATNB1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.43853807975917714,-1.161557411071712,0.25301204819277107,0.4784122835238251,1.0,13/16,30.75%,IL10;NLRP12;CCR7;MEFV;TLR4;ORM2;TMED10;SIRPA;ORM1;HMGB1;F2R;CEACAM1;ANXA1
prerank,TRRUST_Transcription_Factors_2019__STAT3 mouse,-0.31842590014721395,-1.1614430705428176,0.19607843137254902,0.47825394553169776,1.0,21/67,18.69%,MUC1;IL10;CXCL11;TNF;PNP;HGF;FOS;SOX6;MAF;EGR1;IL6;KLF4;IGFBP5;PIK3R1;AKT1;SPI1;PRDM1;BCL2;LIF;TWIST1;BATF
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.4321357498330829,1.1613885851817887,0.2742857142857143,0.8596502347667132,1.0,4/29,9.66%,UBE2T;UBE2C;PRKN;UBE2S
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,0.31761403848040415,1.1611952658607267,0.14782608695652175,0.8596873918490398,1.0,77/338,15.52%,GRPR;HTR1D;GNG4;GLP1R;GHRHR;PTH2R;RXFP4;GCG;ADRA2C;NTS;APLN;CALCA;UCN2;QRFPR;UTS2R;PLPPR1;F2RL3;OPN1SW;GPR35;WNT4;RAMP1;KISS1;GAL;GPHA2;WNT9B;TAS1R3;LPAR4;RHO;WNT8B;CCL13;OPRL1;HTR4;CCL25;AVPR2;CHRM4;SAA2;HRH3;CCL20;ADRA1D;PTGER1;PTGER3;KISS1R;IHH;TRH;CRHR2;SSTR5;CCR3;GALR2;ADORA1;GALR3;HCAR1;PTHLH;OXTR;GNG3;C5AR2;CHRM5;ADM2;ACKR1;BDKRB2;NPW;RAMP2;LHB;GALR1;PTGFR;MC1R;UCN;BDKRB1;MLNR;GNB5;HTR1B;CCL11;IAPP;GNG8;WNT2B;DHX34;GRM1;WNT6
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.348481115450437,1.1603272483261047,0.23696682464454977,0.8622817532258682,1.0,41/103,39.28%,SIX1;SIX4;PLK1;BMP4;MSX1;COL1A1;RRS1;MMP12;IPO4;LMNA;ABCA7;GBP2;ARL2;BCL3;TOR1AIP2;TSC2;NUP62;TPR;NUP133;IPO9;FAM53B;ARL2BP;DVL1;TOR1AIP1;BBS4;NUP155;IPO13;EIF4ENIF1;NUP188;NXT1;SKP1;PINX1;HNRNPU;E2F3;TAF8;NUTF2;HIKESHI;FAM53A;RAN;IPO11;NOL8
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,0.36902583617503615,1.1599073996003193,0.22105263157894736,0.8632202197062477,1.0,37/81,39.25%,NEK2;PLK1;CDK1;TUBA4A;CEP131;PRKCA;CETN2;CEP250;HAUS4;HAUS5;MZT2B;PLK4;DYNLL1;CEP70;SFI1;TUBGCP6;SSNA1;MZT2A;CSNK1D;TUBA1A;ALMS1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;TUBG1;CEP72;PPP2R1A;TUBGCP2;NDE1;HAUS1;TUBB4B;SDCCAG8;HSP90AA1;CSNK1E
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.39621636154070816,1.1598579107742428,0.24861878453038674,0.8625745836015826,1.0,13/57,15.60%,MT3;GFI1;THY1;LRP4;STMN2;ACP4;EFNA1;PRAG1;LINGO1;CBFA2T2;ADCY6;GDI1;RTN4RL1
prerank,WikiPathway_2021_Human__Wnt signaling in kidney disease WP4150,-0.35428224976791484,-1.1595732697926229,0.24,0.48216387131230204,1.0,16/35,21.43%,WNT7B;WNT7A;FZD3;WNT16;WNT2;FZD1;WNT10B;WNT1;WNT11;FZD8;MAPK10;FZD7;WNT5A;INVS;WNT5B;WNT10A
prerank,KEGG_2021_Human__Dopaminergic synapse,0.35786200307039867,1.159389376457054,0.21052631578947367,0.8636150788556868,1.0,23/119,16.57%,GNG4;CALY;KCNJ6;PPP2R2C;CALML6;MAPK12;SCN1A;KCNJ9;MAPK11;KCNJ5;KIF5A;SLC6A3;CAMK2A;GNAL;GRIN2A;GNG3;CACNA1C;CREB3L1;GNB5;GNG8;PRKCA;CREB3L4;PPP1R1B
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.34078266034339955,1.1591872068566913,0.1848341232227488,0.8636607412330848,1.0,12/133,5.85%,ISL2;PAX2;CTNNA2;MNX1;EPHB2;PAK3;MAPK8IP2;BRSK2;NRCAM;LRP4;POU4F1;ADGRB1
prerank,Elsevier_Pathway_Collection__TAM Receptor Signaling Activation in Cancer,-0.30206528462432225,-1.1591406178324817,0.19642857142857142,0.48274744225710886,1.0,23/72,18.59%,IL1B;HGF;FOS;CDH1;CCL3;ESR1;MAP2K1;PRKCB;CXCL2;IL6;AXL;CXCL8;FLT3;AKT1;RASGRP1;PGR;CSF2;TIAM1;VAV1;CXCL1;BCL2;TWIST1;AR
prerank,Elsevier_Pathway_Collection__Nuclear Envelope in Cell Division,0.43902595312252113,1.1587669598928385,0.22988505747126436,0.8646129319641037,1.0,11/21,27.92%,LMNA;LBR;NRM;PLEC;NPM1;CBX5;EMD;LMNB1;SYNE2;LMNB2;TOR1AIP1
prerank,Elsevier_Pathway_Collection__CHRM1 -> IL2 Production,0.4193787212503901,1.1586040050332809,0.21468926553672316,0.864502079605056,1.0,5/27,14.95%,RASGRF1;SRC;MAPKAPK2;SHC1;PDPK1
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,0.3671768544894115,1.158546172665384,0.21951219512195122,0.8639831127170025,1.0,38/81,44.08%,MRPL55;MRPS21;MRPL24;MRPS24;MRPL13;MRPL9;MRPS14;MRPS23;GADD45GIP1;MRPL23;MRPL52;MRPL12;MRPL15;MRPL36;MRPL41;AURKAIP1;MRPL21;MRPS34;TUFM;MRPL17;MRPS15;MRPL51;MRPL4;MRPL33;OXA1L;CHCHD1;MRPL1;MRPS5;MRPL43;PTCD3;MRPS27;MRPS18C;MRPL58;MRPL50;MRPS11;MRPS26;DLGAP3;MRPL49
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.358518550227052,1.1585317035959801,0.2193877551020408,0.8632458756595056,1.0,19/85,17.27%,APLN;KCNE5;S100A1;FOXN4;CASQ1;KCNG2;FXYD7;ATP1A2;ATP1A4;ATP2B4;ATP1B3;NPR2;ATP2A1;GJA5;FXYD2;CORIN;KCNJ11;CACNA1H;SLC8A3
prerank,TRRUST_Transcription_Factors_2019__SREBF1 human,-0.3946649906901056,-1.1584545275790077,0.25,0.4838609068417221,1.0,7/26,11.37%,PDX1;THRSP;CETP;PCK1;SCD5;ACACB;APOA5
prerank,MSigDB_Oncogenic_Signatures__BMI1 DN.V1 DN,-0.2912295062700617,-1.15820580276288,0.15384615384615385,0.48386972942161516,1.0,39/119,21.67%,TFF2;ESRP1;TCEAL2;CHL1;MSX2;KCNJ16;SEMA3E;WFDC2;WNT16;SOCS2;FOS;ID4;NDRG2;PPARGC1A;EGR1;LPAR2;SCNN1A;CA2;EHHADH;GPR88;DPYD;ISOC1;DDX60;CREM;SH3BGRL;GPR162;ARHGAP15;VAV3;METTL7A;SUCLG2;TSPAN1;CHMP2B;PID1;GPD1L;SSPN;SFXN1;PDE5A;IDH1;SNX4
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.39399594803708166,-1.1580386197026324,0.2702702702702703,0.4838057914925606,1.0,7/29,11.30%,EREG;EVPL;SPRR3;WNT16;KRT16;TGM1;ST14
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.4342736583796742,1.1580305624791691,0.2611111111111111,0.8644596673813713,1.0,7/29,7.55%,CEND1;FOXN4;MAPT;WNT9B;KNDC1;FAIM2;TOX
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.370342891124369,-1.1580215639853129,0.21428571428571427,0.4833993527671017,1.0,10/28,20.66%,SLC45A3;APOA4;PDK4;APOA1;ACADL;APOA5;ERLIN1;PRKAG2;ERLIN2;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.36445914903674076,-1.157934349843814,0.27956989247311825,0.48316481713640536,1.0,8/36,13.06%,ASCL1;IL1B;FOXO1;BHLHE41;ASCL2;HEY2;HDAC9;AKT1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.3439624132442655,-1.1578962385283076,0.17567567567567569,0.48281671973054247,1.0,14/34,21.66%,IFNG;TNF;NTRK2;SLC2A13;CHRNA7;SORL1;RTN4;IGF1;LRRTM3;CLU;PRNP;RTN1;GSAP;TMED10
prerank,MSigDB_Oncogenic_Signatures__SNF5 DN.V1 DN,0.3426635238813431,1.1577979971932735,0.17117117117117117,0.8645863858450167,1.0,29/141,14.07%,DIO2;CACNB4;LMOD1;SIM2;EBF2;FABP4;HOXB9;MYH3;P2RX5;BEX1;DPEP1;CDKN2A;EFNA3;FGF13;CBR3;IL3RA;CNTN1;IL11;SLC16A3;CELF4;HSD17B7;MMP10;ATP9A;CD99L2;EFEMP1;PKP1;RGS16;UCHL1;RGS5
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.3587560423749186,1.1576763185534982,0.21608040201005024,0.8642452941355211,1.0,43/95,39.58%,NEK2;PLK1;CDK1;TUBA4A;CEP131;CETN2;CEP250;HAUS4;HAUS5;KIF24;MARK4;B9D2;B9D1;PLK4;DYNLL1;CEP70;SFI1;SSNA1;NPHP4;FBF1;CEP97;CSNK1D;TUBA1A;ALMS1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;CEP89;TUBG1;CEP72;PPP2R1A;RPGRIP1L;NDE1;C2CD3;HAUS1;TUBB4B;SDCCAG8;HSP90AA1;CSNK1E;CEP83
prerank,KEGG_2021_Human__Other glycan degradation,0.47872411430070716,1.1572291974701012,0.2631578947368421,0.865197107652343,1.0,8/17,27.70%,NEU3;GBA;ENGASE;GLB1;GBA2;NEU1;HEXB;HEXA
prerank,Elsevier_Pathway_Collection__IFN-gamma/TNF-alpha Mediated Cell Proliferation in Psoriasis,-0.3795007716665563,-1.1571964977856732,0.2682926829268293,0.4840689025266129,1.0,12/21,29.72%,IFNG;TNF;KLF4;AKT1;BCL2;JAK2;STAT1;IFNGR1;IRF1;STAT3;NFKBIA;IFNGR2
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.36194034615731985,1.157091569879725,0.21761658031088082,0.8649712525152458,1.0,39/87,39.25%,NEK2;PLK1;CCNB2;CDK1;TUBA4A;CCNB1;AURKA;CEP131;PRKCA;CETN2;CEP250;HAUS4;HAUS5;PLK4;DYNLL1;CEP70;SFI1;UBA52;SSNA1;CSNK1D;TUBA1A;ALMS1;CUL1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;SKP1;TUBG1;CEP72;PPP2R1A;NDE1;HAUS1;TUBB4B;SDCCAG8;HSP90AA1;CSNK1E
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,0.4620714608742158,1.1567721235027963,0.2375,0.8654937591201018,1.0,12/19,45.00%,POLD1;DNA2;FEN1;POLR1A;BLM;PCNA;TERF1;ACD;TERF2;POLD3;POLD4;WRN
prerank,WikiPathway_2021_Human__Wnt signaling WP428,0.35023309138172865,1.1559924690320682,0.19801980198019803,0.8679728360877802,1.0,21/107,16.51%,NKD1;DKK1;DKK4;LEF1;NOTUM;SFRP4;WNT4;ROR1;NKD2;TCF7;CAMK2A;PORCN;DAAM2;KREMEN1;PLAU;PRICKLE2;DVL2;WNT2B;WNT6;PRKCA;ROCK2
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.3310322847117069,-1.1559070334994412,0.22413793103448276,0.4866531624465851,1.0,11/45,13.58%,RIMBP2;LRAT;BCO2;APOA4;GPC5;APOA1;AKR1C4;GPC6;BCO1;GPC4;TTR
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.4295273722549278,1.155831335076141,0.24293785310734464,0.8677995332406797,1.0,5/29,13.06%,CELF3;NOL3;CELF4;SRSF12;PUF60
prerank,Elsevier_Pathway_Collection__SOCS3 and PTPN1 in Hypothalamic Neuron Insensitivity to Insulin and Leptin,0.5044140715929685,1.1556172453641507,0.27647058823529413,0.8678530478117101,1.0,3/15,15.00%,AGRP;LEP;LEPR
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.423105385363429,1.1555055755382833,0.30357142857142855,0.8674749692301658,1.0,2/32,1.43%,HMGA2;LEF1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.4052152628653842,1.1551597508487155,0.23728813559322035,0.868044207891265,1.0,8/40,14.68%,SLC7A11;SLC22A4;TSPO2;SLC7A6;SLC7A10;SLC38A11;SLC7A1;SLC25A12
prerank,TRRUST_Transcription_Factors_2019__MEF2C mouse,0.4468546337958396,1.1548041939015388,0.2616279069767442,0.8686907575049676,1.0,6/24,6.42%,DLX5;DLX6;MYH1;MYH4;RHO;HDAC4
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.3972505372953954,1.154708269493727,0.2573099415204678,0.8683249783679975,1.0,30/48,44.29%,TOMM40L;TOMM20L;DNLZ;TIMM17B;BCAP31;ROMO1;TIMM17A;TOMM20;AIFM1;TIMM10;TOMM5;SLC25A6;FIS1;TSPO;TOMM40;TIMM13;TIMM9;PAM16;AIP;HSPD1;GRPEL2;CHCHD4;TIMM10B;TOMM7;TIMM50;TIMM8B;TOMM34;MFF;PITRM1;TIMM22
prerank,Elsevier_Pathway_Collection__VEGFR -> AP-1/CREB/MYC Signaling,0.3921603834817931,1.1546466148175012,0.24022346368715083,0.8678275429078743,1.0,7/43,14.95%,VEGFD;RASGRF1;SRC;FLT1;MAPKAPK2;SHC1;PDPK1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.2918490755119787,-1.1545936910818904,0.125,0.48931533519250553,1.0,19/98,13.06%,GCK;NR4A2;TSHR;CRHBP;PRKAR2B;NR4A3;PCK1;NR4A1;CPEB1;ZFP36L1;GCGR;FOXO1;GPLD1;CYSLTR2;HDAC9;SLC39A14;ADCY5;PIK3R1;AKT1
prerank,Elsevier_Pathway_Collection__I-cell: CCK-8 Secretion and Regulation of Eating Behavior,-0.38367112169284834,-1.1543631051251544,0.23595505617977527,0.48934488288382416,1.0,7/24,14.75%,CASR;CCK;TLR4;LPAR5;TLR2;PLCB2;MYD88
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4336032118160501,1.1541865874034671,0.27956989247311825,0.8688420913086228,1.0,4/27,12.42%,CACNB4;STRIT1;HPCA;JPH1
prerank,TRRUST_Transcription_Factors_2019__EP300 mouse,0.39193305611889506,1.1541202619049205,0.26455026455026454,0.8682940497100416,1.0,14/54,16.65%,COL2A1;ALDH3A1;SPP1;AXIN2;WNT4;NEUROD1;BIRC5;CCNB2;CPT1B;POU5F1;BGLAP;COL1A2;PPARG;SMAD3
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,0.43703875543603316,1.1540297833247426,0.25882352941176473,0.8678849211960803,1.0,6/23,9.15%,OR1N2;OR51E1;ANO2;OR2B6;GNAL;EBF1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.327650046012698,1.1539622527535365,0.2017167381974249,0.867401604123234,1.0,54/275,14.90%,COL2A1;COL22A1;KLK4;COL7A1;COL15A1;APLP1;LAMA3;SPP1;SPINK5;MATN1;COL9A1;BCAN;ICAM5;MMP11;VWF;MATN3;ITGA2;ITGA6;SCUBE1;COL10A1;FGF2;MMP21;COL4A1;ELN;COL4A5;COL8A1;NPNT;COL1A1;TIMP1;LOXL2;COMP;COL11A1;MMP12;NCAN;ADAM15;COL4A2;MMP17;LAMC1;MMP10;HAS1;CRTAP;LOXL1;CREB3L1;PDGFB;MFAP2;TLL2;SH3PXD2B;PDGFA;COL1A2;HTRA1;CMA1;COL5A1;SMOC2;MADCAM1
prerank,WikiPathway_2021_Human__NAD+ biosynthetic pathways WP3645,-0.3804298035343016,-1.153730889702861,0.2571428571428571,0.4902821437311227,1.0,3/22,6.64%,TDO2;BST1;CD38
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.39478445048779115,1.153723595779662,0.2616279069767442,0.8675867189297551,1.0,5/47,3.87%,TLCD3B;CERS1;ALOX12B;SPTSSB;ARG2
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.358274386140028,1.1533399562802618,0.21,0.8683069029682376,1.0,44/97,39.58%,NEK2;PLK1;CDK1;TUBA4A;CEP131;PRKCA;CETN2;CEP250;HAUS4;HAUS5;KIF24;MARK4;B9D2;B9D1;PLK4;DYNLL1;CEP70;SFI1;SSNA1;NPHP4;FBF1;CEP97;CSNK1D;TUBA1A;ALMS1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;CEP89;TUBG1;CEP72;PPP2R1A;RPGRIP1L;NDE1;C2CD3;HAUS1;TUBB4B;SDCCAG8;HSP90AA1;CSNK1E;CEP83
prerank,Elsevier_Pathway_Collection__Renin-Angiotensin-Aldosterone System in Myocardial ischemia,0.48590508223808637,1.1530733971647558,0.3116883116883117,0.8685865298801065,1.0,5/15,14.29%,REN;CYP21A2;NPR2;ACE;CMA1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.3487840296736344,-1.152887451909423,0.22857142857142856,0.4917020664371249,1.0,13/36,23.08%,PCK1;ENO3;ALDOB;FBP1;PPARGC1A;SLC39A14;ALDOC;PCK2;PGM1;ENO2;SLC25A10;PGAM1;CRY1
prerank,KEGG_2021_Human__Primary bile acid biosynthesis,-0.42695315755218555,-1.1525162776993867,0.25,0.4922235776193937,1.0,5/17,9.63%,AKR1D1;CYP39A1;SCP2;CYP8B1;AKR1C4
prerank,Elsevier_Pathway_Collection__Hyperseborrhea in Acne Vulgaris,-0.38030067434368764,-1.1523091242076997,0.3150684931506849,0.4923120716582383,1.0,10/26,23.89%,FGF10;FGFR2;FOXO1;PIK3R1;AKT1;IGF1;IRS2;LDLR;IGF1R;PTEN
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,0.3264309769172525,1.1518488357224268,0.20434782608695654,0.87269046791867,1.0,135/202,47.30%,LHX3;ROBO1;LHX9;LHX4;MSI1;SRC;PSMD4;COL4A5;RNASE1;ARHGAP39;PSMB4;ABL2;ELOC;RPL8;PRKCA;CASC3;MRPL13;ELOB;SRGAP2;RBM8A;RPL30;RPLP1;RPS27;RPS21;RPLP2;RPS5;RPL28;PSMB3;RPS14;RPSA;HOXA2;RPL26L1;PABPC1;PSMD14;RPL39;UPF3B;UBA52;RPLP0;RPS15;PSMB5;ROBO3;RPS2;PSMD2;RPL31;RPS19;PSMA1;RPL36;PKN1;RPL37A;PSMD10;RPL37;RPL7;RPS4X;RPS20;PSMC4;PSMC3;PRKAR2A;NRP1;RPL27;RPL38;RPL35;ENAH;RPL10A;AKAP5;PSMC5;RPS8;RPS12;RPL22L1;RPL35A;SEM1;MAGOHB;PSMB6;RPS3A;PSMD8;MYO9B;RPS7;ABL1;RPS11;RPL36A;GSPT2;RPL7A;PSME2;FAU;RPS3;RPL18A;RPL32;RPS24;PSMD13;RPL3L;SRGAP1;PSMB7;PSMA7;RPL29;RPL23;RPL5;DCC;RPL14;PSME3;RPS16;RPL13A;RPL41;RPL9;RPS28;SLIT3;RPS23;RPL27A;RPL23A;RPL18;PSMB2;RBX1;PSMA6;RPL12;UBC;PFN1;PSMD9;RNPS1;RPS9;RPL6;RPS15A;RPL4;RPL19;PSMC2;RPL39L;RPS6;RPL26;EIF4A3;RPS27A;MAGOH;RPS4Y1;PSME1;RPL34;RPS13;PSMB1;ETF1;PSMD3
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.5011750206474191,1.1513068482847957,0.30246913580246915,0.8739711067591102,1.0,3/17,3.40%,SCG2;VEGFD;CDH13
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.3675745964731218,-1.1510937244995287,0.2638888888888889,0.4948721950167334,1.0,13/33,19.01%,SLC45A3;GNMT;PDK4;FBP1;GCGR;RUBCNL;GPLD1;AKT1;PDK3;MLYCD;KHK;PMAIP1;IRS2
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.38160284672273465,1.150997642628168,0.26865671641791045,0.8744060052961015,1.0,28/66,34.38%,FGF20;PIK3R2;FGF13;ATP6V0D2;FGF17;FGF23;FLT3LG;ATP6V0A1;SHC1;PDPK1;ATP6AP1;HRAS;THEM4;ATP6V0B;TCIRG1;FGF18;ATP6V0D1;ATP6V0E1;ATP6V1C1;ATP6V1H;FGFR4;KLB;ATP6V1F;ATP6V1E1;IRS1;PIGU;ATP6V1E2;FGF1
prerank,Elsevier_Pathway_Collection__TGFB2 Signaling Impairement in Osteoarthritis,0.4585087180687235,1.1508918964091346,0.2883435582822086,0.8740777828739335,1.0,5/22,21.40%,COL2A1;TIMP1;SMAD3;ACVRL1;TGFB2
prerank,WikiPathway_2021_Human__Renin-angiotensin-aldosterone system (RAAS) WP4756,0.4089451058611513,1.1508675176370957,0.23118279569892472,0.8734079640499295,1.0,9/39,16.28%,REN;CALML6;CYP21A2;CAMK2A;CREB3L1;ACE;CMA1;CAMK1D;CREB3L4
prerank,Elsevier_Pathway_Collection__MUC5AC Expression by NTHi and S. Pneumoniae,-0.3916616200602622,-1.1506785019169667,0.2,0.49534316304321196,1.0,9/21,21.42%,MUC5AC;FOS;MAP2K1;TLR4;TLR2;MYD88;MAP2K3;MAP2K6;JUN
prerank,Elsevier_Pathway_Collection__Podocyte Dysfunction in Diabetic Nephropathy,0.4091526062543765,1.1504489037766557,0.2648648648648649,0.8741989512367188,1.0,2/38,0.43%,PAX2;NPHS1
prerank,Elsevier_Pathway_Collection__ROS in Angiotensin Mediated Cardiovascular Remodeling and Hypertrophy,0.38130637541988266,1.1503720192440077,0.24607329842931938,0.8737886003660358,1.0,10/51,16.65%,REN;RASGRF1;SRC;HSPB1;ACE;COL1A2;MAPKAPK2;SHC1;PDPK1;SMAD3
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,0.4393126033948011,1.1503424556530093,0.2616279069767442,0.8731474889230711,1.0,6/25,9.43%,SLC7A11;SLC7A6;ITGA6;SLC7A10;ATP1B3;SLC16A3
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.40044676517877065,1.1503016245988114,0.27485380116959063,0.8725578971675889,1.0,7/37,11.68%,KCNH6;KCNE5;KCNH2;KCNJ5;CACNA1G;SCN4B;CACNA1C
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3419115046686365,1.1502760720643606,0.2336448598130841,0.8718893424224066,1.0,33/135,26.43%,HMGA2;SOX1;H3C13;H1-5;SOX2;H3C1;HDAC4;NPM2;ACTL6B;PRDM16;EZH2;LOXL2;FAM50A;HDAC11;KAT2A;HDAC5;JARID2;SUV39H1;HDAC10;KDM5B;SMARCA4;SETDB1;HDAC1;DDX11;L3MBTL1;SATB2;NPM1;HMGB2;SNAI1;SMARCD3;HCFC1;MYC;NPM3
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,0.39455555422067856,1.1502683187253306,0.2596685082872928,0.8711657093164574,1.0,41/62,47.37%,CDKN2A;PSMD4;CCNE1;ZNF385A;CCNA2;CCNE2;PSMB4;PCBP4;PSMB3;PSMD14;CHEK2;UBA52;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;MDM4;PSME2;PSMD13;PSMB7;PSMA7;PSME3;CDK2;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PHF20;PSMB1;PSMD3;MDM2
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.4133585113298385,-1.149867116108326,0.2903225806451613,0.4967263125444198,1.0,3/16,0.82%,TFF2;TFF1;MUC6
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.3711603212407071,1.1494093502888794,0.24479166666666666,0.8736283768075351,1.0,18/68,20.39%,ALOX15B;PLA2G2A;PLPPR1;PLPP2;PLA2G2C;CYP2W1;LPL;PLA2G4C;ACP6;APOA2;PLA2G4F;PLPP1;PLPPR2;PGP;GNPAT;PLPPR3;FDFT1;GPAM
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,0.3479151415878303,1.1491977838163645,0.23809523809523808,0.8737022793797538,1.0,82/111,46.98%,RPL8;SCLY;TXNRD1;MRPL13;EPRS1;RPL30;RPLP1;RPS27;RPS21;QARS1;RPLP2;PAPSS1;RPS5;RPL28;LARS1;RPS14;RPSA;RPL26L1;RPL39;UBA52;RPLP0;EEF1E1;RPS15;NNMT;RPS2;AIMP1;RPL31;RPS19;RPL36;RPL37A;RPL37;RPL7;RPS4X;RPS20;RPL27;RPL38;RPL35;RPL10A;RPS8;RPS12;RPL22L1;RPL35A;RPS3A;RPS7;RPS11;RPL36A;RPL7A;FAU;RPS3;RPL18A;RPL32;RPS24;RPL3L;MARS1;RPL29;RPL23;RPL5;RPL14;RPS16;RPL13A;RPL41;RPL9;IARS1;RPS28;RPS23;RPL27A;RPL23A;RPL18;RPL12;RPS9;RPL6;RPS15A;RPL4;RPL19;RPL39L;RPS6;RPL26;RPS27A;RARS1;RPS4Y1;RPL34;RPS13
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.32872559913216864,-1.1489561637545789,0.22727272727272727,0.49861941021835104,1.0,22/69,18.22%,HACD1;PTGS2;CYP2C8;HPGD;LIPH;CYP1A2;ELOVL2;SCD5;ELOVL7;LIPG;ACSM3;ASAH2;CYP2C9;ALOX5;CYP3A4;EPHX2;ACSM5;LIPC;MLYCD;ABHD2;CBR4;HACD4
prerank,Elsevier_Pathway_Collection__SOCS in Negative Feedback Regulation in Myocarditis,-0.4225722009872292,-1.1488399610409465,0.21052631578947367,0.4984558950236112,1.0,9/17,30.21%,IFNG;TNF;IL6;JAK2;STAT1;IFNGR1;STAT3;IFNGR2;IFNAR1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.3170076431099129,1.1488280756465319,0.1446280991735537,0.8742956440065269,1.0,68/437,14.36%,REG1A;REG3A;HMGA2;IGF2;PAX2;GHRHR;REG1B;POU3F2;FGF20;OSR2;ESM1;VEGFD;LEF1;CGA;E2F1;OSR1;CHP2;NODAL;DISP3;STOX1;TERT;CDH13;CRLF2;SIX2;TDGF1;S100A13;MDK;HES5;IL31RA;FOXM1;TBX3;FGF17;BMP4;HDAC4;KIF14;BIRC5;ADRA1D;FGF2;SPHK1;TMEM119;TOX;FGF23;TTK;PDGFRB;TIMP1;IL11;CDC7;ZNF703;EZH2;PTHLH;AKR1C3;FLT3LG;SOX8;MVD;LAMC1;IL6R;RASSF10;EPO;PDGFB;PTGFR;FLT1;NOX1;NME1;PDGFA;SAPCD2;PGF;HILPDA;CEP131
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.36270035388906713,-1.1487072559492275,0.23809523809523808,0.4983182552945535,1.0,10/33,13.00%,TNFSF11;IFNG;CD4;TNF;ID2;ZFP36L1;EVI2B;CCR1;IL12B;HCLS1
prerank,Elsevier_Pathway_Collection__Insulin Synthesis in beta-Cell,0.42578388110041165,1.1486108337677166,0.25862068965517243,0.8744160367291685,1.0,8/32,16.93%,MAFA;GLP1R;NEUROD1;PCSK1;ABCC8;IAPP;KCNJ11;PASK
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,0.36486029938894543,1.1483774104431768,0.2079207920792079,0.8745244330532428,1.0,37/81,44.08%,MRPL55;MRPS21;MRPL24;MRPS24;MRPL13;MRPL9;MRPS14;MRPS23;GADD45GIP1;MRPL23;MRPL52;MRPL12;MRPL15;MRPL36;MRPL41;AURKAIP1;MRPL21;MRPS34;MRPL17;MRPS15;MRPL51;MRPL4;MRPL33;OXA1L;CHCHD1;MRPL1;MRPS5;MRPL43;PTCD3;MRPS27;MRPS18C;MRPL58;MRPL50;MRPS11;MRPS26;DLGAP3;MRPL49
prerank,Elsevier_Pathway_Collection__Frizzled Receptors -> ARRB1/ARRB2 Canonical Signaling,0.49464068404817413,1.1482779453478205,0.3128834355828221,0.8741497322241073,1.0,14/16,47.62%,LEF1;DVL2;DVL1;CTNNB1;ARRB1;LRP5;AXIN1;GSK3B;CSNK1E;TCF4;BTRC;CSNK1A1;LRP6;FRAT1
prerank,Elsevier_Pathway_Collection__NOTCH Signaling Deregulation in Cancer,0.4197066341052682,1.1481853053152313,0.2554347826086957,0.8737433150418641,1.0,12/28,28.26%,SNAI2;NOTCH3;JAG2;NOTCH4;HEY1;HDAC1;SNAI1;MYC;MAML1;NCOR2;NCSTN;CDKN1A
prerank,Elsevier_Pathway_Collection__Endothelial Cell Dysfunction in Glomerulonephritis,-0.314257029860256,-1.147944756149028,0.1746031746031746,0.4996220988392884,1.0,16/54,15.81%,TNF;IL1B;FOS;IL1RAP;MAP2K1;CXCL2;CCL2;IL6;F2RL2;CXCL8;TLR4;AKT1;VCAM1;MYD88;TNFRSF1B;KNG1
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,0.4837034975242825,1.147867457603161,0.28901734104046245,0.8742988149045692,1.0,7/18,25.08%,SRC;SPHK1;PDPK1;PRKCA;HRAS;PLCG1;ITPR2
prerank,Elsevier_Pathway_Collection__Luteinizing Hormone in Oocyte Meiotic Resumption,-0.39921862613772696,-1.147776733034792,0.26436781609195403,0.4995755574741975,1.0,5/18,13.38%,EREG;MAP2K1;PTGER2;BTC;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.4782893799131103,1.1476782790227118,0.2608695652173913,0.8742982710209355,1.0,6/16,23.52%,WNT4;BMP4;RGCC;CREB3L1;SCX;SUCO
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.3015235840286558,-1.1476269147255067,0.16129032258064516,0.49947298483224983,1.0,16/77,14.39%,CPNE6;PLAAT1;CETP;LCAT;IP6K3;APOA4;APOA1;PLA2G2D;PLEK;GPLD1;PLA2G4A;APOA5;PLCB2;ABHD6;CLN3;PON1
prerank,TRRUST_Transcription_Factors_2019__USF1 human,-0.3101171529806527,-1.1473890123005117,0.20634920634920634,0.49956937445327393,1.0,18/63,17.12%,GCK;PTGS2;IFNG;ID4;SCN9A;CEACAM5;FBP1;FCER1A;CD2;TBX21;ASCL2;APOA5;CXCR4;PIGR;FMO3;LIPC;CTSB;HMOX1
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.40151931901642296,1.1471003506387047,0.23316062176165803,0.8757825578904135,1.0,10/45,17.63%,FGF20;PIK3R2;FGF13;FGF17;FGF23;FLT3LG;SHC1;PDPK1;HRAS;THEM4
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.4261703975919672,-1.1467630158677606,0.25,0.5005363526634832,1.0,9/17,17.81%,CXCL10;CXCL11;CCL3;PIK3CD;GPR183;XG;ZAP70;SLC12A2;MYO1G
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.47616402402396274,1.1467061574898758,0.2792207792207792,0.8763964445564394,1.0,11/18,38.12%,SMYD2;SUV39H1;EHMT2;KMT2D;KMT2B;ASH1L;SUV39H2;SETD4;SETD1B;SETD1A;CSKMT
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.40510895198375835,1.146540718817828,0.2897727272727273,0.8763237957263895,1.0,8/35,20.61%,TP73;POU4F1;PHLDA3;ZNF385B;MSH2;AEN;BCL3;FHIT
prerank,MSigDB_Oncogenic_Signatures__ESC V6.5 UP EARLY.V1 DN,0.3452838323631664,1.1464742156364514,0.21929824561403508,0.8758707749962977,1.0,38/154,18.37%,IGF2;CACNA1E;SPINK1;SFN;SNTG1;SP5;BCAN;FAP;FGF17;BMP4;CCDC80;CCDC34;FGF2;COL4A1;COL1A1;KIF18A;COL11A1;COL4A2;KLK10;LOXL1;PLAU;COL1A2;HTRA1;ABCA7;INHBB;TSHZ2;GJB3;MRAS;TTYH2;SLC41A3;TRIM54;GBP2;GPX2;SLC8A3;GAP43;SCARA3;B4GALT7;LOX
prerank,KEGG_2021_Human__Gastric cancer,0.34029683818746415,1.146329907763376,0.24299065420560748,0.8756641792597528,1.0,27/138,15.74%,CTNNA2;FGF20;LEF1;E2F1;PIK3R2;AXIN2;WNT4;TERT;SHC3;WNT9B;WNT8B;FGF17;TCF7;FGF2;FGF23;E2F2;CCNE1;CDH17;CCNE2;CDKN2B;CDX2;APC2;SHC1;DVL2;WNT2B;WNT6;HRAS
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,0.3912033806382384,1.1462960601763308,0.2994652406417112,0.8750167327328496,1.0,39/58,47.30%,PSMD4;CCNE1;CCNA2;CCNE2;PSMB4;CKS1B;PSMB3;PSMD14;UBA52;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;CDK4;SKP2;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;CDK2;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,TRRUST_Transcription_Factors_2019__HDAC4 human,-0.3717457508993458,-1.1462191835639097,0.20930232558139536,0.5014099997626091,1.0,9/22,21.42%,IL10;PTGS2;KLF4;PTGES;VCAM1;RUNX2;RECK;CA9;JUN
prerank,WikiPathway_2021_Human__Development of ureteric collection system WP5053,0.3874934221458456,1.1462080248988067,0.25136612021857924,0.8745951865411863,1.0,8/44,10.39%,PAX2;SIX1;ROBO1;SIX2;FRAS1;BMP4;FOXC1;GDF11
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.27912480498818776,-1.1461103120433696,0.1702127659574468,0.5012044769196524,1.0,25/111,13.62%,EREG;RET;ERBB4;EPHB1;CD4;TNF;MUSK;NTRK3;LTK;NTRK2;PDGFRA;EPHA1;ALK;CCR7;EPHA7;FGFR2;PTPRC;EPHB3;AXL;LCP2;CCN1;NTRK1;FLT3;LAT;EPHB6
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.38831652844813525,-1.145211044415842,0.3291139240506329,0.5027005729223099,1.0,8/24,11.52%,IL10;MZB1;FCRL3;PTPRC;IL6;CR1;SASH3;FCGR2B
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.3023978411796398,-1.1450796734571005,0.1111111111111111,0.5025906554155694,1.0,20/71,11.14%,KCNJ13;NKAIN2;KCNJ3;SYT9;CLDN10;SYT10;KCNJ16;SYT8;KCNA2;SYT1;SIK1;SYT7;KCNJ10;TF;ANK3;KCNJ15;NKAIN1;SYT4;KCNJ12;CA2
prerank,MSigDB_Oncogenic_Signatures__KRAS.LUNG.BREAST UP.V1 DN,0.3557600758137927,1.144991035022504,0.25,0.8786838725164947,1.0,27/112,14.61%,COL2A1;CACNA1I;HCN2;AMBN;CDH16;IGF2-AS;VAX2;TNNI3;SYNDIG1;ALOX12B;CYP21A2;FRAS1;NOX5;SLC6A9;MXD3;OLFML2A;AKR1B10;IGFBP2;YPEL1;RAG1;MAST3;RPL13P5;CD36;FLT1;KIF25;BDKRB1;HTR1B
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.46994895253790026,1.1448550365164316,0.2883435582822086,0.8784376929986645,1.0,2/16,3.01%,APLN;TAFA5
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.36546693840208605,-1.144823990838244,0.23943661971830985,0.5028155015354006,1.0,11/24,29.29%,IL1B;IL18;CASP1;CHMP2B;GZMB;CASP4;IRF2;GSDME;IRF1;HMGB1;CASP3
prerank,WikiPathway_2021_Human__DNA Mismatch Repair WP531,0.45078557915578427,1.1447145406256314,0.25925925925925924,0.8782734671222211,1.0,18/23,51.92%,EXO1;RFC4;POLD1;MSH2;MSH6;PCNA;LIG1;RPA2;RFC3;POLD3;POLD4;RPA1;RFC1;POLE2;POLE4;RFC5;RFC2;POLE
prerank,Elsevier_Pathway_Collection__Proteins Involved in Gout,-0.36292935238978186,-1.1444448340836397,0.2571428571428571,0.5033792686486688,1.0,16/32,17.02%,IL10;TNF;IL1B;SLC2A9;XDH;CASP1;NLRP3;IL6;IL1RN;CXCL8;TLR4;TLR2;VCAM1;PLAUR;LIPC;CTSB
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.42924526055237044,-1.1443836822449986,0.3055555555555556,0.5030413355614328,1.0,8/18,16.88%,CD27;RHOH;AXL;BTK;GATA3;NCKAP1L;SYK;ZAP70
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.3317613653931049,-1.1443216373550198,0.24242424242424243,0.5027141228152011,1.0,16/40,23.45%,IL5RA;IL2RB;IL15;LCK;IL21R;PIK3R1;SYK;HAVCR2;CSF2;LGALS9;INPP5D;CSF2RB;JAK2;STAT1;CSF2RA;GAB2
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.3994931158948031,1.1442466670278606,0.22826086956521738,0.8794507683419225,1.0,16/42,35.23%,MRPS21;MRPS24;MRPS12;TWNK;POLRMT;MRPS14;MRPL23;MRPL12;IARS2;TFB2M;SLC25A33;MRPS28;HARS1;MRPS34;MRPS15;MRPL51
prerank,MSigDB_Oncogenic_Signatures__CSR LATE UP.V1 UP,0.3405557084633491,1.1441462482865403,0.24752475247524752,0.8790824727080137,1.0,61/154,28.03%,MYH1;BEX1;KISS1;ITGA6;FOXM1;NUF2;ANLN;BIRC5;CCDC34;FAM83D;NETO2;PBK;UBE2C;TIMP1;UHRF1;CDC6;CDC7;SHCBP1;EZH2;SLC16A3;TRIP13;LTBP2;CDK1;TCF19;CDCA8;TUBA4A;DIAPH3;PRIM1;MYBL2;TPM2;SRM;NMB;ZWINT;FABP5;POLD1;MRAS;MCM3;RRM2;SSTR1;PREB;TRPC4;ILF2;FEN1;MMP3;DTYMK;CLSPN;GMNN;MAZ;ZNF367;NUDCD1;CDK5;CYP4B1;FARSB;GINS2;RAD18;LMNB2;CKAP2;PSMD14;CHEK2;HIP1;POLR3K
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,0.41384850820737606,1.14399996362287,0.22033898305084745,0.878871645743517,1.0,9/35,21.80%,FGF20;FGF13;FGF17;SRC;FGF23;SHC1;HRAS;FGF18;PLCG1
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.39616632916246713,1.143853068316132,0.24175824175824176,0.878751139566155,1.0,37/56,47.30%,PSMD4;NFKB2;PSMB4;RELB;PSMB3;UBE2M;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;MAP3K14;PSME2;PSMD13;PSMB7;PSMA7;PSME3;FBXW11;PSMB2;PSMA6;UBC;PSMD9;BTRC;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.40433488710445425,1.1434324384973393,0.24725274725274726,0.8796166824631225,1.0,8/42,17.49%,MUC13;PIK3R2;DLG5;KIF14;PRAG1;SCRIB;PLXND1;CKAP4
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,0.4008478708924702,1.143241969650162,0.27419354838709675,0.8796000433252308,1.0,4/39,9.66%,LEF1;CDKN2A;UBE2C;UBE2S
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,0.35843416767050146,1.143007184229223,0.2376237623762376,0.8797136904675358,1.0,39/87,44.08%,MRPL55;MRPS21;MRPL24;MRPS24;MRPL13;MRPL9;MRPS14;MRPS23;GADD45GIP1;MRPL23;MRPL52;MRPL12;MRPL15;MRPL36;MRPL41;AURKAIP1;MRPL21;MRPS34;TUFM;MRPL17;MRPS15;MRPL51;MRPL4;MRPL33;OXA1L;CHCHD1;MRPL1;MRRF;MRPS5;MRPL43;PTCD3;MRPS27;MRPS18C;MRPL58;MRPL50;MRPS11;MRPS26;DLGAP3;MRPL49
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.47270680015764754,1.1428515980729148,0.30434782608695654,0.8795581731441556,1.0,3/21,5.57%,KIF1A;FOXO6;DLG5
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.3903706856186632,1.142790456008576,0.24861878453038674,0.879044593727364,1.0,30/47,48.45%,LEF1;ACTL6B;BEND3;ING5;JADE2;APBB1;TRIM16;BRD8;JADE3;HCFC1;WDR5;EP400;OGT;BRCA2;RUVBL2;RUVBL1;HAT1;DMAP1;MORF4L2;KAT8;TRRAP;MCRS1;ATF2;KANSL1;MSL1;PHF20;MEAF6;NAA60;ACTL6A;KANSL3
prerank,TRRUST_Transcription_Factors_2019__FLI1 human,-0.3772084380157173,-1.1426596898889159,0.29292929292929293,0.5060746546682612,1.0,5/22,6.21%,CCK;IL10;MMP1;ID2;IGFBP3
prerank,Elsevier_Pathway_Collection__CDC73 Mutations Cause Hyperparathyroidism,0.48194852943637917,1.1424412599764533,0.3254437869822485,0.8796319357225397,1.0,7/16,35.35%,E2F2;CDK6;KMT2B;WDR5;RNF20;CDK4;E2F3
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.4531222672837697,1.1423079927166753,0.275,0.8794191851668997,1.0,8/20,18.38%,GRIN1;MAPK8IP2;CHRNA3;GRIN2A;CHRNA4;INSYN1;INSYN2A;GRIN2C
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,-0.37077065609822346,-1.1422475408370254,0.2465753424657534,0.5065678559223207,1.0,10/32,21.34%,UPP2;ENTPD8;XDH;DPYS;DPYD;ENTPD5;AGXT2;NT5C3A;ENTPD3;NUDT15
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,0.46666828546148115,1.1420650160710546,0.28125,0.8797025667035103,1.0,11/17,45.00%,POLD1;DNA2;FEN1;POLR1A;PCNA;TERF1;ACD;TERF2;POLD3;POLD4;WRN
prerank,Elsevier_Pathway_Collection__Monoblast -> Promonocyte Surface Expression Markers,-0.3911857065940757,-1.1418769816014966,0.2413793103448276,0.5070702537496634,1.0,8/18,18.67%,CD4;TNF;NCAM1;TLR4;CXCR4;CSF1R;CD33;SELPLG
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.3663818783387376,-1.1418297686934997,0.30864197530864196,0.5067405970975887,1.0,6/23,8.53%,NTRK3;NTF3;CCL5;ESR1;PDGFRA;FGFR2
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5032941825087407,1.1417749978284009,0.2916666666666667,0.8802129873606408,1.0,6/16,23.50%,ITPKA;FGF2;ISYNA1;PPIP5K1;IP6K1;ITPKC
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.40298323245950707,1.1416047916983245,0.25882352941176473,0.8801470395134736,1.0,26/36,46.64%,QRICH2;MAP1A;FHIT;HSP90AB1;PARK7;HIPK2;DDRGK1;SDCBP;OGT;EIF3H;CAMLG;GIPC1;RPS7;TAF9;TAF1;RPL23;BAG6;RPL5;USP7;PDCL3;UBXN1;UCHL5;CSNK2A2;SGTA;TRIM39;NOP53
prerank,WikiPathway_2021_Human__Amino Acid metabolism WP3925,-0.2999753991264234,-1.1414910098166795,0.20408163265306123,0.507126184382004,1.0,27/83,22.07%,ADH4;DBH;TH;BHMT;PCK1;TDO2;PDK4;OAT;CBS;ADH1C;FTCD;ACAA1;TAT;EHHADH;ADH7;OTC;HMGCS2;ACADM;DDC;MCCC1;HMGCL;ASS1;CTH;LARS2;AOC3;IDH1;GPT2
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.298462412637403,-1.1412110567031335,0.2571428571428571,0.5072546394058369,1.0,30/72,27.89%,WNT7B;EDAR;WNT7A;IL1B;WNT16;CD27;CCR7;FCGR2B;RASGRP1;MTURN;RASSF2;MBIP;NCF1;TPD52L1;SLAMF1;GADD45A;FZD7;SERPINF2;NOD2;SH3RF1;APP;MAP3K5;GADD45G;F2RL1;UNC5CL;CARD9;HMGB1;TRAF4;PJA2;ANKRD6
prerank,Elsevier_Pathway_Collection__CD38/CD19 -> JUN/FOS/NF-kB Signaling in B-cell Proliferation,-0.35125521103519447,-1.1412105158160402,0.2361111111111111,0.5068001101590575,1.0,15/39,22.01%,FOS;CD79A;CD38;MAP2K1;PRKCB;CARD11;LCK;LAT;AKT1;SYK;PLCG2;ZAP70;CD19;JUN;PIK3AP1
prerank,KEGG_2021_Human__GABAergic synapse,0.36680457161953484,1.1410071628444496,0.2538860103626943,0.8817257683313222,1.0,10/77,3.92%,GNG4;KCNJ6;GABRD;GLUL;CACNA1S;GABRR3;GABRQ;GAD1;SLC6A11;SLC12A5
prerank,WikiPathway_2021_Human__Immune response to tuberculosis WP4197,-0.3868277652418373,-1.1409661318026678,0.2597402597402597,0.5069587425689003,1.0,14/23,32.69%,IFIT3;IFIT1;JAK2;STAT1;OAS1;IRF9;IFNGR1;IRF1;IFNGR2;TAP1;STAT2;IFNAR1;MED14;JAK1
prerank,Elsevier_Pathway_Collection__Serotonin Receptors Signaling,0.4059728104478305,1.1406617099097065,0.266304347826087,0.8822963962939468,1.0,7/37,16.31%,HTR1D;RASGRF1;HTR4;HTR1B;PDPK1;HTR2B;ELK4
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,0.41779196502224886,1.140469567006412,0.2958579881656805,0.8822977492871346,1.0,7/33,19.97%,E2F1;CDKN2A;E2F2;CDKN2C;CDKN2B;DAND5;CDK6
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.41006079264777534,1.140456022408815,0.28160919540229884,0.881616547801601,1.0,6/35,8.21%,ROBO1;GATA5;SNAI2;BMP4;ELN;EFNA1
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Endometriosis,-0.3550760696191161,-1.1403472158758277,0.27586206896551724,0.5078843487024658,1.0,14/40,18.51%,CYP26A1;PTGS2;TNF;IL1B;MMP1;CDH1;FOXO1;MMP7;HSD17B2;PGR;CRABP2;ALDH1A2;RBP1;TWIST1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.3687174867586826,-1.1403061230738054,0.24444444444444444,0.507575773220148,1.0,8/26,24.27%,GBP5;PAQR3;SORL1;VPS13A;ZDHHC15;TMED10;RAB33B;RAB6A
prerank,WikiPathway_2021_Human__Estrogen metabolism WP697,-0.41962143310733657,-1.1402467708951134,0.3170731707317073,0.5072527313654783,1.0,10/17,24.32%,GSTA1;UGT1A9;UGT2B7;CYP1A2;CYP3A4;STS;GSTM1;ARSD;COMT;SULT1A1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.3710041393427027,1.1400717313119453,0.2623762376237624,0.8824236631711332,1.0,28/75,30.14%,SFN;PRDM15;KIF20A;PLK1;PLK5;RAB11FIP4;TLE6;KIF18B;AURKB;KLHL21;KLHL13;AURKA;POU5F1;CDK2AP2;HTR2B;PRC1;CETN2;AHCTF1;BLM;PLK4;OOEP;MYO19;MYC;SUSD2;BBS4;CSPP1;RACK1;PIN1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.4397704551260282,1.1400661290474432,0.2631578947368421,0.8817034162449555,1.0,7/20,16.85%,SLC22A4;TSPO2;SLC6A9;SLC1A4;SLC1A2;SLC7A1;SLC1A3
prerank,Elsevier_Pathway_Collection__Persistent Double Strand DNA Homologous Repair in Cancer,0.45376392158222834,1.1399924902202938,0.294478527607362,0.8812532783129945,1.0,16/20,48.29%,XRCC2;HMGA1;BARD1;RAD51;MDC1;ABRAXAS1;UIMC1;BRCA2;SMC1A;XRCC3;RAD52;ATRX;BRCC3;NBN;MRE11;RAD50
prerank,WikiPathway_2021_Human__Insulin Signaling WP481,0.3338082881272757,1.1398007338666736,0.2311111111111111,0.8812412079794615,1.0,7/158,5.33%,REG1A;PIK3R2;PRKAA2;MAPK12;SHC3;SLC2A4;MAPK11
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.42841618303069234,1.1397385137086153,0.3107344632768362,0.8807236693944087,1.0,17/32,39.28%,EME1;EXO1;XRCC2;BARD1;DNA2;RMI1;RAD51AP1;RAD51;BLM;BRIP1;RMI2;MUS81;BRCA2;SEM1;EME2;XRCC3;SPIDR
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,0.38064565396773214,1.1396036634964626,0.29533678756476683,0.8805180254822464,1.0,25/52,37.36%,ATP6V0D2;CASTOR2;LAMTOR2;ATP6V0B;CASTOR1;LAMTOR4;TCIRG1;WDR24;ATP6V0D1;ATP6V0E1;ATP6V1C1;SH3BP4;ATP6V1H;RHEB;KPTN;ATP6V1F;ATP6V1E1;MLST8;ATP6V1E2;LAMTOR5;RRAGD;NPRL3;RPTOR;NPRL2;RRAGA
prerank,TRRUST_Transcription_Factors_2019__PML human,-0.39476901562936845,-1.139202599055512,0.33707865168539325,0.5093559131000364,1.0,4/18,12.73%,NR4A1;TNFSF10;FLT3;HCK
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,0.47408065203119354,1.1391616438970413,0.27586206896551724,0.8815301428441328,1.0,12/17,43.67%,POLR2L;POLR2K;POLR3K;POLR2H;POLR3H;POLR3A;POLR3C;POLR3G;POLR3GL;POLR3E;POLR3F;POLR2F
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.36238406681975943,1.1391578031521208,0.22926829268292684,0.880800005431114,1.0,22/89,20.23%,THBS4;SCG2;VEGFD;CDH13;CCL26;EGFL7;BMP4;FGF2;PRKD1;PPP1R16B;LEP;RGCC;PDGFB;PGF;CCL24;CCL11;PRKCA;HTR2B;EGF;ACVRL1;FGF18;SPARC
prerank,WikiPathway_2021_Human__Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.454588240481133,1.1390028153752083,0.3051948051948052,0.8806773562357103,1.0,3/22,5.33%,MAPK12;NQO1;MAPK11
prerank,MSigDB_Oncogenic_Signatures__JNK DN.V1 DN,0.3323719855447419,1.1389074490276871,0.2102803738317757,0.8802904224762785,1.0,48/154,22.12%,ZIC2;APLP1;PTP4A3;CAPN11;THY1;CABP1;SLC12A5;PLK1;SRC;ARR3;UBE2C;YPEL1;CDKN3;ERVW-1;PAQR4;FAM182B;CDC45;DAAM2;KNTC1;IDUA;CTRC;SLC14A2;STEAP1;PDGFB;SMYD2;RGS16;CRYM;NMB;UBL4A;FBP2;CCL11;TYMP;FXYD2;RGS14;DEFA3;ANKRD1;POLD1;MAP1B;ACVRL1;GRIN2C;FLRT1;TBKBP1;LRP8;DYRK3;ARHGAP4;STK35;LINC00342;BCL9
prerank,WikiPathway_2021_Human__Focal Adhesion WP306,0.32413444675643716,1.1388742162487746,0.23504273504273504,0.8796881715059405,1.0,38/191,18.80%,COL2A1;THBS4;VEGFD;RASGRF1;LAMA3;SPP1;PIK3R2;PAK3;SHC3;VWF;ITGA2;ITGA6;SRC;COL4A1;PARVB;PDGFRB;COL1A1;COMP;COL4A2;LAMC1;PDGFB;FLT1;PDGFA;PGF;COL1A2;SHC1;MYLPF;PDPK1;THBS2;PRKCA;HRAS;SRMS;ROCK2;MYLK2;EGF;LAMA4;ITGA7;ITGA11
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,0.3709081683287895,1.1388461186653467,0.25,0.8790613694979361,1.0,33/69,39.25%,NEK2;PLK1;CDK1;TUBA4A;CEP131;PRKCA;CETN2;CEP250;HAUS4;HAUS5;PLK4;DYNLL1;CEP70;SFI1;SSNA1;CSNK1D;TUBA1A;ALMS1;CEP290;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;TUBG1;CEP72;PPP2R1A;NDE1;HAUS1;TUBB4B;SDCCAG8;HSP90AA1;CSNK1E
prerank,Elsevier_Pathway_Collection__Cyclosporine Induced Nephrotoxicity,0.4557431598818742,1.1377458731825372,0.2822085889570552,0.88264836942221,1.0,3/22,4.68%,REN;SPP1;SLC12A1
prerank,Elsevier_Pathway_Collection__anti-Inflammatory Function of Macrophage M2 Lineage,-0.3252501390596228,-1.1376964684774606,0.21666666666666667,0.5125096868956018,1.0,18/61,17.49%,IRF4;IL10;TNF;IL1B;FOS;CD163;MAP2K1;CCR2;FCGR2B;CCL22;MSR1;MYD88;ADORA3;CD86;IL10RA;CSF1R;INPP5D;TNFRSF10C
prerank,Elsevier_Pathway_Collection__Proteins Involved in Glioblastoma,0.3326091638901936,1.1376102998995732,0.26244343891402716,0.8824595004414537,1.0,40/161,20.23%,DLK1;IGF2;REN;GLUL;TERT;SOX2;SNAI2;CDKN2A;ITGA6;FOXM1;ASPM;BMP4;BIRC5;FGF2;TRPC6;IGFBP2;PRKN;CDKN2C;ADORA1;TIMP1;AURKB;EZH2;AURKA;PDGFB;PDPN;PLAU;TYMP;HRAS;KIF11;HMGCR;HMGA1;EGF;ZBTB18;NES;TRAF2;PIAS3;MMP9;CDK6;ADM;SPARC
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,0.4461679556781071,1.137475623697785,0.3149171270718232,0.8821859799314394,1.0,3/23,3.41%,H3C13;PIK3R2;CRLF2
prerank,Elsevier_Pathway_Collection__Apoptosis Block by BCL2 Family Proteins in Cancer,0.40515196553768695,1.1373510257762565,0.2391304347826087,0.88194404102365,1.0,7/39,18.71%,SFN;TP53AIP1;TP73;BIK;BMF;BCL6;BBC3
prerank,Elsevier_Pathway_Collection__Coagulation Factors and PAR1/2 Receptors (F2R/F2RL1) in Endometriosis,-0.3440058739072838,-1.137346823457091,0.2235294117647059,0.5128321300737362,1.0,11/32,17.85%,PTGS2;TNF;FOS;MAP2K1;CCL2;IL6;CXCL8;AKT1;RASGRP1;F3;F7
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4335568418950673,1.1373337626163258,0.29069767441860467,0.8812812093944457,1.0,10/27,23.37%,BCAN;B3GAT1;NCAN;CSPG5;CSPG4;VCAN;B3GAT3;CHST15;XYLT2;CHPF
prerank,TRRUST_Transcription_Factors_2019__NR4A1 human,0.5066659207397171,1.1373315785389189,0.3374233128834356,0.880557322236046,1.0,3/15,9.63%,CYP17A1;E2F1;CCNA2
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.41549096856682927,1.1370544272784222,0.25165562913907286,0.8809044724658854,1.0,7/28,8.78%,EPHB2;ACTN2;GRIN1;MAPK8IP2;SLC6A9;CAMK2A;GRIN2A
prerank,Elsevier_Pathway_Collection__Epigenetic Alterations Triggers Genomic Instability,0.4864552543893633,1.136990349845299,0.32413793103448274,0.8804246530424464,1.0,10/18,25.74%,MTR;DNMT3A;TYMS;MTHFR;SUV39H1;HDAC1;DNMT1;CBX5;DNMT3B;SLC46A1
prerank,KEGG_2021_Human__Fanconi anemia pathway,0.3956000609693875,1.1369176253483992,0.25925925925925924,0.8799963524772049,1.0,28/50,40.77%,UBE2T;EME1;FANCI;POLN;FANCE;RMI1;ATRIP;RAD51;FANCD2;BLM;FANCB;FANCG;CENPS;TELO2;BRIP1;RMI2;MUS81;BRCA2;FAN1;CENPX;EME2;FAAP24;POLH;ATR;FANCM;RPA2;POLK;USP1
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,0.3228917547480991,1.1368836150435335,0.16810344827586207,0.8794335998261404,1.0,108/243,40.85%,H2AC19;AXIN2;H2BC13;H2BC18;H2AC11;CDC20;H2AC20;H2BC17;H2BC21;PRKN;PSMD4;H2BC9;H2BC15;CCNA2;JOSD2;IKBKG;H2BC11;CDK1;H2BC12;H2BC4;H2AC6;FOXK1;UCHL1;PSMB4;KAT2A;H2BC5;USP22;ACTR5;SMAD3;USP49;CDC25A;MAVS;BARD1;OTUD7B;STAMBPL1;CLSPN;ASXL2;TOMM20;ASXL1;RNF135;OTUB2;INO80E;TAF10;USP11;TRIM25;NEDD8;NFRKB;HCFC1;TFPT;MYC;PSMB3;UFD1;PSMD14;UBA52;HGS;TNIP2;PSMB5;PSMD2;ABRAXAS1;PSMA1;BABAM2;PSMD10;ARRB1;KEAP1;ADRM1;PSMC4;PSMC3;FKBP8;UIMC1;DDB2;TGFB1;KDM1B;SKP2;OGT;SMURF2;PSMC5;RUVBL1;OTUD3;TNFAIP3;TRAF3;USP5;SEM1;PSMB6;PSMD8;MDM4;OTUD5;USP14;PSME2;VCP;AXIN1;TGFBR2;TAB1;ACTR8;PSMD13;PSMB7;PSMA7;BABAM1;INO80D;PSME3;PTRH2;NOD1;USP7;USP30;JOSD1;SMAD2;USP20;USP13;FOXO4
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.42778649221373394,-1.1366610917743236,0.26506024096385544,0.5140268970183981,1.0,6/17,9.50%,AMHR2;BMP10;INHBA;GDF2;GDF6;ACVR1C
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.4904971631031468,1.1366558672051976,0.3081395348837209,0.879617349381704,1.0,11/16,43.49%,PRKDC;RPS27;RPS5;RPS14;RPSA;RPS15;RPS19;RRP7A;PWP2;RPS28;MRPS11
prerank,Elsevier_Pathway_Collection__Glutamate Overdose and Aura Effect in Migraine Type 2,0.4702085219576442,1.1365272511560052,0.33544303797468356,0.8793819318106821,1.0,8/18,20.62%,SLC7A6;ATP1A2;CAMK2A;SLC1A2;SNAP25;SLC1A3;SNAPIN;STX1A
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,0.4440690438973483,1.1363100709145828,0.33532934131736525,0.8794783468618531,1.0,2/23,8.07%,DYNC1I1;PRKN
prerank,KEGG_2021_Human__Ras signaling pathway,0.3250117613520942,1.1362505581049283,0.2026431718061674,0.8790020677691252,1.0,40/212,16.44%,GNG4;IGF2;FGF20;VEGFD;RASGRF1;PLA2G2A;PIK3R2;PAK3;CALML6;GRIN1;SHC3;EFNA3;PLA2G2C;FGF17;FGF2;EFNA4;FGF23;BDNF;EFNA1;PDGFRB;GRIN2A;GNG3;IKBKG;FLT3LG;RASGRF2;PLA2G4C;RIN1;PDGFB;FLT1;PLA2G4F;PDGFA;PGF;ABL2;GNB5;SHC1;GNG8;PRKCA;HRAS;ANGPT2;MRAS
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.46851214148958575,1.1358987492599497,0.3157894736842105,0.8797688500500865,1.0,7/16,35.13%,BCL3;NF2;INPP5F;HGS;SOCS3;ADIPOR1;PPP2R1A
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.48403263824750037,1.135699180435278,0.28994082840236685,0.8798114731284763,1.0,13/16,48.08%,METTL18;HEATR1;TRMT112;UTP15;SIRT7;BUD23;WDR75;RIOK2;YTHDF2;SHQ1;RIOK1;DIMT1;USP36
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.34546764283561576,1.1355487517383558,0.25118483412322273,0.8796860478823447,1.0,22/120,16.28%,GNG4;RXFP4;VEGFD;PIK3R2;MAPK12;SHC3;MAPK11;SRC;COL4A1;COL4A5;COL1A1;GNG3;COL4A2;CREB3L1;COL1A2;GNB5;SHC1;ADCY6;GNG8;PRKCA;HRAS;CREB3L4
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.3954867332606809,-1.1354933748728682,0.32142857142857145,0.5161115957408755,1.0,8/20,12.95%,AKR1D1;SRD5A2;SRD5A1;UGT2B7;HSD3B1;AKR1C4;HSD17B6;CYP3A4
prerank,Elsevier_Pathway_Collection__Ras-GRF Regulation Signaling,0.3915347221027934,1.1353936493981145,0.30851063829787234,0.8795943963925894,1.0,11/44,19.68%,RASGRF1;RASGEF1A;STMN3;SRC;DGKI;CDK1;RASGRF2;PACSIN3;SHC1;RAPGEF3;CDK5R1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.4342047579649845,1.1350090365797882,0.3067484662576687,0.8803945172776161,1.0,3/25,4.96%,MT3;MDK;HES5
prerank,WikiPathway_2021_Human__Base Excision Repair WP4752,0.41166970193135094,1.13498538178454,0.2716049382716049,0.8797550537362214,1.0,14/31,35.93%,NEIL3;POLD1;MUTYH;FEN1;PARP1;APEX2;LIG3;POLB;PCNA;XRCC1;OGG1;LIG1;PNKP;POLL
prerank,KEGG_2021_Human__Insulin resistance,-0.2857752225942473,-1.1349064273490805,0.18421052631578946,0.5171220795100998,1.0,26/104,19.01%,SLC27A6;TNF;PPP1R3B;PCK1;GYS2;PPARGC1A;PIK3CD;PRKCB;FOXO1;PRKCQ;ACACB;IL6;RPS6KA1;PIK3R1;AKT1;SLC2A2;RPS6KA6;PPP1R3C;PRKCE;CREB5;PRKAG2;PYGL;MAPK10;PCK2;SLC27A5;IRS2
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.37610702306656196,-1.1348756562333484,0.2328767123287671,0.5167478012070682,1.0,12/25,12.95%,GLYATL2;APOA4;CYP4F2;LIPH;CYP1A2;LIPG;HSD17B14;ACADL;CYP4F12;PLAAT3;CYP4F3;CYP3A4
prerank,MSigDB_Oncogenic_Signatures__ATF2 UP.V1 DN,-0.2650652950334304,-1.1348405264065333,0.2,0.5163940677095371,1.0,56/166,19.63%,SPINT2;CCK;PTGS2;BHMT;TNFRSF11B;CD1B;SCRG1;FOS;ID4;SIK1;DENND2D;ANXA10;GAS1;IL1RAP;AK4P3;PNMA2;CXCL12;LIMCH1;GCH1;CCL2;IL33;TCF21;PLA2G4A;PELI2;SHOX2;MFAP4;NEAT1;GALNT12;CELF2;ATP8B4;HEXIM1;KLRK1;VCAM1;AK4;ABCA8;C1RL;PLSCR4;SERPINB9;SLC12A8;KCND2;ACVR2A;RAB11FIP1;PTER;PER3;SLC39A8;SLC25A15;PTGIS;VTN;SDC3;KCTD12;EIF2AK3;CA9;IRS2;PID1;CTH;PLN
prerank,Elsevier_Pathway_Collection__Aryl Hydrocarbon Receptor Genomic and non-Genomic Signaling,0.39704060658225393,1.1348050272928105,0.27472527472527475,0.8797584470734726,1.0,5/38,6.66%,RASGRF1;ALDH3A1;E2F1;NQO1;SRC
prerank,WikiPathway_2021_Human__Nuclear Receptors Meta-Pathway WP2882,-0.24710020381734799,-1.134488073978666,0.11764705882352941,0.5167610156884805,1.0,78/301,15.50%,GSTA2;SLC6A19;PMP2;CYP2C19;SLC5A1;SLC5A7;SLC6A20;PTGS2;CYP2B6;IFNG;SLC39A2;TNF;IL1B;HGF;GSTA1;IP6K3;PCK1;CYP4A11;SLC10A1;SLC39A5;SLC2A9;UGT1A9;UGT2B7;CYP3A7;CYP1A2;ESR1;PDK4;APOA1;PPARGC1A;SLC5A12;SCP2;CYP8B1;SLC2A13;SLC39A12;TGFA;FOXO1;CYP2C9;PPP1R14C;CCL2;EGR1;GPR153;GSTM5;SLC2A14;ETNK2;CYP4F12;SCNN1A;ACAA1;ABCB1;ALOX5AP;AMIGO2;IL12B;NR1I2;APOA5;SLC2A12;EHHADH;CES4A;SLC39A14;SLCO2B1;SLC7A5;ADH7;SRGN;ABCG8;PTGR1;CYP3A4;RGS2;ACOX1;TNS4;ABCG5;SERPINB2;CES3;SLC5A3;SLC2A2;SULT2A1;HBEGF;SLCO1B1;IGFBP1;SERPINB9;ACADM
prerank,Elsevier_Pathway_Collection__Endosomal Recycling,-0.3443704210832331,-1.1344014301013845,0.2,0.5164872805878588,1.0,8/32,23.34%,PLD1;TF;EPN3;RAB11FIP1;REPS2;SNX4;LDLR;PIK3CG
prerank,Elsevier_Pathway_Collection__ERK5/MAPK7 Signaling,-0.3279754003145909,-1.13419077413143,0.24,0.5165312848454834,1.0,8/35,12.78%,CSF3;RCAN1;FOS;NR4A1;CTF1;NGF;NTRK1;SH2D2A
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.4163165259637043,1.1341185708151587,0.2840909090909091,0.8817498239265545,1.0,9/36,16.50%,SPP1;SLCO2A1;MSX1;TIMP1;LPL;JAG2;PDGFA;STC1;VCAN
prerank,Elsevier_Pathway_Collection__HPV E6 and E7 Induced Disruption of TNFR/NF-kB Signaling in Keratinocytes,-0.3087108043215958,-1.1341173996220746,0.19672131147540983,0.5162285199083303,1.0,13/53,17.08%,TNF;IL1B;TLR3;IL6;TLR8;CXCL8;TICAM2;TLR4;SELE;VCAM1;MYD88;TNFRSF1B;BCL2
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.3247579056076952,-1.1341134328566747,0.25396825396825395,0.5157926836012607,1.0,10/39,22.16%,EREG;TGFA;BTC;ERRFI1;HBEGF;SH3KBP1;SPRY2;LGMN;ZFYVE28;SH3GL2
prerank,Elsevier_Pathway_Collection__beta-Cell Destruction in Diabetes Mellitus Type 1,-0.32269003471000873,-1.1340677303780908,0.1864406779661017,0.515471327964919,1.0,29/54,31.39%,IFNG;IL1B;CD8A;FASLG;CASP1;PRF1;CD2;IL1RN;MYD88;CASP6;GZMA;LTA;CASP7;GZMB;JAK2;STAT1;DFFB;CRADD;IFNGR1;IRF1;HMGB1;NOS2;NFKBIA;CASP3;CASP8;IFNGR2;TRAF6;SET;IRAK4
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.37574682603721643,1.1340301484280517,0.2742857142857143,0.881431201692691,1.0,31/49,47.29%,SAMM50;ATP5MF;ROMO1;ATP5F1D;TIMM10;APOO;NDUFA13;MTX1;MICOS13;ATP5F1E;UQCC3;ATP5MC1;ATP5ME;TIMM13;TIMM9;MICOS10;TIMM10B;APOOL;ATP5MG;CHCHD6;LETM1;MTX2;TIMM8B;ATP5PO;MTX3;TIMM22;TIMM8A;ATP5MC2;HSPA9;IMMT;ATP5PD
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,0.3137990432612328,1.1337905814865723,0.2,0.8817282869879899,1.0,147/349,38.79%,MPZ;E2F1;TP53AIP1;TP73;PRKAA2;E2F7;POU4F1;CDKN2A;CDC25C;ARID3A;MAPK11;BIRC5;AGO2;CCNE1;EXO1;E2F8;AURKB;ZNF385A;LAMTOR2;CCNA2;CCNE2;CDK1;CCNB1;RGCC;AURKA;NDRG1;SMYD2;SERPINA2;FANCI;RFC4;UBL4A;ELOC;PDPK1;TNFRSF10D;CHEK1;GPX2;POLR2L;COX6C;MSH2;BCL6;BARD1;COX20;ING5;COX7B;LAMTOR4;DNA2;BBC3;RMI1;PCBP4;TXNRD1;ELOB;CDK5R1;TSC1;POLR1A;TP53I3;TPX2;EHMT2;ATRIP;COX6B1;RAD9B;HDAC1;AIFM2;TSC2;FANCD2;POLR2K;GATAD2B;L3MBTL1;BLM;PDZD2;NELFE;NPM1;TAF10;COX8A;PRKAB2;RHNO1;CDK5;POLR2G;PIP4K2B;CHEK2;UBA52;RBL1;CDKN1A;RHEB;CHD3;CHD4;MDC1;NUAK1;PPP1R13L;TAF6;PCNA;PRDX2;COX4I1;BRPF3;HIPK2;POLR2H;GDNF;FASN;RBBP7;PIDD1;COX5B;TP63;PRELID1;PRDX5;BRIP1;MLST8;RMI2;CNOT3;NELFA;DDB2;TOPBP1;POLR2I;TP53RK;LAMTOR5;POLR2J;TNFRSF10A;CASP2;COX19;REXO2;CTDP1;RRAGD;TMEM219;CSNK2B;BAX;CNOT10;SGK1;PPP2R1A;SSRP1;AGO1;YWHAH;MDM4;DDIT4;RPTOR;COX7C;SUPT5H;PIP4P1;NELFB;TAF9;E2F4;RRAGA;CNOT6;CNOT6L;BID;CNOT9;POLR2A;DAXX;TAF1;ERCC2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.4764092170468225,1.13367073993342,0.3271604938271605,0.8814825177028047,1.0,13/15,47.42%,RGS14;HMGA1;NPM1;NXT1;BANF1;NUP205;RBM15B;XPO1;NUTF2;PSIP1;NXT2;AAAS;ANP32A
prerank,Elsevier_Pathway_Collection__Mast-Cell Activation without Degranulation through IL1R1 and TLR Signaling,-0.4190131632214934,-1.1335692140911489,0.25609756097560976,0.5161928034890989,1.0,11/17,31.39%,TNF;IL6;CXCL8;MYD88;MAP2K3;MAP2K6;MAP3K5;NOS2;NFKBIA;TRAF6;IRAK4
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.4020088001939013,-1.133420587887059,0.25,0.5160641379367096,1.0,10/18,26.63%,IFNG;TNF;SLC2A13;CHRNA7;LRRTM3;CLU;GSAP;PICALM;EPHA4;IFNGR1
prerank,MSigDB_Oncogenic_Signatures__STK33 SKM DN,-0.2720784867840414,-1.1332618657076188,0.043478260869565216,0.5160145939912673,1.0,55/226,17.44%,GABRA5;SLCO4C1;TBL1Y;TEX15;GABRA4;KCNN2;PROK2;KRT23;PRKAR2B;PHACTR3;BPI;GPR84;CCL5;GPM6B;TBC1D30;LRRK2;SPIB;BANK1;BTLA;CAMK4;TEKT2;TNFSF10;SYDE2;PYROXD2;LILRA2;MCTP2;SPP2;ICAM3;CDA;KAZN;RXFP1;ALOX5;CCDC26;CCR2;HBA2;FOXP2;FLT3;CYP4F3;GALNT12;SORL1;OGDHL;SERPINB2;ARHGEF26;EPHX2;N4BP2L1;RAB38;PPP1R3C;RAB27B;BMX;NLRC3;BMP2K;BCL2;TPD52L1;ACAP1;UCA1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.45964819519328726,1.1330931546718845,0.313953488372093,0.88307414790897,1.0,3/19,2.61%,TNNC1;TNNI3;IRX3
prerank,MSigDB_Oncogenic_Signatures__STK33 NOMO UP,-0.24661848810135972,-1.1330113247757645,0.0,0.5162016149806865,1.0,64/261,19.39%,EGR3;IL10;EGR2;PPP1R3B;JAKMIP2;IL1B;EOMES;MMP1;FOS;IL7R;CD80;TDO2;CXCL3;TNFAIP6;CCL4;PTPRO;TNFSF15;ACSM3;RND3;ZFP36L1;KCNJ15;SEMA4D;CXCL2;SIGLEC9;FAM13A;MEIS3P1;ARRDC3;TFEC;STK17B;ADAM28;TMEM159;CSRNP1;ARL4C;ZEB2;C1QC;CLEC7A;NEAT1;GBP3;RGS2;KYNU;HAVCR2;CD300C;KMO;SAMD9L;LRRC25;KLF6;GCNT2;IL10RA;CXCL1;OTUD1;PPP1R15A;HMOX1;SLC12A6;ABHD2;MTMR9;VWA5A;DUSP1;C3AR1;NCEH1;PID1;IFI16;WNT5A;MIR22HG;CLEC2B
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.34693920871953093,1.1328921728160275,0.25742574257425743,0.8830748240336934,1.0,63/127,39.37%,SQLE;NQO1;PSAPL1;PSMD4;OAZ3;FDPS;NR1D1;MVD;PSMB4;ODC1;ABCA7;ACACA;SREBF2;PPARG;PLPP1;ROCK2;HMGCR;TM7SF2;SCD;IDI1;PMVK;FDFT1;GPAM;HMGCS1;ANGPTL8;CYP51A1;PRKAB2;SMARCD3;PSMD1;PSMB3;NCOR2;PSMD14;SIN3B;BBS4;FGFR4;PSMB5;C1QTNF2;AZIN1;PSMD2;PSMA1;GGPS1;PSMD10;FASN;APOE;PSMC4;PSMC3;SERPINA3;EDF1;OPA3;ADIPOR1;TBL1X;PSMC5;NCOA2;PSMB6;PSMD8;NCOA6;ZFP69;PSME2;PSMD13;PSMB7;PSMA7;NFYC;PSME3
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.4029648573688952,1.1325429573541674,0.2994350282485876,0.8836470671654715,1.0,23/48,39.37%,NQO1;PSMD4;OAZ3;PSMB4;ODC1;PSMD1;PSMB3;PSMD14;PSMB5;AZIN1;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.41640078375513173,1.1322783602473145,0.30113636363636365,0.8838496582237773,1.0,19/34,30.72%,SQLE;FDPS;HSD17B7;MVD;ACLY;HMGCR;TM7SF2;IDI1;LBR;PMVK;NSDHL;FDFT1;HMGCS1;CYP51A1;NPC1L1;INSIG2;ARV1;G6PD;GGPS1
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,0.45424204396716805,1.1322039087722993,0.28125,0.8834314183961468,1.0,6/21,19.19%,GJB6;CLTCL1;GJB7;GJA5;GJB3;CLTB
prerank,MSigDB_Hallmark_2020__Complement,-0.2714264849352091,-1.1319655524484276,0.2608695652173913,0.518244013450244,1.0,86/198,26.90%,CR2;PCLO;HPCAL4;TFPI2;SCG3;CCL5;APOA4;GZMK;C9;CASP1;KLKB1;LGALS3;CP;PRSS3;PLEK;IL6;CDA;FYN;CR1;LCP2;CD40LG;CA2;PLA2G4A;PLG;GATA3;LCK;C1QC;C1R;PIK3R5;ADRA2B;RASGRP1;KYNU;SERPINB2;GNG2;S100A12;FCER1G;GZMA;DOCK10;SERPING1;CLU;CASP7;CXCL1;F3;PLAUR;CSRP1;DUSP6;CTSB;HSPA1A;GP1BA;PPP2CB;F7;CTSC;LGMN;GZMB;FCN1;CTSO;C1S;LAP3;C1QA;USP15;ITIH1;CD55;JAK2;APOBEC3G;ITGAM;F2;CASP4;GNGT2;IRF2;L3MBTL4;SH2B3;PIK3CG;C3;GNB4;ANXA5;PLSCR1;CTSS;ZFPM2;GNAI2;GCA;PSMB9;CALM1;CFB;ME1;FDX1;PLA2G7
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.321228630608265,1.1318454310383805,0.2328767123287671,0.8840877833997688,1.0,52/184,18.06%,HTR1D;CACNA1E;CHRND;CACNB4;SYT5;GABRD;CEL;MPZ;GABRR3;GRIN1;GABRQ;SNCG;BSN;GAD1;SLC12A5;CHRFAM7A;CHRNB2;GRIK2;HTR4;CHRM4;CHRNA3;HRH3;KIF5A;GRIK4;CHRNB4;GRIN2A;GALR3;PCDHB14;NPTX1;GABRE;CHRNA5;CHRM5;CHRNA4;SYN1;SLC1A2;SNAP25;CPLX1;DLG4;CBLN1;UNC13B;HTR1B;PCDHB2;GRM1;SLC6A2;HTR2B;PCDHB11;SLC12A7;NPTX2;SLC1A3;SYN2;NLGN2;NRXN2
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Endometrial Cancer,-0.3959932104583398,-1.1316546511341108,0.2535211267605634,0.5186107159226001,1.0,11/22,13.84%,CLDN4;WNT7A;EPCAM;CDH1;ESR1;FGFR2;TGFA;WNT10B;AKT1;PGR;IGF1
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.4454389239917585,1.1316341765678566,0.3058823529411765,0.8841125258398088,1.0,10/21,20.62%,PPFIA3;PPFIA4;SLC1A2;SNAP25;CPLX1;UNC13B;PPFIA2;SLC1A3;STXBP1;STX1A
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.43230766095255846,1.131620247317515,0.3146067415730337,0.883471256221838,1.0,24/29,47.36%,RRS1;DCAF13;HEATR1;RPS21;WDR46;KRI1;RPS14;RPS19;RPP40;RPS8;TBL3;DHX37;UTP4;RRP36;PWP2;RPS16;NOL10;TSR2;MRPS11;NOP9;TSR1;UTP20;UTP6;BMS1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.26958668904340766,-1.1311281287169594,0.1388888888888889,0.5193551281118939,1.0,42/149,15.76%,EREG;CSF3;RET;ERBB4;FGF10;TNF;TSPYL5;P2RY12;HGF;CD80;CCL3;ESR1;IL18;PDGFRA;NRG4;ICOS;CCR7;PIK3CD;CALCR;FGFR2;TGFA;FAM110C;OSM;TRAT1;FYN;AXL;FERMT2;RAC2;KL;BTC;GATA3;LCK;FLT3;PIK3R5;HCLS1;PIK3R1;RTN4;HBEGF;VAV1;SPRY2;CD86;GCNT2
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,0.3977152813231483,1.1305635343276472,0.30726256983240224,0.8869340686595096,1.0,23/48,39.37%,NQO1;PSMD4;OAZ3;PSMB4;SLC25A21;PSMB3;PSMD14;PSMB5;AZIN1;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3
prerank,WikiPathway_2021_Human__Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.43750133941747027,1.1304631326815866,0.30952380952380953,0.8866778010947033,1.0,8/24,23.94%,FBN3;LTBP2;SHC1;ANGPT2;SMAD3;TGFBR3;NR2C2;FBN1
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,0.33043123790976814,1.1302216410411272,0.19911504424778761,0.8868795552303004,1.0,71/167,41.18%,H2AC19;AXIN2;H2BC13;H2BC18;H2AC11;CDC20;H2AC20;H2BC17;H2BC21;PSMD4;H2BC9;H2BC15;CCNA2;IKBKG;H2BC11;H2BC12;H2BC4;H2AC6;PSMB4;KAT2A;H2BC5;USP22;SMAD3;USP49;CDC25A;CLSPN;TOMM20;TAF10;USP11;MYC;PSMB3;UFD1;PSMD14;UBA52;HGS;PSMB5;PSMD2;PSMA1;PSMD10;ARRB1;KEAP1;ADRM1;PSMC4;PSMC3;FKBP8;DDB2;SKP2;SMURF2;PSMC5;RUVBL1;USP5;SEM1;PSMB6;PSMD8;MDM4;USP14;PSME2;AXIN1;TAB1;PSMD13;PSMB7;PSMA7;PSME3;PTRH2;USP7;USP30;SMAD2;USP20;USP13;FOXO4;USP37
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,-0.4211304974291875,-1.1296825296777895,0.2808988764044944,0.5222878138488685,1.0,5/16,14.80%,EREG;TGFA;BTC;PIK3R1;HBEGF
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,0.35069848706689893,1.129644069529922,0.2561576354679803,0.8884802432576471,1.0,17/101,13.75%,CHGB;SCG2;SPARCL1;AMBN;NOTUM;TNNI3;MATN3;BMP4;GPC3;FGF23;TIMP1;VGF;MFGE8;LAMC1;STC2;VWA1;MELTF
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.26976940857069376,-1.1295075882014425,0.10714285714285714,0.5222625153660316,1.0,27/135,12.59%,TCN1;SLC6A19;SLC5A7;SLC6A20;SLC18A1;SLC52A1;ZG16;SLC3A1;SLC44A4;RHCG;SLC7A8;LRP1B;SLC25A47;TMEM30B;SLC22A1;CMTM6;SLC38A4;HBB;ARRDC3;CD3G;SLC18A2;SLC7A7;ARRDC4;SLC15A2;SLC7A5;SLC16A10;SLC38A5
prerank,WikiPathway_2021_Human__Notch Signaling WP268,0.3892739314250738,1.1294697715302313,0.26881720430107525,0.88844352691059,1.0,14/43,28.24%,HES5;KCNJ5;NOTCH3;JAG2;KAT2A;DVL2;NOTCH4;DLL4;HDAC1;LFNG;DVL1;MAML1;NCOR2;NCSTN
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,0.3030382754018577,1.1293395776550914,0.18442622950819673,0.8882061190872627,1.0,106/498,16.95%,GRPR;HTR1D;GNG4;GLP1R;GHRHR;RGSL1;PTH2R;RXFP4;GCG;ADRA2C;NTS;APLN;CALCA;GNAZ;PIK3R2;RGS20;QRFPR;UTS2R;F2RL3;OPN1SW;RAMP1;KISS1;GAL;GPHA2;TAS1R3;LPAR4;RHO;CCL13;OPRL1;GPSM1;HTR4;CCL25;AVPR2;CHRM4;ARHGEF39;FGD1;SAA2;CCL20;SRC;ADRA1D;PTGER1;PTGER3;KISS1R;TRPC6;PDE4C;ARHGEF37;ARHGEF10;DGKI;CAMK2A;TRH;CRHR2;SSTR5;PDE1C;RGS9BP;CCR3;GNAL;GALR2;ADORA1;GALR3;HCAR1;PTHLH;OXTR;GNG3;CHRM5;RASGRF2;ADM2;DGKD;ARHGEF11;BDKRB2;NPW;GPR150;RAMP2;LHB;GALR1;PTGFR;RGS16;MC1R;OBSCN;BDKRB1;PDE10A;RGS5;MLNR;GNB5;HTR1B;SHC1;ADCY6;IAPP;PDPK1;GNG8;RGS14;DHX34;PLEKHG2;GRM1;PRKCA;HRAS;ARHGEF2;ADORA2A;ARHGEF15;TACR1;GRK3;ECT2;ROCK2;PPP1R1B;RHOC;GPR4;RRH
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.448959173867974,1.12927021049592,0.27388535031847133,0.8877630089602743,1.0,6/21,22.12%,DLX1;DKK3;ZNF703;SMAD3;TGFBR3;BCL9
prerank,Elsevier_Pathway_Collection__Dendritic Cell Dysfunction in Psoriatic Arthritis,-0.3118497378665875,-1.1292506054000462,0.19696969696969696,0.5225117049714328,1.0,19/62,22.05%,TNF;IL1B;S100A8;IL18;CASP1;NLRP3;IL6;IL33;REL;TLR4;TLR2;AKT1;MYD88;TNFRSF1B;CTSB;MAP2K3;MAP2K6;JAK2;STAT1
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.4068014305368544,-1.128952986261612,0.25882352941176473,0.5227898383294864,1.0,7/21,14.60%,CETP;LCAT;APOA1;ABCG8;ABCG5;ABCA8;MSR1
prerank,KEGG_2021_Human__RNA transport,0.3274946062294104,1.1289288435182516,0.23660714285714285,0.8881744884541158,1.0,105/163,50.34%,EEF1A2;NCBP2L;RNU4-2;PABPC4L;RNU4-1;EIF4EBP3;PABPC1L;CASC3;NUP37;RPP21;EIF3CL;THOC5;RBM8A;EIF2B4;NUP62;POP1;NXF1;TPR;EIF3E;CYFIP2;EIF4EBP2;NUP133;RANGAP1;XPO5;PABPC1;EIF3D;UPF3B;GEMIN8;NUP155;TACC3;NUP160;THOC1;UBE2I;GEMIN7;RPP25;FUS;FMR1;NXF5;THOC6;NUP188;NXT1;EIF3H;RPP40;THOC2;DDX39B;POP5;EIF3B;MAGOHB;NUP205;POP4;XPOT;XPO1;EIF5B;RPP25L;EIF3G;NUP210;DDX20;RAN;GEMIN4;RAE1;FXR2;NUP214;NUP210L;RPP38;GLE1;ALYREF;PHAX;PABPC4;NUP107;EIF2B5;EIF2S3;TGS1;RNPS1;EIF3C;UPF1;EIF3F;GEMIN5;NXT2;AAAS;EIF1;GEMIN6;POP7;EIF2B1;EEF1A1;DDX19A;EIF4A3;MAGOH;FXR1;NUP93;EIF3A;EIF4G3;PRMT5;EIF2B2;SNUPN;PABPC3;NCBP2;NUP88;SEC13;THOC3;ACIN1;SEH1L;POM121C;NUP42;EIF1AY;UPF2
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.38453297261429553,-1.1289251215494243,0.2988505747126437,0.5224266041110425,1.0,8/21,19.04%,APOA4;APOA1;APOA5;HDAC9;ANGPTL3;PCSK5;LIPC;APOH
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.4120662919479585,1.1285691169175027,0.2756756756756757,0.8888020331906435,1.0,5/33,6.66%,ACTN2;LAMA3;THY1;ITGA6;SRC
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.4780550818214741,1.1284783325683891,0.2962962962962963,0.8883951474087062,1.0,2/17,2.31%,ALOX15B;OSR1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.2756989379739098,-1.1284183405276946,0.25,0.5232224509914185,1.0,37/107,22.94%,MFSD2A;FABP2;CETP;APOA4;SLC10A1;ABCD2;ACSL1;APOA1;SLCO1B3;SCP2;AKR1C4;PEX3;STARD5;APOA5;SLCO2B1;ABCG8;ABCG5;ABCG4;PRELID2;MFSD2B;CLN3;ABCA8;SLCO1B1;MTTP;PLTP;APOL2;ABCA9;SLC27A5;NR1H4;PCTP;CLN8;FABP3;TTPA;ABCC3;LDLR;PITPNA;ABCA13
prerank,Elsevier_Pathway_Collection__Androgens in Sebocyte Maturation,0.36569223038654103,1.1282986700880593,0.25906735751295334,0.8883888048699915,1.0,7/64,6.91%,DKK1;LGR6;LEF1;AXIN2;BMP4;PTGDS;IHH
prerank,KEGG_2021_Human__Endometrial cancer,0.3750432840691653,1.1281355395677422,0.27,0.8882593175349667,1.0,5/58,6.48%,CTNNA2;LEF1;PIK3R2;AXIN2;TCF7
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4051277737845569,1.1273763485620982,0.27717391304347827,0.8898207397952115,1.0,26/34,52.83%,NUP37;NUP62;TPR;NUP133;NUP155;NUP160;NUP188;SSB;NUP205;XPOT;NUP210;RAN;RAE1;NUP214;NOL6;NUP107;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.4051277737845569,1.1273763485620982,0.27717391304347827,0.8898207397952115,1.0,26/34,52.83%,NUP37;NUP62;TPR;NUP133;NUP155;NUP160;NUP188;SSB;NUP205;XPOT;NUP210;RAN;RAE1;NUP214;NOL6;NUP107;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,0.4306194369063765,1.1272145400425524,0.2742857142857143,0.8897149895612226,1.0,1/30,0.07%,SH3GL3
prerank,Elsevier_Pathway_Collection__Potassium Cycling in the Inner Ear (Noise-Induced),0.4432806254740834,1.1270435227892563,0.36363636363636365,0.8896721529995104,1.0,4/20,9.05%,GJB6;TMC1;CLCNKA;PCDH15
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.3869414797678639,1.1269303091771168,0.2513089005235602,0.8893731552052706,1.0,9/47,17.13%,DKK1;PYDC1;KIF14;SRC;GBA;PRRT2;IAPP;ANKRD27;THRA
prerank,Elsevier_Pathway_Collection__Aldosterone Synthesis Chronic Regulation,0.41160867063954004,1.126744569691123,0.296969696969697,0.8893279361586865,1.0,6/29,11.68%,CYP17A1;CYP21A2;KCNJ5;SRC;PRKD1;CACNA1C
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,0.3678616903881427,1.1267254462076715,0.25906735751295334,0.8886595657274265,1.0,30/57,44.23%,COLEC12;SARNP;DDX39A;CPSF1;CASC3;THOC5;RBM8A;CHTOP;CPSF4;UPF3B;CSTF2;THOC1;POLDIP3;THOC6;THOC2;DDX39B;MAGOHB;SLU7;PABPN1;ZC3H11A;SYMPK;CPSF3;ALYREF;CPSF7;U2AF1;U2AF2;CPSF6;FIP1L1;RNPS1;PCF11
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.29523323697318204,-1.1266967861979456,0.16666666666666666,0.5271717863055861,1.0,30/86,18.49%,CSF3;FGF10;GHR;NTF3;HGF;SFRP1;CD80;BANK1;BST1;ANGPT4;IL15;EPHA7;SEMA4D;PTPRC;IL6;OSM;FYN;IL12B;SAMSN1;HCLS1;IGF1;PLCG2;EFNA5;ITGB2;ITGB3;PRNP;GATA1;VTN;SFRP2;LIF
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.35651651196833445,-1.1266629542776567,0.2564102564102564,0.5267764100320347,1.0,11/28,17.67%,IL10;TNF;BPI;CD200R1;NLRP12;PTPN22;NCKAP1L;TLR4;LILRB4;NLRC3;SLAMF1
prerank,TRRUST_Transcription_Factors_2019__SP1 human,-0.24056578594952843,-1.126520032813603,0.0,0.52675223762676,1.0,114/441,18.13%,KLK3;NKX2-1;SERPINB5;MUC6;MUC5AC;PADI1;CHST4;PNOC;ADRA1A;CCK;IL10;PTGS2;CXCL14;PLAC1;HAS2;TNF;TH;PPP2R2B;TFPI2;SLC19A3;KRT19;IL2RB;KRT14;CETP;HGF;CCL5;KRT5;FOS;LCAT;PROM1;PCK1;ID4;NR4A1;LAMA1;FASLG;SLC15A1;PHGDH;IGFBP3;CYP3A7;ESR1;TNFSF10;APOA1;FBP1;CD1D;TF;CD163;MMRN1;OAT;CAT;KRT16;GIPR;CDC42BPG;HSD3B1;TGFA;ITGAD;CCL2;EGR1;CBS;IL6;ABCB1;TBX21;C4A;ALOX5;PTGES;PGLYRP2;MNDA;BTK;HSD17B2;SPN;SLC7A5;GATA3;FGL2;SLC31A1;TLR2;CYP3A4;ADRA2B;SOX9;PGR;EDNRB;ST6GAL1;PON1;PTN;SLC9A2;CREM;HBEGF;CD83;ADGRE5;PRKCE;SPRY2;IGFBP1;UGT2B15;CFTR;ITGB2;CXCL1;TPMT;ITGB3;PRNP;F3;PLAUR;IGFBP4;PTK6;CTSB;TBXA2R;EZR;BCL2;LTBP4;SLC39A8;ATP2A3;SNAPC1;RECK;F7;LOXL4;SIGIRR;PDE6A
prerank,WikiPathway_2021_Human__FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.41521293521615993,1.1262125632142768,0.2786885245901639,0.889762545230375,1.0,12/27,28.26%,MAPK12;MAPK11;BMP4;IHH;PTHLH;NPR2;THRA;FGF18;MAP2K2;SNAI1;RBL1;CDKN1A
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,0.38342664562989787,1.1262010270387701,0.28804347826086957,0.8890948930569104,1.0,27/55,39.37%,NQO1;PSMD4;OAZ3;PSMB4;SRMS;SLC25A21;PSMB3;PSMD14;SMOX;PSMB5;AZIN1;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;AZIN2;NPRL2;PSME2;PSMD13;PSMB7;PSMA7;PSME3
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.3397601696445629,-1.12618366867454,0.22580645161290322,0.5271616242907958,1.0,23/43,27.44%,AKR1D1;CYP39A1;SLC10A1;SLCO1B3;CYP8B1;ALB;AKR1C4;STARD5;SLCO1B1;PTGIS;SLC27A5;NR1H4;OSBPL6;ACOX2;ABCC3;SLC27A2;SLC51A;NCOA1;OSBPL9;SLC51B;OSBPL7;OSBP;OSBPL1A
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.3663302433012475,1.126152360771123,0.29411764705882354,0.8886074934943647,1.0,16/70,9.01%,KCNJ6;HCN2;ATP4A;KCNH2;KCNJ9;SLC12A5;SLC39A4;SLC12A1;KCNJ5;SLC5A2;ATP1A2;ATP1A4;ATP2B4;SLC9C2;ATP1B3;KCNJ14
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.4312434830062324,1.1261222241242543,0.2914285714285714,0.8880177806410533,1.0,6/23,22.14%,NOTUM;HDAC4;LYPLAL1;HDAC5;HDAC10;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.41297351990756265,-1.1259573708154542,0.3010752688172043,0.5272198942141195,1.0,6/17,17.34%,FCRL3;PTPRC;CD300A;PPP1R14D;PPP1R15A;CD33
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.4624822774256115,1.125931845049297,0.2751677852348993,0.8880226460958783,1.0,4/19,4.96%,DLX1;DISP3;SOX2;HES5
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,0.38227631271436274,1.1256629012109098,0.3023255813953488,0.8883471116061894,1.0,29/48,45.65%,EXTL1;EXTL3;LMNA;SHC1;PREB;TSPYL2;ATP6V0D1;DDX11;KDELR3;CUL7;ARFGAP1;MYDGF;ZBTB17;DNAJB11;TATDN2;HSPA5;ACADVL;CTDSP2;CXXC1;SRPRB;WFS1;ACD;HYOU1;PLA2G4B;TLN1;FKBP14;PPP2R5B;EXTL2;GSK3A
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.340625736707789,1.1250618061398845,0.27488151658767773,0.8900919185967028,1.0,58/142,40.48%,IGF2BP1;E2F1;RBM24;AXIN2;IGF2BP2;PSMD4;HSPB1;EXOSC4;PSMB4;MAPKAPK2;PRKCA;ROCK2;PCBP4;NPM1;METTL3;LARP1;PSMD1;IGF2BP3;EXOSC5;PSMB3;PABPC1;PSMD14;UBA52;SAMD4B;TENT5B;PSMB5;PSMD2;PSMA1;PSMD10;GDNF;SLC11A1;PSMC4;FUS;PSMC3;FMR1;EIF4ENIF1;PSMC5;HNRNPU;PSMB6;HSPA8;PSMD8;EXOSC2;PSME2;XPO1;METTL16;PSMD13;PSMB7;PSMA7;VIM;FASTKD3;TBRG4;EXOSC1;EXOSC7;PSME3;CARHSP1;EXOSC9;FXR2;NUP214
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.4221906875937153,-1.1249531508749462,0.3055555555555556,0.5294224383750711,1.0,7/15,23.90%,OASL;IL27;EBI3;OAS2;JAK2;STAT1;OAS1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.4389202120489567,-1.1247028900833267,0.28205128205128205,0.5296243976623961,1.0,8/16,27.28%,PCK1;SSTR2;ZFP36L1;BCL2L11;PCK2;KLF9;NR3C1;ZFP36
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.35835613051225307,-1.1246387772780664,0.2714285714285714,0.5293357422185209,1.0,8/30,8.31%,KCNJ13;CLTRN;KCNJ3;ACE2;KCNJ16;KCNJ10;PRKCB;KCNJ15
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.3726485293556514,-1.1244889764899852,0.3068181818181818,0.5292367326698646,1.0,9/19,24.54%,PNP;IL12B;CCR2;SYK;EBI3;CD55;HLA-DRA;GLI3;HLA-DRB1
prerank,MSigDB_Oncogenic_Signatures__IL2 UP.V1 DN,0.3281512367624628,1.1244684683706663,0.2557077625570776,0.8916311418385833,1.0,25/156,10.36%,ODAM;CHGB;CACNA1E;HHIPL2;INHA;CEL;PAK3;ASPHD1;SNAI2;GDF5;TGM3;PLCH1;TRIB2;CD34;EFNA4;MEOX1;RHOBTB1;SSTR5;PDE1C;CHRNB4;RASL12;GALR3;KLHDC8A;TNNT3;SARNP
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.3966325128627044,1.1243929066061464,0.2717391304347826,0.891176474881644,1.0,9/30,26.59%,SLC6A4;AGO2;CAMK2A;AURKB;PRKCA;LBR;HDAC1;MECP2;NCOR2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.2979551181679495,-1.1243248885507884,0.23728813559322035,0.5290942828058242,1.0,26/77,21.48%,RET;NDNF;MIP;MEGF10;AGR2;TNF;P2RY12;CCL5;CCR7;SIRPG;CXCL12;FUT3;FUT7;IL12B;NCKAP1L;CITED2;SYK;DUSP26;STX3;SFRP2;LIF;ADAM8;PPP3CA;ADGRG1;SMAD7;JAK2
prerank,WikiPathway_2021_Human__PI3K-Akt signaling pathway WP4172,0.3154283036038347,1.1242935103644096,0.24050632911392406,0.8908872254534803,1.0,62/300,18.80%,COL2A1;GNG4;IGF2;PPP2R2C;THBS4;FGF20;VEGFD;LAMA3;SPP1;PIK3R2;PRKAA2;COL9A1;VWF;ITGA2;LPAR4;ITGA6;EFNA3;FGF13;FGF17;FGF2;EFNA4;FGF23;BDNF;COL4A1;EFNA1;COL4A5;CCNE1;PDGFRB;COL1A1;IL3RA;COMP;GNG3;CCNE2;FGF14;IKBKG;COL4A2;FLT3LG;LAMC1;IL6R;EPO;CREB3L1;PDGFB;FLT1;PDGFA;PGF;COL1A2;GNB5;PDPK1;GNG8;THBS2;PRKCA;HRAS;ANGPT2;CREB3L4;LAMB4;FGF12;EGF;THEM4;GNG10;LAMA4;ITGA7;ITGA11
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.29460420415125216,-1.1239103707390545,0.19607843137254902,0.5296541013525548,1.0,21/71,17.10%,CYP39A1;CETP;LCAT;APOA4;DGAT2;GRAMD1B;IL18;APOA1;LIPG;ACSM3;APOA5;HDAC9;TSKU;ABCG8;ABCG5;ABCG4;ANGPTL3;EPHX2;MTTP;LIPC;LIMA1
prerank,TRRUST_Transcription_Factors_2019__NR1H3 mouse,0.4611251418433683,1.1236727275537683,0.32450331125827814,0.8924977090369317,1.0,3/16,8.46%,CYP7A1;ARG2;MAP3K8
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,-0.39376448536625075,-1.1235799843716514,0.2727272727272727,0.5300049475394261,1.0,6/20,22.05%,GHR;SOCS2;CISH;IRS2;JAK2;STAT1
prerank,Elsevier_Pathway_Collection__Smooth Muscle Cell Dysfunction in Pulmonary Hypertension,0.34950295033112827,1.123343597175686,0.29441624365482233,0.8930570196302804,1.0,20/86,19.77%,SLC6A4;RASGRF1;NOX4;HES5;KCNB1;TRPC6;PDGFRB;NOTCH3;CACNA1C;JAG2;PDGFB;PDGFA;HTR1B;SHC1;PDPK1;HTR2B;EGF;LIMK2;DLL4;MMP9
prerank,TRRUST_Transcription_Factors_2019__RELA mouse,-0.29000831571679503,-1.1233382741768707,0.1702127659574468,0.5302005268604684,1.0,30/103,17.45%,IRF4;IL10;CXCL10;PTGS2;KLF5;CXCL11;IFNG;TNF;HGF;CCL5;FOS;CD80;ATP12A;CD38;PDK4;CCL2;IL6;IL12B;PGLYRP1;TLR2;AKT1;SOX9;VCAM1;CXCR4;CD86;TNFSF13B;BCL2;ITCH;EBI3;PTAFR
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,0.4648023977723819,1.1233294583248594,0.35443037974683544,0.8924168059325248,1.0,5/19,18.45%,GNG4;GNG3;GNB5;GNG8;GNG10
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.35561213515633155,1.1232473923747281,0.29901960784313725,0.8920305985152454,1.0,44/91,39.37%,PLK1;BUB1B;GTSE1;CDC20;UBE2C;ATP2B4;PSMD4;UBE2S;CDK1;CCNB1;PSMB4;TFAP4;ZNF16;DBF4B;ANAPC11;PSMD1;ANAPC7;PSMB3;PSMD14;MAD2L1;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;PSMB6;CDC23;PSMD8;PSME2;DBF4;DDB1;MN1;PSMD13;PSMB7;TAF1;PSMA7;ERCC2;ANAPC1;PSME3
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.40472205634459946,-1.1228059275074822,0.3,0.5310670034987414,1.0,9/21,16.47%,CCL3;LGALS3;PLPP4;CXCL12;FCRL3;CCL2;FYN;SPHK2;PRNP
prerank,Elsevier_Pathway_Collection__Bone Remodeling in Hyperthyroidism,0.3719477946564877,1.122651321047966,0.28217821782178215,0.8936539300260189,1.0,12/56,17.13%,DKK1;DLX5;WNT4;COL10A1;SRC;IHH;IGFBP2;PTHLH;BGLAP;PDPK1;PRKCA;THRA
prerank,MSigDB_Oncogenic_Signatures__PKCA DN.V1 UP,0.3276294454345259,1.1225756284443813,0.2676056338028169,0.8931679297999646,1.0,18/144,10.52%,REG1A;DKK4;LIX1;DLX1;SLCO1C1;RTBDN;SLC2A5;BSN;ICAM5;SP6;DBNDD1;SLC5A4;PTGDS;PSAPL1;TUB;SLC16A3;CXCL17;RNASE1
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.42850307018310946,1.1224786493607148,0.2976190476190476,0.8927847280942574,1.0,19/29,44.23%,COLEC12;CPSF1;SNRPE;CPSF4;ZNF473;LSM10;LSM11;SNRPB;CSTF2;SNRPD3;PABPN1;SYMPK;CPSF3;SNRPG;CPSF7;SLBP;CPSF6;FIP1L1;PCF11
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.4055803110235818,1.1219975015611057,0.30978260869565216,0.8938724064549942,1.0,28/38,45.22%,EME1;TONSL;RTEL1;ZGRF1;DNA2;TRAIP;DDX11;RAD51;BLM;OOEP;MMS22L;CENPS;PCNA;THOC1;RFWD3;SMARCAL1;BRCA2;CENPX;EME2;ATR;FANCM;ALYREF;CDK9;ATRX;SETMAR;CORT;WRN;PRIMPOL
prerank,TRRUST_Transcription_Factors_2019__PAX3 mouse,0.49884273049608663,1.1219969855636969,0.345679012345679,0.8931702286023194,1.0,3/15,8.31%,POU3F2;LEF1;LBX2
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.4086334618532411,1.1219234656395864,0.3107344632768362,0.892769176016822,1.0,3/37,2.85%,MT3;MAPT;NRCAM
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.3985793130656957,1.121871129535954,0.3021978021978022,0.8922777455727816,1.0,5/39,10.38%,UBE2T;PRKN;DTL;UHRF1;RAG1
prerank,WikiPathway_2021_Human__Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.3634102395085827,1.1214252956736082,0.2648648648648649,0.8932233335697527,1.0,8/71,10.13%,PAX2;NPHS1;DKK1;KIRREL2;TRPC6;MKI67;COL4A5;FAT1
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.45581115487585266,1.1213011431758588,0.3522012578616352,0.8930316352619799,1.0,7/16,24.95%,GAD1;SLC6A11;SNAP25;CPLX1;STXBP1;STX1A;DNAJC5
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,0.3881520261488812,1.1208468660589537,0.2891566265060241,0.8941433882658554,1.0,28/46,45.65%,EXTL1;EXTL3;LMNA;SHC1;PREB;TSPYL2;ATP6V0D1;DDX11;KDELR3;CUL7;ARFGAP1;MYDGF;ZBTB17;DNAJB11;TATDN2;ACADVL;CTDSP2;CXXC1;SRPRB;WFS1;ACD;HYOU1;PLA2G4B;TLN1;FKBP14;PPP2R5B;EXTL2;GSK3A
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,0.4452906128475942,1.120819810402015,0.32954545454545453,0.8935270100043038,1.0,2/20,2.76%,TP53AIP1;TP73
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.3388035949714453,-1.1206438111925259,0.2191780821917808,0.5359028547105165,1.0,15/39,23.74%,PCK1;ENO3;ALDOB;FBP1;PPARGC1A;SLC39A14;ALDOC;PCK2;PGM1;ENO2;SLC25A10;PGAM1;CRY1;AKR1B1;SORD
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,0.4033126394248024,1.120636460067594,0.29651162790697677,0.8935328239889204,1.0,7/32,15.74%,MAPK12;SHC3;MAPK11;SRC;MAPKAPK2;SHC1;HRAS
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.3429241337930484,1.1205462395903445,0.2871287128712871,0.8931363440292901,1.0,50/81,50.08%,SARNP;DDX39A;CPSF1;CASC3;NUP37;THOC5;RBM8A;CHTOP;NUP62;NXF1;TPR;NUP133;CPSF4;UPF3B;NUP155;NUP160;THOC1;POLDIP3;THOC6;NUP188;NXT1;THOC2;DDX39B;MAGOHB;SLU7;ZC3H11A;NUP205;NUP210;SYMPK;CPSF3;NUP214;GLE1;ALYREF;NUP107;SLBP;U2AF1;U2AF2;FIP1L1;RNPS1;AAAS;EIF4A3;MAGOH;NUP93;NCBP2;NUP88;SEC13;THOC3;SEH1L;POM121C;NUP42
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.4677224024055285,1.1203901823171738,0.3167701863354037,0.8929507853495416,1.0,7/17,36.48%,SPTSSB;PPP1R3F;EMP2;LDB1;NABP2;PINX1;FEM1A
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.34993832485838433,-1.1201207612612483,0.2676056338028169,0.5366665237811894,1.0,11/30,17.38%,CYP2C8;UGT2B7;CYP3A7;CYP1A2;HSD3B1;CYP2C9;HSD17B14;HSD17B2;CYP3A4;UGT2B15;UGT1A7
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.43245426172624285,1.120098132844042,0.3107344632768362,0.8932389932945917,1.0,2/26,1.57%,MT3;CEL
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.30026019661793923,-1.1200922345854554,0.2037037037037037,0.5362921684583474,1.0,19/71,17.81%,PLPP4;FCGR3A;CD3G;FYN;FCGR2B;CD247;NCKAP1L;HCK;PIK3R1;MYO10;SYK;FGR;PLCG2;WIPF1;FCER1G;VAV1;PRKCE;VAV3;MYO1G
prerank,Elsevier_Pathway_Collection__Sertoli Cells Dysfunction Causes Male Infertility,-0.34355617402914973,-1.1199958613679992,0.3013698630136986,0.5360483917643769,1.0,8/27,15.90%,SRD5A2;PTGS2;CAMK4;MAP2K1;SHBG;RASGRP1;CREM;CFTR
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.37790854077432423,1.1198865184983515,0.3027027027027027,0.8934151199476678,1.0,30/45,47.10%,DTL;RFC4;POLN;POLD1;MSH2;PCLAF;ISG15;UBE2A;FAAP20;PARP10;TRIM25;RAD18;UBA52;SPRTN;NSMCE1;PCNA;UBE2V1;POLH;VCP;RPA2;POLK;RFC3;POLD3;UBE2V2;UBC;POLD4;PRIMPOL;RPS27A;RPA1;RFC1
prerank,Elsevier_Pathway_Collection__MEN1 Mutation in Hyperparathyroidism,0.4259546249907945,1.1196726769997467,0.2839506172839506,0.8935166088093232,1.0,13/21,40.24%,CDKN2C;CDC7;NFKB2;CDK6;KMT2B;FANCD2;WDR5;CDKN1A;CDK4;DBF4;RBBP5;CDK2;RPA2
prerank,Elsevier_Pathway_Collection__Polycystic Ovary Syndrome,0.37538239731974027,1.119667737145907,0.2774869109947644,0.8928377285273122,1.0,8/49,15.42%,IGF2;CYP17A1;NR5A1;AMH;MAPKAPK2;SHC1;PDPK1;HSD17B1
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.4257567841972057,1.1192752015435512,0.3132530120481928,0.8935414482872782,1.0,22/30,51.92%,DTL;RFC4;POLD1;POLR1A;RAD18;CUL4B;UBA52;PCNA;DDB1;SLC19A1;USP1;RFC3;POLD3;RBX1;UBC;POLD4;RPS27A;POLE2;POLE4;RFC5;RFC2;POLE
prerank,Elsevier_Pathway_Collection__Proteins Involved in Chronic Myeloid Leukemia,0.4344228613872727,1.1192477769917983,0.32727272727272727,0.8930305314102307,1.0,3/23,6.66%,LCN2;BIRC5;SRC
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.37043120287513287,-1.1192040318454923,0.2716049382716049,0.537511985253299,1.0,9/25,22.05%,IFNG;GHR;SOCS2;CCL2;CCR2;SOCS6;NMI;JAK2;STAT1
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.4519843613278802,1.1191601295329614,0.27564102564102566,0.8926316066175576,1.0,15/22,43.67%,POLR2L;POLR2K;NELFE;POLR2G;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;SUPT5H;NELFB;POLR2A;POLR2B;GTF2F1;POLR2F
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.4684456802592902,1.119097899931078,0.32934131736526945,0.8921565793286766,1.0,13/17,44.92%,EXOSC4;RRP15;PRKDC;LAS1L;PES1;URB1;NOL9;WDR12;FTSJ3;EXOSC10;EIF6;NSA2;MTREX
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.4095955275513833,1.1188479095929202,0.29411764705882354,0.8923563809442698,1.0,7/30,8.27%,CACNA1I;SYT5;SYT3;KCNB1;SYT15;CACNA1G;SYT2
prerank,TRRUST_Transcription_Factors_2019__E2F1 human,0.3329989194174283,1.1184690524729928,0.25339366515837103,0.8930286938756911,1.0,37/131,19.13%,E2F1;TP73;TERT;CDCA7;NOX4;CDKN2A;FOXM1;KIF2C;PLK1;TOP2A;BIRC5;ISYNA1;CCNE1;AURKB;UHRF1;CDC6;CDK1;CCNB1;MUC4;TYMS;AURKA;DAPK2;RACGAP1;MYBL2;FLT1;CDKN1C;ERICD;PPARG;CHEK1;MCM5;ECT2;HMGA1;RRM2;ASF1B;ATAD2;BBC3;IRF3
prerank,Elsevier_Pathway_Collection__WNT Canonical Signaling Activation in Cancer,0.4279458251129242,1.118378231505228,0.2710843373493976,0.8926521199143378,1.0,9/26,26.12%,LEF1;AXIN2;FOXM1;DVL2;SMARCA4;BCL9;DVL1;MYC;CTNNB1
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.40274764405054636,1.118359589113662,0.3081081081081081,0.8920414017619446,1.0,10/40,20.14%,FGF20;PIK3R2;FGF13;FGF17;FGF23;FLT3LG;PDPK1;HRAS;THEM4;FGF18
prerank,Elsevier_Pathway_Collection__SCF/FBXW7 Complex,0.44923551644926163,1.1182237991400683,0.32679738562091504,0.8918480100018937,1.0,6/20,12.73%,TRIM17;CCNE1;CDC6;CCNE2;AURKA;NFKB2
prerank,MSigDB_Oncogenic_Signatures__BRCA1 DN.V1 UP,0.34849136953929427,1.1178353526511404,0.25757575757575757,0.8925871060396717,1.0,19/93,12.82%,PAEP;HMGA2;CDH22;SIX1;OSR2;TLX3;EXTL1;CDH13;CD34;ISYNA1;CDX1;TP53TG5;CLDN6;MYBPC1;LHX6;DNAAF1;MTMR8;GJA5;TIMP4
prerank,"Elsevier_Pathway_Collection__Myocarditis, Acute Viral Overiew",-0.3938775884713927,-1.1176829323708828,0.36585365853658536,0.5406401262356997,1.0,7/20,23.82%,FYN;AKT1;SGCA;SGCD;DMD;CD55;SGCB
prerank,Elsevier_Pathway_Collection__NTRK -> FOXO/MYCN Signaling,-0.42491856998429256,-1.1176762024317763,0.33766233766233766,0.5401820494974838,1.0,7/16,13.06%,NTRK3;NTF3;NTRK2;FOXO1;NGF;NTRK1;AKT1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.4362907904138675,1.1173473663178615,0.3235294117647059,0.893796060235665,1.0,8/17,20.62%,CACNA1I;KCNB1;CACNA1G;RAB3D;CACNA1H;DOC2B;RAB15;STX1A
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,0.3725383128129911,1.1173028326725327,0.32653061224489793,0.8932809956496425,1.0,17/48,26.78%,H1-5;MAPT;H1-2;STK26;H1-4;PKP1;BCAP31;LMNA;PLEC;CLSPN;FNTA;H1-0;GSN;HMGB2;PTK2;CTNNB1;LMNB1
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,0.4123484661727776,1.1172579774838551,0.2972972972972973,0.8927562151937789,1.0,5/32,10.88%,MAPK12;MAPK11;IRAK1;IKBKG;IRAK2
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.4596019970129486,1.1168992971570062,0.3248407643312102,0.8934949636713115,1.0,12/18,46.01%,CEP131;STIL;SPAG5;BBS4;CSNK1D;DCTN2;NUDCD3;C2CD3;CEP83;CEP192;KIAA0753;CCDC14
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.37404821658172516,-1.1168907495395741,0.27710843373493976,0.5418301899511491,1.0,8/24,22.89%,SLC44A4;SCP2;PRELID2;MTTP;PLTP;PCTP;LDLR;PITPNA
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.44026729015362237,1.116815052662751,0.3,0.8930967382669759,1.0,12/22,38.10%,GPC3;KIF7;HHIP;TULP3;GLIS2;MEGF8;GPR161;RACK1;ULK3;KCTD21;VCP;SUFU
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,0.3892953943484633,1.1165164793617786,0.3149171270718232,0.8936139122851865,1.0,32/49,47.30%,PSMD4;PSMB4;CHEK1;CDC25A;PSMB3;PSMD14;CHEK2;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.45001776275176153,1.116486438627021,0.3058823529411765,0.893025008406138,1.0,14/21,37.08%,BLOC1S1;UQCRB;ATP5F1D;MDH2;NDUFS7;SLC25A14;ME3;UQCRHL;NDUFS8;MTFR2;UQCRH;UQCRC1;OXA1L;UQCR10
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.3513685971174397,-1.1161123430228304,0.3048780487804878,0.5434515536860917,1.0,8/28,28.90%,SEC14L3;SEC24B;PIK3R4;SEC24D;SEC24A;SEC23A;SAR1B;SEC14L2
prerank,Elsevier_Pathway_Collection__Familial Partial Lipodystrophy Type 2 Progression (Hypothesis),0.46718009229618535,1.1160366620586817,0.3333333333333333,0.8939575707561177,1.0,6/15,15.45%,SLC2A4;LPL;LEP;LMNA;ACACA;PPARG
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.4136640819394686,-1.1160176249588967,0.27586206896551724,0.5431981243695222,1.0,6/18,17.26%,MFSD2A;SLC15A2;CLN3;SLC28A1;PLTP;SLC15A4
prerank,WikiPathway_2021_Human__ErbB signaling pathway WP673,-0.27121890103333196,-1.1159895410043383,0.15217391304347827,0.5428398861337048,1.0,18/89,15.02%,PAK5;SHC4;EREG;ERBB4;PAK6;NRG4;MAP2K1;PIK3CD;PRKCB;TGFA;CAMK2B;FOXO1;BTC;PIK3R1;AKT1;PLCG2;HBEGF;BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.44018668096306945,1.1159081071690824,0.2640449438202247,0.8937981894496432,1.0,4/20,14.64%,CDKN2A;PLK1;TFAP4;CDKN1C
prerank,Elsevier_Pathway_Collection__Airway Epithelial Cell Dysfunction,-0.30702530846208786,-1.1157040384232424,0.19298245614035087,0.5431322872264636,1.0,16/49,21.43%,MUC5AC;TNF;IL1B;DEFB1;IL6;CXCL8;TICAM2;TLR4;TLR2;MYD88;CFTR;EZR;AQP3;MAP2K3;MAP2K6;ADRB2
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.40976402127432027,1.1156022013331846,0.327683615819209,0.8943550526172621,1.0,17/32,39.34%,ATP6V0D2;TMEM9;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V0D1;GPR89B;ATP6V0E1;ATP6V1C1;ATP6V1H;ATP6V1F;SLC11A1;ATP6V1E1;ATP6V1E2;DMXL2;GPR89A;ATP6V1C2
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.4093392795749865,1.1150614317903909,0.3181818181818182,0.8957988515322384,1.0,8/27,16.99%,SLC4A3;SLC4A1;SLC26A6;ATP1A4;SLC9C2;SLC9A3;ATP6AP1;SLC9B1
prerank,TRRUST_Transcription_Factors_2019__JUN human,-0.26894083830709536,-1.1150491029763634,0.17777777777777778,0.5443984024433592,1.0,41/136,17.07%,TFF1;CCK;ITGB8;PTGS2;SPRR3;IL5RA;IFNG;TNF;IL1B;MMP1;CCL5;FASLG;CYP1A2;LGALS3;DCN;KRT16;CCL2;IL6;NGF;ABCB1;IL12B;CA2;MMP7;CXCL8;SYK;CD82;PGR;RARB;VCAM1;PTN;MSR1;CREM;RUNX2;CSF2;SPI1;TNFRSF1B;UGT2B15;CYP2J2;F3;PLAUR;EZR
prerank,KEGG_2021_Human__Selenocompound metabolism,0.45523375205147654,1.1148959537906495,0.34,0.8957036566850461,1.0,6/17,24.27%,MTR;TXNRD2;SCLY;TXNRD1;KYAT1;PAPSS1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4368633563766714,1.1145858794931647,0.30409356725146197,0.8961769662632993,1.0,5/21,19.49%,TP73;PHLDA3;MSH2;AEN;BCL3
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.33118066630626086,1.1144994567210502,0.26842105263157895,0.8958289274891176,1.0,13/89,11.38%,MT3;SIX1;FGF20;SIX4;POU4F1;MDK;CD34;KIF14;BDNF;PRKN;CD200;IKBKG;NENF
prerank,Elsevier_Pathway_Collection__EphrinB -> Cytoskeleton Signaling,0.45428494099994754,1.1142212174953499,0.3105590062111801,0.8961738639322581,1.0,3/20,6.66%,EPHB2;EFNA3;SRC
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.4264327987221377,1.114078767917617,0.3202247191011236,0.8960526615825886,1.0,6/29,18.26%,MAPT;SPHK1;NAA10;DSCC1;BLOC1S1;ING5
prerank,Elsevier_Pathway_Collection__Metastatic Colorectal Cancer,0.3435577752162643,1.1138041606400941,0.2916666666666667,0.8964332911311026,1.0,19/109,17.74%,IGF2;CTNNA2;VEGFD;LEF1;AXIN2;CDKN2A;BIRC5;SRC;PTGER1;CDX2;IL6R;PGF;SHC1;PDPK1;DVL2;PPARG;SMAD3;EGF;MSH2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Diabetic Neuropathy,-0.3069870690333031,-1.1135274749901156,0.2653061224489796,0.5478477031388859,1.0,15/61,10.28%,PTGS2;TNF;IL1B;NTF3;HGF;SCN9A;NR3C2;NTRK2;XDH;PPARGC1A;SCN11A;CAT;PRKCB;IL6;NGF
prerank,MSigDB_Oncogenic_Signatures__ESC J1 UP LATE.V1 DN,0.3263500992907443,1.1133380708457465,0.2488479262672811,0.8974107043755095,1.0,51/167,28.20%,NPHS1;SFN;SULT4A1;NOTUM;FOXN4;TCF15;MMP11;TDGF1;TGM3;FGF17;FAM169A;SLC4A3;AMH;TRH;E2F8;NAA10;GNG3;PHLDA2;GPATCH4;RASIP1;TBCE;ERCC6L;RRP12;ZNF423;MRAS;TUBB2B;PASK;GPX2;GAP43;CLTB;BCL3;TRAIP;ETV4;FGF18;NNAT;NAPSA;HARS2;POLA1;CRMP1;GLI1;UXT;NXF1;RRP9;SMARCD3;TSPAN17;MYC;ICAM1;LMNB2;PDSS1;POLR3K;ZFP62
prerank,MSigDB_Oncogenic_Signatures__MEL18 DN.V1 UP,0.3297630025525699,1.1132995666593455,0.2535211267605634,0.8968735970849876,1.0,23/134,11.97%,SLC7A11;COL7A1;CACNG4;SLCO4A1;SPP1;SLC22A4;P2RX5;CDH13;GAL;GDF5;SLCO2A1;FAP;SLC6A9;NTM;MEOX1;KCNN3;PTHLH;SLC1A4;KIF21B;LPL;GPR3;BDKRB2;STC2
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.38236683582806597,1.1129570204709447,0.32653061224489793,0.897405738849507,1.0,19/44,37.37%,RTN2;TOMM40L;TOMM20L;DNLZ;TIMM17B;ROMO1;TIMM17A;TOMM20;AIFM1;SEC61G;ZFAND2B;TOMM40;HSPA5;PEX6;PAM16;HSPD1;GRPEL2;CHCHD4;SEC61B
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.3458827467416646,-1.1127486139824834,0.24719101123595505,0.5494127708197519,1.0,16/36,18.85%,XKR4;MARCO;MEGF10;IGLL5;IGLL1;RHOH;RAC2;BIN2;FCGR2B;MSR1;ITGB2;THBS1;XKR9;SH3BP1;AIF1;ARHGAP25
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,0.40294521664884597,1.112539891952902,0.35638297872340424,0.8982972651992922,1.0,9/32,19.71%,NOX4;AQP8;NOX5;ATOX1;TXNRD2;GPX3;GPX2;TXNRD1;NUDT2
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.3391295547879823,1.1117836698476993,0.2857142857142857,0.9004329152211593,1.0,23/103,13.37%,SLC2A5;GFI1;TNNI3;GAD1;DMC1;CLVS1;NEK2;KIF2C;CHRM4;CCNB2;BUB1;NCAPH;CDKN3;TTK;OAZ3;EZH2;ARL4A;CDK1;AURKA;ELOVL3;ACE;HSPA2;RFC4
prerank,MSigDB_Oncogenic_Signatures__CORDENONSI YAP CONSERVED SIGNATURE,0.3884047686468049,1.111726296869976,0.2896174863387978,0.8999908787238151,1.0,21/52,25.16%,CENPF;HMMR;TOP2A;CDC20;BIRC5;FGF2;CDKN2C;SHCBP1;NDRG1;ANKRD1;STMN1;ECT2;CRIM1;GGH;AGFG2;TGM2;TGFB2;DUT;EMP2;MDFIC;TK1
prerank,WikiPathway_2021_Human__Neural Crest Cell Migration during Development WP4564,-0.34079863123307763,-1.1115501618360863,0.27692307692307694,0.5521803137364224,1.0,12/39,14.92%,PAK5;EPHB1;PAK6;FOS;NGFR;PIK3CD;EPHB3;F2RL2;PIK3R5;AKT1;EPHB6;TIAM1
prerank,KEGG_2021_Human__TGF-beta signaling pathway,-0.29609780737899766,-1.1113622633750635,0.2608695652173913,0.5521684659454436,1.0,24/92,17.80%,AMHR2;BMP5;IFNG;TNF;INHBE;INHBA;ID4;NOG;ID2;INHBC;GDF6;DCN;GREM2;ACVR1C;THSD4;BMP7;GREM1;LEFTY2;SMAD9;BMPR2;ACVR2A;THBS1;BMPR1B;PPP2CB
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,0.43511018889953346,1.1113559198614225,0.3076923076923077,0.9007310512120195,1.0,17/21,52.33%,RFC4;POLD1;FEN1;POLR1A;PCNA;SLC19A1;RFC3;POLD3;APEX1;POLG2;POLD4;POLE2;POLE4;RFC5;RFC2;POLE;LRIG1
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.3758878016486843,-1.1111735494440647,0.35294117647058826,0.5522184571227234,1.0,10/22,18.49%,IL1B;NLRP12;IGFBP3;OSM;TRAT1;MPIG6B;KIF26A;UBASH3B;PTK6;LIF
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.44277074576149994,1.1108347553163485,0.327683615819209,0.9019351272879061,1.0,3/20,9.66%,CDC20;UBE2C;UBE2S
prerank,KEGG_2021_Human__Mismatch repair,0.4292513417136786,1.1107994614496262,0.29411764705882354,0.9013922785496334,1.0,15/23,47.10%,EXO1;RFC4;POLD1;MSH2;MSH6;PCNA;MLH3;LIG1;RPA2;RFC3;POLD3;POLD4;SSBP1;RPA1;RFC1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hutchinson-Gilford Progeria Sindrome,0.46462892691362623,1.1107910846864941,0.3090909090909091,0.9007341701374382,1.0,6/16,27.10%,CDKN2A;LMNA;DOT1L;SUV39H1;MMP3;SYNE2
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.3808671996525051,1.1105316622043657,0.3068181818181818,0.9011287223858032,1.0,9/37,19.02%,PLPPR1;PLPP2;INPP5J;MTMR11;MTMR8;PLPP1;PLPPR2;MTMR3;PLPPR3
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.4654114848448434,1.1102934231872172,0.3076923076923077,0.9013398066060967,1.0,2/17,6.10%,INHA;NR5A1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.31926722737660895,1.1101549996831985,0.2610619469026549,0.9011670872358897,1.0,117/162,47.36%,MAPT;BOP1;EXOSC4;UTP14A;NVL;RPL8;RRP12;DCAF13;HEATR1;RPL30;SLFN14;RPLP1;BYSL;RPS27;LAS1L;RRP1;RPLP2;WDR46;NOP58;PDCD11;RRP9;EXOSC5;RPL28;RPS14;RPL10;RPL39;UBA52;NOC4L;NOP56;RPLP0;PELP1;FBL;RPS15;DKC1;RPS2;RPL31;RPS19;RPL36;RPL37A;PES1;RPL37;RPL7;RPL13;RPL27;RRP7A;RPL38;WDR55;RPL35;SNU13;UTP15;RPL10A;POP5;DDX49;RPL35A;NOL9;NIFK;RPS7;EXOSC2;RPL36A;WDR12;TBL3;DHX37;POP4;WDR75;RPL7A;RPL18A;RPL32;UTP4;RPS24;PIH1D1;RRP36;IMP4;UTP18;PWP2;RPL29;RPL23;RPL5;EXOSC1;RPL14;NOL8;EXOSC7;EXOSC10;RPS16;MRTO4;EXOSC9;RPL13A;RPL41;RPL9;NOL6;RPS28;EBNA1BP2;RPL27A;RPL23A;RPL18;DDX54;RPL12;TRIR;SLFN13;RPS9;RPL6;DDX10;EMG1;RPL4;DDX27;MTREX;RPL19;UTP20;RPS6;RPL26;NOB1;WDR74;NOP53;RPL34;TEX10;MPHOSPH10;UTP6;BMS1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.36451789216646463,-1.1099195991355952,0.3111111111111111,0.5549100684639299,1.0,8/25,11.05%,IL10;TNF;SSTR2;ZFP36L1;CALCR;HSD3B1;IL6;IL1RN
prerank,MSigDB_Oncogenic_Signatures__IL15 UP.V1 DN,0.32676857720166397,1.1097613784376725,0.29545454545454547,0.9019847660819204,1.0,23/141,9.13%,CACNA1E;DOCK3;GUCY1B2;OSR2;EBF2;ACTN2;ASPHD1;GPR35;WNT4;VWF;SNAI2;FLG;TGM3;S100A3;PTGDS;MEOX1;ARHGEF10;RHOBTB1;EFNA1;RASL12;CNTN1;FRMD1;GALR3
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.3791186165696647,1.1097060662872476,0.2814070351758794,0.9015291376504436,1.0,21/52,32.24%,E2F1;E2F7;NDRG1;CHEK1;H2AX;DOT1L;BCL3;CLSPN;ATRIP;DONSON;RHNO1;CHEK2;TIPRL;STK33;MAD2L2;INTS7;ACER2;TP53BP1;RAD1;CASP9;BRIP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.3103844947263711,-1.1095514275523577,0.29508196721311475,0.5554418725176603,1.0,15/49,13.84%,EREG;IFNG;TNF;NR4A3;CCL5;ID2;IGFBP3;IL18;NDRG4;IL6;IL12B;IGFBP5;TRIB1;AKT1;IGF1
prerank,KEGG_2021_Human__Tuberculosis,-0.256324531058843,-1.1093685887159708,0.2,0.5554178190078858,1.0,60/156,26.78%,CLEC4M;IL10;IFNG;TNF;IL1B;FCGR3B;IL18;CAMK2B;FCGR3A;IL6;CLEC4E;CR1;IL12B;FCGR2B;HLA-DQA2;TLR4;CLEC7A;TLR2;SPHK2;HLA-DOB;AKT1;CR1L;CAMP;SYK;MYD88;FCER1G;PLA2R1;IL10RA;ITGB2;CORO1A;BCL2;HLA-DQA1;MAPK10;PPP3CA;MAPK13;NOD2;HLA-DOA;HLA-DRB5;HLA-DRA;JAK2;ITGAM;STAT1;CD209;AKT3;HLA-DPA1;MRC2;C3;LAMP1;TLR1;HLA-DPB1;HLA-DRB1;CTSS;CD14;CARD9;VDR;CALM1;LSP1;HLA-DMB;IFNGR1;ARHGEF12
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,-0.4279771071978252,-1.109353492965198,0.3655913978494624,0.5549720156782071,1.0,8/15,33.31%,MCUB;MICU1;PHB2;MAIP1;AFG3L2;SPG7;YME1L1;MICU2
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.39407143028945313,1.1092036341149258,0.2914285714285714,0.9027150935313406,1.0,30/39,50.98%,RPS27;NPM1;RPS5;RPS14;RPSA;RPS15;RPS19;RRP7A;SNU13;RPS7;TSR3;UTP4;RPS24;RRP36;PWP2;RIOK2;RPS16;RPS28;SURF6;MRPS11;EMG1;RIOK1;NOM1;RPS6;NOB1;SRFBP1;MRPS7;DDX52;RPS25;NOL11
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3085520599789995,-1.1090918040823314,0.30303030303030304,0.5552419830432935,1.0,20/59,20.14%,GRIN2B;NLRP2;TNF;AIM2;TNFSF10;CASP1;NLRP3;ACVR1C;FYN;NKX3-1;MEFV;CLEC7A;TTBK1;SYK;NLRC4;PERP;PMAIP1;LGMN;IFI16;ARL6IP5
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.36130244903721087,1.108915772002727,0.3112244897959184,0.9031243383287908,1.0,17/65,20.14%,DKK1;DIRAS1;ROBO1;FGF2;IRAK1;PDGFRB;EZH2;PDGFB;FLT1;PDGFA;DVL2;HRAS;HTR2B;DIRAS2;EGF;TRAF2;FGF18
prerank,WikiPathway_2021_Human__Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,-0.28123144599249594,-1.1088936712559165,0.26666666666666666,0.5552465464330982,1.0,33/142,12.18%,ASCL1;TAC1;GCK;PLP1;RET;HTR2A;IL10;ADCYAP1R1;TNF;PRKAR2B;TH;IL1B;ATP1A3;NTRK2;SSTR2;PBX1;TF;VIPR1;PPARGC1A;VIPR2;EGR1;IL6;SCN3B;RUNX3;G6PC;NKX3-1;NGF;C4A;IL1RN;HDAC9;CXCL8;GATA3;CHRNA7
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.30769334506952,1.1087713613477301,0.21008403361344538,0.9029381067572378,1.0,150/343,40.65%,SFN;E2F1;RBM24;TP73;MAPK12;TOP2A;PLK5;TICRR;UBE2T;DTL;PRAP1;EXO1;RECQL4;WDR76;ZNF385A;IKBKG;CDK1;FBXO31;CHRNA4;POLQ;XRCC2;RFC4;MAPKAPK2;RTEL1;ZBTB40;MCM10;POLD1;CHEK1;H2AX;MSH2;BCL6;BARD1;SLF2;PCLAF;UBQLN4;IRF3;DOT1L;BCL3;TRAIP;SUV39H1;RAD54L;MUTYH;FEN1;ATRIP;PARP1;PAXX;RAD9B;UBE2A;NUDT1;APBB1;FAAP20;RAD51AP1;TAOK2;DDX11;RAD51;TRIM28;MCM7;UBR5;WDHD1;PRKDC;POLA1;UBA1;BLM;KMT5C;NPM1;MICA;CBX5;METTL3;INTS3;MYC;RAD18;FANCG;CHD1L;BRSK1;AATF;CHEK2;DDIT3;CUL4B;NABP2;CDKN1A;STK33;MSH6;SPRTN;CENPS;TIMELESS;BRAT1;MRNIP;RECQL5;POLB;YAP1;PARK7;CCDC13;STXBP4;BABAM2;OGG1;PIDD1;HROB;CBX3;ACER2;IKBKE;FMR1;TP53BP1;BCL2L2;RAD1;MORC2;CASP9;RMI2;RFWD3;MCM8;SMARCAL1;DDB2;TOPBP1;LIG1;MUS81;MMS19;PNKP;NEK4;CASP2;ALKBH7;BAX;SMC1A;FAN1;SIRT7;CIB1;CDK3;IGHMBP2;GNL1;ABL1;NCOA6;TAF9;POLH;MAPK3;VCP;RPS3;DDB1;BID;BAZ1B;XRCC3;TAF1;CSNK1E;SPIDR;RBBP5;ATR;HPF1;HERC2;FOXP1;RAD52;RECQL;POLK;CHCHD6
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.35294709612791714,1.108748681798525,0.28426395939086296,0.9023294028840311,1.0,19/78,13.18%,SLC22A12;SLC6A7;SLC22A11;SLC22A4;RHBG;SLC22A15;SLC6A11;SLC39A4;SLC30A3;SLC13A3;SLC6A9;SLC30A2;SLC6A3;SLC16A3;SLC22A16;SLC10A6;SLC14A2;SLC39A3;SLC47A2
prerank,MSigDB_Oncogenic_Signatures__EIF4E DN,-0.2908613439505523,-1.1086207739672365,0.24489795918367346,0.555548917682259,1.0,22/92,21.29%,ESRP1;SH3YL1;PTGS2;FZD3;DENND2D;PDK4;SGPP2;GALNT5;SLC46A3;SEMA4D;PARP8;SAA4;MYO10;NKAPL;FRMD4B;PTER;SNAPC1;CTSC;IQGAP1;RCBTB2;CLINT1;CD55
prerank,Elsevier_Pathway_Collection__NOTCH Signaling in Hepatocellular Carcinoma,0.41880190523443983,1.108234569284585,0.3352941176470588,0.9035368017667901,1.0,7/24,26.12%,LEF1;JAG2;KAT2A;SMAD3;DLL4;MYC;CTNNB1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.3986273255380761,1.1082120628236007,0.3155080213903743,0.9029285616962345,1.0,4/40,5.57%,MUC13;PIK3R2;CKB;DLG5
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,0.33681941605565974,1.1081824832749025,0.25120772946859904,0.9023621348515395,1.0,28/131,16.14%,GNG4;GLP1R;GHRHR;PTH2R;GCG;CALCA;GNAZ;DPEP1;RAMP1;GPHA2;HTR4;AVPR2;SRC;CRHR2;PTHLH;GNG3;ADM2;GPR150;RAMP2;LHB;MC1R;GNB5;ADCY6;IAPP;GNG8;RHBDF2;PRKCA;ADORA2A
prerank,Elsevier_Pathway_Collection__Double Strand DNA Homologous Repair,0.4455934241982541,1.108168420292475,0.3333333333333333,0.9017556845617148,1.0,15/19,48.29%,XRCC2;BARD1;RAD51;MDC1;ABRAXAS1;UIMC1;BRCA2;SMC1A;XRCC3;RAD52;ATRX;BRCC3;NBN;MRE11;RAD50
prerank,TRRUST_Transcription_Factors_2019__SMAD1 mouse,0.4653834539658829,1.1080115152994614,0.3184713375796178,0.9016861772154967,1.0,7/21,12.12%,COL2A1;SPP1;DSG4;COL4A1;COL1A1;COL4A2;CRELD2
prerank,MSigDB_Oncogenic_Signatures__IL21 UP.V1 UP,0.32067612892346803,1.1078610533523316,0.2688679245283019,0.9014943428779065,1.0,31/153,13.87%,ST8SIA3;DLX6;SPARCL1;COL15A1;SMPX;ZIC4;MPZ;SPP1;S100A1;TP53AIP1;PTPRN;MYH4;CHI3L1;EVX1;OPRL1;DNASE1L2;HTR4;DPYSL4;GNAL;GRIN2A;CLDN6;KIF21B;ABCC8;MVD;NUDT11;SEMA7A;SLCO5A1;ITIH4;CLDN7;HABP4;SLC29A2
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.28233980939750764,-1.1075417517911255,0.17073170731707318,0.5577495253672651,1.0,36/115,19.11%,CSF3;AMHR2;PTPN20;GHR;TNF;IL1B;CCL5;SOCS2;SFRP1;IL18R1;NLRP12;PTPN13;LRRK2;CCL3;IL18;CASP1;CCR7;ASAH2;ROBO2;IL1RL2;CCL2;ACVR1C;KLF4;IGFBP5;FLT3;HCLS1;CXCR4;BMPR2;PTPN7;CSF1R;ACVR2A;BMPR1B;AKAP6;SIGIRR;NR1H4;PID1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.465999372110976,1.107465806161256,0.3619631901840491,0.902271315752985,1.0,4/17,6.38%,WNT8B;GSC;MESP1;GPC3
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.3839844280100915,-1.1071813479558725,0.29545454545454547,0.5582191745074644,1.0,8/17,18.75%,NTRK2;CHRNA7;SORL1;RTN4;IGF1;CLU;PRNP;RTN1
prerank,MSigDB_Oncogenic_Signatures__ALK DN.V1 UP,0.33749428864726333,1.1069793844004179,0.33004926108374383,0.9034138734352974,1.0,39/122,21.33%,GRPR;SLC7A11;DLX6;SMPX;SPP1;SCN1A;SAA1;CHI3L1;GDF5;RIBC2;UNC13A;STMN2;FAP;SLC6A9;CCL20;ACTL6B;VNN2;VSTM4;PYY2;GDF15;BDKRB2;STC2;SPACA1;ETV1;GRM1;AQP9;TREM1;ANGPT2;MRAS;SLC1A3;PYGB;CH25H;FBXL8;NNAT;FBXW4P1;CLSPN;ARHGAP4;LTC4S;PDZD7
prerank,WikiPathway_2021_Human__Glucocorticoid Receptor Pathway WP2880,0.3618033563010501,1.1067532161893556,0.3238095238095238,0.9036385496232221,1.0,13/67,15.58%,ZIC2;S100P;DNER;SNAI2;CCL20;IL11;B3GNT5;MFGE8;NFKB2;POU5F1;CDKN1C;SLC26A2;ANKRD1
prerank,Elsevier_Pathway_Collection__Neuroblastoma,0.32924954521621724,1.1067247984793218,0.2780487804878049,0.903084720426874,1.0,15/123,7.78%,DLK1;IGF2;HOXD10;E2F1;TERT;NEUROD1;SHC3;MDK;CDKN2A;BMP4;BIRC5;SRC;E2F2;BDNF;MSX1
prerank,KEGG_2021_Human__Oocyte meiosis,0.3372542383944734,1.10670796686742,0.3118811881188119,0.9024707284560051,1.0,17/116,11.47%,SMC1B;CALML6;FBXO43;MAPK12;CDC25C;PLK1;MAPK11;CDC20;CCNB2;BUB1;CAMK2A;CCNE1;CCNE2;PTTG1;CDK1;CCNB1;AURKA
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.37064175291464746,1.1066514075243712,0.2893401015228426,0.9019846129993755,1.0,14/59,15.74%,RASGRF1;ACTN2;PRKAA2;MAPT;GPRIN1;SRC;CAMK2A;GRIN2A;RNASE1;MPP3;RASGRF2;PDPK1;PRKCA;HRAS
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.41135892275102565,1.1065491111932675,0.288135593220339,0.9016666867312156,1.0,21/39,38.37%,LAMTOR2;LEP;GPR137C;LAMTOR4;WDR24;GPR137B;SMCR8;LARS1;RHEB;CLEC16A;TELO2;GAS6;TREM2;MLST8;LAMTOR5;RRAGD;RPTOR;PIP4P1;RRAGA;PIH1D1;GPR137
prerank,WikiPathway_2021_Human__Intraflagellar transport proteins binding to dynein WP4532,0.4168067891119309,1.1065243609921296,0.35502958579881655,0.9011185038503959,1.0,7/25,26.75%,DYNC1I1;TCTEX1D2;IFT81;DYNLRB2;DYNLL1;IFT27;DYNLRB1
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.4230664948940501,1.1064730174940556,0.32558139534883723,0.9006192733268263,1.0,2/24,0.35%,MT3;PAX2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4391970283414042,1.1058237644600386,0.3419354838709677,0.9024043965900661,1.0,9/22,31.84%,GPR35;ATP1A2;GSTM2;GNB5;CBARP;CASQ2;THADA;DRD4;FMR1
prerank,KEGG_2021_Human__Toxoplasmosis,-0.27097573484291615,-1.1057591782340717,0.2857142857142857,0.5617011126682488,1.0,43/109,25.20%,IL10;GNAO1;IFNG;TNF;LAMA1;CCR5;PPIF;CD40LG;IL12B;ALOX5;HSPA1B;LAMC2;HLA-DQA2;TLR4;PIK3R5;TLR2;HLA-DOB;AKT1;BIRC7;MYD88;IL10RA;BCL2;HLA-DQA1;HSPA1A;MAPK10;MAPK13;HLA-DOA;TAB2;HLA-DRB5;MAP2K3;MAP2K6;HLA-DRA;JAK2;CD40;STAT1;LDLR;AKT3;HLA-DPA1;PIK3CG;HLA-DPB1;HLA-DRB1;LY96;GNAI2
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.2632178388334437,-1.1053832324191288,0.15625,0.5622891466911446,1.0,43/172,20.75%,CPNE6;PITPNM3;PCYT1B;MFSD2A;SLC44A4;GPD1;LCAT;PLD1;PTPN13;PEMT;LIPH;PIK3C2G;APOA1;SLC44A3;PHOSPHO1;PLA2G2D;PIK3CD;SLC44A5;AGPAT2;ETNK2;PLA2G4A;DGKE;ABHD5;PLEKHA2;PIK3R5;PIK3R1;TPTE2;CLN3;PLCG2;DGKB;PI4K2B;BMX;PIP4K2A;PIK3R4;INPP5D;PLA2G12A;MTMR9;DDHD1;MTMR2;RAB14;PCTP;GPD1L;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.41724666138952426,-1.105292664683835,0.32142857142857145,0.5621088894327778,1.0,7/16,27.27%,CD300A;FCGR2B;TLR2;SIRPA;PLSCR1;SNX3;HMGB1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.39247729550710364,1.1051449637222515,0.31843575418994413,0.9043462535063677,1.0,10/39,16.85%,GLUL;SLC22A4;TSPO2;ATP1A2;SLC5A6;SNAP25;SLC7A1;SLC29A2;SLC12A7;SLC1A3
prerank,KEGG_2021_Human__beta-Alanine metabolism,-0.34828898823326493,-1.1050832978365412,0.30120481927710846,0.5621452926865749,1.0,15/29,20.73%,CNDP1;ALDH1B1;ALDH6A1;DPYS;ACADS;EHHADH;DPYD;ACOX1;ABAT;ALDH2;ECHS1;MLYCD;ALDH3B2;ACOX3;AOC3
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.37668554865440385,-1.1050265472570393,0.30952380952380953,0.5618056754152444,1.0,10/25,22.94%,CETP;APOA4;APOA1;LIPG;APOA5;ABCA8;OSBPL6;TTC39B;NUS1;ABCA13
prerank,TRRUST_Transcription_Factors_2019__LEF1 mouse,0.4209375915734924,1.1048616809973806,0.3333333333333333,0.9047659229491833,1.0,7/23,14.81%,COL2A1;DKK1;MESP1;DSG4;COL11A1;POU5F1;FOXJ1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,0.37656216249500535,1.1047216864359033,0.33519553072625696,0.9046418596318012,1.0,39/63,47.30%,UBE2C;PSMD4;UBE2S;PSMB4;ANAPC11;ANAPC7;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;CDC23;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;ANAPC1;PSME3;ANAPC2;PSMB2;PSMA6;ANAPC4;UBC;PSMD9;PSMC2;ANAPC15;RPS27A;ANAPC5;PSME1;PSMB1;PSMD3
prerank,Elsevier_Pathway_Collection__ADRA2C/ADRB2 -> Synaptic Endocytosis,0.42502041191957474,1.1045704325403742,0.3253012048192771,0.9045205040715629,1.0,3/26,6.66%,ADRA2C;RASGRF1;SRC
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3754233456178374,-1.10456670581546,0.3291139240506329,0.5624433030370991,1.0,6/20,10.36%,SEMA3E;SEMA4A;SEMA6D;SEMA4D;SEMA6A;SEMA3D
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,0.362684210642676,1.1041741618004346,0.3193717277486911,0.9052720664901829,1.0,24/59,39.76%,DYNC1I1;PRKAA2;SRC;PRKN;SQSTM1;MTERF3;TOMM20;DYNLL1;PRKAB2;HSF1;TOMM5;UBA52;ULK1;TOMM40;PARK7;DYNC1H1;CSNK2B;HSPA8;UBE2V1;VCP;HSP90AA1;PLIN3;USP30;TOMM7
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.4060921184232008,1.103984182052795,0.33707865168539325,0.9053117369342228,1.0,3/27,6.55%,EPHB2;FAP;CD34
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,0.4068450701685832,1.103882753012382,0.32558139534883723,0.9050239252572316,1.0,6/36,14.79%,FBXW10;SPHK1;CCNE1;CCNE2;CCT3;KIFC3
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,0.3797142590110941,1.1037902904033747,0.33513513513513515,0.9046761352312582,1.0,32/52,47.30%,AXIN2;PSMD4;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;SMURF2;PSMC5;SEM1;PSMB6;PSMD8;PSME2;AXIN1;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2732714934172759,-1.103774434273461,0.21428571428571427,0.5640510305892279,1.0,36/119,17.22%,CSF3;ERBB4;IFNL1;FGF10;IFNG;GHR;TNF;NTF3;HGF;CCL5;CD80;BANK1;IL18;ANGPT4;IL15;LILRA5;SEMA4D;CTF1;PTPRC;IL6;OSM;IL12B;GREM1;FLT3;HCLS1;TSLP;IGF1;PLCG2;EFNA5;CSF2;DLG3;CSF1R;ITGB3;PRNP;PTK6;GATA1
prerank,Elsevier_Pathway_Collection__Aldosterone Synthesis Acute Regulation,0.41209734751141414,1.1037665592016233,0.32941176470588235,0.9041025140246655,1.0,8/24,29.23%,RASGRF1;CYP21A2;PRKD1;MAPKAPK2;ADCY10;MAP2K2;POMC;AGT
prerank,Elsevier_Pathway_Collection__FOXL2 Mutation in Ovarian Dysgenesis,-0.39162637016282476,-1.1036940556653987,0.2978723404255319,0.5637950504766803,1.0,4/17,13.49%,PTGS2;PPARGC1A;BCL2A1;SOX9
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.37871344210675256,1.1036587263108242,0.31443298969072164,0.9038463855510819,1.0,25/57,26.20%,KLK4;MMP11;SCUBE1;TIMP1;MMP12;ADAM15;LAMC1;MMP10;TLL2;SH3PXD2B;HTRA1;CMA1;MMP9;MMP3;DYRK3;ELANE;GSN;ADAMTS15;ADAMTS4;CAPN2;WASHC1;CTSV;A2M;KIF9;BSG
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.4088729385578435,1.103367464215086,0.32432432432432434,0.9042460649393005,1.0,14/36,29.67%,OPN1SW;RHO;ECT2;RRH;FIGNL1;EEF1D;RAD9B;RAD51AP1;RAD51;BLM;RHNO1;CDKN1A;TRPM1;INTS7
prerank,Elsevier_Pathway_Collection__Prolactin Production,-0.31662666229718706,-1.1030524076867676,0.2753623188405797,0.5648837456457666,1.0,10/49,8.53%,ADCYAP1R1;TNF;FOS;FASLG;ESR1;LIFR;OXT;VIPR1;MAP2K1;FGFR2
prerank,WikiPathway_2021_Human__Sleep regulation WP3591,0.4183738783831413,1.1029425840571252,0.30851063829787234,0.9051269581200304,1.0,7/28,9.62%,CACNA1I;UTS2R;CHRNB2;PTGDS;GRIN2A;ADORA1;OXTR
prerank,Elsevier_Pathway_Collection__Vitamin C Related Norepinephrine Synthesis,0.46459920391068377,1.102690349060204,0.32075471698113206,0.905439852933555,1.0,3/16,6.70%,ADRA2C;REN;ADRA1D
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,0.40864460145594395,1.1026852776613725,0.36904761904761907,0.9048126514375383,1.0,19/29,47.29%,SAMM50;ATP5MF;ATP5F1D;APOO;MTX1;MICOS13;ATP5F1E;ATP5MC1;ATP5ME;MICOS10;APOOL;ATP5MG;CHCHD6;MTX2;ATP5PO;ATP5MC2;HSPA9;IMMT;ATP5PD
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.30058281481542504,-1.1026779009161018,0.2631578947368421,0.5653856383187841,1.0,29/63,23.65%,TNF;MAP2K1;PIK3CD;FCER1A;FYN;LCP2;ALOX5AP;RAC2;ALOX5;PLA2G4A;BTK;LAT;PIK3R1;AKT1;SYK;PLCG2;CSF2;FCER1G;VAV1;VAV3;INPP5D;MAPK10;MAPK13;MAP2K3;MAP2K6;AKT3;MS4A2;GAB2;MAP2K4
prerank,WikiPathway_2021_Human__Signal transduction through IL1R WP4496,-0.34812262829072765,-1.1025920915245768,0.34146341463414637,0.5651104816829752,1.0,9/30,21.42%,TNF;IL1B;IL1RAP;IL6;IL1RN;MYD88;MAP2K3;MAP2K6;JUN
prerank,WikiPathway_2021_Human__mRNA Processing WP411,0.3318226196903907,1.1025619510795035,0.29411764705882354,0.9045444222301582,1.0,72/126,49.08%,CELF4;PSKH1;PRPF3;CPSF1;SNRPE;SF3B4;SNRNP70;NXF1;METTL3;TXNL4A;CPSF4;SF3B5;SNRPD2;SF3A2;PRPF6;CLASRP;LSM2;SNRPB;CLK2;SNRPD1;SUGP2;CSTF2;LSM7;SUGP1;FUS;NONO;PPM1G;RBMX;SNU13;SNRPA;SNRPD3;SMC1A;HNRNPU;PABPN1;DHX9;SUPT5H;HNRNPA1;RNMT;POLR2A;DDX20;PRPF8;HNRNPH2;CD2BP2;PTBP1;PHF5A;CPSF3;CLP1;SF3A3;HNRNPR;SNRPG;HNRNPAB;DDX1;U2AF1;U2AF2;SFSWAP;SNRPA1;RNPS1;RBM5;HNRNPM;PRMT1;SFPQ;SF3B3;RBM39;SNRNP40;CLK4;SRPK1;CSTF2T;DHX16;DHX8;SF3A1;NCBP2;SF3B1
prerank,Elsevier_Pathway_Collection__CRH Secretion Regulation,0.42325246305083475,1.1019566291506393,0.34146341463414637,0.9061531044790477,1.0,3/22,5.35%,RASGRF1;GRIN1;HTR4
prerank,Elsevier_Pathway_Collection__Extracellular Matrix Turnover,0.46156845545348557,1.1018383923836517,0.32748538011695905,0.9059042877944257,1.0,8/18,19.77%,FAP;ELN;TIMP1;TIMP4;CMA1;THBS2;DPP4;MMP9
prerank,Elsevier_Pathway_Collection__Proteins Involved in Epilepsy,0.3052829473605488,1.1015509276199178,0.26495726495726496,0.9063653699122644,1.0,44/242,12.86%,SOX1;KCNC1;CACNB4;SLC6A4;APLN;SEZ6;GLUL;RASGRF1;KCNC2;KCNH2;ASIC1;MAPT;SCN1A;BSN;GAD1;NEUROD1;GAL;SLC12A5;OTX1;CHRNB2;GRIK2;HTR4;SERPINI1;HRH3;SRC;PTGER1;FGF2;BDNF;GALR2;GRIN2A;ADORA1;SLC6A8;HSPB1;MANF;IRAK2;KCNH3;LEP;SCN2A;BDKRB2;CHRNA4;SYN1;SLC1A2;GALR1;SNAP25
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.37754876075698096,1.1013221732397063,0.32386363636363635,0.9065586483769977,1.0,6/37,10.47%,SLC7A11;SLC7A6;SLC13A3;SLC7A10;SLC5A6;SLC38A11
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.2689743258282145,-1.1009016594828178,0.20588235294117646,0.568984590681277,1.0,24/128,13.03%,ASCL1;GRIN2B;FOSB;EGR3;EGR2;ADCYAP1R1;NTRK3;NTF3;FOS;ID4;ID2;NTRK2;BCL11B;TF;MAP2K1;KCNH8;EGR1;FYN;NGF;NTRK1;RPS6KA1;TRIB1;EGR4;PIK3R1
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.30154082904103174,-1.1008772602453383,0.25806451612903225,0.5685621817431543,1.0,13/55,16.80%,IGLL5;FYN;BTK;CD247;NCKAP1L;HCK;MYO10;WASF3;SYK;FGR;WIPF1;VAV1;VAV3
prerank,WikiPathway_2021_Human__Neovascularisation processes WP4331,0.3836187348241077,1.100750520432559,0.35135135135135137,0.9080913026552644,1.0,12/37,23.29%,EPHB2;NOTCH3;NFKB2;PDGFB;RELB;SMAD3;ACVRL1;NOTCH4;DLL4;MMP9;TGFB2;EPHB4
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.42641605306630365,1.1005703268011486,0.345679012345679,0.9081334648664497,1.0,20/26,51.78%,POLR2L;POLR2K;POLR3K;POLR2H;POLR3H;POLR3A;POLR3C;GTF3C5;POLR3G;POLR3GL;GTF3C3;POLR3E;POLR3F;POLR2F;GTF3C6;CRCP;GTF3C2;POLR1D;BRF1;GTF3C1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.3796263392984692,1.1005676449875053,0.3155080213903743,0.9074880311892972,1.0,8/41,14.24%,PAX2;PIK3R2;PRKAA2;CYP7A1;KCNB1;NR1D1;FOXK1;UNC13B
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.30055675678574423,-1.1004448104136502,0.34782608695652173,0.5692319232890473,1.0,16/52,13.11%,CYP2D7;CYP4A22;GSTA1;CYP4A11;ACSL1;CYP4F2;ELOVL2;SCD5;SCP2;CYP4F12;ACAA1;ALOX5;PLA2G4A;CYP4F3;PTGR1;ACOX1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Follicular Lymphoma,-0.39581671900957327,-1.099763208167032,0.3625,0.5705949552928382,1.0,7/16,22.03%,MS4A1;FCGR2B;SYK;VAV1;TNFSF13B;BCL2;CD40
prerank,WikiPathway_2021_Human__Integrin-mediated Cell Adhesion WP185,0.3363597106384354,1.0993840828910342,0.32019704433497537,0.9110777524129722,1.0,10/98,6.66%,CAPN9;PIK3R2;PAK3;CAPN11;MAPK12;SHC3;ITGA2;RHO;ITGA6;SRC
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.40308976279626446,1.099007681532216,0.32571428571428573,0.911819102431995,1.0,2/30,5.93%,B4GALNT2;DPM3
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.4409722658490229,1.0989982840056114,0.3313953488372093,0.9111699090333871,1.0,3/25,8.84%,MT3;CAMK2A;TIMP1
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,-0.38216949826471236,-1.0987338711234398,0.3717948717948718,0.5726076412633561,1.0,8/21,17.30%,ENPP3;ALDH1B1;VNN1;DPYS;DPYD;PANK1;ALDH2;ENPP1
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.39572223632622955,1.0985978802960632,0.324468085106383,0.9119548215282265,1.0,6/37,10.41%,FGF20;PIK3R2;FGF13;FGF17;FGF23;FLT3LG
prerank,Elsevier_Pathway_Collection__Neutrophil and Macrophage Function in Systemic Lupus Erythematosus,-0.3598664964870813,-1.0984817671987943,0.3125,0.5728163941850827,1.0,12/28,16.88%,TNF;FCGR3B;FCGR3A;IL6;LCP2;IL12B;LAT;SYK;MYD88;VAV1;ITGB2;ZAP70
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,-0.3135633839816684,-1.0982734533808747,0.2857142857142857,0.5729504195430968,1.0,11/48,19.23%,GCK;CHIA;HK3;GNPNAT1;UGP2;CYB5R2;PGM3;GNE;PGM2;CMAS;PGM1
prerank,MSigDB_Oncogenic_Signatures__RAF UP.V1 UP,-0.2538973682050731,-1.0982219402544195,0.23076923076923078,0.5725732745525822,1.0,53/181,18.38%,CAPN6;L1CAM;MSX2;SPRR3;UGT8;VGLL1;TFPI2;RCAN1;HPGD;NR4A3;SOCS2;ACSL1;S100A8;TSPAN12;VTCN1;HSD3B1;FAM13A;RSAD2;FYN;CCR1;RRAS2;ITGB6;FERMT2;PTGER4;HERC5;ENPEP;TES;ACOX1;GALNT12;PTMS;ABHD6;DBNDD2;COTL1;CLDN1;SLC31A2;SGCE;B3GNT3;MAN1A1;HBEGF;GNE;KLF6;TMSB15B;MAPRE2;CORO1A;ZNF331;PTER;PHYH;PER3;PYGL;DSC2;VTN;TNFRSF21;KCTD12
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.347491530975828,1.0981421916663614,0.3170731707317073,0.9129942391579559,1.0,3/87,1.31%,TRIM71;IGF2BP1;TM4SF20
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.4099425493055999,1.0979406727195964,0.3236994219653179,0.9130400643132479,1.0,10/31,17.41%,KCNJ6;KCNE5;KCNH2;KCNJ9;KCNJ5;KCNJ14;KCNJ4;KCNJ11;NEDD4L;NEDD4
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.403704833427742,1.0976647331906662,0.3220338983050847,0.9133386200234628,1.0,7/32,14.95%,GLUL;S100A1;FGF2;E2F2;PPP1R16B;CREB3L1;PDPK1
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.38306210501775895,-1.0971758133169822,0.3103448275862069,0.5747540216032685,1.0,9/18,18.49%,IL1B;NLRP12;IGFBP3;OSM;MPIG6B;KIF26A;UBASH3B;PTK6;LIF
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.2836140278941021,-1.0969705444253264,0.23529411764705882,0.5748119149186969,1.0,38/104,25.56%,WNT7B;EDAR;WNT7A;EPHB1;MARVELD3;IL1B;WNT16;CD27;CCR7;DUSP10;DACT1;FCGR2B;PER1;RASGRP1;MTURN;RASSF2;MBIP;ITCH;NCOR1;NCF1;TPD52L1;SLAMF1;GADD45A;FZD7;SERPINF2;NOD2;SH3RF1;APP;MAP3K5;SIRPA;GADD45G;KLHL31;IGF1R;F2RL1;UNC5CL;CARD9;PINK1;CYLD
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.3547417280432384,1.0965104502864809,0.35384615384615387,0.9170990355304945,1.0,24/67,24.96%,USH1G;BSN;CABP1;LRRC52;CACNA2D2;FSCN2;TMC1;ATP2B4;PCDH15;WHRN;MYO7A;SYN1;SNAP25;SYP;TWF2;CIB2;TPRN;STX1A;CACNA1D;USH1C;GSN;EPB41L1;DNAJC5;TMIE
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.4620671589234331,1.0964011309025827,0.3313253012048193,0.9168769798290806,1.0,7/19,24.86%,TRIM40;CABP1;APOD;OTUD7B;POLR1A;MFHAS1;MDFIC
prerank,Elsevier_Pathway_Collection__Th17-Cell Numbers Reduction in HIV,-0.3497962732364237,-1.096365594481902,0.3108108108108108,0.5758937089194847,1.0,7/27,15.16%,IL1B;IL1RAP;IL18;IL6;IL21R;MYD88;IL12RB1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.3299731606530344,-1.096104135944688,0.2894736842105263,0.5761172326081905,1.0,5/32,6.58%,CRHBP;SOCS2;SFRP1;SSTR2;ESR1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.32478911382971737,1.096064161872165,0.33014354066985646,0.9175529504777279,1.0,16/149,10.06%,LGR6;RSPO2;LGR5;PTK7;AXIN2;SFRP4;PRDM15;TERT;GPC3;RSPO4;TMEM198;PSMD4;LBX2;JRK;COL1A1;DAAM2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.4083560669166428,1.0960365357393738,0.34054054054054056,0.9169997435954675,1.0,3/30,3.47%,AVIL;PRKAA2;CYP7A1
prerank,Elsevier_Pathway_Collection__STAT3 Inhibits Maturation of Dendritic Cells and Facilitates Cancer Progression,-0.3931988433598018,-1.0957338012655984,0.30952380952380953,0.5765485494261089,1.0,5/16,15.92%,IL10;CD80;IL6;CD86;IL10RA
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.3398582708053605,-1.0955947802396155,0.28169014084507044,0.5764245140976215,1.0,12/34,12.32%,RET;CCL5;CRTAM;CCL4;CCL3;XCL1;CCL23;CCL2;XCL2;TBX21;GATA3;CCL22
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.3571797473739565,1.0955284581085287,0.30612244897959184,0.9182821285037527,1.0,10/59,12.69%,MAPT;CASQ1;VIL1;FGF13;UBE2C;PRKN;UBE2S;CATIP;DIAPH3;SPIRE2
prerank,WikiPathway_2021_Human__Dopaminergic Neurogenesis WP2855,-0.3685172633368184,-1.0954571447431871,0.31645569620253167,0.5763006831106968,1.0,5/23,3.65%,ASCL1;NR4A2;RET;LMX1A;TH
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.3911347089103785,1.095276431289391,0.32786885245901637,0.9186348222227325,1.0,5/34,7.36%,OSR2;OSR1;WNT4;BMP4;TMEM119
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.40891738789981197,1.0952145428969187,0.35135135135135137,0.9182102579142766,1.0,6/25,19.68%,MAPT;STMN2;ANKRD53;PSRC1;ARL2;CDK5R1
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.32525785879555963,1.0952048891712307,0.32673267326732675,0.9175743951802323,1.0,55/111,40.37%,NDUFA1;NDUFS6;NDUFV1;NDUFB9;COX6C;ATP5MF;COX20;COX7B;NDUFA3;UQCRB;NDUFS2;NDUFA9;NDUFAF2;ATP5F1D;COX6B1;NDUFB11;NDUFA2;NDUFS7;SLC25A14;COX8A;UQCRQ;NDUFAF6;TRAP1;NDUFA13;NDUFA11;ATP5F1E;NDUFA6;ATP5MC1;UQCR11;UCP3;NDUFS8;COX4I1;NDUFV2;ATP5ME;COX5B;NDUFA8;NDUFB7;ETFB;TMEM186;UQCRH;NDUFAB1;COX19;NDUFB2;NDUFB10;UQCRC1;NDUFAF3;ACAD9;COX7C;UQCR10;NDUFB3;NDUFS4;SDHA;ATP5MG;NDUFB8;COX6A1
prerank,KEGG_2021_Human__Glutathione metabolism,-0.30953108566902165,-1.0951979053562513,0.2903225806451613,0.5763985471607725,1.0,17/52,23.94%,GSTA2;GGT6;CHAC1;GSTA1;GSTT2B;GSTM5;HPGDS;GSTO2;LAP3;GSTP1;GSTM1;IDH1;NAT8B;PGD;ANPEP;GGT5;GSR
prerank,TRRUST_Transcription_Factors_2019__CEBPD human,-0.41737392303175913,-1.0947703935964017,0.3469387755102041,0.5771232925659864,1.0,4/16,6.85%,PTGS2;TNF;TNFAIP6;PDGFRA
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,-0.3910023535015615,-1.094684178097644,0.35365853658536583,0.5769162699492336,1.0,8/19,25.98%,GCH1;AKT1;PDSS2;DHFR;IDH1;PTS;COQ9;CALM1
prerank,Elsevier_Pathway_Collection__Tumor Infiltrating Macrophages in Cancer Progression and Immune Escape,-0.3398763815018538,-1.0944824070338572,0.275,0.5768752965124642,1.0,13/34,14.60%,IL10;IL1B;CCL5;VTCN1;CXCL12;CCL2;IL6;CYBB;CD274;CXCL8;CCL22;CAMP;MSR1
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,0.3619933803052651,1.094296451978867,0.30256410256410254,0.9204014572117678,1.0,10/72,12.03%,H2BC13;UBE2T;H2BC17;UBE2C;H2BC9;H2BC15;UBE2S;H2BC11;H2BC12;H2BC4
prerank,Elsevier_Pathway_Collection__G-cell: Gastrin Secretion,-0.39749241018886644,-1.094225663119371,0.31645569620253167,0.5770919487712258,1.0,4/16,6.54%,MEP1B;PCSK2;GNAO1;SSTR2
prerank,WikiPathway_2021_Human__MAP3K1 role in promoting and blocking gonadal determination WP4872,0.45705351652366233,1.0940019512971295,0.34502923976608185,0.920837724494016,1.0,2/15,5.33%,WNT4;MAPK11
prerank,"Reactome_2022__Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.4341379108598485,1.093938712833775,0.34806629834254144,0.9204398429854347,1.0,9/20,19.76%,BCAN;GPC3;NCAN;CSPG5;CSPG4;GPC2;VCAN;B4GALT7;HSPG2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.3774191001615222,-1.093865970221074,0.28735632183908044,0.5775426157770882,1.0,3/19,6.58%,FCN3;TNF;ESR1
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.4426205422370928,1.0938306736011425,0.35714285714285715,0.9202612066130271,1.0,5/19,18.45%,GNG4;GNG3;GNB5;GNG8;GNG10
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2886924431046752,-1.093491813167339,0.2909090909090909,0.5781716218574577,1.0,18/70,17.81%,PLPP4;FCGR3A;CD3G;FYN;FCGR2B;CD247;NCKAP1L;HCK;PIK3R1;MYO10;SYK;FGR;PLCG2;WIPF1;VAV1;PRKCE;VAV3;MYO1G
prerank,Reactome_2022__cGMP Effects R-HSA-418457,-0.41054244821260705,-1.0933773805168752,0.358695652173913,0.5779829402945436,1.0,6/15,21.32%,KCNMA1;PDE1B;KCNMB4;PDE2A;PRKG1;PDE5A
prerank,WikiPathway_2021_Human__Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.40723004382120404,1.0931013837413648,0.296969696969697,0.9224226555129479,1.0,6/24,23.19%,CGA;SRC;BDNF;PRKCA;TSC2;GRK6
prerank,WikiPathway_2021_Human__Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.3094464072867123,1.0928620386403751,0.28936170212765955,0.922672205797192,1.0,49/283,16.28%,COL2A1;GNG4;PPP2R2C;THBS4;FGF20;VEGFD;LAMA3;SPP1;PIK3R2;PRKAA2;VWF;ITGA2;LPAR4;ITGA6;SLC2A4;EFNA3;FGF13;FGF17;FGF2;EFNA4;COL4A1;EFNA1;PDGFRB;COL1A1;IL3RA;COMP;COL11A1;GNG3;FGF14;PFKFB4;IKBKG;COL4A2;LAMC1;IL6R;EPO;CREB3L1;PDGFB;FLT1;PDGFA;PGF;COL1A2;COL5A1;PDPK1;GNG8;ACACA;THBS2;HRAS;ANGPT2;CREB3L4
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.45677682986314805,1.092680300990363,0.3231707317073171,0.9226909380952173,1.0,9/20,26.96%,DISP3;MDK;TOX;RASSF10;NES;DLL4;SMARCD3;CTNNB1;NAP1L1
prerank,Reactome_2022__Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.43581269567790315,1.092670057973386,0.32947976878612717,0.922070210169382,1.0,9/20,19.76%,BCAN;GPC3;NCAN;CSPG5;CSPG4;GPC2;VCAN;B3GAT3;HSPG2
prerank,Elsevier_Pathway_Collection__IL6 Expression Targets -> Nociception,-0.35085393752445393,-1.0925580113360804,0.2631578947368421,0.5794265481339107,1.0,5/26,11.86%,PTGS2;MAP2K1;IL6;PTGER4;CXCL8
prerank,MSigDB_Oncogenic_Signatures__MYC UP.V1 UP,0.3274348747334274,1.0924388422280646,0.3140096618357488,0.9222239972646434,1.0,60/147,31.47%,GP2;P2RX5;ICAM5;IL17D;SLC29A4;ANO2;ERVMER34-1;PRAP1;CCDC78;HS6ST2;FUT5;IPO4;FOXRED2;LHX6;DGKD;JPH1;SAC3D1;MTFP1;UTP14A;PRR7;TMEM201;QSOX2;RRP12;TDRD10;CGREF1;TTYH2;AMPD2;MNT;RRP15;CHKA;PUS1;TOP1MT;TRNAU1AP;TECTB;TMEM132B;NR2C2AP;LAS1L;DPP7;RRP9;CCDC124;TRMT1;TSSC4;REPIN1;WDR4;EXOSC5;KLF16;FARSB;ALG3;TFB2M;NOC4L;EEF1E1;METTL1;HSPBAP1;PES1;WDR83;NLE1;HSPE1;QTRT1;PPRC1;PUS7
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.3238010610767288,-1.0923593443558588,0.3194444444444444,0.5794432707840947,1.0,12/42,17.09%,CR2;IL10;CD79A;NFAM1;PTPRC;MS4A1;HDAC9;FLT3;VCAM1;PLCG2;KLF6;ITGA4
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.4096947088984506,1.0922764081821832,0.367816091954023,0.9222087606431733,1.0,9/29,24.75%,CENPA;PLK1;NDC80;KIF25;SAPCD2;SPDL1;LLGL1;GPSM2;GJA1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.4031985124477616,1.0922260628618838,0.3089887640449438,0.921736392332427,1.0,3/27,5.21%,CLDN19;SNAI2;CHRNB2
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.4359706374748656,1.0919650374190983,0.3588235294117647,0.9220659784615274,1.0,7/21,23.37%,BCAN;NCAN;CSPG5;CSPG4;VCAN;CHST15;CHPF
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.3551080888580895,1.0918443278938905,0.33507853403141363,0.9218751230524647,1.0,38/67,46.51%,SARNP;DDX39A;CPSF1;CASC3;THOC5;RBM8A;CHTOP;CPSF4;UPF3B;CSTF2;THOC1;POLDIP3;RPRD2;THOC6;TUT1;THOC2;DDX39B;MAGOHB;SLU7;PABPN1;TUT7;ZC3H11A;SYMPK;CPSF3;CLP1;ALYREF;CPSF7;U2AF1;U2AF2;FIP1L1;RNPS1;SUPV3L1;PCF11;TUT4;EIF4A3;RPRD1B;MAGOH;MTPAP
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4129556954218208,1.0918032007889815,0.3620689655172414,0.9213674147325436,1.0,4/31,3.21%,CEMIP;F2RL3;THY1;CASQ1
prerank,Elsevier_Pathway_Collection__Alveolar Epithelial Cell Autophagy in COPD,-0.3570973953021124,-1.0912890106182942,0.37037037037037035,0.5817254481889814,1.0,10/24,30.81%,FOXO1;EGR1;BCL2;HMOX1;EIF2AK3;XBP1;ATG5;HMGB1;DAPK1;NFE2L2
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,0.3440244030795799,1.091214658752448,0.2822966507177033,0.9228934622058976,1.0,29/73,38.17%,ANLN;CCDC187;ARHGEF10;IQGAP3;DIAPH3;ARHGEF11;RACGAP1;ARHGAP39;MCAM;ROCK2;RHOC;LBR;ARHGEF28;STARD13;ARHGAP26;MCF2L;PKN3;FMNL2;ARHGEF40;PKN1;FLOT1;ARHGAP1;DEPDC1B;FLOT2;ARHGEF10L;MYO9B;TJP2;CAVIN1;TFRC
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,0.3580097407705452,1.0908660590211285,0.30158730158730157,0.9235671858446385,1.0,50/82,47.62%,LEF1;AXIN2;TCF7;PSMD4;PSMB4;AMER1;HDAC1;PPP2R5A;MYC;CTNNB1;PSMB3;TLE1;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;TCF7L1;PSMC4;PSMC3;CUL1;SKP1;PSMC5;PPP2R1A;SEM1;PSMB6;PSMD8;PSME2;AXIN1;GSK3B;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;TLE2;BTRC;PPP2R5B;PSMC2;CSNK1A1;RPS27A;PSME1;PSMB1;PSMD3;FRAT1
prerank,WikiPathway_2021_Human__Target Of Rapamycin (TOR) Signaling WP1471,0.3943586193864517,1.0907944539429286,0.3693181818181818,0.9231761990591791,1.0,19/36,38.14%,PRKAA2;PRR5L;PRKCA;HMGCR;IDI1;TSC1;TSC2;PRKAB2;RHEB;DDIT4L;ULK1;ULK3;MLST8;RRAGD;DDIT4;RPTOR;AKT1S1;RRAGA;FKBP1A
prerank,KEGG_2021_Human__Olfactory transduction,0.37175253672286784,1.0907753099039939,0.29444444444444445,0.9226106315038333,1.0,8/46,8.66%,OR1N2;CALML6;OR51E1;ANO2;OR2B6;CAMK2A;PDE1C;GNAL
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.376434215786465,1.0907397365879425,0.3227848101265823,0.922096915171146,1.0,10/34,22.70%,PAX2;GRHL3;SCRIB;DVL2;MTHFD1L;MTHFR;STIL;DEAF1;TGFB2;TSC2
prerank,WikiPathway_2021_Human__Pathways Regulating Hippo Signaling WP4540,0.33958171990148744,1.0906667505193293,0.3170731707317073,0.9217393868371748,1.0,17/92,16.65%,CDH22;CDH8;CDH16;LEF1;PRKAA2;CDH13;TCF7;CDH24;PDGFRB;GNAL;CDH17;TEAD2;FLT1;TEAD4;TAZ;PRKCA;SMAD3
prerank,MSigDB_Oncogenic_Signatures__BMI1 DN MEL18 DN.V1 DN,-0.2768940469625565,-1.0905634780670133,0.25,0.5831075949488967,1.0,29/123,13.54%,ESRP1;DIRAS3;TCEAL2;SPINT2;SPINT1;CHL1;CXCL14;KCNJ16;SEMA3E;WFDC2;SOCS2;FOS;PROM1;ID4;ID2;PPARGC1A;DUSP2;MAP7;MXRA5;SCNN1A;CA2;UNC5C;EHHADH;SLC16A4;GPR88;NEAT1;DPYD;OGDHL;DDX60
prerank,Elsevier_Pathway_Collection__IGF1R/AKT Signaling in Breast Cancer,0.39463174936892126,1.0903848040968136,0.3430232558139535,0.9220911339481903,1.0,7/42,15.60%,IGF2;LEF1;TCF7;SRC;SHC1;PDPK1;PRKCA
prerank,Elsevier_Pathway_Collection__Cardiomyocyte Dysfunction,0.38115370637627,1.090265231483294,0.367816091954023,0.9219354393049625,1.0,11/42,25.03%,TNNC1;ACTN2;TNNI3;CACNA1C;LMNA;ANKRD1;SMAD3;LAMA4;SCN5A;MYBPC3;EMD
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,0.4249487212560469,1.0899092052347077,0.3333333333333333,0.9225798316838784,1.0,14/21,43.67%,NFIX;POLR2L;POLR2K;POLR3K;POLR2H;POLR3H;POLR3A;POLR3C;POLR3G;POLR3GL;SSB;POLR3E;POLR3F;POLR2F
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.3542072263642276,1.0898985599354964,0.3469387755102041,0.9219807640272895,1.0,7/60,9.00%,RFX6;GCG;PRKAA2;NEUROD1;SLC2A4;KCNB1;VGF
prerank,Elsevier_Pathway_Collection__CFTR Expression in Epithelial Cells (Class I Mutations),-0.3651697056824805,-1.0898832171986896,0.3373493975903614,0.5844280882927444,1.0,8/22,22.85%,IL1B;IL1RAP;MYD88;CFTR;MAP2K3;MAP2K6;ADRB2;MAP3K5
prerank,KEGG_2021_Human__Adherens junction,0.34679295153469913,1.0897763632160538,0.3448275862068966,0.921813376936353,1.0,6/71,8.76%,CTNNA2;LEF1;SNAI2;TCF7;SRC;NECTIN1
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.36337925876671573,-1.0896569018283877,0.3253012048192771,0.5845319945660823,1.0,5/23,4.13%,SOX10;GFRA3;EGR2;UGT8;NTF3
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,0.42314276286817487,1.0896339065478324,0.3353658536585366,0.9216268776455517,1.0,14/24,39.99%,AGO2;POLR2L;POLR2K;POLR2G;XPO5;POLR2H;POLR2I;POLR2J;AGO1;DROSHA;POLR2A;RAN;BCDIN3D;POLR2B
prerank,KEGG_2021_Human__Serotonergic synapse,0.3342814395424617,1.0890583187694807,0.32663316582914576,0.9232074472691016,1.0,21/96,15.92%,HTR1D;GNG4;ALOX15B;SLC6A4;KCNJ6;CACNA1S;ALOX12B;KCNJ9;HTR4;KCNJ5;GNG3;CACNA1C;PLA2G4C;ALOX12;PLA2G4F;GNB5;HTR1B;GNG8;PRKCA;HRAS;HTR2B
prerank,TRRUST_Transcription_Factors_2019__WT1 human,-0.310137169623186,-1.089023763681833,0.2318840579710145,0.5857168867949635,1.0,5/54,5.56%,KLK3;EREG;IL2RB;NDRG2;CDH1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.4623512775154564,1.08899815259514,0.34810126582278483,0.9227956062606958,1.0,11/16,46.01%,CEP131;STIL;SPAG5;BBS4;CSNK1D;DCTN2;C2CD3;CEP83;CEP192;KIAA0753;CCDC14
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.46410009017933523,1.0889039009812382,0.36416184971098264,0.9224591678504216,1.0,6/15,32.29%,PTP4A3;CTSD;CEP295;OOEP;TREM2;CEP290
prerank,Elsevier_Pathway_Collection__Estrogens/ESR1 Genomic Canonical Signaling,-0.3723965611887739,-1.088552935197933,0.30120481927710846,0.586466830321063,1.0,10/22,25.23%,FOS;ESR1;TGFA;IL6;REL;IGF1;BCL2;JUN;NCOA1;PHB2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.38631006469098417,-1.0883950647109581,0.2625,0.5863137794564421,1.0,5/19,15.04%,BMP5;BMP10;NOG;BMP7;ADGRG6
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,-0.30702865546329816,-1.0882699997999696,0.22033898305084745,0.5861791799601068,1.0,16/55,17.93%,GABRB1;EREG;ERBB4;ESR1;NRG4;ADAP1;GABRG3;CXCL12;S100B;BTC;PIK3R1;PGR;HBEGF;ITCH;NCOR1;NRG3
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.40622884294628553,-1.0881236138788566,0.30337078651685395,0.5860584399017209,1.0,7/15,23.80%,AGPAT2;AXL;TSLP;WNT5A;IFIH1;TRIM44;DDX58
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.4586802445002337,1.0880130894649396,0.3503184713375796,0.9250680680175475,1.0,1/15,0.43%,CALY
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.4018092036671975,-1.0879526835202953,0.3191489361702128,0.5860787394349921,1.0,7/16,15.47%,NRXN1;NCAM2;RET;ASTN1;CNTN4;NLGN4X;NLGN4Y
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.31801373782998266,-1.087888388829734,0.34328358208955223,0.5857539909560873,1.0,18/41,21.79%,PNP;PCK1;DUSP10;RHOH;VNN1;CR1;TESPA1;IL12B;GATA3;NCKAP1L;IL12RB1;LILRB4;LILRB2;ZAP70;ADAM8;XBP1;HLA-DRA;GLI3
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.2951800710049069,-1.08776462109372,0.23333333333333334,0.5855250239601514,1.0,18/69,16.36%,CSF3;MT1G;TNFSF11;IFNG;CD4;CAMK4;CBFA2T3;IL15;CCR7;PIK3CD;GPR183;TNFRSF11A;PDE1B;OSCAR;CSF2;SPI1;CSF1R;LGALS9
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.4462075406357796,1.0877574835620565,0.3712574850299401,0.9253812382877258,1.0,2/16,4.00%,ARG2;NQO1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.43193910362934346,1.0876480801112096,0.3463687150837989,0.9251592926172905,1.0,5/20,16.68%,STOX1;RGCC;PDGFB;PSRC1;PKD1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.37774908473087504,1.0868237723128964,0.34408602150537637,0.9275826701179581,1.0,8/45,12.45%,CDH22;CDH8;CDH13;CDH24;NECTIN1;ZNF703;CDH17;RAMP2
prerank,WikiPathway_2021_Human__Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.3316365606661825,1.0868024664151896,0.2961165048543689,0.9270035389845003,1.0,51/89,42.98%,NDUFA1;NDUFS6;NDUFV1;NDUFB9;COX6C;ATP5MF;COX7B;NDUFA3;UQCRB;NDUFS2;NDUFA9;ATP5F1D;COX6B1;NDUFA2;NDUFS7;SLC25A14;COX8A;UQCRQ;SLC25A6;COX7A1;ATP5F1E;NDUFA6;ATP5MC1;UQCR11;UCP3;NDUFS8;COX4I1;NDUFV2;ATP5ME;COX5B;NDUFA8;NDUFB7;UQCRH;NDUFAB1;NDUFB2;NDUFB10;UQCRC1;COX7C;UQCR10;NDUFB3;NDUFS4;SDHA;ATP5MG;NDUFB8;SDHC;COX6A1;COX17;ATP5PO;NDUFA4;SLC25A5;NDUFA10
prerank,Elsevier_Pathway_Collection__Proteins Involved in Glioma,0.30272375600082224,1.0867807602978101,0.3037974683544304,0.9264516604098664,1.0,53/256,18.21%,DLK1;GRPR;SLC7A11;IGF2;DKK1;PTP4A3;E2F1;SPP1;PEG3;GLIPR1;TERT;DKK3;BCAN;CHI3L1;CDKN2A;PANX2;FOXM1;ASPM;BMP4;BIRC5;FGF2;TRPC6;UBE2C;IGFBP2;EFNA1;PDGFRB;AURKB;HSPB1;NOTCH3;NOL3;DCX;CDK1;NDRG1;IL6R;EFEMP1;SLC1A2;PDGFB;PDGFA;PLAU;CSPG4;PPARG;PRKCA;ANGPT2;TACR1;ECT2;VCAN;HMGA1;EGF;PANX1;GAP43;SEMA3F;ACSL5;NES
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.4532609484556518,1.086709716055995,0.3625,0.9260710765501146,1.0,10/17,35.20%,CD200;PRKD1;CAMK1D;CRTC1;LRP8;CRTC2;RELN;ADCY8;OPRD1;RPS6KA4
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.38121538536371596,1.0865843421978252,0.35260115606936415,0.9259166253935747,1.0,19/38,30.44%,THY1;NOX4;EFNA1;PDGFB;ACE;DLG4;SHC1;DOK7;SH3BP5L;LRP8;SRCIN1;GPRC5B;ERBB3;RELN;HYAL2;IL34;AGT;GAS6;MVP
prerank,Elsevier_Pathway_Collection__mTOR/NF-kB/BCR Signaling Disregulation in Mantle Cell Lymphoma,-0.3069862248984502,-1.0865769950153732,0.34,0.588237911319708,1.0,12/49,17.08%,TNF;CD79A;PRKCB;BTK;CARD11;AKT1;SYK;PLCG2;BCL2L11;TNFRSF13C;TNFSF13B;BCL2
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.29358684132558366,-1.0864124214206188,0.35294117647058826,0.5881839260342838,1.0,22/62,22.65%,AKR1D1;CYP39A1;HOGA1;LIPH;LIPG;ACSM3;SCP2;CYP8B1;AKR1C4;ALOX5;GATM;ACSM5;ALDH1A2;LIPC;MLYCD;CBR4;SLC27A5;OSBPL6;ACOX2;XBP1;SLC27A2;ACSM4
prerank,TRRUST_Transcription_Factors_2019__ATF3 human,-0.3989479525593958,-1.086176989843613,0.2988505747126437,0.5883743788074152,1.0,8/15,25.00%,IFNG;CCL5;SELE;CD82;AK4;ADIPOR2;LDLR;ID1
prerank,MSigDB_Oncogenic_Signatures__GCNP SHH UP EARLY.V1 DN,0.3228601712190215,1.086117346633557,0.2922374429223744,0.9269399497571021,1.0,10/145,3.24%,DLK1;SLC6A4;GABRD;SEZ6;RSPO2;POPDC3;SIX4;HOXB9;GRIN1;RAMP1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.42139221662581644,-1.0860278455305181,0.32926829268292684,0.588311327805123,1.0,3/15,5.84%,ADARB2;APOBEC3C;APOBEC3A
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.40416715053634034,1.0860142069108485,0.3551912568306011,0.9266868446870269,1.0,5/28,14.95%,VIL1;TDGF1;SNAI2;FOXC1;PDPK1
prerank,Elsevier_Pathway_Collection__Eosinophil Survival in Asthma,-0.3113037426903524,-1.085995331480588,0.2878787878787879,0.5879005136360574,1.0,13/47,17.50%,IL5RA;SIGLEC8;NGFR;MAP2K1;CCL2;IL6;IL33;CXCL8;SYK;PLCG2;CSF2;BCL2;CSF2RB
prerank,Elsevier_Pathway_Collection__Platelet Activation via Adhesion Molecules,-0.28434877642344764,-1.0854160921706402,0.2545454545454545,0.5889303547425283,1.0,24/65,21.97%,TNF;GP5;MAP2K1;IL6;FYN;LCP2;CD40LG;CXCL8;LAT;AKT1;SYK;PLCG2;HBEGF;FCER1G;VAV1;ITGB3;F3;GP1BA;GP6;IQGAP1;PRKG1;APBB1IP;MAP2K6;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.36688387021129465,-1.0853238465566692,0.3253012048192771,0.5886865904152863,1.0,1/19,0.10%,CIDEA
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.2644543022742415,-1.0853218518056715,0.25,0.5882223833426045,1.0,33/140,17.31%,MARCO;JCHAIN;STAB2;LRP1B;CXCR1;CXCR2;FPR2;HBA1;FCHO1;APOA1;CD163;HBB;APOL1;ALB;CLEC9A;LILRB1;FCGR2B;CXCL8;CD207;SFTPD;MX2;SORL1;SYK;CLN3;MSR1;FCER1G;STAB1;LILRB4;ARHGAP27;ITGB2;HP;TPCN2;CAV2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.41816404568791754,1.0851740973406305,0.3192771084337349,0.9290301881503303,1.0,17/24,47.10%,RFC4;POLD1;LIG3;UBA52;POLB;PCNA;XRCC1;LIG1;RPA2;POLK;RFC3;POLD3;UBC;POLD4;RPS27A;RPA1;RFC1
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.348957271474728,1.085108606057271,0.355,0.9286251981063702,1.0,37/81,39.56%,E2F1;PSMD4;CCNE1;CCNA2;CCNE2;PSMB4;CKS1B;CDC25A;E2F5;LIN37;LIN9;MYC;PSMB3;PSMD14;UBA52;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;CDK4;SKP2;SKP1;PSMC5;SEM1;PSMB6;PSMD8;E2F4;PSME2;PSMD13;PSMB7;PSMA7;PSME3;CDK2
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.42822195606591884,1.0850900063970232,0.3463687150837989,0.9280485831054137,1.0,14/23,35.45%,GTSE1;PTPN14;IFI27;BARD1;RAPGEF3;TPR;EMD;RANGAP1;PARK7;GAS6;RBM22;BAG3;UHMK1;SIRT7
prerank,TRRUST_Transcription_Factors_2019__BCL6 human,-0.3980704824807828,-1.084699952692312,0.36904761904761907,0.5894701416466299,1.0,2/17,5.57%,IRF4;CD80
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,0.4122570519969162,1.0845078032071194,0.34104046242774566,0.9295161305032315,1.0,19/25,53.25%,RFC4;POLD1;FEN1;POLR1A;PARP1;PCNA;SLC19A1;RFC3;POLD3;APEX1;POLG2;POLD4;POLE2;POLE4;RFC5;RFC2;POLE;LRIG1;PARG
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.2950403696710282,-1.0845001490857604,0.3333333333333333,0.5895954978475149,1.0,17/51,17.56%,CETP;LCAT;APOA4;APOA1;LIPG;STARD5;APOA5;TSKU;ABCG8;ABCG5;ABCG4;ABCA8;MSR1;CLU;LIPC;LIMA1;STARD4
prerank,"WikiPathway_2021_Human__Metabolic pathway of LDL, HDL and TG, including diseases WP4522",-0.40240285774745693,-1.0844890693665594,0.358695652173913,0.58915865459984,1.0,8/16,22.41%,CETP;LCAT;APOA1;LIPG;MTTP;LIPC;APOB;LDLR
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3781412356877068,1.0843081585825016,0.32972972972972975,0.9295510824160099,1.0,29/42,45.22%,EME1;TONSL;RTEL1;POLD1;TRAIP;DDX11;RAD51;DONSON;BLM;OOEP;TIPIN;MMS22L;CENPS;TIMELESS;PCNA;THOC1;RFWD3;SMARCAL1;CENPX;EME2;ATR;FANCM;ALYREF;CDK9;ATRX;SETMAR;CORT;WRN;PRIMPOL
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.4045996550706291,1.0840283343894574,0.3516483516483517,0.9299893117478208,1.0,10/26,24.03%,PLCH2;INPP5J;ITPKA;PLCH1;PLCD3;PLCD4;PLCG1;INPPL1;ITPKC;OCRL
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,0.37913319006272606,1.0839988738738788,0.3370165745856354,0.9294538982030269,1.0,35/56,47.30%,IHH;PSMD4;PSMB4;DHH;HHAT;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;VCP;PSMD13;PSMB7;PSMA7;SHH;PSME3;PSMB2;PSMA6;UBC;PSMD9;ERLEC1;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.46568284472284016,1.0835500598354575,0.3696969696969697,0.9304397223400404,1.0,9/18,29.86%,FAP;FAM83D;TMEM9;ODC1;NEDD4L;RARRES2;CHEK2;HGS;SNF8
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.457628390871277,1.0834680503813467,0.3717948717948718,0.9300905026377886,1.0,4/15,8.78%,GRIN1;MAPK8IP2;CHRNA3;GRIN2A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.32243359575351,-1.0834654303054196,0.30434782608695654,0.5914763431905157,1.0,10/42,10.45%,MUC21;SPINT2;MEGF10;CDH1;EPHA7;SIRPG;FUT3;WNT1;EPHB3;FUT7
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.3036267618199047,1.0832403461152382,0.3275862068965517,0.9303200830528422,1.0,71/281,26.07%,HMGA2;ALOX15B;INHA;TP73;MAPK12;SOX2;POU4F1;CENPF;CDKN2A;FOXM1;PLK1;FAP;TBX3;BMP4;BEX2;BIRC5;CCNB2;SPATA22;BRINP1;CDKN3;DTL;BOP1;CDKN2C;ZNF703;DLGAP5;ZBED6;CCNB1;LEP;RGCC;CDKN2B;USP51;MYBL2;TFAP4;CKS1B;E4F1;PRR11;HRAS;CHEK1;SMAD3;PKD1;CDC25A;BARD1;FIGNL1;PCLAF;CAMK2N1;GAS2L1;SRA1;FBXL6;CDK6;FBXL8;PRCC;TSC1;TSPYL2;TGFB2;APBB1;PPP2R3B;YY1AP1;GMNN;LIN37;TSC2;ARNTL;NF2;CDKN2D;L3MBTL1;GADD45GIP1;METTL3;CDK5;LIN9;HSP90AB1;HCFC1;MYC
prerank,MSigDB_Oncogenic_Signatures__PRC2 EDD UP.V1 DN,-0.2513397923031184,-1.0828031699231584,0.25,0.5927489217338792,1.0,44/154,20.74%,CIDEA;IL13RA2;CDHR2;CCK;CXCL10;CLGN;SATB1;RFPL2;GALNT3;CD244;GPC5;ASB4;ANXA10;NR3C2;SEMA6D;KCNJ15;RABGAP1L;CNGA1;TNFRSF11A;HDAC9;ARL4C;PDZRN4;TRIB1;CD5;IRF8;PRSS12;SERPINB2;FPR3;SLC28A1;PLSCR4;SLC12A8;RBM47;PTPN7;BMP2K;GATA1;ACAP1;VTN;CBR4;CTSO;MPDZ;MTHFD2L;DMD;EVI5;MS4A4A
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.30172210196683297,1.082796697066658,0.30666666666666664,0.9313222684657654,1.0,64/238,18.38%,HTR1D;CACNA1E;CHRND;CACNB4;SYT5;CDH8;GABRD;CEL;MPZ;GABRR3;GRIN1;GABRQ;PTPRN2;SNCG;BSN;GAD1;SLC12A5;NQO1;CHRFAM7A;CHRNB2;UNC13A;GRIK2;HTR4;CHRM4;CHRNA3;HRH3;KIF5A;SYN3;GRIK4;CHRNB4;GRIN2A;GALR3;SLC1A4;PCDHB14;NPTX1;GABRE;CHRNA5;CHRM5;PPFIA3;CHRNA4;SYN1;SLC1A2;SNAP25;SHISA6;CPLX1;DLG4;CBLN1;UNC13B;HTR1B;PCDHB2;GRM1;RIMBP3;SLC6A2;HTR2B;PCDHB11;SLC12A7;NPTX2;SLC1A3;SYN2;PDLIM4;NLGN2;NRXN2;SNAPIN;GRIN2C
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3967351349457495,1.0822242739872299,0.3544973544973545,0.9328506576227574,1.0,4/29,9.66%,PLK1;CDC20;UBE2C;UBE2S
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.276938852114835,-1.0820347439847926,0.32653061224489793,0.5943558539115504,1.0,18/91,12.55%,CASR;TMPRSS3;ATP2C2;HTR2A;TRPV4;ATP13A4;CCL5;PTH1R;ATP1A3;ATP12A;CCL3;CCL23;KCNMA1;CXCL12;CCR1;CCR2;CHRNA7;SLC8A1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.37698031999567494,1.0817498270511914,0.33668341708542715,0.93391381005186,1.0,7/53,10.75%,TRIM71;IGF2;SIX4;HES5;EGFL8;COL1A1;SOX8
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.38020045247344814,1.0816957147337807,0.3505747126436782,0.933444725231113,1.0,34/51,47.30%,PSMD4;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;GSK3B;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;BTRC;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.3630179227881933,1.0815867951625764,0.3315508021390374,0.9332158259788558,1.0,36/62,47.30%,PSMD4;PSMB4;ELOC;ELOB;EGLN1;HIF3A;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;UBE2D2;PSME2;PSMD13;PSMB7;PSMA7;LIMD1;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.44985279554445246,1.081585747406231,0.3878787878787879,0.932567759433037,1.0,6/17,16.56%,HS3ST5;HS6ST2;EXTL3;NDST1;HS6ST1;B3GAT3
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,0.31089843656932303,1.0814668125027298,0.29906542056074764,0.9323989946637088,1.0,34/174,15.74%,GRPR;GNG4;RGSL1;GCG;NTS;PIK3R2;QRFPR;UTS2R;F2RL3;KISS1;LPAR4;SAA2;ADRA1D;PTGER1;KISS1R;TRPC6;DGKI;TRH;OXTR;GNG3;CHRM5;DGKD;BDKRB2;PTGFR;RGS16;BDKRB1;RGS5;MLNR;GNB5;GNG8;DHX34;GRM1;PRKCA;HRAS
prerank,Elsevier_Pathway_Collection__TNF-alpha/TNFRSF1A Signaling,-0.3499345447107517,-1.0813623195820112,0.3157894736842105,0.5955972065206171,1.0,10/32,23.65%,RIPK3;TNF;FOS;BAG4;MAPK10;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,Elsevier_Pathway_Collection__Adiponectin in Insulin Resistance Prevention,-0.3753141004850048,-1.0813576293417746,0.2876712328767123,0.5951349239978361,1.0,10/23,21.12%,PCK1;PPARGC1A;ACACB;G6PC;AKT1;ACOX1;UCP2;PCK2;ADIPOR2;MAP2K3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.44845870637942803,1.0812712366303145,0.35,0.932490799410448,1.0,10/15,48.68%,RTEL1;PARP1;PINX1;TERF1;TERF2;SLX4;NBN;ERCC1;RAD50;TNKS
prerank,WikiPathway_2021_Human__Regulatory circuits of the STAT3 signaling pathway WP4538,-0.28691448186678226,-1.0811325441165716,0.27906976744186046,0.5951879420377061,1.0,17/77,13.48%,IL20RA;IL20RB;IL5RA;GHR;IL2RB;IL7R;CSF3R;LIFR;PDGFRA;DUSP2;PRKCB;CTF1;PTPRC;F2RL2;PTPRD;IL21R;MAPK15
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,0.3291437207161808,1.0810332548404045,0.3248730964467005,0.932769315530296,1.0,61/106,48.14%,RFC4;POLD1;ACTR5;POLR2L;PIAS3;CETN2;UVSSA;POLR1A;PARP1;PIAS1;POLR2K;INO80E;NFRKB;TFPT;POLR2G;COPS5;CHD1L;CUL4B;UBA52;PCNA;XRCC1;UBE2I;POLR2H;DDB2;COPS6;POLR2I;POLR2J;RUVBL1;XAB2;DDB1;ACTR8;POLR2A;ERCC2;INO80D;COPS8;USP7;SLC19A1;GPS1;ELL;POLR2B;POLK;XPC;RFC3;POLD3;RBX1;UBE2V2;UBC;POLR2F;ERCC3;POLD4;COPS7A;MCRS1;INO80;COPS4;XPA;ERCC1;RPS27A;PRPF19;GTF2H2;POLE2;ACTL6A
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.46058732623386606,1.0808354701528005,0.40606060606060607,0.9328347391817282,1.0,9/15,43.83%,TERT;NABP2;BRCA2;PINX1;ACD;TPP1;ATR;TERF2;ATRX
prerank,WikiPathway_2021_Human__miRNA targets in ECM and membrane receptors WP2911,0.43055556264276246,1.0806625339246514,0.41040462427745666,0.9328008778433284,1.0,8/22,18.80%,COL4A1;COL4A2;LAMC1;COL1A2;COL5A1;THBS2;LAMA4;ITGA11
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.33640139383094503,1.080438314734078,0.3333333333333333,0.9329487940440148,1.0,19/90,16.72%,CACNA1I;CACNA1S;CALML6;CYP21A2;KCNJ5;CACNA1G;ATP1A2;ATP1A4;ATP2B4;CAMK2A;ATP1B3;PRKD1;CACNA1C;CREB3L1;ADCY6;PRKCA;CAMK1D;CREB3L4;CACNA1H
prerank,Elsevier_Pathway_Collection__Double Strand DNA non-Homologous Repair,0.4354398692704525,1.080358392842383,0.379746835443038,0.9319948675780672,1.0,9/20,34.02%,NHEJ1;FEN1;PARP1;PRKDC;LIG3;POLB;XRCC1;TP53BP1;PNKP
prerank,Elsevier_Pathway_Collection__Persistent Double Strand DNA non-Homologous Repair in Cancer,0.4354398692704525,1.080358392842383,0.379746835443038,0.9319948675780672,1.0,9/20,34.02%,NHEJ1;FEN1;PARP1;PRKDC;LIG3;POLB;XRCC1;TP53BP1;PNKP
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.32026728921564224,-1.080324910136766,0.32727272727272727,0.5970337023899902,1.0,13/58,11.85%,GABRA5;GABRA3;SLC5A1;GABRB1;GABRA4;GABRG1;GLRB;GLRA3;ANO1;GABRG3;APOL1;ANO5;GABRP
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.3578006043128848,1.0802030876137971,0.3422459893048128,0.9319640345888607,1.0,21/60,32.22%,OPN1SW;RHO;AURKB;SAG;POLD1;BMF;RRH;NEDD4;CDC25A;PARP1;TMEM161A;NPM1;METTL3;COPS9;RHNO1;MYC;SDE2;TRPM1;PCNA;FMR1;CASP9
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,0.3329193241111363,1.0800820014984118,0.3177570093457944,0.9317567220059887,1.0,25/115,17.26%,HS3ST4;HS3ST5;HPSE2;CEMIP;UST;BCAN;HMMR;B3GAT1;GPC3;CHST6;NCAN;HS6ST2;IDUA;NDST1;CSPG5;CSPG4;HS3ST2;SLC26A2;ABCC5;HS6ST1;GPC2;VCAN;B3GAT3;B4GALT3;ST3GAL3
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.4409457163065633,1.0799771022081268,0.3473053892215569,0.9314485589070156,1.0,7/20,23.37%,BCAN;NCAN;CSPG5;CSPG4;VCAN;CHST15;CHPF
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.36580341029918645,1.079859098910811,0.34502923976608185,0.9312254341848049,1.0,13/49,17.27%,CASQ1;FXYD7;ATP1A2;ATP1A4;ATP2B4;ATP1B3;NPR2;ATP2A1;GJA5;FXYD2;CORIN;KCNJ11;SLC8A3
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.389881404476605,1.0796706384603127,0.37566137566137564,0.9312492373063349,1.0,2/39,0.34%,KIF1A;DYNC1I1
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,0.38377302787600154,1.0792300887517594,0.3631578947368421,0.9321344129791265,1.0,9/33,16.38%,SFN;PIK3R2;ATP1A2;ATP1A4;ATP1B3;PDPK1;FXYD2;PRKCA;NEDD4L
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer Metabolic Reprogramming,0.33464208690396685,1.079189129691217,0.345,0.9316485764255863,1.0,26/85,26.20%,SLC7A11;FABP4;TP73;PDK1;MSTN;SLC16A3;CD36;ACLY;ACACA;SREBF2;HRAS;SCD;EGF;TSC1;TGFB2;PECAM1;LIPE;TSC2;CAPN2;LPCAT1;PGK1;HSF1;SNAI1;MYC;CTNNB1;BSG
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.3593277807553028,-1.0788079120825407,0.2948717948717949,0.6008555473694667,1.0,10/21,21.10%,NLRP7;APOA1;NLRP3;MEFV;CARD16;IGF1;LILRB4;CD33;GSTP1;CX3CR1
prerank,TRRUST_Transcription_Factors_2019__ATF1 human,0.4511956821779305,1.0788017214716086,0.3493975903614458,0.932398657957699,1.0,5/19,13.30%,NTS;CGA;TOP2A;PCSK1;FLT1
prerank,Elsevier_Pathway_Collection__PHOX2B Effects in Neuroblastoma,-0.359813327360367,-1.0780721251396783,0.3625,0.6023769284685587,1.0,9/26,11.92%,ASCL1;SOX10;RET;DBH;TH;ALK;HAND2;BMP7;GATA3
prerank,WikiPathway_2021_Human__Endometrial cancer WP4155,0.35918519485353845,1.077997751020922,0.33,0.9346022909193159,1.0,6/63,6.72%,CTNNA2;LEF1;PIK3R2;AXIN2;TCF7;FGF2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Obesity,-0.2656718120368827,-1.0779645196708982,0.24324324324324326,0.6022366872334771,1.0,21/93,13.84%,TAC1;CCK;IL10;PTGS2;SFRP5;TNF;IL1B;HGF;CCL5;ESR1;IL18;OXT;GCGR;CCL2;IL6;IL1RN;CXCL8;TLR4;TLR2;AKT1;IGF1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.39787746473797636,1.0779308442763365,0.3546511627906977,0.9341672570915966,1.0,7/31,24.46%,TERT;ELL3;PRIM1;NAT14;POLA1;POLA2;TAF10
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.38287864575366526,1.0778793177331056,0.38333333333333336,0.9337421760478054,1.0,5/39,4.68%,MT3;KCNH2;GRIN1;SLC12A5;SLC12A1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3449182294545821,1.0777819300046498,0.3384615384615385,0.9334696152976046,1.0,48/78,49.28%,SARNP;DDX39A;CPSF4L;CPSF1;CASC3;THOC5;RBM8A;CHTOP;CPSF4;ZNF473;PABPC1;UPF3B;LSM11;CSTF2;THOC1;POLDIP3;RPRD2;THOC6;TUT1;THOC2;DDX39B;MAGOHB;SLU7;PABPN1;ZC3H11A;SYMPK;CPSF3;CLP1;ALYREF;CPSF7;SLBP;U2AF1;U2AF2;CPSF6;FIP1L1;RNPS1;PCF11;EIF4A3;RPRD1B;MAGOH;MTPAP;SSU72;PAF1;CSTF2T;LEO1;CDC73;NCBP2;THOC3
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,-0.3306614924861066,-1.077756504216036,0.34615384615384615,0.6022972192912834,1.0,11/29,19.33%,HAO2;GLDC;HOGA1;CAT;MMUT;GCSH;SHMT1;HAO1;ACAT1;AGXT;PCCA
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.3710951474281361,1.0775532318654286,0.34536082474226804,0.933643586016992,1.0,24/57,26.20%,KLK4;MMP11;SCUBE1;TIMP1;MMP12;ADAM15;LAMC1;MMP10;TLL2;SH3PXD2B;HTRA1;CMA1;MMP9;MMP3;ELANE;GSN;ADAMTS15;ADAMTS4;CAPN2;WASHC1;CTSV;A2M;KIF9;BSG
prerank,Elsevier_Pathway_Collection__TNFR/NF-kB Alternative Pathway in Multiple Myeloma Plasma Cells,-0.3609137472773982,-1.0773506846606526,0.38461538461538464,0.6029187501035269,1.0,7/21,17.08%,TNF;IL6;CXCL8;VCAM1;TNFRSF13C;TNFSF13B;BCL2
prerank,Elsevier_Pathway_Collection__G0/G1 Phase Transition,0.3782704110467622,1.0771782643336107,0.3699421965317919,0.9343612129450891,1.0,11/38,21.80%,RASGRF1;SRC;CCNE1;CCNA2;CCNE2;CDKN1C;SHC1;PDPK1;EGF;CDK6;PLCG1
prerank,Reactome_2022__Assembly Of Active LPL And LIPC Lipase Complexes R-HSA-8963889,-0.36593210386837904,-1.0767680916622149,0.35714285714285715,0.6040999439588873,1.0,6/19,16.80%,CIDEC;APOA4;APOA5;ANGPTL3;PCSK5;LIPC
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.32595658411837947,1.0765298792917337,0.3435897435897436,0.9362045598463202,1.0,24/103,17.66%,WNK4;GRIN1;TRPM3;SLC12A5;SLC12A1;PANX2;CHRNB2;CHRNA3;TRPC6;SLC4A1;SLC26A6;ATP1A4;CHRNB4;PLP2;KCNN3;PIEZO2;SLC9A3;CHRNA4;SLC1A2;SLC26A2;SLC12A7;SLC1A3;SLC8A3;PANX1
prerank,KEGG_2021_Human__Cholesterol metabolism,-0.2968108100628788,-1.0761624282204176,0.3333333333333333,0.6051503283204337,1.0,16/50,22.41%,LPA;CETP;LCAT;APOA4;APOA1;LIPG;ABCG8;ABCG5;ANGPTL3;LIPC;PLTP;NCEH1;APOH;MYLIP;APOB;LDLR
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.38991420095373247,1.0761347104493488,0.33714285714285713,0.9370523310030222,1.0,9/37,25.26%,GLUL;SPHK1;PORCN;NAA10;KAT2A;ING5;HHAT;ZDHHC1;ZDHHC9
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.3402066894088833,-1.07561637072761,0.3142857142857143,0.6063634223359123,1.0,5/24,13.82%,ATP10B;TMEM30B;ATP11C;ABCB1;ATP8B4
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.24735338850285268,-1.0754125375277932,0.23529411764705882,0.6064692766903176,1.0,77/297,17.18%,CXCL13;NLRP7;TSHR;WNT7B;RET;CRHBP;IL10;CXCL10;AOC1;CXCL11;KCNE1;IL1B;ACOD1;P2RY12;NR4A3;FOS;STAP1;SFRP1;LTK;CD80;CXCL3;FFAR2;TNIP3;CXCL9;CPEB1;CPEB3;CCR5;SSTR2;ESR1;PDK4;CASP1;PDGFRA;OR51E2;ZFP36L1;P2RX3;WNT2;CXCL2;NLRP3;FOXO1;WNT10B;CCL2;EGR1;IL6;WNT11;AXL;GPLD1;LILRB1;CD274;IGFBP5;P2RY1;PDCD1LG2;CXCL8;CD180;TICAM2;RORB;TLR4;SHMT1;BRINP2;TLR2;CARD16;AKT1;SOX9;GNG2;PF4V1;MYD88;LDOC1;NUGGC;CD86;TNFRSF1B;CFTR;CXCL1;PDK3;GUCY1B1;PTK6;LILRB2;EZR;NCF1
prerank,Elsevier_Pathway_Collection__Sonic Hedgehog Signaling in Neuroblastoma,0.4213889377602568,1.0753622310734017,0.3502824858757062,0.9392034814300854,1.0,1/19,0.23%,IGF2
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.40122686361582494,1.0753295662193156,0.3270440251572327,0.9386745653644086,1.0,7/27,18.45%,GNG4;GRIK4;GNG3;MPP3;GNB5;GNG8;GNG10
prerank,Elsevier_Pathway_Collection__Neurotrophic Factor Deprivation in Retinal Ganglion Cell Death,-0.32324147690969984,-1.0752858200738746,0.28378378378378377,0.6063842362372129,1.0,12/34,22.85%,NTF3;NTRK2;LIFR;NGFR;NGF;NTRK1;AKT1;IRS2;MAP2K3;MAP2K6;JAK2;MAP3K5
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.3863475297110911,1.0751742368151147,0.34502923976608185,0.9385860512521411,1.0,8/34,21.40%,EPHB2;STMN3;ARHGAP44;RASIP1;ABL2;STMN1;SPRY3;TGFB2
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.3841072294733301,1.0750943340603147,0.3575418994413408,0.9382256597477936,1.0,5/41,10.88%,DUSP9;TNFRSF19;IRAK1;IKBKG;IRAK2
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,0.37038680938852064,1.0749335121447015,0.3763440860215054,0.9382165600730035,1.0,37/56,47.30%,PSMD4;PSMB4;PRKCA;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;GSK3B;SUFU;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;BTRC;PSMC2;CSNK1A1;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.35778913069041596,-1.0747747246344574,0.34177215189873417,0.6071768687397056,1.0,7/24,9.37%,CLTRN;SYT9;SYT10;SYT8;SYT1;SYT7;SYT4
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.4602751753447444,1.074644760512125,0.3931034482758621,0.9386787588248829,1.0,10/16,36.17%,HDAC4;RASD2;PIAS3;PIAS1;CTNNB1;PARK7;PIAS4;SAE1;UBA2;GNL3L
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.36070373714660264,1.0745956602525277,0.36363636363636365,0.9382355182859191,1.0,3/55,1.11%,MUC7;MUC13;GXYLT2
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.4542562920737292,1.0743960037815976,0.45962732919254656,0.9383771298251512,1.0,2/15,4.00%,ARG2;NQO1
prerank,Elsevier_Pathway_Collection__Leukocyte Adhesion to Endothelial Cell,-0.3489058632218736,-1.0743905286342825,0.30434782608695654,0.6076449676932432,1.0,13/30,21.99%,GPR182;ICAM3;CD2;SELE;CD226;VCAM1;ITGB2;ITGA9;ITGA4;SELPLG;SELL;SELP;ITGAM
prerank,Elsevier_Pathway_Collection__TNF-alpha/TNFRSF1B Signaling,-0.3639074176809566,-1.0743611764164827,0.38961038961038963,0.6072361744559115,1.0,7/22,21.42%,TNF;FOS;AKT1;LTA;TNFRSF1B;MAP2K3;JUN
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.3369632273701225,1.0743254602056642,0.3160621761658031,0.9380157866018116,1.0,44/73,47.20%,RFC4;POLD1;POLR2L;UVSSA;POLR2K;LIG3;POLR2G;COPS5;CUL4B;UBA52;PCNA;XRCC1;POLR2H;COPS7B;COPS6;LIG1;POLR2I;POLR2J;XAB2;DDB1;POLR2A;ERCC2;COPS8;USP7;GPS1;POLR2B;RPA2;POLK;RFC3;POLD3;RBX1;UBC;POLR2F;ERCC3;POLD4;COPS7A;COPS4;XPA;ERCC1;RPS27A;RPA1;PRPF19;RFC1;GTF2H2
prerank,Elsevier_Pathway_Collection__Axonal Transport,0.4002862871955564,1.074261053046005,0.34782608695652173,0.9375715826522751,1.0,4/25,12.86%,KIF1A;KIF5A;BDNF;SNAP25
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.37044670417042447,1.0741655256182818,0.3651685393258427,0.937303824971021,1.0,10/45,12.10%,GHRHR;SYT3;MAPT;RNF157;UNC13A;BDNF;SYT2;ZP3;LEP;SEMA7A
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.3343561007606577,1.0741109673372684,0.39805825242718446,0.9368722661262605,1.0,7/83,11.43%,TRIM71;IGF2BP1;IGF2BP2;RTN2;SPHK1;NANOS1;TYMS
prerank,Elsevier_Pathway_Collection__IL1R -> NF-kB Signaling,-0.3677699349106883,-1.0740979446309122,0.3950617283950617,0.6075619994539198,1.0,7/19,22.85%,IL1B;IL1RAP;MAP2K1;MYD88;MAP2K3;MAP2K6;MAP3K5
prerank,TRRUST_Transcription_Factors_2019__SP3 mouse,0.3344409755496799,1.074094820087248,0.30456852791878175,0.9363142084740351,1.0,18/70,22.19%,COL2A1;HMGA2;TERT;RHO;ITGA6;TESC;TFAP2C;KCNN3;LPL;LMNA;ACACA;ANGPT2;NES;ADCY4;CDK5R1;MGP;SETDB1;LIPE
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.4096582109890022,1.0738843868864174,0.38011695906432746,0.936532743392405,1.0,2/31,2.84%,DYNC1I1;MAPT
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.377715600526081,1.0728144001289794,0.34594594594594597,0.93982915940345,1.0,33/52,47.30%,CDC20;PSMD4;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;BTRC;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,TRRUST_Transcription_Factors_2019__YY1 mouse,0.4176343954150869,1.0727781432695407,0.3696969696969697,0.9392979060836344,1.0,6/20,13.06%,PAX2;PEG3;CDKN2C;COL1A1;TNFRSF4;RGS16
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.38856626907271496,-1.0727094525280962,0.3950617283950617,0.6106618416605682,1.0,2/19,5.74%,RIPK3;TLR3
prerank,Elsevier_Pathway_Collection__Dedifferentiation and Metastatic Progression in Melanoma,0.3914658180119985,1.072569762398091,0.38341968911917096,0.9394494615212249,1.0,16/37,29.93%,NODAL;KISS1;SNAI2;EFNA1;JAG2;POU5F1;MCAM;PDPK1;NOTCH4;DLL4;SNAI1;ROR2;PTK2;TRPM1;FZD2;MMP14
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.31627762786935104,1.072513525600335,0.3165137614678899,0.9389997796186556,1.0,73/137,46.75%,CDC20;UBE2C;PRKN;RHOBTB1;UBE2S;KLHL13;UBE2Q1;ELOC;NEDD4L;NEDD4;DET1;PIAS3;ELOB;RHOBTB2;UBE2A;MID1;PIAS1;ANAPC11;UBR5;UBA1;COP1;CUL7;ANAPC7;UBE2M;CUL4B;UBA52;UBE4B;SMURF1;SOCS3;UBE2O;PIAS4;UBE2I;KEAP1;CUL1;UBE2QL1;DDB2;SKP2;SMURF2;SKP1;SAE1;UBA2;CDC23;UBE2Q2;UBE2D2;HERC1;DDB1;ANAPC1;UBE2J2;HUWE1;ANAPC2;HERC2;UBOX5;CBL;FBXW8;FBXW11;PPIL2;FBXO4;RBX1;ANAPC4;UBC;STUB1;WWP2;XIAP;BTRC;UBE3B;CDC34;TRIP12;RPS27A;ANAPC5;UBE2W;UBE2E3;UBE2F;PRPF19
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.27104313217440973,-1.0725039038748538,0.27450980392156865,0.6107813862387474,1.0,33/89,24.86%,S100A14;SFTPA1;TLR3;TNIP3;S100A8;SCIMP;RFTN1;TLR8;BTK;TICAM2;TLR4;TLR2;SFTPD;PLCG2;MYD88;ITGB2;LGALS9;CTSB;PIK3R4;TLR10;LGMN;NR1H4;CNPY3;TAB2;NMI;APOB;ITGAM;PIK3AP1;OAS1;TLR1;CTSS;CD14;LY96
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3273567917004122,-1.0720552467630309,0.34782608695652173,0.6115403508254147,1.0,16/37,25.56%,MARVELD3;PTPN22;DUSP10;FOXO1;DACT1;PER1;EZR;ITCH;NCOR1;DUSP1;GSTP1;SIRPA;KLHL31;F2RL1;PINK1;CYLD
prerank,Elsevier_Pathway_Collection__Cytokines Trigger Otitis Media,-0.29524913545391246,-1.0719879878060707,0.2923076923076923,0.611249107882929,1.0,24/66,25.27%,MUC5AC;CSF3;TNF;IL1B;IL1RAP;ITK;MAP2K1;CCL2;IL6;CXCL8;IL17RC;MYD88;HBEGF;VAV1;CXCL1;MAPK10;MAP2K3;MAP2K6;JAK2;STAT1;MAP3K5;MAP2K4;NR3C1;GAB1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.36582493049940484,1.0717585889013492,0.387434554973822,0.9412684862076904,1.0,33/53,48.53%,TERT;RECQL4;NSMCE2;RTEL1;H4-16;POLD1;DNA2;PARP1;RAD51;PRKDC;BLM;PCNA;DCLRE1B;TERF1;XRCC3;ACD;XRCC6;ATR;RPA2;TERF2;POLD3;APEX1;POLD4;LTO1;WRN;NBN;RIF1;CTC1;RPA1;STN1;MRE11;RAD50;PTGES3
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.4309503248718496,1.0716178655283062,0.36363636363636365,0.9411263449495436,1.0,7/24,21.74%,IGF2;EGFL8;SOX8;PTPRR;PKD1;STIL;ARNT2
prerank,Reactome_2022__Mitophagy R-HSA-5205647,0.39632500235194146,1.071270448888859,0.375,0.9417703643329426,1.0,9/27,29.98%,SRC;PRKN;SQSTM1;MTERF3;TOMM20;TOMM5;UBA52;ULK1;TOMM40
prerank,Reactome_2022__Digestion And Absorption R-HSA-8963743,0.4635624099708551,1.0711696394231813,0.3973509933774834,0.9414581275758869,1.0,5/16,12.26%,GUCY2C;CEL;SLC2A5;GUCA2B;PIR
prerank,MSigDB_Oncogenic_Signatures__BRCA1 DN.V1 DN,0.3315043980879269,1.0711359053300482,0.3383838383838384,0.9409351648331647,1.0,33/106,25.01%,PTH2R;AMBN;SMPX;PNMA3;ATP4A;GPR35;INPP5J;GDF5;OLFML2B;MSH5;SLC5A2;E2F2;GPR19;CNIH4;ITGB1BP2;MEOX2;CA14;ZMYND10;FOXJ1;GSDMD;GRIP1;HSD11B2;PDLIM3;KLHL11;STX10;GREB1L;PPP1R9A;DLK2;HHAT;ITIH3;CES1P1;SNAI1;CARD10
prerank,MSigDB_Oncogenic_Signatures__ATF2 S UP.V1 UP,0.315712174923022,1.070600572501531,0.33649289099526064,0.9421995587860847,1.0,38/162,16.44%,ODAM;SPDEF;HOXD10;PITX1;MPZ;PAGE4;KIF20A;ZFR2;ITGA6;NRXN3;FOXM1;TOP2A;SLC13A3;KCNB1;DBNDD1;STEAP1B;BAALC;PTGDS;OR2B6;FOXH1;CDKN3;GALR2;EZH2;MYO7A;KIF23;HBD;LHX6;PIR;IL32;CACNA2D3;PLAU;SCIN;UPP1;FOXJ1;CHML;HTR2B;MAP1B;MRAS
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.26935576295359903,-1.0703268562350536,0.25,0.6153668869211998,1.0,19/105,13.49%,ASCL1;NOCT;IL1B;SOCS2;PCK1;S100A14;APOA4;PTPN22;S100A8;ESR1;FOXO1;GCH1;NKX3-1;TNFRSF11A;HSD17B2;TRIB1;TLR4;SELE;SOX9
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.3347362472575574,1.0702647431623682,0.3299492385786802,0.9428571712089714,1.0,44/72,50.08%,SARNP;DDX39A;CASC3;NUP37;THOC5;RBM8A;CHTOP;NUP62;NXF1;TPR;NUP133;UPF3B;NUP155;NUP160;THOC1;POLDIP3;THOC6;NUP188;NXT1;THOC2;DDX39B;MAGOHB;SLU7;ZC3H11A;NUP205;NUP210;NUP214;GLE1;ALYREF;NUP107;U2AF1;U2AF2;RNPS1;AAAS;EIF4A3;MAGOH;NUP93;NCBP2;NUP88;SEC13;THOC3;SEH1L;POM121C;NUP42
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,0.37076859941128054,1.0701120682154392,0.3502824858757062,0.9427053743256246,1.0,36/54,47.37%,CDKN2A;SRC;PSMD4;PSMB4;PSMB3;PSMD14;UBA52;SMURF1;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;TGFB1;SMURF2;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;CBFB;PSMB1;PSMD3;MDM2
prerank,"Reactome_2022__Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",0.44579947546431914,1.0700423668005743,0.36538461538461536,0.9423752462778922,1.0,5/17,13.26%,GCG;CRHR2;PCSK1;LEP;UCN
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,0.3680238524466965,1.069808183380782,0.34946236559139787,0.9426174040961615,1.0,28/62,39.37%,NOTUM;SCUBE2;IHH;PSMD4;PSMB4;DHH;HHAT;DISP2;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;VCP;PSMD13;PSMB7;PSMA7;SHH;PSME3
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.28334591993318287,-1.0696064273688957,0.288135593220339,0.616978602155813,1.0,27/97,20.63%,WNT7B;EDAR;WNT7A;IL1B;WNT16;CD27;XDH;GDF6;CCR7;SCIMP;HAND2;FCGR2B;RASGRP1;MTURN;SPI1;RASSF2;MBIP;NCF1;TPD52L1;SLAMF1;GADD45A;FZD7;SERPINF2;NOD2;ARL6IP5;INAVA;SH3RF1
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.3610027063030933,1.06955725749593,0.33532934131736525,0.9429232410792219,1.0,14/40,28.07%,LEF1;SOX2;TCF7;PYGO2;BCL9L;BCL9;HDAC1;SOX13;KMT2D;SOX17;CTNNB1;TLE1;SOX7;UBA52
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.32422657581683945,1.0695036934621989,0.35046728971962615,0.9425113949060069,1.0,27/120,23.21%,KCNU1;CALCA;PLA2G2A;CACNA1S;CALML6;RAMP1;PLA2G2C;ADRA1D;NPR2;CACNA1C;PLA2G4C;ARHGEF11;RAMP2;PLA2G4F;ADCY6;PRKCA;ADORA2A;ROCK2;MYLK2;ADCY4;ADM;PLA2G6;ADCY2;CACNA1D;MYLK4;PLA2G4E;CALCRL
prerank,Elsevier_Pathway_Collection__Cortisol Signaling in Arterial Hypertension,-0.3996126698843673,-1.069485158851564,0.33783783783783783,0.616868463769783,1.0,3/17,10.26%,NR3C2;SCNN1G;SCNN1A
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.25978867883494294,-1.0692244860222253,0.22916666666666666,0.6171583343279045,1.0,17/113,12.39%,ITLN1;SCARA5;MIP;EHD3;GBP5;GNMT;TDO2;GLRA3;C9;P2RX3;PRF1;ACACB;ALOX5AP;KCNJ12;MAT1A;CARD11;SHMT1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.35380386693950705,1.069146357216164,0.34183673469387754,0.9431935528952011,1.0,11/63,10.11%,GRPR;CALCA;ACTN2;F2RL3;GPR35;LPAR4;OPRL1;ADRA1D;PTGER3;GALR2;C5AR2
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.45732794214740763,1.0691198553136587,0.38509316770186336,0.9426725762750492,1.0,5/15,24.92%,TOP2A;NAA10;HMGB3;TOP1MT;HMGB2
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.38446060650194425,-1.0691139528708764,0.38636363636363635,0.6169604203934075,1.0,6/17,16.35%,BMP10;NOG;HEY2;SHOX2;BMPR2;NOTCH2
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,-0.2661377835744708,-1.0690352759798576,0.2926829268292683,0.6167145599580288,1.0,20/111,13.03%,ASCL1;FOSB;EGR3;EGR2;ADCYAP1R1;FOS;ID4;ID2;NTRK2;BCL11B;TF;MAP2K1;KCNH8;EGR1;NGF;NTRK1;RPS6KA1;TRIB1;EGR4;PIK3R1
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Ovarian Cancer,-0.35479114440691206,-1.0689216793139733,0.34328358208955223,0.616574287970548,1.0,7/28,13.06%,WNT7A;HGF;NTRK2;ESR1;PDGFRA;LPAR2;AKT1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.46239907727796986,1.068806606686356,0.37341772151898733,0.9426419574762109,1.0,15/15,53.79%,JADE2;JADE3;HCFC1;WDR5;OGT;KAT8;MCRS1;KANSL1;PHF20;MEAF6;KANSL3;ING4;KANSL2;JADE1;KAT7
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.46239907727796986,1.068806606686356,0.37341772151898733,0.9426419574762109,1.0,15/15,53.79%,JADE2;JADE3;HCFC1;WDR5;OGT;KAT8;MCRS1;KANSL1;PHF20;MEAF6;KANSL3;ING4;KANSL2;JADE1;KAT7
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.4637424131982929,1.0686603163726154,0.39156626506024095,0.9418537873801938,1.0,6/15,32.85%,SRC;FHDC1;KCTD13;ARRB1;FAM171A1;ITGB5
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.4637424131982929,1.0686603163726154,0.39156626506024095,0.9418537873801938,1.0,6/15,32.85%,SRC;FHDC1;KCTD13;ARRB1;FAM171A1;ITGB5
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.38584788661494557,1.0685585624496219,0.33727810650887574,0.9415718992311297,1.0,9/33,17.92%,MESP1;BMP4;COL4A1;RASIP1;PODXL;SCRIB;PKD1;MEGF8;ACVRL1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.32647345835833985,1.0685213387601231,0.3434343434343434,0.9411108870177574,1.0,26/94,18.92%,CPLX2;CEL;CACNG5;MAPK8IP2;CHRNB2;UNC13A;GRIK2;SYN3;ATP1A2;BDNF;GRIK4;DGKI;CAMK2A;CHRNB4;MCTP1;NPTX1;SYN1;CPLX1;DLG4;GRM1;NPTX2;TMEM108;SLC8A3;NLGN2;SNCAIP;USP46
prerank,KEGG_2021_Human__Linoleic acid metabolism,-0.34667394792352507,-1.0684388214388671,0.37333333333333335,0.6173934715829825,1.0,10/25,17.42%,CYP2C19;CYP2C8;CYP1A2;PLA2G2D;CYP2C9;PLA2G4A;PLAAT3;CYP3A4;CYP2J2;PLA2G12A
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.2929361405290771,1.0683195405823418,0.3404255319148936,0.9412385821427889,1.0,52/307,15.00%,PAX2;GHRHR;DIO2;SIX1;PTH2R;C1QTNF3;EBF2;LEF1;LCN2;SIX4;FABP4;AXIN2;NODAL;ALOX12B;TERT;SAA1;GATA5;S100A13;MDK;MESP1;NOX5;AVPR2;BMP4;ADRA1D;FGF2;TMEM119;AGO2;PRDM16;TLE6;COL1A1;ZNF703;EZH2;LOXL2;OXTR;FOXC1;GPR3;SOX8;ZBTB7B;LEP;RGCC;CD36;ELOVL3;PDGFB;MFAP2;PDPN;UCN;HILPDA;KAT2A;ABCA7;FOXJ1;INHBB;LEPR
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.34345383017105174,1.0682016230037819,0.38,0.9410779288367781,1.0,43/83,43.56%,E2F1;PSMD4;CCNE1;CCNA2;CCNE2;PSMB4;CKS1B;CDC25A;E2F5;LIN37;LIN9;MYC;PSMB3;PSMD14;UBA52;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;CDK4;SKP2;SKP1;PSMC5;SEM1;PSMB6;PSMD8;E2F4;PSME2;PSMD13;PSMB7;PSMA7;PSME3;CDK2;CDC25B;PSMB2;PSMA6;RBBP4;UBC;PSMD9
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.33239319754480245,-1.067923077116391,0.3902439024390244,0.6183645591710313,1.0,9/28,12.59%,SLC6A19;SLC6A20;SLC3A1;SLC7A8;SLC38A4;SLC7A7;SLC7A5;SLC16A10;SLC38A5
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.3415403818352176,-1.0678792979440979,0.35802469135802467,0.6179784268409381,1.0,7/29,17.93%,EREG;ERBB4;NRG4;BTC;AKT1;HBEGF;NRG3
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.32101210319763057,1.0677548984820044,0.3140096618357488,0.942105719439833,1.0,18/96,11.42%,EPHB2;NRCAM;SCN1A;SCN4A;ITGA2;KIF4A;ANK1;SRC;CNTN1;NCAN;DCX;CNTNAP1;DNM3;RNASE1;MPP3;SCN4B;SCN2A;LAMC1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.35314881986487145,1.0677411030139212,0.366120218579235,0.9415186750958534,1.0,13/61,17.44%,CDH22;GJB6;CDH8;CDH24;GJC1;ZNF703;CNTNAP1;RAMP2;GJA5;PKP1;PRKCA;RHOC;CLDN5
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.3292443735146851,1.0677217924845144,0.3488372093023256,0.9409527912946098,1.0,17/94,10.26%,ACTL8;PAX2;SIX1;CCNO;SPINK5;E2F7;DLX3;VIL1;UPK1A;MESP1;SCUBE1;BMP4;DMBT1;UPK3A;E2F8;ZNF703;CDK1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.37776222159910555,1.0677009246950169,0.37209302325581395,0.9404034997312773,1.0,14/37,31.20%,TRIM40;ADGRB1;TIMP1;TIMP4;CTSA;HMGCR;RGP1;SNRNP70;CYP51A1;MAD2L1;MAD2L2;AZIN1;PIN1;DAB2IP
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,-0.3184569604977706,-1.067211627652927,0.40350877192982454,0.6192665425486579,1.0,3/44,3.20%,GSTA2;IL10;IFNG
prerank,WikiPathway_2021_Human__Gastric Cancer Network 2 WP2363,0.3999058741537717,1.06709902489833,0.4011627906976744,0.9418338400294775,1.0,15/31,27.37%,COL9A1;TOP2A;UBE2T;UBE2C;FANCI;RFC4;DSCC1;LBR;ATAD2;AHCTF1;CHTF18;MYC;CTNNB1;S100A6;LMNB2
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.4550245248297101,1.0670257001486478,0.4034090909090909,0.9415016627659382,1.0,6/17,24.51%,KAT2A;STIL;NUP62;CEP295;NPM1;PLK4
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.419254936010361,1.066822245693801,0.3625,0.9415222684767587,1.0,7/22,16.45%,MRAP2;APLP1;RNF157;KLK14;RGS14;STMN1;GRK3
prerank,WikiPathway_2021_Human__Oxysterols derived from cholesterol WP4545,-0.3173403557245461,-1.0666743753281716,0.37037037037037035,0.6203081317708683,1.0,11/41,14.14%,AKR1D1;ACOT11;CYP39A1;ESR1;GPR183;SCP2;CYP8B1;AKR1C4;NR1I2;CYP3A4;EPHX2
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,0.4105566231409975,1.066638192579113,0.38271604938271603,0.9414886761214447,1.0,4/27,7.62%,FGF20;FGF13;FGF17;FGF23
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.3817148110070497,1.066595339323738,0.37305699481865284,0.941037837497318,1.0,16/40,29.33%,FOXM1;USP51;SPIRE2;RTEL1;CHEK1;FIGNL1;SLF2;RAD51AP1;DDX11;RAD51;UBR5;OTUB2;OOEP;SIRT6;TIMELESS;MRNIP
prerank,Elsevier_Pathway_Collection__Myeloid Derived Suppressor Cells in Cancer Immune Escape,-0.29829067443051155,-1.066283423507317,0.3698630136986301,0.6209423378752508,1.0,16/50,19.32%,CSF3;IL10;IFNG;CSF3R;S100A8;IL6;PTGER4;CD247;CSF2;IL10RA;CSF1R;BCL2;NCF1;CSF2RB;NCF2;SELL
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.3892083347001878,1.0660025507758015,0.4095744680851064,0.9425374215699779,1.0,14/36,26.70%,PIK3R2;CHP2;CABP1;BMP4;APOD;ZIC1;ECT2;SMAD3;MAVS;TRIM28;UBR5;TPR;MDFIC;HYAL2
prerank,Elsevier_Pathway_Collection__CD157/ITGB2 Signaling in Myeloid Cell,-0.3583151688918386,-1.065967881282795,0.3466666666666667,0.6212137076031347,1.0,10/26,21.99%,BST1;CYBB;HCK;AKT1;SYK;FGR;VAV1;ITGB2;IQGAP1;ITGAM
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.3605316386172342,1.0658135060147427,0.34408602150537637,0.9425820683300498,1.0,28/42,47.91%,DTL;RFC4;POLN;POLD1;PCLAF;ISG15;FAAP20;PARP10;NPLOC4;TRIM25;UFD1;UBA52;SPRTN;MAD2L2;PCNA;POLH;VCP;RPA2;POLK;RFC3;POLD3;UBC;POLD4;PRIMPOL;RPS27A;RPA1;RFC1;POLE2
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.3665594592391845,1.0657939257043159,0.35294117647058826,0.9420233448738095,1.0,28/42,47.10%,DTL;RFC4;POLN;POLD1;PCLAF;ISG15;FAAP20;PARP10;POLA1;CDKN2D;TRIM25;UBA52;SPRTN;PCNA;HROB;POLH;VCP;RPA2;POLK;RFC3;POLD3;UBC;POLD4;WRN;PRIMPOL;RPS27A;RPA1;RFC1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.291862706888263,-1.0657920051105947,0.3,0.6212363492724063,1.0,22/54,18.93%,CYP2D7;PTGS2;CYP2C8;HPGD;CYP4A22;CYP4A11;CYP4F2;CYP2C9;CYP4F12;ALOX5AP;DPEP2;ALOX5;PLA2G4A;PON3;CYP4F3;PTGR1;TBXAS1;PON1;CYP2J2;MGLL;PTGIS;CYP4Z1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.3391289015700925,1.0657643845304596,0.3588516746411483,0.9415373477192683,1.0,9/80,8.21%,EPHA6;EPHB2;PAK3;GRIN1;EFNA3;SRC;EPHA10;EFNA4;EFNA1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.3912228242857617,1.065739787910968,0.36464088397790057,0.9409867932028139,1.0,2/29,0.92%,MT3;ADRA2C
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.39598464791297117,-1.0655790762563415,0.33663366336633666,0.6212197799577222,1.0,2/16,3.50%,SMPD3;TNF
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.40145415618387903,1.0654323870929419,0.35802469135802467,0.9415086469269391,1.0,4/30,5.63%,GLP1R;LGR5;CAP2;AVPR2
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,0.43970524360911833,1.0652236204111083,0.3493150684931507,0.9416818021864887,1.0,2/15,6.66%,VWF;SRC
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,0.3675103609064372,1.0650492675188132,0.3548387096774194,0.9416595225219094,1.0,10/43,17.26%,B3GALT1;B4GALNT1;A4GALT;B3GNT5;ST6GALNAC4;FUT5;ST8SIA5;GLA;B4GALT3;ST3GAL3
prerank,Elsevier_Pathway_Collection__Endothelial Cell Dysfunction in Early Diabetic Nephropathy,-0.32917787556701916,-1.0649752628515377,0.38028169014084506,0.622399346824981,1.0,7/24,14.37%,FOS;MAP2K1;CCL2;IL6;SELE;AKT1;VCAM1
prerank,WikiPathway_2021_Human__Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.3701097807346954,1.0649643538404603,0.3386243386243386,0.9413771668261574,1.0,22/45,34.82%,MAP3K9;TAZ;ADCY6;HRAS;SMAD3;LBR;ADCY4;PLEC;ADCY10;ADCY2;TGFB2;YY1AP1;MAP2K2;EMD;SYNE2;CFL1;ADCY8;TGFB1;ADCY9;SYNE3;BANF1;SYNE4
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,-0.33637727730513756,-1.0647162268970611,0.373134328358209,0.6226426689064626,1.0,10/27,16.80%,KLRD1;FYN;LCP2;BTK;LCK;PIK3R1;SYK;KLRK1;PLCG2;VAV3
prerank,KEGG_2021_Human__TNF signaling pathway,-0.27348840060570795,-1.064423355462291,0.2857142857142857,0.6228812712821638,1.0,35/111,21.42%,CXCL10;PTGS2;RIPK3;TNF;IL1B;CCL5;FOS;IL18R1;CXCL3;IL15;MAP2K1;PIK3CD;CXCL2;CCL2;IL6;SELE;PIK3R1;AKT1;VCAM1;CSF2;BAG4;CREB5;LTA;TNFRSF1B;CASP7;CXCL1;ITCH;MAPK10;LIF;MAPK13;NOD2;TAB2;MAP2K3;MAP2K6;JUN
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.298671365119045,1.0642831937609991,0.34334763948497854,0.9433628865523319,1.0,123/271,42.26%,PRKAA2;MAPK12;RHO;NEK2;PLK1;MAPK11;UNC119B;CDK1;TUBA4A;NR1D1;CCT3;BBS5;CEP131;IFT81;PRKCA;BBS2;SAMM50;MEF2D;PKD1;ATP5MF;PPARGC1B;TWNK;CETN2;CEP250;HAUS4;HAUS5;CRTC1;GLUD2;KIF24;DYNLRB2;POLRMT;ATP5F1D;MARK4;B9D2;B9D1;CRTC2;APOO;NUDT19;PLK4;DYNLL1;IFT27;PRKAB2;LIN9;SMARCD3;HCFC1;DYNLRB1;CEP70;SFI1;TFB2M;MTX1;SSNA1;ASAP1;BBS4;SMOX;MICOS13;NPHP4;FBF1;KIFAP3;ATP5F1E;CEP97;ATP5MC1;ATP5ME;EXOC4;GDNF;CSNK1D;PPRC1;TUBA1A;ALMS1;EXOC3;CEP290;TTC30A;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;CEP89;KIF3B;TBL1X;TUBG1;CEP72;DYNC2LI1;NCOA2;PPP2R1A;CCT8;HSPB11;RPGRIP1L;RAB11FIP3;NDE1;MICOS10;C2CD3;CCT4;HAUS1;TTC30B;PTGES2;NCOA6;ARL3;INPP5E;TUBB4B;IFT80;SDCCAG8;CCT2;HSP90AA1;IFT140;CSNK1E;APOOL;MCHR1;CEP83;ATAT1;ATP5MG;EXOC8;CEP192;CHCHD6;NRF1;IFT172;PERM1;MTX2;ATP5PO;SSTR3;CKAP5;CCT5;TUBB4A;PRKD2
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.4160212651064056,1.0641967247569755,0.3742690058479532,0.9430529115751324,1.0,8/25,21.80%,FGF20;FGF13;FGF17;FGF23;SHC1;HRAS;FLRT1;PLCG1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.34684321982947175,-1.063814897695641,0.3283582089552239,0.6240568132330709,1.0,11/25,14.55%,LRRK2;CCL4;BST1;CCL3;P2RX3;PLEK;TRAT1;SLA2;CLEC7A;GBP1;PLCG2
prerank,"WikiPathway_2021_Human__GPCRs, Other WP117",0.34233374252340665,1.0634226782315683,0.3386243386243386,0.9450729721230807,1.0,9/63,7.51%,GRPR;GHRHR;LGR6;UTS2R;CELSR3;GPR62;ADRA1D;VN1R1;OR2B6
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.32256291563412004,-1.0633917293485056,0.3283582089552239,0.6248099412660625,1.0,10/36,16.35%,CSF3;SEMA3E;NTRK3;NTF3;STAP1;PDGFRA;HCK;HCLS1;CSF1R;NOTCH2
prerank,TRRUST_Transcription_Factors_2019__TRP53 mouse,0.31001296137434875,1.0633327631591174,0.3459715639810427,0.9447578099521301,1.0,38/145,18.71%,COL2A1;PAX2;E2F1;GLIPR1;TERT;FOXM1;SLC2A4;ADGRB1;GTSE1;BIRC5;SRC;PTGDS;CCNB2;SALL2;EDIL3;PDGFRB;CDKN2C;UHRF1;CCNA2;GDF15;GABRE;CCNB1;TYMS;NDRG1;CKS1B;E4F1;UPP1;CDKN1C;PSRC1;ANKRD1;HRAS;CHEK1;SMAD3;PKD1;GAP43;MCTS1;PIAS3;BBC3
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,0.35905503935262917,1.0632774301671917,0.3631578947368421,0.9443536627670244,1.0,29/47,50.08%,POLR2L;NUP37;NUP62;POLR2K;TPR;NUP133;POLR2G;NUP155;NUP160;POLR2H;NUP188;POLR2I;POLR2J;NUP205;POLR2A;NUP210;POLR2B;NUP214;GTF2F1;NUP107;GNL3;POLR2F;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.36077795732304563,-1.0631037079643884,0.4367816091954023,0.6251329693299442,1.0,14/22,31.20%,SERPINA5;PF4V1;CD177;F13B;PF4;SERPIND1;THBD;PROS1;FGG;FGB;F8;PROC;F2R;FGA
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.3912276849512172,-1.0627819090303658,0.39361702127659576,0.6255117799358085,1.0,6/15,16.17%,WNT7B;ERBB4;ID2;WNT2;AKT1;CSF1R
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.4407108990041473,1.0627436163353925,0.3558282208588957,0.9456832268704846,1.0,2/16,1.15%,COL22A1;COL15A1
prerank,WikiPathway_2021_Human__Matrix Metalloproteinases WP129,0.40784468864517825,1.0623452483496778,0.3614457831325301,0.9464753666613572,1.0,10/26,20.59%,MMP11;MMP21;TIMP1;MMP12;MMP17;MMP10;TIMP4;TCF20;MMP9;MMP3
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.4563750961765194,1.0623291754060993,0.38509316770186336,0.945939286132745,1.0,5/17,11.68%,HCN2;CACNA1G;ATP1A2;SCN4B;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.3802285933783782,1.062276075076105,0.39444444444444443,0.9454774663976317,1.0,6/38,5.95%,KCNJ6;KCNE5;ACTN2;KCNH2;KCNJ9;KCNJ5
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.3833358892959232,1.0622545177235734,0.3313953488372093,0.9449315988299866,1.0,8/32,16.48%,KIF14;SSTR5;AURKB;CDC6;KIF23;RACGAP1;HTR2B;ECT2
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.37798714703368397,1.0620499540232649,0.40236686390532544,0.9450810170905195,1.0,19/36,33.58%,AGBL1;TTLL10;TUBB8;TUBB8B;TTLL4;TUBA3E;TPGS1;TTL;TUBB2B;TUBA3D;TTLL11;SVBP;TTLL1;TUBB2A;AGBL5;VASH2;TUBA1A;TUBA1B;TTLL3
prerank,MSigDB_Oncogenic_Signatures__BMI1 DN MEL18 DN.V1 UP,0.31052680337179284,1.0618512390973318,0.37383177570093457,0.9451457001780212,1.0,24/131,15.45%,HTR1D;SLC7A11;COL7A1;SLC22A4;P2RX5;CDH13;GAL;GDF5;FAP;SLC6A9;NTM;KCNN3;PTHLH;SLC1A4;KIF21B;ARL4A;ADM2;STC2;PODXL;ARNTL2;CSPG4;TUFT1;VLDLR;PIM1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.38838865426733066,1.0616267131222028,0.39080459770114945,0.9453592598925113,1.0,20/37,30.72%,SQLE;FDPS;HSD17B7;MVD;ACLY;HMGCR;TM7SF2;IDI1;LBR;PMVK;NSDHL;CH25H;FDFT1;HMGCS1;CYP51A1;NPC1L1;INSIG2;ARV1;G6PD;GGPS1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.2268860406206884,-1.061499126041254,0.2916666666666667,0.6283514999572368,1.0,16/255,4.42%,KLK3;CNDP1;CAPN13;PCSK2;CAPN6;TMPRSS3;TMPRSS4;RET;PRSS16;PRSS21;PRSS22;ADAMTS13;WFDC2;MMP1;HGF;CPA5
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.32703713582570815,1.0614620902112044,0.3582089552238806,0.9453792406170864,1.0,38/75,45.00%,CDKN2A;NSMCE2;PCGF2;CETN2;NUP37;POLR1A;PARP1;PIAS1;CBX8;NUP62;BLM;TPR;NUP133;MDC1;NSMCE1;NUP155;NUP160;PIAS4;SMC3;UBE2I;CBX2;NUP188;SMC1A;NUP205;STAG2;PMEPA1;HDAC7;NUP210;HERC2;RAD52;NUP214;XPC;RAD21;NUP107;RING1;AAAS;PHC2;WRN
prerank,TRRUST_Transcription_Factors_2019__VDR human,-0.3370616468001024,-1.0614345279943302,0.3333333333333333,0.628070199889407,1.0,13/37,13.38%,FOXP3;TRPV6;IL10;CST5;PLD1;CDH1;IGFBP3;CYP3A7;IL6;IL12B;CXCL8;CYP3A4;CAMP
prerank,MSigDB_Oncogenic_Signatures__PDGF ERK DN.V1 UP,0.31923152169472935,1.0611802999531963,0.38028169014084506,0.9457389171615769,1.0,11/123,6.79%,PAX2;FSTL4;TSPAN5;ZIC4;LUZP2;OCA2;OXCT1;CCL25;RALYL;COL10A1;PTGDS
prerank,Elsevier_Pathway_Collection__IgE Induces Airway Smooth Muscle Cell Proliferation,-0.31239923029686767,-1.0609247144247416,0.3225806451612903,0.6289641922037283,1.0,12/41,14.94%,MAP2K1;FCER1A;EGR1;IL6;BTK;AKT1;TSLP;RASGRP1;SYK;LAT2;PLCG2;FCER1G
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.4035068384395924,1.0606913252669101,0.3888888888888889,0.9467638140923389,1.0,3/22,5.23%,IRX3;ALPK3;MESP1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.4226742164839158,1.0604802783745177,0.4057142857142857,0.9468959366725646,1.0,4/25,3.21%,CEMIP;F2RL3;THY1;CASQ1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.2783344452185158,-1.060478683958897,0.2708333333333333,0.6296107955599225,1.0,26/98,20.96%,GABRB1;TSHR;CRHBP;AOC1;KCNE1;P2RY12;SFRP1;CDH1;CPEB1;CPEB3;ZFP36L1;P2RX3;EGR1;IGFBP5;P2RY1;SOX9;CFTR;EZR;AKAP6;SESN2;NR1H4;MAPK13;PDE2A;IMPACT;GABRB2;XBP1
prerank,Elsevier_Pathway_Collection__EGFR -> SMAD1 Signaling,-0.35835704063164836,-1.0601468227448314,0.43209876543209874,0.630088209261734,1.0,9/23,17.93%,EREG;ITK;MAP2K1;TGFA;BTC;RASGRP1;HBEGF;VAV1;NRG3
prerank,KEGG_2021_Human__Huntington disease,0.29431709936287964,1.0600701064523448,0.32051282051282054,0.9477015755554589,1.0,136/274,40.49%,GRIN1;COX4I2;DNAH17;KIF5A;BDNF;NDUFA4L2;PSMD4;TUBB8;DNAH12;CLTCL1;TUBA4A;NDUFA1;SLC1A2;TUBA3E;CREB3L1;DNAH11;PSMB4;DLG4;GPX3;PPARG;TUBA8;NDUFS6;DNAH14;CREB3L4;SLC1A3;TUBB2B;GPX2;POLR2L;NDUFV1;NDUFB9;COX6C;COX7B;NDUFA3;TRAF2;BBC3;UQCRB;CLTB;TUBA3D;NDUFS2;STX1A;NDUFA9;TGM2;ATP5F1D;DNAH5;COX6B1;HDAC1;NDUFB11;NDUFA2;NDUFS7;POLR2K;COX8A;UQCRQ;CYC1;KLC2;GPX1;PSMD1;POLR2G;PSMB3;SLC25A6;COX7A1;PSMD14;NDUFA13;CLTA;RB1CC1;HIP1;UQCRHL;TUBB2A;NDUFA11;ATP5F1E;GPX8;PSMB5;NDUFA6;ULK1;ATP5MC1;UQCR11;PSMD2;NDUFS8;COX4I1;PSMA1;NDUFV2;POLR2H;COX5B;ADRM1;PSMC4;PSMC3;TUBA1A;NDUFA8;CASP9;NDUFB7;DCTN4;TUBA1B;DCTN2;UQCRH;DCTN3;POLR2I;NDUFAB1;POLR2J;NDUFB2;NDUFB10;UQCRC1;DNAH1;POLR2J2;BAX;PSMC5;CREB3L3;SEM1;PSMB6;PSMD8;POLR2J3;COX7C;AP2A1;MAP3K10;TUBB6;UQCR10;MAPK9;NDUFB3;PLCB4;TUBB4B;AP2S1;HTT;POLR2A;NDUFS4;PSMD13;PSMB7;PSMA7;DNAI1;DNAH10;DNAH6;DCTN5;SDHA;POLR2B;NDUFB8;SDHC;MTOR;COX6A1;TUBA1C
prerank,Elsevier_Pathway_Collection__P2RY1/2/4/6 -> Potassium Channels,0.4428154412901446,1.0597124599128411,0.3870967741935484,0.9482581290960791,1.0,2/16,5.95%,KCNJ6;KCNJ5
prerank,WikiPathway_2021_Human__Glycolysis and Gluconeogenesis WP534,-0.3158691624215403,-1.0596067369323678,0.3333333333333333,0.6310518483444474,1.0,10/43,14.58%,GCK;PCK1;HK3;ENO3;ALDOB;FBP1;G6PC;ALDOC;MPC1;SLC2A2
prerank,TRRUST_Transcription_Factors_2019__EGR1 mouse,-0.2802635005862293,-1.0594901196445448,0.3,0.6308858182796451,1.0,14/66,12.18%,PDX1;TNF;TH;RCAN1;IL1B;NR4A1;NGFR;CAT;CXCL2;CCL2;ITGB6;NTRK1;PTGES;CHRNA7
prerank,WikiPathway_2021_Human__Prion disease pathway WP3995,-0.3208189217320833,-1.059486847155082,0.32432432432432434,0.6304188498726756,1.0,8/33,18.69%,IRF4;NCAM1;FYN;POU2F2;SPI1;PRNP;BCL2;BATF
prerank,"WikiPathway_2021_Human__GPCRs, Class A Rhodopsin-like WP455",0.30610096955280514,1.0592617720112059,0.3271889400921659,0.9492942261095324,1.0,36/155,14.61%,GRPR;HTR1D;ADRA2C;F2RL3;OPN1SW;GPR35;LPAR4;RHO;OPRL1;HTR4;AVPR2;CHRM4;HRH3;ADRA1D;PTGER1;PTGER3;OR2B6;SSTR5;CCR3;GALR2;ADORA1;GALR3;HCAR1;OXTR;GPR19;C5AR2;GPR3;CHRM5;BDKRB2;GALR1;PTGFR;MC1R;BDKRB1;MLNR;GPR21;HTR1B
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.3712044209422187,1.0591828049815872,0.36548223350253806,0.9489687416429241,1.0,5/36,7.36%,OSR2;OSR1;WNT4;BMP4;TMEM119
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,-0.36941981409967195,-1.0590952704465506,0.323943661971831,0.6309285751227057,1.0,8/24,15.22%,IGLL5;PLPP4;CD247;PLD4;PIK3R1;SYK;PLCG2;PRKCE
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,0.3176441945610303,1.0590339485716758,0.36936936936936937,0.9488846055704478,1.0,16/128,6.72%,DLX5;DUSP9;PIK3R2;AXIN2;MAPK12;NODAL;WNT4;SOX2;WNT9B;OTX1;WNT8B;MAPK11;TBX3;BMP4;TCF7;FGF2
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.32266886789366916,1.0588384982827581,0.3605769230769231,0.9489640375160394,1.0,49/125,40.31%,DYNC1I1;PRKAA2;SRC;PRKN;LAMTOR2;VPS28;RNASE1;MVB12B;SQSTM1;MTMR3;VPS37D;WDR45;LAMTOR4;MTERF3;TSC1;TOMM20;TSC2;ATG10;DYNLL1;PRKAB2;HSF1;TOMM5;HSP90AB1;RB1CC1;UBA52;GFAP;RHEB;ULK1;TOMM40;PARK7;CHMP2A;MLST8;DYNC1H1;GABARAP;LAMTOR5;RRAGD;CSNK2B;HSPA8;MVB12A;RPTOR;UBE2V1;RRAGA;VCP;HSP90AA1;PLIN3;USP30;TOMM7;ATG4A;MTOR
prerank,TRRUST_Transcription_Factors_2019__LEF1 human,0.41969859588154695,1.0588019035912328,0.40425531914893614,0.948480459807692,1.0,5/25,7.28%,NRCAM;OCA2;SNAI2;BIRC5;DSG4
prerank,Elsevier_Pathway_Collection__Neurofibrillary Tangle Formation,0.46187003258019627,1.0587283753506544,0.44785276073619634,0.9481475187541882,1.0,7/16,25.23%,MAPT;GRIN2A;HSPB1;CDK5R1;TGM2;FADD;CDK5
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.34858389377979676,1.0583668725169413,0.3595505617977528,0.9490033012626984,1.0,34/76,39.37%,SLC7A11;NQO1;CDKN2A;PSMD4;TKT;PSMB4;UBL4A;MAFG;SQSTM1;TXNRD1;MYC;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;BRIP1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;TALDO1;GSK3B;PSMD13;PSMB7;PSMA7;PSME3
prerank,Elsevier_Pathway_Collection__Apoptosis Block by Death Receptor Signaling in Cancer,-0.2947859191875938,-1.0583487332559374,0.2835820895522388,0.6325631145500535,1.0,11/50,18.26%,TNF;FASLG;TNFSF10;TNFSF15;NGFR;NGF;REL;BCL2;TNFRSF10C;MAPK10;TNFRSF21
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.3547540668651388,-1.0583459590422637,0.42857142857142855,0.6320873487594327,1.0,8/20,18.45%,IFNL2;APOA4;FFAR2;DEFB1;CAMP;PIGR;BPIFB1;RAB17
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.3694224933899855,1.0583258762979617,0.35233160621761656,0.9485691052276269,1.0,16/47,24.03%,PLCH2;INPP5J;ITPKA;PLCH1;FGF2;ISYNA1;NUDT11;PPIP5K1;PLCD3;PLCD4;IP6K1;PLCG1;INPPL1;ITPKC;IMPA1;OCRL
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.41845793287645316,1.0583115793470432,0.3496932515337423,0.9479923536606302,1.0,15/23,47.41%,USP27X;OTUD7B;OTUB2;BAP1;MINDY1;OTUD3;TNFAIP3;USP5;MINDY2;OTUD5;USP20;USP37;OTUD7A;USP34;OTUB1
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.40364364214854587,-1.058026671815044,0.4024390243902439,0.6325174147878637,1.0,10/18,31.68%,FCGR2B;PIK3R1;BCL2L11;PMAIP1;XBP1;RNFT1;RNF185;ERN1;ATXN3;RNF183
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.30458438641560115,1.0577995643237141,0.34841628959276016,0.9493350612270882,1.0,70/181,34.33%,REN;PIK3R2;TNNI3;MAPK12;COX4I2;SLC2A4;MAPK11;NDUFA4L2;CAMK2A;COL1A1;ATP2A1;CPT1B;CD36;NDUFA1;ACE;COL1A2;CMA1;PRKCA;NDUFS6;SMAD3;NDUFV1;NDUFB9;COX6C;COX7B;NDUFA3;UQCRB;CTSD;MMP9;NDUFS2;NDUFA9;ATP5F1D;TGFB2;COX6B1;PARP1;NDUFB11;NDUFA2;NDUFS7;COX8A;UQCRQ;CYC1;SLC25A6;MPC2;COX7A1;NDUFA13;UQCRHL;NDUFA11;ATP5F1E;AGT;GAPDH;NDUFA6;ATP5MC1;UQCR11;COL3A1;NDUFS8;G6PD;COX4I1;NDUFV2;COX5B;PIK3R3;ATP2A2;NDUFA8;IRS1;SLC2A1;NDUFB7;TGFB1;UQCRH;NDUFAB1;NDUFB2;NDUFB10;UQCRC1
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.4136204999159585,1.057797475488045,0.3674698795180723,0.9487321720407922,1.0,2/17,7.91%,SRC;AGO2
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.3396875382260775,1.0577030691199718,0.3645320197044335,0.9484926513975217,1.0,10/64,11.46%,AGRP;PRKAA2;ACSBG2;ACSL6;SLC2A4;ACSL4;IKBKG;LEP;CPT1B;CD36
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.38949305828995406,-1.057642916430645,0.41379310344827586,0.6330625536449895,1.0,2/17,3.95%,TNF;IL1B
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3355053661511063,1.0573137033772282,0.3875598086124402,0.9494085949369191,1.0,18/91,15.53%,SLC22A12;CA4;SLC22A11;SLCO1C1;SLCO4A1;SLCO2A1;CA5B;SLC4A3;SLC4A1;SLC26A6;CA1;SLCO5A1;CYB5RL;CA14;SLC52A2;CYB5R1;ABCC5;AQP9
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.3480192274254446,-1.0572592694721792,0.34523809523809523,0.6336711051547357,1.0,4/25,13.58%,CSF3;CSF3R;HCK;SYK
prerank,KEGG_2021_Human__Taste transduction,-0.2977876212516611,-1.0572387299487136,0.2777777777777778,0.6332430237370565,1.0,17/50,18.37%,GABRA5;GABRA3;GABRA4;TAS2R60;TAS2R19;SCN9A;P2RX3;SCNN1G;SCNN1A;P2RY1;PDE1B;PLCB2;KCNK5;SCN3A;TAS2R31;TAS2R14;CHRM3
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.36741701660557435,1.057095748323902,0.40217391304347827,0.9496210558944955,1.0,19/42,33.69%,LAGE3;CTU1;FTSJ1;PUS1;EPRS1;DUS2;WDR4;TRMT61A;TRMU;TRMT112;THADA;METTL1;ADAT3;QTRT1;TRMT12;TYW5;PUS7;CTU2;TP53RK
prerank,WikiPathway_2021_Human__1q21.1 copy number variation syndrome WP4905,0.4077526353936788,1.056814463298493,0.40860215053763443,0.9499758076905293,1.0,10/25,27.32%,PRKAA2;GJA5;ACP6;PYGO2;BCL9;PRKAB2;GJA1;F11R;CTNNB1;CHD1L
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.383830427417343,1.0565499063539934,0.3539325842696629,0.9503388713301747,1.0,2/31,5.93%,B4GALNT2;DPM3
prerank,TRRUST_Transcription_Factors_2019__HNF1A mouse,-0.3842121947869967,-1.0563165643943,0.37037037037037035,0.6352660318469264,1.0,5/19,8.37%,SLC6A19;CYP39A1;PCK1;CYP1A2;CYP8B1
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.24401353035670617,-1.0561749167343217,0.35294117647058826,0.6351707003714069,1.0,51/181,24.54%,IRF4;GBP6;IFNG;GBP5;EIF4E3;OASL;BCL11B;NCAM1;GBP7;IFI30;CAMK2B;RSAD2;GBP4;EGR1;TRIM10;HLA-DQA2;HERC5;IRF8;TRIM22;MX2;GBP1;USP18;VCAM1;IFIT2;RNASE7;MT2A;IFIT3;HLA-DQA1;TRIM5;PTAFR;UBE2E1;UBE2L6;HLA-DQB2;OAS3;OAS2;HLA-DRB5;IFIT1;SMAD7;HLA-DRA;JAK2;STAT1;EIF4A1;TRIM31;IRF2;HLA-DPA1;OAS1;TRIM21;TRIM29;TRIM14;IRF9;HLA-DRB1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.38103240186343285,-1.0559688245538694,0.4117647058823529,0.6352719336170857,1.0,7/16,25.98%,AGL;AOAH;PYGL;PGM2;PGM2L1;MGAM;CALM1
prerank,WikiPathway_2021_Human__Nanoparticle-mediated activation of receptor signaling WP2643,0.39539910005228696,1.0555179201168357,0.3898305084745763,0.953468039620607,1.0,4/28,8.70%,MAPK12;MAPK11;SRC;COL1A1
prerank,Elsevier_Pathway_Collection__Vascular Smooth Muscle Cell/Pericyte Migration and Proliferation,0.35429644575131064,1.0552374367895712,0.35638297872340424,0.9539509854014518,1.0,8/48,14.64%,SPP1;SRC;FGF2;PDGFRB;HSPB1;PDGFB;MAPKAPK2;SHC1
prerank,TRRUST_Transcription_Factors_2019__E2F4 human,0.4181355245893231,1.0551155644074177,0.40372670807453415,0.9538229528379158,1.0,12/23,26.07%,PLK1;BIRC5;TTK;AURKB;CCNB1;MCM10;PPARG;PCLAF;RAD51;PLK4;HCFC1;MYC
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.3506707198695232,-1.054773653744634,0.36923076923076925,0.6380994594634227,1.0,9/28,23.72%,ADRA1A;SLC35G1;JPH3;SLC8A1;MCUB;ATP2A3;JPH4;MICU1;ITPR3
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.32683255537794925,1.0547719141857599,0.4009216589861751,0.9544690224317105,1.0,20/100,17.35%,HMGA2;DIRAS1;CEMIP;ROBO1;SRC;FGF2;IRAK1;ATP2B4;PDGFRB;EZH2;RGCC;PDGFB;FLT1;PDGFA;PSRC1;HRAS;HTR2B;DIRAS2;PKD1;EGF
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.3200881646623121,1.0546873067165499,0.35348837209302325,0.9541310749960882,1.0,20/114,15.60%,HMGA2;VEGFD;S100A1;NODAL;CHI3L1;MDK;CD34;FGF2;SPHK1;AGO2;CCR3;HSPB1;PRKD1;ADM2;RAMP2;FLT1;PGF;SMOC2;PDPK1;PRKCA
prerank,WikiPathway_2021_Human__MAPK pathway in congenital thyroid cancer WP4928,-0.39055605571972785,-1.0543949719227717,0.41379310344827586,0.6386417150348634,1.0,3/16,7.46%,FOS;ALK;MAP2K1
prerank,TRRUST_Transcription_Factors_2019__REST human,0.41867009410233413,1.0543122013809525,0.41040462427745666,0.9548634594840675,1.0,6/20,12.45%,CHGB;GRIN1;BDNF;VGF;PCSK1;SYN1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.4384129012955022,1.0542813546126395,0.39215686274509803,0.954346762082881,1.0,1/18,0.71%,SFN
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.3720876608005712,1.054272757263667,0.3611111111111111,0.953787111438451,1.0,9/47,11.34%,MAPK12;ROBO1;MAPK11;SRC;TRPC6;UNC5A;RGMA;RNASE1;ABLIM2
prerank,KEGG_2021_Human__Fatty acid biosynthesis,0.43787849592156564,1.0542725923895984,0.3630573248407643,0.9531780519803166,1.0,6/18,17.93%,ACSBG2;ACSL6;ACSL4;ACACA;OLAH;ACSL5
prerank,MSigDB_Oncogenic_Signatures__NRL DN.V1 UP,0.31075161685543623,1.0542340434603852,0.3767441860465116,0.9527135109309216,1.0,19/119,13.97%,RHBDL3;DIRAS1;ELAVL3;ARG2;RHO;NUF2;KCNB1;RHPN1;FOXH1;KCNJ14;CCNA2;ZC3H3;TFF3;SCN2A;HAS1;APC2;MC1R;SLC29A2;HIC2
prerank,Elsevier_Pathway_Collection__DNMT and MBD Families Activation in DNA Methylation in Cancer,0.43443118454488633,1.0539844354265144,0.4090909090909091,0.9529808683420716,1.0,9/17,29.80%,PDK1;CDKN2A;UHRF1;DNMT3A;DNMT1;DNMT3B;MECP2;CDKN1A;PCNA
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.34759627748733257,-1.0539492401339245,0.39,0.6393492964671266,1.0,4/22,9.95%,CIDEA;CIDEC;HSD17B13;SMIM22
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.3206668183715291,1.0532164258624452,0.3888888888888889,0.9551271873911059,1.0,14/100,15.74%,SFN;CEMIP;EPHB2;E2F1;TP73;KCNB1;NKD2;ATP2B4;PRKN;DPP10;TCAF2;SQSTM1;PDPK1;HRAS
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.34521659292324136,1.0532153159518909,0.3627450980392157,0.9545188261252517,1.0,16/71,15.74%,RASGRF1;ACTN2;PRKAA2;MAPT;GPRIN1;SRC;CAMK2A;GRIN2A;GRIN3B;RNASE1;MPP3;RASGRF2;PPM1F;PDPK1;PRKCA;HRAS
prerank,Elsevier_Pathway_Collection__FOXO1 and SREBP-1C Role in beta-Cell Suppression (Rodent Model),0.3755871792158905,1.0523696161708815,0.37640449438202245,0.9570502843387672,1.0,2/31,3.38%,MAFA;NEUROD1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.34994489963009845,-1.0523391515099014,0.3218390804597701,0.6430272036737779,1.0,8/26,11.52%,NRXN1;WNT7A;EPHB1;IL1RAP;SEMA4A;SEMA4D;EPHB3;PTPRD
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.4007594815707944,1.0523154243209076,0.367816091954023,0.9566151511311173,1.0,11/25,33.82%,ATP6V0D2;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1C1;ATP6V1H;ATP6V1F;ATP6V1E1;ATP6V1E2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.341662041489498,1.052172557471726,0.4019138755980861,0.9564344129051671,1.0,34/71,35.93%,FGF13;STMN2;PRKN;CHADL;SPEF1;APC2;IAPP;STMN1;ARHGEF2;PFDN2;CYRIB;TRIM54;TWF2;TPX2;KANK3;SHANK3;ARPIN;CAMSAP2;CAMSAP1;CLIP3;MID1IP1;VBP1;KATNB1;TBCD;PFDN6;APOE;TREM2;SHANK1;KANK1;CRYAB;SSH1;CAMSAP3;CIB1;HSPA8
prerank,Elsevier_Pathway_Collection__Club-Cell Role in Asthma,-0.3202163935824325,-1.0521546476643733,0.3870967741935484,0.6430029858135993,1.0,8/38,12.28%,IL13RA2;MUC5AC;SFTPB;LGALS3;NGFR;NGF;TICAM2;TLR4
prerank,MSigDB_Oncogenic_Signatures__CAHOY OLIGODENDROCUTIC,-0.27644321829428875,-1.0520416669538006,0.3448275862068966,0.6428087820517798,1.0,21/82,20.48%,ATP10B;FA2H;SOX10;RBM11;COL20A1;UGT8;FBP1;PRKCQ;SEMA3D;WIPF1;CPOX;DOCK10;TSPAN2;MAP3K15;PRKAG2;GAB3;SEMA5A;BCAS1;PPP1R21;CLN8;RNF122
prerank,Elsevier_Pathway_Collection__CC Chemokine Receptor Signaling,-0.2717138424920727,-1.0519903767516783,0.3617021276595745,0.6424789574835481,1.0,22/85,17.18%,CCR9;CCL5;CCR5;CCL4;CCL3;ITK;CCL23;MAP2K1;CCR7;PRKCB;CCL2;EGR1;CCR1;CCR2;GNA14;CCL22;AKT1;CCR4;TIAM1;VAV1;VAV3;NCF1
prerank,Elsevier_Pathway_Collection__Proplatelet Maturation,-0.267537404368797,-1.0519549752579134,0.3018867924528302,0.642119923359782,1.0,26/79,18.69%,PTGS2;TNF;CCL5;GP5;VIPR1;MAP2K1;CXCL12;CCL2;IL6;CD40LG;CXCL8;AKT1;RASGRP1;VCAM1;HBEGF;CXCR3;CSF2;CXCR4;SPI1;ITGB3;F3;GP1BA;GATA1;CSF2RB;ETS1;BATF
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",0.3853599307290668,1.0518178165956824,0.4067796610169492,0.9571407018299368,1.0,6/35,13.34%,GLUL;NAT8L;GAD1;RIMKLA;ASRGL1;CAD
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.3189389264794014,-1.051711789431285,0.34782608695652173,0.6423551611786741,1.0,12/37,17.78%,NLRP7;IL10;CHAC1;ECM1;LRRK2;GAS1;CST7;AKT1;CLN3;KNG1;PRNP;MAGEA3
prerank,MSigDB_Oncogenic_Signatures__PRC2 EZH2 UP.V1 DN,-0.2402029557119343,-1.051256752963924,0.3448275862068966,0.6431663725276572,1.0,52/172,19.88%,NR4A2;IL13RA2;EREG;SLC5A7;L1CAM;CCK;ART3;FOLR3;HS3ST3A1;KCNA2;PCDH9;GPM6B;SRD5A1;TSPAN7;TNFAIP6;COLEC10;NR3C2;KIR2DL4;SLC14A1;APOF;CDCP1;KCNJ10;FZD1;PRSS3;KLF4;CLEC4E;IL33;ARL4C;TRIB1;IRF8;PKIA;PAMR1;KYNU;SERPINB2;TBXAS1;FPR3;ST6GAL1;CROT;HBEGF;CCDC68;ALDH1A2;MEGF9;VWA5A;KCTD12;CCNJL;TTLL7;FXYD6;CLEC2B;ASPN;MTHFD2L;KIAA0895;DMD
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer-Associated Enabling of Replicative Immortality,0.4312295232100115,1.0510937979509014,0.4161849710982659,0.9590703541836988,1.0,2/19,3.20%,E2F1;TERT
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.3312257307591656,1.0510829964083264,0.42,0.958492123409683,1.0,12/96,11.20%,MUC7;MUC13;GXYLT2;GALNT13;SDF2L1;DPM3;MGAT5B;GALNTL6;B3GNT5;ST6GALNAC4;GALNT9;MUC4
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.37935568852122076,-1.0508164842025165,0.3684210526315789,0.643845088560412,1.0,5/21,4.76%,NDST3;B3GALT5;HAS2;B3GALT2;B3GNT7
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.32261712554177374,-1.0506322636511842,0.36619718309859156,0.6438415379607109,1.0,7/32,12.50%,NKX2-1;WNT7B;FGF10;FGFR2;WNT11;TCF21;ERRFI1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.3679912483952845,1.0505779392832226,0.375,0.9596870110504643,1.0,10/41,15.82%,ALOX15B;PLPPR1;PLPP2;ALOX12B;DGKI;PORCN;DGKD;ALOX12;PLPP1;PLPPR2
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.2660606099999663,-1.0505576648383228,0.32432432432432434,0.6435631644810884,1.0,32/90,23.30%,IL10;INHBA;SFRP1;TNFRSF13B;FGFR2;PLEK;PTPRC;WNT10B;RUNX3;ZNF160;LCK;RASGRP4;FLT3;PLD4;PGM3;RUNX2;CSF2;MIXL1;ARMC6;CSF1R;NOTCH2;SFRP2;SELPLG;MEIS1;IFI16;WNT5A;ASH2L;TEK;FUT10;GLRX5;SNRK;SH2B3
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.3614850419797574,1.0502451403740845,0.4134078212290503,0.9602575229306819,1.0,26/52,39.68%,SCUBE2;IHH;CDON;KIF7;DISP1;HHIP;GRK3;MEGF8;DHH;BOC;IQCE;HHAT;GLI1;GPR161;SMURF1;SMO;ARRB1;CSNK1D;CUL1;SMURF2;CSNK1G1;GSK3B;SUFU;SHH;CSNK1E;CSNK1G2
prerank,Reactome_2022__SUMOylation Of DNA Methylation Proteins R-HSA-4655427,0.4456785150127953,1.0502116109298885,0.39864864864864863,0.9597531245812311,1.0,7/15,31.65%,DNMT3A;PCGF2;CBX8;DNMT1;DNMT3B;UBE2I;CBX2
prerank,Elsevier_Pathway_Collection__ADRA1 -> Prostaglandin Generation,0.39792549468875776,1.0498648638049322,0.3821656050955414,0.960439511118411,1.0,4/22,8.09%,RASGRF1;ADRA1D;PTGDS;CAMK2A
prerank,WikiPathway_2021_Human__Aryl Hydrocarbon Receptor Pathway WP2873,-0.3010260738170044,-1.0497342350885857,0.3142857142857143,0.645304732097756,1.0,11/43,15.46%,GSTA2;IFNG;TNF;IL1B;UGT1A9;CYP1A2;IL12B;SLC7A5;SERPINB2;CES3;IGFBP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4207759376979575,1.0496644191167872,0.3860759493670886,0.9605896942988512,1.0,4/21,13.72%,TNNI3;ATP1A2;CACNA1C;GSTM2
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,-0.3410445298763644,-1.0496215362535426,0.4268292682926829,0.6451101112332047,1.0,8/29,17.74%,IGLL5;FOS;LCP2;SYK;PLCG2;VAV1;VAV3;MAPK10
prerank,WikiPathway_2021_Human__DNA Repair Pathways Full Network WP4946,0.3122604064200466,1.0496098002505232,0.3932038834951456,0.9601788040073704,1.0,72/119,48.60%,EXO1;NEIL3;NHEJ1;FANCI;RFC4;POLD1;CHEK1;FANCE;MSH2;CETN2;MUTYH;FEN1;PARP1;RAD51;PRKDC;FANCD2;APEX2;LIG3;FANCB;FANCG;CUL4B;MSH6;CENPS;POLB;PCNA;XRCC1;POLM;OGG1;BRIP1;DDB2;LIG1;BRCA2;PNKP;FAN1;CENPX;POLL;FAAP24;POLH;DDB1;GTF2H2C;ERCC2;XRCC6;ATR;FANCM;RPA2;RAD52;POLK;USP1;XPC;TERF2;RFC3;POLD3;RBX1;APEX1;ERCC3;RAD54B;POLD4;WRN;NBN;FANCA;XPA;ERCC1;RPA1;RAD51C;RFC1;GTF2H2;POLE2;MRE11;FAAP100;RAD50;NTHL1;PALB2
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.37691637356667457,-1.0495538154357804,0.38372093023255816,0.6448314116039707,1.0,9/20,25.86%,GCK;HK3;PGM2;DERA;SHPK;PGM2L1;PGD;HK2;RBKS
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.4195140470280304,1.0492049653727908,0.42073170731707316,0.9610727413849053,1.0,15/22,47.10%,RFC4;POLD1;NPLOC4;UFD1;UBA52;SPRTN;PCNA;POLH;VCP;RPA2;RFC3;UBC;RPS27A;RPA1;RFC1
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.437729231622395,1.0490032839580945,0.4034090909090909,0.9611683773397106,1.0,5/22,16.51%,SFN;SFRP4;BMP4;MAFG;ROCK2
prerank,Elsevier_Pathway_Collection__ROS and RNS in Vasoconstriction and Vasodilation Regulation,0.4038617812736522,1.048940264471242,0.39106145251396646,0.9608138818586118,1.0,4/26,13.13%,REN;RASGRF1;ARHGEF11;ACE
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.3769920262427579,-1.04882801973415,0.40217391304347827,0.6462814493875955,1.0,6/15,22.36%,ATP1A3;ABCD2;CHRNA7;PRNP;LGMN;APP
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.39832156864346385,-1.048679126862072,0.38271604938271603,0.6462634475893761,1.0,2/16,1.24%,PLP1;SOX10
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.4461836560712312,1.0482941115726354,0.40853658536585363,0.9624115195677108,1.0,2/17,3.74%,GPR62;ADGRB2
prerank,KEGG_2021_Human__Parkinson disease,0.29879090311941253,1.0482873838860869,0.37662337662337664,0.9618416427043451,1.0,108/222,40.49%,CALML6;MAPT;COX4I2;SEPTIN5;KIF5A;SLC6A3;NDUFA4L2;PRKN;CAMK2A;PSMD4;GNAL;TUBB8;TUBA4A;NDUFA1;TUBA3E;UCHL1;PSMB4;TUBA8;NDUFS6;ADORA2A;TUBB2B;NDUFV1;NDUFB9;COX6C;SNCAIP;COX7B;NDUFA3;UQCRB;TUBA3D;NDUFS2;NDUFA9;ATP5F1D;COX6B1;PLCG1;TXN;NDUFB11;NDUFA2;NDUFS7;UBA1;DRD1;COX8A;UQCRQ;CYC1;ITPR2;KLC2;PSMD1;PSMB3;SLC25A6;ATF6;COX7A1;TRAP1;PSMD14;NDUFA13;DDIT3;GNAI1;UBA52;UQCRHL;TUBB2A;NDUFA11;ATP5F1E;PSMB5;NDUFA6;ATP5MC1;UQCR11;PSMD2;PARK7;NDUFS8;COX4I1;PSMA1;NDUFV2;HSPA5;COX5B;ADRM1;PSMC4;PSMC3;TUBA1A;NDUFA8;CASP9;NDUFB7;TUBA1B;UQCRH;NDUFAB1;NDUFB2;NDUFB10;UQCRC1;BAX;PSMC5;SEM1;PSMB6;PSMD8;COX7C;TUBB6;UQCR10;MAPK9;NDUFB3;TUBB4B;NDUFS4;PSMD13;DAXX;PSMB7;PSMA7;CALM3;SDHA;UBE2J2;NDUFB8;SDHC;COX6A1;TUBA1C
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.37178413067843596,1.0482403365018933,0.3403141361256545,0.9614336656083098,1.0,23/36,50.08%,CCNB2;CDK1;CCNB1;NUP37;NUP62;TPR;NUP133;NUP155;NUP160;NEK7;NUP188;NUP205;NUP210;NUP214;NUP107;AAAS;NUP93;NUP88;NEK9;SEC13;SEH1L;POM121C;NUP42
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.2949067412747944,1.0480237385705846,0.32272727272727275,0.9615996489575719,1.0,57/240,16.95%,GRPR;HTR1D;RXFP4;ADRA2C;NTS;APLN;QRFPR;UTS2R;PLPPR1;F2RL3;OPN1SW;GPR35;KISS1;GAL;GPHA2;LPAR4;RHO;CCL13;OPRL1;HTR4;CCL25;AVPR2;CHRM4;SAA2;HRH3;CCL20;ADRA1D;PTGER1;PTGER3;KISS1R;TRH;SSTR5;CCR3;GALR2;ADORA1;GALR3;HCAR1;OXTR;C5AR2;CHRM5;ACKR1;BDKRB2;NPW;LHB;GALR1;PTGFR;MC1R;BDKRB1;MLNR;HTR1B;CCL11;DHX34;PLPPR2;ADORA2A;TACR1;GPR4;RRH
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.3947383680859786,1.0479969077378404,0.367816091954023,0.9611021888331933,1.0,8/28,16.38%,HS3ST4;HS3ST5;GPC3;HS6ST2;NDST1;HS3ST2;HS6ST1;GPC2
prerank,"Elsevier_Pathway_Collection__EDN, NRG, NRTN, and GDNF/RET Signaling in Hirschsprung Disease",-0.30404997928153904,-1.0476439797896966,0.3972602739726027,0.6486488581180176,1.0,3/37,1.86%,RET;L1CAM;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.41481614881633594,1.0473550644446636,0.40588235294117647,0.9627954414213645,1.0,6/22,14.64%,INHA;CDKN2A;BMP4;CDKN2C;CDKN2B;CDKN1C
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.36070049891803047,1.0472410245680102,0.4126984126984127,0.962621552931657,1.0,19/49,27.70%,UST;BCAN;B3GAT1;GPC3;NCAN;IDUA;CSPG5;CSPG4;GPC2;VCAN;B3GAT3;B4GALT7;HSPG2;CHST15;XYLT2;CHPF;HYAL3;HEXB;HEXA
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,0.370874997384741,1.0472221378052426,0.4010989010989011,0.9620729717851976,1.0,31/49,47.30%,PSMD4;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CDK4;PSMC5;SEM1;PSMB6;PSMD8;PSME2;GSK3B;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,Reactome_2022__GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.40547424936006493,1.0472159309685873,0.4069767441860465,0.9614908228758212,1.0,11/26,19.76%,BCAN;B3GAT1;GPC3;NCAN;CSPG5;CSPG4;GPC2;VCAN;B3GAT3;B4GALT7;HSPG2
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,0.4256970261458738,1.0471403023097758,0.3522012578616352,0.9611190908179572,1.0,2/15,6.66%,VWF;SRC
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.3257874220780612,1.047031080375649,0.36548223350253806,0.9608868154835708,1.0,3/85,3.41%,REG1A;PLA2G2A;CRLF2
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.3890925873600938,1.0468320449875557,0.4125,0.9610437618505129,1.0,3/25,4.24%,ANKRD33;NEUROD1;POU4F1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Osteoarthritis,0.3258798288258086,1.0467144905696313,0.4228855721393035,0.9609036571066552,1.0,13/80,9.53%,COL2A1;CALCA;SPP1;MATN1;COL9A1;MATN3;GDF5;COL10A1;FGF2;PTGDS;TIMP1;COMP;PTHLH
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.3771063563975035,1.046251748176833,0.4,0.9621083426408175,1.0,11/38,22.46%,GNG4;AVPR2;GNG3;GNB5;ADCY6;GNG8;PRKCA;GNG10;ADCY4;ADCY2;MINDY4
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.4047103815699628,1.046208042272197,0.423841059602649,0.9616414023919837,1.0,6/20,13.72%,ALOX15B;ALOX12B;ELOVL3;ABCD1;ALOX12;GSTM2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.33882422530618644,1.0460626400123798,0.41414141414141414,0.9615182400353098,1.0,7/75,5.96%,RFX6;GCG;PIK3R2;PRKAA2;NEUROD1;SLC2A4;KCNB1
prerank,"Elsevier_Pathway_Collection__Proteins Involved in Adhesion, Migration and Invasion of Endometriotic Cell",-0.36526765312059456,-1.0460265720847932,0.4050632911392405,0.6527887656509976,1.0,6/17,11.86%,TNF;IL1B;MMP1;CDH1;MMP7;CXCL8
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.2861726592967545,-1.0459135733463985,0.32653061224489793,0.6526398431699767,1.0,11/69,9.97%,GCK;CRHBP;GHR;NR4A3;SOCS2;SFRP1;ATP1A3;ZFP36L1;ROBO2;AKR1C4;NKX3-1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.3536217839724546,1.045805149132761,0.39790575916230364,0.9618234243019319,1.0,9/53,10.18%,EPHB2;IRX3;SYNDIG1;CLDN19;THY1;DLG5;BDNF;S100A10;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.28460024520161215,1.0452244328031397,0.38333333333333336,0.9632885239706133,1.0,75/387,18.18%,ALOX15B;NKD1;CTNNA2;LGR6;CEMIP;FGF20;EPHB2;LEF1;CGA;TWIST2;CLDN19;THY1;DPEP1;CDH13;PTPRT;ROBO1;VIL1;TDGF1;ADGRG3;SNAI2;CCL26;MDK;PRR5L;ITGA6;DLG5;ARHGEF39;FGF17;SRGAP3;GTSE1;KIF14;SRC;FGF2;SPHK1;FGF23;CAMK2A;PDGFRB;PLXNC1;COL1A1;MCTP1;STK26;ZNF703;FAM83H;ADAM15;TCAF2;SEMA7A;PLXNA2;SEMA6C;PODXL;LMNA;PDGFB;PDPN;ACE;FLT1;PPM1F;PDGFA;PLAU;SEMA5B;CCL24;CCL11;FRMD5;SEMA6B;PRKCA;HRAS;PLXND1;TMSB15A;STC1;CYRIB;ROCK2;ADAM9;RHOC;EGF;CLDN5;ACVRL1;SEMA3F;PLXNA3
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,0.3508664299562966,1.0449388513797844,0.3865979381443299,0.9636241388874163,1.0,35/52,50.08%,SNRPE;NUP37;NUP62;TPR;NUP133;LIN9;SNRPD2;SNRPB;GEMIN8;NUP155;NUP160;GEMIN7;NUP188;SNRPD3;NUP205;NUP210;DDX20;GEMIN4;NUP214;PHAX;SNRPG;NUP107;GEMIN5;AAAS;GEMIN6;WDR77;NUP93;PRMT5;SNUPN;NCBP2;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,0.36047629378764273,1.0449367010781276,0.3956043956043956,0.9630322553392594,1.0,21/42,42.12%,VARS1;EPRS1;DTD1;PARS2;QARS1;DARS2;FARSB;LARS1;IARS2;EEF1E1;AIMP1;HARS1;GARS1;VARS2;CARS2;AARS2;TARS2;MARS1;IARS1;FARSA;PPA1
prerank,Elsevier_Pathway_Collection__Immunoglobulin Class-Switch Recombination Activation,-0.3274763552587044,-1.0447620559081372,0.391304347826087,0.6553132900947278,1.0,6/26,16.76%,TNFRSF17;TNFRSF13B;CD40LG;TNFSF13;TNFRSF13C;TNFSF13B
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.2839976731653326,1.0447521053039885,0.37083333333333335,0.9631359861260446,1.0,94/398,27.78%,TBX4;MAFA;HMGA2;SOX1;IGF2;SIX1;GCM1;ZIM2;PTP4A3;E2F1;MYT1;ZNF341;FOXN4;NKX6-2;ELAVL2;SOX2;SNAI2;ZNF648;KLF1;MSC;PLAG1;VSX1;TCF7;ZNF703;EZH2;DLX4;GTF2IRD1;FOXC1;PRRX2;GLI4;SOX18;TEAD2;ARNTL2;EFEMP1;NFKB2;POU5F1;MYBL2;SPIN2B;TULP3;DVL2;SKOR1;ACTR5;ZNF423;HES6;HMGA1;ZNF219;ACVRL1;MAGED1;PPARGC1B;PQBP1;GLRX2;ZNF646;ACVR2B;PCGF1;HDAC10;ZNF205;RHOXF1;HOXB7;ZNF221;ZNF280C;ARNT2;NSD1;APBB1;YY1AP1;ZNF628;SOX13;KMT2D;ARNTL;ESR2;ZNF398;SAP30L;NR2C2;ZNF516;TCF3;ZFHX3;ATXN1L;SOX17;CRX;TESMIN;HCFC1;DVL1;SPIN4;WT1;MZF1;ZNF74;LDB1;HINT1;ZNF282;APBB3;NSD2;SOX7;CHEK2;DDIT3;GON4L
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.3753587118815267,1.0446729222348567,0.4046242774566474,0.9628021088029975,1.0,4/33,8.27%,SYT5;CEL;SNCG;SYT2
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3664083723588173,1.0441038624568793,0.3785310734463277,0.9642153521748065,1.0,7/36,15.70%,E2F7;CDKN2A;PLK5;CDKN2C;CDKN2B;CDK2AP2;NACC2
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.362368149288678,-1.043720589233379,0.3956043956043956,0.6576134446977604,1.0,7/18,13.79%,BMP10;PDGFRA;HEY2;TTN;SLC8A1;MYH11;FHOD3
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer-Associated Resisting to Cell Death,-0.2981912391768276,-1.0437071618647598,0.35384615384615387,0.6571635206254332,1.0,11/47,17.74%,CASP1;MITF;BCL2A1;AKT1;IGF1;BIRC7;CASP6;BCL2L11;CASP7;BCL2;PMAIP1
prerank,Elsevier_Pathway_Collection__Hedgehog Family -> ARRB1/ARRB2 Canonical Signaling,0.4337764308116742,1.04349587851263,0.3888888888888889,0.9657053175299227,1.0,10/16,39.03%,IHH;KIF7;PDPK1;DHH;GLI1;SMO;ARRB1;GSK3B;SUFU;SHH
prerank,WikiPathway_2021_Human__miRNAs involvement in the immune response in sepsis WP4329,-0.3286830370388828,-1.0434465984350312,0.37662337662337664,0.6573763216772347,1.0,11/36,14.75%,IL10;TNF;CCL4;CCL3;IL6;TLR8;CXCL8;REL;TLR4;VCAM1;MYD88
prerank,KEGG_2021_Human__p53 signaling pathway,0.34504633637052,1.0432971868880778,0.38071065989847713,0.9658452854055851,1.0,11/72,10.65%,SFN;TP53AIP1;TP73;CDKN2A;ADGRB1;GTSE1;CCNB2;CCNE1;CCNE2;CDK1;CCNB1
prerank,Elsevier_Pathway_Collection__Osteoblast Function Decline in Osteoporosis,-0.3109324218411451,-1.0431953807444438,0.40540540540540543,0.6575762436475556,1.0,8/30,17.97%,FOS;ESR1;MAP2K1;AKT1;IGF1;RUNX2;ITGB3;VTN
prerank,WikiPathway_2021_Human__Thermogenesis WP4321,0.3228587096870553,1.043128975246465,0.38190954773869346,0.9658261986490038,1.0,34/105,29.36%,GCG;PRKAA2;MAPK12;ACSL6;MAPK11;ACTL6B;PRDM16;ACSL4;CPT1B;CREB3L1;ADCY6;PPARG;HRAS;CREB3L4;ACSL5;ADCY4;ADCY10;TSC1;ADCY2;SMARCA4;CPT1C;LIPE;TSC2;ZNF516;PRKAB2;SLC25A29;SMARCD3;ACSL3;SIRT6;KLB;RHEB;SMARCC1;KDM3A;KDM3B
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.39463492094803376,1.043123552499332,0.3743016759776536,0.9652503389545956,1.0,5/27,10.78%,KCNE5;KCNH2;ATP2B4;DPP10;KCNIP3
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.4174960871546695,1.0429349992912786,0.3505747126436782,0.9653395497381156,1.0,12/20,40.51%,ATP6V0D2;TMEM9;ATP6V0A1;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1H;SLC11A1;TMEM199;DMXL2;GRN;ATP6AP2
prerank,KEGG_2021_Human__Small cell lung cancer,0.3344379209498816,1.042929332589735,0.3883495145631068,0.964758361719809,1.0,14/92,11.42%,LAMA3;E2F1;PIK3R2;ITGA2;ITGA6;E2F2;COL4A1;COL4A5;CCNE1;CCNE2;IKBKG;COL4A2;CDKN2B;LAMC1
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,0.35510381412308145,1.0426849839289556,0.42021276595744683,0.9650569699627939,1.0,23/53,40.48%,PLK1;CCNB2;CDK1;CCNB1;LMNA;PRKCA;NUP37;LPIN1;NUP62;TPR;NUP133;EMD;LMNB1;NUP155;NUP160;NEK7;NUP188;BANF1;NUP205;NUP210;LEMD2;TMPO;NUP214
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.35670543427096485,1.0424822305234052,0.4148936170212766,0.9652242735028277,1.0,37/56,47.30%,PSMD4;PSMB4;PRKCA;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;GSK3B;SUFU;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;BTRC;PSMC2;CSNK1A1;RPS27A;PSME1;PSMB1;PSMD3
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,0.29748626093509317,1.0424675204368583,0.37333333333333335,0.9646948882704606,1.0,51/227,17.27%,SLC7A11;SLC22A12;SLC6A7;SLC22A11;SLCO1C1;SLC34A3;SLCO4A1;SLC22A4;RHBG;SLC22A15;SLC6A11;SLC12A5;SLC7A6;SLC39A4;SLC12A1;SLCO2A1;SLC2A4;SLC29A4;SLC30A3;SLC13A3;SLC6A9;SLC30A2;SLC5A4;SLC7A10;SLC4A3;SLC4A1;SLC6A3;SLC5A2;SLC26A6;SLC5A6;SLC16A3;SLC1A4;SLC22A16;SLC9A3;SLC10A6;SLC14A2;APOD;SLC1A2;SLC7A1;SLC39A3;SLC47A2;SLC29A2;SLC26A2;SLC5A11;SLC6A2;SLC12A7;SLC50A1;SLC1A3;SLC16A8;ARL2;SLC8A3
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.36124742145844696,1.0424244683311032,0.3882978723404255,0.9642336532996695,1.0,10/46,14.04%,ST8SIA3;B4GALNT1;A4GALT;ESYT3;ST8SIA5;CERK;NEU3;GBA;CTSA;GLA
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.26015601425562823,-1.0422150813625997,0.38596491228070173,0.6597841643013663,1.0,21/71,15.71%,EREG;ERBB4;FGF10;CD80;ESR1;PDGFRA;NRG4;ICOS;FGFR2;TGFA;TRAT1;FYN;RAC2;KL;BTC;LCK;FLT3;PIK3R1;HBEGF;VAV1;CD86
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.33616087473965606,1.0416945431577256,0.36764705882352944,0.9662203108666843,1.0,2/62,0.53%,MUC7;MUC13
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.36247723055725733,1.0416466744457507,0.4186046511627907,0.965832436194154,1.0,10/50,14.49%,PRSS56;PAX2;SOX2;HES5;SALL2;FOXC1;CACNA1C;EFEMP1;SH3PXD2B;COL5A1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.40744377367805784,1.0415797123800377,0.3609467455621302,0.965495568316145,1.0,5/27,10.78%,KCNE5;ACTN2;KCNH2;DPP10;KCNIP3
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.3236481278209195,-1.0415622751875853,0.375,0.661085732250311,1.0,3/29,6.68%,RIPK3;FASLG;TNFSF10
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),0.36053181312763494,1.0414356211311233,0.4101123595505618,0.965401080989003,1.0,34/43,53.38%,VARS1;EPRS1;PARS2;HARS2;QARS1;DARS2;FARSB;LARS1;IARS2;EEF1E1;AIMP1;HARS1;GARS1;VARS2;CARS2;AARS2;TARS2;MARS1;IARS1;FARSA;PPA1;FARS2;RARS1;TARS3;PPA2;AIMP2;SARS1;WARS2;NARS2;EARS2;YARS2;AARS1;SARS2;KARS1
prerank,KEGG_2021_Human__Melanoma,0.34287816515786085,1.041282502850696,0.39901477832512317,0.9653277375835453,1.0,9/66,8.44%,FGF20;E2F1;PIK3R2;CDKN2A;FGF17;FGF2;FGF23;E2F2;PDGFRB
prerank,Elsevier_Pathway_Collection__BMP2 and Canonical WNT Signaling in Pulmonary Artery Endothelial Cells,0.41786073149203373,1.0407689760279795,0.42168674698795183,0.9665889076860908,1.0,2/19,6.65%,LEF1;BIRC5
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.3247370238105501,1.0407102430824668,0.3854166666666667,0.96621250044843,1.0,35/97,32.95%,DTL;AURKB;MC1R;POLD1;BMF;NEDD4;CDC25A;MSH2;USF1;SCARA3;PCLAF;BCL3;UVSSA;FEN1;PARP1;UBE2A;ELANE;TMEM161A;CDKN2D;NPM1;METTL3;COPS9;RHNO1;GPX1;MYC;TP53I13;BRSK1;MSH6;UBE4B;SPRTN;SDE2;PCNA;FMR1;CASP9;DDB2
prerank,Elsevier_Pathway_Collection__NCAM1 -> CREB/ELK/SRF/MYC Signaling,-0.3898687527697724,-1.0406227083065434,0.3888888888888889,0.663400545647847,1.0,3/15,9.77%,NCAM1;MAP2K1;FYN
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.26305002897986873,-1.0405015678029124,0.30952380952380953,0.6632572434276832,1.0,34/119,22.14%,CASR;ATP2C2;HTR2A;TRPV4;ATP13A4;SLC35G1;CCL5;PTH1R;CCL3;CCL23;TRPC3;CXCL12;CCR1;CCR2;CHRNA7;SLC8A1;CLN3;SCGN;MCUB;HERPUD1;SLC24A4;BCL2;TPCN2;CAV2;ATP2A3;PDZD8;RYR1;PLN;ANXA6;ANK2;SLC24A3;MICU1;CD40;F2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.43824991810772296,1.040431142326129,0.40350877192982454,0.966667708327587,1.0,4/15,19.88%,PYDC1;H2BC11;TRAIP;PELI3
prerank,WikiPathway_2021_Human__Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,-0.2737972286761874,-1.0401930010892313,0.3898305084745763,0.6636022199548377,1.0,11/64,15.04%,ERBB4;PFN2;FZD3;WNT16;MAP2K1;FZD1;TGFA;WNT11;FZD8;AKT1;GRIA1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.3540255033562442,1.0400450303663074,0.40512820512820513,0.9673971394878592,1.0,12/54,16.50%,HPSE2;CEMIP;BCAN;HMMR;GPC3;FGF2;NCAN;IDUA;CSPG5;CSPG4;GPC2;VCAN
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.31544747080163704,-1.0399988471553663,0.4383561643835616,0.6636632324068782,1.0,11/36,9.92%,CCL5;CCL4;CCL3;LGALS3;LILRA2;P2RX3;LILRA5;TRPC3;CXCL12;CCL2;CCR1
prerank,KEGG_2021_Human__Notch signaling pathway,0.33501409501344176,1.0398934492306542,0.3854166666666667,0.9673290841300675,1.0,18/56,28.24%,HES5;TLE6;NOTCH3;JAG2;KAT2A;DVL2;NOTCH4;DLL4;HEY1;HDAC1;LFNG;ATXN1L;DVL1;MAML1;TLE1;NCOR2;HEYL;NCSTN
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.41866643905213075,1.0398457882795182,0.37575757575757573,0.9669280067390731,1.0,6/18,23.52%,WNT4;BMP4;RGCC;CREB3L1;SCX;SUCO
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.3145809446464137,-1.0393874558237621,0.3625,0.6648904386590592,1.0,16/35,27.48%,ZBP1;CASP1;AGPAT2;AXL;HSPA1B;TICAM2;TSLP;CXCR4;HSPA1A;WNT5A;TRIM44;CASP4;LAPTM5;TRIM6;TXK;EDN1
prerank,KEGG_2021_Human__Base excision repair,0.3740670225203916,1.0390387647171342,0.41975308641975306,0.969029414978975,1.0,13/33,35.93%,NEIL3;POLD1;MUTYH;FEN1;PARP1;APEX2;LIG3;POLB;PCNA;XRCC1;OGG1;LIG1;POLL
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.3439158400836955,-1.038996268071305,0.367816091954023,0.6654373826540447,1.0,6/27,8.55%,GRIN2B;TH;CCR5;CCL3;CCR7;HSD3B1
prerank,KEGG_2021_Human__ErbB signaling pathway,-0.265023120600489,-1.0389180470248824,0.3191489361702128,0.6651475317054745,1.0,16/83,14.80%,PAK5;SHC4;EREG;ERBB4;PAK6;NRG4;MAP2K1;PIK3CD;PRKCB;TGFA;CAMK2B;BTC;PIK3R1;AKT1;PLCG2;HBEGF
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.3990033872419533,1.0389065071586443,0.4222222222222222,0.9689374672357259,1.0,13/25,40.17%,SMYD3;SMYD2;METTL18;SUV39H1;ANTKMT;EHMT2;EEF2KMT;TRMT112;SUV39H2;SETD4;N6AMT1;CSKMT;METTL21A
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.32446944857316745,1.0387831429813084,0.3915343915343915,0.968791262206242,1.0,14/91,14.28%,CPLX2;RAB3C;CDH13;OLFM4;SEPTIN5;RAB3B;LGI3;SRC;SPHK1;ATP9A;PACSIN3;RAB3D;CPLX1;ABL2
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.3709890822233266,1.0386895124137434,0.39893617021276595,0.9685261135341957,1.0,13/39,19.76%,BCAN;GPC3;CHST6;NCAN;CSPG5;CSPG4;SLC26A2;GPC2;VCAN;B3GAT3;ST3GAL3;B4GALT7;HSPG2
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,0.3167391847315133,1.0386851503957577,0.39351851851851855,0.9679438232597682,1.0,16/100,17.63%,VEGFD;PIK3R2;MAPK12;MAPK11;SRC;SPHK1;HSPB1;RNASE1;FLT1;PGF;MAPKAPK2;PDPK1;PRKCA;HRAS;ROCK2;THEM4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3533644263075074,-1.0383673685026245,0.38202247191011235,0.6661173901637103,1.0,7/19,15.35%,CCBE1;TSPAN12;XDH;DCN;SEMA6A;IL12B;SPRY2
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.26262083827272975,-1.0383226445811387,0.36363636363636365,0.66577347643469,1.0,23/77,20.96%,PTPRQ;TNF;NOCT;SFRP1;ID2;ZFP36L1;FOXO1;WNT10B;IL6;WNT1;FERMT2;ALOX5;GATA3;AKT1;CCDC71L;ZADH2;ENPP1;SFRP2;MEDAG;WNT5A;BBS12;CMKLR1;XBP1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.3922972734301319,-1.0383061139931133,0.42391304347826086,0.6653055752500586,1.0,5/15,27.45%,LRRK2;AK4;GIMAP7;AK3;OPA1
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.2757216830818124,-1.0377951854980663,0.37735849056603776,0.6662441370434153,1.0,20/77,17.07%,LRRC19;TNF;IL1B;TCIM;CD27;NLRP12;PTPN22;TLR3;NR3C2;NLRP3;BMP7;IL12B;TLR4;TLR2;SPI1;CD86;RASSF2;LGALS9;NLRC3;EZR
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,0.3666117476659902,1.0376545342098602,0.4198895027624309,0.9709252930149262,1.0,5/40,16.28%,DYNC1I1;AVPR2;CREB3L1;ADCY6;CREB3L4
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.36492943882128187,1.0376488294745383,0.39378238341968913,0.9703505922546574,1.0,5/37,7.36%,OSR2;OSR1;WNT4;BMP4;TMEM119
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.42197274113508504,1.037629803777362,0.4233128834355828,0.9698141194112799,1.0,4/19,8.48%,SIX4;MYMK;MYMX;ERVW-1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.31481713511274395,1.0369992606698764,0.3804878048780488,0.9714305495492159,1.0,28/111,18.34%,AVIL;PTK7;ROBO1;MDK;ITGA6;STMN2;SERPINI1;ROR1;PLK5;TOX;BDNF;PLXNC1;IL1RAPL1;PRKD1;CBFA2T2;PLXNA2;DLG4;ABL2;METRN;DVL2;CAMK1D;PLXND1;GPC2;MAP6;GRIP1;TWF2;PLXNA3;OBSL1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.4572913427673991,1.0369046537130664,0.41566265060240964,0.9711668434431937,1.0,3/15,9.88%,EN1;WNT9B;MANF
prerank,MSigDB_Oncogenic_Signatures__ATM DN.V1 UP,0.3089996744888175,1.0368437537084305,0.3867924528301887,0.9707702780119771,1.0,25/119,15.73%,CHGB;GHRHR;GCM1;DLX6;ICAM5;S100A2;S100A3;SLC5A2;BDNF;OCM;EFNA1;CRHR2;RECQL4;TNNT3;CD36;F13A1;SYN1;LHB;SPAG4;FLT1;BDKRB1;KCNJ4;H6PD;ACACA;TREM1
prerank,MSigDB_Oncogenic_Signatures__AKT UP.V1 DN,-0.23386247139600996,-1.0368053206259422,0.3793103448275862,0.6685404620032821,1.0,51/169,19.48%,PI16;SLC18A1;SCARA5;KRT15;GHR;EIF4E3;SATB1;GNMT;NR4A3;KRT5;PROM1;PM20D1;SH3BGR;FXYD1;GAS1;PDGFRA;NCAM1;CHAD;VSIG2;DPT;CBS;TCF21;PLA2G4A;SLC7A5;GNA14;C1R;HMGCS2;FHOD3;IL17RC;PPP1R3C;KCNK3;KLF2;COL17A1;FMO3;FUT8;PLTP;MATN2;CAV2;TPD52L1;RECK;PDIA5;PTGIS;SFRP2;BEX4;HEBP1;ASS1;KCTD12;IRS2;C1S;ISLR;SERPINF2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Polycystic Kidney Disease,0.31293182454281465,1.0365541389436184,0.37948717948717947,0.9712539021261467,1.0,17/90,17.48%,PAX2;REN;HAVCR1;LCN2;CLDN19;FRAS1;GPSM1;AVPR2;SRC;DNAAF1;EPO;ANKS6;ACE;ADCY6;PKD1;EGF;CDC25A
prerank,MSigDB_Oncogenic_Signatures__PRC1 BMI UP.V1 DN,0.3041198529541715,1.0364064246510754,0.3891402714932127,0.9711944702869238,1.0,38/154,20.27%,ACTL8;CDH22;S100P;SIM2;SLCO4A1;MYT1;PRND;DPEP1;EPS8L3;COL10A1;NTM;PTGDS;TRPC6;KIF5A;MDFI;CCR3;MCTP1;GNG3;TTLL4;MTMR8;SLC1A2;CACNA2D3;RGS16;ACE;HIC2;IDO1;PAX5;MADCAM1;TMEM187;ZNF423;FGF12;XPNPEP2;GRIN2C;USP46;PLEKHF1;CDK6;LRRC31;TOR1AIP2
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.2965095445976861,1.0363745789384224,0.3824884792626728,0.9707072174451156,1.0,24/154,17.27%,KCNU1;ADRA2C;CACNA1S;CALML6;ADRA1D;TRPC6;ATP1A2;ATP1A4;ATP2B4;ATP1B3;ADORA1;GTF2IRD1;NPR2;ATP2A1;CACNA1C;BDKRB2;CREB3L1;ADCY6;FXYD2;CREB3L4;ROCK2;MEF2D;MYLK2;SLC8A3
prerank,Elsevier_Pathway_Collection__Hematopoietic Cell Lineage: B-cell,-0.3066181880109126,-1.0362117601329217,0.4,0.6698354884507208,1.0,12/36,15.35%,IGHM;IGLL1;CD27;CD79A;CD38;CXCL12;PTPRC;IKZF1;SPN;FLT3;CXCR4;SPI1
prerank,"WikiPathway_2021_Human__Relationship between inflammation, COX-2 and EGFR WP4483",-0.35301639713413413,-1.036148149375422,0.38095238095238093,0.6694818245212274,1.0,7/25,13.06%,PTGS2;MMP1;ESR1;PIK3CD;PTGER2;PTGER4;AKT1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.2662423400025935,-1.0360125557009916,0.30303030303030304,0.6693932956004613,1.0,46/152,15.35%,FOXP3;GPR25;TSHR;GPR83;ENPP3;IFNL1;IL10;GPR15;ADCYAP1R1;PRKAR2B;ACOD1;GPR84;PTH1R;LGALS3;CD163;VIPR1;GIPR;GPR27;CALCR;RLN2;FCGR3A;VIPR2;CD3G;PTGER2;IL6;FYN;CR1;CD300A;RXFP1;LILRB1;SAMSN1;CCR2;CYSLTR2;PTGER4;FCGR2B;CD247;ADCY5;HCK;SYK;GNG2;HAVCR2;FGR;PTGDR;PLCG2;HTR7;SPI1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.35271554786276693,1.0358013201560887,0.39779005524861877,0.9721469820825512,1.0,3/50,2.76%,SFN;E2F1;TP73
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.3644801177751994,1.0356616107432721,0.42168674698795183,0.9714654398241057,1.0,21/38,27.40%,CPLX2;PTPRN2;GAD1;UNC13A;HRH3;SYN3;PPFIA3;SYN1;SNAP25;CPLX1;SYN2;NRXN2;SNAPIN;STXBP1;STX1A;LIN7B;DNAJC5;CDK5;DVL1;BRSK1;PDZD11
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.3644801177751994,1.0356616107432721,0.42168674698795183,0.9714654398241057,1.0,21/38,27.40%,CPLX2;PTPRN2;GAD1;UNC13A;HRH3;SYN3;PPFIA3;SYN1;SNAP25;CPLX1;SYN2;NRXN2;SNAPIN;STXBP1;STX1A;LIN7B;DNAJC5;CDK5;DVL1;BRSK1;PDZD11
prerank,MSigDB_Oncogenic_Signatures__SRC UP.V1 DN,0.30737429999885735,1.0356546774751274,0.4099099099099099,0.9708963215304901,1.0,46/145,24.51%,GJB6;PAK3;UTS2R;SLC7A14;CDCA7;SLC12A5;PRR19;CERKL;IRX5;SYT15;TRIM73;IFITM10;GALNTL6;ACSL4;COL8A1;E2F8;UHRF1;EZH2;PHLDA2;IRAK2;MMP10;MEGF6;RACGAP1;WT1-AS;SEMA6B;SPDYE1;MCM3;MCM5;ATAD2;CAPN12;MCM4;WASH3P;EIF3CL;SNX32;POLR1A;MMP3;KIAA1841;OTUD6B;SH3TC2;MAP3K6;ZNF628;PLAT;LFNG;POP1;DISP2;PLK4
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.4147126165049887,1.035626926547058,0.43373493975903615,0.9704169404702576,1.0,5/21,20.83%,FATE1;ATP2A1;BCAP31;SLC8A3;TGM2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.44226902699342474,1.0352979315545676,0.42441860465116277,0.9709460332613092,1.0,2/17,8.07%,SNAI2;PRKN
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,0.43411406421075416,1.0352596835406511,0.44025157232704404,0.9704837498608229,1.0,8/18,30.28%,HPSE2;IDUA;GLB1;HYAL2;HYAL3;HEXB;HEXA;HGSNAT
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2821466184970909,1.035234643414765,0.37448559670781895,0.9699827518070032,1.0,105/435,27.78%,TBX4;MAFA;HMGA2;SOX1;IGF2;SIX1;GCM1;ZIM2;PTP4A3;E2F1;MYT1;ZNF341;FOXN4;NKX6-2;ELAVL2;SOX2;SNAI2;ZNF648;KLF1;MSC;PLAG1;VSX1;TCF7;ZNF703;EZH2;DLX4;CCNA2;GTF2IRD1;FOXC1;PRRX2;GLI4;SOX18;TEAD2;ARNTL2;EFEMP1;NFKB2;POU5F1;MYBL2;PDGFA;METTL18;DSCC1;SPIN2B;TULP3;DVL2;SKOR1;ACTR5;ZNF423;HES6;HMGA1;TCOF1;ZNF219;ACVRL1;MAGED1;PPARGC1B;PQBP1;GLRX2;RBM3;ZNF646;ACVR2B;PCGF1;HDAC10;TSC1;ZNF205;EHMT2;RHOXF1;HOXB7;ZNF221;ZNF280C;ARNT2;NSD1;EIF2B4;APBB1;YY1AP1;GMNN;ZNF628;SOX13;KMT2D;ARNTL;ESR2;ZNF398;SAP30L;NR2C2;ZNF516;TCF3;ZFHX3;ATXN1L;SOX17;CRX;TESMIN;HCFC1;DVL1;SPIN4;WT1;MZF1;ZNF74;RPL10;LDB1;HINT1;ZNF282;APBB3;NSD2;SOX7;CHEK2;DDIT3;GON4L
prerank,WikiPathway_2021_Human__Wnt signaling pathway and pluripotency WP399,0.3193663564157463,1.035117154006893,0.4009433962264151,0.9698190915516132,1.0,17/97,15.60%,NKD1;PPP2R2C;LEF1;AXIN2;WNT4;SOX2;WNT9B;NKD2;TCF7;PRKD1;RACGAP1;POU5F1;PLAU;DVL2;WNT2B;WNT6;PRKCA
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.3127114190370628,-1.0349925359699679,0.38961038961038963,0.6717507671878868,1.0,19/34,26.77%,ATP1A3;FPR2;NGFR;FYN;NTRK1;FCGR2B;TLR4;IGF1;VCAM1;PRNP;ITGA4;LGMN;ADRB2;APP;CASP4;IGF1R;EPHA4;CACNA1A;SNX6
prerank,Elsevier_Pathway_Collection__Myeloid Cell Differentiation Block in Leukemia,-0.32703339643386686,-1.034845975273005,0.44155844155844154,0.671685468820267,1.0,8/25,17.22%,CSF3R;CBFA2T3;FLT3;MYH11;SPI1;CSF1R;NCOR1;GATA1
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,-0.28895199064809224,-1.034612602738156,0.42105263157894735,0.6719626794774476,1.0,12/54,22.89%,GSTA2;IL10;IFNG;IL27;IL12B;SERPINB2;IL12RB1;EBI3;IL12RB2;JAK2;STAT1;PITPNA
prerank,WikiPathway_2021_Human__Hypertrophy Model WP516,-0.3782311689837343,-1.0346024550326711,0.38372093023255816,0.6715098135072408,1.0,5/17,15.22%,IFNG;NR4A3;IL18;HBEGF;DUSP14
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.38669219383668807,1.034213617853065,0.4,0.9723024288480504,1.0,11/26,34.31%,H1-5;PRDM12;JARID2;CHTOP;DNMT1;DNMT3B;CTNNB1;WDR5;PHF19;OGT;PAXIP1
prerank,MSigDB_Oncogenic_Signatures__KRAS.600 UP.V1 DN,0.29793469075015844,1.0341901042560353,0.39826839826839827,0.9718094932847203,1.0,26/222,8.23%,COL2A1;HTR1D;GP2;CACNA1I;DLX6;SLC22A11;AQP6;AMBN;CDH16;C1QL1;HOXB8;IGF2-AS;TNNI3;PRODH;FRAS1;NRXN3;HRH3;CA5B;MAGIX;MXD3;SLC6A3;SLC5A2;OLFML2A;EDIL3;AKR1B10;TRH
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.28915834956854986,1.0333292761648019,0.39662447257383965,0.9742267641720679,1.0,52/313,16.28%,COL2A1;GNG4;IGF2;PPP2R2C;THBS4;FGF20;VEGFD;LAMA3;SPP1;PIK3R2;PRKAA2;COL9A1;VWF;ITGA2;LPAR4;ITGA6;EFNA3;FGF17;FGF2;EFNA4;FGF23;BDNF;COL4A1;EFNA1;COL4A5;CCNE1;PDGFRB;COL1A1;IL3RA;COMP;GNG3;CCNE2;IKBKG;COL4A2;FLT3LG;LAMC1;IL6R;EPO;CREB3L1;PDGFB;FLT1;PDGFA;PGF;COL1A2;GNB5;PDPK1;GNG8;THBS2;PRKCA;HRAS;ANGPT2;CREB3L4
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.36546690252177894,-1.0330004749804258,0.38636363636363635,0.6754530070253024,1.0,3/20,12.22%,CHAC1;MTHFS;GATM
prerank,WikiPathway_2021_Human__Copper homeostasis WP3286,-0.29836862630023714,-1.0329821489327193,0.3958333333333333,0.6750147088879819,1.0,14/51,16.77%,MT1G;MT1F;MT1H;MT1E;MT1X;STEAP3;MT1A;FOXO1;MT1B;SLC31A1;AKT1;SLC31A2;PRNP;MT2A
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.32118335913813967,1.0327929899790296,0.39408866995073893,0.9755571106389116,1.0,23/110,16.14%,GLP1R;GHRHR;PTH2R;GCG;CALCA;CGA;DPEP1;RAMP1;GPHA2;HTR4;AVPR2;SRC;CRHR2;PTHLH;ADM2;GPR150;RAMP2;LHB;MC1R;ADCY6;IAPP;RHBDF2;ADORA2A
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.318952684535878,1.0327244925012835,0.36792452830188677,0.975188739075194,1.0,18/100,15.60%,HMGA2;VEGFD;NODAL;CHI3L1;CD34;FGF2;SPHK1;AGO2;CCR3;HSPB1;PRKD1;ADM2;RAMP2;FLT1;PGF;SMOC2;PDPK1;PRKCA
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,-0.35119611147536445,-1.0325403704997385,0.4186046511627907,0.6757658120273776,1.0,5/20,16.53%,L1CAM;NCAM1;MAP2K1;ITGB3;ITGA9
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.3480296999053406,1.0323806124010715,0.40414507772020725,0.9757717742281088,1.0,14/53,19.76%,HS3ST5;HPSE2;B3GAT1;GPC3;HS6ST2;IDUA;NDST1;HAS1;HS3ST2;HS6ST1;GPC2;B3GAT3;B4GALT7;HSPG2
prerank,Elsevier_Pathway_Collection__Ras-GAP Regulation Signaling,-0.29493399096909023,-1.032277253207029,0.38461538461538464,0.6759773600478373,1.0,7/46,12.21%,GNAO1;IFNG;TNF;CD200R1;BTK;DDAH1;DOK2
prerank,Elsevier_Pathway_Collection__Neonatal Diabetes Mellitus,-0.38689535959191906,-1.0322021697542425,0.4392523364485981,0.6756792900463237,1.0,3/15,1.15%,GCK;FOXP3;PDX1
prerank,Elsevier_Pathway_Collection__Vascular Endothelial Cell Activation by Blood Coagulation Factors,-0.2887792937839091,-1.0319573438334388,0.4090909090909091,0.6758823830403856,1.0,17/57,15.81%,TNF;IL1B;FOS;MAP2K1;CXCL2;CCL2;IL6;CCN1;F2RL2;CXCL8;TLR4;AKT1;RASGRP1;VCAM1;MYD88;HBEGF;KNG1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.2521822653190957,-1.0319075817342114,0.36363636363636365,0.6755150962758998,1.0,29/105,19.16%,LRFN5;ENPP3;IL10;AJAP1;ACOD1;GPR31;NLRP12;TNFAIP6;FPR2;APOA1;LILRA2;NLRP3;KLF4;ALOX5;MEFV;PTGER4;GATA3;TRIB1;CARD16;TNFAIP8L2;AOAH;NLRC3;ITCH;PTGIS;SIGIRR;PTPRS;NR1H4;IFI16;MACIR
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,-0.3493304847829099,-1.0316821760772437,0.36,0.6756647342698063,1.0,7/21,17.93%,EREG;ERBB4;NRG4;BTC;HBEGF;PRKCE;NRG3
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.32566852682768643,1.0315083892529444,0.3842364532019704,0.9782775131104119,1.0,57/76,47.36%,UTP14A;NVL;TCOF1;FBLL1;REXO5;NHP2;HEATR1;POP1;NXF1;NOP58;NOP56;FBL;DKC1;RPP25;REXO1;NXF5;RRP7A;RBM28;NXT1;RPP40;SNU13;UTP15;REXO2;GTPBP4;NOP10;POP5;CSNK2B;GNL2;GNL3L;TBL3;POP4;DROSHA;WDR75;XPO1;UTP4;RPP25L;IMP4;UTP18;PWP2;RAN;RIOK2;AK6;NAT10;NOL6;RPP38;EIF6;GNL3;EMG1;NXT2;RIOK1;POP7;CSNK2A2;NOB1;MPHOSPH10;UTP6;LSG1;BMS1
prerank,WikiPathway_2021_Human__Vitamin D in inflammatory diseases WP4482,-0.3596901080850646,-1.0313995691935876,0.41379310344827586,0.6759779665398247,1.0,14/22,35.09%,TNF;IL6;DUSP1;PPP3CA;MAP2K3;MAP2K6;NR3C1;VDR;NFKBIA;NFATC1;MED14;CHUK;SMAD4;MAPK14
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.3759001903825454,1.0313064763824102,0.4371584699453552,0.9783357915498233,1.0,9/32,15.03%,CA4;CA5B;SLC4A3;SLC4A1;SLC26A6;CA1;CYB5RL;CA14;CYB5R1
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,0.29914856400767376,1.030857635425504,0.41013824884792627,0.9793884467373962,1.0,91/182,44.10%,RHO;NEK2;PLK1;UNC119B;CDK1;TUBA4A;CCT3;BBS5;CEP131;IFT81;PRKCA;BBS2;PKD1;CETN2;CEP250;HAUS4;HAUS5;KIF24;DYNLRB2;MARK4;B9D2;B9D1;NUDT19;PLK4;DYNLL1;IFT27;DYNLRB1;CEP70;SFI1;SSNA1;ASAP1;BBS4;SMOX;NPHP4;FBF1;KIFAP3;CEP97;EXOC4;CSNK1D;TUBA1A;ALMS1;EXOC3;CEP290;TTC30A;CEP152;DCTN2;DYNC1H1;DCTN3;CEP41;CEP89;KIF3B;TUBG1;CEP72;DYNC2LI1;PPP2R1A;CCT8;HSPB11;RPGRIP1L;RAB11FIP3;NDE1;C2CD3;CCT4;HAUS1;TTC30B;PTGES2;ARL3;INPP5E;TUBB4B;IFT80;SDCCAG8;CCT2;HSP90AA1;IFT140;CSNK1E;MCHR1;CEP83;ATAT1;EXOC8;CEP192;IFT172;SSTR3;CKAP5;CCT5;TUBB4A;PRKD2;IFT22;PDE6D;IQCB1;PCNT;WDR35;KIF3A
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.281288344317471,-1.0307778056207664,0.3559322033898305,0.6770723771101255,1.0,29/60,28.61%,SFTPA1;TLR3;FFAR2;S100A8;CLEC4E;TLR8;TLR4;TLR2;SFTPD;PLCG2;MYD88;CTSB;TLR10;LGMN;FCN1;CNPY3;NOD2;INAVA;TAB2;APOB;TLR1;CTSS;CD14;LY96;ALPK1;HMGB1;FGG;FGB;SFTPA2
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4141712963117185,1.0306178425895811,0.47368421052631576,0.979604098888201,1.0,4/20,14.53%,PPEF1;RHO;SAG;GUCY2D
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.4375659169189768,1.029847685301818,0.45180722891566266,0.9817813675360362,1.0,3/15,10.87%,CHRM4;HRH3;CHRM5
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.3165764525878983,-1.0296245732520628,0.36065573770491804,0.6796332670697205,1.0,11/35,22.31%,RAB25;CLDN10;LRRK2;TRAT1;USP6;REEP6;ARL6IP5;MYO6;ICA1;CLDN3;SNCA
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.3858961462779572,1.0295794450274194,0.39880952380952384,0.9821101749706383,1.0,8/26,24.92%,RECQL4;HMGB3;RTEL1;PIF1;DNA2;DDX11;BLM;HMGB2
prerank,Elsevier_Pathway_Collection__MIF Role in Cholesteatoma,-0.33140109375203947,-1.0295172703632114,0.3333333333333333,0.6794484714639635,1.0,10/26,21.97%,NR4A2;CXCR2;LGALS3;MAP2K1;AKT1;RARB;CXCR4;JUN;JAK2;RAP1A
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.3917888056014969,-1.0294846545746534,0.43617021276595747,0.6790597754876533,1.0,8/15,30.00%,PNP;XDH;DERA;NUDT3;NUDT15;GDA;NT5C1B;NT5E
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3029336915523691,1.029448403708929,0.4312796208530806,0.981954856749677,1.0,19/129,14.12%,MRAP2;RAB3C;TSPAN5;ACTN2;RAMP1;RAB3B;FGF13;KCNB1;ANK1;TMEM88;NKD2;TESC;ATP1B3;DPP10;S100A10;KCNIP3;RAMP2;RAB3D;RAB34
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.29724867344011097,1.029198517760929,0.4144144144144144,0.982141820477957,1.0,55/171,32.28%,TP73;FBXO43;NEK2;CDC25C;PLK1;BUB1B;CDC20;SPHK1;UBE2C;MKI67;BRINP1;PSMD4;DLGAP5;UBE2S;CDK1;FOXC1;CCNB1;PSMB4;SCRIB;TFAP4;CKS1B;CDKN1C;SMOC2;PRKCA;PKMYT1;USP22;SMAD3;TTL;OBSL1;SRA1;BTG3;ANAPC11;L3MBTL1;CUL7;ANGEL2;HSF1;PSMD1;ANAPC7;PSMB3;PSMD14;MAD2L1;PSMB5;PSMD2;CUL9;PIN1;PSMA1;TMEM8B;PSMD10;NEK7;DAPK3;RNF20;PSMC4;PSMC3;CUL1;SDCBP
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.3582899728589081,1.029163989034402,0.3894736842105263,0.9816570628245327,1.0,28/45,49.08%,CELF3;NOL3;CELF4;PUF60;SNRPE;KHDC4;TXNL4A;SNRPD2;SF3A2;PRPF6;LUC7L;SNRPD1;LUC7L3;DDX39B;USP39;ZRSR2;SF3A3;SNRPG;CRNKL1;DDX1;SNRNP200;RBM5;PRPF19;LUC7L2;SRPK1;SF1;SF3A1;SF3B1
prerank,WikiPathway_2021_Human__Hedgehog Signaling Pathway Netpath WP47,0.4287296780919646,1.029130752691981,0.41566265060240964,0.9812178988508643,1.0,9/16,39.03%,IHH;KIF7;DHH;ARNTL;GLI1;SMO;STK36;SUFU;SHH
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.26754430348862634,-1.0289984348827323,0.425531914893617,0.6799324948358225,1.0,19/73,19.48%,TACSTD2;PFN2;SFRP1;APOA1;GPR65;EPHA1;TMEFF2;PHLDB2;LIMCH1;WNT11;FERMT2;PTGER4;PIK3R1;PPM1E;SYNPO2L;LPAR1;CARMIL1;DLC1;SERPINF2
prerank,Elsevier_Pathway_Collection__TRRAP/TIP60 in Chromatin Remodeling,0.40261508782792843,1.0288362847109265,0.45180722891566266,0.9816748808666643,1.0,13/22,48.14%,KAT2A;VPS72;BRD8;MRGBP;MAD2L1;CBX3;RUVBL2;RUVBL1;DMAP1;MORF4L2;TRRAP;MEAF6;ACTL6A
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.3090010752711297,-1.028724366624028,0.35294117647058826,0.6802534888031592,1.0,12/41,14.97%,SLC27A6;SLCO4C1;SLC28A3;SLCO1B3;SLC28A2;NLRP3;SLC16A2;SLC35A3;SLCO2B1;SLC35D1;SLC28A1;SLCO1B1
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",0.40816966464609716,1.0287080877096562,0.4514285714285714,0.9814855476443869,1.0,6/25,15.60%,PPEF1;RHO;RGS9BP;GNB5;GUCY2D;PRKCA
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.3870717741724185,-1.028558776360115,0.4268292682926829,0.6802439826513796,1.0,7/15,18.59%,NR3C2;ESR1;OR51E2;BMP7;PGR;ABHD2;AR
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.3625149870312136,1.0283958949512577,0.38333333333333336,0.9819806271147823,1.0,18/38,34.74%,FOXM1;SPIRE2;SLF2;PARP1;RAD51AP1;DDX11;PRKDC;KMT5C;OOEP;FANCB;MAD2L2;TIMELESS;MRNIP;SHLD3;FUS;MMS19;PNKP;SHLD1
prerank,MSigDB_Oncogenic_Signatures__CYCLIN D1 UP.V1 UP,0.2978030526971238,1.0283078981039817,0.3972602739726027,0.9817219392545763,1.0,16/165,7.47%,GP2;PAX2;CA4;CACNG1;MNX1;RASGRF1;ATP4A;MYT1;THY1;SHC3;EVX1;RHO;FGD1;SLC6A9;SLC6A3;MKI67
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.36357571480178474,-1.0281712842139252,0.43956043956043955,0.6809551510124804,1.0,2/19,3.20%,SMPD3;IFNG
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.23901171389524542,-1.0281628146852435,0.3793103448275862,0.6804813319478834,1.0,39/185,16.02%,CRHBP;ST18;EDAR;TNFSF11;HAS2;TNFRSF17;TNF;AIM2;TNFRSF11B;ACOD1;CCL5;CD27;SFRP1;CCL4;CCL3;TNFSF15;XCL1;CCL23;TNFRSF13B;ZFP36L1;CCL2;NKX3-1;XCL2;CD40LG;TCL1A;TNFRSF11A;CXCL8;GATA3;CCL22;TNFRSF9;GBP3;AKT1;TNFSF13;GBP1;TNFRSF13C;BAG4;LTA;TNFRSF1B;TNFSF8
prerank,Elsevier_Pathway_Collection__GFs/TNF -> Ion Channels,-0.311645648749558,-1.028105048030665,0.38461538461538464,0.6801830219232524,1.0,13/34,22.85%,RET;TNF;NTF3;NTRK2;NGFR;NGF;NTRK1;TNFRSF1B;IRS2;MAP2K3;MAP2K6;APP;MAP3K5
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3268581179771925,1.0279719481656688,0.37566137566137564,0.9822428043452706,1.0,9/70,11.41%,E2F1;E2F7;TM4SF5;CDKN2A;PLK5;KIF14;CDKN2C;RGCC;CDKN2B
prerank,Elsevier_Pathway_Collection__Plasmin Effects in Inflammation,-0.2761583478890649,-1.0279076258714364,0.42105263157894735,0.6802223465276197,1.0,24/65,22.05%,TNF;TFPI2;IL1B;MMP1;FOS;KLKB1;TF;MAP2K1;CCL2;PLG;C1R;AKT1;RASGRP1;PRKCE;SERPING1;KNG1;PLAUR;C1S;SERPINF2;MAP2K3;MAP2K6;JUN;CD40;STAT1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.32308133640483755,1.0278754930963045,0.40404040404040403,0.9819414565191075,1.0,6/86,3.29%,MT3;PAX2;SFN;NODAL;DPEP1;SOX2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Retinitis Pigmentosa,0.3144631553049329,1.0275718462047043,0.430622009569378,0.9824065569560156,1.0,13/101,9.86%,COL2A1;REG3A;CA4;RHO;CERKL;AVPR2;FGF2;FSCN2;CRB1;DGKI;PCDH15;TUB;MYO7A
prerank,KEGG_2021_Human__Cellular senescence,0.3030095751759818,1.027551179084883,0.38461538461538464,0.9818916644016488,1.0,50/149,32.27%,E2F1;PIK3R2;CALML6;MAPK12;CDKN2A;FOXM1;MAPK11;CCNB2;E2F2;CCNE1;CCNA2;CCNE2;CDK1;CCNB1;CDKN2B;MYBL2;MAPKAPK2;HIPK4;SQSTM1;HRAS;CHEK1;MRAS;SMAD3;CDC25A;E2F5;CDK6;TSC1;TGFB2;RAD9B;CACNA1D;LIN37;TSC2;CAPN2;MAP2K2;ITPR2;LIN9;CCNB3;MYC;SLC25A6;CHEK2;RBL1;CDKN1A;RHEB;HLA-F;HIPK2;NFATC4;RRAS;PIK3R3;RAD1;CDK4
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.29877841172641173,1.0275422218857804,0.410958904109589,0.9813224398481541,1.0,12/144,7.73%,IGF2;ALOX15B;SIX1;GCM1;DLX1;NEUROD1;ELL3;SNAI2;MDK;HES5;KLHL41;BDNF
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.3804783745810942,1.02746378092975,0.4020618556701031,0.9810182912077801,1.0,3/35,2.90%,OSR2;NOTUM;SFRP4
prerank,MSigDB_Oncogenic_Signatures__PDGF UP.V1 DN,-0.25540056220194185,-1.0274176156192754,0.391304347826087,0.6810979198841322,1.0,36/105,21.42%,IGHV1-69;IGHM;TACSTD2;PRSS16;KLF5;SLC13A2;IL7R;FBN2;CTNND2;DUSP10;MAP7;MXRA5;ALB;SP140;ACADL;LILRB5;TCL1A;ITGB6;KL;CYP3A4;PAFAH2;FPR3;SLC28A1;SLC9A2;SEMA3C;TNFSF8;HERC3;LY75;DSC1;LY86;KIR3DL1;PF4;KIAA1217;KRT13;GNLY;JUN
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.35305068703325004,-1.027388989400616,0.3888888888888889,0.6806618801041833,1.0,9/22,12.55%,TMPRSS3;CYP4A11;ATP1A3;ATP12A;CYP4F2;SCNN1G;CYP4F12;SCNN1A;SLC8A1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.3756278799106725,1.0273149027130886,0.40437158469945356,0.9809889079250649,1.0,19/34,44.23%,CPSF1;SNRPE;MAZ;CPSF4;ZNF473;LSM10;LSM11;SNRPB;CSTF2;SNRPD3;PABPN1;SYMPK;CPSF3;CLP1;SNRPG;CPSF7;SLBP;FIP1L1;PCF11
prerank,Elsevier_Pathway_Collection__WNT Signaling in Melanoma,0.39993646590379983,1.0271698490612147,0.4540229885057471,0.9809128372989064,1.0,3/23,8.09%,LEF1;KISS1;CAMK2A
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,0.3032097712326556,1.0271596273353414,0.44495412844036697,0.9803617910996701,1.0,76/135,45.32%,SNAI2;AGO2;PSMD4;CBX6;EZH2;LAMTOR2;PSMB4;PPARG;HDAC5;NEDD4;LAMTOR4;HDAC1;CBX8;GATAD2B;SNAI1;PSMB3;MAF1;PSMD14;UBA52;RHEB;CHD3;CHD4;PSMB5;TRIM27;PSMD2;PSMA1;PSMD10;GDNF;RBBP7;PSMC4;CBX2;PSMC3;MLST8;LAMTOR5;RRAGD;CSNK2B;PSMC5;MTA3;OTUD3;AGO1;SEM1;PSMB6;PSMD8;RPTOR;RRAGA;MAPK3;PSME2;CNOT6L;HDAC7;EED;PSMD13;PSMB7;PSMA7;PSME3;USP7;MTOR;USP13;ATN1;PSMB2;RRAGB;MOV10;PSMA6;RBBP4;TNRC6B;KDM1A;UBC;STUB1;MAPK1;PSMD9;RING1;WWP2;XIAP;MECOM;PHC2;PSMC2;GATAD2A
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.4360960880790901,1.0270692650353204,0.4407894736842105,0.9800508209368313,1.0,9/15,21.24%,PPFIA3;PPFIA4;SNAP25;CPLX1;UNC13B;PPFIA2;STXBP1;STX1A;SH2D3C
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.3877251854244944,1.027057971032887,0.39664804469273746,0.979504997334629,1.0,7/24,23.44%,MYBPH;ATP1A2;TNNT3;GJA5;SLC8A3;RNF207;MYBPC3
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.3600652965661639,1.026787039802232,0.3791208791208791,0.9798596235791149,1.0,9/36,20.45%,GHRHR;RASL10B;ACSL4;TRH;UCN;NLGN2;DOC2B;NNAT;FFAR4
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.3974995173682888,1.0266890997113929,0.40555555555555556,0.9796426724578838,1.0,6/25,10.75%,ACTN2;GPRIN1;CAMK2A;GRIN2A;GRIN3B;MPP3
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,0.3955247250872902,1.0264605086272636,0.4393063583815029,0.9798955875642869,1.0,13/24,42.12%,VARS1;EPRS1;QARS1;FARSB;LARS1;EEF1E1;AIMP1;HARS1;GARS1;MARS1;IARS1;FARSA;PPA1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.317911141697097,-1.0264202787850276,0.3384615384615385,0.6831087692723822,1.0,10/34,15.03%,AGR2;TNF;CLMP;FGFR2;EPHB3;CXCL8;RARB;EDNRB;PCSK5;MIXL1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3182837720809883,1.026296789354929,0.4029126213592233,0.9798164347168457,1.0,23/111,16.14%,GLP1R;GHRHR;PTH2R;GCG;CALCA;CGA;DPEP1;RAMP1;GPHA2;HTR4;AVPR2;SRC;CRHR2;PTHLH;ADM2;GPR150;RAMP2;LHB;MC1R;ADCY6;IAPP;RHBDF2;ADORA2A
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.2805734959431476,1.0262645185367596,0.42323651452282157,0.9793168458579828,1.0,35/352,8.08%,HMGA2;ODAM;MT3;DKK1;HOXD3;FGF20;OSR2;EPHB2;LEF1;E2F1;OSR1;CRP;CLDN19;SFRP4;STOX1;ALOX12B;ROBO1;TCF23;GATA5;POU4F1;MAPK11;AVPR2;POU3F1;FGF17;NR5A1;BMP4;CD34;TESC;FGF2;TMEM119;AMH;FGF23;AGO2;PRKN;IL36G
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.3855542084426028,1.0261906759862751,0.42196531791907516,0.9790320301466945,1.0,6/30,18.45%,GNG4;GNG3;GNB5;PDPK1;GNG8;GNG10
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.3609865952642493,-1.0259138433961605,0.38636363636363635,0.683947951652875,1.0,6/18,17.13%,EGR2;ID2;PTN;CXCR4;TNFRSF1B;TENM4
prerank,WikiPathway_2021_Human__Small cell lung cancer WP4658,0.3298725063587888,1.0257117802609619,0.417910447761194,0.9802156445512693,1.0,21/95,20.61%,LAMA3;E2F1;PIK3R2;ITGA2;ITGA6;E2F2;COL4A1;COL4A5;CCNE1;CCNE2;IKBKG;COL4A2;CDKN2B;LAMC1;CKS1B;CDKN1C;LAMB4;LAMA4;TRAF2;CDK6;FHIT
prerank,WikiPathway_2021_Human__Melatonin metabolism and effects WP3298,-0.3150299094575555,-1.025602890883682,0.36764705882352944,0.6843042088429596,1.0,18/33,30.46%,CYP2C19;CYP1A2;FOXO1;PER1;PER3;AANAT;CRY1;CYP2D6;SULT1A1;ECE1;CALM1;CYP1B1;EDN1;SIRT1;MAOA;CYP1A1;TRAF6;ACHE
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.34543500280721445,-1.0253755156268467,0.4666666666666667,0.6843484799534258,1.0,5/21,12.58%,BMP5;ASXL3;SIK1;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.35911206572778626,1.0248501030527577,0.3917525773195876,0.982663264829993,1.0,15/34,33.82%,ATP6V0D2;RAB34;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1C1;MREG;ATP6V1H;MCOLN1;RAB43;ATP6V1F;ATP6V1E1;ATP6V1E2
prerank,Elsevier_Pathway_Collection__Protein Nuclear Import and Export,0.41110624164157233,1.0247798479576073,0.42592592592592593,0.9823608403361813,1.0,9/17,38.97%,KPNA2;NXF1;RANGAP1;XPO5;NXT1;XPOT;XPO1;NUTF2;RAN
prerank,Elsevier_Pathway_Collection__NOTCH -> RBPJ/HES/HEY Signaling,0.42915273718899627,1.024443615778537,0.43037974683544306,0.9829195226387069,1.0,6/16,26.59%,HEY1;HDAC1;LFNG;DVL1;MAML1;NCOR2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.40347309079396404,1.0242368399619919,0.4161849710982659,0.9830161980704643,1.0,11/18,47.29%,ATP5MF;ATP5F1D;ATP5F1E;ATP5MC1;ATP5ME;ATP5MG;VPS9D1;ATP5PO;STOML2;ATP5MC2;ATP5PD
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.34810022524631085,1.0241264207385237,0.41847826086956524,0.9828369197493367,1.0,38/59,47.47%,PSMD4;NFKB2;PSMB4;RELB;PSMB3;UBE2M;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;MAP3K14;PSME2;PSMD13;PSMB7;PSMA7;PSME3;FBXW11;PSMB2;PSMA6;UBC;PSMD9;BTRC;PSMC2;RPS27A;PSME1;PSMB1;PSMD3;RELA
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,0.2900840976492608,1.0239352813733487,0.44782608695652176,0.9829516400521088,1.0,71/277,21.44%,COL2A1;COL22A1;COL7A1;FBN3;COL15A1;CAPN9;MATN1;TNNI3;CAPN11;COL9A1;LRP4;BCAN;ICAM5;MMP11;MATN3;ITGA2;GDF5;ITGA6;SCUBE1;FGF13;CAPN8;BMP4;COL10A1;COL4A1;COL4A5;COL8A1;COL1A1;TIMP1;LOXL2;COMP;COL11A1;MMP12;NCAN;ADAM15;COL4A2;MMP17;LAMC1;MMP10;EFEMP1;CRTAP;CAPN14;LOXL1;PDGFB;MFAP2;TLL2;PDGFA;COL1A2;HTRA1;CMA1;COL5A1;MADCAM1;PRKCA;VCAN;ADAM9;ADAMTS18;CAPN12;LOX;LAMA4;ITGA7;ITGA11;PLEC;CTSD;HSPG2;MMP9;SPARC;P4HA2;MMP3;COL11A2;COL27A1;TGFB2;PECAM1
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.25209486748980076,-1.0239323945119285,0.3958333333333333,0.6879498007664467,1.0,18/97,16.76%,EDAR;TNFSF11;TNFRSF17;TNF;TNFRSF11B;CD27;FASLG;TNFSF15;TNFRSF13B;CD40LG;TNFRSF11A;TNFRSF9;TNFSF13;TNFRSF13C;LTA;TNFRSF1B;TNFSF8;TNFSF13B
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.32744476776788384,1.023612385350325,0.4325581395348837,0.9834644141216043,1.0,36/79,41.40%,KASH5;NEK2;GOLGA6D;ARHGEF10;KIFC1;SAC3D1;KIFC2;KIF11;GOLGA8M;HAUS4;GOLGA8A;HAUS5;TPX2;TUBGCP6;CHEK2;ABRAXAS1;SMC3;NEK7;CSNK1D;WRAP73;CCDC61;KIF3B;TOGARAM2;SMC1A;TUBGCP2;GOLGA8B;KIF2A;HAUS1;STAG2;RPS3;FLNA;NUMA1;CEP192;GOLGA6B;STARD9;ZNF207
prerank,Elsevier_Pathway_Collection__Glioma Invasion Signaling,0.32969279548345526,1.0235213336838036,0.457286432160804,0.9832148430932184,1.0,16/75,20.59%,COL2A1;EPHB2;HMMR;FGF2;EFNA1;PDGFRB;COL11A1;PDGFB;PDGFA;PLAU;SHC1;PDPK1;EGF;LIMK2;MMP9;MMP3
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,0.3548215582268364,1.0234059980052508,0.42408376963350786,0.9830459133732569,1.0,25/52,43.21%,H2BC13;H2BC17;H2BC9;H2BC15;H2BC11;H2BC12;H2BC4;H2BC5;UBE2A;PRKDC;RAD18;RNF181;UBA52;PCNA;RNF20;DERL1;UBE2D2;RRAGA;VCP;HLA-A;UBE2J2;RNF144A;HLA-B;UBE2V2;UBC
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.3196330203548981,-1.0234012902939063,0.38095238095238093,0.6888921370597448,1.0,3/32,7.48%,FOXP3;IL1B;PPARGC1A
prerank,Elsevier_Pathway_Collection__Adherens Junction Assembly (Cadherins),0.3832908021662958,1.0234009189336506,0.423728813559322,0.982477688603696,1.0,3/30,6.66%,LEF1;SNAI2;SRC
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,0.35623845224947065,1.0233326618886622,0.41530054644808745,0.9821027392649609,1.0,34/54,47.37%,CDKN2A;PSMD4;PSMB4;PSMB3;PSMD14;CHEK2;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;MDM4;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PHF20;PSMB1;PSMD3;MDM2
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.3776357592175852,1.0232934190888932,0.4,0.9816620606576527,1.0,17/28,47.29%,SAMM50;ATP5MF;ATP5F1D;APOO;MICOS13;ATP5F1E;UQCC3;ATP5MC1;ATP5ME;APOOL;ATP5MG;CHCHD6;LETM1;ATP5PO;ATP5MC2;IMMT;ATP5PD
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.40385915167639197,1.023253921105064,0.4069767441860465,0.9812299154627404,1.0,11/20,37.43%,KCTD17;ATP2A1;BCAP31;TMCO1;TGM2;FIS1;THADA;ATP2A2;BAX;RAP1GDS1;WFS1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.40057950991448243,1.0231817821915499,0.4437869822485207,0.980930461886354,1.0,9/28,25.23%,KIF1A;ARHGAP44;IL1RAPL1;PPFIA2;TANC2;CDK5R1;SRCIN1;SHANK3;CDK5
prerank,KEGG_2021_Human__Cholinergic synapse,0.3184468670974171,1.02304880136255,0.4362745098039216,0.9808455328476284,1.0,22/103,16.28%,GNG4;KCNJ6;CACNA1S;PIK3R2;CHRNB2;CHRM4;CHRNA3;CAMK2A;CHRNB4;KCNJ14;GNG3;CHRM5;CACNA1C;CHRNA4;CREB3L1;GNB5;ADCY6;GNG8;KCNJ4;PRKCA;HRAS;CREB3L4
prerank,TRRUST_Transcription_Factors_2019__NFIC human,0.39254186990111684,1.0228693380589182,0.43373493975903615,0.9809087363844287,1.0,5/25,12.07%,CYP17A1;MATN1;VWF;COL1A1;C4BPB
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.31067202308913416,-1.0228428292943714,0.43243243243243246,0.6901196976463376,1.0,10/32,18.87%,XKR4;FCN3;FCN2;MEGF10;RHOH;RAC2;ITGB3;THBS1;XKR9;FCN1
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,0.37883851160723714,1.0227356075832859,0.4367816091954023,0.9807759369994848,1.0,14/25,46.82%,NOTCH3;JAG2;EGF;DLL4;UBA52;NCSTN;TACC3;PSEN2;APH1A;UBC;WWP2;RPS27A;DLL1;MIB2
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.3371586446864804,-1.022714685826891,0.345679012345679,0.6899781522868557,1.0,15/25,23.73%,BST1;CD38;GPR183;FCRL3;PTPRC;SASH3;NCKAP1L;TNFRSF13C;TNFSF13B;VAV3;BCL2;IRS2;NFATC2;CD40;CD81
prerank,MSigDB_Oncogenic_Signatures__EGFR UP.V1 DN,-0.23465115420453056,-1.0224925151429778,0.40625,0.6900463990788469,1.0,50/164,23.82%,ASCL1;TCN1;TMPRSS3;OVOL2;EGR3;AGL;ID2;ELOVL2;CBFA2T3;NPY1R;MSMB;ANK3;SNX7;CALCR;XK;GALC;CYP26B1;RASGRP1;DDX60;ENPP4;PGR;WIPF1;CASP6;MAFB;ARMCX1;EPB41L2;BCL2;MATN2;SLC39A8;DERA;CBR4;HEBP1;ZNF43;DLC1;KIF5C;PCYOX1;MPDZ;MYB;SMAD7;CYBA;NDUFA5;SLC27A2;PRR15L;HSPA4L;NET1;IGF1R;ANXA9;BAZ2B;PRKACB;SGCB
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.25435600134574415,-1.0223629182980074,0.36363636363636365,0.6898688608496019,1.0,18/92,12.60%,MT1G;MT1HL1;MT1F;MT1H;SCARA5;MT1M;MT1E;SLC39A5;MT1X;GDF2;TF;CP;SLC39A12;MT1A;SLC39A14;LCK;MT1B;SLC31A1
prerank,MSigDB_Oncogenic_Signatures__PKCA DN.V1 DN,-0.2442510361235183,-1.02223541463634,0.34285714285714286,0.6897358499229085,1.0,29/135,13.99%,NKX2-1;IGHG1;MUC5AC;IGHM;TTC36;HS3ST3A1;DNAH8;EIF4E3;SIK1;GLDC;SLC14A1;ST6GALNAC1;ABI3BP;APOF;CP;BCKDHB;NFKBIZ;CLEC4D;COL25A1;ITGB6;MBL2;ZEB2;TRIB1;CLEC7A;TLR2;CAMP;ENPP4;NFIL3;GBP1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.31658812130742486,-1.0222215007348416,0.4024390243902439,0.689289323453807,1.0,15/27,32.61%,ABCD2;PEX3;ABCD4;ACBD5;PXMP2;GDAP1;RAB8B;PEX7;PEX13;PEX14;ABCD3;ATAD1;SLC25A17;ALDH3A2;PEX12
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.3748820825110897,1.0222169590226367,0.3888888888888889,0.982025980838967,1.0,13/28,28.30%,FGF2;PDGFRB;RGCC;PDGFB;PDGFA;SMOC2;ANKRD1;SMG5;ACVRL1;MYC;NABP2;CDKN1A;FGFR4
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.42645529869188736,1.022135122479058,0.4240506329113924,0.9817449099727741,1.0,16/19,53.79%,JADE2;JADE3;HCFC1;WDR5;OGT;KAT8;MCRS1;KANSL1;MSL1;PHF20;MEAF6;KANSL3;ING4;KANSL2;JADE1;KAT7
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.3622705306482167,-1.0220396185904996,0.3875,0.6893659063272779,1.0,5/18,11.12%,ITGB8;PTGS2;XCL1;ITGB6;LILRB1
prerank,Elsevier_Pathway_Collection__Ketogenic Diet Mechanism (Hypothesis),-0.3487060184506149,-1.0220084031041687,0.4222222222222222,0.6889524135003905,1.0,6/25,13.06%,KCNK2;TNF;IL1B;PPARGC1A;IL6;AKT1
prerank,Elsevier_Pathway_Collection__AGE Related Insulin Resistance in Skeletal Muscles,0.3966222175032478,1.0215532035111392,0.430939226519337,0.9831485949229072,1.0,3/22,6.65%,NOX4;SLC2A4;BIRC5
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.30556927765717756,1.0215272919395195,0.42857142857142855,0.9826477904594133,1.0,31/116,22.70%,POPDC3;OSR1;TNNI3;ALPK3;TDGF1;POU4F1;FOXC1;PDLIM7;SOX18;CACNA1C;FOXL1;RAMP2;MICAL2;PDGFB;SH3PXD2B;KAT2A;DVL2;PKD1;FGF12;CRB2;ACVRL1;PDLIM4;NOTCH4;HSPG2;HEY1;PDLIM3;FOXC2;TGFB2;BORCS8;LDB3;TSC2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.3820361103727939,1.0214353307701827,0.4161849710982659,0.9824067176209405,1.0,5/29,18.57%,CELF3;CELF4;HABP4;SF3B4;RBM3
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.3817423678138159,1.0213267547246023,0.423728813559322,0.9822296789321712,1.0,11/32,27.03%,KNDC1;CHRNB2;CHRNA3;IL1RAPL1;LZTS1;NEDD4L;NEDD4;OBSL1;CUL7;CDKL3;HECW1
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,0.39301322628244584,1.021295698460307,0.43529411764705883,0.9817402426918399,1.0,6/22,14.98%,CA4;ATP1A2;ATP1A4;ATP1B3;SLC9A3;FXYD2
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.34356829674806855,1.0211204699278604,0.421875,0.9817249848749329,1.0,10/46,17.35%,FAM83A;SHC3;VIL1;TDGF1;SRC;DGKD;EFEMP1;SHC1;PDPK1;EGF
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.26069148249351365,-1.0211146452647808,0.4074074074074074,0.6910518007604142,1.0,22/69,19.04%,EREG;KRT4;MARVELD3;SFRP1;GDF2;XDH;DUSP10;FGFR2;MCC;RUNX3;NKX3-1;ALOX5;GATA3;ATOH8;TNMD;SOX9;SYNJ2BP;NLRC3;THBS1;CAV2;SFRP2;APOH
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,0.43342284225853644,1.0210528730067292,0.4970414201183432,0.9813975050503797,1.0,12/19,43.21%,RFC4;POLR1A;NPLOC4;UFD1;UBA52;SPRTN;PCNA;POLH;VCP;SLC19A1;RFC3;UBC
prerank,Elsevier_Pathway_Collection__ADRA1A -> IL6 Production,-0.3121835266907906,-1.0209858644902519,0.4050632911392405,0.6908903468027661,1.0,10/30,25.06%,ADRA1A;FOS;MAP2K1;IL6;RASGRP1;MAP2K3;MAP2K6;JUN;MAP2K4;JUND
prerank,Elsevier_Pathway_Collection__EGFR/ERBB -> STAT Signaling,-0.3607488446785475,-1.020609983490937,0.3977272727272727,0.6914945566362848,1.0,9/20,22.05%,EREG;ERBB4;NRG4;TGFA;BTC;HBEGF;NRG3;JAK2;STAT1
prerank,MSigDB_Oncogenic_Signatures__LEF1 UP.V1 UP,0.29068948592118626,1.0204446393004438,0.43555555555555553,0.9827777810086993,1.0,32/177,14.01%,GNG4;CHGB;DKK1;DKK4;PTPRN2;PRKAA2;TM4SF5;EN2;ARG2;CDKN2A;FGF13;S100A2;ERVMER34-1;S100A3;PTGDS;ISYNA1;PARVB;DHRS2;GNAL;NMNAT2;SLC6A8;IL11;LTBP2;LPL;PHLDA3;DNAJC6;STC2;RAMP2;LOXL1;MFAP2;PDGFA;FOXF2
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.40937107085921215,1.0203356497744507,0.4233128834355828,0.9825871362680608,1.0,2/21,2.90%,APLN;SFRP4
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.3434289819162412,1.0203009773911607,0.4585635359116022,0.982130680772493,1.0,13/58,25.26%,GLUL;ALOX12B;DPM3;PORCN;PGAP4;WDR45;PIGZ;PIGC;PIGM;HHAT;ATG10;ZDHHC1;ZDHHC9
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,0.33439337127354296,1.020236896533503,0.39893617021276595,0.9818116633127631,1.0,10/52,11.42%,MATN1;TNNI3;COL9A1;LRP4;BCAN;MATN3;ITGA2;COMP;NCAN;LAMC1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.3210271180030813,1.020204859121612,0.44559585492227977,0.9813462738130275,1.0,52/97,49.08%,CELF3;NOL3;SCNM1;PRPF3;SF3B4;RNF113A;RBM8A;TXNL4A;SNRPD2;WT1;PRPF6;NOVA1;SNRPB;LSM4;SNRPD1;WDR83;TCERG1;FUS;NONO;LUC7L3;RNPC3;DDX39B;SNRPD3;PPP2R1A;MAGOHB;SLU7;USP39;ZRSR2;PRPF8;SNRNP35;PTBP1;ZMAT5;SF3A3;SNRPG;U2AF1;SNRPA1;RNPS1;RP9;IVNS1ABP;SFPQ;MAGOH;SF3B3;YJU2;SNRNP25;MPHOSPH10;SNRNP40;SRPK1;DBR1;DHX16;DHX8;NCBP2;SF3B1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.36739770368756264,1.0201192902364644,0.43103448275862066,0.981043937265069,1.0,16/37,30.07%,H1-5;H1-2;H1-4;USP51;RTEL1;CHEK1;MSH2;FIGNL1;RAD51AP1;H1-0;RAD51;KPNA2;BLM;MSH6;SIRT6;THOC1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.3497326326556034,-1.0199519841294244,0.40425531914893614,0.6927626735528533,1.0,4/18,11.49%,P2RY12;P2RX3;TRPC3;P2RY1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.3675972913843753,-1.0198087585631688,0.4090909090909091,0.6926963868993247,1.0,11/17,19.02%,BMP5;IGFBP3;WNT1;NKX3-1;CILP;IGFBP5;IGFBP6;IGF1;IGFBP1;IGFBP4;CDH3
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.37238898549639654,1.0194499757232838,0.4431818181818182,0.9827622744939474,1.0,6/38,11.34%,ST8SIA3;DPM3;A4GALT;B3GNT5;PGAP4;ST8SIA5
prerank,MSigDB_Oncogenic_Signatures__NOTCH DN.V1 UP,-0.23627569656098985,-1.0194231725388054,0.4375,0.693445975964219,1.0,32/149,14.83%,HHLA2;FOXP3;SLC5A1;HPCAL4;CDHR2;RFPL1;NME5;BARX2;CDHR1;KLRD1;S100A8;CPEB3;ANGPT4;ADAP1;P2RX3;EPN3;DPT;CTF1;PAIP2B;AMPH;ADAMTS1;MEFV;DLGAP1;DGKE;P2RY1;SPTBN2;FLT3;RGS2;RASGRP1;PF4V1;RUNX2;LDOC1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.34812978660947824,1.019026298129082,0.42702702702702705,0.9836194893569108,1.0,13/50,18.18%,PAK3;BRSK2;THY1;LRP4;ROBO1;PLXNC1;LINGO1;PLXNA2;METRN;GDI1;PLXND1;MAP6;PLXNA3
prerank,Elsevier_Pathway_Collection__Norepinephrine Release Regulation,0.36515324483043415,1.01876829003682,0.4124293785310734,0.9839019708131141,1.0,10/34,20.62%,CACNB4;CACNA2D2;SLC29A4;SNAP25;CPLX1;UNC13B;SLC6A2;TACR1;SNAPIN;STX1A
prerank,WikiPathway_2021_Human__Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,-0.3790066031227997,-1.0187212492644298,0.36046511627906974,0.6948258766398119,1.0,7/16,24.09%,TLR8;TLR4;TLR2;MYD88;TLR10;JUN;TLR1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3782881293293917,1.018605943531425,0.4161849710982659,0.983863807860982,1.0,2/31,8.12%,SRARP;FOXH1
prerank,WikiPathway_2021_Human__Bladder cancer WP2828,0.36865369947394205,1.018605230776604,0.4517766497461929,0.9833000409097434,1.0,10/40,19.77%,E2F1;PIK3R2;CDKN2A;SRC;UPK3A;DAPK2;TYMP;HRAS;EGF;MMP9
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.41236280149985566,1.0184725580101122,0.45294117647058824,0.9831674715494283,1.0,2/20,1.93%,LEF1;E2F1
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,-0.2933846095304622,-1.018444839397813,0.43859649122807015,0.6951575851834595,1.0,14/56,17.07%,GRIN2B;NRXN1;SYT9;SYT10;LRRTM4;SYT1;SYT7;DLGAP2;DLGAP1;NLGN4X;LRRTM3;NLGN4Y;EPB41L3;EPB41L2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.3089757909104068,1.0183680511347024,0.43137254901960786,0.9829620236355192,1.0,53/105,46.29%,SARNP;DDX39A;CPSF1;SMG5;ZC3H11B;CASC3;NUP37;THOC5;RBM8A;CHTOP;NUP62;NXF1;TPR;NUP133;CPSF4;UPF3B;NUP155;NUP160;THOC1;SMG7;POLDIP3;NXF5;THOC6;NUP188;NXT1;THOC2;DDX39B;MAGOHB;SLU7;PABPN1;ZC3H11A;NUP205;MCM3AP;RBM15B;NUP210;ENY2;SYMPK;CPSF3;RAE1;NUP214;GLE1;ALYREF;NUP107;SLBP;U2AF1;U2AF2;FIP1L1;RNPS1;UPF1;AAAS;DDX19A;EIF4A3;MAGOH
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.37671043364543966,1.0181729670176773,0.43455497382198954,0.9831099255014416,1.0,14/27,42.01%,MAPT;ANKRD53;PSRC1;ARL2;CDK5R1;MECP2;GIT1;MET;DRG1;RPS3;NAV3;NUMA1;OCLN;CKAP5
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,0.35241115062550327,1.018014883545608,0.41530054644808745,0.9830328992561808,1.0,26/48,44.05%,DTL;RFC4;POLD1;PCLAF;POLR1A;ISG15;NPLOC4;TRIM25;RAD18;UFD1;CUL4B;UBA52;SPRTN;MAD2L2;PCNA;POLH;VCP;DDB1;SLC19A1;POLK;USP1;RFC3;POLD3;RBX1;UBC;POLD4
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.3798636982558799,1.0179561767850496,0.4431137724550898,0.9826958670047615,1.0,6/25,16.03%,THBS4;MDK;C5AR2;DAPK2;DPP4;CAMK1D
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.35648336641218464,1.017608826460722,0.4293785310734463,0.9833379555227532,1.0,6/44,13.38%,SCG2;RAB3C;RAB3B;NECAB3;LTBP2;RAB3D
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,0.3628786375763748,1.0172216319100913,0.42105263157894735,0.9840422840498158,1.0,32/51,47.30%,PSMD4;PSMB4;ELOC;ELOB;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.3248322973902656,1.0171815514632472,0.4074074074074074,0.9835951002679191,1.0,12/80,13.52%,MT3;CACNA1E;CSN2;CACNA1S;RAMP1;CHRNB2;CAMK2A;ATP2A1;CACNA1C;CHRNA4;RAMP2;CACNG8
prerank,Elsevier_Pathway_Collection__Proteins Involved in Arterial Hypertension,0.289704484089536,1.0170618173335813,0.4690265486725664,0.9834413472234227,1.0,45/223,17.41%,SLC6A4;GCG;REN;APLN;CALCA;CYP17A1;WNK4;PLA2G2A;TNNI3;ARG2;VWF;SLC12A1;SLC2A4;AVPR2;KCNJ5;BMP4;SRC;PTGER1;TRPC6;BDNF;ELN;ATP2B4;HSPB1;MMP12;LPL;LEP;ADM2;CD36;SLC9A3;BDKRB2;ACE;UCN;FLT1;NOX1;CMA1;SHC1;LEPR;PPARG;SLC6A2;HTR2B;ADORA2A;SMAD3;HMGCR;EGF;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.3011812081636649,-1.0169714007465582,0.4117647058823529,0.6989804115794764,1.0,16/43,23.80%,IL10;ACOD1;LILRB1;REL;HERC5;HAVCR2;LILRA4;NLRC3;ITCH;PTPRS;UBE2L6;DHX58;IFIH1;RNF125;SIRPA;DDX58
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.3622001721022091,1.0168502867079652,0.441340782122905,0.9836001655714949,1.0,13/44,29.96%,TRIM71;ZNF385A;NANOS1;METTL18;TCOF1;RBM3;TSC1;EIF2B4;LARP1;MATR3;RPL10;ATXN2;ZC3H10
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.413382317172208,1.0164977697049187,0.4508670520231214,0.9842182868211206,1.0,9/17,37.99%,ACE;ABCA7;MME;BACE2;NCSTN;MGAT3;PSEN2;APEH;APH1A
prerank,WikiPathway_2021_Human__Oncostatin M Signaling Pathway WP2374,-0.28689712099997094,-1.0164026087799511,0.4576271186440678,0.7001779794231879,1.0,12/63,15.99%,MMP1;FOS;LIFR;MAP2K1;PRKCB;CCL2;EGR1;OSM;PIK3R1;AKT1;PRKCE;CASP7
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,-0.3254956971418595,-1.0162935829391697,0.4125,0.6999672400717659,1.0,6/25,14.80%,EREG;ERBB4;NRG4;BTC;PIK3R1;HBEGF
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,0.3128846814544573,1.0162819241216343,0.4444444444444444,0.9843862881644921,1.0,42/111,40.31%,DYNC1I1;PRKAA2;SRC;PRKN;LAMTOR2;SQSTM1;MTMR3;WDR45;LAMTOR4;MTERF3;TSC1;TOMM20;TSC2;ATG10;DYNLL1;PRKAB2;HSF1;TOMM5;RB1CC1;UBA52;RHEB;ULK1;TOMM40;PARK7;CHMP2A;MLST8;DYNC1H1;GABARAP;LAMTOR5;RRAGD;CSNK2B;HSPA8;RPTOR;UBE2V1;RRAGA;VCP;HSP90AA1;PLIN3;USP30;TOMM7;ATG4A;MTOR
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,0.3975423938069947,1.0160215870270617,0.46629213483146065,0.9846796232451305,1.0,6/26,15.60%,PPEF1;RHO;RGS9BP;GNB5;GUCY2D;PRKCA
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.2820345075394041,1.0158683925626402,0.45867768595041325,0.9846138992002444,1.0,105/383,30.84%,TRIM50;TRIM17;TRIM40;H2BC13;TRIM7;MKRN3;RNF182;ZNRF3;RNF157;PLK1;UBE2T;KLHL41;H2BC17;TRIM73;UBE2C;PRKN;H2BC9;H2BC15;UHRF1;KLHL21;UBE2S;CCNF;H2BC11;RNF43;H2BC12;KLHL13;SPSB2;ASB12;FBXO24;NSMCE2;UFC1;TRIM55;ELOC;H2BC5;ANKRD9;TRIM74;TRIM11;NEDD4L;TRIM54;NEDD4;TRIM24;TRIM72;BARD1;DET1;PIAS3;RNF113A;NUP37;ELOB;TRAIP;RNF187;UVSSA;ASB1;STX1A;ISG15;RNF135;PDZRN3;UBE2A;EYA1;PIAS1;ANAPC11;TRIM28;CCDC22;PRKDC;GAN;HIF3A;KLHL25;NUP62;ATG10;UBA1;FBXL15;CUL7;TPR;NUP133;LZTR1;TRIM47;NEDD8;TSPAN17;TRIM52;TRPM4;RANGAP1;TRIM38;ANAPC7;RAD18;HECW1;RNF181;UBE2M;CUL4B;UBA52;KCTD13;SMURF1;SDE2;RNF25;SPSB1;NUP155;TRIM27;RACK1;PCNA;NUP160;CUL9;TRAF7;DDRGK1;PIAS4;UBE2I;ARRB1;KEAP1
prerank,MSigDB_Hallmark_2020__Apical Surface,0.34979968616333695,1.0157863149125363,0.4090909090909091,0.9843562583170953,1.0,5/43,5.24%,SLC22A12;SLC34A3;THY1;SCUBE1;SLC2A4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.33062092723478675,1.015742178729071,0.4030612244897959,0.9839638123686085,1.0,10/67,16.51%,VEGFD;PIK3R2;MAPK11;SRC;HSPB1;PRKD1;FLT1;PGF;MAPKAPK2;ROCK2
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.4114293031457999,1.01569934596759,0.4858757062146893,0.9835561616057327,1.0,3/21,8.07%,MT3;GRIN1;PRKN
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,0.3624623513672365,1.0155832842744208,0.42391304347826086,0.9834521172957122,1.0,3/39,6.66%,PIK3R2;DLG5;SRC
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.33738772660394845,1.0154346577689948,0.4105263157894737,0.9834126945220087,1.0,18/48,27.00%,MESP2;MESP1;TBX3;ANKRD1;HTR2B;TBX19;MYLK2;MEGF8;ACVRL1;OLFM1;TGFBR3;HEY1;TGFB2;EPHB4;MYBPC3;SOX17;PTK2;HEYL
prerank,Reactome_2022__Cellular Hexose Transport R-HSA-189200,-0.35100024955624,-1.01529196434685,0.40298507462686567,0.7023569718612912,1.0,6/20,14.58%,SLC5A1;SLC45A3;SLC2A9;SLC2A14;SLC2A12;SLC2A2
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.320221419305827,1.015091591694894,0.425,0.9841273671122313,1.0,27/89,31.29%,PRKAA2;MAPK12;MAPK11;NR1D1;SAMM50;MEF2D;ATP5MF;PPARGC1B;TWNK;CRTC1;GLUD2;POLRMT;ATP5F1D;CRTC2;APOO;PRKAB2;LIN9;SMARCD3;HCFC1;TFB2M;MTX1;MICOS13;ATP5F1E;ATP5MC1;ATP5ME;GDNF;PPRC1
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.31901723301172624,1.0147175361174117,0.41798941798941797,0.9848900315104729,1.0,47/81,48.14%,RFC4;POLD1;ACTR5;PIAS3;CETN2;POLR1A;PARP1;PIAS1;INO80E;NFRKB;TFPT;COPS5;CHD1L;CUL4B;UBA52;PCNA;XRCC1;UBE2I;DDB2;COPS6;RUVBL1;DDB1;ACTR8;ERCC2;INO80D;COPS8;SLC19A1;GPS1;POLK;XPC;RFC3;POLD3;RBX1;UBE2V2;UBC;ERCC3;POLD4;COPS7A;MCRS1;INO80;COPS4;XPA;ERCC1;RPS27A;GTF2H2;POLE2;ACTL6A
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.4062919408364088,1.0145309250557972,0.46551724137931033,0.9849259535246705,1.0,6/21,12.84%,IGF2;NPM2;PDGFRB;RGCC;AURKA;PDGFB
prerank,TRRUST_Transcription_Factors_2019__XBP1 human,-0.35523599993922383,-1.0142362885689788,0.3563218390804598,0.7048308508817693,1.0,7/18,17.11%,ESR1;CCL2;IL6;PTGER4;CXCL8;PRNP;HSPA1A
prerank,TRRUST_Transcription_Factors_2019__NR3C1 human,0.3634189687917843,1.0141671127372411,0.41621621621621624,0.9856443866899206,1.0,2/35,2.06%,S100P;SPP1
prerank,Elsevier_Pathway_Collection__Lipolysis Regulation in Adipocyte,0.3577018503326711,1.0141585902404733,0.40229885057471265,0.9851029223749996,1.0,4/34,8.78%,GCG;FABP4;PTGER3;ADORA1
prerank,Elsevier_Pathway_Collection__Proteins Involved in HPV Infection,0.4328986225092971,1.01390014707793,0.4880952380952381,0.9854366935785532,1.0,3/15,9.81%,CDKN2A;ITGA6;S100A10
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.3969455069391228,1.0137553817944203,0.44242424242424244,0.9853962961232371,1.0,9/19,38.87%,DLG5;FRMD1;MOB3B;NF2;VGLL4;WWC3;SCHIP1;SHANK2;LIMD1
prerank,Elsevier_Pathway_Collection__HPV E1 and E2 Expression in Early Phase of Cancer,0.42918879926271536,1.0134544899121016,0.4472049689440994,0.9858735014200716,1.0,4/16,11.47%,CDC20;CCNB2;CCNA2;AURKA
prerank,Elsevier_Pathway_Collection__Proteins Involved in Astrocytoma,-0.2473455744310421,-1.0133505520150337,0.4423076923076923,0.7068598584029577,1.0,13/89,11.58%,ASCL1;IL13RA2;IL10;IFNG;TNF;IL1B;MMP1;HGF;TNFSF10;IL6;ALOX5;MMP7;BTK
prerank,Elsevier_Pathway_Collection__Histone Sumoylation,0.4231037956163217,1.0133491729722874,0.45751633986928103,0.9856539985361907,1.0,9/19,38.08%,HDAC4;PIAS1;CBX5;HSF1;RANGAP1;UBE2I;SAE1;UBA2;MBD1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.3245051254992526,-1.0133229236703132,0.375,0.7064423364735383,1.0,3/32,7.48%,FOXP3;IL1B;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.25174419327946657,-1.0130304419109017,0.4444444444444444,0.706740115056718,1.0,20/92,13.93%,RET;ERBB4;EPHB1;CD4;MUSK;NTRK3;LTK;NTRK2;PDGFRA;EPHA1;ALK;EPHA7;FGFR2;EPHB3;AXL;NTRK1;FLT3;TTN;EPHB6;FGR
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.3491103545389538,-1.013017509785783,0.43209876543209874,0.7062835908818694,1.0,10/24,27.23%,AIM2;ACOD1;PYHIN1;MNDA;IFI16;STAT1;OAS1;PLSCR1;TRIM6;IRF1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.31741185642059716,1.0129845529535648,0.37623762376237624,0.9857440696129414,1.0,3/105,2.14%,MUC7;MUC13;PAK3
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.31741185642059716,1.0129845529535648,0.37623762376237624,0.9857440696129414,1.0,3/105,2.14%,MUC7;MUC13;PAK3
prerank,MSigDB_Oncogenic_Signatures__MEL18 DN.V1 DN,0.30003510797171606,1.0129616922944775,0.430622009569378,0.9852668253890594,1.0,12/125,6.77%,DLK1;CDH22;DIO2;NTS;EBF2;EEF1A2;PEG3;SOX2;OLFM4;B3GAT1;SERPINI1;BAALC
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.41458618322144725,1.0126887399321647,0.40372670807453415,0.9856146965282312,1.0,2/18,5.23%,POPDC3;MESP1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3351878314701963,1.0126653239986387,0.42857142857142855,0.9851303118597111,1.0,10/54,12.28%,DKK1;INHA;NODAL;GDF5;MSTN;BMP4;TTK;GDF15;GDF11;GDF7
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.34282604537023864,-1.0124907573445943,0.4567901234567901,0.7074256034370039,1.0,2/23,3.68%,RIPK3;ZBP1
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.4034226971825378,1.0117328597246646,0.45664739884393063,0.9877297838399056,1.0,5/21,18.02%,NPHS1;BSN;NECTIN1;DLG4;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.31363775442858266,-1.011498787172122,0.4666666666666667,0.7097744691757237,1.0,10/31,20.58%,NTF3;SFRP1;SEMA4D;PTPRC;CD300A;SAMSN1;LILRB4;PTK6;SFRP2;PRKCZ
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.3572797490480408,1.0114693976918732,0.39655172413793105,0.9880892229446275,1.0,32/52,47.30%,PSMD4;HSPB1;PSMB4;PSMB3;PABPC1;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;HSPA8;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.38180215265674805,1.011082797485621,0.4161849710982659,0.9888915454278333,1.0,3/30,2.85%,SIX1;SIX4;NRCAM
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.42137915844465157,1.01076976507594,0.4472049689440994,0.9893795414196328,1.0,2/17,7.91%,TERT;AGO2
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.3393022095100532,1.010290175277115,0.4421052631578947,0.9904973301036776,1.0,7/62,10.88%,DUSP9;TNFRSF19;MAPK11;IRAK1;MAP3K8;IKBKG;IRAK2
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.36968490078861443,1.0100045733303777,0.42934782608695654,0.990933619661003,1.0,7/30,13.53%,IGF2;PDGFRB;DLGAP5;RGCC;AURKA;PDGFB;NSMCE2
prerank,Reactome_2022__Defects Of Contact Activation System (CAS) And Kallikrein/Kinin System (KKS) R-HSA-9651496,-0.3832866524737047,-1.0098907564629038,0.43478260869565216,0.7137987985954893,1.0,7/15,19.28%,F9;KLKB1;GP5;ZNF160;SERPING1;GP1BA;TPST2
prerank,KEGG_2021_Human__Prolactin signaling pathway,0.33568618102626097,1.0097154392427343,0.40860215053763443,0.9913211307210378,1.0,8/67,6.66%,CSN2;CYP17A1;CGA;PIK3R2;MAPK12;SHC3;MAPK11;SRC
prerank,WikiPathway_2021_Human__Integrated Cancer Pathway WP1971,0.3482163600672499,1.0094882832275256,0.4308510638297872,0.9915055224769825,1.0,20/44,34.58%,E2F1;PLK1;CDK1;CDKN2B;CHEK1;SMAD3;CDC25A;MSH2;BARD1;BBC3;BLM;MYC;CHEK2;CDKN1A;MSH6;CASP9;CDK4;POU2F1;NOXA1;BAX
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.3279215489546358,1.009482934842498,0.4861878453038674,0.9909643252399911,1.0,24/57,37.99%,HES5;HDAC4;HDAC11;JAG2;KAT2A;HDAC5;DLL4;HDAC10;HEY1;HDAC1;MYC;MAML1;NCOR2;HEYL;UBA52;NCSTN;MAMLD1;CUL1;HDAC8;SKP1;TBL1X;PSEN2;HDAC7;APH1A
prerank,WikiPathway_2021_Human__Cannabinoid receptor signaling WP3869,-0.32506988064593756,-1.009420406601455,0.4305555555555556,0.7145730395335848,1.0,8/28,19.38%,CYP2C19;PRKAR2B;CYP2C9;CNR2;CYP3A4;MAPK10;ADCY1;MAPK13
prerank,WikiPathway_2021_Human__Transcription co-factors SKI and SKIL protein partners WP4533,0.4191173063247474,1.0093081765717087,0.46060606060606063,0.990984820574996,1.0,9/18,34.77%,TEAD2;TEAD4;HDAC1;SATB2;MECP2;TEAD3;MERTK;TEAD1;STK3
prerank,Elsevier_Pathway_Collection__Drugs Targets in Autistic Disoreder (Hypothesis),-0.37447547267476144,-1.0091964575494436,0.4431818181818182,0.7147570714548824,1.0,7/17,11.04%,HTR2A;NTRK3;NTRK2;NGFR;EGR1;IL6;NTRK1
prerank,Elsevier_Pathway_Collection__Insulin Resistance in Myocytes Induced by Obesity,-0.29005363299832637,-1.0091209645090584,0.4507042253521127,0.714498329862579,1.0,10/39,14.75%,CXCR2;ACSL1;PPARGC1A;PRKCQ;ACACB;TLR4;TLR2;PIK3R1;AKT1;MYD88
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,0.2941274790528194,1.0088947513012752,0.43171806167400884,0.991737562210632,1.0,37/173,20.59%,GNG4;H3C13;H2AC19;PIK3R2;H2BC13;GREB1;H2AC20;H2BC17;SRC;SPHK1;AGO2;H2BC21;H2BC9;H2BC15;GNG3;H2BC11;H2BC12;TFF3;H2BC4;H4C15;H2AC6;GNB5;SHC1;PDPK1;GNG8;H2BC5;HRAS;DAND5;H2AX;POLR2L;EGF;USF1;GNG10;CTSD;MMP9;GPAM;MMP3
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,0.37776638220215064,1.008535414832987,0.4682080924855491,0.9924701948770185,1.0,5/26,9.80%,CDH8;CDH13;CDH24;NECTIN1;CDH17
prerank,Elsevier_Pathway_Collection__FXN Role in Friedreich Ataxia Progression,-0.36623346662565365,-1.0084486649331341,0.42857142857142855,0.7159929697540891,1.0,17/17,63.40%,SDHB;FXN;TFAP2A;NFE2L2;FECH;EPAS1;SRF;HIF1A;ACO2;PMPCB;HSCB;TP53;ISCU;NFS1;HSPA9;LYRM4;HSPD1
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.341821695214096,1.00823555602639,0.5,0.9929209728480723,1.0,2/51,0.53%,MUC7;MUC13
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,0.28103041767095804,1.0081626884913675,0.4419642857142857,0.992599812416346,1.0,33/245,9.77%,HTR1D;GNG4;RGSL1;RXFP4;ADRA2C;APLN;GNAZ;RGS20;OPN1SW;GAL;TAS1R3;RHO;CCL13;OPRL1;GPSM1;CCL25;CHRM4;SAA2;CCL20;SRC;PTGER3;PDE4C;CAMK2A;SSTR5;PDE1C;RGS9BP;CCR3;GNAL;GALR2;ADORA1;GALR3;HCAR1;GNG3
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.3137281977671092,-1.0080531913608168,0.4675324675324675,0.7167161416655088,1.0,4/29,5.57%,LGI1;TNF;SYT1;CD80
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.2757308064220949,-1.0078525112927184,0.5161290322580645,0.7167995817233692,1.0,14/43,20.90%,PFN2;SFRP1;APOA1;GPR65;EPHA1;LIMCH1;WNT11;FERMT2;PPM1E;SYNPO2L;LPAR1;CARMIL1;SERPINF2;CCDC88A
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.3956149960561149,1.0077137870048587,0.4642857142857143,0.9935499068340121,1.0,8/24,28.21%,CENPA;PLK1;NDC80;SAPCD2;SPDL1;GPSM2;GJA1;MAD2L1
prerank,TRRUST_Transcription_Factors_2019__RUNX3 human,0.3762290843381881,1.0076323230971773,0.47058823529411764,0.9932229891409151,1.0,11/29,29.34%,WNT4;TIMP1;PEA15;CD36;CLDN7;MMP9;FADD;MYC;CAPN10;CDKN1A;DNASE1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Congenital Deafness,-0.32719711868839746,-1.0072769232696965,0.44155844155844154,0.7179939599342703,1.0,9/23,14.22%,ILDR1;RET;KCNE1;KCNJ10;KCNMA1;MYH15;GJB2;AKT1;EDNRB
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3071499207437304,1.0071009689539503,0.43434343434343436,0.9943982847039172,1.0,47/98,44.56%,SARNP;DDX39A;CPSF1;SMG5;CASC3;NUP37;THOC5;RBM8A;CHTOP;NUP62;NXF1;TPR;NUP133;CPSF4;UPF3B;NUP155;NUP160;THOC1;SMG7;POLDIP3;NXF5;THOC6;NUP188;NXT1;THOC2;DDX39B;MAGOHB;SLU7;ZC3H11A;NUP205;MCM3AP;RBM15B;NUP210;SYMPK;CPSF3;RAE1;NUP214;GLE1;ALYREF;NUP107;SLBP;U2AF1;U2AF2;FIP1L1;RNPS1;UPF1;AAAS
prerank,Elsevier_Pathway_Collection__Proteins Involved in Osteopetrosis,-0.30322477611620113,-1.0069605876737708,0.4657534246575342,0.7183795457039188,1.0,11/40,16.47%,TNFSF11;TNFRSF11B;FOS;MITF;RAC2;TNFRSF11A;CA2;RUNX2;FCER1G;SPI1;ITGB3
prerank,KEGG_2021_Human__Morphine addiction,0.32131521008674824,1.0067834126224364,0.42424242424242425,0.9949158103786712,1.0,18/79,16.45%,GNG4;KCNJ6;GABRD;GABRR3;GABRQ;KCNJ9;KCNJ5;PDE4C;PDE1C;ADORA1;GNG3;GABRE;PDE10A;GNB5;ADCY6;GNG8;PRKCA;GRK3
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.32106109033438934,1.006585227756533,0.46632124352331605,0.9950701843474838,1.0,5/64,2.84%,MT3;DKK1;AXIN2;PRODH;MAPT
prerank,KEGG_2021_Human__Apelin signaling pathway,0.29862044012974365,1.0062533623297774,0.4481132075471698,0.995642352223755,1.0,29/126,25.08%,GNG4;APLN;SPP1;CALML6;PRKAA2;HDAC4;SPHK1;GNG3;NOTCH3;GNB5;ADCY6;GNG8;HRAS;HDAC5;MRAS;MEF2D;SMAD3;MYLK2;SLC8A3;GNG10;ADCY4;ADCY10;ADCY2;LIPE;MYLK4;PLAT;MAP2K2;PRKAB2;ITPR2
prerank,WikiPathway_2021_Human__Glycosaminoglycan degradation WP4815,0.4217626267861765,1.0059953420969616,0.4409937888198758,0.9959858491861584,1.0,7/17,30.28%,HPSE2;IDUA;GLB1;HYAL2;HEXB;HEXA;HGSNAT
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.3978634619334501,1.0057234137735016,0.4528301886792453,0.9964151414640228,1.0,16/26,48.29%,RTEL1;PIF1;SMG5;MYC;SIRT6;HDAC8;USP7;TERF2;GNL3;ATRX;UPF1;NBN;PPP1R10;ERCC1;MRE11;RAD50
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.2643291015458311,-1.0054456925571797,0.3953488372093023,0.7223094695255792,1.0,23/72,22.90%,RAB25;GRHL2;POF1B;EPHA1;TMEFF2;USH2A;EPHB3;FERMT2;PIK3R1;BVES;SPI1;PARVG;ITGB3;MEGF9;ITGA4;TEK;FERMT3;LPXN;NTNG2;NTN4;RILPL2;CLDN3;PROX1
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,0.34820488961948415,1.0053724733120968,0.44385026737967914,0.9970315296453016,1.0,32/53,47.30%,PSMD4;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;VCP;PSMD13;PSMB7;PSMA7;SHH;PSME3;PSMB2;PSMA6;UBC;PSMD9;ERLEC1;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.412259825718793,1.0053222475578376,0.45454545454545453,0.9966276070630661,1.0,9/19,33.23%,USP51;EPOP;KAT2A;USP22;USP49;TAF10;USP21;UIMC1;ATXN7L3
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.24557751157531751,-1.0052212570179915,0.5111111111111111,0.7224988386156261,1.0,30/98,19.01%,EREG;ERBB4;FGF10;CD80;IL1RAP;ESR1;PDGFRA;NRG4;ICOS;FGFR2;TGFA;TRAT1;FYN;IL33;RAC2;KL;BTC;LCK;FLT3;PIK3R1;AKT1;MYD88;HBEGF;VAV1;CD86;PIP4K2A;PPP2CB;NRG3;CD19;IRS2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.40448012365030894,1.0052103575679914,0.4878048780487805,0.9964726854770622,1.0,3/20,13.72%,CASQ1;ATP2A1;GSTM2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.395478132500471,1.0050500771911037,0.4585635359116022,0.9964536070466407,1.0,5/22,19.27%,CDKN2A;PLK1;TFAP4;CDKN1C;CAMK2N1
prerank,Elsevier_Pathway_Collection__KIT -> MITF Signaling,0.405377035246434,1.0049710259863185,0.47468354430379744,0.996153813611376,1.0,6/21,24.71%,RASGRF1;SRC;SHC1;PDPK1;PLCG1;MAP2K2
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,0.35555113110572417,1.0049104628518724,0.4438202247191011,0.995800911830586,1.0,29/47,47.30%,PSMD4;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.39924234589802127,1.0048177767415103,0.4935064935064935,0.9955609551051189,1.0,5/17,21.40%,ROBO1;BMP4;GJA5;HEY1;TGFB2
prerank,Elsevier_Pathway_Collection__NOTCH1 Signaling in Breast Cancer,0.36623758800745043,1.0047749552500163,0.45664739884393063,0.9951878065594154,1.0,9/35,20.59%,LEF1;TCF7;CCNB1;JAG2;KAT2A;SMAD3;DLL4;MMP9;MMP3
prerank,WikiPathway_2021_Human__Differentiation of white and brown adipocyte WP2895,0.3908750667950297,1.00463445376285,0.45652173913043476,0.995095184070444,1.0,10/23,18.26%,EBF3;HOXC9;BMP4;SLC7A10;PRDM16;LEP;ZIC1;PPARG;ZNF423;PPARGC1B
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.3317672653562717,1.0046231426285144,0.4627659574468085,0.9945779742693323,1.0,11/60,16.72%,CACNA1I;CYP17A1;CACNA1S;CYP21A2;NR5A1;CACNA1G;CACNA1C;CREB3L1;ADCY6;CREB3L4;CACNA1H
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.3514494769645273,-1.0045910010274437,0.42105263157894735,0.7238783895905394,1.0,6/25,5.88%,PCLO;CPLX4;OTOF;SYT10;WNT7A;SYT7
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,0.31773721532895105,1.004484040981499,0.46116504854368934,0.994468664790987,1.0,12/87,10.42%,BEST4;WNK4;TRPM3;ASIC1;ANO2;ANO4;TRPM5;TRPC6;SLC9C2;CLCNKA;ASIC3;CLCN1
prerank,WikiPathway_2021_Human__One-carbon metabolism and related pathways WP3940,-0.29505740637418637,-1.0043851793991094,0.4339622641509434,0.7239996507742568,1.0,10/49,12.39%,PCYT1B;BHMT;GNMT;PLD1;PEMT;SARDH;ETNK2;DMGDH;MAT1A;SHMT1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3603291974363037,1.003696860693587,0.4666666666666667,0.9964995865115612,1.0,29/39,48.97%,SNRPE;RGS14;NPM1;SNRPD2;SNRPB;GEMIN8;SNRPD1;GEMIN7;NXT1;SNRPD3;MALT1;HTATIP2;NUP205;RBM15B;HNRNPA1;XPO1;NUTF2;DDX20;GEMIN4;PHAX;SNRPG;GEMIN5;NXT2;AAAS;GEMIN6;LSG1;ANP32A;SNUPN;NCBP2
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.3494904620543559,1.003574145209969,0.4444444444444444,0.9963513030979715,1.0,23/54,40.03%,CCNB2;CDK1;CCNB1;LMNA;LBR;NUP37;AHCTF1;NUP133;EMD;RANGAP1;NUP155;VPS4A;NUP160;UBE2I;CHMP2A;NUP188;NSFL1C;BANF1;PPP2R1A;NUP205;LEMD2;RAN;CC2D1B
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.3226664679434103,1.0033224588392455,0.4607329842931937,0.9966003268229259,1.0,27/70,39.32%,LEF1;ACTL6B;BEND3;KAT2A;ING5;JADE2;APBB1;TRIM16;BRD8;TAF10;JADE3;MRGBP;WDR5;PHF20L1;YEATS2;EP400;TAF6;BRPF3;BRCA2;RUVBL2;RUVBL1;HAT1;SGF29;DMAP1;TAF9;TAF5L;BRPF1
prerank,Elsevier_Pathway_Collection__NGFR -> AP-1/CEBPB/CREB/ELK/SRF/TP53 Signaling,-0.31498305922183334,-1.0032395091860675,0.4583333333333333,0.7267611703802105,1.0,11/33,23.65%,NTF3;FOS;NGFR;MAP2K1;NGF;MAPK10;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,KEGG_2021_Human__Human papillomavirus infection,0.28055186419849454,1.0032323842671955,0.47435897435897434,0.9963666909221016,1.0,67/302,22.79%,COL2A1;PPP2R2C;THBS4;LAMA3;E2F1;SPP1;PIK3R2;AXIN2;COL9A1;WNT4;TERT;WNT9B;VWF;ITGA2;WNT8B;HES5;ITGA6;ATP6V0D2;TCF7;COL4A1;COL4A5;CCNE1;PDGFRB;COL1A1;COMP;CCNA2;CCNE2;NOTCH3;IKBKG;HES2;COL4A2;LAMC1;BCAP31;CREB3L1;APC2;SCRIB;COL1A2;ATP6V0A1;DVL2;WNT2B;THBS2;WNT6;ATP6AP1;HRAS;CREB3L4;HES6;LAMB4;EGF;ATP6V0B;LAMA4;ITGA7;ITGA11;IRF3;NOTCH4;CDK6;TCIRG1;TSC1;HEY1;FADD;THBS3;ISG15;PPP2R3B;ATP6V0D1;HDAC1;LLGL1;TSC2;PPP2R5A
prerank,WikiPathway_2021_Human__Translation Factors WP107,0.3308038311184698,1.0031510965803576,0.49206349206349204,0.9960820665475043,1.0,30/50,48.50%,EEF1A2;EIF4EBP3;EEF1D;EIF3CL;EIF2B4;EIF3E;EIF4EBP2;PABPC1;EIF3D;EIF3H;EIF3B;GSPT2;EIF5B;EIF3G;EEF2K;CLUH;EEF1B2;EIF2B5;EIF6;EIF2S3;EIF3C;EIF3F;EEF2;EIF1;EIF2B1;EEF1A1;ETF1;EIF3A;EIF4G3;EIF2B2
prerank,Elsevier_Pathway_Collection__PTPRC -> BCL6 Signaling,-0.3628190277195766,-1.0030188199029835,0.4222222222222222,0.7268253572652204,1.0,7/17,15.00%,ITK;MAP2K1;PTPRC;FYN;LCK;RASGRP1;VAV1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4146848015330196,1.00299956384404,0.47337278106508873,0.9960348876296821,1.0,1/15,0.53%,PYDC1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.3982320383106256,1.0028551151012357,0.47770700636942676,0.9959650093927203,1.0,6/19,21.51%,NAT8L;NAALAD2;GADL1;SLC25A12;MTHFR;GOT1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.3116073406620303,-1.0026906949380578,0.4605263157894737,0.7273635187429512,1.0,8/31,17.19%,CETP;APOA1;LIPG;SCP2;CYP8B1;PON1;ABCA8;PLTP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3716188495206407,-1.0026824609311478,0.4020618556701031,0.7268869045315365,1.0,9/16,21.35%,TNF;IL6;FUT7;ALOX5;SELE;ITGB2;ETS1;FUT4;SELP
prerank,Elsevier_Pathway_Collection__Androgen Deficiency in Male Obesity,-0.32997022697953043,-1.0025994912269296,0.49382716049382713,0.7266378758026064,1.0,7/22,13.06%,SRD5A2;TNF;SRD5A1;FOXO1;IL6;SHBG;AKT1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.3483695728474427,-1.0024443515971317,0.46511627906976744,0.7266706921011733,1.0,8/19,18.75%,NTRK2;CHRNA7;SORL1;RTN4;IGF1;CLU;PRNP;RTN1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.3022778839871581,1.0022729359923108,0.45365853658536587,0.9974168340200995,1.0,50/102,44.56%,SARNP;DDX39A;CPSF1;SMG5;CASC3;NUP37;THOC5;RBM8A;CHTOP;NUP62;NXF1;TPR;NUP133;CPSF4;XPO5;UPF3B;NUP155;NUP160;THOC1;SMG7;POLDIP3;NXF5;THOC6;NUP188;NXT1;THOC2;DDX39B;MAGOHB;SLU7;ZC3H11A;NUP205;MCM3AP;RBM15B;HNRNPA1;NUP210;RAN;SYMPK;CPSF3;RAE1;NUP214;GLE1;ALYREF;NUP107;SLBP;U2AF1;U2AF2;FIP1L1;RNPS1;UPF1;AAAS
prerank,KEGG_2021_Human__GnRH signaling pathway,0.31135984593017474,1.0020883694321583,0.4320388349514563,0.9975432293439427,1.0,14/87,15.74%,CGA;CACNA1S;CALML6;MAPK12;MAPK11;SRC;CAMK2A;CACNA1C;PLA2G4C;LHB;PLA2G4F;ADCY6;PRKCA;HRAS
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.3546277654350291,1.0020565947524198,0.4540229885057471,0.9965470285017582,1.0,22/51,40.03%,CCNB2;CDK1;CCNB1;LMNA;LBR;NUP37;AHCTF1;NUP133;EMD;RANGAP1;NUP155;VPS4A;NUP160;UBE2I;CHMP2A;NUP188;BANF1;PPP2R1A;NUP205;LEMD2;RAN;CC2D1B
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.3546277654350291,1.0020565947524198,0.4540229885057471,0.9965470285017582,1.0,22/51,40.03%,CCNB2;CDK1;CCNB1;LMNA;LBR;NUP37;AHCTF1;NUP133;EMD;RANGAP1;NUP155;VPS4A;NUP160;UBE2I;CHMP2A;NUP188;BANF1;PPP2R1A;NUP205;LEMD2;RAN;CC2D1B
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.3432316474910891,-1.0019914345050072,0.4473684210526316,0.7275004836968306,1.0,10/24,16.17%,MT1G;IKZF1;AXL;BLK;LILRB1;PDE1B;FLT3;IRF8;CSF2;CSF1R
prerank,WikiPathway_2021_Human__7q11.23 copy number variation syndrome WP4932,0.3132986043664527,1.0019578451577098,0.5,0.9963125669081384,1.0,30/99,29.80%,TMEM270;TRIM50;CLIP2;ELN;GTF2IRD1;VPS28;SNAP25;HSPA2;CDKN1C;SQSTM1;ACACA;VPS37D;HMGA1;CLDN5;GRIP1;USF1;METTL27;STX1A;ATP5F1D;NRG1;NUP62;FBN1;CHTF18;MYC;CTNNB1;ATP5F1E;GAPDH;ULK1;ATP5MC1;PCNA
prerank,MSigDB_Oncogenic_Signatures__KRAS.50 UP.V1 DN,-0.31328112372881683,-1.0018449656206418,0.4788732394366197,0.7275092281176195,1.0,12/32,14.14%,KRT4;HYAL4;SPRR3;NTF3;PYHIN1;KRT16;NCR3;TGM1;ABCB1;MX2;EPHB6;EPHX2
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.33921589129905944,-1.0018218048124645,0.4342105263157895,0.7271004968523952,1.0,5/27,9.63%,AKR1D1;CYP39A1;SCP2;CYP8B1;AKR1C4
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,0.37027177890798335,1.0017378311207206,0.4476744186046512,0.9965394467392265,1.0,2/30,2.76%,E2F1;TP73
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.41900018738168676,1.0017007546807146,0.43902439024390244,0.9960993877761228,1.0,2/16,2.40%,KCNC2;GRIN1
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.32832564358133254,-1.0015839260600239,0.425,0.7272498646069735,1.0,6/24,14.80%,EREG;ERBB4;NRG4;BTC;PIK3R1;HBEGF
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.40024617166438964,1.0006523676460717,0.4528301886792453,0.9990348248465851,1.0,1/23,0.21%,MT3
prerank,Elsevier_Pathway_Collection__Dentin Formation Disruption,0.36434420216126684,1.0005187047544966,0.46774193548387094,0.9989240184644678,1.0,5/30,7.78%,RASGRF1;EDARADD;SPP1;BMP4;MSX1
prerank,MSigDB_Oncogenic_Signatures__DCA UP.V1 DN,0.28726412223443154,1.0004193236544592,0.4369369369369369,0.9987039753273101,1.0,22/148,12.58%,CDH16;LAMA3;CACNA1S;UPK1A;MSH5;NR5A1;ASPM;STEAP1B;MCTP1;LRRC14;GALR3;GPR19;CDON;GRAMD4;SPC25;PTPRG;PRRX2;MFGE8;ADM2;PLA2G4C;NUDT11;PKP1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.2670475153709645,-1.0001048288039374,0.47619047619047616,0.7308665587716638,1.0,23/82,16.47%,GRIN2B;EPHB1;IFNG;GPR75;CCL5;FOS;CD200R1;PM20D1;LRRK2;KIR3DL2;PPARGC1A;EGR1;FYN;RRAS2;FCGR2B;CHRNA7;AKT1;SORL1;CHP1;CLU;TNFRSF1B;ITGB2;PRNP
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.3679263127684879,1.0000635620926785,0.4606741573033708,0.9993416054933859,1.0,6/31,16.56%,PRR5L;BMP4;PTPN14;IFI27;CEP131;B3GAT3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.28355567205353294,1.0000097200220284,0.47863247863247865,0.998976551263736,1.0,21/239,7.73%,MT3;IGF2;GHRHR;LGR6;RSPO2;ESM1;TSPAN5;GRIN1;TERT;CRLF2;ROBO1;VWF;MESP1;SLC2A4;DLG5;ERFE;JCAD;SRC;IHH;RSPO4;BDNF
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.36432048712648646,-1.0000088591660818,0.525,0.730615976950277,1.0,7/15,24.58%,CRTAM;DOCK8;LILRB1;RASGRP1;CTPS1;PIK3CG;BTN3A1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.4181344589850091,0.9994672883541799,0.5030674846625767,1.0,1.0,2/17,10.83%,KIF20A;CEP55
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.41408691713846196,0.999095448694792,0.5031847133757962,1.0,1.0,7/17,42.18%,RTEL1;SMG5;PARP1;PINX1;TERF1;TERF2;SLX4
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,-0.3560860044273203,-0.9988477068611477,0.5125,0.7333927060597343,1.0,8/20,21.32%,KCNMA1;PDE1B;GUCY1B1;KCNMB4;GUCY1A1;PDE2A;PRKG1;PDE5A
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,0.42334839572806615,0.9987285582436567,0.4634146341463415,1.0,1.0,5/19,22.67%,KIF14;RNASE1;RHOC;PRC1;LLGL1
prerank,Elsevier_Pathway_Collection__Multiple Myeloma,-0.2429398421836906,-0.9986323005469512,0.42424242424242425,0.733556735950077,1.0,27/120,17.09%,MUC1;ERBB4;TNFSF11;TNFRSF17;TNF;TNFRSF11B;HGF;FOS;TNFRSF13B;CXCL12;MAF;IL6;TNFRSF11A;HCK;AKT1;TNFSF13;IGF1;FGR;VCAM1;HBEGF;MAFB;CXCR4;TNFRSF13C;ITGB2;TNFSF13B;BCL2;ITGA4
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.33594652118654666,0.9984811727612214,0.46195652173913043,1.0,1.0,32/68,39.37%,TP73;TCF15;PSMD4;FOXC1;PSMB4;PRKDC;METTL3;TCF3;PSMD1;PSMB3;LDB1;PSMD14;PSMB5;PSMD2;YAP1;PSMA1;PSMD10;PUS7;PSMC4;PSMC3;GATA2;PSMC5;PSMB6;PSMD8;ABL1;SETD1A;TAL1;PSME2;PSMD13;PSMB7;PSMA7;PSME3
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.3319241265248898,-0.9983224725218887,0.4567901234567901,0.7339458862203208,1.0,4/23,13.03%,TACSTD2;TMEFF2;PHLDB2;PIK3R1
prerank,Elsevier_Pathway_Collection__Metabolic Effects of Oncogenes and Tumor Suppressor in Cancer Cells,0.3343948840990861,0.9983042749756078,0.48704663212435234,1.0,1.0,14/66,20.39%,SLC7A11;LEF1;PDK1;SLC2A4;CAD;ACLY;PDPK1;ACACA;SREBF2;HRAS;HMGCR;SCD;TSC1;GPAM
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.304149367390481,0.9982218417045271,0.4634146341463415,1.0,1.0,22/95,19.03%,CDH22;CDH8;DNER;NRCAM;POU4F1;SDK1;ITGA6;BDNF;CDH24;GJC1;PCDHB14;DNM3;PKP1;PCDHB2;PLXND1;PCDHB11;SDK2;CLDN5;NLGN2;NRXN2;OBSL1;PCDHB3
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.34246662131932704,0.9980940647905151,0.4727272727272727,1.0,1.0,9/43,12.28%,INHA;NODAL;GDF5;MSTN;BMP4;TTK;GDF15;GDF11;GDF7
prerank,Elsevier_Pathway_Collection__TGFBR -> AP-1 Signaling,-0.38432819553754327,-0.9980018784725129,0.47619047619047616,0.7343966193406016,1.0,7/16,23.65%,FOS;MAPK10;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.3676767782191454,0.997959011864396,0.4727272727272727,1.0,1.0,5/29,13.27%,CHP2;SRC;CDCA2;PPP1R16B;GBA
prerank,KEGG_2021_Human__Glioma,0.31964018046224446,0.9979409620698945,0.45794392523364486,1.0,1.0,15/71,17.35%,E2F1;PIK3R2;CALML6;SHC3;CDKN2A;E2F2;CAMK2A;PDGFRB;PDGFB;PDGFA;SHC1;PRKCA;HRAS;CAMK1D;EGF
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.40263194111845124,0.9979186803369247,0.46296296296296297,1.0,1.0,5/18,25.23%,KIF5A;IKBKG;SNAPIN;LIMK2;CDK5
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.35157411449470544,0.9978643696644286,0.4659090909090909,1.0,1.0,7/41,11.27%,PAX2;SIX1;BMP4;FGF2;COL4A1;NPNT;RASIP1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hypoxia-Induced Pulmonary Hypertension,0.39277718802730277,0.9975987073445334,0.4858757062146893,1.0,1.0,2/22,8.44%,SLC6A4;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.3572268330346916,-0.997536911412516,0.5274725274725275,0.7353239597561851,1.0,7/20,18.09%,RIPK3;IFNG;PLEK;CD300A;GPLD1;PPP1R15A;MTMR9
prerank,MSigDB_Oncogenic_Signatures__RAPA EARLY UP.V1 DN,0.28855142344353707,0.9973036966576408,0.45454545454545453,1.0,1.0,42/173,23.50%,CDH22;PAX2;CACNB4;GLUL;GRIN1;COL9A1;KISS1;INPP5J;MEP1A;TROAP;COL10A1;NCAPH;GALR3;FAM182B;FLT3LG;GUCA2B;LHB;CCDC85B;LMNA;IFI27;CNKSR2;PDZK1IP1;GRM1;PSD;PLXND1;TACR1;MTMR3;CIB2;BCAT2;MAP1A;BBC3;PCBP4;SYNGR4;ARHGAP4;NHLH1;RBMS1;MID1;FAM168A;TSPAN4;CRMP1;EPHB4;ITPKC
prerank,WikiPathway_2021_Human__Parkinson's disease pathway WP2371,0.3560809886993464,0.9970882735075034,0.45077720207253885,1.0,1.0,7/36,13.71%,MAPK12;MAPK11;SLC6A3;PRKN;CCNE1;CCNE2;UCHL1
prerank,WikiPathway_2021_Human__Corticotropin-releasing hormone signaling pathway WP2355,-0.2580782370177502,-0.9970777297334785,0.4883720930232558,0.736044523568165,1.0,17/86,14.73%,FOSB;NR4A2;CRHBP;GNAO1;KRT14;FOS;NR4A1;IL18;MAP2K1;PRKCB;HSD3B1;PRKCQ;CXCL8;TLR4;AKT1;PLCG2;SULT2A1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.32035981528393304,0.9969930383122483,0.4358974358974359,1.0,1.0,44/70,48.98%,CPSF1;SNRPE;POLR2L;POLR1A;MAZ;POLR2K;CPSF4;ZNF473;TAF1A;POLR1H;LSM10;POLR3K;LSM11;SNRPB;POLR1G;CSTF2;POLR2H;SNRPD3;MTERF2;PABPN1;CAVIN1;POLR2A;ERCC2;TAF1D;SYMPK;UBTF;CPSF3;CLP1;SNRPG;CPSF7;SLBP;POLR1C;FIP1L1;TAF1B;POLR2F;ERCC3;PCF11;TAF1C;GTF2H2;SSU72;PRMT5;CSTF2T;NCBP2;GTF2H5
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.2980597080495992,0.9969499775390811,0.47685185185185186,1.0,1.0,29/135,19.76%,MUC7;MUC13;BCAN;SBSPON;EGFL7;DPM3;GPC3;CHST6;SPON2;NCAN;NOTCH3;MUC4;CSPG5;CTSA;SEMA5B;CSPG4;SLC26A2;THBS2;GPC2;VCAN;B3GAT3;ADAMTS18;ST3GAL3;B4GALT7;MUC16;MUC12;THSD1;NOTCH4;HSPG2
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling,0.29050560505578105,0.9969260855922338,0.481981981981982,1.0,1.0,36/170,17.48%,IGF2;EPHB2;LEF1;E2F1;MDK;CDKN2A;FOXM1;SRC;FGF2;E2F2;BDNF;EFNA1;CCNE1;PDGFRB;CDKN2C;IL11;CCNA2;CCNE2;NOTCH3;CDK1;FLT3LG;CDKN2B;IL6R;JAG2;NFKB2;PDGFB;MYBL2;PDGFA;PLAU;CDKN1C;SHC1;HRAS;TYRO3;SMAD3;EGF;CDC25A
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.3036385214108453,-0.9965958986531751,0.5180722891566265,0.7368338336139866,1.0,8/37,17.15%,ATP10B;ACP3;LRRK2;CLVS2;HOOK2;CLN3;CORO1A;TPCN2
prerank,WikiPathway_2021_Human__ACE Inhibitor Pathway WP554,0.41663186515131617,0.996394285808276,0.4662576687116564,1.0,1.0,5/15,14.29%,REN;BDKRB2;ACE;BDKRB1;CMA1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.3524415382147216,-0.9962942860247403,0.4157303370786517,0.7372232488338054,1.0,6/20,18.01%,TNF;PLEK;NCKAP1L;LCP1;FHOD3;FMNL1
prerank,WikiPathway_2021_Human__IL-2 signaling pathway WP49,-0.29554761279581554,-0.9957055258680466,0.49206349206349204,0.738494308123654,1.0,14/41,23.45%,IL2RB;FOS;MAP2K1;FYN;LCK;PIK3R1;AKT1;SYK;CISH;BCL2;NMI;JUN;STAT1;GAB2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.3800479442752716,0.9954436285318754,0.48255813953488375,1.0,1.0,12/27,32.85%,AK8;GUK1;TYMS;NME1;RRM2;TXNRD1;DTYMK;DUT;NME3;AK1;RRM1;AK7
prerank,Elsevier_Pathway_Collection__B-Cell Acute Lymphoblastic Leukemia,0.3256456450317709,0.9953357478758154,0.5074626865671642,1.0,1.0,11/72,14.95%,LEF1;E2F1;TERT;CDKN2A;BIRC5;SRC;EBF1;RAG1;CDKN2B;PAX5;PDPK1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.27509398993054984,-0.9953191966182676,0.43548387096774194,0.7391063009041821,1.0,19/54,23.90%,PCK1;ENO3;ALDOB;FBP1;PPARGC1A;SLC39A14;ALDOC;PCK2;IRS2;PGM1;ENO2;SLC25A10;PGAM1;AKR1A1;GALM;CRY1;DCXR;SORD;OAS1
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.37339990238685694,0.9952209921180781,0.4939759036144578,1.0,1.0,13/28,34.61%,HDAC4;NOTCH3;HDAC11;KAT2A;HDAC5;NOTCH4;HDAC10;HDAC1;MAML1;NCOR2;MAMLD1;HDAC8;TBL1X
prerank,TRRUST_Transcription_Factors_2019__MITF human,-0.3236751533970749,-0.9950696315609885,0.4625,0.7393503811378288,1.0,6/24,13.89%,FOS;PPARGC1A;KCNMA1;PRKCB;BCL2A1;BIRC7
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.3155700266714207,0.9950494437764495,0.4427860696517413,1.0,1.0,18/73,21.79%,MAPT;THY1;WNT9B;IL17D;FOXM1;BMP4;PRKN;LOXL2;FOXC1;FOXJ1;ARHGEF15;ROCK2;RAPGEF3;NOTCH4;CDK6;SPRY3;HEY1;GRIN3A
prerank,Elsevier_Pathway_Collection__Synaptic Potentiation by PKMZ in LTP Maintenance - Active State,0.3949849415015285,0.9949072727950226,0.49710982658959535,1.0,1.0,6/22,17.79%,EPHB2;GRIP2;DLG4;IQSEC1;PDPK1;GRIP1
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,0.32922290203346244,0.9946976554532196,0.47643979057591623,1.0,1.0,37/59,45.32%,SNAI2;CBX6;EZH2;LAMTOR2;PPARG;HDAC5;LAMTOR4;HDAC1;CBX8;GATAD2B;SNAI1;MAF1;RHEB;CHD3;CHD4;GDNF;RBBP7;CBX2;MLST8;LAMTOR5;RRAGD;MTA3;RPTOR;RRAGA;MAPK3;HDAC7;EED;MTOR;ATN1;RRAGB;RBBP4;KDM1A;MAPK1;RING1;MECOM;PHC2;GATAD2A
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.34899158944783026,0.9943697112074259,0.47126436781609193,1.0,1.0,4/43,9.93%,RBM24;PRR5L;AGO2;NANOS1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3303090641117659,0.9943565822082621,0.4504950495049505,1.0,1.0,7/54,7.62%,OSR2;NOTUM;OSR1;WNT4;BMP4;TMEM119;FGF23
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.3868203628200823,0.9943104671622701,0.49171270718232046,1.0,1.0,1/24,0.31%,HS3ST4
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.30651795213233446,0.9942577199568179,0.41379310344827586,1.0,1.0,22/105,17.66%,CACNA1E;CACNA1I;CSN2;CACNA1S;TRPM3;RAMP1;CHRNB2;TRPM5;CACNA1G;TRPC6;ATP2B4;CAMK2A;ATP2A1;CACNA1C;CHRNA4;RAMP2;CACNG8;CATSPER1;PKD1;CACNA1H;SLC8A3;PANX1
prerank,TRRUST_Transcription_Factors_2019__TCF4 human,0.38355866292218427,0.993980039678815,0.4913294797687861,1.0,1.0,4/23,6.65%,LGR5;NOTUM;WNT4;BIRC5
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,-0.36216516596703896,-0.9939565717985936,0.5072463768115942,0.7420923365445373,1.0,4/20,6.79%,PTPN20;IL18R1;PTPN13;CASP1
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.36557914140794073,0.9938927688767107,0.49411764705882355,1.0,1.0,15/36,34.38%,FGF20;FGF13;FGF17;FGF23;HRAS;POLR2L;FGF18;PLCG1;POLR2K;POLR2G;POLR2H;PIGU;POLR2I;POLR2J;FGF1
prerank,WikiPathway_2021_Human__Regulation of Actin Cytoskeleton WP51,0.2956556538420646,0.9937415079446181,0.5022026431718062,1.0,1.0,24/139,17.35%,FGF20;PIK3R2;PAK3;VIL1;FGF13;CHRM4;FGD1;FGF17;FGF2;FGF23;PIP5K1B;PDGFRB;FGF14;CHRM5;DIAPH3;BDKRB2;PDGFB;APC2;PDGFA;BDKRB1;MRAS;ROCK2;FGF12;EGF
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.26279939609582914,-0.9936540593595622,0.4666666666666667,0.7424343484367405,1.0,18/70,16.80%,PROM2;PLXNA4;NTRK2;APOA1;EPHA1;ADAP1;EPHB3;SERPINA5;ARHGAP9;BVES;FGD3;EFNA5;VAV1;FGD2;ARHGAP27;ARHGAP15;FGD4;VAV3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.3386274093992617,0.9934473302220468,0.4230769230769231,1.0,1.0,28/39,48.98%,RFC4;POLD1;PARP1;CHD1L;CUL4B;UBA52;PCNA;OGG1;DDB2;FAN1;DDB1;ERCC2;RPA2;POLK;RFC3;POLD3;RBX1;UBC;ERCC3;POLD4;XPA;ERCC1;RPS27A;RPA1;RFC1;GTF2H2;NTHL1;GTF2H5
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,0.3425435705502267,0.9933486182255925,0.46408839779005523,1.0,1.0,34/53,47.30%,PSMD4;PSMB4;DVL2;PSMB3;HECW1;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;KLHL12;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;DVL3;PSMB2;RBX1;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3424044445315378,-0.9933120918724127,0.5277777777777778,0.7428761435973106,1.0,6/22,19.29%,TNF;LGALS3;PPP1R14D;NCKAP1L;PPP1R15A;PPP4R4
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.3959364034711629,0.9932716913932216,0.4506172839506173,1.0,1.0,16/18,54.01%,RPP21;DTD1;DARS2;POP1;POP5;SSB;ADAT1;SLFN13;POP7;FARS2;SARS1;THG1L;YARS2;AARS1;KARS1;RPP30
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.3815817528026085,0.9928475696233202,0.46706586826347307,1.0,1.0,20/27,51.78%,POLR2L;POLR2K;POLR3K;POLR2H;POLR3H;POLR3A;POLR3C;GTF3C5;POLR3G;POLR3GL;GTF3C3;POLR3E;POLR3F;POLR2F;GTF3C6;CRCP;GTF3C2;POLR1D;BRF1;GTF3C1
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,0.4254903781427956,0.992786981443615,0.461038961038961,1.0,1.0,10/17,46.20%,RFC4;POLR1A;UBA52;MAD2L2;PCNA;SLC19A1;POLK;RFC3;UBC;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.3522587389377112,-0.992716705663425,0.46153846153846156,0.7441958751823425,1.0,5/17,17.64%,ERBB4;BMP10;FGFR2;IGF1;AKAP6
prerank,Reactome_2022__Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.40104921107890135,0.9924337651591729,0.5058823529411764,1.0,1.0,8/20,19.76%,BCAN;GPC3;NCAN;CSPG5;CSPG4;GPC2;VCAN;HSPG2
prerank,TRRUST_Transcription_Factors_2019__E2F1 mouse,0.3394606731632499,0.9924066235331119,0.46153846153846156,1.0,1.0,6/46,9.63%,DLX1;NOX4;CDKN2A;MXD3;CDKN2C;CCNA2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.29315281684355765,0.9922532748647266,0.4528301886792453,1.0,1.0,19/133,14.12%,MRAP2;RAB3C;TSPAN5;ACTN2;RAMP1;RAB3B;FGF13;KCNB1;ANK1;TMEM88;NKD2;TESC;ATP1B3;DPP10;S100A10;KCNIP3;RAMP2;RAB3D;RAB34
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.3108118971575818,0.991736534413082,0.46842105263157896,1.0,1.0,15/90,13.27%,MT3;PAX2;PAGE4;POU4F1;BMP4;CD34;FGF2;PRKN;CD200;ZBED6;IKBKG;PRKD1;NENF;SPEF1;GBA
prerank,Elsevier_Pathway_Collection__EGFR -> AP-1/ATF2 Signaling,-0.28930481182390516,-0.9916559704796296,0.4788732394366197,0.7467459908722562,1.0,14/42,21.42%,EREG;FOS;ITK;MAP2K1;TGFA;BTC;RASGRP1;HBEGF;VAV1;MAPK10;NRG3;MAP2K3;MAP2K6;JUN
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.38704173880472414,0.9914695499808835,0.5030674846625767,1.0,1.0,4/24,9.59%,SLC6A7;SLC6A9;SLC7A10;SLC1A4
prerank,Elsevier_Pathway_Collection__Leptin and CCK8 Activate Nodose Ganglia Neuron,-0.316319532771451,-0.9910606572775305,0.4875,0.7480343190376296,1.0,4/23,9.49%,PCSK2;FOS;MAP2K1;EGR1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.366345255574987,0.9907530619448657,0.4911242603550296,1.0,1.0,2/27,4.55%,REG3A;MDK
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.42200500954355474,0.9906779048800466,0.48366013071895425,1.0,1.0,5/15,9.59%,CDH8;UNC13A;GRIK2;GRIK4;SLC1A4
prerank,Elsevier_Pathway_Collection__Proteins Involved in Alzheimer's Disease,-0.2385582957799869,-0.9905916002367943,0.4878048780487805,0.7489325012823638,1.0,32/122,17.08%,GRIN2B;IL10;BCHE;PTGS2;TNF;IL1B;FPR2;CCR5;APOA1;OXT;NGFR;CCL2;EGR1;PTGER2;IL6;FYN;NGF;CD40LG;ABCB1;ALOX5;S100B;PLG;CHRNA7;AKT1;SORL1;TTR;IGF1;CSF2;CLU;PRNP;CTSB;BCL2
prerank,WikiPathway_2021_Human__Epithelial to mesenchymal transition in colorectal cancer WP4239,0.2931571991616536,0.990588570829199,0.5047169811320755,1.0,1.0,39/154,21.78%,DLK1;PIK3R2;TWIST2;MAPK12;CLDN19;WNT4;WNT9B;SNAI2;WNT8B;FOXM1;MAPK11;CLDN15;COL4A1;COL4A5;EZH2;CLDN6;NOTCH3;GDF15;COL4A2;PKP1;JAG2;CLDN7;SHC1;WNT2B;WNT6;HRAS;MEF2D;SMAD3;PKD1;CLDN5;CLDN2;NOTCH4;DLL4;MMP9;SPARC;EIF5A2;FOXC2;TGFB2;FOXQ1
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,0.34007339283920074,0.9903322554378527,0.46153846153846156,1.0,1.0,16/45,21.24%,GAD1;SLC6A11;SYN3;PPFIA3;PPFIA4;SYN1;SLC1A2;SNAP25;CPLX1;UNC13B;PPFIA2;SLC1A3;SYN2;STXBP1;STX1A;SH2D3C
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hepatocellular Carcinoma,0.30417327513475695,0.9902742713951074,0.46226415094339623,1.0,1.0,18/120,15.74%,IGF2;VEGFD;E2F1;GABRQ;TP73;FAM43B;HEPACAM;CDKN2A;ARHGEF39;SRC;FGF2;CCNE1;CDK1;FBXO31;FLT1;SHC1;TYMP;HRAS
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.38180121580456794,0.989874846268259,0.45714285714285713,1.0,1.0,1/22,0.45%,DKK1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.308197936796469,0.9898054737659722,0.515625,1.0,1.0,21/88,22.97%,ODAM;PAK3;MDK;RHOBTB1;PDGFRB;ARHGAP44;IQGAP3;PDGFA;GRHL3;ABL2;ROCK2;RHOC;NEB;TWF2;RAPGEF3;PHPT1;ARHGEF19;BST2;RHOBTB2;TAOK2;ESAM
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.3538495654258065,-0.9897811273757698,0.45454545454545453,0.7509361492456728,1.0,4/16,10.32%,DBH;TH;GCH1;DAO
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,0.33654203615551376,0.9895386658480492,0.46842105263157896,1.0,1.0,10/44,21.80%,FGF20;FGF13;FGF17;SRC;FGF23;SHC1;HRAS;FLRT1;FGF18;PLCG1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.40989555290373436,0.9895258895173471,0.5,1.0,1.0,6/18,27.00%,SNAI2;FOXC1;SOX8;TCOF1;NRG1;HEYL
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.3217218607464083,-0.9893199246774049,0.5,0.7518887145351307,1.0,11/30,18.85%,MARCO;IGLL5;IGLL1;SPIRE1;BIN2;FCGR2B;MSR1;ITGB2;SH3BP1;AIF1;ARHGAP25
prerank,MSigDB_Oncogenic_Signatures__P53 DN.V2 DN,0.2954975145343944,0.9890606709798262,0.4976958525345622,1.0,1.0,23/126,10.40%,POU3F2;GUCY2C;SMPX;PNMA3;FABP4;TP73;ELAVL2;KCNJ9;SLCO2A1;CENPA;HMMR;NRXN3;ANO2;PTGDS;ADAM11;SLC6A3;E2F2;NDC80;CLTCL1;CCNF;NOL3;HBD;SIL1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.3524552265648866,-0.9890038072539636,0.44047619047619047,0.7522413356038361,1.0,5/19,10.78%,GRAMD1C;CCR5;CCL3;GRAMD1B;GPLD1
prerank,Elsevier_Pathway_Collection__Local Estrogen Production in Endometriosis,-0.31032900510361083,-0.9889959608697804,0.4492753623188406,0.7517383110842705,1.0,7/25,13.64%,PTGS2;IL1B;ESR1;PTGER2;PTGER4;HSD17B2;PGR
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.3475332617227782,-0.9889501356444234,0.47435897435897434,0.751354772159392,1.0,6/21,12.55%,GRIN2B;ADRA1A;TRPV4;MS4A1;JPH3;SLC8A1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.3492960851116578,-0.9889066241011005,0.5194805194805194,0.7509985642111849,1.0,3/23,8.03%,TEX15;FOS;DNMT3L
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.3373808621480698,-0.9887485977804022,0.4725274725274725,0.750979615009642,1.0,9/23,25.56%,TMPRSS4;CD4;AXL;VPS37B;LGALS9;CHMP2B;CD209;HLA-DRB1;TMPRSS2
prerank,TRRUST_Transcription_Factors_2019__CEBPA human,-0.28388206080842154,-0.988711095034028,0.4507042253521127,0.7505514862899845,1.0,16/47,15.35%,IL10;PCK1;HK3;CXCR2;SLC10A1;CSF3R;F9;CD163;ALB;CCL2;IL6;SFTPD;CYP3A4;IGF1;MSR1;SPI1
prerank,MSigDB_Oncogenic_Signatures__MTOR UP.V1 DN,-0.23878460672675048,-0.9886576241660601,0.45161290322580644,0.7502156630655077,1.0,39/168,18.34%,CLEC4M;PI16;SLC6A20;KRT15;COL20A1;TH;KRT5;NELL2;OLFML3;ID2;SH3BGR;FXYD1;XDH;LIFR;NCAM1;NGFR;VSIG2;GCOM1;PTGER4;SH2D1B;C1R;MYH11;NFIL3;IGF1;CES3;ADAMTS8;L2HGDH;PPP1R3C;KCNK3;KLF2;PDE6G;CXCL1;HSPA1A;PLTP;PDIA5;PTGIS;PTPRS;RBP1;DUSP1
prerank,Elsevier_Pathway_Collection__Megakaryocyte -> Platelet Precursor Cell Surface Expression Markers,-0.28791448090940863,-0.988597713055746,0.4714285714285714,0.7498917547827527,1.0,17/40,23.54%,CD4;FASLG;CD38;TNFSF10;VIPR1;P2RY1;FLT3;LAT;CD226;CXCR4;ITGB3;GP1BA;GP6;PTGIR;SELP;THBD;S1PR1
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.3841291735248687,0.9885765517839612,0.4682080924855491,1.0,1.0,13/29,37.36%,PRKAA2;LAMTOR2;LAMTOR4;TSC1;TSC2;PRKAB2;STRADA;RHEB;MLST8;LAMTOR5;RRAGD;RPTOR;RRAGA
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.30573091965897536,0.9884744306473401,0.4449760765550239,1.0,1.0,3/108,2.14%,MUC7;MUC13;PAK3
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.23730469553130012,-0.9882854975339854,0.5151515151515151,0.750331595319936,1.0,27/137,12.49%,NKX2-1;TACSTD2;PFN2;MARVELD3;TNN;TMIGD3;BMP10;SFRP1;NOG;CDH1;IGFBP3;EPHA1;TMEFF2;NGFR;PHLDB2;KRT16;DUSP10;MITF;LIMCH1;NDRG4;MCC;ACVR1C;WNT11;DACH1;IGFBP5;TRIB1;CITED2
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.34160691021438055,0.9882747529058215,0.49171270718232046,1.0,1.0,35/53,47.30%,PSMD4;PSMB4;NOTCH4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;TACC3;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;YWHAZ;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,Elsevier_Pathway_Collection__Gluconeogenesis Impairment in non-Alcoholic Fatty Liver Disease,-0.3585566343388683,-0.9881512207896408,0.4375,0.7502101878346579,1.0,8/15,23.65%,PCK1;FOXO1;G6PC;PIK3R1;AKT1;IRS2;LDLR;IGF1R
prerank,WikiPathway_2021_Human__Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,-0.29859699154366487,-0.9881406853420867,0.49206349206349204,0.7497535466083901,1.0,7/31,13.64%,ATP2C2;ERBB4;TNFSF11;ESR1;TNFRSF11A;GJB2;PGR
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3228584777998875,0.9880846837968512,0.5,1.0,1.0,34/73,43.56%,STOX1;PSMD4;EPO;PSMB4;ELOC;HIF1AN;ELOB;EGLN1;HIF3A;PSMD1;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;PSMB6;PSMD8;EGLN2;PSME2;PSMD13;PSMB7;PSMA7;LIMD1;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.4250605968965282,0.9880443895058962,0.48,1.0,1.0,2/15,2.84%,CRP;MAPT
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.4185143013376171,0.9880095210841697,0.4876543209876543,1.0,1.0,1/15,2.90%,SFRP4
prerank,Elsevier_Pathway_Collection__Ions Reabsorption Dysregulation in Nephrolithiasis,0.41864912810769234,0.9879230597245211,0.4860335195530726,1.0,1.0,3/18,4.68%,CALCA;RAMP1;SLC12A1
prerank,KEGG_2021_Human__Amphetamine addiction,-0.2694574246900182,-0.9879182485676765,0.5192307692307693,0.7498002822533193,1.0,14/60,15.79%,GRIN2B;FOSB;SLC18A1;TH;FOS;CAMK4;GRIA3;PRKCB;CAMK2B;SLC18A2;ADCY5;GRIA1;CREB5;DDC
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.4155300537533248,0.9878820974665103,0.4722222222222222,1.0,1.0,1/15,2.84%,MAPK12
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.3414665425042587,0.9878815936627925,0.45555555555555555,1.0,1.0,12/49,17.30%,DLG5;GPC3;IHH;KIF7;TEDC2;HHIP;ZIC1;RAB34;IFT81;TULP3;GLIS2;MEGF8
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.24525367973880866,-0.9878756703531375,0.4423076923076923,0.749458724576286,1.0,21/109,12.49%,NKX2-1;SPINT2;TACSTD2;TMIGD3;BMP10;SFRP1;NOG;CDH1;SPOCK3;EPHA1;TMEFF2;NGFR;KRT16;DUSP10;MITF;LIMCH1;WNT11;DACH1;IGFBP5;GATA3;CITED2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3960776019337429,0.9877388983018547,0.4682080924855491,1.0,1.0,10/17,47.29%,ATP5MF;ATP5F1D;ATP5F1E;ATP5MC1;ATP5ME;ATP5MG;ATP5PO;STOML2;ATP5MC2;ATP5PD
prerank,WikiPathway_2021_Human__TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.4021032203853645,0.9876824251043061,0.4885057471264368,1.0,1.0,2/18,4.28%,CDH16;SNAI2
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.32583616128667475,-0.987417708031731,0.46835443037974683,0.7502472974469058,1.0,5/26,8.45%,CRHBP;ACE2;TNF;CLEC12B;CALCR
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.304948709906556,-0.9873308054197033,0.48,0.7500085272221777,1.0,9/36,17.22%,P2RY12;PDGFRA;HBB;PLEK;UBASH3B;ITGB3;CSRP1;GP1BA;GATA1
prerank,WikiPathway_2021_Human__Prostaglandin Synthesis and Regulation WP98,-0.2882548086140729,-0.9871157808591602,0.4927536231884058,0.750047366583101,1.0,18/43,19.87%,PTGS2;HPGD;PPARGC1A;MITF;ANXA3;PTGER2;PLA2G4A;PTGES;PTGER4;SOX9;TBXAS1;EDNRB;PTGDR;TBXA2R;HPGDS;PTGIS;ANXA4;ANXA6
prerank,Elsevier_Pathway_Collection__Osteoclast Activation in Multiple Myeloma,-0.2555660272707624,-0.9869559130314165,0.4528301886792453,0.7500140318731277,1.0,26/66,23.89%,TNFSF11;TNFRSF11B;FOS;CCL3;MAP2K1;CALCR;CCR1;TNFRSF11A;CA2;LCK;AKT1;OSCAR;RUNX2;CXCR3;ITGB3;BCL2;INPP5D;MAPK10;TAB2;MAP2K3;MAP2K6;JUN;MAP3K5;FOSL1;MAP2K4;PTEN
prerank,Reactome_2022__Depolymerisation Of Nuclear Lamina R-HSA-4419969,0.4402263011629569,0.9868279333247982,0.46540880503144655,1.0,1.0,7/15,26.78%,CDK1;CCNB1;LMNA;PRKCA;LPIN1;EMD;LMNB1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.26449788850521555,-0.9867929670506317,0.47540983606557374,0.7499997087662786,1.0,15/66,15.08%,CYP26A1;CYP39A1;CETP;LCAT;APOA4;APOF;APOA1;CYP8B1;CYP26B1;TSKU;CYP4V2;ANGPTL3;SULT2A1;SC5D;FAXDC2
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.3415334337568891,-0.9866190621300626,0.4444444444444444,0.7499588698881088,1.0,5/22,4.11%,HYAL4;HAS2;STAB2;IL1B;LYVE1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.2784860816568236,-0.9862353573412351,0.46296296296296297,0.7504863121435195,1.0,14/57,13.58%,AWAT2;LRAT;ADH4;BCO2;APOA4;GPC5;APOA1;AKR1C4;GPC6;BCO1;GPC4;ADH7;CYP4V2;TTR
prerank,WikiPathway_2021_Human__Proteoglycan biosynthesis WP4784,0.4008309439152058,0.9861712916708701,0.463855421686747,1.0,1.0,5/17,22.90%,EXTL3;SLC26A2;B3GAT3;B4GALT7;XYLT2
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.37437875269875215,0.9860939514497492,0.45930232558139533,1.0,1.0,6/28,13.33%,HDAC4;SRC;IHH;COL1A1;RBM14-RBM4;BGLAP
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.3969146007455062,0.9856513741006099,0.49696969696969695,1.0,1.0,3/22,3.30%,GLUL;PRODH;GAD1
prerank,Reactome_2022__Signal Amplification R-HSA-392518,0.37744328552429607,0.9855830152145739,0.44654088050314467,1.0,1.0,6/30,18.45%,GNG4;SRC;GNG3;GNB5;GNG8;GNG10
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.3181148821305454,0.9855064139790264,0.495,1.0,1.0,23/73,25.48%,MT3;CEL;CYP7A1;SQLE;FDPS;HSD17B7;MVD;APOA2;GBA;ACLY;HMGCR;TM7SF2;IDI1;LBR;PMVK;NSDHL;CH25H;FDFT1;HMGCS1;CYP51A1;NPC1L1;GBA2;INSIG2
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.2866565600230086,0.9854182720572185,0.49777777777777776,1.0,1.0,22/193,15.16%,SLC7A11;TSPAN5;SLC22A4;TSPO2;ACSL6;KLF1;BCAM;ANK1;SLC6A9;SLC4A1;E2F2;SLC6A8;HBD;CA1;ACKR1;AHSP;PPOX;IGSF3;ATP6V0A1;PDZK1IP1;MOSPD1;KHNYN
prerank,Reactome_2022__WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.3304778846385832,-0.9853174134768804,0.5,0.7527392826172388,1.0,7/24,9.76%,WNT7B;WNT7A;WNT16;WNT2;WNT10B;WNT1;WNT11
prerank,Elsevier_Pathway_Collection__Growth Factor Signaling in Hepatocellular Carcinoma,0.3139180331393667,0.9852044182802391,0.46601941747572817,1.0,1.0,14/81,17.35%,IGF2;VEGFD;LEF1;E2F1;SRC;PDGFRB;PDGFB;FLT1;PDGFA;SHC1;PDPK1;HRAS;SMAD3;EGF
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.3698177583012635,-0.9851074644737332,0.42857142857142855,0.75230632362783,1.0,3/19,8.03%,TEX15;FOS;DNMT3L
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.3698177583012635,-0.9851074644737332,0.42857142857142855,0.75230632362783,1.0,3/19,8.03%,TEX15;FOS;DNMT3L
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.39180001506840706,0.9850633225457831,0.4583333333333333,1.0,1.0,4/19,6.44%,CACNA1I;SCN1A;SCN4A;CACNA1G
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.32796156887290123,0.9849135954490951,0.4972375690607735,1.0,1.0,18/61,19.03%,DNER;CBLN4;NRCAM;POU4F1;SDK1;FGF13;BDNF;PCDHB14;DNM3;PCDHB2;LGI2;PLXND1;PCDHB11;SDK2;NLGN2;NRXN2;OBSL1;PCDHB3
prerank,TRRUST_Transcription_Factors_2019__DNMT1 human,-0.32175802715449453,-0.9848953865026961,0.48148148148148145,0.7523849628167202,1.0,8/30,9.78%,SFRP5;EPCAM;PROM1;SFRP1;KIR2DL3;CDH1;ESR1;RUNX3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Pulmonary Hypertension,0.28615245237062586,0.9846817866533956,0.49333333333333335,1.0,1.0,36/157,17.27%,KCNC1;SLC6A4;APLN;CALCA;RETNLB;SPP1;S100A1;TERT;NOX4;BMP4;SRC;FGF2;TRPC6;ELN;PDGFRB;TIMP1;IL6R;EPO;PDGFB;MEOX2;ACE;PDGFA;PLAU;PGF;CMA1;HTR1B;PIM1;PPARG;PRKCA;HTR2B;ADORA2A;ANGPT2;TACR1;SMAD3;HMGCR;MME
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.30346397332072317,-0.9844617532009466,0.45977011494252873,0.7532148043123755,1.0,3/31,6.68%,RIPK3;FASLG;TNFSF10
prerank,MSigDB_Oncogenic_Signatures__KRAS.LUNG UP.V1 UP,0.29722379163799145,0.984433046279861,0.4878048780487805,1.0,1.0,19/114,10.79%,MT3;NPHS1;SLC6A4;SMPX;SLCO4A1;SLC6A11;ITGA2;EGFL7;TBX3;CCL20;NTM;OR2B6;GRIN2A;FRMD1;GRIP2;RNASE1;FUT5;GPR3;PCDH17
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.43096032071430246,0.9843568815392759,0.5088757396449705,1.0,1.0,3/16,5.58%,PRODH;DPEP1;ABHD12B
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.33395032068043473,0.984296699914174,0.5054945054945055,1.0,1.0,16/51,35.78%,PRKAA2;ASPSCR1;SLC2A4;RNASE1;LNPEP;STX4;PRKAB2;RAB13;RAB4A;KIFAP3;EXOC4;EXOC3;MYH9;KIF3B;REXO2;YWHAH
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.2768933867788282,0.9841593627488447,0.5152838427947598,1.0,1.0,48/230,20.46%,SH3GL3;ZIC5;ZIC2;DNER;MNX1;ZIC4;SPINK5;VAX2;GRIN1;NRCAM;BCAN;HES5;TBX3;SERPINI1;EMX1;COL4A1;PRKN;GRIN2A;B3GNT5;MAST1;NCAN;DCX;NPTX1;SOX8;PAFAH1B3;NHEJ1;APOD;ZIC1;UFC1;SCIN;FOXJ1;SHROOM4;SEMA6B;MDGA1;GLIS2;ADORA2A;VCAN;PKD1;SLC8A3;ABCB6;NES;GRIN2C;COX7B;CDK5R1;HSPG2;JARID2;NNAT;ASIC2
prerank,Elsevier_Pathway_Collection__P2RY11/13/14 -> IL8/10 Production,-0.3407218815044271,-0.9841535155493499,0.5063291139240507,0.7537303800940608,1.0,5/20,13.38%,IL10;P2RY13;MAP2K1;CXCL8;RASGRP1
prerank,Elsevier_Pathway_Collection__Platelet and Coagulation Cascade Activation by Antiphospholipid Antibodies,-0.3342962500126718,-0.9840471320097518,0.5,0.7530300295616549,1.0,9/23,22.14%,GP5;FGR;TBXA2R;GP1BA;APOH;IQGAP1;PF4;APBB1IP;F2
prerank,Elsevier_Pathway_Collection__Antiphospholipid Antibodies in Platelets and Coagulation Cascade,-0.3342962500126718,-0.9840471320097518,0.5,0.7530300295616549,1.0,9/23,22.14%,GP5;FGR;TBXA2R;GP1BA;APOH;IQGAP1;PF4;APBB1IP;F2
prerank,WikiPathway_2021_Human__PPAR signaling pathway WP3942,-0.2842095558721291,-0.9840028151475292,0.47540983606557374,0.7526899730098896,1.0,23/62,19.83%,SLC27A6;MMP1;FABP2;PCK1;CYP4A11;ACSL1;APOA1;SCP2;CYP8B1;PLIN1;ACADL;ACAA1;APOA5;EHHADH;HMGCS2;ACOX1;ACADM;PLTP;PCK2;SLC27A5;ACOX2;ACOX3;FADS2
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.2910895872648021,0.9837793423154283,0.48,1.0,1.0,10/148,6.24%,SFN;CEMIP;UBL4B;E2F1;PIK3R2;CHP2;TP73;PRR5L;KCNB1;GTSE1
prerank,WikiPathway_2021_Human__15q13.3 copy number variation syndrome WP4942,-0.3385159009962688,-0.983667470420742,0.5,0.7531744149393459,1.0,5/18,14.66%,GPR75;CCL5;FYN;CHRNA7;GOLGA8O
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.3515976467874034,-0.9833504380559529,0.5348837209302325,0.7535679616388559,1.0,18/18,64.87%,NCCRP1;AOAH;DERA;FBXO17;FBXO27;FUCA1;OGA;SAMHD1;FBXO2;NGLY1;NAGA;MANBA;STT3B;NEU4;BPGM;FBXO6;FBXO44;ADAMTS9
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.3486549932846676,0.9832505242086768,0.47191011235955055,1.0,1.0,13/37,24.40%,TEKT5;DNAH17;CABYR;CFAP91;DNAAF1;SPEF1;DNAH11;ADCY10;DNHD1;DNAH5;CCDC40;TEKT4;CFAP53
prerank,WikiPathway_2021_Human__Glycogen Synthesis and Degradation WP500,-0.2930314807636533,-0.9832268164235678,0.4528301886792453,0.7534311443776787,1.0,11/40,19.23%,PPP2R2B;HK3;AGL;GYS2;UGP2;PPP2R3A;PPP2R2A;GBE1;PYGL;PPP2CB;PGM1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.32077422608820916,-0.9828409171239306,0.4567901234567901,0.7540943654838433,1.0,4/29,3.34%,ADRA1A;KCNMB2;ACE2;AVPR1A
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.40450115568235256,0.9828301894445577,0.5029585798816568,1.0,1.0,3/18,10.88%,IRAK1;IKBKG;IRAK2
prerank,Reactome_2022__HS-GAG Degradation R-HSA-2024096,0.39147155069186657,0.9828188459264368,0.48148148148148145,1.0,1.0,5/21,19.76%,HPSE2;GPC3;IDUA;GPC2;HSPG2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.3576456125374524,-0.9825133022206475,0.45454545454545453,0.7545615596594908,1.0,5/15,11.90%,CXCL13;PLEK;FERMT2;PTGER4;SKAP1
prerank,Elsevier_Pathway_Collection__Acute Myeloid Leukemia,-0.24917839259863678,-0.98242154920425,0.5263157894736842,0.7542968467393009,1.0,18/81,17.22%,FOS;CSF3R;CBFA2T3;ALK;MLF1;CXCL12;MNDA;FLT3;AKT1;MYH11;VCAM1;CXCR4;SPI1;CSF1R;PPP1R15A;BCL2;NCOR1;GATA1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.3270074156823055,-0.982308236446124,0.4691358024691358,0.7541036932107107,1.0,4/20,8.53%,ERBB4;BMP10;NOG;FGFR2
prerank,MSigDB_Oncogenic_Signatures__KRAS.DF.V1 DN,-0.23623881738372657,-0.9822853220245141,0.4473684210526316,0.7536711078605316,1.0,37/164,15.75%,KLK2;PCLO;RET;PTGS2;RNF186;KIR2DL1;MOGAT2;LCAT;PRSS8;RDH16;NCR1;IGFBP3;FAM153A;FBN2;SIGLEC6;DUSP2;MAP7;LAMP3;CYP2C9;KLF4;SEMA6A;NGF;CD2;TCL1A;ALOX5;CNR2;SEZ6L;HDAC9;LCP1;OMG;TNFRSF9;CLDN1;SEMA3C;TNXB;RAB3IL1;TSPYL1;SYNE1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.3204961349528884,-0.9821514250748549,0.5238095238095238,0.7536096228272169,1.0,8/25,18.53%,TNF;IL1B;PHLDB2;ROBO2;TLR2;SLIT1;THBS1;DLC1
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,0.3306734658871491,0.9819765661579684,0.483695652173913,1.0,1.0,22/55,33.82%,LCN2;STEAP2;ATP6V0D2;FLVCR1;ATP6V0A1;ATP6AP1;ATP6V0B;TCIRG1;FTL;ATP6V0D1;ATP6V0E1;ATP6V1C1;NEDD8;SLC46A1;ATP6V1H;UBA52;MCOLN1;ATP6V1F;ATP6V1E1;CUL1;SKP1;ATP6V1E2
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.4026184643573802,0.9817234326151818,0.47305389221556887,1.0,1.0,4/24,6.59%,DPEP1;NOX4;GADL1;MTR
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.3127612867444581,0.9815427048082297,0.455026455026455,1.0,1.0,17/82,16.38%,AVIL;PTK7;MDK;ITGA6;STMN2;SERPINI1;ROR1;PLK5;TOX;BDNF;PRKD1;CBFA2T2;ABL2;VLDLR;DBN1;CAMK1D;GPC2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.35450547616516476,0.981324633436471,0.4166666666666667,1.0,1.0,3/29,3.33%,ALOX15B;ALOX12B;ACSBG2
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.3756384552328928,0.981291080712144,0.4879518072289157,1.0,1.0,14/27,31.99%,E2F1;RBM24;AXIN2;PKP1;DHX34;NBAS;LARP1;PABPC1;TENT5B;GDNF;SLC11A1;FUS;FMR1;EIF4ENIF1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.4283591289600235,0.9811045852965369,0.5153374233128835,1.0,1.0,3/16,8.36%,MSH4;TOP2A;EME1
prerank,"Elsevier_Pathway_Collection__Hyaluronic Acid, CD44 and HMMR in Cancer Cell Invasion and Survival",0.3356789649938844,0.9810673545160554,0.49230769230769234,1.0,1.0,10/50,16.80%,HOXD10;SPP1;SOX2;HMMR;SRC;HAS1;POU5F1;PDPK1;VCAN;RHOC
prerank,Elsevier_Pathway_Collection__Plasmin Role in Glomerulonephritis,-0.27679987649204785,-0.9808323705899642,0.49230769230769234,0.756989164671631,1.0,17/49,22.14%,TNF;IL1B;FOS;F9;KLKB1;MAP2K1;CCL2;PLG;AKT1;RASGRP1;PRKCE;KNG1;F11;MAP2K3;MAP2K6;JUN;F2
prerank,Elsevier_Pathway_Collection__SOD1 Mutation,0.3761689036946697,0.9807847930315318,0.4371584699453552,1.0,1.0,1/28,0.21%,CHGB
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.3699003226725613,0.9807108196856985,0.43558282208588955,1.0,1.0,3/25,6.56%,GPR62;RNF157;RASD2
prerank,Elsevier_Pathway_Collection__HPV E6 and E7 Induced Block of Apoptosis in Keratinocytes,0.4073195625735686,0.9806673072008798,0.483695652173913,1.0,1.0,9/19,39.56%,TERT;MYBL2;USF1;MYC;CDKN1A;BAX;E2F4;SAP30;CDK2
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.39779065188029555,0.9806613840860555,0.4797297297297297,1.0,1.0,16/21,51.48%,RFC4;UBA52;MAD2L2;PCNA;POLH;RPA2;POLK;RFC3;UBC;PRIMPOL;RPS27A;RPA1;RFC1;POLE2;RFC5;RFC2
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.29249125501525897,-0.9802521212635409,0.47619047619047616,0.7581851423484008,1.0,8/43,11.90%,CEACAM6;SFRP1;EPHA1;CCR7;CD3E;FERMT2;PLEKHA2;SKAP1
prerank,Elsevier_Pathway_Collection__SWI/SNF BRG1/BAF in Chromatin Remodeling,0.41371532587264986,0.9802232286904135,0.5029585798816568,1.0,1.0,12/15,50.20%,ACTL6B;SMARCA4;SMARCD3;SMARCC1;HAT1;ARID1A;SMARCB1;SMARCC2;SMARCE1;ACTL6A;SMARCD2;SMARCD1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3256356305708815,0.9801249238020279,0.4948453608247423,1.0,1.0,44/87,43.56%,KIF14;PSMD4;FBXL18;FBXL16;CCNF;FBXO31;PSMB4;FBXL6;FBXL8;FBXO39;FBXL15;PSMD1;PSMB3;PSMD14;CUL4B;FBXL22;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;FBXW5;CUL1;SKP2;SKP1;PSMC5;PSMB6;PSMD8;PSME2;FBXO44;PSMD13;PSMB7;PSMA7;FBXL13;PSME3;FBXW11;FBXO6;FBXO4;PSMB2;RBX1;PSMA6;FBXL7;PSMD9
prerank,Elsevier_Pathway_Collection__Proteins Involved in Insulin Resistance,-0.25510146176920095,-0.979923808843618,0.4791666666666667,0.7586847841082602,1.0,18/77,13.84%,PDX1;IL10;IFNG;TNF;IL1B;IL18;ALDOB;PPARGC1A;FOXO1;PRKCQ;CCL2;IL6;CCR2;TLR4;TLR2;PIK3R1;AKT1;IGF1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.3945537072381655,0.9798743421269642,0.50920245398773,1.0,1.0,4/22,7.73%,RBM24;HDAC4;TMEM119;BDNF
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.3498995231902629,0.9796708782884819,0.4444444444444444,1.0,1.0,10/34,30.34%,PLK5;CDK1;UFC1;MCTS1;DYRK3;EIF2D;KIF9;RB1CC1;ULK1;DDRGK1
prerank,WikiPathway_2021_Human__Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.40138077140798406,0.9793642709403809,0.47337278106508873,1.0,1.0,5/19,19.77%,SPP1;BIRC5;HSPB1;EGF;MMP9
prerank,WikiPathway_2021_Human__Apoptosis Modulation by HSP70 WP384,-0.3547953230827027,-0.9792746871837615,0.5164835164835165,0.7601467938337534,1.0,5/19,17.74%,FASLG;CASP6;CASP7;HSPA1A;MAPK10
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hodgkin Lymphoma,-0.2622589772540146,-0.9790406244080061,0.46551724137931033,0.760338588882386,1.0,16/49,17.67%,IL10;PTGS2;TNFRSF17;TNF;POU2AF1;TNFRSF13B;FCGR3A;IL6;CD40LG;CCR4;POU2F2;MYD88;PRDM1;TNFSF8;BCL2;SLAMF1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.265615497626982,-0.9790300580015052,0.5,0.7598442277780751,1.0,13/66,9.76%,NR4A2;WNT7B;WNT7A;SFRP5;FZD3;WNT16;SFRP1;LRRK2;WNT2;FZD1;WNT10B;WNT1;WNT11
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.308106103512264,-0.9787319986287204,0.5396825396825397,0.7601663526180334,1.0,13/35,19.04%,COL4A3;GDF2;XDH;NGFR;CCL2;IL12B;ALOX5;ATOH8;TNMD;SYNJ2BP;THBS1;CAV2;APOH
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.3082449808905936,0.9786714591728453,0.4803921568627451,1.0,1.0,8/91,10.72%,ECEL1;CPXM1;TSPAN5;PHEX;TESC;NAA10;PCSK1;MMEL1
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.34332112683341554,0.9784965381128305,0.5028248587570622,1.0,1.0,6/44,12.73%,SAA2;IRAK1;LRRC14;IKBKG;IRAK2;NFKB2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.2723370574676104,-0.97844955569775,0.4603174603174603,0.7605550595817057,1.0,21/56,21.48%,ERBB4;PDGFRA;EPHA1;FGFR2;FYN;BLK;NTRK1;BTK;LCK;FLT3;HCK;TTBK1;SYK;FGR;CSF1R;ZAP70;EPHA3;DDR2;TPST2;TEK;JAK2
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,0.3068831738555049,0.97813393348817,0.4322916666666667,1.0,1.0,39/96,38.68%,SLC7A11;NQO1;CDKN2A;PSMD4;TKT;PSMB4;UBL4A;MAFG;SQSTM1;TXNRD1;NPLOC4;MYC;PSMB3;UFD1;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;KEAP1;PSMC4;PSMC3;CUL1;BRIP1;SKP2;SKP1;CSNK2B;PSMC5;SEM1;PSMB6;PSMD8;PSME2;VCP;TALDO1;GSK3B;PSMD13;PSMB7;PSMA7
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.36807764261071285,-0.9778915136915574,0.4891304347826087,0.7616277863529443,1.0,3/18,5.71%,SLC27A6;MFSD2A;ACSL1
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.23557883410232944,-0.9778036215653081,0.3870967741935484,0.7614127193115764,1.0,29/158,15.99%,EREG;EGR3;AVPR1A;TNF;SATB1;IL1B;HGF;CD69;FASLG;IL18;CD38;TNFSF10;CASP1;FEZ1;LGALS3;DCN;PRF1;GCH1;IL6;CD2;DPYD;IGFBP6;PLCB2;CASP6;SC5D;BCL2L11;BGN;CLU;CASP7
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.33648746713248234,0.9776464340209069,0.4777777777777778,1.0,1.0,10/47,14.74%,HTR1D;OPRL1;HTR4;CHRM4;HRH3;PSAPL1;GNAL;CHRM5;HTR1B;ADCY6
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.2311696423150156,-0.9775902134277838,0.4722222222222222,0.7615137439163652,1.0,28/143,13.62%,RET;ERBB4;EPHB1;GRHL2;CD4;MUSK;NTRK3;PKIB;LTK;NTRK2;PDGFRA;EPHA1;ALK;EPHA7;FGFR2;PRKCQ;ARRDC3;KLF4;EPHB3;AXL;NTRK1;GREM1;ARRDC4;FLT3;CHRNA7;SORL1;MAPK15;EPHB6
prerank,WikiPathway_2021_Human__Endoderm differentiation WP2853,0.289587936468237,0.977402664184331,0.4803921568627451,1.0,1.0,12/130,9.53%,TRIM71;ZIC5;DKK1;LEF1;NODAL;SOX2;PLCH1;TCF7;TOX;FOXH1;EZH2;PTHLH
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.2855519260859364,0.9772643556854784,0.5231481481481481,1.0,1.0,25/159,15.15%,PAX2;DLX1;NEUROD1;VIL1;FOXO6;MDK;DLG5;BMP4;CDC20;SRC;ADGRL1;TMEM119;AGO2;PRKN;TLE6;ZNF703;ZP3;SOX8;LEP;AURKA;LMNA;PDGFB;DLG4;VLDLR;DVL2
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.29793192600342455,-0.97721147470294,0.5492957746478874,0.7621901359587243,1.0,5/28,13.84%,ITLN1;NR4A3;PIK3R1;AKT1;IGF1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.31093496209864174,0.9771322648954928,0.49504950495049505,1.0,1.0,27/89,22.98%,PAX2;OSR2;SIX4;OSR1;NODAL;SOX2;GDF5;BMP4;FGF2;UHRF1;PRKD1;LEP;NR1D1;CDKN2B;LAMC1;NME1;CDKN1C;HRAS;ACVRL1;MAGED1;CDK6;FGF18;TGFBR3;DEAF1;TGFB2;SCN5A;PRKDC
prerank,TRRUST_Transcription_Factors_2019__SNAI1 mouse,0.3856409458531289,0.9771067504152621,0.5149700598802395,1.0,1.0,1/23,0.13%,COL2A1
prerank,Elsevier_Pathway_Collection__ERK/MAPK Canonical Signaling,0.32892217821668035,0.9770844614882295,0.44324324324324327,1.0,1.0,12/47,25.99%,CDC25C;SRC;SPHK1;PDGFRB;LAMTOR2;MAPKAPK2;SHC1;RAPGEF3;RALGDS;KSR1;MAP2K2;PTK2
prerank,TRRUST_Transcription_Factors_2019__HNF4A mouse,0.37215037835774695,0.9770456274710734,0.5174418604651163,1.0,1.0,3/27,3.47%,HMGA2;CSN2;CYP7A1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.33992797404171643,0.976660913836481,0.5351351351351351,1.0,1.0,15/46,26.12%,PRKAA2;MAPT;GPC3;BDNF;PPM1F;GPC2;EGF;MAP1A;PARP1;TRIM67;ABCA2;HSP90AB1;ATP13A2;DVL1;CTNNB1
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.3658074477362759,0.9765271740037916,0.47126436781609193,1.0,1.0,20/27,53.61%,NUP37;AHCTF1;NUP62;NUP133;RANGAP1;NUP155;NUP160;UBE2I;NUP188;NUP205;RAN;NUP107;RCC1;NUP93;SEC13;SEH1L;TNPO1;NUP43;NUP85;KPNB1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.32293129362573525,-0.9764399180824749,0.4634146341463415,0.7639082702855362,1.0,5/25,11.18%,PTGS2;IL1B;CCBE1;IL6;CCR2
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.4139292212748584,0.9763744441021087,0.4899328859060403,1.0,1.0,8/17,20.62%,PPFIA3;PPFIA4;SNAP25;CPLX1;UNC13B;PPFIA2;STXBP1;STX1A
prerank,WikiPathway_2021_Human__Ebstein-Barr virus LMP1 signaling WP262,0.38468861826922246,0.9760762989974985,0.5031847133757962,1.0,1.0,5/22,12.73%,CCL20;IRAK1;IKBKG;PDLIM7;NFKB2
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,0.3841442281335082,0.9760066356123873,0.5256410256410257,1.0,1.0,6/22,10.75%,ACTN2;GPRIN1;SRC;CAMK2A;GRIN2A;MPP3
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.25481789999276316,-0.9760056399420857,0.42592592592592593,0.7645858919479652,1.0,7/83,3.87%,GRIN2B;ATP2C2;MCOLN3;TRPV6;TRPV4;SLC35G1;MCOLN2
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,0.3842341256248692,0.9759517229025079,0.49382716049382713,1.0,1.0,10/21,38.17%,DTD1;PARS2;QARS1;DARS2;IARS2;GARS1;VARS2;CARS2;AARS2;TARS2
prerank,TRRUST_Transcription_Factors_2019__GATA4 human,-0.3294534844738395,-0.9759021172582325,0.425,0.7643806971588186,1.0,5/17,11.59%,FGF10;FABP2;FCGR3B;FCGR2B;HDAC9
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.2579135422595302,-0.9757787704357768,0.4583333333333333,0.7643016788911814,1.0,21/81,14.75%,NLRP7;HAS2;IL1B;ACOD1;CCL5;SFRP1;CCL4;CCL3;XCL1;CCL23;CCL2;NKX3-1;XCL2;TNFRSF11A;CXCL8;CCL22;GBP3;SELE;SOX9;GBP1;MYD88
prerank,Elsevier_Pathway_Collection__IL33 Signaling Related Eosinophilia in Asthma,0.4039886180851836,0.9756574779437296,0.48214285714285715,1.0,1.0,3/16,10.06%,IRAK1;CCR3;IKBKG
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.3573756589760978,-0.9756444110685818,0.5128205128205128,0.7642190642806636,1.0,5/18,12.93%,PYHIN1;LAMP3;AXL;GATA3;MX2
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.2967787413050399,0.9755858528812436,0.5068493150684932,1.0,1.0,31/110,28.05%,MT3;ZNF541;HDAC4;AURKB;UHRF1;EZH2;CCNA2;EYA4;HDAC11;USP51;KAT2A;HDAC5;USP22;CTCFL;MIER2;HDAC10;EHMT2;NSD1;UBE2A;RCOR3;EYA1;HDAC1;BRD8;PRMT7;TAF10;NTMT1;USP21;MRGBP;SIN3B;PHF20L1;INCENP
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,0.41910649416285006,0.9754275497453893,0.49019607843137253,1.0,1.0,9/16,46.20%,RFC4;POLR1A;UBA52;MAD2L2;PCNA;SLC19A1;RFC3;UBC;RPS27A
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.23361212009848453,-0.9754048271752401,0.5777777777777777,0.7643732445073464,1.0,30/105,19.01%,EREG;ERBB4;FGF10;CD80;IL1RAP;ESR1;PDGFRA;NRG4;ICOS;FGFR2;TGFA;TRAT1;FYN;IL33;RAC2;KL;BTC;LCK;FLT3;PIK3R1;AKT1;MYD88;HBEGF;VAV1;CD86;PIP4K2A;PPP2CB;NRG3;CD19;IRS2
prerank,MSigDB_Oncogenic_Signatures__ALK DN.V1 DN,0.30299821424604834,0.9753510722030188,0.5384615384615384,1.0,1.0,13/110,5.79%,DIO2;AGRP;ST8SIA3;LGR5;MYH1;TRIM17;PRODH;DPEP1;KCNJ9;OLFM4;RHO;DNASE1L2;CHRM4
prerank,KEGG_2021_Human__Basal cell carcinoma,0.313155874171876,0.9753156693302022,0.4873096446700508,1.0,1.0,13/61,15.52%,LEF1;AXIN2;WNT4;WNT9B;WNT8B;BMP4;TCF7;KIF7;APC2;HHIP;DVL2;WNT2B;WNT6
prerank,MSigDB_Oncogenic_Signatures__NRL DN.V1 DN,0.30169629069705695,0.9751292123225189,0.4834123222748815,1.0,1.0,27/112,22.92%,CPLX2;CALCA;TRIM17;RGS20;EN2;IL17D;GREB1;HES5;IFITM10;PDE1C;LAMTOR2;CDT1;ATP2A1;RASGRF2;TUFT1;METRN;MAP6;ST3GAL3;SLC8A3;MOXD1;PLEC;ACBD6;BST2;PECAM1;EYA1;HARS2;INPPL1
prerank,MSigDB_Oncogenic_Signatures__PRC2 SUZ12 UP.V1 UP,0.28890662610059525,0.9747919839448204,0.5238095238095238,1.0,1.0,31/148,16.39%,LMOD1;TM4SF20;CGA;ALDH3A1;ZIC4;MAPT;HOXA10;SLC12A5;SLC7A6;CACNA2D2;UPK1A;ANK1;MYF6;PTGDS;SYN3;CCNE1;MYH13;RECQL4;NAA10;RUNDC3A;DCX;ONECUT2;LHX6;PKP1;DRP2;ORC1;ZNF696;FOXJ1;GP9;CHEK1;TACR1
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.38123616369627306,0.9747209414254189,0.46745562130177515,1.0,1.0,13/24,42.78%,LAMTOR2;LAMTOR4;RHEB;MLST8;LAMTOR5;RRAGD;RPTOR;AKT1S1;RRAGA;FKBP1A;MTOR;EEF2K;RRAGB
prerank,Elsevier_Pathway_Collection__Proteins Involved in Autistic Disorder and Aggression,0.39707615825968434,0.9746398885344926,0.5384615384615384,1.0,1.0,4/19,11.24%,SLC6A4;BDNF;OXTR;LEP
prerank,TRRUST_Transcription_Factors_2019__CDX2 human,0.36731368888208626,0.9745895375730305,0.5185185185185185,1.0,1.0,5/27,11.20%,GUCY2C;AXIN2;MEP1A;CDH17;TFF3
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.4209990109194236,0.9744534944476512,0.5029585798816568,1.0,1.0,10/15,41.28%,RPP21;POP1;RPP25;RPP40;POP5;SSB;POP4;RPP25L;HSD17B10;RPP38
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,0.3324297846830392,0.9741700974307917,0.5,1.0,1.0,36/56,47.30%,PSMD4;PSMB4;PRKCA;GLI1;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;SUFU;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;BTRC;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,WikiPathway_2021_Human__Ciliary landscape WP4352,0.2746912611756474,0.9741541734212625,0.5263157894736842,1.0,1.0,86/208,40.19%,LCN2;TFAP2C;CAMK2A;TCTEX1D2;IQGAP3;WHRN;MCM2;EXOSC4;MCM6;ANKS6;CTSA;BBS5;GLA;IFT81;GDI1;MCM10;BBS2;MCM3;MCM5;COX6C;MSH2;MCM4;DYNLRB2;NDUFA9;HDAC1;USH1C;MCM7;CCDC40;NUP133;DYNLL1;ANKS3;IFT27;GLB1;ACSL3;CTNNB1;SMC4;DYNLRB1;COPS5;TIPRL;SSNA1;BBS4;LSM4;ERF;CEP97;NEFL;VPS4A;YAP1;AIMP1;EXOC4;RMND5B;NEK7;PSMC4;CDH23;COPS7B;EXOC3;CEP290;TTC30A;ZMYND19;MCM8;DYNC1H1;COPS6;DCAF7;CEP170;CNOT10;HSPB11;PSMD8;WDR26;TTC30B;EXOSC2;UBE2D2;MYL6;IFT80;CNOT6L;EIF5B;CNOT9;PSMD13;VIM;CD2BP2;RHBDD2;IFT140;MYL6B;EXOSC7;DVL3;COPS8;EXOC8;EXOSC9
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.30030204467562754,-0.9740498157709518,0.4666666666666667,0.7679088588007384,1.0,11/39,22.05%,NLRP12;TNIP3;ESR1;RHOH;PER1;LILRB4;NLRC3;NR1H4;GSTP1;RIOK3;STAT1
prerank,TRRUST_Transcription_Factors_2019__NR3C1 mouse,-0.34639016756784546,-0.9738387100828861,0.46875,0.7679976183508951,1.0,2/16,5.38%,PTGS2;SLC10A1
prerank,WikiPathway_2021_Human__Male infertility WP4673,-0.23688746938910843,-0.9738181993237816,0.5813953488372093,0.7675215514316365,1.0,28/116,18.59%,KLK2;TEX15;SRD5A2;GNAO1;TNF;BHMT;FASLG;FOLH1B;PEMT;ESR1;MSMB;CAT;SIRPG;ABCB1;CYP26B1;MTHFD1;REC8;SHMT1;TMEM132E;PON1;EPSTI1;CLU;SOX5;THBS1;BCL2;PIWIL2;PSAT1;AR
prerank,Elsevier_Pathway_Collection__Proteins Involved in Clear Cell Ovarian Carcinoma,-0.28039071595287346,-0.9737333130953056,0.484375,0.7673227472319896,1.0,5/46,6.85%,MSLN;HGF;FOS;ESR1;PDGFRA
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.3112429023244735,0.9736625497174095,0.5096153846153846,1.0,1.0,44/78,46.21%,RECQL4;TONSL;RAD51AP2;POLQ;XRCC2;NSMCE2;POLN;RMI1;FEN1;PARP1;RAD51AP1;RAD51;BLM;RHNO1;LIG3;PSMD14;NABP2;MMS22L;NSMCE1;RECQL5;SWSAP1;AP5Z1;XRCC1;RFWD3;MCM8;BRCA2;FAN1;SEM1;POLL;SFR1;XRCC3;SPIDR;RPA2;RAD52;RECQL;ZFYVE26;SLX4;RAD54B;SWI5;WRN;INO80;NBN;SFPQ;RPA1
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.3136593467868074,-0.9735910950150212,0.46153846153846156,0.7672126698649463,1.0,6/28,11.90%,KLK2;MMP1;SPOCK3;KLKB1;MMP7;PLG
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3672455865032197,0.9734625810758316,0.524390243902439,1.0,1.0,7/28,23.56%,SFRP4;DKK3;ZNF703;SMAD3;TGFBR3;BCL9;FSTL3
prerank,WikiPathway_2021_Human__Monoamine Transport WP727,-0.30902434313515204,-0.973064818509345,0.4875,0.768263082901723,1.0,7/32,5.66%,SLC5A7;DBH;TNF;TH;IL1B;TNFRSF11B;TDO2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.3625492459332925,0.9727368926551633,0.49700598802395207,1.0,1.0,12/29,29.97%,ATP4A;NOX5;ATP1A2;ATP1A4;ATP5MF;ATP6V0D1;SLC25A14;ATP6V0E1;SLC46A1;ATP6V1H;UCP3;ATP6V1F
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.2852086779689774,-0.9726721328314264,0.4696969696969697,0.7689587195484556,1.0,8/44,10.36%,SOX10;ERBB4;SEMA3E;SEMA4A;SEMA6D;SEMA4D;SEMA6A;SEMA3D
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.3253429520715072,-0.9724978633467563,0.5,0.76892871906578,1.0,9/27,19.29%,LRFN5;BPI;IL6;IL33;FCGR2B;TLR4;THBS1;SHPK;WNT5A
prerank,MSigDB_Oncogenic_Signatures__RB P130 DN.V1 DN,-0.23941342192172183,-0.9724525843695602,0.5526315789473685,0.7685311188460573,1.0,32/119,25.53%,LIFR;DEFB1;CD1D;CXCL12;BNC1;HSPA1B;GJB2;ARRDC4;GABRP;NEAT1;USP18;CASP6;GUCA2A;CLU;RHOV;PLBD1;CTSB;GADD45A;CTSC;MORC3;TMEM140;EVI5;IDH1;STAT1;UHRF1BP1L;RAB8B;PNRC2;SEC23A;LAMP1;HK2;ZDHHC20;VDR
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.3502808714720445,0.9720365789781358,0.5193370165745856,1.0,1.0,3/42,3.20%,HOXD3;E2F1;TERT
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3021268572486466,-0.9720222666887917,0.4925373134328358,0.7692435821861803,1.0,6/34,8.05%,PTPRQ;PTPN13;PTPN22;PTPRO;DUSP2;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.2728849881141177,0.9711290669348602,0.5364806866952789,1.0,1.0,43/252,17.41%,DLK1;NKD1;DKK1;DKK4;APLN;NOTUM;MAPK8IP2;SFRP4;APCDD1;DKK3;PTPRT;SNAI2;TAX1BP3;RNF157;EGFL7;NKD2;GPC3;FGF2;MDFI;BDNF;LRRC14;EZH2;NOTCH3;GDF15;RNF43;KIF7;BEND6;APOD;SOX30;CREB3L1;SOSTDC1;HHIP;GBA;CBLN1;KLK14;TULP3;RGS14;SRMS;GLIS2;TYRO3;MEGF8;EGF;NEDD4
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.3576659579946997,0.9710719445387759,0.5355191256830601,1.0,1.0,20/35,47.20%,CDKN2B;COL1A2;DAND5;SMAD3;E2F5;HDAC1;MYC;UBA52;RBL1;TGIF1;E2F4;MAPK3;SMAD2;WWTR1;UBC;MAPK1;CDK9;CCNT2;RPS27A;MEN1
prerank,Elsevier_Pathway_Collection__CHRNA7 -> CREB Signaling,-0.3699740154085066,-0.9709741930107679,0.5476190476190477,0.7716991108001333,1.0,4/15,13.38%,MAP2K1;FYN;CHRNA7;RASGRP1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.3876914325438976,0.9708891977294188,0.48520710059171596,1.0,1.0,2/21,5.30%,H1-5;PLK1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.35845738322161824,-0.970805654673162,0.45652173913043476,0.7716233653296851,1.0,7/16,23.80%,NR4A3;CAMK4;LILRB1;PLCG2;WNT5A;LAPTM5;DDX58
prerank,TRRUST_Transcription_Factors_2019__STAT1 mouse,-0.30577954481079067,-0.9707329614407149,0.47619047619047616,0.7713753806041415,1.0,7/30,10.51%,CXCL10;IFNG;IL27;CXCL9;EGR1;IL6;TBX21
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.25345549427116953,-0.9705640500249418,0.6111111111111112,0.7713109388651546,1.0,23/102,13.99%,CRHBP;HAS2;ACOD1;CCL5;SFRP1;CCL4;CCL3;XCL1;CCL23;ZFP36L1;GCH1;CCL2;NKX3-1;XCL2;TCL1A;TNFRSF11A;CXCL8;GATA3;CCL22;GBP3;SELE;AKT1;GBP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.3478818085338876,0.9705364331650466,0.5272727272727272,1.0,1.0,6/34,14.95%,SCG2;NEUROD1;MDK;IL11;RAMP2;PDPK1
prerank,WikiPathway_2021_Human__Cori Cycle WP1946,0.4139116781319221,0.9702663236846545,0.50625,1.0,1.0,8/15,32.13%,SLC2A4;PGK1;PFKP;GPT;GAPDH;ALDOA;G6PD;SLC2A1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.30222321964914084,-0.9700892336177485,0.5135135135135135,0.7720412316234866,1.0,15/34,24.65%,FREM2;MAB21L2;CHRDL1;SLC39A5;PBX1;CPAMD8;BMPR1B;MEIS1;SMOC1;C1QA;ITGAM;PBX4;C3;RAB18;PBX3
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.23716403544831943,-0.9698998301598701,0.5686274509803921,0.7720679292007198,1.0,42/120,22.65%,SLC27A6;FA2H;ACOT11;PTGS2;HAO2;HPGD;CYP4A11;ABCD2;ACSL1;CYP4F2;LIPH;LIPG;ACSM3;PPARGC1A;CYP4F12;ACAA1;ALOX5AP;ALOX5;PON3;ACOX1;ANGPTL3;ACADSB;ACSM5;CROT;PON1;AOAH;ACADM;CYP2J2;LIPC;MLYCD;CBR4;SLC27A5;ACBD5;ACOX2;ACOT2;ADIPOR2;XBP1;NAAA;SLC27A2;ACOT12;ECHDC3;ACSM4
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.32041768571630475,0.9698824576902151,0.46596858638743455,1.0,1.0,35/62,47.51%,PTCD1;CPSF1;CTU1;RPP21;FTSJ1;TSEN2;POP1;ANKRD16;TRMT1;CPSF4;WDR4;TRMT61A;TSEN54;TSEN15;CSTF2;METTL1;ADAT3;QTRT1;TYW5;CTU2;RPP40;POP5;SSB;TRMT10B;AARS2;TRMT6;CLP1;ADAT1;DDX1;TSEN34;POP7;FARS2;DTWD1;LCMT2;RTRAF
prerank,Elsevier_Pathway_Collection__Dentin and Enamel Dysruprion in Bloch-Sulzberger Syndrome,0.4133221763078339,0.969561733674602,0.5176470588235295,1.0,1.0,5/18,14.57%,AMBN;SPP1;IKBKG;BGLAP;TUFT1
prerank,WikiPathway_2021_Human__Gastrin signaling pathway WP4659,-0.24016533772464554,-0.9693979287888136,0.6,0.772902834358358,1.0,17/109,15.22%,TFF2;PTGS2;FOS;CDH1;MAP2K1;FOXO1;PRKCQ;EGR1;FYN;KLF4;MMP7;CXCL8;PIK3R1;AKT1;SERPINB2;CLDN1;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.332765567023673,-0.9693630855202104,0.5176470588235295,0.7724940117127465,1.0,7/24,17.94%,IL1B;XDH;GDF6;HAND2;SPI1;NCF1;GADD45A
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.35330339480142864,-0.9691404083923473,0.5444444444444444,0.772717593922656,1.0,12/17,23.90%,IL10;IL6;KLF4;MEFV;LILRB4;LGALS9;SIGIRR;OAS3;GSTP1;SIRPA;F2RL1;OAS1
prerank,Elsevier_Pathway_Collection__EZH2 Methyltransferase Role in Cancer,0.3589905250537051,0.969102177186916,0.5058823529411764,1.0,1.0,7/28,10.65%,E2F1;CDC25C;CCNE1;EZH2;CDK1;FOXC1;CCNB1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.4178018156458213,0.969033849841622,0.47368421052631576,1.0,1.0,8/15,36.93%,EME1;RAD9B;FANCD2;TIPIN;CHEK2;MDC1;MUS81;EME2
prerank,Elsevier_Pathway_Collection__Hypothalamic-Pituitary-Adrenal Axis in Acute Phase Response,-0.3189331910758651,-0.9690256402629325,0.4925373134328358,0.7725539783849229,1.0,5/26,4.66%,PTGS2;MRAP;TNF;IL1B;FOS
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.4092449459615561,0.9689867443844181,0.5,1.0,1.0,12/17,48.55%,H4-16;PRKDC;DCLRE1B;TERF1;ACD;TERF2;NBN;CTC1;STN1;MRE11;RAD50;TFIP11
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.26572968748248377,-0.9688871849127514,0.4931506849315068,0.7724781202545198,1.0,20/54,22.48%,ATP1A3;PTPN22;FPR2;NGFR;ZFP36L1;FYN;NTRK1;FCGR2B;TLR4;IGF1;VCAM1;LDOC1;PRNP;ITGA4;LGMN;NOD2;XBP1;ADRB2;APP;CASP4
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,0.3738331639853195,0.9688793201358686,0.4885057471264368,1.0,1.0,15/25,46.41%,H3C13;H4C15;KDM5B;JMJD6;KDM3A;KDM3B;KDM1B;KDM5C;KDM5D;RIOX2;KDM2B;UTY;KDM1A;KDM2A;KDM4C
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,0.36176623276941183,0.9688025170165506,0.47305389221556887,1.0,1.0,13/28,31.28%,STEAP2;ATP6V0D2;ATP6V0A1;ATP6AP1;ATP6V0B;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1C1;ATP6V1H;MCOLN1;ATP6V1F;ATP6V1E1
prerank,KEGG_2021_Human__Breast cancer,0.2891101783728159,0.9687542272186759,0.5092592592592593,1.0,1.0,24/137,15.74%,FGF20;LEF1;E2F1;PIK3R2;AXIN2;WNT4;SHC3;WNT9B;WNT8B;HES5;FGF17;TCF7;FGF2;FGF23;E2F2;NOTCH3;JAG2;NFKB2;APC2;SHC1;DVL2;WNT2B;WNT6;HRAS
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.34505889216106894,0.9687477813570583,0.5058823529411764,1.0,1.0,9/35,16.96%,HRH3;FGF23;TRH;STXBP6;IL11;IL1RAPL1;HTR1B;RHBDF2;HMGCR
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.3803373248163557,0.9686735127022278,0.4682080924855491,1.0,1.0,4/19,16.03%,THBS4;MDK;DAPK2;CAMK1D
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.3687683181754212,0.9686399759897576,0.5031446540880503,1.0,1.0,6/27,16.76%,SPHK1;CCNB1;SMOC2;PRKCA;USP22;TTL
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.22142524079222492,-0.968120050630959,0.5185185185185185,0.7743015704024406,1.0,38/135,25.93%,IFNG;TNF;IL1B;APOA4;ABCD2;LRRK2;APOA1;DCN;RNF152;FOXO1;GPLD1;DACT1;MEFV;APOA5;ABHD5;TRIM34;TRIM22;ENTPD5;IGF1;TNFRSF1B;EZR;ITCH;TRIM5;TWIST1;IRS2;ADAM8;SLC4A4;PFKFB3;SNCA;APP;LAPTM5;TRIM21;TRIM14;SNX9;UFL1;TRIM6;RDX;SH3GLB1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.23081562001501346,-0.9681000739432227,0.5294117647058824,0.773882238263122,1.0,35/154,15.85%,OVOL2;MT1G;EGR3;NDNF;AMHR2;WNT7A;HAS2;NTRK3;HGF;CCL5;SFRP1;NR4A1;GDF2;GAS1;NTRK2;XCL1;SOX6;ZFP36L1;WNT2;CCL2;ACVR1C;KLF4;SEMA6A;CILP;BMP7;NTRK1;CXCL8;GAREM1;AKT1;SOX9;RUNX2;SPRY2;SMAD9;SOX5;BMPR2
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.3120993592776582,0.9680779348532317,0.5053191489361702,1.0,1.0,39/69,46.53%,DNASE1L2;TREX2;POLR2L;DNA2;FEN1;POLR2K;KPNA2;DXO;METTL3;POLR2G;ATXN2;RECQL5;POLR2H;TOPBP1;RBMX;POLR2I;MMS19;POLR2J;HNRNPU;DNASE1L1;RBFOX2;HNRNPA1;POLR2A;POLG;HNRNPH2;PTBP1;RAN;POLR2B;PCBP1;GTF2F1;HNRNPR;DDX1;DDX54;POLR2F;SETMAR;HNRNPM;WRN;DNASE2;WDR74
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.3353286935515535,0.9680567564684712,0.5051546391752577,1.0,1.0,15/47,24.03%,PLCH2;INPP5J;ITPKA;PLCH1;ISYNA1;NUDT11;PPIP5K1;PLCD3;PLCD4;IP6K1;PLCG1;INPPL1;ITPKC;IMPA1;OCRL
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.3638939262150208,0.9680305228931185,0.4970414201183432,1.0,1.0,10/25,41.14%,EXOSC4;NEIL3;H4-16;MUTYH;PARP1;EXOSC5;OGG1;TERF1;ACD;TERF2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.32935152445500543,-0.9680229207404665,0.5212765957446809,0.7735908710746251,1.0,7/20,13.84%,CCL5;IGFBP3;NDRG4;IGFBP5;TRIB1;SORL1;IGF1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.4370560939418684,0.967934249908673,0.5342465753424658,1.0,1.0,2/16,2.19%,KCNE5;KCNH2
prerank,WikiPathway_2021_Human__Cysteine and methionine catabolism WP4504,-0.35175677457006316,-0.9678772911499162,0.5280898876404494,0.773467240129061,1.0,6/15,23.39%,BHMT;CBS;MAT1A;CDO1;CTH;SUOX
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.26325826148507186,-0.9677245604260792,0.47692307692307695,0.7734273943131222,1.0,26/61,29.14%,PRSS16;ADAMTS13;GGACT;PLA2G4A;ENPEP;CYP3A4;ALLC;LIPC;CTH;CLN8;TRHDE;UCHL3;ANPEP;PDXDC1;SIAH1;CYP2D6;RENBP;PNPLA8;ENPP2;PLA2G7;ADO;CLPX;PLA2G10;BCKDK;IL4I1;CLN5
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.30489932958945265,-0.9676643561004129,0.5308641975308642,0.7731150873770672,1.0,9/21,20.78%,ACOD1;ATP1A3;OR51E2;NKX3-1;BMP7;ABHD2;AR;TRERF1;ADTRP
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.41612747825979235,0.9674070993386978,0.4716981132075472,1.0,1.0,6/15,29.27%,CPSF1;TSEN2;CPSF4;TSEN54;TSEN15;CSTF2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.42085616829549694,0.9673448315084323,0.554945054945055,1.0,1.0,4/15,15.40%,FAP;PDPN;MELTF;DPP4
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.39642225812927556,0.9673315193384366,0.5,1.0,1.0,4/17,16.68%,RGCC;PDGFB;PSRC1;PKD1
prerank,WikiPathway_2021_Human__Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.2863719123172291,0.9670092292403675,0.5774647887323944,1.0,1.0,14/143,10.06%,IGF2BP1;DOCK3;RASGRF1;SPP1;PIK3R2;GRIN1;PRKAA2;MAPT;SHC3;SRC;BDNF;CAMK2A;LINGO1;IKBKG
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.32232883930593487,0.9669962785756513,0.48743718592964824,1.0,1.0,18/55,32.53%,HMGA2;MSX1;EYA4;ANKRD1;NACC2;H2AX;EYA1;TRIM28;TMEM161A;MYC;EEF1E1;NSMCE1;PCNA;ABRAXAS1;BABAM2;NPAS2;FMR1;UIMC1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3786244711587576,0.9669843210438083,0.5337078651685393,1.0,1.0,4/22,13.72%,CASQ1;ATP1A2;CACNA1C;GSTM2
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.38912498890274966,0.9666805842290689,0.47305389221556887,1.0,1.0,12/21,40.87%,FBLL1;NHP2;TFB2M;TRMT112;FBL;DKC1;NOP10;METTL5;TSR3;BUD23;FTSJ3;NAT10
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.27059029700597353,-0.9664882162741923,0.5161290322580645,0.7759586545585903,1.0,14/72,12.33%,MUC21;MUC1;SPINT2;DSCAM;PLXNA4;CDH1;PTPRO;SEMA4D;PTPRC;WNT1;SEMA6A;SPN;PLG;RIPOR2
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.35604781327736257,-0.9660068702788952,0.5571428571428572,0.7768462463471307,1.0,5/18,22.48%,OASL;DDX60;USP15;DHX58;RNF125
prerank,WikiPathway_2021_Human__Tumor suppressor activity of SMARCB1 WP4204,0.3476150310187134,0.965717680139908,0.48863636363636365,1.0,1.0,12/29,32.27%,CDKN2A;ACTL6B;EZH2;GLI4;CDK6;SMARCA4;GLI1;SMARCD3;DPF2;SMARCC1;SMO;CDK4
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,0.40397736837041315,0.9654675808193959,0.5178571428571429,1.0,1.0,4/17,16.27%,PIK3R2;SHC1;HRAS;ANGPT2
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,0.410303418307545,0.9654169838085326,0.5157232704402516,1.0,1.0,7/17,31.89%,CDKN2A;TFAP2C;PIAS3;PIAS1;PIAS4;UBE2I;TP53BP1
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,0.3389308677581861,0.9654021795007784,0.5272727272727272,1.0,1.0,1/34,0.34%,DYNC1I1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.30330484916424644,0.9651956275032978,0.4788732394366197,1.0,1.0,27/94,23.68%,HS3ST5;CEMIP;UST;BCAN;GPC3;CHST6;NCAN;HS6ST2;NDST1;HAS1;CSPG5;CSPG4;HS3ST2;ABCC5;HS6ST1;GPC2;VCAN;B3GAT3;B4GALT3;ST3GAL3;B4GALT7;HSPG2;CHST15;XYLT2;CHPF;OGN;CHST1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.3432410150833856,-0.9649936146531384,0.4875,0.7793283291164315,1.0,4/16,13.67%,TMEFF2;CCN1;LCP1;CARMIL2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3811050619075179,0.9649413920789794,0.5083798882681564,1.0,1.0,1/24,0.21%,MT3
prerank,WikiPathway_2021_Human__Peptide GPCRs WP24,0.3214662521832651,0.9647494972735666,0.4791666666666667,1.0,1.0,14/50,13.85%,GRPR;TAC4;OPRL1;AVPR2;SSTR5;CCR3;GALR2;GALR3;OXTR;ACKR1;BDKRB2;GALR1;MC1R;BDKRB1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.29958722758515627,-0.9645435944589056,0.5180722891566265,0.7801473612500737,1.0,11/37,18.44%,CSF3;INHBA;HSPA1B;NCKAP1L;MTURN;FAXDC2;ACVR2A;HSPA1A;GATA1;ETS1;HOXA5
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.4024135120616208,0.9642853905125928,0.551948051948052,1.0,1.0,6/17,19.62%,MDK;GDF5;BMP4;LOXL2;ACVRL1;SCX
prerank,Elsevier_Pathway_Collection__Apoptosis Block in Synovial Fibroblast,-0.29155009622714334,-0.9642168506149378,0.5,0.7806321325980361,1.0,4/35,6.68%,TNF;TNFRSF11B;FASLG;TNFSF10
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,0.2761640766029034,0.9637742638993687,0.5720930232558139,1.0,1.0,71/176,38.68%,SLC7A11;NQO1;NOX4;CDKN2A;AQP8;NOX5;PSMD4;ATOX1;TKT;TXNRD2;PSMB4;UBL4A;MAFG;SQSTM1;GPX3;GPX2;COX6C;COX20;COX7B;TXNRD1;NUDT2;HM13;COX6B1;NPLOC4;COX8A;GPX1;LIN9;SMARCD3;MYC;PSMB3;NCOR2;UFD1;PSMD14;SIN3B;UBA52;GPX8;PSMB5;PSMD2;PRDX2;COX4I1;PSMA1;PSMD10;KEAP1;COX5B;PSMC4;PSMC3;CUL1;PRDX5;BRIP1;ABCC1;SKP2;BLVRA;SKP1;COX19;CSNK2B;TBL1X;PSMC5;NCOA2;SEM1;PSMB6;PSMD8;COX7C;NCOA6;PSME2;BLVRB;VCP;TALDO1;GSK3B;PSMD13;PSMB7;PSMA7
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.3086221312530209,0.9636367331496665,0.5102040816326531,1.0,1.0,6/68,9.21%,TRIM71;FGF20;FGF17;FGF2;FGF23;SHCBP1
prerank,Elsevier_Pathway_Collection__NTRK1/2/3 -> Acetylcholine Production,-0.35476079921476406,-0.9636298521912209,0.5057471264367817,0.7819632244890679,1.0,5/15,11.04%,NTRK3;NTF3;NTRK2;NGF;NTRK1
prerank,TRRUST_Transcription_Factors_2019__TCF4 mouse,-0.3440072397104815,-0.9636116685269239,0.5180722891566265,0.7815057543106847,1.0,5/19,8.15%,PTGS2;ID2;CDH1;SSTR2;MITF
prerank,KEGG_2021_Human__Phototransduction,0.3943777160409383,0.9635236630179145,0.5170454545454546,1.0,1.0,5/19,19.92%,CALML6;RHO;SAG;GUCY2D;RGS9
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.31382139445439894,0.9633836953701579,0.5126903553299492,1.0,1.0,18/65,18.30%,SFN;FLG2;ALOX12B;HRNR;FLG;ITGA6;TGM3;COL1A1;AKR1C3;ALOX12;PDGFA;COL1A2;COL5A1;STMN1;PKD1;ADAM9;ABCB6;TMEM79
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.32538792955611073,0.9630338744996864,0.550561797752809,1.0,1.0,7/46,7.48%,GLUL;DPEP1;NAT8L;NOX4;NAALAD2;GADL1;RIMKLA
prerank,WikiPathway_2021_Human__Urea cycle and metabolism of amino groups WP497,0.3803475893766839,0.9628551587714449,0.5647058823529412,1.0,1.0,5/21,15.27%,ARG2;CKB;SRM;ODC1;PYCR3
prerank,Elsevier_Pathway_Collection__BDKRB1/2 -> Interleukins Production,-0.343086146949359,-0.9624292167618257,0.5138888888888888,0.7843708403953615,1.0,5/17,15.81%,IL10;IL6;CXCL8;AKT1;KNG1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.23922803745795976,-0.9623467295595879,0.6,0.7841652787507565,1.0,27/116,18.59%,ST18;NLRP2;RFPL1;TNF;FASLG;NLRP12;COL4A3;S100A8;XDH;TNFSF10;CASP1;TNFSF15;NGFR;NLRP3;ACVR1C;NKX3-1;NGF;LCK;CLEC7A;SYK;LGALS9;F3;NLRC4;ATP2A3;PMAIP1;DLC1;EIF2AK3
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.32988904471451147,-0.9618838413374424,0.48717948717948717,0.7851296564668504,1.0,6/18,18.93%,SLAMF7;KLRD1;ULBP3;KLRK1;GZMB;KIR3DL1
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.34748925634918676,0.9616297978653348,0.5252525252525253,1.0,1.0,6/40,14.36%,PIK3R2;BAIAP2L2;FAM169A;DIAPH3;ARHGAP39;MCAM
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.2844026669613084,0.961565235876558,0.5633802816901409,1.0,1.0,32/145,25.19%,AVIL;LMOD1;KASH5;RFLNA;VIL1;XIRP1;BAIAP2L2;RHOBTB1;TLE6;MYO7A;FAT1;SPIRE2;TMOD4;TPM2;MYO1H;SCIN;SHROOM4;ARHGEF2;DBN1;RHOC;NEB;GAS2L1;FHOD1;RHOBTB2;PPP1R9A;CORO1B;INPPL1;GSN;EMP2;OOEP;MYO19;MYO5B
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,0.30990059584125523,0.9612055964881941,0.5235602094240838,1.0,1.0,50/83,47.30%,IHH;PSMD4;CDON;KIF7;HHIP;PSMB4;DHH;BOC;IQCE;GLI1;GPR161;PSMB3;PSMD14;UBA52;SMOX;SMURF1;GAS8;PSMB5;PSMD2;PSMA1;ULK3;PSMD10;ARRB1;PSMC4;PSMC3;SMURF2;PSMC5;SEM1;PSMB6;PSMD8;PSME2;SUFU;PSMD13;PSMB7;PSMA7;SHH;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;KIF3A;PSMC2;EFCAB7;CSNK1A1;RPS27A;PSME1;PSMB1;PSMD3
prerank,Elsevier_Pathway_Collection__SELE -> ELK-SRF Signaling,0.3892972380761223,0.9609582549532973,0.5031055900621118,1.0,1.0,5/17,24.71%,RASGRF1;MAPKAPK2;ELK4;PLCG1;MAP2K2
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.2927098106149185,0.9609502602439681,0.5326633165829145,1.0,1.0,19/109,18.00%,ODAM;PAK3;PRKAA2;MAPT;STMN3;RHOBTB1;PDGFRB;ARHGAP44;IQGAP3;SPEF1;PDGFA;GRHL3;CDK2AP2;PFDN2;ROCK2;RHOC;MAP6;MAP6D1;TWF2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.2654092621299288,0.9608670837451591,0.5299145299145299,1.0,1.0,23/225,8.21%,ISL2;PAX2;CTNNA2;LGR6;EPHA6;EPHB2;LAMA3;PAK3;BRSK2;NRCAM;SHC3;ROBO1;POU4F1;NRXN3;EFNA3;ADGRB1;NTN3;SRC;EPHA10;EFNA4;KIF5A;BDNF;EFNA1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.39238143521406776,0.9606624655500815,0.4883720930232558,1.0,1.0,4/16,15.45%,SIX1;ZBTB7B;LEP;PIM1
prerank,Elsevier_Pathway_Collection__Catecholamines Secretion from Adrenal Gland,0.3264173003338219,0.9606481646511109,0.5083798882681564,1.0,1.0,3/53,1.59%,CHGB;SCG2;RASGRF1
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.3772374238485778,0.9603180967447009,0.5433526011560693,1.0,1.0,8/21,28.55%,BBS5;BBS2;VPS33A;GPR143;BLOC1S3;MREG;BBS4;MLPH
prerank,TRRUST_Transcription_Factors_2019__ETS1 human,0.30826566468226185,0.9596552384412195,0.49740932642487046,1.0,1.0,16/70,16.80%,GRPR;TERT;VWF;CDKN2A;BMP4;COL1A1;PTHLH;MUC4;NDRG1;MMP10;F13A1;FLT1;PLAU;SQSTM1;ANGPT2;RHOC
prerank,Elsevier_Pathway_Collection__Proteins Involved in Diabetes Mellitus Type 2,0.28975705229634974,0.9595136110492063,0.5406698564593302,1.0,1.0,19/105,15.54%,IGF2;GLP1R;GCG;CRP;PRKAA2;NEUROD1;SLC2A4;BDNF;ABCC8;PEA15;LEP;CD36;ACE;BGLAP;IAPP;LEPR;DPP4;PPARG;KCNJ11
prerank,Reactome_2022__Activation Of SMO R-HSA-5635838,0.3919983603539694,0.9595092409015833,0.532967032967033,1.0,1.0,8/18,30.78%,IHH;CDON;DHH;BOC;IQCE;SMOX;GAS8;ARRB1
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Aging,0.39959130149592026,0.9594564649481995,0.5480225988700564,1.0,1.0,6/19,18.60%,TERT;ELN;COL1A1;COL1A2;HRAS;MTHFR
prerank,TRRUST_Transcription_Factors_2019__TWIST1 mouse,0.3791554072835993,0.95941832509223,0.5083798882681564,1.0,1.0,2/26,0.45%,COL2A1;DKK1
prerank,Elsevier_Pathway_Collection__Complement Cascade Activation by Pentraxins,-0.33526474070666845,-0.9592219213073456,0.5555555555555556,0.7923126122704025,1.0,10/18,24.41%,C9;FCGR3A;MBL2;C1S;C1QA;C5;MASP1;APP;C3;C4B
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.3982814691056109,0.959146189797855,0.5141242937853108,1.0,1.0,1/18,0.56%,HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.26014759509876234,0.9591223855067144,0.6097560975609756,1.0,1.0,40/444,8.08%,HMGA2;ODAM;MT3;DKK1;HOXD3;C1QTNF3;FGF20;OSR2;EPHB2;LEF1;E2F1;RBM24;OSR1;CRP;CLDN19;SFRP4;STOX1;ALOX12B;ROBO1;SAA1;TCF23;GATA5;POU4F1;S100A13;NOX5;MAPK11;AVPR2;POU3F1;FGF17;NR5A1;BMP4;CD34;TESC;FGF2;TMEM119;AMH;FGF23;AGO2;PRKN;IL36G
prerank,WikiPathway_2021_Human__Blood Clotting Cascade WP272,-0.333182308025155,-0.9584256402674517,0.5384615384615384,0.79412139961155,1.0,10/22,22.14%,F9;KLKB1;PLG;SERPINB2;F13B;F3;F11;F7;SERPINF2;F2
prerank,Elsevier_Pathway_Collection__Corneodesmosomes in Atopic Dermatitis,-0.34713597102168964,-0.9583126528019541,0.5888888888888889,0.7939100999768178,1.0,3/15,8.14%,PKP3;CDH1;DSG2
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.33311770493101933,0.958138957255872,0.4943820224719101,1.0,1.0,4/37,6.21%,TNNC1;TNNI3;MESP1;BMP4
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.3519775888730919,0.9579630710821518,0.5112359550561798,1.0,1.0,9/29,19.02%,POU3F2;MPZ;POU3F1;PRX;LAMC1;DRP2;SREBF2;HMGCR;PLPPR3
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.33789023248476513,0.957871196779414,0.5222222222222223,1.0,1.0,23/37,50.08%,NUP37;NUP62;TPR;NPM1;NUP133;RANGAP1;NUP155;NUP160;NUP188;NUP205;XPO1;NUP210;RAN;NUP214;NUP107;RCC1;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,Elsevier_Pathway_Collection__Hepatocellular Carcinoma,0.2925026569677628,0.9578336582074843,0.5416666666666666,1.0,1.0,17/111,17.35%,IGF2;VEGFD;LEF1;E2F1;CDKN2A;SRC;PDGFRB;JAG2;PDGFB;FLT1;PDGFA;KAT2A;SHC1;PDPK1;HRAS;SMAD3;EGF
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.285873411889558,0.9577914795848402,0.5714285714285714,1.0,1.0,10/146,6.06%,DKK1;PYDC1;SFN;CAMK2N2;EPHB2;THY1;INPP5J;PRR5L;TRIB2;DBNDD1
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.28455445029854437,0.9576252866398526,0.5486725663716814,1.0,1.0,34/196,20.38%,SLC7A11;ALOX15B;SFN;CDH13;H2AW;TAX1BP3;CDKN2A;FGF13;H1-2;SPHK1;IRAK1;PTPN14;TSC22D1;PVT1;S100A10;PHLDA3;CDKN2B;COQ8A;NDRG1;JAG2;RGS16;PDGFA;UPP1;INHBB;ABCC5;RHBDF2;HRAS;GPX2;EPHX1;AEN;CTSD;CDK5R1;TSPYL2;ABHD4
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.3405884909802289,0.9569601688690524,0.5084745762711864,1.0,1.0,30/42,50.14%,ACTL6B;ACTR5;VPS72;SMARCA4;HDAC1;GATAD2B;CECR2;SRCAP;CHD3;SMARCC1;CHD4;NASP;DMAP1;ACTR8;ARID1A;SMARCB1;SMARCC2;RBBP4;SMARCE1;INO80;CHD8;ANP32E;RNF8;ACTL6A;MTA2;HDAC2;SMARCD2;ZNHIT1;HNRNPC;MBD3
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.2900971401852897,0.9567973497967496,0.5217391304347826,1.0,1.0,15/126,14.04%,LGR6;LGR5;PTK7;AXIN2;SFRP4;PRDM15;GPC3;TMEM198;PSMD4;JRK;COL1A1;DAAM2;PSMB4;AMER1;TMEM9
prerank,KEGG_2021_Human__Bladder cancer,0.3465032103328937,0.9566543112981115,0.5721925133689839,1.0,1.0,10/41,19.77%,E2F1;CDKN2A;SRC;UPK3A;E2F2;DAPK2;TYMP;HRAS;EGF;MMP9
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.33039305441975364,-0.9566245743200031,0.5368421052631579,0.7980344739341282,1.0,4/20,11.62%,AMPD1;PNP;CDA;ADK
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.254041211498202,-0.9564870914652263,0.5344827586206896,0.7978929043667512,1.0,14/67,19.15%,LGI1;MFSD2A;SLC44A4;AGR2;SFRP1;S100A8;RFTN1;RPS6KA1;AKT1;CSNK2A3;BCL2;AKAP6;SFRP2;CEP43
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.27907125192555127,-0.9563889201449771,0.5535714285714286,0.7976220527487959,1.0,6/49,5.08%,CLDN4;CLDN10;MARVELD3;GRHL2;CLDN8;POF1B
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.3662381852336695,0.9562106433521886,0.546583850931677,1.0,1.0,2/28,8.07%,DYNC1I1;PRKN
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,0.2829447155833642,0.9560713167221876,0.5848214285714286,1.0,1.0,30/153,16.99%,BEST4;WNK4;ATP4A;TRPM3;ASIC1;ATP10A;ANO2;ATP6V0D2;ANO4;TRPM5;FXYD7;TRPC6;ATP1A2;ATP1A4;ATP2B4;SLC9C2;CAMK2A;CLCNKA;ATP1B3;ASIC3;CLCN1;ATP2A1;ATP9A;ATP6V0A1;ATP8B3;FXYD2;ATP6AP1;NEDD4L;TTYH2;SLC9B1
prerank,WikiPathway_2021_Human__Endothelin Pathways WP2197,0.35415321422005064,0.9559489524375631,0.5371428571428571,1.0,1.0,6/29,15.60%,CALCA;RAMP1;RIIAD1;CAD;GNB5;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.3438597227556561,0.9559361136674549,0.5028571428571429,1.0,1.0,5/30,8.98%,F2RL3;GPR35;ROBO1;LPAR4;PRAG1
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.3440571594916352,-0.9558563691554295,0.5476190476190477,0.7986669185917997,1.0,2/16,4.89%,FAM3D;SFRP1
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,0.34071441706916067,0.9555691904546416,0.5363128491620112,1.0,1.0,6/36,15.34%,ADRA2C;VWF;SRC;SHC1;PDPK1;GP9
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.35919439317653,-0.9555368666170112,0.5064935064935064,0.7990711399635556,1.0,2/15,3.65%,DBH;TH
prerank,Elsevier_Pathway_Collection__CR3 Mediated Phagocytosis in Neutrophils and Macrophages,0.4019040138254138,0.9555361796676534,0.48502994011976047,1.0,1.0,4/17,21.80%,RASGRF1;PRKCA;ROCK2;PLCG1
prerank,WikiPathway_2021_Human__Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.2833347977343655,0.9555171552667286,0.5272727272727272,1.0,1.0,11/130,8.50%,DIO2;SLCO1C1;PIK3R2;PRKAA2;MAPK12;SHC3;CYP7A1;SLC2A4;MAPK11;MAP3K8;MAP3K9
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.331417474887578,0.9555134345001421,0.5439560439560439,1.0,1.0,4/41,7.01%,SLC22A12;SLC22A11;SLC13A3;SLC4A1
prerank,WikiPathway_2021_Human__Parkin-Ubiquitin Proteasomal System pathway WP2359,0.3144042543254467,0.9553075773132086,0.5392670157068062,1.0,1.0,35/66,40.49%,PRKN;PSMD4;CCNE1;TUBB8;TUBA4A;TUBA3E;HSPA2;TUBA8;TUBB2B;SNCAIP;TUBA3D;UBA1;PSMD1;PSMD14;HSPA4;TUBB2A;PSMD2;HSPA5;PSMD10;PSMC4;PSMC3;TUBA1A;CUL1;TUBA1B;CASK;HSPA14;PSMC5;HSPA8;PSMD8;TUBB6;TUBB4B;PSMD13;UBE2J2;HSPA1L;TUBA1C
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.331191568625861,0.9553005089556432,0.48314606741573035,1.0,1.0,5/43,10.64%,CERS1;PLPP2;SPTSSB;SPHK1;PRKD1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.29927280038564513,0.9552516528752159,0.5523809523809524,1.0,1.0,40/108,34.37%,PRKAA2;GPSM1;ATP6V0D2;LAMTOR2;IKBKG;MTMR8;GBA;UCHL1;ATP6V0A1;LZTS1;NEDD4;ATP6V0B;LAMTOR4;CDK5R1;SNX32;TSC1;TBC1D25;ATP6V0D1;TSC2;SMCR8;PRKAB2;ATP6V0E1;ATP6V1C1;CDK5;LARP1;ATP13A2;ATP6V1H;RB1CC1;RHEB;GAPDH;ULK1;CLEC16A;RUFY4;EXOC4;ATP6V1E1;MLST8;NRBP2;ATP6V1E2;LAMTOR5;RRAGD
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.26884140729646516,-0.9549624384953737,0.5492957746478874,0.8003649916587184,1.0,12/46,13.84%,EREG;IL10;TNF;NR4A3;CCL5;ID2;IL18;IL6;ADAMTS1;IGFBP5;AKT1;IGF1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.2707671573347439,-0.9549221102043108,0.45614035087719296,0.7999999893198352,1.0,15/50,17.45%,MUC5AC;PLCZ1;PIK3C2G;PDGFRA;PIK3CD;NGF;NTRK1;PIK3R1;PLCB2;IGF1;PLCL2;ADAP2;CSF1R;EZR;PTAFR
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.3242259259867614,0.9546938996851838,0.5510204081632653,1.0,1.0,20/46,33.88%,GLUL;TRIM40;PLK1;BMP4;GTSE1;CDK1;NVL;LIMK2;OTUD7B;BYSL;MFHAS1;TPR;CARD10;ATP13A2;YAP1;PARK7;PIN1;CTNNA1;TGFB1;LAMTOR5
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.31563703836106743,0.9544851318384953,0.5230769230769231,1.0,1.0,6/61,8.95%,HMGA2;SPINK5;THY1;TERT;CD34;MCTP1
prerank,Elsevier_Pathway_Collection__CDH1 Down regulation Promotes Cancer Cell Migration and Metastases,0.3398889427208628,0.9543892715454995,0.5483870967741935,1.0,1.0,13/44,26.12%,LEF1;SNAI2;GSC;PRRX1;FOXC1;DVL2;ZBTB33;FOXC2;FOXQ1;SNAI1;TCF3;DVL1;CTNNB1
prerank,Elsevier_Pathway_Collection__SWI/SNF BRG1/PBAF in Chromatin Remodeling,0.40363753520614337,0.9542933445635503,0.5476190476190477,1.0,1.0,12/16,50.20%,ACTL6B;SMARCA4;SMARCD3;SMARCC1;HAT1;ARID2;SMARCB1;SMARCC2;SMARCE1;ACTL6A;SMARCD2;SMARCD1
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.33884683218533534,0.9542217232182649,0.48554913294797686,1.0,1.0,13/38,32.37%,ITPKA;FGF2;TKT;PPIP5K1;GNPAT;IP6K1;GPAM;ITPKC;LPCAT1;AGPAT5;GPAT2;G6PD;FITM2
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.2638314747337227,-0.9540231299726053,0.5964912280701754,0.8020300440988695,1.0,20/67,19.87%,EREG;EVPL;WNT7A;FGF10;SPRR3;NOG;SYT7;PDGFRA;EVPLL;TSKU;KRT6A;IGF1;CLDN1;ITGB3;HMOX1;JAML;FZD7;WNT5A;PPP3CA;ANXA6
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.34762172199072416,0.9539481870989894,0.515527950310559,1.0,1.0,3/27,4.96%,PAX2;SOX2;HES5
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.32640896567676136,-0.9538292588018528,0.5294117647058824,0.8020800056502058,1.0,5/23,16.98%,ACOD1;PTPN22;LILRA2;TICAM2;BPIFB1
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.2759502375677869,0.953815444617005,0.5662100456621004,1.0,1.0,54/165,31.89%,CDKN2A;TOP2A;NR5A1;HDAC4;BIRC5;TFAP2C;AURKB;IKBKG;CDCA8;DNMT3A;AURKA;H4C15;NFKB2;NSMCE2;PPARG;PCGF2;THRA;PIAS3;CETN2;NUP37;POLR1A;PARP1;HDAC1;PIAS1;CBX8;TRIM28;NUP62;DNMT1;BLM;TPR;SATB2;NPM1;NUP133;CBX5;NOP58;DNMT3B;RANGAP1;NCOR2;INCENP;CHD3;MDC1;NSMCE1;NUP155;TRIM27;PCNA;NUP160;PARK7;HIPK2;PIAS4;SMC3;UBE2I;CBX2;IKBKE;TP53BP1
prerank,MSigDB_Oncogenic_Signatures__BCAT BILD ET AL UP,0.3288885130517596,0.9536189702482433,0.56,1.0,1.0,6/41,11.58%,AXIN2;ICAM5;BMP4;ZNF703;IGSF8;FHDC1
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,0.3299334142206528,0.9535051478210104,0.5544041450777202,1.0,1.0,17/51,23.68%,HS3ST5;UST;EXTL1;CHST6;HS6ST2;EXTL3;NDST1;HS3ST2;HS6ST1;B3GAT3;B4GALT3;ST3GAL3;B4GALT7;CHST15;XYLT2;CHPF;CHST1
prerank,Elsevier_Pathway_Collection__Mineralcorticoids Secretion Regulation,0.34014572442436847,0.9533600624077282,0.47126436781609193,1.0,1.0,6/34,14.29%,RASGRF1;CYP21A2;AVPR2;PRKD1;CACNA1C;MAPKAPK2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Colorectal Neoplasms,0.2949275190260313,0.9533201689250391,0.5211267605633803,1.0,1.0,22/91,22.14%,IGF2;NTS;PLA2G2A;PTP4A3;SPP1;FOXM1;BIRC5;SRC;GDF15;LEP;TYMS;CDX2;PPARG;MSH2;MTHFR;MMP9;MUTYH;SPARC;MMP3;FHIT;PARP1;CCR6
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,0.2786298484284186,0.9532536486585962,0.5633187772925764,1.0,1.0,40/194,15.60%,OR1N2;USH1G;PPEF1;OPN1SW;BSN;OR51E1;CABP1;LRRC52;TAS1R3;RHO;CACNA2D2;ANO2;TRPM5;GPC3;FSCN2;OR2B6;AKR1B10;TMC1;ATP2B4;RGS9BP;GNAL;PCDH15;EBF1;WHRN;MYO7A;AKR1C3;LPL;SCN4B;SCN2A;GPIHBP1;SDR9C7;SYN1;SNAP25;SYP;GNB5;GUCY2D;AKR1C1;HSD17B1;GRM1;PRKCA
prerank,TRRUST_Transcription_Factors_2019__POU2F1 human,0.36168366453258066,0.9531416920816517,0.5480225988700564,1.0,1.0,7/32,13.85%,GCM1;SPP1;VWF;SNAI2;CDX2;PLAU;BDKRB1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.30010840622687196,-0.9531353863867582,0.4788732394366197,0.8035297373246251,1.0,11/30,20.96%,CETP;APOA4;DGAT2;IL18;APOA1;APOA5;ANGPTL3;GCKR;LIPC;NR1H4;XBP1
prerank,KEGG_2021_Human__Proteoglycans in cancer,0.27258660990399164,0.9531093296000339,0.5665236051502146,1.0,1.0,18/194,8.70%,IGF2;HPSE2;HOXD10;PIK3R2;TWIST2;MAPK12;WNT4;WNT9B;ITGA2;WNT8B;MAPK11;ANK1;GPC3;SRC;FGF2;IHH;CAMK2A;COL1A1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.3771884912464855,-0.9525236291314052,0.5425531914893617,0.8047164353862041,1.0,2/15,7.87%,CD4;ZFP36L1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.3383868462068712,0.9524580451031286,0.49171270718232046,1.0,1.0,10/37,21.51%,GLYATL1B;GLUL;PRODH;RIMKLA;PYCR2;CAD;PYCR3;GLUD2;KYAT1;GOT1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.22674517503981323,-0.9524251822229741,0.6896551724137931,0.8044964202309633,1.0,29/133,14.97%,TCN1;MFSD2A;SLC18A1;SLC22A10;ZG16;RHCG;CETP;LRP1B;APOA4;ABCD2;SLC22A1;APOA1;CMTM6;SLCO1B3;ARRDC3;CD3G;SLC18A2;SLC22A25;PEX3;APOA5;ARRDC4;SLCO2B1;ABCG8;ABCG5;ABCG4;MFSD2B;RAB38;ABCA8;SLCO1B1
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,0.31570480242432075,0.9523416116947053,0.5287958115183246,1.0,1.0,9/55,9.80%,CDH8;CLDN19;CDH13;SDK1;CLDN15;CDH24;NECTIN1;CLDN6;CDH17
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,0.3906771403560297,0.9523087641172522,0.4942528735632184,1.0,1.0,9/16,47.29%,ATP5MF;ATP5F1D;ATP5F1E;ATP5MC1;ATP5ME;ATP5MG;ATP5PO;ATP5MC2;ATP5PD
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.3332211032126189,-0.9521112531621599,0.5402298850574713,0.804823399287483,1.0,4/16,17.13%,PIK3C2G;TPTE2;PI4K2B;PIK3R4
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.3104690062641868,0.9521077348873858,0.5970149253731343,1.0,1.0,3/60,3.38%,TBX4;COL2A1;NEUROD1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.3023046433031886,-0.9519569950503955,0.5063291139240507,0.8048000021872665,1.0,10/36,14.80%,EREG;IL10;IFNG;TGFA;CCL2;CCR2;BTC;GREM1;ADRA2B;HBEGF
prerank,MSigDB_Oncogenic_Signatures__IL21 UP.V1 DN,0.28139541939711443,0.9517542699752671,0.5654205607476636,1.0,1.0,29/141,17.11%,CHGB;GUCY1B2;LMOD1;CEL;HOXB8;PNMA3;LCN2;ASPHD1;TNNI3;WNT4;ITGA2;PRR5L;ITGA6;GPC3;PTGDS;PDE1C;KLHDC8A;MIR600HG;HBD;CACNA2D3;MEOX2;CCL24;AP3B2;USP27X;TREM1;GJB3;CNTNAP3B;DIRAS2;GPX2
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.29952256975451463,-0.9517042033012709,0.5538461538461539,0.8050799780686976,1.0,11/37,18.44%,INHBA;ZFP36L1;HSPA1B;NCKAP1L;MAFB;SPI1;ACVR2A;HSPA1A;GATA1;ETS1;HOXA5
prerank,MSigDB_Oncogenic_Signatures__LTE2 UP.V1 UP,-0.21889689610401172,-0.9513592734931845,0.5714285714285714,0.8055700196703669,1.0,39/171,19.87%,CEACAM6;FA2H;GSTZ1;EHD3;RCAN1;TNFRSF11B;PCDH9;VTCN1;EPN3;RLN2;HSD17B14;RFTN1;EPS8L1;BMP7;GCNT1;FERMT2;IGFBP5;PTGER4;GNA14;HMGCS2;ACOX1;GALNT12;SORL1;KMO;PPP1R3C;CXCR4;FAM117A;PLAGL1;TMC6;ALDH3B2;BTG1;SLC12A2;DSC2;AQP3;PGM1;ACOX2;RAB27A;SLC2A10;ANXA6
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3448861847074237,0.9512790568261998,0.5271739130434783,1.0,1.0,9/34,14.29%,VEGFD;SPHK1;HSPB1;FOXC1;PRKD1;RAMP2;FLT1;PGF;MAPKAPK2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.2920915892636399,-0.9511074822026333,0.5384615384615384,0.8057065818142066,1.0,15/29,32.61%,ABCD2;PEX3;ACBD5;PXMP2;GDAP1;LONP2;RAB8B;PEX7;PEX13;PEX14;ABCD3;ATAD1;SLC25A17;ALDH3A2;PEX12
prerank,MSigDB_Oncogenic_Signatures__GCNP SHH UP LATE.V1 UP,0.28294164440802083,0.9504770452349679,0.581081081081081,1.0,1.0,32/163,18.95%,IGF2;SIX4;ELAVL2;CDCA7;SLC7A6;SLC12A1;CDC25C;KIF2C;TOP2A;KIFC1;E2F8;AURKB;DLGAP5;LOXL2;TRIP13;NPTX1;CDK1;MCM6;AURKA;DDX39A;MCM10;CHEK1;MCM5;VCAN;PRC1;GBP2;CDC25A;RRM2;LBR;MCM4;COX7B;PSMC3IP
prerank,KEGG_2021_Human__PPAR signaling pathway,-0.26215598506327564,-0.9504404702322194,0.6190476190476191,0.8071359552182588,1.0,25/69,21.24%,SLC27A6;MMP1;FABP2;PCK1;ACSL1;APOA1;SCD5;SCP2;CYP8B1;PLIN1;ACADL;ACAA1;APOA5;EHHADH;HMGCS2;ACOX1;ACADM;PLTP;PCK2;SLC27A5;ACOX2;ACOX3;FADS2;FABP3;PLIN2
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,-0.263200116487846,-0.9504295242063227,0.546875,0.8066590847451018,1.0,11/49,17.93%,EREG;ERBB4;NRG4;FYN;BTC;PIK3R1;AKT1;HBEGF;PRKCE;PTK6;NRG3
prerank,TRRUST_Transcription_Factors_2019__HDAC1 mouse,0.3666208962639531,0.9504284131931093,0.5443786982248521,1.0,1.0,6/25,17.48%,CSN2;SPP1;COMP;BGLAP;PPARG;CDC25A
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.26255563101377183,0.9501602047037014,0.6188524590163934,1.0,1.0,129/495,31.74%,TRIM71;TRIM50;TRIM17;TRIM40;FBXW10;H2BC13;TRIM7;MKRN3;RNF182;ZNRF3;RNF157;PLK1;UBE2T;SH3RF3;KLHL41;H2BC17;TRIM73;UBE2C;PRKN;PSMD4;DTL;H2BC9;FBXL18;FBXL16;H2BC15;UHRF1;KLHL21;UBE2S;CCNF;H2BC11;RAG1;RNF43;H2BC12;FBXO31;KLHL13;SPSB2;ASB12;FBXO24;PSMB4;UBE2Q1;TRIM55;ELOC;H2BC5;ANKRD9;UNKL;TRIM74;TRIM11;USP22;NEDD4L;TRIM54;NEDD4;TRIM24;TRIM72;BARD1;DET1;TRAF2;RNF113A;ELOB;BLMH;TRAIP;RNF187;PELI3;UVSSA;FBXL8;ASB1;RNF31;MARCHF8;ISG15;RNF135;PDZRN3;UBE2A;ANAPC11;UBR5;CCDC22;PRKDC;GAN;HIF3A;KLHL25;TRIM3;HECTD2;LNPEP;UBA1;FBXL15;CUL7;LZTR1;TRIM47;TRIM25;PSMD1;NEDD8;TSPAN17;TRIM52;RUSC1;SH3RF2;TRIM38;CTNNB1;ANAPC7;PSMB3;RAD18;HECW1;FBXO41;RNF181;PSMD14;CUL4B;UBA52;KCTD13;FBXL22;UBE4B;SMURF1;SDE2;RNF25;SPSB1;PSMB5;TRIM27;RACK1;PSMD2;PCNA;CUL9;TRAF7;PSMA1;UBE2O;PSMD10;ARRB1;KEAP1;VPS11;RNF20;KLHL12;PSMC4;PSMC3;FBXW5
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.3182189706519333,0.9501179622294481,0.5786516853932584,1.0,1.0,19/47,34.61%,HES5;HDAC4;HDAC11;KAT2A;HDAC5;HDAC10;HEY1;HDAC1;MYC;MAML1;TLE1;NCOR2;HEYL;UBA52;MAMLD1;CUL1;HDAC8;SKP1;TBL1X
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,0.386203433718426,0.9499724879879807,0.5246913580246914,1.0,1.0,8/17,36.23%,VPS28;MVB12B;VPS37D;UBA52;PPIA;SGIP1;NMT2;MVB12A
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.3715819979106625,0.9499625875560967,0.5411764705882353,1.0,1.0,11/20,46.42%,UBE2C;UBE2S;ANAPC11;ANAPC7;SKP2;CDC23;ANAPC1;ANAPC2;ANAPC4;ANAPC15;ANAPC5
prerank,MSigDB_Oncogenic_Signatures__ERB2 UP.V1 DN,-0.22706294082506664,-0.9498989894358986,0.6666666666666666,0.807765871924722,1.0,48/177,24.97%,ASCL1;TCN1;EGR3;PRKAR2B;TFPI2;AGL;ID2;NPY1R;MSMB;ZNF430;ANXA3;XK;AMIGO2;CYP26B1;RASGRP1;DDX60;WIPF1;CASP6;TIAM1;CPOX;ARMCX1;BCL2;MATN2;PLA2G12A;PMAIP1;CBR4;ZNF43;ASS1;DLC1;KIF5C;MPDZ;MBNL2;LIN7C;OAS2;MYB;IFIT1;SMAD7;JAK2;IFIH1;HSPA4L;HS2ST1;HSPB8;IGF1R;DDX58;OAS1;RNF138;SLC7A2;ZCCHC2
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.2647415561308757,-0.9495886468652229,0.5434782608695652,0.8080535673768396,1.0,18/63,24.99%,TNF;CCL5;APOBEC3C;OASL;APOBEC3A;RSAD2;CXCL8;IFI16;OAS3;OAS2;PPID;IFIT1;APOBEC3G;IFIH1;PROX1;OAS1;PLSCR1;TRIM6
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.32034293892047383,-0.9495508914664608,0.5384615384615384,0.8076622918994063,1.0,1/20,0.37%,AMPD1
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.33193629559034116,0.9494257343151685,0.526595744680851,1.0,1.0,15/48,24.03%,PLCH2;INPP5J;ITPKA;PLCH1;ISYNA1;NUDT11;PPIP5K1;PLCD3;PLCD4;IP6K1;PLCG1;INPPL1;ITPKC;IMPA1;OCRL
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.2722670220784627,0.949346341591162,0.5695067264573991,1.0,1.0,38/197,19.72%,ALOX15B;EPHB2;PLA2G2A;PLPPR1;PLCH2;PLPP2;INPP5J;CERKL;ITPKA;PLA2G2C;PLCH1;ACP4;CYP2W1;DUSP23;SPHK1;ISYNA1;ALPI;PFKFB4;LPL;COQ8A;PLA2G4C;NUDT11;CERK;ACP6;PLA2G4F;FBP2;PLPP1;PLPPR2;PGP;PPIP5K1;HTR2B;PLCD3;PLCD4;IP6K1;LIMK2;PLPPR3;DUSP12;PFKFB2
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.3146640806255439,0.9492366499927957,0.5816326530612245,1.0,1.0,15/68,25.39%,IGF2;PIK3R2;ATP6V0D2;SOGA1;ATP6V0A1;SHC1;ATP6AP1;ATP6V0B;TCIRG1;FOXC2;ATP6V0D1;SH2B2;ATP6V0E1;ATP6V1C1;RARRES2
prerank,Elsevier_Pathway_Collection__Genes with Mutations Associated with Testicular Male Infertility,0.35959906037533124,0.948803964871871,0.5116279069767442,1.0,1.0,10/26,21.31%,CYP17A1;HOXA10;NR5A1;AMH;ATP2B4;DNAH11;CATSPER1;DHH;CATSPER2;DNAH5
prerank,Elsevier_Pathway_Collection__CHRNA7 -> NOS1 Production,-0.35102934559678733,-0.9486026872803502,0.5647058823529412,0.8098528436180955,1.0,8/17,27.93%,MAP2K1;FYN;CHRNA7;RASGRP1;RAP1A;APP;KRAS;NOS1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.25907578086242455,-0.9484938950370436,0.5909090909090909,0.8096738295550233,1.0,3/66,1.83%,CIDEA;NKX2-1;VEPH1
prerank,KEGG_2021_Human__Vibrio cholerae infection,0.33394159749856506,0.9484593121034784,0.5628140703517588,1.0,1.0,21/46,37.37%,ATP6V0D2;ATP6V0A1;PRKCA;ATP6AP1;ATP6V0B;TCIRG1;PLCG1;ATP6V0D1;SEC61G;KDELR3;ATP6V0E1;ATP6V1C1;ARF1;ATP6V1H;ATP6V1F;ATP6V1E1;ATP6V1E2;ADCY9;TJP1;TJP2;SEC61B
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.382988688911091,0.9484488997409384,0.5375,1.0,1.0,5/19,10.75%,ACTN2;GPRIN1;CAMK2A;GRIN2A;MPP3
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.34693643605201435,0.9483018737574214,0.5059523809523809,1.0,1.0,29/34,51.68%,DCAF13;HEATR1;WDR46;RPS14;RPS19;SNU13;RPS8;TSR3;DHX37;UTP4;RRP36;PWP2;RIOK2;RPS16;NOL10;NAT10;RPS28;TSR2;MRPS11;TSR1;RIOK1;NOB1;SRFBP1;UTP6;BMS1;DDX52;UTP3;NOL11;NGDN
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.26175755338418555,-0.9481898206911732,0.5357142857142857,0.8099347671251447,1.0,15/49,14.75%,FCN2;GBP6;STAB2;DEFB1;GBP7;GBP4;IL6;PGLYRP2;MBL2;PGLYRP1;KRT6A;TLR2;CAMP;FGR;MYD88
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.29240309561474903,0.9479107321882968,0.5121951219512195,1.0,1.0,14/99,12.68%,MT3;DKK1;AXIN2;PRODH;SNCG;OLFM4;BMP4;FGF2;PRKN;ZBED6;AKR1C3;PRKD1;CD36;SPEF1
prerank,Elsevier_Pathway_Collection__HIF1A in Vasculogenic Mimicry of Cancer,0.3358255732853289,0.9478122023220452,0.5463917525773195,1.0,1.0,12/42,20.07%,NODAL;TDGF1;PTGER3;EFNA1;JAG2;FLT1;PLAU;PDPK1;SMAD3;NOTCH4;DLL4;ACVR2B
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.36263418255981245,-0.9476732436279802,0.5384615384615384,0.8107517716970358,1.0,6/16,14.47%,ASCL1;SOX10;NTRK1;GATA3;EDNRB;KIF26A
prerank,Elsevier_Pathway_Collection__Leukotriene Effect on Airway Smooth Muscle Response,0.37487723623417524,0.947401506772411,0.5094339622641509,1.0,1.0,1/19,1.59%,RASGRF1
prerank,Elsevier_Pathway_Collection__BMP/TGF-beta Signaling Impairment in Pulmonary Hypertension,0.3611084254183759,0.9472668937689606,0.5232558139534884,1.0,1.0,8/27,20.32%,BMP4;PDGFRB;CDKN2B;PDGFB;PPARG;SMAD3;ACVRL1;TGFBR3
prerank,TRRUST_Transcription_Factors_2019__FOXM1 mouse,0.36444995965275745,0.9472319113161168,0.5470588235294118,1.0,1.0,7/22,13.28%,AXIN2;SOX2;SNAI2;CDKN2A;PTTG1;NFKB2;POU5F1
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,-0.3420184442190501,-0.9472272519891173,0.5494505494505495,0.8115004519270844,1.0,5/16,24.55%,PI4K2B;PIK3R4;MTMR2;INPP4B;MTMR4
prerank,Elsevier_Pathway_Collection__Aqueous Humor Production,-0.3081003690540943,-0.9472241775050488,0.5517241379310345,0.8109881410357164,1.0,10/22,24.87%,KCNJ13;KCND3;CA2;KCNJ8;CLIC6;CLIC4;SLC4A4;ATP1B2;KCNA5;KCNS3
prerank,TRRUST_Transcription_Factors_2019__CREB1 human,0.30032906563519973,0.9464937085119759,0.5693069306930693,1.0,1.0,19/81,15.78%,GRPR;NTS;CYP17A1;CGA;SNAI2;LAPTM4B;BDNF;TRH;NMNAT2;NDC80;PCSK1;MUC4;BDKRB2;FLT1;PLAU;BDKRB1;ODC1;ACACA;STMN1
prerank,MSigDB_Oncogenic_Signatures__KRAS.BREAST UP.V1 DN,0.29142280474344573,0.9462833706035975,0.5566502463054187,1.0,1.0,22/115,13.45%,PI15;MUC13;HCN2;POU3F2;ASPHD1;TNNI3;SYNDIG1;ALOX12B;CYP21A2;FRAS1;NOX5;SLC30A3;EGFL7;CA5B;EDIL3;YPEL1;GRIP2;MAST3;RPL13P5;PTGFR;WT1-AS;KIF25
prerank,"Elsevier_Pathway_Collection__BSG (CD147) in Cancer Cells Motility, Invasion and Survival",-0.2659356613215246,-0.9461476895709258,0.6271186440677966,0.8135786198058297,1.0,9/46,15.02%,AJAP1;EGR2;MMP1;LGALS3;SCP2;ABCB1;ALOX5;AKT1;BCL2L11
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.26910468607457344,-0.9461301335631508,0.4918032786885246,0.8131115995209555,1.0,6/52,5.08%,CLDN4;CLDN10;MARVELD3;GRHL2;CLDN8;POF1B
prerank,MSigDB_Oncogenic_Signatures__BMI1 DN.V1 UP,0.2783332318618669,0.9459445832930581,0.5637254901960784,1.0,1.0,23/134,15.07%,DKK1;B4GALNT1;COL7A1;SLCO4A1;GAL;GDF5;SLCO2A1;FAP;BMP4;CCL20;SLC5A6;PTHLH;SLC1A4;GABRE;MFGE8;BDKRB2;STC2;PLXNA2;PODXL;CSPG5;SLC29A2;CSPG4;VLDLR
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.40211976625857837,0.9456850527940391,0.5197368421052632,1.0,1.0,2/15,6.70%,ADRA2C;ADRA1D
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3664130679748554,0.9455475857088503,0.5511363636363636,1.0,1.0,6/24,17.41%,NETO1;ACTN2;ATP1B3;KCNS2;NEDD4L;NEDD4
prerank,Elsevier_Pathway_Collection__Proteins Involved in Age-Related Macular Degeneration,-0.2209559416397149,-0.9454457443889869,0.6296296296296297,0.8145351963755678,1.0,46/138,22.36%,IL10;CXCL10;TNF;IL1B;MMP1;FASLG;TLR3;IL18;CASP1;TF;ICOS;CAT;CXCL12;NLRP3;CCL2;IL6;NGF;IL33;IL1RN;CCR2;CXCL8;CRYAA;TLR4;TLR2;SELE;IGF1;CFI;CXCR4;SERPING1;F3;HP;HSPA1A;HMOX1;SELL;C5;GSTP1;AOC3;GSTM1;CX3CR1;APOB;CD55;SELP;TFR2;RAP1A;ITGAM;APP
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,0.30202269649675295,0.9453844667295618,0.5353535353535354,1.0,1.0,15/76,15.40%,GPR119;GCG;INHA;KIF5A;CRHR2;MMP12;PCSK1;LEP;CDX2;LHB;ACE;UCN;CMA1;INHBB;DPP4
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.39365093608474044,0.94533571080888,0.536144578313253,1.0,1.0,2/16,3.20%,S100A1;TERT
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3951045887779071,0.945329572612875,0.546448087431694,1.0,1.0,10/18,34.74%,PARPBP;POLQ;UBQLN4;RADX;FANCB;MAD2L2;SHLD3;TP53BP1;RMI2;SHLD1
prerank,WikiPathway_2021_Human__Rett syndrome causing genes WP4312,0.3177361839678189,0.9451511267808288,0.5217391304347826,1.0,1.0,20/47,27.10%,GABRD;SRRM3;SCN1A;ACTL6B;GRIN2A;SCN2A;HDAC5;STXBP1;KDM5B;RHOBTB2;SMARCA4;HDAC1;IMPDH2;SATB2;SHANK3;SCN8A;CECR2;MECP2;NCOR2;SYNE2
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.27047334147170665,0.9451476566432754,0.6026200873362445,1.0,1.0,67/224,31.28%,MT3;PIK3R2;EEF1A2;PRKAA2;MAPT;ATP6V0D2;PRKN;HSPB1;LAMTOR2;PRKD1;LEP;RASIP1;DAPK2;MTMR8;GBA;KIF25;FOXK1;CTSA;UCHL1;SOGA1;ATP6V0A1;ABL2;MID2;LEPR;SREBF2;HTR2B;BMF;MTMR3;NEDD4;ATP6V0B;LAMTOR4;PLEKHF1;CDK5R1;SNX32;HAX1;WDR24;ATP6V0D1;GPR137B;DRAM1;SMCR8;PRKAB2;ATP6V0E1;WASHC1;ATP6V1C1;CDK5;ATP13A2;TRIM38;PIP4K2B;DAP;SH3BP4;ATF6;ATP6V1H;DDIT3;RB1CC1;GFAP;RHEB;GAPDH;ULK1;TRIM27;TRIM65;NUPR1;EXOC4;TRIM8;KEAP1;DAPK3;TREM2;ATP6V1E1
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.30909040980587005,0.94511872997645,0.5159574468085106,1.0,1.0,12/50,15.01%,GNG4;KCNJ6;GABRR3;GABRQ;KCNJ9;KCNJ5;GNAL;GNG3;GNB5;ADCY6;GNG8;KCNJ4
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.27098249010551073,-0.944880281319913,0.6,0.8156357212341636,1.0,9/44,15.35%,IL1B;PTPN22;DUSP10;PAQR3;CD300A;BMP7;RGS2;SORL1;SPRY2
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.33214611706112956,-0.944708429114843,0.5205479452054794,0.8156304976361214,1.0,6/18,17.95%,PTGS2;PLA2G4A;PTGES;TBXAS1;HPGDS;PTGIS
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.356391374429998,0.9446684050666496,0.5149700598802395,1.0,1.0,10/22,36.23%,VPS28;MVB12B;VPS37D;NEDD4;PTPN23;VPS4A;SNF8;UBAP1L;RNF126;MVB12A
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.32325549554105215,0.9445951264402945,0.5347593582887701,1.0,1.0,27/43,50.08%,CPSF1;NUP37;NUP62;NXF1;TPR;NUP133;CPSF4;NUP155;NUP160;NUP188;NUP205;NUP210;SYMPK;CPSF3;NUP214;ALYREF;NUP107;SLBP;FIP1L1;AAAS;NUP93;NCBP2;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.3707040886877187,0.9444539142134905,0.5604395604395604,1.0,1.0,3/22,6.00%,RBM24;MESP1;MYF6
prerank,Elsevier_Pathway_Collection__Vascular Reactivity in Raynaud Disease,0.3468136346819782,0.944450507091092,0.5595238095238095,1.0,1.0,3/30,6.66%,ADRA2C;ARG2;SRC
prerank,MSigDB_Oncogenic_Signatures__KRAS.300 UP.V1 DN,0.2886839669542474,0.9444010665109768,0.6009615384615384,1.0,1.0,14/112,7.65%,HTR1D;CACNA1I;AMBN;CDH16;HOXB8;IGF2-AS;TNNI3;CA5B;MAGIX;MXD3;SLC6A3;OLFML2A;EDIL3;AKR1B10
prerank,KEGG_2021_Human__Insulin signaling pathway,-0.22202736144738308,-0.9440997794289182,0.6470588235294118,0.8169440413028926,1.0,14/127,9.63%,GCK;SHC4;PRKAR2B;PPP1R3B;SOCS2;PCK1;HK3;GYS2;FBP1;MAP2K1;PPARGC1A;PIK3CD;FOXO1;ACACB
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,0.3947868652590347,0.9435834379210435,0.5414012738853503,1.0,1.0,4/17,9.15%,OR1N2;OR51E1;OR2B6;EBF1
prerank,Elsevier_Pathway_Collection__Dilated Cardiomyopathy,0.3125489302570517,0.9435322841300493,0.5360824742268041,1.0,1.0,15/63,25.03%,TNNC1;ACTN2;TNNI3;TIMP1;CACNA1C;LMNA;PDPK1;ANKRD1;SMAD3;LAMA4;TRAF2;MMP9;PLCG1;MYBPC3;EMD
prerank,WikiPathway_2021_Human__Interleukin-11 Signaling Pathway WP2332,0.3351020184433809,0.9432472419614372,0.5614973262032086,1.0,1.0,9/43,18.70%,PIK3R2;ITGA2;BIRC5;SRC;IL11;BGLAP;PDPK1;HRAS;PIAS3
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.3237942552116623,0.9431588055769379,0.5337078651685393,1.0,1.0,26/61,39.37%,CYP7A1;NQO1;PSMD4;OAZ3;PSMB4;ODC1;PSMD1;PSMB3;NCOR2;PSMD14;FGFR4;PSMB5;AZIN1;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.24389454195758808,-0.9430137111488242,0.5454545454545454,0.8196231999039933,1.0,13/80,12.06%,TNF;FASLG;NLRP12;COL4A3;S100A8;XDH;TNFSF10;CASP1;TNFSF15;NGFR;NKX3-1;NGF;LCK
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.2735785746034512,0.9429116536140482,0.6096491228070176,1.0,1.0,23/154,14.87%,IGF2;ADRA2C;REN;PIK3R2;PAK3;PAGE4;ALOX12B;PRDM15;SOX2;ROR1;JCAD;ADRA1D;FGF2;FAM83D;IL11;GDF15;LEP;PDGFB;FLT1;PDGFA;SHC1;ABCA7;IAPP
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3259192512648466,0.942818256601542,0.5254237288135594,1.0,1.0,26/37,48.98%,RFC4;POLD1;PARP1;CHD1L;CUL4B;UBA52;PCNA;DDB2;DDB1;ERCC2;RPA2;POLK;RFC3;POLD3;RBX1;UBC;ERCC3;POLD4;XPA;ERCC1;RPS27A;RPA1;RFC1;GTF2H2;NTHL1;GTF2H5
prerank,WikiPathway_2021_Human__Unfolded protein response WP4925,-0.3164712332529205,-0.9424267316523512,0.6049382716049383,0.8207670669994181,1.0,7/24,20.96%,IL1B;BCL2L11;PPP1R15A;BCL2;PMAIP1;EIF2AK3;XBP1
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,-0.33475192915373536,-0.9423973078252027,0.5733333333333334,0.8203433393340013,1.0,5/23,14.80%,EREG;TGFA;BTC;PIK3R1;HBEGF
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.3262923600813271,-0.9423688848456844,0.547945205479452,0.8199095915728074,1.0,6/19,15.16%,HHLA2;IL18;IL12B;TMIGD2;IGF1;IL12RB1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.33681653915175547,-0.942308135000074,0.5714285714285714,0.8195642638088004,1.0,7/16,23.73%,BST1;RHOH;RAC2;NCKAP1L;HMOX1;ADTRP;CD81
prerank,Elsevier_Pathway_Collection__Hodgkin and Reed-Sternberg Cells Reprogramming,-0.3012011617956815,-0.942292690100473,0.6043956043956044,0.8191034449968867,1.0,6/21,15.35%,POU2AF1;ID2;GATA3;IL21R;POU2F2;SPI1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.29903840216602323,0.9419919637461004,0.581151832460733,1.0,1.0,15/71,22.39%,ODAM;PAK3;RHOBTB1;PDGFRB;ARHGAP44;IQGAP3;PDGFA;GRHL3;ROCK2;RHOC;TWF2;ARHGEF19;BST2;RHOBTB2;TAOK2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.2779524974976982,-0.9418869668812683,0.5645161290322581,0.8197666088759569,1.0,14/37,28.71%,SMPD3;IFNG;CADPS;UNC13D;CFTR;RAB27B;RAB27A;SNCA;VPS4B;RAB2B;FGG;CADPS2;FGB;RAB7A
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.2656567202706409,-0.9418711816098204,0.6875,0.8192992232934281,1.0,23/67,24.99%,TNF;CCL5;APOBEC3C;OASL;APOBEC3A;RSAD2;MBL2;HEXIM1;TRIM5;IFI16;OAS3;OAS2;IFIT1;APOBEC3G;STAT1;IFIH1;TRIM31;PROX1;OAS1;TRIM21;TRIM14;PLSCR1;TRIM6
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.3664320748300012,0.9417357579949835,0.5705882352941176,1.0,1.0,5/24,17.41%,CTNNA2;CHRNB2;IL1RAPL1;MDGA1;NEDD4
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.3041369452145284,0.9417002382658358,0.5319148936170213,1.0,1.0,31/72,37.49%,ATP6V0D2;CASTOR2;LAMTOR2;PRKD1;ATP6V0B;CASTOR1;LAMTOR4;TCIRG1;WDR24;ATP6V0D1;ATP6V0E1;ATP6V1C1;LARP1;DAP;LARS1;ATP6V1H;CDKN1A;RHEB;KPTN;ATP6V1F;ATP6V1E1;MLST8;GCN1;ATP6V1E2;LAMTOR5;RRAGD;NPRL3;RPTOR;NPRL2;RRAGA;MAPK3
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,-0.3064214682902683,-0.9416409658917803,0.5466666666666666,0.819470560064305,1.0,8/27,11.69%,SCN2B;L1CAM;SCN7A;SCN9A;SCN11A;ANK3;SCN3B;SPTBN2
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.3744046980164115,0.9415251637963664,0.536144578313253,1.0,1.0,6/21,13.43%,ACTN2;GPRIN1;CAMK2A;GRIN2A;MPP3;PPM1F
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,0.31998158090845663,0.94141642597414,0.49171270718232046,1.0,1.0,18/44,41.62%,VARS1;EPRS1;PARS2;HARS2;QARS1;DARS2;FARSB;LARS1;IARS2;HARS1;GARS1;VARS2;CARS2;AARS2;TARS2;MARS1;IARS1;FARSA
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,0.3588436832831031,0.9412122645023675,0.5287356321839081,1.0,1.0,19/25,52.33%,RFC4;POLD1;POLR1A;UBA52;PCNA;XRCC1;SLC19A1;POLK;RFC3;POLD3;UBC;POLD4;RPS27A;POLE2;POLE4;RFC5;RFC2;POLE;LRIG1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.33710189265094154,0.9407337706426631,0.5178571428571429,1.0,1.0,3/35,3.14%,SCG2;NRCAM;THY1
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,0.3734037835507392,0.9406717418114854,0.5766871165644172,1.0,1.0,7/21,29.98%,PRKN;SQSTM1;MTERF3;TOMM20;TOMM5;UBA52;TOMM40
prerank,Elsevier_Pathway_Collection__Hedgehog Family Signaling,0.35924508767591457,0.9406711608728617,0.5444444444444444,1.0,1.0,7/25,18.52%,IHH;CDON;KIF7;POU5F1;PDPK1;DHH;BOC
prerank,Elsevier_Pathway_Collection__CDH2 Activation Promotes Cancer Cell Migration and Survival,0.31679040718968315,0.9400930827213795,0.5478723404255319,1.0,1.0,15/49,26.12%,SNAI2;SRC;FGF2;PDGFRB;FOXC1;PDGFA;SHC1;PDPK1;FOXC2;PLCG1;MAP2K2;SNAI1;TCF3;PTK2;CTNNB1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.2880495803187724,-0.9400433093921111,0.5176470588235295,0.8236818638439434,1.0,6/30,17.49%,TNF;FASLG;NGF;SPI1;BCL2;TNFRSF10C
prerank,Elsevier_Pathway_Collection__BDNF Upregulation Triggered by Seizures,-0.29951180432058955,-0.939754973876016,0.6219512195121951,0.8239518034067607,1.0,4/22,7.46%,GABRA4;EGR3;NTRK2;MAP2K1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.3099888527884903,-0.9397525574263519,0.5232558139534884,0.823440976123735,1.0,13/22,32.61%,ABCD2;PEX3;ACBD5;PXMP2;GDAP1;RAB8B;PEX13;PEX14;ABCD3;ATAD1;SLC25A17;ALDH3A2;PEX12
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,0.3030525390732241,0.9395940360396746,0.5757575757575758,1.0,1.0,7/75,10.52%,CTNNA2;PIK3R2;SEPTIN3;SHC3;SRC;CLTCL1;DNM3
prerank,WikiPathway_2021_Human__Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.31957841248262,0.939400410199622,0.5392156862745098,1.0,1.0,16/50,24.73%,PIK3R2;GRIN1;PRKAA2;BDNF;GRIN2A;GRIN3B;CACNA1C;DLG4;GRM1;HRAS;GRIN2C;TSC1;GRIN3A;TSC2;SHANK3;PRKAB2
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.33749045693114577,0.9392005617993114,0.5287356321839081,1.0,1.0,4/33,3.34%,KCNE5;S100A1;FOXN4;KCNG2
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.31893304714146886,-0.9391967030821985,0.5060240963855421,0.8245571246949754,1.0,6/21,17.93%,EREG;ERBB4;NRG4;BTC;HBEGF;NRG3
prerank,TRRUST_Transcription_Factors_2019__CEBPA mouse,0.36931877402628954,0.9389254418363077,0.4887640449438202,1.0,1.0,5/21,12.32%,ALDH3A1;SLC2A4;MSTN;ABCA3;APOD
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.3575943697494847,0.938655328699351,0.51875,1.0,1.0,9/28,26.73%,TAC4;AGO2;ZP3;INHBB;TACR1;CACNA1H;ANKRD31;CCDC87;HYAL3
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.37777537593661503,0.9382724859427047,0.5370370370370371,1.0,1.0,8/18,23.37%,SCN1A;CACNA1G;SCN4B;CACNA1C;FGF12;CACNA1D;SCN5A;GSN
prerank,Elsevier_Pathway_Collection__Li-Fraumeni Syndrome,0.3925080410539458,0.9381958981591882,0.5604395604395604,1.0,1.0,8/19,34.58%,CCNE1;CDC25A;BBC3;CHEK2;CDKN1A;CASP9;CDK4;BAX
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.2992432960335376,0.9380997844850072,0.5577889447236181,1.0,1.0,11/80,9.80%,CDH8;CLDN19;CDH13;SDK1;ITGA6;CLDN15;PARVB;CDH24;NECTIN1;CLDN6;CDH17
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4005802136604701,0.9378811293944628,0.5621301775147929,1.0,1.0,10/16,45.92%,PRKDC;KMT5C;MAD2L2;SHLD3;PNKP;SHLD1;SHLD2;WRAP53;SETMAR;RIF1
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.33534581542262226,0.9376776048354704,0.5561797752808989,1.0,1.0,25/35,52.83%,NUP37;NUP62;TPR;NUP133;RANGAP1;NUP155;NUP160;NUP188;NUP205;XPO1;NUP210;RAN;NUP214;NUP107;RCC1;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85
prerank,Elsevier_Pathway_Collection__Norepinephrine Neuronal Release,0.31991439809841743,0.9376247126916316,0.5082872928176796,1.0,1.0,9/43,20.62%,CACNB4;CACNA2D2;SYN1;SNAP25;CPLX1;UNC13B;SNAPIN;STXBP1;STX1A
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.2863241605730359,-0.9375860470995203,0.5352112676056338,0.8286184377490937,1.0,10/34,24.99%,AIM2;PTPN22;IL12B;LILRB1;IL12RB1;APOBEC3G;STAT1;TRIM44;DDX58;TRIM6
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.27732181516609555,0.9375072738712217,0.5401785714285714,1.0,1.0,30/117,26.12%,DIO2;SLCO1C1;PIK3R2;WNT4;BMP4;SRC;ATP1A2;ATP1A4;ATP1B3;NOTCH3;ATP2A1;DIO3;KAT2A;PDPK1;FXYD2;PRKCA;HRAS;PLCD3;THRA;PLCD4;NOTCH4;PFKFB2;PLCG1;HDAC1;TSC2;MED12;PFKP;MAP2K2;MYC;CTNNB1
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,0.3362684185300426,0.9373169320248462,0.5111111111111111,1.0,1.0,20/35,46.02%,RHOBTB1;DBN1;ROCK2;RHOBTB2;HSP90AB1;CDC37;RNF20;RBMX;DDX39B;CCT6A;VIM;CCT2;HSP90AA1;CCT7;GPS1;MSI2;CPSF7;RBM15;COPS4;ACTN1
prerank,KEGG_2021_Human__Renin secretion,0.3167537415024854,0.937222111372029,0.5508021390374331,1.0,1.0,8/59,14.74%,REN;CACNA1S;CALML6;PDE1C;ADORA1;CACNA1C;ACE;ADCY6
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.2957576262292446,0.9371807173150429,0.5860215053763441,1.0,1.0,52/76,52.72%,RFC4;POLD1;POLR2L;UVSSA;POLR1A;POLR2K;POLR2G;COPS5;CUL4B;UBA52;PCNA;XRCC1;POLR2H;COPS6;POLR2I;POLR2J;XAB2;DDB1;POLR2A;ERCC2;COPS8;USP7;SLC19A1;GPS1;ELL;POLR2B;POLK;RFC3;POLD3;RBX1;UBC;POLR2F;ERCC3;POLD4;COPS7A;COPS4;XPA;ERCC1;RPS27A;PRPF19;GTF2H2;POLE2;GTF2H5;POLE4;COPS3;RFC5;EP300;RFC2;POLE;LRIG1;MNAT1;CDK7
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.3434969785892392,0.9370140264093918,0.5625,1.0,1.0,11/30,28.36%,H1-5;H1-2;H1-4;RTEL1;ANKRD1;MSH2;ACVRL1;H1-0;BLM;CDKN1A;MSH6
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.29686088631722385,0.9369219846718739,0.5888324873096447,1.0,1.0,8/89,6.06%,PYDC1;SFN;CAMK2N2;THY1;PTPRT;TRIB2;ACP4;DBNDD1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.3370367564099944,0.9368943576745494,0.5714285714285714,1.0,1.0,4/36,8.23%,RFX6;GCG;ACSL4;TRH
prerank,MSigDB_Oncogenic_Signatures__PTEN DN.V2 DN,0.2891267285584652,0.9365932992407843,0.5707317073170731,1.0,1.0,29/118,19.48%,SPDEF;TERT;RIBC2;PLAG1;TBX3;BMP4;SPHK1;MXD3;FOXH1;SSTR5;DHRS2;RECQL4;FRMD1;GPR3;LINC00339;ABLIM2;LOXL1;TUBBP5;APOLD1;NVL;STMN1;BAHCC1;GUSBP11;CBX7;MEGF8;ARHGAP33;BARD1;TRAF2;ZNF446
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,0.32739930064754286,0.9363673103548877,0.5759162303664922,1.0,1.0,6/48,17.59%,SH3GL3;SRC;SHC1;HRAS;EGF;PAG1
prerank,Elsevier_Pathway_Collection__Aldosterone Renal Effects,0.3920312885136206,0.9361970181014623,0.5802469135802469,1.0,1.0,2/17,4.68%,WNK4;SLC12A1
prerank,Elsevier_Pathway_Collection__Aldosterone Signaling in Arterial Hypertension,0.3920312885136206,0.9361970181014623,0.5802469135802469,1.0,1.0,2/17,4.68%,WNK4;SLC12A1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),0.3347795143410002,0.9358584691509801,0.5497076023391813,1.0,1.0,27/38,53.38%,VARS1;EPRS1;HARS2;QARS1;DARS2;FARSB;LARS1;IARS2;EEF1E1;AIMP1;HARS1;GARS1;MARS1;IARS1;FARSA;PPA1;FARS2;RARS1;PPA2;AIMP2;SARS1;WARS2;YARS2;QRSL1;AARS1;SARS2;KARS1
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,0.28789555919443804,0.9355954548526639,0.5694444444444444,1.0,1.0,21/108,17.97%,H3C13;H2AC19;H2BC13;GREB1;H2AC20;H2BC17;AGO2;H2BC21;H2BC9;H2BC15;H2BC11;H2BC12;TFF3;H2BC4;H4C15;H2AC6;H2BC5;DAND5;H2AX;POLR2L;USF1
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.26965450856292067,0.9354810111490116,0.6118721461187214,1.0,1.0,55/171,31.89%,CDKN2A;TOP2A;NR5A1;HDAC4;BIRC5;TFAP2C;AURKB;IKBKG;CDCA8;DNMT3A;AURKA;H4C15;NFKB2;NSMCE2;PPARG;PCGF2;THRA;PIAS3;CETN2;NUP37;POLR1A;PARP1;HDAC1;PIAS1;CBX8;TRIM28;NUP62;DNMT1;BLM;TPR;SATB2;NPM1;NUP133;CBX5;NOP58;DNMT3B;RANGAP1;NCOR2;INCENP;CHD3;MDC1;NSMCE1;NUP155;TRIM27;PCNA;NUP160;PARK7;SENP1;HIPK2;PIAS4;SMC3;UBE2I;CBX2;IKBKE;TP53BP1
prerank,WikiPathway_2021_Human__Transcription factor regulation in adipogenesis WP3599,-0.31311392076610967,-0.9353459976478642,0.524390243902439,0.834585439703949,1.0,7/21,19.01%,TNF;PPARGC1A;FOXO1;IL6;TWIST1;PCK2;IRS2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.27264044803563947,0.9352765495240634,0.5674418604651162,1.0,1.0,16/134,10.10%,ISL2;POU3F2;RASGRF1;MAPT;POU4F1;STMND1;STMN3;VSX1;STMN2;GPRIN1;TENM2;PRDM12;ACTL6B;UNC5A;MANF;DCX
prerank,WikiPathway_2021_Human__BMP Signaling Pathway in Eyelid Development WP3927,-0.3170066928420301,-0.9346993936657453,0.5662650602409639,0.8360172241523192,1.0,4/19,8.69%,FGF10;SFRP1;FGFR2;TGFA
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.32395522100793905,-0.9346592554929938,0.5051546391752577,0.8355842093270786,1.0,3/17,8.30%,IL1B;NR4A3;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.3877302650742819,0.9346156175398852,0.5389221556886228,1.0,1.0,4/15,8.27%,SYT3;RNF157;UNC13A;SYT2
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.31956726900773896,0.9343254942227256,0.582010582010582,1.0,1.0,26/42,50.08%,CPSF1;NUP37;NUP62;NXF1;TPR;NUP133;CPSF4;NUP155;NUP160;NUP188;NUP205;NUP210;SYMPK;CPSF3;NUP214;ALYREF;NUP107;FIP1L1;AAAS;NUP93;NCBP2;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,WikiPathway_2021_Human__ERK Pathway in Huntington's Disease WP3853,0.3965363943124285,0.9342422190947209,0.5290322580645161,1.0,1.0,4/15,17.35%,BDNF;GRM1;HRAS;EGF
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.31904108043188156,0.9341909382480645,0.5531914893617021,1.0,1.0,4/49,5.42%,SOX1;DNER;NRCAM;FGF13
prerank,TRRUST_Transcription_Factors_2019__MTA1 human,-0.31703351061903484,-0.9340482848497482,0.6,0.8368357738534958,1.0,3/24,6.58%,TFF1;CDH1;ESR1
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,0.27641554535341,0.93400107976579,0.6038647342995169,1.0,1.0,77/131,50.35%,VPS28;MVB12B;ELOC;NEDD4L;VPS37D;POLR2L;NUP37;ELOB;NUP62;POLR2K;NELFE;TPR;TAF10;NUP133;RANGAP1;POLR2G;UBA52;NUP155;VPS4A;TAF6;NUP160;PPIA;POLR2H;CHMP2A;SGIP1;NELFA;NUP188;NMT2;POLR2I;POLR2J;CTDP1;SSRP1;MVB12A;NUP205;SUPT5H;NELFB;TAF9;XPO1;RNMT;POLR2A;NUP210;TAF1;ERCC2;RAN;ELL;POLR2B;NUP214;GTF2F1;NUP107;TAF12;UBC;POLR2F;CDK9;ERCC3;TAF5;SUPT16H;RCC1;CCNT2;AAAS;TAF9B;TAF2;GTF2E1;RPS27A;CHMP4C;NUP93;GTF2H2;TSG101;NCBP2;GTF2H5;NUP88;SEC13;TAF7;SEH1L;GTF2A2;POM121C;NUP42;TAF4
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.3299362114885297,0.9339443073206664,0.5568181818181818,1.0,1.0,6/33,18.71%,SFN;CAMK2A;BIK;ATP2A1;THEM4;BBC3
prerank,KEGG_2021_Human__Ovarian steroidogenesis,0.3268256456699441,0.9338587601679645,0.5828571428571429,1.0,1.0,9/44,15.42%,CYP17A1;CGA;AKR1C3;HSD17B7;PLA2G4C;LHB;PLA2G4F;ADCY6;HSD17B1
prerank,WikiPathway_2021_Human__Mitochondrial CIV Assembly WP4922,0.3438403954252127,0.9337724698018214,0.6071428571428571,1.0,1.0,22/32,50.39%,COA6;COX6C;COX20;COX7B;COX6B1;COX8A;COX4I1;COX5B;COA3;COX19;COX7C;PNKD;COX6A1;COX17;NDUFA4;TACO1;COX7A2;PET100;COX5A;COX16;COX14;CMC1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.29348692754311295,0.9334595279840724,0.5670103092783505,1.0,1.0,22/84,27.38%,EPHB2;RASGRF1;RASGEF1A;EPS8L3;FOXM1;KIF14;ARHGAP44;EPO;SHC1;SQSTM1;ARHGEF2;ARHGEF28;SPRY3;STARD13;TGFB2;DENND4B;NUP62;LZTR1;DENND4C;BCR;ARFGAP1;SGSM3
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.3182414382861051,0.9333386401837043,0.5568181818181818,1.0,1.0,12/41,18.18%,MAPT;ROBO1;BDNF;PLXNC1;SEMA7A;PLXNA2;METRN;DBN1;PLXND1;MAP6;TWF2;PLXNA3
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3108026527712984,-0.9332252916392969,0.5617977528089888,0.83867465640035,1.0,6/22,15.53%,IFNG;TNF;SLC2A13;CHRNA7;LRRTM3;CLU
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.29792319626564495,0.9331647938292346,0.5960591133004927,1.0,1.0,13/65,16.76%,TBX3;SPHK1;ZBED6;CCNB1;RGCC;PDGFB;SMOC2;PSRC1;PRKCA;USP22;CHEK1;PKD1;TTL
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.3533852595214564,0.9330505656688532,0.5185185185185185,1.0,1.0,3/28,8.09%,CTNNA2;MDK;CAMK2A
prerank,TRRUST_Transcription_Factors_2019__FOS human,-0.26624306219727434,-0.9327178591890535,0.5909090909090909,0.8395988931602514,1.0,19/53,18.71%,CCK;PTGS2;SPRR3;MMP1;NTF3;FOS;CYP1A2;NGF;CD40LG;MMP7;CXCL8;PGR;CREM;SPI1;CLU;PLAUR;EZR;FMO4;PCK2
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.2308107156261879,-0.9326605921996528,0.6666666666666666,0.8392308527697008,1.0,18/98,15.42%,CASR;NR4A2;TNFSF11;SLC34A2;FOS;PTH1R;PLD1;MAP2K1;PRKCB;EGR1;KL;GATA3;ADCY5;PLCB2;HBEGF;RUNX2;MAFB;CREB5
prerank,Elsevier_Pathway_Collection__BDKRB1/2 -> Prostaglandin Generation,0.35535734687706677,0.9322745524540103,0.5595238095238095,1.0,1.0,4/26,13.85%,RASGRF1;PTGDS;BDKRB2;BDKRB1
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.20221943746047255,-0.9321803654998116,0.8888888888888888,0.8400805603199986,1.0,111/461,24.54%,ZNF468;IFNG;TNF;IL1B;CFP;CCL5;ZNF727;ZNF311;FASLG;TLR3;ZFP1;ZNF737;ZNF860;ZNF816;ZNF888;NXF3;ZNF334;ZNF676;ZNF736;ZNF714;ZNF430;PIK3CD;CCL2;IL6;ZNF83;ZNF14;ZNF670;ZNF347;ZNF611;IL12B;HLA-DQA2;ZNF160;ZNF141;ZNF793;ZNF415;ZNF680;TLR2;HLA-DOB;PIK3R1;AKT1;ZNF90;ZNF726;ZNF649;SYK;ZFP82;ZNF708;POU2F2;ZNF662;MYD88;ZNF93;ZNF257;LTA;ZNF431;ZNF426;ZNF85;ZNF454;ZNF717;ITGB3;ZNF331;ZNF682;ZNF471;ZNF154;BCL2;ZNF254;HLA-DQA1;ZNF100;ZNF610;ZNF658;ZNF559;ZNF43;EIF2AK3;ZNF564;ZNF350;ZNF429;ZNF600;C5;OAS3;ZNF665;OAS2;HLA-DOA;ZNF578;ZNF418;TAB2;HLA-DRB5;HLA-DRA;JAK2;ZNF486;ZNF879;ZNF124;STAT1;ZNF510;ZNF253;IFIH1;ZNF701;AKT3;SRSF8;ZNF506;ZNF519;ZNF354C;PILRA;HLA-DPA1;ZNF19;C3;DDX58;OAS1;HLA-DPB1;ZNF684;IRF9;ZNF439;ZNF808;HLA-DRB1
prerank,Reactome_2022__ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.3356979655832258,-0.9320583898585236,0.4864864864864865,0.8399386058895202,1.0,6/18,13.28%,ABCD2;APOA1;PEX3;ABCG8;ABCG5;ABCG4
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.23615720080944136,-0.9319752513420125,0.56,0.8396335650878393,1.0,44/107,29.27%,GSTA2;GGT6;CHAC1;GSTZ1;GSTA1;B3GNT7;GSTT2B;DCN;CBS;GSTM5;DSE;MAT1A;B3GNT3;BGN;B3GNT4;HPGDS;PRELP;B3GNT2;ESD;GSTO2;GGT2;CDO1;CTH;ST3GAL6;GSTP1;GSTM1;AKR1A1;CBSL;PAPSS2;GGT5;B4GALT1;SLC26A1;TPK1;FMOD;MGST1;CHST11;MAT2B;SLC35B3;CHST7;CNDP2;CHST2;CHSY3;B4GALT5;CHST9
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.33444565182657204,-0.9319679109103081,0.47560975609756095,0.8391344972308175,1.0,2/16,1.38%,SLC5A7;RIMBP2
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.3429598530060019,0.9319266929144046,0.562874251497006,1.0,1.0,6/27,15.11%,CFAP46;DCX;DNAAF1;SPEF1;FOXJ1;DRC1
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.3295322805499533,0.931908450746215,0.5674157303370787,1.0,1.0,24/38,50.08%,HMGA1;NUP37;NUP62;TPR;NUP133;SLC25A6;NUP155;NUP160;SGIP1;NUP188;BANF1;NUP205;NUP210;NUP214;NUP107;PSIP1;SLC25A5;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,WikiPathway_2021_Human__Ciliopathies WP4803,0.2691824925008585,0.9319013132748843,0.6244541484716157,1.0,1.0,43/171,29.92%,ZIC2;CCNO;CCDC114;CENPF;NEK2;TCTEX1D2;TUB;KIF7;DNAAF1;ANKS6;DNAH11;BBS5;ZMYND10;IFT81;ADCY6;DRC1;BBS2;GLIS2;ZNF423;PKD1;CCNQ;CCDC28B;KIZ;FAM161A;B9D2;B9D1;CCDC40;OCRL;CFAP53;PLK4;ANKS3;IFT27;GPR161;POC1A;ARL2BP;CRX;DDX59;BBS4;GAS8;NPHP4;CSPP1;SMO;DNAAF5
prerank,WikiPathway_2021_Human__NRF2 pathway WP2884,0.27740577895435947,0.9317988974362318,0.6093023255813953,1.0,1.0,26/135,15.79%,SLC7A11;SLC6A4;SLC6A7;ALDH3A1;SLC2A5;SLC6A11;NQO1;SLC39A4;SLC2A4;FGF13;CBR3;SLC6A9;SLC5A4;SLC6A3;SLC5A2;SLC5A6;SLC6A8;PDGFB;SLC39A3;GSTM2;MAFG;SQSTM1;ABCC5;GPX3;SLC5A11;SLC6A2
prerank,TRRUST_Transcription_Factors_2019__SMAD4 human,0.3455724656771497,0.9316376259371694,0.5238095238095238,1.0,1.0,9/26,28.26%,COL7A1;CDKN2B;EPO;BGLAP;GLI1;FSTL3;MYC;BAMBI;CDKN1A
prerank,Elsevier_Pathway_Collection__Macrophage Survival through CCR5 and CXCR4 Mediated Signaling,-0.33531464433294705,-0.9312061027535032,0.5408163265306123,0.8408252171903013,1.0,4/17,14.96%,CD4;CCR5;AKT1;CXCR4
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2169768204328181,-0.9311893732313868,0.7045454545454546,0.8403364313194333,1.0,20/113,16.76%,ST18;EDAR;TNFSF11;TNFRSF17;TNF;AIM2;TNFRSF11B;CD27;TNFSF15;TNFRSF13B;CD40LG;TNFRSF11A;TNFRSF9;TNFSF13;TNFRSF13C;BAG4;LTA;TNFRSF1B;TNFSF8;TNFSF13B
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,0.30594208748833374,0.9311571151453071,0.592391304347826,1.0,1.0,14/57,19.75%,ARHGEF39;FGD1;ARHGEF37;ARHGEF10;RNASE1;RASGRF2;ARHGEF11;OBSCN;PLEKHG2;ARHGEF2;ARHGEF15;ECT2;MAGED1;ARHGEF19
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.2831842073292336,0.9311395320630356,0.5645933014354066,1.0,1.0,56/132,39.37%,NOTUM;SCUBE2;IHH;PSMD4;CDON;KIF7;HHIP;PSMB4;ADCY6;TULP3;PRKCA;DHH;BOC;ADCY4;ADCY10;ADCY2;IQCE;HHAT;GLI1;DISP2;GPR161;PSMB3;PSMD14;UBA52;SMOX;SMURF1;GAS8;PSMB5;PSMD2;PSMA1;ULK3;PSMD10;ARRB1;PSMC4;PSMC3;CUL1;PRKAR2A;ADCY8;SMURF2;SKP1;ADCY9;PSMC5;SEM1;PSMB6;RPGRIP1L;PSMD8;PSME2;VCP;GSK3B;SUFU;PSMD13;PSMB7;PSMA7;IFT140;SHH;PSME3
prerank,Elsevier_Pathway_Collection__ESR1/ERBB Positive Luminal Breast Cancer,0.28941486108703257,0.9311081636890498,0.5887850467289719,1.0,1.0,13/92,18.12%,IGF2;VEGFD;LEF1;E2F1;TCF7;SRC;FLT1;SHC1;PDPK1;PRKCA;EGF;MSH2;BARD1
prerank,Reactome_2022__Plasma Lipoprotein Assembly R-HSA-8963898,-0.34704278568062696,-0.9310593369808953,0.5247524752475248,0.8402051526548091,1.0,2/15,6.74%,APOA4;APOA1
prerank,MSigDB_Oncogenic_Signatures__CYCLIN D1 UP.V1 DN,0.2705497816238249,0.9309001565470199,0.6118721461187214,1.0,1.0,22/166,14.86%,KIF1A;SLC6A4;SPINK1;GUCY2C;GNAZ;PLA2G2A;MAPK8IP2;GAL;POU3F1;TRH;HPCA;EZH2;NR6A1;RRS1;TNNT3;TUBA4A;PAFAH1B3;RGS16;TPM2;LMAN2;CBLN1;CCL11
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.3287048444581968,0.9308233290667381,0.5722543352601156,1.0,1.0,9/36,17.41%,KCNE5;FXYD7;TRPC6;SCN4B;TCAF2;FXYD2;NEDD4L;FGF12;NEDD4
prerank,Reactome_2022__Zinc Transporters R-HSA-435354,0.3934170801031651,0.9303863781646202,0.524390243902439,1.0,1.0,4/16,12.99%,SLC39A4;SLC30A3;SLC30A2;SLC39A3
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.3226799341810486,0.9303468803472147,0.5837837837837838,1.0,1.0,22/46,33.59%,USH1G;FSCN2;TMC1;ATP2B4;PCDH15;WHRN;MYO7A;TWF2;CIB2;TPRN;USH1C;GSN;EPB41L1;TMIE;OTOGL;PJVK;CHRNA10;CLIC5;CDH23;SPTAN1;CASK;MYH9
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,0.2785038851145623,0.9299503456692375,0.6073059360730594,1.0,1.0,2/130,0.53%,MUC7;MUC13
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,0.27662621179813796,0.9298353799135423,0.625615763546798,1.0,1.0,26/124,18.69%,GNG4;KCNJ6;GABRD;CACNA1S;GABRR3;GABRQ;MAPK12;KCNJ9;MAPK11;KCNJ5;NDUFA4L2;GNG3;GABRE;CACNA1C;NDUFA1;GNB5;ADCY6;GNG8;GRM1;PRKCA;NDUFS6;NDUFV1;NDUFB9;GNG10;NDUFA3;ADCY4
prerank,MSigDB_Oncogenic_Signatures__HOXA9 DN.V1 UP,-0.22239761805119024,-0.9296854524110498,0.6470588235294118,0.843620084281067,1.0,65/169,27.06%,FOS;CXCR2;SRD5A1;GPR18;S100A8;MS4A6A;BST1;IPCEF1;OAT;IFI30;SLC46A3;GPR183;ICAM3;GALC;PAQR3;TFEC;FYN;KLF4;CD84;CCR2;PTGER4;MNDA;ARL4C;FGL2;TRIM22;SORL1;FCER1G;RBM47;CD86;IL10RA;GADD45A;FCGRT;ERLIN2;NCF2;IFI16;SERPINB8;USP15;NOD2;ST3GAL6;SCPEP1;RCBTB2;MS4A4A;HLA-DRA;JAK2;HPSE;CD209;TYROBP;UHRF1BP1L;THBD;CSNK1G3;CRY1;AGTPBP1;LY96;TOB1;ZCCHC2;TPK1;CARD9;CYLD;LPAR6;ZNF277;CYP1B1;RNF11;DICER1;ANKRD46;CRISPLD2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.37187267273587643,0.9296273917477398,0.5481927710843374,1.0,1.0,10/20,35.95%,ARL2;BARD1;BCL3;ARL2BP;RANGAP1;BBS4;PARK7;SKP1;HNRNPU;TAF8
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.3046778400918471,-0.92931890903356,0.6282051282051282,0.8441860223425479,1.0,4/25,11.12%,PROM2;LGALS3;CD300A;LILRB1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.23313476359681276,-0.9291455307316548,0.5901639344262295,0.8441494544323715,1.0,10/67,12.39%,GRIN2B;MIP;GBP5;GNMT;TDO2;MS4A1;ACACB;KCNJ12;MAT1A;SHMT1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.3933716324237713,0.9290515235666905,0.5568862275449101,1.0,1.0,4/16,16.70%,COL4A1;RAMP2;CMA1;LAMB4
prerank,Elsevier_Pathway_Collection__Osteoclasts Function in Osteopetrosis,-0.3249903124672555,-0.9289609454438228,0.6172839506172839,0.8442131710596855,1.0,6/19,21.02%,TNFSF11;TNFRSF11A;CA2;ITGB3;VTN;FERMT3
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.38190359842473887,0.9288483231795575,0.5747126436781609,1.0,1.0,4/18,10.39%,TCF15;MESP1;TBX3;GDF11
prerank,Elsevier_Pathway_Collection__Disorders of Phenylalanine and Tyrosine Metabolism,-0.34531174164234957,-0.9284976201009265,0.5802469135802469,0.8449745985672632,1.0,7/15,19.52%,GSTZ1;DBH;TH;TAT;DDC;QDPR;TYRP1
prerank,WikiPathway_2021_Human__Notch Signaling Pathway Netpath WP61,0.3007554371466938,0.9284187510086882,0.5876288659793815,1.0,1.0,17/59,28.26%,PIK3R2;MAPT;HES5;SRC;NOTCH3;JAG2;HES6;NOTCH4;DLL4;HEY1;HDAC1;MYC;MAML1;TLE1;NCOR2;NCSTN;CDKN1A
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.336001403640737,0.9283413939685075,0.580110497237569,1.0,1.0,23/40,43.71%,MID2;TRIM11;POLR2L;IFITM3;POLR2K;NELFE;MDFIC;POLR2G;TRIM27;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;DHX9;SUPT5H;NELFB;POLR2A;POLR2B;TRIM62;GTF2F1;POLR2F;CDK9
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,0.3175116829473295,0.9282997930712087,0.572972972972973,1.0,1.0,36/63,47.30%,PSMD4;PSMB4;HRAS;RASA4;PSMB3;PSMD14;UBA52;PSMB5;RASAL1;PSMD2;PSMA1;PSMD10;RASAL2;DAB2IP;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;SPRED3;PSMB2;RBX1;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.29146370847537034,0.9281569508917697,0.5606060606060606,1.0,1.0,12/86,13.69%,B4GALNT1;CERS1;PLPP2;ARSF;SPTSSB;EGFL7;SPHK1;PRKD1;ESYT3;CERK;NEU3;CTSA
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.31699494287236,0.9279334652570633,0.5918367346938775,1.0,1.0,16/51,33.96%,PIK3R2;DIAPH3;RACGAP1;ARHGAP39;MCAM;DBN1;LBR;ARHGAP26;PLXNA1;EMD;LMNB1;TOR1AIP1;RHOD;ESYT1;ARHGAP1;DEPDC1B
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.2588519904125337,0.9276548048649063,0.6260504201680672,1.0,1.0,30/286,11.00%,MT3;SCG2;DUSP9;FGF20;RASGRF1;ACTN2;PLVAP;PIK3R2;GRIN1;MAPK12;RASGEF1A;SHC3;NRG2;IL31RA;MAPK11;FGF13;FGF17;FGF2;FGF23;CAMK2A;PSMD4;PDGFRB;MAP3K8;IL3RA;LAMTOR2;IKBKG;CDK1;FLT3LG;PEA15;RASGRF2
prerank,Elsevier_Pathway_Collection__Hematopoietic Cell Lineage: B-cell (mouse),-0.2695628919878472,-0.9275510879076929,0.6388888888888888,0.8470193349768378,1.0,10/42,12.15%,IGLL1;CD27;CD79A;IL7R;ID2;CD48;PTPRC;IKZF1;SPN;FLT3
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.3984456483087676,0.9273992616461806,0.5632911392405063,1.0,1.0,3/15,13.46%,PDK1;PRKN;FOXK1
prerank,Elsevier_Pathway_Collection__Chronic Myeloid Leukemia,0.3018017092866258,0.9272468896572215,0.5913461538461539,1.0,1.0,15/69,26.07%,E2F1;TP73;CDKN2A;BIRC5;SRC;CDK1;PDPK1;HRAS;SMAD3;TGFB2;RAD51;AIFM1;PRKDC;MAP2K2;MYC
prerank,Elsevier_Pathway_Collection__Proteins Involved in Primary Ovarian Insufficiency,0.31149827397778734,0.9272410657448051,0.6041666666666666,1.0,1.0,10/55,13.28%,INHA;SYCE1;WNT4;ACSL6;NR5A1;KISS1R;AMH;ZP3;LHB;POU5F1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.27313726749204253,-0.9272257866504313,0.6081081081081081,0.8474572343940178,1.0,15/45,21.28%,FABP2;CETP;MOGAT2;LIPH;DGAT2;MOGAT1;LIPG;APOA5;PLAAT3;APOBR;LIPC;SLC27A5;APOH;FABP3;APOB
prerank,MSigDB_Oncogenic_Signatures__EGFR UP.V1 UP,-0.20669691330501233,-0.9271523454122027,0.6551724137931034,0.847201541255996,1.0,80/180,28.20%,CEACAM6;PLAC1;RCAN1;TNFRSF11B;MMP1;PCDH9;SOCS2;INHBA;S100A8;SEL1L3;MEIS3P1;CCL2;KLF4;BMP7;ITGB6;GCNT1;FERMT2;CCL22;PGM3;NFIL3;DBNDD2;GBP1;COTL1;CLDN1;HBEGF;PLAGL1;ARAP2;CCDC68;CASP7;VAV3;DUSP6;IFIT3;MGLL;ENPP1;SLC12A2;PMAIP1;SNAPC1;TNFRSF21;GK3P;LIF;ITGA3;WNT5A;MIR22HG;SAMD4A;MBNL2;RAB27A;ABCC3;ETS2;MAP3K5;SGMS1;PAPSS2;MPZL2;SEC23A;MAP2K4;F2RL1;ALAS1;TMEM45A;KCNS3;HK2;SPAG1;TNFAIP8;ATF3;PSMB9;LPAR6;PDE4B;DUSP4;ARID5B;CYP1B1;ANGPTL4;CRISPLD2;IRF1;EDN1;ATXN1;FGG;SLC4A7;GLRX;CADPS2;PTPRE;FGB;GK
prerank,Elsevier_Pathway_Collection__Vascularization in Hepatocellular Carcinoma,0.38045258442155966,0.9268293839378681,0.5664739884393064,1.0,1.0,4/17,16.65%,E2F1;EPO;PDGFA;SMAD3
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.28278573176808897,0.9263423067720302,0.5865384615384616,1.0,1.0,53/120,43.56%,IGF2BP1;RBM24;PRR5L;IGF2BP2;PSMD4;HSPB1;EXOSC4;PKP1;PSMB4;MAPKAPK2;PRKCA;PCBP4;PSMD1;IGF2BP3;EXOSC5;PSMB3;PABPC1;PSMD14;UBA52;SAMD4B;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;FMR1;PSMC5;PSMB6;HSPA8;PSMD8;EXOSC2;PSME2;XPO1;PSMD13;PSMB7;PSMA7;VIM;EXOSC1;EXOSC7;PSME3;CARHSP1;EXOSC9;FXR2;NUP214;CNOT1;PSMB2;MOV10;APEX1;PSMA6;YTHDF2;UBC;PSMD9
prerank,MSigDB_Oncogenic_Signatures__SINGH KRAS DEPENDENCY SIGNATURE ,0.4051637410012987,0.9262192537041576,0.5276073619631901,1.0,1.0,4/16,13.72%,FAM83A;LAMA3;CLDN7;TMEM45B
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.3584987026447071,0.9259547793232109,0.543859649122807,1.0,1.0,8/19,34.22%,HES5;KAT2A;SMAD3;NOTCH4;HEY1;MAML1;MAMLD1;ACTA2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3279305093393081,0.9259104033153082,0.5892857142857143,1.0,1.0,10/36,15.92%,HTR1D;HTR4;CHRM4;HRH3;SSTR5;GALR3;CHRM5;MC1R;HTR1B;HTR2B
prerank,Elsevier_Pathway_Collection__HTR7 -> IL6 Production,-0.31735947704620443,-0.925871075610597,0.5641025641025641,0.8502197771812277,1.0,4/18,15.29%,MAP2K1;EGR1;IL6;HTR7
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.29833829618552066,-0.9258638498996691,0.5428571428571428,0.8497250795097386,1.0,7/35,10.36%,SEMA3E;PLXNA4;SEMA4A;SEMA6D;SEMA4D;SEMA6A;SEMA3D
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,0.25674433462705026,0.925833820036468,0.6791666666666667,1.0,1.0,36/299,13.84%,IGF2BP1;DUSP9;FGF20;RASGRF1;ACTN2;PIK3R2;MAPK12;RASGEF1A;SHC3;VWF;NRG2;FGF13;FGF17;GPRIN1;SRC;FGF23;AGO2;CAMK2A;PSMD4;PDGFRB;IL3RA;HSPB1;LAMTOR2;CDK1;RAG1;FLT3LG;RNASE1;PEA15;MPP3;RASGRF2;MMP10;IL6R;PDGFB;CNKSR2;PDGFA;PSMB4
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.36996382935423205,0.9257575992923625,0.5535714285714286,1.0,1.0,3/22,8.07%,APLP1;ATP2B4;PRKN
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.3268103175088396,0.9257528561218458,0.5645161290322581,1.0,1.0,6/40,5.95%,KCNJ6;KCNE5;ACTN2;KCNH2;KCNJ9;KCNJ5
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.3052650110936546,-0.9254910498352461,0.5294117647058824,0.8502531680305329,1.0,8/29,22.37%,TKFC;PTPN22;FCGR2B;HERC5;FGR;TRIM5;CD55;DHX58
prerank,Elsevier_Pathway_Collection__Insulin Influence on Lipogenesis,0.3901151477031919,0.9254260772004863,0.525,1.0,1.0,4/15,14.95%,SLC2A4;LPL;CD36;PDPK1
prerank,TRRUST_Transcription_Factors_2019__NR5A1 human,0.3949479450500477,0.9254012364323482,0.6181818181818182,1.0,1.0,4/15,13.28%,CYP17A1;AMH;LHB;POU5F1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.2976369339260501,0.9252475534217762,0.5625,1.0,1.0,30/71,37.49%,ATP6V0D2;CASTOR2;LAMTOR2;PRKD1;ATP6V0B;CASTOR1;LAMTOR4;TCIRG1;WDR24;ATP6V0D1;ATP6V0E1;ATP6V1C1;DAP;LARS1;ATP6V1H;CDKN1A;RHEB;KPTN;ATP6V1F;ATP6V1E1;MLST8;GCN1;ATP6V1E2;LAMTOR5;RRAGD;NPRL3;RPTOR;NPRL2;RRAGA;MAPK3
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.2363565858652829,-0.9252098513188733,0.6521739130434783,0.8505535970954888,1.0,18/82,16.80%,IGLL5;PLPP4;FYN;BTK;CD247;NCKAP1L;PLD4;HCK;PIK3R1;MYO10;WASF3;SYK;FGR;PLCG2;WIPF1;VAV1;PRKCE;VAV3
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,0.38155067540380017,0.9251928363981746,0.5864197530864198,1.0,1.0,8/22,24.60%,B3GAT1;MGAT5B;B4GALT3;ST3GAL3;B3GALNT2;LARGE2;CHST10;B4GAT1
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,0.3222316264717773,0.9251925598465358,0.56353591160221,1.0,1.0,24/42,50.08%,KPNA7;NUP37;ISG15;NUP62;KPNA2;TPR;NUP133;CPSF4;NUP155;NUP160;NUP188;PABPN1;NUP205;NUP210;NUP214;NUP107;GNL3;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,Elsevier_Pathway_Collection__Pancreatic Neuroendocrine Tumors,0.29809861646424246,0.9250339339657963,0.6105769230769231,1.0,1.0,18/70,26.12%,IGF2;LEF1;E2F1;SRC;CDKN2C;SHC1;PDPK1;HRAS;SMAD3;EGF;CDK6;TGFB2;NRG1;RAD51;ERBB3;MAP2K2;MYC;CTNNB1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.3193332836414825,-0.9250282499953143,0.5581395348837209,0.8505374115129313,1.0,10/19,22.48%,ZBP1;AIM2;CASP1;GZMA;GSDMA;NLRC4;GZMB;NAIP;GSDMB;CASP4
prerank,Reactome_2022__Apoptosis R-HSA-109581,0.270885878843627,0.9250028594110272,0.6467889908256881,1.0,1.0,71/171,39.37%,E2F1;H1-5;TP73;MAPT;CDKN2A;H1-2;PSMD4;STK26;UNC5A;H1-4;DAPK2;PKP1;BCAP31;LMNA;PSMB4;GSDMD;BMF;MAGED1;BBC3;PLEC;CLSPN;FADD;FNTA;H1-0;MED12;NDUFA2;GSN;DYNLL1;HMGB2;PTK2;CTNNB1;PSMB3;LMNB1;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;FASN;DAPK3;TP63;DIABLO;PSMC4;PSMC3;SPTAN1;CASP9;SEPTIN4;TNFRSF10A;REXO2;APIP;BAX;PSMC5;TRADD;DNM1L;SEM1;PSMB6;YWHAH;TJP1;PSMD8;TICAM1;TJP2;MAPK3;PSME2;BID;PSMD13;PSMB7;PSMA7;VIM;DCC;PSME3
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.3122125537759194,-0.9249503071841659,0.5,0.8502189347068434,1.0,5/31,5.71%,SLC27A6;MFSD2A;THRSP;ABCD2;ACSL1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.38278266400389493,0.9248904119390764,0.5290322580645161,1.0,1.0,2/16,2.14%,EPHB2;PAK3
prerank,Elsevier_Pathway_Collection__Necrosis,-0.2899582029823412,-0.9248133620924728,0.5970149253731343,0.8501068429060153,1.0,7/36,12.28%,RIPK3;TNF;TLR3;XDH;CAT;TICAM2;TLR4
prerank,Elsevier_Pathway_Collection__mTOR Signaling,0.3029832723508774,0.9246570560389489,0.5858585858585859,1.0,1.0,33/80,38.05%,SLC2A5;MAPT;TERT;SLC2A4;LAMTOR2;SHC1;PDPK1;PPARG;KCNJ11;PRKCA;TSC1;LPIN1;TSC2;EIF4EBP2;DAP;MAF1;RB1CC1;RHEB;DDIT4L;ULK1;NFATC4;POLDIP3;CUL1;IRS1;MLST8;SKP1;RRAGD;SGK1;DDIT4;RPTOR;AKT1S1;RRAGA;GSK3B
prerank,MSigDB_Oncogenic_Signatures__CSR EARLY UP.V1 DN,0.27305103400854,0.9246377674737611,0.588495575221239,1.0,1.0,49/134,36.77%,SIX1;SLC7A14;STOX1;ROBO1;HOXA10;CKB;GDF5;AMT;COL1A1;DAAM2;ANKRD33B;STC2;SAG;PRRT2;EIF4EBP3;ANKZF1;ZNF467;BBC3;RAPGEF3;HSPG2;ADM;SIX5;AKIP1;BRD8;FBN1;ZNF337;LDB1;APBB3;ABCC10;YEATS2;FZD2;ZNF302;RNF20;FUS;ZFP64;PEX6;SNPH;SKP2;NMT2;PAPLN;INCA1;ZNF500;ELMOD3;ZNF226;CC2D1A;POLL;ACYP1;LRIG2;ALDH1L2
prerank,TRRUST_Transcription_Factors_2019__ELK1 human,0.3740390501276213,0.9246015489393399,0.5379746835443038,1.0,1.0,4/18,12.84%,EZH2;DAP3;MUC4;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.36345642163081265,0.9243774601812106,0.5542168674698795,1.0,1.0,8/25,23.52%,GDF5;HES5;BMP4;ZNF423;CRB2;ACVRL1;ACVR2B;FBXL15
prerank,WikiPathway_2021_Human__Melanoma WP4685,0.3065282145342464,0.9241566470964316,0.5555555555555556,1.0,1.0,6/64,8.78%,E2F1;PIK3R2;CALML6;CDKN2A;E2F2;GRIN2A
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.35318352406396286,-0.9237980649184677,0.5531914893617021,0.8524584526421075,1.0,3/15,9.65%,SCN2B;LRRK2;SCN3B
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.28930434858820964,0.9235511550632997,0.58,1.0,1.0,13/70,18.10%,F2RL3;GPR35;ROBO1;EPS8L3;LPAR4;PRAG1;RASIP1;ABL2;STMN1;ARHGEF2;P2RY8;GPR4;ARHGEF28
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.3079751111931599,0.923440672691208,0.625,1.0,1.0,8/55,14.68%,MT3;PAX2;FOXM1;PRKN;PDGFRB;AKR1C3;PDGFB;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.32055094115368676,0.9232826965522968,0.5187165775401069,1.0,1.0,4/35,12.90%,OLFM4;MDK;S100A10;CSPG5
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.3541921162243045,0.9228518763946235,0.5535714285714286,1.0,1.0,11/27,33.47%,BLOC1S1;ABCB6;SNAPIN;GPR143;LYST;BLOC1S3;DTNBP1;AP3D1;HPS4;TRAPPC6A;AP3B1
prerank,MSigDB_Oncogenic_Signatures__CRX NRL DN.V1 DN,0.2884482186137533,0.9227305813971713,0.6111111111111112,1.0,1.0,9/104,6.26%,CPLX2;TCAM1P;MYBPH;IL17D;RBP7;GREB1;HES5;GRIK2;CHRNA3
prerank,Elsevier_Pathway_Collection__Lipid Metabolism Impairement in non-Alcoholic Fatty Liver Disease,-0.27904349799446826,-0.9226942267862793,0.5657894736842105,0.8551740940922589,1.0,11/31,23.65%,GCK;ACSL1;PPARGC1A;PIK3R1;AKT1;PCK2;IRS2;PGM1;FADS2;LDLR;IGF1R
prerank,MSigDB_Oncogenic_Signatures__NOTCH DN.V1 DN,0.2768597510499081,0.9226863782441659,0.6272727272727273,1.0,1.0,19/147,11.55%,DLK1;CHRND;CA4;DIO2;HOXA3;TM4SF20;CEL;SLC45A2;LRP4;RHO;TBX3;VN1R1;E2F2;CRHR2;VNN2;IL11;NOTCH3;LHX6;PPFIA4
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.29916757823711804,0.9225891995767955,0.5654450261780105,1.0,1.0,10/65,10.13%,SYT5;SYT3;CHP2;PRKAA2;DPEP1;CPNE7;SYT15;SYT2;HPCA;AKR1C3
prerank,WikiPathway_2021_Human__Nanomaterial induced apoptosis WP2507,-0.32402349765075755,-0.9225797873598328,0.5411764705882353,0.8550043477559927,1.0,5/20,17.08%,FASLG;PRF1;CASP6;CASP7;BCL2
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.2681753125851074,0.9225262649285301,0.6167400881057269,1.0,1.0,15/160,7.62%,IGF2;LEF1;E2F1;PIK3R2;AXIN2;WNT4;TERT;SHC3;WNT9B;NQO1;WNT8B;CDKN2A;TCF7;ACTL6B;E2F2
prerank,WikiPathway_2021_Human__Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.369263556271871,0.9223989681886657,0.5771428571428572,1.0,1.0,5/19,16.31%,RASGRF1;MAPKAPK2;HRAS;HTR2B;ELK4
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.3234981094913848,-0.9223343517480836,0.5681818181818182,0.8551635953773535,1.0,6/19,16.70%,AADAT;PIPOX;MAT1A;DDO;AASS;GCDH
prerank,MSigDB_Oncogenic_Signatures__P53 DN.V1 UP,0.2630194884792457,0.9222314301706525,0.672645739910314,1.0,1.0,35/178,15.58%,S100P;DKK1;PITX1;SCG2;GLUL;PTK7;RAMP1;CDH13;ITGA2;CDKN2A;GRIK2;REEP2;BMP4;OLFML2A;EDIL3;TSPAN8;NMNAT2;NDC80;CLTCL1;ARL4A;TUBA4A;C4BPB;PODXL;EFEMP1;KLK10;LOXL1;IFI27;SNHG3;PLAU;UCHL1;COL1A2;UNC13B;INHBB;PPARG;ANKRD1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.30162308966521556,-0.9222001390602433,0.53125,0.8550385587110402,1.0,6/25,12.90%,NRXN1;WNT7A;LRRK2;TMEM25;CHRNA7;NLGN4X
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.2575549390073441,0.9218914482687904,0.6751054852320675,1.0,1.0,149/330,40.49%,GRIN1;MAPK12;COX4I2;NRG2;DNAH17;MAPK11;PFN4;KIF5A;TOMM40L;CASP12;NDUFA4L2;PRKN;PSMD4;GRIN2A;TUBB8;DNAH12;TUBA4A;NDUFA1;SLC1A2;TUBA3E;DNAH11;PSMB4;SQSTM1;GPX3;TUBA8;NDUFS6;DNAH14;TUBB2B;GPX2;NDUFV1;NDUFB9;COX6C;GRIN2C;COX7B;NDUFA3;TRAF2;UBQLN4;UQCRB;TUBA3D;NUP37;NDUFS2;NDUFA9;ATP5F1D;DNAH5;COX6B1;NRG1;NDUFB11;NDUFA2;NUP62;NDUFS7;NXF1;TPR;SMCR8;NUP133;COX8A;UQCRQ;CYC1;KLC2;GPX1;PSMD1;MATR3;PSMB3;ATF6;COX7A1;PSMD14;NDUFA13;DDIT3;RB1CC1;UQCRHL;TUBB2A;ATXN2;NDUFA11;ATP5F1E;GPX8;PSMB5;NDUFA6;NEFL;NUP155;ULK1;ATP5MC1;UQCR11;PSMD2;TOMM40;NUP160;NDUFS8;COX4I1;PSMA1;NDUFV2;HSPA5;ATXN2L;COX5B;PFN3;ADRM1;PSMC4;FUS;PSMC3;TUBA1A;NXF5;NDUFA8;CASP9;GRIN2D;DERL1;NDUFB7;DCTN4;TUBA1B;DCTN2;NUP188;NXT1;GABARAP;UQCRH;DCTN3;NDUFAB1;NDUFB2;NDUFB10;UQCRC1;DNAH1;BAX;PSMC5;SEM1;PSMB6;PSMD8;COX7C;NUP205;TUBB6;UQCR10;ANXA11;NDUFB3;TUBB4B;VCP;HNRNPA1;BID;NDUFS4;PSMD13;NUP210;DAXX;PSMB7;PSMA7;DNAI1;DNAH10;DNAH6;DCTN5;SDHA;RAE1;NDUFB8;SDHC;MTOR;COX6A1;NUP214;TUBA1C
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.26490063784240686,-0.9217292045813849,0.6666666666666666,0.855878306636078,1.0,9/41,17.74%,BMP5;SFRP1;FASLG;TNFSF10;LGALS3;TMC8;THBS1;HMOX1;PMAIP1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.29341831092306114,-0.9216126577975452,0.581081081081081,0.8556675217759129,1.0,5/23,13.67%,WNT7A;TMEFF2;CCN1;LCP1;CARMIL2
prerank,Elsevier_Pathway_Collection__MERTK Signaling,-0.26054323642298155,-0.9215949793157113,0.581081081081081,0.8551905058869543,1.0,11/45,15.00%,TNF;FOS;LGALS3;MAP2K1;PRKCB;IL6;CXCL8;AKT1;PLCG2;TIAM1;VAV1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.19423643034541646,-0.9214585836618138,0.8888888888888888,0.8550145409600814,1.0,84/353,19.00%,FOXP3;EREG;ADRA1A;ST18;ERBB4;KRT4;IFNL1;IL10;BMP5;SFRP5;MARVELD3;IFNG;RFPL1;TNN;TMIGD3;IL1B;CCN6;ATF5;INHBA;SFRP1;NOG;COL4A3;IGFBP3;SSTR2;CBFA2T3;CCL23;MAP2K1;DUSP10;SIRPG;NDRG4;MCC;ACVR1C;IL6;OSM;RUNX3;KLF4;NKX3-1;CD300A;ADAMTS1;NGF;GPLD1;IL12B;NTRK1;SLC16A2;IGFBP5;HSPA1B;DDAH1;GREM1;KDF1;CXCL8;PLG;GATA3;TRIB1;AZGP1;IGFBP6;TES;TPTE2;SOX9;P3H2;ADAMTS8;LDOC1;POU1F1;ADORA3;DLG3;BMPR2;CXCL1;ALDH1A2;NLRC3;IFIT3;PODN;BMPR1B;HSPA1A;HMOX1;CD33;BTG1;SMARCA2;ETS1;SFRP2;AIF1;TENM1;DLC1;AR;MORC3;FRK
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.3429626353485524,-0.9214076982609769,0.5795454545454546,0.854657935523089,1.0,1/16,0.37%,AMPD1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.2970383168131594,-0.9213463811916006,0.5909090909090909,0.8542813022484302,1.0,12/31,16.47%,SEMA3E;APOA1;SEMA4A;EPHA7;SEMA6D;SEMA4D;SEMA6A;SEMA3D;UNC5C;SEMA3C;SLIT1;ITGB3
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.23835684003908306,-0.9212162629344304,0.5957446808510638,0.8541232519588929,1.0,17/90,12.92%,NR4A2;WNT7B;WNT7A;SFRP5;FZD3;WNT16;SFRP1;LRRK2;WNT2;FZD1;WNT10B;WNT1;WNT11;FERMT2;GPC4;CCDC88C;FZD8
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.34217871732850336,-0.9209466960072877,0.5789473684210527,0.8544184094874167,1.0,3/15,12.28%,FASLG;TNFSF10;TLR4
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.33012214132721257,0.9209261108115216,0.580110497237569,1.0,1.0,8/39,16.50%,DPEP1;BCAN;GADL1;NCAN;IDUA;CSPG5;CSPG4;VCAN
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.3441939185000222,0.920733467833486,0.5797872340425532,1.0,1.0,11/30,26.70%,PIK3R2;CHP2;ZIC1;ECT2;SMAD3;MAVS;PDCD5;TRIM28;UBR5;TPR;HYAL2
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.3933019648662468,0.9206964486839189,0.5925925925925926,1.0,1.0,3/15,14.95%,S100A1;FGF2;PDPK1
prerank,KEGG_2021_Human__Measles,-0.22730890621973454,-0.9205220067652647,0.6944444444444444,0.8552170103024529,1.0,33/122,22.46%,CLEC4M;IL1B;IL2RB;FOS;FASLG;PIK3CD;CD3E;CD3G;IL6;IL12B;HSPA1B;FCGR2B;TLR4;TLR2;MX2;PIK3R1;AKT1;CSNK2A3;MYD88;BCL2;HSPA1A;SLAMF1;MAPK10;EIF2AK3;CD3D;OAS3;OAS2;TAB2;JUN;STAT1;CD209;IFIH1;AKT3
prerank,Elsevier_Pathway_Collection__Genes with Mutations Associated with Retinitis Pigmentosa,0.3116642555106951,0.9204778356933482,0.5585106382978723,1.0,1.0,15/50,25.69%,CA4;RHO;CERKL;FSCN2;CRB1;SAG;PRPF3;GUCY2D;ROM1;PRCD;EYS;FAM161A;ABCA4;BEST1;CRX
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3568655972145583,0.9204149965378446,0.5301204819277109,1.0,1.0,13/24,42.18%,SRC;PIF1;PARP1;PINX1;HNRNPU;GNL3L;TERF1;HNRNPA1;ACD;EXOSC10;NAT10;TERF2;SLX4
prerank,MSigDB_Oncogenic_Signatures__YAP1 UP,0.33767679546893165,0.9203105329716804,0.5813953488372093,1.0,1.0,4/36,9.34%,DLX5;SHISA4;ARHGEF10;FAM167A
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.264779244465311,0.9199645826394856,0.6486486486486487,1.0,1.0,25/182,12.98%,IGF2;HOXB8;E2F1;OSR1;CRP;TWIST2;DISP3;SOX2;TCF23;SNAI2;GDF5;HES5;MSTN;TRIB2;TBX3;BMP4;FGF23;EFNA1;CHADL;PTHLH;ZBED6;SOX8;EFEMP1;CCDC85B;SOSTDC1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.29811603305890744,0.9199447602337261,0.576530612244898,1.0,1.0,13/65,17.35%,FAM83A;SHC3;VIL1;TDGF1;NRG2;SRC;DGKD;EFEMP1;SHC1;PDPK1;PRKCA;PTPRR;EGF
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.26497456715639356,0.919751938090328,0.6607142857142857,1.0,1.0,33/208,16.43%,GNG4;GLP1R;GHRHR;PTH2R;GCG;CALCA;GNAZ;DPEP1;RAMP1;GPHA2;HTR4;AVPR2;SRC;CRHR2;PTHLH;GNG3;RNASE1;ADM2;GPR150;RAMP2;LHB;NFKB2;MC1R;NOX1;GNB5;ADCY6;IAPP;GNG8;DVL2;RHBDF2;PRKCA;ADORA2A;GSDMD
prerank,Elsevier_Pathway_Collection__EphrinR -> STAT Signaling,0.401146592510894,0.9195172505585485,0.554140127388535,1.0,1.0,3/15,8.21%,EFNA3;EFNA4;EFNA1
prerank,WikiPathway_2021_Human__Nucleotide metabolism WP404,0.3828518487115257,0.9193473086840858,0.5782312925170068,1.0,1.0,10/18,43.22%,SRM;POLD1;RRM2;POLA1;POLB;RRM1;PRPS2;POLG;RRM2B;PRPS1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.27345763714279475,0.9193469116081854,0.6161137440758294,1.0,1.0,26/133,20.19%,ZIC2;PAX2;CTNNA2;SLC6A4;GRIN1;CENPF;HES5;EMX1;COL4A1;GRIN2A;B3GNT5;MAST1;PAFAH1B3;APOD;ZIC1;UFC1;FOXJ1;SHROOM4;MDGA1;BBS2;ABCB6;NES;GRIN2C;CDK5R1;HSPG2;NNAT
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.2776034987236434,-0.9187461988446682,0.6666666666666666,0.8596003499414989,1.0,9/33,12.87%,IL10;KLF5;TNF;FOS;NGFR;EGR1;KLF4;GATA3;ATOH8
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.3376284118469017,0.9184799298921671,0.5058139534883721,1.0,1.0,19/28,51.24%,KAT2A;BRD8;MRGBP;PHF20L1;TAF6;RUVBL2;RUVBL1;SGF29;BAG6;ATAT1;MORF4L2;KAT8;TRRAP;TAF6L;KAT6A;PHF20;CREBBP;KAT2B;EP300
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.30789352639711104,0.9180949006032433,0.6460674157303371,1.0,1.0,13/61,23.24%,IGF2BP1;IGF2BP2;AHNAK2;FAM50A;PRX;METTL18;MBNL3;PQBP1;PCBP4;NOVA2;SNRNP70;FASTK;PCBP3
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,0.3303868702239809,0.9179159971677305,0.5888888888888889,1.0,1.0,25/34,53.61%,NUP37;NUP62;TPR;NPM1;NUP133;NUP155;NUP160;NUP188;NUP205;NUP210;RAN;NUP214;NUP107;RCC1;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85;KPNB1
prerank,Elsevier_Pathway_Collection__RAS/RAF/MAPK Signaling Activation by Blocking of Tumor Suppressors,-0.2625350954395314,-0.917632440205464,0.6119402985074627,0.8623022043124491,1.0,9/41,17.74%,RASSF6;FOS;MAP2K1;AKT1;RASSF3;TIAM1;RASSF2;RASSF5;MAPK10
prerank,Elsevier_Pathway_Collection__Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway,-0.24829055294832297,-0.9173516050264565,0.6444444444444445,0.8625475169740257,1.0,13/72,14.96%,RAB25;FOXP3;ERBB4;PTGS2;FOS;CDH1;MAP2K1;TGFA;MMP7;PIK3R1;AKT1;HBEGF;CXCR4
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.319126139797769,0.917104425580612,0.5898876404494382,1.0,1.0,17/41,39.32%,LEF1;KAT2A;ING5;JADE2;TRIM16;TAF10;JADE3;LDB1;WDR5;YEATS2;BRPF3;BRCA2;PHF14;SGF29;TAF9;TAF5L;BRPF1
prerank,KEGG_2021_Human__Ether lipid metabolism,0.3215206770121702,0.9167300249103894,0.6043956043956044,1.0,1.0,8/44,15.65%,PLA2G2A;PLPP2;PLA2G2C;GDPD1;PAFAH1B3;PLA2G4C;PLA2G4F;PLPP1
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.3319003410912223,0.9166428020217563,0.5586592178770949,1.0,1.0,23/32,52.83%,NUP37;MAP4K2;NUP62;TPR;NUP133;NUP155;NUP160;NUP188;NUP205;NUP210;NUP214;NUP107;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42;MAP4K5;NUP153;NUP43;NUP85
prerank,Elsevier_Pathway_Collection__TERT Activation in Cancer,0.33635386184577265,0.916455812136968,0.5891891891891892,1.0,1.0,8/28,26.12%,E2F1;TERT;NFKB2;USF1;GLI1;MYCN;MYC;CTNNB1
prerank,Elsevier_Pathway_Collection__High Level of Homocystine Effects (Methylation Cycle),0.36205840328413696,0.9164460331717633,0.5892857142857143,1.0,1.0,5/23,11.43%,MAPT;AMT;MTR;ELN;TYMS
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3079784403274231,-0.9164415380781381,0.5802469135802469,0.8644632750665465,1.0,4/23,9.64%,PTGS2;IL1B;CCBE1;IL6
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.29417280741070495,0.9162483909437811,0.5920398009950248,1.0,1.0,9/83,8.47%,INHA;EPHB2;MAPT;PRR5L;CDKN2A;BMP4;HDAC4;PRKN;CDKN2C
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.35670538272824237,0.9162017420870283,0.5813953488372093,1.0,1.0,3/24,3.17%,CERS1;KCNH2;DPEP1
prerank,"Elsevier_Pathway_Collection__L-cell: GCG, PYY and 5-HT Release",0.37755269056828195,0.9160333238885362,0.5892857142857143,1.0,1.0,3/19,4.10%,GPR119;GCG;TAS1R3
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.310071605093631,-0.9159833973996466,0.5568181818181818,0.8652024719411177,1.0,3/25,9.77%,NOCT;NLRP3;BHLHE41
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,-0.26475010256424764,-0.9156215154268051,0.6212121212121212,0.8656253454510707,1.0,7/43,17.17%,CLEC1B;HBA1;APOA1;PPARGC1A;TLR4;HMOX1;NCOR1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.2984508956856954,0.9153936575648934,0.5783783783783784,1.0,1.0,18/67,23.56%,DLX1;SFRP4;GDF5;HES5;BMP4;SOSTDC1;PPARG;SKOR1;DAND5;ZNF423;CRIM1;CRB2;ACVRL1;NBL1;ACVR2B;RBPMS2;FBXL15;FSTL3
prerank,MSigDB_Oncogenic_Signatures__PRC1 BMI UP.V1 UP,0.27076313066843716,0.9152488521816909,0.6438356164383562,1.0,1.0,16/151,8.45%,KCNC1;KCNF1;HHIPL2;CALCA;LMOD1;TM4SF20;SNTG1;PAGE4;HOXA10;CACNA2D2;FLG;UPK1A;STMN3;CHRNA3;SYN3;MYH13
prerank,Elsevier_Pathway_Collection__Proteins Involved in Endometrial Cancer,-0.2633101537878366,-0.9150827316123991,0.6206896551724138,0.8666714048841858,1.0,12/49,13.84%,CLDN4;L1CAM;WNT7A;EPCAM;CDH1;ESR1;FGFR2;TGFA;WNT10B;AKT1;PGR;IGF1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.3117881604588827,0.9147545948172707,0.6073298429319371,1.0,1.0,6/46,12.16%,INHA;TSPO2;KLF1;FLVCR1;AHSP;EPO
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,0.3864673034183123,0.914617715941064,0.5921052631578947,1.0,1.0,9/17,46.20%,RFC4;POLR1A;UBA52;MAD2L2;PCNA;SLC19A1;RFC3;UBC;RPS27A
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.3292621772815818,0.9142852137156391,0.5842696629213483,1.0,1.0,11/32,26.12%,ACTN2;TAX1BP3;BDNF;ABCA7;NEDD4L;EGF;MAP1A;STX4;ABCA2;HSP90AB1;CTNNB1
prerank,KEGG_2021_Human__Pyrimidine metabolism,-0.2542296815552977,-0.9142164575120693,0.5606060606060606,0.8684038852049482,1.0,14/53,21.20%,UPP2;ENPP3;ENTPD8;PNP;DPYS;CDA;DPYD;ENTPD5;CTPS1;NT5C3A;ENPP1;ENTPD3;CMPK1;DCTD
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.3865081932004256,0.9141328956916973,0.6193548387096774,1.0,1.0,2/15,9.33%,PLA2G2A;CD200
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.389062088402786,0.913972387856756,0.5308641975308642,1.0,1.0,4/16,11.78%,HCN2;SLC5A2;SLC9C2;SLC9A3
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.34641250424600817,-0.9138271981757533,0.5851063829787234,0.8689933376799901,1.0,4/16,15.02%,FASLG;FOXO1;CITED2;BCL2L11
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.32400587361776656,0.9137980366933728,0.553763440860215,1.0,1.0,24/35,52.83%,NUP37;NUP62;TPR;NUP133;NUP155;NUP160;NUP188;NUP205;XPO1;NUP210;RAN;NUP214;NUP107;GNL3;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85
prerank,Elsevier_Pathway_Collection__Epithelial to Mesenchymal Transition in Cancer: Overview,0.28576447387356035,0.9137169466911835,0.6119402985074627,1.0,1.0,19/85,20.91%,SIX1;SNAI2;SRC;FGF2;PDGFRB;NOTCH3;FOXC1;IL6R;JAG2;CLDN7;PDGFA;SHC1;PDPK1;EGF;NOTCH4;DLL4;MMP9;HEY1;FOXC2
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.30104604407193264,0.9136851301060281,0.631578947368421,1.0,1.0,6/60,4.21%,RASGRF1;RASGEF1A;F2RL3;GPR35;ROBO1;LPAR4
prerank,KEGG_2021_Human__VEGF signaling pathway,0.3105510424735871,0.9135717542037224,0.5989847715736041,1.0,1.0,11/56,15.74%,PIK3R2;MAPK12;MAPK11;SRC;SPHK1;HSPB1;PLA2G4C;PLA2G4F;MAPKAPK2;PRKCA;HRAS
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.257289635797046,-0.9126257073776984,0.6363636363636364,0.8716561776884153,1.0,6/56,5.08%,CLDN4;CLDN10;MARVELD3;GRHL2;CLDN8;POF1B
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,0.3441338172079765,0.9126050945339207,0.592814371257485,1.0,1.0,15/27,43.67%,POLR2L;POLR2K;POLR3K;ZNF143;POLR2H;POLR3H;POLR3A;SNAPC2;POLR3C;POLR3G;POU2F1;POLR3GL;POLR3E;POLR3F;POLR2F
prerank,WikiPathway_2021_Human__Mammalian disorder of sexual development WP4842,0.3515293217769876,0.9125907222474315,0.5314285714285715,1.0,1.0,6/21,10.75%,WNT4;MAPK11;NR5A1;PTGDS;AMH;SOX8
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.26517595659699067,-0.9125318155737874,0.6231884057971014,0.8714043501843626,1.0,7/38,10.67%,MFSD2A;CSMD3;BMP5;ADGRB3;ALK;SEMA4D;BMP7
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.3157096199284074,0.9124888173185184,0.5721925133689839,1.0,1.0,23/48,38.71%,TRIM40;ADGRB1;IAPP;INHBB;PFDN2;HMGCR;CYP51A1;HSP90AB1;MAD2L1;MAD2L2;VBP1;AZIN1;PFDN6;PIN1;APOE;TREM2;ITGAV;CRYAB;FLOT2;MDM4;AZIN2;FLNA;PFDN4
prerank,Elsevier_Pathway_Collection__Macroautophagy Decline,-0.29568826722925623,-0.9122582287271248,0.5584415584415584,0.8716563632824506,1.0,8/23,28.42%,BCL2;HMOX1;PIK3R4;ATG5;ULK2;SH3GLB1;HMGB1;DAPK1
prerank,KEGG_2021_Human__Arginine and proline metabolism,0.30957340748543916,0.9113831260542687,0.5989304812834224,1.0,1.0,10/49,15.27%,CKMT1B;PRODH;ARG2;CKB;CKMT1A;PYCR2;CARNS1;SRM;ODC1;PYCR3
prerank,Elsevier_Pathway_Collection__Keratinocyte Proliferation in Acne Vulgaris,-0.31844436523552466,-0.9111427552984896,0.5679012345679012,0.8741878226296628,1.0,7/19,22.85%,IL1RAP;MAP2K1;MYD88;AR;MAP2K3;MAP2K6;MAP3K5
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.26247037764525555,0.9111125777622316,0.6651982378854625,1.0,1.0,36/198,18.91%,FGF20;VEGFD;PIK3R2;CALML6;GRIN1;MAPK12;F2RL3;LPAR4;EFNA3;MAPK11;FGF17;PFN4;SRC;FGF2;EFNA4;FGF23;EFNA1;PDGFRB;GRIN2A;PRKD1;PDGFB;ARAP3;FLT1;PDGFA;PGF;ADCY6;RGS14;PRKCA;HRAS;ADORA2A;ANGPT2;MRAS;EGF;SIPA1L2;ADCY4;RAPGEF3
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.3763433893656151,0.9108894131490122,0.5941176470588235,1.0,1.0,7/21,30.54%,LMOD1;SPIRE2;SCIN;ARPC1A;WASHC1;TRIM27;ARPC5
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.3052091379580333,-0.910678458409828,0.4927536231884058,0.8748665289807972,1.0,5/27,7.48%,GCK;GNMT;SIK1;FBP1;PPARGC1A
prerank,TRRUST_Transcription_Factors_2019__YY1 human,-0.23259933914423322,-0.9105296860700272,0.6792452830188679,0.8747820430884801,1.0,18/84,16.78%,HAS2;IFNG;DBH;IL1B;CETP;TDO2;CCR5;FCGR3B;TF;FCER1A;WDFY4;FCGR2B;DNAJB4;GBP1;CXCR4;TSIX;CFTR;FMO3
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,-0.28211477456065837,-0.9104203327403547,0.6547619047619048,0.8744953799332693,1.0,7/28,17.12%,GSTA1;SLCO1B3;ALB;SLCO2B1;SLCO1B1;CPOX;HMOX1
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3564545167069429,0.9101763328818211,0.6086956521739131,1.0,1.0,6/22,26.76%,GOLGA7B;ZDHHC11B;ZDHHC11;ZDHHC1;ZDHHC9;CLIP3
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3564545167069429,0.9101763328818211,0.6086956521739131,1.0,1.0,6/22,26.76%,GOLGA7B;ZDHHC11B;ZDHHC11;ZDHHC1;ZDHHC9;CLIP3
prerank,WikiPathway_2021_Human__TP53 network WP1742,0.3694726693046708,0.9099101467881097,0.6057142857142858,1.0,1.0,2/18,4.61%,TP73;CDKN2A
prerank,Elsevier_Pathway_Collection__Proteins Involved in Prolactinoma,0.3430416659363022,0.9098978317002445,0.5947368421052631,1.0,1.0,5/27,13.68%,GHRHR;BMP4;FGF2;PTTG1;PDGFA
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.33073354021450896,0.9098154633713919,0.5872093023255814,1.0,1.0,4/24,16.90%,INPP5J;MTMR11;MTMR8;MTMR3
prerank,Elsevier_Pathway_Collection__FcIgER -> ELK-SRF Signaling,-0.2964650227865468,-0.9096961695100106,0.5373134328358209,0.8761194478826824,1.0,10/27,16.88%,MAP2K1;FCGR3A;LCP2;LCK;CD247;LAT;RASGRP1;SYK;VAV1;ZAP70
prerank,WikiPathway_2021_Human__Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,-0.2680319040331188,-0.9096504674357574,0.5483870967741935,0.8757414096701303,1.0,11/47,14.02%,IL7R;MAP2K1;IL6;FYN;BTK;CXCL8;LCK;HCK;AKT1;TSLP;CISH
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.2627278742407243,0.9096292670710348,0.6301369863013698,1.0,1.0,12/169,6.91%,IGF2BP1;DKK1;PRDM7;TRIM17;TRIM40;TP73;PEG3;STOX1;SOX2;IGF2BP2;PRDM12;IHH
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,0.29556543971731175,0.9095061692518114,0.6052631578947368,1.0,1.0,35/80,39.37%,HES5;PSMD4;PSMB4;KAT2A;SMAD3;NOTCH4;DLL4;HEY1;PSMB3;MAML1;PSMD14;UBA52;NCSTN;PSMB5;PSMD2;TACC3;PSMA1;MAMLD1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;ACTA2;PSMC5;SEM1;PSMB6;PSMD8;PSEN2;PSME2;APH1A;PSMD13;PSMB7;PSMA7;PSME3
prerank,KEGG_2021_Human__Fat digestion and absorption,0.3281279829300303,0.9094419795429664,0.5879120879120879,1.0,1.0,4/35,5.34%,CEL;PLA2G2A;PLPP2;PLA2G2C
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,0.33074815509852223,0.9087612252566365,0.5888888888888889,1.0,1.0,10/42,22.70%,PIK3R2;SRC;RNASE1;CMA1;PRKCA;HRAS;CHEK1;MMP9;PTPRU;SH2B2
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.2319305451332628,-0.908400039418036,0.6666666666666666,0.878769451906581,1.0,24/98,15.71%,EREG;ERBB4;FGF10;NR4A1;CD80;ESR1;PDGFRA;NRG4;ICOS;FGFR2;TGFA;FOXO1;TRAT1;FYN;RAC2;KL;BTC;LCK;FLT3;PIK3R1;AKT1;HBEGF;VAV1;CD86
prerank,MSigDB_Oncogenic_Signatures__ESC V6.5 UP LATE.V1 UP,0.2669210598146139,0.9083096502211733,0.6531531531531531,1.0,1.0,26/167,15.40%,COL2A1;DKK1;CA4;TNNC1;VIL1;EVX1;GSC;IGF2BP2;GPC3;COL4A1;EFNA1;TMEM98;LOXL2;COL4A2;SIL1;NENF;NDRG1;NUDT11;PODXL;RAMP2;MFAP2;CA14;MOSPD1;FXYD2;GPX3;DPP4
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.32137126265637633,-0.908297485544851,0.5714285714285714,0.8785416226876605,1.0,4/15,6.85%,NTRK3;NTF3;ESR1;PDGFRA
prerank,WikiPathway_2021_Human__GDNF/RET signaling axis WP4830,0.3572831100560064,0.9080304753794435,0.588957055214724,1.0,1.0,8/20,26.12%,PAX2;BMP4;FOXC1;FOXC2;EYA1;IFT27;SOX17;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.2951256294841498,-0.9079618314584703,0.6136363636363636,0.8783051309456185,1.0,9/22,17.22%,TNF;IL1B;HSPA1B;AKT1;CSF2;EYA2;BCL2;HSPA1A;GATA1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.2951256294841498,-0.9079618314584703,0.6136363636363636,0.8783051309456185,1.0,9/22,17.22%,TNF;IL1B;HSPA1B;AKT1;CSF2;EYA2;BCL2;HSPA1A;GATA1
prerank,KEGG_2021_Human__Arginine biosynthesis,0.3670303430940012,0.9079415318435479,0.5620915032679739,1.0,1.0,2/21,3.87%,GLUL;ARG2
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.31357087971524,0.9078047580685309,0.5706521739130435,1.0,1.0,13/40,21.05%,DOCK3;NOX4;SRC;BDNF;EFNA1;PDGFB;ACE;DLG4;EGF;DOK7;LRP8;SRCIN1;GPRC5B
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.322151208598884,0.9076805013135631,0.6012269938650306,1.0,1.0,23/41,44.26%,ELOC;POLR2L;ELOB;POLR2K;NELFE;POLR2G;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;POLR2A;ERCC2;ELL;POLR2B;GTF2F1;POLR2F;CDK9;ERCC3;SUPT16H
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.37137610287429645,0.9072229941039035,0.6140350877192983,1.0,1.0,7/19,25.84%,IL1RAPL1;DBN1;OBSL1;LRP8;CUL7;RELN;CDKL3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.23879292048515335,-0.9071523513823089,0.6379310344827587,0.8801930144742293,1.0,8/71,10.55%,IFNG;TNF;CD27;INHBA;FASLG;TLR3;NGF;BCL2A1
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.2776866367801682,0.9066996010415753,0.6359223300970874,1.0,1.0,60/104,47.20%,RFC4;POLD1;POLR2L;CETN2;UVSSA;PARP1;POLA1;POLR2K;LIG3;POLR2G;COPS5;CHD1L;CUL4B;UBA52;POLB;PCNA;XRCC1;POLR2H;OGG1;COPS7B;BRIP1;DDB2;COPS6;LIG1;POLR2I;BRCA2;MMS19;POLR2J;PNKP;FAN1;POLL;XAB2;DDB1;GTF2H2C;POLR2A;ERCC2;COPS8;USP7;GPS1;POLR2B;RPA2;POLK;XPC;RFC3;POLD3;SLX4;RBX1;UBC;POLR2F;ERCC3;POLD4;COPS7A;COPS4;XPA;ERCC1;RPS27A;RPA1;PRPF19;RFC1;GTF2H2
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.269532292748365,-0.9066534957998243,0.5753424657534246,0.8811693862236936,1.0,11/32,19.04%,SEMA3E;SEMA4A;SEMA6D;SEMA4D;ROBO2;SEMA6A;SEMA3D;SEMA3C;THBS1;AIF1;SEMA5A
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,-0.2942383930303654,-0.9065984455094441,0.575,0.8807899104089563,1.0,1/26,0.61%,ESRP1
prerank,Elsevier_Pathway_Collection__PTGER2/3 -> Inflammation-Related Expression Targets,-0.3097907028355141,-0.9064437633950635,0.6125,0.8806823324588926,1.0,5/24,11.86%,FOS;MAP2K1;PTGER2;IL6;CXCL8
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.3841552604178502,0.9063159088214009,0.5914634146341463,1.0,1.0,2/18,5.93%,SDF2L1;DPM3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Pancreatic Cancer,-0.22688380184557924,-0.9061463940763049,0.7575757575757576,0.8809332432948858,1.0,15/87,13.84%,MUC1;PDX1;IFNG;TNF;IL1B;HGF;CDH1;TNFSF10;TGFA;KLF4;MMP7;CXCL8;GATA3;AKT1;IGF1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3316361375910172,0.905967804916271,0.5857988165680473,1.0,1.0,18/34,38.37%,CASTOR2;GPR137C;CASTOR1;DYRK3;GPR137B;SPAAR;SMCR8;LARS1;CLEC16A;KPTN;TELO2;DGKQ;LAMTOR5;RRAGD;PIP4P1;RRAGA;PIH1D1;GPR137
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.3437821051524439,0.9058592388340077,0.6211180124223602,1.0,1.0,16/27,46.20%,MAPK11;MAP3K8;IKBKG;TAOK2;UBA52;TNIP2;CUL1;SKP1;MAPK3;FBXW11;CCM2;UBC;MAPK1;BTRC;MAP2K7;RPS27A
prerank,KEGG_2021_Human__Alzheimer disease,0.24918038828836087,0.9058100488379845,0.7033898305084746,1.0,1.0,111/333,32.81%,DKK1;DKK4;CACNA1S;PIK3R2;CALML6;GRIN1;AXIN2;MAPT;WNT4;COX4I2;WNT9B;WNT8B;NOX4;KIF5A;CASP12;NDUFA4L2;PSMD4;GRIN2A;TUBB8;LPL;TUBA4A;ATP2A1;CHRM5;CACNA1C;NDUFA1;TUBA3E;APC2;NOX1;PSMB4;DVL2;WNT2B;WNT6;TUBA8;HRAS;NDUFS6;TUBB2B;MME;NDUFV1;NDUFB9;COX6C;GRIN2C;COX7B;NDUFA3;TRAF2;UQCRB;TUBA3D;CDK5R1;NDUFS2;NDUFA9;FADD;ATP5F1D;COX6B1;CACNA1D;APBB1;BACE2;DKK2;NDUFB11;NDUFA2;NDUFS7;CAPN2;COX8A;MAP2K2;UQCRQ;CYC1;ITPR2;KLC2;CDK5;FZD6;PSMD1;DVL1;CTNNB1;PSMB3;SLC25A6;ATF6;WNT3;COX7A1;PSMD14;NDUFA13;DDIT3;RB1CC1;NCSTN;UQCRHL;TUBB2A;NDUFA11;ATP5F1E;PSMB5;GAPDH;NDUFA6;ULK1;ATP5MC1;UQCR11;FZD2;PSMD2;NDUFS8;COX4I1;PSMA1;NDUFV2;APOE;COX5B;PIK3R3;ADRM1;ATP2A2;PSMC4;PSMC3;TUBA1A;NDUFA8;IRS1;CASP9;GRIN2D;NDUFB7;TUBA1B
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.2937250367528043,0.9057470208280679,0.5846153846153846,1.0,1.0,27/64,38.62%,PIK3R2;MAPT;PRKN;HSPB1;DAPK2;ABCD1;SOGA1;ABL2;MTMR3;WDR24;GPR137B;DRAM1;SMCR8;PIP4K2B;DDIT3;NUPR1;KEAP1;DAPK3;ACER2;DEPP1;RRAGD;RPTOR;ABL1;TYSND1;RRAGA;GPR137;CISD2
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.2870933740617152,0.9056844138085778,0.6179245283018868,1.0,1.0,17/87,19.77%,EPHA6;EPHB2;EFNA3;GPRIN1;SRC;EPHA10;EFNA4;EFNA1;CLTCL1;RNASE1;HRAS;ROCK2;VPS72;ARHGEF28;LIMK2;CLTB;MMP9
prerank,TRRUST_Transcription_Factors_2019__KLF6 human,-0.34140171465934077,-0.9056751754926448,0.6025641025641025,0.8818131209525244,1.0,3/16,5.56%,TFPI2;LAMA1;CDH1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Huntington Disease,0.27807085661832864,0.9054415084802899,0.6492890995260664,1.0,1.0,19/94,19.10%,CPLX2;GRIK2;RASD2;FGF2;BDNF;GRIN2A;HPCA;SLC1A2;UCHL1;DLG4;PDE10A;PPARG;GRM1;HDAC5;ADORA2A;PPP1R1B;PQBP1;BBC3;CTSD
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.2420095373498614,0.9052551944436121,0.7510373443983402,1.0,1.0,70/484,18.26%,HMGA2;MT3;ZIC2;RFX6;PAX2;LHX3;SIX1;DLX5;GCM1;IRX6;OSR2;LEF1;E2F1;SIX4;SPP1;KCNH2;EBF3;TP73;WNT4;SOX2;NEUROD1;KLF1;HES5;IL31RA;FOXM1;MESP1;MSTN;POU3F1;BMP4;HDAC4;TESC;FGF2;TNNI2;PRDM16;FOXH1;COL1A1;ZP3;FOXC1;SOX8;NR1D1;SOX18;TEAD2;ARHGEF11;EPO;GDF7;ARNTL2;LBHD1;PDGFB;ZIC1;FOXK1;FOXF2;KAT2A;TFAP4;CDKN1C;SHC1;PSRC1;PPARG;GLIS2;USP22;ZNF423;CTCFL;SMAD3;HMGA1;EGF;MSANTD1;NAT14;ACVRL1;WBP2NL;ATAD2;ING5
prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.24571480133634832,0.9052023460459784,0.7333333333333333,1.0,1.0,153/429,34.58%,DKK1;DKK4;CACNA1S;CALML6;GRIN1;AXIN2;MAPK12;MAPT;WNT4;COX4I2;WNT9B;SEPTIN5;WNT8B;NOX4;DNAH17;MAPK11;KIF5A;SLC6A3;TOMM40L;CASP12;BDNF;NDUFA4L2;PRKN;CAMK2A;PSMD4;GRIN2A;TUBB8;DNAH12;TUBA4A;ATP2A1;CHRM5;CACNA1C;NDUFA1;TUBA3E;APC2;NOX1;DNAH11;UCHL1;PSMB4;DLG4;SQSTM1;DVL2;GPX3;WNT2B;GRM1;WNT6;TUBA8;PRKCA;HRAS;NDUFS6;DNAH14;TUBB2B;GPX2;NDUFV1;NDUFB9;COX6C;SNCAIP;GRIN2C;COX7B;NDUFA3;TRAF2;UQCRB;TUBA3D;CDK5R1;NDUFS2;STX1A;NDUFA9;FADD;ATP5F1D;DNAH5;COX6B1;PLCG1;CACNA1D;DKK2;NDUFB11;NDUFA2;NDUFS7;UBA1;CAPN2;SMCR8;COX8A;MAP2K2;UQCRQ;CYC1;ITPR2;KLC2;CDK5;FZD6;GPX1;ATXN1L;PSMD1;DVL1;CTNNB1;PSMB3;SLC25A6;ATF6;WNT3;COX7A1;TRAP1;PSMD14;NDUFA13;DDIT3;RB1CC1;HIP1;UBA52;UQCRHL;TUBB2A;ATXN2;NDUFA11;ATP5F1E;GPX8;PSMB5;NDUFA6;NEFL;ULK1;ATP5MC1;UQCR11;FZD2;PSMD2;TOMM40;PARK7;NDUFS8;COX4I1;PSMA1;NDUFV2;HSPA5;ATXN2L;COX5B;ADRM1;ATP2A2;PSMC4;FUS;PSMC3;TUBA1A;NDUFA8;CASP9;GRIN2D;DERL1;NDUFB7;DCTN4;TUBA1B;DCTN2;GABARAP;LRP5;UQCRH;DCTN3;NDUFAB1;NDUFB2;NDUFB10;UQCRC1;DNAH1;CSNK2B;BAX
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.2926091309059231,0.9051172392291867,0.6229508196721312,1.0,1.0,7/57,7.63%,PAX2;PTK7;STRA8;WNT9B;WNT8B;TESC;BRINP1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.2860098993142619,-0.9049927384880281,0.6329113924050633,0.8831769975150734,1.0,5/26,12.12%,PRKAR2B;CYP4A11;CYP4F2;CYP4F12;ADCY5
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.30482970313000163,0.9049906801612168,0.6354166666666666,1.0,1.0,35/63,43.56%,PSMD4;AURKB;AURKA;PSMB4;CHEK1;PSMD1;INTS3;PSMB3;PSMD14;NABP2;PSMB5;VPS4A;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PINX1;PSMC5;PSMB6;PSMD8;ZFYVE19;PSME2;PSMD13;PSMB7;PSMA7;PSME3;CDK5RAP3;PSMB2;RBX1;PSMA6;FBXL7;PSMD9
prerank,KEGG_2021_Human__Coronavirus disease,-0.21241532056436835,-0.904971242337777,0.8125,0.8826871313603212,1.0,55/210,22.41%,CSF3;CXCL10;ACE2;TNF;IL1B;MMP1;FOS;TLR3;C9;CASP1;C7;C6;PIK3CD;PRKCB;NLRP3;CCL2;IL6;TLR8;CYBB;IL12B;C4A;MBL2;CXCL8;TLR4;C1QC;C1R;TLR2;MX2;PIK3R1;SYK;PLCG2;MYD88;C1QB;HBEGF;CSF2;F13B;MAPK10;C8A;C3AR1;C8B;C1S;MAPK13;C1QA;C5;OAS3;AGTR1;OAS2;TAB2;SELP;JUN;MAS1;MASP1;STAT1;F2;IFIH1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.3660495701959144,0.9048562114976502,0.5950920245398773,1.0,1.0,11/19,41.14%,SRC;PIF1;PINX1;HNRNPU;GNL3L;TERF1;HNRNPA1;ACD;EXOSC10;NAT10;TERF2
prerank,Elsevier_Pathway_Collection__NOTCH Receptors Signaling,0.33224273195225884,0.9048069854116708,0.6285714285714286,1.0,1.0,9/29,28.26%,NOTCH3;JAG2;NEDD4;NOTCH4;HEY1;HDAC1;MAML1;NCOR2;CDKN1A
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.35228658189521767,-0.9046799849154196,0.6097560975609756,0.882862743415482,1.0,2/15,6.66%,GSTZ1;PDK4
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.30376980566667966,0.9046468960824167,0.6042780748663101,1.0,1.0,14/45,19.58%,UTS2R;SGCZ;TNNI3;ELN;BDKRB2;EPO;MEOX2;ACE;ADCY6;ADORA2A;ROCK2;ACVRL1;TBC1D8;DLL4
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.2583952986178176,0.9045405287669822,0.7021276595744681,1.0,1.0,17/205,8.75%,ODAM;MT3;IGF2;FGF20;VEGFD;AXIN2;CLDN19;RAMP1;KNDC1;ASPSCR1;FGF17;BMP4;FGF2;TMEM119;FGF23;EFNA1;CDCA2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.26090817462831356,0.9044419165070784,0.6828193832599119,1.0,1.0,32/178,16.53%,GLP1R;GHRHR;PTH2R;GCG;C1QTNF3;CALCA;CGA;DPEP1;RAMP1;GPHA2;SAA1;MDK;HTR4;AVPR2;SRC;CRHR2;CD200;PTHLH;CXCL17;NR1D1;ADM2;GPR150;RAMP2;LHB;MC1R;GBA;ADCY6;IAPP;RHBDF2;PPARG;ADORA2A;TYRO3
prerank,Elsevier_Pathway_Collection__Vascular Endothelial Cell Activation by Growth Factors,-0.24944525161591105,-0.9041722311014553,0.65625,0.8837393756825601,1.0,22/51,29.33%,PTGS2;MAP2K1;PTGES;SELE;AKT1;VCAM1;TBXA2R;PTGIS;NFATC2;MAP2K3;MAP2K6;SELP;JAK2;STAT1;MAP3K5;THBD;MAP2K4;PROS1;XYLT1;EDN1;NFKBIA;PROC
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.2497630696951617,0.9041307775458108,0.7068965517241379,1.0,1.0,33/363,10.75%,HMGA2;MT3;PAX2;DKK1;GCG;LEF1;FATE1;SIX4;OSR1;PAGE4;PRKAA2;DPEP1;TDGF1;POU4F1;IL31RA;RNF157;PLK1;TBX3;BMP4;KIF14;BIRC5;SRC;SPHK1;IRAK1;FAIM2;NUAK2;PRAP1;DHRS2;HSPB1;COMP;NOL3;CDK1;SOX8
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.29683718185366004,-0.9040099798265756,0.7195121951219512,0.8836304903398634,1.0,4/22,7.14%,BMP5;TNF;CCL5;LGALS3
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.3658645325808161,0.9038912877938705,0.5914634146341463,1.0,1.0,3/18,10.86%,MSTO1;TLE6;ATP2A1
prerank,Elsevier_Pathway_Collection__Familial Partial Lipodystrophy Type 4 Progression (Hypothesis),0.3638242996967856,0.9038253896011886,0.5688622754491018,1.0,1.0,5/17,15.45%,SLC2A4;LPL;LEP;ACACA;PPARG
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,0.2711828488065452,0.9034606689477691,0.642512077294686,1.0,1.0,16/137,15.60%,GNG4;LEF1;AXIN2;WNT4;TCF7;AGO2;CAMK2A;PSMD4;GNG3;RNASE1;PSMB4;SCRIB;GNB5;GNG8;DVL2;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.3350757937720638,0.9033251258539831,0.5789473684210527,1.0,1.0,17/28,38.97%,PIK3R2;CHP2;ZIC1;ECT2;SMAD3;MAVS;TRIM28;UBR5;TPR;HYAL2;TGFB1;ZPR1;RBM22;BAG3;DMAP1;FLNA;RAN
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.3832295330020877,0.903209144272043,0.6163522012578616,1.0,1.0,8/17,23.04%,KASH5;PTTG1;MAJIN;SGO2;IHO1;SGO1;ANKRD31;FANCD2
prerank,Elsevier_Pathway_Collection__Smooth Muscle Cell Dysfunction in Arterial Hypertension,-0.25291777373802915,-0.9031490248826196,0.578125,0.8854594943168954,1.0,9/49,14.22%,ADRA1A;AVPR1A;FOS;MAP2K1;EGR1;PIK3R1;AKT1;RASGRP1;EDNRB
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.3534654721732386,0.902921657093023,0.5802469135802469,1.0,1.0,9/23,29.88%,CDKN2A;CDC25C;LMNA;CDC25A;CDK5R1;CAPN2;CDK5;LMNB1;PRDX2
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,0.35555570266358394,0.9027909240851002,0.6071428571428571,1.0,1.0,7/21,21.74%,FDPS;MVD;HMGCR;IDI1;PMVK;HMGCS1;FNTA
prerank,TRRUST_Transcription_Factors_2019__ESR1 mouse,-0.2954252771020696,-0.9027888712207348,0.6031746031746031,0.885893032577046,1.0,4/27,4.74%,TNFSF11;TH;FOS;NELL2
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.3925644403379114,0.9027324344090636,0.6111111111111112,1.0,1.0,11/16,51.13%,SRSF12;SNRPC;RBM22;DCPS;SART1;PSIP1;SFSWAP;SNRNP200;NCBP2;PRPF39;CACTIN
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.33094366374971607,-0.9026877157326699,0.6067415730337079,0.8856398178648605,1.0,2/15,3.50%,IFNG;TNF
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.3213233054355614,-0.9025191465322185,0.5632183908045977,0.885626611550179,1.0,5/21,16.17%,TNFSF11;GPR183;TNFRSF11A;OSCAR;CSF1R
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.3384483729635344,-0.9019472584954419,0.5609756097560976,0.8866914652452932,1.0,6/15,21.38%,CD8A;CRTAM;BTN3A3;MYO1G;CD55;BTN3A2
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.29476073641523615,-0.9018824556240487,0.6341463414634146,0.8863052145731334,1.0,8/23,24.15%,TNF;CCL3;EPHA7;PRNP;ITGAM;TYROBP;FBXW7;TFAP2A
prerank,Elsevier_Pathway_Collection__Hair Follicle Keratinocyte Apoptosis,0.30709906884337157,0.9018000816661556,0.6075268817204301,1.0,1.0,3/37,6.79%,DKK1;AXIN2;PTGDS
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.25482492450286476,0.9016948282230112,0.7008928571428571,1.0,1.0,23/199,11.29%,PAEP;REG3A;DKK1;SLC6A4;HS3ST5;DLX1;NODAL;LRP4;TNNT1;ROBO1;WNT9B;IL17D;MDK;KREMEN2;BMP4;ATP2B4;EFNA1;TIMP1;LOXL2;GDF15;PTPRG;RGCC;NR1D1
prerank,WikiPathway_2021_Human__Proximal tubule transport WP4917,0.2960270827331194,0.9015243637870037,0.581151832460733,1.0,1.0,7/50,7.80%,CA4;SLC22A11;SLC34A3;ATP6V0D2;SLC13A3;SLC5A2;SLC26A6
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.336149518736707,0.9015130933786251,0.6277777777777778,1.0,1.0,8/29,15.40%,GCG;PAK3;NEUROD1;DCX;PCSK1;ABCC8;IAPP;DPP4
prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.2229891616262707,-0.9013957420653625,0.7058823529411765,0.8870360683213745,1.0,18/95,13.55%,SLC5A7;PCYT1B;SLC44A4;FOS;PLD1;SLC22A1;SLC44A3;PDGFRA;MAP2K1;PIK3CD;PRKCB;SLC44A5;RAC2;PLA2G4A;DGKE;PIK3R1;AKT1;WASF3
prerank,Elsevier_Pathway_Collection__Postsynaptic Neuron Activation,0.328079748067537,0.9013621151573044,0.6089385474860335,1.0,1.0,7/25,14.95%,CALCA;RASD1;BDNF;CAMK2A;PRKD1;DLG4;PDPK1
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.32053680078805236,0.9010716276407482,0.6277777777777778,1.0,1.0,22/35,50.08%,HMGA1;NUP37;NUP62;TPR;NUP133;NUP155;NUP160;SGIP1;NUP188;BANF1;NUP205;NUP210;NUP214;NUP107;PSIP1;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.36128993462499365,0.900978733216,0.5697674418604651,1.0,1.0,14/22,46.15%,FBLL1;NSUN5;NOP2;TFB2M;TRMT112;FBL;METTL5;BUD23;FTSJ3;METTL16;EMG1;DIMT1;MRM1;MRM3
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.19859633072282304,-0.9007603182048021,0.8095238095238095,0.8882908347831482,1.0,39/234,13.06%,CSF3;IL10;TNFSF11;RIPK3;TNF;AIM2;IL1B;IL18R1;S100A8;IL18RAP;IL1RAP;ESR1;IL18;ALK;PPARGC1A;NFAM1;ANXA3;PRKCB;WNT2;FZD1;NLRP3;PRKCQ;IL6;WNT1;CD40LG;NTRK1;TNFRSF11A;HSPA1B;BTK;CARD11;TRIM34;TLR4;LPAR5;CLEC7A;TRIM22;TLR2;CARD16;HCLS1;AKT1
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.3454917940767584,0.9007571442179111,0.593939393939394,1.0,1.0,2/30,3.20%,CYP17A1;CYP21A2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3440699940555133,0.9006118496277273,0.6057142857142858,1.0,1.0,5/26,12.71%,GRIN1;PAGE4;ADGRB1;CD36;ABCD1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.3740155683174975,0.9006012127346682,0.5868263473053892,1.0,1.0,3/17,3.15%,CEL;BSN;LRP4
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,0.277406160053949,0.900506725119109,0.6255924170616114,1.0,1.0,45/89,45.65%,EXTL1;EXOSC4;EXTL3;LMNA;CREB3L1;SHC1;CREB3L4;PREB;TSPYL2;ATP6V0D1;DDX11;KDELR3;CUL7;EXOSC5;ARFGAP1;ATF6;DDIT3;MYDGF;ZBTB17;DNAJB11;TATDN2;HSPA5;ACADVL;CTDSP2;CXXC1;CREB3L3;SRPRB;EXOSC2;WFS1;MBTPS2;ACD;NFYC;EXOSC1;EXOSC7;EXOSC9;HYOU1;PLA2G4B;NFYB;TLN1;EIF2S3;FKBP14;HSP90B1;PPP2R5B;EXTL2;GSK3A
prerank,Elsevier_Pathway_Collection__Ca2+ Toxicity in Neurons,0.3394500303344735,0.9004486666430563,0.5348837209302325,1.0,1.0,10/25,31.57%,MAPT;ATP2A1;CDK5R1;LRP8;APBB1;CDK5;GPX1;RELN;APOE;ATP2A2
prerank,Elsevier_Pathway_Collection__Exocytosis: Vesicle Fusion,-0.33656339164918864,-0.9003180885853305,0.5555555555555556,0.8889665368062855,1.0,2/16,4.09%,OTOF;SYT1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.23743867161738527,-0.9002237553432036,0.671875,0.8886926475513534,1.0,23/72,22.65%,AMPD1;ACOT11;GLYAT;LRRK2;SULT1A2;ACSM3;SULT1C2;SULT1C4;ACSM5;CROT;AK4;ADSS1;SULT2A1;MLYCD;ENPP1;ACAT1;AMPD3;TPST2;ACOT2;GIMAP7;ACOT12;AK3;ACSM4
prerank,WikiPathway_2021_Human__Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,-0.3372388576980113,-0.9001212760550658,0.625,0.8884654991139875,1.0,7/16,22.08%,SYTL3;UNC13D;RPH3A;RAB27B;RAB27A;SYTL5;SYTL2
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.332910137180935,0.8999738129817912,0.6140350877192983,1.0,1.0,6/29,13.30%,EEF1A2;FGF2;PDGFRB;PRKD1;PDGFB;FLT1
prerank,MSigDB_Oncogenic_Signatures__PRC2 SUZ12 UP.V1 DN,-0.2165836758861001,-0.8997915528828604,0.7368421052631579,0.8887986060671713,1.0,38/151,18.13%,CIDEA;ST18;CCK;FCN2;KRT15;SLC39A2;FOLR3;SEMA3E;STAB2;LCAT;SPIB;FCHO1;HR;IPCEF1;KCNJ15;XK;IL1RL2;PPIEL;GPC6;CLEC4E;CYP4F12;DACH1;ARL4C;DOK2;LCP1;UPK3B;SERPINB2;HBEGF;CXCR3;TNFRSF1B;ALDH1A2;ZNF471;PRKY;GATA1;ACAP1;GIMAP4;FMNL1;PDE6A
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.26912493734469134,-0.8997875580320104,0.5882352941176471,0.8882901795308046,1.0,21/41,26.77%,ATP1A3;FPR2;NGFR;CALCR;FYN;NTRK1;FCGR2B;CHRNA7;TLR4;IGF1;VCAM1;PRNP;ITGA4;LGMN;ADRB2;APP;CASP4;IGF1R;EPHA4;CACNA1A;SNX6
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.27512452910825996,0.89973770863228,0.6650246305418719,1.0,1.0,22/103,17.13%,DIO2;PTH2R;EBF2;LCN2;FABP4;DISP3;PRDM16;OXTR;GPR3;ZBTB7B;LEP;CD36;ELOVL3;MFAP2;BEND3;ACLY;LEPR;ACACA;FABP5;CAMK1D;SCD;THRA
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.37153825144054103,0.8997314889672843,0.6726190476190477,1.0,1.0,10/18,40.20%,ANKRD53;PSRC1;TPX2;GPSM2;NUP62;GNAI1;TACC3;DYNC1H1;RAE1;NUMA1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.2391987355151387,-0.8997064029131685,0.6981132075471698,0.8879610727329572,1.0,13/50,17.57%,PFN2;SFRP1;APOA1;GPR65;EPHA1;PLEK;LIMCH1;WNT11;FERMT2;PPM1E;SYNPO2L;LPAR1;CARMIL1
prerank,WikiPathway_2021_Human__Breast cancer pathway WP4262,0.26524961626149934,0.8996878005314805,0.6376146788990825,1.0,1.0,23/145,15.74%,FGF20;LEF1;E2F1;PIK3R2;AXIN2;SFRP4;WNT4;SHC3;HES5;FGF17;TCF7;FGF2;FGF23;E2F2;NOTCH3;JAG2;NFKB2;APC2;SHC1;DVL2;WNT2B;WNT6;HRAS
prerank,MSigDB_Oncogenic_Signatures__MEK UP.V1 UP,0.2626743160292823,0.8996578501043702,0.6990740740740741,1.0,1.0,38/181,20.38%,SLC7A11;S100P;ALDH3A1;PTK7;GAL;SIX2;UPK1A;NT5DC2;IGF2BP2;BCAM;DBNDD1;TTC9;AKR1B10;MAP3K9;AKR1C3;GDF15;AGAP1;PDLIM7;LAMC1;APOD;MICAL2;LOXL1;PACSIN3;VWA1;PLAU;GPX3;PPARG;AKR1C2;GPX2;EPHX1;CRLF1;TNS3;CAMK2N1;TBC1D8;BCL3;ADM;CHKA;LRP8
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.28529216328909696,-0.8994774289535232,0.6708860759493671,0.8880524280032794,1.0,9/34,18.06%,ACOD1;TLR3;LILRA2;CD300A;TICAM2;TLR4;LILRA4;BPIFB1;PTPRS
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.24814651065950455,0.8993797438636519,0.746938775510204,1.0,1.0,110/408,34.15%,AVIL;LMOD1;CCNO;KASH5;MAPT;SQLE;TEKT5;CENPF;RHO;NEK2;GOLGA6D;CENPA;CENPE;ANLN;CD34;KLHL41;UNC119B;ABCA3;CILK1;DLGAP5;VPS28;FHDC1;DNAAF1;PLA2G4C;PGM5;SAC3D1;UBAP2L;TMOD4;SH3PXD2B;BBS5;CEP131;IFT81;FOXJ1;BBS2;PKD1;GOLGA8M;VPS37D;ABLIM1;ABCB6;WDR45;CEP250;HAUS4;GOLGA8A;HAUS5;KIF24;EHD2;CCDC28B;TMEM250;DNAH5;POGZ;FNBP1L;FAM161A;ATP6V0D1;B9D2;B9D1;NUP62;GSN;OCRL;TEKT4;NPM1;PLK4;DYNLL1;CENPW;BICD1;PTPN23;EDC3;ARMC9;TUBGCP6;RILPL1;CPLANE2;RB1CC1;HGS;ASAP1;BBS4;PRRC2C;LSM4;FBF1;ATXN2;ULK1;VPS4A;SNF8;RAB43;RUFY4;EXOC4;NEK7;ATXN2L;CHMP2A;CSNK1D;ATP2A2;HPS4;EIF4ENIF1;TRAPPC6A;EXOC3;CEP290;FITM2;CFAP70;HYLS1;SSX2IP;DYNC1H1;G3BP1;NUDCD3;GABARAP;CCDC61;CFAP43;CEP41;TTLL3;CEP89;CENPT;KIF3B;TMOD2
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.362083640345222,-0.8993786832693896,0.6395348837209303,0.8877370723546785,1.0,5/16,17.12%,CASP1;NLRP3;MEFV;PSTPIP1;HMOX1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.33149339449334997,0.8992643445582492,0.5773809523809523,1.0,1.0,4/31,8.31%,POPDC3;SGCZ;MYF6;LBX2
prerank,TRRUST_Transcription_Factors_2019__SMARCA4 mouse,-0.334025119354916,-0.8992606847372602,0.581081081081081,0.8875079863626993,1.0,4/15,10.17%,SFTPB;CDH1;MITF;ADAMTS1
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.34664398916637607,0.8992476638932284,0.6127167630057804,1.0,1.0,12/28,34.62%,AK8;GUK1;TYMS;RRM2;TXNRD1;DTYMK;DUT;NME3;AK1;RRM1;AK7;DCTPP1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.28875770921608135,-0.8992246616035026,0.640625,0.8870711553318555,1.0,7/32,12.49%,CRHBP;SLC34A2;KRT19;SFRP1;ESR1;GATA3;CITED2
prerank,WikiPathway_2021_Human__AMP-activated protein kinase (AMPK) signaling WP1403,0.29862905078985763,0.8991505430839376,0.6262135922330098,1.0,1.0,16/63,22.80%,PIK3R2;PRKAA2;SLC2A4;CCNA2;CCNB1;LEP;CPT1B;LEPR;ACACA;HMGCR;PPARGC1B;TSC1;CPT1C;LIPE;TSC2;CRTC2
prerank,WikiPathway_2021_Human__Differentiation Pathway WP2848,0.32000978167602245,0.8991365232877065,0.6149425287356322,1.0,1.0,12/41,15.29%,DKK1;NODAL;GDF5;BMP4;FGF2;IL11;FLT3LG;IL6R;EPO;PDGFB;PDGFA;WNT2B
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,0.35201166115897214,0.898931722858945,0.6046511627906976,1.0,1.0,7/22,23.48%,ITGA2;ITGA6;LAMC1;LAMA4;ITGA7;HSPG2;LAMA5
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.30276514048574926,0.8989203365139042,0.6236559139784946,1.0,1.0,8/43,13.04%,SLC7A11;SLC7A14;SLC7A6;SLC7A10;SLC1A4;SLC38A11;SLC7A1;PDPN
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.34292118953077455,-0.8986594984939462,0.5853658536585366,0.8879712898936588,1.0,6/15,25.98%,AGL;PYGL;PGM2;PGM2L1;MGAM;CALM1
prerank,TRRUST_Transcription_Factors_2019__ETS2 human,0.3349428226497202,0.8985299439920225,0.5857988165680473,1.0,1.0,4/31,4.61%,CGA;TERT;VWF;CDKN2A
prerank,Elsevier_Pathway_Collection__Clear Cell Endometrial Cancer and Papillary Serous Endometrial Cancer,-0.23983036172282673,-0.8984759104208871,0.75,0.8878743879489865,1.0,19/65,23.65%,CLDN4;ERBB4;EPCAM;FOS;CDH1;MAP2K1;TGFA;FOXO1;PIK3R1;AKT1;HBEGF;BCL2;MAPK10;MAP2K3;JUN;JAK2;CLDN3;MAP3K5;MAP2K4
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.2727939448963138,-0.8983767950231462,0.6764705882352942,0.8876029119395933,1.0,14/36,24.49%,ACOT11;ACSM3;MMUT;ACADL;ACADS;ACAD11;ACADM;ECHS1;PCCA;PCTP;ACOT2;ACOT12;ACOT13;ACAA2
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.37333035652025826,0.8982134187902677,0.6012658227848101,1.0,1.0,6/18,19.62%,MDK;BMP4;PTHLH;KAT2A;SCIN;SCX
prerank,Elsevier_Pathway_Collection__Androgens in Adipocyte Activation,-0.32088427518263324,-0.897819150851162,0.5760869565217391,0.8885307940358873,1.0,5/16,13.06%,SRD5A2;SRD5A1;FOXO1;SHBG;AKT1
prerank,TRRUST_Transcription_Factors_2019__NOTCH1 mouse,0.36852753193769316,0.8975843935455421,0.5636363636363636,1.0,1.0,10/20,32.72%,HES5;CCNE1;DLL4;HEY1;TCF3;CTNNB1;CDKN1A;SMARCC1;NRARP;GATA2
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,0.28959173658873083,0.8975719582110798,0.6203208556149733,1.0,1.0,43/64,53.12%,RFC4;POLD1;POLR2L;UVSSA;POLR1A;POLR2K;POLR2G;CUL4B;UBA52;PCNA;POLR2H;POLR2I;POLR2J;XAB2;DDB1;POLR2A;ERCC2;USP7;SLC19A1;POLR2B;POLK;RFC3;POLD3;RBX1;UBC;POLR2F;ERCC3;POLD4;XPA;ERCC1;RPS27A;PRPF19;GTF2H2;POLE2;GTF2H5;POLE4;RFC5;EP300;RFC2;POLE;MNAT1;CDK7;POLR2D
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,0.3182438191290946,0.8973919838361957,0.574585635359116,1.0,1.0,29/49,47.30%,PSMD4;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.28213913563866727,0.8972986644295823,0.6157635467980296,1.0,1.0,19/83,16.85%,SLCO1C1;SLC2A4;SLC29A4;SLC13A3;SLC6A9;SLC4A3;ATP1A2;ATP1A4;ATP2B4;SLC5A6;SLC1A4;CD36;SLC1A2;SLC7A1;SLC29A2;LEPR;ABCC5;FABP5;SLC1A3
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.3670193605015004,0.8971945821368015,0.6130952380952381,1.0,1.0,9/19,38.39%,SAXO1;KCTD17;ZMYND10;MARK4;CROCC;BBS4;WRAP73;SEPTIN9;HTT
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.28503421045394006,0.8971676520193985,0.678391959798995,1.0,1.0,39/79,44.56%,MAPT;CD34;CAMK2A;MAPKAPK2;NUP37;NUP62;TPR;NUP133;HSF1;HSP90AB1;IER5;NUP155;NUP160;MLST8;CRYAB;NUP188;BAG3;HSPA8;RPTOR;AKT1S1;NUP205;MAPK3;GSK3B;HIKESHI;NUP210;HSP90AA1;ATR;DNAJB6;RAE1;HSPA1L;RPA2;MTOR;NUP214;HSPH1;NUP107;MAPK1;CAMK2G;DNAJC2;AAAS
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.2749371789124554,-0.8969726094826077,0.6025641025641025,0.8901950233663105,1.0,9/35,22.90%,NEK10;NLRP12;EPHA7;ERRFI1;CHP1;RASSF2;ENPP1;IMPACT;PDGFC
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.3940471147716587,0.896865247628239,0.6073619631901841,1.0,1.0,5/15,15.54%,VGF;DUOX1;TYMS;AKR1C1;KCNJ11
prerank,Elsevier_Pathway_Collection__Proteins Involved in Noise-Induced Hearing Loss,-0.2670648524005074,-0.8968648965541001,0.6428571428571429,0.8899555654042218,1.0,9/39,11.60%,CSF3;GRHL2;TNF;KCNE1;CAT;IL6;MMP7;PTGER4;GJB2
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,0.3098668637087877,0.8967891327011601,0.6086956521739131,1.0,1.0,29/41,51.92%,RFC4;POLD1;POLR1A;PARP1;CHD1L;CUL4B;UBA52;PCNA;DDB2;DDB1;ERCC2;SLC19A1;POLK;RFC3;POLD3;RBX1;UBC;ERCC3;POLD4;XPA;ERCC1;RPS27A;GTF2H2;POLE2;GTF2H5;POLE4;RFC5;RFC2;POLE
prerank,WikiPathway_2021_Human__Proteasome Degradation WP183,0.3062592150223735,0.8967759267990043,0.6055555555555555,1.0,1.0,31/59,43.56%,PSMD4;UCHL1;PSMB4;NEDD4;UBA1;PSMD1;PSMB3;PSMB5;PSMD2;PSMA1;HLA-F;PSMD10;PSMC4;PSMC3;PSMC5;PSMB6;RPN2;PSMD8;UBE2D2;PSME2;PSMD13;PSMB7;PSMA7;HLA-A;PSME3;HLA-B;PSMB2;PSMA6;HLA-G;UBC;PSMD9
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.3724820834757247,0.8965245702051903,0.6024844720496895,1.0,1.0,7/18,28.55%,BBS5;BBS2;GPR143;BLOC1S3;MREG;BBS4;MLPH
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.3724820834757247,0.8965245702051903,0.6024844720496895,1.0,1.0,7/18,28.55%,BBS5;BBS2;GPR143;BLOC1S3;MREG;BBS4;MLPH
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.2947665232796003,-0.8964490387869631,0.6091954022988506,0.8905417434608008,1.0,8/23,12.81%,CYP4A11;CYP4F2;ALOX5AP;DPEP2;ALOX5;PLA2G4A;CYP4F3;PTGR1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.3626899922265409,0.8964431493914518,0.5947712418300654,1.0,1.0,5/18,21.40%,GATA5;BMP4;ACVRL1;HEY1;TGFB2
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,0.28055256659003114,0.8958108132033366,0.6744186046511628,1.0,1.0,26/101,20.59%,COL15A1;CAPN9;CAPN11;COL9A1;BCAN;MMP11;SCUBE1;CAPN8;TIMP1;MMP12;ADAM15;MMP17;LAMC1;MMP10;CAPN14;TLL2;HTRA1;CMA1;ADAM9;ADAMTS18;CAPN12;LAMA4;CTSD;HSPG2;MMP9;MMP3
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.32769034487687126,-0.8955581379787791,0.6463414634146342,0.8924844927317581,1.0,1/16,0.83%,MUC1
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.280808523986112,0.8953352580043232,0.6331658291457286,1.0,1.0,17/77,15.63%,GP2;LYPD1;PRND;THY1;LY6H;DPM3;NTM;GPAA1;VNN2;LYPD5;LYPD2;GPIHBP1;MELTF;CD109;LY6K;RTN4RL1;MDGA1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.33882941555294205,0.8950465966336186,0.6036585365853658,1.0,1.0,17/28,46.51%,EXOSC4;SNRPE;ZNF473;LSM10;LSM11;SNRPB;TUT1;SNRPD3;SSB;TUT7;EXOSC10;CPSF3;SNRPG;SLBP;UPF1;TUT4;MTPAP
prerank,Elsevier_Pathway_Collection__Muscular Dystrophies,-0.2516800695071722,-0.8946487077151505,0.7419354838709677,0.8945596267932499,1.0,10/49,13.84%,PVALB;TNF;IL1B;FOS;CAT;FOXO1;TTN;SLC8A1;AKT1;IGF1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Female Infertility,0.2970528327823629,0.8945879019386138,0.6304347826086957,1.0,1.0,10/54,11.24%,PTPRN2;KISS1;MSH4;PLK1;MSX1;DLGAP5;ZP3;CDK1;NPR2;LEP
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,0.3701659556820456,0.8945832792635466,0.5576923076923077,1.0,1.0,7/17,27.37%,ITGA2;SRC;LAMC1;LAMA4;LAMA5;PTK2;LMNB2
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.23406395595313212,-0.8945607291583241,0.7272727272727273,0.8942623718735662,1.0,19/76,17.95%,FOXP3;IL10;NLRP2;TMIGD3;AIM2;ACOD1;NLRP12;TCEAL7;NLRP3;KLF4;BMP7;HAVCR2;MTURN;CHP1;ADORA3;SPI1;NLRC3;ITCH;PTGIS
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.3622857761110576,0.8941819880621051,0.5823529411764706,1.0,1.0,4/18,15.00%,THBS4;MDK;LEP;LEPR
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.36359408568455376,0.8941265395988998,0.5872093023255814,1.0,1.0,8/21,38.28%,CDC25C;RGCC;NPM1;CNOT3;CNOT10;CNOT6;CNOT6L;CNOT9
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,0.3132010320877792,0.8939327815946566,0.6914285714285714,1.0,1.0,24/38,52.33%,RFC4;POLD1;MUTYH;FEN1;POLR1A;PARP1;PCNA;XRCC1;OGG1;PNKP;SLC19A1;RFC3;POLD3;APEX1;POLG2;POLD4;NEIL1;POLE2;NTHL1;POLE4;RFC5;RFC2;POLE;LRIG1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.28801237730509893,-0.8938160535174695,0.647887323943662,0.895786181781049,1.0,6/28,14.55%,NKX2-1;WNT7B;FGFR2;TCF21;HECA;PCSK5
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.23555308445057904,-0.8936547052979934,0.7560975609756098,0.8956656044864127,1.0,24/75,21.82%,TNF;APOA4;APOA1;LGALS3;TMEFF2;TMC8;LILRB1;HSPA1B;CRACD;SORL1;CARMIL2;PON1;SPRY2;CLU;HSPA1A;CARMIL1;EPHA3;AR;NR1H4;MTMR2;IMPACT;PRKCZ;RIOK3;DNAJB1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.3102057476226248,0.8933999663361434,0.6439024390243903,1.0,1.0,24/46,38.97%,PIK3R2;CHP2;GTSE1;ZIC1;ECT2;SMAD3;NEDD4;MAVS;RAPGEF3;TRIM28;UBR5;TPR;EMD;HYAL2;GAS6;TGFB1;ZPR1;RBM22;BAG3;DHX9;DMAP1;GSK3B;FLNA;RAN
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.31955009651265354,0.8933830524642311,0.6166666666666667,1.0,1.0,6/31,20.61%,E2F7;POU4F1;NDRG1;ZNF385B;BCL3;FHIT
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3066381574768683,0.8930597576055175,0.6288659793814433,1.0,1.0,4/49,3.21%,CEMIP;F2RL3;THY1;CASQ1
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,-0.24486630687604446,-0.8929485834575398,0.6376811594202898,0.8968820765912118,1.0,7/49,18.73%,ACE2;PARP6;MOGAT1;PARP8;ST6GAL1;PIK3R4;CHMP2B
prerank,Elsevier_Pathway_Collection__SCF/SKP2 Complex,0.34585427020124876,0.8928885717709419,0.5909090909090909,1.0,1.0,11/25,33.80%,CCNE1;CCNA2;CKS1B;CDKN1C;CDK6;PARP1;CDKN1A;CUL1;CDK4;SKP2;SKP1
prerank,MSigDB_Oncogenic_Signatures__AKT UP MTOR DN.V1 DN,-0.21424756268295417,-0.8928075541061933,0.8571428571428571,0.8967184273408418,1.0,47/170,18.75%,ITLN1;PI16;GPR83;SLC18A1;PHGR1;SFRP5;CHRDL1;EIF4E3;SATB1;HPGD;GNMT;NR4A3;PROM1;SH3BGR;FXYD1;GAS1;CHAD;DPT;NDRG4;CBS;BMP7;PLA2G4A;JPH3;SLC7A5;MTHFD1;GNA14;SHMT1;C1R;DPYD;LRRC1;IL17RC;PPP1R3C;KCNK3;STAB1;COL17A1;GSDMA;FMO3;CAV2;MYO1G;PDIA5;PSAT1;BEX4;ITSN1;KCNAB3;ASS1;KCTD12;RTN1
prerank,Elsevier_Pathway_Collection__N2 Neutrophils in Tumor-Promoting Inflammation and Tumor Progression,-0.28179260000634027,-0.8925092584645368,0.5806451612903226,0.8969771746359778,1.0,7/34,14.96%,IL1B;CCL5;CCL2;IL6;PIK3R1;AKT1;CXCR4
prerank,MSigDB_Oncogenic_Signatures__CRX NRL DN.V1 UP,0.26504650885091696,0.8923493341265597,0.6889952153110048,1.0,1.0,27/122,20.07%,RTBDN;TNNT1;ARG2;RHO;BUB1B;KCNB1;RHPN1;CDKN2C;CKMT1A;PAQR4;KCNJ14;SLC16A3;MYO7A;ZC3H3;ANKRD33B;TFF3;DIAPH3;CCDC107;MC1R;SLC29A2;PSD;CAMK1D;DHH;PPARGC1B;NRM;SSBP4;ACVR2B
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.29008628273123627,-0.8920294701822203,0.5679012345679012,0.8976739341652789,1.0,10/27,20.76%,P2RY12;FPR2;PDGFRA;CCR7;FLT3;FGR;PIK3R4;CD19;NOD2;TEK
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.29663045229775875,0.8917928433512471,0.6062176165803109,1.0,1.0,4/50,5.48%,PRSS56;VEGFD;MDK;MSTN
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.2709669318779079,-0.8917754868938279,0.6617647058823529,0.8978893243470564,1.0,4/38,11.16%,RET;NGFR;PRKCQ;MMP7
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,0.391311168741744,0.8917376319289911,0.6073619631901841,1.0,1.0,6/15,32.70%,SHC1;HRAS;EGF;PLCG1;CDC37;PIGU
prerank,WikiPathway_2021_Human__G Protein Signaling Pathways WP35,0.2788345799770023,0.8916304873307243,0.6310679611650486,1.0,1.0,14/87,18.69%,GNG4;GNAZ;PDE4C;PDE1C;GNAL;GNG3;PRKD1;GNB5;ADCY6;GNG8;PRKCA;HRAS;GNG10;ADCY4
prerank,Elsevier_Pathway_Collection__Pancreatic Ductal Carcinoma,0.27045236908255754,0.8916146407169637,0.6727272727272727,1.0,1.0,24/116,26.12%,IGF2;VEGFD;LEF1;E2F1;CDKN2A;SRC;JAG2;FLT1;KAT2A;SHC1;PDPK1;HRAS;SMAD3;EGF;DLL4;CDK6;TGFB2;SMARCA4;NRG1;ERBB3;MAP2K2;DVL1;MYC;CTNNB1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.3827764289016662,0.8915571209087177,0.6130952380952381,1.0,1.0,3/17,6.72%,CEMIP;HMMR;FGF2
prerank,TRRUST_Transcription_Factors_2019__FOXO1 human,0.35555992878651926,0.8915277512632371,0.5925925925925926,1.0,1.0,6/20,16.27%,FABP4;RAG1;LHB;PDGFB;PDGFA;ANGPT2
prerank,Elsevier_Pathway_Collection__MicroRNAs Role in Melanoma,0.3437556268044135,0.8914784177945339,0.5953757225433526,1.0,1.0,3/22,7.65%,E2F1;BMP4;TFAP2C
prerank,TRRUST_Transcription_Factors_2019__NKX2-5 mouse,-0.3375607777854505,-0.8913882956662643,0.6,0.8983985104843131,1.0,3/15,5.48%,MSX2;FGF10;ID2
prerank,Elsevier_Pathway_Collection__Mantle Cell Lymphoma,-0.220942073606748,-0.891272720704949,0.78125,0.8981691488823802,1.0,21/103,17.08%,CXCL13;IL10;TNF;CD79A;PRKCB;CXCL12;MS4A1;IL6;CD40LG;BTK;CARD11;LCK;AKT1;SYK;PLCG2;CXCR4;BCL2L11;TNFRSF13C;IL10RA;TNFSF13B;BCL2
prerank,MSigDB_Oncogenic_Signatures__KRAS.PROSTATE UP.V1 UP,0.2738892076298235,0.8908965454405088,0.6442307692307693,1.0,1.0,19/109,15.55%,SYT5;SLCO1C1;CEL;PLCH2;MMP11;ITGA2;REEP2;FAM155B;KREMEN2;CHRNA3;YPEL1;FOXH1;MMP17;KRT8P12;ADM2;TIMP4;FOXF2;OPLAH;TUBA8
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.3014753056618219,-0.8908353688756984,0.5789473684210527,0.898778744320672,1.0,2/21,2.92%,CLDN4;PRSS22
prerank,Elsevier_Pathway_Collection__FGFR -> AP-1/CREB/CREBBP/ELK/SRF/MYC Signaling,0.2904035774936654,0.8907653233192959,0.6190476190476191,1.0,1.0,8/49,16.31%,RASGRF1;SRC;FGF2;FGF23;MAPKAPK2;SHC1;PDPK1;ELK4
prerank,KEGG_2021_Human__Pancreatic secretion,0.27225316590342125,0.8906837761351866,0.6439024390243903,1.0,1.0,13/78,15.60%,CEL;PLA2G2A;CPA1;PLA2G2C;ATP1A2;ATP1A4;ATP2B4;ATP1B3;ATP2A1;RAB3D;ADCY6;FXYD2;PRKCA
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.2342618322249535,-0.8903059564590019,0.7,0.8995931041900861,1.0,26/94,17.36%,PLD1;FCGR3B;MAP2K1;PIK3CD;PRKCB;PTPRC;FCGR3A;AMPH;RAC2;PLA2G4A;FCGR2B;HCK;LAT;SPHK2;PIK3R1;AKT1;MYO10;WASF3;SYK;PLCG2;VAV1;PRKCE;ACTR3C;VAV3;NCF1;INPP5D
prerank,WikiPathway_2021_Human__Phosphodiesterases in neuronal function WP4222,0.29727006307584347,0.8902889222125888,0.6302083333333334,1.0,1.0,13/50,21.35%,GRIN1;CHRFAM7A;PDE4C;PDE1C;GRIN2A;PDE10A;ADCY6;ADORA2A;PPP1R1B;GRIN2C;ADCY4;ADCY10;ADCY2
prerank,Elsevier_Pathway_Collection__PDGFR -> AP-1/MYC Signaling,0.3042635197987906,0.8902322249050652,0.6420454545454546,1.0,1.0,6/37,14.95%,RASGRF1;SRC;PDGFRB;PDGFB;SHC1;PDPK1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.21371012737671152,-0.8901284600086316,0.8055555555555556,0.8995362064131995,1.0,24/148,14.75%,NLRP7;ST18;HAS2;IL1B;ACOD1;CCL5;SFRP1;CCL4;CCL3;IL1RAP;XCL1;CCL23;CCL2;EGR1;NKX3-1;XCL2;IL1RN;PELI2;CXCL8;CCL22;GBP3;SOX9;GBP1;MYD88
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,0.2776332690162166,0.8901072245674991,0.6682464454976303,1.0,1.0,13/112,13.84%,DLX5;DLX6;TWIST2;HDAC4;SRC;IHH;PSMD4;COL1A1;RBM14-RBM4;CDK1;CCNB1;BGLAP;PSMB4
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.2296416194429654,-0.8899696134143039,0.6585365853658537,0.8993653553740047,1.0,15/95,13.84%,CPNE6;LGI1;MFSD2A;L1CAM;SLC44A4;SYT1;SFRP1;S100A8;SEMA4D;SYT4;NGF;RPS6KA1;AKT1;CSNK2A3;IGF1
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,-0.2779673751482255,-0.8899071546309186,0.5822784810126582,0.8989993544754029,1.0,3/27,3.70%,CLDN4;CLDN10;CLDN8
prerank,WikiPathway_2021_Human__RAS and bradykinin pathways in COVID-19 WP4969,-0.3037595520923903,-0.8899055541863675,0.5921052631578947,0.8984873522313656,1.0,7/25,15.81%,ACE2;TNF;IL1B;KLKB1;CYP3A4;SERPING1;KNG1
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.35119145404332236,0.8896545239261338,0.5689655172413793,1.0,1.0,10/21,30.64%,DLG5;IHH;KIF7;TEDC2;RAB34;GLI1;ARMC9;GAS8;SMO;ULK3
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.25819260340297334,-0.8895965018287256,0.6935483870967742,0.8987141542775842,1.0,14/42,23.45%,IL5RA;IL2RB;FYN;HCK;PIK3R1;SYK;CSF2;VAV1;INPP5D;CSF2RB;YES1;JAK2;CSF2RA;GAB2
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,0.3043683682505852,0.8895904360629072,0.6382978723404256,1.0,1.0,12/47,14.98%,ATP4A;ATP10A;FXYD7;ATP1A2;ATP1A4;ATP2B4;CAMK2A;ATP1B3;ATP2A1;ATP9A;ATP8B3;FXYD2
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.3603645788335391,0.8895891564550352,0.5660377358490566,1.0,1.0,9/21,32.35%,FOXO6;DLG5;DBN1;LRP8;SHANK3;RELN;APOE;FMR1;SHANK1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.2364600014604622,-0.8895737604609963,0.6984126984126984,0.8982256619910441,1.0,11/62,11.90%,AJAP1;SEMA3E;SFRP1;GPM6B;BST1;EPHA1;CCR7;LIMCH1;CD3E;PLEKHA2;SKAP1
prerank,Elsevier_Pathway_Collection__Alveolar Epithelial Cell Apoptosis in COPD,-0.30328902126302587,-0.8892282010717873,0.5921052631578947,0.8985498006340973,1.0,6/25,18.80%,TNF;FASLG;PRF1;MMP7;BCL2;GZMB
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.30832895082869766,0.8891483855492038,0.6108108108108108,1.0,1.0,8/51,10.78%,KCNJ6;KCNE5;KCNH2;KCNJ9;KCNJ5;KCNN3;DPP10;KCNIP3
prerank,Elsevier_Pathway_Collection__BMP2 and WNT Signaling in Pulmonary Artery Smooth Muscle Cells,0.36443071678081135,0.889094079807325,0.63125,1.0,1.0,1/19,1.43%,LEF1
prerank,TRRUST_Transcription_Factors_2019__SIRT1 human,0.3005926180262237,0.8888035719617027,0.6302083333333334,1.0,1.0,20/45,28.86%,TP73;TERT;NQO1;TBX3;COL10A1;EZH2;NDRG1;COL1A2;SHC1;PPARG;DLL4;EGLN1;MMP9;HSF1;MYC;CTNNB1;ICAM1;ACAN;CDKN1A;HSPA4
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.24223328743795336,-0.8887393818300398,0.647887323943662,0.8993280569162126,1.0,6/63,4.09%,GRIN2B;NRXN1;LGI1;ADRA1A;TNF;SYT1
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.36363607818960886,0.888670105178946,0.6265060240963856,1.0,1.0,7/19,28.55%,BBS5;BBS2;GPR143;BLOC1S3;MREG;BBS4;MLPH
prerank,TRRUST_Transcription_Factors_2019__PARP1 human,-0.31685841031388406,-0.8884155989838184,0.5949367088607594,0.8996187374387754,1.0,4/24,8.93%,IL10;IFNG;CDH1;FOXO1
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,0.28181622351581287,0.8883279210953465,0.6479591836734694,1.0,1.0,25/90,28.48%,PIK3R2;MAPK12;CDC25C;PLK1;MAPK11;CCNB2;BUB1;CCNA2;CDK1;CCNB1;AURKA;ADCY6;PKMYT1;SPDYE1;CDC25A;ADCY4;ADCY2;ANAPC11;HSP90AB1;CCNB3;ANAPC7;SPDYE18;GNAI1;MAD2L1;MAD2L2
prerank,MSigDB_Oncogenic_Signatures__TBK1.DN.48HRS DN,0.30506866725813686,0.8882708499494992,0.6223404255319149,1.0,1.0,9/49,20.62%,BIRC5;COL4A1;CDK1;PAFAH1B3;PPOX;PDGFA;KIAA0100;EGF;STX1A
prerank,TRRUST_Transcription_Factors_2019__NR0B2 mouse,0.37368950354570896,0.888220507697637,0.622093023255814,1.0,1.0,5/17,16.65%,NEUROD1;CYP7A1;BGLAP;PPARG;SMAD3
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3150393398951062,-0.8881673788752883,0.6413043478260869,0.8996561570885704,1.0,3/18,3.70%,CLDN4;CLDN10;CLDN8
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,0.29567456819590465,0.8881013010291569,0.6335078534031413,1.0,1.0,3/55,4.61%,E2F1;TP73;CDKN2A
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.3105037056813309,0.887861196469401,0.643979057591623,1.0,1.0,23/39,50.08%,NUP37;PIAS1;NUP62;TPR;NUP133;NUP155;TRIM27;NUP160;PIAS4;UBE2I;NUP188;NUP205;NUP210;NUP214;NUP107;AAAS;NUP93;MDM2;NUP88;SEC13;SEH1L;POM121C;NUP42
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.3309711415451537,0.8878445489242452,0.6089385474860335,1.0,1.0,8/29,25.90%,VIL1;CATIP;DIAPH3;SPIRE2;PSTPIP2;WASHC3;GSN;WASHC5
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.2513549190239695,0.8873953219747194,0.7436974789915967,1.0,1.0,22/238,8.61%,ODAM;MT3;IGF2;EPHA6;FGF20;EPHB2;VEGFD;AXIN2;PRKAA2;CLDN19;KNDC1;ITGA6;ROR1;FGF17;BMP4;FGF2;EPHA10;TMEM119;FGF23;EFNA1;PDGFRB;INSRR
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.28824365246123984,0.8873737649342749,0.6413043478260869,1.0,1.0,18/56,33.01%,HDAC4;H4C15;PCGF2;NUP37;HDAC1;PIAS1;CBX8;NUP62;TPR;SATB2;NUP133;CBX5;CHD3;NUP155;NUP160;UBE2I;CBX2;NUP188
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.2755828602064953,0.8873663822999753,0.6650485436893204,1.0,1.0,7/100,4.24%,SFN;E2F1;PRODH;TP73;BRSK2;PDK1;POU4F1
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,0.379695700565012,0.8871092681415806,0.6012269938650306,1.0,1.0,2/17,10.46%,MAPK11;EXOSC4
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.27919574232330735,0.886921350696558,0.6395939086294417,1.0,1.0,10/77,10.74%,SCG2;TERT;SNAI2;ITGA6;BMP4;SRC;FAIM2;NOL3;PEA15;EYA4
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.30870263297834677,0.8868307618310155,0.6555555555555556,1.0,1.0,3/44,4.61%,HMGA2;ARG2;CDKN2A
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,0.35693125474787285,0.8867582495918845,0.6022727272727273,1.0,1.0,11/20,44.23%,COLEC12;CPSF1;CPSF4;CSTF2;PABPN1;SYMPK;CPSF3;CPSF7;CPSF6;FIP1L1;PCF11
prerank,WikiPathway_2021_Human__Biomarkers for pyrimidine metabolism disorders WP4584,0.3908992318898815,0.8867573879079242,0.5941176470588235,1.0,1.0,5/15,20.58%,CKB;TYMS;TYMP;RRM2;PUS1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.23764265428492828,-0.8864076471574903,0.7454545454545455,0.9035824324379277,1.0,8/51,10.36%,SOX10;ERBB4;SEMA3E;SEMA4A;SEMA6D;SEMA4D;SEMA6A;SEMA3D
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.3276968863050421,-0.8861921798300029,0.6,0.9035527414844349,1.0,3/15,4.24%,TCHH;DES;KRT14
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.31400714931247237,0.8859518485874298,0.6349206349206349,1.0,1.0,20/45,32.53%,FOXM1;EYA4;SPIRE2;H2AX;SLF2;HDAC10;PARP1;EYA1;DDX11;TRIM28;FAM168A;TMEM161A;OOEP;TIMELESS;PCNA;ABRAXAS1;XRCC1;BABAM2;NPAS2;UIMC1
prerank,WikiPathway_2021_Human__Sphingolipid Metabolism (general overview) WP4725,0.32890218389755826,0.8853007226870911,0.5952380952380952,1.0,1.0,3/22,12.32%,CERS1;SPHK1;CERK
prerank,Elsevier_Pathway_Collection__Synaptic Exocytosis in Dementia,0.35161702253897964,0.8852677206921348,0.6387096774193548,1.0,1.0,6/23,20.62%,MAPT;SYN1;SNAP25;UNC13B;STXBP1;STX1A
prerank,Elsevier_Pathway_Collection__Acetaminophen Induced Hepatotoxicity,-0.3297948268038313,-0.8851981840621563,0.5882352941176471,0.9055656361877934,1.0,3/15,12.99%,DNASE1L3;CAT;HMGCS2
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.3385967599462856,0.884633140968879,0.6123595505617978,1.0,1.0,12/26,37.32%,TEAD2;TEAD4;DVL2;DCHS1;TEAD3;NPHP4;YAP1;TEAD1;STK3;AMOT;TJP1;TJP2
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.28885133003663643,-0.8843847202502926,0.631578947368421,0.9072526939671077,1.0,6/27,13.42%,GRIN2B;AIM2;FYN;CR1;MEFV;TTBK1
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.22478762969377655,-0.8839283180780725,0.7083333333333334,0.9079678238828439,1.0,25/99,22.41%,EREG;SYT9;SYT8;CD4;SYT1;IL7R;FCHO1;TF;TGFA;NLRP3;BTC;REPS1;HBEGF;SH3KBP1;CFTR;CHRM2;REPS2;ITSN1;WNT5A;CD3D;AGTR1;APOB;ADRB2;SH3GL2;LDLR
prerank,WikiPathway_2021_Human__7-oxo-C and 7beta-HC pathways WP5064,0.32739491941379295,0.8838005105714382,0.627906976744186,1.0,1.0,3/27,6.61%,THEM5;CYP7A1;AMACR
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,0.35122435553644676,0.8835988013425707,0.6309523809523809,1.0,1.0,11/19,40.89%,FGF13;POLR2L;POLR2K;POLR2G;POLR2H;POLR2I;POLR2J;FGF1;POLR2A;POLR2B;GTF2F1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.2738759211684047,0.8834905469116956,0.6865671641791045,1.0,1.0,17/89,17.13%,DIO2;PTH2R;EBF2;LCN2;FABP4;PRDM16;OXTR;GPR3;ZBTB7B;LEP;CD36;ELOVL3;MFAP2;LEPR;FABP5;SCD;THRA
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.3089413196398388,-0.8834574588486181,0.6867469879518072,0.9086724352119345,1.0,7/23,13.30%,IL1B;APOA4;HSD17B13;APOA1;APOA5;AKT1;ANGPTL3
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.30540911234065987,0.8833685875561357,0.6460674157303371,1.0,1.0,19/48,33.88%,NQO1;ATOX1;TXNRD2;GPX3;GLRX2;TXNRD1;NDUFS2;FTL;TXN;CDKN2D;PFKP;PRDX4;NDUFA6;PRDX2;G6PD;STK25;SBNO2;ABCC1;LAMTOR5
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.2686060587021293,0.8832572707538855,0.6889952153110048,1.0,1.0,30/121,18.34%,DKK1;CACNB4;DNER;PAK3;MAPT;NRCAM;SNCG;LRP4;POU4F1;SDK1;UNC13A;BDNF;PCDHB14;DNM3;PPFIA3;PPFIA4;ARHGAP39;CBLN1;UNC13B;PPFIA2;PCDHB2;PLXND1;PCDHB11;SDK2;SLC8A3;NEDD4;DOK7;NLGN2;NRXN2;OBSL1
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.28329027430148523,-0.8829019374529654,0.6973684210526315,0.9096087622606762,1.0,4/30,13.58%,CSF3;CSF3R;HCK;SYK
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.3228149264305144,0.8828731599494828,0.6130952380952381,1.0,1.0,16/34,41.44%,CENPA;PLK1;MSH2;SLF2;IFFO1;MRNIP;MCM8;PINX1;BOD1;ACD;LEMD2;TPP1;ATR;RPA2;TERF2;RAD21
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.27262956269519734,0.882738782555263,0.6666666666666666,1.0,1.0,41/81,42.53%,SARNP;DDX39A;PKD1;CASC3;THOC5;RBM8A;CHTOP;NUP62;NXF1;TPR;RANBP3L;STRADA;XPO5;CCHCR1;UPF3B;SMURF1;NUP155;THOC1;POLDIP3;THOC6;NUP188;TGFB1;XPO6;THOC2;DDX39B;MAGOHB;SLU7;MALT1;ZC3H11A;HNRNPA1;XPO1;NUTF2;RAN;RAE1;NUP214;ALYREF;PHAX;RANBP3;RANBP17;U2AF1;U2AF2
prerank,TRRUST_Transcription_Factors_2019__RXRA human,-0.3126712242089578,-0.8826909513629483,0.6451612903225806,0.9096015259899096,1.0,8/18,25.59%,IL2RB;PLD1;HSD17B2;CYP3A4;TLR10;ABCC3;THBD;ABCA1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.26402695546403865,0.882555094057497,0.7081339712918661,1.0,1.0,24/146,19.34%,DUSP9;PPEF1;PTPRN2;PLPPR1;PLPP2;PTPN5;PTPRT;ACP4;DUSP23;PTPN14;ALPI;PTPRG;ACP6;SBF1;PPM1F;PLPP1;PLPPR2;PGP;PTPRR;MTMR3;PDP1;PLPPR3;PHPT1;DUSP12
prerank,WikiPathway_2021_Human__Head and Neck Squamous Cell Carcinoma WP4674,0.28271114170359596,0.8824834777060006,0.6701570680628273,1.0,1.0,5/73,4.61%,E2F1;PIK3R2;PRKAA2;TERT;CDKN2A
prerank,WikiPathway_2021_Human__Sphingolipid Metabolism (integrated pathway) WP4726,0.3217486761940884,0.882227911018561,0.5862068965517241,1.0,1.0,3/23,12.32%,CERS1;SPHK1;CERK
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.32467978469103165,-0.8819546977795844,0.6704545454545454,0.9108846308424967,1.0,4/17,10.16%,ASXL3;ABCD2;IL6;SLC18A2
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.3058226552216403,0.8818537454635862,0.6023391812865497,1.0,1.0,24/43,44.54%,ELOC;POLR2L;ELOB;POLR2K;NELFE;POLR2G;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;POLR2A;ERCC2;ELL;POLR2B;GTF2F1;POLR2F;CDK9;ERCC3;SUPT16H;CCNT2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.33327041693130766,0.8815030116500095,0.6012658227848101,1.0,1.0,7/27,16.85%,SLC13A3;PRAF2;SLC26A6;SLC1A2;PDPN;SLC25A12;SLC1A3
prerank,KEGG_2021_Human__Butanoate metabolism,-0.2910482360732888,-0.8813004752933673,0.5714285714285714,0.9120501968418971,1.0,12/27,18.14%,HMGCLL1;BDH2;ACSM3;ACADS;EHHADH;HMGCS2;ACSM5;ABAT;L2HGDH;ECHS1;HMGCL;ACAT1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.31749040765828773,0.881182999226529,0.6193181818181818,1.0,1.0,17/37,35.93%,HJURP;CD36;METTL18;ROCK2;SNCAIP;TRAF2;PARP10;HCFC1;GFAP;AGT;RAPGEF1;APOE;DAB2IP;VPS11;NCLN;TJP1;HSPA8
prerank,WikiPathway_2021_Human__BDNF-TrkB Signaling WP3676,0.30943582923314994,0.8811218202521022,0.6214689265536724,1.0,1.0,9/33,22.70%,GRIN1;TRPC6;BDNF;DLG4;SHC1;HRAS;TSC1;PLCG1;TSC2
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,0.2874681673091331,0.8810024182020627,0.6538461538461539,1.0,1.0,40/66,50.35%,ELOC;POLR2L;ELOB;POLR2K;NELFE;TAF10;POLR2G;TAF6;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;TAF9;RNMT;POLR2A;TAF1;ERCC2;ELL;POLR2B;GTF2F1;TAF12;POLR2F;CDK9;ERCC3;TAF5;SUPT16H;CCNT2;TAF9B;TAF2;GTF2E1;GTF2H2;NCBP2;GTF2H5;TAF7;GTF2A2;TAF4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.31596713539560517,0.8808547262086864,0.615819209039548,1.0,1.0,10/34,28.26%,E2F7;CDKN2A;CDKN2C;CDKN2B;CDK2AP2;CDK6;CDKN2D;SUSD2;RBL1;CDKN1A
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.36762608344341624,0.8806843211747601,0.6518987341772152,1.0,1.0,6/15,35.18%,TWNK;POLRMT;MRPL12;TFB2M;SLC25A33;MTERF2
prerank,Elsevier_Pathway_Collection__Thyroid Stimulating Hormone (TSH) Secretion in Overt Hypothyroidism,0.3236401865650311,0.8804216289726308,0.6494252873563219,1.0,1.0,7/27,17.13%,CGA;GAL;TRH;LEP;PDPK1;LEPR;THRA
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.3611573415222894,0.8804182723374022,0.5864197530864198,1.0,1.0,4/16,8.27%,SYT3;RNF157;UNC13A;SYT2
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.34057718712038293,0.8802223614125946,0.6404494382022472,1.0,1.0,1/30,0.14%,REG3A
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,0.3014894608300066,0.8801310068900173,0.6611111111111111,1.0,1.0,15/47,30.57%,HES5;DLGAP5;NOTCH3;JAG2;KAT2A;PLXND1;EGF;DLL4;HEY1;MAML1;HEYL;UBA52;NCSTN;TACC3;MAMLD1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.2968210506573731,0.8800682566391961,0.6703910614525139,1.0,1.0,15/63,22.45%,UCN2;PRKAA2;KCNB1;STK26;AKR1C3;LPL;CDKN2B;CD68;INHBB;SREBF2;WDR45;GAS2L1;TSC1;EHMT2;PCSK9
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.2955195066385611,-0.8799909758197535,0.6666666666666666,0.9148673727929101,1.0,4/23,7.89%,UNC13C;MUSK;LRRK2;ANK3
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3296909263601261,-0.8799819429538662,0.6944444444444444,0.9143547700423101,1.0,2/16,2.58%,NRXN1;WNT7A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.36922917299709856,0.8798686840335436,0.6035502958579881,1.0,1.0,2/18,3.41%,HAVCR1;CRLF2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.30341060610037524,0.8794040526456145,0.6276595744680851,1.0,1.0,9/53,16.88%,CDH13;EPS8L3;TAX1BP3;ARHGEF11;PDPN;COL1A2;ROPN1B;ROCK2;CDC42EP5
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3279462705847609,0.8792508413966016,0.6375,1.0,1.0,19/29,46.64%,MAP1A;FHIT;HSP90AB1;PARK7;DDRGK1;SDCBP;OGT;EIF3H;CAMLG;GIPC1;TAF9;USP14;BAG6;USP7;UBXN1;UCHL5;SGTA;TRIM39;NOP53
prerank,WikiPathway_2021_Human__Ectoderm Differentiation WP2858,0.2661421952403143,0.879197064915981,0.6941747572815534,1.0,1.0,17/130,12.38%,CTNNA2;CDH8;VAX2;SOX2;CAP2;CLVS1;GREB1;BMP4;TFAP2C;RHPN1;TSC22D1;CDON;RGMA;ZBTB7B;PLXNA2;PODXL;FOXL1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.2578073036220625,-0.878967991151638,0.6578947368421053,0.916465772024885,1.0,4/41,7.88%,PLP1;INA;NDRG2;ZNF430
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,0.32044633819907364,0.8789594616912139,0.6574585635359116,1.0,1.0,9/38,20.59%,COL15A1;COL9A1;MMP11;MMP12;MMP10;ADAM9;CTSD;MMP9;MMP3
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.33814941508655766,0.8789377932914921,0.6312849162011173,1.0,1.0,5/25,12.59%,CRP;SAA1;C2CD4A;IL6R;ITIH4
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.30375186334427645,-0.8787920619003,0.6382978723404256,0.9164128111183554,1.0,12/20,32.61%,ABCD2;PEX3;ACBD5;PXMP2;GDAP1;PEX13;PEX14;ABCD3;ATAD1;SLC25A17;ALDH3A2;PEX12
prerank,TRRUST_Transcription_Factors_2019__FOXM1 human,-0.3232375601054218,-0.8787386389149702,0.6447368421052632,0.9160384375523368,1.0,3/17,5.56%,SFTPB;KRT15;CDH1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.33726971274267387,0.8787003981093928,0.6390532544378699,1.0,1.0,8/25,24.01%,VIL1;PFN4;SCIN;TMSB15A;CYRIB;TWF2;GSN;KANK3
prerank,Elsevier_Pathway_Collection__EGFR and PTAFR Signaling in Ovarian Cancer,0.336505396414428,0.8786083698820942,0.6172839506172839,1.0,1.0,4/21,17.35%,RASGRF1;SHC1;HRAS;EGF
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.2871617664235447,0.8784380577197147,0.6666666666666666,1.0,1.0,36/67,38.97%,PIK3R2;CHP2;TERT;PLK1;GTSE1;CDK1;CCT3;ZIC1;ECT2;SMAD3;MAVS;LIMK2;TRIM28;UBR5;TPR;CARD10;HYAL2;MEPCE;DKC1;YAP1;PARK7;TGFB1;ZPR1;LAMTOR5;PINX1;RBM22;BAG3;CCT8;CCT6A;CCT4;DMAP1;TFRC;FLNA;CCT2;CCT7;RAN
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.3603811408048065,0.8784338267520122,0.653179190751445,1.0,1.0,11/20,40.19%,EXOSC4;INTS8;EXOSC5;INTS7;INTS1;TUT1;TOE1;EXOSC2;INTS5;EXOSC7;EXOSC9
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.2697895111900402,0.878301274648057,0.6615384615384615,1.0,1.0,13/110,13.27%,PAEP;NKD1;IL17D;SLC6A9;GPC3;PRKN;DTL;UHRF1;OAZ3;VPS28;C4BPB;APC2;GBA
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.34262955064820966,0.8782109196072196,0.6325301204819277,1.0,1.0,4/25,8.88%,NKX6-2;HES5;KIF14;TMEM98
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.29869011111430144,0.8781639243453879,0.6850828729281768,1.0,1.0,34/51,47.39%,NEK2;SRC;AURKB;CCT3;PIF1;SMG5;CTNNB1;NEK7;PNKP;PINX1;HNRNPU;CCT8;GNL3L;CCT6A;CCT4;TERF1;MAPK3;HNRNPA1;ACD;CCT2;CCT7;ATR;EXOSC10;NAT10;TERF2;CCT5;FBXO4;MAPK1;MAP2K7;CTC1;MAP3K4;STN1;TCP1;MAPKAPK5
prerank,TRRUST_Transcription_Factors_2019__MYB human,0.3193186912979181,0.8773740141506147,0.6464088397790055,1.0,1.0,14/33,29.91%,SIM2;KLF1;CD34;DHRS2;COL1A1;COL1A2;ELANE;TK1;MYC;WT1;MZF1;ICAM1;CTSG;HRH1
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.36987415812829344,0.8772406459260836,0.6089743589743589,1.0,1.0,7/15,36.23%,VPS28;MVB12B;VPS37D;UBA52;SGIP1;NMT2;MVB12A
prerank,TRRUST_Transcription_Factors_2019__TCF3 mouse,0.3254586222440037,0.8771382165153906,0.6413043478260869,1.0,1.0,2/31,1.43%,COL2A1;LEF1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.355543387189742,0.8769868210685541,0.6413793103448275,1.0,1.0,9/19,46.98%,SRSF12;PCBP4;RBMX;PTBP1;U2AF2;SFSWAP;RNPS1;RPS26;RPS13
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.33464403008701155,0.876686702408458,0.6294117647058823,1.0,1.0,5/24,12.24%,THEM5;ACSBG2;ACSL6;ACSL4;ELOVL3
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.3086099691510265,0.8765826298204218,0.6486486486486487,1.0,1.0,11/33,24.92%,NEUROD1;POU4F1;PRKN;FOXC1;NME1;PPARG;EGF;MMP9;H1-0;TXN;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.2531566139809521,0.8762630571225637,0.7104072398190046,1.0,1.0,40/213,16.80%,LGR6;CEMIP;EPHB2;LEF1;CGA;TWIST2;CDH13;VIL1;TDGF1;SNAI2;CCL26;MDK;ITGA6;ARHGEF39;GTSE1;SPHK1;PDGFRB;COL1A1;ZNF703;FAM83H;DUOX1;TCAF2;SEMA7A;SEMA6C;PODXL;PDGFB;PDPN;FLT1;PPM1F;PDGFA;PLAU;SEMA5B;CCL24;CCL11;SEMA6B;PRKCA;HRAS;ROCK2;ADAM9;RHOC
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.3720391573529619,0.8762314321537908,0.6467065868263473,1.0,1.0,1/15,0.44%,CHRND
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.2924728775712063,0.8762295578787972,0.6559139784946236,1.0,1.0,12/50,19.86%,ALOX15B;CYP7A1;SQLE;AMACR;AKR1C3;ALOX12;HSD17B1;HMGCR;TM7SF2;LBR;PMVK;CH25H
prerank,TRRUST_Transcription_Factors_2019__SOX9 mouse,0.33209678416754584,0.8761948307086638,0.6588235294117647,1.0,1.0,3/24,4.23%,COL2A1;MATN1;PHEX
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.3673827147794659,0.8760808407493299,0.6227544910179641,1.0,1.0,2/16,8.61%,ASIC1;INSRR
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.3222381450761027,0.8760647589891007,0.6551724137931034,1.0,1.0,10/36,14.86%,CALCA;CCL26;CCL13;CCL25;CCL20;IL6R;PDGFB;FLT1;CCL24;CCL11
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.25160158386890136,0.8759517485836372,0.7456896551724138,1.0,1.0,105/227,43.25%,FBXW10;KLHL41;BIRC5;PSMD4;DTL;FBXL18;FBXL16;KLHL21;CCNF;FBXO31;KLHL13;SPSB2;ASB12;ASB16;PSMB4;SQSTM1;ELOC;ANKRD9;COMMD5;DCAF13;OBSL1;DCAF8;COMMD4;ELOB;FBXL8;ASB1;KLHL11;CCDC22;GAN;HIF3A;KLHL25;FBXL15;NPLOC4;CUL7;NEDD8;PSMB3;COPS5;FBXO41;UFD1;UBE2M;PSMD14;WDR5;CUL4B;UBA52;FBXL22;SPSB1;SOCS3;PSMB5;PSMD2;CUL9;PSMA1;SOCS5;PSMD10;KEAP1;RBBP7;NEURL2;PSMC4;PSMC3;FBXW5;CUL1;DDB2;COPS6;SKP2;DCAF7;SKP1;PSMC5;KCTD7;SEM1;TULP4;PSMB6;FBXO32;PSMD8;UBE2D2;PSME2;FBXO44;VCP;DDB1;PSMD13;PSMB7;PSMA7;FBXL19;ZBTB16;FBXL13;RBBP5;PSME3;COPS8;GPS1;KLHL5;KLHL22;UBXN7;FBXW8;ASB6;FBXW11;COMMD3;KCTD6;FBXO6;FBXO4;PSMB2;RBX1;DDA1;PSMA6;ASB11;NAE1;UBC;FBXL7
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.2768306551248219,0.8758787617867122,0.6548223350253807,1.0,1.0,39/73,46.08%,ELL3;DAND5;POLR2L;INTS8;POLR2K;INTS3;POLR2G;NABP2;ZNF143;INTS7;TAF6;INTS1;POLR2H;SNAPC2;RPRD2;INTS11;POLR2I;POLR2J;POU2F1;INTS9;TAF8;SUPT5H;INTS5;TAF9;POLR2A;ELL;POLR2B;GTF2F1;PHAX;POLR2F;CDK9;TAF5;SRRT;INTS4;PCF11;CCNT2;SNAPC4;GTF2E1;RPRD1B
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.35906544364111564,0.8757471112441773,0.6219512195121951,1.0,1.0,5/20,31.22%,KIF20A;CEP55;KLHDC8B;VPS4A;CHMP2A
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.2871906486487825,-0.8756536399263399,0.6904761904761905,0.92326619480708,1.0,7/28,13.38%,JCHAIN;WFDC2;DEFB1;TF;PI3;SFTPD;CAMP
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.2632610576993646,0.8756117000341459,0.6952380952380952,1.0,1.0,39/122,27.67%,KIF1A;PAK3;BRSK2;MAPT;KNDC1;CHRNB2;CHRNA3;FGF2;CDX1;ARHGAP44;LEP;CDX2;PPFIA2;PLXND1;CYRIB;LZTS1;NEDD4L;NEDD4;CRB2;BCL6;TANC2;CDK5R1;EGLN1;SPARC;SRCIN1;BCL9L;LFNG;SHANK3;ZMYM3;EMP2;MYO19;POGLUT1;CDK5;CTNNB1;FMNL2;CAMSAP1;HECW1;BRSK1;STRIP1
prerank,WikiPathway_2021_Human__Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,-0.28018787817481294,-0.8755987969446605,0.6756756756756757,0.922881902782553,1.0,6/31,13.68%,TNFSF11;TNFRSF11B;FZD1;WNT1;TNFRSF11A;P3H2
prerank,Elsevier_Pathway_Collection__Growth Factor Signaling in Pancreatic Neoplasms,0.2812412506764619,0.8755609562927763,0.6619047619047619,1.0,1.0,10/69,17.35%,IGF2;VEGFD;LEF1;SRC;FLT1;SHC1;PDPK1;PRKCA;HRAS;EGF
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.27832305777384875,-0.8753714829639727,0.6933333333333334,0.9228703194701066,1.0,6/33,9.65%,NKAIN2;PRSS8;SIK1;ANK3;NKAIN1;SCN3B
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,0.29618841488324327,0.8747448449160754,0.6411764705882353,1.0,1.0,7/39,12.95%,FBN3;GDF5;BMP4;LOXL2;EFEMP1;LOXL1;MFAP2
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.1835638592102754,-0.8745346938418161,1.0,0.9244111201567677,1.0,85/473,17.18%,ASCL1;GRIN2B;ESRP1;FOSB;GABRB1;SPINT2;EREG;SPINT1;EGR3;ERBB4;FGF10;EGR2;ADCYAP1R1;NTRK3;NTF3;GALNT3;FOS;ID4;LAMA1;COL6A6;ID2;COL4A3;NTRK2;ESR1;PDGFRA;BCL11B;NRG4;ALK;TF;MAP2K1;ADAP1;KCNH8;GABRG3;PRKCB;CXCL12;FGFR2;TGFA;EGR1;FYN;AXL;CILP;NGF;CYBB;KL;NTRK1;S100B;CD274;BTC;LAMC2;RPS6KA1;PLG;LCK;TRIB1;FLT3;NCKAP1L;EGR4;SH2D2A;PIK3R1;AKT1;TNS4;WASF3;PGR;IGF1;FLRT3;GRAP;FLRT2;PTN;PCSK5;HBEGF;SH3KBP1;TIAM1;VAV1;PRKCE;SPRY2;PRDM1;ITGB3;F3;PTK6;VAV3;THBS1;DUSP6;PIK3R4;ITCH;NCOR1;NCF1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.23944335191755495,-0.8744573025316118,0.6964285714285714,0.9241262045340201,1.0,10/60,13.06%,TNF;TLR3;IRAK1BP1;TLR8;CARD11;REL;TICAM2;TLR4;TLR2;AKT1
prerank,Elsevier_Pathway_Collection__WNT Signaling in Cystic Kidney Disease,0.30275699736935013,0.8743777573448831,0.6610169491525424,1.0,1.0,3/43,3.64%,LEF1;WNT4;WNT9B
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.21335368766636825,-0.8743590252381116,0.8518518518518519,0.9238448182411266,1.0,38/130,21.42%,GSTA2;TRPV4;IFNG;TNF;IL1B;GSTA1;FOS;GSTT2B;PIK3CD;SUMO4;CCL2;GSTM5;RAC2;SELE;PIK3R1;AKT1;VCAM1;KLF2;BMPR2;ITGB3;ACVR2A;BMPR1B;BCL2;HMOX1;NCF1;CAV2;MAPK10;ASS1;DUSP1;GSTO2;NCF2;MAPK13;GSTP1;PRKCZ;GSTM1;MAP2K6;CYBA;JUN
prerank,MSigDB_Oncogenic_Signatures__CAMP UP.V1 UP,0.25289303856232714,0.8740684220384324,0.7345132743362832,1.0,1.0,53/179,31.17%,PLCH1;TOMM40L;ELN;ACSL4;NUAK2;CKMT1A;ZNF385A;SIL1;IPO4;DAP3;PRIM1;PYCR2;NME1;TMEM9;UPP1;TYMP;NDUFV1;GAS5;CHAF1A;MAGED1;IFITM3;CEP250;ILF2;WASH3P;HAX1;NDUFS2;COPE;WDR24;CS;MDH2;ZNF367;TMED9;COX8A;HMGB2;CCDC124;ARF1;TRMT61A;TRIM38;MYC;STRADA;AATF;ATXN7L3B;MAD2L1;TGFBI;MRPL15;AZIN1;ALDOA;VAMP4;ANKHD1-EIF4EBP3;PDE4DIP;HSPA5;POLR3H;LONP1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3551537311717434,-0.8739669115269023,0.6506024096385542,0.924274571231215,1.0,7/15,19.70%,SCP2;ACAA1;EHHADH;ACOX1;CROT;ACOX2;ACOX3
prerank,Elsevier_Pathway_Collection__Ca2+ Overload in Muscular Dystrophies,0.3472955758880094,0.8738058133364803,0.6807228915662651,1.0,1.0,3/21,6.66%,CACNA1S;SCN4A;SRC
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.2985216583866142,0.8737005305034112,0.6182795698924731,1.0,1.0,12/47,19.76%,B3GALT1;HS3ST5;GPC3;HS6ST2;NDST1;HAS1;HS3ST2;HS6ST1;GPC2;B3GAT3;B4GALT7;HSPG2
prerank,Elsevier_Pathway_Collection__EGFR Transactivation in Cancer and Non-Cancer Cells,0.2871855342579681,0.8731078798734963,0.6701570680628273,1.0,1.0,13/60,17.96%,GRPR;LPAR4;SRC;BDKRB2;PTGFR;PACSIN3;BDKRB1;NMB;SHC1;HTR2B;ADAM9;EGF;BCL6
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.33285165434698627,0.8729627513436726,0.6304347826086957,1.0,1.0,3/33,6.86%,RFLNA;BAIAP2L2;FSCN2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.3559297140266993,0.8729063424564075,0.6331360946745562,1.0,1.0,3/18,6.72%,ROBO1;TDGF1;FGF2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.28164456982676467,0.8726650021043513,0.6666666666666666,1.0,1.0,27/71,33.56%,DLX1;APLN;FGF2;ATP2B4;CREB3L1;SOSTDC1;PPARG;SKOR1;DAND5;CRIM1;NEDD4;NBL1;ACVR2B;SPRY3;RBPMS2;FSTL3;HTRA3;BAMBI;HGS;SMURF1;AGT;HIPK2;DAB2IP;MMRN2;ADAMTS12;CASK;SMURF2
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,0.3265491061632284,0.8726170183685152,0.6369047619047619,1.0,1.0,7/27,17.49%,ADRA2C;DMBT1;ABCA3;PGA5;LMCD1;ADORA2A;CKAP4
prerank,Elsevier_Pathway_Collection__ER Associated Protein Degradation in Vesicular Transport,-0.30719833884488196,-0.8725591269324738,0.7073170731707317,0.9271678758273114,1.0,19/19,69.31%,HERPUD1;EDEM1;RNF5;SEL1L;SELENOS;NGLY1;AMFR;RAD23A;RPN1;DERL2;UBQLN1;SYVN1;DNAJC10;UBQLN2;ERLEC1;DERL3;VCP;DERL1;HSPA5
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.2980762866565181,0.87253117841468,0.6467391304347826,1.0,1.0,31/46,52.83%,PCGF2;NUP37;CBX8;NUP62;TPR;NUP133;NOP58;NUP155;NUP160;UBE2I;CBX2;NUP188;NUP205;NUP210;NUP214;NUP107;RING1;AAAS;PHC2;NUP93;NUP88;SEC13;SEH1L;POM121C;HNRNPC;NUP42;SCMH1;NUP153;PHC3;NUP43;NUP85
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,0.3129842982419015,0.8724923399979165,0.6574585635359116,1.0,1.0,6/31,13.69%,ST8SIA3;EGFL7;ST6GALNAC4;ST8SIA5;NEU3;CTSA
prerank,Elsevier_Pathway_Collection__SNS Related Adrenal Cortex Response,0.3312371454126266,0.8723773869141989,0.6158536585365854,1.0,1.0,3/25,6.70%,ADRA2C;REN;ADRA1D
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.30497294402119846,0.8723178026038094,0.7111111111111111,1.0,1.0,15/46,20.80%,BUB1B;BMP4;WEE2;BRINP1;BUB1;FOXC1;RGCC;SCRIB;CDKN1C;ZWINT;CHEK1;SMAD3;BCL6;PRCC;BTG3
prerank,TRRUST_Transcription_Factors_2019__JUND human,-0.2595899932439684,-0.8721699149088158,0.6883116883116883,0.9276144322471952,1.0,11/30,17.94%,PTGS2;CCL5;IL6;CD40LG;SFTPD;CCR4;CLU;ITGB3;F3;PLAUR;GADD45A
prerank,Elsevier_Pathway_Collection__Autocrine Cytokine/Chemokine Loops in Systemic Scleroderma,-0.27342205003974135,-0.8720790828030329,0.7222222222222222,0.9272773600281132,1.0,14/32,23.65%,IL1B;FOS;PDGFRA;CCL2;EGR1;CCR2;MYD88;MAP2K3;MAP2K6;JUN;JAK2;MAP3K5;PDGFC;MAP2K4
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.26267603794581257,0.8717986057730842,0.722488038277512,1.0,1.0,72/127,48.97%,AGO2;LAGE3;RNASE1;RNASEL;POLR2L;RBM3;ADAR;RBMS1;PCBP3;POLR2K;METTL3;BICD1;ADAD2;POLR2G;NOVA1;ATXN2;DKC1;THOC1;RNASE4;POLR2H;RBMX;POLR2I;TP53RK;POLR2J;RNASEH2C;DDX39B;HNRNPU;AGO1;NOL9;PABPN1;DHX9;DROSHA;RBFOX2;ISG20;HNRNPA1;POLR2A;DDX20;HNRNPH2;PTBP1;TBRG4;RBM4;EXOSC7;RBM6;POLR2B;RNASET2;CLP1;PCBP1;GTF2F1;HNRNPR;RNASEH2B;PABPC4;RNASE2;DDX17;DDX54;POLR2F;SUPV3L1;SKIV2L;RBM5;HNRNPM;SND1;MTREX;RNASEH1;WDR74;RBM39;MPHOSPH10;HNRNPUL1;SNRNP40;HNRNPF;DHX8;TFIP11;PABPC3;NCBP2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.29740949121368687,0.8714941970252705,0.671957671957672,1.0,1.0,9/49,14.68%,CRP;GRIN1;MAPT;ADGRB1;PDGFRB;AKR1C3;CD36;PDGFB;AKR1C1
prerank,Elsevier_Pathway_Collection__Deacetylases Activation in Histone Deacetylation in Cancer,0.37686371185779066,0.8714729404831115,0.6419753086419753,1.0,1.0,7/15,37.91%,HDAC4;HDAC5;HDAC1;SIRT6;HDAC8;SIRT7;HDAC7
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.23238781625200544,-0.8714084628895102,0.7843137254901961,0.9284261537829688,1.0,24/80,18.83%,WNT7B;TNN;NOCT;HGF;NOG;FBN2;SEMA4D;FGFR2;IL6;CCN1;BMP7;FERMT2;GREM1;RORB;SOX9;IGF1;RUNX2;BMPR2;ACVR2A;BMPR1B;GDF10;TWIST1;SMOC1;DDR2
prerank,Elsevier_Pathway_Collection__Sperm Motility Impairement in Testicular Male Infertility,0.38020974373527355,0.8713783457239191,0.6625,1.0,1.0,7/15,21.31%,ATP2B4;DNAH11;CATSPER1;ACR;ADCY10;CATSPER2;DNAH5
prerank,WikiPathway_2021_Human__IL-5 signaling pathway WP127,-0.26354049988851924,-0.8709754899854601,0.6923076923076923,0.9289350860415639,1.0,14/39,23.34%,IL5RA;FOS;MAP2K1;BTK;RPS6KA1;PIK3R1;AKT1;SYK;BCL2;CSF2RB;JUN;JAK2;STAT1;PIK3CG
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.2935435966581481,0.8708805615321303,0.7071823204419889,1.0,1.0,12/65,18.12%,NKD1;GPC3;PRKN;DTL;OAZ3;VPS28;C4BPB;APC2;APOA2;NEDD4L;NEDD4;BARD1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.32890751881469793,0.8707371001168872,0.6352941176470588,1.0,1.0,4/27,15.58%,SNAI2;MSX1;SMYD2;ANKRD1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.245929279516087,-0.87054714982082,0.78125,0.9293636652753965,1.0,8/42,11.92%,NDNF;IL10;TNF;CD160;FASLG;CCL2;CD40LG;GATA3
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,0.3370768469255156,0.870456626080346,0.5977653631284916,1.0,1.0,4/23,11.88%,DUSP9;CDK1;PEA15;IL6R
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.19541054686146367,-0.8702603401575874,1.0,0.9295621393497068,1.0,24/154,13.93%,ERBB4;RIPK3;EPHB1;MUSK;SIK1;LRRK2;CAMK4;NTRK2;PDGFRA;EPHA1;ALK;MYO3A;ITK;FGFR2;CAMK2B;STK17B;EPHB3;NTRK1;MAK;FLT3;HCK;AKT1;MAPK15;FGR
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.337933809993024,0.8701473244539828,0.6271186440677966,1.0,1.0,7/25,26.97%,ABHD12B;GDPD1;PLA2G4C;PLA2G4F;PLA2G6;PLA2G4E;INPP5F
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.3602440771957462,0.8698901157986673,0.6172839506172839,1.0,1.0,4/15,27.50%,COQ8A;AIFM2;FDXR;PDSS1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.29014945250831864,0.8698278022954866,0.616580310880829,1.0,1.0,11/55,20.87%,PYDC1;SPHK1;PRKN;IKBKG;H2BC11;SHARPIN;TRAF2;TRAIP;PELI3;RNF31;FADD
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.2974542977933756,-0.869781170458446,0.7012987012987013,0.9301556154455091,1.0,3/19,7.43%,PRSS22;ECM1;CST7
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.26097464374127327,0.8695784509312778,0.7081339712918661,1.0,1.0,30/142,21.81%,ODAM;RASGRF1;CHP2;MAPK12;THY1;CCL26;CCL13;ITGA6;CCL25;CCL20;ARHGAP11B;EZH2;CD200;S100A10;ASAP3;ARHGAP11A;RGS16;CCL24;GNB5;CCL11;HRAS;ECT2;RHOC;SGSM2;RAPGEF3;SRGAP2;TGM2;RGP1;FNTA;CCL18
prerank,Elsevier_Pathway_Collection__Telomere Maintenance,0.35079067754266685,0.8695456006128284,0.6477987421383647,1.0,1.0,1/20,3.20%,TERT
prerank,WikiPathway_2021_Human__MTHFR deficiency WP4288,0.3425380534613701,0.8695341067838539,0.6526946107784432,1.0,1.0,8/23,24.95%,GRIN1;GRIN2A;DNMT3A;MTHFR;CHKA;EHMT2;DNMT1;DNMT3B
prerank,WikiPathway_2021_Human__16p11.2 distal deletion syndrome WP4950,-0.29113303343351604,-0.8695318853575346,0.6463414634146342,0.9301750255003323,1.0,9/29,23.77%,CR2;LAT;CD82;CD19;PLN;NFATC2;JAK2;CD81;C3
prerank,WikiPathway_2021_Human__Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.31552466653619216,0.8695124385322106,0.6707317073170732,1.0,1.0,3/31,6.21%,GJB6;LEF1;BMP4
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.3391831615484944,0.8691154913293402,0.6352201257861635,1.0,1.0,11/24,39.59%,UHRF1;RAG1;PCGF1;CUL4B;BCOR;RNF20;DDB2;ATXN7L3;SKP1;DDB1;KDM2B
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.24175810533590494,-0.8690461706084618,0.6785714285714286,0.9308502557458493,1.0,14/58,18.63%,EHD3;CXCR1;CXCR2;LILRB1;CXCL8;MX2;SYK;FCER1G;LILRB4;ITGB2;NSG1;PIK3R4;REP15;LGMN
prerank,Elsevier_Pathway_Collection__Proteins Involved in Dilated Cardiomyopathy,-0.19978139731063047,-0.8689758459052402,0.8947368421052632,0.9305351507380334,1.0,19/151,9.64%,CSF3;ERBB4;IL10;ACE2;IFNG;TNF;RCAN1;NEBL;MMP1;HGF;CDH1;TLR3;NR3C2;XDH;DCN;PPARGC1A;DSG2;CCL2;IL6
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,0.31510394887377746,0.8688844073434173,0.6593406593406593,1.0,1.0,6/37,8.72%,PIK3R2;SLC2A5;TAS1R3;ATP1A2;ATP1A4;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.23907335201073399,0.8688565797153021,0.8135593220338984,1.0,1.0,30/348,8.25%,ODAM;MT3;IGF2;THBS4;INHA;CEMIP;FGF20;VEGFD;AXIN2;CLDN19;NODAL;STOX1;KNDC1;TDGF1;CHI3L1;GDF5;PLK1;MSTN;CENPE;FGF17;BMP4;SRC;FGF2;SPHK1;TMEM119;FGF23;BDNF;ATP2B4;EFNA1;TTK
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.2334155772200296,0.8687900653631667,0.78099173553719,1.0,1.0,36/456,8.56%,HMGA2;MT3;PAX2;DKK1;SIX1;GCG;SFN;FGF20;LEF1;FATE1;SIX4;OSR1;PAGE4;MAPK8IP2;PRKAA2;DPEP1;TDGF1;POU4F1;SNAI2;MDK;IL31RA;RNF157;PLK1;TBX3;BMP4;KIF14;BIRC5;SRC;SPHK1;IRAK1;FAIM2;BDNF;PRKN;NUAK2;PRAP1;DHRS2
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.25941521810726403,0.8686409696857977,0.7163461538461539,1.0,1.0,16/115,18.32%,DKK1;TERT;XIRP1;PLK1;BMP4;HDAC4;PRKN;AURKB;AURKA;PDGFB;NVL;HDAC5;PKD1;CLDN5;NES;SNAPIN
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.2862065364268697,-0.8684031511689068,0.6282051282051282,0.9314256567307118,1.0,10/31,23.90%,CXCL10;CCL5;POU2AF1;IL6;POU2F2;LGALS9;RIOK3;IFIH1;DDX58;OAS1
prerank,TRRUST_Transcription_Factors_2019__PPARA mouse,0.2966000411088918,0.8683127982769063,0.648936170212766,1.0,1.0,7/42,11.46%,SPP1;FABP4;CYP7A1;CDKN2A;MMP12;LPL;CD36
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.2749926483047534,-0.8677393588340244,0.7162162162162162,0.9325376330793923,1.0,6/31,11.35%,IL10;MZB1;XCL1;PTPRC;IL6;SASH3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.3250495764817718,0.8672390100965919,0.6149425287356322,1.0,1.0,14/29,41.21%,CENPA;PLK1;NDC80;SAPCD2;SPDL1;GPSM2;GJA1;MAD2L1;NSFL1C;ESPL1;NDE1;HTT;NUMA1;FBXW11
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.2897091886369657,0.8671799826337129,0.6994219653179191,1.0,1.0,29/51,47.20%,POLR2L;UVSSA;POLR2K;POLR2G;COPS5;CUL4B;UBA52;POLR2H;COPS6;POLR2I;POLR2J;XAB2;DDB1;POLR2A;ERCC2;COPS8;USP7;GPS1;POLR2B;RBX1;UBC;POLR2F;ERCC3;COPS7A;COPS4;XPA;RPS27A;PRPF19;GTF2H2
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.3107564555231761,0.8670159025669858,0.6519337016574586,1.0,1.0,6/37,11.19%,HCN2;AQP8;SLC26A6;VGF;HCN3;DUOX1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Autistic Disorder,0.33172725484698384,0.8667954264045511,0.6447368421052632,1.0,1.0,3/21,11.30%,SLC6A4;BDNF;DIAPH3
prerank,Elsevier_Pathway_Collection__GNRH Signaling Impairment in Hypogonadotrophic Hypogonadism,0.3274086524799813,0.8663132127617877,0.6453488372093024,1.0,1.0,5/30,16.31%,CGA;RASGRF1;LHB;MAPKAPK2;ELK4
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.25549750319899883,-0.8662309579629308,0.717948717948718,0.9357448294887247,1.0,5/37,9.97%,NR4A2;BCL2L14;TNF;ASAH2;NKX3-1
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.3408883964015794,0.8661147826795076,0.6687116564417178,1.0,1.0,8/24,23.04%,KASH5;SYCE1;TRIP13;MAJIN;IHO1;P3H4;ANKRD31;FANCD2
prerank,Elsevier_Pathway_Collection__Hepatic Stellate Cells in non-Alcoholic Fatty Liver Disease,-0.243348818598537,-0.8660959388338757,0.6935483870967742,0.9355229072251202,1.0,13/53,15.37%,TNF;FOS;CDH1;PDGFRA;MAP2K1;TGFA;CCL2;EGR1;IL6;CXCL8;TLR4;MYD88;KLF6
prerank,Elsevier_Pathway_Collection__HIF1 Signaling,0.3296186234092673,0.8659995248365302,0.6369047619047619,1.0,1.0,8/24,32.13%,EPO;HIF1AN;TXNRD1;EGLN1;TXN;GAPDH;HIPK2;SLC2A1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.3645087661429963,0.8657696322100088,0.639751552795031,1.0,1.0,4/15,27.50%,COQ8A;NDUFA9;FDXR;PDSS1
prerank,Elsevier_Pathway_Collection__mTOR Signaling Activation by Amino Acids,-0.2604410318071347,-0.8653727061383549,0.6101694915254238,0.9365830835627453,1.0,9/45,19.01%,SLC6A19;ACE2;SLC7A8;SLC7A5;AKT1;IGF1;PPP1R15A;SESN2;IRS2
prerank,WikiPathway_2021_Human__Ras signaling WP4223,0.2516419306705768,0.8653366877151438,0.755656108597285,1.0,1.0,25/171,16.44%,GNG4;RASGRF1;PLA2G2A;PIK3R2;PAK3;CALML6;GRIN1;SHC3;PLA2G2C;PDGFRB;GRIN2A;GNG3;IKBKG;RASGRF2;PLA2G4C;RIN1;FLT1;PLA2G4F;ABL2;GNB5;SHC1;GNG8;PRKCA;HRAS;MRAS
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.35436790333805773,0.8653272357189391,0.61875,1.0,1.0,6/15,27.00%,NODAL;FOXH1;SMARCA4;HDAC1;NCOR2;HEYL
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.34229142637447135,-0.8652599754428688,0.6559139784946236,0.936322885076549,1.0,15/15,65.79%,AKT1;BCL2;AKT3;AKT2;PPP3CC;YWHAE;YWHAB;YWHAQ;PPP3R1;YWHAG;BAD;YWHAZ;BID;YWHAH;REXO2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.243426911472279,0.8652285590144351,0.8083333333333333,1.0,1.0,132/315,43.89%,TRIM71;CDC20B;PLK1;BUB1B;CDC20;KIF14;UBE2C;PRKN;PSMD4;FBXL18;FBXL16;AURKB;KCTD17;UBE2S;CCNF;PTTG1;CDK1;CCNB1;FOXRED2;FBXO31;AURKA;SPSB2;IFI27;UCHL1;PSMB4;ANKRD9;ANKZF1;NEDD4L;NEDD4;TRIM72;SHARPIN;RNF187;FBXL6;FBXL8;FBXO39;UBE2A;ANAPC11;ARNTL;TRIM3;FBXL15;COP1;NPLOC4;TRIM25;PSMD1;AGAP3;CTNNB1;ANAPC7;PSMB3;RNF216;HECW1;ZFAND2B;UFD1;PSMD14;DDIT3;CUL4B;UBA52;MAD2L1;KCTD13;FBXL22;UBE4B;SMURF1;SPSB1;PSMB5;PSMD2;PSMA1;RMND5B;HSPA5;PSMD10;ARRB1;PSMC4;PSMC3;FBXW5;CUL1;DNAJB2;DERL1;SKP2;SMURF2;SKP1;NSFL1C;TBL1X;PSMC5;RNF126;PSMB6;CDC23;PSMD8;FEM1A;DNAJC18;SEC61B;FAM8A1;WFS1;PSME2;FBXO44;VCP;DDB1;DERL3;PSMD13;PSMB7;TAF1;PSMA7;FBXL19;RHBDD2;ANAPC1;BAG6;FBXL13;PSME3;UBE2J2;CDK2;HUWE1;ANAPC2;FAF1;KLHL22;FBXW11;MAN1B1;FBXO6;ZFAND2A;FBXO4;PSMB2;HECW2;RBX1;PSMA6;KCTD10;FAF2;ANAPC4;UBC;FBXO45;FBXL7;STUB1;ECPAS;PSMD9;WWP2;UBXN1;KCTD2
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.21787413136541253,-0.8651738177958231,0.7142857142857143,0.9360376263466983,1.0,13/81,18.04%,SMPD3;IFNG;TNF;PLD1;CPEB3;SLC2A13;IL6;CHRNA7;SPHK2;LRRTM3;CLU;THBS1;PIWIL2
prerank,KEGG_2021_Human__Glutamatergic synapse,0.2637700949181615,0.86492358813399,0.7135416666666666,1.0,1.0,23/101,18.69%,GNG4;GLUL;GRIN1;GRIK2;GRIK4;GRIN2A;GNG3;GRIN3B;CACNA1C;PLA2G4C;SLC1A2;PLA2G4F;DLG4;GNB5;ADCY6;GNG8;GRM1;PRKCA;GRK3;SLC1A3;GRIN2C;GNG10;ADCY4
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.28005532610456413,0.8648539422015779,0.7303921568627451,1.0,1.0,15/79,22.04%,AVIL;EPS8L3;MSTN;ANLN;SAXO1;TENM2;KCTD17;HRAS;CDC42EP5;TWF2;PALM;WASF2;FNBP1L;MARK4;MIEN1
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.2706733947824012,-0.8646674442470911,0.6419753086419753,0.9366681008718473,1.0,5/29,13.64%,NR4A2;NR3C2;ESR1;NR1I2;PGR
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.31082775416363767,-0.8644755043360585,0.6458333333333334,0.9366140671615542,1.0,4/16,8.31%,APOA4;HBA1;CAT;HBB
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,0.27369259208590035,0.8643008764897132,0.6772486772486772,1.0,1.0,13/81,18.69%,GNG4;PDE4C;CAMK2A;PDE1C;GNAL;GNG3;GNB5;ADCY6;GNG8;PRKCA;PPP1R1B;GNG10;ADCY4
prerank,WikiPathway_2021_Human__STING pathway in Kawasaki-like disease and COVID-19 WP4961,-0.2935377552379211,-0.8640543389188178,0.6629213483146067,0.9371865539226747,1.0,4/20,16.58%,IL1B;NLRP3;REL;F3
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,0.2669284915298945,0.8639343123905389,0.6650717703349283,1.0,1.0,10/93,7.43%,SLC22A12;SLC34A3;SLC39A4;TAC4;SLC12A1;SLCO2A1;AVPR2;SLC4A1;SLC6A3;SLC5A2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.32087912533012897,0.8635876225478095,0.6296296296296297,1.0,1.0,2/28,2.50%,TNNC1;TNNI3
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.18751098897648494,-0.8635308847791378,1.0,0.9378659080783045,1.0,59/217,25.46%,EDAR;CD4;TNF;IL1B;ECM1;FASLG;NLRP12;TNIP3;ESR1;TNFSF10;CASP1;CCR7;PRKCB;SUMO4;RHOH;APOL3;S100B;PELI2;CARD11;REL;TRIM34;TICAM2;CLEC7A;TRIM22;CARD16;SPHK2;PER1;S100A12;PLCG2;MYD88;SECTM1;LILRB4;LGALS9;NLRC3;HMOX1;TRIM5;LPAR1;NDFIP2;NR1H4;WNT5A;NOD2;GSTP1;INAVA;TAB2;TMEM106A;RIOK3;CD40;STAT1;F2RL1;TRIM21;TRIM14;UNC5CL;ZDHHC13;HLA-DRB1;UFL1;TRIM6;MIER1;CARD9;PINK1
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.3207531588391086,-0.8634594838437574,0.6813186813186813,0.9374794517152292,1.0,2/15,6.67%,IFNG;CBFA2T3
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,0.34753324024920457,0.8634201293416252,0.6568047337278107,1.0,1.0,8/20,37.49%,CDKN2A;GSDMD;DIABLO;CASP9;SEPTIN4;APIP;BAX;MAPK3
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,0.3299361451847545,0.8634176235352389,0.6073619631901841,1.0,1.0,6/24,25.29%,SAA2;IKBKG;NFKB2;MAVS;RNF135;TRIM25
prerank,Elsevier_Pathway_Collection__ERBB2/3 -> EP300/ETS/ETV/SP1 Signaling,0.31814226111210553,0.8631547378737267,0.6235294117647059,1.0,1.0,10/28,24.71%,RASGRF1;NRG2;ETV1;SHC1;PDPK1;ETV4;PLCG1;NRG1;ERBB3;MAP2K2
prerank,WikiPathway_2021_Human__Ferroptosis WP4313,0.30268123920650347,0.8631274209936693,0.625,1.0,1.0,3/39,8.13%,SLC7A11;ACSL6;ACSL4
prerank,Elsevier_Pathway_Collection__EGFR/ERBB2 -> HIF1A Signaling,-0.2683020397622934,-0.8630898993622151,0.65,0.9378799195305377,1.0,9/32,15.00%,EREG;ITK;MAP2K1;TGFA;BTC;AKT1;RASGRP1;HBEGF;VAV1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.32295809812315435,-0.8628564604469826,0.6276595744680851,0.9379137463145477,1.0,5/15,16.17%,IFNG;CD4;IL15;CSF2;CSF1R
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.34237427475687887,0.8625964864556274,0.6424242424242425,1.0,1.0,4/20,21.93%,UHRF1;RAG1;USP22;UBE2A
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,0.30773808552511395,0.8624442338529593,0.6685393258426966,1.0,1.0,20/39,44.05%,RFC4;POLD1;PCLAF;POLR1A;ISG15;NPLOC4;TRIM25;UFD1;UBA52;SPRTN;MAD2L2;PCNA;POLH;VCP;SLC19A1;POLK;RFC3;POLD3;UBC;POLD4
prerank,Elsevier_Pathway_Collection__ER Stress (Unfolded Protein Response),-0.2789428699157171,-0.8619238626048926,0.7058823529411765,0.9397585247306414,1.0,11/31,24.47%,AKT1;CASP7;PPP1R15A;BCL2;HSPA1A;EIF2AK3;XBP1;MAP2K3;MAP2K6;MAP3K5;EDEM1
prerank,MSigDB_Oncogenic_Signatures__E2F3 UP.V1 DN,0.27123172522820105,0.8618651488532153,0.6968325791855203,1.0,1.0,35/118,24.44%,SOX1;S100P;UTS2R;LINC00173;GALNTL6;RUSC1-AS1;MRPL55;PVT1;NR6A1;IRAK2;LHX6;ADM2;BDKRB2;MEGF6;WT1-AS;SNHG3;NACC2;DOK7;OLFM1;ZNF646;WASH3P;EIF3CL;POLR1A;MMP3;STX1A;TGM2;BYSL;B9D2;HSD17B7P2;PCSK9;PLAT;CDH15;LFNG;POP1;RNF215
prerank,WikiPathway_2021_Human__Pyrimidine metabolism WP4022,0.2747417099023313,0.8615717067001567,0.6751269035532995,1.0,1.0,43/81,42.20%,UCK2;NT5M;TYMS;PRIM1;CAD;NME1;UPP1;TYMP;POLD1;POLR2L;RRM2;ENTPD1;POLR1A;DTYMK;POLA1;POLA2;POLR2K;DUT;TK1;POLR2G;POLR3K;NME3;POLR2H;POLR3H;POLR3A;POLR3C;RRM1;POLR2I;POLR3G;POLR2J;POLR2J2;DCTPP1;POLR3GL;POLR2J3;POLR2A;DCK;POLR3E;NME6;POLR2B;UMPS;POLD3;POLR3F;RRM2B
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.36813344025125083,0.8615297598007678,0.6647398843930635,1.0,1.0,6/17,25.82%,PRND;ATOX1;ANKRD9;ABCB6;CCDC22;ARF1
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.26545328428543125,0.8613512352232328,0.698019801980198,1.0,1.0,17/92,17.27%,SLC7A11;SLC34A3;SLC12A5;SLC7A6;SLC12A1;SLC7A10;SLC4A3;SLC4A1;SLC26A6;SLC1A4;SLC9A3;SLC1A2;SLC7A1;SLC26A2;SLC12A7;SLC1A3;SLC8A3
prerank,Elsevier_Pathway_Collection__Adipose Tissue Inflammation Provokes Insulin Resistance,-0.3212045745861643,-0.8612936655072134,0.6470588235294118,0.9407151620147187,1.0,4/15,11.82%,TNF;CCL2;IL6;ABHD5
prerank,Reactome_2022__Axon Guidance R-HSA-422475,0.23456133633312726,0.8611498838650239,0.8775510204081632,1.0,1.0,219/498,38.94%,LHX3;CACNB4;EPHA6;EPHB2;CACNA1S;PIK3R2;MAPK12;NRCAM;COL9A1;SCN1A;SHC3;SCN4A;ROBO1;ITGA2;LHX9;LHX4;EFNA3;MAPK11;KIF4A;DPYSL4;ANK1;GPRIN1;MSI1;CACNA1G;SRC;EPHA10;TRPC6;EFNA4;COL4A1;PSMD4;EFNA1;COL4A5;PLXNC1;CNTN1;UNC5A;NCAN;CLTCL1;RGMA;DCX;COL4A2;CNTNAP1;DNM3;RNASE1;MPP3;PDLIM7;SCN4B;ABLIM2;SCN2A;LAMC1;CACNA1C;ARHGEF11;SEMA7A;PLXNA2;ARHGAP39;PSMB4;ABL2;SHC1;ELOC;RPL8;VLDLR;PRKCA;HRAS;PLXND1;ROCK2;CACNA1H;RHOC;ABLIM1;GAP43;VPS72;ARHGEF28;PLXNA3;CASC3;LIMK2;CLTB;TRPC4;MRPL13;ELOB;CDK5R1;MMP9;SRGAP2;RBM8A;PLCG1;RPL30;CACNA1D;RPLP1;SCN5A;LLGL1;RPS27;KCNQ3;RPS21;CRMP1;EPHB4;RPLP2;ARPC1A;PLXNA1;SHANK3;MAP2K2;RPS5;HJV;CDK5;SCN8A;CACNB1;RELN;HSP90AB1;PTK2;RPL28;PSMB3;RPS14;ALCAM;NGEF;RPSA;HOXA2;RPL26L1;PABPC1;PSMD14;RPL39;CLTA;UPF3B;UBA52;NCSTN;RPLP0;RPS15;PSMB5;ROBO3;RPS2;PSMD2;RPL31;CACNB3;RPS19;PSMA1;EFNA2;RPL36;PKN1;RPL37A;ARPC5;PSMD10;GDNF;RRAS;RPL37;MAPK7;RPL7;TREM2;PIK3R3;RPS4X;RPS20;ITGAV;PSMC4;PSMC3;SPTAN1;PRKAR2A;ITGA10;SDCBP;NRP1;AGRN;RPL27;CNTN2;GIT1;PIGU;DPYSL3;COL9A3;RPL38;RND1;LAMB1;SCN1B;RPL35;SPTBN4;MYH9;ENAH;RPL10A;CSNK2B;AKAP5;PSMC5;RPS6KA3;RPS8;RPS12;RPL22L1;RPL35A;RPS6KA4;SEM1;MAGOHB;PSMB6;RPS3A;HSPA8;PSMD8;PIP5K1C;MYO9B;RPS7;ITGA2B;ABL1;COL6A3;AP2A1;RPS11;RPL36A;GSPT2;MYL6;RPL7A;MAPK3;PSEN2;PSME2;FAU;COL6A2;RPS3;RPL18A;RPL32;MMP2;APH1A;GSK3B;RPS24;TRIO;RNMT;AP2S1;PSMD13;RPL3L;SRGAP1;PSMB7;PSMA7;RPL29;RPL23;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.29220658978125713,0.8609354187809712,0.6833333333333333,1.0,1.0,7/42,12.83%,GRIN1;WNT4;ADGRB1;BMP4;RGCC;CD36;CREB3L1
prerank,"Elsevier_Pathway_Collection__Hyperparathyroidism, Neonatal Severe",0.35649403734314866,0.8608306472936951,0.6842105263157895,1.0,1.0,2/16,6.66%,E2F1;SRC
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.27807217198208095,-0.8607812912043138,0.6557377049180327,0.9414532711939384,1.0,15/31,32.74%,OTOF;RTP5;GET4;RTP3;PRNP;HMOX1;CYB5A;APP;SERP1;MAIP1;EGFR;COX18;TRAM1L1;ALDH3A2;CCDC47
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,0.282387584349007,0.8607430334497771,0.6931216931216931,1.0,1.0,10/63,19.86%,SH3GL3;ITGA2;SRC;RNASE1;LAMC1;SHC1;HRAS;TNS3;LAMA4;HGFAC
prerank,Elsevier_Pathway_Collection__VEGFA Dependent Angiogenesis in Cancer,-0.2298389236708671,-0.86050976842865,0.7575757575757576,0.941607853419064,1.0,18/60,23.89%,TNF;IL1B;FOS;ESR1;MAP2K1;IL6;AKT1;PGR;IGF1;BGN;HMOX1;MAPK10;AR;JUN;JAK2;MAP2K4;IGF1R;PTEN
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.33393635896917634,0.8604557214054511,0.6568047337278107,1.0,1.0,4/20,16.03%,THBS4;MDK;DAPK2;CAMK1D
prerank,Elsevier_Pathway_Collection__Mitochondrial Protein Transport,0.35054731305532133,0.8604079311096179,0.6392405063291139,1.0,1.0,10/19,46.67%,TIMM17A;TOMM20;TOMM5;TOMM40;PAM16;HSPBP1;TOMM7;TIMM50;HSPA9;TOMM22
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,0.2977153714191305,0.8602075686828143,0.6810810810810811,1.0,1.0,19/43,42.26%,TBC1D16;TSC1;TBC1D25;TSC2;TBC1D10A;TBC1D13;RAB4A;RABGEF1;ULK1;RAB43;TBC1D17;GABARAP;RAB6B;GGA2;TBC1D20;GGA1;TBC1D14;RAB35;RAB5C
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.29358297805605277,-0.8601459353661318,0.7228915662650602,0.9420266897146654,1.0,8/22,20.96%,LRRK2;BCL2L11;HERPUD1;HSPA1A;PMAIP1;MAGEA3;EIF2AK3;XBP1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.2816904716266323,0.8600360707280301,0.6994818652849741,1.0,1.0,29/66,38.70%,B4GALNT2;DPM3;MGAT5B;UGGT1;B4GALT7;KRTCAP2;PMM1;ALG3;SRD5A3;TMEM258;ALG1;ST3GAL1;MGAT4B;MGAT4A;OST4;MGAT3;UGGT2;DPM2;MGAT5;ASGR2;ALG6;RPN2;ALG13;DAD1;ASGR1;ALG8;DERL3;MGAT4C;DDOST
prerank,TRRUST_Transcription_Factors_2019__KLF4 human,0.30868969425686776,0.8599813160344218,0.6404494382022472,1.0,1.0,9/38,14.64%,LAMA3;BIRC5;ALPI;GDF15;CCNB1;CDX2;BDKRB2;ODC1;CDKN1C
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.3522520478506538,0.8596164379293671,0.6432748538011696,1.0,1.0,3/19,5.73%,SLC2A5;SLC2A4;SLC45A1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.36809868763413867,0.8593271363985703,0.675,1.0,1.0,6/17,27.00%,DLGAP5;NOTCH3;PLXND1;NOTCH4;MAML1;HEYL
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.30214338845320404,0.859044622599315,0.6666666666666666,1.0,1.0,7/36,16.55%,APLN;TAFA5;FGF2;PDGFB;HTR1B;PPARG;MEF2D
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.28558289387660746,0.8590185269134045,0.6972972972972973,1.0,1.0,11/57,16.84%,MT3;LEP;RASIP1;MTMR8;KIF25;FOXK1;CTSA;LEPR;HTR2B;LZTS1;BMF
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,0.28116769327272406,0.8590106707535253,0.6858638743455497,1.0,1.0,8/64,10.35%,TNNI3;COL9A1;ICAM5;ITGA2;ITGA6;COL4A1;COMP;COL4A2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.3683931875632891,0.8588047174907738,0.6626506024096386,1.0,1.0,1/17,1.49%,SLC34A3
prerank,WikiPathway_2021_Human__nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.35696444057800863,0.858622002227672,0.6832298136645962,1.0,1.0,11/17,47.28%,EIF3CL;EIF3E;EIF3D;EIF3H;EIF3B;EIF3G;EIF2S3;EIF3C;EIF3F;EIF1;EIF3A
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.2823891357518641,0.858573558644619,0.7058823529411765,1.0,1.0,16/65,21.40%,DLX5;DLX1;NODAL;GDF5;BMP4;AMH;RGMA;GDF15;GDF7;SMAD3;MEGF8;ACVRL1;SCX;ACVR2B;TGFBR3;TGFB2
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.31008658639225684,-0.8580321030704852,0.691358024691358,0.9464029526628641,1.0,11/19,29.33%,MMUT;ABCD4;MCCC1;MMACHC;PCCA;LMBRD1;MMADHC;TCN2;AMN;MCCC2;PROC
prerank,Elsevier_Pathway_Collection__SPP1 Induced Survival of Myelin Specific T-Cells in Multiple Sclerosis,0.3233027622867966,0.8579333131341526,0.6978021978021978,1.0,1.0,2/29,6.66%,SPP1;SRC
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.2210708065799894,-0.8578259178679553,0.7727272727272727,0.9464129999759721,1.0,17/87,15.21%,IFNG;TNF;IL1B;IL2RB;FPR2;APOA1;IL15;SIRPB1;SIRPG;GPLD1;FCGR2B;CLEC7A;SFTPD;DOCK2;PON1;FCER1G;CHP1
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.27440556584659814,0.8576929537609486,0.717391304347826,1.0,1.0,23/74,29.31%,ARHGEF39;FGD1;ARHGEF37;ARHGEF10;RNASE1;RASGRF2;ARHGEF11;OBSCN;SQSTM1;PLEKHG2;ARHGEF2;ARHGEF15;ECT2;MAGED1;ARHGEF19;MCF2L;NGEF;ITGB3BP;AATF;PLEKHG5;UBA52;NCSTN;ARHGEF40
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.29658023201378353,0.857678501421007,0.7,1.0,1.0,8/48,21.73%,CELF3;RBM24;CELF4;SRSF12;PUF60;MBNL3;NOVA2;RBM8A
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.26027474215794827,0.8576657720809734,0.7475247524752475,1.0,1.0,51/103,46.29%,SARNP;DDX39A;CPSF1;SMG5;CASC3;NUP37;THOC5;RBM8A;CHTOP;NUP62;NXF1;TPR;NUP133;CPSF4;UPF3B;NUP155;NUP160;THOC1;SMG7;POLDIP3;FMR1;NXF5;THOC6;NUP188;NXT1;THOC2;DDX39B;MAGOHB;SLU7;ZC3H11A;NUP205;MCM3AP;RBM15B;NUP210;SYMPK;CPSF3;RAE1;NUP214;GLE1;ALYREF;NUP107;SLBP;U2AF1;U2AF2;FIP1L1;RNPS1;UPF1;AAAS;ARC;EIF4A3;MAGOH
prerank,Elsevier_Pathway_Collection__Vascular Endothelial Cell Permeability Activation,0.3073644032992818,0.8576381917437409,0.6685714285714286,1.0,1.0,6/37,21.80%,RASGRF1;SRC;CAMK2A;PDPK1;LIMK2;PLCG1
prerank,WikiPathway_2021_Human__RANKL/RANK signaling pathway WP2018,-0.24347243622322148,-0.8575198786678958,0.8235294117647058,0.9465990246889412,1.0,12/55,15.35%,TNFSF11;TNFRSF11B;FOS;MAP2K1;MITF;CALCR;TNFRSF11A;PIK3R1;AKT1;SYK;VCAM1;SPI1
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.30776758260711057,-0.8572271844223145,0.6666666666666666,0.9468225317002688,1.0,5/17,17.30%,ENPP3;VNN1;PANK1;SLC25A16;ENPP1
prerank,Elsevier_Pathway_Collection__EGFR/ERBB2 -> TP53 Signaling,-0.25315472230668373,-0.8570514771109009,0.7272727272727273,0.9466816487060092,1.0,12/41,21.15%,EREG;ITK;MAP2K1;TGFA;BTC;RASGRP1;HBEGF;VAV1;MAPK10;NRG3;MAP2K3;MAP2K6
prerank,WikiPathway_2021_Human__Pyrimidine metabolism and related diseases WP4225,-0.3112625019665074,-0.8569959751904933,0.6627906976744186,0.9462428723967103,1.0,5/17,16.70%,GLS2;DPYS;DPYD;OTC;NT5C3A
prerank,Elsevier_Pathway_Collection__FGFR -> RUNX2 Signaling,0.32433966957038574,0.8569801441081895,0.6666666666666666,1.0,1.0,7/22,24.71%,RASGRF1;FGF2;FGF23;SHC1;FGF18;PLCG1;MAP2K2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.2772502132791799,-0.8568653300547632,0.7012987012987013,0.9460648436940037,1.0,9/29,19.40%,GPC5;GPC6;FYN;GPC4;GBP1;CLN3;SLC5A3;AR;VTI1B
prerank,TRRUST_Transcription_Factors_2019__PAX5 human,0.3578350203737709,0.856832281109139,0.6506024096385542,1.0,1.0,3/20,8.84%,LEF1;TERT;TIMP1
prerank,Elsevier_Pathway_Collection__Autophagic-Lysosomal System Decline Associated with Aging,-0.27115710109247576,-0.8568155947948847,0.7037037037037037,0.9456331704308926,1.0,29/29,72.92%,HSPA1A;XBP1;MAP1LC3A;ATG5;EDEM1;ULK2;SIRT1;ERN1;FOXO3;WIPI1;BECN1;PIK3C3;ATG14;RUBCN;MAP1LC3B;ATG101;ATG16L1;ATG12;DNAJC10;ATG7;ATG13;AMBRA1;LAMP2;MTOR;HSPA8;HSPA5;ULK1;RB1CC1;ATF6
prerank,TRRUST_Transcription_Factors_2019__BRCA1 human,-0.22949773386323505,-0.8566965917524502,0.8148148148148148,0.9453993030864977,1.0,5/56,6.58%,TFF1;CASR;KRT5;FOS;ESR1
prerank,Elsevier_Pathway_Collection__Positive Acute Phase Proteins Synthesis,-0.24113566303900566,-0.8565192008782435,0.7288135593220338,0.9452689991718496,1.0,13/57,16.81%,GHR;TNF;IL1B;IL1RAP;CP;MAP2K1;EGR1;IL6;MBL2;TLR4;MYD88;TNFRSF1B;HP
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.27901631004673316,0.8563516476498821,0.7096774193548387,1.0,1.0,43/63,53.12%,RFC4;POLD1;POLR2L;UVSSA;POLR1A;POLR2K;POLR2G;CUL4B;UBA52;PCNA;XRCC1;POLR2H;POLR2I;POLR2J;XAB2;DDB1;POLR2A;ERCC2;USP7;SLC19A1;POLR2B;POLK;RFC3;POLD3;RBX1;UBC;POLR2F;ERCC3;POLD4;RPS27A;PRPF19;GTF2H2;POLE2;GTF2H5;POLE4;RFC5;EP300;RFC2;POLE;LRIG1;MNAT1;CDK7;POLR2D
prerank,Elsevier_Pathway_Collection__Invadopodia Formation in Cancer Cells,0.28096680069561586,0.8561677436161036,0.7244897959183674,1.0,1.0,23/75,28.25%,FGD1;SRC;PDGFRB;KCNN3;DIAPH3;SH3PXD2B;PDGFA;ABL2;IQSEC1;PDPK1;PRKCA;EGF;MMP9;PLA2G6;TGFB2;FNBP1L;INPPL1;CAPN2;ROR2;BSG;SH3PXD2A;ADAM12;ASAP1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.2803289265560761,0.8559921581377227,0.6915422885572139,1.0,1.0,26/70,30.34%,PRKAA2;MAPT;PLK1;GTSE1;PRKN;NDC80;VPS28;CDK1;CDT1;ABCA7;MAP1A;LIMK2;CEP250;MARK4;GPR137B;NUP62;STX4;CROCC;CARD10;BICD1;HSP90AB1;PDZK1;GAS8;YAP1;PARK7;DDRGK1
prerank,Elsevier_Pathway_Collection__mTOR Signaling Activation by Taste Sensor Receptors (Rodent Model),0.310186199844111,0.8558504593971675,0.6529411764705882,1.0,1.0,3/29,5.86%,RASGRF1;TAS1R3;TRPM5
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.22270544374723142,-0.8558404636469962,0.8035714285714286,0.9463715189355936,1.0,20/75,16.47%,ITGB8;ADAMTS13;PRAM1;APOA1;FYB1;PLEK;ADAMTS1;CD40LG;ITGB6;FERMT2;FYB2;HCK;LAT;MPIG6B;ANGPTL3;SYK;FGR;PTN;ITGB2;ITGB3
prerank,Elsevier_Pathway_Collection__GUCY2C Signaling in Colorectal Cancer,0.3286985099739123,0.855758338379778,0.6666666666666666,1.0,1.0,6/26,16.65%,GUCY2C;SRC;GUCA2B;CDX2;PDPK1;SMAD3
prerank,TRRUST_Transcription_Factors_2019__RB1 human,0.31801704258536295,0.8557169899617433,0.7411764705882353,1.0,1.0,5/31,10.73%,E2F1;BIRC5;E2F2;CDK1;DNMT3A
prerank,WikiPathway_2021_Human__SARS coronavirus and innate immunity WP4912,-0.31716728705720953,-0.8557072183584743,0.6625,0.9461376310967919,1.0,2/17,5.74%,ACE2;TLR3
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.25067626935508897,0.8555542976613728,0.759090909090909,1.0,1.0,91/172,46.81%,HIGD1B;TERT;MSTO1;PRKN;BIK;DNM3;ATP2A1;TIMM17B;BCAP31;GBA;MTFP1;TYMP;SAMM50;TMEM70;TWNK;TIMM17A;RAB5IF;POLRMT;HAX1;ATP5F1D;TOMM20;PARP1;AIFM2;AIFM1;TIMM10;ATAD3B;TOMM5;WDR81;HCFC1;HIGD2A;FANCG;SLC25A6;COX7A1;TFB2M;MTX1;SLC25A33;FIS1;TSPO;TOMM40;PARK7;TIMM13;LONP1;PPRC1;TIMM9;MTFR2;BCS1L;BAX;AIP;DNM1L;OXA1L;HSPD1;CHCHD4;BID;ATAD3A;TIMM10B;RAB29;CHCHD2;ADCK1;USP30;HSD17B10;TOMM7;CLUH;NRF1;MPV17;TIMM50;MTX2;TIMM8B;MIEF2;PLD6;TOMM34;MTX3;TRAK2;MFF;MX1;POLG2;BCL2L1;HAP1;SUPV3L1;PITRM1;TIMM22;RHOT2;SSBP1;MTFR1;FMC1;ATP7A;COX7A2;IMMP2L;STOML2;ESRRA;TOMM22;DNM2
prerank,Elsevier_Pathway_Collection__Receptors and Adaptor Proteins Activated in Cancer,0.25496000251951756,0.8552686987955671,0.7252252252252253,1.0,1.0,19/119,14.64%,COL2A1;IGF2;EPHB2;MDK;EFNA3;FGF17;SRC;FGF2;BDNF;EFNA1;PDGFRB;IL11;COL11A1;FLT3LG;IL6R;PDGFB;PDGFA;PLAU;SHC1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),0.37192406101618236,0.8552185082863432,0.6529411764705882,1.0,1.0,5/16,15.53%,AQP6;AQP8;UPK3A;PDPN;AQP9
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.2566142574929807,0.8550564297913572,0.705607476635514,1.0,1.0,27/138,23.55%,CDH13;SHC3;EPS8L3;TAX1BP3;CDKN2A;MAPK11;FGF2;CCNA2;PRKD1;ARHGEF11;PDPN;COL1A2;SHC1;GDI1;HRAS;ROPN1B;MRAS;ROCK2;CDC42EP5;RAPGEF3;ARHGAP4;RALGDS;SETDB1;TRIM28;GPSM2;KSR1;DNMT1
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.24158212523850167,-0.8549408558287326,0.7866666666666666,0.9473446922164639,1.0,16/58,24.22%,IRF4;OASL;RSAD2;EGR1;IRF8;MX2;USP18;IFIT2;IFIT3;OAS3;OAS2;IFIT1;STAT1;IRF2;OAS1;IRF9
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.33404991101743947,0.8549140496792271,0.6551724137931034,1.0,1.0,11/19,38.77%,SARNP;ZC3H11B;NXF1;NUP133;POLDIP3;NXF5;THOC2;PABPN1;ZC3H11A;MCM3AP;ENY2
prerank,WikiPathway_2021_Human__Triacylglyceride synthesis WP325,-0.29294973372064126,-0.8545826589139509,0.7037037037037037,0.947741448831322,1.0,5/22,9.56%,GPD1;MOGAT2;DGAT2;MOGAT1;AGPAT2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.21745025588671021,-0.8545765069295211,0.7948717948717948,0.9472168748041329,1.0,22/101,17.51%,CIDEA;NKX2-1;VEPH1;BMPER;NOG;SPART;WNT1;CILP;GREM1;IL17RD;SORL1;WFIKKN2;PBLD;SPRY2;SMAD9;BMPR2;LDLRAD4;ACVR2A;ADAMTSL2;BMPR1B;HSPA1A;IGSF1
prerank,Elsevier_Pathway_Collection__ERBB/VEGFR/Akt Signaling in Breast Cancer,0.28928118272391856,0.8545309330689701,0.6825396825396826,1.0,1.0,14/54,26.12%,VEGFD;LEF1;TCF7;SRC;FLT1;SHC1;PDPK1;PRKCA;EGF;NRG1;ERBB3;MAP2K2;MYC;CTNNB1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.31123556550676046,-0.8542479397272442,0.6375,0.9474947040156507,1.0,2/17,7.46%,EHD3;MAP2K1
prerank,Reactome_2022__Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,0.36897200475782316,0.8541863993458755,0.6583850931677019,1.0,1.0,4/15,7.35%,SLC6A7;SLC6A11;SLC6A9;SLC6A3
prerank,Elsevier_Pathway_Collection__FSH Action in Polycystic Ovary Syndrome,0.3479167256950325,0.853809255391119,0.6607142857142857,1.0,1.0,4/20,14.95%,RASGRF1;AMH;MAPKAPK2;PDPK1
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.28208560444454817,0.8537926717223527,0.7010869565217391,1.0,1.0,37/71,47.30%,PSMD4;PSMB4;ELOC;HIF1AN;ELOB;EGLN1;HIF3A;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;UBE2D2;PSME2;PSMD13;PSMB7;PSMA7;LIMD1;PSME3;PSMB2;RBX1;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.34252522259918255,0.853574185145689,0.6395348837209303,1.0,1.0,9/22,39.07%,PUS1;METTL3;TRMT61A;VIRMA;DKC1;PUS7;RPUSD2;METTL16;TRMT6
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.31504668847083683,0.8533949757573602,0.6589595375722543,1.0,1.0,18/35,40.20%,PLK1;ANKRD53;PSRC1;TPX2;GPSM2;NUP62;TPR;GNAI1;CEP97;CCSAP;TACC3;CHMP2A;DYNC1H1;HNRNPU;DRG1;EML3;RAE1;NUMA1
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,0.2642377017039735,0.8529952325209461,0.722488038277512,1.0,1.0,13/91,17.63%,PIK3R2;MAPK12;MAPK11;SRC;SPHK1;HSPB1;RNASE1;MAPKAPK2;PDPK1;PRKCA;HRAS;ROCK2;THEM4
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.30166643427983153,0.8528970260054136,0.6685082872928176,1.0,1.0,23/51,39.37%,NQO1;PSMD4;OAZ3;PSMB4;ODC1;PSMD1;PSMB3;PSMD14;PSMB5;AZIN1;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.23833747179654838,0.8527789600913864,0.7713004484304933,1.0,1.0,36/187,18.75%,GNG4;FRRS1L;RGS20;MAPK8IP2;TDGF1;GDF5;SRC;IRAK1;IGFBP2;CASTOR2;KAZALD1;TIMP1;PRAG1;AKR1C3;PRKD1;IRAK2;CD36;FOXL1;RGS16;HHIP;ZIC1;RGS5;IFT81;TULP3;RGS14;SREBF2;SRMS;GRK3;TMEM108;SLC8A3;TSPEAR;IGFBPL1;CASTOR1;GLRX2;SHARPIN;RGS12
prerank,MSigDB_Hallmark_2020__Glycolysis,0.2491482891941554,0.8527622420142086,0.7566371681415929,1.0,1.0,47/194,24.66%,LHX9;KIF20A;DEPDC1;CENPA;HMMR;B3GAT1;EFNA3;DPYSL4;GPC3;CHST6;BIK;SLC16A3;NOL3;HS6ST2;CDK1;TFF3;IDUA;AURKA;PPFIA4;STC2;SPAG4;COL5A1;FBP2;VLDLR;STMN1;STC1;ANKZF1;VCAN;B3GAT3;CACNA1H;ELF3;ABCB6;B4GALT7;NSDHL;PYGB;P4HA2;HAX1;GOT1;TXN;MDH2;XYLT2;CHPF;KDELR3;CHST1;PGK1;PFKP;COG2
prerank,WikiPathway_2021_Human__Spinal Cord Injury WP2431,0.2656343479147964,0.8524223589504573,0.7658536585365854,1.0,1.0,21/110,17.68%,COL2A1;PLA2G2A;E2F1;GRIN1;BCAN;NOX4;BDNF;COL4A1;MMP12;NCAN;RGMA;CDK1;LEP;PLXNA2;CSPG4;PRKCA;TACR1;VCAN;ROCK2;RHOC;GAP43
prerank,MSigDB_Oncogenic_Signatures__BCAT GDS748 DN,0.2944187201316743,0.8523392633684745,0.7258064516129032,1.0,1.0,3/41,7.64%,COL2A1;SNAI2;ISYNA1
prerank,WikiPathway_2021_Human__Urea cycle and associated pathways WP4595,-0.2994343348419459,-0.8521876589329128,0.725,0.9517635005358941,1.0,11/24,29.16%,GLS2;OAT;OTC;SLC25A15;ASS1;LDHB;ARG1;SLC25A13;NOS2;NOS1;GOT2
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.2833680882917811,0.8517076018579693,0.6758241758241759,1.0,1.0,7/52,12.16%,INHA;KLF1;FLVCR1;IL11;CDKN2B;AHSP;EPO
prerank,MSigDB_Oncogenic_Signatures__BCAT.100 UP.V1 DN,0.33431216104914063,0.8517021835624069,0.6789473684210526,1.0,1.0,3/21,7.48%,DOCK3;SNAI2;AMH
prerank,Elsevier_Pathway_Collection__Genes with Mutations in Cancer-Associated Evading of Growth Suppressors,0.30295883083503294,0.85163322415773,0.6956521739130435,1.0,1.0,2/47,2.57%,CTNNA2;AXIN2
prerank,TRRUST_Transcription_Factors_2019__CTNNB1 human,0.3436959958155049,0.8516021384688682,0.6904761904761905,1.0,1.0,3/21,6.65%,NRCAM;TCF7;BIRC5
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.3429075617414545,0.85148029116877,0.6744186046511628,1.0,1.0,5/20,15.60%,CLDN19;MDK;FGF2;CD109;RTN4RL1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.3264627979604393,0.8514309810340122,0.6573033707865169,1.0,1.0,4/25,16.53%,GFI1;LRRC14;CD36;TYRO3
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,0.362999825188147,0.8512894422790107,0.6506024096385542,1.0,1.0,2/19,6.66%,PIK3R2;SRC
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.33272097376721604,0.8512462470497297,0.6666666666666666,1.0,1.0,1/18,0.73%,ST8SIA3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.30577503981975107,0.8512193570085658,0.6511627906976745,1.0,1.0,14/31,41.26%,UBL4B;SREBF2;RNF31;PDCD5;RHOU;VPS11;HPS4;BAP1;SAE1;UBE2J2;HUWE1;TOMM7;HSPA1L;UBL5
prerank,MSigDB_Oncogenic_Signatures__CSR LATE UP.V1 DN,-0.19578283905452698,-0.8512048885901562,0.8333333333333334,0.9536091850557236,1.0,41/147,22.71%,SFTPB;L1CAM;CHL1;MAMDC2;ITGB8;IL1B;GAS1;PYROXD2;SAMD5;TCEAL7;COL8A2;CCL2;APOL3;CMBL;LONRF1;TSKU;TRIM22;PRSS12;PAMR1;EPHB6;MAN1A1;EPSTI1;TNXB;RASSF2;RCAN2;STARD4;ASS1;TRERF1;IRS2;UBE2L6;FIBIN;FADS2;LPAR3;PRKG1;PDE5A;NYNRIN;GLT8D2;GLI3;NTN4;LDLR;OAF
prerank,WikiPathway_2021_Human__EGF/EGFR signaling pathway WP437,0.24932614486976323,0.8511587502630883,0.7533632286995515,1.0,1.0,23/161,18.77%,SH3GL3;E2F1;PIK3R2;PTPN5;SRC;CAMK2A;AURKA;RIN1;MYBL2;SHC1;IQSEC1;PDPK1;PRKCA;HRAS;STMN1;ELK4;PTPRR;MEF2D;EGF;NEDD4;LIMK2;PIAS3;STXBP1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.25727423184552567,0.8509982305975412,0.7342995169082126,1.0,1.0,16/113,14.04%,B4GALNT1;CERS1;PLPP2;ALOX12B;SPTSSB;CERKL;SPHK1;PRKD1;FUT5;ESYT3;ELOVL3;CERK;NEU3;GBA;CTSA;GLA
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,0.3545468476563532,0.8508684359750327,0.6790123456790124,1.0,1.0,2/18,10.06%,LRRC14;IKBKG
prerank,KEGG_2021_Human__Arachidonic acid metabolism,0.283621573261737,0.8506101168859038,0.7010309278350515,1.0,1.0,11/54,15.24%,ALOX15B;PLA2G2A;ALOX12B;PLA2G2C;CBR3;PTGDS;AKR1C3;PLA2G4C;ALOX12;PLA2G4F;GPX3
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,0.24841729882286276,0.8504854952795158,0.7727272727272727,1.0,1.0,56/144,34.98%,PIK3R2;PRKAA2;MAPK12;COX4I2;MAPK11;NDUFA4L2;LEP;IL6R;NDUFA1;LEPR;PPARG;NDUFS6;NDUFV1;NDUFB9;COX6C;COX7B;NDUFA3;TRAF2;UQCRB;NDUFS2;NDUFA9;COX6B1;NDUFB11;NDUFA2;NDUFS7;COX8A;PRKAB2;UQCRQ;MLXIP;CYC1;COX7A1;NDUFA13;DDIT3;UQCRHL;SOCS3;NDUFA11;NDUFA6;UQCR11;NDUFS8;COX4I1;NDUFV2;COX5B;PIK3R3;CYP2E1;NDUFA8;IRS1;NDUFB7;TGFB1;UQCRH;NDUFAB1;NDUFB2;NDUFB10;ADIPOR1;UQCRC1;BAX;MAP3K11
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.23016588621239276,0.8504607640788471,0.8600823045267489,1.0,1.0,63/437,18.00%,HMGA2;MT3;ZIC2;PAX2;CALCA;LEF1;E2F1;SIX4;GFI1;TWIST2;NKX6-2;WNT4;DKK3;LHX9;CENPF;FOXS1;CDKN2A;DEPDC1;FOXM1;MESP1;TBX3;ZNF541;BMP4;ZSCAN10;HDAC4;BEND5;BIRC5;PRDM16;TNFRSF4;ZNF703;EZH2;LOXL2;ZP3;ZBED6;SOX8;ZMYND15;NR1D1;SOX18;RIPPLY1;CBFA2T2;CCDC85B;CREB3L1;PDGFB;PPM1F;FOXK1;ZNF425;HIC2;TFAP4;CDKN1C;SHC1;PPARG;NACC2;ZNF503;HDAC5;GLIS2;ZNF423;ZBTB33;THRA;ELF3;HMGA1;ZNF219;BCL6;ZBTB18
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.24425645283734093,-0.8502176657182126,0.7352941176470589,0.9551631498549953,1.0,1/52,0.01%,ERN2
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,0.3471427569975878,0.8501010098543432,0.6610169491525424,1.0,1.0,3/18,10.52%,EPHB2;SRC;RNASE1
prerank,Elsevier_Pathway_Collection__Vitamine D Deficite and Dentin Formation,0.31118432851565825,0.8499055255341009,0.6704545454545454,1.0,1.0,7/28,18.91%,SPP1;PHEX;SRC;FGF23;BGLAP;PRKCA;RAPGEF3
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.2806544260679772,0.8498567860195402,0.7157360406091371,1.0,1.0,12/59,20.43%,HOXD3;SNAI2;MDK;HES5;DLGAP5;NOTCH3;JAG2;PLXND1;ZNF423;NOTCH4;DLL4;HEY1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.34798580198950557,0.8498440072620779,0.6521739130434783,1.0,1.0,7/17,31.25%,COX4I2;COX6C;COX7B;COX6B1;COX8A;COX4I1;COX5B
prerank,MSigDB_Oncogenic_Signatures__DCA UP.V1 UP,-0.20327034210305908,-0.8497404934112508,0.9629629629629629,0.955697441072105,1.0,33/139,16.86%,IGLV2-14;IGKV3D-15;GLS2;SPIN2A;CD1B;ADARB2;WNT16;MOGAT2;CD27;KLHL3;CYP3A43;AK4P3;GIPR;WNT2;MCTP2;KLRB1;SARDH;ELAVL4;EFS;SERPINA4;CLEC7A;GARNL3;TNS4;EPHB6;CD82;SLC28A1;GRIA1;EYA2;CREB5;SERPING1;IFIT2;BMX;PRRG4
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.26715553502711453,0.8495575512144218,0.7093596059113301,1.0,1.0,16/81,15.05%,SLCO1C1;SLC2A4;SLC29A4;SLC13A3;SLC6A9;SLC4A3;ATP1A2;ATP1A4;ATP2B4;SLC5A6;SLC1A4;SLC1A2;SLC7A1;SLC29A2;LEPR;ABCC5
prerank,WikiPathway_2021_Human__Small Ligand GPCRs WP247,-0.331896040103426,-0.8491950384955094,0.632183908045977,0.9564022587584403,1.0,11/16,25.41%,PTGER2;CNR2;PTGER4;PTGDR;TBXA2R;LPAR1;PTAFR;PTGIR;S1PR1;S1PR3;S1PR4
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.34254358814872904,0.8491509338383906,0.6994219653179191,1.0,1.0,4/20,12.85%,CCL20;ADGRL1;BCAP31;PTGFR
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.32920888125084513,0.8489389801819256,0.6329113924050633,1.0,1.0,7/19,27.00%,GJA5;DAND5;DLL4;HEY1;SCN5A;MATR3;HEYL
prerank,KEGG_2021_Human__Sphingolipid metabolism,0.28844206182671484,0.8488781349802174,0.6611111111111111,1.0,1.0,9/47,15.65%,CERS1;PLPP2;SPHK1;PSAPL1;CERK;NEU3;GBA;GLA;PLPP1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.2671351967606886,0.8482649279510497,0.7871287128712872,1.0,1.0,31/121,25.48%,IGF2;PIK3R2;SLC2A4;ATP6V0D2;SOGA1;ATP6V0A1;SHC1;PDPK1;INHBB;PPARG;ATP6AP1;HDAC5;USF1;ATP6V0B;RAB15;TCIRG1;FOXC2;LPIN1;EPRS1;GOT1;PARP1;ATP6V0D1;PCSK9;SH2B2;PRKDC;ATP6V0E1;RAB13;ATP6V1C1;DENND4C;RARRES2;INSIG2
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.3075375130250432,0.8482554906017779,0.6994219653179191,1.0,1.0,13/36,17.27%,USH1G;OPRL1;CHRNB2;PRDM12;GNAL;PCDH15;WHRN;ASIC3;MYO7A;CHRNA4;TMEM150C;ADORA2A;MME
prerank,KEGG_2021_Human__Lysosome,0.2581724331043667,0.8482206242336592,0.7535545023696683,1.0,1.0,48/126,33.91%,ATP6V0D2;LAPTM4B;PSAPL1;CLTCL1;IDUA;CD68;GBA;CTSA;GLA;ATP6V0A1;AP3B2;ATP6AP1;ATP6V0B;DNASE2B;CTSD;CLTB;TCIRG1;ATP6V0D1;NAPSA;NPC1;AP4B1;NAGPA;AP4M1;GLB1;ABCA2;CTSV;NEU1;ARSG;PPT2;HYAL2;HYAL3;ABCB9;HEXB;CTSH;HEXA;ATP6V1H;CLTA;CTSG;AP3D1;MCOLN1;HGSNAT;SLC11A1;AP3M2;GNPTG;ARSA;CTSK;AP3B1;CD63
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.28366767632951717,0.8482070115236164,0.7180851063829787,1.0,1.0,3/50,3.55%,PYDC1;DCST1;ROBO1
prerank,Elsevier_Pathway_Collection__RAGE/AGER and S100 Proteins in Cardiovascular Injury,-0.25964940672534553,-0.8481679531694594,0.6338028169014085,0.958197742257584,1.0,9/30,14.75%,S100A8;MAP2K1;CCL2;IL6;TLR4;AKT1;S100A12;VCAM1;MYD88
prerank,WikiPathway_2021_Human__Selenium Micronutrient Network WP15,0.264736593282374,0.847759723229157,0.745945945945946,1.0,1.0,11/84,12.73%,ALOX15B;DIO2;CRP;SAA1;SAA2;MTR;SELENOM;TXNRD2;DIO3;FLAD1;NFKB2
prerank,WikiPathway_2021_Human__IL-7 signaling pathway WP205,-0.2620322762752066,-0.8476739220772375,0.6779661016949152,0.9588226972296464,1.0,5/25,13.06%,IL7R;MAP2K1;FYN;PIK3R1;AKT1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.2849744010686138,-0.8473778650044614,0.6941176470588235,0.9589624093840442,1.0,6/20,18.93%,SLAMF7;ULBP3;KLRK1;CORO1A;GZMB;KIR3DL1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.33854247471313953,0.8471000875150589,0.6910112359550562,1.0,1.0,12/19,43.89%,CTCFL;DNMT1;DNMT3B;CTNNB1;WDR5;BCOR;ZNF335;PAXIP1;PIH1D1;MACROH2A1;KDM1A;WDR61
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,-0.24450487088100353,-0.8470355723837611,0.7567567567567568,0.9592758116556457,1.0,8/45,13.51%,PRKAR2B;CAMK4;CAMK2B;PLA2G4A;ADCY5;PDE1B;GNA14;PLCB2
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.3052656319655412,0.8468702873867768,0.6666666666666666,1.0,1.0,11/34,24.51%,TDGF1;KAZALD1;GJA5;TYMP;GRK3;IGFBPL1;GLRX2;TSPYL2;GRK6;NUP62;CASQ2
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,0.3561378536665357,0.8467282879358906,0.6575342465753424,1.0,1.0,10/16,48.66%,VLDLR;PCSK9;CLTA;UBA52;AP2A1;AP2S1;UBC;NR1H2;RPS27A;AP2B1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.27239124622314015,-0.8466293914087638,0.7294117647058823,0.9597036652540001,1.0,8/26,17.64%,TNF;RCAN1;CLEC7A;IGF1;PLCG2;CHP1;PRNP;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.335912271443449,0.8465582288945127,0.6363636363636364,1.0,1.0,5/21,24.58%,EPHB2;CYRIB;SPRY3;TGFB2;LZTR1
prerank,Elsevier_Pathway_Collection__IL6 Promotes Inflammation in Muscular Dystrophies,-0.2713062946528658,-0.8464445844691016,0.7619047619047619,0.9595449682709802,1.0,14/29,34.17%,FOS;IL6;AKT1;VAV1;JUN;JAK2;MAP2K4;GAB1;STAT3;NFKBIA;PTPN6;PTPN11;CHUK;IL6ST
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,0.30409133350446604,0.8463276133451133,0.6494252873563219,1.0,1.0,12/31,31.28%,ATP6V0D2;NANOS1;ATP6V0A1;ATP6V0B;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1C1;ATP6V1H;ATP6V1F;SLC11A1;ATP6V1E1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.23773067407891132,-0.8460946940160605,0.7297297297297297,0.9598513303227358,1.0,12/42,17.03%,WNT7B;HGF;FBN2;IL6;CCN1;BMP7;FERMT2;IGF1;RUNX2;BMPR2;ACVR2A;BMPR1B
prerank,Elsevier_Pathway_Collection__FibronectinR -> AP-1/ELK/SRF/SREBF Signaling,0.28067172970218585,0.8458689217012051,0.7379679144385026,1.0,1.0,7/47,16.31%,RASGRF1;SRC;MAPKAPK2;SHC1;PDPK1;SREBF2;ELK4
prerank,MSigDB_Oncogenic_Signatures__PIGF UP.V1 DN,0.24137044654442266,0.8452858347688306,0.7748917748917749,1.0,1.0,35/165,17.07%,PAX2;PIK3R2;ELAVL3;THY1;ZFR2;BCAM;SRGAP3;MSI1;CDC20;TROAP;ACTL6B;IGFBP2;CDKN2C;GNAL;VGF;MAST1;NR6A1;DAAM2;NPR2;PPFIA4;CACNA1C;SLC14A2;KLK10;NFKB2;LOXL1;PTGFR;PDPN;NOX1;OBSCN;SLC29A2;DHX34;RELB;PKD1;CACNA1H;KCNC3
prerank,KEGG_2021_Human__Ferroptosis,0.29977376077392875,0.8452561251204496,0.671957671957672,1.0,1.0,3/40,8.13%,SLC7A11;ACSL6;ACSL4
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.28131082908922767,0.8452470969064108,0.7379679144385026,1.0,1.0,27/57,39.07%,CTU1;ADAR;FTSJ1;NSUN5;ANKRD16;METTL3;TRMT1;WDR4;TRMT61A;NOP2;JMJD6;MEPCE;METTL1;ADAT3;QTRT1;TYW5;PUS7;CTU2;PUS7L;NOP10;SSB;TSR3;RBM15B;FTSJ3;AARS2;TRMT6;BCDIN3D
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.25339540610211225,-0.8445854960663207,0.7121212121212122,0.9626601432273028,1.0,34/34,74.70%,ZFP36L1;QKI;NCBP1;PAPOLA;LARP7;KHDRBS3;SLTM;RBM23;CWC22;YTHDC1;SRPK3;CDK11A;SRSF10;AHCYL1;SRSF3;HNRNPK;PTCD2;SRPK2;KHDRBS1;IWS1;SAFB;CDK11B;SON;SF1;SRPK1;RBM39;TIA1;SUPT6H;SAFB2;METTL16;DHX9;PABPN1;JMJD6;CPSF4
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.30873316454645955,-0.8444814836596052,0.6966292134831461,0.9623607655667528,1.0,5/15,15.53%,HGF;PPIF;AKT1;IGF1;CLU
prerank,Elsevier_Pathway_Collection__InsulinR -> ELK/SRF/SREBF Signaling,0.3321752565653459,0.8444801735578407,0.6280487804878049,1.0,1.0,5/20,16.31%,MAPKAPK2;SHC1;PDPK1;SREBF2;ELK4
prerank,Elsevier_Pathway_Collection__Endothelin Signaling in Arterial Hypertension,-0.27705858736960176,-0.8444641327538922,0.7411764705882353,0.9618606023186455,1.0,6/26,14.22%,NR4A2;FOS;MAP2K1;AKT1;RASGRP1;EDNRB
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.24964075492464013,0.8443496842348418,0.7393364928909952,1.0,1.0,20/156,10.18%,REG3A;CDH22;CDH8;MPZ;CLDN19;CDH13;PTPRT;ROBO1;GATA5;SDK1;TENM2;CLDN15;ADGRL1;CRB1;CDH24;NECTIN1;CLDN6;PCDHB14;CDH17;IL1RAPL1
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.34685329432281947,0.8441662682957362,0.6545454545454545,1.0,1.0,4/17,15.29%,RASGRF1;SLC2A4;KAT2A;RGS14
prerank,WikiPathway_2021_Human__MET in type 1 papillary renal cell carcinoma WP4205,-0.2277695519378064,-0.8441107808574447,0.8253968253968254,0.9621155330310472,1.0,6/57,7.91%,PAK5;PAK6;HGF;ALK;MAP2K1;PIK3CD
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.36075492136536474,0.8440335706116302,0.6923076923076923,1.0,1.0,4/17,16.85%,PRAF2;SLC1A2;SLC25A12;SLC1A3
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.35692408404250875,0.8439076906445885,0.6686390532544378,1.0,1.0,14/17,46.95%,UBL4A;EMC9;EMC2;GET3;CAMLG;EMC10;BAG6;EMC6;GET1;EMC8;EMC3;MMGT1;SGTA;EMC7
prerank,WikiPathway_2021_Human__Angiogenesis WP1539,0.32628451769419137,0.8437815369801839,0.6511627906976745,1.0,1.0,7/24,25.99%,SRC;FGF2;PDGFB;FLT1;MMP9;PLCG1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.23790855403552502,0.8437074378178337,0.7905982905982906,1.0,1.0,42/249,16.68%,MT3;IGF2;DIRAS1;ADRA2C;PLA2G2A;NODAL;ALOX12B;SOX2;ROBO1;CHI3L1;CCL26;CCL13;CCL25;ROR1;CCL20;JCAD;ADRA1D;FGF2;IRAK1;PDGFRB;NPNT;IL11;EZH2;GDF15;LEP;CD36;SEMA7A;PDGFB;FLT1;PDGFA;CCL24;SHC1;ABCA7;CCL11;IAPP;PRKCA;DSTYK;ATP6AP1;HRAS;HTR2B;ROCK2;DIRAS2
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.20352030254215614,-0.8436909119844027,0.9444444444444444,0.9626174371825587,1.0,18/104,14.55%,IFNG;HK3;ENO3;ALDOB;ANGPT4;TF;MAP2K1;PIK3CD;PRKCB;CAMK2B;IL6;CYBB;ALDOC;TLR4;PIK3R1;AKT1;IGF1;PLCG2
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.28598978798742747,-0.8434066721387319,0.6781609195402298,0.962670886387377,1.0,3/17,7.89%,KCNS1;KCNE1;ANK3
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,0.23734950874937694,0.8433835698777745,0.8396624472573839,1.0,1.0,57/270,24.66%,B4GALNT2;HS3ST4;B3GALT1;HS3ST5;HPSE2;CEMIP;UST;BCAN;TAC4;HMMR;B3GAT1;GPC3;CHST6;NCAN;PFKFB4;HS6ST2;TKT;FUT5;IDUA;NDST1;CSPG5;UBL4A;GOLT1A;CSPG4;HS3ST2;SLC25A12;SLC26A2;ABCC5;PRKCA;HS6ST1;PGP;GPC2;VCAN;B3GAT3;B4GALT3;ST3GAL3;B4GALT7;PYGB;NUP37;PFKFB2;HSPG2;MAP4K2;CHST15;RHD;MDH2;XYLT2;NUP62;CHPF;PHKG1;OGN;CHST1;TPR;PAPSS1;NUP133;PGK1;B4GAT1;PFKP
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.3200158106627751,0.8433583511057665,0.6946107784431138,1.0,1.0,3/30,9.66%,UBE2T;UBE2C;UBE2S
prerank,KEGG_2021_Human__Axon guidance,0.24351070772887048,0.8431031324441379,0.7828054298642534,1.0,1.0,33/176,18.52%,EPHA6;EPHB2;PIK3R2;PAK3;WNT4;ROBO1;EFNA3;SRGAP3;NTN3;SRC;TRPC6;EFNA4;CAMK2A;EFNA1;PLXNC1;UNC5A;RGMA;ABLIM2;SEMA7A;PLXNA2;SEMA6C;GDF7;SEMA5B;PDPK1;SEMA6B;PRKCA;HRAS;ROCK2;ABLIM1;SEMA3F;PLXNA3;LIMK2;BOC
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.26339313087477595,0.8429261234835523,0.7564766839378239,1.0,1.0,47/73,48.29%,DNASE1L2;RNASE1;TREX2;RFC4;IHO1;POLD1;DNA2;FEN1;PARP1;DXO;EDC3;CHD1L;CUL4B;UBA52;DNASE1;PCNA;RNASE4;OGG1;DDB2;MUS81;FAN1;DNASE1L1;EDC4;ISG20;DDB1;ERCC2;RPA2;POLK;RFC3;POLD3;RNASE2;DDX1;RBX1;UBC;ERCC3;SETMAR;POLD4;DCP1B;XPA;ERCC1;RPS27A;RPA1;RFC1;GTF2H2;REXO4;MRE11;RAD50
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.27674923298837034,-0.8429202112635911,0.7375,0.9632460266304805,1.0,7/26,23.36%,SIK1;ID2;PER1;PER3;PDE6B;CRY1;FBXL3
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.3495500302378522,0.842752804503645,0.6706586826347305,1.0,1.0,4/16,12.55%,ATP1A2;GJC1;CACNA1C;GJA5
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.20906190133941852,-0.8426737439089832,0.8285714285714286,0.9632805575833145,1.0,31/123,18.14%,TMPRSS4;MT1G;MT1F;MT1H;MT1M;BMP10;INHBA;SFRP1;MT1E;SCGB3A1;MT1X;GDF2;FBP1;MT1A;CDA;WNT11;HSPA1B;MT1B;SPHK2;RTN4;EI24;ING1;BMPR2;NOTCH2;MT2A;HSPA1A;ENPP1;BTG1;SMARCA2;SFRP2;SESN2
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.3484851614989159,0.8422966288483549,0.6835443037974683,1.0,1.0,5/19,28.07%,SMYD2;EHMT2;L3MBTL1;CHEK2;UBA52
prerank,Elsevier_Pathway_Collection__MITF as a Regulator of Melanoma Cell Development,0.2842547926104219,0.8422332964106813,0.7208121827411168,1.0,1.0,5/53,6.65%,LEF1;SNAI2;CDKN2A;TBX3;BIRC5
prerank,WikiPathway_2021_Human__Purinergic signaling WP4900,0.30946767516770124,0.8419304053886317,0.7471264367816092,1.0,1.0,8/31,17.66%,GNAZ;P2RX5;LPAR4;ADORA1;P2RX2;ADORA2A;P2RY8;PANX1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.27546559956392835,0.8418990585903297,0.7539267015706806,1.0,1.0,11/68,17.41%,MT3;MAPT;SLC30A3;SLC30A2;LOXL2;NDRG1;SLC25A12;AQP9;NEDD4L;ADAM9;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.31692267793812595,0.8417682299615001,0.6892655367231638,1.0,1.0,4/24,15.74%,CEMIP;KCNB1;TCAF2;HRAS
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.24759081676358258,-0.8416441624551548,0.782608695652174,0.9650235207264035,1.0,16/48,23.90%,TLR3;TLR8;LILRB1;REL;TLR4;TLR2;NLRC3;PTPRS;OAS3;OAS2;RIOK3;DHX58;IFIH1;SIRPA;DDX58;OAS1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.24572670810026329,0.8415250111359569,0.8230088495575221,1.0,1.0,43/174,32.13%,TRIM71;IGF2BP1;IGF2BP2;HSPB1;ZNF385A;NANOS1;TYMS;METTL18;PRR16;PASK;TCOF1;RBM3;MRPL13;BCL3;TSC1;NSUN5;MTG2;EPRS1;EIF2B4;PRKDC;KLHL25;EIF3E;NPM1;METTL3;LARP1;IGF2BP3;RPL10;TRAP1;ILF3;EIF3D;UPF3B;SAMD4B;ATXN2;MIF4GD;GAPDH;RACK1;POLDIP3;DAPK3;RPS4X;PUS7;FMR1;EIF4ENIF1;MTG1
prerank,Elsevier_Pathway_Collection__Blau Syndrome,-0.2546071598768664,-0.8411827338612687,0.8311688311688312,0.9654977891019664,1.0,11/38,16.75%,IL1B;CASP1;NLRP3;MEFV;TICAM2;TLR4;TLR2;AKT1;PSTPIP1;MYD88;NLRC4
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.32691494335018195,0.8408849923370253,0.6807228915662651,1.0,1.0,4/22,16.03%,THBS4;MDK;DAPK2;CAMK1D
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.2835522149148133,-0.8407983648579709,0.7101449275362319,0.9657035334727394,1.0,6/24,15.24%,HAS2;GPM6B;MFAP4;MYH11;QSOX1;TNXB
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.27229872700055435,0.8407858901614682,0.6927083333333334,1.0,1.0,25/64,39.07%,TARBP1;PUSL1;CTU1;FTSJ1;PUS1;ANKRD16;DUS2;TRMT1;WDR4;TRMT61A;TRMT112;THADA;METTL1;ADAT3;QTRT1;TRMT12;TYW5;PUS7;CTU2;METTL6;SSB;AARS2;THUMPD3;TRMT6;BCDIN3D
prerank,WikiPathway_2021_Human__Hedgehog Signaling Pathway WP4249,0.3011494299331941,0.8403774217079378,0.7076023391812866,1.0,1.0,19/41,39.68%,IHH;CDON;KIF7;HHIP;GRK3;DHH;BOC;GLI1;GPR161;SMURF1;SMO;ARRB1;CSNK1D;SMURF2;CSNK1G1;SUFU;SHH;CSNK1E;CSNK1G2
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.2805169861921506,0.8400619093406562,0.7357512953367875,1.0,1.0,13/63,20.91%,TLCD3B;WNK4;SLC4A3;SLC4A1;PNPLA5;VGF;TLCD1;PPARG;AQP9;NEDD4L;USF1;ABHD4;EIF5A2
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,0.2913631005749863,0.8397906255025913,0.7189189189189189,1.0,1.0,10/41,19.76%,TNNI3;ITGA2;ITGA6;FGF13;LAMC1;PDGFB;PDGFA;PRKCA;LAMA4;HSPG2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.2953575486291494,0.8397831304098907,0.7071823204419889,1.0,1.0,1/34,0.82%,LIX1
prerank,MSigDB_Hallmark_2020__Coagulation,-0.2008496395492125,-0.8396189684981534,0.9705882352941176,0.9680026363229188,1.0,43/137,20.81%,TFPI2;MMP1;C9;F9;APOA1;KLKB1;TF;PLEK;FYN;CTSE;MMP7;F2RL2;P2RY1;MBL2;PLG;PROZ;C1R;HMGCS2;SERPINB2;LEFTY2;CFI;DUSP14;SERPING1;CLU;F13B;ITGB3;F3;CSRP1;THBS1;DUSP6;F11;CTSB;GP1BA;C8A;LGMN;C8B;CTSO;C1S;ACOX2;C1QA;ITIH1;PF4;GNG12
prerank,MSigDB_Oncogenic_Signatures__HOXA9 DN.V1 DN,0.24461638082089895,0.8391939575146764,0.7725118483412322,1.0,1.0,47/169,26.89%,DLX5;SPP1;SLC2A5;SQLE;PDK1;IGFBP2;PARVB;SPON2;E2F8;CDC6;CDC45;HELLS;CEP55;CDT1;MVD;SOX18;STAG3L1;ARHGAP11A;ALOX12;RGS16;FANCI;ZIC1;SLC29A2;ORC1;MCM10;NPTX2;HMGCR;KCTD15;ATAD2;ADM;HMGCS1;TMEM106C;GINS4;CYP51A1;NCAPD2;MICB;PLK4;GADD45GIP1;PFAS;FZD6;TRMT2B;MCM3AP-AS1;EXOSC5;GINS1;BCAT1;FANCG;TIPIN
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.33848432929721267,0.8390747536300397,0.6363636363636364,1.0,1.0,6/18,16.38%,ATP4A;ATP1A2;ATP1A4;ATP1B3;ATP6AP1;NEDD4L
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.2982925563550408,0.8390350312832654,0.7120418848167539,1.0,1.0,12/36,26.78%,MAPT;STK26;PKP1;BCAP31;LMNA;PLEC;CLSPN;FNTA;GSN;PTK2;CTNNB1;LMNB1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.24075936335413256,-0.8389704779281939,0.7567567567567568,0.9689914433412988,1.0,12/44,15.83%,IL10;KLF5;TNF;FOS;NGFR;EGR1;KLF4;GATA3;ATOH8;SOX9;SPI1;LILRB4
prerank,Elsevier_Pathway_Collection__Mitochondrial Dysfunction in Alzheimer's Disease,-0.2846263317819916,-0.8389564837710195,0.6410256410256411,0.9684875854261344,1.0,26/26,71.57%,CAT;BCL2;HSPA1A;ACAT1;MICU1;APP;COMT;CYP1B1;OPA1;CASP3;SLC8B1;BAG1;CYCS;SOD1;MCU;DNM1;BAD;CYP11A1;SOD2;OGDH;HSD17B10;DNM1L;BAX;G6PD;TSPO;FIS1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.30889307547387446,-0.8387985995259378,0.6979166666666666,0.9683100960919951,1.0,16/16,69.13%,SPRY2;SMAD7;SPRED1;CALM1;CADM4;SPRED2;CALM2;DMTN;INPP5K;EIF4G1;SIRT2;PARD3;SPRED3;CALM3;DDIT4;DGKQ
prerank,Elsevier_Pathway_Collection__Amyloid beta and APP Intracellular Transport in Alzheimer Disease,-0.29464765115859554,-0.8386440336729442,0.7415730337078652,0.9682003864239709,1.0,9/20,30.17%,LRP1B;SORL1;SNX4;APP;PICALM;ABCA1;SPON1;RAB7A;BIN1
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.24066177729388463,0.8386035436251222,0.8448275862068966,1.0,1.0,34/205,18.80%,FGF20;PIK3R2;PAK3;ITGA2;LPAR4;ITGA6;CHRM4;FGD1;FGF17;PFN4;SRC;FGF2;FGF23;PIP5K1B;PDGFRB;INSRR;IQGAP3;CHRM5;DIAPH3;BDKRB2;PDGFB;APC2;PDGFA;BDKRB1;SCIN;MYLPF;HRAS;MRAS;ROCK2;MYLK2;EGF;LIMK2;ITGA7;ITGA11
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.29308555551728044,-0.8384834074262446,0.7051282051282052,0.9680232487753029,1.0,4/17,13.84%,BMP10;NR4A3;HAND2;IGF1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.29058046522778164,0.8384275183416012,0.7212121212121212,1.0,1.0,6/37,8.01%,CACNG4;CACNG5;MAPK8IP2;UNC13A;ATP1A2;DGKI
prerank,WikiPathway_2021_Human__Hippo-Merlin Signaling Dysregulation WP4541,0.2515846369477104,0.8383312157387975,0.8048780487804879,1.0,1.0,15/112,14.59%,CDH22;CDH8;CDH16;PAK3;CDH13;ITGA2;ITGA6;FOXM1;CDH24;PDGFRB;CDH17;TEAD2;FLT1;TEAD4;TAZ
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.2990578734858681,-0.8380894915257775,0.6867469879518072,0.9683649135892692,1.0,20/20,70.12%,RIPK3;ASAH1;CYLD;SPATA2;CASP8;PDCD6IP;BIRC2;PELI1;BIRC3;RIPK1;CFLAR;STUB1;HSP90AA1;FLOT2;MLKL;OGT;FLOT1;SDCBP;CDC37;NUPR1
prerank,TRRUST_Transcription_Factors_2019__GATA1 human,-0.2334265117071347,-0.838054404473438,0.8064516129032258,0.9679363848444105,1.0,13/51,17.41%,MUC1;IFNG;HBA1;FCER1A;HBB;CDA;DACH1;CYBB;HBA2;SPI1;TBXA2R;GATA1;LTBP4
prerank,Elsevier_Pathway_Collection__ANGPT/TEK Stimulates Endothelial Cell Migration in Cancer,-0.29389694570174707,-0.8378476472534067,0.6701030927835051,0.967946667463923,1.0,6/19,21.42%,FOS;FOXO1;DOK2;IGF1;TEK;JUN
prerank,WikiPathway_2021_Human__Aryl Hydrocarbon Receptor Netpath WP2586,-0.25339150007382283,-0.8373045904095401,0.7846153846153846,0.9685666069898208,1.0,6/44,7.46%,RET;PTGS2;TNF;CYP1A2;ESR1;MAP2K1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.29187641721082963,0.8372395367947968,0.6927374301675978,1.0,1.0,10/44,22.35%,MPZ;TP53AIP1;TP73;BIRC5;NDRG1;TNFRSF10D;BCL6;BBC3;TP53I3;AIFM2
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.28794501337144696,0.8371950649770147,0.6966292134831461,1.0,1.0,1/38,0.34%,DYNC1I1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.2713469719740676,-0.8370706970960883,0.7349397590361446,0.9684877365938372,1.0,6/30,12.46%,PLAAT1;PHOSPHO1;PLA2G2D;ETNK2;PLAAT2;PLAAT3
prerank,WikiPathway_2021_Human__AGE/RAGE pathway WP2324,-0.22308293155446057,-0.8370435537981697,0.8125,0.9680049907987501,1.0,15/64,22.05%,LGALS3;MAP2K1;PRKCB;FOXO1;MMP7;PLA2G4A;AKT1;MSR1;MYD88;EZR;NCF1;PRKCZ;JUN;JAK2;STAT1
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,0.23799165123986424,0.8369229275509831,0.7899543378995434,1.0,1.0,63/161,37.31%,SLC16A3;NDUFA1;PDPK1;NDUFS6;PCDHB11;SLC16A8;NDUFV1;NDUFB9;COX6C;ATP5MF;COX20;COX7B;NDUFA3;IDH3G;UQCRB;NDUFS2;NDUFA9;NDUFAF2;ATP5F1D;COX6B1;CS;MDH2;NDUFB11;NDUFA2;NDUFS7;SLC25A14;COX8A;UQCRQ;DLAT;BSG;NDUFAF6;MPC2;PDPR;TRAP1;NDUFA13;LDHAL6A;NDUFA11;ATP5F1E;NDUFA6;ATP5MC1;UQCR11;UCP3;NDUFS8;COX4I1;NDUFV2;ATP5ME;COX5B;NDUFA8;NDUFB7;ETFB;TMEM186;UQCRH;NDUFAB1;COX19;NDUFB2;NDUFB10;UQCRC1;NDUFAF3;ACAD9;PDHA1;COX7C;UQCR10;NDUFB3
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,-0.3188929534626923,-0.83667799202145,0.6881720430107527,0.9683149607458842,1.0,2/15,6.27%,CD4;CCR5
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,0.3081150658803746,0.8365470786067041,0.702247191011236,1.0,1.0,8/31,30.57%,HES5;CNTN1;JAG2;DLL4;MAML1;UBA52;NCSTN;MAMLD1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.3081802293933196,0.8364734250151902,0.6975308641975309,1.0,1.0,5/30,17.92%,CERS1;SRC;PIF1;ANKRD1;ACVRL1
prerank,Elsevier_Pathway_Collection__AHR in Intestinal Cell Antimicrobial Barrier Maintenance,0.3471611496048111,0.836418898289652,0.6524390243902439,1.0,1.0,1/16,1.91%,LCN2
prerank,MSigDB_Oncogenic_Signatures__CAHOY ASTROGLIAL,0.25877998225900906,0.8362430751014432,0.7536945812807881,1.0,1.0,17/87,15.43%,LCN2;NOX4;AKR1B10;CASP12;COL8A1;NUAK2;KAZALD1;TIMP1;KLHL21;LOXL2;LTBP2;PCDH17;COL5A1;FOXJ1;CD109;VLDLR;PSRC1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.3054028826079668,-0.8356437211996195,0.6547619047619048,0.9702050498271013,1.0,2/17,3.24%,SLC6A20;FOLR3
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.21010063492195044,-0.8356044886472195,0.8947368421052632,0.9697802083089324,1.0,29/112,21.43%,OVOL2;AMHR2;WNT7A;HPGD;FOS;SFRP1;APOA1;XCL1;SOX6;ZFP36L1;WNT2;CILP;FERMT2;USP9Y;SOX9;LEFTY2;WFIKKN2;SMAD9;SOX5;GCNT2;GDF10;WNT5A;USP15;PDE2A;PRKCZ;SMAD7;LPXN;JUN;WNT10A
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.2676108808845427,0.8354715876681378,0.7539267015706806,1.0,1.0,18/75,20.39%,CYP17A1;PRKAA2;CYP21A2;ACSL6;ACSM1;LPL;MVD;ACSM6;ACLY;ACACA;HSD17B1;OLAH;HMGCR;GNPAT;SCD;ACSL5;FDFT1;GPAM
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.2852820022792291,0.8354595441130361,0.7227722772277227,1.0,1.0,22/62,31.09%,FGF2;TOX;PDGFRB;EYA4;RGCC;PDGFB;RTEL1;SMOC2;H2AX;EYA1;RAD51;TRIM28;TMEM161A;MYC;WT1;MECP2;FGFR4;SIRT6;PCNA;ABRAXAS1;BABAM2;NPAS2
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.26893561379021463,0.8352789021332159,0.7377049180327869,1.0,1.0,11/65,16.84%,MT3;TIMP1;LEP;RASIP1;MTMR8;TIMP4;KIF25;FOXK1;LEPR;HTR2B;BMF
prerank,Elsevier_Pathway_Collection__ADRA1 -> Vasoconstriction,0.337802094664112,0.8351953847198136,0.6493506493506493,1.0,1.0,2/19,6.70%,RASGRF1;ADRA1D
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.3654803046956839,0.8351160898798569,0.7142857142857143,1.0,1.0,3/15,8.48%,MYMK;MYMX;ERVW-1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.2728604499121857,-0.8350300681139832,0.7662337662337663,0.9703543721692556,1.0,7/27,23.36%,SIK1;ID2;PER1;PER3;PDE6B;CRY1;FBXL3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hearing Loss,0.24038296896520336,0.8349962614383197,0.7991452991452992,1.0,1.0,19/177,11.20%,COL2A1;GJB6;KCNC1;DLX5;CEACAM16;E2F1;USH1G;LOXHD1;FSCN2;TMC1;ELN;COL4A5;PCDH15;COL11A1;ASIC3;MYO7A;FOXC1;EYA4;TFF3
prerank,KEGG_2021_Human__Pathways in cancer,0.2285324244990571,0.8348984198064249,0.9020408163265307,1.0,1.0,74/493,15.74%,GNG4;IGF2;CTNNA2;FGF20;VEGFD;LEF1;LAMA3;E2F1;PIK3R2;CALML6;AXIN2;F2RL3;WNT4;TERT;WNT9B;NQO1;ITGA2;LPAR4;WNT8B;CDKN2A;HES5;ITGA6;FGF17;BMP4;TCF7;BIRC5;PTGER1;FGF2;PTGER3;FGF23;E2F2;COL4A1;CAMK2A;COL4A5;CCNE1;PDGFRB;IL3RA;CCNA2;GNG3;CCNE2;NOTCH3;IKBKG;COL4A2;FLT3LG;TXNRD2;CDKN2B;LAMC1;KIF7;ARHGEF11;IL6R;BDKRB2;EPO;DAPK2;JAG2;NFKB2;PDGFB;APC2;HHIP;PDGFA;GSTM2;BDKRB1;PGF;GNB5;CKS1B;ADCY6;ELOC;GNG8;DVL2;WNT2B;PIM1;PPARG;WNT6;PRKCA;HRAS
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.31630969079402943,0.8344174152180115,0.6777777777777778,1.0,1.0,4/28,11.88%,PTPRT;TDGF1;SRC;IL6R
prerank,WikiPathway_2021_Human__Alzheimer's disease WP2059,0.26305583647181047,0.8342678531069158,0.7609756097560976,1.0,1.0,9/80,11.68%,CACNA1S;GRIN1;CHP2;MAPT;CASP12;GRIN2A;LPL;ATP2A1;CACNA1C
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.2893540423424718,-0.8341789970646633,0.6781609195402298,0.9715260999317042,1.0,6/18,15.47%,NRXN1;MUSK;LRRC4;LHFPL4;NLGN4X;NLGN4Y
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.28802914951835606,0.8341691824513702,0.7303370786516854,1.0,1.0,7/47,16.21%,MAPT;STOX1;PRKN;SQSTM1;IAPP;SREBF2;CYRIB
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.25864271358795915,0.834018424657146,0.7978723404255319,1.0,1.0,23/79,36.67%,DYNC1I1;ANK1;TMED3;COG8;COPE;NAPSA;KDELR3;TMED9;DYNLL1;COG2;ARFGAP1;COPA;SPTAN1;COG4;DCTN4;DCTN2;DYNC1H1;SPTBN4;DCTN3;YKT6;CD59;COG7;PTGES2
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.23703811679666031,0.8340026159111263,0.8675213675213675,1.0,1.0,123/250,45.30%,CDC20;PRKN;PSMD4;CCNA2;JOSD2;IKBKG;CDK1;USP51;FOXK1;UCHL1;PSMB4;KAT2A;USP27X;USP22;ACTR5;SMAD3;USP49;CDC25A;BARD1;DESI2;TRAF2;USP46;OTUD7B;STAMBPL1;USP31;CLSPN;OTUD6B;ASXL2;TOMM20;ASXL1;OTUB2;INO80E;TAF10;USP11;PSMD1;NEDD8;NFRKB;HCFC1;USP21;TFPT;MYC;PSMB3;COPS5;UFD1;PSMD14;UBA52;HGS;TNIP2;PSMB5;POLB;PSMD2;SENP1;ABRAXAS1;PSMA1;BABAM2;PSMD10;KEAP1;ADRM1;PSMC4;PSMC3;BAP1;COPS7B;UIMC1;USP35;DDB2;KDM1B;COPS6;SKP2;OGT;SMURF2;PSMC5;RUVBL1;OTUD3;TNFAIP3;TRAF3;USP5;PSMB6;PSMD8;MDM4;OTUD5;USP14;PSME2;VCP;TAB1;ACTR8;PSMD13;PSMB7;PSMA7;BABAM1;USP40;INO80D;PSME3;COPS8;USP7;USP30;GPS1;JOSD1;SMAD2;USP20;USP13;USP1;FOXO4;USP37;MBD6;SENP5;PSMB2;PSMA6;UBC;PSMD9;OTUD7A;EIF3F;USP19;USP24;COPS7A;UCHL5;TRRAP;MCRS1;TAF9B;BRCC3;INO80;PSMC2;COPS4;USP34
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.3034117193310603,-0.8338873705883814,0.7325581395348837,0.9715587817401906,1.0,6/17,20.12%,ASAH2;SPTLC3;GCH1;SPHK2;QDPR;DHFR
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.2736731231456427,0.8338528605618972,0.7431693989071039,1.0,1.0,28/60,40.89%,TYRO3;POLR2L;ADAR;TMEM250;POLR2K;KPNA2;NELFE;MDFIC;LARP1;POLR2G;PABPC1;VPS4A;PPIA;POLR2H;NELFA;PPIH;POLR2I;HACD3;POLR2J;CTDP1;DHX9;SUPT5H;NELFB;TBC1D20;DDB1;POLR2A;POLR2B;GTF2F1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.3064874897970229,-0.8337164669992609,0.6538461538461539,0.9714877733759724,1.0,7/17,18.36%,NR4A3;CCL5;ADAMTS1;IGFBP5;IGF1;VTN;AIF1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.3229349661665823,-0.8335295088891603,0.7096774193548387,0.9713254319338953,1.0,4/15,21.34%,ENTPD8;ENTPD5;ENTPD3;NUDT15
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.2793950906390845,0.8333263557492715,0.7121212121212122,1.0,1.0,21/48,44.27%,AKR1B10;COG8;NAA38;RAB9B;STX10;NAPSA;COG2;RABEPK;VPS54;STX6;RAB43;VAMP4;COG4;RHOBTB3;RAB6B;COG7;PLIN3;ARFRP1;ARFIP2;NSF;COG1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.3369229729566854,0.8333243706445664,0.7076023391812866,1.0,1.0,1/20,1.00%,MRAP2
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,-0.3146322723198005,-0.8332386291863813,0.7391304347826086,0.9714251672646871,1.0,2/15,8.44%,GRIN2B;TRPC3
prerank,Elsevier_Pathway_Collection__NMDA Receptors -> Ca2+/CREB Activation/PGE2 Synthesis,0.34536318116505343,0.8330573768269659,0.6763005780346821,1.0,1.0,8/17,24.71%,GRIN1;BDNF;GRIN2A;GRIN3B;HRAS;GRIN2C;GRIN3A;MAP2K2
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.2765034652426417,-0.8330225125181527,0.6710526315789473,0.9713847840902431,1.0,8/25,20.96%,LRRK2;ALOX5;CLU;HERPUD1;HSPA1A;MAGEA3;LPCAT3;XBP1
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,0.29615276712723265,0.8328925142925624,0.7055555555555556,1.0,1.0,27/46,47.30%,PSMD4;PSMB4;PSMB3;PSMD14;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;MRC1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;PSMD9;PSMC2;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.26653138858170844,0.8327437801767826,0.7150259067357513,1.0,1.0,37/70,46.08%,ELL3;POLR2L;INTS8;POLR2K;INTS3;POLR2G;NABP2;ZNF143;INTS7;TAF6;INTS1;POLR2H;SNAPC2;RPRD2;INTS11;POLR2I;POLR2J;POU2F1;INTS9;TAF8;INTS5;TAF9;POLR2A;ELL;POLR2B;GTF2F1;PHAX;POLR2F;CDK9;TAF5;SRRT;INTS4;CCNT2;SP1;SNAPC4;GTF2E1;RPRD1B
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.3091206819350611,-0.8326451836207217,0.7727272727272727,0.9717064485502557,1.0,7/17,21.64%,PROK2;ZDHHC21;CHRM2;CHRM3;MYOCD;ADRB2;SETD3
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.29470243059015666,0.8325283728945865,0.6685082872928176,1.0,1.0,7/31,19.76%,HPSE2;CHI3L1;GPC3;IDUA;GPC2;CHIT1;HSPG2
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.2666493166907631,0.8324664220876279,0.7868020304568528,1.0,1.0,18/89,17.35%,DIRAS1;ROBO1;TRIB2;BMP4;FGF2;IRAK1;PDGFRB;EZH2;PDGFB;GBA;FLT1;PDGFA;UCHL1;RGS14;HRAS;HTR2B;DIRAS2;EGF
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.3150925048206775,-0.8324000448712437,0.7108433734939759,0.9717328454175986,1.0,7/17,30.13%,PIK3R1;CEP43;STAT1;GAB2;STAT3;ZMYM2;FGFR1OP2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2766020022185004,0.8322324612521818,0.7150259067357513,1.0,1.0,32/72,39.37%,TP73;PSMD4;FOXC1;PSMB4;PRKDC;METTL3;TCF3;PSMD1;PSMB3;LDB1;PSMD14;PSMB5;PSMD2;YAP1;PSMA1;PSMD10;PUS7;PSMC4;PSMC3;GATA2;PSMC5;PSMB6;PSMD8;KITLG;ABL1;SETD1A;TAL1;PSME2;PSMD13;PSMB7;PSMA7;PSME3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.24412994915002348,-0.8322104582254809,0.765625,0.9715799273485122,1.0,12/38,23.90%,PCK1;ALDOB;FBP1;ALDOC;KHK;IRS2;PGM1;AKR1A1;GALM;DCXR;SORD;OAS1
prerank,Elsevier_Pathway_Collection__Tubular Cell Dysfunction in Progressive Diabetic Nephropathy,0.2818281638908557,0.8321857261927597,0.723404255319149,1.0,1.0,13/46,26.07%,NOX4;SRC;MMP12;SHC1;PDPK1;PRKCA;SMAD3;PIAS3;MMP9;MMP3;PIAS1;MAP2K2;MYC
prerank,Elsevier_Pathway_Collection__Amyloid beta Traffic and Degradation in Extracellular Matrix in Alzheimer's Disease,0.32653728940100324,0.8321578337780797,0.6453488372093024,1.0,1.0,7/24,19.77%,ITGA6;LGI3;CD36;ACE;VLDLR;MME;MMP9
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.2802741380901208,0.8320931506606194,0.7307692307692307,1.0,1.0,22/52,39.37%,ECSCR;PRKN;FOXF2;PKD1;UBQLN4;GPX1;HSP90AB1;PSMD14;NUPR1;DDRGK1;APOE;GLMN;TREM2;DAB2IP;PSMC3;FMR1;PSMC5;USP14;PSME2;GNA12;XPO1;PSME3
prerank,WikiPathway_2021_Human__Oxidative Stress WP408,0.3126089595022931,0.8318723962422844,0.7085714285714285,1.0,1.0,7/32,15.87%,NQO1;NOX4;NOX5;TXNRD2;NOX1;GPX3;NFIX
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.2537908286515069,0.8318716476886266,0.7941176470588235,1.0,1.0,7/108,6.06%,PYDC1;SFN;CAMK2N2;THY1;CENPE;TRIB2;DBNDD1
prerank,WikiPathway_2021_Human__Nuclear receptors WP170,-0.2524435634912746,-0.8318315564439687,0.8,0.9719465199251858,1.0,8/36,18.59%,NR4A2;NR4A1;ESR1;NR1I2;PGR;RARB;NR1I3;AR
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.36600614971602435,0.8316686456930695,0.7168674698795181,1.0,1.0,8/17,28.78%,SYNGR1;SNAP25;SYP;PRRT2;STX1A;STX4;STX1B;AP3D1
prerank,MSigDB_Oncogenic_Signatures__KRAS.DF.V1 UP,0.2430633421412124,0.831602645201569,0.7964601769911505,1.0,1.0,41/182,22.81%,S100P;DKK1;TSPAN5;SLC22A4;PLCH2;CCL20;E2F8;AURKB;DLGAP5;LOXL2;SMYD3;AKR1C3;CHRNA5;PTPRG;RASIP1;CDKN2B;STEAP1;ATP9A;CCDC85B;IFI27;TIMP4;SPAG4;PDPN;HSPA2;PLAU;OPLAH;SLC26A2;ANKRD36B;VCAN;CLDN5;BCL6;TMEM160;TBC1D8;BCL3;LRP8;TP53I3;DSN1;MAP3K6;PPP2R3B;PLAT;FAM168A
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,0.3073491614748962,0.8315292051641973,0.7034883720930233,1.0,1.0,22/35,49.52%,POLR2L;POLR2K;POLR3K;ZNF143;POLR2H;POLR3H;POLR3A;SNAPC2;POLR3C;GTF3C5;POLR3G;POU2F1;POLR3GL;GTF3C3;POLR3E;POLR3F;POLR2F;SNAPC4;GTF3C6;CRCP;GTF3C2;POLR1D
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.28562109730341284,0.8313432375893457,0.7447916666666666,1.0,1.0,22/49,44.54%,CDKN2B;COL1A2;DAND5;NEDD4L;SMAD3;E2F5;PARP1;HDAC1;MYC;NCOR2;UBA52;RBL1;SMURF2;TGIF1;E2F4;MAPK3;SMAD2;WWTR1;UBC;MAPK1;CDK9;CCNT2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Ichthyosis,0.3262649674857791,0.8313217890920896,0.6529411764705882,1.0,1.0,3/21,4.81%,SPINK5;ALOX12B;FLG
prerank,MSigDB_Oncogenic_Signatures__SIRNA EIF4GI DN,0.26557081200325594,0.8312029599961801,0.746268656716418,1.0,1.0,19/83,25.33%,OPN1SW;IGF2BP2;ATP2B4;CDKN2C;CYTL1;CDC6;SHCBP1;LOXL2;TRIP13;NEDD4;PSMC3IP;SCML2;MRPL9;EIF5A2;CDH11;IMPA1;ATP6V0E1;MYO19;MAN2A2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Medulloblastoma,0.27544025031773006,0.831159891489095,0.7295918367346939,1.0,1.0,20/65,26.12%,IGF2;E2F1;BIRC5;FGF2;AMH;CDKN2C;MCM2;ZIC1;PAX5;MCM3;MMP9;NNAT;TGFB2;PARP1;MCM7;GLI1;ESR2;MYCN;MYC;CTNNB1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.326138476189594,0.831113303982291,0.6818181818181818,1.0,1.0,3/23,4.68%,KCNH2;SLC12A5;SLC12A1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.2770758860294368,0.830839969154173,0.7219251336898396,1.0,1.0,15/53,22.11%,MYH3;MAPK12;MYMX;MSTN;ITGB1BP2;TEAD4;MRAS;MEF2D;CACNA1H;TRIM72;NEB;ITGA7;ITGA11;ANKRD2;VAMP5
prerank,Elsevier_Pathway_Collection__VEGF Independent Angiogenesis in Cancer,0.2757274323621382,0.8308048175447965,0.7405405405405405,1.0,1.0,8/52,14.95%,RASGRF1;SRC;FGF2;EFNA1;PDGFRB;PDGFB;SHC1;PDPK1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.24762360935944525,0.8307107985701984,0.7731481481481481,1.0,1.0,50/117,40.78%,MAPT;PRKN;CAMK2A;MANF;USP51;ABCD1;MAPKAPK2;ROCK2;NUP37;DYRK3;AIFM2;ARNTL;NUP62;TPR;NPM1;NUP133;HSF1;HSP90AB1;NUAK1;NUP155;NUPR1;NUP160;NPAS2;CASP9;MLST8;CRYAB;ADCY8;NUP188;NEK4;BAG3;HSPA8;RPTOR;ABL1;AKT1S1;NUP205;MAPK3;GSK3B;MBTPS2;HIKESHI;NUP210;HSP90AA1;CHCHD2;ATR;DNAJB6;RAE1;HSPA1L;RPA2;MTOR;NUP214;HSPH1
prerank,TRRUST_Transcription_Factors_2019__ING4 human,-0.31060764668568197,-0.8306918512080896,0.686046511627907,0.9736634955742344,1.0,6/15,20.14%,PTGS2;NGF;NTRK1;CXCL8;BCL2;ARL6IP5
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.35483328368617717,0.8306880752322185,0.6568047337278107,1.0,1.0,3/15,22.58%,DMC1;NSMCE2;RAD51
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,0.2779488439358068,0.8306732654535298,0.7526315789473684,1.0,1.0,38/65,47.30%,PSMD4;PSMB4;NEDD4;PSMB3;PSMD14;UBA52;PSMB5;TRIM27;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CSNK2B;PSMC5;OTUD3;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;USP13;PSMB2;PSMA6;UBC;STUB1;PSMD9;WWP2;XIAP;PSMC2;CSNK2A2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.30130985665232884,0.8304180579069551,0.7028571428571428,1.0,1.0,16/34,34.62%,DKK1;SFRP4;ANKRD13B;DLG4;EGF;WDR54;PCSK9;ARF1;ATXN2;ARRB1;FMR1;SDCBP;FLOT1;ANGPT1;CD63;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.30795126468488176,0.8302759666722136,0.7241379310344828,1.0,1.0,5/28,14.64%,RASGRF1;RASGEF1A;SRC;EPO;SHC1
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.294336275406416,0.8301328615672943,0.7415730337078652,1.0,1.0,23/35,52.83%,NUP37;NUP62;TPR;NUP133;NUP155;NUP160;PIAS4;UBE2I;NUP188;NUP205;NUP210;NUP214;NUP107;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.29745517145204325,-0.8300784916814617,0.6521739130434783,0.9744684675700451,1.0,6/19,13.06%,SGPP2;ASAH2;GCH1;DEGS2;SPHK2;AKT1
prerank,Elsevier_Pathway_Collection__Apoptosis and Immediate Early Gene Activation in Epileptiform Disorders,-0.24207152251191158,-0.8296901681906566,0.746268656716418,0.9747358734566487,1.0,10/47,15.04%,HTR2A;TNF;FOS;FASLG;CAMK4;MAP2K1;AKT1;RASGRP1;BCL2L11;GRIA1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.26185837258541833,0.8296023516487614,0.798941798941799,1.0,1.0,16/84,17.92%,INHA;NODAL;GDF5;HES5;MSTN;BMP4;TTK;GDF15;GDF11;CDKN2B;GDF7;CDKN1C;INHBB;ZNF423;CRB2;ACVRL1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.2640169917743102,-0.829255795507554,0.7283950617283951,0.9750908758687743,1.0,9/30,18.51%,TNN;NOCT;NOG;SEMA4D;GREM1;RORB;SOX9;GDF10;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.26544198209132464,-0.8291940594452849,0.7464788732394366,0.9747306740341499,1.0,4/23,13.84%,ITLN1;PIK3R1;AKT1;IGF1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.23491185113280033,-0.8289719570982935,0.7647058823529411,0.9741203594458476,1.0,16/52,24.22%,IRF4;OASL;RSAD2;EGR1;IRF8;MX2;MYD88;IFIT2;IFIT3;OAS3;OAS2;IFIT1;STAT1;IRF2;OAS1;IRF9
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.23491185113280033,-0.8289719570982935,0.7647058823529411,0.9741203594458476,1.0,16/52,24.22%,IRF4;OASL;RSAD2;EGR1;IRF8;MX2;MYD88;IFIT2;IFIT3;OAS3;OAS2;IFIT1;STAT1;IRF2;OAS1;IRF9
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.2957889555340475,0.8288072520180723,0.7395833333333334,1.0,1.0,27/45,46.06%,AXIN2;EYA4;H2AX;RADX;EYA1;TRIM28;UBR5;TMEM161A;PCNA;ABRAXAS1;BABAM2;NPAS2;UIMC1;SIRT7;DHX9;UBE2V1;POLH;RPS3;BABAM1;RAD52;USP1;UBE2V2;CDK9;WRAP53;BRCC3;DEK;TRIP12
prerank,WikiPathway_2021_Human__PKC-gamma calcium signaling pathway in ataxia WP4760,-0.2908673575482592,-0.8287179586658419,0.6893203883495146,0.9740999519337066,1.0,5/19,15.04%,GRIA3;TRPC3;GNA14;PLCB2;GRIA1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.25740172614510315,-0.828706657802569,0.7866666666666666,0.9735929648846845,1.0,5/34,11.02%,FAM3D;IL1B;SFRP1;RSAD2;IL12B
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.2576683167736648,0.8286106755548893,0.766497461928934,1.0,1.0,26/95,28.24%,ARHGEF39;FGD1;ARHGEF37;IRAK1;ARHGEF10;SORCS3;LINGO1;RNASE1;RASGRF2;ARHGEF11;OBSCN;SQSTM1;PLEKHG2;ARHGEF2;ARHGEF15;ECT2;MAGED1;ARHGEF19;HDAC1;MCF2L;NGEF;ITGB3BP;AATF;PLEKHG5;UBA52;NCSTN
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.23266555553909773,0.8284658792474366,0.8921161825726142,1.0,1.0,81/345,31.74%,TRIM71;DCST1;ZNRF3;PLK1;BUB1B;CDC20;KIF14;UBE2C;PRKN;PSMD4;DTL;RNF133;AURKB;UHRF1;KCTD17;UBE2S;VPS28;PTTG1;RNF43;AURKA;SPSB2;RNF148;IFI27;UCHL1;PSMB4;MVB12B;SQSTM1;ELOC;ANKRD9;NEDD4L;VPS37D;NEDD4;TRIM72;SHARPIN;UBQLN4;OTUD7B;RNF187;UBE2A;ANAPC11;KLHL25;ARNTL;TRIM3;UBA1;COP1;NPLOC4;RNF215;TRIM25;PSMD1;NEDD8;PTPN23;WDR81;AGAP3;CTNNB1;ANAPC7;PSMB3;RNF216;HECW1;ZFAND2B;UFD1;PSMD14;DDIT3;MAD2L1;KCTD13;FBXL22;UBE4B;SMURF1;SPSB1;PSMB5;VPS4A;PSMD2;PSMA1;RMND5B;UBE2I;PSMD10;ARRB1;KEAP1;ADRM1;RNF20;PSMC4;PSMC3;FBXW5
prerank,Elsevier_Pathway_Collection__Ovarian Cancer,0.25103369651361485,0.8281659852206074,0.7568807339449541,1.0,1.0,19/128,17.35%,IGF2;VEGFD;LEF1;CDC20;SRC;ACTL6B;BDNF;PDGFRB;NOTCH3;JAG2;PDGFB;FLT1;PDGFA;SHC1;PDPK1;HRAS;CHEK1;SMAD3;EGF
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.3150974116631228,0.827480598753915,0.6797752808988764,1.0,1.0,1/29,0.21%,MT3
prerank,WikiPathway_2021_Human__Cardiac Hypertrophic Response WP2795,0.27047796593098333,0.8271468845740139,0.7397959183673469,1.0,1.0,9/54,17.35%,PLA2G2A;HDAC4;FGF2;IKBKG;PRKD1;PDPK1;PRKCA;HDAC5;EGF
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.33026989824163816,0.8270795031946654,0.6625,1.0,1.0,3/21,13.63%,PLA2G2A;ABCA3;PLA2G4F
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.30391934266598775,0.8269968409068645,0.7567567567567568,1.0,1.0,6/36,17.60%,PRKAA2;MAPT;AURKA;CDK2AP2;MAP6;MAP6D1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.2280752763210459,0.8269601044566467,0.8271604938271605,1.0,1.0,114/302,40.40%,AVIL;CCNO;CFAP46;TEKT5;RHO;NEK2;PLK1;UNC119B;CILK1;DCX;CDK1;TUBA4A;FHDC1;DNAAF1;BBS5;ZMYND10;CEP131;IFT81;FOXJ1;BBS2;PKD1;ABLIM1;CETN2;CEP250;HAUS4;HAUS5;KIF24;DYNLRB2;EHD2;CCDC28B;TMEM250;DNAH5;FNBP1L;FAM161A;MARK4;ATP6V0D1;B9D2;B9D1;GSN;CCDC40;OCRL;TEKT4;PLK4;DYNLL1;IFT27;PTPN23;DYNLRB1;CEP70;SFI1;ARMC9;TMEM80;RILPL1;CPLANE2;SSNA1;ASAP1;BBS4;GAS8;NPHP4;FBF1;KIFAP3;CEP97;CCDC13;EXOC4;CSNK1D;TUBA1A;ALMS1;EXOC3;CEP290;CFAP70;HYLS1;SSX2IP;CEP152;DCTN2;DYNC1H1;NUDCD3;CFAP43;DCTN3;CEP41;TTLL3;CEP89;KIF3B;TUBG1;CEP72;DYNC2LI1;PPP2R1A;HSPB11;RPGRIP1L;RAB11FIP3;NDE1;STK36;C2CD3;HAUS1;WDR90;TTC30B;TXNDC15;E2F4;ARL3;RSPH1;INPP5E;TUBB4B;IFT80;SDCCAG8;CFAP44;FLNA;HSP90AA1;IFT140;CSNK1E;CEP83;TMEM138;ATAT1;TEKT3;RFX3;EXOC8;CEP192
prerank,Elsevier_Pathway_Collection__Proteins Involved in Sleep Disorders,0.3527259974317652,0.8268746642655534,0.6745562130177515,1.0,1.0,4/16,7.73%,SLC6A4;SLC6A11;PTGDS;BDNF
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.29948864346014026,-0.8268466271918566,0.7777777777777778,0.9769772390542003,1.0,5/16,19.11%,CBFA2T3;FBP1;PPIF;NCOR1;PID1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.29586509019148793,0.8268011366092166,0.7556818181818182,1.0,1.0,18/34,43.82%,POLR2L;TCOF1;POLR1A;POLR2K;TAF1A;POLR1H;POLR1G;POLR2H;CAVIN1;MAPK3;TAF1;ERCC2;TAF1D;UBTF;POLR1C;TAF1B;POLR2F;ERCC3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Neuroblastoma,0.23671956573484565,0.8266841088129014,0.8325991189427313,1.0,1.0,39/199,18.21%,IGF2;KIF1A;SPP1;KCNH2;CEND1;TP73;PRND;EXTL1;TERT;NEUROD1;GAL;PLK1;BMP4;GPC3;CCL20;BIRC5;SRC;FGF2;BDNF;MSX1;CYTL1;CDK1;ADM2;AURKA;STC2;MPPED2;NME1;ODC1;PAX5;PPARG;TNFRSF10D;HRAS;CD248;B4GALNT3;TACR1;EGF;BCL6;BARD1;NES
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.3243304761859777,-0.8265313188200409,0.7058823529411765,0.9771183582662958,1.0,6/16,17.09%,CD160;FASLG;CCL2;CD40LG;THBS1;ITGA4
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.30345629933215545,0.8263104494485592,0.7457627118644068,1.0,1.0,2/29,5.58%,PLA2G2A;ABHD12B
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,0.2611044848928043,0.8262196852912346,0.7537688442211056,1.0,1.0,32/81,37.36%,PRKAA2;AGO2;LAMTOR2;UBL4A;GPX2;COX6C;COX20;COX7B;LAMTOR4;TXNRD1;TSC1;COX6B1;TSC2;COX8A;PRKAB2;RHEB;PRDX2;COX4I1;COX5B;TP63;PRDX5;MLST8;LAMTOR5;COX19;REXO2;RRAGD;AGO1;YWHAH;DDIT4;RPTOR;COX7C;RRAGA
prerank,Reactome_2022__TCR Signaling R-HSA-202403,-0.2067964716012144,-0.8260641445912587,0.8888888888888888,0.9775731445104346,1.0,24/111,21.46%,CD4;PTPN22;ITK;FYB1;PTPRC;PRKCQ;CD3E;TRAT1;LCP2;HLA-DQA2;CARD11;LCK;CD247;PIK3R1;PLCG2;ZAP70;HLA-DQA1;INPP5D;CD101;HLA-DQB2;CD3D;TAB2;HLA-DRB5;HLA-DRA
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",0.23255684315146516,0.8256776244221029,0.8326180257510729,1.0,1.0,34/245,16.21%,GNG4;IGF2;ADRA2C;VEGFD;ACTN2;PIK3R2;F2RL3;VWF;SRC;TRPC6;DGKI;TIMP1;GNG3;MANF;RNASE1;TUBA4A;CD36;DGKD;F13A1;ITIH4;PDGFB;PDPN;HABP4;PDGFA;GNB5;SHC1;PDPK1;CD109;GNG8;CYB5R1;GP9;PRKCA;SYTL4;CYRIB
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.3069411798214131,0.825655763417484,0.7486033519553073,1.0,1.0,7/32,13.38%,SYT5;SYT3;SEPTIN5;SYT15;SYT2;SYN1;RAB3D
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.27398465165153574,-0.8256289039802958,0.6962025316455697,0.9780002986746998,1.0,8/25,17.58%,INHBA;TLR3;CCL3;TLR4;C1QC;MAFB;LILRB4;LILRB3
prerank,Elsevier_Pathway_Collection__Synovial Fibroblast Proliferation in Rheumatoid Arthritis,-0.2297466550444638,-0.825571666238782,0.8,0.9776191758302412,1.0,8/56,9.77%,TNF;IL1B;FOS;INHBA;PDGFRA;MAP2K1;IL6;FYN
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.3011573874698892,0.8254484671194459,0.7142857142857143,1.0,1.0,5/28,15.74%,CEMIP;KCNB1;TCAF2;GDI1;HRAS
prerank,TRRUST_Transcription_Factors_2019__CREBBP human,-0.2778435887746858,-0.8247676198801099,0.6888888888888889,0.978814065695879,1.0,2/22,2.47%,CCK;PTGS2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.2620707541224177,0.8246998893504798,0.7772277227722773,1.0,1.0,38/74,44.40%,MMP12;IPO4;SNRPE;TSC2;NUP62;TPR;NUP133;IPO9;FAM53B;SNRPD2;SNRPB;GEMIN8;SNRPD1;NUP155;GEMIN7;IPO13;EIF4ENIF1;NUP188;NXT1;SNRPD3;E2F3;HTATIP2;HNRNPA1;NUTF2;HIKESHI;DDX20;FAM53A;RAN;GEMIN4;IPO11;NUP214;SNRPG;RANBP17;NUP107;FAM53C;GEMIN5;NXT2;TNPO2
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,0.2685357171903176,0.824683508902245,0.7551020408163265,1.0,1.0,14/69,20.59%,GNG4;PIK3R2;SRC;SPHK1;GNG3;GNB5;SHC1;PDPK1;GNG8;HRAS;EGF;GNG10;MMP9;MMP3
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.22720022726513295,0.8245780145601577,0.8922413793103449,1.0,1.0,31/314,12.84%,TRIM71;IGF2BP1;APLN;H3C13;PRKAA2;MAPT;CLDN19;STOX1;WNT4;TERT;ROBO1;GATA5;H3C1;POU4F1;IGF2BP2;BMP4;CD34;FGF2;ATP2B4;AGO2;PRKN;EZH2;HELLS;NANOS1;DNMT3A;RGCC;TYMS;AURKA;STC2;CREB3L1;PDGFB
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.23725987916157654,0.8245547567558806,0.8701298701298701,1.0,1.0,103/241,41.38%,CDC20;PRKN;PSMD4;CCNA2;JOSD2;IKBKG;CDK1;USP51;FOXK1;UCHL1;PSMB4;KAT2A;USP27X;USP22;ACTR5;SMAD3;USP49;CDC25A;BARD1;DESI2;TRAF2;USP46;OTUD7B;STAMBPL1;USP31;CLSPN;OTUD6B;ASXL2;TOMM20;ASXL1;OTUB2;INO80E;TAF10;USP11;PSMD1;NEDD8;NFRKB;HCFC1;USP21;TFPT;MYC;PSMB3;COPS5;UFD1;PSMD14;UBA52;HGS;TNIP2;PSMB5;POLB;PSMD2;ABRAXAS1;PSMA1;BABAM2;PSMD10;KEAP1;ADRM1;PSMC4;PSMC3;BAP1;UIMC1;USP35;DDB2;KDM1B;ATXN7L3;SKP2;OGT;SMURF2;MINDY1;PSMC5;RUVBL1;OTUD3;TNFAIP3;TRAF3;USP5;MINDY2;PSMB6;PSMD8;MDM4;OTUD5;USP14;PSME2;VCP;TAB1;ACTR8;PSMD13;PSMB7;PSMA7;ENY2;BABAM1;USP40;INO80D;PSME3;USP7;USP30;JOSD1;SMAD2;USP20;USP13;USP1;FOXO4;USP37;MBD6
prerank,Elsevier_Pathway_Collection__beta-Cell Function Inhibition by Ciclosporine and Tacrolimus (Rodent Model),0.3252153450699134,0.8244251501438951,0.650887573964497,1.0,1.0,4/22,16.03%,GLP1R;PDPK1;KCNJ11;SYTL4
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Asthma,-0.28003578597551304,-0.8242734726272237,0.75,0.9792157771363659,1.0,7/19,13.84%,CXCL10;ANO1;NGF;IL33;CXCL8;TSLP;IGF1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.23981614309698468,0.8240743949800428,0.7866666666666666,1.0,1.0,37/175,21.44%,CPLX2;IGF2;SYT5;SYT3;VEGFD;ACTN2;VWF;STEAP2;SYT15;SYNGR1;SYT2;TIMP1;MANF;TUBA4A;CD36;F13A1;ITIH4;PDGFB;SNAP25;CPLX1;HABP4;PDGFA;SCIN;CD109;CYB5R1;SYTL4;CYRIB;EGF;TMEM79;SNAPIN;STXBP1;TAGLN2;MAGED2;SPARC;STX1A;TGFB2;PECAM1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.32848982273517474,0.8240466915264207,0.7065868263473054,1.0,1.0,3/18,13.49%,PRKN;DNM3;MTFP1
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.25394940735661387,0.8240283834750513,0.7601809954751131,1.0,1.0,17/99,17.69%,VEGFD;PIK3R2;MAPK12;NOX4;MAPK11;COL4A1;COL4A5;COL1A1;COL4A2;NOX1;COL1A2;PIM1;PRKCA;HRAS;PLCD3;SMAD3;PLCD4
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.26233228218137605,0.8236343617538585,0.7941176470588235,1.0,1.0,19/77,22.84%,CDH22;CDH8;CDH13;SDK1;CDH24;GJC1;NECTIN1;CDH17;PKP1;SMAD3;SDK2;CLDN5;NLGN2;TLN2;TGFB2;CDH11;DCHS1;CADM1;CDH15
prerank,KEGG_2021_Human__Gap junction,0.2590494864149756,0.823542349761452,0.7696335078534031,1.0,1.0,23/79,25.08%,SRC;PDGFRB;TUBB8;CDK1;TUBA4A;TUBA3E;PDGFB;PDGFA;ADCY6;GRM1;TUBA8;PRKCA;HRAS;HTR2B;TUBB2B;EGF;ADCY4;TUBA3D;ADCY2;DRD1;MAP2K2;GJA1;ITPR2
prerank,MSigDB_Oncogenic_Signatures__MTOR UP.V1 UP,0.24151595868366715,0.823303718021832,0.8053097345132744,1.0,1.0,37/145,18.54%,ANKRD33;SQLE;PDK1;TMEM40;CDC20;TESC;UBE2C;PTPN14;PRAF2;ISYNA1;UHRF1;FDPS;CDH17;HELLS;CDK1;TCF19;MCM6;CDKN2B;GSDMC;NEIL3;STEAP1;DLG4;FAM3B;CMA1;H6PD;KRBA1;FABP5;PRKCA;STMN1;MCM5;SLC41A3;GPX2;RRM2;IDI1;CAPN12;COMTD1;NSDHL
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.23881952880740842,0.8232578413446893,0.8071748878923767,1.0,1.0,23/170,15.49%,HMGA2;SIX1;H3C13;TLX1;SIX4;TLX3;HOXA10;H3C1;ASPSCR1;H3C2;H3C10;CDKN2C;CCNA2;H3C8;H3C6;FLT1;PDGFA;PLAU;DEFA4;ETV1;PAX5;PPARG;DEFA3
prerank,WikiPathway_2021_Human__Statin inhibition of cholesterol production WP430,-0.2691443981937179,-0.8232315558077135,0.7662337662337663,0.9808388701941174,1.0,10/29,17.19%,CETP;LCAT;APOA4;APOA1;APOA5;ABCG8;ABCG5;MTTP;LIPC;PLTP
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.2532113533028963,0.8231843453867357,0.803921568627451,1.0,1.0,2/97,0.53%,MUC7;MUC13
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.26515694383099586,0.8230160247902377,0.7941176470588235,1.0,1.0,16/73,24.03%,PLCH2;INPP5J;ITPKA;PLCH1;ISYNA1;PIP5K1B;MTMR8;PLCD3;MTMR3;PLCD4;PI4KB;PLCG1;INPPL1;ITPKC;IMPA1;OCRL
prerank,Elsevier_Pathway_Collection__ER Stress in Macular Degeneration,-0.27069743568293014,-0.822998280595223,0.7974683544303798,0.9807277422851867,1.0,9/25,22.85%,FOS;IL6;CXCL8;BCL2;EIF2AK3;XBP1;JUN;CASP4;MAP3K5
prerank,Elsevier_Pathway_Collection__Androgen Receptor Genomic Signaling,0.34185513732714545,0.8228904990877753,0.6666666666666666,1.0,1.0,2/18,7.48%,CYP17A1;AMH
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.2723829387320406,-0.8225866009335654,0.7710843373493976,0.9810436088469069,1.0,1/31,0.38%,PKP3
prerank,WikiPathway_2021_Human__NOTCH1 regulation of endothelial cell calcification WP3413,0.34202240586091104,0.8224808126353899,0.7142857142857143,1.0,1.0,5/16,22.80%,GJA5;JAG2;DLL4;MGP;PLAT
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.31753138960485744,0.8224458088333036,0.6707317073170732,1.0,1.0,11/23,44.54%,ELL3;THOC5;THOC1;TCERG1;DDX39B;SUPT5H;ELL;ALYREF;SUPT6H;SUPT16H;CCNT2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.311774176573791,0.8219317594575232,0.6994219653179191,1.0,1.0,4/27,10.09%,PAGE4;PRKN;HSPB1;NOL3
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,0.28747937988308225,0.8218141604289749,0.7252747252747253,1.0,1.0,12/46,25.06%,GXYLT2;GALNT13;GALNT17;GALNTL6;GALNT9;GALNT15;B4GALT3;ST3GAL3;LFNG;PLOD3;GALNT18;POGLUT1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.27932157052117784,0.8217716693715674,0.7474747474747475,1.0,1.0,14/52,23.96%,NPM2;CDC6;CCNA2;CDT1;DSCC1;EGF;ACVRL1;DNA2;TSPYL2;EHMT2;ATAD5;GMNN;GLI1;BLM
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.27802200983543435,-0.8216994544227808,0.6805555555555556,0.9823326120489018,1.0,8/25,16.95%,TRPC3;PRKCQ;DGKE;RASGRP1;ABHD6;PRKCE;DGKB;MGLL
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.2824565451469005,-0.8216008207366446,0.7105263157894737,0.9820136595111003,1.0,21/21,71.78%,PNLDC1;SAMD4A;CNOT7;ZFP36;PAN3;CNOT2;PARN;TNKS1BP1;CNOT8;CNOT4;PAN2;CNOT11;TUT4;CNOT1;CNOT9;CNOT6L;CNOT6;TUT7;CNOT10;CNOT3;SAMD4B
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.25970017261913836,0.821426020245951,0.7704081632653061,1.0,1.0,10/68,13.43%,CDH13;OLFM4;MDK;CCL25;NPNT;S100A10;CD36;PDGFB;CSPG5;PPM1F
prerank,WikiPathway_2021_Human__ESC Pluripotency Pathways WP3931,0.24608668178207826,0.8214132887638894,0.7523809523809524,1.0,1.0,20/108,17.35%,FGF20;PIK3R2;MAPK12;WNT4;WNT9B;FGF13;FGF17;BMP4;FGF2;FGF23;PDGFRB;FGF14;PDGFB;PDGFA;DVL2;WNT2B;WNT6;HRAS;FGF12;EGF
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.316892505135544,0.8209637475762686,0.6993865030674846,1.0,1.0,12/24,39.38%,ZNRF3;RNF43;VLDLR;NEDD4;PCSK9;CLTA;SMURF1;TGFB1;MVB12A;AP2A1;AP2S1;KIF16B
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,0.23018732646276174,0.8208405376444637,0.847457627118644,1.0,1.0,30/261,13.84%,DUSP9;FGF20;RASGRF1;ACTN2;PIK3R2;MAPK12;RASGEF1A;SHC3;VWF;NRG2;FGF13;FGF17;GPRIN1;SRC;FGF23;CAMK2A;PSMD4;PDGFRB;IL3RA;LAMTOR2;CDK1;FLT3LG;PEA15;MPP3;RASGRF2;IL6R;PDGFB;CNKSR2;PDGFA;PSMB4
prerank,Elsevier_Pathway_Collection__BMP Signaling Impairment in Granulosa Cell in POF,-0.28360326978551426,-0.8208196111538869,0.7142857142857143,0.9830546537575082,1.0,6/20,17.03%,PTGS2;HAS2;TNFAIP6;SMAD9;BMPR2;BMPR1B
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.2319074597677636,0.820652216368393,0.8318965517241379,1.0,1.0,119/296,43.26%,TRIM71;TRIM50;FBXW10;RNF182;CDC20;KLHL41;UBE2C;PRKN;PSMD4;FBXL18;FBXL16;KLHL21;UBE2S;CCNF;FBXO31;KLHL13;SPSB2;ASB12;ASB16;PSMB4;UBE2Q1;ELOC;UNKL;TRIM11;NEDD4L;NEDD4;DET1;ELOB;BLMH;TRAIP;FBXL8;ASB1;KLHL11;UBE2A;ANAPC11;GAN;KLHL25;HECTD2;LNPEP;UBA1;FBXL15;CUL7;ANAPC7;PSMB3;FBXO41;UBE2M;PSMD14;UBA52;FBXL22;SMURF1;RNF25;SPSB1;SOCS3;PSMB5;PSMD2;TRAF7;PSMA1;UBE2O;PSMD10;KEAP1;GLMN;PSMC4;PSMC3;FBXW5;CUL1;THOP1;SKP2;SMURF2;SKP1;PSMC5;RNF126;KCTD7;SEM1;PSMB6;RNF220;CDC23;FBXO32;UBE2Q2;PSMD8;UBE2V1;UBE2D2;DZIP3;HERC1;PSME2;FBXO44;PSMD13;PSMB7;PSMA7;FBXL19;ANAPC1;ZBTB16;FBXL13;PSME3;UBE2J2;HUWE1;ANAPC2;TRIM41;HERC2;KLHL5;RNF213;KLHL22;UBOX5;FBXW8;ASB6;FBXW11;KCTD6;PJA1;FBXO6;FBXO4;PSMB2;HECW2;RBX1;UBE2V2;PSMA6;ASB11;ANAPC4;UBC;FBXL7;STUB1
prerank,Elsevier_Pathway_Collection__WNT Signaling in Hepatocellular Carcinoma,0.3569361215949433,0.8206438490294993,0.7177914110429447,1.0,1.0,1/15,1.43%,LEF1
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.24431755945931194,0.8206075641790014,0.8207547169811321,1.0,1.0,14/171,10.06%,GNG4;LEF1;E2F1;PIK3R2;CALML6;MAPK12;MAPK11;TCF7;SRC;FGF2;E2F2;CCR3;GNG3;IKBKG
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.2357487244099927,0.8205656090821448,0.8333333333333334,1.0,1.0,46/262,16.80%,LGR6;CEMIP;EPHB2;LEF1;CGA;TWIST2;CDH13;VIL1;TDGF1;SNAI2;CCL26;MDK;FERMT1;ITGA6;ARHGEF39;GTSE1;SRC;SPHK1;AGO2;PDGFRB;COL1A1;ZNF703;ZP3;FAM83H;TCAF2;SEMA7A;SEMA6C;PODXL;PDGFB;PDPN;FLT1;PPM1F;PDGFA;PLAU;SEMA5B;CCL24;CCL11;MADCAM1;SEMA6B;PRKCA;HRAS;ARHGEF2;TNFRSF18;ROCK2;ADAM9;RHOC
prerank,Elsevier_Pathway_Collection__Proteins Involved in Amyotrophic Lateral Sclerosis,-0.1926303548136829,-0.8204950203569301,0.9047619047619048,0.9831466192589335,1.0,32/172,15.02%,TAC1;CCK;PTGS2;GRIK3;PVALB;TNF;IL1B;NTF3;HGF;LRRK2;S100A8;CASP1;NCAM1;LGALS3;NGFR;PPARGC1A;CCL2;PTGER2;IL6;CYBB;KL;S100B;PTGES;TLR4;TLR2;AKT1;RTN4;IGF1;PON1;MYD88;CSF2;BCL2L11
prerank,Elsevier_Pathway_Collection__Blood-Brain Barrier Disruption in Epileptiform Disorders,-0.2719659476420885,-0.8200629423802507,0.7333333333333333,0.9835113158860072,1.0,5/24,13.06%,IL1B;ALB;CCL2;IL6;AKT1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.26871494830075837,0.8194831161811419,0.7526315789473684,1.0,1.0,32/72,39.50%,CHI3L1;IRAK1;PSMD4;NFKB2;PSMB4;RELB;TRAF2;CARD10;PSMD1;PSMB3;PSMD14;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;TNFRSF10A;PSMC5;PSMB6;PSMD8;MALT1;MAP3K14;TIRAP;PSME2;PSMD13;PSMB7;PSMA7;PSME3;COPS8
prerank,WikiPathway_2021_Human__Joubert Syndrome WP4656,0.2622762366874669,0.8190088220627949,0.7346938775510204,1.0,1.0,44/75,49.91%,ARR3;ANKS6;BBS5;BBS2;ZNF423;ARL2;CETN2;PARP1;B9D2;B9D1;DVL1;ARMC9;BBS4;RHEB;NPHP4;CEP97;CSPP1;CEP290;CEP41;RPGRIP1L;ARL3;INPP5E;SUFU;FLNA;SHH;DVL3;TMEM138;MTOR;NIN;PDE6D;PCNT;KIAA0586;BBS1;TMEM67;TMEM237;AHI1;MRE11;OFD1;RAD50;CEP164;TCTN1;CPLANE1;RHOA;NPHP3
prerank,MSigDB_Oncogenic_Signatures__JNK DN.V1 UP,0.24105674697746104,0.818881726751254,0.8525345622119815,1.0,1.0,33/160,17.86%,AGRP;GNAZ;CGA;TNNC1;ALOX12B;SHC3;ARSF;KCNJ9;INPP5J;SNAI2;KCNJ5;OR2B6;AKR1B10;ELN;HOXA4;KCNN3;ARL4A;AKR1C3;MMP17;MVD;PPFIA4;STC2;C8G;ABCD1;NOX1;DEFA4;ABL2;HSPA12A;TACR1;MRAS;CACNA1H;TRIM24;MYOM1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.22717410590112724,-0.818322377647435,0.7903225806451613,0.9864586261733785,1.0,8/46,18.73%,ANXA8;ANXA8L1;SRGN;HOOK2;CORO1A;PI4K2B;CAV2;CHMP2B
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,0.23998009308335108,0.818308947451596,0.7876106194690266,1.0,1.0,28/146,21.03%,PIK3R2;ANLN;ARHGEF10;RHPN1;ARHGAP11B;ARHGAP44;IQGAP3;RASGRF2;DIAPH3;ARHGEF11;RACGAP1;ARHGAP39;ARHGAP11A;BCAP31;ARAP3;OBSCN;ARHGAP28;MCAM;ATP6AP1;ARHGEF2;ARHGEF15;ECT2;ROCK2;LBR;ARHGEF28;ARHGEF19;ARHGAP4;STARD13
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,0.2837259515268304,0.8183020933457555,0.7272727272727273,1.0,1.0,7/43,13.69%,B4GALNT1;ARSF;EGFL7;ESYT3;CERK;NEU3;CTSA
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.2559461275952276,0.818188277224316,0.7738693467336684,1.0,1.0,11/99,13.33%,MT3;PRKAA2;STOX1;NOX4;PRR5L;NOX5;DHRS2;PRKD1;TXNRD2;PYCR2;NOX1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.33703248201484953,0.8175349812575667,0.7423312883435583,1.0,1.0,4/16,20.43%,PDGFRB;ACVRL1;DLL4;HEY1
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,0.36883831694375735,0.8174901650390847,0.70625,1.0,1.0,9/15,32.74%,DPYSL4;PLXNA2;PLXNA3;CDK5R1;CRMP1;PLXNA1;CDK5;NRP1;DPYSL3
prerank,KEGG_2021_Human__Gastric acid secretion,-0.2180456429468686,-0.8174317210068788,0.8484848484848485,0.9876866967020126,1.0,18/64,20.04%,KCNK2;KCNJ16;ATP1A3;SSTR2;KCNJ10;PRKCB;KCNJ15;CAMK2B;CA2;ADCY5;PLCB2;CFTR;EZR;KCNK10;CHRM3;ADCY1;MYLK3;SLC26A7
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.2967607340242431,0.8171912024572782,0.7405405405405405,1.0,1.0,7/32,13.04%,CHI3L1;BMP4;FGF2;ABCA3;DNAAF1;DISP1;PDPN
prerank,Elsevier_Pathway_Collection__EphrinB -> MAPK/JUN/FOS Signaling,0.2862569805208609,0.8171546557731838,0.7055555555555556,1.0,1.0,3/33,6.66%,EPHB2;EFNA3;SRC
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.31941734947439115,0.8170596004084936,0.7197802197802198,1.0,1.0,4/22,7.43%,SLC2A5;SLC2A4;SLC45A1;SLC5A2
prerank,WikiPathway_2021_Human__Trans-sulfuration and one-carbon metabolism WP2525,-0.2588371219716581,-0.8169250344741547,0.7,0.9881890714629132,1.0,11/31,20.12%,BHMT;PHGDH;DNMT3L;CBS;MAT1A;MTHFD1;SHMT1;PSAT1;CTH;MTHFD2L;DHFR
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.29268476425076956,0.8167051670467695,0.711864406779661,1.0,1.0,17/41,40.34%,PRKAA2;LAMTOR2;LAMTOR4;TSC1;TSC2;PRKAB2;STRADA;RHEB;MLST8;LAMTOR5;RRAGD;RPTOR;AKT1S1;RRAGA;FKBP1A;MTOR;EEF2K
prerank,Elsevier_Pathway_Collection__CFTR Misfolding and Degradation (Class II Mutations),-0.2711675322177342,-0.816702375224246,0.7375,0.9880776060800338,1.0,30/30,72.92%,CFTR;HSPA1A;EIF2AK3;XBP1;EDEM1;HDAC6;RNF5;GOPC;ERN1;ATXN3;DNAJA1;SELENOS;BAG1;EIF2S1;ERP29;UBE2D1;RHOQ;DERL2;EDEM2;CANX;DNAJC10;STUB1;UBE2J2;VCP;HSPA8;HSPBP1;DERL1;HSPA5;STX6;ATF6
prerank,WikiPathway_2021_Human__Myometrial relaxation and contraction pathways WP289,0.244596052410528,0.8166983442855577,0.8056872037914692,1.0,1.0,20/145,15.60%,GNG4;SFN;CALCA;RGS20;RAMP1;IGFBP2;CAMK2A;OXTR;GNG3;PRKD1;GUCA2B;RAMP2;RGS16;RGS5;GNB5;ADCY6;GNG8;RGS14;CORIN;PRKCA
prerank,MSigDB_Oncogenic_Signatures__ATF2 S UP.V1 DN,0.23718990373316284,0.8166574804920265,0.8457943925233645,1.0,1.0,28/165,18.04%,GABRD;COL7A1;REN;COL15A1;MYH1;PLA2G2A;MYBPH;SFRP4;CHI3L1;STMN2;ROR1;MAGIX;IGFBP2;NDUFA4L2;COMP;COL11A1;DGKD;EFEMP1;RGS5;CCL11;ACACA;DPP4;HSD17B1;TREM1;SLC1A3;CBX7;CRLF1;SNCAIP
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.32368494309341433,0.8165881390707929,0.7209302325581395,1.0,1.0,3/21,12.37%,PRR5L;FGF2;HAS1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.29094816449978483,0.8164781036500788,0.7219251336898396,1.0,1.0,6/38,10.18%,REG3A;TENM2;ADGRL1;CRB1;NECTIN1;IL1RAPL1
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.33948859860043695,0.8163131003192331,0.6601307189542484,1.0,1.0,1/15,3.00%,TSPO2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.3114150430492508,0.8162326436305455,0.6967741935483871,1.0,1.0,16/24,46.67%,SAMM50;BMF;ROMO1;TIMM10;NDUFA13;HSPA4;TIMM13;TIMM9;BAX;HSP90AA1;TIMM10B;TIMM8B;TIMM22;TIMM8A;BAD;TOMM22
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.24826193415760284,-0.8161707360758019,0.7540983606557377,0.9886061476703193,1.0,12/29,23.89%,AJAP1;TNF;PHLDB2;ALOX5;KNG1;SLC12A2;VTN;APOH;ADTRP;CLDN3;THBD;PTEN
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),0.3450727962370961,0.816090263359561,0.7222222222222222,1.0,1.0,4/15,16.08%,ATP1A2;EPO;PACSIN3;STC1
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.3181985067033153,0.8160773652015761,0.6933333333333334,1.0,1.0,3/23,6.21%,NODAL;GDF5;BMP4
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.26012829728890857,0.8160193788801181,0.7853658536585366,1.0,1.0,42/81,48.45%,CELF3;RBM24;CELF4;SRSF12;PUF60;SF3B4;MBNL3;RBM3;PCBP4;NOVA2;RBM8A;NOVA1;JMJD6;ZC3H10;FMR1;RBMX;HNRNPU;RBM15B;RBFOX2;HNRNPA1;METTL16;PTBP1;RBM4;FXR2;ZBTB7A;U2AF2;SFSWAP;DDX17;RBM15;RNPS1;TIA1;RBM5;DDX5;PRDX6;MAGOH;FXR1;RBM39;DAZAP1;NCL;SRPK1;CIRBP;SF1
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.3155250378307266,0.8160105053370289,0.7457627118644068,1.0,1.0,6/27,15.55%,FABP4;ABHD12B;PNPLA5;LPL;APOA2;FABP5
prerank,MSigDB_Oncogenic_Signatures__RB DN.V1 DN,-0.20184225787940432,-0.8159837123669048,0.875,0.9884049226790016,1.0,29/110,20.47%,CHAC1;AGR3;ATF5;LRRC4;IGFBP3;LIFR;ADAMTS1;IL33;BNC1;LAMC2;GJB2;SLC7A5;FAM102A;NFIL3;CISH;USP18;BASP1;S1PR5;DUSP14;RHOV;LMAN1;LGALS9;H19;GADD45A;CTSC;ANXA6;P4HA1;TMEM140;PPBP
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.31958111640731957,0.8159605508666686,0.7037037037037037,1.0,1.0,5/20,18.05%,SLC22A4;SLC29A4;ABCA3;ABCC5;SLC22A18
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.32951270282089656,0.81578834687396,0.7454545454545455,1.0,1.0,1/16,3.38%,DCST1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.23903685060683744,0.8157276982240467,0.8482142857142857,1.0,1.0,46/197,31.59%,DCST1;ZNRF3;PLK1;BUB1B;CDC20;UBE2C;PRKN;DTL;RNF133;AURKB;UHRF1;UBE2S;PTTG1;RNF43;AURKA;SPSB2;RNF148;SQSTM1;ELOC;NEDD4L;NEDD4;UBQLN4;ISG15;UBE2A;ANAPC11;KLHL25;UBA1;NPLOC4;RNF215;TRIM25;NEDD8;WDR81;ANAPC7;UFD1;PSMD14;UBA52;MAD2L1;UBE4B;SMURF1;SPSB1;UBE2I;ARRB1;KEAP1;LONP1;ADRM1;RNF20
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,0.2963689164218286,0.8156758166257515,0.751412429378531,1.0,1.0,6/33,17.63%,PIK3R2;SRC;MAP3K8;RNASE1;PDPK1;THEM4
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,-0.2772459378578027,-0.8156086539876518,0.6790123456790124,0.9886668885933437,1.0,6/25,12.60%,SLC39A2;SLC39A5;CP;SLC41A2;SLC39A14;SLC31A1
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.341249086127871,0.8154603418490735,0.6964285714285714,1.0,1.0,10/18,43.21%,SHC1;HRAS;EGF;PLCG1;UBA52;CDC37;PIGU;HSP90AA1;CBL;UBC
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.23078388078338433,0.8151552905496332,0.8916666666666667,1.0,1.0,89/330,32.21%,CHGB;SCG2;SPARCL1;AMBN;SPP1;NOTUM;FBXW10;MATN3;BMP4;GPC3;KLHL41;FGF23;PSMD4;DTL;FBXL18;FBXL16;TIMP1;KLHL21;VGF;CCNF;FBXO31;MFGE8;LAMC1;KLHL13;STC2;SPSB2;ASB12;ASB16;APOA2;VWA1;MELTF;PSMB4;DSCC1;ELOC;ANKRD9;CHML;VCAN;CKAP4;DCAF13;TMEM132A;OBSL1;DCAF8;ELOB;FBXL8;ASB1;LGALS1;KLHL11;PCSK9;CCDC22;GAN;HIF3A;KLHL25;FBXL15;FSTL3;COP1;CUL7;FBN1;F5;RAB13;PSMD1;NEDD8;PSMB3;COPS5;FBXO41;UBE2M;PSMD14;WDR5;CUL4B;FBXL22;SPSB1;SOCS3;PSMB5;PSMD2;CUL9;PSMA1;GAS6;SOCS5;PSMD10;APOE;KEAP1;RBBP7;NEURL2;MGAT4A;IGFBP7;PSMC4;PSMC3;FBXW5;CUL1;COPS7B
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.31614558393419945,0.8150498735844052,0.6994219653179191,1.0,1.0,6/22,15.90%,C1QTNF3;ERFE;HDAC4;SOGA1;PGP;C1QTNF12
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.2987606082044598,-0.8150397283280721,0.6823529411764706,0.9891763599582396,1.0,1/15,1.99%,IL10
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.2311373679625886,-0.8150294893984713,0.8235294117647058,0.9886678248949291,1.0,7/42,11.90%,NDNF;AGR2;BST1;PTPRO;WNT1;RAC2;PLG
prerank,WikiPathway_2021_Human__Sphingolipid pathway WP1422,-0.2627167847044,-0.8150181075824342,0.7333333333333333,0.9881538664689203,1.0,5/28,12.84%,UGT8;SGPP2;ASAH2;SPTLC3;SPHK2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.2660795375170474,0.8149988919771176,0.77,1.0,1.0,19/71,25.90%,LMOD1;PAK3;VIL1;CCL26;BAIAP2L2;ARHGAP28;CCL24;CCL11;PLEKHG2;DBN1;CYRIB;CDC42EP5;TWF2;HAX1;ESAM;KANK3;GBA2;ALOX15;WASHC5
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,0.30579381220581153,0.814932578959541,0.6707317073170732,1.0,1.0,12/28,33.36%,ITGA2;SRC;RNASE1;LAMC1;TNS3;LAMA4;LAMA5;PTK2;LMNB2;RAPGEF1;PIGU;LAMB1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.31606671342128895,0.8148120856488199,0.7071823204419889,1.0,1.0,1/23,0.23%,IGF2
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,-0.27541248413522557,-0.8147690338822378,0.6829268292682927,0.988126291224618,1.0,24/24,72.49%,EIF4A1;CNOT7;PAN3;EIF4E;CNOT2;EIF4B;EIF4A2;PARN;TNKS1BP1;CNOT8;CNOT4;EIF4G1;PAIP1;CNOT11;EIF4A3;TUT4;CNOT1;CNOT9;CNOT6L;CNOT6;TUT7;CNOT10;CNOT3;PABPC1
prerank,WikiPathway_2021_Human__Fatty Acid Biosynthesis WP357,0.3195278193908688,0.814613819695304,0.7485029940119761,1.0,1.0,6/22,17.93%,ACSL6;ACSL4;ACLY;ACACA;SCD;ACSL5
prerank,KEGG_2021_Human__Acute myeloid leukemia,0.26761952473622996,0.8145533183552885,0.7461139896373057,1.0,1.0,7/65,15.74%,LEF1;PIK3R2;TCF7;CCNA2;IKBKG;PIM1;HRAS
prerank,Elsevier_Pathway_Collection__Ethanol Induced Efects in Hyperprolactinemia,0.33920465558862506,0.8143917461940078,0.7037037037037037,1.0,1.0,2/18,6.72%,RASGRF1;FGF2
prerank,Elsevier_Pathway_Collection__RNA and DNA Metabolism Dysregulation,0.35751633986928094,0.8143477600661385,0.6942675159235668,1.0,1.0,15/15,64.27%,FUS;DROSHA;HNRNPA1;PTBP1;DDX17;TARDBP;HNRNPA2B1;ADARB1;ANG;TAF15;YBX1;TBP;SRSF2;SRSF10;SETX
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.240649618231162,0.8142258968996465,0.8211009174311926,1.0,1.0,39/140,27.97%,RASGRF1;PIK3R2;FOXM1;FGD1;SRGAP3;SRC;ARHGAP11B;ARHGAP44;RASGRF2;ARHGEF11;RACGAP1;ARHGAP39;ARHGAP11A;ARAP3;OBSCN;ARHGAP28;SQSTM1;PLEKHG2;ARHGEF2;CYRIB;ECT2;RHOC;ARHGAP33;ARHGEF19;SRGAP2;TGM2;ARHGAP4;STARD13;ARHGAP26;NUP62;OCRL;MCF2L;RELN;A2M;BCR;NGEF;ARHGAP45;RHOU;PLEKHG5
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.2842978829576652,0.813986109116933,0.7454545454545455,1.0,1.0,1/35,0.35%,PAX2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.24701034495665125,0.8137972346429818,0.8029556650246306,1.0,1.0,30/119,31.22%,LIX1;PRKAA2;SRC;PRKN;VPS28;SQSTM1;TMEM74;MTMR3;VPS37D;MTERF3;TCIRG1;HDAC10;TOMM20;VPS33A;ATG10;DYNLL1;PRKAB2;TOMM5;ATP13A2;PIP4K2B;VPS16;RB1CC1;HGS;ULK1;VPS4A;SNF8;TOMM40;LIX1L;ULK3;CHMP2A
prerank,Elsevier_Pathway_Collection__Doxorubicin Induced Cardiotoxicity,-0.2786044673180812,-0.8136497778057784,0.7397260273972602,0.9897372005447571,1.0,4/22,13.06%,FASLG;EGR1;TTN;AKT1
prerank,WikiPathway_2021_Human__Overview of nanoparticle effects WP3287,0.3190489114933506,0.8136410168439772,0.7262569832402235,1.0,1.0,3/19,7.78%,LAMA3;CRP;COL4A1
prerank,Elsevier_Pathway_Collection__Airway Smooth Muscle Cell High Rate Proliferation,0.27312685780707463,0.8134727460966922,0.776595744680851,1.0,1.0,10/54,15.74%,RASGRF1;SRC;FGF2;PDGFRB;IL11;IL6R;PDGFA;SHC1;PDPK1;HRAS
prerank,Elsevier_Pathway_Collection__Contraction Due Vasospasm,-0.24039086640098495,-0.8133335498236286,0.7945205479452054,0.9897534751445372,1.0,6/36,17.05%,HTR2A;GNAO1;MAP2K1;RASGRP1;EDNRB;TBXA2R
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.2923912903271224,0.8132180165515972,0.7257142857142858,1.0,1.0,24/39,49.52%,NFIX;POLR2L;POLR2K;POLR3K;ZNF143;POLR2H;POLR3H;POLR3A;SNAPC2;POLR3C;GTF3C5;POLR3G;POU2F1;POLR3GL;SSB;GTF3C3;POLR3E;POLR3F;POLR2F;SNAPC4;GTF3C6;CRCP;GTF3C2;POLR1D
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,0.2520127412847072,0.8130171954679142,0.8613861386138614,1.0,1.0,12/100,13.69%,DYNC1I1;KIF20A;KIF2C;KIF4A;CENPE;KIF5A;KIF15;KIF18A;KIF23;DNM3;RACGAP1;CTSA
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.31128745914428746,0.8130027645703952,0.7011494252873564,1.0,1.0,2/25,2.50%,TNNC1;TNNI3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.25987309388445634,0.8130016201229096,0.7918781725888325,1.0,1.0,15/75,20.80%,ALOX15B;INHA;CDKN2A;PLK1;BMP4;BRINP1;FOXC1;SCRIB;TFAP4;CDKN1C;SMAD3;CAMK2N1;CDK6;TSPYL2;BTG3
prerank,Elsevier_Pathway_Collection__Peripheral Tissue Microangiopathy,-0.23705654330236464,-0.8128223972458186,0.8142857142857143,0.9901893269135033,1.0,9/46,14.96%,GNPNAT1;MAP2K1;PRKCB;CXCL12;PLG;AKT1;PGM3;VCAM1;CXCR4
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.2877536519342349,0.8126953930713612,0.7626262626262627,1.0,1.0,17/48,32.77%,PRAP1;HRAS;ECT2;FIGNL1;EEF1D;RAD9B;RAD51AP1;RAD51;BLM;HSF1;RHNO1;TMEM109;CDKN1A;INTS7;YAP1;RAD1;CRYAB
prerank,Elsevier_Pathway_Collection__Lipogenesis Regulation in Adipocyte,0.3056169947343808,0.8125628873170342,0.7365591397849462,1.0,1.0,7/24,17.12%,SLC2A4;LPL;CD36;ACLY;PDPK1;ACACA;SCD
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.2770509820093785,0.8122642110045878,0.7528089887640449,1.0,1.0,8/54,15.64%,HMGA2;C1QTNF3;PRDM16;IL11;SOX8;INHBB;PPARG;BBS2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.2324479121138791,0.8121637313864438,0.8433179723502304,1.0,1.0,45/187,26.20%,MRAP2;RAB3C;TSPAN5;ACTN2;THY1;RAMP1;RAB3B;FGF13;KCNB1;ANK1;TMEM88;NKD2;TESC;ATP1B3;DPP10;S100A10;KCNIP3;RAMP2;RAB3D;SH3PXD2B;DLG4;SCRIB;RAB34;MADCAM1;ROCK2;NLGN2;NRXN2;STXBP1;PLEKHF1;RAB15;EHD2;NPC1;AP4M1;LIN7B;SHANK3;TM9SF1;FRMPD1;EMP2;RAB13;DENND4C;TSPAN17;F11R;DVL1;ABCA12;BSG
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.2779891941984193,0.8121396716060331,0.7679558011049724,1.0,1.0,2/47,1.28%,DUSP9;EPHB2
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.2899490960060288,0.812080764933774,0.7558139534883721,1.0,1.0,25/36,52.83%,NUP37;NUP62;NXF1;TPR;NUP133;NUP155;NUP160;NUP188;NUP205;NUP210;NUP214;ALYREF;NUP107;SLBP;AAAS;NUP93;NCBP2;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85
prerank,Elsevier_Pathway_Collection__Proteins Involved in Diabetic Nephropathy,0.2360353999980079,0.8119154599725878,0.868421052631579,1.0,1.0,13/164,6.79%,IGF2;DKK1;GCG;REN;SPP1;CRP;SOX2;ARG2;NOX4;BMP4;CCL20;FGF2;PTGDS
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.2621171977428245,0.8116815143325237,0.7794871794871795,1.0,1.0,8/76,10.09%,SCG2;MAPK8IP2;ITGA6;BMP4;SRC;BDNF;PRKN;NOL3
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.26761241234544253,-0.8116641411812137,0.8333333333333334,0.9920166738677657,1.0,7/31,16.73%,EREG;ERBB4;NRG4;BTC;PIK3R1;HBEGF;PTK6
prerank,"Elsevier_Pathway_Collection__Hypoparathyroidism, Primary",0.3270284511566189,0.8115485231248566,0.7483870967741936,1.0,1.0,2/18,6.66%,E2F1;SRC
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.24757996857824927,0.8114659450518324,0.8309178743961353,1.0,1.0,39/100,38.90%,HMGA2;HDAC4;NPM2;ACTL6B;KAT2A;HDAC5;ACTR5;JARID2;KDM5B;SMARCA4;HDAC1;GATAD2B;SATB2;NPM1;SMARCD3;HCFC1;CECR2;MYC;NPM3;SRCAP;CHD1L;CHD3;SMARCC1;CHD4;SUV39H2;EZH1;CBX3;MORC2;RUVBL2;RUVBL1;KDM5C;BAHD1;ACTR8;PIH1D1;BAZ1B;BAZ1A;DAXX;KDM5D;BAZ2A
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.2759090945790011,0.8114465731415514,0.7282608695652174,1.0,1.0,9/51,14.04%,B4GALNT1;B3GNT5;ST6GALNAC4;ESYT3;CERK;NEU3;GBA;CTSA;GLA
prerank,Elsevier_Pathway_Collection__PTGIR -> IL6 Production,0.3284003257064524,0.8113253101914757,0.727810650887574,1.0,1.0,1/17,1.59%,RASGRF1
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.2886628720065278,0.8112615703590534,0.7231638418079096,1.0,1.0,23/34,51.29%,ACTL6B;CBX6;SMARCA4;CBX8;SMARCD3;SMARCC1;HIPK2;CBX2;CSNK2B;ARID2;ARID1A;SMARCB1;SMARCC2;SMARCE1;RING1;PHC2;CSNK2A2;CBFB;ACTL6A;SMARCD2;SMARCD1;EP300;SCMH1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway,0.27694467273934115,0.8111229856125978,0.7668393782383419,1.0,1.0,11/54,20.59%,IGF2;SRC;IGFBP2;CCNE1;MUC4;SHC1;PDPK1;PRKCA;SMAD3;MMP9;MMP3
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.3005434702112838,0.8110714298961696,0.7430167597765364,1.0,1.0,5/30,11.62%,WNT4;E2F7;E2F8;AURKA;DNAAF1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.255456062536918,0.8110285980141863,0.795,1.0,1.0,6/88,6.21%,DUSP9;EPHB2;PIK3R2;PRDM15;FOXM1;BMP4
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2645640147011418,0.8107331231533368,0.8010471204188482,1.0,1.0,6/77,8.07%,CDC20B;PLK1;TRIB2;CDC20;NKD2;PRKN
prerank,WikiPathway_2021_Human__Host-pathogen interaction of human coronaviruses - interferon induction WP4880,-0.24912595892615372,-0.8106396429685692,0.7333333333333333,0.993607240398975,1.0,18/33,33.98%,FOS;MYD88;OAS3;OAS2;JUN;STAT1;IFIH1;DDX58;OAS1;IRF9;NFKBIA;STAT2;IFNAR1;TRAF6;TLR7;JAK1;CHUK;TBK1
prerank,KEGG_2021_Human__Renin-angiotensin system,-0.2808236544000327,-0.8105543436911707,0.7840909090909091,0.9932292422853459,1.0,2/20,2.70%,KLK2;ACE2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.3240425283313676,0.8104792669963482,0.6890243902439024,1.0,1.0,6/19,20.68%,TDRD9;PTTG1;SGO2;MOV10L1;SGO1;HSF2BP
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,0.28191100572477884,0.8103866815102023,0.7049180327868853,1.0,1.0,30/50,47.30%,PSMD4;PSMB4;MED12;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.2756019598476255,0.8101862006017736,0.7821229050279329,1.0,1.0,19/46,31.10%,ADGRB1;DEFB132;DMBT1;H2BC11;H2BC12;IL6R;DEFA4;DEFA3;GSDMD;ROMO1;RPL30;ELANE;HMGB2;RARRES2;LBP;CTSG;RPS19;SLC11A1;TREM2
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.2983738014221963,-0.8099736024883952,0.7441860465116279,0.9937543854747418,1.0,5/15,25.51%,PPIF;GSTO2;MAPK13;CPEB2;ATF3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.27529415292437165,-0.8098084208842272,0.7840909090909091,0.9934924605189406,1.0,5/21,13.84%,IL10;NR4A3;ADAMTS1;IGFBP5;IGF1
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,-0.290301277685893,-0.8097905002352478,0.7578947368421053,0.9930023999324201,1.0,6/20,18.06%,GRIN2B;LRFN2;GRIA3;PTPRD;GRIA1;PTPRS
prerank,Elsevier_Pathway_Collection__Melanoma,0.2454746188610579,0.8097007144368332,0.8609865470852018,1.0,1.0,22/140,14.95%,LEF1;NODAL;KISS1;SNAI2;CDKN2A;TBX3;BIRC5;SRC;EFNA1;CCNE1;CCNA2;CCNE2;CDKN2B;JAG2;MC1R;POU5F1;FLT1;PLAU;PGF;MCAM;SHC1;PDPK1
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.2198036142901478,-0.8093654264364826,0.926829268292683,0.993274819299932,1.0,21/92,21.34%,AMPD1;UPP2;ENTPD8;ACOD1;XDH;DPYS;CDA;ADK;DPYD;ENTPD5;AK4;ADSS1;AGXT2;CTPS1;NT5C3A;AMPD3;ENTPD3;GMPR;CMPK1;DCTD;NUDT15
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.28804653662806484,0.8092670454577976,0.7684210526315789,1.0,1.0,9/41,16.72%,TRPM3;SLC29A4;TRPM5;SLC6A9;ATP1A2;ABCC8;SLC7A1;KCNJ11;CACNA1H
prerank,TRRUST_Transcription_Factors_2019__NR1H4 human,-0.30142389479063053,-0.8092404664974513,0.7764705882352941,0.9929720774292509,1.0,9/18,31.07%,DCN;SLCO1B3;NR1I2;PLTP;KRT13;EDN1;ABCB4;ABCC4;KLF11
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.21862383603048935,-0.8091050316353252,0.8771929824561403,0.9927318510893322,1.0,9/51,17.93%,EREG;ERBB4;LRRK2;NRG4;BTC;AKT1;HBEGF;PTK6;NRG3
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.2504159460151977,0.809095049183926,0.7970297029702971,1.0,1.0,37/92,35.04%,DISP3;SQLE;PSAPL1;FDPS;NR1D1;MVD;ABCA7;ACACA;SREBF2;PPARG;PLPP1;HMGCR;TM7SF2;SCD;IDI1;PMVK;FDFT1;GPAM;HMGCS1;ANGPTL8;CYP51A1;SMARCD3;RARRES2;NCOR2;MID1IP1;SIN3B;BBS4;FGFR4;C1QTNF2;GGPS1;FASN;SERPINA3;EDF1;OPA3;ADIPOR1;TBL1X;NCOA2
prerank,Elsevier_Pathway_Collection__WNT in Epithelial to Mesenchymal Transition in Cancer,0.2817895097479869,0.8089417774300203,0.7566137566137566,1.0,1.0,11/43,26.12%,LEF1;SNAI2;GSC;FOXC1;CLDN7;DVL2;MMP9;FOXC2;SNAI1;DVL1;CTNNB1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.2790696884371437,-0.8087324683607447,0.8076923076923077,0.9929181378838513,1.0,5/19,17.95%,PTGS2;HAAO;KYNU;NUDT12;PTGIS
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.29956133547941916,0.8086563218153053,0.7317073170731707,1.0,1.0,2/26,4.25%,AGRP;FOXO6
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.2696803577709357,-0.8084810717496171,0.8048780487804879,0.9928202050532767,1.0,2/25,6.76%,KDM8;HR
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2953274025715907,0.8078954385975651,0.7078651685393258,1.0,1.0,18/35,45.13%,EXOSC4;EXOSC5;EDC3;POLR2G;LSM2;LSM4;LSM7;DIS3L2;EXOSC2;DCPS;EDC4;CNOT6;EXOSC1;EXOSC7;EXOSC9;WDR61;SKIV2L;DCP1B
prerank,WikiPathway_2021_Human__IL-9 signaling pathway WP22,0.33630409099730857,0.8076512129195188,0.7085714285714285,1.0,1.0,1/16,2.10%,PIK3R2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.2328382669800059,0.8073085745137971,0.867579908675799,1.0,1.0,88/171,49.08%,CELF3;NOL3;SCNM1;PRPF3;SF3B4;RNASEL;RBM3;ADAR;AKAP8L;RBM8A;RBMS1;TSEN2;METTL3;BICD1;ADAD2;SNRPD2;WT1;SF3A2;PRPF6;TSEN54;NOVA1;SNRPB;LSM4;SNRPD1;DKC1;THOC1;TCERG1;FUS;NONO;TUT1;AURKAIP1;LUC7L3;RNPC3;DDX39B;SNRPD3;HNRNPU;PPP2R1A;MAGOHB;SLU7;NOL9;PABPN1;TUT7;DROSHA;USP39;ZRSR2;DDX20;PRPF8;SNRNP35;PTBP1;RBM4;RBM6;ZMAT5;CLP1;SF3A3;HNRNPR;SNRPG;PABPC4;U2AF1;U2AF2;SNRPA1;DDX17;DDX54;CPSF6;RNPS1;RP9;RBM5;TSEN34;IVNS1ABP;TUT4;SFPQ;MAGOH;MTPAP;SF3B3;YJU2;SNRNP25;RBM39;MPHOSPH10;HNRNPUL1;SNRNP40;FASTKD5;SRPK1;HNRNPF;DHX16;DHX8;SF3A1;TFIP11;NCBP2;SF3B1
prerank,KEGG_2021_Human__alpha-Linolenic acid metabolism,0.31466193638723244,0.8070825621139875,0.735632183908046,1.0,1.0,4/21,13.63%,PLA2G2A;PLA2G2C;PLA2G4C;PLA2G4F
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,0.254422333635103,0.8070521038262264,0.7817258883248731,1.0,1.0,61/95,49.63%,PSMD4;KIF7;PSMB4;ADCY6;TULP3;PRKCA;ADCY4;ADCY10;ADCY2;GLI1;GPR161;PSMB3;PSMD14;UBA52;SMOX;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;PRKAR2A;ADCY8;SKP1;ADCY9;PSMC5;SEM1;PSMB6;RPGRIP1L;PSMD8;PSME2;GSK3B;SUFU;PSMD13;PSMB7;PSMA7;IFT140;PSME3;IFT172;PSMB2;RBX1;PSMA6;UBC;PSMD9;WDR35;KIF3A;INTU;BTRC;PSMC2;CSNK1A1;RPS27A;PSME1;PSMB1;PSMD3;OFD1;WDR19;PRKAR1A;GLI2;TTC21B;PSMC6
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.2030293213712674,-0.8070001769164737,0.9433962264150944,0.9950318024132946,1.0,26/91,22.36%,CSF3;PFN2;TNF;NTRK3;NTF3;CALCR;PAQR3;IL6;OSM;NGF;TCL1A;SH2D3A;FNIP2;HCLS1;AKT1;SPRY2;RASSF2;SFRP2;TENM1;LIF;DMD;GPD1L;SMAD7;SNCA;CREBL2;APP
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.34983533450151555,0.8067303401191952,0.718562874251497,1.0,1.0,4/15,21.41%,CDCA5;DSCC1;SGO1;POGZ
prerank,MSigDB_Hallmark_2020__UV Response Up,0.2369022372905895,0.8066511066146418,0.832579185520362,1.0,1.0,34/156,20.80%,COL2A1;KCNH2;MAPK8IP2;GAL;IGFBP2;MSX1;AGO2;CCNE1;SLC6A8;CHRNA5;TUBA4A;CDKN2B;C4BPB;HSPA2;RFC4;DLG4;PRPF3;CDKN1C;SQSTM1;CYB5R1;GPX3;H2AX;TYRO3;NPTX2;EPHX1;GGH;OLFM1;CLTB;E2F5;FGF18;FEN1;CHKA;PDLIM3;BTG3
prerank,KEGG_2021_Human__mRNA surveillance pathway,0.2573453054752148,0.8066289351112449,0.7951219512195122,1.0,1.0,44/92,44.77%,PPP2R2C;NCBP2L;PABPC4L;MSI1;CPSF4L;CPSF1;PABPC1L;SMG5;CASC3;RBM8A;PPP2R3B;PPP2R5A;NXF1;CPSF4;PABPC1;UPF3B;CSTF2;SMG7;FUS;NXF5;NXT1;DDX39B;PPP2R1A;MAGOHB;PABPN1;GSPT2;RNMT;SYMPK;CPSF3;MSI2;CLP1;GLE1;ALYREF;CPSF7;PABPC4;PELO;CPSF6;FIP1L1;PPP1CA;RNPS1;UPF1;PCF11;NXT2;PPP2R5B
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.32469022665019753,0.8066141772930172,0.754601226993865,1.0,1.0,2/22,5.93%,SDF2L1;DPM3
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,-0.2760527720001574,-0.8065043058954122,0.7875,0.9953939094230322,1.0,3/18,6.74%,MARCO;SCARA5;APOA1
prerank,Elsevier_Pathway_Collection__TNFRSF1A -> CREB/ELK-SRF Signaling,-0.24451092971222826,-0.8064256566907354,0.8354430379746836,0.9949964834054139,1.0,7/29,23.65%,TNF;MAP2K1;LTA;MAP2K3;MAP2K6;MAP3K5;MAP2K4
prerank,WikiPathway_2021_Human__PDGFR-beta pathway WP3972,-0.24378921817283344,-0.8062057379892881,0.7441860465116279,0.9948651866621512,1.0,8/29,23.65%,FOS;MAP2K1;PRKCB;PIK3R1;JUN;JAK2;STAT1;MAP2K4
prerank,TRRUST_Transcription_Factors_2019__MITF mouse,-0.2714783361472716,-0.8061678118934971,0.7792207792207793,0.9944005891533775,1.0,7/24,19.52%,IRF4;FOS;NGFR;PIK3R1;SLC2A2;ITGA4;TYRP1
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.3136077081950299,0.8060797442865538,0.75,1.0,1.0,8/23,27.00%,HES5;DLGAP5;NOTCH3;KAT2A;PLXND1;HEY1;MAML1;HEYL
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.2357504957504695,-0.8059851229365617,0.8387096774193549,0.9942019115998818,1.0,14/38,19.10%,ACOD1;PCK1;SFRP1;PTGER2;PTGER4;ADCY5;SPHK2;GNG2;CFTR;AR;PCK2;TRERF1;MAP4K1;ADCY1
prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.2600030632019474,0.8059324016676754,0.7922705314009661,1.0,1.0,9/76,16.65%,E2F1;PIK3R2;SHC3;CDKN2A;E2F2;IKBKG;SHC1;HRAS;SMAD3
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.31528639410873827,0.8059016417515673,0.7440476190476191,1.0,1.0,3/24,10.88%,IRAK1;IKBKG;IRAK2
prerank,Elsevier_Pathway_Collection__HPV Infection and Cancer,0.27122576517432884,0.8055678463576756,0.7807486631016043,1.0,1.0,6/55,11.47%,TERT;ITGA6;CDC20;CCNB2;CCNA2;AURKA
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.23241521739930815,0.8053148144398988,0.8826291079812206,1.0,1.0,27/163,18.63%,MNX1;EPHB2;RASGRF1;PAK3;MAPT;POU4F1;STMND1;STMN3;STMN2;GPRIN1;PRDM12;BDNF;WHRN;UNC5A;MANF;CNTNAP1;GBA;DLG4;BLOC1S1;STMN1;DBN1;ANKRD27;TMEM108;NEDD4;SNAPIN;PQBP1;NBL1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.29578568135408656,0.8051328858977556,0.7734806629834254,1.0,1.0,6/32,16.21%,ZSWIM5;CCL26;PDGFRB;PDGFB;PPM1F;CYRIB
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.24687397089453106,-0.8048921447838681,0.75,0.9957867921088867,1.0,7/35,17.12%,TRPV4;TCIM;ANO1;HSPA1B;THBS1;HSPA1A;HMOX1
prerank,"Elsevier_Pathway_Collection__Lymphoma, GCB Subtype",0.3314409829476776,0.8048466250681731,0.7359550561797753,1.0,1.0,5/22,17.96%,CDKN2A;CDKN2B;PDPK1;CHEK1;BCL6
prerank,WikiPathway_2021_Human__Extracellular vesicle-mediated signaling in recipient cells WP2870,0.3087756387012277,0.8044619191218604,0.7485714285714286,1.0,1.0,7/29,21.40%,DKK4;TSPAN8;MFGE8;HRAS;SMAD3;TGFBR3;TGFB2
prerank,TRRUST_Transcription_Factors_2019__FOXO3 human,0.3329775152419526,0.8043896189209478,0.7454545454545455,1.0,1.0,5/18,18.71%,FOXM1;BIRC5;CDKN2B;BCL6;BBC3
prerank,Elsevier_Pathway_Collection__Hypertrophic Cardiomyopathy,0.2516255119322298,0.8041883646557363,0.8080808080808081,1.0,1.0,4/81,2.50%,TNNC1;RASGRF1;ACTN2;TNNI3
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.2332238440057104,-0.8040614325714376,0.8813559322033898,0.996816133464478,1.0,8/48,14.75%,IL1B;TLR3;CASP1;TLR8;PTGER4;TLR4;SOX9;MYD88
prerank,Elsevier_Pathway_Collection__Myocyte Dysfunction in Hypoparathyroidism,-0.3029906886427658,-0.8039324084970572,0.6923076923076923,0.9965369964027677,1.0,5/15,13.06%,MAP2K1;FOXO1;TTN;SLC8A1;AKT1
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,-0.26408307459039815,-0.8039185083547062,0.7105263157894737,0.9960344811668594,1.0,6/30,11.82%,FABP2;MOGAT2;DGAT2;MOGAT1;PLIN1;ABHD5
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.2826703143513996,0.8039177054828321,0.8011363636363636,1.0,1.0,8/48,15.60%,MT3;GFI1;STMN2;ACP4;PRAG1;CBFA2T2;ADCY6;RTN4RL1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.24288306501286222,0.803759326133237,0.85,1.0,1.0,8/110,7.25%,MT3;ADRA2C;CALCA;PAK3;CHI3L1;CHRNA3;KIF14;IRAK1
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.25625436337727703,0.8037304000714546,0.8115183246073299,1.0,1.0,13/67,20.67%,GALNT13;GALNTL6;CDK1;PRKD1;CAD;HIPK4;PDPK1;PRKCA;CHEK1;ROCK2;MYLK2;CDK5R1;DYRK3
prerank,Elsevier_Pathway_Collection__Exocytosis: Vesicle Docking,0.33527270653072283,0.8036582036163551,0.7142857142857143,1.0,1.0,5/19,28.40%,SNAP25;STXBP1;STX1A;RAB13;MYRIP
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.24563922683424733,0.8035498892429652,0.8254716981132075,1.0,1.0,16/89,15.92%,PIK3R2;CALML6;ASIC1;MAPK12;MAPK11;SRC;CAMK2A;ASIC3;PLA2G4C;BDKRB2;ALOX12;PLA2G4F;BDKRB1;ADCY6;PRKCA;HTR2B
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.2907936255502715,0.8035119278809038,0.7303370786516854,1.0,1.0,1/32,0.45%,DKK1
prerank,KEGG_2021_Human__Proteasome,0.28827236725012123,0.803311278850315,0.7403314917127072,1.0,1.0,28/44,47.30%,PSMD4;PSMB4;PSMD1;PSMB3;PSMD14;PSMB5;PSMD2;PSMA1;ADRM1;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;POMP;PSMB2;PSMA6;PSMD9;PSMC2;PSME1;PSMB1;PSMD3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hypertrophic Cardiomyopathy,0.2635335640741451,0.803171287466709,0.7395833333333334,1.0,1.0,10/57,17.35%,TNNC1;ACTN2;TNNI3;FGF2;ACE;OBSCN;TPM2;ANKRD1;HRAS;EGF
prerank,Elsevier_Pathway_Collection__AXL Receptor Tyrosine Kinase Signaling,-0.22802740143867528,-0.8030735455355553,0.8360655737704918,0.9970326574263745,1.0,9/46,17.08%,TNF;FOS;MAP2K1;AXL;FLT3;AKT1;RASGRP1;TIAM1;BCL2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Presbycusis,-0.229660676944674,-0.8027841444554512,0.8115942028985508,0.9969772826002146,1.0,12/43,20.51%,ESRRG;RET;TNF;CAT;GJB2;ADK;TECTA;BCL2;SLC12A2;C1QA;MYO6;MYO15A
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.29842678631113484,-0.802383149822197,0.7246376811594203,0.9972304994038305,1.0,3/20,6.10%,SLC5A7;SLC44A4;SLC22A1
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,0.28113041312084514,0.8021872350994248,0.7182320441988951,1.0,1.0,31/49,47.30%,PSMD4;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;SKP1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;BTRC;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.32732652033502596,0.8020546970484382,0.6942675159235668,1.0,1.0,3/16,15.45%,LPL;SREBF2;PPARG
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.26371743428870104,-0.8019065632463086,0.7951807228915663,0.9975451253129386,1.0,12/24,26.70%,SLC6A20;SLC7A8;SLC7A5;SLC38A5;SLC25A22;ARL6IP5;SFXN1;SLC38A3;SLC7A2;SLC36A4;SLC38A2;SLC25A13
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.2825669024915411,-0.8018208671367717,0.7282608695652174,0.9971725526274242,1.0,17/17,71.77%,CLN3;NSG1;ACHE;PSEN1;TMCC2;LDLRAP1;ADAM17;ADAM10;BACE1;PSENEN;APH1B;ADAM19;ABCG1;APH1A;PSEN2;APOE;NCSTN
prerank,Elsevier_Pathway_Collection__TGFBR -> MEF/MYOD/MYOG Signaling,0.3056644765174968,0.8015901873362096,0.7231638418079096,1.0,1.0,13/25,40.94%,MEF2D;SMAD3;TRAF2;TGFB2;MAPK7;GATA2;TGFB1;TGFBR2;DAXX;MAP2K5;SMAD2;TGFB3;MAP3K3
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),-0.2980436235550079,-0.8013560534404662,0.7228915662650602,0.9973959317123409,1.0,1/15,1.51%,CHST4
prerank,WikiPathway_2021_Human__Canonical and non-canonical TGF-B signaling WP3874,0.3336892523624981,0.8012670857974404,0.7530864197530864,1.0,1.0,4/17,18.37%,LOXL2;LOXL1;SMAD3;LOX
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.22556704396636584,0.8011817725067882,0.88,1.0,1.0,62/200,32.18%,SLC7A11;SQLE;PDK1;SDF2L1;PLK1;BUB1;SLC1A4;CCNF;MCM2;TUBA4A;AURKA;DDX39A;GLA;ACLY;SQSTM1;VLDLR;ACACA;STC1;HMGCR;TM7SF2;SCD;CDC25A;RRM2;IDI1;MCM4;TXNRD1;HMGCS1;ABCF2;EPRS1;GOT1;FDXR;CYP51A1;PGK1;GMPS;RRP9;STIP1;ACSL3;BCAT1;COPS5;PSMD14;DDIT3;CYB5B;CDKN1A;EEF1E1;HSPA4;PSMB5;GAPDH;ATP5MC1;CACYBP;ALDOA;NUPR1;TOMM40;G6PD;PPIA;HSPA5;HSPE1;PIK3R3;ATP2A2;PSMC4;CD9;SLC2A1;PSPH
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.28511116585410096,0.8010194138779738,0.7329545454545454,1.0,1.0,24/35,52.83%,NUP37;NUP62;NXF1;TPR;NUP133;NUP155;NUP160;NUP188;NUP205;NUP210;NUP214;ALYREF;NUP107;AAAS;NUP93;NCBP2;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85
prerank,TRRUST_Transcription_Factors_2019__SMAD3 mouse,0.2788952348883997,0.8009827654456956,0.7704918032786885,1.0,1.0,6/41,15.45%,COL2A1;GSC;CDKN2B;PLAU;COL1A2;PPARG
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.23315407097039897,-0.8009428193798582,0.8771929824561403,0.9976923838316826,1.0,13/44,19.10%,GRAMD1C;SFRP1;CDH1;GRAMD1B;PTGER2;GPLD1;PTGER4;ADCY5;SPHK2;GNG2;CFTR;MAP4K1;ADCY1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.32778443951569536,0.80078777123616,0.6511627906976745,1.0,1.0,3/17,13.72%,ATP1A2;CACNA1C;GSTM2
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,0.23205848744700247,0.8004117931533604,0.8711111111111111,1.0,1.0,76/187,39.45%,H3C13;H2AC19;TP73;H2BC13;H2AC20;H2BC17;SRC;ACTL6B;AGO2;H2BC21;PSMD4;H2BC9;H2BC15;CBX6;H2BC11;H2BC12;H2BC4;H4C15;H2AC6;PSMB4;PAX5;H2BC5;TNFRSF18;H2AX;CLDN5;CDK6;GPAM;SMARCA4;HDAC1;CBX8;H2AJ;KMT2D;KMT2B;SMARCD3;CTSV;PSMB3;PSMD14;WDR5;SIN3B;UBA52;SMARCC1;SOCS3;PSMB5;PSMD2;YAP1;PSMA1;HIPK2;PSMD10;TCF7L1;PSMC4;CBX2;PSMC3;H2AZ1;NFE2;GATA2;CTSK;CSNK2B;PSMC5;AGO1;SEM1;PSMB6;SETD1B;TJP1;PSMD8;ITGA2B;ABL1;SETD1A;TAL1;PSME2;AXIN1;PSMD13;PSMB7;PSMA7;RBBP5;PSME3;ARID2
prerank,WikiPathway_2021_Human__Toll-like Receptor Signaling related to MyD88 WP3858,-0.2563839488030932,-0.8002571216865816,0.85,0.9983783137679141,1.0,7/30,14.75%,TLR3;TLR8;REL;TICAM2;TLR4;TLR2;MYD88
prerank,WikiPathway_2021_Human__Splicing factor NOVA regulated synaptic proteins WP4148,0.2832363186053694,0.7997126145443938,0.7700534759358288,1.0,1.0,3/39,5.32%,KCNJ6;GRIN1;GRIK2
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,0.22480659300552458,0.7996679967579216,0.8851063829787233,1.0,1.0,24/255,11.00%,DUSP9;FGF20;RASGRF1;ACTN2;PIK3R2;MAPK12;RASGEF1A;SHC3;VWF;NRG2;FGF13;FGF17;GPRIN1;SRC;FGF23;CAMK2A;PSMD4;PDGFRB;IL3RA;LAMTOR2;FLT3LG;PEA15;MPP3;RASGRF2
prerank,Elsevier_Pathway_Collection__Breast Cancer,0.245617515358298,0.7996455388734102,0.8169014084507042,1.0,1.0,39/108,38.05%,VEGFD;LEF1;TCF7;SRC;JAG2;FLT1;KAT2A;SHC1;PDPK1;PRKCA;SMAD3;EGF;MSH2;BARD1;TRAF2;DLL4;PARP1;NRG1;RAD51;MAP2K2;DVL1;MYC;CTNNB1;MSH6;SMURF1;CASP9;BRIP1;TGFB1;LRP5;SMURF2;BRCA2;TNFRSF10A;BAX;TRADD;KITLG;MAP3K14;MAPK3;AXIN1;GSK3B
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.28453877802130195,-0.7996149952900506,0.7472527472527473,0.9990078720824815,1.0,18/18,71.57%,GDAP1;OPA1;AFG3L2;MFN2;SPG7;MIGA1;CHCHD3;MIGA2;MFN1;THG1L;MIEF1;STOML2;MFF;PLD6;MIEF2;USP30;BAX;FIS1
prerank,Elsevier_Pathway_Collection__Mitochondria Enlargement and Apoptosis in Alzheimer's Disease,-0.30211113514169896,-0.799202827639501,0.7333333333333333,0.9992971626933495,1.0,7/15,29.90%,BCL2;HSPA1A;MICU1;APP;OPA1;CASP3;SLC8B1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Vasospasm,0.33327611318112316,0.7990172104058106,0.7484662576687117,1.0,1.0,4/17,22.80%,CALCA;EPO;ADM;PLAT
prerank,Elsevier_Pathway_Collection__Glutamate Toxiicity Effects on Striatum Medium Spiny Neurons in Hantington's Disease,0.3086364754206027,0.7989416186189324,0.7861271676300579,1.0,1.0,8/27,24.10%,SRC;BDNF;SLC1A2;DLG4;PDPK1;ADORA2A;PLCG1;DRD1
prerank,WikiPathway_2021_Human__Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,-0.2255305961300535,-0.7983859538456116,0.7727272727272727,1.0,1.0,4/45,5.56%,PAK5;ITGB8;PAK6;CDH1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.2559505184753329,0.7982713432370758,0.8148148148148148,1.0,1.0,36/86,39.37%,RBM24;TP73;TCF15;HES5;PSMD4;PSMB4;PRKDC;METTL3;TCF3;PSMD1;PSMB3;LDB1;PSMD14;PSMB5;PSMD2;YAP1;PSMA1;PSMD10;GDNF;PUS7;PSMC4;PSMC3;GATA2;PSMC5;HNRNPU;PSMB6;PSMD8;ABL1;SETD1A;NELFB;TAL1;PSME2;PSMD13;PSMB7;PSMA7;PSME3
prerank,WikiPathway_2021_Human__PI3K/AKT/mTOR - VitD3 signaling WP4141,-0.2805352393268932,-0.797726877571653,0.8260869565217391,1.0,1.0,3/21,5.57%,IL10;HK3;CD80
prerank,Elsevier_Pathway_Collection__mTOR Hyperactivation after Status Epilepticus,0.31944374636918904,0.7973656576275874,0.7261904761904762,1.0,1.0,9/16,42.11%,PDPK1;GRM1;TSC1;TSC2;RHEB;SHANK2;MTOR;PLCB3;HOMER1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.312413646482828,0.7972775084224675,0.7857142857142857,1.0,1.0,5/22,17.12%,THEM5;ACSL4;ACLY;ACACA;SCD
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,0.3052160223071894,0.7972504298414299,0.75,1.0,1.0,11/23,40.53%,DBN1;RHOBTB2;HSP90AB1;CDC37;RBMX;DDX39B;CCT6A;CCT2;HSP90AA1;CCT7;MSI2
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.2831946110299176,0.7972337866208443,0.7897727272727273,1.0,1.0,5/39,15.74%,REG3A;FERMT1;DUOX1;SMOC2;HRAS
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.22359378116147813,-0.7968519649489331,0.8387096774193549,1.0,1.0,8/51,14.66%,A4GNT;ADAMTS13;ST8SIA6;ST8SIA1;NCCRP1;GCNT1;MAN1C1;MAN1A1
prerank,Elsevier_Pathway_Collection__Eat me Signal: Apoptotic Cell Induces Phagocytosis,0.2950751462885293,0.7967083222245216,0.8058823529411765,1.0,1.0,11/29,30.27%,ADGRB1;SRC;MFGE8;CD36;TYRO3;TGM2;PLCG1;ANXA2;PTK2;MERTK;GAS6
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,0.27968855278268784,0.7965143655880319,0.7894736842105263,1.0,1.0,14/35,40.31%,CDKN2A;CCNA2;CDK1;PDPK1;CHEK2;UBA52;MLST8;SGK1;PPP2R1A;MDM4;DAXX;CDK2;USP7;MTOR
prerank,MSigDB_Oncogenic_Signatures__GCNP SHH UP LATE.V1 DN,0.23855608786488852,0.7964744771397504,0.8657407407407407,1.0,1.0,37/163,24.89%,GJB6;DLX5;TNNC1;S100A13;ARID3A;SLC30A3;MDFI;TUBA4B;IKBKG;ANKRD33B;GPR3;SOX18;PPFIA4;DLG4;GLA;RAB34;PDZK1IP1;NACC2;B3GAT3;GRIN2C;ITGA7;SSBP4;HSPG2;PUS1;STX1A;ZNHIT2;LTC4S;PTPRU;NUDT1;EYA1;TNNC2;RHD;MED12;EEPD1;KANK3;PPM1M;MIIP
prerank,Elsevier_Pathway_Collection__beta-Cell Destruction through Cytokines in Diabetes Mellitus,-0.22799930068707214,-0.7963611913349374,0.8545454545454545,1.0,1.0,18/57,22.05%,IFNG;TNF;IL1B;FOS;IL1RAP;MAP2K1;CCL2;AKT1;SLC2A2;MYD88;TNFRSF1B;BCL2;HMOX1;MAP2K3;MAP2K6;JUN;JAK2;STAT1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.3099636966588801,0.7963500144424015,0.7471264367816092,1.0,1.0,7/24,16.85%,SLC6A9;PRAF2;SLC1A4;SLC1A2;SLC7A1;SLC25A12;SLC1A3
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,0.23818623524580498,0.7960609650600671,0.8883720930232558,1.0,1.0,24/123,21.44%,IGF2;VEGFD;ACTN2;VWF;TIMP1;MANF;TUBA4A;CD36;F13A1;ITIH4;PDGFB;HABP4;PDGFA;CD109;CYB5R1;SYTL4;CYRIB;EGF;VPS72;TAGLN2;MAGED2;SPARC;TGFB2;PECAM1
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.3006399564735775,0.7959392201615259,0.7674418604651163,1.0,1.0,3/33,6.10%,AVIL;PRKAA2;NR5A1
prerank,Elsevier_Pathway_Collection__FBLN5 Potentiates Migration and Proliferation of Endothelial Cells in Cancer,0.32413612785118684,0.7959209829275796,0.7674418604651163,1.0,1.0,4/19,16.65%,ELN;LOXL2;LOXL1;SMAD3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.3089192753844114,0.7953164051140376,0.7212121212121212,1.0,1.0,4/19,15.65%,PLPP2;SPHK1;GBA;PLPP1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.24372350861839398,-0.7950758736955632,0.813953488372093,1.0,1.0,7/31,13.06%,PM20D1;SULT1A2;ASAH2;SPTLC3;GCH1;SPHK2;AKT1
prerank,WikiPathway_2021_Human__Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.27762805993367456,0.7950093191696456,0.765625,1.0,1.0,4/36,7.48%,KISS1;PDK1;KISS1R;AMH
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,0.2915874770836742,0.79500452625175,0.7696629213483146,1.0,1.0,2/40,2.84%,DUSP9;MAPK12
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.2464215337887333,-0.7949716917151561,0.8026315789473685,1.0,1.0,7/32,12.06%,IL10;IFNG;IGFBP3;NDRG4;IL12B;IGFBP5;TRIB1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.3009783610983668,0.7949459154113314,0.6987951807228916,1.0,1.0,10/30,27.70%,BCAN;NCAN;IDUA;CSPG5;CSPG4;VCAN;CHST15;CHPF;HEXB;HEXA
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,0.22844535526984905,0.7947854969904495,0.9013452914798207,1.0,1.0,36/228,19.76%,MUC7;MUC13;CYP17A1;CYP21A2;BCAN;SBSPON;EGFL7;DPM3;GPC3;MTR;CHST6;ABCA3;SPON2;NCAN;NOTCH3;MUC4;IDUA;CSPG5;CTSA;SEMA5B;CSPG4;OPLAH;SLC26A2;ACACA;THBS2;GPC2;VCAN;B3GAT3;ADAMTS18;ST3GAL3;B4GALT7;MUC16;MUC12;THSD1;NOTCH4;HSPG2
prerank,WikiPathway_2021_Human__Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3186717544788443,0.7945615235768679,0.7845303867403315,1.0,1.0,3/19,19.72%,PDK1;ACACA;EGLN1
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.26138874662038836,0.7945287716102524,0.803030303030303,1.0,1.0,21/79,25.48%,GHRHR;PIK3R2;SLC2A4;ZBTB7B;LEP;PDPK1;INHBB;PPARG;HDAC5;USF1;RAB15;TSC1;LPIN1;EPRS1;GOT1;PARP1;PCSK9;PRKDC;RAB13;DENND4C;INSIG2
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.28753824901405045,-0.7944796951030386,0.7931034482758621,1.0,1.0,4/17,9.64%,TNF;ESR1;MAP2K1;IL6
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,0.30619047776884534,0.794208384880076,0.7426900584795322,1.0,1.0,7/22,21.80%,DOCK3;SRC;RNASE1;SHC1;HRAS;CDK5R1;PLCG1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.2408165097156313,0.7941817050423732,0.863849765258216,1.0,1.0,22/134,22.79%,PPP2R2C;DUSP9;PPEF1;PTPRN2;PTPN5;PTPRT;PTPN14;EYA4;PTPRG;SBF1;PPM1F;PGP;PTPRR;MTMR3;PDP1;PHPT1;DUSP12;PTPRH;PTPRU;PPP2R3B;EYA1;PPP2R5A
prerank,WikiPathway_2021_Human__Apoptosis Modulation and Signaling WP1772,-0.19729628006206643,-0.7941646775814304,0.9411764705882353,1.0,1.0,18/87,17.74%,TNFRSF11B;FOS;FASLG;PTPN13;TNFSF10;CASP1;BLK;BCL2A1;BIRC7;MYD88;CASP6;BCL2L11;TNFRSF1B;CASP7;BCL2;HSPA1A;TNFRSF10C;PMAIP1
prerank,WikiPathway_2021_Human__NO/cGMP/PKG mediated Neuroprotection WP4008,-0.24684055168269187,-0.79414119768753,0.8235294117647058,1.0,1.0,6/43,10.08%,GRIN2B;IFNG;TNF;IL1B;CAMK2B;CNGA1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.26004740442192475,0.794037772201441,0.8190954773869347,1.0,1.0,10/66,17.26%,LMOD1;MAPT;CCL26;BAIAP2L2;ANKRD53;CCL24;CCL11;PSRC1;CDC42EP5;ARL2
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,0.3228587144929688,0.793977829567526,0.7151162790697675,1.0,1.0,1/19,2.10%,PIK3R2
prerank,Elsevier_Pathway_Collection__Adipocyte Hypertrophy and Hyperplasia,0.2910973702334492,0.7937406129787855,0.7526881720430108,1.0,1.0,8/28,17.12%,SLC2A4;LPL;CD36;ACLY;PDPK1;ACACA;PPARG;SCD
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.24517314547283742,-0.7934846562330276,0.8461538461538461,1.0,1.0,11/41,16.86%,SOCS2;IP6K3;PIK3C2G;PIK3CD;SLA2;FAM126A;FAM126B;PIK3R1;CISH;PI4K2B;PIP4K2A
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.25528321729072423,0.7934225153096529,0.8097826086956522,1.0,1.0,8/78,12.47%,EPHB2;PRKAA2;MAPT;PRR5L;ATP2B4;PRKN;PPP1R16B;CRTAP
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.32706302480638044,0.7933588823508968,0.7066666666666667,1.0,1.0,6/17,27.00%,SNAI2;BMP4;DLL4;HEY1;SNAI1;HEYL
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.2652637688489259,0.7933148880168303,0.7872340425531915,1.0,1.0,11/61,14.99%,NEK2;FGF2;PDGFRB;AURKB;RGCC;CCT3;PDGFB;RFC4;DSCC1;SMOC2;NVL
prerank,WikiPathway_2021_Human__PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.3086039462363733,0.7925966158313859,0.7844311377245509,1.0,1.0,2/30,4.15%,PIK3R2;PDK1
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.31152348782050054,0.7925480898892876,0.7439024390243902,1.0,1.0,2/23,3.47%,CYP21A2;CYP7A1
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,0.29704862028862977,0.7923803953332109,0.7865168539325843,1.0,1.0,5/27,18.91%,VWF;SRC;SHC1;PDPK1;RAPGEF3
prerank,Reactome_2022__Phase 4 - Resting Membrane Potential R-HSA-5576886,-0.2981539807887544,-0.7919942663769014,0.72,1.0,1.0,7/16,17.60%,KCNK2;KCNK15;KCNJ12;KCNK6;KCNK3;KCNK5;KCNK10
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.321229678097165,0.7918486181817722,0.7901234567901234,1.0,1.0,9/21,38.14%,PPP1R16B;PPP1R1B;MFHAS1;TIPRL;ENSA;STYXL1;BOD1;GSK3B;FKBP1A
prerank,Elsevier_Pathway_Collection__Axonal Transport Impairment in Hungtington Disease,0.3113947919458061,0.7913723526563247,0.7162162162162162,1.0,1.0,3/19,12.86%,KIF5A;BDNF;SNAP25
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.2780821262957163,0.7913567477205925,0.8297872340425532,1.0,1.0,15/47,28.28%,BRSK2;PRKN;KIAA1614;NR1D1;PPM1F;TTL;CDK16;PARP1;GSN;TRIM67;HSP90AB1;DVL1;ABCA12;BRSK1;SPAG5
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.25373434314373133,-0.7913356577143441,0.7368421052631579,1.0,1.0,9/28,17.09%,NRXN1;MUSK;DLG2;PTN;PIGR;DLG3;ITGB2;SYNJ2BP;ITGA4
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.2533888866083304,0.7907748832161293,0.8477157360406091,1.0,1.0,33/79,41.94%,SERPINA2;HSPA2;MAPKAPK2;HSPA12A;HSPA12B;NUP37;POLR1A;NUP62;TPR;NUP133;HSF1;RPS19BP1;HSPA4;NUP155;NUP160;HSPA5;CRYBA4;NUP188;HSPA14;BAG3;HSPA8;NUP205;MAPK3;GSK3B;HIKESHI;SERPINH1;NUP210;DNAJB6;HSPA1L;NUP214;HSPH1;NUP107;COL4A6
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3330953911936262,0.7906170497183743,0.7559523809523809,1.0,1.0,3/15,10.68%,JCAD;FGF2;PPP1R16B
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.31360382588769087,-0.7903572654202439,0.7157894736842105,1.0,1.0,6/15,21.54%,PPARGC1A;ETFDH;ETFRF1;PDIA5;SDHB;NDUFA5
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,-0.24914385323832894,-0.7902609186528898,0.8356164383561644,1.0,1.0,6/33,12.13%,PRKAR2B;CAMK4;CAMK2B;PLA2G4A;ADCY5;PDE1B
prerank,TRRUST_Transcription_Factors_2019__MYCN human,0.28250526929043285,0.7898438308214735,0.8031088082901554,1.0,1.0,13/44,19.10%,DKK3;BIRC5;MCM2;MCM6;NDRG1;MYBL2;MCM10;MCM3;MCM5;HMGA1;NES;MCM4;CTSD
prerank,Elsevier_Pathway_Collection__Proteins Involved in Mucinous Ovarian Carcinoma,-0.22906800978348696,-0.7895454533121453,0.84375,1.0,1.0,4/42,8.69%,MSLN;FOS;ESR1;TGFA
prerank,"Elsevier_Pathway_Collection__Oxidative Stress, All-Trans-Retinal and Lipofuscin Toxicity in AMD",-0.28641306688282453,-0.7895451315654869,0.775,1.0,1.0,5/18,18.37%,HTR2A;BCL2A1;BCL2;HMOX1;CHRM3
prerank,Elsevier_Pathway_Collection__IL22 Induces Keratinocyte Proliferation in Psoriasis,-0.25296672516634877,-0.789332176288129,0.7272727272727273,1.0,1.0,4/33,7.46%,MMP1;FOS;S100A8;MAP2K1
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.3147782234532261,0.7892255697685979,0.696969696969697,1.0,1.0,2/22,6.21%,ROBO1;BMP4
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.18041460771817983,-0.7890767528043248,1.0,1.0,1.0,47/188,22.52%,CLDN4;CLDN10;TNF;CLDN8;IL1B;FOS;FASLG;IL18;TNFSF10;CASP1;NLRP3;LPAR2;SEC24B;IL6;FYN;TUBB1;CXCL8;NCKAP1L;TLR4;LPAR5;HCLS1;MYO10;MYH11;MYO1F;WASF3;CLDN1;WIPF1;MYD88;CLDN11;CASP7;ACTR3C;EZR;LPAR1;MAPK10;MYO1G;SEC24D;MAPK13;NAIP;MYO6;TAB2;JUN;TMED10;CLDN34;F2;CLDN3;CASP4;SEC24A
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.3293576433788078,0.7889562450477088,0.7317073170731707,1.0,1.0,11/16,49.89%,F11R;UBA52;SMURF1;TGFB1;TGFBR2;FKBP1A;CGN;UBC;RPS27A;PARD3;RHOA
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.18040082126697551,-0.788750792973971,0.9642857142857143,1.0,1.0,38/159,22.36%,RIPK3;BPI;FOS;TLR3;S100A8;MAP2K1;KCNH8;TLR8;S100B;BTK;PELI2;RPS6KA1;CD180;TLR4;TLR2;S100A12;USP18;PLCG2;MYD88;ITGB2;DUSP6;CTSB;PIK3R4;TLR10;MAPK10;PPP2CB;LY86;SIGIRR;LGMN;CNPY3;NOD2;TAB2;MAP2K3;MAP2K6;APOB;JUN;ITGAM;APP
prerank,Elsevier_Pathway_Collection__Astrocytoma,0.27323331708904874,0.7880961918314658,0.7967914438502673,1.0,1.0,12/41,28.26%,CDKN2A;PDGFRB;PDGFB;PDGFA;SHC1;PDPK1;EGF;CDK6;PLCG1;MAP2K2;MYC;CDKN1A
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.3311612299013056,0.7877770027316476,0.7530864197530864,1.0,1.0,5/17,24.40%,CABYR;DNAAF1;ADCY10;CCDC40;CFAP53
prerank,Elsevier_Pathway_Collection__mRNA Degradation,-0.26074079772298936,-0.7876104150964577,0.7926829268292683,1.0,1.0,26/26,73.96%,PATL1;TENT4B;XRN1;LSM5;DCP2;DCP1A;PAN3;DHX36;LSM1;LSM6;LSM3;PDLIM1;ZCCHC3;TENT4A;PARN;PAN2;XRN2;MTREX;UPF1;SKIV2L;EDC4;LSM7;LSM4;LSM2;PABPC1;EDC3
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3187007563360243,0.7875485816573489,0.7714285714285715,1.0,1.0,2/18,6.21%,ROBO1;BMP4
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,-0.2496437302608216,-0.7874573207736136,0.8214285714285714,1.0,1.0,9/34,22.41%,APOA1;LSR;CES3;APOBR;LIPC;NCEH1;MYLIP;APOB;LDLR
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.2936112377706787,0.7874368169372955,0.7757575757575758,1.0,1.0,2/27,2.11%,LAMA3;FLG2
prerank,TRRUST_Transcription_Factors_2019__AHR mouse,0.3140553061830337,0.7871734644841788,0.7195121951219512,1.0,1.0,5/19,14.85%,NQO1;SNAI2;E2F2;LHB;SMOC2
prerank,Elsevier_Pathway_Collection__IL17F Signaling in Bronchial Epithelial Cell in Asthma,0.31657653652199935,0.7871009017326966,0.7687861271676301,1.0,1.0,4/20,14.29%,CCL20;IL11;IKBKG;MAPKAPK2
prerank,Elsevier_Pathway_Collection__CHRM1/2/3 -> Vascular Motility,0.3276680839192729,0.7870895032144954,0.7532467532467533,1.0,1.0,1/20,1.59%,RASGRF1
prerank,MSigDB_Oncogenic_Signatures__CAHOY ASTROCYTIC,0.24701932448476824,0.7870605053973598,0.8195121951219512,1.0,1.0,6/93,3.77%,SLC7A11;DIO2;TNFRSF19;PAK3;RGS20;SLC6A11
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 27-Hydroxycholesterol R-HSA-193807,-0.2883261320031589,-0.7869124731613811,0.7978723404255319,1.0,1.0,3/15,9.63%,AKR1D1;CYP8B1;AKR1C4
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.2209930094191521,0.7867436588248501,0.923728813559322,1.0,1.0,17/254,8.21%,ODAM;MT3;IGF2;FGF20;EPHB2;VEGFD;AXIN2;CLDN19;KNDC1;PRR5L;FGF17;BMP4;FGF2;TMEM119;FGF23;PRKN;EFNA1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.3064444761516275,0.7866573874524693,0.7948717948717948,1.0,1.0,7/19,41.14%,NEIL3;H4-16;MUTYH;OGG1;TERF1;ACD;TERF2
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.2613041721903466,0.7863018482380377,0.8054054054054054,1.0,1.0,5/62,8.61%,PTK7;BRSK2;CLDN19;PARVB;INSRR
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,0.2645668379348697,0.7861781902808611,0.8074866310160428,1.0,1.0,5/49,8.78%,CGA;PIK3R2;FABP4;PTGER3;ADORA1
prerank,MSigDB_Oncogenic_Signatures__JAK2 DN.V1 DN,-0.20018378725119262,-0.7860550101261128,0.8888888888888888,1.0,1.0,20/114,14.57%,EREG;PLGLA;DSCAM;DBH;IKZF2;SPIB;ALDH8A1;DAPP1;GPR1;TRIM36;PEX3;DGKE;ZNF160;SLC15A2;LONRF1;NEAT1;REPS1;SLC25A16;GRIK1;SGCE
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.2033003059529214,-0.7859536845085898,0.9523809523809523,1.0,1.0,16/88,16.50%,SMPD3;PFN2;IFNG;TNF;MMP1;LGALS3;PLEK;BMP7;TCL1A;CLEC7A;FNIP2;SYK;SYNPO2L;BCL2L11;CLU;MPP7
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.3076247141390374,0.7857637456059768,0.7734806629834254,1.0,1.0,3/21,5.32%,TGM4;FLG;TGM3
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.3171935578562817,0.7857281791104204,0.7365269461077845,1.0,1.0,5/21,16.82%,CYP17A1;DHRS2;AKR1C3;AKR1C1;AKR1C2
prerank,KEGG_2021_Human__Necroptosis,0.2338599773502273,0.7853781420288768,0.8506787330316742,1.0,1.0,26/130,22.98%,GLUL;H2AC19;H2AC18;H2AC16;H2AC13;H2AW;H2AC11;H2AC8;H2AC20;CAMK2A;PLA2G4C;H2AC6;PLA2G4F;SQSTM1;H2AX;SHARPIN;TRAF2;PYGB;GLUD2;RNF31;FADD;FTL;PARP1;AIFM1;H2AJ;PLA2G4E
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.25131541903191734,-0.7851611404592549,0.8461538461538461,1.0,1.0,1/26,0.15%,TDRD1
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.3276693588267592,0.7849307121184411,0.7076023391812866,1.0,1.0,4/16,15.55%,FABP4;PNPLA5;LPL;FABP5
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.3170064581731613,0.7848901519104913,0.6987179487179487,1.0,1.0,1/18,0.68%,GCG
prerank,Elsevier_Pathway_Collection__Endothelial Cell Dysfunction in Pulmonary Hypertension,0.25524295636495187,0.7848518254594812,0.8137254901960784,1.0,1.0,5/66,6.66%,LEF1;ARG2;NOX4;BIRC5;SRC
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.21022464314717682,-0.7848441351451393,0.9069767441860465,1.0,1.0,13/65,17.15%,EREG;AGR2;TGFA;BTC;ERRFI1;AKT1;HBEGF;SH3KBP1;PDE6G;SPRY2;PLAUR;PTK6;AFAP1L2
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.25751330046633436,0.7848157248208123,0.8274111675126904,1.0,1.0,18/61,28.49%,ST8SIA3;EGFL7;DPM3;ST6GALNAC4;MVD;ST8SIA5;NEU3;CTSA;GFUS;ST3GAL3;FCSK;PMM1;GLB1;AMDHD2;SRD5A3;DOLK;ST6GALNAC5;ST3GAL2
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,0.23389943135078917,0.784801301589394,0.8894009216589862,1.0,1.0,25/127,21.44%,IGF2;VEGFD;ACTN2;VWF;TIMP1;MANF;TUBA4A;CD36;F13A1;ITIH4;PDGFB;HABP4;PDGFA;CD109;CYB5R1;PRKCA;SYTL4;CYRIB;EGF;VPS72;TAGLN2;MAGED2;SPARC;TGFB2;PECAM1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.282433609155689,0.7847814874069323,0.7701149425287356,1.0,1.0,14/33,33.82%,ATP6V0D2;ATP6V0A1;ATP6AP1;ATP6V0B;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1C1;ATP6V1H;MCOLN1;ATP6V1F;ATP6V1E1;ARHGAP1;ATP6V1E2
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.2527086208622949,0.7846452880099943,0.803030303030303,1.0,1.0,17/60,30.29%,CAMK2A;CDK1;PRKD1;CAD;HIPK4;PDPK1;PRKCA;CHEK1;ROCK2;MYLK2;CDK5R1;DYRK3;PRKDC;CDK5;CDC42BPA;ULK1;HIPK2
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.2716053434486957,-0.7844821835319559,0.7746478873239436,1.0,1.0,5/26,8.78%,LGALS12;TSPAN7;GRIA3;PRKCB;CAMK2B
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.22826013495245934,0.7843128689384564,0.8883720930232558,1.0,1.0,30/181,18.18%,ODAM;RASGRF1;THY1;CCL26;CCL13;ITGA6;STMN3;GPSM1;CCL25;FGD1;CCL20;PLXNC1;ARHGAP11B;ARHGAP44;EZH2;S100A10;RASIP1;ASAP3;PLXNA2;ARHGAP11A;RGS16;CCL24;GNB5;CCL11;HRAS;PLXND1;ECT2;ARL2;SGSM2;PLXNA3
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.23552469353463976,0.7842177613348249,0.8627450980392157,1.0,1.0,14/135,9.33%,PYDC1;GFI1;TRIM40;SFRP4;ADGRG3;FOXS1;CDKN2A;HDAC4;IRAK1;MDFI;FOXH1;LRRC14;TNFRSF4;CD200
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.2668233539317164,0.7840883563760335,0.8080808080808081,1.0,1.0,23/45,44.20%,STOX1;TICRR;CDT1;PDGFA;PIF1;SMG5;RADX;KPNA2;MYC;THOC1;HDAC8;KDM1B;SIRT7;UBE2V1;POLH;WDR70;USP1;MPV17;TERF2;ALYREF;UBE2V2;CDK9;UPF1
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.24501712405985354,0.7840102918961844,0.8606965174129353,1.0,1.0,46/97,44.56%,CAMK2A;SERPINA2;HSPA2;MAPKAPK2;HSPA12A;HSPA12B;NUP37;POLR1A;NUP62;TPR;NUP133;HSF1;HSP90AB1;RPS19BP1;HSPA4;NUP155;NUP160;HSPA5;MLST8;CRYBA4;CRYAB;NUP188;HSPA14;BAG3;HSPA8;RPTOR;AKT1S1;NUP205;MAPK3;VCP;GSK3B;HIKESHI;SERPINH1;NUP210;HSP90AA1;DNAJB6;HSPA1L;MTOR;NUP214;HSPH1;NUP107;COL4A6;MAPK1;CAMK2G;DNAJC2;AAAS
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.25508020016134625,-0.7840088109665224,0.8352941176470589,1.0,1.0,7/24,17.15%,AGR2;AKT1;RTN4;PDE6G;PLAUR;PTK6;AFAP1L2
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.31004031468480026,0.7839646758123223,0.7682926829268293,1.0,1.0,4/23,11.38%,ROBO1;TDGF1;FGF2;SOX18
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.28686463910487914,0.7837891334952396,0.7288135593220338,1.0,1.0,6/35,15.92%,S100A1;TERT;ATP2B4;LEP;GLA;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.31863298675074114,0.7837652171206689,0.7456647398843931,1.0,1.0,3/18,9.33%,SPINK5;IL17D;CD200
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.33210558010107527,0.783385251082511,0.7900552486187845,1.0,1.0,6/16,27.07%,SNAI2;NACC2;TMEM161A;CDKN2D;SNAI1;DDIAS
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.3312456208614289,0.7832657686753417,0.7241379310344828,1.0,1.0,10/15,40.02%,KMT5C;MAD2L2;SHLD3;TP53BP1;TGFB1;PAXIP1;SHLD1;CLCF1;TFRC;SHLD2
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.33988784462014826,0.7832062604124501,0.7261146496815286,1.0,1.0,4/15,20.32%,BMP4;ANKRD1;MYLK2;TGFBR3
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.22565454895296283,-0.7830776144935371,0.9012345679012346,1.0,1.0,9/45,17.19%,CETP;PCK1;PLIN1;ARL4C;ABCG8;ABCG5;ANGPTL3;NCOR1;PLTP
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.30787888880995057,0.7830161356049457,0.7672955974842768,1.0,1.0,11/21,46.82%,CNTN1;JAG2;DLL4;UBA52;NCSTN;PSEN2;APH1A;UBC;RPS27A;DLL1;MIB2
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Breast Cancer,0.2990845910493422,0.7825864118356554,0.7954545454545454,1.0,1.0,6/28,20.59%,VEGFD;SRC;CCNB1;FLT1;MMP9;MMP3
prerank,Elsevier_Pathway_Collection__Enterocyte Mediated Mucosal Damage in Celiac Disease,0.3043936599507955,0.782403857624958,0.7232704402515723,1.0,1.0,6/24,15.56%,SRC;MAP3K8;NFKB2;PDPK1;ULBP1;RELB
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.2631912256805748,0.7823267596087004,0.8212290502793296,1.0,1.0,8/47,16.08%,DKK1;FOXM1;PRKN;TBC1D16;GBA;ACLY;ACACA;PM20D2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.21565867170932704,0.7820295227044918,0.9628099173553719,1.0,1.0,52/382,16.53%,TRIM71;IGF2;EPHA6;FGF20;EPHB2;VEGFD;PIK3R2;PAK3;GRIN1;SHC3;PTPRT;IL31RA;EFNA3;MAPK11;ATP6V0D2;ROR1;FGF17;CHRNA3;SRC;FGF2;EPHA10;EFNA4;FGF23;BDNF;EFNA1;PDGFRB;INSRR;COL1A1;SHCBP1;GDF15;COL4A2;FOXC1;PRKD1;PTPRG;BDKRB2;PDGFB;FLT1;PDGFA;SOGA1;PGF;SH2D6;ATP6V0A1;MAPKAPK2;SHC1;RGS14;ATP6AP1;HRAS;STMN1;SRMS;ANGPT2;ROCK2;TYRO3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Thrombophilia,-0.22859661532665487,-0.7819510434543399,0.855072463768116,1.0,1.0,20/40,25.66%,TNF;ADAMTS13;IL1B;IL6;PLG;PROZ;SERPINA10;ITGB3;F3;F11;F7;AGTR1;PF4;SERPIND1;F2;THBD;ANXA5;CPB2;HRG;PROS1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.28162366713422593,0.7819080224483136,0.8409090909090909,1.0,1.0,19/32,47.20%,POLR2L;POLR1A;POLR2K;TAF1A;POLR1H;POLR1G;POLR2H;CAVIN1;MAPK3;TAF1;ERCC2;TAF1D;UBTF;POLR1C;TAF1B;POLR2F;ERCC3;TAF1C;GTF2H2
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,0.32563872093164287,0.7814607723999043,0.75,1.0,1.0,4/19,18.50%,ROCK2;RHOC;VPS72;LIMK2
prerank,KEGG_2021_Human__AMPK signaling pathway,0.24251804198927235,0.7811079588519994,0.8681818181818182,1.0,1.0,26/114,22.80%,PPP2R2C;PIK3R2;PRKAA2;SLC2A4;CCNA2;PFKFB4;LEP;CPT1B;CD36;CREB3L1;FBP2;PDPK1;LEPR;ACACA;PPARG;CREB3L4;HMGCR;SCD;PFKFB2;TSC1;CPT1C;PPP2R3B;LIPE;TSC2;PPP2R5A;CRTC2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.3210501365374306,0.7810328211936123,0.7371794871794872,1.0,1.0,4/18,9.41%,NOX5;BMP4;CD34;LOXL2
prerank,Elsevier_Pathway_Collection__Osteoarthritis,0.2483422248874133,0.7809786447372181,0.8556701030927835,1.0,1.0,19/79,26.12%,COL2A1;SPP1;COL10A1;IHH;IRAK1;BGLAP;SHC1;PDPK1;SMAD3;ACVRL1;TRAF2;SPARC;MMP3;TGFB2;GLI1;ADAMTS4;MAP2K2;DVL1;CTNNB1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.2245534464613638,-0.7809707902237194,0.9152542372881356,1.0,1.0,55/56,72.07%,RAB19;MAP1LC3C;STX17;MAP1LC3A;ATG5;GABARAPL1;TP53INP2;ULK2;RAB1B;UBXN2A;RAB7A;MAP1LC3B2;TRAPPC8;MFN2;VMP1;TP53INP1;WDR45B;WIPI1;RAB23;STING1;BECN1;STX12;PIK3C3;ATG2B;ATG14;RAB1A;UBXN2B;ATG9A;WIPI2;MAP1LC3B;ATG2A;UBQLN1;ATG101;ATG16L1;TMEM41B;GABARAPL2;ATG12;UBQLN2;ATG3;ATG7;ATG13;ATG16L2;PACS2;AMBRA1;EMC6;ATG9B;ELAPOR1;NSFL1C;GABARAP;ATP2A2;RUFY4;RAB43;ULK1;SMURF1;RB1CC1
prerank,Elsevier_Pathway_Collection__Angiogenesis in Endometriosis,0.2541378654970481,0.7809350211378253,0.8461538461538461,1.0,1.0,9/57,16.27%,RASGRF1;SRC;SPHK1;HSPB1;FLT1;MAPKAPK2;SHC1;PDPK1;ANGPT2
prerank,WikiPathway_2021_Human__TLR4 Signaling and Tolerance WP3851,-0.25878987355330385,-0.7808923406396586,0.8767123287671232,1.0,1.0,6/27,17.36%,TNF;IL6;CXCL8;TLR4;MYD88;INPP5D
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.2547155755980152,0.7806975690499869,0.8272251308900523,1.0,1.0,32/60,44.54%,SERPINA2;FANCI;ELOC;CHEK1;POLR2L;MSH2;ELOB;FANCD2;POLR2K;NELFE;POLR2G;MDC1;POLR2H;GDNF;NELFA;DDB2;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;POLR2A;ERCC2;ELL;POLR2B;GTF2F1;POLR2F;CDK9;ERCC3;SUPT16H;CCNT2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Endometrioid Ovarian Carcinoma,-0.22976013497563458,-0.7806304384833634,0.8679245283018868,1.0,1.0,7/47,14.80%,MSLN;FOS;ESR1;TGFA;LPAR2;AKT1;HBEGF
prerank,Elsevier_Pathway_Collection__Cathepsins Role in Periodontitis,-0.2734157408515725,-0.7804873230072131,0.8636363636363636,1.0,1.0,2/15,4.70%,MMP1;CXCR1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.2959362380563932,0.7804739628915587,0.7954545454545454,1.0,1.0,12/31,31.90%,FAM9A;PIWIL1;ZMYND15;SOX30;PTCHD3;RIMBP3;TDRD5;ACRBP;BBS4;SYCP3;NECTIN2;IQCG
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.2849939920159395,0.7803138969609837,0.7440476190476191,1.0,1.0,7/31,19.60%,THEM5;ACSL6;ACSM1;ACSM6;ACLY;THEM4;ACBD6
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.2849939920159395,0.7803138969609837,0.7440476190476191,1.0,1.0,7/31,19.60%,THEM5;ACSL6;ACSM1;ACSM6;ACLY;THEM4;ACBD6
prerank,WikiPathway_2021_Human__Hepatitis C and Hepatocellular Carcinoma WP3646,0.2649578403947411,0.7801339190903163,0.837696335078534,1.0,1.0,9/49,17.70%,LEF1;BIRC5;E2F2;COL4A2;IL6R;PODXL;UCHL1;SMAD3;RRM2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.2556740119678452,0.780086511365693,0.7696335078534031,1.0,1.0,15/62,21.40%,DLX5;NODAL;GDF5;BMP4;AMH;RGMA;GDF15;GDF7;SMAD3;MEGF8;ACVRL1;SCX;ACVR2B;TGFBR3;TGFB2
prerank,TRRUST_Transcription_Factors_2019__STAT3 human,0.22977945968503186,0.7799145512368725,0.8657407407407407,1.0,1.0,23/134,15.45%,CRP;TWIST2;TERT;SAA1;CHI3L1;NOX4;GREB1;NOX5;ROR1;BIRC5;FGF2;TRH;TIMP1;IL11;HSPB1;MUC4;LEP;MMP10;NOX1;NME1;PGF;CCL11;PIM1
prerank,Elsevier_Pathway_Collection__Apoptosis Block in Acute Myeloid Leukemia Cell,0.2916700873023033,0.7794184432513784,0.7708333333333334,1.0,1.0,7/32,18.71%,BIRC5;FLT3LG;SHC1;PDPK1;PIM1;HRAS;BBC3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.27530379941547456,-0.7791201551416702,0.8333333333333334,1.0,1.0,21/21,72.50%,TENM1;AR;CEBPA;DHX36;ICE2;NAB2;BRF2;ZC3H8;ICE1;CHD8;ZNF345;POLR3F;MTOR;ELL;RPTOR;ZNF76;POLR3G;PRDX5;POLR3C;ZNF143;MAF1
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.2940067808785964,0.7790760547977682,0.7845303867403315,1.0,1.0,7/30,24.71%,SRC;CAMK2A;HRAS;MRAS;PPP2R5A;KSR1;MAP2K2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.24565646314039838,0.7790565875992941,0.8341708542713567,1.0,1.0,12/73,13.04%,LEF1;AXIN2;ELL3;MDK;EFNA1;COL1A1;ZNF703;EZH2;LOXL2;FOXC1;RGCC;PDPN
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.260629802253949,-0.7789430582616046,0.8,1.0,1.0,4/29,6.17%,GLRB;GLRA3;CPEB1;CPEB3
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.19825154817787796,-0.7789429446525048,0.8936170212765957,1.0,1.0,15/94,14.92%,CXCL13;NTRK3;NTF3;TBC1D30;SYDE2;GPR65;EPHA1;CCR7;RABGAP1L;USP6;TBC1D3B;GARNL3;RASGRP1;ARHGEF26;TIAM1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.3348555017326246,0.7784093493603476,0.7531645569620253,1.0,1.0,2/15,12.81%,PRKN;IFI27
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.2013709848714763,-0.778265736446162,0.9047619047619048,1.0,1.0,24/79,24.21%,CSF3;PFN2;NTRK3;BMP10;NTF3;STAP1;CCR7;PLEK;NCKAP1L;CRACD;HCK;HCLS1;SYNPO2L;PRKCE;CARMIL1;TENM1;SEMA5A;MYLK3;TEK;SYNPO2;FCHSD2;PROX1;F2RL1;SNX9
prerank,Elsevier_Pathway_Collection__SIRT3 Signaling in Aging,-0.2479608269066761,-0.7782242756595377,0.7808219178082192,1.0,1.0,5/26,15.67%,ACSL1;ACADL;OTC;HMGCS2;ALDH2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.2582953538498496,0.778214758936858,0.7979274611398963,1.0,1.0,5/49,12.90%,OLFM4;MDK;S100A10;IL1RAPL1;CSPG5
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.2740001772639436,0.7782004177753451,0.7934782608695652,1.0,1.0,23/35,53.61%,NUP37;NUP62;TPR;NUP133;NUP155;NUP160;NUP188;NUP205;NUP210;NUP214;NUP107;GNL3;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85;KPNB1
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.24347670807504704,-0.7781470590637373,0.8765432098765432,1.0,1.0,2/32,1.57%,MFSD2A;CLDN4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.3005172218651212,0.7781088336033032,0.7469879518072289,1.0,1.0,13/25,49.08%,PRPF3;SF3B4;TXNL4A;PRPF6;WDR83;SLU7;PRPF8;SF3A3;SF3B3;MPHOSPH10;SNRNP40;DBR1;SF3B1
prerank,MSigDB_Oncogenic_Signatures__MYC UP.V1 DN,0.2292994929272807,0.7777737271009417,0.9029126213592233,1.0,1.0,19/135,12.33%,BANF2;PAK3;UTS2R;PLK1;MEG3;PLK5;CCL20;LINC00173;MTMR11;CLIP2;GALNTL6;RUSC1-AS1;LMTK3;NR6A1;AKR1C3;CDCA8;IRAK2;ASAP3;MEGF6
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.1679986646955355,-0.7776592394787759,1.0,1.0,1.0,44/232,22.41%,ATP10B;EREG;SYT9;OTOF;CD4;SYT1;IL7R;RTP5;FCHO1;TF;STX11;ANK3;TGFA;CD3G;AMPH;CR1;BTC;REPS1;MX2;SUN3;CLN3;HBEGF;SH3KBP1;CHP1;CFTR;RTP3;CHRM2;REPS2;ITSN1;CHMP2B;WNT5A;VTI1B;CD3D;ANK2;LPCAT3;CCDC88A;TMEM170A;TTPA;APOB;ADRB2;CHMP4A;MYADM;SH3GL2;LDLR
prerank,Elsevier_Pathway_Collection__Endometrial Cancer,0.23590027123256835,0.7773856199177492,0.8669724770642202,1.0,1.0,8/105,9.24%,IGF2;VEGFD;LEF1;CDKN2A;SRC;FGF2;ACTL6B;EZH2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.26196168005343573,0.7773750309179817,0.828125,1.0,1.0,13/54,21.80%,FGF2;ATP2B4;HSPB1;PRKD1;RGCC;PDGFB;PDPK1;PPARG;PRKCA;ANGPT2;ACVRL1;FGF18;PLCG1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.24650851179101888,-0.7772588153574974,0.8309859154929577,1.0,1.0,6/34,13.48%,GRHL2;PKIB;PRKCQ;KLF4;GREM1;MAPK15
prerank,Elsevier_Pathway_Collection__Proteins Involved in Male Infertility,0.22523413109255966,0.7770519962872201,0.8783783783783784,1.0,1.0,38/153,23.56%,PAEP;DLX5;E2F1;PRND;DMC1;SPAG6;MSH5;CALR3;PIWIL1;CDKN2C;OAZ3;DNMT3A;LEP;SBF1;CLDN7;HSPA2;CEP131;TSSK6;TAZ;CATSPER1;MOV10L1;DHH;MSH2;PYGO2;MTHFR;CATSPER2;LRP8;CADM1;RPLP1;HDAC1;LIPE;PCSK9;TXN;FANCD2;ESR2;CDKN2D;DNMT1;FSTL3
prerank,Reactome_2022__Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,-0.26778509048063637,-0.7770071014518531,0.8,1.0,1.0,5/19,13.58%,LRAT;RDH16;HSD17B6;CYP4V2;TTR
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.32102674397206465,0.7768676612161769,0.7631578947368421,1.0,1.0,3/18,8.39%,TEX19;TDRD9;PIWIL1
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,0.3035675077321631,0.7765739295256867,0.7529411764705882,1.0,1.0,11/23,42.13%,CCT3;BBS5;BBS2;BBS4;SMOX;CCT8;CCT4;CCT2;MCHR1;SSTR3;CCT5
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.29805252845360053,0.776227950185901,0.7712765957446809,1.0,1.0,5/29,17.00%,CDH13;PARVB;ABLIM2;SPEF1;ABLIM1
prerank,WikiPathway_2021_Human__Photodynamic therapy-induced AP-1 survival signaling. WP3611,-0.22151569962628595,-0.7761817714217963,0.8524590163934426,1.0,1.0,16/49,23.65%,IFNG;TNF;FOS;FASLG;TNFSF10;PDGFRA;IL6;HBEGF;BCL2L11;BCL2;MAPK13;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4
prerank,MSigDB_Oncogenic_Signatures__ESC J1 UP EARLY.V1 DN,0.22823047694879411,0.7760290691532133,0.9144144144144144,1.0,1.0,26/154,20.14%,SFN;VAX2;MAPT;TCF15;RAMP1;KLF1;TGM3;FGF17;BMP4;AMH;TMEM98;GPATCH4;NUDT11;KLF13;INHBB;RELB;RRP12;ZNF423;MRAS;GBP2;RNASEL;GAP43;BCL3;TRAIP;ETV4;FGF18
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.2758621167238657,0.7758055891809366,0.8212290502793296,1.0,1.0,9/40,18.02%,EPHB2;SYNDIG1;DLG5;BDNF;IL1RAPL1;RASSF10;RGS14;MME;NLGN2
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.33619033447865254,0.7756870363192573,0.757396449704142,1.0,1.0,3/15,13.63%,PLA2G2A;PLA2G4C;PLA2G4F
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.20158884072198646,-0.775628855515354,0.925,1.0,1.0,15/107,15.00%,IGLL5;CD79A;PRKCB;DAPP1;FYN;BLK;BTK;CARD11;REL;PIK3R1;RASGRP1;SYK;PLCG2;SH3KBP1;VAV1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.22650757441383484,-0.7755830463066652,0.8787878787878788,1.0,1.0,1/43,0.57%,GCK
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.2966937585560648,-0.7755188646805189,0.7628865979381443,1.0,1.0,2/15,8.03%,GBA3;ASAH2
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.26586661486973595,0.775509398686055,0.8192090395480226,1.0,1.0,6/46,14.99%,CERS1;NEK2;SRC;AURKB;PIF1;NVL
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.26628329278652413,0.7753418345781169,0.8,1.0,1.0,17/55,34.38%,FGF20;FGF13;FGF17;FGF23;HRAS;POLR2L;TRIM24;FGF18;PLCG1;POLR2K;POLR2G;FGFR4;POLR2H;PIGU;POLR2I;POLR2J;FGF1
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,0.24999411030864221,0.7750027423977723,0.83,1.0,1.0,45/86,47.42%,MAPK11;PSMD4;HSPB1;EXOSC4;PSMB4;MAPKAPK2;PRKCA;EXOSC5;PSMB3;PABPC1;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;HSPA8;PSMD8;EXOSC2;PSME2;XPO1;PSMD13;PSMB7;PSMA7;EXOSC1;EXOSC7;PSME3;EXOSC9;NUP214;PSMB2;PSMA6;UBC;PSMD9;YWHAZ;PSMC2;RPS27A;PSME1;PSMB1;PSMD3;ANP32A
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,-0.23850111164834534,-0.7749205350861257,0.8192771084337349,1.0,1.0,8/28,17.97%,ITGB8;BMP10;BMP7;ITGB6;MFAP4;ITGB3;LTBP4;VTN
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.24877693602829942,0.7748572640068981,0.8072916666666666,1.0,1.0,37/71,46.08%,ELL3;POLR2L;INTS8;POLR2K;INTS3;POLR2G;NABP2;ZNF143;INTS7;TAF6;INTS1;POLR2H;SNAPC2;RPRD2;INTS11;POLR2I;POLR2J;POU2F1;INTS9;TAF8;INTS5;TAF9;POLR2A;ELL;POLR2B;GTF2F1;PHAX;POLR2F;CDK9;TAF5;SRRT;INTS4;CCNT2;SP1;SNAPC4;GTF2E1;RPRD1B
prerank,Elsevier_Pathway_Collection__HTR5 -> TNF Production,0.30453048362334884,0.7736098771965066,0.7885714285714286,1.0,1.0,3/19,14.95%,RASGRF1;MAPKAPK2;PDPK1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.28398204566633745,0.7735944540914494,0.8372093023255814,1.0,1.0,6/34,13.30%,PIK3R2;FGF2;PDGFRB;PRKD1;PDGFB;FLT1
prerank,TRRUST_Transcription_Factors_2019__EZH2 human,-0.23524463628719733,-0.773425824454839,0.8032786885245902,1.0,1.0,7/38,10.17%,SATB1;SFRP1;CDH1;CPEB1;RUNX3;AXL;ADAMTS1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.24592759919393975,-0.7734007597424787,0.7976190476190477,1.0,1.0,7/29,13.84%,MEGF10;NEBL;HEY2;TTN;SLC8A1;MYH11;IGF1
prerank,Elsevier_Pathway_Collection__EctodysplasinR -> AP-1 Signaling,-0.2773930019518102,-0.7733057474111571,0.8160919540229885,1.0,1.0,3/19,7.46%,EDAR;FOS;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.19280975351208007,-0.7732753444582483,0.9777777777777777,1.0,1.0,21/94,19.31%,RAB25;FGF10;IFNG;ANGPT4;PIK3CD;ANXA3;GPLD1;GATA3;ATOH8;AKT1;SOX9;RTN4;PLCG2;PRKCE;BMPR2;MAPRE2;ITGB3;THBS1;ETS1;WNT5A;INSL3
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,0.2231955905177139,0.7732304087342781,0.9017857142857143,1.0,1.0,81/199,39.37%,E2F1;H1-5;TP73;MAPT;CDKN2A;H1-2;PSMD4;STK26;UNC5A;H1-4;DAPK2;PKP1;BCAP31;LMNA;PSMB4;GSDMD;BMF;MAGED1;BBC3;PLEC;CLSPN;FADD;FNTA;H1-0;ELANE;MED12;NDUFA2;GSN;DYNLL1;HMGB2;PTK2;CTNNB1;PSMB3;LMNB1;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;FASN;DAPK3;CDC37;CHMP2A;TP63;DIABLO;PSMC4;PSMC3;SPTAN1;CASP9;SDCBP;SEPTIN4;RRM1;FLOT1;OGT;TNFRSF10A;REXO2;APIP;MLKL;BAX;PSMC5;TRADD;DNM1L;SEM1;FLOT2;PSMB6;YWHAH;TJP1;PSMD8;TICAM1;TJP2;MAPK3;PSME2;BID;PSMD13;PSMB7;PSMA7;VIM;HSP90AA1;DCC;PSME3
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,0.25614149656616303,0.773138886269449,0.798941798941799,1.0,1.0,38/64,47.47%,PSMD4;IKBKG;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;MALT1;PSME2;PSMD13;NFKBIE;PSMB7;PSMA7;PSME3;FBXW11;PSMB2;PSMA6;NFKBIB;UBC;PSMD9;BTRC;PSMC2;RPS27A;PSME1;PSMB1;PSMD3;RELA
prerank,Elsevier_Pathway_Collection__Dexamethasone Induced Osteoporosis,0.3214303834598931,0.7731112856959378,0.7664670658682635,1.0,1.0,1/19,0.45%,DKK1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.18742772613927797,-0.7729152775902873,0.9411764705882353,1.0,1.0,17/125,13.84%,GCK;EREG;IFNL1;IFNG;IL1B;HGF;PLD1;NLRP12;CPEB3;CCL2;IL6;KLF4;IL33;TLR4;TLR2;AKT1;IGF1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.29185749579624776,-0.7729048547053397,0.7608695652173914,1.0,1.0,6/15,28.81%,ITK;NTRK1;BMX;IGF1R;TXK;EGFR
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.28335144753797814,0.7728650208646088,0.8103448275862069,1.0,1.0,17/34,40.31%,PDGFRB;PPP1R1B;TSC1;HSP90AB1;PPP6R2;TIPRL;NUAK1;STYXL1;PPP1R2;PPP6R1;CSNK2B;BOD1;GSK3B;FKBP1A;HTT;CALM3;MTOR
prerank,Elsevier_Pathway_Collection__Telomer Attrition Triggers Genomic Instability,0.272457786485998,0.7726468522528734,0.8268156424581006,1.0,1.0,24/39,48.68%,TERT;RTEL1;USF1;GLI1;MYCN;MYC;CTNNB1;CDKN1A;DKC1;PINX1;ABL1;TERF1;HNRNPA1;TPP1;XRCC6;ATR;TERF2;PAX8;WRN;NBN;SP1;MRE11;RAD50;TNKS
prerank,Elsevier_Pathway_Collection__TNFRSF6 -> HSF1 Signaling,-0.2927845028837288,-0.7725975798338482,0.7023809523809523,1.0,1.0,2/15,7.46%,FASLG;MAP2K1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.2522369174776476,0.7725291202909902,0.8412698412698413,1.0,1.0,14/60,20.44%,CYP17A1;CYP21A2;CYP7A1;SQLE;AMACR;AKR1C3;HSD17B1;HMGCR;TM7SF2;LBR;PMVK;CH25H;FDFT1;HSD11B2
prerank,Elsevier_Pathway_Collection__mTOR Signaling Activation by Fatty Acids and Glucose,-0.21363651635593484,-0.7724363225428935,0.8641975308641975,1.0,1.0,6/48,13.06%,GCK;GPD1;PLD1;ALDOB;RAC2;AKT1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.23766002644633494,0.7721226255269963,0.8793969849246231,1.0,1.0,12/92,13.04%,SLC7A11;SLCO1C1;SLC7A14;SLC7A6;SLC13A3;SLC7A10;SLC26A6;SLC5A6;SLC1A4;SLC10A6;SLC7A1;PDPN
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.25811935201102143,0.7718743851701214,0.827027027027027,1.0,1.0,24/47,40.78%,PRKN;HSPB1;HSPA2;HSF1;HSP90AB1;DDIT3;HSPA4;HSPA5;HSPE1;PACRG;DAB2IP;DNAJB2;DERL1;HSPA14;BAX;BAG3;HSPA8;HSPD1;DNAJB5;SERPINH1;DAXX;HSP90AA1;HSPA1L;HSPH1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.28575347746775837,-0.7717525719709477,0.7849462365591398,1.0,1.0,6/18,28.33%,RGPD2;RGPD3;RGPD1;KPNA1;RGPD4;KPNA5
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.2578378663935003,-0.7717512418885728,0.8837209302325582,1.0,1.0,7/27,17.96%,INHBA;HSPA1B;NCKAP1L;ACVR2A;HSPA1A;GATA1;ETS1
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.21903888582741746,-0.771736173947162,0.8620689655172413,1.0,1.0,5/57,9.30%,TUSC3;MOGAT2;PARP6;MOGAT1;PARP8
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.2650062285261361,-0.7717069798119353,0.7906976744186046,1.0,1.0,4/21,18.52%,GPM6B;LIMCH1;EFNA5;EPHA3
prerank,Elsevier_Pathway_Collection__VEGF Signaling,0.24527506597766388,0.7716988659617687,0.8205128205128205,1.0,1.0,8/58,14.95%,VEGFD;SRC;SPHK1;HSPB1;FLT1;MAPKAPK2;SHC1;PDPK1
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.2051661875493303,-0.7715854710607885,0.9583333333333334,1.0,1.0,9/82,9.78%,KLF5;EGR2;TNF;PCK1;PPARGC1A;WNT10B;PLIN1;WNT1;KLF4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.2912606763636001,0.7715834790587071,0.75,1.0,1.0,5/26,16.08%,FGF13;ATP2A1;CACNA1C;GJA5;STC1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.24137170486525966,0.7712801823371475,0.8391959798994975,1.0,1.0,7/85,9.21%,TRIM71;FGF20;TDGF1;FGF17;FGF2;FGF23;SHCBP1
prerank,Elsevier_Pathway_Collection__Insulin Influence on Glycogenesis,-0.24922378383073446,-0.7712604248648083,0.7647058823529411,1.0,1.0,5/23,14.58%,GYS2;MAP2K1;UGP2;AKT1;SLC2A2
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.22537057285728457,-0.7712498210743891,0.8939393939393939,1.0,1.0,1/43,0.57%,GCK
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.22619628949173962,0.7712376287816551,0.9181818181818182,1.0,1.0,35/165,25.78%,MAPK12;TDGF1;GALNT13;PLK1;MGAT5B;CAMK2A;TTK;CDC7;MAST1;NAA10;CDK1;MAST3;PRKD1;AURKA;PDGFB;MAPKAPK2;HIPK4;PDPK1;STK32C;PRKCA;CAMK1D;ROCK2;PKD1;PNCK;CDK5R1;CLSPN;DYRK3;PARP1;PRKDC;STK32B;POGLUT1;CDK5;PKN3;NTMT1;MAST2
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.294880483933173,0.7711089177051207,0.7964071856287425,1.0,1.0,10/25,34.62%,ANKRD13B;NEU3;DLG4;WDR54;PCSK9;ABCA2;ATXN2;ITGAV;SDCBP;LRPAP1
prerank,WikiPathway_2021_Human__Phosphoinositides metabolism WP4971,0.256982291415141,0.7710636373600801,0.8232323232323232,1.0,1.0,9/49,17.69%,PLCH2;PLCH1;MTMR11;PIP5K1B;MTMR8;SBF1;PLCD3;MTMR3;PLCD4
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,0.28569682153998205,0.7709952077930691,0.7634408602150538,1.0,1.0,8/32,18.50%,GPRIN1;SRC;RNASE1;HRAS;ROCK2;VPS72;ARHGEF28;LIMK2
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.27237472631972826,0.7709564316495349,0.7745664739884393,1.0,1.0,16/33,40.76%,PDGFRB;CDCA2;PPP1R16B;GBA;PPP2R5A;HSP90AB1;PIN1;PPIA;TGFB1;PTBP1;CALM3;SYMPK;MTOR;CDH5;PPP1R7;CAMTA1
prerank,Elsevier_Pathway_Collection__Genes with Mutations Associated with Asthma,-0.2837272223364259,-0.7708503855778867,0.7816091954022989,1.0,1.0,8/17,29.18%,TNF;SIGLEC8;ADRB2;MS4A2;HLA-DRB1;CD14;HLA-DQB1;FCER2
prerank,Elsevier_Pathway_Collection__Frizzled Receptors -> ARRB1/ARRB2 non-Canonical Signaling,0.32045242028149756,0.7703087679127744,0.7560975609756098,1.0,1.0,6/17,34.98%,DVL2;ROCK2;DVL1;ARRB1;LRP5;MAP3K11
prerank,Elsevier_Pathway_Collection__RET1 Mutation in Hyperparathyroidism,0.2943175364218835,0.7701644788160104,0.7758620689655172,1.0,1.0,7/21,26.07%,RASGRF1;SHC1;PDPK1;PLCG1;MAP2K2;PTK2;MYC
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.21811819797468174,-0.7699317759917715,0.8888888888888888,1.0,1.0,10/57,16.80%,IGLL5;BTK;CD247;NCKAP1L;MYO10;WASF3;SYK;WIPF1;VAV1;VAV3
prerank,TRRUST_Transcription_Factors_2019__ARNT human,-0.26551154959486856,-0.7698053854523474,0.8311688311688312,1.0,1.0,3/20,6.58%,MFSD2A;FOS;ESR1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.22814126987738215,-0.7697401802802771,0.8426966292134831,1.0,1.0,1/33,0.64%,TULP2
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,0.29430817077812516,0.7695158739646467,0.8,1.0,1.0,7/26,26.07%,PIK3R2;SRC;SHC1;PLCG1;HDAC1;MYCN;MYC
prerank,Elsevier_Pathway_Collection__Eicosanoids in Myeloid Cell Activation,-0.2518256633263352,-0.7695107256356927,0.8202247191011236,1.0,1.0,5/23,15.22%,MAP2K1;CYSLTR2;PTGER4;AKT1;PRKCE
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.2751393962699481,-0.7694212456975776,0.8023255813953488,1.0,1.0,20/20,72.51%,PPIF;PPID;FKBP1B;PPIC;FKBP4;PPIG;PPIE;PPIL6;NKTR;CWC27;PPIL1;PPWD1;PPIL2;FKBP1A;PPIB;PPIH;PPIA;PIN1;FKBP5;PPIL3
prerank,Reactome_2022__TNF Signaling R-HSA-75893,-0.21351810762346224,-0.7692334651865566,0.9154929577464789,1.0,1.0,2/44,3.50%,SMPD3;TNF
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3122745055653573,0.7689671014574366,0.7888198757763976,1.0,1.0,6/19,24.82%,CRB1;SCRIB;FOXJ1;CRB2;PARD3B;OOEP
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.2999324938606961,0.7689566305789086,0.7317073170731707,1.0,1.0,12/23,45.24%,RHOBTB1;DBN1;ROCK2;RNF20;RBMX;VIM;CCT2;CCT7;GPS1;CPSF7;RBM15;COPS4
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.30867131276323884,0.7689068930077027,0.7730061349693251,1.0,1.0,3/19,10.36%,NEUROD1;POU4F1;FOXC1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.23108255815821876,-0.7687523545690108,0.84375,1.0,1.0,3/36,3.28%,TMPRSS4;FCN3;CD4
prerank,WikiPathway_2021_Human__EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.23599983537039956,0.7686669073957917,0.8490566037735849,1.0,1.0,15/83,17.35%,PIK3R2;SHC3;NRG2;SRC;FGF2;PDGFRB;IL6R;PDGFB;PDGFA;SHC1;PDPK1;PRKCA;HRAS;MRAS;EGF
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.28881665472024676,0.7686067352656804,0.7941176470588235,1.0,1.0,12/29,31.84%,ECSCR;PRKN;GBA;CCDC22;PTK2;SMURF1;NUPR1;DDRGK1;TREM2;DAB2IP;PSMC3;FMR1
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,0.2862934561490685,0.7685127160536633,0.8395061728395061,1.0,1.0,9/27,32.04%,VPS28;MVB12B;NEDD4L;VPS37D;UBA52;VPS4A;PPIA;CHMP2A;SGIP1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.2500730162755408,-0.7684395926368977,0.7926829268292683,1.0,1.0,4/26,13.03%,TACSTD2;TMEFF2;PHLDB2;PIK3R1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.3064159734480925,0.768011677101046,0.8208092485549133,1.0,1.0,4/18,12.24%,ACSBG2;ACSL6;ACSL4;ELOVL3
prerank,WikiPathway_2021_Human__Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.2494941670682966,0.7679340953768605,0.845,1.0,1.0,9/65,15.74%,CGA;E2F1;PIK3R2;SRC;CCNE1;KCNIP3;SCRIB;PDPK1;HRAS
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.22682035194625602,0.7677885331314984,0.9220183486238532,1.0,1.0,89/200,45.65%,TRIM71;BRSK2;KIF14;PRKN;PSMD4;KCTD17;NR1D1;SPSB2;IFI27;UCHL1;PSMB4;ANKRD9;NEDD4L;NEDD4;TRIM72;SHARPIN;RNF187;UBE2A;ARNTL;TRIM3;COP1;PSMD1;AGAP3;CTNNB1;PSMB3;RNF216;HECW1;ZFAND2B;PSMD14;DDIT3;CUL4B;KCTD13;FBXL22;UBE4B;SMURF1;SPSB1;PSMB5;PSMD2;PSMA1;RMND5B;PSMD10;ARRB1;PSMC4;PSMC3;FBXW5;DERL1;SKP2;SMURF2;NSFL1C;TBL1X;PSMC5;RNF126;PSMB6;PSMD8;PSME2;FBXO44;VCP;DDB1;PSMD13;PSMB7;PSMA7;FBXL19;BAG6;PSME3;HUWE1;FAF1;KLHL22;FBXW11;ZFAND2A;PSMB2;HECW2;RBX1;PSMA6;KCTD10;FBXO45;STUB1;PSMD9;WWP2;UBXN1;KCTD2;ENC1;GID8;BTRC;ERLEC1;PSMC2;CDC34;PLAA;KLHL42;GSK3A
prerank,MSigDB_Oncogenic_Signatures__ESC J1 UP EARLY.V1 UP,0.23329769979140602,0.767725469635032,0.8828828828828829,1.0,1.0,26/139,17.13%,ZIC2;LHX3;EDARADD;NEK2;TRIB2;GPRIN1;A4GALT;TLE6;PDGFRB;LOXL2;NECAB3;NANOS1;FGF14;SIL1;TFF3;CPT1B;NR1D1;NDRG1;CD68;PDPN;TYMP;TMED3;STC1;HES6;AKR1C2;THRA
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.25242492951845436,0.7673973867385427,0.8894736842105263,1.0,1.0,14/84,18.12%,NKD1;GPC3;PRKN;DTL;OAZ3;VPS28;C4BPB;PACSIN3;APC2;AMER1;NEDD4L;ADAM9;NEDD4;BARD1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Bronchiectasis,0.3235747508435105,0.7672278830857315,0.7764705882352941,1.0,1.0,2/17,7.83%,CALCA;ELN
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.2777049160727268,0.7670540949911567,0.7740112994350282,1.0,1.0,6/34,15.90%,RTN2;ERFE;CLTCL1;PEA15;LEP;C1QTNF12
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.30820229606761596,0.7669519635409535,0.7865853658536586,1.0,1.0,5/22,19.72%,PRKAA2;PFKFB4;PDGFB;EGF;PFKFB2
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.3235541999011495,0.766766519716135,0.7771084337349398,1.0,1.0,2/17,7.73%,APLN;ATP1A2
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.199321920925855,-0.7666535070917613,0.9130434782608695,1.0,1.0,15/92,13.65%,PCYT1B;GPD1;LCAT;PLD1;PEMT;PHOSPHO1;PLA2G2D;PLPP4;AGPAT2;ETNK2;PLA2G4A;DGKE;PLAAT3;PLD4;PNPLA7
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.2299605747320894,0.7662426193282296,0.9227272727272727,1.0,1.0,30/143,21.57%,LEF1;PTPN5;CHI3L1;POU4F1;HDAC4;SRC;SPHK1;IRAK1;PTPN14;FOXH1;TIMP1;IL1RAPL1;IRAK2;IL6R;ITIH4;TIMP4;MAPKAPK2;RELB;PRKCA;SMAD3;ADAM9;MME;IFITM3;IFITM2;ADAR;CXCL16;HAX1;BST2;NFAT5;ISG15
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.28646796035807887,0.7662127225013317,0.7844311377245509,1.0,1.0,8/26,28.44%,PRKN;DNM3;MTFP1;TMCC1;SEC16B;WASHC5;PEX11B;FIS1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.23362504681401144,-0.7659320335013049,0.9210526315789473,1.0,1.0,11/35,20.42%,TNF;FOXO1;WNT10B;IL6;WNT1;FERMT2;GATA3;ZADH2;ENPP1;WNT5A;BBS12
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3180002291824316,0.7657818144541754,0.7916666666666666,1.0,1.0,1/15,1.34%,SULT4A1
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,-0.183549432239969,-0.7655540456725712,0.9791666666666666,1.0,1.0,12/92,15.00%,ACE2;ZBP1;IGLL5;CD79A;ATP1A3;FXYD1;DPEP3;BTK;SYK;PLCG2;SH3KBP1;VAV1
prerank,WikiPathway_2021_Human__DNA damage response (only ATM dependent) WP710,0.23155902133570228,0.7652350865224103,0.8468468468468469,1.0,1.0,18/109,18.71%,LEF1;PIK3R2;TP73;WNT4;PDK1;CDKN2A;TCF7;BIK;NFKB2;PLAU;SHC1;DVL2;WNT2B;WNT6;HRAS;SMAD3;BCL6;BBC3
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.2979073337884305,0.7650839195002085,0.7944444444444444,1.0,1.0,6/26,20.75%,CDH13;PARVB;ABLIM2;SPEF1;ABLIM1;SRGAP2
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.2776505123826598,-0.7648129831119203,0.7857142857142857,1.0,1.0,6/19,23.80%,TLR3;TLR8;TLR4;STAT1;IFIH1;DDX58
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.28117875456201696,0.7647508285427955,0.8,1.0,1.0,8/30,17.93%,ACSBG2;ACSL6;ACSL4;ELOVL3;ACLY;ACACA;SCD;ACSL5
prerank,Elsevier_Pathway_Collection__beta-Cell Recovery in Diabetes Mellitus,0.3008212442752189,0.7646513317972963,0.8164556962025317,1.0,1.0,6/22,15.54%,GLP1R;ABCC8;NOX1;DPP4;PPARG;KCNJ11
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.28981965973841517,0.7645393205255174,0.8245614035087719,1.0,1.0,6/30,22.39%,DPM3;GPAA1;PGAP4;PIGZ;PIGC;PIGM
prerank,WikiPathway_2021_Human__IL-6 signaling pathway WP364,0.2653277766846173,0.764440529623527,0.8563829787234043,1.0,1.0,5/43,14.64%,PIK3R2;CRP;TIMP1;IL6R;SHC1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.2172352666696016,0.7644128629503485,0.9344978165938864,1.0,1.0,57/218,34.06%,AVIL;CCNO;TEKT5;RHO;UNC119B;CILK1;CATIP;FHDC1;DNAAF1;BBS5;CEP131;IFT81;FOXJ1;BBS2;ROPN1B;PKD1;ABLIM1;CEP250;KIF24;EHD2;CCDC28B;TMEM250;DNAH5;FNBP1L;FAM161A;MARK4;ATP6V0D1;B9D2;B9D1;GSN;OCRL;TEKT4;PLK4;DYNLL1;PTPN23;ARMC9;RILPL1;CPLANE2;ASAP1;BBS4;FBF1;KIFAP3;EXOC4;IQCG;EXOC3;CEP290;CFAP70;HYLS1;TSGA10IP;SSX2IP;NUDCD3;CFAP43;CFAP126;CEP41;TTLL3;CEP89;KIF3B
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.3130251559308001,0.7643844393251202,0.8109756097560976,1.0,1.0,1/20,1.00%,MRAP2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.25446153846153846,-0.7643366248996886,0.8352941176470589,1.0,1.0,25/25,74.58%,PPIF;P3H2;PPID;FKBP1B;PPIC;FKBP4;PPIG;PPIE;FKBP7;PPIL6;OGFOD1;NKTR;CWC27;PPIL1;PPWD1;PPIL2;FKBP10;FKBP1A;PPIB;PPIH;PPIA;PIN1;FKBP5;PPIL3;NTMT1
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.3247175149086674,0.764287214412647,0.7948717948717948,1.0,1.0,3/15,9.62%,AVPR2;ADRA1D;OXTR
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.24786433226700935,0.76427795870784,0.8461538461538461,1.0,1.0,16/79,23.21%,GNG4;TRPC6;ATP2B4;GNG3;NANOS1;ATP2A1;PDE10A;GNB5;GNG8;P2RX2;SLC8A3;GNG10;LRP8;PECAM1;PPP2R5A;ATP2B3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.2673214479811076,0.7642586889026749,0.8341968911917098,1.0,1.0,8/47,22.84%,STEAP2;STXBP6;CCDC93;RAB34;BBS2;VAMP5;LLGL1;CCDC22
prerank,Elsevier_Pathway_Collection__Airway Smooth Muscle Cell Contraction,0.2651671261551015,0.7641862130861286,0.8033707865168539,1.0,1.0,5/40,8.78%,RASGRF1;NOX4;SRC;CAMK2A;ADORA1
prerank,Elsevier_Pathway_Collection__CCL2 Role in CGRP Expression and Release,0.30535823349951435,0.7639786832649854,0.8116883116883117,1.0,1.0,6/20,20.62%,CALCA;PRKD1;SNAP25;SNAPIN;STXBP1;STX1A
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.2590421220045324,-0.7639370439896103,0.7934782608695652,1.0,1.0,9/21,24.17%,LIFR;APOA1;KLF4;WNT5A;ELF1;IFIH1;SH2B3;DDX58;CD24
prerank,WikiPathway_2021_Human__Integrated breast cancer pathway WP1984,0.21986020237854198,0.7637788362315495,0.9276018099547512,1.0,1.0,41/151,32.27%,E2F1;PIK3R2;MYT1;RASGEF1A;RHO;PLK1;AURKA;CERK;ODC1;GDI1;CHEK1;HMGCR;CDC25A;MSH2;BARD1;RAD54L;TSC1;FADD;MAP3K7CL;SMARCA4;HDAC1;PIAS1;RAD51;TSC2;ITPKC;BLM;IMPA1;TPR;USP21;MYC;CTNNB1;CHEK2;MSH6;RHEB;HIPK2;RRAS;CSNK1D;JAKMIP1;IRS1;CASP9;CDK4
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.2411923076923077,-0.7637384737125441,0.8045977011494253,1.0,1.0,25/25,75.91%,HEXIM1;EAF2;BRD4;LARP7;EAF1;EAPP;CDK12;ZMYND11;NELFCD;RNF168;WDR43;CDK13;CDC73;LEO1;RNF8;SUPT16H;SUPT6H;ELL;NELFB;HNRNPU;NELFA;TCERG1;RECQL5;LDB1;NELFE
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.21060808910927176,-0.7637262955407312,0.8688524590163934,1.0,1.0,4/61,5.74%,RIPK3;ZBP1;AIM2;TLR3
prerank,Reactome_2022__Eicosanoid Ligand-Binding Receptors R-HSA-391903,0.31435203691316277,0.7634806679995496,0.7738095238095238,1.0,1.0,3/15,12.85%,PTGER1;PTGER3;PTGFR
prerank,Elsevier_Pathway_Collection__Estrogens/ESR1 non-Genomic Signaling,-0.2340078762135802,-0.7633879603988201,0.8604651162790697,1.0,1.0,9/31,23.65%,FOS;ESR1;MAP2K1;AKT1;IGF1;BCL2;JUN;LDLR;IGF1R
prerank,Elsevier_Pathway_Collection__OipA Signaling in Helicobacter Pylori Infection,-0.2371734096086334,-0.7628768828066074,0.8701298701298701,1.0,1.0,9/32,23.65%,FOS;CDH1;MAP2K1;CXCL8;AKT1;MAPK10;JUN;STAT1;MAP2K4
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,0.2559677332875706,0.762837252077386,0.8272251308900523,1.0,1.0,2/69,0.88%,DLX5;DLX6
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.22461229603389332,-0.762647184518844,0.8656716417910447,1.0,1.0,12/46,17.03%,CHRDL1;BMPER;NOG;SPART;GREM2;WNT1;GREM1;SORL1;SMAD9;BMPR2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.2789822499248033,0.7623591899447962,0.80625,1.0,1.0,6/32,12.45%,TNNI3;EGFL7;PDGFRB;RASIP1;SOX18;RAMP2
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,0.2645758536277156,0.762209783500227,0.8547486033519553,1.0,1.0,25/49,43.24%,RHO;UNC119B;CCT3;BBS5;BBS2;PKD1;NUDT19;ASAP1;BBS4;SMOX;EXOC4;EXOC3;CCT8;RAB11FIP3;CCT4;PTGES2;ARL3;INPP5E;CCT2;MCHR1;EXOC8;SSTR3;CCT5;PRKD2;PDE6D
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.2843100865179335,0.7621429450076899,0.7732558139534884,1.0,1.0,12/26,45.66%,ELL3;THOC5;LDB1;THOC1;DDX39B;HTATSF1;SUPT5H;ELL;ALYREF;SUPT16H;CCNT2;TCEA2
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.3116230445644324,0.7617169326155226,0.7960526315789473,1.0,1.0,12/17,50.95%,PCGF1;UBE2A;CUL4B;BCOR;DDB2;SKP1;DDB1;KDM2B;RING1;RNF8;DTX3L;TRIM37
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.2931778994749162,0.7614554764916621,0.7964071856287425,1.0,1.0,6/24,17.06%,FXYD7;ATP2B4;SCN4B;FXYD2;NEDD4L;FGF12
prerank,Elsevier_Pathway_Collection__Cochlear Hair Cell Stereocilia Proteins Mutations (Age-Related),-0.27316405993307635,-0.7614258496019336,0.8227848101265823,1.0,1.0,4/16,13.84%,PTPRQ;MYO3A;USH2A;ADGRV1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.3013754955235176,-0.7614050401529799,0.7865168539325843,1.0,1.0,6/15,25.46%,PPARGC1A;SPHK2;AK4;PID1;TMSB4X;PINK1
prerank,Elsevier_Pathway_Collection__Goblet-Cell Exocytosis in Asthma,0.3233191316663178,0.7612202601418169,0.8037974683544303,1.0,1.0,7/18,25.99%,SYT2;SHC1;PDPK1;EGF;PLCG1;DNAJC5;PTK2
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.2695026519487718,0.7612061475285125,0.8440860215053764,1.0,1.0,24/36,52.83%,NUP37;NUP62;TPR;NUP133;NUP155;NUP160;NUP188;NUP205;XPO1;NUP210;RAN;NUP214;NUP107;GNL3;AAAS;NUP93;NUP88;SEC13;SEH1L;POM121C;NUP42;NUP153;NUP43;NUP85
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.28926101313681024,0.7610829724811231,0.8089887640449438,1.0,1.0,21/28,51.78%,POLR2L;POLR2K;POLR3K;POLR3H;SNAPC2;GTF3C5;POLR3G;POLR3GL;RO60;GTF3C3;ELL;ZNF345;IVNS1ABP;SNAPC4;ICE1;GTF3C6;CRCP;GTF3C2;ZC3H8;BRF1;GTF3C1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.23785035377975705,-0.7610795284071469,0.9090909090909091,1.0,1.0,3/33,4.33%,MUC1;RET;P2RY12
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.3006564533091879,0.7609836496541035,0.8313253012048193,1.0,1.0,3/20,14.88%,SULT4A1;BPNT2;SLC26A2
prerank,Elsevier_Pathway_Collection__Intraflagellar Transport: Retrograde Transport,0.27607914285902624,0.7608614741167304,0.8103448275862069,1.0,1.0,22/36,49.47%,BBS5;IFT81;BBS2;IFT27;BBS4;KIFAP3;KIF3B;DYNC2LI1;HSPB11;TTC30B;IFT80;IFT140;IFT172;IFT22;WDR35;KIF3A;BBS1;IFT74;TTC26;IFT43;WDR19;TTC21B
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.27224391673101317,0.7606735746532056,0.8156424581005587,1.0,1.0,9/35,17.93%,ACSBG2;ACSL6;ACSL4;ELOVL3;ACLY;ACACA;OLAH;SCD;ACSL5
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.2796190155904985,0.7602983016983985,0.7679558011049724,1.0,1.0,4/31,10.69%,HCN2;AQP8;SLC26A6;HCN3
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.23533910825430873,-0.7601384998162387,0.9178082191780822,1.0,1.0,15/34,27.44%,AKR1D1;CYP39A1;CYP8B1;AKR1C4;PTGIS;SLC27A5;NR1H4;OSBPL6;ACOX2;SLC27A2;NCOA1;OSBPL9;OSBPL7;OSBP;OSBPL1A
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.28393657830216973,0.7598786477396744,0.7784090909090909,1.0,1.0,3/27,10.88%,IRAK1;IKBKG;IRAK2
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.32468042188333884,0.7597682765094939,0.7857142857142857,1.0,1.0,7/17,24.51%,CACNA1S;GSTM2;HTR1B;TGM2;RAD51;BLM;CASQ2
prerank,Elsevier_Pathway_Collection__Sialophorin -> CTNNB/MYC/TP53 Signaling,0.29073095947138095,0.7597198236148389,0.8095238095238095,1.0,1.0,2/25,4.61%,LEF1;CDKN2A
prerank,Elsevier_Pathway_Collection__GDNF -> HSF1 Signaling,0.2799784296315694,0.75971811490366,0.838150289017341,1.0,1.0,7/29,24.85%,RASGRF1;SRC;SHC1;PDPK1;PLCG1;MAP2K2;HSF1
prerank,Elsevier_Pathway_Collection__EDNRA/B -> Vascular Motility,0.26583752398855165,0.759351176460764,0.7923497267759563,1.0,1.0,3/39,14.29%,RASGRF1;CAMK2A;MAPKAPK2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.23739908097277135,-0.7591495702644367,0.835820895522388,1.0,1.0,7/30,16.22%,P2RY12;RHOH;PLEK;RAC2;NCKAP1L;RHOV;PARVG
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.22435158219206333,-0.7589535132557667,0.8588235294117647,1.0,1.0,1/36,0.08%,CPNE6
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.25758435904468235,0.758945541513098,0.8191489361702128,1.0,1.0,13/58,30.34%,DYNC1I1;PRKN;LGALS8;UFC1;SQSTM1;DYNLL1;WDR81;PJVK;RB1CC1;UBA52;ULK1;PARK7;DDRGK1
prerank,WikiPathway_2021_Human__Nucleotide Excision Repair WP4753,0.25530588153941663,0.7587087704447144,0.8641304347826086,1.0,1.0,30/44,52.72%,RFC4;POLD1;CETN2;CUL4B;PCNA;DDB2;LIG1;DDB1;GTF2H2C;ERCC2;RPA2;XPC;RFC3;POLD3;RBX1;ERCC3;POLD4;XPA;ERCC1;RPA1;RFC1;GTF2H2;POLE2;GTF2H5;POLE4;RFC5;RFC2;POLE;MNAT1;CDK7
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.307714647400021,0.7585356694775334,0.7763157894736842,1.0,1.0,1/20,0.68%,GCG
prerank,TRRUST_Transcription_Factors_2019__NFE2L2 mouse,0.2630073189624374,0.7585244974409985,0.8045977011494253,1.0,1.0,8/45,15.45%,SLC7A11;NQO1;PTGDS;CDKN2C;CD36;BGLAP;SQSTM1;PPARG
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.25656857959764173,0.7583833424999237,0.8655913978494624,1.0,1.0,39/60,50.81%,TARBP1;FBLL1;FTSJ1;NSUN5;METTL3;TRMT61A;NOP2;VIRMA;TFB2M;TRMT112;FBL;MEPCE;THADA;METTL1;TRMT12;METTL6;METTL5;RBM15B;BUD23;FTSJ3;THUMPD3;METTL16;TRMT6;BCDIN3D;TRMT5;GTPBP3;TGS1;RBM15;DIMT1;TRMT13;LCMT2;PCIF1;TRMT10A;METTL2A;TRMT61B;TRMO;THUMPD2;NSUN4;TRMT10C
prerank,Elsevier_Pathway_Collection__Proteins Involved in Myocardial Ischemia,0.214739749604008,0.7580309344829631,0.9243697478991597,1.0,1.0,45/236,20.62%,GCG;REN;APLN;CALCA;SPP1;CRP;TNNI3;CDH13;SAA1;VWF;MDK;NOX4;SLC2A4;HRH3;FGF2;SPHK1;HSPB1;ASIC3;GDF15;LPL;ABCC8;LEP;ADM2;BDKRB2;EPO;ACE;PGF;CMA1;PDPK1;DPP4;ANKRD1;SLC6A2;ADORA2A;HMGCR;ATP5MF;MTHFR;CTSD;EGLN1;HSPG2;MMP9;ADM;PLA2G6;ENTPD1;C1QTNF9;STX1A
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.26521680642467443,-0.7580239643736729,0.7951807228915663,1.0,1.0,9/20,24.11%,EVI2B;NCKAP1L;TLR2;MPIG6B;GATA1;APP;SH2B3;ALAS1;NRROS
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.23680236473453192,-0.7579905638318755,0.8313253012048193,1.0,1.0,4/31,12.28%,TLR3;TNIP3;TICAM2;TLR4
prerank,KEGG_2021_Human__FoxO signaling pathway,0.226953194154455,0.7578533866534043,0.8899082568807339,1.0,1.0,17/123,17.96%,PIK3R2;PRKAA2;MAPK12;FOXO6;SLC2A4;PLK1;MAPK11;CCNB2;RAG1;CCNB1;CDKN2B;PDPK1;GRM1;HRAS;SMAD3;EGF;BCL6
prerank,Elsevier_Pathway_Collection__Proteins Involved in Cataract,0.23610502129449937,0.7577929413703911,0.8636363636363636,1.0,1.0,19/82,21.45%,CTNNA2;BFSP2;ALDH3A1;SRC;FGF2;HSF4;COL4A2;SIL1;BFSP1;IDO1;CRYBB2;MMP9;SPARC;MMP3;SIX5;TGM2;FTL;TGFB2;NFAT5
prerank,KEGG_2021_Human__One carbon pool by folate,0.318039624433667,0.7575415102846464,0.7733333333333333,1.0,1.0,5/19,18.60%,AMT;MTR;TYMS;MTHFD1L;MTHFR
prerank,WikiPathway_2021_Human__Nonalcoholic fatty liver disease WP4396,0.22093919728344977,0.757505586057978,0.9311926605504587,1.0,1.0,62/144,38.43%,PIK3R2;PRKAA2;COX4I2;NDUFA4L2;LEP;IL6R;NDUFA1;LEPR;NDUFS6;NDUFV1;NDUFB9;COX6C;COX7B;NDUFA3;TRAF2;BBC3;UQCRB;NDUFS2;NDUFA9;COX6B1;NDUFB11;NDUFA2;NDUFS7;COX8A;PRKAB2;UQCRQ;MLXIP;CYC1;COX7A1;NDUFA13;DDIT3;UQCRHL;SOCS3;NDUFA11;NDUFA6;UQCR11;NDUFS8;COX4I1;NDUFV2;COX5B;PIK3R3;CYP2E1;NDUFA8;IRS1;NDUFB7;TGFB1;UQCRH;NDUFAB1;NDUFB2;NDUFB10;ADIPOR1;UQCRC1;BAX;MAP3K11;COX7C;UQCR10;MAPK9;NDUFB3;MLXIPL;BID;GSK3B;NDUFS4
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.2298568422238092,0.7574035213250955,0.8808290155440415,1.0,1.0,13/86,21.63%,KCNC1;KCNC2;NOL3;POLQ;BEND3;NACC2;GSDMD;ECT2;KCNC3;TRIM72;TWNK;TMEM120B;RNF135
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.2230029354809754,0.7566371908863874,0.9245283018867925,1.0,1.0,38/123,31.41%,GNG4;MT3;CDKN2A;FGF13;MSX1;TP53TG5;CDKN2C;ADAM15;CCDC85B;PSRC1;SMAD3;ACVRL1;BCL6;TSPYL2;BST2;TGFB2;SMARCA4;APBB1;ESR2;CDKN2D;GJA1;SOX17;CDKL3;KIAA0319;WT1;SH3BP4;HYAL2;NDUFA13;CDKN1A;VGLL4;ULK1;TCHP;RACK1;PRDM11;RTN4R;RBBP7;CYP27B1;FRZB
prerank,WikiPathway_2021_Human__Mitochondrial Gene Expression WP391,-0.28549956658805953,-0.7561050445701865,0.8372093023255814,1.0,1.0,3/19,9.68%,CAMK4;PPARGC1A;MYEF2
prerank,Elsevier_Pathway_Collection__Cell Cycle Dysregulation in Melanoma,0.2653548999312855,0.7560318092274879,0.7979274611398963,1.0,1.0,9/39,24.71%,CDKN2A;CCNE1;CCNA2;CCNE2;CDKN2B;PDPK1;CDK6;PLCG1;MAP2K2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.22312704917127063,0.7559991513338369,0.9162790697674419,1.0,1.0,11/149,9.24%,HMGA2;DKK1;CALCA;PAK3;STOX1;NOX4;CENPE;KIF14;SRC;EFNA1;EZH2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.25295357378195005,0.7559434281882412,0.8333333333333334,1.0,1.0,7/57,12.24%,CERS1;PLPP2;SPTSSB;SPHK1;B3GNT5;PRKD1;ELOVL3
prerank,Elsevier_Pathway_Collection__Apoptosis of Chondrocyte,-0.25257811115284207,-0.7558647596014118,0.8292682926829268,1.0,1.0,6/22,22.85%,TNF;TNFRSF1B;BCL2;MAP2K3;MAP2K6;MAP3K5
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2421291032083411,0.7558254629681602,0.8358974358974359,1.0,1.0,35/85,39.37%,STOX1;PSMD4;EPO;PSMB4;ELOC;CHEK1;HIF1AN;ELOB;EGLN1;ANKRD2;HIF3A;PSMD1;PSMB3;PSMD14;DDIT3;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;MAPK7;PSMC4;PSMC3;GCN1;BAG3;PSMC5;PSMB6;PSMD8;EGLN2;PSME2;PSMD13;PSMB7;PSMA7;LIMD1;PSME3
prerank,Reactome_2022__Hyaluronan Metabolism R-HSA-2142845,0.3344324426040842,0.7557104319246,0.7901234567901234,1.0,1.0,2/15,5.05%,CEMIP;HMMR
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.21068369959674543,-0.7556576504983187,0.9152542372881356,1.0,1.0,11/47,18.12%,PTGS2;NOCT;FNDC5;SFRP1;ID2;ZFP36L1;BMP7;AKT1;CCDC71L;SFRP2;MEDAG
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.278461990596013,0.755649516471695,0.7777777777777778,1.0,1.0,10/28,29.81%,NEDD4;LAMTOR4;GLMP;NAGPA;AP4M1;ATP13A2;SH3BP4;HGS;VPS4A;KPTN
prerank,WikiPathway_2021_Human__Type 2 papillary renal cell carcinoma WP4241,0.2696355931469431,0.7555709688299025,0.8131868131868132,1.0,1.0,19/34,42.89%,PDGFB;ELOC;DVL2;ELOB;EGLN1;PRCC;TGFB2;ARNT2;FH;CDKN1A;SLC2A1;CTSK;TGFB1;EGLN2;TFE3;TGFB3;COL21A1;TFEB;RBX1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.29025709312679304,0.7552469507462996,0.7757575757575758,1.0,1.0,7/28,20.83%,MYF6;BMP4;RASSF10;RGS14;ATP6AP1;MME;TGM2
prerank,WikiPathway_2021_Human__One-carbon metabolism WP241,-0.24214534217168543,-0.7548571535134382,0.872093023255814,1.0,1.0,7/30,12.39%,BHMT;FOLH1B;FTCD;MAT1A;MTHFD1;MTHFS;SHMT1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.23099529187706483,0.7548458834184415,0.8717948717948718,1.0,1.0,15/100,15.45%,MT3;SLCO1C1;SFRP4;PDGFRB;UHRF1;AKR1C3;CDK1;CCNB1;PDGFB;APOA2;SCRIB;ACLY;AKR1C1;ACACA;PPARG
prerank,WikiPathway_2021_Human__Interferon type I signaling pathways WP585,-0.2218253851184568,-0.754811238552985,0.9310344827586207,1.0,1.0,27/54,33.34%,PIK3CD;PTPRC;FYN;REL;LCK;PIK3R1;VAV1;ZAP70;IRS2;MAP2K3;MAP2K6;RAP1A;STAT1;EIF4A1;GAB2;IRF9;EIF4EBP1;STAT3;CRK;STAT2;IFNAR1;STAT4;PDCD4;JAK1;EIF4E;PTPN6;PTPN11
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.2828796205184356,-0.754578699829601,0.7954545454545454,1.0,1.0,4/15,19.60%,AGL;PYGL;PGM2;PGM2L1
prerank,Elsevier_Pathway_Collection__Growth Factor Signaling in Neuroblastoma,0.25887568196537136,0.7544915474780335,0.8716577540106952,1.0,1.0,8/46,18.64%,IGF2;BIRC5;SRC;BDNF;SHC1;PDPK1;EGF;TRAF2
prerank,Elsevier_Pathway_Collection__Endothelial Cell Dysfunction in Arterial Hypertension,-0.2399823538181707,-0.7543317830307469,0.8805970149253731,1.0,1.0,6/32,15.81%,PTGS2;FOS;MAP2K1;PIK3R1;AKT1;KNG1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.197443979591429,-0.7543021433441999,0.9607843137254902,1.0,1.0,10/72,14.30%,IFNG;TNF;ZBP1;LIFR;PTPRC;AGPAT2;AXL;TSLP;SYK;USP18
prerank,Elsevier_Pathway_Collection__T-Cell Acute Lymphoblastic Leukemia,-0.19198443759512435,-0.7540413266042975,1.0,1.0,1.0,21/102,17.08%,FOS;IL7R;ITK;CXCL12;FOXO1;PRKCQ;FYN;NKX3-1;LCP2;BCL2A1;CARD11;GATA3;LCK;LAT;AKT1;RASGRP1;PLCG2;CXCR4;VAV1;ZAP70;BCL2
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.3034841190328605,0.7540367234306812,0.7818181818181819,1.0,1.0,3/21,6.14%,SLC39A4;SLC30A3;SLC30A2
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.3175106859497043,0.7539827302884047,0.7852760736196319,1.0,1.0,8/17,30.17%,NPM2;CDT1;EGF;DNA2;ATAD5;GLI1;PCNA;BRPF3
prerank,TRRUST_Transcription_Factors_2019__SP1 mouse,0.2090265268375066,0.7537338515584603,0.9336283185840708,1.0,1.0,50/241,22.19%,COL2A1;HMGA2;APLP1;ALDH3A1;CEND1;CLDN19;TERT;RHO;LHX4;ITGA6;SLC2A4;NR5A1;BMP4;TESC;SRC;SLC5A2;TFAP2C;ACSL4;CDKN2C;COL1A1;KCNN3;LPL;BFSP1;TYMS;NDRG1;LMNA;POU5F1;BGLAP;COL1A2;COL5A1;CDKN1C;ACACA;PKD1;HMGCR;THRA;SYN2;HMGA1;NES;ADCY4;CDK5R1;MMP9;CDK6;SPARC;LGALS1;CSRP2;MGP;SETDB1;PARP1;CADM1;LIPE
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.22852357593018752,-0.7537226654368072,0.8888888888888888,1.0,1.0,12/46,21.42%,CETP;LCAT;APOA4;APOF;APOA1;TSKU;ANGPTL3;SULT2A1;APOL2;CLN8;APOB;IDH1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.30691757032635886,0.7536010471909552,0.8322981366459627,1.0,1.0,3/15,15.58%,MSX1;ZNF385A;ANKRD1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.27254055119603454,0.7531602051786603,0.8294117647058824,1.0,1.0,17/33,34.51%,FGF2;ATP2B4;RGCC;MEOX2;PPARG;HDAC5;ANGPT2;ACVRL1;DLL4;STARD13;CARD10;MECP2;APOE;MMRN2;TGFB1;ITGB1BP1;CSNK2B
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.31693175331845885,0.7531554826258182,0.8539325842696629,1.0,1.0,3/18,13.43%,THY1;S100A10;PPM1F
prerank,Elsevier_Pathway_Collection__APP and Glutamate Signaling Cause Neuronal Dysfunction in Alzheimer Disease,0.28340900316897244,0.7529468775126673,0.8160919540229885,1.0,1.0,9/26,25.47%,MAPT;DLG4;SHC1;VLDLR;CDK5R1;LRP8;TGM2;CDK5;RELN
prerank,Elsevier_Pathway_Collection__SIRT1 Signaling in Aging,0.26188482399736884,0.7525230353528983,0.8556701030927835,1.0,1.0,15/40,31.89%,CDKN2A;HDAC4;TSC1;PECAM1;PARP1;TRIM28;TSC2;ARNTL;HSF1;MYC;RPS19BP1;CDKN1A;RHEB;LONP1;TP53BP1
prerank,WikiPathway_2021_Human__Circadian rhythm related genes WP3594,-0.19174326867260563,-0.7524724371589391,0.9565217391304348,1.0,1.0,34/177,18.23%,NKX2-1;PROK2;CLDN4;EGR3;KCNH7;NOCT;TH;NTRK3;ATF5;ID4;SIK1;ID2;NGFR;PPARGC1A;KCNMA1;PRF1;EGR1;IL6;BHLHE41;NTRK1;TNFRSF11A;RORB;PER1;NFIL3;CREM;HTR7;DDC;MTTP;KCND2;NCOR1;PER3;MAPK10;F7;HEBP1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.2993721251047593,-0.752278422596174,0.8125,1.0,1.0,2/15,10.10%,PHOSPHO1;ETNK2
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.311016138303111,0.752270585131429,0.7697368421052632,1.0,1.0,2/16,7.25%,CHI3L1;IRAK1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.23051331150217005,0.7518317848232265,0.9108910891089109,1.0,1.0,8/94,9.95%,DYNC1I1;KIF2C;KIF4A;CENPE;KIF5A;KIF15;KIF18A;KIF23
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.26700396929677084,0.7512143618758077,0.8352272727272727,1.0,1.0,10/36,24.81%,CEL;LRP4;S100A10;IL1RAPL1;TLCD1;NLGN2;NRXN2;STX4;ANXA2;EMP2
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.25382239332200796,-0.7510682419261785,0.8068181818181818,1.0,1.0,5/25,15.09%,ABCD2;PEX3;PLAAT3;ABCD4;PEX11G
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,0.23257345590980555,0.7510146018199128,0.8851674641148325,1.0,1.0,10/76,17.53%,DUSP9;VWF;KIAA1549;SRC;CAMK2A;LMNA;CNKSR2;HRAS;MRAS;TRIM24
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.30294404133548736,0.7508633626667904,0.8192771084337349,1.0,1.0,2/21,3.00%,SLC22A4;TSPO2
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,0.22957896284156148,0.7505247786025595,0.910377358490566,1.0,1.0,14/114,15.74%,PIK3R2;CALML6;TP73;MAPK12;SHC3;MAPK11;IRAK1;BDNF;CAMK2A;IRAK2;MAPKAPK2;SHC1;PDPK1;HRAS
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.219002776610216,-0.7505102949844504,0.9433962264150944,1.0,1.0,2/41,2.54%,ANXA8;ANXA8L1
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,0.25279989991336155,0.7502100890420256,0.8539325842696629,1.0,1.0,12/47,19.19%,ATP1A2;ATP1A4;ATP2B4;ATP1B3;CLTCL1;DNM3;BDKRB2;ADCY6;FXYD2;PRKCA;SLC8A3;CLTB
prerank,MSigDB_Oncogenic_Signatures__TGFB UP.V1 UP,0.21790892997208747,0.7500871263960015,0.9389671361502347,1.0,1.0,23/173,15.20%,HTR1D;LYPD1;MATN1;WNT4;SLC7A6;SLCO2A1;TBX3;ANK1;S100A3;SPHK1;IL11;LTBP2;CDKN2B;NDST1;PDGFB;CCDC93;PDGFA;LMCD1;RNF126P1;FOXF2;HS3ST2;SLC26A2;TMC7
prerank,WikiPathway_2021_Human__NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.29768319050872516,0.7500712435180432,0.8100558659217877,1.0,1.0,6/23,22.76%,SLC2A4;NMNAT2;HMGA1;GOT1;PARP1;MDH2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.24328532901415334,-0.7500295380034854,0.898989898989899,1.0,1.0,4/26,13.41%,FGF10;ADAMTS1;AKT1;UBE2E2
prerank,Elsevier_Pathway_Collection__Lactate as a Signaling Molecule in Cancer Cells,0.28003219093690285,0.7499384313360845,0.8453038674033149,1.0,1.0,7/24,26.20%,SLC16A3;EGLN1;TGFB2;PECAM1;HSF1;MYC;BSG
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,-0.2529729554753446,-0.7495146880591893,0.8795180722891566,1.0,1.0,10/25,20.75%,PLAAT1;PLA2G2D;PLAAT2;PLA2G4A;PLAAT3;PLA2R1;PLBD1;PLA2G12A;MBOAT2;LPCAT3
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.31870220771209634,0.7492788823641717,0.8074534161490683,1.0,1.0,7/17,40.19%,EXOSC4;MAPKAPK2;EXOSC5;EXOSC2;EXOSC1;EXOSC7;EXOSC9
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.22414644910126044,0.7492267553871801,0.9178743961352657,1.0,1.0,22/128,18.18%,EPHB2;CDH13;SAA1;MDK;KIF14;TESC;SRC;EFNA1;PLXNC1;C2CD4A;PLXNA2;PODXL;PLAU;ABL2;FRMD5;PRKCA;PLXND1;TNFRSF18;ROCK2;GPR4;ACVRL1;PLXNA3
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.22120113384751328,0.7490316625776712,0.8975609756097561,1.0,1.0,25/123,20.47%,FGF20;NRG2;ADGRG3;FGF17;KIF14;FGF2;FGF23;PLXNC1;PRAG1;DUOX1;PLXNA2;LMNA;ABL2;FRMD5;PLXND1;TMSB15A;CYRIB;ROCK2;EGF;PLXNA3;PHPT1;CDK6;DUOXA2;FGF18;SRCIN1
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,-0.24301395688119118,-0.748806812691556,0.8333333333333334,1.0,1.0,8/25,17.80%,SCN2B;SCN9A;SCNN1G;SCNN1A;PLCB2;SCN3A;TAS2R31;TAS2R14
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.2890222922561749,0.7485364474836114,0.8011363636363636,1.0,1.0,1/23,0.56%,HS3ST5
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.27559114395439893,0.7484913214039615,0.7804878048780488,1.0,1.0,24/34,50.81%,TARBP1;FTSJ1;TRMT1;TRMT61A;TRMT112;THADA;METTL1;TRMT12;METTL6;THUMPD3;BCDIN3D;HSD17B10;TRMT5;GTPBP3;TRMT13;TRMT1L;LCMT2;TRMT10A;METTL2A;TRMT61B;DALRD3;TRMO;THUMPD2;TRMT10C
prerank,KEGG_2021_Human__Phenylalanine metabolism,0.3183795171320002,0.7482893068890092,0.8323353293413174,1.0,1.0,1/15,1.69%,ALDH3A1
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,-0.1851223943001197,-0.7482081384465841,0.972972972972973,1.0,1.0,18/117,17.41%,AMHR2;ITGB8;CHRDL1;BMP10;INHBA;NOG;GDF2;GREM2;ACVR1C;ITGB6;SMAD9;BMPR2;ITGB3;ACVR2A;PPP1R15A;BMPR1B;NCOR1;LTBP4
prerank,Elsevier_Pathway_Collection__Genes with Mutations Associated with Cataract,0.3178101651403371,0.7480943338751398,0.8024691358024691,1.0,1.0,3/16,11.11%,BFSP2;HSF4;BFSP1
prerank,Elsevier_Pathway_Collection__OPTN Associated Glaucoma,0.3081808770900706,0.7476728318090112,0.793939393939394,1.0,1.0,4/21,15.50%,PLK1;IKBKG;CDK1;GRM1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.2629467616885544,0.74737698702915,0.8081395348837209,1.0,1.0,9/32,31.90%,TLE6;CDK1;RACGAP1;CRB2;NR2C2;POGLUT1;SOX17;CCSAP;CFL1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.3233229542545608,0.7471034960404976,0.7710843373493976,1.0,1.0,4/18,16.65%,RGCC;PDPN;MELTF;SMAD3
prerank,Elsevier_Pathway_Collection__Primary Mediastinal B-cell Lymphoma (PMBL) Subtype,-0.23852951985596024,-0.7468851583747788,0.8591549295774648,1.0,1.0,8/28,22.05%,TNFSF11;TNFRSF11A;CD274;PDCD1LG2;PRDM1;BCL2;JAK2;STAT1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.289522517640443,0.7467898906678373,0.8012048192771084,1.0,1.0,11/25,36.78%,PLK1;GPSM2;TPR;SPAG5;CEP97;CCSAP;CHMP2A;DYNC1H1;HNRNPU;DRG1;EML3
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,0.2638670165310892,0.7464955163175581,0.8797814207650273,1.0,1.0,12/38,34.22%,LMOD1;CACNA1G;TPM2;CACNA1H;TRIM72;ANXA2;ACTG2;PKN1;TPM3;ITGB5;MYL5;ACTA2
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.2551301303898351,-0.7464310226306028,0.8076923076923077,1.0,1.0,3/22,12.56%,TRPV4;ZFP36L1;RCSD1
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.2951447371976653,0.7463093534051215,0.8128342245989305,1.0,1.0,5/24,18.50%,RNASE1;ARHGEF11;ROCK2;RHOC;LIMK2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Photoaging,0.28796779690043345,0.7462273625527216,0.813953488372093,1.0,1.0,8/21,23.40%,ELN;HSPB1;MMP10;MC1R;MMP9;MMP3;ELANE;ESR2
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.27794317706682276,-0.74609086642536,0.8210526315789474,1.0,1.0,3/15,10.78%,GRAMD1C;GRAMD1B;GPLD1
prerank,Elsevier_Pathway_Collection__Cowden Syndrome,0.2686029084614057,0.7460647470018257,0.8258426966292135,1.0,1.0,6/42,15.60%,LEF1;TCF7;SRC;SHC1;PDPK1;PRKCA
prerank,MSigDB_Hallmark_2020__Hypoxia,0.2135812836544041,0.7460511167966754,0.933920704845815,1.0,1.0,28/194,16.38%,B4GALNT2;INHA;SLC2A5;HOXB9;BCAN;PDK1;EFNA3;DPYSL4;GPC3;KIF5A;EFNA1;NCAN;PPFIA4;NDRG1;NDST1;STC2;HAS1;PKP1;PDGFB;PGF;COL5A1;CDKN1C;VLDLR;PIM1;PRKCA;STC1;ANKZF1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.2815574663076532,-0.7459454141149061,0.8588235294117647,1.0,1.0,2/16,9.65%,ADRA1A;SCN3B
prerank,KEGG_2021_Human__Melanogenesis,0.22881224851740373,0.7459045530759174,0.8962264150943396,1.0,1.0,16/93,16.28%,LEF1;CALML6;WNT4;WNT9B;WNT8B;TCF7;CAMK2A;CREB3L1;MC1R;ADCY6;DVL2;WNT2B;WNT6;PRKCA;HRAS;CREB3L4
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.2808132807240439,0.7458916438820645,0.8121212121212121,1.0,1.0,9/28,26.88%,UPK3A;SLC5A6;SLC14A2;DISP1;PDPN;GLTPD2;SLC46A1;ABCA12;ABCB9
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,0.275948985541905,0.7456271148852894,0.8562874251497006,1.0,1.0,17/32,43.82%,POLR2L;POLR2K;NELFE;POLR2G;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;SUPT5H;NELFB;POLR2A;ERCC2;POLR2B;GTF2F1;POLR2F;ERCC3
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.30618103671605557,0.7456232439501382,0.7875,1.0,1.0,4/16,15.29%,PDGFRB;PDGFB;PDGFA;RGS14
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.30393151579002764,0.7454916943421075,0.8265895953757225,1.0,1.0,1/21,0.21%,MT3
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.27498776178666023,0.7454595309013295,0.8197674418604651,1.0,1.0,7/32,16.99%,SLC4A3;SLC4A1;SLC26A6;SLC9C2;SLC9A3;NOX1;SLC9B1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.2863131663282904,0.7452177947269094,0.8023255813953488,1.0,1.0,8/23,41.19%,COA6;COX20;COA3;BCS1L;COX19;OXA1L;FASTKD3;COX17
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,0.21782896905416876,0.7448940637923394,0.9476190476190476,1.0,1.0,39/130,37.21%,DYNC1I1;COL7A1;ANK1;LMAN2;CNIH3;TMED3;CNIH2;PREB;COG8;TRAPPC9;COPE;TRAPPC5;NAPSA;SEC16B;KDELR3;TMED9;DYNLL1;COG2;F5;TRAPPC2L;ARFGAP1;COPA;CSNK1D;TRAPPC1;SPTAN1;TRAPPC6A;COG4;DCTN4;DCTN2;DYNC1H1;SPTBN4;DCTN3;PPP6R1;TRAPPC4;YKT6;CD59;COG7;PTGES2;TBC1D20
prerank,Elsevier_Pathway_Collection__Metabolic Reprogramming in Cancer: Overview,-0.19670185066317905,-0.7446506939580827,0.9666666666666667,1.0,1.0,21/61,26.64%,GLS2;PHGDH;ALDOB;FBP1;SHMT1;SLC38A5;MPC1;AKT1;SDHD;PDK3;PSAT1;SDHB;ENO2;IDH1;PFKFB3;PGAM1;PTEN;LDHB;HK2;SHMT2;ME1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.27115510116481556,0.7444725177707684,0.8287292817679558,1.0,1.0,13/35,33.84%,S100A13;BORCS6;RAB34;BLOC1S1;SYTL4;MAP6;SNAPIN;VPS33A;KLC2;DEF8;PLEKHM2;MYH9;KXD1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.18143739865217565,-0.7443757261313177,0.975,1.0,1.0,31/169,17.74%,CIDEA;GLS2;CXCL10;BCL2L14;RIPK3;CIDEC;TNF;NTF3;LRRK2;STEAP3;IGFBP3;GAS1;CASP1;ALK;IKZF3;CD3E;ALB;AMIGO2;NTRK1;FLT3;AKT1;SOX9;RTN4;CASP6;BCL2L11;CLU;NLRC4;PERP;CTSB;TNFRSF10C;PMAIP1
prerank,WikiPathway_2021_Human__Signaling of Hepatocyte Growth Factor Receptor WP313,-0.22969182102468572,-0.7439545163051416,0.8333333333333334,1.0,1.0,3/34,7.46%,HGF;FOS;MAP2K1
prerank,Elsevier_Pathway_Collection__Peutz-Jeghers Syndrome,0.25661922248910457,0.7438528895480484,0.8571428571428571,1.0,1.0,24/52,41.89%,ACTL6B;PDPK1;SMAD3;TSC1;SMARCA4;TSC2;STK11IP;SMARCD3;MYC;STRADA;CDKN1A;RHEB;SMARCC1;CASP9;CDK4;BAX;RPTOR;ARID2;CDK2;MTOR;SMAD2;ARID1A;SMARCB1;SMARCC2
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.23308283927249043,0.7437575442423775,0.8940092165898618,1.0,1.0,11/97,10.33%,HOXD3;ACTN2;THY1;ITGA2;FERMT1;BCAM;CD34;SRC;NPNT;LYPD5;ADAM15
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.20977139264068367,0.7437435709801171,0.9469026548672567,1.0,1.0,16/187,8.07%,APLN;PRKAA2;MAPT;CLDN19;STOX1;WNT4;TERT;ROBO1;GATA5;POU4F1;BMP4;CD34;FGF2;ATP2B4;AGO2;PRKN
prerank,KEGG_2021_Human__Fatty acid elongation,-0.2515095490046047,-0.7435856790422091,0.85,1.0,1.0,7/27,20.35%,HACD1;ELOVL2;ELOVL7;HSD17B12;ECHS1;HACD4;ACOT2
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,0.25931312438722587,0.7434192311622625,0.8764705882352941,1.0,1.0,21/42,47.20%,PIAS3;CETN2;POLR1A;PARP1;PIAS1;CHD1L;CUL4B;UBA52;UBE2I;DDB2;DDB1;ERCC2;XPC;RBX1;UBE2V2;UBC;ERCC3;XPA;ERCC1;RPS27A;GTF2H2
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.2721427691693719,0.7434042546952929,0.8579545454545454,1.0,1.0,17/30,47.20%,POLR2L;POLR1A;POLR2K;TAF1A;POLR1H;POLR1G;POLR2H;CAVIN1;ERCC2;TAF1D;UBTF;POLR1C;TAF1B;POLR2F;ERCC3;TAF1C;GTF2H2
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.3096536586965003,0.7433767408333425,0.78125,1.0,1.0,1/17,0.88%,SCG2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.21885455918194116,0.7429269685531412,0.9419642857142857,1.0,1.0,30/153,25.78%,MAPK12;TDGF1;PLK1;CAMK2A;TTK;CDC7;MAST1;CDK1;MAST3;PRKD1;AURKA;PDGFB;MAPKAPK2;HIPK4;PDPK1;STK32C;PRKCA;CAMK1D;ROCK2;PKD1;PNCK;CDK5R1;CLSPN;DYRK3;PRKDC;STK32B;MAP2K2;CDK5;PKN3;MAST2
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.21878417535243652,0.7423657778055909,0.9534883720930233,1.0,1.0,38/196,21.24%,ODAM;RASGRF1;THY1;CCL26;TAX1BP3;CCL13;ITGA6;SGSM1;CCL25;CCL20;ARHGEF10;ARHGAP11B;EZH2;S100A10;TBC1D16;ASAP3;ARHGAP11A;APC2;RGS16;SCRIB;CCL24;GNB5;FOXJ1;CCL11;HRAS;ARHGEF15;ECT2;SGSM2;SIPA1L2;RAPGEF3;TBC1D8;ARHGEF19;TSC1;SRGAP2;TGM2;RAP1GAP2;TBC1D25;RGP1
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,0.2052036474361478,0.7423226154884568,0.9742489270386266,1.0,1.0,92/275,38.70%,B4GALNT2;DYNC1I1;ST8SIA3;COL7A1;EGFL7;DPM3;ANK1;ST6GALNAC4;MVD;ST8SIA5;LHB;NEU3;CTSA;LMAN2;CNIH3;TMED3;GFUS;CNIH2;B4GALT3;ST3GAL3;UGGT1;PREB;COG8;TRAPPC9;COPE;TRAPPC5;EDEM3;FCSK;ENGASE;MLEC;NAPSA;SEC16B;KDELR3;PMM1;TMED9;CHST10;DYNLL1;COG2;GLB1;F5;MAN2A2;AMDHD2;TRAPPC2L;ARFGAP1;ALG3;SRD5A3;DOLK;ST6GALNAC5;UBA52;ST3GAL2;ALG1;COPA;ST3GAL1;MGAT4B;CSNK1D;MGAT4A;TRAPPC1;SPTAN1;TRAPPC6A;COG4;DERL1;NPL;DCTN4;DCTN2;DYNC1H1;SPTBN4;UGGT2;DPM2;DCTN3;B4GALT6;PPP6R1;TRAPPC4;MGAT5;YKT6;ASGR2;ALG6;ST3GAL5;RPN2;SLPI;ALG13;CD59;COG7;PTGES2;DAD1;TBC1D20;VCP;GMPPA;ASGR1;ALG8;MGAT4C;TMEM115;DDOST
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.26109592775577284,-0.7422257020778484,0.8202247191011236,1.0,1.0,9/22,21.40%,S100A8;PRKCB;CYBB;RAC2;PIK3R4;NCF1;NCF2;PRKCZ;CYBA
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.19197627866923014,-0.7421628405516157,0.9491525423728814,1.0,1.0,18/94,19.82%,CIDEA;NKX2-1;VEPH1;NREP;ZEB2;CITED2;IL17RD;WFIKKN2;PBLD;SPRY2;LDLRAD4;THBS1;ADAMTSL2;HSPA1A;LTBP4;ITGA3;ASPN;SLC2A10
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.284571109045562,0.7420184726846674,0.8314606741573034,1.0,1.0,4/27,11.01%,CYP17A1;CYP21A2;AKR1B15;HSD17B7
prerank,KEGG_2021_Human__Phagosome,-0.17582596421477623,-0.7419471842146006,1.0,1.0,1.0,46/143,24.83%,CLEC4M;MARCO;FCAR;SFTPA1;FCGR3B;FCGR3A;SEC61A2;CYBB;TUBB1;FCGR2B;HLA-DQA2;MBL2;TLR4;CLEC7A;C1R;TLR2;SFTPD;HLA-DOB;MSR1;PLA2R1;ITGB2;CORO1A;ITGB3;SEC22B;THBS1;HLA-DQA1;NCF1;DYNC2H1;NCF2;HLA-DOA;ATP6V1B2;HLA-DRB5;CYBA;HLA-DRA;ITGAM;CD209;HLA-DPA1;MRC2;ATP6V1G2;C3;LAMP1;HLA-DPB1;HLA-DRB1;STX7;CTSS;CD14
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.31511462113660266,0.7417117412911169,0.8258064516129032,1.0,1.0,4/16,16.85%,RHBG;SLC26A6;SLC1A2;SLC1A3
prerank,Elsevier_Pathway_Collection__HGFR -> AP-1/CREB/MYC Signaling,0.2549369863308065,0.7409155242598998,0.8870056497175142,1.0,1.0,5/38,14.95%,RASGRF1;SRC;MAPKAPK2;SHC1;PDPK1
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.2592080093910162,-0.7408964615527445,0.8588235294117647,1.0,1.0,2/18,6.17%,CPEB1;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.2208447271898185,-0.7407153739289375,0.9666666666666667,1.0,1.0,3/38,6.47%,SFRP5;BANK1;XDH
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.1732596551795499,-0.7404682375970963,1.0,1.0,1.0,33/114,22.65%,SMPD3;ACOT11;PLAAT1;GLYAT;PM20D1;ACSM3;ASAH2;FUT3;CYP2C9;VNN1;FUT7;PLAAT2;MTHFD1;MTHFS;SHMT1;PLAAT3;ACSM5;ST6GAL1;GNE;MCCC1;MLYCD;NLN;PCCA;MTHFD2L;DHFR;ACOT2;CLN8;VNN3;NAAA;MIPEP;ACOT12;PLPP3;ACSM4
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.24373025953670704,0.7403539279199172,0.8638743455497382,1.0,1.0,21/51,36.17%,ADGRB1;VPS28;PRR7;SQSTM1;PIAS3;ISG15;COPS9;SH3RF2;CTNNB1;SVBP;PARK7;ARRB1;PRMT3;HDAC8;OGT;GTPBP4;PINX1;CAMLG;TNFAIP3;SIRT7;GNL3L
prerank,MSigDB_Oncogenic_Signatures__PIGF UP.V1 UP,-0.16426698025556927,-0.7403245291261108,1.0,1.0,1.0,55/182,28.73%,CR2;PTGS2;PCDHA12;TFPI2;GLRB;AGL;TNFSF10;IRAK1BP1;MMRN1;NAT1;UGP2;AMPH;NAP1L3;PLA2G4A;CCL22;RGS2;TTR;RARB;ABCA8;ACADM;ARMC6;F11;CRYBG3;ATP2A3;ARMCX2;CLEC2B;RCBTB2;PPID;MIPEP;RAP1A;KIAA0040;SGMS1;HS2ST1;MAP2K4;BAZ2B;PRKACB;SUCLA2;CCPG1;UFL1;IL1RL1;STK38L;PAPOLA;DNAJB9;CALB2;RUNX1T1;RFK;GRB14;NEK1;OPA1;SLC4A7;GGCX;ZC3H14;DZIP1;NECAP1;BCAS2
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.28054256913558273,0.7402764314235095,0.8282208588957055,1.0,1.0,1/30,0.35%,GJB6
prerank,TRRUST_Transcription_Factors_2019__ETV4 human,-0.26671938360283465,-0.7402154019575214,0.8461538461538461,1.0,1.0,3/21,4.10%,PTGS2;TNF;MMP1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.28651400205121114,0.7401511669327383,0.8580246913580247,1.0,1.0,3/21,7.73%,MAPT;STMN2;BDNF
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.27040275450377466,-0.7400682413753467,0.8969072164948454,1.0,1.0,6/20,15.07%,IFNG;TNF;KLF4;GATA3;CHRNA7;KLF2
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.23710934423819177,0.7399945498907587,0.8762886597938144,1.0,1.0,21/66,26.96%,ROBO1;PLXNC1;IL1RAPL1;SOX8;RASSF10;PLXNA2;METRN;RGS14;PLXND1;MAP6;MME;PLXNA3;OBSL1;TGM2;CUL7;PLXNA1;SHANK3;SMARCD3;CDKL3;CTNNB1;NAP1L1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.25884610002752434,0.7396572582864711,0.8514285714285714,1.0,1.0,6/45,11.32%,ACTN2;RAB3B;CHRNB2;TRPC6;CAMK2A;SCN4B
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.2821704528936941,0.7395996776999393,0.8224852071005917,1.0,1.0,4/25,16.21%,MAPT;PRKN;AURKA;CYRIB
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.24379720474303207,-0.7395058131724963,0.8641975308641975,1.0,1.0,6/28,20.62%,FGF10;RIC3;WNT11;CD177;FCN1;ANK2
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2707160905999183,0.7392865438353526,0.8571428571428571,1.0,1.0,14/31,40.61%,USP27X;OTUD7B;STAMBPL1;OTUB2;PSMD14;ABRAXAS1;BABAM2;UIMC1;TNFAIP3;OTUD5;BABAM1;USP7;USP20;USP13
prerank,Elsevier_Pathway_Collection__CD38 -> cADPR/Calcium Signaling,0.28334222841482304,0.7392594249092416,0.8571428571428571,1.0,1.0,2/25,6.66%,RASGRF1;SRC
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.26121175413883047,0.7392546630599276,0.8411764705882353,1.0,1.0,25/40,51.21%,CEP131;IFT81;DYNLRB2;DYNLL1;IFT27;DYNLRB1;KIFAP3;SSX2IP;KIF3B;DYNC2LI1;HSPB11;TTC30B;IFT80;IFT140;IFT172;IFT22;WDR35;KIF3A;IFT74;TTC26;IFT43;WDR19;TTC21B;TNPO1;CLUAP1
prerank,WikiPathway_2021_Human__Photodynamic therapy-induced unfolded protein response WP3613,-0.24942429614366088,-0.7391249878395497,0.8108108108108109,1.0,1.0,11/25,30.81%,BCL2L11;PPP1R15A;UBE2E1;EIF2AK3;XBP1;EDEM1;ATF3;DNAJB9;ASNS;ERN1;NFE2L2
prerank,KEGG_2021_Human__Cocaine addiction,0.2645579167440617,0.7390037383218867,0.8594594594594595,1.0,1.0,13/44,19.92%,GRIN1;GPSM1;SLC6A3;BDNF;GRIN2A;GRIN3B;CREB3L1;DLG4;CREB3L4;PPP1R1B;GRIN2C;CDK5R1;RGS9
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.28223760092272204,-0.7389915167273388,0.8351648351648352,1.0,1.0,15/15,71.80%,USP44;SMAD7;FBXO5;BAG5;BAG2;RPL11;DTX3L;LIMK1;RPL5;RPL23;ABL1;RPS7;PARK7;MAD2L2;MAD2L1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.3075499139273924,0.738746449755926,0.8227848101265823,1.0,1.0,13/19,49.79%,PRKN;SREBF2;HAX1;ATP13A2;PARK7;DNM1L;HTT;GSK3A;CSNK2A2;HTRA2;USP36;VDAC1;CAMKK2
prerank,TRRUST_Transcription_Factors_2019__HDAC3 human,0.2988635967973657,0.7387113483582268,0.8292682926829268,1.0,1.0,2/22,4.61%,GCM1;CDKN2A
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,-0.23883280511228844,-0.7386520847923312,0.8160919540229885,1.0,1.0,9/25,23.45%,IL5RA;IL2RB;PIK3R1;CSF2;INPP5D;CSF2RB;JAK2;CSF2RA;GAB2
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.295951053435287,0.738340353333992,0.8470588235294118,1.0,1.0,1/22,0.95%,DUSP9
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.30425942540721157,0.7381841368721891,0.7987804878048781,1.0,1.0,10/20,43.95%,PSMB4;PSMB3;PSMB5;PSMA1;PSMB6;PSMB7;PSMA7;PSMB2;PSMA6;ENC1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.3160946237204341,0.7376676304878872,0.7894736842105263,1.0,1.0,2/15,6.20%,DPEP1;CYP2W1
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.3160946237204341,0.7376676304878872,0.7894736842105263,1.0,1.0,2/15,6.20%,DPEP1;CYP2W1
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.3160946237204341,0.7376676304878872,0.7894736842105263,1.0,1.0,2/15,6.20%,DPEP1;CYP2W1
prerank,MSigDB_Oncogenic_Signatures__TGFB UP.V1 DN,0.21426421651154345,0.7374443159295372,0.9339622641509434,1.0,1.0,20/164,14.69%,CHRND;OSR2;RASGRF1;WNT8B;IRX5;PGBD5;SCGB1D2;PAQR5;COL4A1;IL36G;KIF18A;PRX;RNF43;EYA4;BDKRB2;PLXNA2;MPPED2;ATRNL1;TUFT1;ZNF696
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.2253866775660778,-0.7374247830834824,0.8658536585365854,1.0,1.0,4/34,11.92%,TBC1D30;LRRK2;FEZ1;ODF2L
prerank,WikiPathway_2021_Human__Hippo-Yap signaling pathway WP4537,0.2865414273799094,0.7373652759925002,0.872093023255814,1.0,1.0,12/23,34.77%,TEAD2;NDRG1;TEAD4;TAZ;MAP4K2;YY1AP1;NF2;TEAD3;MAP4K4;TEAD1;RASSF1;STK3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.24012745795763404,0.7373219682173634,0.8974358974358975,1.0,1.0,25/63,43.12%,LEF1;CDKN2A;CDK1;CCNB1;TRIM28;MED12;CTNNB1;MECP2;CDKN1A;MED31;MED7;MED27;CDK4;MED25;PAXIP1;BAX;AGO1;HNF1A;MED8;MED16;MED15;MED17;MED24;MOV10;TNRC6B
prerank,MSigDB_Oncogenic_Signatures__CRX DN.V1 UP,0.22028525210821642,0.7370208827648118,0.9095238095238095,1.0,1.0,13/113,13.23%,ANKRD33;RTBDN;OPN1SW;ARG2;SP6;BUB1B;RHPN1;CKMT1A;PAQR4;KCNJ14;CCDC107;CLDN7;MC1R
prerank,WikiPathway_2021_Human__16p11.2 proximal deletion syndrome WP4949,0.24148093972510057,0.7370021963487895,0.8693467336683417,1.0,1.0,32/70,38.96%,SEZ6L2;ASPHD1;UNC13A;CCT3;UNC13B;PRRT2;PPARG;TRAF2;TBX6;TAOK2;MAZ;KMT2D;INO80E;KCTD13;KIF22;ALDOA;PCNA;MVP;CDIPT;DOC2A;HIRIP3;YPEL3;PAXIP1;TMEM219;PPP2R1A;CCT8;CCT6A;CCT4;MAPK3;PPP4R1;CCT2;CCT7
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,0.260487761846623,0.7368424281470088,0.8465909090909091,1.0,1.0,7/34,16.71%,GALNT13;GALNT17;GALNTL6;ST6GALNAC4;GALNT9;GALNT15;GCNT3
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.23616113938761468,0.736311474053264,0.8682926829268293,1.0,1.0,23/92,26.97%,PIK3R2;CALML6;ITPKA;DGKI;PIP5K1B;DGKD;BPNT2;MTMR8;PRKCA;PPIP5K1;PLCD3;MTMR3;PLCD4;IP6K1;PI4KB;PLCG1;INPPL1;ITPKC;IMPA1;OCRL;ITPR2;PIP4K2B;INPP5F
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.23020874723131393,0.7362865933116559,0.9183673469387755,1.0,1.0,34/71,42.53%,SARNP;DDX39A;CASC3;THOC5;RBM8A;CHTOP;NUP62;NXF1;TPR;XPO5;UPF3B;ATXN2;NUP155;THOC1;POLDIP3;FMR1;NXF5;THOC6;FLOT1;NUP188;THOC2;DDX39B;MAGOHB;SLU7;ZC3H11A;TGFBR2;HNRNPA1;RAE1;NUP214;ALYREF;CKAP5;SLBP;U2AF1;U2AF2
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.28482537288804693,0.7360180420448003,0.8098159509202454,1.0,1.0,3/23,8.39%,TEX19;TDRD9;PIWIL1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.2548518698415492,0.7359997914300241,0.8742857142857143,1.0,1.0,3/43,8.27%,PRKAA2;BRSK2;NUAK2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.26276779899042174,0.735589611038656,0.8397790055248618,1.0,1.0,23/36,47.39%,NEK2;AURKB;CCT3;RTEL1;CTNNB1;NEK7;PNKP;CCT8;CCT6A;CCT4;MAPK3;HNRNPA1;ACD;CCT2;CCT7;ATR;CCT5;FBXO4;MAPK1;MAP2K7;MAP3K4;TCP1;MAPKAPK5
prerank,Elsevier_Pathway_Collection__Peroxisome Protein Import and Peroxisome Division,-0.23627015181135808,-0.735549039595887,0.8947368421052632,1.0,1.0,5/27,17.11%,ABCD2;CAT;PEX3;PEX11G;HSPA1A
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.31073971144539986,0.7355049670171193,0.8352941176470589,1.0,1.0,4/17,24.30%,COLEC12;MAVS;PQBP1;NPM1
prerank,KEGG_2021_Human__Prion disease,0.20784818160738025,0.7353001792619674,0.9568965517241379,1.0,1.0,106/246,38.68%,CACNA1S;PIK3R2;GRIN1;MAPK12;COX4I2;MAPK11;KIF5A;CASP12;NDUFA4L2;PSMD4;GRIN2A;TUBB8;GRIN3B;TUBA4A;LAMC1;CACNA1C;C8G;NDUFA1;TUBA3E;CREB3L1;HSPA2;PSMB4;TUBA8;NDUFS6;CREB3L4;TUBB2B;NDUFV1;NDUFB9;COX6C;GRIN2C;COX7B;NDUFA3;UQCRB;TUBA3D;NDUFS2;NDUFA9;ATP5F1D;COX6B1;GRIN3A;CACNA1D;NDUFB11;NDUFA2;NDUFS7;COX8A;UQCRQ;CYC1;ITPR2;KLC2;PSMD1;STIP1;PSMB3;SLC25A6;COX7A1;PSMD14;NDUFA13;DDIT3;UQCRHL;TUBB2A;NDUFA11;ATP5F1E;PSMB5;NDUFA6;ATP5MC1;UQCR11;PSMD2;NDUFS8;COX4I1;PSMA1;NDUFV2;HSPA5;COX5B;PIK3R3;ADRM1;PSMC4;PSMC3;TUBA1A;NDUFA8;CASP9;GRIN2D;NDUFB7;TUBA1B;UQCRH;NDUFAB1;NDUFB2;NDUFB10;UQCRC1;CSNK2B;BAX;PSMC5;CREB3L3;SEM1;PSMB6;HSPA8;PSMD8;COX7C;TUBB6;UQCR10;MAPK9;NDUFB3;MAPK3;TUBB4B;GSK3B;NDUFS4;PSMD13;PSMB7;PSMA7
prerank,Reactome_2022__RET Signaling R-HSA-8853659,0.260674874803294,0.7351851858281192,0.8539325842696629,1.0,1.0,6/38,15.60%,PIK3R2;SHC3;SRC;PDLIM7;SHC1;PRKCA
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.20063470846281448,-0.7348962003309703,0.9166666666666666,1.0,1.0,16/64,21.29%,SLC6A20;SLC13A2;SLC44A4;SLC7A8;LRRC8B;SLC35A3;SLC7A5;SLC38A5;SLC16A12;SLC13A5;SLC25A22;SLC39A8;SLC25A38;ARL6IP5;SLC25A10;SFXN1
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.3035242125189329,0.7348136947841618,0.8128654970760234,1.0,1.0,9/20,42.26%,RHO;PKD1;ASAP1;EXOC4;EXOC3;RAB11FIP3;PTGES2;EXOC8;PRKD2
prerank,WikiPathway_2021_Human__Nicotine Activity on Dopaminergic Neurons WP1602,0.3033849090847622,0.7345494900477304,0.8544303797468354,1.0,1.0,9/19,27.75%,CHRNB2;CHRNA3;CHRNA5;CHRNA4;PPP1R1B;KCNK9;ADCY2;CDK5;GNAI1
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,0.27008749705383917,0.7344487020688765,0.8448275862068966,1.0,1.0,15/32,44.05%,RFC4;POLD1;PCLAF;POLR1A;ISG15;TRIM25;UBA52;PCNA;POLH;SLC19A1;POLK;RFC3;POLD3;UBC;POLD4
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,0.2528586502320598,0.7339166790552863,0.861271676300578,1.0,1.0,30/45,53.17%,POLR2L;POLR2K;TAF10;POLR2G;TAF6;POLR2H;POLR2I;POLR2J;TAF9;POLR2A;TAF1;ERCC2;POLR2B;GTF2F1;TAF12;POLR2F;ERCC3;TAF5;TAF9B;TAF2;GTF2E1;GTF2H2;GTF2H5;TAF7;GTF2A2;TAF4;MNAT1;CDK7;POLR2D;GTF2B
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.24546153846153848,-0.7338011176781406,0.8518518518518519,1.0,1.0,25/25,75.48%,TLR2;CORO1A;KPNA1;RAB7A;DUSP16;UBB;B2M;RAB5A;LTF;KPNB1;RPS27A;GSK3A;VPS33B;MAPK1;UBC;RNF213;MAPK3;ENO1;MRC1;TRIM27;HGS;CTSG;UBA52;ATP6V1H;PGK1
prerank,Elsevier_Pathway_Collection__ICAM1 -> AP-1/CREB/ELK/SRF Signaling,0.2811989148144876,0.7337843548558964,0.8402366863905325,1.0,1.0,6/23,27.25%,RASGRF1;MAPKAPK2;ELK4;PLCG1;MAP2K2;ICAM1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Melanoma,0.20743540248341555,0.7333684511964094,0.9653679653679653,1.0,1.0,37/228,16.80%,SFN;POU3F2;SPP1;TP73;NODAL;TERT;KISS1;CDKN2A;FAP;TBX3;BMP4;BIRC5;SRC;FGF2;EFNA1;NPNT;EZH2;GDF15;ADAM15;LEP;CDKN2B;MC1R;FLT1;PLAU;MELTF;PGF;CSPG4;MCAM;PDPK1;PPARG;GRM1;PRKCA;HRAS;VCAN;TYRO3;ADAMTS18;RHOC
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.30917803772709196,0.7331629652396577,0.8525641025641025,1.0,1.0,8/17,38.29%,MVD;ALG3;SRD5A3;DOLK;ALG1;ALG6;ALG13;ALG8
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.2297847715758859,-0.7330828831142465,0.8987341772151899,1.0,1.0,6/30,17.80%,FOS;KCNH8;RPS6KA1;DUSP6;MAPK10;PPP2CB
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.27161369423513465,0.7329641883164727,0.8848484848484849,1.0,1.0,6/31,10.02%,GRIN1;GRIK2;KCNB1;GRIK4;GRIN2A;GRIN3B
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.21969435877568977,0.73291588597288,0.9305555555555556,1.0,1.0,24/124,21.44%,IGF2;VEGFD;ACTN2;VWF;TIMP1;MANF;TUBA4A;CD36;F13A1;ITIH4;PDGFB;HABP4;PDGFA;CD109;CYB5R1;SYTL4;CYRIB;EGF;STXBP1;TAGLN2;MAGED2;SPARC;TGFB2;PECAM1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.18427099539005304,-0.7327490125610181,0.9622641509433962,1.0,1.0,25/109,23.65%,NR4A3;FOS;ITK;FCER1A;PRKCQ;LCP2;BTK;CARD11;LAT;PIK3R1;SYK;LAT2;PLCG2;FCER1G;VAV1;LILRA4;VAV3;MAPK10;PPP3CA;TAB2;NFATC2;JUN;MS4A2;GAB2;MAP2K4
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.3153007958666368,0.7327089381544394,0.8238993710691824,1.0,1.0,8/16,32.34%,RNASE1;PLXNA2;VPS72;PLXNA3;PLXNA1;HSP90AB1;PKN1;NRP1
prerank,KEGG_2021_Human__mTOR signaling pathway,-0.1715865497000584,-0.7326831905735711,0.9696969696969697,1.0,1.0,21/147,13.84%,WNT7B;WNT7A;TNF;FZD3;WNT16;MAP2K1;RNF152;PIK3CD;PRKCB;WNT2;FZD1;WNT10B;WNT1;WNT11;RPS6KA1;SLC7A5;FNIP2;FZD8;PIK3R1;AKT1;IGF1
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.30819159546398867,0.7325391971859847,0.8284023668639053,1.0,1.0,2/18,15.74%,NOX4;HRAS
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,0.253353122073896,0.7324875433578492,0.8594594594594595,1.0,1.0,29/46,49.52%,KAT2A;POLR2L;POLR1A;EHMT2;HDAC1;POLR2K;GATAD2B;TAF1A;POLR1H;POLR1G;CHD3;CHD4;POLR2H;RBBP7;MTA3;ERCC2;TAF1D;UBTF;RBBP4;TAF1B;POLR2F;ERCC3;GATAD2A;TAF1C;GTF2H2;MTA2;GTF2H5;HDAC2;POLR1D
prerank,Elsevier_Pathway_Collection__Single-Strand Nucleotide Excision,0.3043594106784603,0.7323262217145046,0.8301886792452831,1.0,1.0,11/18,48.98%,PCNA;LIG1;XAB2;DDB1;ERCC2;XPC;ERCC3;XPA;ERCC1;RFC1;GTF2H5
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.29556608909601445,0.7320383649293019,0.8387096774193549,1.0,1.0,8/20,29.88%,CDC25C;LMNA;CDC25A;CDK5R1;CAPN2;CDK5;LMNB1;PRDX2
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.3211141735992042,0.7317311665585969,0.791907514450867,1.0,1.0,8/15,38.05%,GTSE1;RAPGEF3;TPR;EMD;GAS6;RBM22;BAG3;GSK3B
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.26905555166566164,0.7316861201434491,0.8571428571428571,1.0,1.0,16/33,45.13%,EXOSC4;EXOSC5;EDC3;LSM2;LSM4;LSM7;EXOSC2;DCPS;EDC4;CNOT6;EXOSC1;EXOSC7;EXOSC9;WDR61;SKIV2L;DCP1B
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.22797652165915105,0.7315772149825103,0.8604651162790697,1.0,1.0,6/88,5.98%,LMOD1;MAPT;VIL1;CCL26;STMN2;BAIAP2L2
prerank,TRRUST_Transcription_Factors_2019__TRP73 mouse,0.3039580938227744,0.7315763674481504,0.8092485549132948,1.0,1.0,5/18,18.71%,E2F1;PDGFRB;CDKN1C;PSRC1;BBC3
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.27267037872165584,0.731447396544153,0.8497109826589595,1.0,1.0,5/34,16.10%,MT3;TRPC6;ATOX1;MELTF;HEPHL1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.2066601717459679,0.7314193413302291,0.9502262443438914,1.0,1.0,76/176,39.77%,MT3;H1-5;SAXO1;GTSE1;TMEM88;TESC;MSX1;PRKN;EFNA1;ATP1B3;DNLZ;GPIHBP1;AHSP;CCT3;CRTAP;APOA2;USP27X;AAK1;TSC1;GLMP;HSP90AB1;SOX17;WDR81;HCFC1;DVL1;CHEK2;HIP1;CDKN1A;TNIP2;GAPDH;SWSAP1;TELO2;PARK7;PIN1;STXBP4;CDC37;HPS4;PEX6;CRYAB;FLOT1;MCM8;ATP1B1;NCLN;FKBPL;WIZ;GTPBP4;TBL1X;BAG3;STK3;CAMLG;OTUD3;CCT8;FLOT2;PPIB;MDM4;RPS7;CCT6A;COG7;CCT4;HSPD1;TAF9;WFS1;HIP1R;P3H1;TAF1;FLNA;CCT2;RPL23;HSP90AA1;CCT7;BAG6;NAA15;RPL5;DVL3;USP7;GRN
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.22041024097004688,-0.7314128653891042,0.9047619047619048,1.0,1.0,10/37,17.74%,HGF;TNFSF10;PPIF;AKT1;IGF1;BCL2L11;CLU;PLAUR;MLLT11;PMAIP1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.20489523749376903,0.7313974108118128,0.9789029535864979,1.0,1.0,43/270,24.81%,AVIL;CCNO;ACTN2;CDH13;TEKT5;RHO;FGD1;UNC119B;PARVB;CILK1;STK26;DNM3;ABLIM2;FHDC1;DNAAF1;SPEF1;BBS5;CEP131;IFT81;FOXJ1;BBS2;PKD1;ABLIM1;CEP250;KIF24;EHD2;CCDC28B;SRGAP2;TMEM250;DNAH5;FNBP1L;FAM161A;ATP6V0D1;B9D2;B9D1;GSN;OCRL;TEKT4;EMP3;AIF1L;PLK4;DYNLL1;EMP2
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.2911618149739532,0.7311162206835065,0.8333333333333334,1.0,1.0,5/20,15.50%,TAS1R3;TRPM5;SCN4B;SCN2A;GRM1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.2401552940717167,-0.7310428688929549,0.84,1.0,1.0,8/24,19.59%,ECM1;HEY2;SOX9;BMP2K;ENPP1;TWIST1;DDR2;AHSG
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,0.2001357476225846,0.7309844243242399,0.9918032786885246,1.0,1.0,55/430,18.10%,DOCK3;MUC13;MPZ;PIK3R2;CKB;STMN2;DLG5;ANLN;BAIAP2L2;ARHGEF39;FGD1;CCDC187;MTR;KIF14;SRC;FAM169A;PLEKHG4B;ARHGEF10;RHPN1;RHOBTB1;ARHGAP11B;ARHGAP44;PRAG1;IQGAP3;RNASE1;RASGRF2;DIAPH3;ARHGEF11;RACGAP1;IL32;ARHGAP39;ARHGAP11A;BCAP31;ARAP3;NOX1;OBSCN;ARHGAP28;SCRIB;ABL2;MCAM;PLEKHG2;ATP6AP1;ARHGEF2;DBN1;PLXND1;ARHGEF15;ECT2;SAMM50;ROCK2;RHOC;CDC42EP5;ARHGAP33;CKAP4;LBR;ARHGEF28
prerank,Elsevier_Pathway_Collection__Proteins Involved in Cystic Kidney Disease,-0.22899140622869052,-0.7306537593644453,0.8904109589041096,1.0,1.0,2/30,2.47%,RET;PTGS2
prerank,TRRUST_Transcription_Factors_2019__ATF4 human,0.256139742597517,0.7305929298184853,0.8524590163934426,1.0,1.0,4/34,13.69%,S100P;NDC80;BGLAP;PLAU
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.23912858225208047,0.7304722916079277,0.9121951219512195,1.0,1.0,17/83,16.38%,PPEF1;OPN1SW;RHO;GPC3;AKR1B10;RGS9BP;MYO7A;AKR1C3;LPL;GPIHBP1;SDR9C7;GNB5;GUCY2D;AKR1C1;HSD17B1;PRKCA;GPC2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.24545290638363512,0.730416479644601,0.8702702702702703,1.0,1.0,29/55,44.29%,FLVCR1;TIMM17B;BCAP31;TIMM17A;TOMM20;TIMM10;TOMM5;SLC25A6;FIS1;TSPO;TOMM40;TIMM13;TIMM9;BCS1L;AIP;OXA1L;STARD3;HSP90AA1;TIMM10B;TOMM7;MTX2;TIMM8B;TOMM34;SLC25A5;ABCB10;MFF;BCL2L1;PITRM1;TIMM22
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.2589120358535907,-0.7304136672161459,0.8773584905660378,1.0,1.0,11/20,29.80%,FTCD;MTHFD1;MTHFS;SHMT1;MTHFD2L;DHFR;SHMT2;FOLR2;SLC25A32;MTHFD2;DHFR2
prerank,WikiPathway_2021_Human__Eukaryotic Transcription Initiation WP405,0.2467242588418911,0.7303275397503963,0.864406779661017,1.0,1.0,24/42,49.89%,POLR1A;POLR2K;POLR2G;POLR3K;TAF6;POLR2H;POLR3H;POLR2I;POLR2J;TAF9;GTF2H2C;POLR2A;ERCC2;POLR3E;POLR2B;TAF12;POLR2F;ERCC3;TAF5;GTF2E1;GTF2H2;POLR1D;TAF7;GTF2A2
prerank,WikiPathway_2021_Human__Non-small cell lung cancer WP4255,0.24082708113088727,0.7302474312553853,0.8930232558139535,1.0,1.0,5/70,7.62%,E2F1;PIK3R2;PDK1;CDKN2A;E2F2
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.2511173633945881,0.7299475315750023,0.8630952380952381,1.0,1.0,13/46,24.55%,GUCY2C;NPR2;GUCY2D;ADCY6;SLC26A2;ADCY4;AMPD2;ADCY10;NUDT2;ADCY2;IMPDH2;PAPSS1;GMPS
prerank,Elsevier_Pathway_Collection__Proteins Involved in High-Grade Serous Ovarian Carcinoma,0.24130242369159477,0.7299403872333107,0.8844221105527639,1.0,1.0,10/56,18.47%,VEGFD;SRC;FGF2;CCNE1;NOTCH3;FLT1;HRAS;MSH2;BARD1;MUC16
prerank,Elsevier_Pathway_Collection__Penile Detumescense Augmentation Mechanisms,0.31755129240532015,0.7296252383829629,0.8333333333333334,1.0,1.0,4/16,27.75%,PTGFR;PDPK1;PLCG1;GNAI1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.22947193784349748,0.7295542085472875,0.8921568627450981,1.0,1.0,27/74,29.34%,SQLE;FDPS;LPL;HSD17B7;MVD;GSTM2;SREBF2;PPARG;FABP5;HMGCR;TM7SF2;SCD;IDI1;PMVK;NSDHL;FDFT1;CXCL16;CHKA;HMGCS1;CYP51A1;ABCA2;CTNNB1;ALCAM;GNAI1;ATXN2;ANXA13;GPX8
prerank,Elsevier_Pathway_Collection__Hypoxia Inhibits mTOR Signaling,-0.2419103810489292,-0.729535225620923,0.8780487804878049,1.0,1.0,1/25,0.57%,GCK
prerank,Elsevier_Pathway_Collection__Adipokines and Cytokines in Insulin Resistance in Skeletal Muscles,0.24340838277085874,0.7294092141204139,0.8636363636363636,1.0,1.0,11/51,16.96%,SLC2A4;LPL;LEP;CPT1B;CD36;IL6R;ACLY;PDPK1;LEPR;ACACA;HMGCR
prerank,WikiPathway_2021_Human__Exercise-induced Circadian Regulation WP410,-0.2069904285797199,-0.7293584910505813,0.9137931034482759,1.0,1.0,14/46,24.95%,UGP2;ERC2;PER1;PPP1R3C;HERPUD1;BTG1;PPP2CB;GSTP1;TAB2;QKI;KLF9;CRY1;DAZAP2;TOB1
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.20090382449974548,0.7292980536251594,0.9836734693877551,1.0,1.0,112/409,33.89%,DKK1;DKK4;DUSP9;FGF20;PIK3R2;VWF;NRG2;FOXO6;NOX4;HES5;KIAA1549;FGF13;KREMEN2;FGF17;HDAC4;SRC;IHH;FGF23;CAMK2A;PSMD4;PDGFRB;PORCN;FLT3LG;RNF43;RNASE1;HDAC11;KREMEN1;JAG2;LMNA;PDGFB;CNKSR2;PDGFA;PSMB4;AMER1;KAT2A;SHC1;SQSTM1;PDPK1;HRAS;HDAC5;MRAS;SMAD3;POLR2L;EGF;TRIM24;DHH;DLL4;FGF18;HDAC10;HEY1;PLCG1;HDAC1;NRG1;TSC2;DKK2;PPP2R5A;HHAT;KSR1;POLR2K;ESR2;TPR;PAPSS1;NPM1;ERBB3;MAP2K2;FZD6;ATIC;MYC;CTNNB1;POLR2G;MECP2;PSMB3;MAML1;NCOR2;HEYL;PSMD14;HIP1;UBA52;NCSTN;CDKN1A;FGFR4;KLB;PSMB5;PSMD2;PSMA1;MAMLD1;PSMD10;ARRB1;POLR2H;DUSP7;CDC37;LONP1;PIK3R3;WDCP;PSMC4;PSMC3;CUL1;IRS1;CASP9;MLST8;KANK1;PIGU;TPM3;TGFB1;HDAC8;LRP5;AP3B1;POLR2I;MYH9;MPRIP;SKP1;POLR2J
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.2511714622894368,-0.7292895677285747,0.8421052631578947,1.0,1.0,5/22,15.60%,MOGAT2;DGAT2;MOGAT1;DGKE;DGKB
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.21458395003781036,0.7292331090751011,0.9323671497584541,1.0,1.0,25/122,22.79%,RASGRF1;MAPT;POU4F1;STMND1;STMN3;STMN2;GPRIN1;PRDM12;UNC5A;MANF;CATIP;GBA;BLOC1S1;STMN1;ROPN1B;TMEM108;NEDD4;SNAPIN;PQBP1;CDK5R1;CDK16;FAM161A;MARK4;PPP1R9A;CORO1B
prerank,TRRUST_Transcription_Factors_2019__TWIST2 human,0.28431663580185235,0.7291889662642966,0.8466257668711656,1.0,1.0,1/25,0.45%,DKK1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.2810655822194996,0.7287156890864548,0.8533333333333334,1.0,1.0,2/27,2.14%,EPHB2;PAK3
prerank,Elsevier_Pathway_Collection__Platelet Activation via GPCR Signaling,0.2550601143125112,0.728036908593764,0.8571428571428571,1.0,1.0,7/49,16.14%,RASGRF1;F2RL3;ITGA2;PTGFR;PDPK1;PRKCA;ADORA2A
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.22415062452425646,0.727748329269819,0.9476190476190476,1.0,1.0,5/101,6.08%,SFN;E2F1;PRKAA2;PDK1;FGF17
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,-0.2063684130760751,-0.7275599217585773,0.9552238805970149,1.0,1.0,8/49,13.51%,PRKAR2B;CAMK4;CAMK2B;PLA2G4A;ADCY5;PDE1B;GNA14;PLCB2
prerank,WikiPathway_2021_Human__TGF-beta Receptor Signaling WP560,-0.21989037479218337,-0.7275386746498115,0.9444444444444444,1.0,1.0,18/54,22.68%,IFNG;TNF;FOS;INHBA;NOG;WNT1;RUNX3;ITGB6;ZEB2;LEFTY2;RUNX2;SMAD9;THBS1;LIF;SMAD7;JUN;STAT1;SMAD1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.22205273899445183,0.7270558427269858,0.9359605911330049,1.0,1.0,8/96,9.95%,DYNC1I1;KIF2C;KIF4A;CENPE;KIF5A;KIF15;KIF18A;KIF23
prerank,WikiPathway_2021_Human__PDGF Pathway WP2526,0.25433342081734744,0.72703286731388,0.8771929824561403,1.0,1.0,6/39,15.74%,SRC;PDGFRB;PDGFB;PDGFA;SHC1;HRAS
prerank,KEGG_2021_Human__Apoptosis,-0.1774458349281835,-0.7267578112906851,1.0,1.0,1.0,30/137,18.89%,TNF;FOS;FASLG;PTPN13;TNFSF10;NGFR;MAP2K1;PIK3CD;PRF1;NGF;BCL2A1;NTRK1;PIK3R1;AKT1;BIRC7;CASP6;BCL2L11;CASP7;CTSW;CTSB;BCL2;CSF2RB;MAPK10;PMAIP1;CTSZ;GADD45A;CTSC;EIF2AK3;GZMB;CTSO
prerank,Elsevier_Pathway_Collection__IL6/IGF1/VEGFA Signaling in Multiple Myeloma,-0.2149402536498175,-0.7266392733794141,0.9047619047619048,1.0,1.0,8/47,14.37%,TNF;FOS;MAP2K1;IL6;CXCL8;AKT1;IGF1;VCAM1
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.2843579665193687,0.7263659023188681,0.8701298701298701,1.0,1.0,18/26,46.93%,NEDD4L;SMAD3;BAMBI;UBA52;SMURF1;TGFB1;SMURF2;PMEPA1;TGFBR2;XPO1;SMAD2;UBC;STUB1;PPP1CA;ZFYVE9;UCHL5;RPS27A;SRFBP1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.2940323189862406,0.7262888201089636,0.83125,1.0,1.0,9/17,37.14%,INTS8;INTS3;MEPCE;INTS7;INTS1;INTS11;TUT1;INTS9;INTS5
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,-0.2735471553722167,-0.7262567131233891,0.7831325301204819,1.0,1.0,5/17,22.41%,LSR;CES3;NCEH1;APOB;LDLR
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.22867778154834656,0.7262376566161803,0.8866995073891626,1.0,1.0,35/89,39.37%,E2F7;CDKN2A;PSMD4;CDKN2C;RGCC;CDKN2B;AURKA;PSMB4;CDK2AP2;CDK6;CDKN2D;PSMD1;PSMB3;PSMD14;RBL1;CDKN1A;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;CDK4;SKP1;PINX1;PSMC5;PSMB6;PSMD8;PSME2;KANK2;PSMD13;PSMB7;PSMA7;PSME3
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.16424085192151086,-0.7256894364591461,0.9565217391304348,1.0,1.0,27/164,17.55%,EDAR;CD4;TNF;ECM1;FASLG;TNFSF10;CASP1;CCR7;PRKCB;APOL3;S100B;PELI2;CARD11;REL;TRIM34;TICAM2;CLEC7A;TRIM22;CARD16;S100A12;MYD88;SECTM1;LGALS9;HMOX1;TRIM5;LPAR1;NDFIP2
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,0.28906933421639774,0.725646377624899,0.803680981595092,1.0,1.0,14/21,46.20%,PGK1;ATP6V1H;UBA52;CTSG;HGS;TRIM27;ENO1;MAPK3;RNF213;UBC;MAPK1;VPS33B;GSK3A;RPS27A
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.22346296428302995,0.7254721256650267,0.9178082191780822,1.0,1.0,17/106,19.77%,CTNNA2;PIK3R2;MAPK12;CLDN19;THY1;MAPK11;CLDN15;CLDN6;CD99L2;CLDN7;MYLPF;PRKCA;ROCK2;CLDN5;CLDN2;RAPGEF3;MMP9
prerank,Elsevier_Pathway_Collection__Mast-Cell Related Chemokines Signaling in Asthma,0.27210480964503136,0.7251678739937434,0.8248587570621468,1.0,1.0,5/30,14.95%,RASGRF1;SRC;CCR3;CCL11;PDPK1
prerank,Elsevier_Pathway_Collection__Apoptosis Block in Melanoma Cell,-0.21086872989872613,-0.7251073435016405,0.9444444444444444,1.0,1.0,11/39,23.89%,MAP2K1;MITF;RPS6KA1;AKT1;RASGRP1;BIRC7;BCL2L11;BCL2;JAK2;STAT1;PTEN
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.288340111569065,0.7250911037079446,0.8238636363636364,1.0,1.0,4/22,13.63%,GDPD1;PLA2G4C;APOA2;PLA2G4F
prerank,Elsevier_Pathway_Collection__Mucinous Ovarian Carcinoma,-0.20254030767680453,-0.7245442504876763,0.9761904761904762,1.0,1.0,18/60,24.93%,ERBB4;FOS;ESR1;MAP2K1;TGFA;FOXO1;PIK3R1;AKT1;HBEGF;BCL2;MAPK10;MAP2K3;JUN;JAK2;MAP3K5;MAP2K4;PTEN;NCOA1
prerank,Elsevier_Pathway_Collection__Steroids Induced Cataract,-0.1991740590283515,-0.7243199025456681,0.8913043478260869,1.0,1.0,21/58,25.27%,MIP;FOS;CDH1;MAP2K1;FGFR2;MAF;CRYAA;PIK3R1;AKT1;IGF1;MAPK10;IRS2;IQGAP1;MAP2K3;MAP2K6;JUN;MAP3K5;MAP2K4;IGF1R;NR3C1;GAB1
prerank,Elsevier_Pathway_Collection__Androgen Receptor non-Genomic Signaling,0.26985835605740066,0.7241750573349582,0.8457142857142858,1.0,1.0,2/28,6.66%,LEF1;SRC
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.27147374856618117,-0.7238388233465711,0.8461538461538461,1.0,1.0,10/16,34.31%,ADGRB3;C1QA;ANKS1A;APP;C3;B4GALT5;CLN5;CX3CL1;FARP2;LGI4
prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.20535607244195045,0.7237464963364993,0.9527896995708155,1.0,1.0,32/201,21.35%,GNG4;E2F1;PIK3R2;CALML6;MAPK12;CDKN2A;MAPK11;SRC;PTGER1;PTGER3;E2F2;CCR3;GNG3;IKBKG;ARHGEF11;IL6R;CREB3L1;GNB5;ADCY6;GNG8;PRKCA;HRAS;CREB3L4;ROCK2;GNG10;TRAF2;ADCY4;IRF3;CDK6;TSC1;FADD;ADCY2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.21980123554363362,-0.7236658999502762,0.9577464788732394,1.0,1.0,8/44,11.82%,GPD1;PLD1;LIPH;PLA2G2D;AGPAT2;PLA2G4A;DGKE;ABHD5
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.3099744578207021,0.7229743260001821,0.8831168831168831,1.0,1.0,6/16,42.04%,PIGZ;PIGC;PIGM;DPM2;PIGF;PIGX
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.23475559745215818,-0.7227929080024702,0.9310344827586207,1.0,1.0,8/37,17.13%,ASCL1;IL1B;BHLHE41;ASCL2;HEY2;PTN;TNFRSF1B;TENM4
prerank,WikiPathway_2021_Human__MicroRNAs in cardiomyocyte hypertrophy WP1544,-0.18681381836050176,-0.7226602278877803,0.8809523809523809,1.0,1.0,15/82,14.02%,TNF;RCAN1;MAP2K1;PIK3CD;PRKCB;CTF1;FZD1;FGFR2;MYEF2;HDAC9;PIK3R1;AKT1;PLCB2;IGF1;CISH
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.2692544726449512,0.7226375140186657,0.8448275862068966,1.0,1.0,8/30,23.86%,CYP17A1;CYP21A2;PYCR2;PYCR3;HSD17B1;FDFT1;FDXR;CYP51A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.28282783096179076,0.7226117820879854,0.850828729281768,1.0,1.0,4/22,11.25%,SFRP4;ECSCR;AKR1C3;RGCC
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.2499237726504876,-0.7225716492112724,0.8076923076923077,1.0,1.0,6/22,22.36%,OTOF;GET4;PRNP;HMOX1;CYB5A;APP
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.22353082822470885,0.722174179625444,0.9,1.0,1.0,26/79,32.05%,MAPT;STOX1;STMN3;PRKN;CDT1;SPEF1;SQSTM1;MAVS;PREB;TBC1D25;CENPV;CAPN2;TMED9;F11R;ATP13A2;PTK2;CAMSAP2;PJVK;CPLANE2;FIS1;CLEC16A;PDE4DIP;S100A9;VPS11;STX18;RBSN
prerank,Elsevier_Pathway_Collection__Translation,0.2848454270851328,0.7212036836749326,0.838150289017341,1.0,1.0,1/24,2.63%,EEF1A2
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.301874187942231,0.7211258394437393,0.8414634146341463,1.0,1.0,10/17,45.96%,PCGF2;PCGF1;CUL4B;BCOR;DDB2;SKP1;DDB1;KDM2B;RING1;BMI1
prerank,Elsevier_Pathway_Collection__Rett Syndrome,-0.24824869447444362,-0.7211142889552238,0.9021739130434783,1.0,1.0,3/19,9.49%,IGFBP3;NTRK2;EGR1
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.23484185478797054,-0.7210280873699756,0.875,1.0,1.0,4/29,14.33%,PARP6;MOGAT1;PARP8;ST6GAL1
prerank,WikiPathway_2021_Human__Netrin-UNC5B signaling pathway WP4747,-0.2146430659266264,-0.7208549619965477,0.9206349206349206,1.0,1.0,8/49,14.37%,IL10;TNF;MAP2K1;CCL2;FYN;SELE;AKT1;VCAM1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.28538126038432027,0.7206593026032054,0.8855421686746988,1.0,1.0,5/21,18.00%,MAPT;SEMA7A;DBN1;MEGF8;TWF2
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.22847302582795076,-0.7206077424978192,0.8648648648648649,1.0,1.0,13/37,23.99%,ACOD1;VSIG4;CR1;USP18;SERPING1;NLRC3;IFI16;OAS3;USP15;NMI;DHX58;OAS1;TRIM21
prerank,Elsevier_Pathway_Collection__ANGPT/TEK Maintains Endothelial Cell Quiescence in Cancer,0.26184956721436753,0.720454081905672,0.8864864864864865,1.0,1.0,7/35,19.58%,HOXC9;BIRC5;GJA5;NFKB2;PDPK1;ANGPT2;DLL4
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,0.23378094376425507,0.720250656068655,0.8838383838383839,1.0,1.0,5/65,7.62%,FGF20;FGF13;FGF17;SRC;FGF23
prerank,Elsevier_Pathway_Collection__Bone Loss in Osteoporosis,0.25700314273643726,0.7201910183699444,0.8936170212765957,1.0,1.0,2/43,1.93%,DKK1;E2F1
prerank,Elsevier_Pathway_Collection__Tight Junction Assembly (Occludin),-0.2486442829121957,-0.7201332481026114,0.9066666666666666,1.0,1.0,24/24,75.16%,AKT1;YBX3;PTEN;ILK;EPB41;AFDN;MAP3K20;MAGI3;VASP;VAPA;MAGI2;ACTN1;CTTN;VCL;OCLN;CGN;SYMPK;TJP2;TJP1;CTNNA1;CDK4;CTNNB1;RAB13;HSF1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.24656796769851952,-0.7201076863272869,0.8732394366197183,1.0,1.0,20/20,75.37%,BCL2A1;BCL2;CASP3;MOAP1;APPL1;BCL2L10;MCL1;BOK;BAK1;GSK3A;BCL2L1;FAS;DCC;GSK3B;BAX;CASP2;CASP9;BCL2L2;ITGAV;ERBB3
prerank,Elsevier_Pathway_Collection__ALK Associated Neuroblastoma,0.2752659890761663,0.7199007736163044,0.8160919540229885,1.0,1.0,2/24,4.55%,SHC3;MDK
prerank,KEGG_2021_Human__Hepatitis B,0.21523486167070507,0.7197569034440452,0.9590909090909091,1.0,1.0,25/146,21.40%,E2F1;PIK3R2;MAPK12;MAPK11;BIRC5;SRC;IRAK1;E2F2;CASP12;CCNE1;CCNA2;CCNE2;IKBKG;CREB3L1;PRKCA;ATP6AP1;HRAS;CREB3L4;SMAD3;MAVS;IRF3;HSPG2;MMP9;FADD;TGFB2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.2688753108575618,0.7196798409667214,0.8074534161490683,1.0,1.0,6/31,16.51%,CRP;BDKRB2;ACE;ADCY6;HTR2B;ROCK2
prerank,TRRUST_Transcription_Factors_2019__TWIST1 human,0.2656890092274805,0.7192275350668911,0.8222222222222222,1.0,1.0,4/34,10.52%,DKK1;TIMP1;GDF15;DNM3
prerank,Elsevier_Pathway_Collection__EGFR -> NCOR2 Signaling,0.26294831312549083,0.7190073515814439,0.8855421686746988,1.0,1.0,7/28,22.51%,RASGRF1;SRC;SHC1;PDPK1;EGF;PLCG1;NRG1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.28711438931654104,0.718908921163275,0.8663101604278075,1.0,1.0,4/23,14.70%,THY1;S100A10;PPM1F;IQSEC1
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,-0.2785495495303945,-0.7188929991368783,0.8333333333333334,1.0,1.0,3/15,12.15%,SOCS2;SLA2;FLT3
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.22236218778389738,0.7188441499484334,0.9504950495049505,1.0,1.0,18/89,22.71%,TERT;GPSM1;BMP4;PRKN;FOXC1;CDT1;NME1;NVL;PPARG;STMN1;PKD1;EGF;CLDN5;MMP9;ZNF618;GMNN;DDX11;TXN
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.21592687630642465,-0.7188134033695307,0.8666666666666667,1.0,1.0,11/41,20.48%,BCO2;CCN6;LRRK2;SPART;TCL1A;AKT1;BCL2;PMAIP1;PID1;ARL6IP5;RNF122
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.24565790791043834,0.7187252448924243,0.8901098901098901,1.0,1.0,17/50,31.83%,ZSWIM5;NRG2;PRAG1;PDPN;ABL2;ROCK2;EGF;CDK6;TGFBR3;NRG1;ERBB3;INPP5F;ARAP1;RPS19;PKN1;DAPK3;CD9
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.24406055867243615,-0.7187165780028831,0.9215686274509803,1.0,1.0,4/20,13.49%,SOX10;SOX6;PRDM8;SOX9
prerank,Elsevier_Pathway_Collection__Vascular Smooth Muscle Cell/Pericyte Differentiation and Proliferation,-0.24662546373243102,-0.7183535937817972,0.8589743589743589,1.0,1.0,6/20,25.00%,ID2;KLF4;MYH11;MYOCD;SMAD1;ID1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.28070656523714066,0.7179751381555322,0.84472049689441,1.0,1.0,3/20,10.27%,MDK;MSTN;CXCL17
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.20406291144531136,-0.7177502216319808,0.9710144927536232,1.0,1.0,5/54,5.98%,PRSS22;IFNG;TNF;IL1B;CCBE1
prerank,WikiPathway_2021_Human__Galanin receptor pathway WP4970,0.29682505184469826,0.7175737959213556,0.8546511627906976,1.0,1.0,4/18,15.45%,CRP;SLC2A4;CDKN1C;PPARG
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,0.3015931341041697,0.7174854983483262,0.8525641025641025,1.0,1.0,6/17,42.04%,PIGZ;PIGC;PIGM;DPM2;PIGF;PIGX
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",0.22156780410186838,0.7172717783900403,0.9523809523809523,1.0,1.0,20/109,21.95%,GHRHR;CACNA1S;PIK3R2;MAPK12;SHC3;MAPK11;SSTR5;CACNA1C;CREB3L1;SHC1;ADCY6;PRKCA;HRAS;CREB3L4;ADCY4;SSTR1;ADCY10;ADCY2;PLCG1;CACNA1D
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.21646381644489002,-0.7170509117068281,0.9166666666666666,1.0,1.0,16/39,26.51%,SLC10A1;SLCO1B3;AKR1C4;STARD5;SLCO2B1;ABCG8;ABCG5;SLC5A3;SLCO1B1;SLC27A5;NR1H4;ABCC3;SLC51A;NCOA1;SLC51B;OSBP
prerank,MSigDB_Oncogenic_Signatures__AKT UP.V1 UP,0.20870262457244965,0.7169243696240375,0.9483568075117371,1.0,1.0,39/144,25.66%,HOXB9;P2RX5;SAA1;PDK1;TMEM40;SAA2;TESC;SPHK1;UBE2C;PTPN14;GTF2IRD1;RUNDC3A;CDKN2B;GSDMC;PACSIN3;FLT1;DLG4;FAM3B;HIC2;ABCA7;FABP5;PPP1R3F;GPX2;IDI1;CRLF1;COMTD1;TPRN;FDFT1;CXCL16;GOT1;VAMP5;BACE2;PLAT;HIF3A;CYP51A1;PFKP;MYO5B;INSIG2;NEU1
prerank,Elsevier_Pathway_Collection__Eat me Signal: Apoptotic Cell Initiates Phagocytosis,0.28421907990479256,0.7168612195617964,0.8910256410256411,1.0,1.0,4/25,11.46%,HAVCR1;ADGRB1;MFGE8;CD36
prerank,Elsevier_Pathway_Collection__TSLP Signaling in Bronchial Epithelial Cell in Asthma,0.266552873578583,0.7165282152065383,0.8833333333333333,1.0,1.0,6/33,15.56%,CRLF2;CDKN2A;IRAK1;TNFRSF4;PIM1;RELB
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.2650992299584597,0.7161239041880311,0.884393063583815,1.0,1.0,2/30,5.42%,MAPT;FGF13
prerank,Elsevier_Pathway_Collection__Dopamine Receptors Signaling,0.2540369840243146,0.7161169588931148,0.8852459016393442,1.0,1.0,7/35,24.71%,RASGRF1;SRC;PDPK1;ELK4;PLCG1;DRD1;MAP2K2
prerank,Elsevier_Pathway_Collection__Nuclear Lamina Cleavage,0.2848415129003672,0.7161167387232311,0.8764705882352941,1.0,1.0,8/20,27.92%,LMNA;LBR;CBX5;EMD;LMNB1;SYNE2;LMNB2;TOR1AIP1
prerank,MSigDB_Oncogenic_Signatures__RB DN.V1 UP,0.2160789757443376,0.7159419759648894,0.9389671361502347,1.0,1.0,37/126,30.18%,ALPK3;LYNX1;UBE2T;CCNE1;LAGE3;CCNE2;AKR1C3;MCM6;PRIM1;SNAP25;STMN1;TNFRSF18;GNB1L;THRA;EPHX1;RRM2;DNA2;BBC3;RAD54L;PLA2G6;DSN1;MCM7;DNMT1;PMM1;PPM1M;IFT27;ADA;MYC;PEX11B;TIPIN;VPS16;MSH6;TIMELESS;DDIT4L;ARHGEF40;PCNA;CRIP2
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,0.25130790190239527,0.7159143525641455,0.8611111111111112,1.0,1.0,5/30,19.00%,COL7A1;LMAN2;CNIH3;CNIH2;PREB
prerank,KEGG_2021_Human__Long-term depression,-0.19101377113295737,-0.715702181635561,0.9242424242424242,1.0,1.0,13/53,20.90%,GNAO1;MAP2K1;GRIA3;PRKCB;PLA2G4A;PLCB2;IGF1;GRIA1;GUCY1B1;PPP2CB;GUCY1A1;RYR1;PRKG1
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,0.22737687114012195,0.7155546236760459,0.9019607843137255,1.0,1.0,20/75,29.12%,ST8SIA3;EGFL7;DPM3;ST6GALNAC4;MVD;ST8SIA5;NEU3;CTSA;GFUS;ST3GAL3;FCSK;PMM1;GLB1;AMDHD2;ALG3;SRD5A3;DOLK;ST6GALNAC5;ST3GAL2;ALG1
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.27102861089079383,0.7151753266095744,0.8518518518518519,1.0,1.0,5/29,12.32%,CDKN2A;SRC;MMP12;ADAM15;APOD
prerank,WikiPathway_2021_Human__TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,-0.21051898326154808,-0.7150813902326882,0.9315068493150684,1.0,1.0,6/42,15.99%,TNF;CCL5;CCL2;IL6;AKT1;CASP7
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.20230393402173427,0.7150311808774713,0.9744680851063829,1.0,1.0,120/307,43.68%,TRIM71;FBXW10;MKRN3;UBE2T;UBE2C;PRKN;PSMD4;DTL;FBXL18;FBXL16;UBE2S;CCNF;FBXO31;IFI27;PSMB4;UBE2Q1;UNKL;NEDD4L;NEDD4;BARD1;SHARPIN;TRAF2;BLMH;RNF187;PELI3;FBXL8;RNF31;MARCHF8;RNF135;UBE2A;ANAPC11;UBR5;TRIM3;HECTD2;LNPEP;FBXL15;PSMD1;RUSC1;TRIM38;CTNNB1;ANAPC7;PSMB3;RNF216;HECW1;FBXO41;PSMD14;UBA52;FBXL22;UBE4B;SMURF1;SPSB1;TRAF5;PSMB5;TRIM27;PSMD2;PSMA1;UBE2O;PSMD10;RNF20;PSMC4;PSMC3;FBXW5;CUL1;THOP1;UBE2QL1;DDB2;SKP2;SMURF2;SKP1;MAGEL2;ANKRD39;PSMC5;TNFAIP3;RNF126;TRAF3;PSMB6;CDC23;FBXO32;UBE2Q2;PSMD8;UBE2V1;UBE2D2;DZIP3;PSME2;FBXO44;TRIM56;PSMD13;PSMB7;TAF1;PSMA7;FBXL19;ANAPC1;FBXL13;PSME3;UBE2J2;HUWE1;ANAPC2;ARIH1;RNF213;TRIM62;UBOX5;FBXW8;FBXW11;FBXO6;RNF144A;PPIL2;FBXO4;PSMB2;HECW2;RBX1;UBE2V2;DDA1;PSMA6;ANAPC4;UBC;FBXL7;STUB1;PSMD9;TRAF1;WWP2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.19877709972368135,0.7149679415820812,0.9829059829059829,1.0,1.0,50/300,22.72%,HMGA2;SPDEF;DUSP9;PNMA3;E2F1;SFRP4;NEUROD1;DKKL1;MELK;ITGA6;TOP2A;FAP;FGD1;BMP4;RASGRF2;PHLDA3;ARHGEF11;DAPK2;OBSCN;SCRIB;UNC13B;TFAP4;SCIN;PRR7;SQSTM1;IAPP;USP27X;PLEKHG2;PLEKHN1;ANKRD1;ARHGEF2;ECT2;BMF;STPG1;BCL6;BARD1;ING5;OLFM1;CTSD;CDK5R1;ARHGEF19;TGM2;FADD;TGFB2;PDCD5;APBB1;IRF5;AIFM2;PCSK9;AIFM1
prerank,MSigDB_Oncogenic_Signatures__MTOR UP.N4.V1 DN,-0.17077891826986344,-0.7148164616295857,1.0,1.0,1.0,18/152,13.40%,SMPD3;ST18;CD1A;IKZF2;CD1B;CBFA2T3;CD1E;ZNF711;EVI2B;TRAT1;DACH1;ZNF14;BIN2;CD1C;REL;EPM2A;NEAT1;SLC35D1
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,0.2081959531826928,0.7146645803514785,0.95260663507109,1.0,1.0,81/144,50.08%,VPS28;MVB12B;ELOC;NEDD4L;VPS37D;HMGA1;POLR2L;NUP37;ELOB;FEN1;NUP62;POLR2K;NELFE;TPR;TAF10;NUP133;RANGAP1;POLR2G;UBA52;NUP155;VPS4A;TAF6;NUP160;PPIA;POLR2H;CHMP2A;SGIP1;NELFA;NUP188;NMT2;POLR2I;POLR2J;CTDP1;BANF1;SSRP1;MVB12A;NUP205;SUPT5H;NELFB;TAF9;XPO1;RNMT;POLR2A;NUP210;TAF1;ERCC2;RAN;XRCC6;ELL;POLR2B;NUP214;GTF2F1;NUP107;PSIP1;TAF12;UBC;POLR2F;CDK9;ERCC3;TAF5;SUPT16H;RCC1;CCNT2;AAAS;TAF9B;TAF2;GTF2E1;RPS27A;CHMP4C;NUP93;GTF2H2;TSG101;NCBP2;GTF2H5;NUP88;SEC13;TAF7;SEH1L;GTF2A2;POM121C;NUP42
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.21876538484058478,0.7146184620262368,0.9405940594059405,1.0,1.0,8/99,9.95%,DYNC1I1;KIF2C;KIF4A;CENPE;KIF5A;KIF15;KIF18A;KIF23
prerank,Elsevier_Pathway_Collection__Proteins Involved in Breast Cancer Related to WNT Signaling Pathway,-0.22424074842173589,-0.7145698692484086,0.9,1.0,1.0,10/33,21.42%,FOS;CDH1;WNT10B;WNT11;MMP7;AKT1;PRKCE;FZD7;WNT5A;JUN
prerank,Elsevier_Pathway_Collection__Myostatin in Skeletal Muscles in Muscular Dystrophies,0.2957974693195034,0.7143187208508051,0.8461538461538461,1.0,1.0,4/17,23.56%,MSTN;SMAD3;ACVR2B;FSTL3
prerank,TRRUST_Transcription_Factors_2019__ESR2 mouse,0.3019719856720696,0.7140070285834135,0.8538011695906432,1.0,1.0,3/17,15.45%,SLC2A4;PTGDS;PPARG
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.2833539198231203,0.7138498143002965,0.8595505617977528,1.0,1.0,8/22,31.20%,GPSM1;HRAS;ARL2;RASA4;F11R;SH3BP4;FICD;DAB2IP
prerank,WikiPathway_2021_Human__Fluoropyrimidine Activity WP1601,-0.22641550246480885,-0.7134847999289107,0.9240506329113924,1.0,1.0,5/33,12.59%,UPP2;SLC22A7;DPYS;CDA;DPYD
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.2496059014280511,0.7134026680220831,0.9047619047619048,1.0,1.0,14/36,40.31%,CDKN2A;CCNA2;CDK1;PDPK1;CHEK2;UBA52;MLST8;SGK1;PPP2R1A;MDM4;DAXX;CDK2;USP7;MTOR
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.205999349285705,-0.7133151414952957,0.9333333333333333,1.0,1.0,6/50,17.23%,GCK;GCGR;RUBCNL;GCKR;PRKAG2;KHK
prerank,WikiPathway_2021_Human__Glioblastoma signaling pathways WP2261,0.2325443999787288,0.7132773923014112,0.905940594059406,1.0,1.0,11/81,15.74%,E2F1;PIK3R2;CDKN2A;SRC;CCNE1;PDGFRB;CDKN2C;CDKN2B;PDPK1;PRKCA;HRAS
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,0.2614742978097751,0.7130786597687897,0.9017341040462428,1.0,1.0,18/30,49.52%,POLR2L;POLR1A;POLR2K;TAF1A;POLR1H;POLR1G;POLR2H;CAVIN1;ERCC2;TAF1D;UBTF;TAF1B;POLR2F;ERCC3;TAF1C;GTF2H2;GTF2H5;POLR1D
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.28237436810390704,0.7129986540562053,0.891566265060241,1.0,1.0,16/22,48.98%,CETN2;PARP1;CHD1L;CUL4B;UBA52;DDB2;DDB1;ERCC2;XPC;RBX1;UBC;ERCC3;XPA;RPS27A;GTF2H2;GTF2H5
prerank,Elsevier_Pathway_Collection__EGFR -> AP-1/CREB/ELK/SRF/MYC Signaling,-0.20008666793246857,-0.7125575908284673,0.890625,1.0,1.0,12/49,21.42%,EREG;FOS;MAP2K1;TGFA;BTC;RASGRP1;HBEGF;MAPK10;NRG3;MAP2K3;MAP2K6;JUN
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.20105463597565054,0.7124649381966983,0.9868995633187773,1.0,1.0,47/279,22.72%,HMGA2;SPDEF;DUSP9;PNMA3;E2F1;SFRP4;NEUROD1;DKKL1;MELK;ITGA6;TOP2A;FGD1;BMP4;RASGRF2;PHLDA3;ARHGEF11;DAPK2;OBSCN;SCRIB;UNC13B;TFAP4;SCIN;PRR7;SQSTM1;IAPP;USP27X;PLEKHG2;PLEKHN1;ANKRD1;ARHGEF2;ECT2;BMF;STPG1;BCL6;BARD1;ING5;OLFM1;CTSD;ARHGEF19;TGM2;FADD;MARK4;PDCD5;APBB1;IRF5;AIFM2;AIFM1
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.27567608345750444,0.7120117984005905,0.8875,1.0,1.0,14/27,43.82%,POLR2L;POLR2K;POLR2G;POLR2H;POLR2I;POLR2J;SUPT5H;RNMT;POLR2A;ERCC2;POLR2B;GTF2F1;POLR2F;ERCC3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.2585734899847846,-0.711240947377794,0.8953488372093024,1.0,1.0,5/18,20.37%,SFRP1;CD300A;NLRC3;MORC3;GSTP1
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.285142167799316,0.7101077738552739,0.9117647058823529,1.0,1.0,6/19,28.96%,SNAI2;ROCK2;CLDN5;SNAI1;F11R;NPHP4
prerank,Elsevier_Pathway_Collection__Skin Fibrosis,-0.18854267660739557,-0.7099036354862802,1.0,1.0,1.0,19/67,23.65%,TNF;MMP1;FOS;PDGFRA;MAP2K1;CCL2;IL6;IGF1;EDNRB;MAPK10;AGTR1;MAP2K3;MAP2K6;JUN;JAK2;STAT1;PDGFC;MAP2K4;IGF1R
prerank,Elsevier_Pathway_Collection__Fatty Acid Synthase (FASN) Signaling,-0.2540493396569827,-0.709863738802259,0.825,1.0,1.0,2/16,13.06%,KLF5;AKT1
prerank,Elsevier_Pathway_Collection__Androgen Receptor/Akt Signaling,-0.2209559747317188,-0.709645351656006,0.927536231884058,1.0,1.0,13/35,24.93%,ESR1;FOXO1;AKT1;BCL2;INPP5D;MAPK10;AR;MAP2K3;INPP4B;MAP3K5;MAP2K4;PTEN;NCOA1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.23815303450013012,0.7095844335728417,0.8961748633879781,1.0,1.0,11/54,24.92%,H3C13;H3C1;TESC;SCIN;H4-16;ZNF16;HDAC1;KMT2D;KMT2B;L3MBTL1;HMGB2
prerank,WikiPathway_2021_Human__Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.24860640120133737,0.7094925839991577,0.8723404255319149,1.0,1.0,7/36,21.00%,MAPK12;MAPK11;MAP3K9;IFI27;IFITM3;IFITM2;BST2
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,0.2667874593555138,0.7089437302552383,0.8228571428571428,1.0,1.0,12/29,30.29%,CYP17A1;CYP21A2;AKR1B15;LHB;HSD17B1;HSD11B2;FDXR;CD163L1;SRD5A3;POMC;TSPO;HSD17B11
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.2611366566590248,0.7085726867565352,0.8666666666666667,1.0,1.0,6/31,17.92%,MT3;SEMA7A;SEMA6C;SEMA5B;SEMA6B;SEMA3F
prerank,KEGG_2021_Human__Thyroid hormone synthesis,0.22855246143459243,0.7083684953565226,0.9368421052631579,1.0,1.0,15/68,21.35%,CGA;ATP1A2;ATP1A4;ATP1B3;DUOX1;CREB3L1;ADCY6;FXYD2;GPX3;PRKCA;CREB3L4;GPX2;ADCY4;DUOXA2;ADCY2
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.23075614876299752,-0.70816688715893,0.8625,1.0,1.0,10/24,27.93%,JPH3;JSRP1;AKAP6;DMD;JPH4;CLIC2;FKBP1B;CALM1;PDE4D;NOS1
prerank,Elsevier_Pathway_Collection__Advanced Glycation End Products Pathway in Diabetic Microangiopathy,0.2705433991178592,0.7080203295536286,0.8666666666666667,1.0,1.0,8/22,27.25%,NOX4;NOX1;PLAU;PDPK1;HRAS;PLAT;MAP2K2;ICAM1
prerank,"Elsevier_Pathway_Collection__Glioblastoma, Primary",0.24140487998815377,0.707807299748982,0.8941798941798942,1.0,1.0,11/48,21.80%,CDKN2A;SRC;FGF2;PDGFRB;PDGFB;PDGFA;SHC1;PDPK1;EGF;CDK6;PLCG1
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,0.30307814344760886,0.7077723632494545,0.8581081081081081,1.0,1.0,5/18,23.35%,NOTCH3;ATP2A1;ST3GAL3;NOTCH4;LFNG
prerank,KEGG_2021_Human__Fructose and mannose metabolism,-0.22416526557665226,-0.7077013480126235,0.9459459459459459,1.0,1.0,4/33,6.95%,HK3;TKFC;ALDOB;FBP1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.2888714243002525,0.7075115291942289,0.8715083798882681,1.0,1.0,5/19,15.10%,PRKAA2;CPT1B;CD36;ABCD1;ACACA
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.20879134113890205,0.7073746141787808,0.9669811320754716,1.0,1.0,26/111,25.67%,CALY;CLDN19;LRP4;ATP10A;CDC20;GPC3;ADGRL1;BIK;CDT1;GBA;NOX1;NEDD4L;RHOC;BMF;SLF2;RAPGEF3;MMP3;TGFB2;NRG1;TRABD2A;FRMPD4;TMED9;SHANK3;GPX1;RELN;PTPN23
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.2012490337747712,0.7070369414044686,0.9737991266375546,1.0,1.0,11/192,7.90%,C1QTNF3;PIK3R2;TRIM40;PRKAA2;PRDM15;ADGRG3;RNF157;MSTN;DLG5;SRC;ATP2B4
prerank,Elsevier_Pathway_Collection__TNFRSF5/6 -> RB1/E2F Signaling,0.3000349115862365,0.7065240723538777,0.8333333333333334,1.0,1.0,1/16,1.93%,E2F1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.21912589437358937,0.7063855656342286,0.9263157894736842,1.0,1.0,2/61,2.84%,PAX2;MAPT
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.24479214688239342,0.70604032963097,0.8526315789473684,1.0,1.0,8/47,16.88%,LMOD1;CCL26;BAIAP2L2;SPIRE2;CCL24;SCIN;CCL11;CDC42EP5
prerank,WikiPathway_2021_Human__TGF-beta receptor signaling in skeletal dysplasias WP4816,-0.20861351393148675,-0.7057700807455015,1.0,1.0,1.0,14/58,16.94%,IFNG;TNF;FOS;INHBA;NOG;WNT1;RUNX3;ITGB6;ZEB2;LEFTY2;RUNX2;SMAD9;THBS1;ADAMTSL2
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,0.28766880714407106,0.7052382713437463,0.8719512195121951,1.0,1.0,13/19,46.20%,RNASE1;HSP90AB1;UBA52;GFAP;PARK7;HSPA8;HSP90AA1;PLIN3;UBC;PCNT;LAMP2;EEF1A1;RPS27A
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.25585318988463585,0.7051557502600869,0.8579545454545454,1.0,1.0,4/33,11.29%,PLK1;SERF1A;PRKN;NR1D1
prerank,KEGG_2021_Human__Long-term potentiation,0.22505110634162176,0.7051226008508731,0.9035532994923858,1.0,1.0,10/59,18.91%,CALML6;GRIN1;CAMK2A;GRIN2A;CACNA1C;GRM1;PRKCA;HRAS;GRIN2C;RAPGEF3
prerank,WikiPathway_2021_Human__Signal Transduction of S1P Receptor WP26,0.2706128184935471,0.7049053431935717,0.8765432098765432,1.0,1.0,3/25,12.41%,MAPK12;SPHK1;RACGAP1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.23820328423643425,-0.7047738488641344,0.8918918918918919,1.0,1.0,22/22,76.20%,GDAP1;CYP26C1;OPA1;AFG3L2;MFN2;SPG7;MIGA1;CHCHD3;MIGA2;EEA1;MFN1;THG1L;MIEF1;VPS18;MFF;PLD6;MIEF2;USP30;BAX;VPS11;FIS1;STX4
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.21822540058552214,-0.704725663962184,0.8765432098765432,1.0,1.0,7/29,21.21%,HPGD;NOG;HEY2;ANGPTL3;BMPR2;HOXA1;SMAD7
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3088178535667301,0.7039929460058904,0.8372093023255814,1.0,1.0,6/15,38.99%,ARPC1A;WASHC1;TRIM27;ARPC5;MAGEL2;ARPC5L
prerank,KEGG_2021_Human__Tight junction,-0.17053707586392694,-0.7034488028312663,1.0,1.0,1.0,41/159,24.07%,CLDN4;CLDN10;CD1A;MARVELD3;PPP2R2B;CLDN8;CD1B;CD1D;CD1E;IGSF5;CD1C;DLG2;HCLS1;MYH11;PPP2R2A;CLDN1;BVES;TIAM1;PRKCE;CLDN11;DLG3;CFTR;ACTR3C;PRKAG2;EZR;MAPK10;PPP2CB;YBX3;MPDZ;PRKCZ;JUN;CLDN34;RAP1A;CLDN3;MAP3K5;AMOTL2;PPP2R2D;RAB8B;CLDN23;PRKACB;RAB8A
prerank,Reactome_2022__Protein Localization R-HSA-9609507,-0.16389712603327627,-0.7027743118173115,1.0,1.0,1.0,35/159,22.70%,OTOF;HAO2;GLYAT;ABCD2;PIPOX;DAO;ACAA1;PEX3;EHHADH;OTC;ACOX1;HAO1;EPHX2;CROT;DDO;GET4;PRNP;PHYH;HMOX1;MLYCD;HMGCL;AGXT;ACBD5;CYB5A;ACOX2;ACOX3;PECR;ACOT2;PXMP2;IDH1;GDAP1;SLC27A2;FXN;APP;LONP2
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.2362103637604028,-0.7026402379769284,0.8983050847457628,1.0,1.0,5/29,14.13%,ARHGAP40;PFN2;CXCL12;HCLS1;COTL1
prerank,WikiPathway_2021_Human__Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.27014294347764223,0.702436662781033,0.8773006134969326,1.0,1.0,4/27,11.57%,MPZ;RAB3B;HSPB1;NDRG1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Glaucoma,0.23005852558104192,0.7022639229445906,0.94,1.0,1.0,10/75,12.78%,EPHB2;SLC13A3;BMP4;CASP12;BDNF;HSPB1;LINGO1;FOXC1;SLC1A2;LOXL1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.265097539308744,0.7022536286935992,0.8834355828220859,1.0,1.0,4/25,14.95%,SCG2;IL11;RAMP2;PDPK1
prerank,Elsevier_Pathway_Collection__Lysophosphatidic Acid/LPARs Signaling,0.25626424291147387,0.7020658192672004,0.8611111111111112,1.0,1.0,6/36,18.91%,RASGRF1;LPAR4;PDPK1;PPARG;ROCK2;RAPGEF3
prerank,WikiPathway_2021_Human__Osteoblast differentiation WP4787,0.21526851782758794,0.7016885828128391,0.966824644549763,1.0,1.0,18/107,16.59%,PIK3R2;MAPK12;WNT4;WNT9B;WNT8B;MAPK11;BMP4;FGF2;IHH;NOTCH3;HES2;PRKD1;JAG2;WNT2B;PPARG;WNT6;PRKCA;HES6
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.24842664285866278,0.7014036296028029,0.8736263736263736,1.0,1.0,8/37,21.21%,THEM5;ACSL6;ACSM1;ACSM6;ACACA;THEM4;ACBD6;HMGCS1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.2572263375420641,0.7011978313006569,0.8920454545454546,1.0,1.0,22/33,47.39%,NEK2;AURKB;CCT3;CTNNB1;NEK7;PNKP;CCT8;CCT6A;CCT4;MAPK3;HNRNPA1;ACD;CCT2;CCT7;ATR;CCT5;FBXO4;MAPK1;MAP2K7;MAP3K4;TCP1;MAPKAPK5
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.21080533800808615,-0.7009121885342695,0.96,1.0,1.0,8/45,11.82%,GPD1;PLD1;LIPH;PLA2G2D;AGPAT2;PLA2G4A;DGKE;ABHD5
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.29587479518312265,0.7008277400351238,0.8395061728395061,1.0,1.0,6/15,35.45%,HDAC4;ELK4;HDAC1;SIRT6;HDAC8;SIRT7
prerank,Elsevier_Pathway_Collection__CFTR Facilitates Oxidative Stress in Airway Epithelium in CF,0.226869021384427,0.7006399857666833,0.9114583333333334,1.0,1.0,1/57,0.20%,SLC7A11
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.21266097791391603,0.7006121532135173,0.9468599033816425,1.0,1.0,25/121,26.05%,MT3;PRKAA2;MAPT;NOX4;PRR5L;NOX5;DHRS2;AKR1C3;PRKD1;TXNRD2;PYCR2;GPX3;GPX2;ROMO1;TXNRD1;NUDT2;MMP9;ANKRD2;PARP1;TMEM161A;ARNTL;STX4;GPX1;ATP13A2;AGAP3
prerank,Elsevier_Pathway_Collection__Intraflagellar Transport: Anterograde Transport,0.25252635406104945,0.7005593504072494,0.888268156424581,1.0,1.0,22/37,49.47%,BBS5;IFT81;BBS2;IFT27;BBS4;KIFAP3;KIF3B;DYNC2LI1;HSPB11;TTC30B;IFT80;IFT140;IFT172;IFT22;WDR35;KIF3A;BBS1;IFT74;TTC26;IFT43;WDR19;TTC21B
prerank,Elsevier_Pathway_Collection__MTOR/TP53 Regulates Cell Metabolism,-0.23081548679540143,-0.7000614593589752,0.8636363636363636,1.0,1.0,6/27,17.21%,GLS2;PCK1;FOXO1;G6PC;PANK1;MLYCD
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.27320805970527956,0.6996858147492759,0.838150289017341,1.0,1.0,9/22,35.25%,DNASE1L2;DNASE2B;H1-0;HMGB2;CECR2;DNASE1;EXOG;MUS81;DNASE1L1
prerank,Elsevier_Pathway_Collection__Endometrioid Endometrial Cancer,0.2165829941319842,0.6995199176120506,0.9447004608294931,1.0,1.0,6/91,9.24%,IGF2;LEF1;SRC;FGF2;ACTL6B;EZH2
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.2655632989649209,0.6993841211246385,0.8617021276595744,1.0,1.0,12/30,32.15%,TFAP2C;MYBL2;KCTD15;ATAD2;KDM5B;NPM1;MYC;NOP2;CDKN1A;UBE2I;APOE;KCTD1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2523789782979601,-0.6990896226848272,0.927710843373494,1.0,1.0,3/17,13.06%,NME5;VNN1;AKT1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.21066794721497473,0.6988436493780031,0.9768518518518519,1.0,1.0,18/117,14.86%,THY1;KISS1;MDK;CCL13;ANK1;FGD1;RHOBTB1;MAST1;CNTNAP1;MAST3;DIAPH3;MICAL2;PACSIN3;CSPG5;ARAP3;PALLD;CCL24;CCL11
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.25568376214198074,0.6988341941188753,0.9265536723163842,1.0,1.0,4/32,7.93%,CEL;GRIK2;BDNF;GRIK4
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.2721656161440095,0.6988096935753091,0.8630952380952381,1.0,1.0,3/21,14.88%,SULT4A1;BPNT2;SLC26A2
prerank,WikiPathway_2021_Human__Autophagy WP4923,0.2660385147889949,0.698183642168463,0.8516483516483516,1.0,1.0,1/30,2.82%,PRKAA2
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,0.29800413191971775,0.6981018528364489,0.8354430379746836,1.0,1.0,3/15,28.07%,JAG2;DLL4;UBA52
prerank,Elsevier_Pathway_Collection__TRPM8 Effects in Prostate Cancer (Hypothesis),-0.2665994593389881,-0.6978622837604308,0.900990099009901,1.0,1.0,5/15,21.42%,FOS;MAP2K1;TRPM8;AR;JUN
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.23086903046294763,-0.6977976879612848,0.9459459459459459,1.0,1.0,4/23,15.61%,IL1B;DDAH1;AKT1;ZDHHC21
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.26063052672049214,-0.6974324559559766,0.9038461538461539,1.0,1.0,15/15,73.96%,PATL1;XRN1;LSM5;DCP2;DCP1A;LSM1;LSM6;LSM3;DDX6;DCP1B;EDC4;LSM7;LSM4;LSM2;EDC3
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.24864415214298896,0.6973890620677982,0.921875,1.0,1.0,2/43,5.96%,IGF2;ERFE
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.26482025677646576,0.6972700953879625,0.8914285714285715,1.0,1.0,3/27,10.88%,IRAK1;IKBKG;IRAK2
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,0.2850590354150504,0.697205179091145,0.9024390243902439,1.0,1.0,3/18,15.60%,FABP4;PNPLA5;PRKCA
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.262070564130694,0.6971731230527851,0.893491124260355,1.0,1.0,15/27,43.71%,PRKN;HSPA2;HSF1;HSPA5;PACRG;DAB2IP;HSPA14;BAX;BAG3;HSPA8;HSPD1;DAXX;HSPA1L;ABCB10;PTPN1
prerank,TRRUST_Transcription_Factors_2019__NRF1 mouse,-0.2551507052463373,-0.6970817606496612,0.9078947368421053,1.0,1.0,1/18,0.57%,GRIN2B
prerank,Elsevier_Pathway_Collection__HPV E5 Regulates EDNRA and EGFR Signaling Pathway in Keratinocytes,-0.1969148981267804,-0.6970334285217178,0.9264705882352942,1.0,1.0,13/51,21.42%,PTGS2;FOS;MAP2K1;PLA2G4A;PTGER4;AKT1;RASGRP1;CASP7;BCL2;MAPK10;MAP2K3;MAP2K6;JUN
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,-0.19316115048973054,-0.696908985053626,0.9692307692307692,1.0,1.0,13/61,17.94%,PLXNA4;GLYAT;PCK1;FASLG;PPARGC1A;FOXO1;KLF4;CITED2;AKT1;BCL2L11;IGFBP1;BTG1;GADD45A
prerank,WikiPathway_2021_Human__Airway smooth muscle cell contraction WP4962,-0.27300430397345343,-0.6968954500715928,0.8160919540229885,1.0,1.0,6/15,25.98%,CD38;RYR1;ADRB2;ITPR3;MYLK;CALM1
prerank,Elsevier_Pathway_Collection__Lipogenesis/Lipolysis Activation in Cancer Cells and Cancer-Associated Adipocytes,0.2537522421718805,0.6968139570349701,0.8977272727272727,1.0,1.0,11/32,25.99%,FABP4;CD36;ACLY;PDPK1;ACACA;SCD;EGF;LPIN1;LIPE;LPCAT1;PTK2
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.19660384637412193,0.6967241719360227,0.9867256637168141,1.0,1.0,94/200,44.38%,NDUFA1;SLC25A12;ATP6AP1;NDUFS6;NDUFV1;COX6C;PDP1;MRPS12;ATP5MF;ATP6V0B;COX7B;NDUFA3;IDH3G;UQCRB;TIMM17A;TCIRG1;NDUFS2;NDUFA9;ATP5F1D;COX6B1;FH;CS;AIFM1;TIMM10;MDH2;NDUFA2;NDUFS7;COX8A;ATP6V0E1;UQCRQ;CYC1;ATP6V1C1;DLAT;SLC25A6;ATP6V1H;MGST3;MRPL15;ATP5F1E;NDUFA6;ATP5MC1;UQCR11;ATP6V1F;NDUFS8;CYB5R3;COX4I1;NDUFV2;ATP5ME;TIMM13;COX5B;ATP6V1E1;TIMM9;ACADVL;NDUFA8;NDUFB7;ATP1B1;HCCS;ETFB;UQCRH;NDUFAB1;NDUFB2;UQCRC1;BAX;MRPS15;OXA1L;PDHA1;COX7C;UQCR10;NDUFB3;NDUFS4;ECI1;SDHA;HSD17B10;GPX4;ATP5MG;NDUFB8;SDHC;COX6A1;GPI;COX17;TIMM50;HADHA;MTX2;TIMM8B;ATP5PO;NDUFA4;OGDH;SLC25A5;VDAC2;MRPS11;POLR2F;SUPV3L1;DECR1;NDUFB1;RHOT2
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.2092112686673508,-0.6966340808544446,0.8974358974358975,1.0,1.0,7/37,17.89%,LRRK2;GAS1;CRYAA;LCP1;MX2;REEP6;NDEL1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.2727626912433666,0.6963431374128641,0.88125,1.0,1.0,3/26,7.62%,S100A1;TERT;FGF23
prerank,Elsevier_Pathway_Collection__Clear Cell Ovarian Carcinoma,0.22357201201954083,0.696222525009665,0.93,1.0,1.0,11/81,16.35%,LEF1;CDC20;SRC;ACTL6B;PDGFRB;PDGFB;PDGFA;SHC1;PDPK1;HRAS;CHEK1
prerank,Elsevier_Pathway_Collection__Hereditary Hemorrhagic Telangiectasia,0.26835549802042374,0.695948709183184,0.9127906976744186,1.0,1.0,5/25,17.92%,PIK3R2;SRC;PDPK1;SMAD3;ACVRL1
prerank,Elsevier_Pathway_Collection__FibronectinR -> NF-kB Signaling,-0.247041439862587,-0.6957077123136858,0.896551724137931,1.0,1.0,7/17,29.69%,AKT1;VAV1;MAP2K3;MAP2K6;MAP2K4;NFKBIA;CRK
prerank,Elsevier_Pathway_Collection__Eosinophil Activation and Degranulation in Asthma,0.23880148954280112,0.6955141816393858,0.9166666666666666,1.0,1.0,9/43,18.50%,CCL26;SRC;CCR3;CCL24;CCL11;MADCAM1;TACR1;ROCK2;LIMK2
prerank,Elsevier_Pathway_Collection__AngiopoietinR -> AP-1 Signaling,0.24919310121131028,0.6954585168172731,0.8870056497175142,1.0,1.0,4/31,16.27%,RASGRF1;SRC;PDPK1;ANGPT2
prerank,Elsevier_Pathway_Collection__Find me Signal: Apoptotic Cell Attracts Phagocyte,-0.2617792801206515,-0.6953441980616385,0.8085106382978723,1.0,1.0,9/16,30.89%,CXCL8;CXCR3;CASP7;THBS1;CX3CR1;ABCA1;CASP3;ANXA1;CX3CL1
prerank,KEGG_2021_Human__Nucleotide excision repair,0.2336098224211478,0.6952485929753208,0.907608695652174,1.0,1.0,30/45,52.72%,RFC4;POLD1;CETN2;CUL4B;PCNA;DDB2;LIG1;DDB1;GTF2H2C;ERCC2;RPA2;XPC;RFC3;POLD3;RBX1;ERCC3;POLD4;XPA;ERCC1;RPA1;RFC1;GTF2H2;POLE2;GTF2H5;POLE4;RFC5;RFC2;POLE;MNAT1;CDK7
prerank,WikiPathway_2021_Human__Leptin signaling pathway WP2034,0.22664712276766608,0.6948211365097399,0.9317073170731708,1.0,1.0,11/76,16.51%,PIK3R2;PRKAA2;SRC;IKBKG;SOCS7;LEP;SHC1;LEPR;ACACA;HRAS;ROCK2
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.24497883801462125,0.6946565860951862,0.8947368421052632,1.0,1.0,35/35,75.54%,UGGT1;EDEM3;ENGASE;MLEC;UBA52;DERL1;UGGT2;VCP;MAN1B1;UBC;UBXN1;RPS27A;RNF103;CANX;PRKCSH;EDEM2;PDIA3;SYVN1;DERL2;MARCHF6;MOGS;CALR;TRIM13;AMFR;RNF139;PSMC1;NGLY1;GANAB;OS9;UBB;RAD23B;SEL1L;RNF5;RNF185;EDEM1
prerank,TRRUST_Transcription_Factors_2019__PPARG human,0.2266429426515383,0.6944633939833429,0.9226804123711341,1.0,1.0,8/63,11.46%,REN;FABP4;SLC2A4;CCNE1;GDF15;SOCS7;CPT1B;CD36
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.19946055709758082,0.6943400070834131,0.995575221238938,1.0,1.0,106/210,46.44%,HOXD3;GCM1;E2F1;ELL3;TSC22D1;TRIP13;ZBTB7B;PIR;KLF13;PMF1;PAX5;ELOC;NFIX;THRA;POLR2L;TRIM24;NAT14;TWNK;MNT;BCL3;ELOB;SCX;POLRMT;HSF2BP;DEAF1;PARP1;POLR2K;NELFE;TAF10;HSF1;GMEB2;TAF1A;RPAP1;MRPL12;POLR2G;TFB2M;POLR3K;SLC25A33;TCFL5;TAF6;POLR2H;POLR3H;POLR3A;SNAPC2;GTF3C5;NELFA;RBMX;POLR2I;POLR3G;MMS19;POLR2J;DRAP1;CTDP1;SSRP1;POLR3GL;NFE2L3;XAB2;PTMA;DRG1;SUPT5H;NELFB;NCOA6;TAF9;RO60;MBD1;RNMT;POLR2A;TAF5L;TAF1;ERCC2;GTF3C3;BAZ2A;ELL;POLR2B;UBTF;GTF2F1;MED16;CEBPD;PAX8;PKNOX1;TAF12;SUPT6H;POLR1C;NFKBIB;RNPS1;TAF1B;POLR2F;CDK9;NFIC;ERCC3;WDR61;TAF5;MED20;SUPT16H;ZNF345;CCNT2;TAF9B;DDX5;IVNS1ABP;TAF2;TCEA2;DEK;GTF2E1;PWP1;DTX1;TAF1C
prerank,WikiPathway_2021_Human__Ethanol effects on histone modifications WP3996,0.26092333739368917,0.6939528975645294,0.8863636363636364,1.0,1.0,8/31,22.14%,HDAC4;MTR;TYMS;HDAC5;MTHFR;HDAC10;EHMT2;HDAC1
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.28723778882713014,0.6938710496929854,0.8525641025641025,1.0,1.0,3/17,14.41%,NEK2;AURKB;RTEL1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.22766395347909726,0.6935785725693547,0.8984771573604061,1.0,1.0,6/50,13.75%,OLFM4;MDK;S100A10;CSPG5;PDPN;MELTF
prerank,KEGG_2021_Human__Renal cell carcinoma,-0.18542770919462076,-0.6935389428684102,0.9791666666666666,1.0,1.0,6/68,8.69%,PAK5;PAK6;HGF;MAP2K1;PIK3CD;TGFA
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.20154936182244904,-0.6934572685525127,0.9836065573770492,1.0,1.0,53/54,74.25%,RAB19;MAP1LC3C;MAP1LC3A;ATG5;GABARAPL1;TP53INP2;ULK2;RAB1B;UBXN2A;RAB7A;MAP1LC3B2;VMP1;TP53INP1;WDR45B;WIPI1;RAB23;STING1;BECN1;STX12;PIK3C3;ATG2B;ATG14;RAB1A;UBXN2B;ATG9A;WIPI2;MAP1LC3B;ATG2A;UBQLN1;ATG101;ATG16L1;TMEM41B;GABARAPL2;ATG12;UBQLN2;ATG3;ATG7;ATG13;ATG16L2;PACS2;AMBRA1;EMC6;ATG9B;ELAPOR1;NSFL1C;GABARAP;ATP2A2;ULK3;RUFY4;RAB43;ULK1;RB1CC1;ATP13A2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.27377613100533205,0.6932402035185758,0.8630952380952381,1.0,1.0,3/18,17.63%,CAMK2A;ARHGAP11B;THEM4
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.22451111243751845,-0.6931398476853564,0.9594594594594594,1.0,1.0,11/35,23.90%,TLR3;TLR8;TLR4;TLR2;OAS3;OAS2;RIOK3;DHX58;IFIH1;DDX58;OAS1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.2487053888360158,-0.6926819623199644,0.9054054054054054,1.0,1.0,5/18,22.05%,ST18;IL6;SPI1;JAK2;STAT1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.252052846202231,0.6925955108604552,0.8888888888888888,1.0,1.0,4/35,14.93%,MYMK;MYMX;DNM3;RABIF
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.2725330908152023,0.6924175673026582,0.8571428571428571,1.0,1.0,13/21,50.81%,MTG2;UQCC2;RPUSD3;MTG1;COA3;MPV17L2;FASTKD3;MRPS27;RPUSD4;MALSU1;RCC1L;TRUB2;TRMT10C
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.2994373379588806,0.6922648917888041,0.869281045751634,1.0,1.0,4/16,16.78%,ALOX12;PDGFB;PDGFA;ADAMTS18
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,0.2401089890207364,0.6922269951208198,0.8907103825136612,1.0,1.0,33/58,47.30%,PSMD4;PSMB4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;DERL1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;VCP;DERL3;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;ERLEC1;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.21362796170995352,-0.6920178099899608,0.9565217391304348,1.0,1.0,11/31,26.01%,ADRA1A;BMP10;SLC8A1;RGS2;PLN;ANK2;SMAD7;PIK3CG;CALM1;PDE4B;PDE4D
prerank,KEGG_2021_Human__Pentose phosphate pathway,-0.2237887278091309,-0.6919729407839811,0.9523809523809523,1.0,1.0,12/27,28.20%,ALDOB;FBP1;ALDOC;IDNK;PGM2;DERA;PGM1;PGD;RBKS;TKTL1;GLYCTK;RGN
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.28098037572729895,0.6913789460200372,0.8395061728395061,1.0,1.0,3/17,15.78%,RASIP1;ABL2;STMN1
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.2639622959936357,0.6913778511380178,0.8677248677248677,1.0,1.0,12/27,39.68%,WNT8B;AMER1;DVL2;PPP2R5A;CTNNB1;FZD2;LRP5;PPP2R1A;AXIN1;GSK3B;DVL3;CSNK1G2
prerank,MSigDB_Oncogenic_Signatures__VEGF A UP.V1 UP,0.19826467592310107,0.6913238720162919,0.9955947136563876,1.0,1.0,31/173,17.51%,LMOD1;THY1;CPA1;CABP1;INPP5J;EVX1;GRIK2;MTMR11;AKR1B10;CLIP2;TUB;DCX;GDF11;PPFIA4;PLA2G4C;IL32;ITIH4;NFKB2;PTGFR;RHBDD3;TLL2;GUCY2D;FBP2;RELB;HDAC5;ADORA2A;ETV2;PKD1;TM7SF2;KCNC3;EPHX1
prerank,Elsevier_Pathway_Collection__Estrogen Effects in Mitochondria in Alzheimer Disease,0.28143129883105705,0.691218692356297,0.8364779874213837,1.0,1.0,1/15,2.84%,MAPT
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,0.24929543288048442,0.6911200194860347,0.94375,1.0,1.0,4/31,12.73%,S100A1;IKBKG;CD36;NFKB2
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.22502341689357702,-0.6910829015209619,0.9240506329113924,1.0,1.0,8/30,25.00%,GYS2;ALDOB;PPP1R3C;GBE1;KHK;NHLRC1;DCXR;GALNS
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.2086924934202538,0.690962424169804,0.957345971563981,1.0,1.0,8/122,8.15%,LEF1;SFRP4;CELSR3;WNT4;WNT9B;AGO2;CAMK2A;PSMD4
prerank,WikiPathway_2021_Human__IL-1 signaling pathway WP195,-0.19506770185282252,-0.6907418581007703,0.9818181818181818,1.0,1.0,14/53,21.42%,IL1B;IL1RAP;MAP2K1;CCL2;PELI2;REL;PIK3R1;AKT1;MYD88;PRKCZ;TAB2;MAP2K3;MAP2K6;JUN
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.29791079165879725,0.6905191866527309,0.8650306748466258,1.0,1.0,1/15,2.98%,NODAL
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.24472750491308126,-0.6904600197027124,0.9080459770114943,1.0,1.0,6/21,25.85%,MITF;TWIST1;JUN;FOSL1;MED4;HNF1B
prerank,MSigDB_Oncogenic_Signatures__MTOR UP.N4.V1 UP,0.19983463792582065,0.6903416556137487,0.9864253393665159,1.0,1.0,49/179,29.50%,SLC7A11;SLCO4A1;ASPHD1;ARG2;SLC39A4;SDF2L1;OPRL1;SLC6A9;CYTL1;KIF21B;ARL4A;CNIH4;PIR;CDRT1;VLDLR;ACACA;ULBP1;RRP12;DBN1;ADAM9;MAP1A;GLRX2;E2F5;GAS2L1;RRP15;ADM;CDK16;PECAM1;GOT1;USH1C;OGN;STX4;PDXK;RRP9;DNMT3B;RPAP1;MAST2;TFPT;BCAT1;RABEPK;HYAL3;VPS54;DDIT3;CCDC86;DLEU1;CTSG;TUBB2A;NUP155;TSC22D3
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.26274460885114514,0.6903225758380093,0.8950617283950617,1.0,1.0,10/25,42.04%,GPAA1;PIGZ;PIGC;PIGM;PIGU;DPM2;PIGF;PIGT;PGAP1;PIGX
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,0.23194256120662834,0.6898452431412047,0.9171270718232044,1.0,1.0,23/52,46.07%,EXOSC4;EXOSC5;EDC3;PABPC1;LSM2;LSM4;LSM7;CNOT3;CNOT10;TUT7;EXOSC2;DCPS;EDC4;CNOT6;CNOT6L;CNOT9;EXOSC1;EXOSC7;EXOSC9;CNOT1;DCP1B;TUT4;EIF4A3
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.2430883992771177,-0.6897085253323527,0.926829268292683,1.0,1.0,18/18,75.71%,ALK;BCL2A1;STAT3;KIF5B;CLTC;CEBPB;FN1;STAT5A;ZC3HC1;RPS6;MAPK1;RBX1;EML4;MAPK3;SKP1;CUL1;MECP2;NPM1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.209480566507291,-0.6894906658606995,0.9466666666666667,1.0,1.0,3/33,6.68%,BMP5;FASLG;TNFSF10
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.2901950248028576,0.6889880368500738,0.8354430379746836,1.0,1.0,6/16,33.80%,MAP3K8;IKBKG;UBA52;TNIP2;CUL1;SKP1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.25479703815320304,-0.6889780266681811,0.8924731182795699,1.0,1.0,1/15,1.54%,MFSD2A
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.26228053996725065,0.6889610067293381,0.8529411764705882,1.0,1.0,16/26,47.20%,CETN2;PARP1;CHD1L;CUL4B;UBA52;DDB2;DDB1;ERCC2;XPC;RBX1;UBC;ERCC3;XPA;ERCC1;RPS27A;GTF2H2
prerank,Elsevier_Pathway_Collection__Cancer Cells Inhibit Adipocyte Differentiation,0.26920882574033744,0.6889136755402139,0.8685714285714285,1.0,1.0,5/25,18.64%,AXIN2;IL11;IL6R;PPARG;TRAF2
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.2014790302840908,0.6886942242037696,0.9771689497716894,1.0,1.0,32/139,22.98%,PIK3R2;PLPP2;SHC3;LPAR4;AVPR2;SPHK1;DGKI;PIP5K1B;PDGFRB;DNM3;PLA2G4C;DGKD;PDGFB;PTGFR;PLA2G4F;PDGFA;SHC1;ADCY6;GRM1;PRKCA;PLPP1;HRAS;MRAS;EGF;ADCY4;RAPGEF3;TSC1;ADCY2;RALGDS;PLCG1;TSC2;PLA2G4E
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.23042544521582434,0.6885493931941268,0.9315789473684211,1.0,1.0,13/70,18.02%,PAK3;MAPT;SNCG;LRP4;SDK1;PPFIA3;PPFIA4;CBLN1;PPFIA2;SMAD3;SDK2;SLC8A3;NLGN2
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.2641068013711855,0.6885385037270236,0.8728323699421965,1.0,1.0,4/22,12.24%,ACSBG2;ACSL6;ACSL4;ELOVL3
prerank,Elsevier_Pathway_Collection__Ras Signaling,0.24446154727442376,0.6878991301911916,0.9239766081871345,1.0,1.0,7/33,25.26%,TERT;SPHK1;RIN1;PDPK1;RALGDS;FNTA;ZDHHC9
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",0.23527191072549247,0.6878723084915606,0.9184782608695652,1.0,1.0,6/52,12.73%,MAPK12;MAPK11;IRAK1;IKBKG;IRAK2;NFKB2
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.27547250747544,0.6876960908398965,0.8351648351648352,1.0,1.0,1/22,1.74%,HOXB8
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.19137274579442112,0.6876037913147014,1.0,1.0,1.0,114/401,32.00%,CHGB;IGF2;PAPPA2;SCG2;SPARCL1;AMBN;SPP1;NOTUM;EEF1A2;MATN3;PHEX;TGM3;BMP4;GPC3;DMBT1;FGF23;IGFBP2;AGO2;ABCA3;PRKN;MRPL55;PGA5;TIMP1;VGF;LOXL2;UBE2S;MRPS21;MRPL24;MFGE8;LAMC1;STC2;APOA2;VWA1;LMCD1;MELTF;UBL4A;ABL2;QPCT;RPL8;NTAQ1;ADORA2A;VCAN;CKAP4;MRPS12;TMEM132A;B4GALT7;LOX;DUSP12;MRPL13;MRPL9;HM13;MRPS14;LGALS1;RPL30;RPLP1;NAPSA;PCSK9;PLAT;HARS2;FDXR;PRKDC;TMEM208;RPS27;RPS21;RPLP2;FSTL3;FBN1;NAGPA;EIF4EBP2;MRPL23;RPS5;F5;MRPL28;NEDD8;IGF2BP3;CDKL3;MRPL52;RPL28;FARSB;RPS14;RPL10;SEC11C;COPS5;RPSA;CTSH;UBE2M;CHEK2;RPL39;UBA52;CTSG;NCSTN;RPLP0;RPS15;RPS2;RPL31;HARS1;RPS19;GAS6;RPL36;ST3GAL1;RPL37A;UBE2I;APOE;RPL37;RPL7;DAB2IP;RPS4X;CPE;MGAT4A;RPS20;IGFBP7;MRPL36;RPL13;BAP1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.22830781631824965,0.687096985189854,0.9278350515463918,1.0,1.0,13/61,29.05%,LEF1;CDKN2A;CDK1;CCNB1;THRA;TRIM28;MED12;CTNNB1;MECP2;CDKN1A;MED31;MED7;MED27
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.23391984572487712,-0.6865333154045999,0.9047619047619048,1.0,1.0,3/26,10.84%,A4GNT;ST8SIA6;GCNT1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.2775718410500865,0.685937820253571,0.8947368421052632,1.0,1.0,10/19,38.96%,PTP4A3;CCT3;CEP295;DKC1;TREM2;CCT8;CCT6A;CCT4;CCT2;CCT7
prerank,Elsevier_Pathway_Collection__Proteins Involved in Low-Grade Serous Ovarian Carcinoma,-0.19999657181084257,-0.6859043006274046,0.9666666666666667,1.0,1.0,4/47,8.69%,MSLN;FOS;ESR1;TGFA
prerank,WikiPathway_2021_Human__Senescence and Autophagy in Cancer WP615,-0.17651674479869237,-0.6852441732902841,0.9761904761904762,1.0,1.0,30/101,24.12%,CXCL14;IFNG;SLC39A2;IL1B;INHBA;IGFBP3;CCL3;TNFSF15;MAP2K1;IL6;IGFBP5;CXCL8;SERPINB2;IGF1;ING1;CXCL1;THBS1;BCL2;MAP1LC3C;VTN;IFI16;IL24;MAP2K3;JUN;MAP1LC3A;ATG5;IGF1R;PTEN;LAMP1;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.2029927177073766,-0.6851938406555177,0.9538461538461539,1.0,1.0,12/45,20.37%,EREG;SFRP1;PDGFRA;WNT2;WNT1;CD300A;IGF1;NLRC3;MORC3;DDR2;WNT5A;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.26681605759127025,0.685114730249201,0.8895705521472392,1.0,1.0,1/24,1.00%,MRAP2
prerank,KEGG_2021_Human__Platelet activation,0.20782911273849242,0.6847653341633204,0.9863013698630136,1.0,1.0,15/121,16.94%,PIK3R2;MAPK12;F2RL3;VWF;ITGA2;MAPK11;SRC;COL1A1;PLA2G4C;PLA2G4F;COL1A2;ADCY6;GP9;ROCK2;MYLK2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2409327827396752,0.68463431049426,0.8864864864864865,1.0,1.0,3/36,8.09%,LEF1;AGO2;CAMK2A
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.1683888241679692,-0.6845593860490926,1.0,1.0,1.0,17/128,15.00%,IGLL5;SLC7A8;FOS;ITK;FCER1A;PRKCQ;FYN;LCP2;BTK;CARD11;RASGRP4;PIK3R1;RASGRP1;SYK;PLCG2;FCER1G;VAV1
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,0.24662603852256676,0.684422019255616,0.9230769230769231,1.0,1.0,24/38,51.21%,IFT81;DYNLRB2;DYNLL1;IFT27;DYNLRB1;KIFAP3;TTC30A;KIF3B;DYNC2LI1;HSPB11;TTC30B;IFT80;IFT140;IFT172;IFT22;WDR35;KIF3A;IFT74;TTC26;IFT43;WDR19;TTC21B;TNPO1;CLUAP1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Fragile X Syndrome,0.2834861405679446,0.6843957070509402,0.8956043956043956,1.0,1.0,4/18,19.77%,BDNF;GRM1;KCNT1;MMP9
prerank,Elsevier_Pathway_Collection__EGFR Signaling,0.22281372462682827,0.6840725977464714,0.9459459459459459,1.0,1.0,11/52,26.07%,RASGRF1;SRC;SHC1;PDPK1;EGF;RALGDS;PLCG1;TSC2;MAP2K2;PTK2;MYC
prerank,Elsevier_Pathway_Collection__MacrophageR -> CEBPB -> NF-kB Signaling,-0.27060062720394257,-0.6838888637570828,0.8795180722891566,1.0,1.0,5/15,15.99%,HCK;AKT1;SYK;FGR;ITGB2
prerank,WikiPathway_2021_Human__Translation inhibitors in chronically activated PDGFRA cells WP4566,0.23591493798806346,0.6835072039141076,0.9027027027027027,1.0,1.0,2/46,4.15%,PIK3R2;PDK1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.2717280442596244,0.6834549987345203,0.9,1.0,1.0,5/20,18.38%,CRHR2;GRIN2A;RGS14;SLC8A3;GRIN2C
prerank,WikiPathway_2021_Human__Cell migration and invasion through p75NTR WP4561,0.25634402273673207,0.6834391782457444,0.8743169398907104,1.0,1.0,4/30,8.21%,EFNA3;EFNA4;BDNF;EFNA1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.2331133675768957,0.683391755265855,0.9312169312169312,1.0,1.0,9/47,20.21%,RAMP1;ARR3;DNM3;CD36;RAMP2;SAG;GRK3;NEDD4;ADM
prerank,TRRUST_Transcription_Factors_2019__MYOD1 mouse,0.24490207951837276,0.6833741928095126,0.9119170984455959,1.0,1.0,12/40,22.84%,SNAI2;MYF6;CDC6;CDON;DCX;ATP9A;CDKN1C;ZBTB18;ITGA7;ANKRD2;SMARCA4;CDH15
prerank,WikiPathway_2021_Human__Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,-0.19484040433628175,-0.6833317883047111,0.9827586206896551,1.0,1.0,5/55,8.49%,CXCL10;IFNG;TNF;TKFC;CXCL12
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,-0.22869977590378673,-0.6832492712078095,0.8732394366197183,1.0,1.0,7/24,23.34%,PIK3R5;PIK3R1;PLCG2;VAV1;IRS2;JAK2;PIK3CG
prerank,Elsevier_Pathway_Collection__Glutamate Mediated Excitotoxicity in Amyotrophic Lateral Sclerosis,-0.26118712171804637,-0.6832188809337596,0.8314606741573034,1.0,1.0,3/15,13.06%,XDH;DAO;AKT1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.25926948629053276,0.682892599368296,0.9065934065934066,1.0,1.0,8/29,31.95%,CCNF;CEP131;STIL;CEP295;NPM1;CHMP2A;FBXW5;ALMS1
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.22321225116922672,0.6828025033680293,0.95,1.0,1.0,37/69,48.20%,TBC1D16;MTMR3;STIL;TBC1D8;GSN;TBC1D10A;CEP295;NPM1;TBC1D13;KIF9;SGSM3;TBC1D9B;ATXN2;ATXN2L;VPS11;STX18;ALMS1;TBC1D17;NPRL3;DYNC2LI1;CDKL5;NPRL2;TBC1D20;SDCCAG8;IFT140;TBC1D14;TRAPPC12;TBC1D12;TBC1D5;CDKL1;MSN;TBC1D2B;RABEP2;ATG3;TSG101;UBQLN2;TBC1D10B
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.19619307756499169,0.682791892620526,0.9914893617021276,1.0,1.0,27/211,16.65%,E2F1;PIK3R2;TERT;CDKN2A;BUB1B;CDC20;CCNB2;E2F2;MSX1;CCNE1;CDKN2C;FDPS;CCNA2;CCNE2;IKBKG;PTTG1;CDKN2B;NFKB2;CREB3L1;KAT2A;ADCY6;RELB;HRAS;CREB3L4;ELK4;CHEK1;SMAD3
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,0.20466450182531531,0.6823889638389353,0.9858490566037735,1.0,1.0,46/143,31.04%,CYP17A1;CYP21A2;CYP7A1;SQLE;AMACR;FDPS;AKR1B15;AKR1C3;MVD;LHB;AKR1C1;ACACA;SREBF2;HSD17B1;PKMYT1;DAND5;AKR1C2;HMGCR;TM7SF2;SCD;IDI1;LBR;PMVK;NSDHL;CH25H;FDFT1;GPAM;HSD11B2;HMGCS1;FDXR;CYP51A1;CD163L1;LIN9;SMARCD3;INSIG2;SRD5A3;SYCP2;ARV1;POMC;TSPO;HSD17B11;PIAS4;GGPS1;UBE2I;FASN;CYP27B1
prerank,WikiPathway_2021_Human__p53 transcriptional gene network WP4963,0.2226018062929313,0.6822452843641443,0.9536082474226805,1.0,1.0,17/64,28.26%,SLC7A11;TP53AIP1;ADGRB1;ULBP1;TNFRSF10D;MSH2;BBC3;TP53I3;ISG15;CPT1C;IRF5;DRAM1;PRKAB2;GPX1;ULBP2;ICAM1;CDKN1A
prerank,Elsevier_Pathway_Collection__NTRK -> AP-1/CREB/ELK/SRF/MYC/SMAD3/TP53 Signaling,0.22531187296676042,0.6822440136606326,0.9505494505494505,1.0,1.0,8/50,16.65%,RASGRF1;SRC;BDNF;MAPKAPK2;SHC1;PDPK1;ELK4;SMAD3
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.22762735772507117,0.6821506243128534,0.9408602150537635,1.0,1.0,10/56,19.77%,PTPRN;MAPT;STK26;AKR1C3;TXNRD2;APOD;ADAM9;GLRX2;ROMO1;MMP9
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2733107214093289,0.6819459715365508,0.8795180722891566,1.0,1.0,3/18,10.09%,PRKN;HSPB1;NOL3
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.26950416636654806,0.6818786501728793,0.8988095238095238,1.0,1.0,11/22,33.58%,TTLL10;NAA10;TTLL4;TPGS1;PARP1;TTLL11;TTLL1;AGBL5;NAA80;CEP41;TTLL3
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.24899605979411943,0.681585896829486,0.9209039548022598,1.0,1.0,2/35,6.38%,HAVCR1;GPC3
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.22826211797364063,-0.6814249038620402,0.95,1.0,1.0,2/25,3.58%,CHAC1;ADAMTS13
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.2925634147383286,0.6810310069796421,0.8376623376623377,1.0,1.0,5/17,20.07%,PDGFRB;SOX18;ACVRL1;NOTCH4;ACVR2B
prerank,Elsevier_Pathway_Collection__STAT3 and NFkB Activate Inflammation-Induced Tumorigenesis,0.22668741354423202,0.6807337299114637,0.9424083769633508,1.0,1.0,13/65,19.77%,BIRC5;SRC;FGF2;IRAK1;IL11;IKBKG;CCNB1;IL6R;SHC1;EGF;MSH2;TRAF2;MMP9
prerank,Elsevier_Pathway_Collection__Ovulation Block,0.2565167831726324,0.6805739969465079,0.9022988505747126,1.0,1.0,4/30,14.95%,RASGRF1;AMH;MAPKAPK2;PDPK1
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,-0.2528934517629869,-0.6803679717597992,0.9310344827586207,1.0,1.0,18/18,74.73%,NCOA1;MBD4;HELZ2;SREBF1;TBL1XR1;CHD9;RXRA;RORA;PPARA;CARM1;EP300;CREBBP;CPT1A;NCOA6;NCOA2;TBL1X;SMARCD3;LIN9
prerank,Elsevier_Pathway_Collection__DRD2 Expression Targets,0.2334899176941247,0.6803337377589008,0.9081081081081082,1.0,1.0,6/38,14.95%,RASGRF1;SRC;BDNF;MAPKAPK2;SHC1;PDPK1
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.2345757126328655,-0.6802859257842273,0.9479166666666666,1.0,1.0,10/21,33.31%,MCUB;MICU1;AKAP1;PHB2;MAIP1;SLC8B1;AFG3L2;SPG7;YME1L1;MICU2
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.2311168450006523,0.6801731645717217,0.9123711340206185,1.0,1.0,21/46,38.39%,SAXO1;KCTD17;MARK4;GPSM2;NUP62;PLK4;CROCC;PIP4K2B;ASAP1;SPAG5;BBS4;RAB3GAP2;STX18;SDCBP;DYNC1H1;G3BP1;ELAPOR1;CAPG;CNOT6;CNOT6L;HTT
prerank,MSigDB_Oncogenic_Signatures__GLI1 UP.V1 DN,-0.2385178442366626,-0.6796229312468811,0.9545454545454546,1.0,1.0,3/24,8.82%,SLC22A1;CYP3A7;RSAD2
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.24232053097672857,0.6796169761641372,0.9027027027027027,1.0,1.0,6/40,15.04%,CHRNB2;CBR3;HRH3;SLC1A4;CHRNA4;SHROOM4
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.2793985096245989,0.6794640438626727,0.8947368421052632,1.0,1.0,1/19,1.68%,PLA2G2A
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.2516402284812615,0.679194135665913,0.8830409356725146,1.0,1.0,14/28,46.16%,RNASE1;KHNYN;NHP2;SLFN14;POP1;ZC3H12B;RNASE4;TOE1;CPSF3;RNASE2;TRIR;PCF11;POP7;RNASEH1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.1865861175042793,0.6790710302676014,1.0,1.0,1.0,120/428,32.51%,REN;PIK3R2;PAK3;TP73;PRKAA2;MAPT;VWF;POU4F1;MAPK11;FGD1;SRGAP3;RASD2;FAM83D;CASTOR2;PIP5K1B;BOP1;EXO1;ARHGAP11B;AURKB;ARHGAP44;HSPB1;ZNF385A;RRS1;IKBKG;CDK1;PPP1R16B;RASGRF2;AURKA;ARHGEF11;DAPK2;RACGAP1;ARHGAP39;ARHGAP11A;SMYD2;ARAP3;GBA;OBSCN;RFC4;ARHGAP28;SQSTM1;PDPK1;PLEKHG2;ARHGEF2;CHEK1;ECT2;RHOC;ARHGAP33;BARD1;CASTOR1;ING5;MOB3B;DNA2;TRAF2;RMI1;BCL3;CDK5R1;ARHGEF19;WDR54;TPX2;SRGAP2;EHMT2;ARHGAP4;STARD13;ATRIP;RAD9B;HDAC1;TAOK2;GPR143;ARHGAP26;NF2;L3MBTL1;BLM;OCRL;TAF10;MCF2L;PRKAB2;RHNO1;CDK5;A2M;PIP4K2B;BCR;NGEF;ARHGAP45;TBCK;RHOU;NOP2;CHEK2;GNAI1;PLEKHG5;CHD3;TRAF5;ANKRD54;CHD4;NUAK1;RHOD;PPP1R13L;TAF6;ULK4;ARAP1;TELO2;PIN1;PRDM11;HIPK2;MAP4K4;STYXL1;RRAS;RBBP7;PIDD1;TREM2;DAB2IP;WWC3;TP63;ARHGEF16;ITGAV;RAD1;PRKAR2A;BRIP1;MLST8;RMI2;GRM2
prerank,WikiPathway_2021_Human__Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.2842607971725276,0.6786700158892757,0.8431372549019608,1.0,1.0,8/16,43.08%,EZH2;JARID2;RBBP7;EZH1;EED;TRIM35;ELL;RBBP4
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.22006006580699414,-0.6785986265123645,0.9615384615384616,1.0,1.0,12/27,25.74%,SLC10A1;SLCO1B3;AKR1C4;STARD5;SLCO2B1;SLCO1B1;SLC27A5;NR1H4;ABCC3;SLC51A;NCOA1;SLC51B
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.23063083722493422,0.6785630377537669,0.9114583333333334,1.0,1.0,10/47,21.80%,JCAD;FGF2;HSPB1;PRKD1;PDGFB;PDPK1;PRKCA;FGF18;FOXC2;PLCG1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.23977569328904993,0.6777530221167513,0.9171270718232044,1.0,1.0,7/41,15.43%,CFAP46;KIF20A;PLK1;DCX;SPEF1;FOXJ1;PSRC1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.22431763040394181,0.6776298853132141,0.9518716577540107,1.0,1.0,3/68,4.18%,H3C13;HOXB8;H3C1
prerank,Elsevier_Pathway_Collection__Glutamate Mediated Excitotoxicity in Glaucoma,0.26838125744119967,0.6775633252083542,0.9230769230769231,1.0,1.0,5/20,22.72%,SLC1A2;PDPK1;GRM1;SLC1A3;AIFM1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.279444102898338,0.6769875505300247,0.8622754491017964,1.0,1.0,8/16,35.52%,PIEZO2;PKDREJ;PKD1;PTK2;CTNNB1;PIEZO1;TCAP;PKD1L1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.17111953947005942,-0.6767255636934374,0.9807692307692307,1.0,1.0,25/110,23.65%,FOS;ITK;FCER1A;PRKCQ;LCP2;BTK;CARD11;LAT;PIK3R1;SYK;LAT2;PLCG2;FCER1G;VAV1;PIGR;LILRA4;VAV3;MAPK10;PPP3CA;TAB2;NFATC2;JUN;MS4A2;GAB2;MAP2K4
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.183052920268462,-0.6765517955622435,0.9622641509433962,1.0,1.0,13/68,22.36%,GCK;IFNG;CBFA2T3;FBP1;ENTPD5;IGF1;GCKR;PRKAG2;NCOR1;SLC4A4;PFKFB3;PGAM1;APP
prerank,Elsevier_Pathway_Collection__mTOR Signaling Hyperfunction,-0.20623126930538532,-0.6763035154250316,0.9850746268656716,1.0,1.0,5/46,13.84%,GCK;TNF;MAP2K1;AKT1;IGF1
prerank,TRRUST_Transcription_Factors_2019__SREBF2 human,-0.2465270195414748,-0.6762293952629044,0.8617021276595744,1.0,1.0,6/19,16.80%,PRSS8;ABCG8;ABCG5;PON1;MTTP;LIPC
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,0.21414601045818135,0.6760052381612988,0.9633507853403142,1.0,1.0,45/76,50.35%,ELOC;POLR2L;ELOB;POLR2K;NELFE;TAF10;POLR2G;TAF6;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;DMAP1;TAF9;POLR2A;TAF1;ERCC2;ELL;POLR2B;GTF2F1;TAF12;SUPT6H;POLR2F;CDK9;ERCC3;TAF5;SUPT16H;CCNT2;TAF9B;TAF2;GTF2E1;GTF2H2;PAF1;LEO1;MLLT1;CDC73;NCBP2;GTF2H5;TAF7;GTF2A2;TAF4
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.22863362919258548,0.6755301419518318,0.9459459459459459,1.0,1.0,1/50,0.15%,HMGA2
prerank,MSigDB_Oncogenic_Signatures__CAMP UP.V1 DN,0.19580943000445264,0.6755021938565718,0.990909090909091,1.0,1.0,18/189,12.12%,PAEP;TSPAN5;PAK3;BSN;DLG5;RASD2;NTM;ASAP2;ATP2B4;TSC22D1;TMEM98;TARBP1;FAM189B;PFKFB4;TUBA4A;NDRG1;NUDT11;ATP9A
prerank,Reactome_2022__CaM Pathway R-HSA-111997,-0.22088148217774345,-0.6753349797974344,0.9583333333333334,1.0,1.0,5/31,12.13%,PRKAR2B;CAMK4;CAMK2B;ADCY5;PDE1B
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,0.30058240314572277,0.6751949336214181,0.8895705521472392,1.0,1.0,1/18,2.10%,PIK3R2
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.2176659673039929,-0.6749415879908652,0.9101123595505618,1.0,1.0,5/25,17.54%,CCR7;HSD3B1;NKX3-1;THBS1;ABHD2
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,0.2607814175354489,0.6748732719051345,0.8681318681318682,1.0,1.0,3/27,15.74%,NOX4;FLT3LG;HRAS
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.17403404194175445,-0.67474366442241,0.9821428571428571,1.0,1.0,17/75,20.37%,PRKAR2B;IL1B;PKIB;PAQR3;CD300A;BMP7;SLC8A1;PKIA;RGS2;AKT1;SORL1;HEXIM1;SPRY2;GADD45A;DUSP1;MYOCD;GSTP1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.24851980007689353,-0.674685655468693,0.8539325842696629,1.0,1.0,15/15,75.17%,CMTR1;METTL8;NSUN2;METTL14;WTAP;CBLL1;ZC3H13;TRMT10C;TRMT61B;PCIF1;TRMT6;METTL16;VIRMA;TRMT61A;METTL3
prerank,Elsevier_Pathway_Collection__CD157 -> cADPR/Calcium Signaling,0.26819332259259415,0.6744692543854378,0.8875739644970414,1.0,1.0,5/21,24.71%,RASGRF1;LIMK2;PECAM1;PLCG1;MAP2K2
prerank,Elsevier_Pathway_Collection__VEGFA in Neovascular Glaucoma,0.23768716669106116,0.6741514262577674,0.9101123595505618,1.0,1.0,5/39,14.95%,RASGRF1;SRC;HSPB1;FLT1;PDPK1
prerank,Elsevier_Pathway_Collection__OPTN Effects on NF-kB Signaling in Glaucoma,-0.2173883941190364,-0.6740061378640632,0.95,1.0,1.0,2/26,5.29%,TNF;FASLG
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.25757730885771746,0.6733841859122447,0.8685714285714285,1.0,1.0,3/21,14.16%,CRP;LPL;HILPDA
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.23283766886306384,0.6732242865114979,0.9319371727748691,1.0,1.0,11/40,26.12%,SOX2;PLK5;SPHK1;PDGFB;SHC1;ACVRL1;TWF2;ACVR2B;EMD;MYC;CTNNB1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.18407507636838394,0.6732014715976998,1.0,1.0,1.0,70/390,23.19%,EPHB2;WNK4;CDKL4;PAK3;PRKAA2;BRSK2;PDK1;CERKL;NEK2;MELK;PLK1;TRIB2;BIRC5;SPHK1;IRAK1;DGKI;CAMK2A;NUAK2;CCNE1;MAP3K9;LMTK3;CILK1;AURKB;PRAG1;STK26;MAST1;CDK1;PRKD1;ADM2;AURKA;COQ8A;DGKD;DAPK2;CERK;PDGFB;NEK3;MAPKAPK2;TSSK6;CCL11;PDPK1;PIM1;PRKCA;MEX3B;HTR2B;CHEK1;GRK3;ROCK2;PASK;TSSK3;RNASEL;ACVRL1;LIMK2;AAK1;CDK6;FAM20B;ACVR2B;FGGY;DYRK3;CDK16;TGFB2;MAP3K6;MATK;MARK4;MAP4K2;HUNK;LIPE;TAOK2;FASTK;PRKDC;GRK6
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.2599633336721435,0.673029955511713,0.8837209302325582,1.0,1.0,6/26,20.23%,VIL1;PRKN;ASAP3;ROCK2;FHOD1;TSC1
prerank,WikiPathway_2021_Human__Genotoxicity pathway WP4286,0.22763009847869006,0.6726092282903468,0.94,1.0,1.0,11/52,24.73%,E2F7;CENPE;E2F8;PHLDA3;AMER1;MEX3B;AEN;TP53I3;RPS27;ITPKC;PRKAB2
prerank,Elsevier_Pathway_Collection__NGFR -> MEF Signaling,0.25735856432278886,0.6725094431260653,0.8647058823529412,1.0,1.0,4/22,18.64%,MAPK12;BDNF;MEF2D;TRAF2
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,0.24702822882994174,0.6714643983686887,0.9485714285714286,1.0,1.0,3/27,10.52%,KIF4A;SRC;DNM3
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.2248536130227084,0.6709038211161824,0.9344262295081968,1.0,1.0,21/49,38.66%,ADGRB1;VPS28;PRR7;SQSTM1;ISG15;SH3RF2;SVBP;PARK7;ARRB1;PRMT3;HDAC8;OGT;GTPBP4;PINX1;CAMLG;TNFAIP3;SIRT7;GNL3L;ABL1;RPS3;TAF1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.26179535884953453,0.6708382144826786,0.9022988505747126,1.0,1.0,9/21,38.94%,PTGES3L;PSMG3;HSP90AB1;HSPA4;PFDN6;LONP1;HSPD1;CCT2;HSP90AA1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.2262851357634942,-0.67082575421826,0.9529411764705882,1.0,1.0,3/22,12.02%,PNP;XDH;MTHFD1
prerank,WikiPathway_2021_Human__Kit receptor signaling pathway WP304,0.2252956916967923,0.6704936990723055,0.9319371727748691,1.0,1.0,4/59,6.66%,PIK3R2;MAPT;SNAI2;SRC
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.19904216790849152,0.6702561683433902,0.971830985915493,1.0,1.0,28/138,25.85%,SIX1;SIX4;BMP4;MSX1;COL1A1;TUB;FAM83H;CD68;LMNA;OBSCN;ABCA7;TULP3;BBS2;ROPN1B;ZNF423;GBP2;OBSL1;CEP250;CEP68;STX1A;ISG15;TSPAN10;SEC61G;CROCC;EMD;BICD1;TSPAN17;DVL1
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.20670513883218286,0.670082393680026,0.9853658536585366,1.0,1.0,29/104,30.76%,HDAC4;LOXL2;LOXL1;NSMCE2;BLOC1S1;LOX;PIAS3;P3H4;RNF113A;NUP37;NNAT;HDAC10;STX1A;EYA1;PIAS1;TRIM28;NUP62;PLOD3;TPR;NUP133;TRPM4;RANGAP1;P3H3;NUP155;NUP160;PARK7;SENP1;PIAS4;UBE2I
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,0.23839439965673875,0.6699899008871808,0.917098445595855,1.0,1.0,5/36,15.74%,VWF;SRC;LAMTOR2;CNKSR2;HRAS
prerank,Elsevier_Pathway_Collection__Genes with Mutations in Cancer Metabolic Reprogramming,-0.2244126690146453,-0.6696573339793777,0.9659090909090909,1.0,1.0,3/19,13.06%,PHGDH;MPC1;AKT1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.22572278988131117,0.6696380898328363,0.9398907103825137,1.0,1.0,3/47,9.97%,CALY;GPC3;VPS28
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.19214750110021447,0.6695445599552983,0.991304347826087,1.0,1.0,38/198,25.34%,SPARCL1;COL15A1;FABP4;SNCG;PTGER3;COL4A1;SLC5A6;CDKN2C;ATP1B3;ARL4A;LPL;TKT;LEP;CD36;RAB34;ACLY;ADCY6;GPX3;PPARG;SAMM50;BCL6;COX7B;LAMA4;ITGA7;IDH3G;PREB;GPAM;LTC4S;LIPE;CS;AIFM1;MDH2;ABCB8;COX8A;UQCRQ;CYC1;CYP4B1;DLAT
prerank,KEGG_2021_Human__Colorectal cancer,0.2123791544772356,0.6694942466390343,0.9656862745098039,1.0,1.0,5/86,6.65%,LEF1;PIK3R2;AXIN2;TCF7;BIRC5
prerank,Elsevier_Pathway_Collection__PI3K/AKT/MTOR Signaling Activation in Cancer,-0.236764596513849,-0.6691243420115737,0.9104477611940298,1.0,1.0,5/17,23.89%,FOXO1;PIK3R1;AKT1;AKT3;PTEN
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.26924786383784116,0.6687777500452128,0.8988095238095238,1.0,1.0,1/19,3.40%,CDH13
prerank,WikiPathway_2021_Human__SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.2767024398100243,0.6687363640572064,0.8711656441717791,1.0,1.0,6/16,30.80%,SREBF2;HMGCR;SCD;HMGCS1;SIRT6;FASN
prerank,Elsevier_Pathway_Collection__PI3K/RAC1 Signaling,0.2363825723025575,0.6686892638003753,0.927461139896373,1.0,1.0,2/36,6.66%,PIK3R2;SRC
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.2605424097740193,0.6686859552809097,0.9393939393939394,1.0,1.0,9/20,43.12%,AGO2;MOV10L1;AGO1;CNOT6;LIMD1;CNOT1;EIF6;MOV10;TNRC6B
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,-0.2113201069118496,-0.6684786782244457,0.9615384615384616,1.0,1.0,9/34,20.71%,GPD1;LIPH;PLA2G2D;AGPAT2;PLA2G4A;PLA2R1;PLA2G12A;DDHD1;GPD1L
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.26510408162560467,0.668241244153027,0.8728323699421965,1.0,1.0,10/20,49.34%,COX20;COA3;BCS1L;COX19;OXA1L;FASTKD3;COX17;PET100;COX16;COX14
prerank,WikiPathway_2021_Human__IL-4 signaling pathway WP395,0.22305587298302137,0.6679693275145877,0.9105263157894737,1.0,1.0,3/53,6.65%,PIK3R2;MAPK11;BIRC5
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.25902286065717195,0.6678148950660383,0.8953488372093024,1.0,1.0,1/24,0.73%,ST8SIA3
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2569653843796645,0.6676934865075165,0.8922155688622755,1.0,1.0,6/26,24.33%,PLA2G2A;PLA2G4C;PLA2G4F;PLA2G6;PLA2G4E;LPCAT1
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.22613897254309656,0.6674384709063533,0.9631578947368421,1.0,1.0,34/60,47.30%,PSMD4;PSMB4;SCRIB;DVL2;PSMB3;PSMD14;UBA52;SMURF1;PSMB5;FZD2;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;SMURF2;PSMC5;SEM1;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;PSMB2;PSMA6;UBC;PSMD9;PSMC2;RPS27A;PSME1;PSMB1;PSMD3
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.23302238837066908,-0.6673859641873822,0.9540229885057471,1.0,1.0,7/20,25.69%,EGR1;HSPA1B;HSPA1A;ITCH;DCUN1D3;PINK1;DCUN1D1
prerank,TRRUST_Transcription_Factors_2019__ATM human,0.26167583611862094,0.6672900249608399,0.8571428571428571,1.0,1.0,2/22,7.14%,FOXM1;PBK
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.2112159456345763,0.6669751454042593,0.958139534883721,1.0,1.0,23/76,32.00%,PHEX;TGM3;LOXL2;UBE2S;UBL4A;ABL2;QPCT;NTAQ1;B4GALT7;LOX;DUSP12;PARP1;PLAT;PRKDC;NAGPA;NEDD8;CDKL3;UBE2M;UBA52;ST3GAL1;UBE2I;CPE;BAP1
prerank,Reactome_2022__Regulation Of TLR By Endogenous Ligand R-HSA-5686938,0.2676253147521883,0.6666922612441772,0.9146341463414634,1.0,1.0,5/18,25.61%,S100A1;CD36;GSDMD;NDUFA2;LBP
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.26171704954735775,0.6662744338249922,0.8941176470588236,1.0,1.0,4/22,17.63%,PIK3R2;MAP3K8;PDPK1;THEM4
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.19193532981463432,0.666201270882642,0.9824561403508771,1.0,1.0,41/241,20.59%,GNG4;H3C13;H2AC19;PIK3R2;H2BC13;GREB1;H2AC20;H2BC17;SRC;SPHK1;AGO2;H2BC21;H2BC9;H2BC15;GNG3;AKR1C3;H2BC11;H2BC12;TFF3;H2BC4;APOD;H4C15;H2AC6;GNB5;SHC1;PDPK1;GNG8;H2BC5;HRAS;DAND5;H2AX;SCD;POLR2L;EGF;USF1;GNG10;CTSD;UGT1A3;MMP9;GPAM;MMP3
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.2275660622136052,-0.6660349521582896,0.926829268292683,1.0,1.0,2/22,12.28%,RIPK3;TLR4
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.2562373771013409,0.6659285693947816,0.8742857142857143,1.0,1.0,4/23,20.07%,ROBO1;GJA5;ACVRL1;ACVR2B
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.21374296507520146,0.6658218245154524,0.9552238805970149,1.0,1.0,26/61,43.02%,AGO2;HSPB1;HABP4;EIF4EBP3;KLHL25;TPR;EIF3E;NPM1;EIF4EBP2;LARP1;POLR2G;MIF4GD;FMR1;CTIF;EIF3H;CDC123;EIF3B;UHMK1;PAIP2;EIF5B;RBM4;RPS6KB2;GLE1;EIF2B5;DDX1;YTHDF2
prerank,WikiPathway_2021_Human__Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.26209700272197684,0.6656808889946931,0.875,1.0,1.0,3/18,16.31%,HTR4;MAPKAPK2;ELK4
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.27913762208699533,0.6653999394077117,0.9047619047619048,1.0,1.0,8/17,36.87%,CAP2;CACNA1C;PALM;CACNA1D;GRM2;AKAP5;LTB4R2;GABBR2
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.1826839318254203,-0.6648597512735775,1.0,1.0,1.0,18/62,20.96%,CETP;APOA4;DGAT2;APOA1;LIPG;TM6SF2;TLCD4;APOA5;ABHD5;ACOX1;ANGPTL3;RBP1;IRS2;ACOX2;ACOX3;CLN8;FABP3;XBP1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.24064746818409014,-0.6648206818765993,0.8928571428571429,1.0,1.0,16/16,75.95%,VPS13A;RAB14;DOP1B;AP1AR;MON2;WIPI1;EPS15;VPS13C;KLHL20;SYS1;GBF1;KIF16B;AP2A1;SORT1;CORO7;AP4M1
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.2650903498654364,-0.6647725410561367,0.9080459770114943,1.0,1.0,15/15,73.51%,HERC5;ITCH;ELMOD2;IFNLR1;PCBP2;RNF26;C1QBP;TRAF3IP1;ZMPSTE24;PPM1B;ILRUN;DHX9;TRAF3;TNFAIP3;RNF216
prerank,WikiPathway_2021_Human__Disruption of postsynaptic signaling by CNV WP4875,0.2493115147725047,0.6646793786218728,0.8841463414634146,1.0,1.0,9/33,20.62%,GRIN1;NRXN3;CAMK2A;GRIN2A;GRM1;NLGN2;NRXN2;GRIN2C;STX1A
prerank,Elsevier_Pathway_Collection__Genes with Mutations in Cancer-Associated Sustaining of Proliferative Signaling,0.20124759323560096,0.6644923546332542,0.9730941704035875,1.0,1.0,16/112,16.65%,EPHB2;E2F1;CDKN2A;E2F2;CCNE1;PDGFRB;CDKN2C;CCNA2;NOTCH3;CDKN2B;NFKB2;MYBL2;CDKN1C;HRAS;CHEK1;SMAD3
prerank,WikiPathway_2021_Human__Regucalcin in proximal tubule epithelial kidney cells WP4838,0.2565349506708827,0.6643340641422016,0.9056603773584906,1.0,1.0,1/30,1.20%,CALCA
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.21964831341923194,0.6638599419151853,0.955,1.0,1.0,5/62,10.09%,SCG2;ITGA6;BMP4;SRC;NOL3
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.21040944330314693,-0.6637378311374827,0.9240506329113924,1.0,1.0,9/29,25.61%,PCK1;OGDHL;SDHD;SUCLG2;PCK2;SDHB;IDH1;SUCLA2;SUCLG1
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,0.19113580585245712,0.6637228032328297,0.9954337899543378,1.0,1.0,44/159,34.90%,DYNC1I1;ST8SIA3;COL7A1;ANK1;LHB;LMAN2;CNIH3;TMED3;CNIH2;B4GALT3;PREB;COG8;TRAPPC9;COPE;TRAPPC5;NAPSA;SEC16B;KDELR3;TMED9;CHST10;DYNLL1;COG2;F5;MAN2A2;TRAPPC2L;ARFGAP1;COPA;MGAT4B;CSNK1D;MGAT4A;TRAPPC1;SPTAN1;TRAPPC6A;COG4;DCTN4;DCTN2;DYNC1H1;SPTBN4;DCTN3;B4GALT6;PPP6R1;TRAPPC4;MGAT5;YKT6
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.2208557875156145,0.6636986911725902,0.9312169312169312,1.0,1.0,12/61,17.61%,MYMK;MYMX;AHNAK2;A4GALT;FER1L6;ABCD1;TLCD1;PACSIN3;COL5A1;ABCA7;SYTL4;TRIM72
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,0.2739443539464228,0.6635178396789011,0.9064327485380117,1.0,1.0,1/19,1.68%,PLA2G2A
prerank,WikiPathway_2021_Human__22q11.2 copy number variation syndrome WP4657,0.19889485719910616,0.6634374916636975,0.9757281553398058,1.0,1.0,25/102,27.44%,PRODH;VWF;SLC2A4;PLK1;CCDC188;PRKN;CDC45;CLTCL1;FOXC1;TXNRD2;RTL10;GP9;SREBF2;GNB1L;CLDN5;FOXC2;CDH15;ARNTL;LZTR1;TANGO2;CBX5;RELN;RANGAP1;ZNF74;UFD1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.2809182223025387,0.6633214535620211,0.891566265060241,1.0,1.0,6/19,29.61%,WNT8B;AMER1;DVL2;DVL1;CTNNB1;FZD2
prerank,"Elsevier_Pathway_Collection__Hyperparathyroidism, Secondary Effect",-0.215517563719197,-0.6631645909777377,0.9672131147540983,1.0,1.0,3/32,4.96%,TNFSF11;TNFRSF11B;PTH1R
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.2001230543660549,0.6630406561373259,0.9530516431924883,1.0,1.0,32/127,31.70%,MT3;STOX1;TERT;PSMD4;RGCC;SCN2A;NDRG1;EPO;LMNA;PSMB4;HILPDA;ELOC;SLC8A3;HIF1AN;ELOB;EGLN1;SUV39H1;HIF3A;PGK1;PSMD1;MYC;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;SUV39H2;PSMA1;HIPK2;PSMD10;PSMC4;PSMC3
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.23197741229706542,-0.662932382154556,0.9010989010989011,1.0,1.0,3/15,15.61%,DDAH1;AKT1;ZDHHC21
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.2250756986895491,0.6628766504728053,0.9459459459459459,1.0,1.0,20/56,35.58%,LCN2;ERFE;FLVCR1;ATP6AP1;HEPHL1;ABCB6;FTL;ATP6V0D1;HJV;NEDD8;SLC46A1;ATP13A2;MYC;SLC11A1;CUL1;TMEM199;ALAS2;SKP1;CYB561A3;FTH1
prerank,WikiPathway_2021_Human__Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2663494970510989,0.6628697356764417,0.9085714285714286,1.0,1.0,2/21,5.33%,MAPK12;MAPK11
prerank,Elsevier_Pathway_Collection__Oncogene Induced Cellular Senescence,0.23256483126914942,0.6627958581805566,0.9417989417989417,1.0,1.0,21/46,40.31%,CDKN2A;CDK1;PDPK1;HRAS;SUV39H1;CDK6;TSC1;TSC2;GLB1;LMNB1;CHEK2;CDKN1A;RHEB;CDK4;MLST8;RPTOR;AKT1S1;GSK3B;ATR;CDK2;MTOR
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.21971593564821124,0.662471774128368,0.9375,1.0,1.0,17/53,35.73%,MAPT;STMN3;CLIP2;FIGNL1;FIGNL2;LIMK2;CAMSAP2;CAMSAP1;CLIP3;TUBGCP6;FIGN;CCDC13;MAP10;DYNC1H1;CAMSAP3;CIB1;TUBGCP2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.2841103804886265,0.6624673682770965,0.9090909090909091,1.0,1.0,4/15,30.31%,SMG5;BARD1;MCM7;SMG7
prerank,WikiPathway_2021_Human__EPO Receptor Signaling WP581,0.26296044816665753,0.661138013062563,0.9101796407185628,1.0,1.0,4/26,14.64%,PDK1;SRC;EPO;SHC1
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,0.24077603611060172,0.660965858555198,0.9461077844311377,1.0,1.0,8/29,31.22%,VPS28;MVB12B;VPS37D;UBA52;HGS;VPS4A;SNF8;CHMP2A
prerank,WikiPathway_2021_Human__Regulation of apoptosis by parathyroid hormone-related protein WP3872,-0.2247284923368798,-0.6602487029684498,0.8947368421052632,1.0,1.0,5/22,17.08%,BCL2L14;BCL2A1;AKT1;BCL2L15;BCL2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Pathogenesis of Arrhythmogenic Right Ventricular Cardiomyopathy,0.2760622716216112,0.6601346242497785,0.8734177215189873,1.0,1.0,8/18,29.68%,LMNA;PPARG;GJA1;EMD;CTNNB1;LMNB1;RPSA;PPP1R13L
prerank,Elsevier_Pathway_Collection__Tight Junction Assembly (JAMs),0.2630493196153515,0.6599913721215191,0.9257142857142857,1.0,1.0,11/23,40.95%,LLGL1;STX4;F11R;TJAP1;SMURF1;SPTAN1;CDK4;CASK;TJP1;CGN;JAM3
prerank,WikiPathway_2021_Human__Amyotrophic lateral sclerosis (ALS) WP2447,-0.20495666354961453,-0.6599692377129018,1.0,1.0,1.0,8/36,22.85%,TNF;CASP1;CAT;GRIA1;BCL2;PPP3CA;MAP2K6;MAP3K5
prerank,Elsevier_Pathway_Collection__PGF2-alpha Effect on Treatment,-0.2479022654832181,-0.6598420074092055,0.9139784946236559,1.0,1.0,3/17,7.46%,MMP1;FOS;MAP2K1
prerank,MSigDB_Oncogenic_Signatures__EIF4E UP,0.20917464321614576,0.6598067725919591,0.946078431372549,1.0,1.0,12/81,19.41%,CAMK2N2;KCNC2;TAX1BP3;VPS28;NDRG1;UBL4A;ATP8B3;PFDN2;DEDD;VPS72;BOLA1;NTPCR
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.2620005068245304,0.6597434174581414,0.9325153374233128,1.0,1.0,9/23,34.66%,SEMA5B;MAP1B;SEMA3F;CDK5;HSP90AB1;ALCAM;ULK1;NRP1;SLC9A6
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,0.2448940343859382,0.6587896018428039,0.9141104294478528,1.0,1.0,26/26,75.54%,UGGT1;EDEM3;UBA52;UGGT2;MAN1B1;UBC;RPS27A;RNF103;CANX;PRKCSH;EDEM2;PDIA3;SYVN1;DERL2;MARCHF6;CALR;TRIM13;AMFR;RNF139;GANAB;OS9;UBB;SEL1L;RNF5;RNF185;EDEM1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.23120409183555743,-0.6587267002133991,0.9529411764705882,1.0,1.0,22/22,76.90%,ESR1;MED4;HNF1B;MED14;DHX36;MED1;SRF;MED13;MED30;TP53;PSMC6;SUB1;PSMC2;MED24;MED17;MED16;HNF1A;PSMC5;PAXIP1;PSMC3;PSMC4;MED12
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.18886793222324225,-0.6586566900330336,0.9620253164556962,1.0,1.0,7/49,10.07%,RIPK3;HBA1;CAT;HBB;IL6;FYN;PPIF
prerank,Elsevier_Pathway_Collection__Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway,0.21953235614596764,0.6586116827228408,0.9603960396039604,1.0,1.0,16/64,26.12%,CYP17A1;E2F1;SRC;CCNE1;MUC4;SHC1;PDPK1;PRKCA;SMAD3;MMP9;MMP3;HDAC1;ESR2;PTK2;MYC;CTNNB1
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,-0.25142826287291187,-0.6584738420376938,0.8571428571428571,1.0,1.0,2/16,4.13%,NTRK3;NTF3
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,0.19257755501115023,0.6584317386266447,0.9911504424778761,1.0,1.0,26/175,20.90%,DOCK3;MPZ;PIK3R2;ARHGEF39;ARHGEF10;ARHGAP44;IQGAP3;RNASE1;RASGRF2;DIAPH3;ARHGEF11;RACGAP1;ARHGAP39;ARAP3;NOX1;ABL2;MCAM;PLEKHG2;ARHGEF15;ECT2;ARHGAP33;LBR;ARHGEF19;SRGAP2;ARHGAP4;WASF2
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.18607336695022905,-0.6583537503955951,0.9848484848484849,1.0,1.0,46/46,81.43%,HSPA1B;NUDT12;ZC3H12D;HSPA1A;NCBP1;AGO3;ZFP36;RNASE6;LSM5;SIDT2;ERN1;PNPT1;DCP2;LSM6;RIDA;NUDT16;ZFP36L2;HNRNPD;NUDT16L1;PPP1R8;AGO4;XRN2;RNASEH1;MTREX;SND1;SKIV2L;SUPV3L1;YTHDF2;RNASE2;PABPC4;RNASEH2B;RNASET2;EXOSC7;METTL16;ISG20;RNH1;CNOT10;RNASEH2C;ZPR1;DIS3L2;LSM2;METTL3;DXO;SLFN14;FEN1;DNA2
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.27376045921561915,0.6581658691256317,0.8860759493670886,1.0,1.0,9/16,37.14%,INTS8;INTS3;INTS7;INTS1;INTS11;TUT1;INTS9;TOE1;INTS5
prerank,MSigDB_Oncogenic_Signatures__BCAT BILD ET AL DN,0.22452696164279431,0.6579989767303945,0.9261363636363636,1.0,1.0,14/44,36.42%,FAM182A;PTHLH;IRAK2;SHC1;STARD13;PRKDC;LNPEP;IER5;ASH1L;RASAL2;SMURF2;TNFAIP3;EFR3A;SMAD5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.24184257869929027,0.6579475159722376,0.91875,1.0,1.0,17/29,47.20%,CETN2;PARP1;CHD1L;CUL4B;UBA52;DDB2;DDB1;ERCC2;RPA2;XPC;RBX1;UBC;ERCC3;XPA;RPS27A;RPA1;GTF2H2
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,0.23090250913754456,0.6577610052076782,0.9528795811518325,1.0,1.0,5/37,15.74%,VWF;SRC;CAMK2A;CNKSR2;HRAS
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.25136217740838035,0.6577330995426415,0.9265536723163842,1.0,1.0,12/35,26.52%,PAK3;MAPT;ARHGAP28;PLEKHG2;DBN1;ARL2;HAX1;ESAM;PRUNE1;GBA2;CAMSAP2;CAMSAP1
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.294086043880749,0.6576329791653063,0.8947368421052632,1.0,1.0,6/15,38.05%,AMER1;PPP2R5A;CTNNB1;PPP2R1A;AXIN1;GSK3B
prerank,"Elsevier_Pathway_Collection__Glioblastoma, Secondary",0.2220719492664325,0.6575369780912346,0.9368421052631579,1.0,1.0,13/50,26.07%,CDKN2A;FGF2;PDGFRB;PDGFB;PDGFA;SHC1;PDPK1;EGF;CDK6;PLCG1;NF2;MAP2K2;MYC
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.22848770235548094,0.6572549984390598,0.9700598802395209,1.0,1.0,21/42,44.96%,PCGF2;PIAS3;PIAS1;CBX8;TRIM28;NPM1;NCOR2;PARK7;HIPK2;PIAS4;UBE2I;CBX2;MRTFA;NCOA2;MBD1;DAXX;ZNF131;DDX17;RING1;PHC2;DDX5
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.16254625849364746,-0.6572516990588829,1.0,1.0,1.0,26/123,20.46%,PITPNM3;CWH43;SOCS2;IP6K3;PTPN13;PIK3C2G;PIK3CD;SLA2;PLEKHA2;FAM126A;PIK3R5;FAM126B;PIK3R1;TPTE2;CISH;PLCG2;PI4K2B;BMX;PIP4K2A;PIK3R4;INPP5D;MTMR9;MTMR2;RAB14;PIGV;SOCS6
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.23046724393455462,0.6569902787491144,0.9069767441860465,1.0,1.0,1/37,0.45%,DKK1
prerank,WikiPathway_2021_Human__Host-pathogen interaction of human coronaviruses - autophagy WP4863,-0.23394601245866337,-0.6563620012627063,0.9080459770114943,1.0,1.0,19/19,76.63%,PIK3R4;MAP1LC3A;ATG5;ULK2;ZFYVE1;WIPI1;BECN1;PIK3C3;ATG16L1;ATG12;ATG3;ATG7;ATG13;ATG16L2;MTOR;ATG4A;ULK1;RB1CC1;ATG10
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.28090443470508,0.6563525745764363,0.9056603773584906,1.0,1.0,3/16,12.68%,FGD1;DNM3;SPEF1
prerank,Elsevier_Pathway_Collection__ESR1 Signaling in Breast Cancer,-0.1926638591984967,-0.656105619997028,1.0,1.0,1.0,15/51,24.93%,FOS;ESR1;MAP2K1;FOXO1;PIK3R1;AKT1;PGR;BCL2;MAPK10;MAP2K3;JUN;JAK2;MAP3K5;MAP2K4;NCOA1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.2520209470305374,0.6559464843202881,0.8972602739726028,1.0,1.0,5/19,27.00%,EFNA1;OLFM1;HEY1;TGFB2;HEYL
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.20535178631365422,0.6558569644919393,0.9855072463768116,1.0,1.0,16/86,21.80%,TDGF1;BMP4;FGF2;HSPB1;PRKD1;PDGFB;SMOC2;PDPK1;PRKCA;GFUS;ROCK2;EGF;FGF18;SPARC;FOXC2;PLCG1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.22127111076340938,0.6558100516190948,0.9680851063829787,1.0,1.0,8/55,13.30%,TNNI3;EGFL7;COL4A1;RASIP1;SOX18;RAMP2;GJA5;FLT1
prerank,Elsevier_Pathway_Collection__Histone Acetylation,0.26203250613240586,0.6556594381939468,0.9588235294117647,1.0,1.0,6/20,30.96%,KAT2A;HDAC1;KPNA2;MECP2;NCOR2;RBBP7
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2656010597464834,0.6552112907696049,0.9329268292682927,1.0,1.0,6/22,22.98%,PLA2G2A;PLA2G4C;PLA2G4F;PLA2G6;ABHD4;PLA2G4E
prerank,MSigDB_Oncogenic_Signatures__RB P107 DN.V1 DN,-0.16102410738965042,-0.65504397383447,1.0,1.0,1.0,34/113,28.91%,CHAC1;S100A8;CXCL12;PEX3;GJB2;TLR2;PRSS12;PANK1;CRABP2;CCDC90B;GUCA2A;HSD17B12;GBE1;PIK3R4;CBR4;ANXA4;LPAR3;PPBP;LPCAT3;GNG12;NMI;PGD;COG6;STX7;TPRG1L;COQ9;BSDC1;ELOVL6;NIPSNAP1;EDN1;GLRX;PTPRE;SAR1B;DGAT1
prerank,KEGG_2021_Human__Pancreatic cancer,0.21236744076645167,0.6538864174426896,0.9752475247524752,1.0,1.0,11/76,22.58%,E2F1;PIK3R2;CDKN2A;E2F2;IKBKG;SMAD3;EGF;CDK6;TGFB2;RALGDS;RAD51
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.2740819555941775,0.6536690194608819,0.9101123595505618,1.0,1.0,1/20,4.77%,FERMT1
prerank,Elsevier_Pathway_Collection__Transcytosis,-0.20007629028491145,-0.6536321122615686,0.9696969696969697,1.0,1.0,3/37,8.73%,TRPV4;TF;LAMP3
prerank,WikiPathway_2021_Human__Ebola Virus Pathway on Host WP4217,-0.15897837389331285,-0.6534775381327241,1.0,1.0,1.0,36/125,24.54%,CLEC4M;TIMD4;PIK3CD;ICAM3;AXL;CD300A;HLA-DQA2;MBL2;REL;TLR4;HLA-DOB;PIK3R1;AKT1;HAVCR2;TIAM1;ITGB3;CLEC10A;CTSB;HLA-DQA1;ITGA4;TPCN2;CAV2;ITGA3;IQGAP1;HLA-DQB2;HLA-DOA;HLA-DRB5;HLA-DRA;STAT1;CD209;HLA-DPA1;IGF1R;DDX58;TFAP2A;HLA-DPB1;HLA-DRB1
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.15860799379324614,-0.653280780604144,1.0,1.0,1.0,48/144,26.96%,HAS2;PRKAR2B;MT1E;RND3;KCNMA1;PIK3CD;BCKDHB;ADGRL2;FYN;AMPH;CCN1;GCNT1;IGFBP5;DDAH1;CITED2;CELF2;PRKCE;SYNE1;NOTCH2;ITGB3;ACVR2A;F3;MGLL;LPAR1;DUSP1;DLC1;ANXA4;MIOS;SMAD7;ICA1;INPP4B;PLPP3;LDLR;AKT3;MGMT;PDLIM5;PTPN21;IGF1R;PTEN;KALRN;ID1;NR3C1;DMAC2L;INSIG1;CACNA1A;PEX14;CDKN1B;NR1D2
prerank,Reactome_2022__Metabolism Of Angiotensinogen To Angiotensins R-HSA-2022377,-0.24121539315365295,-0.6532558716639394,0.9404761904761905,1.0,1.0,7/18,25.16%,ACE2;ENPEP;GZMH;CTSZ;AGXT;ANPEP;CPB2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.2681539345560868,0.6528328068892022,0.906832298136646,1.0,1.0,8/19,36.78%,PLK1;TPR;CEP97;CCSAP;CHMP2A;HNRNPU;DRG1;EML3
prerank,Elsevier_Pathway_Collection__HRAS Signaling,0.22447350203633082,0.6527667891338655,0.9542857142857143,1.0,1.0,8/44,21.73%,RASGRF1;RASGRF2;RIN1;PDPK1;RGS14;HRAS;FDFT1;RALGDS
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.16894262878299024,-0.652521135803398,1.0,1.0,1.0,20/78,23.01%,GSTA2;GSTZ1;ADAMTS13;GSTA1;GSTT2B;GSTM5;ENPEP;PCSK5;HPGDS;NLN;CARNMT1;MMACHC;GGT2;DMD;GSTP1;TRHDE;GSTM1;MIPEP;NAT8B;ANPEP
prerank,WikiPathway_2021_Human__RAC1/PAK1/p38/MMP2 Pathway WP3303,0.20922133015276692,0.6523861346434909,0.9466019417475728,1.0,1.0,9/67,17.74%,MAPK12;MAPK11;BIRC5;SRC;IKBKG;HRAS;STMN1;ANGPT2;MSH2
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.27123812317023066,0.6523355562501096,0.9132947976878613,1.0,1.0,4/20,18.50%,ARHGEF11;ROCK2;RHOC;LIMK2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.21531554744367243,0.6522534740481604,0.9516129032258065,1.0,1.0,35/71,47.30%,PSMD4;IKBKG;CD36;PSMB4;PSMD1;PSMB3;PSMD14;PSMB5;PSMD2;PSMA1;HLA-F;PSMD10;ITGAV;PSMC4;PSMC3;ITGB5;PSMC5;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;HLA-A;PSME3;HLA-B;PSMB2;PSMA6;HLA-G;PSMD9;PSMC2;TAP2;PSME1;PSMB1;PSMD3
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.2830506107455697,0.6520202217159241,0.9034090909090909,1.0,1.0,9/17,47.62%,AMER1;PPP2R5A;CTNNB1;PPP2R1A;AXIN1;GSK3B;PPP2R5B;CSNK1A1;FRAT1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.21678402121002555,0.6519208631826122,0.9696969696969697,1.0,1.0,26/56,47.49%,EXOSC4;EXOSC5;EDC3;LSM2;SAMD4B;LSM4;LSM7;CNOT3;CNOT10;TUT7;EXOSC2;DCPS;EDC4;CNOT6;CNOT6L;CNOT9;EXOSC1;EXOSC7;EXOSC9;CNOT1;WDR61;SKIV2L;DCP1B;TUT4;TTC37;CNOT11
prerank,MSigDB_Oncogenic_Signatures__WNT UP.V1 DN,0.19642185550256283,0.6519021583478624,0.981651376146789,1.0,1.0,27/147,21.57%,DIO2;TSPAN5;TAL2;TNNI3;COL9A1;NT5DC2;MEP1A;RASD1;BIK;CNTN1;LHB;APC2;GPX3;STC1;SDSL;SLC22A18;GRIN2C;ADCY4;OLFM1;ADAR;ETV4;SYNGR4;TGFBR3;HEY1;MMP3;TRAPPC5;ISG15
prerank,WikiPathway_2021_Human__Pathways in clear cell renal cell carcinoma WP4018,-0.16811324989499143,-0.6516981133284511,1.0,1.0,1.0,11/83,13.06%,ENPP3;HK3;ENO3;PHGDH;PDGFRA;ALDOB;ACACB;BHLHE41;ALDOC;SHMT1;AKT1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.2263232943452201,0.6513676111734433,0.9505494505494505,1.0,1.0,25/45,40.09%,FAM83D;ACE;GBA;TMEM9;ODC1;ABCA7;PM20D2;NEDD4L;ROCK2;ANGPTL8;NEDD8;HSP90AB1;CHEK2;HGS;SNF8;APOE;MAPK7;SSH1;TRAF3;WFS1;PARL;FKBP1A;MAP2K5;SHH;FAF1
prerank,MSigDB_Oncogenic_Signatures__ERB2 UP.V1 UP,0.1908664973943337,0.6507453006869649,0.9955357142857143,1.0,1.0,36/173,23.24%,S100P;APLP1;TNNT1;UPK1A;FGF13;BCAM;TTC9;AKR1B10;NOTCH3;GDF15;MVD;NDRG1;LOXL1;PACSIN3;SPAG4;HSPA2;VWA1;METRN;SERHL2;AKR1C2;ZNF467;EPHX1;CRLF1;BCL6;CAMK2N1;TBC1D8;BCL3;P4HA2;HEY1;HOXB7;PTPRU;ARNT2;BACE2;PGPEP1;DRAM1;PCSK1N
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.21763344935813178,0.6506425570834311,0.9578947368421052,1.0,1.0,24/59,40.27%,SAXO1;KCTD17;TBC1D16;LIMK2;TBC1D8;MARK4;TBC1D10A;CROCC;TBC1D13;SGSM3;BBS4;TBC1D9B;CEP97;TCHP;YAP1;TBC1D17;DYNC2LI1;CDKL5;TBC1D20;SDCCAG8;HTT;IFT140;TESK1;TBC1D14
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.25582557871260514,0.6502707403985116,0.9019607843137255,1.0,1.0,19/19,74.44%,UGGT1;UBA52;UGGT2;MAN1B1;UBC;RPS27A;RNF103;EDEM2;SYVN1;DERL2;MARCHF6;TRIM13;AMFR;RNF139;OS9;UBB;SEL1L;RNF5;RNF185
prerank,Elsevier_Pathway_Collection__WHIM Syndrome,-0.23652874053727307,-0.6497615548041085,0.898876404494382,1.0,1.0,4/16,14.96%,MAP2K1;CXCL12;AKT1;CXCR4
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.25313797163204804,0.649713157100271,0.9570552147239264,1.0,1.0,3/23,14.41%,NEK2;AURKB;RTEL1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.2239873696679563,0.649341512885221,0.9722222222222222,1.0,1.0,10/48,25.38%,TM4SF20;PLK1;CAMK2N1;FADD;PLAT;CSTB;TBC1D10A;CYFIP2;CDK5;NEDD8
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.16022124002567056,-0.6492692322727771,1.0,1.0,1.0,20/136,18.88%,ESRRG;NR4A2;NR4A3;NR4A1;NR3C2;ESR1;GTF2H4;PPARGC1A;NR1I2;HDAC9;TAF4B;RORB;PGR;RARB;NOTCH2;NR1I3;NCOR1;NRBF2;AR;NR1H4
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.20345761667176201,0.6490926514020244,0.9631578947368421,1.0,1.0,23/88,31.22%,STEAP2;CLVS1;STXBP6;DNAJC6;SCAMP3;CCDC93;RABIF;BLOC1S1;FTL;LLGL1;CCDC22;AP4B1;STX4;AP4M1;ARF1;BLOC1S3;CLTA;HGS;DTNBP1;EXOC4;CORO7;ARRB1;CHMP2A
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.2582083819696732,0.6484684702364023,0.9137931034482759,1.0,1.0,5/24,16.82%,CYP7A1;AMACR;AKR1C3;AKR1C1;AKR1C2
prerank,WikiPathway_2021_Human__Pancreatic adenocarcinoma pathway WP4263,0.2061588777653289,0.648311770419366,0.9656862745098039,1.0,1.0,6/88,10.06%,E2F1;PIK3R2;PAK3;CDKN2A;E2F2;IKBKG
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.27100503742248394,0.6479922758418292,0.9235294117647059,1.0,1.0,3/18,13.63%,GDPD1;PLA2G4C;PLA2G4F
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,0.18943685398245078,0.6479201615927124,1.0,1.0,1.0,34/139,28.24%,ARHGEF39;FGD1;ARHGEF37;IRAK1;ARHGEF10;SORCS3;LINGO1;IKBKG;RNASE1;RASGRF2;ARHGEF11;OBSCN;SQSTM1;TNFRSF10D;PLEKHG2;ARHGEF2;ARHGEF15;ECT2;MAGED1;SHARPIN;OTUD7B;ARHGEF19;RNF31;FADD;HDAC1;MCF2L;NSMAF;CLIP3;NGEF;ITGB3BP;AATF;PLEKHG5;UBA52;NCSTN
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.2482034885911592,-0.6477587651205203,0.9302325581395349,1.0,1.0,6/16,21.40%,IL10;CR1L;FZD7;WNT5A;CD55;CYBA
prerank,Elsevier_Pathway_Collection__VEGFA/NOTCH1/WNT Cross-talk in Blood Vessel Sprouting and Branching in Cancer,0.2315940436427502,0.6477475087376551,0.9398907103825137,1.0,1.0,8/38,20.91%,LEF1;FOXC1;FLT1;PDPK1;DVL2;DLL4;HEY1;FOXC2
prerank,Elsevier_Pathway_Collection__Interstitial Fibroblasts in Pyelonephritis,-0.1931491918480653,-0.6475123078872526,0.9733333333333334,1.0,1.0,4/40,7.46%,TNF;FOS;PDGFRA;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.2352408775145276,-0.6474566070797455,0.8846153846153846,1.0,1.0,5/17,20.75%,CCBE1;KLKB1;NLRC4;ADAM8;LPCAT3
prerank,KEGG_2021_Human__Thyroid cancer,0.2355744671910329,0.6470957122493722,0.9281767955801105,1.0,1.0,15/37,34.58%,LEF1;TCF7;PPARG;HRAS;TPR;MAP2K2;MYC;CTNNB1;CDKN1A;RXRG;TCF7L1;RXRB;TPM3;DDB2;BAX
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.2140928137714624,0.6470380351896206,0.9740932642487047,1.0,1.0,11/67,20.23%,MT3;TERT;RGCC;SCN2A;NDRG1;LMNA;HILPDA;SLC8A3;EGLN1;SUV39H1;TSC1
prerank,KEGG_2021_Human__Hepatitis C,-0.16447208985949713,-0.6468289584635069,1.0,1.0,1.0,12/139,8.82%,CLDN4;CLDN10;CXCL10;IFNG;TNF;PPP2R2B;CLDN8;FASLG;TLR3;MAP2K1;PIK3CD;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.22763923077278553,0.6466762570494966,0.9239766081871345,1.0,1.0,13/38,36.80%,PRKAA2;CASTOR2;CASTOR1;TSC1;TSC2;SPAAR;ARNTL;SH3BP4;KPTN;NPRL3;DDIT4;NPRL2;AKT1S1
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.22873404091678204,-0.6464453405460149,0.9466666666666667,1.0,1.0,21/21,77.15%,BHMT;PCMT1;ETFBKMT;VCPKMT;FAM98B;CAMKMT;PRMT2;METTL22;EEF1AKMT2;FAM98A;GSPT1;LCMT1;ETF1;EEF1AKMT1;PRMT1;METTL21A;CSKMT;SNRPD3;PRMT3;SNRPB;EEF2KMT
prerank,Elsevier_Pathway_Collection__EGFR Nuclear Signaling in Colorectal Cancer,0.24892087663947213,0.6464114160785066,0.9053254437869822,1.0,1.0,6/22,29.80%,E2F1;AURKA;EGF;PRKDC;MDC1;PCNA
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.19609691900512374,0.646372626207324,0.9805825242718447,1.0,1.0,52/92,48.14%,AGO2;HABP4;PRR16;JMJD4;PASK;RBM3;BCL3;NSUN5;EIF5A2;PRKDC;EIF3E;NPM1;METTL3;LARP1;POLR2G;EIF3D;UPF3B;UQCC2;POLDIP3;RPS4X;FMR1;RPUSD3;COA3;CDC123;UHMK1;MPV17L2;METTL5;DHX9;VIM;FASTKD3;RPL5;MRPS27;FXR2;MTOR;RPS6KB2;NAT10;EIF2B5;EIF6;YTHDF2;EIF2S3;PKM;RPS9;EIF3C;EEF2;RPL26;EIF4A3;YTHDF3;FXR1;RPUSD4;PCIF1;RCC1L;CIRBP
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.2199722905653884,-0.6462946097414455,0.9069767441860465,1.0,1.0,3/20,12.65%,NKX2-8;CITED2;LSR
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.21722789369952317,0.646079181907325,0.9787234042553191,1.0,1.0,3/48,5.17%,PAGE4;MAPK8IP2;FOXM1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.20798343216224097,0.6458554578206435,0.9629629629629629,1.0,1.0,35/65,48.98%,ELL3;ELOC;POLR2L;ELOB;POLR2K;NELFE;POLR2G;POLR2H;ADRM1;NELFA;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;POLR2A;ERCC2;ELL;POLR2B;GTF2F1;SUPT6H;POLR2F;CDK9;ERCC3;WDR61;SUPT16H;CCNT2;GTF2H2;PAF1;LEO1;MLLT1;CDC73;NCBP2;GTF2H5
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.2566464260911889,0.6458256369943207,0.9216867469879518,1.0,1.0,3/19,10.27%,MDK;MSTN;CXCL17
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,-0.2362501881655951,-0.6457815839165431,0.9354838709677419,1.0,1.0,3/16,14.75%,NGFR;NGF;MYD88
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.23430894016740725,0.6455586580228792,0.9347826086956522,1.0,1.0,7/30,25.49%,DCST1;RNASEL;MAVS;FADD;ISG15;METTL3;HSP90AB1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.22157299999987973,0.6455241092562651,0.9640718562874252,1.0,1.0,6/46,12.71%,MPZ;HES5;ARHGEF10;CNTNAP1;SCN2A;ABCD1
prerank,WikiPathway_2021_Human__Apoptosis WP254,0.20303548749176495,0.6450333180120252,0.9797979797979798,1.0,1.0,6/83,10.06%,IGF2;TP73;CDKN2A;BIRC5;HELLS;IKBKG
prerank,Elsevier_Pathway_Collection__Exocytosis: Vesicle Trafficking,0.26755241385366463,0.6450109993189201,0.901840490797546,1.0,1.0,5/18,34.06%,RAB13;RAB4A;MYRIP;KIFAP3;KIF3B
prerank,Elsevier_Pathway_Collection__Proteins Involved in Mantle Cell Lymphoma,-0.22647863603534427,-0.6449607603831664,0.9518072289156626,1.0,1.0,8/19,28.92%,CD40LG;AKT1;ING1;TNFSF13B;GSTP1;FMOD;MCPH1;STAT3
prerank,MSigDB_Oncogenic_Signatures__GLI1 UP.V1 UP,-0.20853714794181233,-0.6444100104996504,0.922077922077922,1.0,1.0,8/23,30.58%,PTH1R;IGFBP6;HLA-DQB1;SAR1A;M6PR;CCND2;TMOD3;WEE1
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,-0.2064096645121576,-0.6441798478070371,0.9726027397260274,1.0,1.0,33/33,79.39%,STX11;STX19;SEC22B;STX3;VTI1B;STX17;BET1;STX7;VTI1A;GOSR1;STX16;BET1L;VAMP3;VAMP8;STX5;VAMP2;SNAP23;STX8;BNIP1;VAMP7;SNAP29;GOSR2;STX2;VAMP1;USE1;YKT6;STX18;VAMP4;STX6;STX1B;STX4;VAMP5;STX1A
prerank,"Elsevier_Pathway_Collection__Apoptosis of Cochlear Hair Cells (Noise-Induced, Mouse Model)",0.25288183488761534,0.6439296306374309,0.9401197604790419,1.0,1.0,4/22,22.72%,NOX4;NOX1;ROCK2;AIFM1
prerank,Elsevier_Pathway_Collection__Cardiovascular Effects in Hyperthyroidism,0.2269329575949916,0.6438671430319418,0.9590643274853801,1.0,1.0,8/38,25.99%,TNNI3;ADCY6;PDPK1;THRA;PLCG1;EIF4EBP2;MAP2K2;PTK2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.2726758634236019,0.6435956178397796,0.8987341772151899,1.0,1.0,3/16,17.92%,SRC;APOD;ACVRL1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.2726758634236019,0.6435956178397796,0.8987341772151899,1.0,1.0,3/16,17.92%,SRC;APOD;ACVRL1
prerank,Elsevier_Pathway_Collection__AMPK Signaling,0.22729511222018978,0.6431433547985421,0.9111111111111111,1.0,1.0,16/41,32.33%,RASGRF1;SLC2A4;CPT1B;ACACA;HDAC5;HMGCR;LIPE;TSC2;CRTC2;STK11IP;MAP2K2;STRADA;RHEB;ULK1;LONP1;MLST8
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.22554778368281314,0.6430569471582004,0.9392265193370166,1.0,1.0,3/34,11.51%,BRSK2;PRKN;GPIHBP1
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,0.20889796905900532,0.643041819408045,0.9633507853403142,1.0,1.0,33/55,48.98%,ELOC;POLR2L;ELOB;POLR2K;NELFE;POLR2G;POLR2H;NELFA;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;DMAP1;POLR2A;ERCC2;ELL;POLR2B;GTF2F1;SUPT6H;POLR2F;CDK9;ERCC3;SUPT16H;CCNT2;GTF2H2;PAF1;LEO1;MLLT1;CDC73;NCBP2;GTF2H5
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.1591831410976719,-0.6424650893262305,1.0,1.0,1.0,6/121,4.86%,GCK;EREG;DSCAM;CCL5;INHBA;STAP1
prerank,WikiPathway_2021_Human__Methionine De Novo and Salvage Pathway WP3580,-0.22601631264361371,-0.6423758252806224,0.9444444444444444,1.0,1.0,4/22,14.62%,BHMT;TAT;MAT1A;MSRA
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.19400396945158466,0.6412642608775744,0.9903381642512077,1.0,1.0,11/111,14.29%,S100A1;MAPK11;SAA2;IRAK1;MAP3K8;LRRC14;IKBKG;IRAK2;CD36;NFKB2;MAPKAPK2
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,0.19334102183137136,0.6411725262402854,0.9857142857142858,1.0,1.0,32/120,33.19%,MPZ;TBC1D16;RIN1;SBF1;GDI1;CHML;ANKRD27;TSC1;RAB9B;TRAPPC9;TRAPPC5;TBC1D25;DENND4B;TSC2;TBC1D10A;RAB13;DENND4C;TBC1D13;TRAPPC2L;RAB4A;DENND6B;RABGEF1;ULK1;RAB43;RAB3GAP2;DENND5A;TRAPPC1;HPS4;TRAPPC6A;RINL;TBC1D17;GABARAP
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.18988261060780853,0.6410918244005975,0.9952153110047847,1.0,1.0,54/134,38.94%,PAPPA2;CDH13;HJURP;KIF14;SPHK1;MKI67;LAMTOR2;CD36;AURKA;ARHGEF11;PACSIN3;MELTF;ABL2;ROCK2;NEDD4;SNCAIP;TRAF2;MUC12;MARK4;TAOK2;TSC2;HCFC1;CAMSAP2;ARFGAP1;RAB4A;RUFY1;HIP1;MAD2L2;GFAP;AGT;RAPGEF1;PARK7;APOE;DAB2IP;RUFY2;BAP1;NCLN;SGK1;HNRNPU;SSRP1;CAMSAP3;TJP1;HSPA8;RPTOR;ABL1;EGLN2;SETD1A;HIP1R;PLCE1;TFRC;AP2S1;PACSIN2;ATAD3A;HSP90AA1
prerank,Elsevier_Pathway_Collection__V(D)J Recombination Activation,0.2404734230583097,0.6409516394967018,0.9668508287292817,1.0,1.0,5/34,14.55%,LEF1;EBF1;RAG1;FLT3LG;PAX5
prerank,WikiPathway_2021_Human__Common Pathways Underlying Drug Addiction WP2636,0.22378986080409538,0.64039689899668,0.9562841530054644,1.0,1.0,5/36,15.60%,GRIN1;CAMK2A;GRIN2A;GRM1;PRKCA
prerank,Elsevier_Pathway_Collection__PPARGC1A Repression in Huntington Disease,0.267115154845406,0.6403889590871259,0.9627329192546584,1.0,1.0,9/18,42.76%,PPARG;HMGCR;HMGCS1;GPX1;TFB2M;HTT;NRF1;PPARD;SOD2
prerank,KEGG_2021_Human__Protein export,-0.2276363356664872,-0.6400805114909038,0.9746835443037974,1.0,1.0,23/23,77.26%,SEC61A2;SEC62;SRPRA;IMMP1L;SRP54;SPCS3;SEC63;SEC11A;SRP68;SRP72;IMMP2L;SPCS2;SRP19;SEC61A1;SRP14;SPCS1;SEC61B;SRPRB;OXA1L;HSPA5;SRP9;SEC11C;SEC61G
prerank,WikiPathway_2021_Human__Vitamin D-sensitive calcium signaling in depression WP4698,0.22905083772306437,0.6398162649402325,0.8983050847457628,1.0,1.0,15/36,33.27%,GRIN1;ATP2B4;GRIN2A;CACNA1C;GRIN2C;KCNQ3;ATP2B3;ITPR2;TPH1;KDM3A;G6PD;CYP27B1;GRIN2D;KDM1B;CALB1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.17747787359438244,-0.6396960114988739,0.9777777777777777,1.0,1.0,22/69,26.44%,OTOF;LRRK2;MAPK15;RTN4;REEP6;GET4;LMAN1;PRNP;HMOX1;CAV2;EIF2AK3;CYB5A;LPCAT3;TMEM170A;APP;DOP1B;SHTN1;LMAN2L;RAB18;ATL1;TMEM33;SERP1
prerank,Elsevier_Pathway_Collection__TRPM4/6/7/8 Signaling in Arterial Hypertension (Hypothesis),0.22201026598681456,0.6396804088892445,0.95,1.0,1.0,4/39,14.95%,RASGRF1;SRC;CACNA1C;PDPK1
prerank,WikiPathway_2021_Human__Hepatitis B infection WP4666,-0.16000735106960656,-0.6394302851644726,1.0,1.0,1.0,31/137,22.46%,EGR3;EGR2;TNF;FOS;FASLG;SLC10A1;TLR3;MAP2K1;PIK3CD;PRKCB;IL6;CXCL8;TICAM2;TLR4;TLR2;PIK3R1;AKT1;MYD88;CREB5;BCL2;MAPK10;MAPK13;TAB2;NFATC2;MAP2K3;MAP2K6;JUN;JAK2;STAT1;IFIH1;AKT3
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.25458841499129986,0.6394193488114637,0.927710843373494,1.0,1.0,5/18,23.52%,WNT8B;MDFI;ACVRL1;NBL1;FBXL15
prerank,Elsevier_Pathway_Collection__BDKRB1/2 -> Ion Channels,0.27466069869740617,0.6394152029851495,0.9053254437869822,1.0,1.0,2/16,13.85%,BDKRB2;BDKRB1
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.15736195676084597,-0.6390622800520132,1.0,1.0,1.0,26/136,22.41%,EREG;SYT9;SYT8;CD4;SYT1;IL7R;FCHO1;TF;TGFA;NLRP3;AMPH;BTC;REPS1;HBEGF;SH3KBP1;CFTR;CHRM2;REPS2;ITSN1;WNT5A;CD3D;AGTR1;APOB;ADRB2;SH3GL2;LDLR
prerank,Elsevier_Pathway_Collection__Hypoxia-Induced Cell Death Evasion in Cancer,0.2642957655968883,0.6389165237708179,0.9257142857142857,1.0,1.0,1/23,2.68%,TWIST2
prerank,Elsevier_Pathway_Collection__High-Grade Serous Ovarian Carcinoma,0.2041453583250446,0.6387889228621694,0.9903846153846154,1.0,1.0,18/81,26.54%,VEGFD;LEF1;SRC;BDNF;NOTCH3;JAG2;FLT1;SHC1;PDPK1;HRAS;EGF;DLL4;NRG1;ERBB3;MAP2K2;MYC;CTNNB1;MAML1
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.24681311688165214,-0.638678220740761,0.9263157894736842,1.0,1.0,5/16,20.99%,ENTPD8;ENTPD5;AK4;ENTPD3;CMPK1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.20512479351795962,0.6385063168789241,0.9789473684210527,1.0,1.0,36/67,48.98%,ELL3;ELOC;POLR2L;ELOB;POLR2K;NELFE;POLR2G;POLR2H;ADRM1;NELFA;POLR2I;POLR2J;CTDP1;SSRP1;SUPT5H;NELFB;POLR2A;ERCC2;ELL;POLR2B;GTF2F1;SUPT6H;POLR2F;CDK9;ERCC3;WDR61;SUPT16H;CCNT2;TCEA2;GTF2H2;PAF1;LEO1;MLLT1;CDC73;NCBP2;GTF2H5
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.21299406674709245,0.638208011505633,0.9545454545454546,1.0,1.0,20/60,32.29%,TRIM17;PPM1F;AAK1;CTSD;STX10;PARP1;TPR;OOEP;TRIM67;TRIM25;HSP90AB1;DVL1;TRIM38;STX6;TRIM27;SLC26A4;VPS4A;RACK1;PLEKHM2;CEP290
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.20507306594129437,0.6381873401071513,0.9747474747474747,1.0,1.0,6/71,12.84%,DKK1;XIRP1;AURKB;ADAM15;AURKA;PDGFB
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.24247729074952173,-0.6380497697965997,0.9629629629629629,1.0,1.0,7/15,27.45%,LRRK2;HERPUD1;HSPA1A;MAGEA3;XBP1;TMBIM6;OPA1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.2586348228663462,0.6378905930016229,0.9226190476190477,1.0,1.0,6/21,27.10%,MYO7A;MYO1H;FNBP1L;MYO19;MYO5B;SYNE2
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.18640274219717287,0.6377299108609099,0.9954954954954955,1.0,1.0,14/189,10.65%,GNG4;PIK3R2;PAK3;CALML6;MAPK12;CDC25C;MAPK11;WEE2;CCNB2;IRAK1;GNG3;IKBKG;CDK1;CCNB1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.2779166361456392,0.6377006088141985,0.9272727272727272,1.0,1.0,1/15,5.34%,REEP2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Erectile Dysfunction,0.2199012660183777,0.6375309361526897,0.9459459459459459,1.0,1.0,6/40,16.51%,ARG2;FGF2;TRPC6;GUCA2B;ACE;ROCK2
prerank,Elsevier_Pathway_Collection__DNA Persistent Repair Inhibits mTOR Signaling,0.2248246677155789,0.6374200472134479,0.9735449735449735,1.0,1.0,18/40,40.31%,FANCI;PDPK1;CHEK1;CDC25A;TSC1;RAD51;TSC2;FANCD2;CHEK2;RHEB;IRS1;BRCA2;DDIT4;RPTOR;AKT1S1;ATR;CDK2;MTOR
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.21312162132394707,-0.6372950893173718,0.9759036144578314,1.0,1.0,10/27,29.14%,PRSS16;PIK3R4;LGMN;CLN8;UCHL3;SIAH1;SNX25;SH3GLB1;CLPX;CLN5
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.17835454790384234,0.6372541960328543,1.0,1.0,1.0,137/367,43.26%,TRIM71;TRIM50;S100A1;FBXW10;RNF182;CDC20;KLHL41;UBE2C;PRKN;PSMD4;FBXL18;FBXL16;KLHL21;UBE2S;CCNF;IKBKG;FBXO31;KLHL13;CD36;SPSB2;ASB12;ASB16;PSMB4;UBE2Q1;ELOC;UNKL;TRIM11;NEDD4L;NEDD4;DET1;ELOB;BLMH;TRAIP;FBXL8;ASB1;KLHL11;UBE2A;ANAPC11;SEC61G;GAN;NDUFA2;KLHL25;HECTD2;LNPEP;UBA1;FBXL15;STX4;CUL7;CTSV;ANAPC7;PSMB3;FBXO41;UBE2M;PSMD14;UBA52;FBXL22;SMURF1;RNF25;SPSB1;SOCS3;PSMB5;PSMD2;TRAF7;PSMA1;HLA-F;UBE2O;HSPA5;PSMD10;KEAP1;GLMN;S100A9;ITGAV;PSMC4;PSMC3;FBXW5;CUL1;THOP1;ITGB5;MRC1;SKP2;SMURF2;SKP1;PSMC5;RNF126;KCTD7;SEM1;PSMB6;RNF220;CDC23;FBXO32;UBE2Q2;PSMD8;UBE2V1;UBE2D2;DZIP3;TIRAP;SEC61B;HERC1;PSME2;FBXO44;PSMD13;PSMB7;PSMA7;FBXL19;ANAPC1;HLA-A;ZBTB16;FBXL13;PSME3;UBE2J2;HUWE1;ANAPC2;TRIM41;HERC2;KLHL5;RNF213;KLHL22;UBOX5;FBXW8;ASB6;FBXW11;KCTD6;PJA1;FBXO6;HLA-B;FBXO4;PSMB2;HECW2;RBX1;UBE2V2;PSMA6;ASB11;ANAPC4;HLA-G;UBC;FBXL7;STUB1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.21735142533820262,-0.6371729358632257,0.9552238805970149,1.0,1.0,5/25,18.07%,MUC1;CXCL12;CLU;BCL2;SFRP2
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.23696453940879017,0.6366161864056549,0.9435897435897436,1.0,1.0,9/30,30.76%,SNAI2;RTEL1;THOC5;TMEM161A;CDKN2D;SNAI1;DDIAS;THOC1;PSMD10
prerank,Elsevier_Pathway_Collection__IL6 and Insulin Resistance in Muscular Dystrophies,0.251169836269578,0.6365843298951824,0.935672514619883,1.0,1.0,4/23,14.95%,SLC2A4;CPT1B;IL6R;PDPK1
prerank,TRRUST_Transcription_Factors_2019__GATA2 human,-0.2342241509262935,-0.6365099758194526,0.9743589743589743,1.0,1.0,6/17,18.59%,ADH1A;FCER1A;CYBB;SPI1;GATA1;AR
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.22419771005964798,0.6365047131598371,0.9585798816568047,1.0,1.0,23/35,50.53%,MAP1A;FHIT;HSP90AB1;PARK7;DDRGK1;SDCBP;OGT;EIF3H;CAMLG;GIPC1;TAF9;BAG6;USP7;UBXN1;UCHL5;F8A1;TRIM39;NOP53;GABARAPL2;OPHN1;MARCHF7;WAC;N4BP1
prerank,Elsevier_Pathway_Collection__Myostatin-IGF1 Crosstalk in Skeletal Muscles in Muscular Dystrophies,0.23928390053274287,0.6364456007150934,0.9473684210526315,1.0,1.0,5/29,20.07%,SLC2A4;MSTN;PDPK1;SMAD3;ACVR2B
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.16256403214146617,-0.6363435465617491,1.0,1.0,1.0,29/100,24.08%,HAO2;ABCD2;ACSL1;CAT;SCP2;ALB;ACAA1;ABCB1;NR1I2;EHHADH;DIO1;ISOC1;ACOX1;TTR;EPHX2;CRABP2;SEMA3C;CTPS1;MLYCD;HMGCL;STS;CLN8;IDH1;SLC27A2;LONP2;ALDH9A1;VPS4B;SIAH1;CRAT
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.2127392137288957,0.6362525909907991,0.9746192893401016,1.0,1.0,12/54,29.99%,LIX1;WNT8B;AMER1;DVL2;VPS33A;DVL1;MYC;CTNNB1;VPS16;VPS4A;FZD2;LIX1L
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.26782864111886684,0.6361302140434415,0.9161676646706587,1.0,1.0,2/17,6.72%,JCAD;FGF2
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.22112510674371114,0.6357178797759279,0.9635416666666666,1.0,1.0,5/39,15.74%,VWF;SRC;CAMK2A;CNKSR2;HRAS
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.24518526212878816,0.6350124206362836,0.90625,1.0,1.0,6/20,27.00%,BMP4;ACVRL1;HEY1;TGFB2;CRELD1;HEYL
prerank,MSigDB_Oncogenic_Signatures__CRX DN.V1 DN,0.19224516679319248,0.6349528472677008,0.9907834101382489,1.0,1.0,44/121,30.61%,LIX1;CALCA;CHRNA3;EFNA1;MAP3K8;CHRNB4;TIMP1;COL4A2;SPSB2;SEMA5B;SMOC2;INHBB;H6PD;FABP5;ST3GAL3;CAPN12;PLEC;TAGLN2;BCL3;ACBD6;TGM2;C1QTNF6;EYA1;IRF5;TNNC2;PLAT;KSR1;KDELR3;GDAP1L1;ANXA2;S100A6;TLE1;SH3BP4;LDB1;CDKN1A;GFAP;LAD1;SOCS3;RXRG;FKBP5;SLC26A4;NUPR1;RNASE4;ACSS1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.1722085687130389,0.6344161293548063,1.0,1.0,1.0,66/484,17.13%,EPHB2;WNK4;CDKL4;PAK3;PRKAA2;BRSK2;MAPK12;TDGF1;PDK1;NEK2;MELK;PLK1;TRIB2;BMP4;BIRC5;SRC;IRAK1;CAMK2A;TTK;NUAK2;CCNE1;PDGFRB;MAP3K9;LMTK3;INSRR;CILK1;AURKB;PRAG1;STK26;CDC7;MAST1;CCNA2;CDK1;MAST3;PRKD1;ADM2;AURKA;COQ8A;DAPK2;GDF7;EFEMP1;PDGFB;FLT1;CAD;NEK3;ABL2;MAPKAPK2;HIPK4;TSSK6;CCL11;PDPK1;STK32C;PIM1;PRKCA;SRMS;MEX3B;CAMK1D;CHEK1;GRK3;ROCK2;TYRO3;PKD1;PASK;MYLK2;TSSK3;RNASEL
prerank,Elsevier_Pathway_Collection__Proteins Involved in Azoospermia,0.2397924126936234,0.6344086648408872,0.9491525423728814,1.0,1.0,4/28,11.16%,CDC20;CDC7;PCDH17;ZMYND15
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,0.20539567095771416,0.634238153844345,0.9896373056994818,1.0,1.0,34/85,39.50%,WNT4;PSMD4;RNASE1;PSMB4;SCRIB;DVL2;PRKCA;CLTB;FZD6;PSMB3;PSMD14;CLTA;UBA52;SMURF1;PSMB5;FZD2;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;SMURF2;PSMC5;SEM1;PSMB6;PSMD8;AP2A1;PSME2;AP2S1;PSMD13;PSMB7;PSMA7;PSME3;DVL3
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.23645593443866164,0.6339295556530233,0.9588235294117647,1.0,1.0,9/30,25.39%,CCL26;PDGFRB;DUOX1;PDGFB;PPM1F;PHPT1;DUOXA2;STX4;RARRES2
prerank,Elsevier_Pathway_Collection__Skin Aging,0.21204461892852597,0.6338241545910475,0.9562841530054644,1.0,1.0,11/49,24.71%,RASGRF1;SRC;SHC1;EGF;TRAF2;MMP9;MMP3;FADD;PLCG1;TXN;MAP2K2
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.23144007215435847,0.6336878797829436,0.9337016574585635,1.0,1.0,8/30,24.28%,B3GAT1;EXTL3;FOXL1;B3GAT3;B4GALT7;FAM20B;XYLT2;CHST10
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.19140150792861052,0.6336313825332787,0.985981308411215,1.0,1.0,10/110,13.78%,THBS4;RASGRF1;PIK3R2;BRSK2;PRKN;ATP2A1;RASGRF2;BCAP31;CREB3L1;UFC1
prerank,Elsevier_Pathway_Collection__rRNA Transcription and Processing,0.2620680908938306,0.6336028359022219,0.8975903614457831,1.0,1.0,8/18,46.44%,CDK1;TAF1A;MAF1;FBL;RPL5;UBTF;TAF1B;TAF1C
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.2229293203857331,0.6331801449844909,0.9425287356321839,1.0,1.0,16/38,41.26%,UBL4B;PRKN;SREBF2;RNF31;HAX1;RHOU;VPS11;HPS4;BAP1;SAE1;PARL;UBE2J2;HUWE1;TOMM7;HSPA1L;UBL5
prerank,TRRUST_Transcription_Factors_2019__CIITA human,-0.20532687328951868,-0.6331724673196844,0.9583333333333334,1.0,1.0,13/28,28.46%,FASLG;HLA-DOB;HLA-DOA;HLA-DRB5;HLA-DRA;STAT1;IRF2;HLA-DPB1;HLA-DRB1;HLA-DMB;IRF1;HLA-DQB1;SIRT1
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.24321695025263723,0.6327262853388943,0.9779005524861878,1.0,1.0,13/31,31.03%,CHST6;B4GALT3;ST3GAL3;OGN;CHST1;B4GAT1;GLB1;HEXB;HEXA;ACAN;ST3GAL2;ST3GAL1;GLB1L
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.2591994210644101,0.6325832743514506,0.9244186046511628,1.0,1.0,5/19,25.19%,MYO7A;MYO1H;FNBP1L;MYO19;MYO5B
prerank,WikiPathway_2021_Human__Structural Pathway of Interleukin 1 (IL-1) WP2637,0.21049541363761076,0.6325496254755081,0.9664804469273743,1.0,1.0,5/48,14.29%,MAPK11;IRAK1;MAP3K8;IRAK2;MAPKAPK2
prerank,Elsevier_Pathway_Collection__Apoptosis Block in Infected Cells,-0.19626726848428006,-0.6320169320943039,0.9552238805970149,1.0,1.0,7/31,22.85%,TNF;FASLG;TNFRSF1B;BCL2;MAP2K3;MAP2K6;MAP3K5
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,0.25393228480391766,0.6316889956057995,0.9440993788819876,1.0,1.0,6/23,24.33%,PLA2G2A;PLA2G4C;PLA2G4F;PLA2G6;PLA2G4E;LPCAT1
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,0.28493403981788556,0.631479747829875,0.9239766081871345,1.0,1.0,2/15,15.74%,NOX4;HRAS
prerank,Elsevier_Pathway_Collection__Glycolysis Activation in Cancer (Warburg Effect),-0.18919408095109763,-0.6314643344430207,0.9848484848484849,1.0,1.0,13/40,24.89%,PHGDH;ALDOB;FBP1;ARRDC4;SHMT1;AKT1;PDK3;PSAT1;ENO2;PFKFB3;PGAM1;PTEN;HK2
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,0.1972865394767978,0.6313234106544043,0.9792746113989638,1.0,1.0,27/71,38.72%,CLVS1;DNAJC6;BLOC1S1;SNAPIN;CLTB;FTL;NAPSA;AP4B1;STX4;OCRL;AP4M1;BLOC1S3;CLTA;HGS;DTNBP1;ARRB1;CHMP2A;AP3B1;HOMER2;ACBD3;FTH1;HSPA8;SORT1;PTGES2;HIP1R;TFRC;AP1S1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.2682062027834939,0.6312195353606789,0.9341317365269461,1.0,1.0,4/15,14.91%,DPYSL4;NT5M;UPP1;TYMP
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.24660790916109082,0.6311780478135516,0.9263803680981595,1.0,1.0,6/22,23.73%,DNAH17;DNAAF1;ZMYND10;DRC1;DNAH5;CCDC40
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.23683198769703961,-0.630386521367257,0.9545454545454546,1.0,1.0,15/15,76.33%,HERPUD1;TMEM129;SEL1L;SELENOS;OS9;DERL2;SYVN1;AUP1;HSP90B1;FAF2;VCP;SEC61B;DERL1;UFD1;NPLOC4
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.2323042023914799,-0.6302008686248921,0.9444444444444444,1.0,1.0,16/16,76.79%,SPHK2;ING3;MSL3;EPC1;MORF4L1;YEATS4;NAA40;ACTL6A;MEAF6;TRRAP;MORF4L2;DMAP1;RUVBL1;RUVBL2;EP400;BRD8
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.2183319026115968,-0.6294601109412901,0.9642857142857143,1.0,1.0,8/21,29.72%,IFNG;JAK2;STAT1;ARG1;TXK;IFNGR1;SUMO1;IFNGR2
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.15087969864923864,-0.6294495796520282,1.0,1.0,1.0,30/138,22.36%,RIPK3;BPI;FOS;S100A8;MAP2K1;KCNH8;S100B;BTK;PELI2;RPS6KA1;CD180;TLR4;TLR2;S100A12;USP18;PLCG2;MYD88;ITGB2;DUSP6;MAPK10;PPP2CB;LY86;SIGIRR;NOD2;TAB2;MAP2K3;MAP2K6;JUN;ITGAM;APP
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.23092048940506354,0.6294311924303007,0.9529411764705882,1.0,1.0,1/28,1.28%,EPHB2
prerank,Elsevier_Pathway_Collection__Wolfram Syndrome Progression (Hypothesis),0.266599069399613,0.6292805590749849,0.9325153374233128,1.0,1.0,9/17,38.62%,ABCC8;KCNJ11;CLDN5;ATF6;HSPA5;SLC2A1;ADCY8;WFS1;CISD2
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,0.24484694662359657,0.6292061531055311,0.9411764705882353,1.0,1.0,21/21,75.54%,UGGT1;EDEM3;UBA52;UGGT2;MAN1B1;UBC;RPS27A;RNF103;EDEM2;SYVN1;DERL2;MARCHF6;TRIM13;AMFR;RNF139;OS9;UBB;SEL1L;RNF5;RNF185;EDEM1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.17390629819324574,0.6290856935551219,1.0,1.0,1.0,108/406,32.53%,TSPO2;THY1;TERT;KISS1;SPTSSB;MDK;GOLGA6D;CCL13;KIF4A;ANK1;FGD1;ABCA3;MSTO1;PRKN;MAST1;CDCA8;CNTNAP1;MAST3;PRKD1;CEP55;CATIP;DIAPH3;MICAL2;ABCD1;PACSIN3;CSPG5;ARAP3;GBA;KIF25;LMAN2;PALLD;RAB34;HILPDA;CCL24;ATP8B3;CCL11;TMED3;TMED6;ROPN1B;GOLGA8M;NCKIPSD;OBSL1;TWNK;PLEKHF1;GOLGA8A;TOR1AIP2;POLRMT;HAX1;DYRK3;ARHGAP4;FNBP1L;FAM161A;MARK4;HPS3;PARP1;TMCC1;SEC16B;SPRYD3;BRWD3;NPLOC4;STX4;CUL7;TMED9;COG2;TANGO2;ZMYM3;ATAD3B;CENPW;WDR81;MAST2;HCFC1;CECR2;KIF9;MYC;PEX11B;FMNL2;CAMSAP1;FANCG;TJAP1;SEC31B;RHOU;MREG;STRIP1;TFB2M;MTX1;SLC25A33;STRIP2;MCOLN1;KIFAP3;VPS4A;NECTIN2;RAB43;PARK7;PPIA;APOE;PLEKHM2;LONP1;CHMP2A;CSNK1D;PPRC1;VPS11;CFL1;IQCG;COG4;FITM2;PEX6;MTFR2;TSGA10IP
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,0.18746869977964198,0.6289025336774601,1.0,1.0,1.0,12/168,8.15%,SLC22A12;SLC34A3;SLC39A4;TAC4;SLC12A1;SLCO2A1;AVPR2;SLC4A1;SLC6A3;SLC5A2;ABCA3;PSMD4
prerank,TRRUST_Transcription_Factors_2019__HIF1A mouse,0.2535152152999435,0.6288616189002342,0.9320987654320988,1.0,1.0,7/19,26.20%,MDK;EPO;TUFT1;DLL4;HEY1;SNAI1;BSG
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,0.21320385943514658,0.6284827187609577,0.9502487562189055,1.0,1.0,10/62,20.38%,RAB3C;MPZ;RAB3B;RAB41;RAB3D;RAB34;CHML;RAB24;RAB15;RAB9B
prerank,Elsevier_Pathway_Collection__Apoptosis of Melanocyte in Vitiligo,0.23344170449632623,0.628473790562646,0.9298245614035088,1.0,1.0,2/29,6.66%,RASGRF1;SRC
prerank,Elsevier_Pathway_Collection__BMPR2 Signaling,-0.20963787227420094,-0.6283684436652548,0.9722222222222222,1.0,1.0,9/30,22.68%,BMP5;BMP7;SMAD9;BMPR2;BMPR1B;MAP2K3;SMAD7;JUN;SMAD1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.2322184341548647,0.6281871130197265,0.9302325581395349,1.0,1.0,2/26,7.91%,BMP4;AGO2
prerank,MSigDB_Oncogenic_Signatures__TBK1.DF DN,0.17961283121299068,0.6276627568374334,1.0,1.0,1.0,32/263,21.51%,DKK1;TSPAN5;ALDH3A1;ITGA2;MTR;KIF14;COL4A1;COL4A5;CBX6;SLC6A8;CCNE2;RCBTB1;PAFAH1B3;KLF13;PDGFA;UBL4A;ADCY6;SLC26A2;ZWINT;USP22;ROCK2;TCOF1;MFSD6;UGGT1;MSH2;USP46;CAMK2N1;BLMH;CDK6;HMGCS1;DSN1;FNBP1L
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.2701746180737066,0.6271059930332848,0.9141104294478528,1.0,1.0,13/18,51.78%,TCOF1;POLR1G;GTF3C5;SIRT7;NIFK;CAVIN1;MARS1;GTF3C3;TAF1B;GTF3C6;GTF3C2;BRF1;GTF3C1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.23666937822438566,0.6268556339780343,0.9408284023668639,1.0,1.0,9/25,39.37%,EFNA1;GBA;PKD1;GPX1;PSMD14;APOE;USP14;PSME2;PSME3
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.17746675932404343,0.6265343808791898,0.995475113122172,1.0,1.0,37/217,22.72%,PAEP;ALOX15B;TNFRSF19;TP53AIP1;MELK;NOX5;FAP;CASP12;BIK;ZNF385A;IKBKG;MCM2;ADAM15;PHLDA2;ATP2A1;SCN2A;DAPK2;KREMEN1;IFI27;IAPP;ADORA2A;CHEK1;IFI27L1;BMF;BNIPL;GLRX2;TNFRSF25;BBC3;IRF3;NUDT2;TRAIP;FADD;PARP1;AIFM2;TAOK2;TSC2;AIFM1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.25714218529666727,0.6263374026168695,0.9748427672955975,1.0,1.0,7/19,26.90%,MDK;MSTN;CXCL17;CAMK1D;RARRES2;PTK2;IL34
prerank,Elsevier_Pathway_Collection__Circadian Clock Genes Mutations Cause Insomnia,-0.23641892438108414,-0.626272167965229,0.9473684210526315,1.0,1.0,4/18,17.59%,BHLHE41;RORB;PER1;PER3
prerank,Elsevier_Pathway_Collection__Circadian Clock and Sleep Regulation by Melatonin,-0.23641892438108414,-0.626272167965229,0.9473684210526315,1.0,1.0,4/18,17.59%,BHLHE41;RORB;PER1;PER3
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),0.2355156606776875,0.6262331285735961,0.9197530864197531,1.0,1.0,11/24,32.10%,PXDNL;HBD;DUOX1;NOX1;GPX3;HBM;GPX1;PRDX4;PRDX2;PARK7;PRDX5
prerank,Elsevier_Pathway_Collection__MTOR/TORC in Cancer Cell Motility and Invasion,0.24251135569650706,0.6261388965897005,0.9213483146067416,1.0,1.0,14/25,40.66%,PLAU;PDPK1;PRKCA;MMP9;TSC1;TSC2;RHEB;MLST8;SGK1;RPTOR;MAPK3;MMP2;MTOR;PXN
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.24593176192059227,0.626078474859248,0.9190751445086706,1.0,1.0,2/21,4.97%,TEKT5;DNAH17
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer-Associated Histone Deacetylation,0.27463479238646477,0.6257853994250092,0.9342105263157895,1.0,1.0,10/15,51.24%,HDAC1;SIRT6;HDAC8;SIRT7;HDAC7;HDAC3;HDAC2;CREBBP;KAT2B;EP300
prerank,Elsevier_Pathway_Collection__Vitamin K Metabolism,-0.23634352030820857,-0.6255607760895746,0.9411764705882353,1.0,1.0,10/16,29.33%,F9;PROZ;F3;PRRG4;F7;PRRG2;F2;PROS1;GGCX;PROC
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.17630181275612497,0.6255185309961757,1.0,1.0,1.0,57/210,32.28%,GNG4;MT3;PAPPA2;H1-5;CDKN2A;KIF14;SPHK1;MSX1;TP53TG5;CDKN2C;LAMTOR2;ADAM15;EXOSC4;ARHGEF11;CCDC85B;MELTF;PSRC1;SMAD3;ACVRL1;BCL6;MUC12;CXCL16;TSPYL2;DNPH1;BST2;TGFB2;SMARCA4;APBB1;TAOK2;ESR2;CDKN2D;GJA1;SOX17;WT1;SH3BP4;HYAL2;HDGFL2;NDUFA13;CDKN1A;SLC25A33;MAD2L2;VGLL4;H3-3A;BRAT1;AGT;TCHP;RACK1;MMP14;PRDM11;PSMD10;RBBP7;CYP27B1;S100A9;FRZB;BAP1;DNAJB2;SDCBP
prerank,KEGG_2021_Human__Endocytosis,0.17783781173114258,0.625096179652342,0.9914529914529915,1.0,1.0,57/246,32.05%,SH3GL3;SRC;RAB11FIP4;KIF5A;ASAP2;PIP5K1B;CLTCL1;VPS28;DNM3;AGAP1;DNAJC6;ASAP3;ARAP3;HSPA2;MVB12B;IQSEC1;PSD;HRAS;NEDD4L;GRK3;SMAD3;VPS37D;NEDD4;CLTB;SNX32;VPS45;EHD2;ACAP3;WASHC3;GRK6;ARPC1A;WASHC1;ARF1;WASHC5;AGAP3;AGAP6;ARFGAP1;RAB4A;RUFY1;CLTA;HGS;ASAP1;FGFR4;SMURF1;VPS4A;SNF8;ARAP1;HLA-F;WASHC2A;ARPC5;ARRB1;RAB11FIP2;CHMP2A;RUFY2;CYTH3;CYTH2;RBSN
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.24218001336725842,0.6243649708055226,0.9548022598870056,1.0,1.0,4/26,15.39%,SAA1;DISP1;PPM1F;RHBDF2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.2604885566262747,0.6240441275068832,0.9329268292682927,1.0,1.0,3/17,18.32%,SEPTIN5;SYN1;SNAPIN
prerank,WikiPathway_2021_Human__Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.20220668766018543,0.6239830117295788,0.9754901960784313,1.0,1.0,4/72,6.65%,LEF1;AXIN2;TCF7;BIRC5
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.2054358714594068,0.6239267109134852,0.972972972972973,1.0,1.0,8/57,22.74%,UBE2T;UBE2C;PRKN;IFI27;NEDD4L;RNF187;UBE2A;UBR5
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,0.2091180959167637,0.6237384827412706,0.9487179487179487,1.0,1.0,17/54,39.54%,PIK3R2;IQGAP3;DIAPH3;SCRIB;FNBP1L;ARHGAP26;OCRL;GJA1;CDC42BPA;PKN1;GIT1;ARHGAP1;DEPDC1B;RHOJ;TFRC;TRIO;TMPO
prerank,Elsevier_Pathway_Collection__EGFR/ERBB3 -> MEF/MYOD/NFATC/MYOG Signaling,0.2086576614988051,0.6235840928402848,0.9698795180722891,1.0,1.0,6/46,17.35%,MAPK12;NRG2;SRC;PDPK1;MEF2D;EGF
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.17444969467620186,0.6235460952740103,1.0,1.0,1.0,82/348,31.28%,SCG2;RAB3C;SYNDIG1;RAMP1;CENPF;RAB3B;SGSM1;ATP6V0D2;UNC119B;NECAB3;ARL4A;LTBP2;TBC1D16;SIL1;CD36;GPIHBP1;RAB41;SCAMP3;RAMP2;RAB3D;CTSA;RAB34;ATP6V0A1;VLDLR;PPARG;TMED3;BBS2;ATP6AP1;ARHGEF2;TMED6;SNX27;SGSM2;RAB24;ATP6V0B;STXBP1;PREB;TBC1D8;RAB15;TCIRG1;VPS45;STX1A;STX10;TBC1D25;VPS33A;ATP6V0D1;VAMP5;CALCRL;STX4;TBC1D10A;ARRDC5;AP4M1;TMED9;NPM1;IFT27;TANGO2;EIF2D;ATP6V0E1;RAB13;ATP6V1C1;TBC1D13;STX1B;ARF1;ABCA12;SVBP;TBCK;RUFY1;SGSM3;SEC31B;ATP6V1H;TBC1D9B;ARRDC2;AP3D1;MCOLN1;COPA;STX6;RAB43;ATP6V1F;RAB3GAP2;VAMP4;APOE;CHMP2A;ATP6V1E1
prerank,KEGG_2021_Human__ABC transporters,-0.18906416345087684,-0.6230865279698811,1.0,1.0,1.0,11/43,18.63%,ABCD2;DEFB1;ABCB1;ABCG8;ABCG5;ABCG4;ABCD4;ABCA8;CFTR;ABCA9;ABCC9
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.2279019335517471,0.6228003178712981,0.9447513812154696,1.0,1.0,13/30,43.44%,NEDD4L;SMAD3;PARP1;HDAC1;NCOR2;UBA52;SMURF2;TGIF1;MAPK3;SMAD2;WWTR1;UBC;MAPK1
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Melanoma,0.22251954863973084,0.6225386038431717,0.9783783783783784,1.0,1.0,10/46,19.77%,NODAL;KISS1;BIRC5;POU5F1;FLT1;PLAU;PGF;EGF;NOTCH4;MMP9
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.21858816033417158,0.6223991760621939,0.9441340782122905,1.0,1.0,21/31,48.68%,NEK2;AURKB;RTEL1;NABP2;SIRT6;NEK7;PNKP;MAPK3;SLX4;MAPK1;GNL3;ATRX;MAP2K7;NBN;PPP1R10;ERCC1;MAP3K4;MAPKAPK5;MRE11;RAD50;TNKS
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.24562285114697235,0.6222754867921916,0.9244186046511628,1.0,1.0,3/23,8.68%,AK8;GUK1;NMNAT2
prerank,WikiPathway_2021_Human__Adipogenesis WP236,0.18661081302797777,0.6222634417116812,0.9953051643192489,1.0,1.0,14/122,17.33%,DLK1;E2F1;SFRP4;SLC2A4;BMP4;EBF1;LPL;LEP;LMNA;PPARG;MEF2D;SMAD3;SCD;HMGA1
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,-0.2171484884307306,-0.6222463858481883,0.9358974358974359,1.0,1.0,4/17,21.28%,PLA2G4A;FGR;PPP2CB;APOB
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.19096195768243268,0.6216763182897842,0.9856459330143541,1.0,1.0,43/107,38.94%,ADGRB1;SPHK1;PRKN;VPS28;FANCI;AMER1;FOXF2;PRR7;SQSTM1;ISG15;WASHC1;HSP90AB1;SH3RF2;SVBP;SPRTN;PHF23;CENPS;PARK7;PSMD10;ARRB1;DNAJB2;SEPTIN4;DERL1;PRMT3;HDAC8;ANGPT1;OGT;HSPBP1;GTPBP4;PAXIP1;PINX1;CAMLG;CENPX;TNFAIP3;SIRT7;MALT1;GNL3L;WFS1;AXIN1;RPS3;FKBP1A;DAXX;HSP90AA1
prerank,KEGG_2021_Human__Glycerolipid metabolism,0.20848255882869487,0.6211437357832339,0.9728260869565217,1.0,1.0,8/54,15.65%,CEL;PLPP2;AKR1B10;DGKI;LPL;DGKD;GLA;PLPP1
prerank,Elsevier_Pathway_Collection__Extraocular Muscles Weakness in Myasthenia Gravis,-0.23456352729727314,-0.6209941912344702,0.9479166666666666,1.0,1.0,2/15,6.35%,MUSK;C9
prerank,WikiPathway_2021_Human__Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,-0.19559796803854587,-0.6206906726959668,0.987012987012987,1.0,1.0,3/43,8.25%,FA2H;CP;SCP2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.22372867100449556,0.6204278858353767,0.9886363636363636,1.0,1.0,9/37,19.58%,ADGRB1;FGF2;ATP2B4;RGCC;PPARG;STC1;ANGPT2;ACVRL1;DLL4
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.1968931577794673,0.6204230529372127,0.9797979797979798,1.0,1.0,5/77,9.37%,MRAP2;EPHB2;NKD2;ATP2B4;DPP10
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.2073799036365611,0.6203559667508773,0.98989898989899,1.0,1.0,24/63,33.59%,DPYSL4;PLXNC1;RNASE1;ARHGEF11;SEMA7A;PLXNA2;PLXND1;ROCK2;RHOC;VPS72;PLXNA3;LIMK2;CDK5R1;CRMP1;PLXNA1;CDK5;HSP90AB1;PKN1;RRAS;TREM2;NRP1;DPYSL3;RND1;MYH9
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.21542802048987275,-0.6202333212212024,0.9468085106382979,1.0,1.0,10/21,35.22%,MCUB;MICU1;PHB2;MAIP1;SLC8B1;AFG3L2;SPG7;YME1L1;MICU2;SLC25A23
prerank,Elsevier_Pathway_Collection__TGFB Family in Epithelial to Mesenchymal Transition in Cancer,0.19404041257378069,0.6198490000433741,0.9853658536585366,1.0,1.0,3/80,6.21%,HMGA2;SNAI2;BMP4
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.18806396991736485,0.6187779881777786,0.9951456310679612,1.0,1.0,23/128,21.74%,DLX5;NODAL;GDF5;BMP4;SRC;AMH;FOXH1;RGMA;LTBP2;GDF15;GDF7;COL1A2;INHBB;SMAD3;ADAM9;MEGF8;CLDN5;ACVRL1;SCX;ACVR2B;TGFBR3;TGFB2;FNTA
prerank,Elsevier_Pathway_Collection__WNT Signaling in Breast Cancer,0.2261099291568839,0.6187399007919048,0.9453551912568307,1.0,1.0,15/35,38.05%,LEF1;TCF7;CCNB1;MMP9;MMP3;DVL1;MYC;CTNNB1;CDK4;LRP5;MAP3K11;MAPK9;AXIN1;MMP2;GSK3B
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.22758382036296526,-0.6186681119689039,0.9139784946236559,1.0,1.0,17/17,77.26%,MAN1A1;SRPRA;EDEM1;SRP54;SPCS3;RYR2;RAB3GAP1;RAB10;SPCS2;SEC61A1;ZFAND2A;SRP14;SPCS1;SRPRB;RAB3GAP2;ZFAND2B;SEC61G
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,-0.20543887991383952,-0.6186155060090801,0.9390243902439024,1.0,1.0,27/27,79.48%,HSPA1B;HSPA1A;TNFRSF21;DNAJB1;HDAC6;FKBP4;UBB;YWHAE;HSPA6;RPA3;MRPL18;HSBP1;DEDD2;POLR1B;PTGES3;EEF1A1;COL4A6;HSPH1;HSPA1L;DNAJB6;HSP90AA1;SERPINH1;VCP;CRYBA4;HSP90AB1;HSF1;POLR1A
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.2022291817128904,0.6185146929638562,0.9792746113989638,1.0,1.0,20/68,33.03%,PRR5L;VPS28;UNC13B;CEP131;ANKRD1;SYTL4;B3GAT3;ADAM9;MYOM1;TGFB2;APBB1;TPR;ACSL3;ATP13A2;APBB3;RACK1;PPIA;TREM2;CEP290;TGFB1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.1966843744347388,0.6184442388625471,0.9740932642487047,1.0,1.0,7/77,12.38%,B3GALT1;ST8SIA3;GAL3ST2;B3GNT5;FUT5;ST8SIA5;FOXL1
prerank,Elsevier_Pathway_Collection__IL2R -> ELK/SRF/MYC Signaling,0.24700817352850962,0.6184280923460478,0.9408284023668639,1.0,1.0,6/19,26.07%,MAPKAPK2;SHC1;PDPK1;ELK4;MAP2K2;MYC
prerank,Reactome_2022__MyD88 Deficiency (TLR2/4) R-HSA-5602498,0.24454548347466049,0.6182864561678899,0.9390243902439024,1.0,1.0,2/17,11.46%,S100A1;CD36
prerank,Elsevier_Pathway_Collection__Proerythroblast -> Erythrocyte Surface Expression Markers,-0.18036414023983852,-0.6182090726276379,1.0,1.0,1.0,13/47,21.29%,TSHR;P2RY13;HBB;XK;P2RY1;SYK;ITGA4;VPS13A;PDE2A;ART4;AGTR1;STOM;CD55
prerank,Elsevier_Pathway_Collection__Myocardial Remodeling,0.20539585691571818,0.6181667605237929,0.994535519125683,1.0,1.0,8/51,20.59%,RASGRF1;SRC;TIMP1;SHC1;PDPK1;HRAS;MMP9;MMP3
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.21235370086866157,0.6177044651983561,0.9746192893401016,1.0,1.0,7/52,12.41%,SLC34A3;ANO4;SLC4A1;SLC26A6;CLCNKA;CLCN1;RACGAP1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.22012966484551857,0.6176330926863522,0.9479768786127167,1.0,1.0,9/31,29.80%,ATP1A2;PAQR8;SOX30;CATSPER1;CATSPER2;TGFB2;ABCA2;CATSPERB;YAP1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.19284693674073466,0.6173613642241393,0.9896907216494846,1.0,1.0,39/87,39.75%,IRAK1;NFKB2;POLR2L;MAVS;PQBP1;IRF3;ISG15;RNF135;IRF5;PRKDC;POLA1;POLR2K;NPLOC4;DDX41;TRIM25;CTNNB1;RNF216;UFD1;POLR3K;GAPDH;PIN1;POLR2H;POLR3H;GPATCH3;POLR3A;POLR3C;IKBKE;G3BP1;POLR3G;TNFAIP3;TRAF3;POLR3GL;DHX9;OTUD5;TIRAP;TRIM56;TAX1BP1;XRCC6;POLR3E
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.18666365445110936,0.6173377368652817,0.995260663507109,1.0,1.0,7/117,8.78%,PPP2R2C;CERS1;PIK3R2;MAPK12;MAPK11;SPHK1;ADORA1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.2420576060058813,0.617152295745868,0.967948717948718,1.0,1.0,13/22,44.96%,MSX1;ANKRD1;EEF1E1;RPS15;RPL37;RPS20;RPS7;RPL23;ATR;CDK5RAP3;SPRED3;HIC1;DDX5
prerank,Elsevier_Pathway_Collection__Proteins Involved in Acute Myeloid Leukemia,-0.18687774406267105,-0.6171201730850845,0.9795918367346939,1.0,1.0,16/34,31.08%,FLT3;AKT1;CXCR4;SPI1;BCL2;GATA1;MEIS1;JUN;JAK2;PTEN;KRAS;RUNX1;HOXA9;RB1;ETV6;CEBPA
prerank,KEGG_2021_Human__Shigellosis,0.17727005570036142,0.6170295785536034,0.9957983193277311,1.0,1.0,11/232,6.66%,H3C13;PIK3R2;SEPTIN3;MAPK12;H3C1;FOXO6;H3C2;MAPK11;H3C10;PFN4;SRC
prerank,Elsevier_Pathway_Collection__Proteins Involved in Friedreich Ataxia,-0.2182405413718856,-0.616858447259525,0.9090909090909091,1.0,1.0,17/17,78.19%,SLC25A37;TTPA;MIPEP;FXN;NFE2L2;PSEN1;ITPR1;ACO2;DST;APTX;ABCB7;ISCU;USP14;LONP1;SACS;MSH6;PARP1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.21283851597244505,-0.6167771853447337,0.9565217391304348,1.0,1.0,6/23,17.74%,TNFSF10;PPIF;BCL2L11;PLAUR;MLLT11;PMAIP1
prerank,MSigDB_Oncogenic_Signatures__AKT UP MTOR DN.V1 UP,0.17838433005324406,0.6167466840433571,1.0,1.0,1.0,22/159,16.13%,HCN2;LYPD1;SAA1;RASD1;TMEM40;SAA2;TESC;SPHK1;A4GALT;RUNDC3A;KCNH3;CDKN2B;GSDMC;NFKB2;PACSIN3;FLT1;SUSD4;PDE10A;HIC2;ABCA7;PPP1R3F;PFDN2
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.20055950728249922,0.6164177462710604,0.9841269841269841,1.0,1.0,42/77,47.47%,PSMD4;IKBKG;PSMB4;HRAS;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PPIA;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;MALT1;PSME2;FKBP1A;PSMD13;NFKBIE;PSMB7;PSMA7;PSME3;FBXW11;PSMB2;PSMA6;NFKBIB;UBC;PSMD9;RASGRP3;BTRC;PSMC2;RPS27A;PSME1;PSMB1;PSMD3;RELA
prerank,WikiPathway_2021_Human__Fatty acid beta-oxidation WP143,0.2252024948189772,0.6160270295974037,0.9529411764705882,1.0,1.0,4/32,11.27%,ACSL6;ACSL4;LPL;CPT1B
prerank,KEGG_2021_Human__Salmonella infection,0.17620399701244815,0.6158789116763322,1.0,1.0,1.0,72/242,35.02%,DYNC1I1;LEF1;PAK3;MAPK12;MAPK11;TCF7;AHNAK2;PFN4;IRAK1;KIF5A;TUBB8;S100A10;IKBKG;TUBA4A;PODXL;TUBA3E;MYLPF;TUBA8;HRAS;GSDMD;ROCK2;TUBB2B;TRAF2;TUBA3D;FHOD1;RAB9B;DYNLRB2;FADD;STX10;VPS33A;TXN;ARPC1A;CYFIP2;DYNLL1;MAP2K2;ANXA2;KLC2;HSP90AB1;ARF1;MYC;CTNNB1;DYNLRB1;FLNB;VPS16;TUBB2A;GAPDH;PKN1;EXOC4;ARPC5;FYCO1;RRAS;PLEKHM2;CYTH3;TCF7L1;VPS11;PFN3;CYTH2;TUBA1A;PIK3C2B;DCTN4;TUBA1B;DCTN2;DYNC1H1;MYL5;DCTN3;SKP1;TNFRSF10A;MLKL;BAX;TRADD;DYNC2LI1;ACBD3
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.23683963233810695,0.6158201965662687,0.9497206703910615,1.0,1.0,15/27,44.01%,STMN2;STMN1;CYRIB;TWF2;KANK3;CLIP3;TBCD;KANK1;SSH1;HIP1R;CDH5;MAP2;TUBB4A;PFN1;EML2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.2574143060790138,0.6158103818841879,0.8848484848484849,1.0,1.0,1/15,5.85%,FAP
prerank,Elsevier_Pathway_Collection__Lamellipodia and Filopodia Formation in Cancer,0.22863789377152433,0.6157737834432504,0.9709302325581395,1.0,1.0,4/29,20.90%,VIL1;DIAPH3;LIMK2;WASF2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.20406058953796952,0.6156154498323307,0.9788359788359788,1.0,1.0,13/59,26.07%,LCN2;ERFE;FLVCR1;ATP6AP1;HEPHL1;ABCB6;FTL;ATP6V0D1;HJV;NEDD8;SLC46A1;ATP13A2;MYC
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.22937622109665184,-0.6154997243628607,0.9775280898876404,1.0,1.0,2/16,10.28%,NGFR;NGF
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.22129663688850257,0.6153643687321307,0.9572192513368984,1.0,1.0,4/32,15.74%,VWF;SRC;CNKSR2;HRAS
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.20209721882740964,0.6152726832404591,0.964824120603015,1.0,1.0,6/51,14.95%,EPHB2;NKD2;ATP2B4;DPP10;SQSTM1;PDPK1
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.22846214306814122,0.6151720121120416,0.9431818181818182,1.0,1.0,8/29,25.73%,GUCY2C;SYT2;SNAP25;TXNRD1;STX1A;MAP2K2;HSP90AB1;STX1B
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.20490838200749867,0.6149080958258509,0.983957219251337,1.0,1.0,8/57,19.77%,TERT;BMP4;BDNF;PRKN;NVL;PKD1;CLDN5;MMP9
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,0.1930266752283253,0.6148266911794315,0.9852216748768473,1.0,1.0,43/89,44.54%,CDKN2B;COL1A2;DAND5;NEDD4L;SMAD3;E2F5;TGFB2;PARP1;HDAC1;LTBP3;NEDD8;F11R;MYC;NCOR2;BAMBI;UBE2M;UBA52;RBL1;SMURF1;ITGAV;ITGB5;TGFB1;SMURF2;TGIF1;E2F4;MAPK3;PMEPA1;TGFBR2;XPO1;FKBP1A;CGN;SMAD2;TGFB3;CBL;WWTR1;UBC;STUB1;PPP1CA;MAPK1;CDK9;ZFYVE9;UCHL5;CCNT2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.16882103269506335,-0.6146626133396487,1.0,1.0,1.0,9/57,17.74%,TNF;S100A8;TNFSF10;NKX3-1;LCK;BCL2L11;BCL2;TPD52L1;PMAIP1
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.2468591542189395,0.614528361103039,0.9047619047619048,1.0,1.0,5/20,29.86%,ANKRD27;EMP2;PTPN23;WDR81;SNF8
prerank,WikiPathway_2021_Human__TGF-beta Signaling Pathway WP366,0.1831770050129974,0.6142677342964818,0.9905660377358491,1.0,1.0,38/131,33.80%,PIK3R2;TERT;ITGA2;PDK1;SRC;CCNB2;FOXH1;MMP12;CDK1;CDKN2B;COL1A2;SHC1;NEDD4L;SMAD3;LIMK2;E2F5;STAMBPL1;TGFBR3;HDAC1;PIAS1;MAP2K2;PTK2;MYC;COPS5;TRAP1;RBL1;HGS;CDKN1A;SMURF1;MAPK4;YAP1;UBE2I;CUL1;ZEB1;PRKAR2A;TGFB1;SMURF2;SKP1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.26506819555259176,0.6140361184120366,0.9426751592356688,1.0,1.0,8/15,46.51%,EXOSC4;TUT1;SSB;TUT7;EXOSC10;UPF1;TUT4;MTPAP
prerank,KEGG_2021_Human__Lysine degradation,0.20466568514284897,0.6139784061125516,0.9794871794871794,1.0,1.0,17/61,28.03%,PRDM7;PRDM16;EZH2;SMYD3;SMYD2;DOT1L;SUV39H1;EHMT2;NSD1;SETDB1;KMT2D;KMT2B;PLOD3;KMT5C;PRDM6;NSD2;ASH1L
prerank,Elsevier_Pathway_Collection__Cochlear Hair Cell Stereocilia Proteins Mutations (Congenital Deafness),-0.19654727369588526,-0.6136223011754247,0.9836065573770492,1.0,1.0,8/33,20.51%,PTPRQ;MYO3A;MYO1F;TECTA;SLC26A5;EZR;MYO6;MYO15A
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.21149695765716625,0.6133582980642837,0.9814814814814815,1.0,1.0,18/41,37.03%,ATP1B3;UHRF1;TNNT3;ATP2A1;FXYD2;MSH2;TOR1AIP2;CHTOP;MYBPC3;DYNLL1;TOR1AIP1;MSH6;DNAJB11;DNAJB2;ATP1B1;HNRNPU;DHX9;DNAJC9
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.24870967712978603,0.6132272163272604,0.9349112426035503,1.0,1.0,8/19,35.95%,ARL2;BCL3;ARL2BP;BBS4;HSPA5;SKP1;HNRNPU;TAF8
prerank,WikiPathway_2021_Human__IL17 signaling pathway WP2112,0.23279921866493156,0.6132257801824671,0.9212121212121213,1.0,1.0,2/27,10.06%,IL17D;IKBKG
prerank,Elsevier_Pathway_Collection__Vitamins Insufficiency Causes Homocysteine High Level Synthesis,-0.23616713265694203,-0.6128716849913538,0.9052631578947369,1.0,1.0,5/15,20.12%,GNMT;CBS;SHMT1;LMBRD1;DHFR
prerank,MSigDB_Oncogenic_Signatures__TBK1.DF UP,0.17136331104916833,0.6127464084480828,1.0,1.0,1.0,24/261,14.93%,CHGB;PTK7;RGS20;P2RX5;SAA1;CKB;SLC39A4;TMEM40;STEAP1B;NETO2;RHOBTB1;EFNA1;PTHLH;AKR1C3;MAST3;STEAP1;TIMP4;ARAP3;HSPA2;PLAU;IGSF3;TUBBP5;TUFT1;RABIF
prerank,"Elsevier_Pathway_Collection__Integrins in Cancer Cell Motility, Invasion and Survival",0.1970344340160964,0.6125949863322532,0.9851485148514851,1.0,1.0,6/73,9.53%,SPP1;ITGA2;SRC;PARVB;TSPAN8;MMP12
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.20771309525090378,0.6125375139398631,0.983957219251337,1.0,1.0,16/52,35.04%,NR1D1;MEF2D;PPARGC1B;TWNK;CRTC1;GLUD2;POLRMT;CRTC2;LIN9;SMARCD3;HCFC1;TFB2M;GDNF;PPRC1;TBL1X;NCOA2
prerank,Elsevier_Pathway_Collection__TGFBR -> CREB/ELK-SRF Signaling,0.2478868291229505,0.6121704936966272,0.9573170731707317,1.0,1.0,7/18,40.67%,MAPKAPK2;ELK4;TGFB2;TGFB1;TGFBR2;DAXX;TGFB3
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,0.1799799146716349,0.6119320214607245,0.9954128440366973,1.0,1.0,92/178,46.98%,IRAK1;IKBKG;IRAK2;PDPK1;SNRPE;MAVS;IRF3;NUP37;VPS45;ISG15;VPS33A;RNF135;RPS27;RPS21;NUP62;KPNA2;TPR;NUP133;GJA1;RPS5;TRIM25;LARP1;HSP90AB1;SNRPD2;RPS14;RPSA;VPS16;SNRPB;GEMIN8;RPS15;NUP155;RPS2;MASP2;NUP160;RPS19;HLA-F;GEMIN7;RPS4X;VPS11;RPS20;IKBKE;NUP188;G3BP1;TUFM;REXO2;SNRPD3;RPS8;RPS12;TRAF3;YWHAH;TJP1;RPS3A;RPS7;RPS11;NUP205;UBE2V1;FAU;RPS3;TAB1;RPS24;NUP210;DDX20;HSP90AA1;GEMIN4;HLA-A;NOD1;RPS16;NUP214;SNRPG;RPS28;NUP107;RPS23;HLA-B;HLA-G;TYK2;VPS18;IRF7;RPS9;IFNAR2;GEMIN5;RPS15A;AAAS;VPS33B;YWHAZ;GEMIN6;TRIM4;RPS6;VPS39;RPS27A;RPS4Y1;NUP93;RPS13
prerank,Elsevier_Pathway_Collection__KRAS Signaling,-0.1911753296918775,-0.6117137384608534,1.0,1.0,1.0,7/35,16.63%,RASSF6;MAP2K1;AKT1;RASGRP1;RASSF3;SPRY2;RASSF5
prerank,Elsevier_Pathway_Collection__NPY1R -> CRH/POMC Production,0.2418460633297134,0.6115813121906222,0.9217877094972067,1.0,1.0,3/21,14.95%,RASGRF1;MAPKAPK2;PDPK1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.20653654926231957,0.6113250082486649,0.9675675675675676,1.0,1.0,17/40,37.99%,MSX1;BCAP31;NACC2;BMF;BBC3;DDIT3;FIS1;RACK1;NUPR1;STYXL1;S100A9;SEPTIN4;BAX;DNM1L;RPS7;RPS3;BID
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.20542960605276914,-0.6110699515969268,0.9879518072289156,1.0,1.0,9/21,28.12%,SDHD;SUCLG2;SDHB;LDLR;FAHD1;SUCLA2;SUCLG1;NNT;LDHD
prerank,WikiPathway_2021_Human__MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,-0.21812519224853893,-0.6106822809989321,0.9523809523809523,1.0,1.0,17/17,78.21%,PRKCQ;ITGB3;JUN;MYLK;CREB1;ITPR1;LPP;ACTN1;MAPK1;VCL;PXN;MAPK3;TJP1;MFAP5;ITGAV;PTK2;PLCG1
prerank,Elsevier_Pathway_Collection__Hippo/YAP1 Signaling Deregulation in Cancer,0.21662335297481528,0.6106350751792694,0.9771428571428571,1.0,1.0,5/40,15.15%,TP73;TEAD2;SCRIB;TEAD4;DVL2
prerank,WikiPathway_2021_Human__Photodynamic therapy-induced HIF-1 survival signaling WP3614,-0.1745864826153059,-0.6104635073791567,0.9838709677419355,1.0,1.0,4/37,10.55%,PTGS2;IGFBP3;TGFA;BCL2A1
prerank,MSigDB_Oncogenic_Signatures__PDGF ERK DN.V1 DN,-0.14498862640181706,-0.6102156812143158,1.0,1.0,1.0,29/138,23.39%,GRIN2B;PRSS16;IL7R;PDGFRA;IRAK1BP1;EGR1;LRRC6;FAM50B;ITGB6;BNC1;TRIB1;FAM102A;PER1;NFIL3;SPRY2;TNFSF8;DUSP6;BTG1;LY86;DUSP1;MORC3;LRRC40;KRT13;SMAD7;JUN;DNAJB1;IRF2;FBXL14;SUOX
prerank,Reactome_2022__mRNA Capping R-HSA-72086,0.23345187077405702,0.6101966986807699,0.9751552795031055,1.0,1.0,17/29,48.98%,POLR2L;POLR2K;POLR2G;POLR2H;POLR2I;POLR2J;SUPT5H;RNMT;POLR2A;ERCC2;POLR2B;GTF2F1;POLR2F;ERCC3;GTF2H2;NCBP2;GTF2H5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.23379562451581726,0.6100224280188075,0.9640718562874252,1.0,1.0,14/21,48.98%,PARP1;CHD1L;CUL4B;DDB2;DDB1;ERCC2;RPA2;RBX1;ERCC3;XPA;ERCC1;RPA1;GTF2H2;GTF2H5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.23379562451581726,0.6100224280188075,0.9640718562874252,1.0,1.0,14/21,48.98%,PARP1;CHD1L;CUL4B;DDB2;DDB1;ERCC2;RPA2;RBX1;ERCC3;XPA;ERCC1;RPA1;GTF2H2;GTF2H5
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.18114054410376781,0.609938235318735,1.0,1.0,1.0,44/113,41.49%,SLC1A4;EXOSC4;STC2;CKS1B;SHC1;H2AX;PREB;NHP2;TSPYL2;ATP6V0D1;KDELR3;NPM1;RRP9;EXOSC5;ARFGAP1;RPS14;ATF6;NOP56;LSM4;ZBTB17;TUBB2A;DKC1;TATDN2;HSPA5;FUS;CXXC1;BANF1;BAG3;DDIT4;SRPRB;EXOSC2;POP4;WFS1;EDC4;CNOT6;SPCS1;XPOT;GEMIN4;EXOSC1;EXOSC10;EXOSC9;HYOU1;IARS1;NFYB
prerank,KEGG_2021_Human__Non-small cell lung cancer,0.19798268558526166,0.6098331884620409,0.9724770642201835,1.0,1.0,5/71,7.62%,E2F1;PIK3R2;CDKN2A;KIF5A;E2F2
prerank,Elsevier_Pathway_Collection__WNT Planar Cell Polarity (PCP) non-Canonical Signaling,-0.20160592027193264,-0.6095289850104448,0.9795918367346939,1.0,1.0,7/22,23.65%,FOS;WNT11;PRICKLE1;MAPK10;WNT5A;JUN;MAP2K4
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.19256808739806125,-0.6093456671872524,0.9473684210526315,1.0,1.0,29/29,80.77%,TBC1D32;TTC8;FUZ;VANGL2;IFT57;DISC1;ARL13B;RPGRIP1;PIBF1;TOGARAM1;TMEM216;TMEM17;IFT122;TMEM107;IFT88;PCM1;DCTN1;BBS10;BBS1;GORAB;C2CD3;RPGRIP1L;CEP89;CEP290;CSNK1D;CCDC13;BBS4;TMEM80;CEP250
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.2545243621344725,0.609225305516451,0.9575757575757575,1.0,1.0,2/19,10.05%,PRKAA2;PFKFB4
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.2545243621344725,0.609225305516451,0.9575757575757575,1.0,1.0,2/19,10.05%,PRKAA2;PFKFB4
prerank,Elsevier_Pathway_Collection__Gap Junction Assembly,-0.20567047749123218,-0.6090424110205457,0.9523809523809523,1.0,1.0,3/19,15.04%,HTR2A;GJB2;GRIA1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.22891219017815326,0.6087339686423959,0.9457831325301205,1.0,1.0,16/25,48.60%,EFNA1;QRICH2;HSP90AB1;HIPK2;RPS7;TAF1;RPL23;RPL5;PDCL3;F8A1;CSNK2A2;SGTA;TRIM39;GABARAPL2;OPHN1;MARCHF7
prerank,Reactome_2022__IRAK4 Deficiency (TLR2/4) R-HSA-5603041,0.239019092735203,0.6085997331914952,0.9308176100628931,1.0,1.0,2/18,11.46%,S100A1;CD36
prerank,Elsevier_Pathway_Collection__Protein Degradation Dysregulation in Dementia (Hypothesis),0.24482811658847992,0.6085937208879123,0.9411764705882353,1.0,1.0,19/19,75.54%,NPLOC4;UFD1;HSPA5;DERL1;VCP;ERLEC1;UBQLN2;DNAJC10;SYVN1;UBQLN1;DERL2;RPN1;RAD23A;AMFR;NGLY1;SELENOS;SEL1L;RNF5;EDEM1
prerank,Elsevier_Pathway_Collection__IL6R -> CEBP/ELK/SRF Signaling,0.24620045727025153,0.6084534692881685,0.9401197604790419,1.0,1.0,3/17,16.31%,IL6R;MAPKAPK2;ELK4
prerank,WikiPathway_2021_Human__Heart Development WP1591,-0.18222468144251297,-0.6084304373941152,0.9850746268656716,1.0,1.0,4/36,11.45%,FGF10;BMP10;HAND2;HEY2
prerank,WikiPathway_2021_Human__Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.2024641825215648,0.6077312871239333,0.9947368421052631,1.0,1.0,18/53,32.54%,NQO1;BIRC5;HSPB1;HELLS;SQSTM1;BCL3;HDAC1;NRG1;ERBB3;PTK2;CDKN1A;SOCS3;PKN1;HSPA5;APOE;CUL1;BEX3;CTNNA1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.19088241458762453,0.6076936801638106,0.995,1.0,1.0,16/89,20.91%,GLUL;TDGF1;ADGRB1;BMP4;FGF2;PRKD1;SMOC2;PRKCA;STC1;GFUS;ROCK2;EGF;ACVRL1;DLL4;SPARC;FOXC2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.2073349505096865,0.6076523240241225,0.956989247311828,1.0,1.0,29/55,43.56%,PSMD4;AURKA;PSMB4;PSMD1;PSMB3;PSMD14;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PINX1;PSMC5;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;PSME3;MACROH2A1;PSMB2;RBX1;PSMA6;FBXL7;PSMD9
prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.1799596041079702,0.6075757880469411,0.9953917050691244,1.0,1.0,37/131,31.70%,PIK3R2;GRIN1;PSMD4;GRIN2A;FGF14;GRIN3B;ATP2A1;PSMB4;VLDLR;GRM1;PRKCA;KCNC3;GRIN2C;TRAF2;TWNK;GRIN3A;ITPR2;ATXN1L;PSMD1;RELN;CIC;PSMB3;SLC25A6;PSMD14;RB1CC1;NOP56;ATXN2;PSMB5;ULK1;PSMD2;PSMA1;ATXN2L;PIK3R3;ADRM1;ATP2A2;PSMC4;PSMC3
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,-0.2266289031352806,-0.6073635989392916,0.9259259259259259,1.0,1.0,9/16,29.80%,MTHFD1;SHMT1;MTHFD2L;DHFR;SHMT2;FOLR2;SLC25A32;MTHFD2;DHFR2
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,0.16930616716481153,0.6069233715628198,1.0,1.0,1.0,22/350,9.09%,DIO2;SLC6A7;GLUL;SLC45A2;PRODH;CYP21A2;NAT8L;OCA2;SLC6A11;ARG2;CKB;NQO1;NAALAD2;AMT;GADL1;MTR;RIMKLA;PSMD4;CKMT1A;ASRGL1;SLC6A8;OAZ3
prerank,Elsevier_Pathway_Collection__SIRT2 Signaling in Aging,-0.20813930602948344,-0.6066064754446537,0.9642857142857143,1.0,1.0,2/22,8.93%,PCK1;FOXO1
prerank,Elsevier_Pathway_Collection__IGF1 Role in Muscle Hypertrophy,-0.18711351734089463,-0.606541846323942,1.0,1.0,1.0,10/31,25.40%,FOS;FOXO1;AKT1;IGF1;IRS2;JUN;IGF1R;PTEN;TRIM63;EIF4EBP1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.20252288285516498,-0.6064259052901801,0.972972972972973,1.0,1.0,23/23,79.77%,BNC1;RASL11A;EIF2AK3;IPPK;ERBB2;ATF4;LYAR;DHX33;WDR43;NOL11;PHF8;NCL;PWP1;SMARCB1;MTOR;UBTF;MARS1;PIH1D1;WDR75;UTP15;DDX11;SMARCA4;HEATR1
prerank,Elsevier_Pathway_Collection__Thyroid Hormones Common non-Genomic Effects in Hyperthyroidism,0.2149915940299783,0.6062650963820014,0.9627659574468085,1.0,1.0,8/36,25.99%,KCNH2;SRC;PDPK1;PRKCA;THRA;PLCG1;MAP2K2;PTK2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.21652378858772936,-0.6048228120007614,0.9642857142857143,1.0,1.0,2/17,14.05%,TNF;CLN3
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.1534960760808851,-0.6045144399537934,1.0,1.0,1.0,18/79,25.75%,SPSB4;TSPYL5;LRRK2;ARRDC3;ARRDC4;BIRC7;PRICKLE1;NDFIP2;DCUN1D3;INAVA;SMAD7;LAPTM5;CRY1;FBXW7;MYCBP2;PINK1;DCUN1D1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.1995824394682126,0.6043362709671981,0.9701492537313433,1.0,1.0,6/51,14.95%,EPHB2;NKD2;ATP2B4;DPP10;SQSTM1;PDPK1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.19215271996070488,0.6034086035471241,0.9946524064171123,1.0,1.0,21/69,31.77%,C1QTNF3;ACSL4;TRH;UNC13B;ANKRD1;SYTL4;ADAM9;MYOM1;NLGN2;DOC2B;NNAT;TGFB2;APBB1;PTPN23;ATP13A2;APBB3;CAPN10;MYRIP;PPIA;TREM2;AACS
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.26340466644158816,0.603173734710729,0.9075144508670521,1.0,1.0,7/15,32.77%,IAPP;PFDN2;VBP1;PFDN6;APOE;TREM2;CRYAB
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.18197501176564726,-0.6028617277834131,1.0,1.0,1.0,5/33,14.55%,FGF10;ADAMTS1;AKT1;UBE2E2;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.23372457697088325,0.6024857231462781,0.9536423841059603,1.0,1.0,1/20,2.32%,CRP
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.22196333010568275,0.6019711152267692,0.9662921348314607,1.0,1.0,4/33,14.87%,MAPT;PRKN;NOL3;IAPP
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.1918176218657546,0.6015564468091025,0.9949748743718593,1.0,1.0,8/61,17.53%,VWF;KIAA1549;SRC;CAMK2A;LMNA;CNKSR2;HRAS;TRIM24
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.15682393897591587,-0.6014370163614647,1.0,1.0,1.0,10/84,12.61%,IFNG;LRRK2;DCN;RNF152;FOXO1;SESN3;MEFV;TRIM34;EPM2A;TRIM22
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.2448860462201214,0.6011401671838666,0.9290322580645162,1.0,1.0,7/21,29.80%,SRC;COL1A1;BGLAP;HEY1;SATB2;ZNF521;YAP1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.22081749917412505,0.6005783077115231,0.9719101123595506,1.0,1.0,11/32,31.10%,ABCA3;NAXE;ABCA7;SREBF2;PPARG;EEPD1;YJEFN3;ABCA2;ABCA12;APOE;TREM2
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.20994121172232666,0.6005573922270123,0.9837837837837838,1.0,1.0,19/42,40.21%,COX4I2;BLOC1S1;UQCRB;ATP5F1D;MDH2;NDUFS7;SLC25A14;ME3;UQCRHL;NDUFS8;MTFR2;ETFB;UQCRH;UQCRC1;OXA1L;UQCR10;NDUFS4;SDHA;SDHC
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.20928724106799998,-0.6003303104932531,0.9583333333333334,1.0,1.0,5/26,16.54%,LRRK2;FEZ1;AKT1;QSOX1;SEC22B
prerank,Elsevier_Pathway_Collection__Bone Resorption in Hyperparathyroidism,0.24149652912676178,0.6002849273977594,0.96045197740113,1.0,1.0,1/21,1.93%,E2F1
prerank,Reactome_2022__Circadian Clock R-HSA-400253,-0.1647874932218306,-0.5993863169341364,1.0,1.0,1.0,9/65,17.85%,NOCT;PPARGC1A;NLRP3;BHLHE41;PER1;NFIL3;CREM;NCOR1;F7
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,0.2530375269147952,0.5992356185165466,0.9655172413793104,1.0,1.0,17/17,74.71%,EEF2KMT;RPS2;PRMT3;ETFB;HSPA8;VCP;METTL21A;EEF2;EEF1A1;EEF1AKMT1;EEF1AKMT2;METTL22;CAMKMT;VCPKMT;KIN;CALM1;ETFBKMT
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,0.24929891850207425,0.5989637155273675,0.9402173913043478,1.0,1.0,2/16,9.11%,IL31RA;IL11
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.20738404655542003,0.5989241072022221,0.9942857142857143,1.0,1.0,9/47,22.14%,ZNF541;HDAC4;HDAC11;HDAC5;ELK4;MIER2;HDAC10;RCOR3;HDAC1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.22683808838062305,0.5988552378233571,0.9560439560439561,1.0,1.0,9/36,33.19%,PRKN;SQSTM1;WDR45;FUNDC2;RB1CC1;FIS1;ULK1;CTSK;GABARAP
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.22173823596833897,-0.5982643892557469,0.9404761904761905,1.0,1.0,6/15,25.72%,EZR;TNIK;RAP1A;RAP2B;RAP1B;RAPGEF2
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.24207521231904677,0.5981063223976908,0.9578313253012049,1.0,1.0,6/19,23.37%,MID2;TRIM11;IFITM3;IFITM2;BST2;GSN
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.17058266145046408,0.5979979018282077,1.0,1.0,1.0,92/255,38.68%,FGF20;PIK3R2;NRG2;FOXO6;SNAI2;FGF13;FGF17;SRC;IRAK1;FGF23;AGO2;PSMD4;PIP5K1B;PDGFRB;CBX6;EZH2;LAMTOR2;FLT3LG;RNASE1;PDGFB;PDGFA;PSMB4;PDPK1;PPARG;HDAC5;EGF;NEDD4;THEM4;LAMTOR4;FGF18;HDAC1;CBX8;NRG1;TSC2;PPP2R5A;ESR2;GATAD2B;ERBB3;SNAI1;PSMB3;PIP4K2B;MAF1;PSMD14;UBA52;CDKN1A;FGFR4;KLB;RHEB;CHD3;CHD4;PSMB5;TRIM27;PSMD2;PSMA1;PSMD10;GDNF;RBBP7;PIK3R3;PSMC4;CBX2;PSMC3;IRS1;CASP9;MLST8;PIGU;LAMTOR5;RRAGD;FGF1;CSNK2B;PSMC5;MTA3;OTUD3;PPP2R1A;AGO1;SEM1;PSMB6;PSMD8;PIP5K1C;KITLG;RPTOR;AKT1S1;RRAGA;MAPK3;PSME2;CNOT6L;HDAC7;EED;GSK3B;RNMT;PSMD13;PSMB7;PSMA7
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.23635036523862935,0.5975442123407614,0.9506172839506173,1.0,1.0,8/20,38.29%,EGFL7;CTSA;GLB1;ALG3;ALG1;ALG6;ALG13;ALG8
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.1831393901664466,0.5974337682307187,1.0,1.0,1.0,42/99,40.20%,PLK1;TRIB2;NKD2;PRKN;FOXF2;DET1;MAP1A;UBQLN4;ELOB;FHIT;PIAS1;COP1;HSP90AB1;SH3RF2;DVL1;RACK1;PARK7;DDRGK1;SOCS5;PSMD10;KEAP1;GLMN;CSNK1D;DNAJB2;SDCBP;GABARAP;OGT;EIF3H;HSPBP1;CAMLG;USP5;GIPC1;TAF9;GNA12;VCP;XPO1;GSK3B;TAF1;BAG6;CSNK1E;USP7;ARIH1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.21477652794740426,0.597270899144405,0.9767441860465116,1.0,1.0,17/32,46.45%,PRKN;HSPA2;HSF1;HSPA5;PACRG;DAB2IP;HSPA14;BAX;BAG3;HSPA8;DNAJC18;DAXX;HSPA1L;STUB1;PTPN1;HSPA9;UBE2W
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.24093101495462044,0.5972368745992888,0.9477124183006536,1.0,1.0,6/19,28.28%,PPP1R16B;PPP1R27;PPP1R35;MFHAS1;SH3RF2;ENSA
prerank,Reactome_2022__Signaling By Activin R-HSA-1502540,0.2645249861245857,0.5971986088110306,0.9171597633136095,1.0,1.0,5/15,23.56%,FOXH1;INHBB;SMAD3;ACVR2B;FSTL3
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,0.21927517391999643,0.5966450456289153,0.9585798816568047,1.0,1.0,4/29,16.94%,VPS28;RNASE1;MVB12B;VPS37D
prerank,KEGG_2021_Human__Folate biosynthesis,0.23225392408056994,0.5961108566183945,0.9526627218934911,1.0,1.0,3/24,10.13%,AKR1B10;ALPI;AKR1C3
prerank,Elsevier_Pathway_Collection__Donohue Syndrome Progression (Hypothesis),0.20750757354895852,0.5960240564804289,0.9829545454545454,1.0,1.0,11/35,32.11%,SLC2A4;MAPKAPK2;SHC1;PDPK1;ACACA;SH2B2;MAP2K2;MYC;SH2B1;FASN;IRS1
prerank,Elsevier_Pathway_Collection__Golgi to Endosome Transport,0.21333134096315146,0.5958522231246399,0.973404255319149,1.0,1.0,14/41,43.67%,SMOC2;CPD;ARF1;STX6;VAMP4;YKT6;GGA2;PLIN3;PACS1;GGA1;ARFRP1;VPS26B;NSF;RASGRP3
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,0.20600631160323718,0.5955516247775499,0.9491525423728814,1.0,1.0,15/35,43.75%,IKBKG;SHARPIN;OTUD7B;RNF31;FADD;CLIP3;UBA52;RACK1;TRADD;TNFAIP3;TAX1BP1;MADD;UBC;TRAF1;XIAP
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.25764160294595306,0.5952340128413376,0.9225806451612903,1.0,1.0,4/16,22.51%,SNAI2;SOX8;TCOF1;NRG1
prerank,Elsevier_Pathway_Collection__Apoptosis of Renal Tubule Epithelial Cell in Pyelonephritis,-0.18845346228359144,-0.5947118357854687,0.971830985915493,1.0,1.0,8/30,23.65%,TNF;BCL2;MAPK10;EIF2AK3;XBP1;MAP2K3;MAP3K5;MAP2K4
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.24812268337781695,0.5945465153447076,0.9534883720930233,1.0,1.0,4/17,16.78%,ALOX12;PDPN;PRKCA;ADAMTS18
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.2211828879798313,0.5941997984625067,0.9565217391304348,1.0,1.0,7/32,27.40%,ANK1;CRB1;SCRIB;CRB2;LIN7B;PARD3B;PDZD11
prerank,WikiPathway_2021_Human__NAD+ metabolism WP3644,-0.21843018837952946,-0.5924655631987603,0.9444444444444444,1.0,1.0,7/16,30.44%,CD38;NRK;SIRT5;SIRT1;NAMPT;NT5E;NMNAT3
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.166866102302196,0.5917236137727674,1.0,1.0,1.0,71/308,29.29%,SEPTIN3;AXIN2;SYNDIG1;SEPTIN5;SGSM1;LAMTOR2;MYO7A;GRIN3B;ARL4A;TBC1D16;SIL1;CNTNAP1;GPIHBP1;RAB41;SH3PXD2B;CTSA;FOXJ1;TMED3;BBS2;ARHGEF2;TMED6;WDR45;SNX27;SGSM2;RAB24;STXBP1;CEP250;CEP68;TBC1D8;DUOXA2;VPS45;STX1A;TMEM250;STX10;REEP1;TBC1D25;PTPRU;VPS33A;CORO1B;ESAM;STX4;TBC1D10A;AP4M1;TMED9;NPM1;TM9SF1;IFT27;EIF2D;GJA1;EMP2;CROCC;BICD1;TBC1D13;STX1B;ARF1;CTNNB1;ABCA12;TBCK;PRRT1;SGSM3;SEC31B;CPLANE2;HGS;BBS4;TBC1D9B;SMURF1;GAS8;AP3D1;SEPTIN8;COPA;STX6
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.17768022181146026,-0.5916769941177059,1.0,1.0,1.0,57/57,82.27%,HBA1;NLRP3;ALB;PTK6;HMOX1;NCOR1;STAP2;NCOA1;FABP1;STAT3;COX18;COX7A2L;NFE2L2;MBD4;SCO1;HELZ2;CYCS;SCO2;SURF1;TBL1XR1;MAFK;CHD9;RXRA;PPARA;CARM1;LRPPRC;CREBBP;HMOX2;COX14;COX16;HDAC3;COX5A;SIN3A;TACO1;TXNIP;COX6A1;BLVRB;NCOA6;COX7C;NCOA2;TBL1X;COX19;BLVRA;ABCC1;BRIP1;COX5B;COX4I1;SIN3B;NCOR2;SMARCD3;LIN9;COX8A;COX6B1;HM13;COX7B;COX20;COX6C
prerank,Elsevier_Pathway_Collection__TGFBR -> ATF/GADD/MAX/TP53 Signaling,-0.21408797293140575,-0.5915716897321801,0.956989247311828,1.0,1.0,17/17,78.61%,MAP2K3;MAP2K6;MAP3K5;MAP2K4;MAX;MAPK14;TGFBR1;MEF2A;TP53;ATF2;MEF2C;TGFB3;DAXX;TGFBR2;TGFB1;DDIT3;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.24149780772846496,0.5914712884770069,0.9567567567567568,1.0,1.0,7/19,31.36%,GBA;AMER1;PCSK9;ABCA2;VGLL4;APOE;VPS11
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.22003077697325918,-0.5913513766990437,0.9555555555555556,1.0,1.0,5/17,25.36%,SCIMP;NOD2;ARL6IP5;INAVA;CARD9
prerank,Reactome_2022__RAS Processing R-HSA-9648002,0.24071400630582643,0.5911990822196174,0.930635838150289,1.0,1.0,10/17,43.90%,HRAS;ARL2;FNTA;ZDHHC9;ABHD17C;ABHD17A;LYPLA1;PDE6D;PRKG2;BCL2L1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.21783815620971178,0.590452118623113,0.9774011299435028,1.0,1.0,11/29,37.32%,PPP1R16B;SOX18;RAPGEF3;PECAM1;ROBO4;F11R;ICAM1;RAPGEF1;RAP2C;TJP1;TJP2
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.22457610827021418,-0.5902420959317213,0.9130434782608695,1.0,1.0,16/16,77.56%,CASP1;FXN;CASP4;TMPRSS2;MYRFL;AFG3L2;F12;OMA1;FAM111A;CTSL;HTRA2;PIDD1;SPRTN;MYRF;HJV;PCSK9
prerank,Elsevier_Pathway_Collection__RAS/RAF/MAPK Signaling Activation in Cancer,-0.18791455883323288,-0.5901734893681255,0.9620253164556962,1.0,1.0,6/29,23.65%,FOS;MAP2K1;AKT1;MAPK10;JUN;MAP2K4
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.24041264404235668,0.5895235842888842,0.9693251533742331,1.0,1.0,7/19,31.84%,ATP2B4;ROCK2;DDX11;BLM;HSF1;TIMELESS;FMR1
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,0.22997013861885246,0.5894261027467532,0.9340659340659341,1.0,1.0,3/25,14.19%,GADL1;MTR;GOLT1A
prerank,WikiPathway_2021_Human__Genes related to primary cilium development (based on CRISPR) WP4536,0.180603969060638,0.5890452404161923,0.9902439024390244,1.0,1.0,48/97,49.58%,TCTEX1D2;TEDC2;BBS5;IFT81;TULP3;BBS2;B9D1;IQCE;CEP295;DYNLL1;IFT27;ARMC9;CPLANE2;SASS6;BBS4;FBF1;KATNB1;KIFAP3;CEP97;KIF3B;DYNC2LI1;HSPB11;RPGRIP1L;C2CD3;TTC30B;TXNDC15;ARL3;INPP5E;IFT80;IFT140;CEP83;CEP192;IFT172;TTC23;WDR35;KIF3A;KIAA0753;BBS1;EFCAB7;IFT74;TMEM67;TTC26;IFT43;OFD1;WDR19;TCTN1;TTC21B;CPLANE1
prerank,Elsevier_Pathway_Collection__Mesangial Cell Dysfunction in Diabetic Nephropathy,-0.16618341336876208,-0.5889038466752889,1.0,1.0,1.0,5/49,9.64%,TNF;FOS;MAP2K1;PRKCB;IL6
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.22513209404294945,0.5884944022746499,0.9776536312849162,1.0,1.0,12/31,30.42%,CHST6;B4GALT3;ST3GAL3;OGN;CHST1;B4GAT1;GLB1;HEXB;HEXA;ACAN;ST3GAL2;ST3GAL1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.1799998430808013,0.5876002840699399,0.9907407407407407,1.0,1.0,11/107,13.63%,PLA2G2A;PIK3R2;INPP5J;FGF2;MTMR11;PIP5K1B;PDGFRB;PLA2G4C;MTMR8;SBF1;PLA2G4F
prerank,TRRUST_Transcription_Factors_2019__NRF1 human,0.24715763957358594,0.58742608621734,0.9259259259259259,1.0,1.0,1/15,4.00%,NQO1
prerank,Elsevier_Pathway_Collection__FLT3/KIT/MLL Signaling in Leukemia,0.21993951732871536,0.5870258975865699,0.9736842105263158,1.0,1.0,6/29,26.12%,FLT3LG;SHC1;PDPK1;HRAS;MAP2K2;CTNNB1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.21868300090947362,0.5867886992689331,0.9545454545454546,1.0,1.0,2/26,6.21%,ROBO1;BMP4
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.18171705425519824,-0.5867648745168459,0.9863013698630136,1.0,1.0,12/34,31.76%,LRRK2;FEZ1;SEC22B;PIP4K2A;CHMP4A;ADPRH;PINK1;SH3GLB1;RAB1B;FEZ2;MTM1;RALB
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.21699603738728568,0.586632883972262,0.9776536312849162,1.0,1.0,7/30,27.00%,NODAL;FOXH1;SMARCA4;HDAC1;ARNTL;NCOR2;HEYL
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,0.19146487443963953,0.5865813960547311,0.9846938775510204,1.0,1.0,30/75,39.37%,ABCA3;PSMD4;ABCC8;ABCD1;PSMB4;KCNJ11;ABCB6;ABCA12;PSMB3;PSMD14;UBA52;ABCC2;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;DERL1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;VCP;DERL3;PSMD13;PSMB7;PSMA7;PSME3
prerank,Elsevier_Pathway_Collection__Scavenger Receptor OLR1 in Inflammation Related Endothelial Dysfunction,0.19992188760931778,0.5864788256028046,0.9891304347826086,1.0,1.0,7/51,16.51%,CRP;ARG2;ACE;MAPKAPK2;SHC1;HRAS;ROCK2
prerank,Elsevier_Pathway_Collection__Ca2+ Toxicity in Lens Cells,0.22996242537671407,0.5862813040662448,0.9642857142857143,1.0,1.0,11/24,32.77%,SRC;ATP2B4;PDGFRB;EGF;TGM2;PLCG1;CAPN2;CAPN10;CRYGS;ATP2A2;CRYAB
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.20513707847887108,-0.586080752369967,0.9809523809523809,1.0,1.0,18/18,79.50%,HSPA1A;MPV17L;ACAA2;FZD9;MUL1;TMEM14A;CHCHD10;BOK;BAK1;GSK3A;SLC25A5;GSK3B;BID;HIP1R;TMEM102;BAX;SLC35F6;ZNF205
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,0.16618909427350081,0.5860423598053595,1.0,1.0,1.0,105/291,38.68%,FGF20;PIK3R2;NRG2;FOXO6;SNAI2;FGF13;FGF17;SRC;IRAK1;FGF23;AGO2;CAMK2A;PSMD4;PIP5K1B;PDE1C;PDGFRB;CBX6;EZH2;LAMTOR2;FLT3LG;RNASE1;PDGFB;PDGFA;PSMB4;ADCY6;PDPK1;PPARG;PRKCA;HDAC5;EGF;NEDD4;THEM4;LAMTOR4;ADCY4;FGF18;ADCY2;PLCG1;HDAC1;CBX8;NRG1;TSC2;PPP2R5A;ESR2;GATAD2B;KPNA2;ERBB3;SNAI1;ITPR2;PSMB3;PIP4K2B;MAF1;PSMD14;UBA52;CDKN1A;FGFR4;KLB;RHEB;CHD3;CHD4;PSMB5;TRIM27;PSMD2;PSMA1;PSMD10;GDNF;RBBP7;PIK3R3;PSMC4;CBX2;PSMC3;IRS1;PRKAR2A;CASP9;MLST8;PIGU;ADCY8;CAMKK1;LAMTOR5;ADCY9;RRAGD;FGF1;CSNK2B;PSMC5;MTA3;OTUD3;PPP2R1A;AGO1;SEM1;PSMB6;PSMD8;PIP5K1C;KITLG;RPTOR;AKT1S1;RRAGA;MAPK3;PSME2;CNOT6L;HDAC7;EED;GSK3B;RNMT;PSMD13;PSMB7;PSMA7
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.2446432626775368,0.5859563945378323,0.9252873563218391,1.0,1.0,9/18,40.02%,POLR2L;HEATR1;POLR2K;MAF1;UTP15;SIRT7;WDR75;FLNA;UBTF
prerank,WikiPathway_2021_Human__Metabolic reprogramming in colon cancer WP4290,0.20380661836668582,0.5849536663083994,0.9946808510638298,1.0,1.0,17/42,37.74%,SLC16A3;TKT;PYCR2;ACLY;FH;MDH2;PGK1;GAPDH;G6PD;FASN;PPAT;SLC2A1;PSPH;ENO1;PYCR1;PDHA1;TALDO1
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.21574161053624474,0.5848686389668803,0.96875,1.0,1.0,3/28,11.46%,IRAK1;IRAK2;CD36
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.1798642279913853,0.5844813780141948,0.9902912621359223,1.0,1.0,9/95,14.29%,MAPK11;SAA2;IRAK1;MAP3K8;LRRC14;IKBKG;IRAK2;NFKB2;MAPKAPK2
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.2118789560692687,-0.5839824848878172,0.979381443298969,1.0,1.0,2/16,12.12%,PRKAR2B;ADCY5
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.1980895057647924,0.58380200792892,1.0,1.0,1.0,3/49,10.06%,PRKAA2;GPSM1;IKBKG
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.2290713324360698,0.5836300616761542,0.943502824858757,1.0,1.0,20/20,77.11%,DVL2;NPHP4;YAP1;AMOT;TJP1;TJP2;WWTR1;AMOTL1;LATS2;STK4;YWHAB;YWHAE;WWC1;MOB1A;STK24;MOB1B;CASP3;LATS1;SAV1;AMOTL2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.19360212388261588,0.5831845445265359,0.9662921348314607,1.0,1.0,21/43,45.20%,EXOSC4;DHX34;NBAS;SLFN14;DXO;METTL3;LSM2;DIS3L2;CNOT10;AGO1;TUT7;RNH1;METTL16;EXOSC10;MRTO4;EXOSC9;YTHDF2;SUPV3L1;UPF1;DDX5;TUT4
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,0.22629610830216632,0.5831714884502975,0.9523809523809523,1.0,1.0,7/25,25.08%,TRPC6;ATP2B4;ATP2A1;P2RX2;SLC8A3;ATP2B3;ITPR2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.20224336925257644,0.5831038654675466,0.9899497487437185,1.0,1.0,12/48,24.05%,KIF14;PARVB;EFNA1;LAMC1;ATRNL1;RADIL;TYRO3;LAMB4;SRCIN1;SRGAP2;LAMA5;ATRN
prerank,Elsevier_Pathway_Collection__Hedgehog Signaling Activation in Cancer,0.2436956515642609,0.5830569930417018,0.9329268292682927,1.0,1.0,9/17,39.03%,CCNB1;GLI1;MYCN;GNAI1;SMO;STK36;GSK3B;SUFU;SHH
prerank,Elsevier_Pathway_Collection__Hedgehog Signaling Activation by Blocking of Tumor Suppressors,0.2436956515642609,0.5830569930417018,0.9329268292682927,1.0,1.0,9/17,39.03%,CCNB1;GLI1;MYCN;GNAI1;SMO;STK36;GSK3B;SUFU;SHH
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.2445269414514317,0.5822857011907192,0.9655172413793104,1.0,1.0,10/15,51.24%,NAA10;NAA80;NAA20;NAA15;NAA25;NAA60;NAA16;CREBBP;KAT2B;EP300
prerank,WikiPathway_2021_Human__Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.20978502502466684,0.5818801189088791,0.9883720930232558,1.0,1.0,6/35,14.59%,FOXO6;LPL;TEAD2;NDRG1;TEAD4;TAZ
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.16096252322646193,0.5814414731777049,1.0,1.0,1.0,83/265,36.73%,COL7A1;LEF1;MATN1;AXIN2;TERT;VIL1;HES5;TCF7;GPAA1;IKBKG;NOL3;KNTC1;TEAD2;LAMC1;SH3PXD2B;DLG4;AMER1;CNIH3;TFAP4;GSDMD;SAMM50;CNIH2;DET1;PYGO2;TRAF2;PREB;ELOB;TRAPPC9;FADD;TRAPPC5;BCL9L;EPRS1;SMARCA4;BCL9;HDAC1;SEC16B;USH1C;LLGL1;KMT2D;TSPAN4;BLM;HSF1;CARD10;F5;MYC;CTNNB1;TRAPPC2L;TLE1;PDZD11;KIFAP3;YAP1;HGSNAT;PDE4DIP;CSNK1D;WDCP;TCF7L1;TEAD1;KLHL12;TRAPPC1;CUL1;TRAPPC6A;SLC2A1;SHANK1;PPIH;ADCY8;ITGB1BP1;TCAP;COL16A1;SKP1;PPP6R1;CDC123;TRAPPC4;CSNK2B;TRADD;RUVBL1;PPP2R1A;DNM1L;TUBGCP2;MDM4;CD59;NIFK;DHX9;CAPG
prerank,Elsevier_Pathway_Collection__Mutations in Krebs Cycle Enzymes in Cancer,-0.1973770239606169,-0.5812857550905969,0.9875,1.0,1.0,24/24,80.28%,SDHD;TET1;SDHB;IDH1;KDM4A;TET2;NFE2L2;EPAS1;ALKBH3;HIF1A;DEPTOR;EGLN3;IDH2;SDHAF1;MTOR;SDHC;SDHA;TET3;KEAP1;SDHAF2;KIF1B;FH;ALKBH2;EGLN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.2249644490916582,0.5809286775748793,0.9767441860465116,1.0,1.0,3/24,12.55%,FGF13;CACNA1C;GJA5
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.13228496645083213,-0.5803302122447016,1.0,1.0,1.0,48/183,24.54%,CR2;CXCL10;TNF;ENTPD8;PIK3CD;CD3E;CD3G;IL6;RUNX3;HLA-DQA2;BTK;CD247;TLR2;HLA-DOB;PIK3R1;AKT1;SYK;PLCG2;MYD88;BCL2L11;BCL2;HLA-DQA1;MAPK10;GADD45A;CD19;MAPK13;ENTPD3;CD3D;OAS3;OAS2;HLA-DOA;TAB2;HLA-DRB5;MAP2K3;MAP2K6;JUN;HLA-DRA;CD40;STAT1;AKT3;HLA-DPA1;GADD45G;MAP2K4;DDX58;OAS1;HLA-DPB1;IRF9;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.25496786183011133,0.5799031886955923,0.967948717948718,1.0,1.0,10/15,40.02%,KMT5C;MAD2L2;TNFSF4;NECTIN2;SHLD3;TP53BP1;PAXIP1;SHLD1;TFRC;SHLD2
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.20833768964952967,-0.5792912353831597,0.9716981132075472,1.0,1.0,10/19,29.80%,MTHFD1;MTHFS;SHMT1;MTHFD2L;DHFR;SHMT2;FOLR2;SLC25A32;MTHFD2;DHFR2
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.1733154802179493,0.5790385188784954,1.0,1.0,1.0,25/146,21.51%,PIK3R2;FGD1;PLEKHG4B;ARHGEF10;ARHGAP11B;ARHGAP44;IQGAP3;RASGRF2;DIAPH3;ARHGEF11;RACGAP1;ARHGAP39;ARAP3;SCRIB;PLEKHG2;ARHGEF15;ECT2;CDC42EP5;ARHGAP33;LBR;ARHGEF19;SRGAP2;ARHGAP4;STARD13;FNBP1L
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,0.23583145815455742,0.5790210967472703,0.9473684210526315,1.0,1.0,3/18,15.74%,RELB;PRKCA;HRAS
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.19992149661523015,0.5787524845124211,0.9945054945054945,1.0,1.0,18/45,38.90%,ZNF541;HDAC4;HDAC11;HDAC5;MIER2;HDAC10;RCOR3;HDAC1;SIN3B;SIRT6;RCOR2;TBL1X;MTA3;SIRT7;BRMS1;HDAC7;FLNA;BAZ2A
prerank,Elsevier_Pathway_Collection__Hereditary Breast and Ovarian Cancer Syndrome,-0.16829144461227213,-0.5786859661898336,0.984375,1.0,1.0,2/32,6.58%,FOS;ESR1
prerank,WikiPathway_2021_Human__VEGFA-VEGFR2 Signaling Pathway WP3888,0.15856888013534523,0.5784097474720908,1.0,1.0,1.0,115/424,33.59%,DKK1;EPHB2;PIK3R2;PRKAA2;MAPK12;SCUBE2;NOX4;SDF2L1;HDAC4;BIRC5;SRC;PBK;PTPN14;PSMD4;HSPB1;TUBB8;HBD;TKT;PRKD1;NDRG1;MMP10;MICAL2;SLC7A1;FLT1;UBAP2L;PLAU;PGF;HTRA1;MAPKAPK2;TEAD4;APOLD1;SHC1;ELOC;SSR4;PDPK1;ACACA;PRKCA;HRAS;HDAC5;ARHGEF15;ROCK2;ADAM9;RHOC;KCNC3;TNFRSF25;NOTCH4;DLL4;FHOD1;P4HA2;FADD;CSRP2;ABCF2;PLCG1;ATP6V0D1;HDAC1;TAOK2;TXN;RPLP2;PLOD3;CAPN2;OCRL;CLIC1;PGK1;MAP2K2;GJA1;CCDC124;GPX1;STIP1;PTK2;CTNNB1;BSG;FARSB;FLNB;RAB4A;NAP1L1;ZNF555;ATF6;ICAM1;PABPC1;PBXIP1;EIF3D;IER5;HGS;PRRC2C;LUC7L;GAPDH;ACOT9;RAPGEF1;RACK1;ALDOA;PRDX2;MMP14;CRIP2;SH3BGRL3;PDE4DIP;RPL7;ATP6V1E1;MMRN2;IGFBP7;ITGAV;CFL1;NRARP;SDCBP;MLST8;PPM1G;RPL27;CTNNA1;KANK1;GATA2;TPM3;ITGB5;RND1;TBCA;EIF3H;MYH9
prerank,Elsevier_Pathway_Collection__NURD in Chromatin Remodeling,0.23292005373442684,0.5779348319324031,0.9693251533742331,1.0,1.0,9/19,36.04%,SHC1;HDAC1;TRIM28;MECP2;CHD3;CHD4;RBBP7;MTA3;HAT1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.2433246437040137,0.5777172118396264,0.9751552795031055,1.0,1.0,2/16,14.04%,SPHK1;GLA
prerank,Elsevier_Pathway_Collection__Huntingtin Gene Mutation in Striatal Neuron,0.2096914151265855,0.5776170073911557,0.9666666666666667,1.0,1.0,9/33,26.35%,BDNF;SLC1A2;SQSTM1;SLC1A3;BBC3;TGM2;HDAC1;DRD1;MECP2
prerank,TRRUST_Transcription_Factors_2019__MYB mouse,0.24862102335936598,0.5775260210025782,0.9161290322580645,1.0,1.0,3/15,13.72%,SNAI2;NOL3;GSTM2
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.22132912852857478,0.577524952466786,0.9714285714285714,1.0,1.0,23/23,77.89%,IBA57;NDOR1;MMS19;CIAO2B;CIAO3;LYRM4;GLRX3;CIAPIN1;HSPA9;NFS1;NUBP2;ISCA2;ISCU;ABCB7;NUBP1;NFU1;NUBPL;HSCB;CIAO1;ISCA1;CIAO2A;FXN;GLRX5
prerank,Elsevier_Pathway_Collection__Mesangial Cell Dysfunction in Glomerulonephritis,-0.16635640063645216,-0.5773923462474844,1.0,1.0,1.0,4/41,9.64%,TNF;FOS;MAP2K1;IL6
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.22530376329221874,0.5773427044572216,0.9822485207100592,1.0,1.0,5/26,22.39%,DPM3;PGAP4;PIGZ;PIGC;PIGM
prerank,TRRUST_Transcription_Factors_2019__NFYA human,-0.20656255957634115,-0.5768753554609962,0.9761904761904762,1.0,1.0,9/19,29.25%,HBB;CBS;ABCB1;GADD45A;HOXB4;CDKN1B;GFI1B;CYP2A6;CCND2
prerank,WikiPathway_2021_Human__Glycerophospholipid Biosynthetic Pathway WP2533,0.20977192133082748,0.5768549848475515,0.9883720930232558,1.0,1.0,1/30,1.68%,PLA2G2A
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.22132061685190169,0.5765968669176691,0.9772727272727273,1.0,1.0,22/22,77.89%,IBA57;NDOR1;MMS19;CIAO2B;CIAO3;LYRM4;CIAPIN1;HSPA9;NFS1;NUBP2;ISCA2;ISCU;ABCB7;NUBP1;NFU1;NUBPL;HSCB;CIAO1;ISCA1;CIAO2A;FXN;GLRX5
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.21569838791545332,-0.5763239144267932,0.987012987012987,1.0,1.0,5/17,18.16%,SCD5;GCDH;MLYCD;ACAT1;CBR4
prerank,Elsevier_Pathway_Collection__MYOC Associated Glaucoma,-0.18650717335282127,-0.576147870449134,0.9726027397260274,1.0,1.0,26/26,81.37%,SFRP1;BCL2;EIF2AK3;XBP1;MAP3K5;EDEM1;ERN1;OPTN;CYCS;EIF2S1;MAPK8;ATF4;EDEM2;RHOA;DAAM1;MAP2K7;BAX;TGFB1;FRZB;HSPA5;DDIT3;ATF6;DVL1;CAPN2;BBC3;TRAF2
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,0.24543572755185636,0.5761413810820174,0.9695121951219512,1.0,1.0,5/15,35.88%,DPM3;SRD5A3;DOLK;DPM2;SLPI
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.2503053687429012,0.5756259832106986,0.9814814814814815,1.0,1.0,5/15,21.21%,MVD;ACLY;ACACA;PMVK;HMGCS1
prerank,Elsevier_Pathway_Collection__Adherens Junction Assembly (Nectin),0.2184781954158688,0.5756190510277098,0.9786096256684492,1.0,1.0,7/27,35.78%,SRC;WASF2;RAPGEF1;KEAP1;CTNNA1;SSX2IP;TJP1
prerank,WikiPathway_2021_Human__Pathogenic Escherichia coli infection WP2272,0.19479773509065634,0.5750550541385824,0.9948979591836735,1.0,1.0,9/52,19.44%,TUBB8;TUBA4A;TUBA3E;TUBA8;PRKCA;ARHGEF2;ROCK2;TUBB2B;TUBA3D
prerank,Elsevier_Pathway_Collection__Alzheimer's Disease,0.18797070171794583,0.5744325383643432,0.9845360824742269,1.0,1.0,16/65,25.47%,MAPT;HSPB1;ATP2A1;ACE;SHC1;MME;CDK5R1;MMP9;LRP8;TGM2;FADD;APBB1;AIFM1;CDK5;GPX1;RELN
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.2137905252080286,0.5743827759015425,0.9829545454545454,1.0,1.0,7/31,21.03%,JCAD;FGF2;MEOX2;HDAC5;DLL4;FOXC2;STARD13
prerank,KEGG_2021_Human__Purine metabolism,0.1720916199423855,0.5739800024401573,1.0,1.0,1.0,28/122,26.03%,GUCY2C;AK8;PDE4C;GUK1;NT5M;PDE1C;NPR2;NME1;PDE10A;GUCY2D;ADCY6;RRM2;ADCY4;AMPD2;NTPCR;ADCY10;NUDT2;ENTPD1;FHIT;ADCY2;IMPDH2;PRUNE1;PAPSS1;GMPS;ENTPD2;PFAS;ADA;ATIC
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.18313988612460172,0.5737734750439045,0.9949238578680203,1.0,1.0,35/86,39.50%,CELSR3;PSMD4;SPEF1;SAPCD2;PSMB4;PRICKLE2;DVL2;ARHGEF19;FZD6;PSMD1;DVL1;ROR2;PSMB3;PSMD14;SMURF1;PSMB5;FZD2;PSMD2;PSMA1;PSMD10;CELSR1;PSMC4;PSMC3;SMURF2;PSMC5;PSMB6;PSMD8;AP2A1;PSME2;AP2S1;PSMD13;PSMB7;PSMA7;PSME3;DVL3
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.16143713392174278,0.5736713490365749,1.0,1.0,1.0,27/251,14.81%,MATN1;SYCE1;BSN;CFAP46;VIL1;HES5;BAIAP2L2;FSCN2;GPAA1;ABCA3;PARVB;TRIP13;IKBKG;DCX;KNTC1;TEAD2;LAMC1;HAS1;PKP1;SPEF1;TLCD1;CHAF1B;PDGFA;DLG4;TFAP4;SCIN;FOXJ1
prerank,Elsevier_Pathway_Collection__Polycystins Mutation Effects in Cystic Kidney Disease,0.19798106003640664,0.5736075661917134,0.9893617021276596,1.0,1.0,8/47,26.07%,RASGRF1;AVPR2;PDPK1;PKD1;TSC1;TSC2;MAP2K2;MYC
prerank,Reactome_2022__Glycolysis R-HSA-70171,0.18368739223482392,0.5734529562062124,0.995049504950495,1.0,1.0,12/65,24.66%,TAC4;PFKFB4;PRKCA;PGP;NUP37;PFKFB2;MAP4K2;NUP62;TPR;NUP133;PGK1;PFKP
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.23362330580388846,0.5734173276071832,0.9512195121951219,1.0,1.0,5/17,26.97%,TBC1D16;SCRIB;PCSK9;ANXA2;INPP5F
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.1996140452770827,-0.5726621227873971,0.95,1.0,1.0,2/21,11.16%,NGFR;MMP7
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.18898209288254703,-0.5721646085195788,0.9759036144578314,1.0,1.0,4/25,13.03%,GPM6A;CCR7;RIPOR2;PIK3R1
prerank,KEGG_2021_Human__Mitophagy,0.19041782296341764,0.5717377897341843,0.9894179894179894,1.0,1.0,6/67,16.44%,E2F1;SRC;PRKN;SQSTM1;HRAS;MRAS
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.20704087971663238,0.570636329753168,0.9767441860465116,1.0,1.0,17/38,38.70%,B4GALNT4;B4GALNT3;B4GALT3;ST3GAL3;MAN2A2;ALG3;HEXB;HEXA;ALG1;MGAT4B;MGAT4A;RPN2;ALG13;DAD1;HEXD;MGAT4C;DDOST
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,0.18001878383409697,0.5705421731350587,0.9951690821256038,1.0,1.0,2/87,2.10%,DOCK3;PIK3R2
prerank,WikiPathway_2021_Human__SARS-CoV-2 mitochondrial interactions WP5038,0.21485650631721637,0.5703203359856339,0.9662921348314607,1.0,1.0,6/30,19.13%,NFKB2;ACE;NOX1;MAVS;NDUFB9;IRF3
prerank,MSigDB_Oncogenic_Signatures__E2F1 UP.V1 DN,0.16326271368594011,0.5701560541833197,1.0,1.0,1.0,38/179,26.07%,ALDH3A1;PAK3;MDK;AQP8;ZFR2;EFNA4;A4GALT;SLC6A8;EBF1;COL11A1;SLC35E4;APC2;POU5F1;PDZK1IP1;PLXND1;VCAN;HES6;PKD1;ABLIM1;GBP2;B4GALT3;BCL6;LAMA4;DCAF8;VPS45;SIX5;TGM2;HMGCS1;RALGDS;LIPE;PLAT;STX4;CAPN2;ERBB3;SNAI1;ITPR2;LBP;MYC
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.22373076923076954,0.5701010577365445,0.9473684210526315,1.0,1.0,25/25,77.65%,CPSF1;PABPC1;TUT1;SYMPK;CPSF3;CLP1;FIP1L1;PCF11;MTPAP;SSU72;PAF1;LEO1;CDC73;CSTF3;WDR33;AHCYL1;TENT2;GRSF1;CPSF2;SCAF8;PAPOLG;PNPT1;PAPOLA;TENT4B;APP
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.22373076923076954,0.5701010577365445,0.9473684210526315,1.0,1.0,25/25,77.65%,CPSF1;PABPC1;TUT1;SYMPK;CPSF3;CLP1;FIP1L1;PCF11;MTPAP;SSU72;PAF1;LEO1;CDC73;CSTF3;WDR33;AHCYL1;TENT2;GRSF1;CPSF2;SCAF8;PAPOLG;PNPT1;PAPOLA;TENT4B;APP
prerank,WikiPathway_2021_Human__Endoplasmic reticulum stress response in coronavirus infection WP4861,-0.16715143344099698,-0.5688055395673658,1.0,1.0,1.0,11/46,22.05%,PPP1R3B;PPP1R14C;PPP1R14D;PPP1R1A;PPP1R3C;PPP1R15A;BCL2;EIF2AK3;XBP1;PPP1R3G;MAP1LC3A
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,0.17996903008795445,0.5681714247717595,1.0,1.0,1.0,5/79,7.62%,FGF20;FGF13;FGF17;SRC;FGF23
prerank,Elsevier_Pathway_Collection__Skeletal Muscle Wasting in Cancer Cachexia,0.1964987257579076,0.5681481559468108,0.9948717948717949,1.0,1.0,7/42,20.07%,CACNA1S;MSTN;IL6R;PDPK1;SMAD3;TRAF2;ACVR2B
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.2009989003250379,0.5665099348429024,0.9736842105263158,1.0,1.0,10/36,34.98%,DLG5;ZNF512B;CEP97;PKN1;SPTAN1;PEAK1;GIT1;TPM3;DEPDC1B;MAP3K11
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.24868181617197804,0.5659862027892841,0.9573170731707317,1.0,1.0,5/15,33.56%,KHNYN;SLFN14;POP1;ZC3H12B;RPP40
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,0.21032233543773526,0.5657775768868379,0.978021978021978,1.0,1.0,14/34,39.11%,MAVS;IRF3;ISG15;RNF135;PDZD2;TRIM25;RNF216;UBA52;IKBKE;TNFAIP3;TRAF3;UBE2D2;OTUD5;TAX1BP1
prerank,Elsevier_Pathway_Collection__Osteoclast Activation in Psoriatic Arthritis,0.19028204765383366,0.5653364063751033,1.0,1.0,1.0,8/45,19.77%,SRC;IRAK1;IKBKG;IL6R;NFKB2;RELB;TRAF2;MMP9
prerank,Elsevier_Pathway_Collection__Endothelial Cell Dysfunction in Progressive Diabetic Nephropathy,0.21406970211714477,0.56445379336463,0.9588235294117647,1.0,1.0,6/26,26.07%,SRC;FLT1;SHC1;SMAD3;MAP2K2;MYC
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.22399619455361192,0.5642337248544119,0.9815950920245399,1.0,1.0,7/22,31.10%,ABCA3;ABCA7;PPARG;EEPD1;ABCA12;APOE;TREM2
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.2233132826515476,0.5638444893037868,0.9629629629629629,1.0,1.0,6/20,36.11%,TPX2;TUBGCP6;CSNK1D;TUBG1;TUBGCP2;NDE1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.18901652066600647,-0.5632752030690485,0.9876543209876543,1.0,1.0,6/21,23.60%,ACADL;EPHX2;NR1H4;TTC39B;LPCAT3;GNB3
prerank,Elsevier_Pathway_Collection__Thrombopoietin Receptors Signaling in Platelet Maturation,0.20786635707868029,0.5629961455015532,0.9700598802395209,1.0,1.0,1/30,1.59%,RASGRF1
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.18275888598245885,-0.562846938513009,1.0,1.0,1.0,29/29,81.75%,DPEP3;AKT1;PIP4K2A;ING3;MAP2K6;AKT3;AKT2;PML;BRD1;PIP4K2C;BRD7;TP53;EP300;HDAC2;MTA2;MEAF6;KAT6A;GATAD2A;RBBP4;PIP4P1;RBBP7;BRPF3;CHD4;CHD3;PIP4K2B;PDZD2;GATAD2B;HDAC1;ING5
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.17270340121368485,0.5625510591074817,1.0,1.0,1.0,18/104,23.95%,SHC3;CDKN2A;MAPK11;FGF2;CCNA2;RUNDC3A;PRKD1;SHC1;HRAS;MRAS;ARHGAP33;RALGDS;SETDB1;NUCB2;TRIM28;KSR1;DNMT1;RHEBL1
prerank,Elsevier_Pathway_Collection__Reperfusion Injury in Myocardial ischemia,0.22011485552434903,0.5624366160557833,0.9882352941176471,1.0,1.0,6/27,22.72%,CACNA1C;CTSA;BBC3;PARP1;HDAC1;AIFM1
prerank,Elsevier_Pathway_Collection__Apoptosis Evasion in Cancer: Overview,0.17199968710434166,0.5622897801485826,1.0,1.0,1.0,16/103,23.37%,SFN;TP53AIP1;TP73;BIRC5;BIK;LMNA;TNFRSF10D;BMF;BCL6;TNFRSF25;TRAF2;BBC3;FADD;PARP1;AIFM1;GSN
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.21985964078363426,0.5622402112028968,0.9728260869565217,1.0,1.0,4/21,15.10%,PRKAA2;CPT1B;ABCD1;ACACA
prerank,Elsevier_Pathway_Collection__Proteins Involved in Frontotemporal Dementia,0.22503401418553068,0.5619072214805955,0.9753086419753086,1.0,1.0,1/22,2.84%,MAPT
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.16116778962038872,0.5613193460957321,1.0,1.0,1.0,41/181,33.55%,DYNC1I1;COL7A1;ANK1;CNIH4;BCAP31;BGLAP;LMAN2;CNIH3;GOLT1A;TMED3;TMED6;CNIH2;PREB;COG8;COPE;TRAPPC5;YIF1B;SEC16B;KDELR3;TRAPPC2B;TMED9;DYNLL1;COG2;F5;TRAPPC2L;ARFGAP1;COPA;GAS6;VAMP4;KLHL12;TRAPPC1;SPTAN1;TRAPPC6A;BCAP29;COG4;NRBP2;DCTN4;DCTN2;DYNC1H1;SPTBN4;DCTN3
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.19014653282566055,-0.560934022126123,1.0,1.0,1.0,24/24,81.01%,LMAN1;HERPUD1;MAP1LC3C;TMEM129;SEL1L;SURF4;SELENOS;OS9;RANGRF;DERL2;SYVN1;TECPR2;SEC13;AUP1;HSP90B1;SEC16A;FAF2;VCP;SEC61B;DERL1;UFD1;TMED9;NPLOC4;PREB
prerank,Reactome_2022__HIV Infection R-HSA-162906,0.15796430052555835,0.5602119801596285,1.0,1.0,1.0,102/222,45.25%,PSMD4;VPS28;RNASE1;PSMB4;MVB12B;ELOC;NEDD4L;VPS37D;HMGA1;POLR2L;NUP37;ELOB;FEN1;NUP62;POLR2K;NELFE;TPR;NPM1;TAF10;NUP133;RANGAP1;POLR2G;PSMB3;SLC25A6;PSMD14;ATP6V1H;UBA52;PSMB5;NUP155;VPS4A;PSMD2;TAF6;NUP160;PPIA;PSMA1;PSMD10;POLR2H;CHMP2A;PSMC4;PSMC3;SGIP1;NELFA;NUP188;NMT2;POLR2I;SKP1;POLR2J;CTDP1;BANF1;PSMC5;SSRP1;SEM1;PSMB6;PSMD8;MVB12A;AP2A1;NUP205;SUPT5H;NELFB;TAF9;PSME2;XPO1;RNMT;AP2S1;POLR2A;PSMD13;NUP210;PSMB7;TAF1;PSMA7;AP1S1;ERCC2;RAN;HLA-A;XRCC6;PSME3;PACS1;ELL;POLR2B;NUP214;GTF2F1;NUP107;PSIP1;SLC25A5;PSMB2;TAF12;RBX1;PSMA6;UBC;PSMD9;POLR2F;CDK9;ERCC3;TAF5;SUPT16H;RCC1;CCNT2;AAAS;TAF9B;BTRC;PSMC2;TAF2
prerank,Elsevier_Pathway_Collection__Vascular Endothelial Cell Activation by NO,0.20336020496084362,0.5601781715224784,0.9883720930232558,1.0,1.0,8/31,29.23%,VWF;SLC7A1;PLAU;PLCG1;PLAT;GJA1;NOSIP;AGT
prerank,WikiPathway_2021_Human__Lipid Metabolism Pathway WP3965,0.21429291673449932,0.5601061782679024,0.9822485207100592,1.0,1.0,4/28,15.10%,PRKAA2;HILPDA;ACLY;ACACA
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.22227084031659392,0.5599403407897511,0.9714285714285714,1.0,1.0,7/18,33.03%,SRC;CATSPER1;CATSPER2;TGFB2;CATSPERB;YAP1;TGFB1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.20274287170315283,0.5598865422193524,0.9751552795031055,1.0,1.0,4/33,13.27%,CLVS1;ACP4;MYO7A;GBA
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.22547365532190328,0.5592785182341882,0.9705882352941176,1.0,1.0,4/18,17.68%,MTR;APOD;RTN4RL1;GAP43
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,0.19610847239508344,0.5592377565557951,0.9947643979057592,1.0,1.0,13/49,27.77%,MTR;DNMT3A;SRM;SDS;SDSL;BCAT2;KYAT1;GOT1;MDH2;DNMT1;DNMT3B;BCAT1;LDHAL6A
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,0.2357407929196989,0.5592084597815481,0.950920245398773,1.0,1.0,1/16,7.96%,PARVB
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,-0.19354141891970644,-0.558694026009281,0.974025974025974,1.0,1.0,4/22,17.80%,KCNH8;RPS6KA1;DUSP6;PPP2CB
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.14243300559090033,-0.5585221346661547,1.0,1.0,1.0,90/90,85.81%,EREG;PPARGC1A;HSPA1B;PRMT9;NUDT12;ZC3H12D;HSPA1A;NCBP1;AGO3;KIN;ZFP36;LSM5;CELF1;SRSF5;ERN1;PNPT1;GEMIN2;DCP2;ALKBH5;NUDT21;PRKACA;HIPK3;LSM6;RIDA;SRSF4;LSM3;SCAF11;SRSF2;SNRPF;PRPF18;SRSF9;SRSF1;PCBP2;SRSF11;NUDT16;ZFP36L2;SRSF7;SF3B2;NUDT16L1;TP53;CSTF3;DHX15;AGO4;HNRNPA0;HNRNPA2B1;SON;NCBP2;PABPC3;SF3A1;SFPQ;DDX5;PCF11;YTHDF2;CPSF6;U2AF2;U2AF1;SLBP;SNRPG;HNRNPR;SF3A3;CPSF3;TBRG4;PTBP1;PRPF8;METTL16;USP39;RNH1;SSB;SNRPD3;CNOT10;AURKAIP1;DIS3L2;NONO;TCERG1;RNASE4;SNRPB;LSM2;LSM11;LSM10;SF3A2;ZNF473;HSF1;METTL3;DXO;PCBP3;SLFN14;AKAP8L;SF3B4;SNRPE;PRPF3
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,0.19815168309180223,0.5583059424066471,1.0,1.0,1.0,10/35,24.84%,SBSPON;SPON2;SEMA5B;THBS2;ADAMTS18;THSD1;ADAMTS15;ADAMTS4;ADAMTS10;ADAMTS7
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.23180725017528597,0.558003009250918,0.9461077844311377,1.0,1.0,5/16,23.37%,MID2;TRIM11;IFITM3;IFITM2;GSN
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.1689952640883229,0.5571808591956743,1.0,1.0,1.0,50/109,40.55%,HJURP;SRC;BIK;CDT1;CD36;GBA;IAPP;RHOC;BMF;SLF2;TRAF2;STXBP1;PREB;MMP3;NRG1;TRABD2A;GSN;HSF1;STX1B;HCFC1;KIF9;GFAP;SEPTIN8;ULK1;RACK1;PARK7;HSPA5;APOE;DAB2IP;CRYAB;TGFB1;NCLN;OPRD1;BAX;HSPA8;FBLIM1;GNL3L;TIRAP;TAL1;VCP;RPS3;BID;GSK3B;TFRC;PIH1D1;HSP90AA1;SPIDR;TRABD2B;FAF1;CDH5
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.2429619221592808,0.5566364210132759,0.9634146341463414,1.0,1.0,2/15,14.81%,SCRIB;FOXJ1
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.16400446480120087,-0.556254103304429,0.9857142857142858,1.0,1.0,44/44,83.63%,ITGB8;ITGB6;ITGB3;PPP1R15A;LTBP4;USP15;SMAD7;MTMR4;PPP1CC;UBB;SMAD4;LTBP1;TGFBR1;FURIN;PPP1CB;ITGA8;ITGB1;SRFBP1;RPS27A;UCHL5;ZFYVE9;PPP1CA;STUB1;UBC;CBL;TGFB3;SMAD2;FKBP1A;XPO1;TGFBR2;PMEPA1;SMURF2;TGFB1;ITGB5;ITGAV;SMURF1;UBA52;UBE2M;BAMBI;NEDD8;LTBP3;TGFB2;SMAD3;NEDD4L
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.16785495346034326,0.5559424565146878,1.0,1.0,1.0,19/110,25.01%,MATN1;VIL1;HES5;GPAA1;IKBKG;KNTC1;TEAD2;LAMC1;DLG4;TFAP4;DET1;TRAF2;ELOB;EPRS1;LLGL1;TSPAN4;TPR;NUP133;CARD10
prerank,WikiPathway_2021_Human__Glutathione metabolism WP100,0.2166989785608976,0.555610505564176,0.9819277108433735,1.0,1.0,7/20,30.15%,GSTM2;OPLAH;GPX3;GPX2;GPX1;GSTT2;G6PD
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.1980119188297878,0.5553734299290535,0.9705882352941176,1.0,1.0,7/31,26.63%,RAB3B;NEB;LAMTOR4;RAP1GAP2;ATP13A2;PEX11B;LARS1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.20708100066362026,0.5552309957392804,0.9824561403508771,1.0,1.0,7/28,33.71%,TOP2A;ADAR;LARP1;PABPC1;PPIA;PPIH;HACD3
prerank,Elsevier_Pathway_Collection__Cardiomyocyte Hypertrophy,0.18244300320178852,0.5547115991315165,0.9948717948717949,1.0,1.0,5/61,11.88%,RASGRF1;TNNI3;TIMP1;CACNA1C;IL6R
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.1821736764905424,0.5544430216370474,0.984375,1.0,1.0,14/67,25.65%,MAPK12;MAPK11;ATP6V0D2;SRC;IKBKG;ATP6V0A1;ATP6AP1;ATP6V0B;TCIRG1;PLCG1;ATP6V0D1;ATP6V0E1;ATP6V1C1;F11R
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.18104936865790006,0.5543767449295207,0.989247311827957,1.0,1.0,32/76,43.56%,PSMD4;IKBKG;CD36;PSMB4;MFSD6;LNPEP;PSMD1;PSMB3;PSMD14;PSMB5;PSMD2;PSMA1;HLA-F;PSMD10;ITGAV;PSMC4;PSMC3;ITGB5;PSMC5;PSMB6;PSMD8;PSME2;PSMD13;PSMB7;PSMA7;HLA-A;PSME3;HLA-B;PSMB2;PSMA6;HLA-G;PSMD9
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.20306131229253113,0.5543132462831643,0.9887005649717514,1.0,1.0,11/32,29.49%,SEMA5B;MAP1B;TMEM108;SEMA3F;FLRT1;CDK5;HSP90AB1;CDKL3;CTNNB1;ALCAM;ULK1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.1789737736899971,-0.5541907725236811,0.9733333333333334,1.0,1.0,4/32,10.20%,CPEB1;CPEB3;FYN;SESN3
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,0.2343726641061501,0.5535954750561252,0.9757575757575757,1.0,1.0,1/16,6.66%,SRC
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.21515929421179927,0.5532584799182003,0.9653179190751445,1.0,1.0,11/24,36.18%,CHP2;PPP1R27;PPP1R35;TSC1;SH3RF2;PPP6R2;TIPRL;PPP1R2;PPP6R1;SH2D4A;ZCCHC9
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.15827243610701347,-0.5519040584045017,1.0,1.0,1.0,15/53,26.45%,GSTZ1;PDK4;MPC1;L2HGDH;SDHD;PDK3;SUCLG2;SDHB;LDLR;FAHD1;ADHFE1;SUCLA2;LDHB;SUCLG1;NNT
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.2418136116841203,0.5513248226993944,0.949685534591195,1.0,1.0,6/15,37.49%,PRKCA;HRAS;MMP3;MAPK7;RPS6KA3;MAPK3
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,0.2146721718419709,0.5510647311586002,0.9783783783783784,1.0,1.0,4/23,17.86%,IL31RA;IL11;IL6R;CRLF1
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,0.17977633140765265,0.5507457319102593,1.0,1.0,1.0,6/62,14.29%,MAPK11;IRAK1;MAP3K8;IKBKG;IRAK2;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.18169810548499235,-0.5503452539419402,1.0,1.0,1.0,9/29,22.36%,IFNG;PPARGC1A;ENTPD5;IGF1;PID1;SLC4A4;PFKFB3;TMSB4X;APP
prerank,WikiPathway_2021_Human__MAPK Cascade WP422,0.19691321547583615,0.5490557483640698,0.9787234042553191,1.0,1.0,1/33,2.84%,MAPK12
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.19532664889898035,0.5488213730828031,1.0,1.0,1.0,10/36,24.84%,SBSPON;SPON2;SEMA5B;THBS2;ADAMTS18;THSD1;ADAMTS15;ADAMTS4;ADAMTS10;ADAMTS7
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.19295091019979005,-0.5479314957892748,0.9885057471264368,1.0,1.0,6/17,27.48%,TNF;NOD2;AGTR1;FXN;RFK;EDN1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.17646153846153848,-0.547887134910062,0.9852941176470589,1.0,1.0,25/25,82.37%,KLHL15;ZER1;RNF185;HDAC6;ZYG11B;RNF5;ATXN3;POMT2;YME1L1;TOR1A;CUL3;NGLY1;FBXL17;OMA1;AUP1;UBE2W;STUB1;BAG6;VCP;CLPP;UGGT2;DERL1;LONP1;UFD1;UGGT1
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.16576849460512486,-0.5462391406127105,1.0,1.0,1.0,6/36,17.19%,CETP;ARL4C;ABCG8;ABCG5;NCOR1;PLTP
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.15653272833215182,-0.5451464432416817,1.0,1.0,1.0,10/56,19.34%,TNFSF10;DCN;PPARGC1A;SPIRE1;PPIF;BCL2L11;PLAUR;MLLT11;PMAIP1;DDHD1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.2078677928082941,0.5450156374507515,0.967741935483871,1.0,1.0,2/33,6.86%,BAIAP2L2;FSCN2
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.16989381779463306,0.544948159985166,1.0,1.0,1.0,48/97,47.47%,SRC;PSMD4;IKBKG;NFKB2;PSMB4;PDPK1;RELB;ITPR2;PSMB3;UBE2M;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;MALT1;MAP3K14;UBE2V1;UBE2D2;PSME2;TAB1;PSMD13;PSMB7;PSMA7;PSME3;FBXW11;PSMB2;PSMA6;UBC;PSMD9;BTRC;PSMC2;CDC34;RPS27A;PSME1;PYCARD;PSMB1;PSMD3;RELA
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.2366444180990468,0.5449376801359925,0.9551282051282052,1.0,1.0,3/16,15.54%,VGF;DUOX1;KCNJ11
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.17526768231357046,0.5448980482934183,1.0,1.0,1.0,30/87,40.43%,CLTCL1;RAB41;SGSM2;SNX32;RAB9B;STX10;RGP1;TBC1D10A;TMED9;WASHC1;VPS54;STX6;TRIM27;WASHC2A;DENND5A;UBE2O;RBSN;TBC1D17;RHOBTB3;MAGEL2;YKT6;RNF126;RAB6B;WASHC2C;RAB29;GGA1;ARFRP1;SNX12;TBC1D14;VPS26B
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.149575361939536,0.5441822208396838,1.0,1.0,1.0,137/307,44.54%,GCM1;ELL3;NR5A1;E2F2;PRRX1;TSC22D1;NR6A1;TRIP13;NOTCH3;ZBTB7B;NR1D1;TEAD2;PIR;KLF13;TEAD4;PMF1;PAX5;CPSF1;ELOC;SNRPE;PPARG;NFIX;HDAC5;THRA;POLR2L;TRIM24;NOTCH4;MNT;ELOB;HDAC10;HSF2BP;DEAF1;PARP1;INTS8;HDAC1;MAZ;NR2C2AP;POLR2K;ESR2;NR2C2;NELFE;TAF10;CPSF4;ZNF473;GMEB2;TAF1A;RPAP1;INTS3;POLR2G;MAML1;NCOR2;TEAD3;LSM10;NABP2;LSM11;SNRPB;TCFL5;MED7;MED27;RXRG;CSTF2;ZNF143;INTS7;TAF6;YAP1;INTS1;POLR2H;ADRM1;TEAD1;SNAPC2;RPRD2;INTS11;RXRB;NR2F1;NELFA;RBMX;POLR2I;POLR2J;DRAP1;POU2F1;CTDP1;TBL1X;SNRPD3;INTS9;NRBP1;SSRP1;E2F3;GTF2I;NPPA;TAF8;PABPN1;NFE2L3;RARG;NR2F6;SUPT5H;NELFB;INTS5;TAF9;HDAC7;MBD1;RNMT;POLR2A;TAF5L;TAF1;ERCC2;SYMPK;ELL;POLR2B;CPSF3;CLP1;GTF2F1;MED16;CEBPD;PPARD;MED17;PHAX;SNRPG;CPSF7;PKNOX1;SLBP;WWTR1;TAF12;SUPT6H;FIP1L1;POLR2F;CDK9;NFIC;ERCC3;WDR61;TAF5;SRRT;INTS4;MED20;PCF11;SUPT16H;ZNF345;CCNT2
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.177039216534461,0.5440523019021426,1.0,1.0,1.0,1/73,0.46%,DOCK3
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.21844691886624498,0.5433337882192179,0.9622641509433962,1.0,1.0,10/18,48.29%,BARD1;DNA2;BLM;RAD52;SLX4;UBE2V2;SETMAR;NBN;MRE11;RAD50
prerank,MSigDB_Oncogenic_Signatures__CSR EARLY UP.V1 UP,-0.13041806945621362,-0.5420805311477004,1.0,1.0,1.0,27/142,22.52%,PTGS2;PNP;INHBA;FAM180A;PPIF;CD274;FZD8;SOX9;PTP4A1;SLC28A1;HBEGF;SPRY2;F3;PLAUR;CD33;REPS2;NRBF2;VTA1;DCBLD1;ETS1;RGMB;MAP2K3;SMAD7;NMD3;EIF4A1;USP12;SEC24A
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,0.17376469823874066,0.5415949841019715,0.9949494949494949,1.0,1.0,41/76,47.47%,PSMD4;IKBKG;PSMB4;PDPK1;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;SKP1;PSMC5;SEM1;PSMB6;PSMD8;MALT1;UBE2V1;UBE2D2;PSME2;TAB1;PSMD13;PSMB7;PSMA7;PSME3;FBXW11;PSMB2;PSMA6;UBC;PSMD9;BTRC;PSMC2;CDC34;RPS27A;PSME1;PSMB1;PSMD3;RELA
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.22493175187934172,0.5410009084482599,0.9693251533742331,1.0,1.0,9/16,43.02%,HABP4;LARP1;POLR2G;CDC123;UHMK1;MTOR;RPS6KB2;EIF2B5;YTHDF2
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.21840479922822312,0.5408601370405187,0.9827586206896551,1.0,1.0,3/22,17.33%,FLVCR1;PPOX;ABCB6
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.20443015580317658,0.5403283426864008,0.9772727272727273,1.0,1.0,5/26,20.00%,DUOX1;PDPN;TUBB2B;PHPT1;DUOXA2
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.2343766640133912,0.540170279880692,0.9707602339181286,1.0,1.0,10/17,44.91%,AMER1;RGP1;VGLL4;DAB2IP;VPS11;HSP90AA1;FAF1;CDK5RAP3;WDR91;MSN
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.188221877530665,0.5398966198861331,0.9792746113989638,1.0,1.0,3/51,8.29%,PIK3R2;INPP5J;PIP5K1B
prerank,Elsevier_Pathway_Collection__PTGER1/4 -> Vascular Motility,-0.18213892769238507,-0.5392002340077728,1.0,1.0,1.0,2/18,11.42%,MAP2K1;PTGER4
prerank,Elsevier_Pathway_Collection__Melanocyte Role in Skin Aging,0.23113163326746577,0.5389960692186405,0.9720670391061452,1.0,1.0,5/16,32.22%,BIRC5;MC1R;TXN;POMC;CASP9
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.23320637215610707,0.5381020069122165,0.9743589743589743,1.0,1.0,8/16,48.24%,WDR45;RB1CC1;ULK1;ATG9B;ATG13;ATG7;ATG3;ATG12
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.18108835611540436,-0.5380864868113249,0.9428571428571428,1.0,1.0,5/19,23.80%,TLR3;RFTN1;IFIT1;IFIH1;DDX58
prerank,Elsevier_Pathway_Collection__AGTR1 -> ARRB1/ARRB2 Signaling,-0.174808037026254,-0.5380781277162812,1.0,1.0,1.0,8/25,23.65%,MAP2K1;AKT1;VAV1;MAPK10;AGTR1;JUN;MAP3K5;MAP2K4
prerank,Elsevier_Pathway_Collection__SIRT7 Signaling in Aging,0.23088978038655705,0.5373293131902467,0.9876543209876543,1.0,1.0,3/15,18.24%,CDK1;ELK4;MAGED1
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.16674003218270902,0.5371883783689175,1.0,1.0,1.0,9/98,14.29%,MAPK11;SAA2;IRAK1;MAP3K8;LRRC14;IKBKG;IRAK2;NFKB2;MAPKAPK2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.17169076096333322,0.5370195293672384,1.0,1.0,1.0,33/83,39.50%,CELSR3;PSMD4;PSMB4;PRICKLE2;DVL2;ARHGEF19;FZD6;PSMD1;DVL1;ROR2;PSMB3;PSMD14;SMURF1;PSMB5;FZD2;PSMD2;PSMA1;PSMD10;CELSR1;PSMC4;PSMC3;SMURF2;PSMC5;PSMB6;PSMD8;AP2A1;PSME2;AP2S1;PSMD13;PSMB7;PSMA7;PSME3;DVL3
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.19941655579714,0.5366704901299255,0.9818181818181818,1.0,1.0,3/28,12.41%,SLC26A6;SLC5A6;RACGAP1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.22229016200915652,0.5365739425669551,0.9517241379310345,1.0,1.0,8/16,43.50%,CYRIB;ROCK2;GSN;RACK1;KANK1;BCAS3;CDH5;KIF20B
prerank,Elsevier_Pathway_Collection__Golgi Transport,-0.19011728513747356,-0.5352243760766011,0.9666666666666667,1.0,1.0,20/20,81.01%,SEC24B;SEC24D;SEC23A;RAB6A;ERGIC1;SEC24C;RAB1A;RAB2A;TRAPPC3;SEC31A;ERGIC2;SEC13;GBF1;SEC16A;ERGIC3;GAPDH;SEC31B;ARFGAP1;ARF1;PREB
prerank,Elsevier_Pathway_Collection__P38 MAPK/MAPK14 Signaling,0.18995303771831787,0.5350052968635478,1.0,1.0,1.0,12/37,40.94%,HSPB1;MAPKAPK2;TRAF2;TAOK2;TRAF5;MAP3K11;RPS6KA4;MAP3K10;TAB1;DAXX;ATF1;MAP3K3
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,0.17736186291299785,0.534965338926104,1.0,1.0,1.0,20/55,38.72%,DNAJC6;BLOC1S1;SNAPIN;FTL;NAPSA;AP4B1;OCRL;BLOC1S3;CLTA;DTNBP1;ARRB1;AP3B1;HOMER2;ACBD3;FTH1;HSPA8;SORT1;HIP1R;TFRC;AP1S1
prerank,KEGG_2021_Human__Glucagon signaling pathway,0.16769088412441996,0.5346267937563739,1.0,1.0,1.0,17/97,25.08%,GCG;CALML6;PRKAA2;CAMK2A;CPT1B;CREB3L1;FBP2;ACACA;CREB3L4;PYGB;ADCY2;CPT1C;CRTC2;PHKG1;PFKP;PRKAB2;ITPR2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.16901544690845116,0.5345141384968337,1.0,1.0,1.0,42/91,43.56%,IRAK1;PSMD4;MAP3K8;IKBKG;IRAK2;PSMB4;SQSTM1;PELI3;PSMD1;PSMB3;PSMD14;UBA52;TNIP2;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;IL1R1;SKP1;PSMC5;RPS6KA4;PSMB6;PSMD8;UBE2V1;MAPK3;PSME2;TAB1;PSMD13;PSMB7;PSMA7;PSME3;NOD1;MAP3K3;FBXW11;PSMB2;RBX1;PSMA6;UBC;PSMD9
prerank,Elsevier_Pathway_Collection__Oxidized LDL/OLR1 Activates Cell Proliferation in Cancer,-0.19312842074612055,-0.5336573261957739,0.9759036144578314,1.0,1.0,3/18,17.08%,BCL2A1;REL;BCL2
prerank,WikiPathway_2021_Human__Pathways affected in adenoid cystic carcinoma WP3651,0.1792126588387607,0.5333643377409001,1.0,1.0,1.0,14/62,28.79%,INSRR;UHRF1;HRAS;CHEK1;BCORL1;NSD1;PRKDC;MAP2K2;MYCN;MYC;SRCAP;CHEK2;FGFR4;BCOR
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.16511732198257353,0.5331413153395944,1.0,1.0,1.0,9/99,14.29%,MAPK11;SAA2;IRAK1;MAP3K8;LRRC14;IKBKG;IRAK2;NFKB2;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.20564261811963278,0.5331179594718501,0.9941860465116279,1.0,1.0,4/27,13.68%,E2F1;SPHK1;PDGFB;PDGFA
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.20054708219745693,-0.5328843786036326,1.0,1.0,1.0,2/17,12.02%,PNP;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.20309084083614237,0.532722785986666,0.9808917197452229,1.0,1.0,3/22,13.68%,PDGFB;ACE;PDGFA
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.14129311826304006,-0.5323939039801384,1.0,1.0,1.0,69/71,76.33%,RNF175;NCCRP1;ERLIN1;MAN1A1;UBXN8;HERPUD1;ERLIN2;FBXO17;SGTB;TMEM129;EDEM1;FBXO27;RNF185;DNAJB9;RNF5;UBE2J1;SEL1L;UBXN4;DNAJB14;SELENOS;UBE2G2;TMUB2;RNF121;FBXO2;OS9;AMFR;YOD1;UBE4A;TRIM13;TMUB1;DNAJB12;MARCHF6;DERL2;UBQLN1;SYVN1;EDEM2;PSMC6;RNF103;DNAJC10;STT3B;UBQLN2;AUP1;TMEM67;JKAMP;SGTA;HSP90B1;USP19;ECPAS;STUB1;FAF2;FBXO6;MAN1B1;UBE2J2;BAG6;RHBDD2;DERL3;VCP;FBXO44;WFS1;FAM8A1;SEC61B;DNAJC18;DERL1;DNAJB2;HSPA5;UBE4B;UFD1;TRIM25;NPLOC4
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.2089994201402008,0.5323210624436582,0.9818181818181818,1.0,1.0,6/22,27.47%,PARVB;PDGFA;SCIN;QRICH2;GSN;RHOU
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.1550439963195634,-0.5318715896597842,1.0,1.0,1.0,7/41,17.97%,NTF3;TF;APOA5;GREM1;SELE;CLU;VTN
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.15540064088721503,0.5318083122069106,1.0,1.0,1.0,51/152,37.90%,PRKAA2;BRSK2;ATP6V0D2;CASTOR2;NUAK2;STK26;LAMTOR2;AKR1C3;PRKD1;INHBB;SREBF2;MTMR3;WDR45;ATP6V0B;CASTOR1;LAMTOR4;GAS2L1;TCIRG1;EHMT2;WDR24;ATP6V0D1;PCSK9;ATP6V0E1;ATP6V1C1;DAP;LARS1;BRSK1;ATP6V1H;CDKN1A;RHEB;NUAK1;CLEC16A;KPTN;ATP6V1F;HSPA5;ATP6V1E1;MLST8;GABARAP;GCN1;ATP6V1E2;LAMTOR5;RRAGD;NPRL3;ELAPOR1;HSPA8;RPTOR;NPRL2;RRAGA;MAPK3;MYBBP1A;HNRNPA1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.22606367852626447,0.5314981212260431,0.975609756097561,1.0,1.0,11/17,47.37%,HRAS;HSF1;TMEM109;YAP1;CRYAB;XRCC6;ATR;KDM1A;WRN;RPL26;MDM2
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,0.1644580484119294,0.5311011191478556,1.0,1.0,1.0,46/110,43.56%,SAA2;IRAK1;PSMD4;MAP3K8;LRRC14;IKBKG;IRAK2;NFKB2;PSMB4;SQSTM1;PELI3;PSMB3;PSMD14;UBA52;TNIP2;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;CUL1;IL1R1;SKP1;PSMC5;SEM1;TIFA;PSMB6;PSMD8;UBE2V1;USP14;PSME2;TAB1;PSMD13;PSMB7;PSMA7;PSME3;NOD1;MAP3K3;FBXW11;PSMB2;RBX1;PSMA6;NFKBIB;UBC;PSMD9
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.23044904866148985,0.5306170367215388,0.95,1.0,1.0,4/15,24.37%,RHO;CEP250;EYS;ABCA4
prerank,KEGG_2021_Human__Circadian rhythm,0.1968517560371853,0.5303843211121924,0.9945054945054945,1.0,1.0,9/30,33.80%,PRKAA2;NR1D1;ARNTL;PRKAB2;NPAS2;CSNK1D;CUL1;BHLHE40;SKP1
prerank,Elsevier_Pathway_Collection__Inhibition of THBS1 Activates Angiogenesis in Cancer,-0.15960985104627062,-0.5301871793884422,0.9821428571428571,1.0,1.0,6/39,16.90%,HGF;FASLG;FYN;AKT1;VAV1;THBS1
prerank,MSigDB_Oncogenic_Signatures__PDGF UP.V1 UP,-0.12976196014805622,-0.5299832307576045,1.0,1.0,1.0,21/135,19.78%,EGR3;ACOT11;TFPI2;FOS;INHBA;SIK1;ELOVL2;POTEKP;NDRG4;EGR1;SLC7A5;NCKAP1L;SLC5A3;KCNK3;P2RX1;TMEM158;EZR;GADD45A;SDC3;KBTBD11;GLOD4
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.16109465869879258,-0.5298430782065634,1.0,1.0,1.0,12/31,31.52%,TRAPPC3L;RAB6D;VTI1B;GOLGA5;RAB33B;RAB6A;COG6;TRAPPC10;COPZ2;VTI1A;GOSR1;NAPG
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.18980143614063472,0.5295846357446579,0.9893617021276596,1.0,1.0,12/40,32.74%,TENM2;ARHGAP44;PPP1R16B;GAP43;PALM;FNBP1L;MIEN1;ARAP1;FMR1;NRP1;AGRN;DPYSL3
prerank,TRRUST_Transcription_Factors_2019__VHL human,0.22256244818859644,0.5295680047808532,0.9751552795031055,1.0,1.0,4/19,20.23%,COL4A2;CDKN1C;ANGPT2;SPARC
prerank,WikiPathway_2021_Human__Imatinib and Chronic Myeloid Leukemia WP3640,0.20823582106606675,0.5294099260359142,0.9705882352941176,1.0,1.0,9/20,36.52%,PDGFRB;FLT1;PIM1;MYC;BCR;NOP2;SKP2;LYL1;ABL1
prerank,Elsevier_Pathway_Collection__Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway,0.19622824239243244,0.5292817291224788,0.988950276243094,1.0,1.0,9/31,26.12%,CCNB1;JAG2;PRKCA;SMAD3;NOTCH4;MMP9;MMP3;MYC;CTNNB1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.21085393614744513,0.5292496213772181,0.9583333333333334,1.0,1.0,7/20,38.76%,SPAG4;EMD;TOR1AIP1;NUP155;VPS4A;DMPK;LEMD2
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.16573370156712913,-0.5292048793294121,1.0,1.0,1.0,6/29,22.10%,PFN2;PLEKHH2;CORO1A;LIMA1;KANK4;MYADM
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,0.16794509395322044,0.5289088573228014,1.0,1.0,1.0,31/87,39.37%,S100A1;PSMD4;IKBKG;CD36;PSMB4;SEC61G;NDUFA2;STX4;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;HLA-F;PSMD10;S100A9;PSMC4;PSMC3;PSMC5;SEM1;PSMB6;PSMD8;TIRAP;SEC61B;PSME2;PSMD13;PSMB7;PSMA7;HLA-A;PSME3
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.1761579722199477,0.5288960076267624,1.0,1.0,1.0,16/53,33.73%,THY1;SRC;S100A10;APOD;PPM1F;ROCK2;ACVRL1;TSC1;PTK2;LDB1;MAP4K4;DAPK3;NRP1;PEAK1;ITGB1BP1;COL16A1
prerank,WikiPathway_2021_Human__Glycosylation and related congenital defects WP4521,0.2047436017233514,0.5283974422330431,0.9822485207100592,1.0,1.0,9/25,38.29%,DPM3;ALG3;SRD5A3;DOLK;ALG1;DPM2;ALG6;ALG13;ALG8
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.17598429043249156,0.5283230838518757,0.9949238578680203,1.0,1.0,23/55,40.48%,NSMCE2;PIAS3;NUP37;STX1A;EYA1;PIAS1;TRIM28;NUP62;TPR;NUP133;TRPM4;RANGAP1;NUP155;NUP160;PIAS4;UBE2I;NUP188;SAE1;UBA2;NUP205;NUP210;RAE1;NUP214
prerank,KEGG_2021_Human__Longevity regulating pathway,-0.13296661139171695,-0.5280469263140909,1.0,1.0,1.0,18/97,19.10%,CAMK4;PPARGC1A;CAT;PIK3CD;FOXO1;SESN3;KL;HSPA1B;ADCY5;PIK3R1;AKT1;IGF1;CREB5;PRKAG2;HSPA1A;SESN2;IRS2;ADCY1
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,0.1919437183472699,0.5275821450391662,0.9943181818181818,1.0,1.0,17/34,41.94%,CAMK2A;HSPA2;HSF1;HSP90AB1;MLST8;CRYBA4;CRYAB;HSPA8;RPTOR;AKT1S1;SERPINH1;HSP90AA1;DNAJB6;HSPA1L;MTOR;HSPH1;COL4A6
prerank,Elsevier_Pathway_Collection__Exocytosis: Vesicle Tethering,0.1938598853537491,0.5275427397710495,1.0,1.0,1.0,32/32,80.64%,SNAP25;STXBP1;RAB13;MYRIP;EXOC4;EXOC3;RAB40B;EXOC8;RALBP1;EXOC7;RHOA;RAC1;SNAP23;RAB10;VAMP2;EXOC6;RAB3A;RHOQ;RAB11A;EXOC1;RAB3IP;VAMP3;EXOC2;RALA;ARF6;MYO5A;CDC42;CLIP1;RAB8A;EXOC5;RAB27A;IQGAP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.1761111650435847,0.5270932499930003,0.9948979591836735,1.0,1.0,7/63,12.83%,SNAI2;SRC;PRKN;HSPB1;NOL3;EPO;CREB3L1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.18606186323765778,-0.5260891336746839,1.0,1.0,1.0,5/19,19.40%,MISP;GBP1;CLN3;AR;VTI1B
prerank,TRRUST_Transcription_Factors_2019__SRF human,0.20238195147746005,0.5259664680694501,0.9941520467836257,1.0,1.0,4/25,19.77%,PRRX1;UBE2S;PLAU;MMP9
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.18581474320702918,-0.5255594271876777,0.9883720930232558,1.0,1.0,15/16,60.65%,SLC25A24;LRRC8C;SLC25A42;ABCC4;SLC25A17;LRRC8A;ABCC6;SLC35B2;SLC25A4;SLC25A41;SLC25A5;LRRC8D;SLC17A9;SLC19A1;LRRC8E
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer-Associated Evading of Growth Suppressors,0.17998283843231352,0.524446233188385,0.9947643979057592,1.0,1.0,7/57,17.41%,AXIN2;SFRP4;GPC3;SCRIB;TEAD4;SMAD3;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.21190526241444507,0.524320542032747,0.9700598802395209,1.0,1.0,6/20,25.98%,CABP1;APOD;GDI1;BARD1;MDFIC;RANGAP1
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.16872827716157157,-0.5239086008941954,0.967741935483871,1.0,1.0,4/27,16.61%,CCL2;CXCL8;IGFBP1;HERPUD1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.2264923463363222,0.523637260696601,0.9683544303797469,1.0,1.0,10/16,44.96%,DEFA3;PPARGC1B;ESR2;PADI2;EGLN2;RBFOX2;ARID1A;DDX17;DDX54;DDX5
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,0.15666472216718702,0.5235133187093408,1.0,1.0,1.0,16/141,16.65%,PTPN5;SAA2;IRAK1;PTPN14;IL36G;PSMD4;MAP3K8;LRRC14;IKBKG;IL1RAPL1;IRAK2;NFKB2;PSMB4;SQSTM1;GSDMD;SMAD3
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.18263421567435223,0.5227296371940887,1.0,1.0,1.0,15/43,38.08%,UBE2T;PRKN;UBE2S;NEDD4;TRAF2;PELI3;RNF135;TRAF5;TRIM27;UBE2O;MAGEL2;RNF126;TRAF3;UBE2V1;TRIM56
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.18996539792387546,-0.5221533948674394,1.0,1.0,1.0,15/15,81.02%,DNASE1L3;DFFB;KPNA1;DICER1;HMGB1;ENDOG;CASP3;KPNB1;DFFA;DNASE2;EXOG;CECR2;HMGB2;H1-0;DNASE2B
prerank,Elsevier_Pathway_Collection__FOXO1 Signaling,-0.1561603211273953,-0.5218172275414414,1.0,1.0,1.0,18/43,29.29%,MAP2K1;FOXO1;IL6;G6PC;AKT1;BCL2L11;GADD45A;PCK2;IRS2;JAK2;IGF1R;GAB1;KRAS;SIRT1;EGFR;STAT3;CCND2;CASP3
prerank,Elsevier_Pathway_Collection__Hippo/YAP1 Signaling,0.19072073638614362,0.521627077934007,0.9883040935672515,1.0,1.0,12/31,37.32%,TP73;SCRIB;BBC3;CTNNB1;MERTK;YAP1;TEAD1;RASSF1;STK3;AMOT;TJP1;TJP2
prerank,WikiPathway_2021_Human__Nanoparticle triggered autophagic cell death WP2509,-0.18236357343383455,-0.5215609868566708,0.9873417721518988,1.0,1.0,22/22,81.78%,BCL2;MAP1LC3A;ATG5;ULK2;SH3GLB1;VMP1;BECN1;UVRAG;ATG14;ATG16L1;ATG12;INSR;ATG3;ATG7;AMBRA1;ATG9B;ATG4A;ULK1;ATG10;TSC2;TSC1;CHAF1A
prerank,Elsevier_Pathway_Collection__Insulin Signaling,0.17335948512099664,0.5201702365433059,0.9946808510638298,1.0,1.0,16/53,32.83%,SLC2A4;SHC1;ACLY;PDPK1;LIPE;SH2B2;TSC2;CRTC2;MAP2K2;MYC;RHEB;ULK1;FASN;IRS1;SLC2A1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.17670209323345965,0.5201649609286003,0.9947368421052631,1.0,1.0,10/49,24.64%,PRKN;MCTP1;PRKD1;PACSIN3;PPM1F;ABCA7;EGF;BST2;NRG1;ERBB3
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.16578537402607343,0.5200359222577617,1.0,1.0,1.0,12/67,25.26%,GOLGA7B;GRIN3B;ZDHHC11B;VPS37D;ZDHHC11;REEP1;YIF1B;TAOK2;NPC1;ZDHHC1;FRMPD1;ZDHHC9
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.17921910216287726,0.5197335494219142,0.994535519125683,1.0,1.0,9/53,21.57%,MAPK12;MAPK11;IKBKG;MAVS;TRAF2;IRF3;TBKBP1;FADD;ISG15
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.1807561804787845,0.5194417766611,0.9947368421052631,1.0,1.0,17/47,33.82%,ATP6V0D2;MELTF;ATP6V0A1;ATP6AP1;HEPHL1;ATP6V0B;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1C1;ATP6V1H;MCOLN1;ATP6V1F;SLC11A1;ATP6V1E1;ARHGAP1;ATP6V1E2
prerank,Elsevier_Pathway_Collection__Hutchinson-Gilford Progeria Syndrome,0.21956100770521364,0.5193589794344682,0.9819277108433735,1.0,1.0,5/16,28.54%,LMNA;PARP1;HDAC1;EMD;SIRT6
prerank,Elsevier_Pathway_Collection__RARA Signaling in Acute Myeloid Leukemia (M3),0.19672069755327842,0.5193323007504907,0.9779005524861878,1.0,1.0,7/27,26.59%,FLT3LG;SHC1;PDPK1;NPM1;MYC;CTNNB1;NCOR2
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,-0.1571685647364231,-0.5189991777420404,1.0,1.0,1.0,5/32,18.59%,CCL2;CXCL8;IGFBP1;HERPUD1;EIF2AK3
prerank,WikiPathway_2021_Human__miRNA regulation of p53 pathway in prostate cancer WP3982,0.20450224410857162,0.5189823233413169,0.9944444444444445,1.0,1.0,1/24,2.69%,TP53AIP1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.16125066810956884,0.5186777129365052,1.0,1.0,1.0,41/124,41.77%,GOLGA6D;PLK5;CDK1;PRKD1;FHDC1;LMAN2;ATP8B3;TMED3;TMED6;GOLGA8M;OBSL1;GOLGA8A;SEC16B;NPLOC4;CUL7;TMED9;COG2;TANGO2;TJAP1;STX6;RAB43;STK25;VAMP4;PLEKHM2;CSNK1D;COG4;ATP8B2;NSFL1C;GOLGA8B;GOLPH3L;COG7;TBC1D20;BCAS3;HTT;RAB29;HUWE1;GOLGA6B;FBXW8;TRAPPC12;PI4K2A;BLZF1
prerank,WikiPathway_2021_Human__Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.19371430331966533,0.51861432529641,0.9940119760479041,1.0,1.0,10/30,37.91%,HDAC4;HDAC5;HDAC1;NELFE;NFATC4;NELFA;HDAC8;SUPT5H;NELFB;HDAC7
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.16760382391678627,-0.5182607620968573,1.0,1.0,1.0,4/30,16.56%,GSTZ1;PDK4;MPC1;PDK3
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.16258547476305782,0.5176306230919291,1.0,1.0,1.0,22/89,32.51%,MPZ;RIN1;SBF1;GDI1;CHML;ANKRD27;RAB9B;TRAPPC9;TRAPPC5;DENND4B;RAB13;DENND4C;TRAPPC2L;DENND6B;RABGEF1;ULK1;RAB3GAP2;DENND5A;TRAPPC1;HPS4;TRAPPC6A;RINL
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,0.1870775047551798,0.5154082945420146,0.989247311827957,1.0,1.0,15/38,39.42%,IKBKG;CDK1;MAVS;OTUD7B;RNF135;OTUB2;TRIM25;UBA52;TNIP2;OTUD3;TNFAIP3;TRAF3;OTUD5;VCP;NOD1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.20152175629526017,0.515127044801991,0.9939024390243902,1.0,1.0,3/27,13.46%,PDK1;PRKN;FOXK1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.1494722064712752,-0.5149948188105515,1.0,1.0,1.0,1/56,0.57%,GCK
prerank,Elsevier_Pathway_Collection__Circadian Clock in Sleep Regulation,0.2085392652984542,0.5149381734072768,0.9696969696969697,1.0,1.0,6/18,33.20%,NR1D1;GRM1;ARNTL;NPAS2;CSNK1D;BHLHE40
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.20624207465745376,0.5145265090052269,0.9939393939393939,1.0,1.0,2/19,11.47%,PRKN;AURKA
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.16331517641063223,0.5140670751121101,1.0,1.0,1.0,18/69,31.10%,KCNB1;RGCC;NMB;UNC13B;ANKRD1;ATP6AP1;SYTL4;ADAM9;MYOM1;STX1A;TGFB2;APBB1;STX1B;ATP13A2;APBB3;DTNBP1;PPIA;TREM2
prerank,WikiPathway_2021_Human__Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.20716470560401568,0.5138148253138085,0.9819277108433735,1.0,1.0,4/20,24.95%,DNMT3A;SMARCA4;DNMT1;DNMT3B
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.19252311432845937,0.5133538465056026,1.0,1.0,1.0,15/32,43.82%,POLR2L;POLR2K;POLR2G;POLR2H;POLR2I;POLR2J;SUPT5H;RNMT;RAMAC;POLR2A;ERCC2;POLR2B;GTF2F1;POLR2F;ERCC3
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.19252311432845937,0.5133538465056026,1.0,1.0,1.0,15/32,43.82%,POLR2L;POLR2K;POLR2G;POLR2H;POLR2I;POLR2J;SUPT5H;RNMT;RAMAC;POLR2A;ERCC2;POLR2B;GTF2F1;POLR2F;ERCC3
prerank,Elsevier_Pathway_Collection__Mitochondrial DNA Replication and Transcription,0.21898679806566188,0.5131235723520192,0.9937888198757764,1.0,1.0,10/16,44.61%,MTERF3;POLRMT;MRPL12;TFB2M;DHX30;LONP1;POLG;PTCD3;POLG2;SSBP1
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.15832522550478412,0.5129848358368396,1.0,1.0,1.0,9/100,14.29%,MAPK11;SAA2;IRAK1;MAP3K8;LRRC14;IKBKG;IRAK2;NFKB2;MAPKAPK2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.14376832647380475,-0.512851016031401,1.0,1.0,1.0,7/54,16.91%,NOG;ID2;CDH1;LEFTY2;BMPR2;THBS1;PPP1R15A
prerank,Elsevier_Pathway_Collection__TGFBR Signaling in Pancreatic Neoplasms,-0.14662406651782278,-0.5127358127473847,1.0,1.0,1.0,47/47,85.37%,FOS;MAP2K1;EGR1;BCL2;MAPK10;JUN;MAP3K5;BRCA1;CDKN1B;KRAS;CASP3;SMAD4;GRB2;TGFBR1;SOS1;CYCS;APAF1;CREB1;ELK1;MAPK8;CEBPB;BRAF;EP300;SP1;MAP2K7;ATRX;MAPK1;TGFB3;SMAD2;CDK2;DAXX;TGFBR2;MAPK3;MAPK9;BAX;BRCA2;TGFB1;CDK4;CASP9;CDKN1A;MYC;MAP2K2;RAD51;TGFB2;SMAD3;HRAS;SHC1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.18977075024758358,0.5123729017896892,0.9881656804733728,1.0,1.0,12/30,40.10%,SDF2L1;HSPA2;UGGT1;HSPA5;HSPE1;HSPA14;HSPA8;DNAJB5;CHCHD4;DNAJC18;CCT2;HSPA1L
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,0.18628216804459735,0.5122318505996855,0.9942857142857143,1.0,1.0,9/37,25.08%,CAMK2A;PDE1C;ADCY6;PRKCA;ADCY4;ADCY2;PLCG1;KPNA2;ITPR2
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.1532614325876824,0.5120717886766478,1.0,1.0,1.0,41/124,36.78%,B3GALT1;ST8SIA3;DPM3;MGAT5B;B3GNT5;FUT5;GALNT9;ST8SIA5;GCNT3;ST3GAL3;B4GALT7;B3GALNT2;KRTCAP2;LARGE2;NPC1;PLOD3;PMM1;SERP2;B4GAT1;GALNT18;POGLUT1;ALG3;TMEM258;ST3GAL2;ALG1;POMK;ST3GAL1;MGAT4B;MGAT4A;GALNT10;TET3;MGAT3;OGT;GCNT4;MGAT5;ALG6;ST3GAL5;RPN2;C1GALT1C1;COG7;DAD1
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.15737440600486702,0.5115212456448776,1.0,1.0,1.0,9/103,14.29%,MAPK11;SAA2;IRAK1;MAP3K8;LRRC14;IKBKG;IRAK2;NFKB2;MAPKAPK2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.16088472627708927,-0.5095776761264688,1.0,1.0,1.0,10/33,29.81%,IFI30;SEC24B;FCER1G;SEC24D;SEC24A;SEC23A;HFE;CLEC4A;SAR1B;TAP1
prerank,WikiPathway_2021_Human__TNF-alpha signaling pathway WP231,0.1566081733448947,0.5095453411989102,1.0,1.0,1.0,32/90,38.94%,GLUL;PLK1;MAP3K8;IKBKG;NFKB2;NOX1;HRAS;TRAF2;OTUD7B;FADD;MAP4K2;TXN;KSR1;NSMAF;TRAP1;PSMD2;CDC37;DIABLO;CUL1;CASP9;SMPD2;SKP1;BAX;TRADD;TNFAIP3;MAP3K14;MAPK9;MAPK3;TAB1;BID;NFKBIE;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.19895336343489914,0.5090384912478626,0.9823529411764705,1.0,1.0,10/22,40.71%,MID2;TRIM11;TRIM28;TRIM25;VPS4A;TRIM8;CHMP2A;DDB1;TRIM35;TRIM62
prerank,Elsevier_Pathway_Collection__Tight Junction Assembly (Claudins),0.1947422864669641,0.5087630550412054,0.9779005524861878,1.0,1.0,7/23,37.32%,CRB1;LLGL1;STX4;SPTAN1;CDK4;TJP1;TJP2
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.19227578074698054,0.5082703843689874,1.0,1.0,1.0,11/25,36.30%,UNC5A;DAPK2;MAGED1;FADD;NDUFA2;FASN;DAPK3;CASP9;TNFRSF10A;TRADD;TICAM1
prerank,KEGG_2021_Human__RNA degradation,0.16469423179550874,0.508100462946779,1.0,1.0,1.0,34/76,47.19%,PABPC4L;EXOSC4;PABPC1L;BTG3;PFKP;EXOSC5;EDC3;PABPC1;LSM2;LSM4;LSM7;CNOT3;CNOT10;ENO1;HSPD1;EXOSC2;DCPS;EDC4;CNOT6;CNOT6L;CNOT9;EXOSC1;EXOSC7;EXOSC10;EXOSC9;PABPC4;CNOT1;WDR61;SKIV2L;MTREX;DCP1B;HSPA9;PFKM;TTC37
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.17423572389925016,-0.5075006646334145,0.9875,1.0,1.0,20/20,82.59%,SORL1;CLU;LAPTM5;RAB7A;M6PR;SCARB2;GCC2;GNPTAB;ZFYVE16;NCOA4;SNX16;GGA3;AP3M1;LAMP2;HSPA8;VPS4A;HGS;AP4M1;NAGPA;NEDD4
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.1764547517403177,-0.5073418490273994,1.0,1.0,1.0,24/24,82.37%,MAN1C1;MAN1A1;EDEM1;RNF185;RNF5;SEL1L;UBB;MAN1A2;OS9;RNF139;AMFR;TRIM13;MARCHF6;DERL2;SYVN1;EDEM2;RNF103;RPS27A;UBC;MAN1B1;UGGT2;UBA52;EDEM3;UGGT1
prerank,Elsevier_Pathway_Collection__FOXA2 Signaling in Prostate Cancer,-0.1793745780030355,-0.5071307997143358,0.9878048780487805,1.0,1.0,5/18,24.80%,AGR2;SOX9;AR;SIAH1;SIAH2
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.19882346235871912,0.5071110755881906,0.9887640449438202,1.0,1.0,3/24,17.33%,FLVCR1;PPOX;ABCB6
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.15195271812116437,-0.5068162705706244,1.0,1.0,1.0,7/41,18.81%,NR3C2;SCGB2A2;ESR1;NKX3-1;PGR;AR;TRERF1
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,0.2152417968091968,0.506075752221382,0.9819277108433735,1.0,1.0,2/15,16.51%,SRC;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.17032854608704628,-0.5058129092216324,1.0,1.0,1.0,5/26,19.29%,PPP1R36;SEMA4D;CHP1;PPP1R15A;PPP4R4
prerank,WikiPathway_2021_Human__Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.1808042454144863,0.5056716300600409,1.0,1.0,1.0,2/37,5.48%,PDK1;MSTN
prerank,WikiPathway_2021_Human__Prolactin Signaling Pathway WP2037,-0.13263620248109553,-0.5048507042370369,1.0,1.0,1.0,16/75,23.45%,SOCS2;FOS;MAP2K1;FYN;PIK3R1;AKT1;CISH;VAV1;ZAP70;IRS2;JUN;JAK2;STAT1;SIRPA;PIK3CG;GAB2
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.20634640566439422,0.5045883373017821,0.9704142011834319,1.0,1.0,1/16,9.97%,VPS28
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,0.21943155097031894,0.5042662883635123,0.967741935483871,1.0,1.0,7/15,33.94%,ADCY6;PRKCA;ADCY4;ADCY2;PRKAR2A;ADCY8;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.1694366704725974,0.5034437187647322,1.0,1.0,1.0,16/53,31.20%,GPSM1;CAMK2A;APOA2;HRAS;PPP1R27;PPP1R35;ARL2;EGLN1;RASA4;CSTB;F11R;SH3RF2;SH3BP4;FICD;MAPK7;DAB2IP
prerank,Elsevier_Pathway_Collection__TLR3 Role in Retinal Pigment Epithelial Cell,-0.19138792772010765,-0.5029619246245135,0.9883720930232558,1.0,1.0,15/15,80.88%,TLR3;JAK2;STAT3;NFKBIA;CASP3;TBK1;CYCS;APAF1;IRF7;SOD2;TICAM1;BAX;CASP9;IKBKE;IRF3
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.19119486071147557,0.5026968129543073,0.9887005649717514,1.0,1.0,9/31,31.52%,PFDN2;DOC2B;SMCR8;TMED9;ANXA2;RAB3GAP2;FYCO1;TREM2;STX18
prerank,Elsevier_Pathway_Collection__Low-Grade Serous Ovarian Carcinoma,0.16424171852029712,0.5024166852880984,1.0,1.0,1.0,15/69,26.54%,LEF1;SRC;NOTCH3;JAG2;SHC1;PDPK1;HRAS;EGF;DLL4;NRG1;ERBB3;MAP2K2;MYC;CTNNB1;MAML1
prerank,WikiPathway_2021_Human__TCA Cycle (aka Krebs or citric acid cycle) WP78,0.2028814670269818,0.5024164113440575,0.9821428571428571,1.0,1.0,4/18,22.76%,IDH3G;FH;CS;MDH2
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,0.21344354611168734,0.501752016233386,0.9935064935064936,1.0,1.0,9/16,46.20%,IRF3;NDUFA2;UBA52;IKBKE;TRAF3;TICAM1;UBC;IRF7;RPS27A
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.21780412367863095,0.5015220963563228,0.9820359281437125,1.0,1.0,3/16,19.32%,MSTN;SMAD3;PCBP4
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.16503808571208742,-0.5011196557350008,1.0,1.0,1.0,31/31,83.52%,PPIF;BCL2;PMAIP1;MAIP1;OPA1;DNAJC11;MFN2;GHITM;SPG7;BNIP3;CHCHD3;SLC25A4;MFN1;TMEM11;BAK1;RCC1L;IMMT;BAD;HSPA9;BCL2L1;MTX3;SLC25A5;MTX2;TIMM50;CHCHD6;APOOL;MICOS10;MICOS13;MTX1;APOO;SAMM50
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,0.17773837151044497,0.5010936222264495,0.9890710382513661,1.0,1.0,13/41,36.41%,RAB41;COG8;VPS45;NAPSA;COG2;MAN2A2;STX6;CYTH3;CYTH2;COG4;YKT6;GOLGA8B;COG7
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.18785161771121398,0.5006433759559225,0.9938650306748467,1.0,1.0,10/26,40.55%,RNASE1;PDPK1;THEM4;CTNNB1;PKN1;MLST8;CTNNA1;HSP90AA1;MTOR;CDH5
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.1318424469070256,-0.5003125333280317,1.0,1.0,1.0,30/84,30.74%,NACA2;ABCD2;RTP5;PEX3;VPS37B;ZDHHC21;RTP3;NCF1;ACBD5;ZDHHC15;SEC62;SRPRA;PXMP2;ZDHHC23;GDAP1;CHMP4A;RAB8B;SGTB;ZDHHC4;PEX13;ZDHHC20;PEX14;ICMT;ARL6;ZDHHC19;ABCD3;ATAD1;ARL6IP1;SLC25A17;ZDHHC2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.18420689294133621,-0.499648918544875,1.0,1.0,1.0,2/16,13.49%,NOG;SOX9
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.15740019806133215,-0.4991348745212871,1.0,1.0,1.0,3/30,12.28%,TLR3;TICAM2;TLR4
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.15747618971457872,0.4980324436487133,1.0,1.0,1.0,34/83,40.61%,PLK1;TRIB2;ECSCR;NKD2;PRKN;DET1;ELOB;PIAS1;COP1;SH3RF2;DVL1;RACK1;NUPR1;DDRGK1;SOCS5;PSMD10;KEAP1;TREM2;DAB2IP;CSNK1D;PSMC3;FMR1;DNAJB2;GABARAP;HSPBP1;PSMC5;USP5;VCP;GSK3B;TAF1;BAG6;CSNK1E;ARIH1;USP13
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,0.16533635431149296,0.4979123487404246,1.0,1.0,1.0,14/58,33.96%,IQGAP3;DIAPH3;OBSCN;SCRIB;ARHGAP33;SRGAP2;ARHGAP26;GJA1;CDC42EP4;CDC42BPA;PKN1;GIT1;ARHGAP1;DEPDC1B
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.1877062119511813,0.4978622445890867,0.9942196531791907,1.0,1.0,15/27,41.76%,PKD1;TPR;RANBP3L;STRADA;XPO5;CCHCR1;SMURF1;TGFB1;XPO6;XPO1;NUTF2;RAN;NUP214;RANBP3;RANBP17
prerank,WikiPathway_2021_Human__Leptin Insulin Overlap WP3935,0.21418168863472775,0.49781053530990355,0.9751552795031055,1.0,1.0,3/15,15.00%,LEP;PDPK1;LEPR
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.15683311447407508,-0.4966371514751147,1.0,1.0,1.0,1/36,1.37%,OTOF
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.15834895585784176,-0.49605967118082556,1.0,1.0,1.0,8/27,25.69%,ARRDC3;ARRDC4;DCUN1D3;SMAD7;FEM1B;FBXW7;PINK1;DCUN1D1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.15885824290998068,0.4952105241870628,1.0,1.0,1.0,23/71,37.89%,FAP;PRKN;NR1D1;OTUD7B;HM13;ISG15;CAPN2;ADAMTS7;NEDD8;CTSV;CTSH;CUL4B;UBA52;VPS4A;LONP1;ADAMTS12;CTSK;CLPP;TNFAIP3;MALT1;FBXO44;VCP;DDB1
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.15323326729970713,0.4948034426984243,1.0,1.0,1.0,9/102,14.29%,MAPK11;SAA2;IRAK1;MAP3K8;LRRC14;IKBKG;IRAK2;NFKB2;MAPKAPK2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.16693249238598598,0.4946268887559133,1.0,1.0,1.0,8/49,22.39%,MNX1;BDNF;CNTNAP1;DBN1;ANKRD27;NBL1;SRGAP2;TAOK2
prerank,Elsevier_Pathway_Collection__MTHFR Activity Regulation,0.20000660732793415,0.49402648393496024,0.9824561403508771,1.0,1.0,4/19,18.64%,CCNB1;PDPK1;MTHFR;TRAF2
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.20887829823535536,0.49360186942694684,0.9938271604938271,1.0,1.0,9/17,47.11%,HM13;NPLOC4;UFD1;DERL1;SEC61B;VCP;FAF2;HSP90B1;AUP1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.20355135550701906,0.49336077001339407,0.9776536312849162,1.0,1.0,8/17,38.97%,SREBF2;ABCA2;APOE;FGF1;MBTPS2;SCAP;ABCG1;RAN
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,0.14831051337275,0.4930645195916241,1.0,1.0,1.0,62/128,45.15%,PSMD4;RNASE1;PSMB4;ELOC;HMGA1;NUP37;ELOB;NUP62;TPR;NPM1;NUP133;RANGAP1;PSMB3;SLC25A6;PSMD14;ATP6V1H;UBA52;PSMB5;NUP155;PSMD2;NUP160;PPIA;PSMA1;PSMD10;PSMC4;PSMC3;SGIP1;NUP188;SKP1;BANF1;PSMC5;SEM1;PSMB6;PSMD8;AP2A1;NUP205;PSME2;XPO1;AP2S1;PSMD13;NUP210;PSMB7;PSMA7;AP1S1;RAN;HLA-A;PSME3;PACS1;NUP214;NUP107;PSIP1;SLC25A5;PSMB2;RBX1;PSMA6;UBC;PSMD9;CDK9;RCC1;AAAS;BTRC;PSMC2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.16168781483445782,-0.49237781935564295,1.0,1.0,1.0,2/26,6.17%,CPEB1;CPEB3
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,0.15326082787249798,0.49217902282873655,1.0,1.0,1.0,9/91,14.36%,PIK3R2;DIAPH3;RACGAP1;IL32;ARHGAP39;ARAP3;NOX1;ABL2;MCAM
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.1516453739149038,0.49177060330549366,1.0,1.0,1.0,15/83,24.66%,TAC4;PFKFB4;GOLT1A;SLC25A12;PRKCA;PGP;NUP37;PFKFB2;MAP4K2;MDH2;NUP62;TPR;NUP133;PGK1;PFKP
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,0.1585767290095595,0.4916412236807064,1.0,1.0,1.0,6/66,14.29%,MAPK11;IRAK1;MAP3K8;IKBKG;IRAK2;MAPKAPK2
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,0.15771290802133525,0.4916026240787908,0.9948979591836735,1.0,1.0,26/81,37.47%,PIK3R2;INPP5J;GDPD1;PIP5K1B;SBF1;MTMR3;PI4KB;INPPL1;OCRL;PIP4K2B;RAB4A;INPP5F;RUFY1;PI4KA;PIK3R3;PNPLA6;PIK3C2B;MTMR1;PLEKHA5;PLEKHA8;VAC14;PIP5K1C;MTMR7;GDPD5;PIP4P1;INPP5E
prerank,Elsevier_Pathway_Collection__Kidney Cells Cilia Organization,0.1873119611254399,0.4914245626493705,1.0,1.0,1.0,13/26,38.69%,PKD1;DVL1;CTNNB1;NPHP4;KIFAP3;ZEB1;CEP290;LRP5;KIF3B;ACTA2;AXIN1;GSK3B;VIM
prerank,Elsevier_Pathway_Collection__Dystrophin Glycoprotein Complex Signaling in Muscular Dystrophies,-0.16340252282385098,-0.490668225954268,1.0,1.0,1.0,3/26,13.06%,CAT;FOXO1;AKT1
prerank,Elsevier_Pathway_Collection__Actin Cytoskeleton,-0.18504421376393695,-0.49022902196787194,1.0,1.0,1.0,15/15,81.51%,AKT1;CFL2;CDC42;CAPZA1;DSTN;VASP;WAS;FSCN1;WASF1;ACTN1;LIMK1;TMOD1;CFL1;GSN;LIMK2
prerank,Elsevier_Pathway_Collection__Endometrioid Ovarian Carcinoma,0.15612031433208398,0.49018958702269066,0.9952380952380953,1.0,1.0,15/76,26.12%,LEF1;CDC20;SRC;ACTL6B;SHC1;PDPK1;HRAS;EGF;SMARCA4;NRG1;ERBB3;MAP2K2;SMARCD3;MYC;CTNNB1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.1422510964631358,-0.4893378816057657,1.0,1.0,1.0,10/52,18.59%,S100A8;NKX3-1;PPIF;LCK;BCL2L11;HERPUD1;PLAUR;BCL2;PMAIP1;EIF2AK3
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,0.17630868011860817,0.4882861354835932,0.9943820224719101,1.0,1.0,10/34,31.22%,CLVS1;DNAJC6;BLOC1S1;CLTB;AP4B1;AP4M1;CLTA;HGS;ARRB1;CHMP2A
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.20028095409434696,0.4870790459028299,0.994413407821229,1.0,1.0,9/19,46.88%,GSDMD;AHCTF1;TPR;PDZD11;NUP205;NUP107;TSPAN33;BAD;NUP93
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,0.15741395161199376,0.4855703703452927,1.0,1.0,1.0,19/65,37.21%,COL7A1;LMAN2;CNIH3;CNIH2;PREB;TRAPPC9;TRAPPC5;NAPSA;SEC16B;F5;TRAPPC2L;CSNK1D;TRAPPC1;TRAPPC6A;PPP6R1;TRAPPC4;YKT6;CD59;TBC1D20
prerank,Elsevier_Pathway_Collection__TGF-beta Signaling,0.15992183241864213,0.48555988426953883,1.0,1.0,1.0,26/62,45.81%,FOXH1;CDK1;CDKN2B;SHC1;PDPK1;SMAD3;TGFB2;TSC2;MAP2K2;CDKN1A;RHEB;TGFB1;SMURF2;MAPK3;TGFBR2;TAB1;DAXX;MTOR;SMAD2;TGFB3;MAPK1;XIAP;ZFYVE9;ATF2;RPS6;SP1
prerank,Elsevier_Pathway_Collection__JNK/MAPK Signaling,0.178775562639748,0.4851911100058259,1.0,1.0,1.0,1/36,2.51%,MAPK8IP2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.14914855525215462,0.4847744723839531,1.0,1.0,1.0,29/101,33.65%,ASPSCR1;PLK1;UHRF1;AMER1;PRR16;PASK;RBM3;BCL3;NSUN5;FADD;PRKDC;ATG10;TBC1D10A;EIF3E;NPM1;CYFIP2;METTL3;EIF3D;UPF3B;FGFR4;VGLL4;AGT;POLDIP3;RPS4X;VPS11;FMR1;TGFB1;OGT;AURKAIP1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.18630338454613188,0.4836235559486011,0.9830508474576272,1.0,1.0,1/24,3.14%,THY1
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.20647745637126935,0.48332780868339764,0.9810126582278481,1.0,1.0,3/16,22.70%,SRC;PRKCA;SH2B2
prerank,MSigDB_Oncogenic_Signatures__TBK1.DN.48HRS UP,0.16485760874360966,0.482592468534634,1.0,1.0,1.0,13/49,32.27%,SOX2;CDKN2A;PSRC1;LBR;TMCO1;MLEC;PTK2;BAMBI;CHEK2;APOE;TP53BP1;PIK3C2B;CDK4
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,0.14933008692172484,0.4823479136690686,1.0,1.0,1.0,9/105,14.29%,MAPK11;SAA2;IRAK1;MAP3K8;LRRC14;IKBKG;IRAK2;NFKB2;MAPKAPK2
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,-0.12616499176209178,-0.48230960602319706,1.0,1.0,1.0,21/89,25.96%,CD4;PRKCQ;CD3E;TRAT1;HLA-DQA2;CARD11;LCK;CD247;PIK3R1;HLA-DQA1;INPP5D;HLA-DQB2;CD3D;TAB2;HLA-DRB5;HLA-DRA;HLA-DPA1;PTEN;HLA-DRB1;PSMB9;PSMF1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.186289195548934,0.48048085510567584,0.9941176470588236,1.0,1.0,11/20,47.11%,UGGT1;UFD1;DERL1;UGGT2;RNF126;DNAJC18;VCP;BAG6;STUB1;UBE2W;AUP1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.19690514762634123,0.48042074619122005,0.9861111111111112,1.0,1.0,9/18,43.50%,CYRIB;ROCK2;LLGL1;RACK1;KANK1;LLGL2;BCAS3;CDH5;KIF20B
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.14625091457686296,0.4785605081028143,1.0,1.0,1.0,36/115,40.43%,CLTCL1;RAB41;ANKRD27;SNX32;RAB9B;STX10;RGP1;TBC1D10A;AP4M1;EMP2;WASHC1;PTPN23;WDR81;VPS54;STX6;TRIM27;SNF8;WASHC2A;DENND5A;UBE2O;CORO7;RBSN;TBC1D17;RHOBTB3;MAGEL2;YKT6;RNF126;RAB6B;SORT1;AP2A1;WASHC2C;RAB29;KIF16B;GGA1;ARFRP1;VPS26B
prerank,Elsevier_Pathway_Collection__Myocardial Infarction,0.15520948500078507,0.4776540183907543,1.0,1.0,1.0,12/74,20.87%,BIRC5;IRAK1;CASP12;TIMP1;IKBKG;CACNA1C;CTSA;PDPK1;TRAF2;MMP9;MMP3;FADD
prerank,Elsevier_Pathway_Collection__Preconditioning Ischemia,0.16796890860931019,0.47691796033659956,0.9943820224719101,1.0,1.0,7/35,22.70%,ADORA1;CACNA1C;ACLY;PDPK1;ACACA;TSC1;TSC2
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.135008610763586,0.4767090707982946,1.0,1.0,1.0,129/264,46.98%,HAVCR1;GPC3;IRAK1;IKBKG;ST6GALNAC4;IRAK2;PDPK1;SNRPE;GPC2;ST3GAL3;MAVS;IRF3;NUP37;HSPG2;VPS45;ZDHHC11;ISG15;VPS33A;RNF135;PARP10;RPS27;RPS21;NUP62;KPNA2;TPR;NUP133;GJA1;RPS5;ZDHHC9;TRIM25;LARP1;HSP90AB1;SNRPD2;RPS14;RPSA;VPS16;UBA52;SNRPB;GEMIN8;ST3GAL2;RPS15;NUP155;RPS2;MASP2;NUP160;RPS19;HLA-F;ST3GAL1;MGAT4B;UBE2I;GEMIN7;CHMP2A;RPS4X;VPS11;MGAT4A;RPS20;IKBKE;NRP1;AGRN;NUP188;G3BP1;TUFM;REXO2;SNRPD3;MGAT5;RPS8;RPS12;TRAF3;YWHAH;TJP1;RPS3A;RPN2;RPS7;ZDHHC8;RPS11;DAD1;NUP205;UBE2V1;FAU;VCP;RPS3;TAB1;GSK3B;RPS24;NUP210;MGAT4C;DDX20;DDOST;HSP90AA1;GEMIN4;HLA-A;NOD1;RPS16;NUP214;SDC2;SNRPG;RPS28;ST3GAL4;NUP107;MAN1B1;ST6GALNAC2;RPS23;HLA-B;HLA-G;UBC;TYK2;VPS18;IRF7;RPS9;IFNAR2;GEMIN5;RPS15A;AAAS;VPS33B;DDX5;YWHAZ;GEMIN6;PRMT1;TRIM4;GSK3A;RPS6;VPS39;CSNK1A1;RPS27A;CHMP4C;MAN2A1;RPS4Y1;NUP93;RPS13
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.17434401727222595,-0.4755049850110045,1.0,1.0,1.0,14/15,60.65%,SLC25A24;LRRC8C;SLC25A42;ABCC4;SLC25A17;LRRC8A;ABCC6;SLC35B2;SLC25A4;SLC25A41;LRRC8D;SLC17A9;SLC19A1;LRRC8E
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.17004395217271173,0.4752314268585854,1.0,1.0,1.0,17/41,42.12%,FOXF2;QRICH2;UBQLN4;CCDC22;PTK2;SMURF1;HIPK2;GLMN;RPS7;GNA12;AXIN1;XPO1;TAF1;RPL23;RPL5;CDK5RAP3;PDCL3
prerank,Elsevier_Pathway_Collection__Insulin Influence on Protein Synthesis,-0.14653381549588368,-0.47442645859561977,1.0,1.0,1.0,31/31,85.37%,MAP2K1;FOXO1;AKT1;IGF1;IRS2;PTEN;EIF4EBP1;EIF4E;GRB2;SOS1;RPS6KB1;RAF1;EIF2S1;EIF2S2;INSR;RPS6;EIF2S3;IDE;EIF2B5;MTOR;GSK3B;MAPK3;RPTOR;IRS1;RHEB;MYC;MAP2K2;TSC2;TSC1;PDPK1;SHC1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.18469898708957083,0.4741021388293534,0.994413407821229,1.0,1.0,9/26,30.42%,CHST6;B4GALT3;ST3GAL3;OGN;CHST1;B4GAT1;ACAN;ST3GAL2;ST3GAL1
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,0.18469898708957083,0.4741021388293534,0.994413407821229,1.0,1.0,9/26,30.42%,CHST6;B4GALT3;ST3GAL3;OGN;CHST1;B4GAT1;ACAN;ST3GAL2;ST3GAL1
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.17742307692307652,0.4740026957502719,0.9883040935672515,1.0,1.0,25/25,82.27%,LAPTM4B;LYST;CHMP2A;MVB12A;SORT1;VCP;DENND10;TMEM50A;CHMP4C;RILP;TMEM50B;CHMP4B;LEPROT;CHMP1B;CHMP6;UBXN6;CHMP1A;CHMP5;CHMP3;CHMP7;LEPROTL1;VPS4B;CHMP4A;CHMP2B;VTA1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.18174743522827863,0.47395442466219956,0.9940476190476191,1.0,1.0,2/25,13.32%,SDF2L1;HSPA2
prerank,Elsevier_Pathway_Collection__Apoptosis,0.15312375883820678,0.47380178545029666,1.0,1.0,1.0,12/76,23.37%,EDARADD;TP53AIP1;BIRC5;BIK;TNFRSF10D;TNFRSF25;TRAF2;BBC3;FADD;PARP1;AIFM1;GSN
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.12077871104078831,-0.47335902182350503,1.0,1.0,1.0,81/82,82.88%,EIF4E3;OASL;HERC5;MX2;USP18;RNASE7;UBE2E1;UBE2L6;OAS3;OAS2;IFIT1;STAT1;EIF4A1;OAS1;KPNA1;KPNA5;NUP58;JAK1;EIF4E;UBB;EIF4E2;UBA7;NUP98;POM121;EIF4A2;RANBP2;NUP50;EIF2AK2;NUP35;NDC1;PDE12;KPNA3;EIF4G2;EIF4G1;NUP54;KPNB1;UBE2N;KPNA4;NUP85;NUP43;NUP153;NUP42;POM121C;SEH1L;ABCE1;SEC13;NUP88;EIF4G3;NUP93;RPS27A;EIF4A3;AAAS;PPM1B;GNL3;UBC;MX1;NUP107;NUP214;ARIH1;FLNA;NUP210;MAPK3;NUP205;NUP188;SGIP1;NUP160;NUP155;UBA52;FLNB;TRIM25;NUP133;TPR;PDZD2;KPNA2;NUP62;PLCG1;ISG15;NUP37;IRF3;NEDD4;RNASEL
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.1489974913885098,0.4732936330857753,1.0,1.0,1.0,24/76,38.14%,HDAC4;RASD2;SPHK1;FANCI;AMER1;PIAS3;PIAS1;SPRTN;PHF23;CENPS;PIAS4;PSMD10;SEPTIN4;DERL1;ANGPT1;HSPBP1;PAXIP1;CENPX;SAE1;UBA2;MALT1;WFS1;AXIN1;FKBP1A
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.1413235859946133,-0.4727362968502524,1.0,1.0,1.0,35/35,85.89%,ANK3;RAB26;NECTIN3;RILPL2;AMN;RAB31;RAB7A;GOLGA7;OPTN;GCC2;GORASP1;AFDN;GOLGA4;GOLPH3;VAMP2;RAB10;SYS1;KIF13A;MACF1;PREPL;GGA3;GORASP2;SPTBN1;BBS1;NSF;BLZF1;ARFRP1;GGA1;GGA2;GOLPH3L;VAMP4;RILPL1;VAMP5;BBS2;RAB34
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.19124484477371845,0.47268305813647704,0.9940476190476191,1.0,1.0,13/21,45.08%,PPM1F;RHBDF2;HMGCR;CYP51A1;APOE;DRD4;PKDCC;IL12A;SNX12;SERGEF;WWP2;RHBDF1;DPH3
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.1884569822769418,0.47170117987254667,1.0,1.0,1.0,8/22,37.99%,ADAM9;HM13;BACE2;NCSTN;RBMX;MYH9;PSEN2;APH1A
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.11561950571733497,-0.4715606889972691,1.0,1.0,1.0,20/105,24.09%,TKFC;NLRP12;NLRP3;SEC24B;TLR8;MBL2;TLR2;SFTPD;IL17RC;RNASE7;PIK3R4;SEC24D;NOD2;TAB2;MASP1;STAT1;IFIH1;SEC24A;SEC23A;TLR1
prerank,Elsevier_Pathway_Collection__Apoptosis Block by Inhibitor of Apoptosis Proteins (IAPs) in Cancer,0.18850053097597597,0.47008190136347894,0.9941520467836257,1.0,1.0,1/19,6.65%,BIRC5
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.20174865965738084,0.46976719333661976,0.9939759036144579,1.0,1.0,7/15,39.42%,CDC6;TSPYL2;GMNN;GTPBP4;CDAN1;TERF1;ATR
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.15903074497394315,0.4683863484036735,1.0,1.0,1.0,29/53,49.36%,SHC1;SQSTM1;PLCG1;TPR;NPM1;ATIC;MECP2;HIP1;WDCP;CUL1;IRS1;TPM3;MYH9;SKP1;MAPK3;EML4;RNF213;FRS3;VCL;RBX1;MAPK1;PPM1B;MSN;RPS6;ZC3HC1;STAT5A;KLC1;PRKAR1A;FN1
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,0.1875017887823598,0.4682686755951126,0.9875,1.0,1.0,3/23,16.57%,PDE4C;PRKCA;PPP1R1B
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.13575371281984427,0.4682399970384223,1.0,1.0,1.0,53/165,40.78%,CASP12;PRKN;SIL1;SSR2;BCAP31;HSPA2;LMAN2;CRYAA2;SSR4;CKAP4;UGGT1;TRAF2;UBQLN4;PREB;EDEM3;SEC61G;NPLOC4;CAPN2;DNAJC5;HSP90AB1;ATF6;SEC31B;UFD1;DDIT3;ERO1B;UBE4B;DNAJB11;HSPA5;CUL1;DNAJB2;DERL1;CRYAB;UGGT2;SKP1;HSPBP1;NSFL1C;BAX;RPN2;HSPA8;DAD1;UBE2D2;MAPK9;SEC61B;WFS1;VCP;MBTPS2;DERL3;DDOST;HSP90AA1;UBE2J2;HSPA1L;HYOU1;HSPH1
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.19254806582504713,0.4678221456109532,0.9938650306748467,1.0,1.0,7/18,33.94%,ADCY6;PRKCA;ADCY4;ADCY2;PRKAR2A;ADCY8;ADCY9
prerank,Elsevier_Pathway_Collection__CagA Phosphorylation Dependent Signaling,-0.13283797984451323,-0.46732950577075877,1.0,1.0,1.0,12/39,30.96%,FOS;MAP2K1;HBEGF;BCL2;IQGAP1;JUN;KRAS;CLIP1;EGFR;CRK;ITGA5;CDC42
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.185204306514009,0.4661427822989795,0.9883040935672515,1.0,1.0,14/24,47.37%,HRAS;FANCD2;HSF1;MYC;TMEM109;YAP1;CRYAB;XRCC6;ATR;KDM1A;WRN;RPL26;MEN1;MDM2
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.17327760563516853,0.4660619308102693,1.0,1.0,1.0,4/26,20.33%,IKBKG;SHARPIN;OTUD7B;RNF31
prerank,MSigDB_Oncogenic_Signatures__SIRNA EIF4GI UP,0.14528210830071808,0.4653392459960354,1.0,1.0,1.0,3/84,4.00%,TNNT1;SAA1;NQO1
prerank,Elsevier_Pathway_Collection__Proliferative Diabetic Retinopathy,0.1541154357581525,0.46531622337298906,1.0,1.0,1.0,14/60,29.23%,RASGRF1;SRC;FLT1;PLAU;CMA1;PDPK1;PLCG1;PLAT;MAP2K2;PTK2;MYC;CTNNB1;CTSG;AGT
prerank,Elsevier_Pathway_Collection__NO Synthesis in Early Vasospasm,0.2043454956545887,0.46498672101450805,1.0,1.0,1.0,6/15,38.49%,PDPK1;RPS2;HRH1;PRMT3;PABPN1;DDAH2
prerank,Reactome_2022__PKA Activation R-HSA-163615,0.19598425603183336,0.46350384443777226,0.98125,1.0,1.0,7/16,33.94%,ADCY6;PRKCA;ADCY4;ADCY2;PRKAR2A;ADCY8;ADCY9
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.17286106607899676,0.46234783881234043,1.0,1.0,1.0,9/40,33.19%,PRKN;SQSTM1;WDR45;FUNDC2;RB1CC1;FIS1;ULK1;CTSK;GABARAP
prerank,WikiPathway_2021_Human__Fas ligand pathway and stress induction of heat shock proteins WP314,-0.13733561558431176,-0.46167116741268144,1.0,1.0,1.0,9/41,24.85%,TNF;FASLG;CASP6;CASP7;BCL2;JUN;MAP2K4;DFFB;ARHGDIB
prerank,WikiPathway_2021_Human__3q29 copy number variation syndrome WP4906,0.15076968601972465,0.46005616726491316,1.0,1.0,1.0,17/58,35.98%,BRINP1;TCTEX1D2;MELTF;PIGZ;DYNLRB2;PIGM;NF2;TM4SF19;DYNLL1;MYC;DYNLRB1;CEP350;WDR53;PIK3R3;TGFB1;DYNC2LI1;ZNF76
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.15233063276048758,0.45993309503614416,1.0,1.0,1.0,13/66,28.07%,SAA2;IKBKG;NFKB2;MAVS;IRF3;FADD;ISG15;RNF135;PDZD2;TRIM25;HSP90AB1;RNF216;UBA52
prerank,"WikiPathway_2021_Human__4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",-0.169121944519406,-0.4595062405599242,1.0,1.0,1.0,6/18,25.40%,MAP2K1;AKT1;MAP2K3;MAP2K6;MAP3K5;EIF4EBP1
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,0.1469032508927653,0.45837538848575654,1.0,1.0,1.0,38/99,39.37%,ABCA3;PSMD4;ABCD1;PSMB4;ABCA7;ABCC5;KCNJ11;ABCB6;ABCB8;ABCA4;ABCA2;ABCA12;PSMB3;ABCB9;ABCC10;PSMD14;UBA52;ABCC2;PSMB5;PSMD2;PSMA1;PSMD10;PSMC4;PSMC3;DERL1;ABCC1;PSMC5;SEM1;PSMB6;PSMD8;PSME2;VCP;DERL3;PSMD13;PSMB7;PSMA7;ABCG1;PSME3
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.15993686984086317,0.45727326138217766,1.0,1.0,1.0,8/35,27.00%,ROBO1;GJA5;DAND5;TGFBR3;HEY1;TGFB2;MATR3;HEYL
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.14659639025849583,0.45625218304874016,1.0,1.0,1.0,1/63,1.03%,COL7A1
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.14659639025849583,0.45625218304874016,1.0,1.0,1.0,1/63,1.03%,COL7A1
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.14659639025849583,0.45625218304874016,1.0,1.0,1.0,1/63,1.03%,COL7A1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.18711519919054015,0.4545476173988785,0.9940119760479041,1.0,1.0,8/19,47.28%,MCTS1;EIF2D;EIF3D;RBM4;EIF3M;EIF2S3;DHX29;EIF3A
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.1556103185880283,0.4540617402119532,0.9946808510638298,1.0,1.0,20/49,38.70%,DPM3;MGAT5B;B4GALT3;MAN2A2;ALG3;SRD5A3;DOLK;ALG1;MGAT4B;MGAT4A;MGAT3;DPM2;MGAT5;ALG6;RPN2;ALG13;DAD1;ALG8;MGAT4C;DDOST
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,0.18191058352647355,0.4537315220157854,0.9823529411764705,1.0,1.0,10/21,47.23%,RNASE1;NF2;PKN1;MYH9;MYL6;FLNA;LIMK1;CTTN;MYL12B;MYL9
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.12810043698756324,-0.4493395523506446,1.0,1.0,1.0,15/41,29.33%,F9;PROZ;F7;STS;TPST2;ARSJ;FN3K;ARSD;EIF5AL1;PROS1;ICMT;TPST1;GGCX;F8;PROC
prerank,WikiPathway_2021_Human__CAMKK2  Pathway WP4874,-0.13176122449130484,-0.4483873423086299,0.9871794871794872,1.0,1.0,7/34,22.05%,CAMK4;MAF;VCAM1;HMOX1;CHRM3;NFATC2;MAP1LC3A
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.1886875803988865,0.44757472889898553,1.0,1.0,1.0,7/15,37.60%,ABCD1;COX7A1;SLC25A33;NUPR1;UQCC2;MLXIPL;VCP
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.1327232189010855,0.44651181535341106,1.0,1.0,1.0,32/121,32.38%,GOLGA7B;LTBP2;TIMM17B;BCAP31;ZDHHC11B;VPS37D;TIMM17A;ZDHHC11;TOMM20;YIF1B;TAOK2;TIMM10;SEC61G;AP4B1;ZDHHC1;AP4M1;TOMM5;HOMER3;ZDHHC9;SLC25A6;ZFAND2B;RABGEF1;FIS1;KATNB1;TSPO;TOMM40;TIMM13;CDC37;TIMM9;HPS4;SDCBP;PEX6
prerank,KEGG_2021_Human__Basal transcription factors,0.15191629271762833,0.4451440562339751,1.0,1.0,1.0,23/41,50.35%,GTF2IRD1;TAF10;TAF6;GTF2I;TAF8;TAF9;GTF2H2C;TAF5L;TAF1;ERCC2;GTF2F1;TAF12;ERCC3;TAF5;TAF9B;TAF2;TAF6L;GTF2E1;GTF2H2;GTF2H5;TAF7;GTF2A2;TAF4
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.14575801861395277,-0.4416319903550672,1.0,1.0,1.0,23/23,85.44%,PLEK;VAV1;VAV3;EZR;PTEN;RDX;EDN1;MTPN;SLC9A3R1;VAV2;DEPTOR;RAC1;RHOA;MSN;MTOR;RARG;AKT1S1;RPTOR;LAMTOR5;LARS1;RAP1GAP2;LAMTOR4;PRR16
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.1763158429459641,0.44072862160273013,1.0,1.0,1.0,6/21,31.74%,AURKA;CEP131;MARK4;NPM1;CHMP2A;FBXW5
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.13042599121507856,0.44033289570382644,1.0,1.0,1.0,32/116,35.04%,GLIPR1;CYP7A1;NR1D1;CD36;SREBF2;PPARG;ANKRD1;PKMYT1;DAND5;HMGCR;PPARGC1B;TXNRD1;FDFT1;HMGCS1;ARNT2;MED12;LIN9;SMARCD3;MED22;NCOR2;SIN3B;MED31;MED7;MED27;NPAS2;RXRB;MED9;MED25;MED11;TBL1X;MED19;NCOA2
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.14579482439926045,0.43895988586367746,1.0,1.0,1.0,57/57,85.45%,FAP;PRKN;VLDLR;TCIRG1;PCSK9;CAPN2;ADAMTS7;CTSV;CTSH;CHEK2;CLTA;LONP1;DAB2IP;ADAMTS12;CTSK;CLPP;MALT1;AP2A1;AP2S1;IDE;PSMA6;MDM2;HTRA2;AP2B1;CTSF;CTSL;RIPK1;CLTC;RNF123;AP2M1;AP2A2;UBE2G2;BNIP3;YME1L1;PISD;CASP8;DENND3;RAB7A;RSPRY1;CLPX;UBE2G1;BNIP3L;RNF5;RAB12;SIAH2;CTSS;AFG1L;MYLIP;CTSO;GZMB;LGMN;CTSC;CTSZ;CTSB;CTSW;GZMA;SPATA18
prerank,Elsevier_Pathway_Collection__ER Stress in Huntington Disease,-0.14820156977296356,-0.43826130940102137,1.0,1.0,1.0,6/23,22.93%,FOXO1;BCL2;EIF2AK3;XBP1;MAP3K5;ATG5
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.12111481970644625,0.43669427377397046,1.0,1.0,1.0,87/316,35.78%,SYNDIG1;SGSM1;RTN2;MMP12;VPS28;ARL4A;LTBP2;TBC1D16;SIL1;IPO4;GPIHBP1;RAB41;CTSA;TMED3;ARHGEF2;TMED6;PKD1;SNX27;SGSM2;RAB24;STXBP1;PREB;TBC1D8;VPS45;STX1A;STX10;TBC1D25;VPS33A;TSC2;NUP62;AP4B1;STX4;TBC1D10A;AP4M1;TPR;TMED9;NPM1;NUP133;IPO9;IFT27;EIF2D;FAM53B;HOMER3;TBC1D13;STX1B;ARF1;ABCA12;RANBP3L;STRADA;CLIP3;TBCK;XPO5;SGSM3;SEC31B;CCHCR1;TBC1D9B;SMURF1;AP3D1;KATNB1;COPA;STX6;NUP155;SNF8;RAB43;RAB3GAP2;CDC37;IPO13;HPS4;EIF4ENIF1;TSNARE1;TBC1D17;NUP188;TGFB1;XPO6;NXT1;GABARAP;BCS1L;AP3B1;ARL17A;BAG3;RAB6B;E2F3;GIPC1;CAMSAP3;SLU7;OXA1L;YWHAH
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,0.13542121538473947,0.43462488728683357,1.0,1.0,1.0,18/74,33.01%,KPNA7;NEDD4;IRF3;NUP37;ISG15;PLCG1;NUP62;KPNA2;PDZD2;TPR;NUP133;TRIM25;FLNB;UBA52;NUP155;NUP160;SGIP1;NUP188
prerank,Elsevier_Pathway_Collection__PI3K/AKT/MTOR Signaling Activation by Blocking of Tumor Suppressors,0.1694131704784457,0.4325640241385356,0.9945652173913043,1.0,1.0,14/25,47.37%,PDPK1;NEDD4;TSC1;TSC2;CTNNB1;RHEB;CASP9;BAX;GSK3B;MTOR;STK11;BMI1;BAD;MDM2
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.1375898428795274,0.4321371821052789,1.0,1.0,1.0,1/70,1.03%,COL7A1
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,0.1364539879781139,0.43163769063877233,1.0,1.0,1.0,36/102,39.37%,S100A1;PSMD4;IKBKG;CD36;PSMB4;SEC61G;NDUFA2;LNPEP;STX4;CTSV;PSMB3;PSMD14;UBA52;PSMB5;PSMD2;PSMA1;HLA-F;PSMD10;S100A9;ITGAV;PSMC4;PSMC3;ITGB5;MRC1;PSMC5;SEM1;PSMB6;PSMD8;TIRAP;SEC61B;PSME2;PSMD13;PSMB7;PSMA7;HLA-A;PSME3
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.1529621092478557,0.4313420732867415,1.0,1.0,1.0,17/43,39.07%,BMP4;HABP4;HRAS;HEATR1;DXO;MAP2K2;MYCN;TRMT112;TGFB1;ZPR1;UTP15;RBM22;SIRT7;BUD23;WDR75;POLR2A;RIOK2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.13789901844444638,0.4308579134535886,1.0,1.0,1.0,28/72,44.40%,KPNA7;MMP12;IPO4;TSC2;NUP62;KPNA2;TPR;NUP133;IPO9;FAM53B;NUP155;IPO13;EIF4ENIF1;NUP188;NXT1;E2F3;NUTF2;HIKESHI;FAM53A;RPL23;RAN;IPO11;NUP214;RANBP17;NUP107;FAM53C;NXT2;TNPO2
prerank,Elsevier_Pathway_Collection__TGFB Signaling activation by Blocking of Tumor Suppressors,0.13807203098757317,0.42895945210099806,1.0,1.0,1.0,24/72,40.67%,FOXH1;CDK1;CDKN2B;SHC1;PDPK1;SMAD3;TGFB2;TSC2;MAP2K2;MYC;CDKN1A;ZBTB17;RHEB;CDK4;TGFB1;SMURF2;MAPK3;TGFBR2;TAB1;GSK3B;DAXX;MTOR;SMAD2;TGFB3
prerank,WikiPathway_2021_Human__TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.17883224342165555,0.42818104126672357,0.9939024390243902,1.0,1.0,4/16,25.34%,ACLY;FH;CS;DLAT
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.15198741469982863,-0.42754818385393994,1.0,1.0,1.0,6/20,25.12%,NGFR;BCL2;TNFRSF21;APP;SIAH1;LIG4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.12303615699809597,0.4273849203654645,1.0,1.0,1.0,59/163,38.82%,NR5A1;E2F2;NR6A1;NOTCH3;NR1D1;TEAD2;TEAD4;PPARG;HDAC5;THRA;POLR2L;NAT14;NOTCH4;HDAC10;POLRMT;POLR1A;HDAC1;MAZ;NR2C2AP;POLR2K;ESR2;NR2C2;TAF10;TAF1A;POLR2G;POLR1H;MAML1;NCOR2;TEAD3;TFB2M;MED7;POLR1G;MED27;RXRG;TAF6;YAP1;POLR2H;POLR3H;TEAD1;RXRB;NR2F1;POLR2I;POLR2J;TBL1X;NRBP1;E2F3;NPPA;TAF8;RARG;NR2F6;NCOA6;TAF9;CAVIN1;MAPK3;HDAC7;POLR2A;TAF1;ERCC2;TAF1D
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.12654905565466476,0.42719809862365205,1.0,1.0,1.0,31/114,35.04%,GLIPR1;CYP7A1;NR1D1;CD36;SREBF2;PPARG;ANKRD1;PKMYT1;DAND5;HMGCR;PPARGC1B;TXNRD1;FDFT1;HMGCS1;ARNT2;MED12;LIN9;SMARCD3;MED22;NCOR2;MED31;MED7;MED27;NPAS2;RXRB;MED9;MED25;MED11;TBL1X;MED19;NCOA2
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.15212259447481424,0.42709061964143524,1.0,1.0,1.0,10/34,38.22%,RNASE1;NCKIPSD;WASF2;ARPC1A;CYFIP2;PTK2;ARPC5;ABL1;MAPK3;WIPF3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.16352548954992063,0.42680411993638817,0.9887640449438202,1.0,1.0,17/30,48.18%,RAB34;BBS2;VAMP5;VAMP4;GOLPH3L;GGA2;GGA1;ARFRP1;BLZF1;KRT18;NSF;SEC16A;BBS1;SPTBN1;GGA3;PREPL;MACF1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.1756843466818377,0.4262599042382315,1.0,1.0,1.0,4/19,21.26%,RGCC;PPM1F;NOTCH4;PTPRU
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.11780611312082134,0.4251673677575617,1.0,1.0,1.0,118/345,39.17%,HAVCR1;GPC3;FXYD7;IRAK1;ATP1A2;ATP1A4;ATP1B3;IKBKG;ST6GALNAC4;IRAK2;IL6R;PDPK1;SNRPE;FXYD2;GPC2;ROCK2;ST3GAL3;MAVS;IRF3;NUP37;HSPG2;VPS45;ZDHHC11;ISG15;VPS33A;RNF135;FNTA;HDAC1;IMPDH2;PARP10;RPS27;RPS21;NUP62;SAP30L;GATAD2B;KPNA2;TPR;NUP133;GJA1;RPS5;ZDHHC9;TRIM25;LARP1;HSP90AB1;SNRPD2;RPS14;RPSA;VPS16;UBA52;SNRPB;GEMIN8;ST3GAL2;RPS15;PHF21A;CHD3;CHD4;NUP155;RPS2;MASP2;NUP160;RPS19;HLA-F;ST3GAL1;MGAT4B;UBE2I;GEMIN7;KEAP1;RBBP7;CHMP2A;RPS4X;VPS11;MGAT4A;RPS20;IKBKE;NRP1;AGRN;JAK3;IL1R1;ATP1B1;NUP188;G3BP1;TUFM;REXO2;SNRPD3;MGAT5;RPS8;RPS12;MTA3;TRAF3;YWHAH;TJP1;RPS3A;RPN2;RPS7;ARID4B;ZDHHC8;AP2A1;RPS11;DAD1;NUP205;UBE2V1;FAU;VCP;RPS3;TAB1;GSK3B;RPS24;FKBP1A;AP2S1;NUP210;MGAT4C;SAP30;PDCD1;DDX20;DDOST;HSP90AA1;GEMIN4;HLA-A
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,0.16604869569912264,0.42341576484186877,0.9940476190476191,1.0,1.0,11/24,41.94%,HSPA2;HSF1;HSP90AB1;CRYBA4;HSPA8;SERPINH1;HSP90AA1;DNAJB6;HSPA1L;HSPH1;COL4A6
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.16030357017479444,0.42148191552789277,1.0,1.0,1.0,10/25,38.20%,DNAJC6;CLTB;FNBP1L;INPP5F;GPR107;CLTA;SGIP1;PIP5K1C;AP2A1;AP2S1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.12317285230319289,-0.42094059926262484,1.0,1.0,1.0,2/39,6.81%,ENTPD8;DNASE1L3
prerank,Elsevier_Pathway_Collection__Tamoxifen Induced Endometrial Cancer,-0.16061482034969818,-0.42043158007186143,0.9846153846153847,1.0,1.0,2/16,13.06%,ESR1;AKT1
prerank,Elsevier_Pathway_Collection__Glucocorticoids in Insulin Resistance in Skeletal Muscles,0.14874202721205088,0.420123015637924,1.0,1.0,1.0,13/34,38.05%,SLC2A4;ACLY;TSC1;TSC2;RHEB;DDIT4L;FASN;IRS1;MLST8;SGK1;NCOA2;DDIT4;GSK3B
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.15624785682892336,0.4167797096179662,1.0,1.0,1.0,6/30,31.22%,VPS28;VPS37D;HGS;VPS4A;SNF8;CHMP2A
prerank,WikiPathway_2021_Human__Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.17461990107844402,0.4159049032580904,1.0,1.0,1.0,7/18,43.44%,HRAS;MRAS;HGS;RRAS;MAPK3;RAB5C;MAPK1
prerank,Elsevier_Pathway_Collection__NOTCH -> TCF3 Signaling,-0.14570258441430115,-0.4152795680962502,1.0,1.0,1.0,5/21,23.65%,MAP2K1;NOTCH2;MAP2K3;MAP2K6;MAP2K4
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.1347834837812342,0.41372370919009477,1.0,1.0,1.0,39/73,49.97%,MMP12;IPO4;CD68;TSPAN10;TSC2;NUP62;TPR;NUP133;IPO9;FAM53B;TSPAN17;NUP155;IPO13;EIF4ENIF1;NUP188;NXT1;E2F3;NUTF2;HIKESHI;FAM53A;RAN;IPO11;NUP214;RANBP17;NUP107;FAM53C;NXT2;PEX19;TNPO2;LAMP2;PPP1R10;NUP93;TNPO3;LRSAM1;NUP88;SEC13;IPO7;NEURL1B;POM121C
prerank,Elsevier_Pathway_Collection__Apoptosis of Mantle Cell Deregulation,0.17822610091431357,0.41200764015853353,1.0,1.0,1.0,1/17,6.65%,BIRC5
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,0.17560371321685225,0.4107456996290822,1.0,1.0,1.0,2/17,14.29%,EXOSC4;MAPKAPK2
prerank,Elsevier_Pathway_Collection__SERPINA1 Associated Liver Damage,0.16139126170921878,0.40993600567860106,1.0,1.0,1.0,8/25,34.58%,CASP12;TRAF2;BBC3;ATF6;DDIT3;HSPA5;CASP9;BAX
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.14922701005226724,0.40885315297311486,1.0,1.0,1.0,9/39,28.37%,EZH2;CTCFL;EHMT2;NSD1;EEF2KMT;PRMT7;NTMT1;TRMT112;SNRPB
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.15508396118175857,-0.40868721172966416,1.0,1.0,1.0,3/16,20.62%,LRRK2;PPP1R15A;ANK2
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.12043636719263645,0.4080694368474487,1.0,1.0,1.0,38/191,31.36%,SPTSSB;GOLGA6D;SYNGR1;LAPTM4B;A4GALT;FER1L6;PRKD1;TLCD1;SPAG4;LMAN2;SYP;ATP8B3;SQSTM1;TMED3;TMED6;GOLGA8M;OBSL1;PLEKHF1;GOLGA8A;TOR1AIP2;TMCC1;SEC16B;NPLOC4;CUL7;TMED9;COG2;TANGO2;WASHC5;TJAP1;SEC31B;MYOF;AP3D1;NUP155;VPS4A;RAB43;PLEKHM2;CSNK1D;VPS11
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.11558198098772923,-0.4077017903008472,1.0,1.0,1.0,1/70,0.61%,ESRP1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.1270458056304652,0.40749196912137015,1.0,1.0,1.0,13/87,21.74%,GDF5;SRC;FOXH1;LTBP2;GDF15;COL1A2;SMAD3;ADAM9;CLDN5;ACVRL1;TGFBR3;TGFB2;FNTA
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.12652834304738916,0.40643815108559345,1.0,1.0,1.0,94/95,83.71%,TSPAN8;SCAMP3;GLA;VPS45;COPE;OCRL;COG2;ARF1;ATP6V1H;CLTA;KIF1B;VAMP4;AP3B1;CD63;RPS6KA3;YKT6;DNM1L;AP2S1;ERGIC3;RER1;KRT18;MAPK1;GBF1;LAMP2;ATP7A;ANP32E;TSG101;ATP1A1;AP3S1;AP2B1;GOSR2;SCAMP1;VAMP7;ARFGEF1;SNAP23;YIPF6;ARFGEF2;TPD52;SEC31A;CLTC;DST;STAM;ADAM10;CLCN3;AP2M1;RAB22A;RAB2A;GNAS;NAPA;GOLGA4;VAMP3;SNX2;COPB2;RAB9A;ARFGAP3;ARFIP1;COPB1;SOD1;STX16;STX12;ZW10;IGF2R;MON2;PPT1;BNIP3;RAB5A;NAPG;TMED2;CLN5;M6PR;EGFR;TOM1L1;PAM;ARCN1;AP1G1;ABCA1;USO1;STX7;VPS4B;BET1;SCRN1;SGMS1;SH3GL2;TMED10;TMX1;ICA1;SSPN;RAB14;DOP1A;CTSC;SEC24D;CAV2;SEC22B;LMAN1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.12770877703492564,0.4024631400167445,1.0,1.0,1.0,41/86,46.88%,MMP12;IPO4;GPIHBP1;ABCD1;SAMM50;TSC2;NUP62;TPR;NUP133;IPO9;FAM53B;PEX11B;FIS1;HSPA4;NUP155;APOE;IPO13;EIF4ENIF1;NUP188;NXT1;E2F3;NUTF2;HIKESHI;FAM53A;HSP90AA1;RAN;IPO11;PEX16;NUP214;RANBP17;NUP107;FAM53C;NXT2;PEX19;TNPO2;LAMP2;PXMP4;PPP1R10;PEX2;TOMM22;NUP93
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.16731244820541752,0.4006067275782892,1.0,1.0,1.0,7/22,32.55%,NR5A1;ABCA2;ARV1;APOE;DGKQ;ACADVL;STAR
prerank,WikiPathway_2021_Human__Energy Metabolism WP1541,0.14106344379989033,0.40019876526928483,1.0,1.0,1.0,9/45,31.29%,PRKAA2;PPARG;MEF2D;PPARGC1B;HDAC1;PRKAB2;TFB2M;UCP3;PPRC1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.13217259192899608,0.3995134266255144,1.0,1.0,1.0,20/64,40.31%,TBC1D16;PPP1R16B;PODXL;GAP43;TWF2;TBC1D8;TBC1D10A;TBC1D13;SGSM3;TBC1D9B;FMR1;TBC1D17;DYNC2LI1;CDKL5;P2RX4;TBC1D20;SDCCAG8;IFT140;TBC1D14;FXR2
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.13520335642418319,0.39821463893406756,1.0,1.0,1.0,11/51,29.86%,RAB11FIP4;CCDC93;ANKRD27;SNX27;EHD2;CCDC22;WASHC1;RAB13;PTPN23;STX6;SNF8
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.15367636029669088,0.3946445265538516,1.0,1.0,1.0,9/21,41.72%,LAPTM4B;MTMR3;ANXA2;NPRL3;ENO1;ELAPOR1;NPRL2;TBC1D14;TBC1D12
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,0.16489646889347626,0.3874037425660142,1.0,1.0,1.0,5/15,37.85%,IRAK2;NDUFA2;UBA52;TICAM1;TAB1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.11757385183802725,0.38324969200224307,1.0,1.0,1.0,40/85,48.13%,BRSK2;PRKN;FOXRED2;ANKZF1;UGGT1;NPLOC4;TRIM25;UFD1;UBE4B;HSPA5;DNAJB2;DERL1;UGGT2;DNAJC18;SEC61B;FAM8A1;WFS1;FBXO44;VCP;DERL3;RHBDD2;BAG6;UBE2J2;USP13;MAN1B1;FBXO6;FAF2;STUB1;ECPAS;USP19;HSP90B1;ERLEC1;SGTA;JKAMP;TMEM67;AUP1;RCN3;UBQLN2;STT3B;DNAJC10
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.13557103814619548,0.38186188555118,1.0,1.0,1.0,46/46,86.47%,CEP55;SPAG4;TPR;NUP133;NUP155;VPS4A;RPS19;CHMP2A;NUP205;DMPK;LEMD2;NUMA1;WDR73;CTDNEP1;CHMP4C;NUP93;USP36;SEH1L;CHMP4B;NUP54;SUN1;CHMP1B;CHMP6;PITPNB;NDC1;CHMP1A;NUP35;CHMP5;PDCD6IP;REEP4;NUP98;CHMP3;TOR1A;LEMD3;CHMP7;SUN2;REEP3;BIN1;ATXN7;VPS4B;CHMP4A;TMEM170A;IRAG2;CHMP2B;SYNE1;SUN3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.12218509129623037,0.3772178614558664,1.0,1.0,1.0,34/76,43.26%,PLK1;TRIB2;NKD2;PRKN;DET1;ELOB;PIAS1;CCDC22;COP1;SH3RF2;DVL1;PTK2;SMURF1;RACK1;DDRGK1;SOCS5;PSMD10;KEAP1;CSNK1D;DNAJB2;GABARAP;HSPBP1;USP5;VCP;AXIN1;GSK3B;TAF1;CSNK1E;ARIH1;CDK5RAP3;RNF144A;RBX1;DDA1;STUB1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.11855608594582885,0.37676371943642833,1.0,1.0,1.0,29/76,39.75%,IRAK1;NFKB2;POLR2L;MAVS;PQBP1;IRF3;ISG15;RNF135;IRF5;PRKDC;POLR2K;DDX41;CTNNB1;POLR3K;GAPDH;POLR2H;POLR3H;POLR3A;POLR3C;FLOT1;G3BP1;POLR3G;POLR3GL;HSPD1;DHX9;TRIM56;HSP90AA1;XRCC6;POLR3E
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.15817215576917912,0.3760302437801545,1.0,1.0,1.0,5/15,40.55%,SCRIB;F11R;TJP1;TJP2;CDH5
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.1278699291751752,0.3740830501334903,1.0,1.0,1.0,2/48,8.07%,DNASE1L2;PRKN
prerank,Elsevier_Pathway_Collection__MAVS in Antiviral Innate Immune Response in Myocarditis,0.15214542420546345,0.371564247356016,1.0,1.0,1.0,3/20,19.13%,IKBKG;MAVS;IRF3
prerank,Elsevier_Pathway_Collection__Ethanol Induced Hepatotoxicity,0.1553054753071025,0.3709329841363048,1.0,1.0,1.0,7/17,37.71%,COL1A1;ACVRL1;COL11A2;COL3A1;TGFB1;SMAD5;TGFBR2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.1379549126721548,0.370646234958713,1.0,1.0,1.0,31/31,86.22%,VPS28;VPS37D;HGS;VPS4A;SNF8;CHMP2A;MVB12A;VPS25;CHMP4C;TSG101;IST1;VPS37C;CHMP4B;STAM2;STAM;CHMP1B;CHMP6;RAB11A;CHMP1A;CHMP5;VPS36;PDCD6IP;CHMP3;VPS37A;CHMP7;VPS4B;CHMP4A;RAB27A;CHMP2B;VTA1;VPS37B
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.10302071005994948,-0.36735507898038566,1.0,1.0,1.0,17/57,29.53%,PRSS16;NCCRP1;PMAIP1;CLN8;SOCS6;UCHL3;FBXO17;SIAH1;FBXO27;SIAH2;RAB12;RNF5;UBE2G1;CLPX;CLN5;CEACAM1;DENND3
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.14676815448923985,0.3659951188435149,1.0,1.0,1.0,1/18,6.66%,SRC
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.14078935392599004,0.36531556820607175,1.0,1.0,1.0,1/26,4.59%,PRR5L
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.1581076145587687,0.3629904106085151,1.0,1.0,1.0,1/15,7.91%,AGO2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.12160194263521008,-0.36274289067377224,1.0,0.9999308428821825,1.0,4/22,19.82%,ZEB2;CITED2;THBS1;SLC2A10
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.12160194263521008,-0.36274289067377224,1.0,0.9999308428821825,1.0,4/22,19.82%,ZEB2;CITED2;THBS1;SLC2A10
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.13919832747426084,0.3608769771239517,1.0,1.0,1.0,1/26,4.25%,FOXO6
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.12909513800878264,0.3576944669543511,1.0,1.0,1.0,15/32,42.89%,NOTCH3;KAT2A;PRKCA;LFNG;HEYL;ARRB1;CUL1;SKP1;DTX2;PSEN2;APH1A;SAP30;FBXW11;PPARD;RBX1
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,0.13036899165126362,0.3565125937682086,1.0,1.0,1.0,3/34,16.51%,MTR;DBN1;ROCK2
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.13888175570739078,0.3315057969236742,1.0,1.0,1.0,1/17,9.53%,MMP12
prerank,KEGG_2021_Human__Autophagy,0.10171319934975774,0.3312541932243231,1.0,1.0,1.0,31/132,37.49%,PIK3R2;PRKAA2;PRAP1;DAPK2;SQSTM1;PDPK1;HRAS;MRAS;MTMR3;CTSD;TSC1;TSC2;ATG10;SMCR8;MAP2K2;RB1CC1;RHEB;ULK1;RRAS;DAPK3;PIK3R3;IRS1;MLST8;GABARAP;RRAGD;DDIT4;RPTOR;AKT1S1;MAPK9;RRAGA;MAPK3
prerank,Elsevier_Pathway_Collection__CagA Phosphorylation Independent Signaling,0.11868270640248196,0.32705531002591426,1.0,1.0,1.0,2/38,10.06%,SRC;IKBKG
prerank,Elsevier_Pathway_Collection__Suppression of Caspase Activity in Cancer,0.10971760832324548,0.31454195602684937,1.0,1.0,1.0,10/45,32.22%,BIRC5;LMNA;PARP1;AIFM1;GSN;CTNNB1;LMNB1;DIABLO;SPTAN1;CASP9
prerank,Elsevier_Pathway_Collection__Focal Junction Assembly,0.10867474514329684,0.30267817181674256,1.0,0.9999930262865412,1.0,30/30,89.15%,SRC;PTK2;ITGAV;ITGB1BP1;FBLIM1;PIP5K1C;PXN;VCL;TLN1;LIMS1;ZYX;ACTN1;BCAR1;ITGB1;LASP1;FN1;CAPN1;PTPN12;DOCK1;VASP;DAB2;PARVA;ILK;TNS1;ITGA5;ELMO1;DLC1;VTN;ITGB3;FERMT2
